PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Azuma, K; Komatsu, N; Hattori, S; Matsueda, S; Kawahara, A; Sasada, T; Itoh, K; Hoshino, T				Azuma, Koichi; Komatsu, Nobukazu; Hattori, Satoshi; Matsueda, Satoko; Kawahara, Akihiko; Sasada, Tetsuro; Itoh, Kyogo; Hoshino, Tomoaki			Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; MELANOMA PATIENTS; CRYSTAL-STRUCTURE; KINASE DOMAIN; POLYMORPHISMS; ACTIVATION; MUTATIONS; BINDING; IMPACT	Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with clinical response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib, in patients with non-small cell lung cancer (NSCLC). However, humoral immune responses to EGFR in NSCLC patients have not been well studied. In this study, we investigated the clinical significance of immunoglobulin G (IgG) responses to EGFR-derived peptides in NSCLC patients receiving gefitinib. Plasma IgG titers to each of 60 different EGFR-derived 20-mer peptides were measured by the Luminex system in 42 NSCLC patients receiving gefitinib therapy. The relationships between the peptide-specific IgG titers and presence of EGFR mutations or patient survival were evaluated statistically. IgG titers against the egfr_481-500, egfr_721-740, and egfr_741-760 peptides were significantly higher in patients with exon 21 mutation than in those without it. On the other hand, IgG titers against the egfr_841-860 and egfr_1001-1020 peptides were significantly lower and higher, respectively, in patients with deletion in exon 19. Multivariate Cox regression analysis showed that IgG responses to egfr_41_60, egfr_61_80 and egfr_481_500 were significantly prognostic for progression-free survival independent of other clinicopathological characteristics, whereas those to the egfr_41_60 and egfr_481_500 peptides were significantly prognostic for overall survival. Detection of IgG responses to EGFR-derived peptides may be a promising method for prognostication of NSCLC patients receiving gefitinib. Our results may provide new insight for better understanding of humoral responses to EGFR in NSCLC patients.	[Azuma, Koichi; Hoshino, Tomoaki] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan; [Komatsu, Nobukazu; Matsueda, Satoko; Sasada, Tetsuro; Itoh, Kyogo] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 830, Japan; [Hattori, Satoshi] Kurume Univ, Ctr Biostat, Kurume, Fukuoka 830, Japan; [Kawahara, Akihiko] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University; Kurume University	Azuma, K (corresponding author), Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka 830, Japan.	azuma@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI [19790571]; Grants-in-Aid for Scientific Research [23591913] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: Grant-in-Aid for Young Scientists (B), JSPS KAKENHI Grant number 19790571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedognetti D, 2010, EXPERT REV VACCINES, V9, P555, DOI [10.1586/erv.10.55, 10.1586/ERV.10.55]; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Breunis WB, 2008, J IMMUNOTHER, V31, P586, DOI 10.1097/CJI.0b013e31817fd8f3; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Everitt BS, 2005, R S PLUS COM MULT AN; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Harada M, 2003, PROSTATE, V57, P152, DOI 10.1002/pros.10280; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Komatsu N, 2004, SCAND J CLIN LAB INV, V64, P535, DOI 10.1080/00365510410007008; Leibovici D, 2005, J CLIN ONCOL, V23, P5746, DOI 10.1200/JCO.2005.01.598; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liu DX, 2005, CLIN CANCER RES, V11, P1237; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Matsueda S, 2013, DEV COMP IMMUNOL, V41, P68, DOI 10.1016/j.dci.2013.04.004; Mine T, 2004, CLIN CANCER RES, V10, P929, DOI 10.1158/1078-0432.CCR-1117-3; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Sabatino M, 2009, J CLIN ONCOL, V27, P2645, DOI 10.1200/JCO.2008.19.1106; Sasada T, 2010, EUR J CANCER, V46, P1514, DOI 10.1016/j.ejca.2010.03.013; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Ugurel S, 2008, CANCER IMMUNOL IMMUN, V57, P685, DOI 10.1007/s00262-007-0407-z; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86667	10.1371/journal.pone.0086667	http://dx.doi.org/10.1371/journal.pone.0086667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497964	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900032
J	Mourabit, S; Moles, MW; Smith, E; van Aerle, R; Kudoh, T				Mourabit, Sulayman; Moles, Michael W.; Smith, Emma; van Aerle, Ronny; Kudoh, Tetsuhiro			Bmp Suppression in Mangrove Killifish Embryos Causes a Split in the Body Axis	PLOS ONE			English	Article							DORSOVENTRAL PATTERN-FORMATION; ZEBRAFISH; GRADIENT; POPULATION; GENETICS; ECTODERM; GENES; CELLS; FIN	Bone morphogenetic proteins (Bmp) are major players in the formation of the vertebrate body plan due to their crucial role in patterning of the dorsal-ventral (DV) axis. Despite the highly conserved nature of Bmp signalling in vertebrates, the consequences of changing this pathway can be species-specific. Here, we report that Bmp plays an important role in epiboly, yolk syncytial layer (YSL) movements, and anterior-posterior (AP) axis formation in embryos of the self-fertilizing mangrove killifish, Kryptolebias marmoratus. Stage and dose specific exposures of embryos to the Bmp inhibitor dorsomorphin (DM) produced three distinctive morphologies, with the most extreme condition creating the splitbody phenotype, characterised by an extremely short AP axis where the neural tube, somites, and notochord were bilaterally split. In addition, parts of caudal neural tissues were separated from the main body and formed cell islands in the posterior region of the embryo. This splitbody phenotype, which has not been reported in other animals, shows that modification of Bmp may lead to significantly different consequences during development in other vertebrate species.	[Mourabit, Sulayman; Moles, Michael W.; Smith, Emma; van Aerle, Ronny; Kudoh, Tetsuhiro] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Kudoh, T (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	t.kudoh@exeter.ac.uk		van Aerle, Ronny/0000-0002-2605-6518	Natural and Environmental Research Council (NERC) in the UK	Natural and Environmental Research Council (NERC) in the UK	SM was funded by a PhD studentship from the Natural and Environmental Research Council (NERC) in the UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2001, DEV GROWTH DIFFER, V43, P591; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; BETCHAKU T, 1978, J EXP ZOOL, V206, P381, DOI 10.1002/jez.1402060310; Connors SA, 1999, DEVELOPMENT, V126, P3119; Dick A, 2000, DEVELOPMENT, V127, P343; Hild M, 1999, DEVELOPMENT, V126, P2149; Kane DA, 1996, DEVELOPMENT, V123, P47; Kelley JL, 2012, INTEGR COMP BIOL, V52, P737, DOI 10.1093/icb/ics094; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kudoh T, 2004, DEVELOPMENT, V131, P3581, DOI 10.1242/dev.01227; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Moore GL, 2012, INTEGR COMP BIOL, V52, P781, DOI 10.1093/icb/ics052; Mourabit S, 2012, INTEGR COMP BIOL, V52, P761, DOI 10.1093/icb/ics076; Mourabit S, 2011, DEV DYNAM, V240, P1694, DOI 10.1002/dvdy.22668; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Neave B, 1997, MECH DEVELOP, V62, P183, DOI 10.1016/S0925-4773(97)00659-X; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmid B, 2000, DEVELOPMENT, V127, P957; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Tatarenkov A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012863; Tatarenkov A, 2009, P NATL ACAD SCI USA, V106, P14456, DOI 10.1073/pnas.0907852106; TRINKAUS JP, 1951, J EXP ZOOL, V118, P269, DOI 10.1002/jez.1401180204; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Turner BJ, 2006, EVOL ECOL RES, V8, P1475; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	31	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e84786	10.1371/journal.pone.0084786	http://dx.doi.org/10.1371/journal.pone.0084786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497921	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100005
J	Pamminger, T; Foitzik, S; Kaufmann, KC; Schutzler, N; Menzel, F				Pamminger, Tobias; Foitzik, Susanne; Kaufmann, Katharina C.; Schuetzler, Natalie; Menzel, Florian			Worker Personality and Its Association with Spatially Structured Division of Labor	PLOS ONE			English	Article							INSECT CUTICULAR HYDROCARBONS; SOCIAL INSECTS; PHYSICAL-PROPERTIES; ANTS; ORGANIZATION; AGGRESSION; BUMBLEBEES; EXPERIENCE; HORMONES; ROLES	Division of labor is a defining characteristic of social insects and fundamental to their ecological success. Many of the numerous tasks essential for the survival of the colony must be performed at a specific location. Consequently, spatial organization is an integral aspect of division of labor. The mechanisms organizing the spatial distribution of workers, separating inside and outside workers without central control, is an essential, but so far neglected aspect of division of labor. In this study, we investigate the behavioral mechanisms governing the spatial distribution of individual workers and its physiological underpinning in the ant Myrmica rubra. By investigating worker personalities we uncover position-associated behavioral syndromes. This context-independent and temporally stable set of correlated behaviors (positive association between movements and attraction towards light) could promote the basic separation between inside (brood tenders) and outside workers (foragers). These position-associated behavior syndromes are coupled with a high probability to perform tasks, located at the defined position, and a characteristic cuticular hydrocarbon profile. We discuss the potentially physiological causes for the observed behavioral syndromes and highlight how the study of animal personalities can provide new insights for the study of division of labor and self-organized processes in general.	[Pamminger, Tobias; Foitzik, Susanne; Kaufmann, Katharina C.; Schuetzler, Natalie; Menzel, Florian] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Pamminger, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Evolutionary Biol, Saarstr 21, Mainz, Germany.	pamminge@uni-mainz.de	Menzel, Florian/H-2436-2017; Foitzik, Susanne/A-6504-2019	Menzel, Florian/0000-0002-9673-3668; Foitzik, Susanne/0000-0001-8161-6306; Pamminger, Tobias/0000-0003-1257-3829	DFG [Fo 298/11]	DFG(German Research Foundation (DFG))	This research was funded by the DFG grant Fo 298/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchinson J., 1986, STAT ANAL COMPOSITIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1971, INSECT SOC; BEATTY DD, 1969, VISION RES, V9, P855, DOI 10.1016/0042-6989(69)90093-5; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Carlson DA, 1998, J CHEM ECOL, V24, P1845, DOI 10.1023/A:1022311701355; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chapman BB, 2011, ANIM BEHAV, V82, P391, DOI 10.1016/j.anbehav.2011.05.019; Dolezal AG, 2012, J EXP BIOL, V215, P454, DOI 10.1242/jeb.060822; Ehrhardt S., 1931, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V20, P755, DOI 10.1007/BF00407687; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs A, 1995, COMP BIOCHEM PHYS B, V112, P667, DOI 10.1016/0305-0491(95)00119-0; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2003, P NATL ACAD SCI USA, V100, P9394, DOI 10.1073/pnas.1633701100; Jandt JM, 2013, BIOL REV, DOI [101111/brv12042, DOI 10.1111/BRV.12042.ACCESSED:2013]; Johnson BR, 2008, NATURWISSENSCHAFTEN, V95, P523, DOI 10.1007/s00114-008-0354-3; Johnson BR, 2010, BEHAV ECOL, V21, P1373, DOI 10.1093/beheco/arq138; Johnson BR, 2009, AM NAT, V174, P537, DOI 10.1086/605373; Kapustjanskij A, 2007, FUNCT ECOL, V21, P1130, DOI 10.1111/j.1365-2435.2007.01329.x; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Lengyel F, 2007, J CHEM ECOL, V33, P167, DOI 10.1007/s10886-006-9185-x; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Modlmeier AP, 2011, BEHAV ECOL, V22, P1026, DOI 10.1093/beheco/arr086; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Development Core Team, 2008, R LANG ENV STAT COMP; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Richardson TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018416; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Seppa P, 1996, BEHAV ECOL SOCIOBIOL, V38, P207, DOI 10.1007/s002650050234; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith A, 1863, INQUIRY NATURE CAUSE; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Tripet F, 2004, ETHOLOGY, V110, P863, DOI 10.1111/j.1439-0310.2004.01023.x; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391	40	48	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e79616	10.1371/journal.pone.0079616	http://dx.doi.org/10.1371/journal.pone.0079616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497911	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100001
J	Pelletier, D; Clark, M; Anderson, MG; Rayfield, B; Wulder, MA; Cardille, JA				Pelletier, David; Clark, Melissa; Anderson, Mark G.; Rayfield, Bronwyn; Wulder, Michael A.; Cardille, Jeffrey A.			Applying Circuit Theory for Corridor Expansion and Management at Regional Scales: Tiling, Pinch Points, and Omnidirectional Connectivity	PLOS ONE			English	Article							GENE FLOW; LANDSCAPE CONNECTIVITY; HABITAT AVAILABILITY; GRAPH-THEORY; POPULATION; MODEL; RESISTANCE; ECOLOGY; GUIDE; LINKS	Connectivity models are useful tools that improve the ability of researchers and managers to plan land use for conservation and preservation. Most connectivity models function in a point-to-point or patch-to-patch fashion, limiting their use for assessing connectivity over very large areas. In large or highly fragmented systems, there may be so many habitat patches of interest that assessing connectivity among all possible combinations is prohibitive. To overcome these conceptual and practical limitations, we hypothesized that minor adaptation of the Circuitscape model can allow the creation of omnidirectional connectivity maps illustrating flow paths and variations in the ease of travel across a large study area. We tested this hypothesis in a 24,300 km(2) study area centered on the Monteregie region near Montreal, Quebec. We executed the circuit model in overlapping tiles covering the study region. Current was passed across the surface of each tile in orthogonal directions, and then the tiles were reassembled to create directional and omnidirectional maps of connectivity. The resulting mosaics provide a continuous view of connectivity in the entire study area at the full original resolution. We quantified differences between mosaics created using different tile and buffer sizes and developed a measure of the prominence of seams in mosaics formed with this approach. The mosaics clearly show variations in current flow driven by subtle aspects of landscape composition and configuration. Shown prominently in mosaics are pinch points, narrow corridors where organisms appear to be required to traverse when moving through the landscape. Using modest computational resources, these continuous, fine-scale maps of nearly unlimited size allow the identification of movement paths and barriers that affect connectivity. This effort develops a powerful new application of circuit models by pinpointing areas of importance for conservation, broadening the potential for addressing intriguing questions about resource use, animal distribution, and movement.	[Pelletier, David; Cardille, Jeffrey A.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Pelletier, David; Cardille, Jeffrey A.] McGill Univ, McGill Sch Environm, Ste Anne De Bellevue, PQ, Canada; [Clark, Melissa; Anderson, Mark G.] Nature Conservancy, Eastern Resource Off, Boston, MA USA; [Rayfield, Bronwyn] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Wulder, Michael A.] Nat Resources Canada, Pacific Forestry Ctr, Canadian Forest Serv, Victoria, BC, Canada	McGill University; McGill University; Nature Conservancy; McGill University; Natural Resources Canada; Canadian Forest Service	Cardille, JA (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.	jeffrey.cardille@mcgill.ca	Wulder, Michael A/J-5597-2016; Rayfield, Bronwyn/ABB-8306-2021	Wulder, Michael A/0000-0002-6942-1896; Rayfield, Bronwyn/0000-0003-1768-1300; Cardille, Jeffrey/0000-0002-4667-9085	Government of Canada, via the Canadian Forest Service of Natural Resources Canada; Canadian Space Agency; Natural Sciences and Engineering Research Council; Ouranos consortium on regional climatology and adaptation to climate change	Government of Canada, via the Canadian Forest Service of Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Canadian Space Agency(Canadian Space Agency); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ouranos consortium on regional climatology and adaptation to climate change	Aspects of this research were supported through the Government of Canada, via the Canadian Forest Service (http://cfs.nrcan.gc.ca/) of Natural Resources Canada (http://www.nrcan.gc.ca/) and the Canadian Space Agency (http://www.asc-csa.gc.ca/), a Discovery grant from the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/) and a grant from the Ouranos consortium on regional climatology and adaptation to climate change (http://www.ouranos.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M., 2012, RESILIENT SITES TERR; [Anonymous], 2008, BAS DONN TOP QUEB; BEIER P, 1992, WILDLIFE SOC B, V20, P434; Beier P, 2011, CONSERV BIOL, V25, P879, DOI 10.1111/j.1523-1739.2011.01716.x; Berger J, 2006, BIOL LETT-UK, V2, P528, DOI 10.1098/rsbl.2006.0508; Bissonette JA, 2007, TEMPORAL DIMENSIONS, P13; Bunnell FL, 1998, POLICY PRACTICES BIO; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Crooks K. R., 2006, CONNECTIVITY CONSERV; Cushman SA, 2012, DIVERS DISTRIB, V18, P873, DOI 10.1111/j.1472-4642.2012.00895.x; Cushman SA, 2010, LANDSCAPE ECOL, V25, P1613, DOI 10.1007/s10980-010-9534-6; Cushman SA, 2010, LANDSCAPE ECOL, V25, P967, DOI 10.1007/s10980-010-9467-0; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; Desrochers A, 2011, LANDSCAPE ECOL, V26, P47, DOI 10.1007/s10980-010-9532-8; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Epps CW, 2011, DIVERS DISTRIB, V17, P603, DOI 10.1111/j.1472-4642.2011.00773.x; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fortin MJ, 2012, SPAT STAT-NETH, V1, P100, DOI 10.1016/j.spasta.2012.02.004; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Howey MCL, 2011, J ARCHAEOL SCI, V38, P2523, DOI 10.1016/j.jas.2011.03.024; Johst K, 2002, OIKOS, V98, P263, DOI 10.1034/j.1600-0706.2002.980208.x; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Koen EL, 2012, MOL ECOL RESOUR, V12, P686, DOI 10.1111/j.1755-0998.2012.03123.x; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; McEachern MB, 2011, CONSERV GENET, V12, P285, DOI 10.1007/s10592-010-0139-z; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Ministere des Ressources naturelles et de la Faune du Quebec, 2012, SYST INF EC; Moilanen A, 2011, J APPL ECOL, V48, P1543, DOI 10.1111/j.1365-2664.2011.02062.x; Moore JA, 2011, MOL ECOL, V20, P4858, DOI 10.1111/j.1365-294X.2011.05313.x; Pascual-Hortal L, 2008, EUR J FOREST RES, V127, P23, DOI 10.1007/s10342-006-0165-z; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Rudnick D.A., 2012, ISSUES ECOL, V16, P1; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Scoble J, 2010, DIVERS DISTRIB, V16, P343, DOI 10.1111/j.1472-4642.2010.00658.x; Shah V. B., 2008, CIRCUITSCAPE TOOL LA, P62; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Soule M. E., 2004, Pacific Conservation Biology, V10, P266; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Walpole AA, 2012, LANDSCAPE ECOL, V27, P761, DOI 10.1007/s10980-012-9728-1; Wulder MA, 2008, CAN J REMOTE SENS, V34, P563, DOI 10.5589/m08-081; Zeigler SL, 2011, BIODIVERS CONSERV, V20, P2779, DOI 10.1007/s10531-011-0107-z; Zetterberg A, 2010, LANDSCAPE URBAN PLAN, V95, P181, DOI 10.1016/j.landurbplan.2010.01.002	60	79	80	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e84135	10.1371/journal.pone.0084135	http://dx.doi.org/10.1371/journal.pone.0084135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497918	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100004
J	Rolin, O; Smallridge, W; Henry, M; Goodfield, L; Place, D; Harvill, ET				Rolin, Olivier; Smallridge, Will; Henry, Michael; Goodfield, Laura; Place, David; Harvill, Eric T.			Toll-Like Receptor 4 Limits Transmission of Bordetella bronchiseptica	PLOS ONE			English	Article							INNATE HOST-DEFENSE; III SECRETION SYSTEM; T-CELLS; QUANTITATIVE HISTOCHEMISTRY; EPITHELIAL MUCOSUBSTANCES; UNIVERSITY-STUDENTS; IMMUNE-RESPONSES; INFECTION; PERTUSSIS; MICE	Transmission of pathogens has been notoriously difficult to study under laboratory conditions leaving knowledge gaps regarding how bacterial factors and host immune components affect the spread of infections between hosts. We describe the development of a mouse model of transmission of a natural pathogen, Bordetella bronchiseptica, and its use to assess the impact of host immune functions. Although B. bronchiseptica transmits poorly between wild-type mice and mice lacking other immune components, it transmits efficiently between mice deficient in Toll-Like Receptor 4 (TLR4). TLR4-mutant mice were more susceptible to initial colonization, and poorly controlled pathogen growth and shedding. Heavy neutrophil infiltration distinguished TLR4-deficient responses, and neutrophil depletion did not affect respiratory CFU load, but decreased bacterial shedding. The effect of TLR4 response on transmission may explain the extensive variation in TLR4 agonist potency observed among closely related subspecies of Bordetella. This transmission model will enable mechanistic studies of how pathogens spread from one host to another, the defining feature of infectious disease.	[Rolin, Olivier; Smallridge, Will; Henry, Michael; Goodfield, Laura; Place, David; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Rolin, Olivier; Smallridge, Will; Goodfield, Laura; Place, David] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	harvill@psu.edu	Place, David/ABD-6703-2021	Place, David/0000-0002-1904-4164; Harvill, Eric/0000-0001-8893-2133; Henry, Michael/0000-0002-0608-9339	National Institutes of Health [GM083113]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113681, R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM083113 (to E. T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An CL, 2003, INFECT IMMUN, V71, P2065, DOI 10.1128/IAI.71.4.2065-2070.2003; Andrews R, 1997, Commun Dis Intell, V21, P145; Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004; Bemis DA, 2003, COMPARATIVE MED, V53, P11; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Bloemendaal ALA, 2011, J MED MICROBIOL, V60, P812, DOI 10.1099/jmm.0.027532-0; Brockmeier SL, 2002, VET MICROBIOL, V89, P267, DOI 10.1016/S0378-1135(02)00204-3; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; CZUPRYNSKI CJ, 1994, INFECT IMMUN, V62, P5161, DOI 10.1128/IAI.62.11.5161-5163.1994; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Gorska M. M., 2004, Journal of Allergy and Clinical Immunology, V113, pS182, DOI 10.1016/j.jaci.2004.01.094; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; HARKEMA JR, 1988, AM J PATHOL, V130, P605; HARKEMA JR, 1991, EXP LUNG RES, V17, P743, DOI 10.3109/01902149109062876; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hellriegel B, 2001, TRENDS PARASITOL, V17, P102, DOI 10.1016/S1471-4922(00)01767-0; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jackson LA, 2000, CLIN INFECT DIS, V31, P3, DOI 10.1086/313911; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mann PB, 2004, INFECT IMMUN, V72, P6650, DOI 10.1128/IAI.72.11.6650-6658.2004; Mann PB, 2004, J INFECT DIS, V189, P833, DOI 10.1086/381898; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Nicholson TL, 2012, INFECT IMMUN, V80, P1025, DOI 10.1128/IAI.06016-11; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Pathak AK, 2010, BMC MICROBIOL, V10, DOI [10.1186/1471-2180-10-226, 10.1186/1471-2431-10-100]; Pilione MR, 2006, INFECT IMMUN, V74, P1043, DOI 10.1128/IAI.74.2.1043-1049.2006; Polyzou A, 2004, J CLIN LAB ANAL, V18, P211, DOI 10.1002/jcla.20025; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Strutt TM, 2011, ADV EXP MED BIOL, V780, P57, DOI 10.1007/978-1-4419-5632-3_6; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Thakar J, 2009, J R SOC INTERFACE, V6, P599, DOI 10.1098/rsif.2008.0363; Wagner JG, 2001, TOXICOL SCI, V60, P338, DOI 10.1093/toxsci/60.2.338; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x; Zhang XQ, 2011, INFECT IMMUN, V79, P527, DOI 10.1128/IAI.00590-10; Zola TA, 2008, J IMMUNOL, V181, P7909, DOI 10.4049/jimmunol.181.11.7909	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85229	10.1371/journal.pone.0085229	http://dx.doi.org/10.1371/journal.pone.0085229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497924	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100007
J	Tipirisetti, NR; Govatati, S; Pullari, P; Malempati, S; Thupurani, MK; Perugu, S; Guruvaiah, P; Rao, KL; Digumarti, RR; Nallanchakravarthula, V; Bhanoori, M; Satti, V				Tipirisetti, Nageswara Rao; Govatati, Suresh; Pullari, Priyanka; Malempati, Sravanthi; Thupurani, Murali Krishna; Perugu, Shyam; Guruvaiah, Praveen; Rao, Lakshmi K.; Digumarti, Raghunadha Rao; Nallanchakravarthula, Varadacharyulu; Bhanoori, Manjula; Satti, Vishnupriya			Mitochondrial Control Region Alterations and Breast Cancer Risk: A Study in South Indian Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; D-LOOP; DNA; WOMEN; ENDOMETRIOSIS; ASSOCIATION; SEQUENCE; REPLICATION; CELLS; TRANSCRIPTION	Background: Mitochondrial displacement loop (D-loop) is the hot spot for mitochondrial DNA (mtDNA) alterations which influence the generation of cellular reactive oxygen species (ROS). Association of D-loop alterations with breast cancer has been reported in few ethnic groups; however none of the reports were documented from Indian subcontinent. Methodology: We screened the entire mitochondrial D-loop region (1124 bp) of breast cancer patients (n = 213) and controls (n = 207) of south Indian origin by PCR-sequencing analysis. Haplotype frequencies for significant loci, the standardized disequilibrium coefficient (D') for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software. Principal Findings: We identified 7 novel mutations and 170 reported polymorphisms in the D-loop region of patients and/or controls. Polymorphisms were predominantly located in hypervariable region I (60%) than in II (30%) of D-loop region. The frequencies of 310'C' insertion (P = 0.018), T16189C (P = 0.0019) variants and 310'C'ins/16189C (P = 0.00019) haplotype were significantly higher in cases than in controls. Furthermore, strong LD was observed between nucleotide position 310 and 16189 in controls (D' = 0.49) as compared to patients (D' = 0.14). Conclusions: Mitochondrial D-loop alterations may constitute inherent risk factors for breast cancer development. The analysis of genetic alterations in the D-loop region might help to identify patients at high risk for bad progression, thereby helping to refine therapeutic decisions in breast cancer.	[Tipirisetti, Nageswara Rao; Satti, Vishnupriya] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India; [Govatati, Suresh; Perugu, Shyam; Guruvaiah, Praveen; Bhanoori, Manjula] Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India; [Pullari, Priyanka] Periyar Univ, Dept Biotechnol, Salem, Tamil Nadu, India; [Malempati, Sravanthi] Krishna Univ, DrMRAR PG Ctr, Dept Biochem, Nuzvid, India; [Thupurani, Murali Krishna] Chaitanya Postgrad Coll, Dept Biotechnol, Hanamkonda, India; [Rao, Lakshmi K.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Digumarti, Raghunadha Rao] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Nallanchakravarthula, Varadacharyulu] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Osmania University; Osmania University; Periyar University; Krishna University Machilipatnam; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences; Sri Krishnadevaraya University	Satti, V (corresponding author), Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India.	sattivishnupriya@gmail.com	Digumarti, Raghunadharao/H-4075-2019; govatati, suresh/M-9418-2019; Bhanoori, Manjula/ACH-9333-2022	Digumarti, Raghunadharao/0000-0003-2876-3475; govatati, suresh/0000-0001-8587-4388; 	Council of Scientific and Industrial Research (CSIR), India; DBT-ISLARE (OU)	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DBT-ISLARE (OU)	We would like to thank Council of Scientific and Industrial Research (CSIR), India and DBT-ISLARE (OU) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhomidi MA, 2013, TUMOR BIOL, V34, P2427, DOI 10.1007/s13277-013-0793-0; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Chopra R, 2001, J CLIN ONCOL, V19, p106S; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Govatati S, 2013, MITOCHONDRION, V13, P782, DOI 10.1016/j.mito.2013.05.003; Govatati S, 2013, FERTIL STERIL, V99, P1980, DOI 10.1016/j.fertnstert.2013.02.021; Govatati S, 2012, GENET TEST MOL BIOMA, V16, P865, DOI 10.1089/gtmb.2011.0295; Govatati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040668; Govatati S, 2012, MOL HUM REPROD, V18, P280, DOI 10.1093/molehr/gar079; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Loueslati BY, 2010, GENET MOL RES, V9, P1690, DOI 10.4238/vol9-3gmr778; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Michikawa Y, 1992, SCIENCE, V86, P774; Mueller EE, 2011, PLOS ONE, V6; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Surekha D, 2011, ASIAN PAC J CANCER P, V12, P1893; Surekha D, 2009, J GENET, V88, P261, DOI 10.1007/s12041-009-0038-6; Tas F, 2005, MED ONCOL, V22, P11, DOI 10.1385/MO:22:1:011; Tipirisetti NR, 2013, MITOCHONDRION, V13, P372, DOI 10.1016/j.mito.2013.04.010; Tipirisetti NR, 2013, GENET TEST MOL BIOMA, V17, P494, DOI 10.1089/gtmb.2012.0485; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang CJ, 2011, BIOCHEM BIOPH RES CO, V406, P493, DOI 10.1016/j.bbrc.2011.02.088; Wang Y, 2005, ANN NY ACAD SCI, V1042, P123, DOI 10.1196/annals.1338.012; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yager JD, 1996, ANNU REV PHARMACOL, V36, P203, DOI 10.1146/annurev.pa.36.040196.001223; Ye CZ, 2008, CANCER EPIDEM BIOMAR, V17, P2117, DOI 10.1158/1055-9965.EPI-07-2798; Ye CZ, 2010, BREAST CANCER RES TR, V119, P431, DOI 10.1007/s10549-009-0397-y; Young CD, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2417	44	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85363	10.1371/journal.pone.0085363	http://dx.doi.org/10.1371/journal.pone.0085363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497926	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100009
J	Isakova, IA; Lanclos, C; Bruhn, J; Kuroda, MJ; Baker, KC; Krishnappa, V; Phinney, DG				Isakova, Iryna A.; Lanclos, Calvin; Bruhn, Julie; Kuroda, Marcelo J.; Baker, Kate C.; Krishnappa, Veena; Phinney, Donald G.			Allo-Reactivity of Mesenchymal Stem Cells in Rhesus Macaques Is Dose and Haplotype Dependent and Limits Durable Cell Engraftment In Vivo	PLOS ONE			English	Article							MARROW STROMAL CELLS; NATURAL-KILLER-CELLS; VERSUS-HOST-DISEASE; IMMUNE-RESPONSE; DENDRITIC CELL; PERIPHERAL-BLOOD; LYMPHOCYTE; NEUTROPHIL; INHIBIT; TRANSPLANTATION	The emerging paradigm that MSCs are immune privileged has fostered the use of "off-the-shelf" allogeneic MSC-based therapies in human clinical trials. However, this approach ignores studies in experimental animals wherein transplantation of MSCs across MHC boundaries elicits measurable allo-immune responses. To determine if MSCs are hypo-immunogeneic, we characterized the immune response in rhesus macaques following intracranial administration of allogeneic vs. autologous MSCs. This analysis revealed unambiguous evidence of productive allo-recognition based on expansion of NK, B and T cell subsets in peripheral blood and detection of allo-specific antibodies in animals administered allogeneic but not autologous MSCs. Moreover, the degree of MHC class I and II mismatch between the MSC donor and recipient significantly influenced the magnitude and nature of the allo-immune response. Consistent with these findings, real-time PCR analysis of brain tissue from female recipients administered varying doses of male, allogeneic MSCs revealed a significant inverse correlation between MSC engraftment levels and cell dose. Changes in post-transplant neutrophil and lymphocyte counts also correlated with dose and were predictive of overall MSC engraftment levels. However, secondary antigen challenge failed to elicit a measurable immune response in allogeneic recipients. Finally, extensive behavior testing of animals revealed no main effect of cell dose on motor skills, social development, or temperament. Collectively, these data indicate that allogeneic MSCs are weakly immunogenic when transplanted across MHC boundaries in rhesus macaques and this negatively impacts durable engraftment levels. Therefore the use of unrelated donor MSCs should be carefully evaluated in human patients.	[Isakova, Iryna A.] Tulane Univ, Hlth Sci Ctr, Ctr Bioenvironm Res, New Orleans, LA 70118 USA; [Lanclos, Calvin; Bruhn, Julie; Kuroda, Marcelo J.] Tulane Natl Primate Res Ctr, Dept Immunol, Covington, LA USA; [Baker, Kate C.] Tulane Natl Primate Res Ctr, Dept Vet Med, Covington, LA USA; [Krishnappa, Veena] Scripps Res Inst, Kellogg Sch Sci & Technol, Jupiter, FL USA; [Krishnappa, Veena; Phinney, Donald G.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Tulane University; Tulane University; Tulane University; Scripps Research Institute; Scripps Research Institute	Phinney, DG (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	dphinney@scripps.edu	Phinney, Donald G/D-2155-2014	Phinney, Donald/0000-0002-8688-2619	National Institute of Health [R01-NS39033- 01A2]; New England National Primate Research Center [P51RR00168-43]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039033, R01NS052301] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institute of Health to DGP (R01-NS39033- 01A2) and the New England National Primate Research Center (P51RR00168-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Becher B, 2000, GLIA, V29, P293; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Boyiadzis M, 2008, BIOL BLOOD MARROW TR, V14, P290, DOI 10.1016/j.bbmt.2007.12.490; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Brazelton TB., 1973, NEONATAL BEHAV ASSES, V1st; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Carbone E, 1997, J EXP MED, V185, P2053, DOI 10.1084/jem.185.12.2053; Chiesa S, 2011, P NATL ACAD SCI USA, V108, P17384, DOI 10.1073/pnas.1103650108; El-Sawy T, 2005, CIRCULATION, V112, P320, DOI 10.1161/CIRCULATIONAHA.104.516708; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Engelhardt B, 2008, CURR PHARM DESIGN, V14, P1555, DOI 10.2174/138161208784705432; Gabriel C, 2009, HUM IMMUNOL, V70, P960, DOI 10.1016/j.humimm.2009.08.009; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Giuliani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019988; Grabie N, 2003, AM J PATHOL, V163, P2413, DOI 10.1016/S0002-9440(10)63596-1; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Hirayama S, 2006, MOL MED, V12, P208, DOI 10.2119/2006-00036.Hirayama; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Ibata M, 2011, MICROBIOL IMMUNOL, V55, P726, DOI 10.1111/j.1348-0421.2011.00369.x; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Isakova IA, 2010, EXP HEMATOL, V38, P957, DOI 10.1016/j.exphem.2010.06.011; Isakova LA, 2006, MOL THER, V13, P1173, DOI 10.1016/j.ymthe.2005.12.014; Kirsner RS, 2012, LANCET, V380, P977, DOI 10.1016/S0140-6736(12)60644-8; Kreisel D, 2011, BLOOD, V118, P6172, DOI 10.1182/blood-2011-04-347823; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Liang J, 2012, CLIN RHEUMATOL, V31, P157, DOI 10.1007/s10067-011-1816-0; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; NOLAN CR, 1995, AM J KIDNEY DIS, V26, P634, DOI 10.1016/0272-6386(95)90601-0; Otting N, 2005, P NATL ACAD SCI USA, V102, P1626, DOI 10.1073/pnas.0409084102; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Renner P, 2009, TRANSPL P, V41, P2607, DOI 10.1016/j.transproceed.2009.06.119; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Seifert M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00202; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Steinbrink K, 2009, HUM IMMUNOL, V70, P289, DOI 10.1016/j.humimm.2009.02.003; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459; von Bahr L, 2012, BIOL BLOOD MARROW TR, V18, P557, DOI 10.1016/j.bbmt.2011.07.023; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; ZEHR KJ, 1993, J HEART LUNG TRANSPL, V12, P837	54	73	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87238	10.1371/journal.pone.0087238	http://dx.doi.org/10.1371/journal.pone.0087238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489878	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000123
J	Kembel, SW; Meadow, JF; O'Connor, TK; Mhuireach, G; Northcutt, D; Kline, J; Moriyama, M; Brown, GZ; Bohannan, BJM; Green, JL				Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.; Bohannan, Brendan J. M.; Green, Jessica L.			Architectural Design Drives the Biogeography of Indoor Bacterial Communities	PLOS ONE			English	Article							RELATIVE-HUMIDITY; HEALTH; MICROBIOTA; DIVERSITY; EXPOSURE; MICROORGANISMS; PATTERN; ALLERGY; FUNGI; AIR	Background: Architectural design has the potential to influence the microbiology of the built environment, with implications for human health and well-being, but the impact of design on the microbial biogeography of buildings remains poorly understood. In this study we combined microbiological data with information on the function, form, and organization of spaces from a classroom and office building to understand how design choices influence the biogeography of the built environment microbiome. Results: Sequencing of the bacterial 16S gene from dust samples revealed that indoor bacterial communities were extremely diverse, containing more than 32,750 OTUs (operational taxonomic units, 97% sequence similarity cutoff), but most communities were dominated by Proteobacteria, Firmicutes, and Deinococci. Architectural design characteristics related to space type, building arrangement, human use and movement, and ventilation source had a large influence on the structure of bacterial communities. Restrooms contained bacterial communities that were highly distinct from all other rooms, and spaces with high human occupant diversity and a high degree of connectedness to other spaces via ventilation or human movement contained a distinct set of bacterial taxa when compared to spaces with low occupant diversity and low connectedness. Within offices, the source of ventilation air had the greatest effect on bacterial community structure. Conclusions: Our study indicates that humans have a guiding impact on the microbial biodiversity in buildings, both indirectly through the effects of architectural design on microbial community structure, and more directly through the effects of human occupancy and use patterns on the microbes found in different spaces and space types. The impact of design decisions in structuring the indoor microbiome offers the possibility to use ecological knowledge to shape our buildings in a way that will select for an indoor microbiome that promotes our health and well-being.	[Kembel, Steven W.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.; Bohannan, Brendan J. M.; Green, Jessica L.] Univ Oregon, Biol & Built Environm Ctr, Eugene, OR 97403 USA; [Kembel, Steven W.; Meadow, James F.; O'Connor, Timothy K.; Bohannan, Brendan J. M.; Green, Jessica L.] Univ Oregon, Inst Ecol & Evolut, Eugene, OR 97403 USA; [O'Connor, Timothy K.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Mhuireach, Gwynne; Northcutt, Dale; Kline, Jeff; Moriyama, Maxwell; Brown, G. Z.] Univ Oregon, Energy Studies Bldg Lab, Eugene, OR 97403 USA; [Brown, G. Z.] Univ Oregon, Dept Architecture, Eugene, OR 97403 USA; [Green, Jessica L.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Quebec; University of Quebec Montreal; University of Oregon; University of Oregon; University of Arizona; University of Oregon; University of Oregon; The Santa Fe Institute	Meadow, JF (corresponding author), Univ Oregon, Biol & Built Environm Ctr, Eugene, OR 97403 USA.	jfmeadow@gmail.com	Bohannan, Brendan J. M./R-1582-2017	Bohannan, Brendan J. M./0000-0003-2907-1016; Kembel, Steven/0000-0001-5224-0952; Meadow, James/0000-0002-5568-1283	Alfred P. Sloan Foundation Microbiology for the Built Environment Program	Alfred P. Sloan Foundation Microbiology for the Built Environment Program	This research was funded by a grant to the Biology and the Built Environment Center from the Alfred P. Sloan Foundation Microbiology for the Built Environment Program (http://www.sloan.org/major-program-areas/basic-research/microbiology-of-the-built-environment/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2000, OR U SYST PHYS FAC I; ARUNDEL AV, 1986, ENVIRON HEALTH PERSP, V65, P351, DOI 10.2307/3430203; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2012, ISME J, P1; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Corsi RL, 2012, INDOOR AIR, V22, P171, DOI 10.1111/j.1600-0668.2012.00782.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Frankel M, 2012, APPL ENVIRON MICROB, V78, P8289, DOI 10.1128/AEM.02069-12; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kembel S. W., 2012, ISME J, V2012, P1; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Lee T, 2006, INDOOR AIR, V16, P37, DOI 10.1111/j.1600-0668.2005.00396.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Low SY, 2011, FUNGAL BIOL-UK, V115, P625, DOI 10.1016/j.funbio.2011.03.006; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Meadow JF, 2013, PEERJ, V1, DOI 10.7717/peerj.53; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rintala H, 2012, ADV APPL MICROBIOL, V78, P75, DOI 10.1016/B978-0-12-394805-2.00004-X; Roberts DW., 2012, LABDSV ORDINATION MU; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shendell DG, 2012, J ASTHMA, V49, P502, DOI 10.3109/02770903.2012.682633; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sternberg E.M., 2009, HEALING SPACES; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Ulrich RS, 2008, HERD-HEALTH ENV RES, V1, P61, DOI 10.1177/193758670800100306; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373	51	137	139	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87093	10.1371/journal.pone.0087093	http://dx.doi.org/10.1371/journal.pone.0087093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489843	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000100
J	Luevano, M; Domogala, A; Blundell, M; Jackson, N; Pedroza-Pacheco, I; Derniame, S; Escobedo-Cousin, M; Querol, S; Thrasher, A; Madrigal, A; Saudemont, A				Luevano, Martha; Domogala, Anna; Blundell, Michael; Jackson, Nicola; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Querol, Sergio; Thrasher, Adrian; Madrigal, Alejandro; Saudemont, Aurore			Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Functional Natural Killer Cells In Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells	PLOS ONE			English	Article							NK-CELLS; PROGENITOR CELLS; ANTITUMOR-ACTIVITY; CULTURE-SYSTEM; T-CELLS; GENERATION; EXPRESSION; MATURATION; EXPANSION; RECEPTOR	Adoptive natural killer (NK) cell therapy relies on the acquisition of large numbers of NK cells that are cytotoxic but not exhausted. NK cell differentiation from hematopoietic stem cells (HSC) has become an alluring option for NK cell therapy, with umbilical cord blood (UCB) and mobilized peripheral blood (PBCD34(+)) being the most accessible HSC sources as collection procedures are less invasive. In this study we compared the capacity of frozen or freshly isolated UCB hematopoietic stem cells (CBCD34(+)) and frozen PBCD34(+) to generate NK cells in vitro. By modifying a previously published protocol, we showed that frozen CBCD34(+) cultures generated higher NK cell numbers without loss of function compared to fresh CBCD34(+) cultures. NK cells generated from CBCD34(+) and PBCD34(+) expressed low levels of killer-cell immunoglobulin-like receptors but high levels of activating receptors and of the myeloid marker CD33. However, blocking studies showed that CD33 expression did not impact on the functions of the generated cells. CBCD34(+)-NK cells exhibited increased capacity to secrete IFN-gamma and kill K562 in vitro and in vivo as compared to PBCD34(+)-NK cells. Moreover, K562 killing by the generated NK cells could be further enhanced by IL-12 stimulation. Our data indicate that the use of frozen CBCD34(+) for the production of NK cells in vitro results in higher cell numbers than PBCD34(+), without jeopardizing their functionality, rendering them suitable for NK cell immunotherapy. The results presented here provide an optimal strategy to generate NK cells in vitro for immunotherapy that exhibit enhanced effector function when compared to alternate sources of HSC.	[Luevano, Martha; Domogala, Anna; Jackson, Nicola; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Madrigal, Alejandro; Saudemont, Aurore] UCL, Inst Canc, London, England; [Luevano, Martha; Domogala, Anna; Pedroza-Pacheco, Isabela; Derniame, Sophie; Escobedo-Cousin, Michelle; Madrigal, Alejandro; Saudemont, Aurore] Anthony Nolan Res Inst, London, England; [Blundell, Michael; Thrasher, Adrian] UCL Inst Child Hlth, Ctr Immunodeficiency, Mol Immunol Unit, London, England; [Querol, Sergio] Programa Concordia Banc Sang & Teixits, Barcelona, Spain	University of London; University College London; University of London; University College London	Saudemont, A (corresponding author), UCL, Inst Canc, London, England.	aurore.saudemont@anthonynolan.org	Blundell, Michael P/M-1276-2015	Madrigal, Alejandro/0000-0001-8359-9917; Saudemont, Aurore/0000-0002-9376-8339; Blundell, Michael/0000-0002-9179-6870	Anthony Nolan	Anthony Nolan	Anthony Nolan funded this work. No current external funding sources were received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Clausen J, 2007, CLIN EXP IMMUNOL, V148, P520, DOI 10.1111/j.1365-2249.2007.03360.x; Colucci F, 2001, BLOOD, V97, P2625, DOI 10.1182/blood.V97.9.2625; Condiotti R, 1998, EXP HEMATOL, V26, P571; Dezell SA, 2012, BIOL BLOOD MARROW TR, V18, P536, DOI 10.1016/j.bbmt.2011.11.023; El Beshlawy A, 2009, EXP CLIN TRANSPLANT, V7, P50; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Frias AM, 2008, EXP HEMATOL, V36, P61, DOI 10.1016/j.exphem.2007.08.031; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Giuliani M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002241; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; HANDGRETINGER R, 1993, IMMUNOL LETT, V37, P223, DOI 10.1016/0165-2478(93)90034-Y; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Kim DH, 2005, EUR J HAEMATOL, V75, P299, DOI 10.1111/j.1600-0609.2005.00514.x; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Lee SM, 1996, BLOOD, V88, P945; Lehmann D, 2012, STEM CELLS DEV; Leung W, 1999, Biol Blood Marrow Transplant, V5, P69, DOI 10.1053/bbmt.1999.v5.pm10371358; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Luevano M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00319; Luevano M, 2012, HUM IMMUNOL, V73, P248, DOI 10.1016/j.humimm.2011.12.015; Martin-Fontecha A, 2011, CELL MOL LIFE SCI, V68, P3495, DOI 10.1007/s00018-011-0800-9; Mayani H, 2011, ARCH MED RES, V42, P645, DOI 10.1016/j.arcmed.2011.11.010; MILLER JS, 1994, BLOOD, V83, P2594; Miller JS, 2001, BLOOD, V98, P705, DOI 10.1182/blood.V98.3.705; Moezzi L, 2005, TRANSPL P, V37, P4500, DOI 10.1016/j.transproceed.2005.10.107; Montaldo E, 2012, BLOOD, V119, P3987, DOI 10.1182/blood-2011-09-379693; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; NAUME B, 1992, J IMMUNOL, V148, P2429; Paul SP, 2000, BLOOD, V96, P483; Perez SA, 2003, BLOOD, V101, P3444, DOI 10.1182/blood-2002-05-1501; Pinho MJ, 2012, J RECEPTOR SIGNAL TR; RABINOWICH H, 1993, CELL IMMUNOL, V152, P481, DOI 10.1006/cimm.1993.1306; Rappold I, 1997, BLOOD, V90, P111; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Taki S, 2005, J IMMUNOL, V174, P6005, DOI 10.4049/jimmunol.174.10.6005; Tanaka M, 2012, LEUKEMIA RES, V36, P699, DOI 10.1016/j.leukres.2011.11.009; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Woll PS, 2005, J IMMUNOL, V175, P5095, DOI 10.4049/jimmunol.175.8.5095; Yoon SR, 2010, BONE MARROW TRANSPL, V45, P1038, DOI 10.1038/bmt.2009.304; Zamai L, 2012, CYTOM PART A, V81A, P294, DOI 10.1002/cyto.a.22025	54	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87086	10.1371/journal.pone.0087086	http://dx.doi.org/10.1371/journal.pone.0087086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489840	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000098
J	Maucort, G; Kasula, R; Papadopulos, A; Nieminen, TA; Rubinsztein-Dunlop, H; Meunier, FA				Maucort, Guillaume; Kasula, Ravikiran; Papadopulos, Andreas; Nieminen, Timo A.; Rubinsztein-Dunlop, Halina; Meunier, Frederic A.			Mapping Organelle Motion Reveals a Vesicular Conveyor Belt Spatially Replenishing Secretory Vesicles in Stimulated Chromaffin Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; ACTIN; EXOCYTOSIS; GRANULES; ENDOCYTOSIS; COMPONENTS; TRANSPORT	How neurosecretory cells spatially adjust their secretory vesicle pools to replenish those that have fused and released their hormonal content is currently unknown. Here we designed a novel set of image analyses to map the probability of tracked organelles undergoing a specific type of movement (free, caged or directed). We then applied our analysis to time-lapse z-stack confocal imaging of secretory vesicles from bovine Chromaffin cells to map the global changes in vesicle motion and directionality occurring upon secretagogue stimulation. We report a defined region abutting the cortical actin network that actively transports secretory vesicles and is dissipated by actin and microtubule depolymerizing drugs. The directionality of this "conveyor belt" towards the cell surface is activated by stimulation. Actin and microtubule networks therefore cooperatively probe the microenvironment to transport secretory vesicles to the periphery, providing a mechanism whereby cells globally adjust their vesicle pools in response to secretagogue stimulation.	[Maucort, Guillaume; Kasula, Ravikiran; Papadopulos, Andreas; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia; [Maucort, Guillaume; Nieminen, Timo A.; Rubinsztein-Dunlop, Halina] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia.	f.meunier@uq.edu.au	Nieminen, Timo K./GXN-2675-2022; Kasula, Ravi Kiran/ABC-3437-2021; Meunier, Frederic A/C-8161-2009; Rubinsztein-Dunlop, Halina/D-2387-2014	Nieminen, Timo K./0000-0001-6599-1835; Meunier, Frederic A/0000-0001-6400-1107; Rubinsztein-Dunlop, Halina/0000-0002-8332-2309; Papadopulos, Andreas/0000-0002-3376-1979; Nieminen, Timo/0000-0003-3055-7275	Australian Research Council [DP120104057]	Australian Research Council(Australian Research Council)	This work was supported by funding from a Australian Research Council grant (DP120104057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi AA, 2013, ANNU REV PHYSIOL, V75, P393, DOI 10.1146/annurev-physiol-020911-153305; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Gil A, 2000, NEUROSCIENCE, V98, P605, DOI 10.1016/S0306-4522(00)00132-9; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; LELKES PI, 1986, FEBS LETT, V208, P357, DOI 10.1016/0014-5793(86)81049-3; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Neco P, 2003, EUR J NEUROSCI, V18, P733, DOI 10.1046/j.1460-9568.2003.02801.x; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Papadopulos Andreas, 2013, Front Endocrinol (Lausanne), V4, P153, DOI 10.3389/fendo.2013.00153; Papadopulos A, 2013, J NEUROSCI, V33, P19143, DOI 10.1523/JNEUROSCI.2634-13.2013; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tomatis VM, 2013, J CELL BIOL, V200, P301, DOI 10.1083/jcb.201204092; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Wen PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1500; Wen PJ, 2008, MOL BIOL CELL, V19, P5593, DOI 10.1091/mbc.E08-06-0595	21	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87242	10.1371/journal.pone.0087242	http://dx.doi.org/10.1371/journal.pone.0087242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489879	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000124
J	Prieto, VM; Matos, S; Alvarez, M; Cacheda, F; Oliveira, JL				Prieto, Victor M.; Matos, Sergio; Alvarez, Manuel; Cacheda, Fidel; Oliveira, Jose Luis			Twitter: A Good Place to Detect Health Conditions	PLOS ONE			English	Article								With the proliferation of social networks and blogs, the Internet is increasingly being used to disseminate personal health information rather than just as a source of information. In this paper we exploit the wealth of user-generated data, available through the micro-blogging service Twitter, to estimate and track the incidence of health conditions in society. The method is based on two stages: we start by extracting possibly relevant tweets using a set of specially crafted regular expressions, and then classify these initial messages using machine learning methods. Furthermore, we selected relevant features to improve the results and the execution times. To test the method, we considered four health states or conditions, namely flu, depression, pregnancy and eating disorders, and two locations, Portugal and Spain. We present the results obtained and demonstrate that the detection results and the performance of the method are improved after feature selection. The results are promising, with areas under the receiver operating characteristic curve between 0.7 and 0.9, and f-measure values around 0.8 and 0.9. This fact indicates that such approach provides a feasible solution for measuring and tracking the evolution of health states within the society.	[Prieto, Victor M.; Alvarez, Manuel; Cacheda, Fidel] Dept Informat & Commun Technol, Coruna, Spain; [Matos, Sergio; Oliveira, Jose Luis] Univ Aveiro, DETI IEETA, P-3800 Aveiro, Portugal	Universidade da Coruna; Universidade de Aveiro	Prieto, VM (corresponding author), Dept Informat & Commun Technol, Campus Elvina S-N, Coruna, Spain.	victor.prieto@udc.es	Cacheda, Fidel/L-8913-2014; Matos, Sérgio/G-4941-2010; Alvarez, Manuel/L-9574-2014; Oliveira, José Luis/A-2223-2012	Cacheda, Fidel/0000-0002-6438-1661; Matos, Sérgio/0000-0003-1941-3983; Alvarez, Manuel/0000-0001-7204-2689; Oliveira, José Luis/0000-0002-6672-6176	Xunta de Galicia [CN2012/211]; Ministry of Education and Science of Spain; FEDER funds of the European Union [TIN2009-14203]; FEDER through the COMPETE programme; Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia" [PTDC/EIA-CCO/100541/2008 (FCOMP-01-0124-FEDER-010029)]; QREN Mais Centro program through the Cloud Thinking project [CENTRO-07-ST24-FEDER-002031]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Ministry of Education and Science of Spain(Spanish Government); FEDER funds of the European Union(European Commission); FEDER through the COMPETE programme; Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia"; QREN Mais Centro program through the Cloud Thinking project	The work of VMP, MA and FC was supported by Xunta de Galicia CN2012/211, the Ministry of Education and Science of Spain and FEDER funds of the European Union (Project TIN2009-14203). SM and JLO were funded by FEDER through the COMPETE programme and by Portuguese national funds through FCT - "Fundacao Para a Ciencia e a Tecnologia" under project number PTDC/EIA-CCO/100541/2008 (FCOMP-01-0124-FEDER-010029), and by the QREN Mais Centro program through the Cloud Thinking project (CENTRO-07-ST24-FEDER-002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, PATTERN RECOGN LETT, V26, P43, DOI 10.1016/j.patrec.2004.08.015; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Bosley JC, 2012, RESUSCITATION; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Culotta A., 2010, ARXIV10074748CSIR; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M., 1998, THESIS U WAIKATO HAM; Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273; KIRA K, 1992, MACHINE LEARNING /, P249; Lampos V., 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Liu H, 1998, FEATURE EXTRACTION C, DOI 10. 1007/978-1-4615-5725-8; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Paul M.J., 2011, 5 INT AAAI C WEBL SO; Porter M. F., 2001, SNOWBALL LANGUAGE ST; Robnik-Sikonja M, 2004, LECT NOTES COMPUT SC, V3201, P359; Santos JC, 2013, P IWBBIO 2013; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Shuyo N, 2012, LANGUAGE DETECTION L; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Twitter, 2012, TWITT SEARCH AP	27	76	76	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86191	10.1371/journal.pone.0086191	http://dx.doi.org/10.1371/journal.pone.0086191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489699	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000028
J	Etherington, SJ; Johnstone, VPA; Everett, AW				Etherington, Sarah J.; Johnstone, Victoria P. A.; Everett, Alan W.			Modulation of Synaptic Vesicle Exocytosis in Muscle-Dependent Long-Term Depression at the Amphibian Neuromuscular Junction	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; SCHAFFER COLLATERAL-CA1 SYNAPSES; NITRIC-OXIDE; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; PRESYNAPTIC INHIBITION; VESICULAR RELEASE; FM DYES; PLASTICITY; POOLS	We have labeled recycling synaptic vesicles at the somatic Bufo marinus neuromuscular junction with the styryl dye FM2-10 and provide direct evidence for refractoriness of exocytosis associated with a muscle activity-dependent form of long-term depression (LTD) at this synapse. FM2-10 dye unloading experiments demonstrated that the rate of vesicle exocytosis from the release ready pool (RRP) of vesicles was more than halved in the LTD (induced by 20 min of low frequency stimulation). Recovery from LTD, observed as a partial recovery of nerve-evoked muscle twitch amplitude, was accompanied by partial recovery of the refractoriness of RRP exocytosis. Unexpectedly, paired pulse plasticity, another routinely used indicator of presynaptic forms of synaptic plasticity, was unchanged in the LTD. We conclude that the LTD induces refractoriness of the neuromuscular vesicle release machinery downstream of presynaptic calcium entry.	[Etherington, Sarah J.; Johnstone, Victoria P. A.; Everett, Alan W.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Etherington, Sarah J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Johnstone, Victoria P. A.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	University of Western Australia; Murdoch University; Monash University	Etherington, SJ (corresponding author), Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia.	s.etherington@murdoch.edu.au	Johnstone, Victoria/B-5083-2015; Etherington, Sarah/HGC-7458-2022	Johnstone, Victoria/0000-0001-9885-3607; 	University of Western Australia (Perth, Australia)	University of Western Australia (Perth, Australia)	This work was supported by The University of Western Australia (Perth, Australia, http://www.uwa.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist S, 2010, NEURON, V66, P220, DOI 10.1016/j.neuron.2010.03.023; BETZ WJ, 1995, CURR BIOL, V5, P1098, DOI 10.1016/S0960-9822(95)00220-X; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Etherington SJ, 2008, SYNAPSE, V62, P291, DOI 10.1002/syn.20493; Etherington SJ, 2004, J PHYSIOL-LONDON, V559, P507, DOI 10.1113/jphysiol.2004.066498; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Frank C.A., 2013, NEUROPHARMACOLOGY; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Frank CA, 2009, NEURON, V61, P556, DOI 10.1016/j.neuron.2008.12.028; Gaffield MA, 2011, J NEUROPHYSIOL, V106, P599, DOI 10.1152/jn.00123.2011; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Giniatullin RA, 1998, BRIT J PHARMACOL, V124, P839, DOI 10.1038/sj.bjp.0701881; Graves AR, 2004, J PHYSIOL-LONDON, V559, P423, DOI 10.1113/jphysiol.2004.064469; Hallermann S, 2013, TRENDS NEUROSCI, V36, P185, DOI 10.1016/j.tins.2012.10.001; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Kuromi H, 2005, NEUROSCIENTIST, V11, P138, DOI 10.1177/1073858404271679; Lindgren CA, 2013, J PHYSIOL-LONDON, V591, P4749, DOI 10.1113/jphysiol.2013.256727; Marques G, 2006, INT REV NEUROBIOL, V75, P267, DOI 10.1016/S0074-7742(06)75012-7; Muller M, 2012, J NEUROSCI, V32, P16574, DOI 10.1523/JNEUROSCI.0981-12.2012; Newman Z, 2007, EUR J NEUROSCI, V25, P1619, DOI 10.1111/j.1460-9568.2007.05422.x; Noronha-Matos JB, 2011, J NEUROCHEM, V117, P797, DOI 10.1111/j.1471-4159.2011.07216.x; Pinard A, 2008, EUR J NEUROSCI, V28, P577, DOI 10.1111/j.1460-9568.2008.06355.x; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Ratnayaka A, 2012, J PHYSIOL-LONDON, V590, P1585, DOI 10.1113/jphysiol.2011.226688; REDMAN RS, 1993, MOL PHARMACOL, V44, P835; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2003, J NEUROCYTOL, V32, P539, DOI 10.1023/B:NEUR.0000020609.19873.e8; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Sanchez-Pastor E, 2007, J PHARMACOL EXP THER, V321, P439, DOI 10.1124/jpet.106.116319; Santos DA, 2003, NEUROSCI LETT, V338, P225, DOI 10.1016/S0304-3940(02)01419-2; Santschi LA, 2006, J NEUROBIOL, V66, P205, DOI 10.1002/neu.20213; Silinsky EM, 1999, PROG BRAIN RES, V120, P145; Stanton PK, 2003, J NEUROSCI, V23, P5936; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Thomas S, 2001, J NEUROSCI, V21, P1087; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Upreti C, 2013, NEUROPHARMACOLOGY, V66, P31, DOI 10.1016/j.neuropharm.2012.05.004; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Weyhersmuller A, 2011, J NEUROSCI, V31, P6041, DOI 10.1523/JNEUROSCI.6698-10.2011; Yakovleva OV, 2013, NEUROCHEM J+, V7, P103, DOI 10.1134/S1819712413020104; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87174	10.1371/journal.pone.0087174	http://dx.doi.org/10.1371/journal.pone.0087174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489862	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000114
J	Grasmeijer, F; Lexmond, AJ; van den Noort, M; Hagedoorn, P; Hickey, AJ; Frijlink, HW; de Boer, AH				Grasmeijer, Floris; Lexmond, Anne J.; van den Noort, Maarten; Hagedoorn, Paul; Hickey, Anthony J.; Frijlink, Henderik W.; de Boer, Anne H.			New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation	PLOS ONE			English	Article							DRY POWDER INHALATION; DRUG PARTICLE DETACHMENT; INTERACTIVE MIXTURES; SALMETEROL XINAFOATE; CARRIER SURFACE; MIXING TIME; DEPOSITION; FORMULATION; DEVICE; SIZE	Fine excipient particles or 'fines' have been shown to improve the dispersion performance of carrier-based formulations for dry powder inhalation. Mechanistic formulation studies have focussed mainly on explaining this positive effect. Previous studies have shown that higher drug contents may cause a decrease in dispersion performance, and there is no reason why this should not be true for fines with a similar shape, size and cohesiveness as drug particles. Therefore, the effects on drug detachment of 'fine lactose fines' (FLF, X-50 = 1.95 mu m) with a similar size and shape as micronised budesonide were studied and compared to those of 'coarse lactose fines' (CLF, X-50 = 3.94 mu m). Furthermore, interactions with the inhalation flow rate, the drug content and the mixing order were taken into account. The observed effects of FLF are comparable to drug content effects in that the detached drug fraction was decreased at low drug content and low flow rates but increased at higher flow rates. At high drug content the effects of added FLF were negligible. In contrast, CLF resulted in higher detached drug fractions at all flow rates and drug contents. The results from this study suggest that the effects of fines may be explained by two new mechanisms in addition to those previously proposed. Firstly, fines below a certain size may increase the effectiveness of press-on forces or cause the formation of strongly coherent fine particle networks on the carrier surface containing the drug particles. Secondly, when coarse enough, fines may prevent the formation of, or disrupt such fine particle networks, possibly through a lowering of their tensile strength. It is recommended that future mechanistic studies are based on the recognition that added fines may have any effect on dispersion performance, which is determined by the formulation and dispersion conditions.	[Grasmeijer, Floris; Lexmond, Anne J.; van den Noort, Maarten; Hagedoorn, Paul; Frijlink, Henderik W.; de Boer, Anne H.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Hickey, Anthony J.] RTI Int, Ctr Aerosol & Nanomat Engn, Res Triangle Pk, NC USA	University of Groningen; Research Triangle Institute	Grasmeijer, F (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	F.Grasmeijer@rug.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198				Adi H, 2006, PHARM RES, V23, P2556, DOI 10.1007/s11095-006-9082-6; Arnold K, 1995, POWDERS INHALATION; de Boer AH, 2012, ADV DRUG DELIVER REV, V64, P257, DOI 10.1016/j.addr.2011.04.004; de Boer AH, 2003, INT J PHARMACEUT, V260, P187, DOI 10.1016/S0378-5173(03)00250-3; Dickhoff BHJ, 2006, INT J PHARMACEUT, V327, P17, DOI 10.1016/j.ijpharm.2006.07.017; Dickhoff B.H.J., 2006, ADHESIVE MIXTURES PO; Dickhoff BHJ, 2002, EUR J PHARM BIOPHARM, V54, P245, DOI 10.1016/S0939-6411(02)00082-6; Dickhoff BHJ, 2003, EUR J PHARM BIOPHARM, V56, P291, DOI 10.1016/S0939-6411(03)00109-7; Donovan MJ, 2012, J PHARM SCI-US, V101, P1097, DOI 10.1002/jps.22824; Grasmeijer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071339; Grasmeijer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069263; Islam N, 2004, PHARM RES-DORDR, V21, P492, DOI 10.1023/B:PHAM.0000019304.91412.18; Jones MD, 2006, PHARM RES, V23, P1665, DOI 10.1007/s11095-006-9012-7; Jones MD, 2010, INT J PHARMACEUT, V391, P137, DOI 10.1016/j.ijpharm.2010.02.031; Kendall K, 2001, POWDER TECHNOL, V121, P223, DOI 10.1016/S0032-5910(01)00386-2; Louey MD, 2002, PHARM RES-DORDR, V19, P1524, DOI 10.1023/A:1020464801786; Lucas P, 1998, PHARMACEUT RES, V15, P562, DOI 10.1023/A:1011977826711; Shur J, 2008, PHARM RES-DORDR, V25, P1931, DOI 10.1007/s11095-008-9538-y; Thalberg K, 2012, INT J PHARMACEUT, V427, P224, DOI 10.1016/j.ijpharm.2012.02.009; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P1497, DOI 10.1164/rccm.200410-1414OC; Zeng XM, 1999, INT J PHARMACEUT, V182, P133, DOI 10.1016/S0378-5173(99)00021-6	21	55	58	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87825	10.1371/journal.pone.0087825	http://dx.doi.org/10.1371/journal.pone.0087825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489969	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000151
J	Wester-Rosenlof, L; Casslen, V; Axelsson, J; Edstrom-Hagerwall, A; Gram, M; Holmqvist, M; Johansson, ME; Larsson, I; Ley, D; Marsal, K; Morgelin, M; Rippe, B; Rutardottir, S; Shohani, B; Akerstrom, B; Hansson, SR				Wester-Rosenlof, Lena; Casslen, Vera; Axelsson, Josefin; Edstrom-Hagerwall, Anneli; Gram, Magnus; Holmqvist, Madlene; Johansson, Martin E.; Larsson, Irene; Ley, David; Marsal, Karel; Morgelin, Matthias; Rippe, Bengt; Rutardottir, Sigurbjorg; Shohani, Behnaz; Akerstrom, Bo; Hansson, Stefan R.			A1M/alpha(1)-Microglobulin Protects from Heme-Induced Placental and Renal Damage in a Pregnant Sheep Model of Preeclampsia	PLOS ONE			English	Article							CELL-FREE HEMOGLOBIN; LIPOCALIN ALPHA(1)-MICROGLOBULIN; SCAVENGER ALPHA(1)-MICROGLOBULIN; INDUCED HYPERTENSION; OXIDATIVE-STRESS; ALPHA-1-MICROGLOBULIN; LIMITS; BLOOD	Preeclampsia (PE) is a serious pregnancy complication that manifests as hypertension and proteinuria after the 20th gestation week. Previously, fetal hemoglobin (HbF) has been identified as a plausible causative factor. Cell-free Hb and its degradation products are known to cause oxidative stress and tissue damage, typical of the PE placenta. A1M (alpha(1)-microglobulin) is an endogenous scavenger of radicals and heme. Here, the usefulness of A1M as a treatment for PE is investigated in the pregnant ewe PE model, in which starvation induces PE symptoms via hemolysis. Eleven ewes, in late pregnancy, were starved for 36 hours and then treated with A1M (n = 5) or placebo (n = 6) injections. After injections, the ewes were re-fed and observed for additional 72 hours. They were monitored for blood pressure, proteinuria, blood cell distribution and clinical and inflammation markers in plasma. Before termination, the utero-placental circulation was analyzed with Doppler velocimetry and the kidney glomerular function was analyzed by Ficoll sieving. At termination, blood, kidney and placenta samples were collected and analyzed for changes in gene expression and tissue structure. The starvation resulted in increased amounts of the hemolysis marker bilirubin in the blood, structural damages to the placenta and kidneys and an increased glomerular sieving coefficient indicating a defect filtration barrier. Treatment with A1M ameliorated these changes without signs of side-effects. In conclusion, A1M displayed positive therapeutic effects in the ewe starvation PE model, and was well tolerated. Therefore, we suggest A1M as a plausible treatment for PE in humans.	[Wester-Rosenlof, Lena; Edstrom-Hagerwall, Anneli; Gram, Magnus; Morgelin, Matthias; Rutardottir, Sigurbjorg; Akerstrom, Bo] Lund Univ, Dept Infect Med, Lund, Sweden; [Casslen, Vera; Holmqvist, Madlene; Larsson, Irene; Marsal, Karel; Shohani, Behnaz; Hansson, Stefan R.] Lund Univ, Dept Obstet & Gynecol, Lund, Sweden; [Axelsson, Josefin; Rippe, Bengt] Lund Univ, Dept Nephrol, Lund, Sweden; [Johansson, Martin E.] Lund Univ, Dept Lab Med, Malmo, Sweden; [Ley, David] Lund Univ, Dept Pediat, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Lund University	Akerstrom, B (corresponding author), Lund Univ, Dept Infect Med, Lund, Sweden.	bo.akerstrom@med.lu.se; stefan.hansson@med.lu.se	Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925	Swedish Research Council; Marianne & Marcus Wallenberg foundation; Torsten Soderbergs foundation; Maggie Stephens foundation; A1M Pharma AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne & Marcus Wallenberg foundation; Torsten Soderbergs foundation; Maggie Stephens foundation; A1M Pharma AB	The project was founded by the Swedish Research Council; the Marianne & Marcus Wallenberg foundation; the Torsten Soderbergs foundation, the Maggie Stephens foundation and A1M Pharma AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1985, J BIOL CHEM, V260, P4839; AKERSTROM B, 1985, EUR J BIOCHEM, V146, P353; Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Akerstrom Bo, 2006, P1; Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Anderson UD, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.058; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Axelsson J, 2013, AM J PHYSIOL-RENAL, V305, pF237, DOI 10.1152/ajprenal.00154.2013; Axelsson J, 2012, AM J PHYSIOL-RENAL, V303, pF790, DOI 10.1152/ajprenal.00153.2012; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021; Berggard T, 1998, J HISTOCHEM CYTOCHEM, V46, P887, DOI 10.1177/002215549804600803; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Centlow M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/472354; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Enders AC, 2006, PLACENTA, V27, pS11, DOI 10.1016/j.placenta.2005.10.013; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; Larsson J, 2001, J LAB CLIN MED, V137, P165, DOI 10.1067/mlc.2001.112957; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lipstein H, 2003, AM J EMERG MED, V21, P223, DOI 10.1016/S0735-6757(02)42241-3; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Malyala P, 2008, J PHARM SCI-US, V97, P2041, DOI 10.1002/jps.21152; Masuda T, 2005, AM J HEMATOL, V78, P159, DOI 10.1002/ajh.20172; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; McWaters P, 2000, VET IMMUNOL IMMUNOP, V73, P155, DOI 10.1016/S0165-2427(99)00158-0; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Olsson MG, 2012, ANTIOXID REDOX SIGN, V17, P813, DOI 10.1089/ars.2011.4282; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Olsson MG, 2010, RADIAT RES, V174, P590, DOI 10.1667/RR2213.1; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Pourcelot L, 1974, APPL CLIN EXAMEN DOP; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; Shennan AH, 2001, LANCET, V357, P1534, DOI 10.1016/S0140-6736(00)04694-8; Talosi G, 1997, BIOCHEM MOL MED, V62, P58, DOI 10.1006/bmme.1997.2602; Talosi G, 2001, EUR J OBSTET GYN R B, V99, P25, DOI 10.1016/S0301-2115(01)00351-7; THATCHER CD, 1986, AM J OBSTET GYNECOL, V155, P201, DOI 10.1016/0002-9378(86)90111-0; Wicher KB, 2010, ANTIOXID REDOX SIGN, V12, P249, DOI 10.1089/ars.2009.2760	48	45	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86353	10.1371/journal.pone.0086353	http://dx.doi.org/10.1371/journal.pone.0086353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489717	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000047
J	Erbakan, M; Shen, YX; Grzelakowski, M; Butler, PJ; Kumar, M; Curtis, WR				Erbakan, Mustafa; Shen, Yue-xiao; Grzelakowski, Mariusz; Butler, Peter J.; Kumar, Manish; Curtis, Wayne R.			Molecular Cloning, Overexpression and Characterization of a Novel Water Channel Protein from Rhodobacter sphaeroides	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; AQUAPORIN; MEMBRANES; RECONSTITUTION; EXPRESSION; RED; PERMEABILITY; LIPOSOMES; FAMILY; AQPZ	Aquaporins are highly selective water channel proteins integrated into plasma membranes of single cell organisms; plant roots and stromae; eye lenses, renal and red blood cells in vertebrates. To date, only a few microbial aquaporins have been characterized and their physiological importance is not well understood. Here we report on the cloning, expression and characterization of a novel aquaporin, RsAqpZ, from a purple photosynthetic bacterium, Rhodobacter sphaeroides ATCC 17023. The protein was expressed homologously at a high yield (similar to 20 mg/L culture) under anaerobic photoheterotrophic growth conditions. Stopped-flow light scattering experiments demonstrated its high water permeability (0.17 +/- 0.05 cm/s) and low energy of activation for water transport (2.93 +/- 0.60 kcal/mol) in reconstituted proteoliposomes at a protein to lipid ratio (w/w) of 0.04. We developed a fluorescence correlation spectroscopy based technique and utilized a fluorescent protein fusion of RsAqpZ, to estimate the single channel water permeability of RsAqpZ as 1.24 (+/- 0.41) x 10(-12) cm(3)/s or 4.17 (+/- 1.38) x 10(10) H2O molecules/s, which is among the highest single channel permeability reported for aquaporins. Towards application to water purification technologies, we also demonstrated functional incorporation of RsAqpZ in amphiphilic block copolymer membranes.	[Erbakan, Mustafa; Butler, Peter J.; Curtis, Wayne R.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Shen, Yue-xiao; Kumar, Manish; Curtis, Wayne R.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Grzelakowski, Mariusz] AquaZ Inc, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kumar, M (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	manish.kumar@psu.edu; wrc2@psu.edu	Kumar, Manish/ABD-7273-2021; Kumar, Manish/HCH-7832-2022	Kumar, Manish/0000-0001-5545-3793; Curtis, Wayne/0000-0001-6976-0890	Grace-Woodward Foundation	Grace-Woodward Foundation	Grace-Woodward Foundation provided support for development of Rhodobacter as a membrane protein expression platform, which set the basis for this work. ARPA-E's support helped development of genetic transformation methods for Rhodobacter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PG, 2012, BBA-BIOENERGETICS, V1817, P1616, DOI 10.1016/j.bbabio.2012.05.013; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Bai HJ, 2008, BIORESOURCE TECHNOL, V99, P7716, DOI 10.1016/j.biortech.2008.01.071; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Ding XD, 2013, BIOL CELL, V105, P118, DOI 10.1111/boc.201200057; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; DONOHUE TJ, 1991, METHOD ENZYMOL, V204, P459; Duong PHH, 2012, J MEMBRANE SCI, V409, P34, DOI 10.1016/j.memsci.2012.03.004; Eroglu I, 1998, BIOHYDROGEN, P143; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gullapalli RR, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2673245; Hill AE, 2004, J MEMBRANE BIOL, V197, P1, DOI 10.1007/s00232-003-0639-6; Hoomann T, 2013, P NATL ACAD SCI US; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Kozono D, 2003, J BIOL CHEM, V278, P10649, DOI 10.1074/jbc.M212418200; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; Kumar M, 2012, J AM CHEM SOC, V134, P18631, DOI 10.1021/ja304721r; Laible PD, 2008, PURPLE PHOTOTROPHIC, P839; Laible Philip D., 2005, Journal of Structural and Functional Genomics, V6, P95, DOI 10.1007/s10969-005-1936-3; Laible Philip D., 2004, Journal of Structural and Functional Genomics, V5, P167, DOI 10.1023/B:JSFG.0000029201.33710.46; LASCELLES J, 1956, BIOCHEM J, V62, P78, DOI 10.1042/bj0620078; LATIMER P, 1972, BIOPHYS J, V12, P764, DOI 10.1016/S0006-3495(72)86120-4; LEE JK, 1989, J BACTERIOL, V171, P3391, DOI 10.1128/jb.171.6.3391-3405.1989; Maiti S, 1997, P NATL ACAD SCI USA, V94, P11753, DOI 10.1073/pnas.94.22.11753; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rigler P, 2006, J AM CHEM SOC, V128, P367, DOI 10.1021/ja056719u; Roy A, 2008, BIOL CHEM, V389, P69, DOI 10.1515/BC.2008.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Schilling M, 2005, FEBS J, V272, P6400, DOI 10.1111/j.1742-4658.2005.05037.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TAGUCHI AKW, 1992, BIOCHEMISTRY-US, V31, P10345, DOI 10.1021/bi00157a024; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang CY, 2013, DESALINATION, V308, P34, DOI 10.1016/j.desal.2012.07.007; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tanghe A, 2004, APPL ENVIRON MICROB, V70, P3377, DOI 10.1128/AEM.70.6.3377-3382.2004; WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002	54	23	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86830	10.1371/journal.pone.0086830	http://dx.doi.org/10.1371/journal.pone.0086830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497982	gold, Green Submitted, Green Published			2022-12-27	WOS:000330621900040
J	Bowles, D; Carson, A; Isaac, P				Bowles, Dianna; Carson, Amanda; Isaac, Peter			Genetic Distinctiveness of the Herdwick Sheep Breed and Two Other Locally Adapted Hill Breeds of the UK	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; POPULATION-STRUCTURE; PROLACTIN RECEPTOR; DIVERSITY; HISTORY	There is considerable interest in locally adapted breeds of livestock as reservoirs of genetic diversity that may provide important fitness traits for future use in agriculture. In marginal areas, these animals contribute to food security and extract value from land unsuitable for other systems of farming. In England, close to 50% of the national sheep flock is farmed on grassland designated as disadvantaged areas for agricultural production. Many of these areas are in the uplands, where some native breeds of sheep continue to be commercially farmed only in highly localised geographical regions to which they are adapted. This study focuses on three of these breeds, selected for their adaptation to near identical environments and their geographical concentration in regions close to one another. Our objective has been to use retrotyping, microsatellites and single nucleotide polymorphisms to explore the origins of the breeds and whether, despite their similar adaptations and proximity, they are genetically distinctive. We find the three breeds each have a surprisingly different pattern of retrovirus insertions into their genomes compared with one another and with other UK breeds. Uniquely, there is a high incidence of the R0 retrotype in the Herdwick population, characteristic of a primitive genome found previously in very few breeds worldwide and none in the UK mainland. The Herdwick and Rough Fells carry two rare retroviral insertion events, common only in Texels, suggesting sheep populations in the northern uplands have a historical association with the original pin-tail sheep of Texel Island. Microsatellite data and analyses of SNPs associated with RXFP2 (horn traits) and PRLR (reproductive performance traits) also distinguished the three breeds. Significantly, an SNP linked to TMEM154, a locus controlling susceptibility to infection by Maedi-Visna, indicated that all three native hill breeds have a lower than average risk of infection to the lentivirus.	[Bowles, Dianna] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Bowles, Dianna; Carson, Amanda] Univ York, Sheep Trust, Registered Char 1094514, York YO10 5DD, N Yorkshire, England; [Isaac, Peter] IDna Genet Ltd, Norwich, Norfolk, England	University of York - UK; University of York - UK	Bowles, D (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	dianna.bowles@york.ac.uk			University of York; Sheep Trust Charity	University of York(European Commission); Sheep Trust Charity	The funding for this research was in part provided by the University of York to DB and in part by The Sheep Trust Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2005, J ANIM SCI, V83, P737; Alvarez I, 2004, J ANIM SCI, V82, P2246; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Brown G, 2009, HERDWICKS HERDWICK S; Carson A, 2009, LIVEST SCI, V123, P288, DOI 10.1016/j.livsci.2008.11.026; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Chu MX, 2007, ANIM BIOTECHNOL, V18, P65, DOI 10.1080/10495390601090950; Defra, 2012, UK COUNTR REP FARM A; FAO, 2009, 167 FAO; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Heaton MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055490; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Hoffmann I, 2013, ANIMAL, V7, P346, DOI 10.1017/S1751731113000815; Johnston SE, 2010, HEREDITY, V104, P196, DOI 10.1038/hdy.2009.109; Johnston SE, 2013, NATURE, V502, P93, DOI 10.1038/nature12489; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Lenstra JA, 2012, ANIM GENET, V43, P483, DOI 10.1111/j.1365-2052.2011.02309.x; Pariset L, 2006, ANIM GENET, V37, P290, DOI 10.1111/j.1365-2052.2006.01441.x; Pariset L, 2006, J HERED, V97, P531, DOI 10.1093/jhered/esl020; Patel JR, 2012, VACCINE, V30, P1767, DOI 10.1016/j.vaccine.2012.01.014; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Peterhans E, 2004, VET RES, V35, P257, DOI 10.1051/vetres:2004014; Pritchard JK, 2000, GENETICS, V155, P945; Sider LH, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-64; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2005, MOL ECOL, V14, P3951, DOI 10.1111/j.1365-294X.2005.02727.x; Tapio M, 2007, AGR FOOD SCI, V16, P157, DOI 10.2137/145960607782219346; Thormar H, 2005, AIDS REV, V7, P233; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S., 1969, Evolution and the genetics of populations. Vol. 2. The theory of gene frequencies., V2	38	26	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87823	10.1371/journal.pone.0087823	http://dx.doi.org/10.1371/journal.pone.0087823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489968	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000183
J	Ebeling, W; Hemmi, JM				Ebeling, Wiebke; Hemmi, Jan M.			Dichromatic Colour Vision in Wallabies as Characterised by Three Behavioural Paradigms	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; TAMMAR WALLABY; AUSTRALIAN MARSUPIALS; SPECTRAL SENSITIVITY; MACROPUS-EUGENII; PHOTORECEPTORS; TRICHROMACY; EVOLUTION; SEQUENCE; RETINA	Despite lacking genetic evidence of a third cone opsin in the retina of any Australian marsupial, most species tested so far appear to be trichromatic. In the light of this, we have re-examined colour vision of the tammar wallaby which had previously been identified as a dichromat. Three different psychophysical tests, based on an operant conditioning paradigm, were used to confirm that colour perception in the wallaby can be predicted and conclusively explained by the existence of only two cone types. Firstly, colour-mixing experiments revealed a Confusion Point between the three primary colours of a LCD monitor that can be predicted by the cone excitation ratio of the short-and middle-wavelength sensitive cones. Secondly, the wavelength discrimination ability in the wallaby, when tested with monochromatic stimuli, was found to be limited to a narrow range between 440 nm and 500 nm. Lastly, an experiment designed to test the wallaby's ability to discriminate monochromatic lights from a white light provided clear evidence for a Neutral Point around 485 nm where discrimination consistently failed. Relative colour discrimination seemed clearly preferred but it was possible to train a wallaby to perform absolute colour discriminations. The results confirm the tammar wallaby as a dichromat, and so far the only behaviourally confirmed dichromat among the Australian marsupials.	[Ebeling, Wiebke] Curtin Univ, Curtin Inst Radio Astron, Bentley, WA, Australia; [Hemmi, Jan M.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Hemmi, Jan M.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia	Curtin University; University of Western Australia; University of Western Australia	Ebeling, W (corresponding author), Curtin Univ, Curtin Inst Radio Astron, Bentley, WA, Australia.	wiebke.ebeling@curtin.edu.au	Hemmi, Jan M/B-6458-2008	Hemmi, Jan M/0000-0003-4629-9362	Australian Research Council through the ARC Centre of Excellence in Vision Science [CE0561903]; Australian Department of Education, Employment and Workplace Relations (DEEWR); Australian National University; Centre for Visual Sciences at the Australian National University; Australian Research Council	Australian Research Council through the ARC Centre of Excellence in Vision Science(Australian Research Council); Australian Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National University(Australian National University); Centre for Visual Sciences at the Australian National University(Australian National University); Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903) and by the Australian Department of Education, Employment and Workplace Relations (DEEWR) and the Australian National University through postgraduate research scholarships to WE. Additional funding was provided by the Centre for Visual Sciences at the Australian National University. JMH is grateful for his current Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2005, P ROY SOC B-BIOL SCI, V272, P791, DOI 10.1098/rspb.2004.3009; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; BLAKESLEE B, 1988, J COMP PHYSIOL A, V162, P773, DOI 10.1007/BF00610966; Carroll J, 2001, J VISION, V1, P80, DOI 10.1167/1.2.2; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Friedman H, 1967, NATURE, V25, P835; Geisbauer G, 2004, CAN J ZOOL, V82, P660, DOI [10.1139/z04-026, 10.1139/Z04-026]; Hemmi JM, 1999, J COMP PHYSIOL A, V185, P509, DOI 10.1007/s003590050411; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Hemmi JM, 2000, VISION RES, V40, P591, DOI 10.1016/S0042-6989(99)00210-2; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; Jacobs GH, 1981, COMP COLOR VISION; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Roth LSV, 2007, J EXP BIOL, V210, P2795, DOI 10.1242/jeb.007377; Strachan J, 2004, VISUAL NEUROSCI, V21, P223, DOI 10.1017/S0952523804213281; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	25	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86531	10.1371/journal.pone.0086531	http://dx.doi.org/10.1371/journal.pone.0086531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489742	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000047
J	Hanson, J; Lee, SJ; Mohanty, S; Faiz, MA; Anstey, NM; Price, RN; Charunwatthana, P; Bin Yunus, E; Mishra, SK; Tjitra, E; Rahman, R; Nosten, F; Htut, Y; Maude, RJ; Chau, TTH; Phu, NH; Hien, TT; White, NJ; Day, NPJ; Dondorp, AM				Hanson, Josh; Lee, Sue J.; Mohanty, Sanjib; Faiz, M. Abul; Anstey, Nicholas M.; Price, Ric N.; Charunwatthana, Prakaykaew; Bin Yunus, Emran; Mishra, Saroj K.; Tjitra, Emiliana; Rahman, Ridwanur; Nosten, Francois; Htut, Ye; Maude, Richard J.; Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.			Rapid Clinical Assessment to Facilitate the Triage of Adults with Falciparum Malaria, a Retrospective Analysis	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; PLASMODIUM-FALCIPARUM; HOSPITAL MORTALITY; FEBRILE TEMPERATURES; AFRICAN CHILDREN; HYPERGLYCEMIA; PREDICTION; SCORE; RISK; DYSFUNCTION	Background: Most adults dying from falciparum malaria will die within 48 hours of their hospitalisation. An essential component of early supportive care is the rapid identification of patients at greatest risk. In resource-poor settings, where most patients with falciparum malaria are managed, decisions regarding patient care must frequently be made using clinical evaluation alone. Methods: We retrospectively analysed 4 studies of 1801 adults with severe falciparum malaria to determine whether the presence of simple clinical findings might assist patient triage. Results: If present on admission, shock, oligo-anuria, hypo-or hyperglycaemia, an increased respiratory rate, a decreased Glasgow Coma Score and an absence of fever were independently predictive of death. The variables were used to construct a simple clinical algorithm. When applied to the 1801 patients, this algorithm's positive predictive value for survival to 48 hours was 99.4 (95% confidence interval (CI) 97.8-99.9) and for survival to discharge 96.9% (95% CI 94.3-98.5). In the 712 patients receiving artesunate, the algorithm's positive predictive value for survival to 48 hours was 100% (95% CI 97.3-100) and to discharge was 98.5% (95% CI 94.8-99.8). Conclusions: Simple clinical findings are closely linked to the pathophysiology of severe falciparum malaria in adults. A basic algorithm employing these indices can facilitate the triage of patients in settings where intensive care services are limited. Patients classified as low-risk by this algorithm can be safely managed initially on a general ward whilst awaiting senior clinical review and laboratory data.	[Hanson, Josh; Lee, Sue J.; Faiz, M. Abul; Charunwatthana, Prakaykaew; Nosten, Francois; Maude, Richard J.; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Hanson, Josh; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT, Australia; [Lee, Sue J.; Price, Ric N.; Nosten, Francois; Maude, Richard J.; White, Nicholas J.; Day, Nicholas P. J.; Dondorp, Arjen M.] Churchill Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Mohanty, Sanjib; Mishra, Saroj K.] Ispat Hosp, Dept Med, Rourkela, Orissa, India; [Faiz, M. Abul] Dev Care Fdn, Dhaka, Bangladesh; [Bin Yunus, Emran] Chittagong Med Coll, Chittagong, Bangladesh; [Tjitra, Emiliana] Natl Inst Hlth Res & Dev, Minist Hlth, Jakarta, Indonesia; [Rahman, Ridwanur] Shaheed Sharwardhy Med Coll, Dhaka, Bangladesh; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Htut, Ye] Minist Hlth, Dept Med Res, Yangon, Myanmar; [Tran Thi Hong Chau; Nguyen Hoan Phu; Tran Tinh Hien] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Charles Darwin University; Menzies School of Health Research; University of Oxford; Chittagong Medical College; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Mahidol University	Hanson, J (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	drjoshhanson@gmail.com	Maude, Richard James/AAV-3567-2020; Rahman, Ridwanur/K-2637-2019; Hanson, Josh/ABD-9328-2020; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019	Maude, Richard James/0000-0002-5355-0562; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874; Hanson, Josh/0000-0002-1423-3839	Wellcome Trust of Great Britain; National Health and medical Research Council of Australia	Wellcome Trust of Great Britain(Wellcome Trust); National Health and medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this work was received from the Wellcome Trust of Great Britain (http://www.wellcome.ac.uk/) and the National Health and medical Research Council of Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2004, J LEUKOCYTE BIOL, V75, P413, DOI 10.1189/jlb.0503195; [Anonymous], 2012, MAN SEV MAL PRACT HD; Brandts CH, 1997, LANCET, V350, P704, DOI 10.1016/S0140-6736(97)02255-1; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Cretikos M, 2007, RESUSCITATION, V73, P62, DOI 10.1016/j.resuscitation.2006.08.020; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Faiz MA, 2005, LANCET, V366, P717; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Freire AX, 2005, CHEST, V128, P3109, DOI 10.1378/chest.128.5.3109; Hanson J, 2012, J INFECT DIS, V206, P571, DOI 10.1093/infdis/jis400; Hanson J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-217; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Koh GCKW, 2012, EUR J CLIN MICROBIOL, V31, P379, DOI 10.1007/s10096-011-1337-4; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Long HY, 2001, PARASITOL RES, V87, P553, DOI 10.1007/s004360100374; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24; Mohapatra M K, 2009, J Assoc Physicians India, V57, P119; Moon A, 2011, RESUSCITATION, V82, P150, DOI 10.1016/j.resuscitation.2010.09.480; Newton PN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-229; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; TRANG TTM, 1992, CLIN INFECT DIS, V15, P874, DOI 10.1093/clind/15.5.874; Udomsangpetch R, 2002, P NATL ACAD SCI USA, V99, P11825, DOI 10.1073/pnas.172398999; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; YOUNG PJ, 2012, INTENSIVE CARE MED; [No title captured]; [No title captured]	41	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87020	10.1371/journal.pone.0087020	http://dx.doi.org/10.1371/journal.pone.0087020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489828	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000092
J	Lima, AR; Mello, MF; Andreoli, SB; Fossaluza, V; de Araujo, CM; Jackowski, AP; Bressan, RA; Mari, JJ				Lima, Adriano R.; Mello, Marcelo F.; Andreoli, Sergio B.; Fossaluza, Victor; de Araujo, Celia M.; Jackowski, Andrea P.; Bressan, Rodrigo A.; Mari, Jair J.			The Impact of Healthy Parenting As a Protective Factor for Posttraumatic Stress Disorder in Adulthood: A Case-Control Study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DEXAMETHASONE SUPPRESSION TEST; PITUITARY-ADRENAL AXIS; BIOCHEMICAL MANIFESTATIONS; CORPUS-CALLOSUM; LIFE STRESS; DEPRESSION; POLYMORPHISM; CHILDHOOD; GENE	Background: Early life social adversity can influence stress response mechanisms and is associated with anxious behaviour and reductions in callosal area later in life. Objective: To evaluate the association between perceptions of parental bonding in childhood/adolescence, hypothalamic-pituitary-adrenal (HPA) axis response, and callosal structural integrity in adult victims of severe urban violence with and without PTSD. Methods: Seventy-one individuals with PTSD and 62 without the disorder were assessed with the Parental Bonding Instrument (PBI). The prednisolone suppression test was administered to assess cortisol levels, and magnetic resonance imaging was used to assess the total area of the corpus callosum (CC), as well as the areas of callosal subregions. Results: The PBI items related to the perception of 'not having a controlling mother' (OR 4.84; 95% CI [2.26-10.3]; p = 0.01), 'having a caring father' (OR 2.46; 95'% CI [1.18-5.12]; p = 0.02), and 'not having controlling parents' (OR 2.70; 95% CI [1.10-6.63]; p = 0.04) were associated with a lower risk of PTSD. The PTSD group showed a blunted response to the prednisolone suppression test, with lower salivary cortisol levels upon waking up (p = 0.03). Individuals with PTSD had smaller total CC area than those without the disorder, but these differences were not statistically significant (e-value = 0.34). Conclusions: Healthy parental bonding, characterized by the perception of low parental control and high affection, were associated with a lower risk of PTSD in adulthood, suggesting that emotional enrichment and the encouragement of autonomy are protective against PTSD in adulthood.	[Lima, Adriano R.; Mello, Marcelo F.; Andreoli, Sergio B.; Jackowski, Andrea P.; Bressan, Rodrigo A.; Mari, Jair J.] Fed Univ Sao Paulo UNIFESP, Sao Paulo Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Fossaluza, Victor] Univ Sao Paulo, Dept Math & Stat, BR-09500900 Sao Paulo, Brazil; [de Araujo, Celia M.; Jackowski, Andrea P.; Bressan, Rodrigo A.] Fed Univ Sao Paulo UNIFESP, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Lima, AR (corresponding author), Fed Univ Sao Paulo UNIFESP, Sao Paulo Sch Med, Dept Psychiat, Sao Paulo, Brazil.	adriano.rlima@uol.com.br	Mello, Marcelo/T-5474-2019; de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/M-7112-2019; Andreoli, Sergio Baxter/D-9568-2012; Jackowski, Andrea P/D-8616-2012; Bressan, Rodrigo A/E-9178-2010; Fossaluza, Victor/B-3377-2014	Mello, Marcelo/0000-0002-0475-4729; de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Andreoli, Sergio Baxter/0000-0002-1976-0881; Jackowski, Andrea P/0000-0001-8842-5406; Bressan, Rodrigo A/0000-0002-0868-4449; Fossaluza, Victor/0000-0002-9328-0210	National Research Council (CNP) [420122/2005-2]; State of Sao Paulo Funding Agency (FAPESP) [2004/15039-0]	National Research Council (CNP); State of Sao Paulo Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study is part of the Millennium Institute of Mental Health and Violence funded by the National Research Council (CNP grant 420122/2005-2) http://www.brasil.gov.br/para/study/exchange/cnpq-national-council-for-scientific-and-technological-development/br, and the State of Sao Paulo Funding Agency (FAPESP) by the Grant: 2004/15039-0. http://www.fapesp.br/en/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli SB, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-34; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barr CS, 2004, BIOL PSYCHIAT, V55, P733, DOI 10.1016/j.biopsych.2003.12.008; BOWLBY J, 1960, PSYCHOANAL STUD CHIL, V15, P9, DOI 10.1080/00797308.1960.11822566; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Collishaw S, 2007, CHILD ABUSE NEGLECT, V31, P211, DOI 10.1016/j.chiabu.2007.02.004; First MB, 1995, J PERS DISORD, V9, P2, DOI DOI 10.1521/PEDI.1995.9.2.92; Flouri E, 2003, J ADOLESCENCE, V26, P63, DOI 10.1016/S0140-1971(02)00116-1; Fonagy P, 2001, B MENNINGER CLIN, V65, P427, DOI 10.1521/bumc.65.3.427.19844; GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606; GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706; Hauck Simone, 2006, Rev. psiquiatr. Rio Gd. Sul, V28, P162, DOI 10.1590/S0101-81082006000200008; Heim C, 1997, PSYCHOPHARMACOL BULL, V33, P185; Heim C, 1997, ANN NY ACAD SCI, V821, P194, DOI 10.1111/j.1749-6632.1997.tb48279.x; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Kandel ER, 1999, AM J PSYCHIAT, V156, P505; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lima AR, 2010, CURR OPIN PSYCHIATR, V23, P383, DOI 10.1097/YCO.0b013e32833a51ce; MEANEY MJ, 1991, NEUROBIOL AGING, V12, P31, DOI 10.1016/0197-4580(91)90036-J; Mehta D, 2012, NEUROPHARMACOLOGY, V62, P654, DOI 10.1016/j.neuropharm.2011.03.009; MILLER AH, 1992, BIOL PSYCHIAT, V32, P850, DOI 10.1016/0006-3223(92)90175-Y; Nemeroff CB, 1996, MOL PSYCHIATR, V1, P336; Pariante CM, 2002, BIOL PSYCHIAT, V51, P922, DOI 10.1016/S0006-3223(01)01314-2; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Pereira C.A.d.B., 1999, ENTROPY-SWITZ, V1, P99, DOI [10.3390/e1040099, DOI 10.3390/E1040099]; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Segman RH, 2003, CNS SPECTRUMS, V8, P693, DOI 10.1017/S1092852900008889; Seidegard J, 2000, CLIN PHARMACOL THER, V67, P373, DOI 10.1067/mcp.2000.105762; Singer JM, 2004, BIOMETRICAL J, V46, P460, DOI 10.1002/bimj.200310045; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009; Teicher MH, 2004, BIOL PSYCHIAT, V56, P80, DOI 10.1016/j.biopsych.2004.03.016; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Yehuda R, 2010, PSYCHOPHARMACOLOGY, V212, P405, DOI 10.1007/s00213-010-1969-6	39	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87117	10.1371/journal.pone.0087117	http://dx.doi.org/10.1371/journal.pone.0087117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489851	Green Published, gold			2022-12-27	WOS:000330570000105
J	Luo, T; Wischgoll, T; Koo, BK; Huo, YL; Kassab, GS				Luo, Tong; Wischgoll, Thomas; Koo, Bon Kwon; Huo, Yunlong; Kassab, Ghassan S.			IVUS Validation of Patient Coronary Artery Lumen Area Obtained from CT Images	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; THINNING ALGORITHM; SHEAR-STRESS; FLOW; SEGMENTATION; ANGIOGRAPHY; PROGRESSION; ATHEROSCLEROSIS; RECONSTRUCTION; CALCIFICATION	Aims: Accurate computed tomography (CT)-based reconstruction of coronary morphometry (diameters, length, bifurcation angles) is important for construction of patient-specific models to aid diagnosis and therapy. The objective of this study is to validate the accuracy of patient coronary artery lumen area obtained from CT images based on intravascular ultrasound (IVUS). Methods and Results: Morphometric data of 5 patient CT scans with 11 arteries from IVUS were reconstructed including the lumen cross sectional area (CSA), diameter and length. The volumetric data from CT images were analyzed at sub-pixel accuracy to obtain accurate vessel center lines and CSA. A new center line extraction approach was used where an initial estimated skeleton in discrete value was obtained using a traditional thinning algorithm. The CSA was determined directly without any circular shape assumptions to provide accurate reconstruction of stenosis. The root-mean-square error (RMSE) for CSA and diameter were 16.2% and 9.5% respectively. Conclusions: The image segmentation and CSA extraction algorithm for reconstruction of coronary arteries proved to be accurate for determination of vessel lumen area. This approach provides fundamental morphometric data for patient-specific models to diagnose and treat coronary artery disease.	[Luo, Tong; Huo, Yunlong; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wischgoll, Thomas] Wright State Univ, Dept Comp Sci & Engn, Fairborn, OH USA; [Koo, Bon Kwon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Surg, Indianapolis, IN 46202 USA; [Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; Wright State University Dayton; Seoul National University (SNU); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu	Huo, Yunlong/N-8155-2013	Huo, Yunlong/0000-0003-4121-3224	National Heart and Lung Institute [HL-092048]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092048] Funding Source: NIH RePORTER	National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded in part by National Heart and Lung Institute grant HL-092048.IVUS Validation of Patient Coronary Artery Lumen Area Obtained from CT Images. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN EL, 1993, J AM COLL CARDIOL, V22, P1141, DOI 10.1016/0735-1097(93)90429-5; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; BERTRAND G, 1995, P SOC PHOTO-OPT INS, V2356, P113, DOI 10.1117/12.198601; Brunner D, 2004, P COMPUTER GRAPHICS, V2004, P48; Calvo B, 2007, INT J NUMER METH ENG, V69, P2036, DOI 10.1002/nme.1825; Cebral JR, 2001, ASME, V50, P619; Cornea ND, 2007, IEEE T VIS COMPUT GR, V13, P530, DOI 10.1109/TVCG.2007.1002; Do S, 2011, PHYS MED BIOL, V56, P7109, DOI 10.1088/0031-9155/56/22/008; Florin C, 2005, LECT NOTES COMPUT SC, V3749, P246; Gong W., 1990, Proceedings. 10th International Conference on Pattern Recognition (Cat. No.90CH2898-5), P188, DOI 10.1109/ICPR.1990.118087; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Hoffmann KR, 2002, MED PHYS, V29, P1622, DOI 10.1118/1.1488603; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Jung JW, 2006, J BIOMECH, V39, P2064, DOI 10.1016/j.jbiomech.2005.06.023; Koo BK, 2011, JACC-CARDIOVASC INTE, V4, P803, DOI 10.1016/j.jcin.2011.03.013; Krams R, 1997, ARTERIOSCL THROM VAS, V17, P2061, DOI 10.1161/01.ATV.17.10.2061; Laban M, 1995, COMPUT CARDIOL, P325, DOI 10.1109/CIC.1995.482638; Lacoste C, 2006, I S BIOMED IMAGING, P157; Ladak HM, 2000, J BIOMECH ENG-T ASME, V122, P96, DOI 10.1115/1.429646; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; Lohou C, 2004, DISCRETE APPL MATH, V139, P171, DOI 10.1016/j.dam.2002.11.002; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Moore JA, 1999, J BIOMECH ENG-T ASME, V121, P265, DOI 10.1115/1.2798319; Nissen SE, 2001, CIRCULATION, V103, P604, DOI 10.1161/01.CIR.103.4.604; Palagyi K, 1999, GRAPH MODEL IM PROC, V61, P199, DOI 10.1006/gmip.1999.0498; Palagyi K, 1999, LECT NOTES COMPUT SC, V1568, P325; Rollano-Hijarrubia E, 2005, P SOC PHOTO-OPT INS, V5745, P67, DOI 10.1117/12.595491; Rollano-Hijarrubia E, 2009, IEEE T MED IMAGING, V28, P446, DOI 10.1109/TMI.2008.2006529; SALZAR RS, 1995, J BIOMECH, V28, P1333, DOI 10.1016/0021-9290(95)00005-3; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Smith N, 2006, AM J PHYSL HEART CIR, V291; STEIN PD, 1994, AM J CARDIOL, V73, P431, DOI 10.1016/0002-9149(94)90671-8; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; THUBRIKAR MJ, 1988, ARTERIOSCLEROSIS, V8, P410, DOI 10.1161/01.ATV.8.4.410; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; TSAO YF, 1981, COMPUT VISION GRAPH, V17, P315, DOI 10.1016/0146-664X(81)90011-3; Voros S, 2011, JACC-CARDIOVASC INTE, V4, P198, DOI 10.1016/j.jcin.2010.10.008; Wang KC, 1999, IEEE ENG MED BIOL, V18, P33, DOI 10.1109/51.805142; Wischgoll T, 2008, ANN BIOMED ENG, V36, P356, DOI 10.1007/s10439-008-9443-x; Zhang L, 2005, INVEST RADIOL, V40, P661, DOI 10.1097/01.rli.0000178433.32526.e0; Zheng Y, 2011, P SPIE MED IMAGING	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86949	10.1371/journal.pone.0086949	http://dx.doi.org/10.1371/journal.pone.0086949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489811	Green Published, gold			2022-12-27	WOS:000330570000083
J	McAssey, MP; Bijma, F; Tarigan, B; van Pelt, J; van Ooyen, A; de Gunst, M				McAssey, Michael P.; Bijma, Fetsje; Tarigan, Bernadetta; van Pelt, Jaap; van Ooyen, Arjen; de Gunst, Mathisca			A Morpho-Density Approach to Estimating Neural Connectivity	PLOS ONE			English	Article							SMALL-WORLD; ORGANIZATION	Neuronal signal integration and information processing in cortical neuronal networks critically depend on the organization of synaptic connectivity. Because of the challenges involved in measuring a large number of neurons, synaptic connectivity is difficult to determine experimentally. Current computational methods for estimating connectivity typically rely on the juxtaposition of experimentally available neurons and applying mathematical techniques to compute estimates of neural connectivity. However, since the number of available neurons is very limited, these connectivity estimates may be subject to large uncertainties. We use a morpho-density field approach applied to a vast ensemble of model-generated neurons. A morpho-density field (MDF) describes the distribution of neural mass in the space around the neural soma. The estimated axonal and dendritic MDFs are derived from 100,000 model neurons that are generated by a stochastic phenomenological model of neurite outgrowth. These MDFs are then used to estimate the connectivity between pairs of neurons as a function of their inter-soma displacement. Compared with other density-field methods, our approach to estimating synaptic connectivity uses fewer restricting assumptions and produces connectivity estimates with a lower standard deviation. An important requirement is that the model-generated neurons reflect accurately the morphology and variation in morphology of the experimental neurons used for optimizing the model parameters. As such, the method remains subject to the uncertainties caused by the limited number of neurons in the experimental data set and by the quality of the model and the assumptions used in creating the MDFs and in calculating estimating connectivity. In summary, MDFs are a powerful tool for visualizing the spatial distribution of axonal and dendritic densities, for estimating the number of potential synapses between neurons with low standard deviation, and for obtaining a greater understanding of the relationship between neural morphology and network connectivity.	[McAssey, Michael P.; Bijma, Fetsje; Tarigan, Bernadetta; de Gunst, Mathisca] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [van Pelt, Jaap; van Ooyen, Arjen] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	McAssey, MP (corresponding author), Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands.	m.p.mcassey@auc.nl	Tarigan, Bernadetta/AAD-1843-2019		Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research); NWO-CLS grant [635.100.017]; Neuroscience Campus Amsterdam	Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research); NWO-CLS grant; Neuroscience Campus Amsterdam	This work was supported by Nederlandse Organizatie voor Wetenschappelijk Onderzoek (Netherlands Organization of Scientific Research, www.nwo.nl), NWO-CLS grant 635.100.017, and Neuroscience Campus Amsterdam (http://www.neurosciencecampus-amsterdam.nl/en/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Amirikian B, 2005, PLOS COMPUT BIOL, V1, P74, DOI 10.1371/journal.pcbi.0010011; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Koene RA, 2009, NEUROINFORMATICS, V7, P195, DOI 10.1007/s12021-009-9052-3; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; LILEY DTJ, 1994, NETWORK-COMP NEURAL, V5, P175, DOI 10.1088/0954-898X/5/2/004; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Uttley A, 1956, P R SOC LOND, V142, P229	18	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86526	10.1371/journal.pone.0086526	http://dx.doi.org/10.1371/journal.pone.0086526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489738	Green Published, gold			2022-12-27	WOS:000330570000045
J	Musharraf, A; Kruspe, D; Tomasch, J; Besenbeck, B; Englert, C; Landgraf, K				Musharraf, Amna; Kruspe, Dagmar; Tomasch, Juergen; Besenbeck, Birgit; Englert, Christoph; Landgraf, Kathrin			BOR-Syndrome-Associated Eya1 Mutations Lead to Enhanced Proteasomal Degradation of Eya1 Protein	PLOS ONE			English	Article							BRANCHIOOTORENAL SYNDROME; EYES-ABSENT; PHOSPHATASE-ACTIVITY; TYROSINE-PHOSPHATASE; DROSOPHILA; GENES; KIDNEY; THYMUS; NEPHROGENESIS; ACTIVATION	Mutations in the human EYA1 gene have been associated with several human diseases including branchio-oto (BO) and branchio-oto-renal (BOR) syndrome, as well as congenital cataracts and ocular anterior segment anomalies. BOR patients suffer from severe malformations of the ears, branchial arches and kidneys. The phenotype of Eya1-heterozygous mice resembles the symptoms of human patients suffering from BOR syndrome. The Eya1 gene encodes a multifunctional protein that acts as a protein tyrosine phosphatase and a transcriptional coactivator. It has been shown that Eya1 interacts with Six transcription factors, which are also required for nuclear translocation of the Eya1 protein. We investigated the effects of seven disease-causing Eya1 missense mutations on Eya1 protein function, in particular cellular localization, ability to interact with Six proteins, and protein stability. We show here that the BOR-associated Eya1 missense mutations S454P, L472R, and L550P lead to enhanced proteasomal degradation of the Eya1 protein in mammalian cells. Moreover, Six proteins lead to a significant stabilization of Eya1, which is caused by Six-mediated protection from proteasomal degradation. In case of the mutant L550P, loss of interaction with Six proteins leads to rapid protein degradation. Our observations suggest that protein destabilization constitutes a novel disease causing mechanism for Eya1.	[Musharraf, Amna; Kruspe, Dagmar; Tomasch, Juergen; Besenbeck, Birgit; Englert, Christoph; Landgraf, Kathrin] Fritz Lipmann Inst eV FLI, Leibniz Inst Age Res, Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Landgraf, K (corresponding author), Univ Leipzig, Hosp Children & Adolescents, Ctr Pediat Res Leipzig CPL, D-04109 Leipzig, Germany.	Kathrin.Landgraf@medizin.uni-leipzig.de	Landgraf, Kathrin/J-4937-2016	Landgraf, Kathrin/0000-0002-6878-6033; Englert, Christoph/0000-0002-5931-3189; Tomasch, Jurgen/0000-0002-3914-2781	Deutsche Forschungsgemeinschaft [SFB604]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft [SFB604, project C7 to C.E.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chang EH, 2004, HUM MUTAT, V23, P582, DOI 10.1002/humu.20048; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; Fan XM, 2000, J BIOL CHEM, V275, P32129, DOI 10.1074/jbc.M004577200; FRASER FC, 1980, AM J MED GENET, V7, P341, DOI 10.1002/ajmg.1320070316; Hoskins BE, 2007, AM J HUM GENET, V80, P800, DOI 10.1086/513322; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kumar S, 1997, GENET TEST, V1, P243, DOI 10.1089/gte.1997.1.243; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Landgraf K, 2010, MOL CELL BIOL, V30, P5764, DOI 10.1128/MCB.01645-09; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Musharraf A, 2008, CHEMBIOCHEM, V9, P2285, DOI 10.1002/cbic.200800224; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Patrick AN, 2009, J BIOL CHEM, V284, P20781, DOI 10.1074/jbc.M109.016832; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Ruf RG, 2004, P NATL ACAD SCI USA, V101, P8090, DOI 10.1073/pnas.0308475101; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sun JB, 2013, MOL CELL BIOL, V33, P927, DOI 10.1128/MCB.01516-12; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; WEIH F, 1994, ONCOGENE, V9, P3289; Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Xu PX, 2002, DEVELOPMENT, V129, P3033	37	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87407	10.1371/journal.pone.0087407	http://dx.doi.org/10.1371/journal.pone.0087407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489909	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000141
J	Mutasa-Apollo, T; Shiraishi, RW; Takarinda, KC; Dzangare, J; Mugurungi, O; Murungu, J; Abdul-Quader, A; Woodfill, CJI				Mutasa-Apollo, Tsitsi; Shiraishi, Ray W.; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen; Murungu, Joseph; Abdul-Quader, Abu; Woodfill, Celia J. I.			Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD SUPPRESSION; MULTIPLE IMPUTATION; MISSING VALUES; ADULT PATIENTS; SCALING-UP; LOW-INCOME; CARE; MORTALITY; DECENTRALIZATION	Background: Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from,5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. Objective: To determine improvement in health status, retention and factors associated with attrition among HIV-infected patients on ART. Methods: A retrospective review of abstracted patient records of adults >= 15 years who initiated ART from 2007 to 2009 was done. Frequencies and medians were calculated for rates of retention in care and changes in key health status outcomes at 6, 12, 24 and 36 months respectively. Cox proportional hazards models were used to determine factors associated with attrition. Results: Of the 3,919 patients, 64% were female, 86% were either WHO clinical stage III or IV. Rates of patient retention at 6, 12, 24 and 36 months were 90.7%, 78.1%, 68.8% and 64.4%, respectively. After ART initiation, median weight gains at 6, 12, and 24 months were 3, 4.5, and 5.0 kgs whilst median CD4+ cell count gains at 6, 12 and 24 months were 122, 157 and 279 cells/mu L respectively. Factors associated with an increased risk of attrition included male gender (AHR 1.2; 95% CI, 1.1-1.4), baseline WHO stage IV (AHR 1.7; 95% CI, 1.1-2.6), lower baseline body weight (AHR 2.0; 95% CI, 1.4-2. 8) and accessing care from higher level healthcare facilities (AHR 3.5; 95% 1.1-11.2). Conclusions: Our findings with regard to retention as well as clinical and immunological improvements following uptake of ART, are similar to what has been found in other settings. Factors influencing attrition also mirror those found in other parts of sub-Saharan Africa. These findings suggest the need to strengthen earlier diagnosis and treatment to further improve treatment outcomes. Whilst decentralisation improves ART coverage it should be coupled with strategies aimed at improving patient retention.	[Mutasa-Apollo, Tsitsi; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen; Murungu, Joseph] Zimbabwe Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe; [Woodfill, Celia J. I.] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Accra, Ghana; [Shiraishi, Ray W.; Abdul-Quader, Abu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Mutasa-Apollo, T (corresponding author), Zimbabwe Minist Hlth & Child Care, AIDS & TB Dept, Harare, Zimbabwe.	tsitsiapollo1@gmail.com		Shiraishi, Ray/0000-0001-7640-0666	U.S. Centers for Disease Control; Expanded Support Program for HIV/AIDS (ESP)	U.S. Centers for Disease Control; Expanded Support Program for HIV/AIDS (ESP)	The survey was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and also the Expanded Support Program for HIV/AIDS (ESP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GLOB UPD HIV TREATM, P7; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brennan AT, 2013, TROP MED INT HEALTH, V18, P619, DOI 10.1111/tmi.12079; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Elston JWT, 2009, INT J STD AIDS, V20, P221, DOI 10.1258/ijsa.2008.008449; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fehd RJ, 1998, COMPARWS COMP SUMMAR; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Fox MP, 2010, AIDS, V24, P2041, DOI 10.1097/QAD.0b013e32833c703e; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Gilks C, 2006, ANTIRETROVIRAL THERA, P13; Hanke SH, 2012, ZIMBABWE HYPERINFLAT; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GLOB REP UNAIDS REP, P253; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, REP GLOB HIV AIDS EP, P272; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Koethe JR, 2009, CLIN INFECT DIS, V49, P787, DOI 10.1086/605285; Kuwane B, 2009, LANCET, V374, P1329, DOI 10.1016/S0140-6736(09)61823-7; Lambdin BH, 2011, JAIDS-J ACQ IMM DEF, V57, pE33, DOI 10.1097/QAI.0b013e3182167e90; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Meldrum A, 2008, LANCET, V371, P1059, DOI 10.1016/S0140-6736(08)60468-7; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Ministry of Health and Child Welfare and WHO Zimbabwe Country office, 2012, EXP SUPP PROGR HIV A; Ministry of Health and Child Welfare (MOHCW), 2013, ZIMB HIV EST 2012, P17; Ministry of Health and Child Welfare (MOHCW), 2009, ZIMB ART ANN REP 200, P15; Ministry of Health and Child Welfare (MOHCW), 2011, ZIMB GUID DEC OI ART, P12; Ministry of Health and Child Welfare (MOHCW), 2008, ZIMB ART ANN REP 200, P17; Ministry of Health and Child Welfare (MOHCW), 2006, ZIMB ART ANN REP 200, P49; Ministry of Health and Child Welfare (MOHCW), 2012, REP NAT HIV DRUG RES, P41; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Muchedzi A, 2012, 19 INT AIDS C; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Perriens J, 2010, ADULT ANTIRETROVIRAL; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Staveteig S, 2013, DHS COMP REPORTS, P39; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-124; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; United Nations General Assembly, 2011, 2011 POL DECL HIV AI, P8; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO UNAIDS UNICEF, 2011, GLOB PROGR EL LYMPH, P93; World Health Organization (WHO) Dept. of HIV/AIDS WHO Integrated Management of Adolescent and Adult Illness Project WHO Integrated Management of Childhood Project, 2007, CHRON HIV CAR ART PR, P61; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2, P220	72	64	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86305	10.1371/journal.pone.0086305	http://dx.doi.org/10.1371/journal.pone.0086305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489714	Green Published, gold			2022-12-27	WOS:000330570000032
J	Seitz, K; Dursch, V; Harnos, J; Bryja, V; Gentzel, M; Schambony, A				Seitz, Katharina; Duersch, Verena; Harnos, Jakub; Bryja, Vitezslav; Gentzel, Marc; Schambony, Alexandra			beta-Arrestin Interacts with the Beta/Gamma Subunits of Trimeric G-Proteins and Dishevelled in the Wnt/Ca2+ Pathway in Xenopus Gastrulation	PLOS ONE			English	Article							CONVERGENT EXTENSION MOVEMENTS; WNT SIGNALING PATHWAYS; WNT/BETA-CATENIN; VERTEBRATE GASTRULATION; PARAXIAL PROTOCADHERIN; TISSUE SEPARATION; ACTIVATION; FRIZZLED-7; LAEVIS; KINASE	beta-Catenin independent, non-canonical Wnt signaling pathways play a major role in the regulation of morphogenetic movements in vertebrates. The term non-canonical Wnt signaling comprises multiple, intracellularly divergent, Wnt-activated and beta-Catenin independent signaling cascades including the Wnt/Planar Cell Polarity and the Wnt/Ca2+ cascades. Wnt/Planar Cell Polarity and Wnt/Ca2+ pathways share common effector proteins, including the Wnt ligand, Frizzled receptors and Dishevelled, with each other and with additional branches of Wnt signaling. Along with the aforementioned proteins, beta-Arrestin has been identified as an essential effector protein in the Wnt/beta-Catenin and the Wnt/Planar Cell Polarity pathway. Our results demonstrate that beta-Arrestin is required in the Wnt/Ca2+ signaling cascade upstream of Protein Kinase C (PKC) and Ca2+/Calmodulin-dependent Protein Kinase II (CamKII). We have further characterized the role of beta-Arrestin in this branch of non-canonical Wnt signaling by knock-down and rescue experiments in Xenopus embryo explants and analyzed protein-protein interactions in 293T cells. Functional interaction of beta-Arrestin, the beta subunit of trimeric G-proteins and Dishevelled is required to induce PKC activation and membrane translocation. In Xenopus gastrulation, beta-Arrestin function in Wnt/Ca2+ signaling is essential for convergent extension movements. We further show that beta-Arrestin physically interacts with the beta subunit of trimeric G-proteins and Dishevelled, and that the interaction between beta-Arrestin and Dishevelled is promoted by the beta/gamma subunits of trimeric G-proteins, indicating the formation of a multiprotein signaling complex.	[Seitz, Katharina; Duersch, Verena; Schambony, Alexandra] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany; [Harnos, Jakub; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, CS-61265 Brno, Czech Republic; [Gentzel, Marc] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Erlangen Nuremberg; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Max Planck Society	Schambony, A (corresponding author), Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany.	alexandra.schambony@fau.de	Bryja, Vít?zslav/H-1925-2014; Harnos, Jakub/AAE-7855-2021; Bryja, Vítězslav/P-4217-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Rauschenberger, Verena/0000-0002-3311-7489; Harnos, Jakub/0000-0002-0752-9260; Schambony, Alexandra/0000-0001-8771-5487; Gentzel, Marc/0000-0002-4482-6010	Deutsche Forschungsgemeinschaft [SCHA965/6-1]; Max-Planck-Society; Czech Science Foundation [204/09/0498, 204/09/J030]; EMBO Installation Grant; Ministry of Education Youth and Sport of the Czech Republic [MSM0021622430]; Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Society(Max Planck Society); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Friedrich-Alexander-Universitat Erlangen-Nurnberg	This work was supported by Deutsche Forschungsgemeinschaft (SCHA965/6-1 to A. S., www.dfg.de), the Max-Planck-Society (to M. G., www.mpg.de) and by Czech Science Foundation (204/09/0498, 204/09/J030 to V. B., www.gacr.cz) and EMBO Installation Grant, the Ministry of Education Youth and Sport of the Czech Republic (MSM0021622430 to V. B., www.embo.org). In addition, the authors acknowledge support by Deutsche Forschungsgemeinschaft (www.dfg.de) and Friedrich-Alexander-Universitat Erlangen-Nurnberg (www.fau.de) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim GH, 2007, EMBO J, V26, P2513, DOI 10.1038/sj.emboj.7601688; Kim GH, 2013, BIOCHEM BIOPH RES CO, V435, P182, DOI 10.1016/j.bbrc.2013.04.088; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Medina A, 2004, EMBO J, V23, P3249, DOI 10.1038/sj.emboj.7600329; Nichols AS, 2013, CELL SIGNAL, V25, P1468, DOI 10.1016/j.cellsig.2013.03.009; Nieuwkoop PD, 1975, NORMAL TABLES XENOPU, P162; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Penzo-Mendez A, 2003, DEV BIOL, V257, P302, DOI 10.1016/S0012-1606(03)00067-8; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; SHIH J, 1992, DEVELOPMENT, V116, P901; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Unterseher F, 2004, EMBO J, V23, P3259, DOI 10.1038/sj.emboj.7600332; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	36	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87132	10.1371/journal.pone.0087132	http://dx.doi.org/10.1371/journal.pone.0087132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489854	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000107
J	Zhao, LP; Wu, F; Jin, LG; Lu, TT; Yang, LH; Pan, XB; Shao, CF; Li, XK; Lin, ZF				Zhao, Leping; Wu, Fan; Jin, Leigang; Lu, Tingting; Yang, Lihui; Pan, Xuebo; Shao, Chuanfeng; Li, Xiaokun; Lin, Zhuofeng			Serum CXCL16 as a Novel Marker of Renal Injury in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SCAVENGER RECEPTOR; CHEMOKINE LIGAND-16; DENSITY-LIPOPROTEIN; CELL-ADHESION; ATHEROSCLEROSIS; NEPHROPATHY; CXCL16/SR-PSOX; PODOCYTES	Background: Soluble C-X-C chemokine ligand 16 (CXCL16), a scavenger receptor for oxidized low density lipoprotein, has been shown to promote atherogenic effects in vivo and to predict long-term mortality in acute coronary syndrome. The aim of this study was to explore the association of circulating CXCL16 levels with diabetic subjects with and without renal disease. Methodology/Principal Findings: One hundred twenty Chinese subjects, which included patients with type 2 diabetes mellitus (T2DM), diabetic nephropathy (DN), and CKD, as well as healthy controls, were enrolled in this study. Serum CXCL16 levels were examined by immunoassay and other clinical biochemical parameters were tested based on standard methods. Our results indicated that, HDL and LDL cholesterol levels are significantly different in DN but not in T2D patients in comparison with healthy subjects. On the other hand, Serum CXCL16 levels were significantly increased in DN subjects compared with age and gender matched healthy and T2DM subjects (p<0.05 respectively). However, no significant changes in serum CXCL16 levels were found between T2DM and healthy subjects. Furthermore, serum CXCL16 concentration negatively correlated with estimated glomerular filtrate rate, creatinine clearance rate and blood albumin, and positively with 24 h proteinuria, blood urea nitrogen (BUN), creatinine, and uric acid after adjusting for age, gender and BMI in subjects with DN. Multiple stepwise regression analyses indicated that serum CXCL16 levels were independently associated with serum 24 h proteinuria, and BUN (p<0.05 respectively). Conclusion: Serum CXCL16 may be an indicator of renal injury in subjects with T2DM. Understanding the exact mechanism of elevated CXCL16 in subjects with DN requires further study.	[Zhao, Leping; Yang, Lihui; Shao, Chuanfeng] Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China; [Wu, Fan; Lin, Zhuofeng] Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China; [Jin, Leigang; Lu, Tingting; Pan, Xuebo; Li, Xiaokun; Lin, Zhuofeng] Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Jilin Agricultural University; Wenzhou Medical University	Lin, ZF (corresponding author), Jilin Agr Univ, Engn Res Ctr Bioreactor & Pharmaceut Dev, Minist Educ, Changchun, Jilin, Peoples R China.	zhuofenglin@wzmc.edu.cn		Leigang, Jin/0000-0002-6916-4009	Scientific Technological Projects of Wenzhou [H20100026, H2009]; Natural Science Project of Zhejiang Province [Y2110339, LY12H07002]	Scientific Technological Projects of Wenzhou; Natural Science Project of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by grants from "Scientific Technological Projects of Wenzhou'', H20100026 (Z. Lin), H2009 (X. Pan), and Natural Science Project of Zhejiang Province, Y2110339 (Z. Lin) and LY12H07002 (L.Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2005, AM J RESP CRIT CARE, V172, P1290, DOI 10.1164/rccm.200501-142OC; Aslanian AM, 2006, CIRCULATION, V114, P583, DOI 10.1161/CIRCULATIONAHA.105.540583; Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276; Barlic J, 2009, J IMMUNOL, V182, P7928, DOI 10.4049/jimmunol.0804112; BERKMAN J, 1973, METABOLISM, V21, P715, DOI 10.1016/0026-0495(73)90243-6; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gong Q, 2012, CLIN BIOCHEM, V45, P1368, DOI 10.1016/j.clinbiochem.2012.05.014; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Gutwein P, 2009, J CELL MOL MED, V13, P3809, DOI 10.1111/j.1582-4934.2009.00761.x; Gutwein P, 2009, AM J PATHOL, V174, P2061, DOI 10.2353/ajpath.2009.080960; Jansson AM, 2009, CIRCULATION, V119, P3181, DOI 10.1161/CIRCULATIONAHA.108.806877; Kouroumichakis I, 2012, EUR J INTERN MED, V23, P309, DOI 10.1016/j.ejim.2011.12.007; Lin ZF, 2011, EUR J CLIN INVEST, V41, P836, DOI 10.1111/j.1365-2362.2011.02473.x; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Lin ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015534; Mathiesen ER, 2012, CLIN J AM SOC NEPHRO, V7, P2081, DOI 10.2215/CJN.00920112; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Okamura DM, 2007, AM J PHYSIOL-RENAL, V293, pF575, DOI 10.1152/ajprenal.00063.2007; Schramme A, 2008, KIDNEY INT, V74, P328, DOI 10.1038/ki.2008.181; Sheikine Y, 2008, ATHEROSCLEROSIS, V197, P487, DOI 10.1016/j.atherosclerosis.2007.11.034; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wuttge DM, 2004, ARTERIOSCL THROM VAS, V24, P750, DOI 10.1161/01.ATV.0000124102.11472.36	26	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87786	10.1371/journal.pone.0087786	http://dx.doi.org/10.1371/journal.pone.0087786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489966	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000182
J	Chen, P; Zhang, XL; Zhao, TJ; Li, Y; Gai, JY				Chen, Pei; Zhang, Xiaolian; Zhao, Tuanjie; Li, Yan; Gai, Junyi			Genome-Wide Identification and Characterization of RBR Ubiquitin Ligase Genes in Soybean	PLOS ONE			English	Article							FAMILY; RING; ARABIDOPSIS; SYSTEM; PARKIN; DOMAIN; PALEOPOLYPLOIDY; FINGER; MODEL	RBR (RING1-IBR-RING2) proteins play an important role in protein ubiquitination and are involved in many cellular processes. Recent studies showed plant RBR genes were induced by abiotic and biotic stresses. However, detailed studies on RBR genes in the important oil crop, soybean (Glycine max (L.) Merr.), is still lacking. Here we performed a genome-wide search and identified 24 RBR domain-containing genes from the soybean genome sequence and cloned 11 of them. Most soybean RBR proteins contain a highly conserved RBR supra-domain. Phylogenetic analyses indicated all 24 soybean RBR proteins are most related to the RBR proteins from Phaseolus vulgaris, and could be classified into seven groups including Ariadne A, Ariadne B, ARA54, Plant IIA, Plant IIB, Plant IIC, and Helicase. Tandem duplication and block duplication were found among the Ariadne B and Plant IIC group of soybean RBR genes. Despite the conserved RBR supra-domain, there are extensive variations in the additional protein motifs and exon-intron structures between different groups, which indicate they might have diverse functions. Most soybean RBR proteins are predicted to localize in nucleus, and four of them were experimentally confirmed by GFP fusion proteins. Soybean RBR genes are broadly expressed in many tissue types with a little more abundant in the roots and flowers than leaves, stems, and seeds. The expression of GmRTRTP3 (Plant IIB) and GmRTRTP5 (Plant IIC) are induced by NaCl treatment, which suggests these RBR genes might be involved in soybean response to abiotic stresses.	[Chen, Pei; Zhang, Xiaolian; Zhao, Tuanjie; Li, Yan; Gai, Junyi] Nanjing Agr Univ, Soybean Res Inst, Natl Ctr Soybean Improvement,Natl Key Lab Crop Ge, MOA Key Lab Biol & Genet Improvement Soybean Gen, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, Y (corresponding author), Nanjing Agr Univ, Soybean Res Inst, Natl Ctr Soybean Improvement,Natl Key Lab Crop Ge, MOA Key Lab Biol & Genet Improvement Soybean Gen, Nanjing, Jiangsu, Peoples R China.	yanli1@njau.edu.cn; sri@njau.edu.cn			National Key Basic Research Program of China [2011CB1093, 2010CB1259]; National Hightech R & D Program of China [2011AA10A105, 2012AA101106]; Natural Science Foundation of China [31071442]; Program for New Century Excellent Talents in University [NCET-12-0891]; MOE 111 Project [B08025]; MOA Public Profit Program [200803060]; Jiangsu Higher Education PAPD Program	National Key Basic Research Program of China(National Basic Research Program of China); National Hightech R & D Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE 111 Project(Ministry of Education, China - 111 Project); MOA Public Profit Program; Jiangsu Higher Education PAPD Program	This work was supported by the National Key Basic Research Program of China (2011CB1093, 2010CB1259), the National Hightech R & D Program of China (2011AA10A105, 2012AA101106), the Natural Science Foundation of China (31071442), the Program for New Century Excellent Talents in University (NCET-12-0891), the MOE 111 Project (B08025), the MOA Public Profit Program (200803060), and the Jiangsu Higher Education PAPD Program. The funders had no role in study design, data collection and analysis, decision or preparation of the manuscript.	Aguilera M, 2000, GENETICS, V155, P1231; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Duda DM, 2013, STRUCTURE; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Lang-Mladek C, 2012, PHYSIOL PLANTARUM, V145, P527, DOI 10.1111/j.1399-3054.2011.01561.x; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Qiu XH, 2006, DEV BIOL, V291, P239, DOI 10.1016/j.ydbio.2005.11.045; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Schallau A, 2010, PLANT J, V62, P773, DOI 10.1111/j.1365-313X.2010.04188.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Steggerda SM, 2002, INT REV CYTOL, V217, P41; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wauer T, 2013, EMBO J; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038	47	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87282	10.1371/journal.pone.0087282	http://dx.doi.org/10.1371/journal.pone.0087282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489889	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000124
J	Marley, CL; Fychan, R; Davies, JW; Scollan, ND; Richardson, RI; Theobald, VJ; Genever, E; Forbes, AB; Sanderson, R				Marley, Christina L.; Fychan, Rhun; Davies, John W.; Scollan, Nigel D.; Richardson, R. Ian; Theobald, Vince J.; Genever, Elizabeth; Forbes, Andy B.; Sanderson, Ruth			Effects of Chicory/Perennial Ryegrass Swards Compared with Perennial Ryegrass Swards on the Performance and Carcass Quality of Grazing Beef Steers	PLOS ONE			English	Article							CHICORY CICHORIUM-INTYBUS; TREFOIL LOTUS-CORNICULATUS; GASTROINTESTINAL NEMATODES; MINERAL-COMPOSITION; LOLIUM-PERENNE; FORAGE; PEPSINOGEN; HERBAGE; GROWTH; CATTLE	An experiment investigated whether the inclusion of chicory (Cichorium intybus) in swards grazed by beef steers altered their performance, carcass characteristics or parasitism when compared to steers grazing perennial ryegrass (Lolium perenne). Triplicate 2-ha plots were established with a chicory/ryegrass mix or ryegrass control. Forty-eight Belgian Bluecross steers were used in the first grazing season and a core group (n = 36) were retained for finishing in the second grazing season. The experiment comprised of a standardisation and measurement period. During standardisation, steers grazed a ryegrass/white clover pasture as one group. Animals were allocated to treatment on the basis of liveweight, body condition and faecal egg counts (FEC) determined 7 days prior to the measurement period. The measurement period ran from 25 May until 28 September 2010 and 12 April until 11 October 2011 in the first and second grazing year. Steers were weighed every 14 days at pasture or 28 days during housing. In the first grazing year, faecal samples were collected for FEC and parasite cultures. At the end of the first grazing year, individual blood samples were taken to determine O. ostertagi antibody and plasma pepsinogen levels. During winter, animals were housed as one group and fed silage. In the second grazing year, steers were slaughtered when deemed to reach fat class 3. Data on steer performance showed no differences in daily liveweight gain which averaged 1.04 kg/day. The conformation, fat grade and killing out proportion of beef steers grazing chicory/ryegrass or ryegrass were not found to differ. No differences in FEC, O. ostertagi antibody or plasma pepsinogen levels of beef steers grazing either chicory/ryegrass or ryegrass were observed. Overall, there were no detrimental effects of including chicory in swards grazed by beef cattle on their performance, carcass characteristics or helminth parasitism, when compared with steers grazing ryegrass.	[Marley, Christina L.; Fychan, Rhun; Davies, John W.; Scollan, Nigel D.; Theobald, Vince J.; Sanderson, Ruth] Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Gogerddan, Ceredigion, Wales; [Richardson, R. Ian] Univ Bristol, Div Farm Anim Sci DFAS, Food Sci & Food Safety Grp, Bristol, Avon, England; [Genever, Elizabeth] Agr & Hort Dev Board, EBLEX, Warwick, England; [Forbes, Andy B.] Merial Anim Hlth, Lyon, France	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Bristol; Agriculture & Horticulture Development Board (AHDB); Merial SASU	Marley, CL (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Gogerddan, Ceredigion, Wales.	cvm@aber.ac.uk		Sanderson, Ruth/0000-0001-5569-5493; Richardson, Ian/0000-0002-3514-7040; Forbes, Andrew/0000-0003-4269-914X	EBLEX	EBLEX	This work was funded by EBLEX (www.eblex.org.uk), with parasitology support and advice from Merial SAS, France (http://www.merial.com). Seed for the swards was donated by Germinal Holdings Ltd, UK. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Barry TN, 1998, J AGR SCI, V131, P251, DOI 10.1017/S002185969800584X; Barthram GT, 1986, EXPT TECHNIQUES HFRO, V1884-1985, P29; Belesky DP, 2001, AGRON J, V93, P468, DOI 10.2134/agronj2001.932468x; BERGHEN P, 1993, VET PARASITOL, V46, P175, DOI 10.1016/0304-4017(93)90057-T; BERGHEN P, 1987, AM J VET RES, V48, P664; Charlier J, 2005, PREV VET MED, V68, P277, DOI 10.1016/j.prevetmed.2005.01.011; CLARK DA, 1990, NEW ZEAL J AGR RES, V33, P219, DOI 10.1080/00288233.1990.10428413; Cockayne AH, 1915, NZ J AGR, VII, P468; Cosgrove G. P., 2003, Proceedings of the New Zealand Grassland Association, V65, P21; CUSHNAHAN A, 1994, ANIM PROD, V59, P415, DOI 10.1017/S0003356100007935; DAVIES DA, 1989, GRASS FORAGE SCI, V44, P213, DOI 10.1111/j.1365-2494.1989.tb01929.x; Dorny P, 1998, RES VET SCI, V65, P259, DOI 10.1016/S0034-5288(98)90153-9; Dorny P, 2000, VET PARASITOL, V89, P277, DOI 10.1016/S0304-4017(00)00220-X; Elliot RH, 1942, CLIFTON PARK SYSTEM; Epe C, 1999, VET REC, V144, P380, DOI 10.1136/vr.144.14.380; Eysker M, 2000, PARASITOLOGY, V120, pS109, DOI 10.1017/S0031182099005752; Fraser T. J., 1988, Proceedings of the New Zealand Grassland Association, V49, P193; Fychan R, 2011, P BRIT GRASSL SOC 10, P51; Hare M. D., 1987, Proceedings, Annual Conference, Agronomy Society of New Zealand, V17, P45; Harrington K. C., 2006, New Zealand Plant Protection, V59, P261; HILDERSON H, 1989, VET REC, V125, P376, DOI 10.1136/vr.125.14.376; Hogh-Jensen H, 2006, EUR J AGRON, V24, P247, DOI 10.1016/j.eja.2005.10.007; Holmes W., 1989, GRASS ITS PRODUCTION; Hoskin S, 2005, P DEER COURS VET DEE, V22, P85; HOSKIN SO, 1995, J AGR SCI-CAMBRIDGE, V124, P289, DOI 10.1017/S0021859600072956; Houdijk JGM, 2011, P BSAS ANN C APR 4 5, P139; Jackson FS, 1996, J SCI FOOD AGR, V72, P483, DOI 10.1002/(SICI)1097-0010(199612)72:4&lt;483::AID-JSFA684&gt;3.0.CO;2-G; JONES DIH, 1975, J SCI FOOD AGR, V26, P711, DOI 10.1002/jsfa.2740260518; KEMPSTER AJ, 1986, MEAT SCI, V17, P107, DOI [10.1016/0309-1740(86)90059-8, 10.1016/0309-1740(86)90058-6]; Komolong M., 1992, Proceedings of the New Zealand Society of Animal Production, V52, P85; Lancashire JA, 1983, P NZ GRASSLAND ASS, V44, P61; Larsson A, 2006, VET PARASITOL, V142, P197, DOI 10.1016/j.vetpar.2006.07.017; Li GD, 2005, ADV AGRON, V88, P187, DOI 10.1016/S0065-2113(05)88005-8; Lloyd-Davies H, 1962, P AUST SOC ANIM PROD, V4, P167; MAFF, 1997, MAFF TECHN B, V18; Marley CL, 2007, GRASS FORAGE SCI, V62, P1, DOI 10.1111/j.1365-2494.2007.00556.x; Marley CL, 2006, VET PARASITOL, V138, P280, DOI 10.1016/j.vetpar.2006.01.029; Marley CL, 2003, VET PARASITOL, V112, P147, DOI 10.1016/S0304-4017(02)00412-0; Marley CL, 2003, VET PARASITOL, V118, P93, DOI 10.1016/j.vetpar.2003.10.004; Marley CL, 2013, P 17 S EGF AK IC 23, P252; Marley CL, 2011, P BGS 10 RES C 20 21, P53; Marley CL, 2013, P 17 S EGF AK IC 23, P249; Matthews PNP, 1990, P AGRONOMY SOC NZ, V20, P41; McCoy JE, 1997, CROP SCI, V37, P239, DOI 10.2135/cropsci1997.0011183X003700010042x; Min BR, 1997, NEW ZEAL J AGR RES, V40, P335, DOI 10.1080/00288233.1997.9513253; MOSS RA, 1993, NEW ZEAL J AGR RES, V36, P371; Niezen J. H., 1994, Proceedings of the New Zealand Society of Animal Production, V54, P15; NIEZEN JH, 1993, J AGR SCI-CAMBRIDGE, V121, P255, DOI 10.1017/S0021859600077133; ORIORDAN EG, 2000, BRIT GRASSLAND SOC O, V35, P43; Parish J. A., 2012, Professional Animal Scientist, V28, P579; Payne RW, 2011, GENSTAT WINDOWS, P150; PEACOCK JM, 1975, J APPL ECOL, V12, P685, DOI 10.2307/2402182; Rossanigo CE, 1995, J HELMINTHOL, V69, P357, DOI 10.1017/S0022149X00014954; Rumball W, 2003, NEW ZEAL J AGR RES, V46, P53, DOI 10.1080/00288233.2003.9513529; RUMBALL W, 1986, NEW ZEAL J EXP AGR, V14, P105, DOI 10.1080/03015521.1986.10426133; SCALES GH, 1994, NZ J AGR RES, V38, P237; Schmidt JR, 2013, J ANIM SCI, V91, P4451, DOI 10.2527/jas.2012-5405; Speijers MHM, 2004, J AGR SCI, V142, P483, DOI 10.1017/S0021859604004496; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; Theil H., 1950, RANK INVARIANT METHO, V53, P386, DOI DOI 10.1007/978-94-011-2546-8_20; THOMAS TA, 1977, J SCI FOOD AGR, V28, P639, DOI 10.1002/jsfa.2740280711; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2	62	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86259	10.1371/journal.pone.0086259	http://dx.doi.org/10.1371/journal.pone.0086259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489708	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000041
J	Nucci, M; Carlesse, F; Cappellano, P; Varon, AG; Seber, A; Garnica, M; Nouer, SA; Colombo, AL				Nucci, Marcio; Carlesse, Fabianne; Cappellano, Paola; Varon, Andrea G.; Seber, Adriana; Garnica, Marcia; Nouer, Simone A.; Colombo, Arnaldo L.			Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing	PLOS ONE			English	Article							CROSS-REACTIVITY; LABORATORY DIAGNOSIS; ANTIFUNGAL TREATMENT; BIOLOGICAL MARKERS; ANTIGENEMIA; INFECTIONS; RECIPIENTS; DISEASES; PROPOSAL; PREDICT	Cross-reactivity of Fusarium species with serum galactomannan antigen (GMI) test has been observed. We sought to evaluate if GMI could help to early diagnose invasive fusariosis and to monitor treatment response. We reviewed the records of all patients with invasive fusariosis between 2008 and 2012 in three Brazilian hospitals. We selected patients who had at least 1 GMI test within 2 days before or after the date of the first clinical manifestation of fusariosis, and analyzed the temporal relationship between the first positive GMI test and the date of the diagnosis of invasive fusariosis, and the kinetics of GMI in relation to patients' response to treatment. We also selected 18 controls to determine the sensitivity and specificity of the test. Among 18 patients, 15 (83%) had at least one positive GMI (median 4, range 1-15). The sensitivity and specificity of was 83% and 67%, respectively. GMI was positive before the diagnosis of invasive fusariosis in 11 of the 15 cases (73%), at a median of 10 days (range 3-39), and after the diagnosis in 4 cases. GMI became negative in 8 of the 15 patients; 3 of these 8 patients (37.5%) were alive 90 days after the diagnosis of fusariosis compared with 2 of 7 (29%) who did not normalize GMI (p = 1.0). GMI is frequently positive in invasive fusariosis, and becomes positive before diagnosis in most patients. These findings may have important implications for the choice of antifungal therapy in settings with high prevalence of invasive fusariosis.	[Nucci, Marcio; Varon, Andrea G.; Garnica, Marcia; Nouer, Simone A.] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil; [Carlesse, Fabianne; Seber, Adriana] Univ Fed Sao Paulo UNIFESP, Inst Pediat Oncol GRAACC, Sao Paulo, Brazil; [Cappellano, Paola; Colombo, Arnaldo L.] Univ Fed Sao Paulo UNIFESP, Univ Hosp, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Nucci, M (corresponding author), Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil.	mnucci@hucff.ufrj.br	Colombo, Arnaldo Lopes/V-4417-2019; Seber, Adriana/AAG-7978-2020; Garnica, Marcia/D-5854-2013; Colombo, Arnaldo Lopes/H-4397-2012; Nucci, Marcio/G-4515-2012	Colombo, Arnaldo Lopes/0000-0003-0793-8491; Seber, Adriana/0000-0003-4578-9423; Garnica, Marcia/0000-0003-1067-6680; Nucci, Marcio/0000-0003-4867-0014; Cappellano, Paola/0000-0001-5984-2120				Bergeron A, 2012, J CLIN MICROBIOL, V50, P823, DOI 10.1128/JCM.00750-11; Chai LYA, 2012, J CLIN MICROBIOL, V50, P2330, DOI 10.1128/JCM.06513-11; Cummings JR, 2007, DIAGN MICR INFEC DIS, V59, P113, DOI 10.1016/j.diagmicrobio.2007.04.022; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Fekkar A, 2009, CLIN INFECT DIS, V49, P1457, DOI 10.1086/644499; Giacchino M, 2006, J CLIN MICROBIOL, V44, P3432, DOI 10.1128/JCM.00856-06; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Koo S, 2010, J CLIN MICROBIOL, V48, P1255, DOI 10.1128/JCM.02281-09; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Maertens J, 2009, CANCER, V115, P355, DOI 10.1002/cncr.24022; Maertens JA, 2012, HAEMATOL-HEMATOL J, V97, P325, DOI 10.3324/haematol.2012.061952; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; McCulloch E, 2012, J CLIN PATHOL, V65, P83, DOI 10.1136/jcp.2011.090464; Mikulska M, 2013, CLIN INFECT DIS, V57, P1786, DOI 10.1093/cid/cit565; Mikulska M, 2012, DIAGN MICR INFEC DIS, V72, P367, DOI 10.1016/j.diagmicrobio.2011.12.009; NOTERMANS S, 1988, J MED VET MYCOL, V26, P41; Nouer SA, 2011, CLIN INFECT DIS, V53, P671, DOI 10.1093/cid/cir441; Nouer SA, 2012, CLIN INFECT DIS, V54, pE173, DOI 10.1093/cid/cis298; Nucci M, 2013, CLIN MICROBIOL INFEC, V19, P745, DOI 10.1111/1469-0691.12002; Nucci M, 2003, CANCER, V98, P315, DOI 10.1002/cncr.11510; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nucci M, 2006, INFECT DIS CLIN N AM, V20, P563, DOI 10.1016/j.idc.2006.06.002; Nucci M, 2010, CLIN INFECT DIS, V51, P1273, DOI 10.1086/657065; Park SH, 2011, MYCOSES, V54, P523, DOI 10.1111/j.1439-0507.2010.02009.x; Reinwald M, 2012, J ANTIMICROB CHEMOTH, V67, P2260, DOI 10.1093/jac/dks208; Tanriover MD, 2010, MYCOSES, V53, P16, DOI 10.1111/j.1439-0507.2008.01652.x; Tortorano AM, 2012, J CLIN MICROBIOL, V50, P1051, DOI 10.1128/JCM.05946-11; Van der Veer J, 2012, MED MYCOL, V50, P396, DOI 10.3109/13693786.2011.608172	29	63	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87784	10.1371/journal.pone.0087784	http://dx.doi.org/10.1371/journal.pone.0087784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489964	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000149
J	van Velden, FHP; Nissen, IA; Hayes, W; Velasquez, LM; Hoekstra, OS; Boellaard, R				van Velden, Floris H. P.; Nissen, Ida A.; Hayes, Wendy; Velasquez, Linda M.; Hoekstra, Otto S.; Boellaard, Ronald			Effects of Reusing Baseline Volumes of Interest by Applying (Non-)Rigid Image Registration on Positron Emission Tomography Response Assessments	PLOS ONE			English	Article							WHOLE-BODY PET; FDG UPTAKE; LUNG-CANCER; HISTOGRAM; CT; HETEROGENEITY; F-18-FDG; AREA	Objectives: Reusing baseline volumes of interest (VOI) by applying non-rigid and to some extent (local) rigid image registration showed good test-retest variability similar to delineating VOI on both scans individually. The aim of the present study was to compare response assessments and classifications based on various types of image registration with those based on (semi)-automatic tumour delineation. Methods: Baseline (n = 13), early (n = 12) and late (n = 9) response (after one and three cycles of treatment, respectively) whole body [F-18]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (PET/CT) scans were acquired in subjects with advanced gastrointestinal malignancies. Lesions were identified for early and late response scans. VOI were drawn independently on all scans using an adaptive 50% threshold method (A50). In addition, various types of (non-) rigid image registration were applied to PET and/or CT images, after which baseline VOI were projected onto response scans. Response was classified using PET Response Criteria in Solid Tumors for maximum standardized uptake value (SUVmax), average SUV (SUVmean), peak SUV (SUVpeak), metabolically active tumour volume (MATV), total lesion glycolysis (TLG) and the area under a cumulative SUV-volume histogram curve (AUC). Results: Non-rigid PET-based registration and non-rigid CT-based registration followed by non-rigid PET-based registration (CTPET) did not show differences in response classifications compared to A50 for SUVmax and SUVpeak,, however, differences were observed for MATV, SUVmean, TLG and AUC. For the latter, these registrations demonstrated a poorer performance for small lung lesions (<2.8 ml), whereas A50 showed a poorer performance when another area with high uptake was close to the target lesion. All methods were affected by lesions with very heterogeneous tracer uptake. Conclusions: Non-rigid PET-and CTPET-based image registrations may be used to classify response based on SUVmax and SUVpeak. For other quantitative measures future studies should assess which method is valid for response evaluations by correlating with survival data.	[van Velden, Floris H. P.; Nissen, Ida A.; Hoekstra, Otto S.; Boellaard, Ronald] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Noord Holland, Netherlands; [Hayes, Wendy; Velasquez, Linda M.] Bristol Myers Squibb Co, Exploratory Clin & Translat Res, Princeton, NJ USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Bristol-Myers Squibb	van Velden, FHP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Noord Holland, Netherlands.	f.vvelden@vumc.nl	van+Velden, Floris/AAR-8414-2020	van Velden, Floris/0000-0003-2859-2119; Hoekstra, Otto S/0000-0003-0767-2734; Nissen, Ida A./0000-0001-6910-1967; Boellaard, Ronald/0000-0002-0313-5686	Center for Translational Molecular Medicine (CTMM), AIRFORCE project [03O-103]	Center for Translational Molecular Medicine (CTMM), AIRFORCE project	The study was financially supported by Center for Translational Molecular Medicine (CTMM), AIRFORCE project (grant 03O-103, http://www.ctmm.nl). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was evaluated by the CTMM publication manager and the consortium partners. CTMM did not request any changes to the manuscript prior to publication.	Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Brooks FJ, 2013, J NUCL MED IN PRESS; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P967, DOI 10.1007/s00259-013-2381-3; Bussink J, 2011, NAT REV CLIN ONCOL, V8, P233, DOI 10.1038/nrclinonc.2010.218; Cheebsumon P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-56; Cheebsumon P, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-35; Cheebsumon P, 2011, EUR J NUCL MED MOL I, V38, P2136, DOI 10.1007/s00259-011-1899-5; Cheebsumon P, 2011, J NUCL MED, V52, P1550, DOI 10.2967/jnumed.111.088914; Cheng G, 2013, MOL IMAGING BIOL, V15, P345, DOI 10.1007/s11307-012-0600-0; De Moor K, 2006, IEEE NUCL SCI CONF R, P3502; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Garrett CR, 2011, BRIT J CANCER, V105, P44, DOI 10.1038/bjc.2011.182; Grgic A, 2009, J NUCL MED, V50, P1921, DOI 10.2967/jnumed.109.065649; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hatt M, 2011, EUR J NUCL MED MOL I, V38, P1191, DOI 10.1007/s00259-011-1755-7; Hutton BF, 2002, EUR J NUCL MED MOL I, V29, P559, DOI 10.1007/s00259-001-0700-6; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Li X, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-62; Shekhar R, 2005, J NUCL MED, V46, P1488; Sugawara Y, 1999, RADIOLOGY, V213, P521, DOI 10.1148/radiology.213.2.r99nv37521; van Elmpt W, 2011, EUR J NUCL MED MOL I, V38, P843, DOI 10.1007/s00259-010-1716-6; van Herk M, 1997, Comput Aided Surg, V2, P346, DOI 10.1002/(SICI)1097-0150(1997)2:6<346::AID-IGS5>3.0.CO;2-#; van Velden FHP, 2013, MOL IMAGING IN PRESS; van Velden FHP, 2013, EUR J NUCL MED MOL I, V40, P1469, DOI 10.1007/s00259-013-2474-z; van Velden FHP, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-10; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Velasquez LM, 2009, J NUCL MED, V50, P1646, DOI 10.2967/jnumed.109.063347; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Watabe T, 2012, ANN NUCL MED, V26, P222, DOI 10.1007/s12149-011-0562-3	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87167	10.1371/journal.pone.0087167	http://dx.doi.org/10.1371/journal.pone.0087167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489860	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000112
J	Wang, ZY; Burwinkel, M; Chai, WD; Lange, E; Blohm, U; Breithaupt, A; Hoffmann, B; Twardziok, S; Rieger, J; Janczyk, P; Pieper, R; Osterrieder, N				Wang, Zhenya; Burwinkel, Michael; Chai, Weidong; Lange, Elke; Blohm, Ulrike; Breithaupt, Angele; Hoffmann, Bernd; Twardziok, Sven; Rieger, Juliane; Janczyk, Pawel; Pieper, Robert; Osterrieder, Nikolaus			Dietary Enterococcus faecium NCIMB 10415 and Zinc Oxide Stimulate Immune Reactions to Trivalent Influenza Vaccination in Pigs but Do Not Affect Virological Response upon Challenge Infection	PLOS ONE			English	Article							SWINE INFLUENZA; H3N2 VIRUSES; PERFORMANCE; PIGLETS; PROBIOTICS; DIARRHEA; PORCINE; HEALTH; REPLICATION; VACCINES	Swine influenza viruses (SIV) regularly cause significant disease in pigs worldwide. Since there is no causative treatment of SIV, we tested if probiotic Enterococcus (E.) faecium NCIMB 10415 or zinc (Zn) oxide as feed supplements provide beneficial effects upon SIV infection in piglets. Seventy-two weaned piglets were fed three different diets containing either E. faecium or different levels of Zn (2500 ppm, Zn-high; 50 ppm, Zn-low). Half of the piglets were vaccinated intramuscularly (VAC) twice with an inactivated trivalent SIV vaccine, while all piglets were then infected intranasally with H3N2 SIV. Significantly higher weekly weight gains were observed in the E. faecium group before virus infection, and piglets in Zn-high and E. faecium groups gained weight after infection while those in the control group (Zn-low) lost weight. Using ELISA, we found significantly higher H3N2-specific antibody levels in the E. faecium+VAC group 2 days before and at the day of challenge infection as well as at 4 and 6 days after challenge infection. Higher hemagglutination inhibition (HI) titers were also observed in the Zn-high+VAC and E. faecium+VAC groups at 0, 1 and 4 days after infection. However, there were no significant differences in virus shedding and lung lesions between the dietary groups. Using flow cytometry analysis significantly higher activated T helper cells and cytotoxic T lymphocyte percentages in the PBMCs were detected in the Zn-high and E. faecium groups at single time points after infection compared to the Zn-low control group, but no prolonged effect was found. In the BAL cells no influence of dietary supplementation on immune cell percentages could be detected. Our results suggest that feeding high doses of zinc oxide and particularly E. faecium could beneficially influence humoral immune responses after vaccination and recovery from SIV infection, but not affect virus shedding and lung pathology.	[Wang, Zhenya; Burwinkel, Michael; Chai, Weidong; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Lange, Elke; Breithaupt, Angele] Friedrich Loeffler Inst, Abt Expt Tierhaltung & Biosicherheit, Greifswald, Germany; [Blohm, Ulrike] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Breithaupt, Angele] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Virusdiagnost, Greifswald, Germany; [Twardziok, Sven] Charite, D-13353 Berlin, Germany; [Rieger, Juliane] Free Univ Berlin, Inst Vet Anat, Berlin, Germany; [Janczyk, Pawel] Fachgrp Mol Diagnost & Genet, Bundesinst Risikobewertung, Abt Biol Sicherheit, Berlin, Germany; [Pieper, Robert] Free Univ Berlin, Inst Tierernahrung, Berlin, Germany	Free University of Berlin; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Free University of Berlin; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Federal Institute for Risk Assessment; Free University of Berlin	Burwinkel, M (corresponding author), Free Univ Berlin, Inst Virol, Berlin, Germany.	michael.burwinkel@fu-berlin.de	Rieger, Juliane/G-8878-2015; Breithaupt, Angele/GON-7227-2022; Blohm, Ulrike/AAW-1851-2020; Breithaupt, Angele/B-6155-2013	Rieger, Juliane/0000-0003-1659-9460; Breithaupt, Angele/0000-0002-6373-5923; Blohm, Ulrike/0000-0003-4597-248X; Pieper, Robert/0000-0002-0292-1482; Twardziok, Sven/0000-0002-0326-5704; Osterrieder, Nikolaus/0000-0002-5313-2176; Burwinkel, Michael/0000-0003-4811-7323	Deutsche Forschungsgemeinschaft (DFG) research consortium [SFB 852]	Deutsche Forschungsgemeinschaft (DFG) research consortium	This study was supported by Deutsche Forschungsgemeinschaft (DFG) research consortium (SFB 852, subproject A5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C, 2004, J ANIM PHYSIOL AN N, V88, P381, DOI 10.1111/j.1439-0396.2004.00492.x; Broom LJ, 2006, RES VET SCI, V80, P45, DOI 10.1016/j.rvsc.2005.04.004; Buff CE, 2005, J ANIM SCI, V83, P2380; Chai WD, 2013, ARCH VIROL, V158, P799, DOI 10.1007/s00705-012-1543-0; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Heinen PP, 2001, VET IMMUNOL IMMUNOP, V82, P39, DOI 10.1016/S0165-2427(01)00342-7; Hill GM, 2001, J ANIM SCI, V79, P934; Hoffmann B, 2010, BERL MUNCH TIERARZTL, V123, P286, DOI 10.2376/0005-9366-123-286; Ibs KH, 2003, J NUTR, V133, p1452S, DOI 10.1093/jn/133.5.1452S; KAWAOKA Y, 1987, ARCH VIROL, V93, P303, DOI 10.1007/BF01310984; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim TS, 2011, TRENDS IMMUNOL, V32, P225, DOI 10.1016/j.it.2011.02.006; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Kreuzer S, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-58; Kritas SK, 2007, VET MICROBIOL, V119, P248, DOI 10.1016/j.vetmic.2006.09.012; Kyriakis CS, 2010, VET MICROBIOL, V144, P67, DOI 10.1016/j.vetmic.2009.12.039; Lefevre EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032400; MacDonald TT, 2010, P NUTR SOC, V69, P442, DOI 10.1017/S0029665110001758; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Melin L, 2002, ACTA VET SCAND, V43, P231, DOI 10.1186/1751-0147-43-231; Molist F, 2011, BRIT J NUTR, V105, P1592, DOI 10.1017/S0007114510004575; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Paton AW, 2005, GASTROENTEROLOGY, V128, P1219, DOI 10.1053/j.gastro.2005.01.050; Porea TJ, 2000, J PEDIATR-US, V136, P688, DOI 10.1067/mpd.2000.103355; Rad AH, 2013, NUTRITION, V29, P805, DOI 10.1016/j.nut.2012.10.009; Rink L, 2007, TRENDS IMMUNOL, V28, P1, DOI 10.1016/j.it.2006.11.005; Roohani N, 2013, J RES MED SCI, V18, P144; Saenz RA, 2006, VECTOR-BORNE ZOONOT, V6, P338, DOI 10.1089/vbz.2006.6.338; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Schierack P, 2007, VET IMMUNOL IMMUNOP, V118, P1, DOI 10.1016/j.vetimm.2007.03.006; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Shu Q, 2001, J PEDIATR GASTR NUTR, V33, P171, DOI 10.1097/00005176-200108000-00014; TEVELTHUIS AJW, 2010, PLOS PATHOG, V0006; Uchide N, 2002, ANTIVIR RES, V56, P207, DOI 10.1016/S0166-3542(02)00109-2; Wang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053043	39	7	9	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87007	10.1371/journal.pone.0087007	http://dx.doi.org/10.1371/journal.pone.0087007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489827	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000099
J	Young, T; Rohwer, A; Volmink, J; Clarke, M				Young, Taryn; Rohwer, Anke; Volmink, Jimmy; Clarke, Mike			What Are the Effects of Teaching Evidence-Based Health Care (EBHC)? Overview of Systematic Reviews	PLOS ONE			English	Article							EVIDENCE-BASED MEDICINE; CRITICAL-APPRAISAL; JOURNAL CLUBS; EDUCATION; UNDERGRADUATE; SKILLS	Background: An evidence-based approach to health care is recognized internationally as a key competency for healthcare practitioners. This overview systematically evaluated and organized evidence from systematic reviews on teaching evidence-based health care (EBHC). Methods/Findings: We searched for systematic reviews evaluating interventions for teaching EBHC to health professionals compared to no intervention or different strategies. Outcomes covered EBHC knowledge, skills, attitudes, practices and health outcomes. Comprehensive searches were conducted in April 2013. Two reviewers independently selected eligible reviews, extracted data and evaluated methodological quality. We included 16 systematic reviews, published between 1993 and 2013. There was considerable overlap across reviews. We found that 171 source studies included in the reviews related to 81 separate studies, of which 37 are in more than one review. Studies used various methodologies to evaluate educational interventions of varying content, format and duration in undergraduates, interns, residents and practicing health professionals. The evidence in the reviews showed that multifaceted, clinically integrated interventions, with assessment, led to improvements in knowledge, skills and attitudes. Interventions improved critical appraisal skills and integration of results into decisions, and improved knowledge, skills, attitudes and behaviour amongst practicing health professionals. Considering single interventions, EBHC knowledge and attitude were similar for lecture-based versus online teaching. Journal clubs appeared to increase clinical epidemiology and biostatistics knowledge and reading behavior, but not appraisal skills. EBHC courses improved appraisal skills and knowledge. Amongst practicing health professionals, interactive online courses with guided critical appraisal showed significant increase in knowledge and appraisal skills. A short workshop using problem-based approaches, compared to no intervention, increased knowledge but not appraisal skills. Conclusions: EBHC teaching and learning strategies should focus on implementing multifaceted, clinically integrated approaches with assessment. Future rigorous research should evaluate minimum components for multifaceted interventions, assessment of medium to long-term outcomes, and implementation of these interventions.	[Young, Taryn; Rohwer, Anke; Volmink, Jimmy] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Young, Taryn; Volmink, Jimmy] South African Med Res Council, South African Cochrane Ctr, Cape Town, South Africa; [Young, Taryn] Univ Stellenbosch, Fac Med & Hlth Sci, Cape Town, South Africa; [Clarke, Mike] Queens Univ Belfast, All Ireland Hub Trials Methodol Res, Belfast, Antrim, North Ireland	Stellenbosch University; South African Medical Research Council; Stellenbosch University; Queens University Belfast	Young, T (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa.	tyoung@sun.ac.za		Young, Taryn/0000-0003-2406-081X	Effective Health Care Research Consortium; UKaid from the UK Government Department for International Development; US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA [T84HA21652]; US President's Emergency Plan for AIDS relief (PEPFAR) via the Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI); National Research Foundation of South Africa (UNIQUE) [86420]; UK Medical Research Council [G0901530]; Queen's University Belfast; University of Ulster; Health and Social Care R&D Division of the Public Health Agency of Northern Ireland; Medical Research Council [G0901530] Funding Source: researchfish; MRC [G0901530] Funding Source: UKRI	Effective Health Care Research Consortium; UKaid from the UK Government Department for International Development; US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA; US President's Emergency Plan for AIDS relief (PEPFAR) via the Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI); National Research Foundation of South Africa (UNIQUE); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Queen's University Belfast; University of Ulster; Health and Social Care R&D Division of the Public Health Agency of Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TY and AR are supported in part by the Effective Health Care Research Consortium, which is funded by UKaid from the UK Government Department for International Development, www.evidence4health.org. This research has been supported in part by the US President's Emergency Plan for AIDS relief (PEPFAR) through HRSA under the terms of T84HA21652 and via the Stellenbosch University Rural Medical Education Partnership Initiative (SURMEPI). This work is based on the research supported in part by the National Research Foundation of South Africa (UNIQUE GRANT NO 86420). The All Ireland Hub for Trials Methodology Research is supported by the UK Medical Research Council (G0901530), Queen's University Belfast, the University of Ulster and the Health and Social Care R&D Division of the Public Health Agency of Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2012, J SURG EDUC, V69, P91, DOI 10.1016/j.jsurg.2011.07.004; Akobeng AK, 2005, ARCH DIS CHILD, V90, P837, DOI 10.1136/adc.2005.071761; Alguire PC, 1998, J GEN INTERN MED, V13, P347, DOI 10.1046/j.1525-1497.1998.00102.x; AUDET N, 1993, CAN MED ASSOC J, V148, P945; Baradan H, 2013, TEACHING EVIDENCE BA; Barr H, 2000, EVALUATIONS INTER PR; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Burls A., 1997, EVALUATION IMPACT HA; Chinnock P, 2005, PLOS MED, V2, P367, DOI 10.1371/journal.pmed.0020107; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; Cook DA, 2012, MED TEACH, V34, P468, DOI 10.3109/0142159X.2012.671978; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Dawes Martin, 2005, BMC Med Educ, V5, P1; Deenadayalan Y, 2008, J EVAL CLIN PRACT, V14, P898, DOI 10.1111/j.1365-2753.2008.01050.x; Ebbert JO, 2001, MED TEACH, V23, P455; Flores-Mateo G, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-119; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Glasziou Paul, 2005, ACP J Club, V142, pA8; Glasziou P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1253; Harris J, 2011, MED TEACH, V33, P9, DOI 10.3109/0142159X.2011.530321; Hartling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049667; Hatala R, 2002, JAMA-J AM MED ASSOC, V288, P1110, DOI 10.1001/jama.288.9.1110; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001270.pub2; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000026.pub2; Horsley T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007335.pub2; Hyde C, 2000, SYSTEMATIC REV EFFEC; Ilic D, 2009, ANN ACAD MED SINGAP, V38, P559; Khan Khalid S, 2006, BMC Med Educ, V6, P59, DOI 10.1186/1472-6920-6-59; Kirkpatrick D.L., 1959, J AM SOC TRAINING DI, V13, P21; Kogan JR, 2007, TEACH TEACH EDUC, V23, P251, DOI 10.1016/j.tate.2006.12.020; Malick SM, 2010, J ROY SOC MED, V103, P231, DOI 10.1258/jrsm.2010.100105; Mi M, 2012, EVID BASED LIBR INF, V7; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5040; Morrison J, 2003, BMJ-BRIT MED J, V326, P385, DOI 10.1136/bmj.326.7385.385; Norman GR, 1998, CAN MED ASSOC J, V158, P177; Pieper D, 2012, J CLIN EPIDEMIOL, V65, P1267, DOI 10.1016/j.jclinepi.2012.06.015; Powell J, 2004, SYSTEMATIC REV J CLU; Ray A., 2013, IS TEACHING LIT SEAR; Reed D, 2005, ANN INTERN MED, V142, P1080, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00008; Rohwer A, 2013, E LEARNING VERSUS FA; Rohwer A, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-77; Sackett DL, 2002, J CLIN EPIDEMIOL, V55, P1161, DOI 10.1016/S0895-4356(02)00521-8; Shaneyfelt T, 2006, JAMA-J AM MED ASSOC, V296, P1116, DOI 10.1001/jama.296.9.1116; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Silva V, 2012, SAO PAULO MED J, V130, P398, DOI 10.1590/S1516-31802012000600007; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Straus SE, 2000, CAN MED ASSOC J, V163, P837; Taheri H, 2008, ANN ACAD MED SINGAP, V37, P764; Tavakol M, 2010, CLIN TEACH, V7, P192, DOI 10.1111/j.1743-498X.2010.00383.x; Taylor R, 2000, MED EDUC, V34, P120, DOI 10.1046/j.1365-2923.2000.00574.x; Werb Sara B, 2004, J Dent Educ, V68, P995; Wong SC, 2013, INT J MED EDUC, V4, P107, DOI 10.5116/ijme.51a0.fd25	55	143	145	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86706	10.1371/journal.pone.0086706	http://dx.doi.org/10.1371/journal.pone.0086706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489771	Green Published, gold			2022-12-27	WOS:000330510000073
J	Hall, SL; McCulley, RL; Barney, RJ; Phillips, TD				Hall, Sarah L.; McCulley, Rebecca L.; Barney, Robert J.; Phillips, Timothy D.			Does Fungal Endophyte Infection Improve Tall Fescue's Growth Response to Fire and Water Limitation?	PLOS ONE			English	Article							TALLGRASS PRAIRIE; LOLIUM-PERENNE; COENOPHIALUM; HERBICIDE; SYMBIOSIS; PASTURES; DROUGHT; RESTORATION; PERFORMANCE; TOLERANCE	Invasive species may owe some of their success in competing and co-existing with native species to microbial symbioses they are capable of forming. Tall fescue is a cool-season, non-native, invasive grass capable of co-existing with native warm-season grasses in North American grasslands that frequently experience fire, drought, and cold winters, conditions to which the native species should be better-adapted than tall fescue. We hypothesized that tall fescue's ability to form a symbiosis with Neotyphodium coenophialum, an aboveground fungal endophyte, may enhance its environmental stress tolerance and persistence in these environments. We used a greenhouse experiment to examine the effects of endophyte infection (E+ vs. E-), prescribed fire (1 burn vs. 2 burn vs. unburned control), and watering regime (dry vs. wet) on tall fescue growth. We assessed treatment effects for growth rates and the following response variables: total tiller length, number of tillers recruited during the experiment, number of reproductive tillers, tiller biomass, root biomass, and total biomass. Water regime significantly affected all response variables, with less growth and lower growth rates observed under the dry water regime compared to the wet. The burn treatments significantly affected total tiller length, number of reproductive tillers, total tiller biomass, and total biomass, but treatment differences were not consistent across parameters. Overall, fire seemed to enhance growth. Endophyte status significantly affected total tiller length and tiller biomass, but the effect was opposite what we predicted (E->E+). The results from our experiment indicated that tall fescue was relatively tolerant of fire, even when combined with dry conditions, and that the fungal endophyte symbiosis was not important in governing this ecological ability. The persistence of tall fescue in native grassland ecosystems may be linked to other endophyte-conferred abilities not measured here (e.g., herbivory release) or may not be related to this plant-microbial symbiosis.	[Hall, Sarah L.; McCulley, Rebecca L.; Phillips, Timothy D.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Hall, Sarah L.; Barney, Robert J.] Kentucky State Univ, Community Res Serv, Frankfort, KY USA	University of Kentucky; Kentucky State University	Hall, SL (corresponding author), Berea Coll, Dept Agr & Nat Resources, CPO 2161, Berea, KY 40404 USA.	sarah_hall@berea.edu			Forage-Animal Production Research Unit of USDA-ARS [58-6440-7-135]; University of Kentucky, Kentucky Agricultural Experiment Station [58-6440-7-135, KY006045]; DOE-NICCR [08-SC-NICCR-1073]; USDACSREES [KYX-10-05-39P]; University of Kentucky Graduate School	Forage-Animal Production Research Unit of USDA-ARS; University of Kentucky, Kentucky Agricultural Experiment Station; DOE-NICCR(United States Department of Energy (DOE)); USDACSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of Kentucky Graduate School	Funding for this project was provided by a Specific Cooperative Agreement (58-6440-7-135) between the Forage-Animal Production Research Unit of USDA-ARS and the University of Kentucky, Kentucky Agricultural Experiment Station Award KY006045, DOE-NICCR award #08-SC-NICCR-1073, USDACSREES Project KYX-10-05-39P, and a fellowship from the University of Kentucky Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1987, AM MIDL NAT, V117, P442, DOI 10.2307/2425988; Aiub MMV, 2001, WEED RES, V41, P265, DOI 10.1046/j.1365-3180.2001.00236.x; Ansley RJ, 2007, RANGELAND ECOL MANAG, V60, P154, DOI 10.2111/06-098R1.1; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Assuero SG, 2006, NEW ZEAL J AGR RES, V49, P359, DOI 10.1080/00288233.2006.9513726; Assuero SG, 2000, NEW ZEAL J AGR RES, V43, P49, DOI 10.1080/00288233.2000.9513408; BACON C W, 1988, Journal of Production Agriculture, V1, P45; BALL DM, 1993, AM SCI, V81, P370; Barnes TG, 2004, WEED TECHNOL, V18, P1364, DOI 10.1614/0890-037X(2004)018[1364:STCEGP]2.0.CO;2; Barnes TG, 2007, NAT AREA J, V27, P56, DOI 10.3375/0885-8608(2007)27[56:UHTRNG]2.0.CO;2; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Belesky DP, 2008, ENVIRON EXP BOT, V63, P368, DOI 10.1016/j.envexpbot.2007.12.013; BELESKY DP, 1995, CROP SCI, V35, P529, DOI 10.2135/cropsci1995.0011183X003500020041x; Belesky DP, 1996, ANN BOT-LONDON, V78, P499, DOI 10.1006/anbo.1996.0147; Brosi G. B., 2011, THESIS U KENTUCKY LE; Buck GW, 1997, NEOTYPHODIUM/GRASS INTERACTIONS, P141; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CHEPLICK GP, 1989, NEW PHYTOL, V111, P89, DOI 10.1111/j.1469-8137.1989.tb04222.x; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; CLAY K, 1990, ECOLOGY, V71, P558, DOI 10.2307/1940309; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Cuomo GJ, 1998, J RANGE MANAGE, V51, P32, DOI 10.2307/4003560; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; DiTomaso JM, 2006, WEED TECHNOL, V20, P535, DOI 10.1614/WT-05-086R1.1; Elbersen HW, 1996, GRASS FORAGE SCI, V51, P333, DOI 10.1111/j.1365-2494.1996.tb02068.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Gwinn KD, 1998, CROP SCI, V38, P201, DOI 10.2135/cropsci1998.0011183X003800010033x; Hall SL, 2012, RESTOR ECOL, V20, P194, DOI 10.1111/j.1526-100X.2010.00749.x; Hall SL, 2011, THESIS U KENTUCKY LE; Hannaway D, 1999, OREGON STATE U EXTEN, V504; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; HILL NS, 1990, CROP SCI, V30, P156, DOI 10.2135/cropsci1990.0011183X003000010034x; Hill NS, 1998, ANN BOT-LONDON, V81, P483, DOI 10.1006/anbo.1998.0583; Hopkins AA, 2006, AGRON J, V98, P1221, DOI 10.2134/agronj2006.0007; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; KELRICK MI, 1990, P INT S ACR GRASS IN, P21; Lacefield GD, 1986, AGR119 U KENT AGR EX; Lacefield GD, 2003, AGR59 U KENT AGR EXP; Madison LA, 2001, WILDLIFE SOC B, V29, P706; Malinowski DP, 1997, NEOTYPHODIUM/GRASS INTERACTIONS, P183; Marks S, 1996, NEW PHYTOL, V133, P727, DOI 10.1111/j.1469-8137.1996.tb01941.x; McGranahan DA, 2013, ECOSYSTEMS, V16, P158, DOI 10.1007/s10021-012-9605-4; Moyes AB, 2005, RESTOR ECOL, V13, P659, DOI 10.1111/j.1526-100X.2005.00084.x; Newman JA, 2003, GLOBAL CHANGE BIOL, V9, P425, DOI 10.1046/j.1365-2486.2003.00601.x; Pecetti L, 2008, J AGRON CROP SCI, V194, P244, DOI 10.1111/j.1439-037X.2008.00302.x; Pyke DA, 2010, RESTOR ECOL, V18, P274, DOI 10.1111/j.1526-100X.2010.00658.x; Rahman MH, 2005, PLANT SOIL, V272, P163, DOI 10.1007/s11104-004-4682-6; Raunkiaer C, 1934, LIFE FORMS PLANTS ST; Rhoades C, 2002, RESTOR ECOL, V10, P656, DOI 10.1046/j.1526-100X.2002.01046.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roberts CA, 2002, J AGR FOOD CHEM, V50, P5742, DOI 10.1021/jf020336n; Rudgers Jennifer A., 2007, Fungal Biology Reviews, V21, P107, DOI 10.1016/j.fbr.2007.05.002; Rudgers JA, 2010, J APPL ECOL, V47, P468, DOI 10.1111/j.1365-2664.2010.01788.x; Rudgers JA, 2009, ECOLOGY, V90, P1531, DOI 10.1890/08-0116.1; Ruffner CM, 2006, J FOREST, V104, P78; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; SHELBY RA, 1987, PLANT DIS, V71, P783, DOI 10.1094/PD-71-0783; SIEGEL MR, 1984, PHYTOPATHOLOGY, V74, P937, DOI 10.1094/Phyto-74-937; Siegrist JA, 2010, FUNCT ECOL, V24, P460, DOI 10.1111/j.1365-2435.2009.01649.x; Spyreas G, 2001, J TORREY BOT SOC, V128, P25, DOI 10.2307/3088657; Taft JB, 2003, J TORREY BOT SOC, V130, P170, DOI 10.2307/3557552; Timper P, 2005, NEMATOLOGY, V7, P105, DOI 10.1163/1568541054192216; Towne EG, 2008, RANGELAND ECOL MANAG, V61, P509, DOI 10.2111/08-043.1; Uchitel A, 2011, OECOLOGIA, V165, P465, DOI 10.1007/s00442-010-1740-z; Vila-Aiub MM, 2003, EVOL ECOL, V17, P441, DOI 10.1023/B:EVEC.0000005580.19018.fb; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; Washburn BE, 2000, WILDLIFE SOC B, V28, P97; Young CA, 2013, J ANIM SCI, V91, P2379, DOI 10.2527/jas.2012-5951	70	15	16	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86904	10.1371/journal.pone.0086904	http://dx.doi.org/10.1371/journal.pone.0086904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497994	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900046
J	Omidi, K; Hooshyar, M; Jessulat, M; Samanfar, B; Sanders, M; Burnside, D; Pitre, S; Schoenrock, A; Xu, JH; Babu, M; Golshani, A				Omidi, Katayoun; Hooshyar, Mohsen; Jessulat, Matthew; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Pitre, Sylvain; Schoenrock, Andrew; Xu, Jianhua; Babu, Mohan; Golshani, Ashkan			Phosphatase Complex Pph3/Psy2 Is Involved in Regulation of Efficient Non-Homologous End-Joining Pathway in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							STRAND BREAK REPAIR; PROTEIN-PROTEIN INTERACTIONS; GENETIC PROFILE ANALYSIS; INTERACTION NETWORKS; DNA-REPAIR; RAD53; ACTIVATION; DELETION; PHOSPHORYLATION; RECOMBINATION	One of the main mechanisms for double stranded DNA break (DSB) repair is through the non-homologous end-joining (NHEJ) pathway. Using plasmid and chromosomal repair assays, we showed that deletion mutant strains for interacting proteins Pph3p and Psy2p had reduced efficiencies in NHEJ. We further observed that this activity of Pph3p and Psy2p appeared linked to cell cycle Rad53p and Chk1p checkpoint proteins. Pph3/Psy2 is a phosphatase complex, which regulates recovery from the Rad53p DNA damage checkpoint. Overexpression of Chk1p checkpoint protein in a parallel pathway to Rad53p compensated for the deletion of PPH3 or PSY2 in a chromosomal repair assay. Double mutant strains Delta pph3/Delta chk1 and Delta psy2/Delta chk1 showed additional reductions in the efficiency of plasmid repair, compared to both single deletions which is in agreement with the activity of Pph3p and Psy2p in a parallel pathway to Chk1p. Genetic interaction analyses also supported a role for Pph3p and Psy2p in DNA damage repair, the NHEJ pathway, as well as cell cycle progression. Collectively, we report that the activity of Pph3p and Psy2p further connects NHEJ repair to cell cycle progression.	[Omidi, Katayoun; Hooshyar, Mohsen; Jessulat, Matthew; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Golshani, Ashkan] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Omidi, Katayoun; Hooshyar, Mohsen; Samanfar, Bahram; Sanders, Megan; Burnside, Daniel; Golshani, Ashkan] Carleton Univ, Ottawa Inst Syst Biol, Ottawa, ON K1S 5B6, Canada; [Jessulat, Matthew; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Pitre, Sylvain; Schoenrock, Andrew] Carleton Univ, Dept Comp Sci, Ottawa, ON K1S 5B6, Canada; [Xu, Jianhua] Zhejian Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Carleton University; Carleton University; University of Ottawa; University of Regina; Carleton University; Zhejiang University	Golshani, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	ashkan_golshani@carleton.ca	Samanfar, Bahram/AAV-7678-2021; Mohan, Babu P./I-7362-2019		Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alamgir M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-583; Amos-Binks A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-225; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Douglas AC, 2012, G3-GENES GENOM GENET, V2, P1279, DOI 10.1534/g3.112.003400; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; Jessulat M, 2011, EXPERT OPIN DRUG DIS, V6, P921, DOI 10.1517/17460441.2011.603722; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim JA, 2011, MOL CELL BIOL, V31, P507, DOI 10.1128/MCB.01168-10; Kroll ES, 1996, GENETICS, V143, P95; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Li FY, 2013, EMBO J, V32, P461, DOI 10.1038/emboj.2012.345; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Ma JL, 2006, J BIOL CHEM, V281, P3954, DOI 10.1074/jbc.M507508200; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Memarian N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-117; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Naiki T, 2004, MOL CELL BIOL, V24, P3277, DOI 10.1128/MCB.24.8.3277-3285.2004; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Oike T, 2012, INT J RADIAT ONCOL, V84, P815, DOI 10.1016/j.ijrobp.2012.01.017; Pierce AJ, 2001, MOL CELL, V8, P1160, DOI 10.1016/S1097-2765(01)00424-5; Pitre S, 2008, NUCLEIC ACIDS RES, V36, P4286, DOI 10.1093/nar/gkn390; Pitre S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00239; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; Saleh-Gohari N, 2005, MOL CELL BIOL, V25, P7158, DOI 10.1128/MCB.25.16.7158-7169.2005; Samanfar B, 2013, MOL BIOSYST, V9, P1351, DOI 10.1039/c3mb25516f; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shim EY, 2005, MOL CELL BIOL, V25, P3934, DOI 10.1128/MCB.25.10.3934-3944.2005; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zha S, 2009, NAT STRUCT MOL BIOL, V16, P798, DOI 10.1038/nsmb0809-798; Zhang Y, 2009, DNA REPAIR, V8, P1235, DOI 10.1016/j.dnarep.2009.07.007	63	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87248	10.1371/journal.pone.0087248	http://dx.doi.org/10.1371/journal.pone.0087248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498054	gold, Green Published			2022-12-27	WOS:000330621900079
J	Ribalet, F; Bastianini, M; Vidoudez, C; Acri, F; Berges, J; Ianora, A; Miralto, A; Pohnert, G; Romano, G; Wichard, T; Casotti, R				Ribalet, Francois; Bastianini, Mauro; Vidoudez, Charles; Acri, Francesco; Berges, John; Ianora, Adrianna; Miralto, Antonio; Pohnert, Georg; Romano, Giovanna; Wichard, Thomas; Casotti, Raffaella			Phytoplankton Cell Lysis Associated with Polyunsaturated Aldehyde Release in the Northern Adriatic Sea	PLOS ONE			English	Article							ACTIVATED CHEMICAL DEFENSE; SHORT-CHAIN ALDEHYDES; SKELETONEMA-COSTATUM; MARINE-PHYTOPLANKTON; LIPID-PEROXIDATION; CYTOPHAGA SP; DIATOMS; NITROGEN; QUANTIFICATION; PHOSPHORUS	Diatoms are able to react to biotic and abiotic stress, such as competition, predation and unfavorable growth conditions, by producing bioactive compounds including polyunsaturated aldehydes (PUAs). PUAs have been shown to act against grazers and either enhance or inhibit the growth of different phytoplankton and bacteria both in culture and in the field. Presence of nanomolar concentrations of dissolved PUAs in seawater has been reported in the North Adriatic Sea (Mediterranean), suggesting that these compounds are released in seawater following diatom cell lysis. However, the origin of the PUAs and their effects on natural phytoplankton assemblages remain unclear. Here we present data from four oceanographic cruises that took place during diatom blooms in the northern Adriatic Sea where concentrations of particulate and dissolved PUAs were monitored along with phytoplankton cell lysis. Cell lysis was positively correlated with both concentrations of particulate and dissolved PUAs (R = 0.69 and R = 0.77, respectively), supporting the hypothesis that these compounds are released by cell lysis. However, the highest concentration of dissolved PUAs (2.53 nM) was measured when cell lysis was high (0.24 d(-1)) but no known PUA-producing diatoms were detected, suggesting either that other organisms can produce PUAs or that PUA-producing enzymes retain activity extracellularly after diatom cells have lysed. Although in situ concentrations of dissolved PUAs were one to three orders of magnitude lower than those typically used in laboratory culture experiments, we argue that concentrations produced in the field could induce similar effects to those observed in culture and therefore may help shape plankton community composition and function in the oceans.	[Ribalet, Francois; Ianora, Adrianna; Miralto, Antonio; Romano, Giovanna; Casotti, Raffaella] Stn Zool Anton Dohrn Napoli, Naples, Italy; [Bastianini, Mauro; Acri, Francesco] ISMAR CNR Ist Sci Marine, Venice, Italy; [Vidoudez, Charles; Pohnert, Georg; Wichard, Thomas] Univ Jena, Inst Inorgan & Analyt Chem, Jena Sch Microbial Commun, Jena, Germany; [Berges, John] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Berges, John] Univ Wisconsin, Sch Freshwater Sci, Milwaukee, WI 53201 USA	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Friedrich Schiller University of Jena; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Casotti, R (corresponding author), Stn Zool Anton Dohrn Napoli, Naples, Italy.	raffa@szn.it	Wichard, Thomas/L-9861-2019; Ianora, Adrianna/O-3408-2019; Berges, John A/D-9520-2012; Casotti, Raffaella/I-9833-2019; Romano, Giovanna/F-4561-2015; Pohnert, Georg/D-3721-2013; Wichard, Thomas/C-2794-2009; Casotti, Raffaella/H-1697-2016; CNR, Ismar/P-1247-2014	Wichard, Thomas/0000-0003-0061-4160; Berges, John A/0000-0002-3124-4783; Casotti, Raffaella/0000-0002-9876-4601; Romano, Giovanna/0000-0002-4898-7153; Pohnert, Georg/0000-0003-2351-6336; Wichard, Thomas/0000-0003-0061-4160; Casotti, Raffaella/0000-0002-9876-4601; Ribalet, Francois/0000-0002-7431-0234; Bastianini, Mauro/0000-0001-6758-4192; CNR, Ismar/0000-0001-5351-1486; Vidoudez, Charles/0000-0003-0953-7800	INTERREG - GRANT EU INTERREG III Italy-Slovenian Project.; Volkswagen Foundation; Swiss National Fonds; VECTOR Project; Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK; Biological Oceanography of the Northern Adriatic (OBAS)	INTERREG - GRANT EU INTERREG III Italy-Slovenian Project.; Volkswagen Foundation(Volkswagen); Swiss National Fonds(Swiss National Science Foundation (SNSF)); VECTOR Project; Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK; Biological Oceanography of the Northern Adriatic (OBAS)	The project was funded by INTERREG - GRANT EU INTERREG III Italy-Slovenian Project. Biological Oceanography of the Northern Adriatic (OBAS 2003-2006), the Volkswagen Foundation, the Swiss National Fonds and the VECTOR Project. This work was also part of the PhD project of FR funded by the Stazione Zoologica Anton Dohrn (SZN) under the Associate Research Center PhD Program of The Open University, Milton Keynes, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Agusti S, 1998, LIMNOL OCEANOGR, V43, P1836; Balestra C, 2011, AQUAT MICROB ECOL, V63, P123, DOI 10.3354/ame01486; Barofsky A, 2007, ORG LETT, V9, P1017, DOI 10.1021/ol063051v; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; BRUSSAARD CPD, 1995, MAR ECOL PROG SER, V123, P259, DOI 10.3354/meps123259; Brussaard CPD, 1998, AQUAT MICROB ECOL, V14, P271, DOI 10.3354/ame014271; CONLEY DJ, 1992, MAR ECOL PROG SER, V81, P121, DOI 10.3354/meps081121; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6133, DOI 10.1016/S0040-4039(02)01285-6; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6137, DOI 10.1016/S0040-4039(02)01283-2; Dittami SM, 2010, NOVA HEDWIGIA, P231, DOI 10.1127/1438-9134/2010/0136-0231; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Grasshoff K, 1999, WILEY ONLINE LIB, P660, DOI [10.1002/9783527613984.fmatter, DOI 10.1002/9783527613984.FMATTER]; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; IMAI I, 1993, MAR BIOL, V116, P527, DOI 10.1007/BF00355470; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; LAWS EA, 1981, MAR BIOL, V65, P13, DOI 10.1007/BF00397062; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; MITSUTANI A, 1992, NIPPON SUISAN GAKK, V58, P2159; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P3528, DOI 10.1128/AEM.71.7.3528-3535.2005; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Pohnert G, 2002, PLANT PHYSIOL, V129, P103, DOI 10.1104/pp.010974; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Pugnetti Alessandra, 2004, Chemistry and Ecology, V20, P399, DOI 10.1080/02757540412331294902; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Ribalet F, 2009, PROTIST, V160, P444, DOI 10.1016/j.protis.2009.01.003; Riegman R, 2003, ACTA OECOL, V24, pS133, DOI 10.1016/S1146-609X(03)00010-9; Rijstenbil JW, 2002, J PLANKTON RES, V24, P1277, DOI 10.1093/plankt/24.12.1277; Socal G, 2002, CHEM ECOL, V18, P61, DOI 10.1080/02757540212686; Soelberg SD, 2009, ANAL CHEM, V81, P2357, DOI 10.1021/ac900007c; Spiteller G, 2003, PHYSIOL PLANTARUM, V119, P5, DOI 10.1034/j.1399-3054.2003.00097.x; Utermohl H., 1958, MITT INT VER THEOR, V9, P1, DOI DOI 10.1080/05384680.1958.11904091; VANBOEKEL WHM, 1992, MAR ECOL PROG SER, V81, P269, DOI 10.3354/meps081269; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Vidoudez C, 2011, MAR DRUGS, V9, P500, DOI 10.3390/md9040500; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Wichard T, 2005, J CHROMATOGR B, V814, P155, DOI 10.1016/j.jchromb.2004.10.021; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Wichard T, 2006, J AM CHEM SOC, V128, P7114, DOI 10.1021/ja057942u	52	41	41	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85947	10.1371/journal.pone.0085947	http://dx.doi.org/10.1371/journal.pone.0085947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497933	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900013
J	Friedman, MR; Wei, CY; Klem, ML; Silvestre, AJ; Markovic, N; Stall, R				Friedman, M. Reuel; Wei, Chongyi; Klem, Mary Lou; Silvestre, Anthony J.; Markovic, Nina; Stall, Ron			HIV Infection and Sexual Risk among Men Who Have Sex with Men and Women (MSMW): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							NEW-YORK-CITY; TRANSMITTED-DISEASE CLINICS; DEPARTMENT-OF-HEALTH; AFRICAN-AMERICAN MEN; BISEXUAL MEN; BLACK-MEN; UNITED-STATES; UNPROTECTED SEX; SAN-FRANCISCO; LATINO MEN	Objectives: To estimate the number of men who have sex with men and women who are HIV-positive in the United States, and to compare HIV prevalence rates between men who have sex with men and women, men who have sex with men only, and men who have sex with women exclusively. Methods: Following PRISMA guidelines, we conducted a systematic review and meta-analysis of reports referencing HIV prevalence and men who have sex with men and women. We searched PubMed and Ovid PsycINFO for peer-reviewed, U. S. -based articles reporting on HIV prevalence among men who have sex with men and women. We conducted event rate, effect size, moderation and sensitivity analyses. Results: We estimate that 1.0% of U. S. males are bisexually-behaving, and that 121,800 bisexually-behaving men are HIV-positive. Men who have sex with men and women are less than half as likely to be HIV-positive as men who have sex with men only (16.9% vs. 33.3%; OR = 0.41, 95% CI: 0.31, 0.54), but more than five times as likely to be HIV-positive as men who have sex with women exclusively (18.3% vs. 3.5%; OR = 5.71, 95% CI: 3.47, 9.39). They are less likely to engage in unprotected receptive anal intercourse than men who have sex with men only (15.9% vs. 35.0%; OR = 0.36, 95% CI: 0.28, 0.46). Men who have sex with men and women in samples with high racial/ethnic minority proportions had significantly higher HIV prevalence than their counterparts in low racial/ethnic minority samples. Conclusions: This represents the first meta-analysis of HIV prevalence in the U. S. between men who have sex with men and women and men who have sex with men only. Data collection, research, and HIV prevention and care delivery specifically tailored to men who have sex with men and women are necessary to better quantify and ameliorate this population's HIV burden.	[Friedman, M. Reuel; Silvestre, Anthony J.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Friedman, M. Reuel; Klem, Mary Lou; Silvestre, Anthony J.; Markovic, Nina; Stall, Ron] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr Lesbian Gay Bisexual & Transgender Hlth Res, Pittsburgh, PA USA; [Wei, Chongyi] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Klem, Mary Lou] Univ Pittsburgh, Hlth Sci Lib Syst, Pittsburgh, PA USA; [Markovic, Nina] Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA; [Stall, Ron] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, MR (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	mrf9@pitt.edu		Klem, Mary/0000-0003-3481-5737; Friedman, M. Reuel/0000-0001-6191-9799	University of Pittsburgh Graduate School of Public Health	University of Pittsburgh Graduate School of Public Health(University of Pittsburgh)	Funding support was limited to a grant from the University of Pittsburgh Graduate School of Public Health (Dean's Office) to the University of Pittsburgh Center for LGBT Health Research, which enabled the purchase of meta-analysis software and open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2006, SEX TRANSM DIS, V33, P596, DOI 10.1097/01.olq.0000233666.67788.fc; Aggleton P, 1996, BISEXUALITIES AIDS I; Agronick G, 2004, AIDS BEHAV, V8, P185, DOI 10.1023/B:AIBE.0000030249.11679.d0; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Borenstein M., 2009, INTRO METAANALYSIS; Bowers JR, 2011, CULT HEALTH SEX, V13, P629, DOI 10.1080/13691058.2011.564301; Cassels S, 2010, SEX TRANSM DIS, V37, P272, DOI 10.1097/OLQ.0b013e3181c37e3e; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; CHU SY, 1992, AM J PUBLIC HEALTH, V82, P220, DOI 10.2105/AJPH.82.2.220; Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Cunningham SD, 2006, SEX TRANSM INFECT, V82, P444, DOI 10.1136/sti.2005.019513; Deren S., 2001, Culture, Health & Sexuality, V3, P329, DOI 10.1080/13691050152484740; Doll LS, 1996, AIDS EDUC PREV, V8, P205; Donate APM, 2010, AM J PUBLIC HEALTH, V100, P2532, DOI 10.2105/AJPH.2009.179648; EKSTRAND ML, 1994, AM J PUBLIC HEALTH, V84, P915, DOI 10.2105/AJPH.84.6.915; Flores SA, 2009, SEX TRANSM DIS, V36, P325, DOI 10.1097/OLQ.0b013e3181924201; Fuller CM, 2005, J URBAN HEALTH, V82, pI51, DOI 10.1093/jurban/jti024; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Goodenow C, 2002, AM J PUBLIC HEALTH, V92, P203, DOI 10.2105/AJPH.92.2.203; Gorbach PM, 2009, J URBAN HEALTH, V86, pS63, DOI 10.1007/s11524-009-9370-7; Hays RB, 1997, AIDS, V11, P1495, DOI 10.1097/00002030-199712000-00014; Hightow LB, 2006, SEX TRANSM DIS, V33, P585, DOI 10.1097/01.olq.0000216031.93089.68; Jeffries WL, 2011, PERSPECT SEX REPRO H, V43, P151, DOI 10.1363/4315111; Jeffries WL, 2007, J SEX RES, V44, P278, DOI 10.1080/00224490701443973; Kahn JG, 1997, AIDS, V11, P1031, DOI 10.1097/00002030-199708000-00012; Kalichman SC, 1998, HEALTH PSYCHOL, V17, P320, DOI 10.1037/0278-6133.17.4.320; Kennamer JD, 2000, AIDS EDUC PREV, V12, P519; Knight KR, 2007, JAIDS-J ACQ IMM DEF, V46, pS80, DOI 10.1097/QAI.0b013e3181576828; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Latkin Carl, 2011, Am J Public Health, V101, pe18, DOI 10.2105/AJPH.2011.300281; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lehner T, 1998, AM J EPIDEMIOL, V147, P269, DOI 10.1093/oxfordjournals.aje.a009446; Levin EM, 2009, SEX TRANSM DIS, V36, P541, DOI 10.1097/OLQ.0b013e3181a819db; LEWIS DK, 1994, J ACQ IMMUN DEF SYND, V7, P190; Malebranche DJ, 2008, ARCH SEX BEHAV, V37, P810, DOI 10.1007/s10508-008-9364-7; MCKIRNAN DJ, 1995, J SEX RES, V32, P65, DOI 10.1080/00224499509551775; Millett G, 2005, J NATL MED ASSOC, V97, p52S; Millett GA, 2006, J INFORM, V96; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P602, DOI 10.1007/s11524-009-9363-6; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molitor F, 1998, WESTERN J MED, V168, P93; Montgomery JP, 2003, AIDS CARE, V15, P829, DOI 10.1080/09540120310001618676; Morin SF, 2011, JAIDS-J ACQ IMM DEF, V57, P175, DOI 10.1097/QAI.0b013e318222c0f9; MORSE EV, 1991, SOC SCI MED, V32, P535, DOI 10.1016/0277-9536(91)90287-M; Munoz-Laboy M, 2007, AM J PUBLIC HEALTH, V97, P1102, DOI 10.2105/AJPH.2005.078345; Myers H F, 1997, Ethn Health, V2, P183; Nakamura N, 2011, ARCH SEX BEHAV, V40, P793, DOI 10.1007/s10508-010-9713-1; O'Leary A, 2006, SEX TRANSM DIS, V33, P594, DOI 10.1097/01.olq.0000225280.44538.f6; Operario D, 2011, AIDS BEHAV, V15, P576, DOI 10.1007/s10461-009-9588-0; Operario D, 2010, AIDS EDUC PREV, V22, P37, DOI 10.1521/aeap.2010.22.1.37; Pathela P, 2010, PEDIATRICS, V126, P879, DOI 10.1542/peds.2010-0396; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Pinkerton SD, 2000, INT J STD AIDS, V11, P38, DOI 10.1258/0956462001914887; Prabhu R, 2004, AIDS, V18, P1604, DOI 10.1097/01.aids.0000131366.05823.87; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; ROFFMAN RA, 1990, PUBLIC HEALTH REP, V105, P202; ROGERS SM, 1991, J SEX RES, V28, P491, DOI 10.1080/00224499109551621; Ross MW, 2003, SEX TRANSM DIS, V30, P110, DOI 10.1097/00007435-200302000-00003; Rust PC, 2000, BISEXUALITY US SOCIA; Salazar LF, 2010, INT J STD AIDS, V21, P691, DOI 10.1258/ijsa.2010.010053; Saleh LD, 2009, SOC SCI MED, V68, P390, DOI 10.1016/j.socscimed.2008.09.052; Sandfort T, 1998, SOC AS AIDS, P68; Satcher AJ, 2007, WOMEN HEALTH, V46, P23, DOI 10.1300/J013v46n02_03; Shoptaw S, 2009, J URBAN HEALTH, V86, pS77, DOI 10.1007/s11524-009-9372-5; Siegel K, 2008, ARCH SEX BEHAV, V37, P720, DOI 10.1007/s10508-008-9357-6; Smith TW, 2006, SEX SEXUALITY, V1, P104; Spikes PS, 2009, AM J PUBLIC HEALTH, V99, P1072, DOI 10.2105/AJPH.2008.144030; Tieu HV, 2012, AIDS CARE, V24, P1111, DOI 10.1080/09540121.2012.672723; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Torian LV, 1996, AIDS, V10, P187, DOI 10.1097/00002030-199602000-00009; Torian LV, 2002, SEX TRANSM DIS, V29, P73, DOI 10.1097/00007435-200202000-00002; Torian LV, 2000, AIDS, V14, P189, DOI 10.1097/00002030-200001280-00015; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Washington TA, 2010, J GAY LESBIAN SOC SE, V22, P432, DOI 10.1080/10538720.2010.491747; Wheeler DP, 2008, ARCH SEX BEHAV, V37, P697, DOI 10.1007/s10508-008-9372-7; Williams CT, 2009, J URBAN HEALTH, V86, pS93, DOI 10.1007/s11524-009-9367-2; Wold C, 1998, J ACQ IMMUN DEF SYND, V17, P361, DOI 10.1097/00042560-199804010-00011; WOOD RW, 1993, AM J PUBLIC HEALTH, V83, P1757, DOI 10.2105/AJPH.83.12.1757; Worth H, 2011, J BISEXUALITY, V11, P488, DOI 10.1080/15299716.2011.620824; Xia Q, 2006, JAIDS-J ACQ IMM DEF, V41, P238, DOI 10.1097/01.qai.0000185574.98472.36; Zellner JA, 2009, AM J PUBLIC HEALTH, V99, P125, DOI 10.2105/AJPH.2007.129809; Zule WA, 2009, J URBAN HEALTH, V86, pS48, DOI 10.1007/s11524-009-9366-3	84	90	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87139	10.1371/journal.pone.0087139	http://dx.doi.org/10.1371/journal.pone.0087139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24498030	Green Accepted, Green Published, gold			2022-12-27	WOS:000330617100051
J	Lazary, J; Dome, P; Csala, I; Kovacs, G; Faludi, G; Kaunisto, M; Dome, B				Lazary, Judit; Dome, Peter; Csala, Iren; Kovacs, Gabor; Faludi, Gabor; Kaunisto, Mari; Dome, Balazs			Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; NICOTINE WITHDRAWAL; SMOKING-CESSATION; ADULT TWINS; DEPRESSION; HAPLOTYPE; DEPENDENCE; TOLERANCE; TOBACCO	Heterogeneous phenotypes of complex disorders pose a great challenge for genetic association studies and for the development of personalized treatment strategies. Cluster analysis of phenotypic data has been recently proposed as a reliable auxiliary method for such studies. A cohort of 236 treatment-seeking smokers was investigated after overnight nicotine abstinence. Alpha4 nicotinic acetylcholine receptor (nAChR) subunit-related phenotypes were assessed by the Fagerstrom Test for Nicotine Dependence (FTND), exhaled carbon monoxide (CO) measurements, the Minnesota Nicotine Withdrawal Scale (MNWS) and the Zung Self-Rating Depression Scale (ZSDS). Seven tag SNPs (single-nucleotide polymorphisms) across CHRNA4 (the gene encoding alpha4 subunit of the nicotinic acetylcholine receptor) were genotyped and two-step cluster analysis was used for phenotypic cluster characterization. Haplotype estimation was determined by HapStat module of R 2.0 software. Three different phenotypic clusters were identified and the C3 cluster was characterized by the highest ZSDS and MNWS scores compared to others. Furthermore, lifetime prevalence of major depression was significantly higher in the C3 cluster (p = 0.019). In genetic association tests, this cluster was also significantly associated with rs3787138 genotypes (p = 0.004) while haplotype analyses of three SNPs (rs3787138, rs1044396, rs3787140) revealed that the risk for C3 phenotype was almost three times higher in GCC haplotype carriers compared to others (p(perm) = 0.013). This is the first report on a significant association between CHRNA4 variants and a subgroup of smokers characterized by massive withdrawal symptoms and affective vulnerability. Identification of such a phenotypic cluster can be a pivotal step for further pharmacogenetic studies on ligands of the alpha4 nAChR subunit. Our results suggest that performing cluster analysis in genetic association studies can be proposed for complex disorders.	[Lazary, Judit; Dome, Peter; Csala, Iren; Faludi, Gabor] Semmelweis Univ, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary; [Dome, Peter] Natl Inst Psychiat & Addict, Budapest, Hungary; [Csala, Iren] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary; [Kovacs, Gabor; Dome, Balazs] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Kaunisto, Mari] Univ Helsinki, FIMM, Helsinki, Finland; [Kaunisto, Mari] Folkhalsan Inst Genet, Helsinki, Finland; [Dome, Balazs] Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Dome, Balazs] Med Univ Vienna, Dept Thorac Surg, Translat Thorac Oncol Lab, Vienna, Austria	Semmelweis University; Semmelweis University; University of Helsinki; National Institute of Oncology Hungary; Medical University of Vienna	Lazary, J (corresponding author), Semmelweis Univ, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary.	lazaryjudit@gmail.com; balazs.dome@meduniwien.ac.at		Dome, Balazs/0000-0001-8799-8624; Kaunisto, Mari/0000-0002-6946-9195	Norwegian Financial Mechanism [HU0125]; OTKA [K108465, K109626]; TAMOP [424A/1-11-1-2012-0001]; KTIA AIK [12-1-2013-0041]; Hungarian Academy of Sciences	Norwegian Financial Mechanism; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; KTIA AIK; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by the Norwegian Financial Mechanism (HU0125) (J Lazary, P Dome, G Kovacs, G Faludi, B Dome); OTKA K108465 (B Dome); TAMOP 424A/1-11-1-2012-0001 (B Dome); KTIA AIK 12-1-2013-0041 (B Dome); OTKA K109626 (B Dome). P Dome is a recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breitling LP, 2009, PHARMACOGENOMICS J, V9, P219, DOI 10.1038/tpj.2009.6; COVEY LS, 1990, COMPR PSYCHIAT, V31, P350, DOI 10.1016/0010-440X(90)90042-Q; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Etter JF, 2009, ADDICT BEHAV, V34, P772, DOI 10.1016/j.addbeh.2009.05.010; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glassman AH, 2001, LANCET, V357, P1929, DOI 10.1016/S0140-6736(00)05064-9; Gold A.B., 2012, HUM GENET; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Kaneko Y, 2013, ALLERGOL INT, V62, P113, DOI 10.2332/allergolint.12-OA-0467; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Madden PAF, 1997, ADDICTION, V92, P889, DOI 10.1046/j.1360-0443.1997.92788911.x; Markett S, 2011, EMOTION, V11, P450, DOI 10.1037/a0021784; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Perera S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041407; Pergadia ML, 2006, PSYCHOL MED, V36, P963, DOI 10.1017/S0033291706007495; Pergadia ML, 2010, TWIN RES HUM GENET, V13, P359, DOI 10.1375/twin.13.4.359; Roe BE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006704; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Spruell T, 2012, NICOTINE TOB RES, V14, P993, DOI 10.1093/ntr/ntr246; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Sun JW, 2012, ADDICT BEHAV, V37, P1138, DOI 10.1016/j.addbeh.2012.05.010; Szadoczky E, 1998, J AFFECT DISORDERS, V50, P153, DOI 10.1016/S0165-0327(98)00056-1; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tsai SJ, 2012, GENES BRAIN BEHAV, V11, P230, DOI 10.1111/j.1601-183X.2011.00741.x; Winterer G, 2007, HUM MOL GENET, V16, P2165, DOI 10.1093/hmg/ddm168; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87141	10.1371/journal.pone.0087141	http://dx.doi.org/10.1371/journal.pone.0087141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498031	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330617100052
J	Lu, J; Zheng, HY; Zhang, Y; Guo, X; Wu, D; Li, H; Liu, L; Zeng, HR; Yi, LN; Fang, L; Mo, YL; Xu, WB; Ke, CW				Lu, Jing; Zheng, Huanying; Zhang, Yong; Guo, Xue; Wu, De; Li, Hui; Liu, Leng; Zeng, Hanri; Yi, Lina; Fang, Ling; Mo, Yanling; Xu, Wenbo; Ke, Changwen			Whole Genomic Sequence and Replication Kinetics of a New Enterovirus C96 Isolated from Guangdong, China with a Different Cell Tropism	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; INTRATYPIC RECOMBINATION; PCR AMPLIFICATION; MOUTH-DISEASE; ENCEPHALITIS; SEROTYPES; EPIDEMIOLOGY; DIVERSITY; EVOLUTION; REVEALS	Enterovirus 96 (EV-C96) is a newly described serotype within the enterovirus C (EV-C) species, and its biological and pathological characters are largely unknown. In this study, we sequenced the whole genome of a novel EV-C96 strain that was isolated in 2011 from a patient with acute flaccid paralysis (AFP) in Guangdong province, China and characterized the properties of its infection. Sequence analysis revealed the close relationship between the EV-C96 strains isolated from the Guangdong and Shandong provinces of China, and suggested that recombination events occurred both between these EV-C96 strains and with other EV-C viruses. Moreover, the virus replication kinetics showed EV-C96 Guangdong strain replicated at a high rate in RD cells and presented a different cell tropism to other strains isolated from Shandong recently. These findings gave further insight into the evolutionary processes and extensive biodiversity of EV-C96.	[Lu, Jing; Zheng, Huanying; Guo, Xue; Wu, De; Li, Hui; Liu, Leng; Zeng, Hanri; Yi, Lina; Fang, Ling; Mo, Yanling; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Lu, Jing; Yi, Lina] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zheng, HY (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	zhenghy.gdcdc@gmail.com		Zhang, Yong/0000-0002-2692-5437	Bill & Melinda Gates Foundation [OPP1039272]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This project was funded by Bill & Melinda Gates Foundation (Project No. OPP1039272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol LNG, 2012, VIRUS GENES, V45, P207, DOI 10.1007/s11262-012-0776-z; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Benschop K, 2010, DIAGN MICR INFEC DIS, V68, P166, DOI 10.1016/j.diagmicrobio.2010.05.016; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Blomqvist S, 2008, J CLIN MICROBIOL, V46, P2410, DOI 10.1128/JCM.00313-08; Cohen BJ, 2007, VACCINE, V26, P59, DOI 10.1016/j.vaccine.2007.10.046; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Dumaine A, 2008, ANN BIOL CLIN-PARIS, V66, P433, DOI 10.1684/abc.2008.0230; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; Hamaguchi T, 2008, EMERG INFECT DIS, V14, P828, DOI 10.3201/eid1405.071121; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Kung CM, 2007, J MED VIROL, V79, P60, DOI 10.1002/jmv.20761; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Pliaka V, 2010, VIRUS GENES, V40, P200, DOI 10.1007/s11262-010-0448-9; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smura T, 2009, ARCH VIROL, V154, P1157, DOI 10.1007/s00705-009-0418-5; Smura TP, 2007, J GEN VIROL, V88, P849, DOI 10.1099/vir.0.82510-0; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055480; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai HP, 2011, J MED MICROBIOL, V60, P1360, DOI 10.1099/jmm.0.027698-0; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x; Yip CCY, 2011, J VIROL, V85, P12098, DOI 10.1128/JVI.05944-11; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	42	12	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86877	10.1371/journal.pone.0086877	http://dx.doi.org/10.1371/journal.pone.0086877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497989	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100037
J	Xu, L; Zhang, F; Zhang, K; Wang, EK; Wang, J				Xu, Li; Zhang, Feng; Zhang, Kun; Wang, Erkang; Wang, Jin			The Potential and Flux Landscape Theory of Ecology	PLOS ONE			English	Article							GLOBAL STABILITY; DISSIPATION COST; ENERGY LANDSCAPE; ROBUSTNESS; NETWORKS; THERMODYNAMICS	The species in ecosystems are mutually interacting and self sustainable stable for a certain period. Stability and dynamics are crucial for understanding the structure and the function of ecosystems. We developed a potential and flux landscape theory of ecosystems to address these issues. We show that the driving force of the ecological dynamics can be decomposed to the gradient of the potential landscape and the curl probability flux measuring the degree of the breaking down of the detailed balance (due to in or out flow of the energy to the ecosystems). We found that the underlying intrinsic potential landscape is a global Lyapunov function monotonically going down in time and the topology of the landscape provides a quantitative measure for the global stability of the ecosystems. We also quantified the intrinsic energy, the entropy, the free energy and constructed the non-equilibrium thermodynamics for the ecosystems. We studied several typical and important ecological systems: the predation, competition, mutualism and a realistic lynx-snowshoe hare model. Single attractor, multiple attractors and limit cycle attractors emerge from these studies. We studied the stability and robustness of the ecosystems against the perturbations in parameters and the environmental fluctuations. We also found that the kinetic paths between the multiple attractors do not follow the gradient paths of the underlying landscape and are irreversible because of the non-zero flux. This theory provides a novel way for exploring the global stability, function and the robustness of ecosystems.	[Xu, Li; Zhang, Feng; Zhang, Kun; Wang, Erkang; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Zhang, Feng; Wang, Jin] Jilin Univ, Coll Phys, Changchun 130023, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Jilin University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu	, 汪尔康/P-1748-2019		NSFC [21190040, 91227114, 11174105]; 973 project [2010CB933600]; NSF	NSFC(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China); NSF(National Science Foundation (NSF))	This study was supported by NSFC grant no. 21190040, 91227114, and 11174105; 973 project 2010CB933600; and NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; Colomer MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060698; Ao P, 2005, PHYS LIFE REV, V2, P117, DOI 10.1016/j.plrev.2005.03.002; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bazykin AD., 1985, MATH BIOPHYSICS INTE; Ge H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051133; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOH BS, 1976, J MATH BIOL, V3, P313, DOI 10.1007/BF00275063; GOH BS, 1977, AM NAT, V111, P135, DOI 10.1086/283144; Graham R., 1989, NOISE NON D, V1, P225; Haken H., 1987, ADV SYNERGETICS INST; Han B, 2007, BIOPHYS J, V92, P3755, DOI 10.1529/biophysj.106.094821; HARRISON GW, 1979, J MATH BIOL, V8, P159, DOI 10.1007/BF00279719; HASTINGS A, 1978, J MATH BIOL, V5, P399; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; HSU SB, 1978, MATH BIOSCI, V39, P1, DOI 10.1016/0025-5564(78)90025-1; HU G, 1986, Z PHYS B CON MAT, V65, P103, DOI 10.1007/BF01308404; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; Lapidus S, 2008, P NATL ACAD SCI USA, V105, P6039, DOI 10.1073/pnas.0708708105; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Mitchell IM, 2008, J SCI COMPUT, V35, P300, DOI 10.1007/s10915-007-9174-4; MURDOCH W W, 1975, P1; MURRAY J. D., 1998, MATH BIOL; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; Qian H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016102; Qian H, 2006, J PHYS CHEM B, V110, P15063, DOI 10.1021/jp061858z; Qian H, 2009, METHOD ENZYMOL, V467, P111, DOI 10.1016/S0076-6879(09)67005-1; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; SCHNAKENBERG J, 1976, REV MOD PHYS, V48, P571, DOI 10.1103/RevModPhys.48.571; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tyson R, 2010, THEOR ECOL-NETH, V3, P97, DOI 10.1007/s12080-009-0057-1; Vandermeer J.H., 2003, POPULATION ECOLOGY 1; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Volterra V, 1931, LECONS THEORIE MATH; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478547; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Wu J, 2008, ENCY ECOLOGY; Wu J., 2007, KEY TOPICS LANDSCAPE; Xu L, 2013, NONLINEARITY, V26, pR69, DOI 10.1088/0951-7715/26/2/R69; Yoda M, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2539037; Zhang F, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734305	45	17	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86746	10.1371/journal.pone.0086746	http://dx.doi.org/10.1371/journal.pone.0086746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497975	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100029
J	Baxter, IR; Ziegler, G; Lahner, B; Mickelbart, MV; Foley, R; Danku, J; Armstrong, P; Salt, DE; Hoekenga, OA				Baxter, Ivan R.; Ziegler, Gregory; Lahner, Brett; Mickelbart, Michael V.; Foley, Rachel; Danku, John; Armstrong, Paul; Salt, David E.; Hoekenga, Owen A.			Single-Kernel Ionomic Profiles Are Highly Heritable Indicators of Genetic and Environmental Influences on Elemental Accumulation in Maize Grain (Zea mays)	PLOS ONE			English	Article							PHOSPHORUS ACQUISITION; ASSOCIATION; ADAPTATIONS; PLANTS	The ionome, or elemental profile, of a maize kernel can be viewed in at least two distinct ways. First, the collection of elements within the kernel are food and feed for people and animals. Second, the ionome of the kernel represents a developmental end point that can summarize the life history of a plant, combining genetic programs and environmental interactions. We assert that single-kernel-based phenotyping of the ionome is an effective method of analysis, as it represents a reasonable compromise between precision, efficiency, and power. Here, we evaluate potential pitfalls of this sampling strategy using several field-grown maize sample sets. We demonstrate that there is enough genetically determined diversity in accumulation of many of the elements assayed to overcome potential artifacts. Further, we demonstrate that environmental signals are detectable through their influence on the kernel ionome. We conclude that using single kernels as the sampling unit is a valid approach for understanding genetic and environmental effects on the maize kernel ionome.	[Baxter, Ivan R.; Ziegler, Gregory] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63166 USA; [Lahner, Brett; Mickelbart, Michael V.; Foley, Rachel] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Danku, John; Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Armstrong, Paul] ARS, USDA, Engn & Wind Eros Res Unit, Manhattan, KS USA; [Hoekenga, Owen A.] ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Aberdeen; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Baxter, IR (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63166 USA.	Ivan.Baxter@ars.usda.gov; Owen.Hoekenga@ars.usda.gov	Baxter, Ivan R/A-1052-2009; Danku, John/C-3477-2014	Baxter, Ivan R/0000-0001-6680-1722; Danku, John/0000-0002-5103-3852; Hoekenga, Owen/0000-0003-4427-2000	U.S. National Science Foundation, Plant Genome Research Program [IOS 0701119, IOS 1126950]; Division Of Integrative Organismal Systems [1126950] Funding Source: National Science Foundation	U.S. National Science Foundation, Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the U.S. National Science Foundation, Plant Genome Research Program (grant # IOS 0701119 awarded to David Salt and grant # IOS 1126950 awarded to Ivan Baxter and Owen Hoekenga) and United States Department of Agriculture-Agricultural Research Service Intramural funds to Ivan Baxter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Basten C, 2000, CARTOGRAPHER VERSION; Baxter I, 2012, SCIENCE, V336, P1661, DOI 10.1126/science.1219992; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Bray E, 2000, BIOCH MOL BIOL PLANT, P1160; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHURCHILL GA, 1994, GENETICS, V138, P963; Food and Agriculture Organization, 2008, FAOSTAT DAT; GOLDMAN IL, 1994, HORTSCIENCE, V29, P209, DOI 10.21273/HORTSCI.29.3.209; Graham RD, 2008, MICRONUTRIENT DEFICI, P2; Haugen JE, 2000, ANAL CHIM ACTA, V407, P23, DOI 10.1016/S0003-2670(99)00784-9; JANSEN RC, 1994, GENETICS, V136, P1447; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; Pongrac P, 2013, FOOD RES INT, V54, P125, DOI 10.1016/j.foodres.2013.06.020; Pongrac P, 2011, J AGR FOOD CHEM, V59, P1275, DOI 10.1021/jf103150d; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Tracy W.F., 1997, PLANT BREEDING REV, V14, P189, DOI [10.1002/9780470650073.ch7, DOI 10.1002/9780470650073.CH7]; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Wickham H, 2007, J STAT SOFTW, V21, P1; Wood S, 2000, SOIL RES COND, P45; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; ZENG ZB, 1994, GENETICS, V136, P1457; Ziegler G, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.07.0012	28	43	45	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87628	10.1371/journal.pone.0087628	http://dx.doi.org/10.1371/journal.pone.0087628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489944	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000164
J	Sandoval-Usme, MC; Umana-Perez, A; Guerra, B; Hernandez-Perera, O; Garcia-Castellano, JM; Fernandez-Perez, L; Sanchez-Gomez, M				Claudia Sandoval-Usme, Maria; Umana-Perez, Adriana; Guerra, Borja; Hernandez-Perera, Orlando; Manuel Garcia-Castellano, Jose; Fernandez-Perez, Leandro; Sanchez-Gomez, Myriam			Simvastatin Impairs Growth Hormone-Activated Signal Transducer and Activator of Transcription (STAT) Signaling Pathway in UMR-106 Osteosarcoma Cells	PLOS ONE			English	Article							OSTEOBLAST-LIKE CELLS; COLORECTAL-CANCER; MELANOMA-CELLS; GH; PHOSPHORYLATION; INHIBITORS; EXPRESSION; METASTASIS; MECHANISMS; LOVASTATIN	Recent studies have demonstrated that statins reduce cell viability and induce apoptosis in various types of cancer cells. The molecular mechanisms underlying these effects are poorly understood. The JAK/STAT pathway plays an important role in the regulation of proliferation and apoptosis in many tissues, and its deregulation is believed to be involved in tumorigenesis and cancer. The physiological activation of STAT proteins by GH is rapid but transient in nature and its inactivation is regulated mainly by the expression of SOCS proteins. UMR-106 osteosarcoma cells express a GH-responsive JAK2/STAT5 signaling pathway, providing an experimental model to study the influence of statins on this system. In this study we investigated the actions of simvastatin on cell proliferation, migration, and invasion on UMR-106 cells and examined whether alterations in GH-stimulated JAK/STAT/SOCS signaling may be observed. Results showed that treatment of osteosarcoma cells with simvastatin at 3 to 10 mu M doses decreases cell proliferation, migration, and invasion in a time-and dose-dependent manner. At the molecular level, although the mechanisms used by simvastatin are not entirely clear, the effect of the statin on the reduction of JAK2 and STAT5 phosphorylation levels may partially explain the decrease in the GH-stimulated STAT5 transcriptional activity. This effect correlated with a time-and dose-dependent increase of SOCS-3 expression levels in cells treated with simvastatin, a regulatory role that has not been previously described. Furthermore, the finding that simvastatin is capable of inducing SOCS-3 and CIS genes expression shows the potential of the JAK/STAT pathway as a therapeutic target, reinforcing the efficacy of simvastatin as chemotherapeutic drug for the treatment of osteosarcoma.	[Claudia Sandoval-Usme, Maria; Umana-Perez, Adriana; Sanchez-Gomez, Myriam] Univ Nacl Colombia, Hormone Lab, Dept Chem, Bogota, Colombia; [Guerra, Borja; Fernandez-Perez, Leandro] Univ Las Palmas Gran Canaria, Dept Clin Sci, Mol & Translat Endocrinol Grp, Canc Res Inst Canary Isl ICIC, Las Palmas Gran Canaria, Spain; [Guerra, Borja; Fernandez-Perez, Leandro] CSIC, Associated Biomed Unit, ULPGC IIBM Alberto Sols, Las Palmas Gran Canaria, Spain; [Hernandez-Perera, Orlando; Manuel Garcia-Castellano, Jose] CHUIMI, Mol Oncol Lab, Res Unit, Las Palmas Gran Canaria, Spain	Universidad Nacional de Colombia; Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Sandoval-Usme, MC (corresponding author), Univ Nacl Colombia, Hormone Lab, Dept Chem, Bogota, Colombia.	mysanchezd@unal.edu.co	Guerra, Borja/ABE-1138-2021; Fernandez-Perez, Leandro/H-1493-2015; Guerra, Borja/G-9739-2015	Guerra, Borja/0000-0003-4355-5682; Fernandez-Perez, Leandro/0000-0001-7802-465X; Guerra, Borja/0000-0003-4355-5682; Sanchez-Gomez, Myriam/0000-0002-9481-7534; Umana-Perez, Adriana/0000-0001-9262-2699	Spanish Ministry of Science and Innovation; European Regional Development Fund-European Social Fund [SAF2003-02117, SAF2006-07824]; National University of Colombia Research Council (DIB) [10879, 12243, 14233, 16056]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund-European Social Fund; National University of Colombia Research Council (DIB)	This work was supported by grants-in-aid to LF-P from the Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund (SAF2003-02117 and SAF2006-07824) and grants to M.S.-G. from the National University of Colombia Research Council (DIB Grants 10879, 12243, 14233 and 16056). The excellent technical assistance of C. Mateos-Diaz is greatly appreciated. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2010, J ENDOCRINOL, V206, P249, DOI 10.1677/JOE-10-0045; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; BARNARD R, 1991, ENDOCRINOLOGY, V128, P1459, DOI 10.1210/endo-128-3-1459; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Cabrera-Benitez NE, 2008, PAPEL INHIBIDORES 3; CARMICHAEL J, 1987, CANCER RES, V47, P936; Collisson EA, 2003, MOL CANCER THER, V2, P941; Cooper JC, 2010, INT J ONCOL, V36, P1201, DOI 10.3892/ijo_00000603; Deng JY, 2010, WORLD J GASTROENTERO, V16, P5380, DOI 10.3748/wjg.v16.i42.5380; Fernandez L, 1998, ENDOCRINOLOGY, V139, P1815, DOI 10.1210/en.139.4.1815; Fromigue O, 2008, J PHARMACOL EXP THER, V325, P595, DOI 10.1124/jpet.108.136127; Gallagher EJ, 2011, CELL METAB, V13, P355, DOI 10.1016/j.cmet.2011.03.003; Gbelcova H, 2008, INT J CANCER, V122, P1214, DOI 10.1002/ijc.23242; Glynn SA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-9; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Huang KC, 2003, FEBS LETT, V555, P385, DOI 10.1016/S0014-5793(03)01297-3; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kodach LL, 2007, GASTROENTEROLOGY, V133, P1272, DOI 10.1053/j.gastro.2007.08.021; Koyuturk M, 2007, CANCER LETT, V250, P220, DOI 10.1016/j.canlet.2006.10.009; Lima GAB, 2006, J ENDOCRINOL INVEST, V29, P1006, DOI 10.1007/BF03349215; Liu J, 2008, LIFE SCI, V82, P991, DOI 10.1016/j.lfs.2008.02.012; Mantha AJ, 2003, J CANCER RES CLIN, V129, P631, DOI 10.1007/s00432-003-0490-2; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; Morales O, 2000, J BONE MINER RES, V15, P2284, DOI 10.1359/jbmr.2000.15.11.2284; Morales O, 2002, J BIOL CHEM, V277, P34879, DOI 10.1074/jbc.M204819200; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Oliveira KAP, 2008, J BIOENERG BIOMEMBR, V40, P307, DOI 10.1007/s10863-008-9155-9; Park SH, 2001, MOL ENDOCRINOL, V15, P2157, DOI 10.1210/me.15.12.2157; Parsons RB, 2006, BIOCHEM J, V399, P205, DOI 10.1042/BJ20060655; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Robles-Valero J, 2010, BLOOD, V115, P4174, DOI 10.1182/blood-2009-12-256222; Sandoval-Usme María Claudia, 2011, Rev. acad. colomb. cienc. exact. fis. nat., V35, P287; Smirnova OV, 2007, WORLD J GASTROENTERO, V13, P6478, DOI 10.3748/wjg.13.6478; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Zhang X, 2008, J IMMUNOL, V180, P6988, DOI 10.4049/jimmunol.180.10.6988	44	17	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87769	10.1371/journal.pone.0087769	http://dx.doi.org/10.1371/journal.pone.0087769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489959	Green Published, gold			2022-12-27	WOS:000330570000176
J	Epstein, M; Barenco, M; Klein, N; Hubank, M; Callard, RE				Epstein, Michael; Barenco, Martino; Klein, Nigel; Hubank, Michael; Callard, Robin E.			Revealing Individual Signatures of Human T Cell CDR3 Sequence Repertoires with Kidera Factors	PLOS ONE			English	Article							PHYSICAL-PROPERTIES	The recent development of High Throughput Sequencing technologies has enabled an individual's TCR repertoire to be efficiently analysed at the nucleotide level. However, with unique clonotypes ranging in the tens of millions per individual, this approach gives a surfeit of information that is difficult to analyse and interpret in a biological context and gives little information about TCR structural diversity. Using publicly available TCR CDR3 sequence data, we analysed TCR repertoires by converting the encoded CDR3 amino acid sequences into Kidera Factors, a set of orthogonal physico-chemical properties that reflect protein structure. This approach enabled the TCR repertoire from different individuals to be distinguished and demonstrated the close similarity of the repertoire in different samples from the same individual.	[Epstein, Michael] UCL, Dept Stat Sci, London, England; [Epstein, Michael; Barenco, Martino; Hubank, Michael; Callard, Robin E.] UCL, CoMPLEX, London, England; [Barenco, Martino; Klein, Nigel; Hubank, Michael; Callard, Robin E.] UCL, Inst Child Hlth, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Callard, RE (corresponding author), UCL, CoMPLEX, London, England.	r.callard@ucl.ac.uk	Hubank, Michael JF/C-1837-2008	Hubank, Michael JF/0000-0002-2901-0742; Klein, Nigel/0000-0003-3925-9258	EPSRC; MRC [G0902107] Funding Source: UKRI; Medical Research Council [G0902107] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by an EPSRC doctoral training centre awarded to UCL CoMPLEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; GORSKI J, 1994, J IMMUNOL, V152, P5109; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Lefranc MP, 2001, T CELL RECEPTOR FACT; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Matsumoto Y, 2003, J IMMUNOL, V170, P4846, DOI 10.4049/jimmunol.170.9.4846; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Rackovsky S, 2009, P NATL ACAD SCI USA, V106, P14345, DOI 10.1073/pnas.0903433106; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86986	10.1371/journal.pone.0086986	http://dx.doi.org/10.1371/journal.pone.0086986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489822	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000088
J	Gregoriano, C; Ceschi, A; Rauber-Luthy, C; Kupferschmidt, H; Banner, NR; Krahenbuhl, S; Taegtmeyer, AB				Gregoriano, Claudia; Ceschi, Alessandro; Rauber-Luethy, Christine; Kupferschmidt, Hugo; Banner, Nicholas R.; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.			Acute Thiopurine Overdose: Analysis of Reports to a National Poison Centre 1995-2013	PLOS ONE			English	Article							6-MERCAPTOPURINE; AZATHIOPRINE	Literature regarding acute human toxicity of thiopurines is limited to a handful of case reports. Our objectives were to describe all cases of overdose with thiopurines reported to the Swiss Toxicological Information Centre between 1995-2013. A retrospective analysis was performed to determine circumstances, magnitude, management and outcome of overdose with these substances. A total of 40 cases (14 paediatric) were reported (azathioprine, n = 35; 6-mercaptopurine, n = 5). Of these, 25 were with suicidal intent, 12 were accidental and 3 were iatrogenic errors. The magnitude of overdose ranged from 1.5 to 43 (median 8) times the usual dose in adults. Twelve cases (30%) had attributable symptoms. The majority of these were minor and included gastrointestinal complaints and liver function test and blood count abnormalities. Symptoms were experienced by patients who took at least 1.5-times their usual daily thiopurine dose. Overdoses over two or more consecutive days, even if of modest size, were less well tolerated. One case of azathioprine and allopurinol co-ingestion over consecutive days led to agranulocytosis. Decontamination measures were undertaken in 11 cases (10 activated charcoal, 1 gastric lavage) and these developed fewer symptoms than untreated patients. This study shows that acute overdoses with thiopurines have a favourable outcome in the majority of cases and provides preliminary evidence that gastrointestinal decontamination with activated charcoal may reduce symptom development after overdose of these substances if patients present to medical services soon after ingestion.	[Gregoriano, Claudia; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.] Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland; [Gregoriano, Claudia; Kraehenbuhl, Stephan; Taegtmeyer, Anne B.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Gregoriano, Claudia] Kantonspital Baselland Liestal, Univ Clin Internal Med, Liestal, Switzerland; [Ceschi, Alessandro; Rauber-Luethy, Christine; Kupferschmidt, Hugo] Univ Zurich, Associated Inst, Swiss Toxicol Informat Ctr, Zurich, Switzerland; [Ceschi, Alessandro] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Banner, Nicholas R.] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Harefield, Middx, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Banner, Nicholas R.] Univ London Imperial Coll Sci Technol & Med, Inst Cardiovasc Med & Res, London, England	University of Basel; University of Basel; Kantonsspital Baselland; University of Zurich; University of Zurich; University Zurich Hospital; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; Imperial College London	Taegtmeyer, AB (corresponding author), Univ Basel, Dept Clin Pharmacol & Toxicol, Basel, Switzerland.		Krähenbühl, Stephan/Z-4744-2019	Ceschi, Alessandro/0000-0002-4308-0405	University Hospital Basel; Swiss Toxicological Information Centre; Swiss National Science Foundation [SNF31003A-132992]	University Hospital Basel; Swiss Toxicological Information Centre; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided through internal funds of the University and University Hospital Basel and the Swiss Toxicological Information Centre. Stephan Krahenbuhl is supported by a grant from the Swiss National Science Foundation (SNF31003A-132992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MICR HEALTHC SER DRU; Benson BE, 2013, CLIN TOXICOL, V51, P140, DOI 10.3109/15563650.2013.770154; Blum M, 2005, THYROID, V15, P1315, DOI 10.1089/thy.2005.15.1315; CARNEY DM, 1974, AM J MED, V56, P133, DOI 10.1016/0002-9343(74)90759-1; Ceschi A, 2013, AM J TRANSPLANT, V13, P786, DOI 10.1111/j.1600-6143.2012.04347.x; Chow LML, 2004, J PEDIATR-US, V144, P669, DOI 10.1016/j.jpeds.2003.12.043; ELION GB, 1961, CANCER CHEMOTH REP, P93; Gupta N, 2009, AM J EMERG MED, V27, P513; Hendrick D, 1984, LANCET, V323, P277; Hoffinan RS, 2007, CLIN TOXICOL, V45, P943, DOI 10.1080/15563650701233370; Howland MA, 2010, GOLDFRANKS TOXICOLOG, P108; Kruger C, 1998, KLIN PADIATR, V210, P136, DOI 10.1055/s-2008-1043866; MAURO LS, 1994, ANN PHARMACOTHER, V28, P915, DOI 10.1177/106002809402800717; Persson HE, 1998, J TOXICOL-CLIN TOXIC, V36, P205, DOI 10.3109/15563659809028940; Pro Concepta Zug AG Zug Switzerland, 2012, PROD INF IM; Pro Concepta Zug AG Zug Switzerland, 2012, PROD INF PUR NETH; Uppsala Monitoring Centre, 2013, US WHO UMC SYST STAN	17	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86390	10.1371/journal.pone.0086390	http://dx.doi.org/10.1371/journal.pone.0086390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489721	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330570000036
J	Mueller, KP; Neuhauss, SCF				Mueller, Kaspar P.; Neuhauss, Stephan C. F.			Sunscreen for Fish: Co-Option of UV Light Protection for Camouflage	PLOS ONE			English	Article							ORGANELLE TRANSPORT; PIGMENT DISPERSION; ZEBRAFISH; MELANOPHORES; ULTRAVIOLET; VISION; CELLS; EYES	Many animals change their body pigmentation according to illumination of their environment. In aquatic vertebrates, this reaction is mediated through aggregation or dispersion of melanin-filled vesicles (melanosomes) in dermal pigment cells (melanophores). The adaptive value of this behavior is usually seen in camouflage by allowing the animal to visually blend into the background. When exposed to visible light from below, however, dark-adapted zebrafish embryos at the age of 2 days post fertilization (dpf) surprisingly display dispersal instead of aggregation of melanosomes, i.e. their body coloration becomes dark on a bright background. Melanosomes of older embryos and early larvae (3-5 dpf) on the other hand aggregate as expected under these conditions. Here we provide an explanation to this puzzling finding: Melanosome dispersion in larvae 3 dpf and older is efficiently triggered by ultraviolet (UV) light, irrespective of the visual background, suggesting that the extent of pigmentation is a trade-off between threats from predation and UV irradiation. The UV light-induced dispersion of melanosomes thereby is dependent on input from retinal short wavelength-sensitive (SWS) cone photoreceptors. In young embryos still lacking a functional retina, protection from UV light predominates, and light triggers a dispersal of melanosomes via photoreceptors intrinsic to the melanophores, regardless of the actual UV content. In older embryos and early larvae with functional retinal photoreceptors in contrast, this light-induced dispersion is counteracted by a delayed aggregation in the absence of UV light. These data suggest that the primary function of melanosome dispersal has evolved as a protective adaption to prevent UV damage, which was only later co-opted for camouflage.	[Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Neurosci Ctr Zurich, Zurich, Switzerland; Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Neuhauss, SCF (corresponding author), Univ Zurich, Inst Mol Life Sci, Neurosci Ctr Zurich, Zurich, Switzerland.	stephan.neuhauss@imls.uzh.ch	Neuhauss, Stephan/AAX-9915-2020	Neuhauss, Stephan/0000-0002-9615-480X	Swiss National Science Foundation [3100A_135598]; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	This study was partially funded by the Swiss National Science Foundation (www.snf.ch; 3100A_135598) and the Canton of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Delfin K, 2009, P NATL ACAD SCI USA, V106, P2023, DOI 10.1073/pnas.0809439106; Bagnara JT, 1973, CHROMATOPHORES COLOR; COOHILL TP, 1970, PHYSIOL ZOOL, V43, P232, DOI 10.1086/physzool.43.3.30155532; Easter SS, 1996, DEV BIOL, V180, P646; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Fleisch VC, 2006, ZEBRAFISH, V3, P191, DOI 10.1089/zeb.2006.3.191; HADLEY ME, 1969, AM ZOOL, V9, P489; HAFEEZ MA, 1970, Z VERGL PHYSIOL, V68, P403, DOI 10.1007/BF00297738; Laurens H, 1914, J EXP ZOOL, V16, P195, DOI 10.1002/jez.1400160203; Logan DW, 2006, PIGM CELL RES, V19, P206, DOI 10.1111/j.1600-0749.2006.00307.x; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; McClure M, 1999, J MORPHOL, V241, P83; Miner BG, 2000, J EXP MAR BIOL ECOL, V249, P235, DOI 10.1016/S0022-0981(00)00201-X; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Parker GH, 1935, P AM ACAD ARTS SCI, V69, P439, DOI 10.2307/20023069; Parker GH, 1934, BIOL BULL-US, V66, P30, DOI 10.2307/1537459; PARKER GH, 1948, ANIMAL COLOUR CHANGE; Reilein AR, 2003, BIOCHEM BIOPH RES CO, V309, P652, DOI 10.1016/j.bbrc.2003.08.047; Rodionov VI, 1998, CURR BIOL, V8, P165, DOI 10.1016/S0960-9822(98)70064-8; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Schmitt EA, 1999, VISUAL NEUROSCI, V16, P601, DOI 10.1017/S0952523899163181; Shiraki T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1498, DOI 10.1039/c0pp00199f; Stoppani AOM, 1942, ENDOCRINOLOGY, V30, P782, DOI 10.1210/endo-30-5-782; Tuma MC, 1999, PIGM CELL RES, V12, P283, DOI 10.1111/j.1600-0749.1999.tb00762.x; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; von Frisch K, 1911, PFLUG ARCH GES PHYS, V138, P319; YOSHIDA M, 1956, J EXP BIOL, V33, P119	29	29	34	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87372	10.1371/journal.pone.0087372	http://dx.doi.org/10.1371/journal.pone.0087372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489905	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000330570000138
J	Sun, ZQ; Zheng, LQ; Zhang, XG; Li, J; Hu, DY; Sun, YX				Sun, Zhaoqing; Zheng, Liqiang; Zhang, Xingang; Li, Jue; Hu, Dayi; Sun, Yingxian			Ethnic Differences in the Incidence of Hypertension among Rural Chinese Adults: Results from Liaoning Province	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; PREHYPERTENSION; PROGRESSION; PREVALENCE; PREDICTORS; WOMEN; RISK; MEN	Background: This study was conducted to examine the differences in the incidence of hypertension and associated risk factors between Mongolian and Han populations in northeast China. Methods: A population-based sample of 4753 Mongolian subjects and 20,247 Han subjects aged >= 35 years and free from hypertension at baseline were followed from 2004-2006 to 2010. Incident hypertension was defined as systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg, or current use of antihypertensive medication. Results: During mean 4.3 years follow-up, a total of 8779 individuals developed hypertension. The age-adjusted incidence of hypertension for Mongolian subjects was 12.64 per 100 person-years, for Han subjects was 9.77 per 100 person-years (P < 0.05). The incidence of hypertension was positively correlated with age, physical activity, drinking, body mass index (BMI), family of hypertension and prehypertension in the Han population. In the Mongolian population, hypertension was positively correlated with age, physical activity, education level, drinking, BMI, prehypertension and family history of hypertension. The rates of awareness, treatment and control of hypertension for newly developed cases among both Han and Mongolian populations were low. (36.5% vs. 42.3%, 13.1% vs. 18.2%, 0.7% vs. 1.3%, P < 0.05, respectively). Conclusions: The incidence rate of hypertension is higher in the Mongolian populations than that in the Han populations, and hypertension in both ethnic populations was associated with similar risk factors. Our results suggest that most newly-diagnosed cases of hypertension are not adequately treated. Improvements in hypertension prevention and control programs in rural China are urgently needed.	[Sun, Zhaoqing; Zheng, Liqiang; Zhang, Xingang; Sun, Yingxian] China Med Univ, Shengjing Hosp, Div Cardiol, Shenyang, Peoples R China; [Li, Jue; Hu, Dayi] Tongji Univ, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China	China Medical University; Tongji University	Sun, YX (corresponding author), China Med Univ, Shengjing Hosp, Div Cardiol, Shenyang, Peoples R China.	sunyingxian@medmail.com.cn			key technology Research and Development program of Liaoning Province [2003225003]	key technology Research and Development program of Liaoning Province	This research was supported by grants from the key technology Research and Development program of Liaoning Province (2003225003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Gelber RP, 2007, AM J HYPERTENS, V20, P370, DOI 10.1016/j.amjhyper.2006.10.011; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2007, J HYPERTENS, V25, P517, DOI 10.1097/HJH.0b013e328013e7f4; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; 김영묵, 2008, Korean Circulation Journal, V38, P43; Hu G, 2004, EUR HEART J, V25, P2212, DOI 10.1016/j.ehj.2004.10.020; Kim J, 2006, J HYPERTENS, V24, P2177, DOI 10.1097/01.hjh.0000249694.81241.7c; Lee JH, 2011, J KOREAN MED SCI, V26, P1286, DOI 10.3346/jkms.2011.26.10.1286; Li N, 2008, BR J NUTR, V19, P1; Natali A, 2009, J HYPERTENS, V27, P2394, DOI 10.1097/HJH.0b013e3283316c31; Sathish T, 2012, PUBLIC HEALTH, V126, P25, DOI 10.1016/j.puhe.2011.11.002; Sugimoto K, 2004, HYPERTENS RES, V27, P551, DOI 10.1291/hypres.27.551; Sun ZQ, 2008, AM J HYPERTENS, V21, P784, DOI 10.1038/ajh.2008.170; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wu XG, 1996, J HYPERTENS, V14, P1267, DOI 10.1097/00004872-199611000-00003; Zheng LQ, 2010, EUR J CARDIOV PREV R, V17, P217, DOI 10.1097/HJR.0b013e328334f417	20	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86867	10.1371/journal.pone.0086867	http://dx.doi.org/10.1371/journal.pone.0086867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489797	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000076
J	Bettembourg, C; Diot, C; Dameron, O				Bettembourg, Charles; Diot, Christian; Dameron, Olivier			Semantic Particularity Measure for Functional Characterization of Gene Sets Using Gene Ontology	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; SIMILARITY MEASURE; KNOWLEDGE; DATABASE; OVERREPRESENTATION; ANNOTATIONS; NETWORKS	Background: Genetic and genomic data analyses are outputting large sets of genes. Functional comparison of these gene sets is a key part of the analysis, as it identifies their shared functions, and the functions that distinguish each set. The Gene Ontology (GO) initiative provides a unified reference for analyzing the genes molecular functions, biological processes and cellular components. Numerous semantic similarity measures have been developed to systematically quantify the weight of the GO terms shared by two genes. We studied how gene set comparisons can be improved by considering gene set particularity in addition to gene set similarity. Results: We propose a new approach to compute gene set particularities based on the information conveyed by GO terms. A GO term informativeness can be computed using either its information content based on the term frequency in a corpus, or a function of the term's distance to the root. We defined the semantic particularity of a set of GO terms Sg1 compared to another set of GO terms Sg2. We combined our particularity measure with a similarity measure to compare gene sets. We demonstrated that the combination of semantic similarity and semantic particularity measures was able to identify genes with particular functions from among similar genes. This differentiation was not recognized using only a semantic similarity measure. Conclusion: Semantic particularity should be used in conjunction with semantic similarity to perform functional analysis of GO-annotated gene sets. The principle is generalizable to other ontologies.	[Bettembourg, Charles; Dameron, Olivier] Univ Rennes 1, Rennes, France; [Bettembourg, Charles; Diot, Christian] INRA, PEGASE, UMR1348, St Gilles, France; [Bettembourg, Charles; Diot, Christian] Agrocampus OUEST, PEGASE, UMR1348, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] IRISA, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] INRIA, Rennes, France	Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Inria	Bettembourg, C (corresponding author), Univ Rennes 1, Rennes, France.	charles.bettembourg@univ-rennes1.fr	Diot, Christian/AAE-2514-2020	Diot, Christian/0000-0001-9525-6401; Dameron, Olivier/0000-0001-8959-7189	French ministry of research	French ministry of research(Ministry of Research, FranceEuropean Commission)	CB was supported by a fellowship from the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MA, 2011, J BIOINF COMPUT BIOL, V9, P681, DOI 10.1142/S0219720011005641; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker EJ, 2012, NUCLEIC ACIDS RES, V40, pD1067, DOI 10.1093/nar/gkr968; Barriot R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-332; Benabderrahmane S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-588; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolshakova N, 2005, BIOINFORMATICS, V21, P2546, DOI 10.1093/bioinformatics/bti317; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cannata N, 2005, PLOS COMPUT BIOL, V1, P531, DOI 10.1371/journal.pcbi.0010076; Chang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055635; Chen Gang, 2013, Int J Bioinform Res Appl, V9, P173, DOI 10.1504/IJBRA.2013.052448; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Clark WT, 2013, BIOINFORMATICS, V29, P53, DOI 10.1093/bioinformatics/btt228; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Diaz-Diaz N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-360; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hawkins T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-265; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Jiang J.J., 1997, P INT C RES COMP LIN; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Klie S, 2012, MOL BIOSYST, V8, P2233, DOI 10.1039/c2mb25089f; Kustra R, 2006, COMP MED SY, P555, DOI 10.1109/CBMS.2006.100; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mazandu Gaston K., 2012, Advances in Bioinformatics, V2012, P975783, DOI 10.1155/2012/975783; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Ochs Michael F, 2007, Methods Mol Biol, V377, P243; Ovaska K, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-11; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Primmer CR, 2013, MOL ECOL, V22, P3216, DOI 10.1111/mec.12309; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Shannon C.E., 1948, BELL SYSTEM TECHNICA, V27; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Staab S, 2002, COLING; Stobbe M.D., 2012, BRIEF BIOINFORM; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teng ZX, 2013, BIOINFORMATICS, V29, P1424, DOI 10.1093/bioinformatics/btt160; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; [No title captured]	51	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86525	10.1371/journal.pone.0086525	http://dx.doi.org/10.1371/journal.pone.0086525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489737	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000056
J	Corbett, EA; Kording, KP; Perreault, EJ				Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.			Dealing with Target Uncertainty in a Reaching Control Interface	PLOS ONE			English	Article							MOTOR; MODELS	Prosthetic devices need to be controlled by their users, typically using physiological signals. People tend to look at objects before reaching for them and we have shown that combining eye movements with other continuous physiological signal sources enhances control. This approach suffers when subjects also look at non-targets, a problem we addressed with a probabilistic mixture over targets where subject gaze information is used to identify target candidates. However, this approach would be ineffective if a user wanted to move towards targets that have not been foveated. Here we evaluated how the accuracy of prior target information influenced decoding accuracy, as the availability of neural control signals was varied. We also considered a mixture model where we assumed that the target may be foveated or, alternatively, that the target may not be foveated. We tested the accuracy of the models at decoding natural reaching data, and also in a closed-loop robot-assisted reaching task. The mixture model worked well in the face of high target uncertainty. Furthermore, errors due to inaccurate target information were reduced by including a generic model that relied on neural signals only.	[Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Corbett, Elaine A.; Koerding, Konrad P.; Perreault, Eric J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Koerding, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Perreault, Eric J.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Northwestern University	Corbett, EA (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	ecorbett@u.northwestern.edu	Perreault, Eric/B-7632-2009; Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Corbett, Elaine/0000-0001-7009-5867; Perreault, Eric/0000-0002-9860-6427	National Science Foundation [0939963]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 0939963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WW, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046016; Batista AP, 2008, IEEE T NEUR SYS REH, V16, P24, DOI 10.1109/TNSRE.2007.906958; Corbett EA, 2013, IEEE T NEUR SYS REH, V21, P674, DOI 10.1109/TNSRE.2013.2251664; Corbett EA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036002; Corbett EA, 2011, IEEE ENG MED BIO, P5428, DOI 10.1109/IEMBS.2011.6091342; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Jacob RJK, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P573, DOI 10.1016/B978-044451020-4/50031-1; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kemere C, 2008, J NEUROPHYSIOL, V100, P2441, DOI 10.1152/jn.00924.2007; Lawhern V, 2012, NEUROCOMPUTING, V82, P117, DOI 10.1016/j.neucom.2011.10.030; Leeb R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025011; Ljung L., 1987, SYSTEM IDENTIFICATIO; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Sachs NA, 2011, IEEE ENG MED BIO, P5432, DOI 10.1109/IEMBS.2011.6091343; Shanechi MM, 2013, IEEE T NEUR SYS REH, V21, P129, DOI 10.1109/TNSRE.2012.2221743; Srinivasan L, 2006, NEURAL COMPUT, V18, P2465, DOI 10.1162/neco.2006.18.10.2465; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	20	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86811	10.1371/journal.pone.0086811	http://dx.doi.org/10.1371/journal.pone.0086811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489788	Green Published, gold			2022-12-27	WOS:000330510000081
J	Lin, QQ; London, E				Lin, Qingqing; London, Erwin			Preparation of Artificial Plasma Membrane Mimicking Vesicles with Lipid Asymmetry	PLOS ONE			English	Article							BIOLOGICAL-MEMBRANES; CELL-MEMBRANES; PHOSPHATIDYLSERINE; CYCLODEXTRINS; CHOLESTEROL; PROTEINS; DOMAINS; ORIGIN	Lipid asymmetry, the difference in lipid distribution across the lipid bilayer, is one of the most important features of eukaryotic cellular membranes. However, commonly used model membrane vesicles cannot provide control of lipid distribution between inner and outer leaflets. We recently developed methods to prepare asymmetric model membrane vesicles, but facile incorporation of a highly controlled level of cholesterol was not possible. In this study, using hydroxypropyl-alpha-cyclodextrin based lipid exchange, a simple method was devised to prepare large unilamellar model membrane vesicles that closely resemble mammalian plasma membranes in terms of their lipid composition and asymmetry (sphingomyelin (SM) and/or phosphatidylcholine (PC) outside/phosphatidylethanolamine (PE) and phosphatidylserine (PS) inside), and in which cholesterol content can be readily varied between 0 and 50 mol%. We call these model membranes "artificial plasma membrane mimicking'' ("PMm'') vesicles. Asymmetry was confirmed by both chemical labeling and measurement of the amount of externally-exposed anionic lipid. These vesicles should be superior and more realistic model membranes for studies of lipid-lipid and lipid-protein interaction in a lipid environment that resembles that of mammalian plasma membranes.	[Lin, Qingqing; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.London@stonybrook.edu			National Science Foundation grant DMR [1104367]	National Science Foundation grant DMR	This work was supported by National Science Foundation grant DMR 1104367 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cheng HT, 2011, BIOPHYS J, V100, P2671, DOI 10.1016/j.bpj.2011.04.048; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Chiantia S, 2012, BIOPHYS J, V103, P2311, DOI 10.1016/j.bpj.2012.10.033; Chiantia S, 2011, BIOPHYS J, V100, pLO1, DOI 10.1016/j.bpj.2010.11.051; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Huang Z, 2013, LANGMUIR, V29, P14631, DOI 10.1021/la4031427; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lin Q, 2014, J BIOL CHEM IN PRESS; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; MARINETTI GV, 1976, CHEM PHYS LIPIDS, V16, P239, DOI 10.1016/0009-3084(76)90019-0; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PAGANO RE, 1981, BIOCHEMISTRY-US, V20, P4920, DOI 10.1021/bi00520a018; SCHICK PK, 1976, J CLIN INVEST, V57, P1221, DOI 10.1172/JCI108390; Shahidullah K, 2008, J MOL BIOL, V379, P704, DOI 10.1016/j.jmb.2008.04.026; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Son M, 2013, J LIPID RES, V54, P223, DOI 10.1194/jlr.M032722; Tsamaloukas A, 2005, BIOPHYS J, V89, P1109, DOI 10.1529/biophysj.105.061846; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	25	58	60	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87903	10.1371/journal.pone.0087903	http://dx.doi.org/10.1371/journal.pone.0087903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489974	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000155
J	Pagetta, A; Tramentozzi, E; Tibaldi, E; Cendron, L; Zanotti, G; Brunati, AM; Vitadello, M; Gorza, L; Finotti, P				Pagetta, Andrea; Tramentozzi, Elisa; Tibaldi, Elena; Cendron, Laura; Zanotti, Giuseppe; Brunati, Anna Maria; Vitadello, Maurizio; Gorza, Luisa; Finotti, Paola			Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RETICULUM CHAPERONE GRP94; TYPE-1 DIABETIC SUBJECTS; REJECTION ANTIGEN GP96; ENDOPLASMIC-RETICULUM; PEPTIDE-BINDING; HSP90; CELLS; NUCLEOTIDE; PLASMA	While the mechanism by which Grp94 displays its chaperone function with client peptides in the cell has been elucidated extensively, much less is known about the nature and properties of how Grp94 can engage binding to proteins once it is exposed on the cell surface or liberated in the extra-cellular milieu, as occurs in pathological conditions. In this work, we wanted to investigate the molecular aspects and structural characteristics of complexes that Grp94 forms with human IgG, posing the attention on the influence that glycosylation of Grp94 might have on the binding capacity to IgG, and on the identification of sites involved in the binding. To this aim, we employed both native, fully glycosylated and partially glycosylated Grp94, and recombinant, non-glycosylated Grp94, as well as IgG subunits, in different experimental conditions, including the physiological setting of human plasma. Regardless of the species and type, Grp94 engages a similar, highly specific and stable binding with IgG that involves sites located in the N-terminal domain of Grp94 and the hinge region of whole IgG. Grp94 does not form stable complex with Fab, F(ab)(2) or Fc. Glycosylation turns out to be an obstacle to the Grp94 binding to IgG, although this negative effect can be counteracted by ATP and spontaneously also disappears in time in a physiological setting of incubation. ATP does not affect at all the binding capacity of non-glycosylated Grp94. However, complexes that native, partially glycosylated Grp94 forms with IgG in the presence of ATP show strikingly different characteristics with respect to those formed in absence of ATP. Results have relevance for the mechanism regulating the formation of stable Grp94-IgG complexes in vivo, in the pathological conditions associated with the extra-cellular location of Grp94.	[Pagetta, Andrea; Tramentozzi, Elisa; Finotti, Paola] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Tibaldi, Elena; Brunati, Anna Maria] Univ Padua, Dept Mol Med, Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe; Gorza, Luisa] Univ Padua, Dept Biomed Sci, Padua, Italy; [Vitadello, Maurizio] Ctr Nazl Ric, CNR Inst Neurosci, Padova Sect, Padua, Italy	University of Padua; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Finotti, P (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	paola.finotti@unipd.it	Brunati, Anna Maria/I-8136-2018	Brunati, Anna Maria/0000-0002-3481-9503; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501; GORZA, LUISA/0000-0003-4897-400X	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; Italian Space Agency [OSMA-WP1B51-2]	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	The work was supported by Ministero dell'Universita e della Ricerca Scientifica e Tecnologica grants "ex-60%" and Italian Space Agency (grant OSMA-WP1B51-2 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Biswas C, 2006, INT IMMUNOL, V18, P1147, DOI 10.1093/intimm/dxl049; BOEHM J, 1994, EUR J CLIN INVEST, V24, P248, DOI 10.1111/j.1365-2362.1994.tb01082.x; Cala SE, 2000, BBA-MOL CELL RES, V1496, P296, DOI 10.1016/S0167-4889(00)00028-8; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; FELDWEG AM, 1995, INT J CANCER, V63, P310, DOI 10.1002/ijc.2910630227; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Linderoth NA, 2001, BIOCHEMISTRY-US, V40, P1483, DOI 10.1021/bi0016218; Linderoth NA, 2000, J BIOL CHEM, V275, P5472, DOI 10.1074/jbc.275.8.5472; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Nicchitta CV, 2004, CELL STRESS CHAPERON, V9, P325, DOI 10.1379/CSC-62.1; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Pagetta A, 2003, DIABETOLOGIA, V46, P996, DOI 10.1007/s00125-003-1133-5; Pagetta A, 2007, MOL IMMUNOL, V44, P2870, DOI 10.1016/j.molimm.2007.01.012; QU DF, 1994, DNA CELL BIOL, V13, P117, DOI 10.1089/dna.1994.13.117; Reed RC, 2002, J BIOL CHEM, V277, P25082, DOI 10.1074/jbc.M203195200; Richter K, 2007, MOL CELL, V28, P177, DOI 10.1016/j.molcel.2007.10.007; Rosser MFN, 2004, BIOCHEMISTRY-US, V43, P8835, DOI 10.1021/bi049539q; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Srivastava PK, 2006, CURR OPIN IMMUNOL, V18, P201, DOI 10.1016/j.coi.2006.01.009; SRIVASTAVA PK, 1994, BIOCHEM J, V301, P919, DOI 10.1042/bj3010919; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Tramentozzi E, 2008, MOL IMMUNOL, V45, P3639, DOI 10.1016/j.molimm.2008.04.020; Tramentozzi E, 2009, J CELL MOL MED, V13, P1336, DOI 10.1111/j.1582-4934.2008.00354.x; Vitadello M, 1998, BIOCHEM J, V332, P351, DOI 10.1042/bj3320351; Vogen S, 2002, J BIOL CHEM, V277, P40742, DOI 10.1074/jbc.M205323200; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; Wearsch PA, 1997, J BIOL CHEM, V272, P5152, DOI 10.1074/jbc.272.8.5152; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Wieten L, 2007, FEBS LETT, V581, P3716, DOI 10.1016/j.febslet.2007.04.082; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009	43	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86198	10.1371/journal.pone.0086198	http://dx.doi.org/10.1371/journal.pone.0086198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489700	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000035
J	Reis, M; Pascoa, I; Rocha, H; Aguiar, B; Vieira, CP; Vieira, J				Reis, Micael; Pascoa, Ines; Rocha, Helder; Aguiar, Bruno; Vieira, Cristina P.; Vieira, Jorge			Genes Belonging to the Insulin and Ecdysone Signaling Pathways Can Contribute to Developmental Time, Lifespan and Abdominal Size Variation in Drosophila americana	PLOS ONE			English	Article							CORRELATED RESPONSES; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; LARVAL DEVELOPMENT; MELANOGASTER; SELECTION; GROWTH; LONGEVITY; PROTEIN; TRAITS	Even within a single genus, such as Drosophila, cases of lineage-specific adaptive evolution have been found. Therefore, the molecular basis of phenotypic variation must be addressed in more than one species group, in order to infer general patterns. In this work, we used D. americana, a species distantly-related to D. melanogaster, to perform an F2 association study for developmental time (DT), chill-coma recovery time (CRT), abdominal size (AS) and lifespan (LS) involving the two strains (H5 and W11) whose genomes have been previously sequenced. Significant associations were found between the 43 large indel markers developed here and DT, AS and LS but not with CRT. Significant correlations are also found between DT and LS, and between AS and LS, that might be explained by variation at genes belonging to the insulin and ecdysone signaling pathways. Since, in this F2 association study a single marker, located close to the Ecdysone receptor (EcR) gene, explained as much as 32.6% of the total variation in DT, we performed a second F2 association study, to determine whether large differences in DT are always due to variation in this genome region. No overlapping signal was observed between the two F2 association studies. Overall, these results illustrate that, in D. americana, pleiotropic genes involved in the highly-conserved insulin and ecdysone signaling pathways are likely responsible for variation observed in ecologically relevant phenotypic traits, although other genes are also involved.	[Reis, Micael; Pascoa, Ines; Rocha, Helder; Aguiar, Bruno; Vieira, Cristina P.; Vieira, Jorge] Univ Porto, IBMC Inst Biol Mol & Celular, P-4100 Oporto, Portugal	Universidade do Porto	Vieira, J (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jbvieira@ibmc.up.pt	Vieira, Jorge/J-7477-2013; Vieira, Cristina/K-1775-2013	Vieira, Jorge/0000-0001-7032-5220; Pascoa, Ines/0000-0003-2297-7480; Vieira, Cristina/0000-0002-7139-2107; Rocha, Helder/0000-0003-1062-2498; Reis, Micael/0000-0002-2601-0886	FEDER Funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT - Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-037277 (PEst-C/SAU/LA0002/2013), FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008)]; FCT [SFRH/BD/61142/2009, SFRH/BD/69207/2010]	FEDER Funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER Funds through the Operational Competitiveness Programme - COMPETE and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-037277 (PEst-C/SAU/LA0002/2013) and FCOMP-01-0124-FEDER-008916 (PTDC/BIA-BEC/099933/2008). Micael Reis and Bruno Aguiar are funded by PhD grants attributed by FCT with the references SFRH/BD/61142/2009 and SFRH/BD/69207/2010, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Bachtrog D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-334; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Bono JM, 2008, MOL ECOL, V17, P3211, DOI 10.1111/j.1365-294X.2008.03823.x; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Chippindale AK, 2004, METHUSELAH FLIES CAS, P413; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; D'Avino PP, 2000, DEV BIOL, V220, P211, DOI 10.1006/dbio.2000.9650; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; Fonseca NA, 2013, GENOME BIOL EVOL, V5, P661, DOI 10.1093/gbe/evt037; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hsu T. C., 1952, University of Texas Publications, Vno. 5204, P35; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Llopart A, 2008, GENETICS, V179, P1009, DOI 10.1534/genetics.107.086231; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Matzkin LM, 2008, GENETICS, V178, P1073, DOI 10.1534/genetics.107.083287; Mensch J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011229; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB455, DOI 10.1093/gerona/55.9.B455; Morales-Hojas R, 2009, HEREDITY, V102, P573, DOI 10.1038/hdy.2009.11; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; Nunney L, 1996, EVOLUTION, V50, P1193, DOI 10.2307/2410660; Oldham S, 2000, PHILOS T R SOC B, V355, P945, DOI 10.1098/rstb.2000.0630; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Reis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025520; Sambucetti P, 2006, HEREDITAS, V143, P77, DOI 10.1111/j.2006.0018-0661.01934.x; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; Walker JA, 2006, GENE DEV, V20, P3311, DOI 10.1101/gad.1466806; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; ZWAAN B, 1995, EVOLUTION, V49, P635, DOI 10.2307/2410317	43	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86690	10.1371/journal.pone.0086690	http://dx.doi.org/10.1371/journal.pone.0086690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489769	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000072
J	Wan, HT; Zhao, YG; Leung, PY; Wong, CKC				Wan, Hin T.; Zhao, Yin G.; Leung, Pik Y.; Wong, Chris K. C.			Perinatal Exposure to Perfluorooctane Sulfonate Affects Glucose Metabolism in Adult Offspring	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR-I; INSULIN-RESISTANCE; PERFLUORINATED COMPOUNDS; GENE-EXPRESSION; POLYFLUOROALKYL CHEMICALS; ENDOCRINE DISRUPTORS; PERFLUOROALKYL ACIDS; NUCLEAR RECEPTORS; RISK-ASSESSMENT	Perfluoroalkyl acids (PFAAs) are globally present in the environment and are widely distributed in human populations and wildlife. The chemicals are ubiquitous in human body fluids and have a long serum elimination half-life. The notorious member of PFAAs, perfluorooctane sulfonate (PFOS) is prioritized as a global concerning chemical at the Stockholm Convention in 2009, due to its harmful effects in mammals and aquatic organisms. PFOS is known to affect lipid metabolism in adults and was found to be able to cross human placenta. However the effects of in utero exposure to the susceptibility of metabolic disorders in offspring have not yet been elucidated. In this study, pregnant CD-1 mice (F-0) were fed with 0, 0.3 or 3 mg PFOS/kg body weight/day in corn oil by oral gavage daily throughout gestational and lactation periods. We investigated the immediate effects of perinatal exposure to PFOS on glucose metabolism in both maternal and offspring after weaning (PND 21). To determine if the perinatal exposure predisposes the risk for metabolic disorder to the offspring, weaned animals without further PFOS exposure, were fed with either standard or high-fat diet until PND 63. Fasting glucose and insulin levels were measured while HOMA-IR index and glucose AUCs were reported. Our data illustrated the first time the effects of the environmental equivalent dose of PFOS exposure on the disturbance of glucose metabolism in F-1 pups and F-1 adults at PND 21 and 63, respectively. Although the biological effects of PFOS on the elevated levels of fasting serum glucose and insulin levels were observed in both pups and adults of F-1, the phenotypes of insulin resistance and glucose intolerance were only evident in the F-1 adults. The effects were exacerbated under HFD, highlighting the synergistic action at postnatal growth on the development of metabolic disorders.	[Wan, Hin T.; Zhao, Yin G.; Leung, Pik Y.; Wong, Chris K. C.] Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University	Wong, CKC (corresponding author), Hong Kong Baptist Univ, Partner State Key Lab Environm & Biol Anal, Croucher Inst Environm Sci, Dept Biol, Hong Kong, Hong Kong, Peoples R China.	ckcwong@hkbu.edu.hk	Wong, Kristy/C-8748-2015; wong, chris/GSN-0962-2022		General Research Fund, University Grants Committee [HKBU 261812]	General Research Fund, University Grants Committee	This work is supported by the General Research Fund (HKBU 261812), University Grants Committee (CKC Wong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Beach SA, 2006, REV ENVIRON CONTAM T, V186, P133, DOI 10.1007/0-387-32883-1_5; Beesoon S, 2011, ENVIRON HEALTH PERSP, V119, P1659, DOI 10.1289/ehp.1003265; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bjork JA, 2008, TOXICOLOGY, V251, P8, DOI 10.1016/j.tox.2008.06.007; Bjork JA, 2009, TOXICOL SCI, V111, P89, DOI 10.1093/toxsci/kfp093; Borai A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-158; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chang SC, 2012, REPROD TOXICOL, V33, P428, DOI 10.1016/j.reprotox.2011.07.002; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Clarke DB, 2010, FOOD ADDIT CONTAM A, V27, P530, DOI 10.1080/19440040903476590; Clemmons DR, 2006, CURR OPIN PHARMACOL, V6, P620, DOI 10.1016/j.coph.2006.08.006; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Guruge KS, 2006, TOXICOL SCI, V89, P93, DOI 10.1093/toxsci/kfj011; Hennig B, 2012, ENVIRON HEALTH PERSP, V120, P771, DOI 10.1289/ehp.1104712; Hernandez JP, 2006, TOXICOL APPL PHARM, V216, P186, DOI 10.1016/j.taap.2006.05.014; Ismail MH, 2011, AM J MED SCI, V341, P485, DOI 10.1097/MAJ.0b013e3182018598; Karrman A, 2006, ENVIRON SCI TECHNOL, V40, P3742, DOI 10.1021/es060301u; Kato K, 2011, J CHROMATOGR A, V1218, P2133, DOI 10.1016/j.chroma.2010.10.051; Kim S, 2011, ENVIRON SCI TECHNOL, V45, P7465, DOI 10.1021/es202408a; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lien GW, 2013, CHEMOSPHERE, V92, P843, DOI 10.1016/j.chemosphere.2013.04.038; Lin CY, 2009, DIABETES CARE, V32, P702, DOI 10.2337/dc08-1816; Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011; Liu JY, 2011, ENVIRON INT, V37, P1206, DOI 10.1016/j.envint.2011.05.001; Loccisano AE, 2012, REPROD TOXICOL, V33, P468, DOI 10.1016/j.reprotox.2011.07.003; Martin MT, 2007, TOXICOL SCI, V97, P595, DOI 10.1093/toxsci/kfm065; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, ENVIRON SCI TECHNOL, V37, P888, DOI 10.1021/es020955c; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Rinaudo P, 2011, ANN REV PHYSL; Rosen MB, 2009, REPROD TOXICOL, V27, P278, DOI 10.1016/j.reprotox.2009.01.007; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Salvalaglio M, 2010, J PHYS CHEM B, V114, P14860, DOI 10.1021/jp106584b; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Sierra-Santoyo A, 2000, TOXICOL SCI, V54, P81, DOI 10.1093/toxsci/54.1.81; So MK, 2006, ENVIRON SCI TECHNOL, V40, P2924, DOI 10.1021/es060031f; Sugden MC, 2008, BIOCHEM SOC T, V36, P891, DOI 10.1042/BST0360891; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Targher G, 2013, J CLIN ENDOCRINOL ME, V98, P483; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Wan HT, 2013, J HAZARD MATER, V261, P763, DOI 10.1016/j.jhazmat.2013.01.034; Wan HT, 2012, BBA-GEN SUBJECTS, V1820, P1092, DOI 10.1016/j.bbagen.2012.03.010; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Yu WG, 2009, ENVIRON SCI TECHNOL, V43, P8416, DOI 10.1021/es901602d; Zhang H, 2008, TOXICOL APPL PHARM, V227, P16, DOI 10.1016/j.taap.2007.09.026; Zhao YG, 2011, CHEMOSPHERE, V85, P277, DOI 10.1016/j.chemosphere.2011.06.002	59	71	74	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87137	10.1371/journal.pone.0087137	http://dx.doi.org/10.1371/journal.pone.0087137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498028	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900070
J	Zhou, Q; Zhao, F; Lv, ZP; Zheng, CG; Zheng, WD; Sun, L; Wang, NN; Pang, SH; de Andrade, FM; Fu, M; He, XH; Hui, J; Jiang, WY; Yang, CY; Shi, XH; Zhu, XQ; Pang, GF; Yang, YG; Xie, HQ; Zhang, WD; Hu, CY; Yang, Z				Zhou, Qin; Zhao, Fan; Lv, Ze-ping; Zheng, Chen-guang; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Pang, Shenghang; de Andrade, Fabiana Michelsen; Fu, Mian; He, Xiang-hua; Hui, Juan; Jiang, Wen-yu; Yang, Chu-yu; Shi, Xiao-hong; Zhu, Xiao-quan; Pang, Guo-fang; Yang, Yi-ge; Xie, Hai-qun; Zhang, Wan-dong; Hu, Cai-you; Yang, Ze			Association between APOC1 Polymorphism and Alzheimer's Disease: A Case-Control Study and Meta-Analysis	PLOS ONE			English	Article							C-I EXPRESSION; APOLIPOPROTEIN-E; GENETIC ASSOCIATION; RISK-FACTOR; MEMORY FUNCTIONS; POPULATION; DEMENTIA; IDENTIFY; CHINESE; MARKERS	Background: Previous association studies examining the relationship between the APOC1 polymorphism and susceptibility to Alzheimer's disease (AD) have shown conflicting results, and it is not clear if an APOC1 variant acts as a genetic risk factor in AD etiology across multiple populations. Methods: To confirm the risk association between APOC1 and AD, we designed a case-control study and also performed a meta-analysis of previously published studies. Results: Seventy-nine patients with AD and one hundred fifty-six unrelated controls were included in case-control study. No association was found between the variation of APOC1 and AD in stage 1 of our study. However, our meta-analysis pooled a total of 2092 AD patients and 2685 controls. The APOC1 rs11568822 polymorphism was associated with increased AD risk in Caucasians, Asians and Caribbean Hispanics, but not in African Americans. APOE epsilon 4 carriers harboring the APOC1 insertion allele, were more prevalent in AD patients than controls (chi(2) = 119.46, OR = 2.79, 95% CI = 2.31-3.36, P<0.01). Conclusions: The APOC1 insertion allele, in combination with APOE epsilon 4, likely serves as a potential risk factor for developing AD.	[Zhou, Qin; Zhao, Fan; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Hui, Juan; Shi, Xiao-hong; Zhu, Xiao-quan; Yang, Yi-ge; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Zhou, Qin; Zhao, Fan; Zheng, Wei-dong; Sun, Liang; Wang, Na-na; Hui, Juan; Shi, Xiao-hong; Zhu, Xiao-quan; Yang, Yi-ge; Yang, Ze] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhou, Qin; Lv, Ze-ping; Zheng, Chen-guang; Pang, Shenghang; Fu, Mian; He, Xiang-hua; Jiang, Wen-yu; Yang, Chu-yu; Pang, Guo-fang; Xie, Hai-qun; Hu, Cai-you] Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China; [de Andrade, Fabiana Michelsen] Univ Feevale, Hlth Sci Inst, Novo Hamburgo, RS, Brazil; [Zhang, Wan-dong] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Beijing Hospital; Universidade Feevale; National Research Council Canada	Hu, CY (corresponding author), Jiangbin Hosp, Dept Neurol, Nanning, Peoples R China.	hucaiyoujb@163.com; yang.ze@live.cn	de Andrade, Fabiana M/E-8513-2010		Natural Science Foundation of China [81061120527, 81241082, 81370445]; Beijing Hospital [BJ-2010-30]; key project of clinical disciplines at the subordinate hospital, Ministry Of Health [10120101]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; Ministry of Scientific Technology [2012BAI10B01]; science and technology development foundation of Guangxi Zhuang Autonomous Region [1355005-6-2]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospital; key project of clinical disciplines at the subordinate hospital, Ministry Of Health; National Department Public Benefit Research Foundation by Ministry of Health P. R. China; Ministry of Scientific Technology; science and technology development foundation of Guangxi Zhuang Autonomous Region	This study was funded by the Natural Science Foundation of China (81061120527, 81241082, 81370445), the major funding from Beijing Hospital (BJ-2010-30), funding from the key project of clinical disciplines at the subordinate hospital, Ministry Of Health (10120101), National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201302008), 12th 5 year national program from Ministry of Scientific Technology (2012BAI10B01), and the science and technology development foundation of Guangxi Zhuang Autonomous Region (1355005-6-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2008, J LIPID RES, V49, P856, DOI 10.1194/jlr.M700518-JLR200; Berbee JFP, 2011, J ALZHEIMERS DIS, V23, P737, DOI 10.3233/JAD-2010-100576; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; Chuang WL, 2010, J GERIATR PSYCH NEUR, V23, P42, DOI 10.1177/0891988709351804; Deeks J., 2011, COCHRANE HDB SYST RE, V5; Devan WJ, 2013, STROKE, V44, P1578, DOI 10.1161/STROKEAHA.111.000089; Dou C, 2013, CURR ALZHEIMER RES, V10, P63; Drigalenko E, 1998, NEUROLOGY, V51, P131, DOI 10.1212/WNL.51.1.131; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Kamino K, 1996, GERONTOLOGY, V42, P12; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; Lucatelli JF, 2011, NEUROCHEM RES, V36, P1533, DOI 10.1007/s11064-011-0481-7; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Mullan M, 1996, ANN NY ACAD SCI, V802, P16, DOI 10.1111/j.1749-6632.1996.tb32594.x; Olgiati P, 2012, CURR ALZHEIMER RES, V9, P491, DOI 10.2174/156720512800492431; Petit-Turcotte C, 2001, NEUROBIOL DIS, V8, P953, DOI 10.1006/nbdi.2001.0441; Poduslo SE, 1998, NEUROCHEM RES, V23, P361, DOI 10.1023/A:1022409617539; Qi HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037858; Retz W, 2001, PSYCHIATR GENET, V11, P115, DOI 10.1097/00041444-200109000-00002; Scacchi R, 1999, NEUROSCI LETT, V259, P33, DOI 10.1016/S0304-3940(98)00889-1; Serra-Grabulosa JM, 2003, NEUROGENETICS, V4, P141, DOI 10.1007/s10048-002-0142-8; Shi J, 2004, ACTA NEUROL SCAND, V109, P140, DOI 10.1034/j.1600-0404.2003.00193.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Vestergaard M, 2010, CURR ALZHEIMER RES, V7, P262, DOI 10.2174/156720510791050821; Yang JD, 2003, NEUROSCI LETT, V350, P25, DOI 10.1016/S0304-3940(03)00815-2; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	33	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87017	10.1371/journal.pone.0087017	http://dx.doi.org/10.1371/journal.pone.0087017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498013	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900059
J	Serrano-Villar, S; Perez-Elias, MJ; Dronda, F; Casado, JL; Moreno, A; Royuela, A; Perez-Molina, JA; Sainz, T; Navas, E; Hermida, JM; Quereda, C; Moreno, S				Serrano-Villar, Sergio; Jesus Perez-Elias, Maria; Dronda, Fernando; Luis Casado, Jose; Moreno, Ana; Royuela, Ana; Antonio Perez-Molina, Jose; Sainz, Talia; Navas, Enrique; Manuel Hermida, Jose; Quereda, Carmen; Moreno, Santiago			Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio	PLOS ONE			English	Article							T-CELL-ACTIVATION; GENERAL-POPULATION; IMMUNE ACTIVATION; OLD POPULATION; KIDNEY-DISEASE; SWEDISH PEOPLE; SURVIVAL; COHORT; ATHEROSCLEROSIS; CD8	Background: A low CD4/CD8 ratio has been identified in the general population as a hallmark of inmmunosenescence and a surrogate of all-cause mortality. We aimed to investigate in treated HIV-infected individuals the relationship between the CD4/CD8 ratio and serious non-AIDS events. Methods: Case-control study within a prospective hospital-based cohort of HIV-infected subjects during at least one year of ART-mediated viral suppression. Cases were patients with serious non-AIDS events (non-AIDS malignancies, cardiovascular disease, and end-stage kidney disease), and controls individuals who did not developed non-AIDS events during follow-up. Data were analyzed using ROC analysis and multivariate logistic regression. Conditional logistic regression was performed in 200 cases/controls matched by age, sex, nadir CD4 and proximal CD4 counts. Results: We analyzed 407 subjects (109 cases, 298 controls). The CD4/CD8 ratio was lower in cases (0.44 vs. 0.70, P<0.0001), with higher discriminatory ability for the detection of non-AIDS events than the CD4 count, CD8 count and nadir CD4. Multivariate analyses (adjusted for age, sex, nadir CD4, proximal CD4 count, year of ART initiation and ART duration) confirmed the independent association of a low CD4/CD8 ratio with the risk of non-AIDS morbidity (per CD4/CD8 ratio quartile decrease, OR, 2.9; 95% CI, 1.3-6.2) and non-AIDS mortality (OR, 2.8; 95% CI, 1.5-5.3). Conclusions: The CD4/CD8 ratio provides additional information to the CD4 counts and nadir CD4 in treated HIV-infected individuals, since it is independently associated with the risk of non-AIDS-related morbidity and mortality. This association is robust and maintained within different subgroups of patients.	[Serrano-Villar, Sergio; Jesus Perez-Elias, Maria; Dronda, Fernando; Luis Casado, Jose; Moreno, Ana; Antonio Perez-Molina, Jose; Navas, Enrique; Manuel Hermida, Jose; Quereda, Carmen; Moreno, Santiago] Univ Hosp Ramon y Cajal, Inst Hlth Res IRICYS, Dept Infect Dis, Madrid, Spain; [Royuela, Ana] Univ Hosp Ramon y Cajal, CIBER, Clin Biostat Unit, IRYCIS, Madrid, Spain; [Sainz, Talia] Univ Hosp Gregorio Maranon, Lab Mol Immune Biol, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital	Serrano-Villar, S (corresponding author), Univ Hosp Ramon y Cajal, Inst Hlth Res IRICYS, Dept Infect Dis, Madrid, Spain.	serranovillar@gmail.com	Elias, Maria Jesus Perez/AAD-8652-2020; Padilla, Sergio/U-7682-2017; Vicente, Ana Royuela/AAC-4284-2021	Vicente, Ana Royuela/0000-0003-1665-081X; Casado, Jose Luis/0000-0002-7639-8591; Serrano-Villar, Sergio/0000-0002-5447-3554; Perez Elias/0000-0001-5700-5257; Perez-Molina, Jose Antonio/0000-0001-8735-4124	Instituto de Salud Carlos III [RD06/0006]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	CORIS is integrated in the Spanish AIDS Research Network Red Tematica Cooperativa de Investigacion en SIDA (RD06/0006), supported by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Devitt E, 2013, 20 C RETR OPP INF MA; Dock JN, 2011, AGING DIS, V2, P382; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Li TS, 2011, CLIN INFECT DIS, V53, P944, DOI 10.1093/cid/cir552; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Odden MC, 2007, ARCH INTERN MED, V167, P2213, DOI 10.1001/archinte.167.20.2213; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Serrano-Villar S, 2014, HIV MED, V15, P40, DOI 10.1111/hiv.12081; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Stephan C, 2012, JAIDS-J ACQ IMM DEF, V61, pE73, DOI 10.1097/QAI.0b013e3182737254; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1	38	136	143	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85798	10.1371/journal.pone.0085798	http://dx.doi.org/10.1371/journal.pone.0085798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497929	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100010
J	van Alphen, LB; Wenzel, CQ; Richards, MR; Fodor, C; Ashmus, RA; Stahl, M; Karlyshev, AV; Wren, BW; Stintzi, A; Miller, WG; Lowary, TL; Szymanski, CM				van Alphen, Lieke B.; Wenzel, Cory Q.; Richards, Michele R.; Fodor, Christopher; Ashmus, Roger A.; Stahl, Martin; Karlyshev, Andrey V.; Wren, Brendan W.; Stintzi, Alain; Miller, William G.; Lowary, Todd L.; Szymanski, Christine M.			Biological Roles of the O-Methyl Phosphoramidate Capsule Modification in Campylobacter jejuni	PLOS ONE			English	Article							SP-NOV.; POLYSACCHARIDE; INFECTION; SEQUENCE; PATHOGEN; LIPOOLIGOSACCHARIDE; LIPOPOLYSACCHARIDES; SEROSTRAIN; SPUTORUM; HUMANS	Campylobacter jejuni is a major cause of bacterial gastroenteritis worldwide, and the capsular polysaccharide (CPS) of this organism is required for persistence and disease. C. jejuni produces over 47 different capsular structures, including a unique O-methyl phosphoramidate (MeOPN) modification present on most C. jejuni isolates. Although the MeOPN structure is rare in nature it has structural similarity to some synthetic pesticides. In this study, we have demonstrated, by whole genome comparisons and high resolution magic angle spinning NMR, that MeOPN modifications are common to several Campylobacter species. Using MeOPN biosynthesis and transferase mutants generated in C. jejuni strain 81-176, we observed that loss of MeOPN from the cell surface correlated with increased invasion of Caco-2 epithelial cells and reduced resistance to killing by human serum. In C. jejuni, the observed serum mediated killing was determined to result primarily from activation of the classical complement pathway. The C. jejuni MeOPN transferase mutant showed similar levels of colonization relative to the wild-type in chickens, but showed a five-fold drop in colonization when co-infected with the wild-type in piglets. In Galleria mellonella waxmoth larvae, the MeOPN transferase mutant was able to kill the insects at wildtype levels. Furthermore, injection of the larvae with MeOPN-linked monosaccharides or CPS purified from the wild-type strain did not result in larval killing, indicating that MeOPN does not have inherent insecticidal activity.	[van Alphen, Lieke B.; Wenzel, Cory Q.; Richards, Michele R.; Fodor, Christopher; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada; [Ashmus, Roger A.; Lowary, Todd L.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Stahl, Martin; Stintzi, Alain] Univ Ottawa, Ottawa Inst Syst Biol, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Karlyshev, Andrey V.] Univ Kingston, Sch Life Sci, London, England; [Wren, Brendan W.] London Sch Hyg & Trop Med, London WC1, England; [Miller, William G.] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	University of Alberta; University of Alberta; University of Ottawa; Kingston University; University of London; London School of Hygiene & Tropical Medicine; United States Department of Agriculture (USDA)	Szymanski, CM (corresponding author), Univ Alberta, Dept Biol Sci, Alberta Glyc Ctr, Edmonton, AB, Canada.	cszymans@ualberta.ca	Karlyshev, Andrey/D-2797-2011; Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011	Karlyshev, Andrey/0000-0003-3124-019X; Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Ashmus, Roger/0000-0001-9580-7533	Alberta Innovates Health Solutions Postdoctoral Fellowship; Alberta Innovates Technology Futures Scholarship; Biotechnology and Biological Sciences Research Council [EGA16167, BB/C519670/1] Funding Source: researchfish	Alberta Innovates Health Solutions Postdoctoral Fellowship; Alberta Innovates Technology Futures Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LVA held an Alberta Innovates Health Solutions Postdoctoral Fellowship. RAA is an Alberta Innovates Technology Futures Scholarship awardee. CMS is an Alberta Innovates Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1985, J INFECT DIS, V151, P227, DOI 10.1093/infdis/151.2.227; Bleumink-Pluym NMC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003393; BOLTON FJ, 1984, J CLIN PATHOL, V37, P677, DOI 10.1136/jcp.37.6.677; Champion OL, 2010, J INFECT DIS, V201, P776, DOI 10.1086/650494; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P815, DOI 10.1099/ijs.0.011056-0; Debruyne L, 2009, INT J SYST EVOL MICR, V59, P1126, DOI 10.1099/ijs.0.000851-0; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; ETOH Y, 1993, INT J SYST BACTERIOL, V43, P631, DOI 10.1099/00207713-43-4-631; FORSGREN A, 1975, J LAB CLIN MED, V85, P904; Foster G, 2004, INT J SYST EVOL MICR, V54, P2369, DOI 10.1099/ijs.0.63147-0; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Labarca JA, 2002, CLIN INFECT DIS, V34, pE59, DOI 10.1086/340266; Lawson AJ, 2001, INT J SYST EVOL MICR, V51, P651, DOI 10.1099/00207713-51-2-651; LAWSON GHK, 1976, J MED MICROBIOL, V9, P163, DOI 10.1099/00222615-9-2-163; Logan JMJ, 2000, INT J SYST EVOL MICR, V50, P865, DOI 10.1099/00207713-50-2-865; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; McNally DJ, 2007, J BIOL CHEM, V282, P28566, DOI 10.1074/jbc.M704413200; McNally DJ, 2006, FEBS J, V273, P3975, DOI 10.1111/j.1742-4658.2006.05401.x; McNally DJ, 2005, FEBS J, V272, P4407, DOI 10.1111/j.1742-4658.2005.04856.x; MISHU B, 1993, CLIN INFECT DIS, V17, P104, DOI 10.1093/clinids/17.1.104; Miyamoto T, 1999, PESTIC BIOCHEM PHYS, V63, P151, DOI 10.1006/pest.1999.2399; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; On SLW, 1998, INT J SYST BACTERIOL, V48, P195, DOI 10.1099/00207713-48-1-195; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PEREZ GIP, 1985, INFECT IMMUN, V48, P528, DOI 10.1128/IAI.48.2.528-533.1985; Rossi M, 2009, INT J SYST EVOL MICR, V59, P2364, DOI 10.1099/ijs.0.007419-0; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; Sorensen MCH, 2011, J BACTERIOL, V193, P6742, DOI 10.1128/JB.05276-11; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Vinogradov E, 2008, CARBOHYD RES, V343, P2701, DOI 10.1016/j.carres.2008.06.006; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Zanoni RG, 2009, INT J SYST EVOL MICR, V59, P1666, DOI 10.1099/ijs.0.007286-0	47	40	42	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87051	10.1371/journal.pone.0087051	http://dx.doi.org/10.1371/journal.pone.0087051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498018	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330617100047
J	Chandrananda, D; Thorne, NP; Ganesamoorthy, D; Bruno, DL; Benjamini, Y; Speed, TP; Slater, HR; Bahlo, M				Chandrananda, Dineika; Thorne, Natalie P.; Ganesamoorthy, Devika; Bruno, Damien L.; Benjamini, Yuval; Speed, Terence P.; Slater, Howard R.; Bahlo, Melanie			Investigating and Correcting Plasma DNA Sequencing Coverage Bias to Enhance Aneuploidy Discovery	PLOS ONE			English	Article							CELL-FREE DNA; FREE FETAL DNA; MATERNAL PLASMA; CIRCULATING DNA; PRENATAL-DIAGNOSIS; ORIGIN; GENOME; SERUM	Pregnant women carry a mixture of cell-free DNA fragments from self and fetus (non-self) in their circulation. In recent years multiple independent studies have demonstrated the ability to detect fetal trisomies such as trisomy 21, the cause of Down syndrome, by Next-Generation Sequencing of maternal plasma. The current clinical tests based on this approach show very high sensitivity and specificity, although as yet they have not become the standard diagnostic test. Here we describe improvements to the analysis of the sequencing data by reducing GC bias and better handling of the genomic repeats. We show substantial improvements in the sensitivity of the standard trisomy 21 statistical tests, which we measure by artificially reducing read coverage. We also explore the bias stemming from the natural cleavage of plasma DNA by examining DNA motifs and position specific base distributions. We propose a model to correct this fragmentation bias and observe that incorporating this bias does not lead to any further improvements in the detection of fetal trisomy. The improved bias corrections that we demonstrate in this work can be readily adopted into existing fetal trisomy detection protocols and should also lead to improvements in sub-chromosomal copy number variation detection.	[Chandrananda, Dineika; Thorne, Natalie P.; Speed, Terence P.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Chandrananda, Dineika; Thorne, Natalie P.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Ganesamoorthy, Devika; Bruno, Damien L.; Slater, Howard R.] Murdoch Childrens Res Inst, Victorian Clin Genet Serv Cytogenet Lab, Melbourne, Vic, Australia; [Ganesamoorthy, Devika; Slater, Howard R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Benjamini, Yuval; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of California System; University of California Berkeley; University of Melbourne	Chandrananda, D (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia.	chandrananda@wehi.edu.au	Bruno, Damien L/C-3665-2013; Ganesamoorthy, Devika/J-8359-2014	Ganesamoorthy, Devika/0000-0001-8149-6703; Chandrananda, Dineika/0000-0002-8834-9500; Bahlo, Melanie/0000-0001-5132-0774	Victorian State Government; Australian Government NHMRC IRIISS; Australian Postgraduate Awards; John and Patricia Farrant Scholarship; National Science Foundation VIGRE Graduate Fellowship; National Health and Medical Research Council Australia Fellowship [575503]; National Institutes of Health [5R01 GM083084-03]; Australian Research Council Future Fellowship [FT100100764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	Victorian State Government; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government); John and Patricia Farrant Scholarship; National Science Foundation VIGRE Graduate Fellowship(National Science Foundation (NSF)); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Future Fellowship(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Additional support provided by Australian Postgraduate Awards (to DC and DG); The John and Patricia Farrant Scholarship (to DC); National Science Foundation VIGRE Graduate Fellowship (to YB); National Health and Medical Research Council Australia Fellowship (grant number 575503 to TPS); National Institutes of Health (grant number 5R01 GM083084-03 to TPS.) and an Australian Research Council Future Fellowship (grant number FT100100764 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, OBSTET GYNECOL, V110, P1459; Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Ashoor G, 2012, FETAL DIAGN THER, V31, P237, DOI 10.1159/000337373; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Bettecken T, 2012, J BIOMOL STRUCT DYN, V30, P211, DOI 10.1080/07391102.2012.677772; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Boon EMJ, 2013, PRENATAL DIAG, V33, P563, DOI 10.1002/pd.4111; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chitty LS, 2013, PRENATAL DIAG, V33, P511, DOI 10.1002/pd.4136; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Driscoll DA, 2009, NEW ENGL J MED, V360, P2556, DOI 10.1056/NEJMcp0900134; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Ferguson-Smith MA, 2010, PRENATAL DIAG, V30, P601, DOI 10.1002/pd.2574; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Jahr S, 2001, CANCER RES, V61, P1659; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lui YNYN, 2002, CLIN CHEM, V48, P421; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Mandel P., 1948, CR SOC BIOL, V142, P241; Morris JK, 2009, BMJ, V339; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters DL, 2011, CLIN CHIM ACTA, V412, P806, DOI 10.1016/j.cca.2011.01.026; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Smit A, 1996, REPEATMASKER OPEN 30; Stroun M, 2005, CELL MOL BIOL, V51, P767, DOI 10.1170/T685; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Suzuki N, 2008, CLIN CHIM ACTA, V387, P55, DOI 10.1016/j.cca.2007.09.001; Szerlong HJ, 2011, BIOCHEM CELL BIOL, V89, P24, DOI 10.1139/O10-139; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; Wataganara T, 2005, AM J OBSTET GYNECOL, V193, P496, DOI 10.1016/j.ajog.2004.12.015; Wellesley D, 2012, EUROPEAN J HUMAN GEN; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993; [No title captured]	47	19	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86993	10.1371/journal.pone.0086993	http://dx.doi.org/10.1371/journal.pone.0086993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489824	Green Published, gold			2022-12-27	WOS:000330570000089
J	Huang, CC; Chung, CM; Leu, HB; Lin, LY; Chiu, CC; Hsu, CY; Chiang, CH; Huang, PH; Chen, TJ; Lin, SJ; Chen, JW; Chan, WL				Huang, Chin-Chou; Chung, Chia-Min; Leu, Hsin-Bang; Lin, Liang-Yu; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Chen, Tzeng-Ji; Lin, Shing-Jong; Chen, Jaw-Wen; Chan, Wan-Leong			Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study	PLOS ONE			English	Article							DEMENTIA; INSULIN; STATE	Objectives: Possible association between diabetes mellitus (DM) and Alzheimer's disease (AD) has been controversial. This study used a nationwide population-based dataset to investigate the relationship between DM and subsequent AD incidence. Methods: Data were collected from Taiwan's National Health Insurance Research Database, which released a cohort dataset of 1,000,000 randomly sampled people and confirmed it to be representative of the Taiwanese population. We identified 71,433 patients newly diagnosed with diabetes (age 58.74 +/- 14.02 years) since January 1997. Using propensity score, we matched them with 71,311 non-diabetic subjects by time of enrollment, age, gender, hypertension, hyperlipidemia, and previous stroke history. All the patients were followed up to December 31, 2007. The endpoint of the study was occurrence of AD. Results: Over a maximum 11 years of follow-up, diabetic patients experienced a higher incidence of AD than non-diabetic subjects (0.48% vs. 0.37%, p<0.001). After Cox proportional hazard regression model analysis, DM (hazard ratio [HR], 1.76; 95% confidence interval [CI], 1.50-2.07, p<0.001), age (HR, 1.11; 95% CI, 1.10-1.12, p<0.001), female gender (HR, 1.24; 95% CI, 1.06-1.46, p=0.008), hypertension (HR, 1.30; 95% CI, 1.07-1.59, p=0.01), previous stroke history (HR, 1.79; 95% CI, 1.28-2.50, p<0.001), and urbanization status (metropolis, HR, 1.32; 95% CI, 1.07-1.63, p=0.009) were independently associated with the increased risk of AD. Neither monotherapy nor combination therapy with oral antidiabetic medications were associated with the risk of AD after adjusting for underlying risk factors and the duration of DM since diagnosis. However, combination therapy with insulin was found to be associated with greater risk of AD (HR, 2.17; 95% CI, 1.04-4.52, p=0.039). Conclusion: Newly diagnosed DM was associated with increased risk of AD. Use of hypoglycemic agents did not ameliorate the risk.	[Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Chin-Chou; Leu, Hsin-Bang; Chiu, Chun-Chih; Hsu, Chien-Yi; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Chan, Wan-Leong] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Leu, Hsin-Bang; Chan, Wan-Leong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Lin, Liang-Yu] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Huang, Chin-Chou; Leu, Hsin-Bang; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lin, Liang-Yu; Chiu, Chun-Chih; Hsu, Chien-Yi; Chiang, Chia-Hung; Huang, Po-Hsun; Chan, Wan-Leong] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Huang, Chin-Chou; Lin, Liang-Yu; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chiang, Chia-Hung; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Chiang, Chia-Hung] Zhudong Vet Hosp, Dept Med, Div Cardiol, Hsinchu, Taiwan; [Chung, Chia-Min] China Med Univ Hosp, Environm Omics Dis Res Ctr, Taichung, Taiwan; [Chung, Chia-Min] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	jwchen@vghtpe.gov.tw; DRWLChan2012@gmail.com	Chen, TJ/AAH-8430-2021; Lin, Liang-Yu/R-8480-2017	Lin, Liang-Yu/0000-0003-0334-790X; Hsu, Chien-Yi/0000-0002-9493-7325	Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-004, V100B-013, V102B-024]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055, NSC 102-2314-B-075-022-MY3]; UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101-A2]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council	The present study was partly supported by research grants V99B1-011, V99C1-125, V100B-004, V100B-013, and V102B-024 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055, NSC 102-2314-B-075-022-MY3, and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101-A2 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BACHMAN DL, 1992, NEUROLOGY, V42, P115, DOI 10.1212/WNL.42.1.115; Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8; Beeri MS, 2008, NEUROLOGY, V71, P750, DOI 10.1212/01.wnl.0000324925.95210.6d; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; *BUR NAT HLTH INS, 2002, NAT HLTH INS ANN STA; Chen HF, 2008, DIABETES CARE, V31, P75, DOI 10.2337/dc07-1072; Chiang CW, 2007, PHARMACOEPIDEM DR S, V16, P412, DOI 10.1002/pds.1322; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Euser SM, 2010, DIABETES, V59, P1601, DOI 10.2337/db09-0568; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; Guideline Subcommittee of the Taiwan Dementia Society, 2011, Acta Neurol Taiwan, V20, P85; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hsu CY, 2013, CIRC J, V77, P405, DOI 10.1253/circj.CJ-12-0658; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; MacKnight C, 2002, DEMENT GERIATR COGN, V14, P77, DOI 10.1159/000064928; Maiorini AF, 2002, J CLIN PHARM THER, V27, P169, DOI 10.1046/j.1365-2710.2002.00415.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Ohara T, 2011, NEUROLOGY, V77, P1126, DOI 10.1212/WNL.0b013e31822f0435; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Roberts JS, 2010, FUTUR NEUROL, V5, P501, DOI 10.2217/FNL.10.31; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Sohn MW, 2009, DIABETES CARE, V32, P816, DOI 10.2337/dc08-1695; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; WHO Collaborating Center for Drugs Statistics Methodology, 2003, ATC IND DDDS 2003; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501; Wu JH, 2003, ANN EPIDEMIOL, V13, P369, DOI 10.1016/S1047-2797(02)00464-7; Xu WL, 2004, NEUROLOGY, V63, P1181, DOI 10.1212/01.WNL.0000140291.86406.D1; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	37	155	157	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87095	10.1371/journal.pone.0087095	http://dx.doi.org/10.1371/journal.pone.0087095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489845	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000101
J	Jiang, YZ; Xia, C; Peng, WT; Yu, KD; Zhuang, ZG; Shao, ZM				Jiang, Yi-Zhou; Xia, Chen; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming			Preoperative Measurement of Breast Cancer Overestimates Tumor Size Compared to Pathological Measurement	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM; MASTECTOMY; CARCINOMA; SURVIVORS; SUBTYPES; THERAPY; RISK	Background: Tumor size is one of the most important factors in making clinical and pathological assessment of breast cancer. In the present study, we aimed to determine whether the preoperative measurement of tumor size, by imaging modalities, deviate from the postoperative pathological measurement in breast cancer. Patients and Methods: 1296 patients diagnosed with invasive ductal breast carcinoma (IDC) during 2007 and 2009 were involved. Pre- and postoperative measurements of tumor size were compared using paired t-test and Chi-square test. Results: The mean maximum diameters of tumors by imaging modalities and pathology were 27.9 mm and 22.4 mm, respectively. There was a statistically significant difference of 5.5 mm (95% CI: 4.7-6.2, p < 0.001) between them. The discordance between pre- and post-surgical measurements of tumor size had significant effect on choosing surgery type, causing less application of breast conserving therapy (p < 0.0001). Conclusion: Compared to pathological size, preoperative measurement by imaging modalities tends to overestimate tumor size. These differences could have implications in the treatment of patients with breast cancer.	[Jiang, Yi-Zhou; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming] Fudan Univ, Ctr Canc, Shanghai Med Coll, Dept Breast Surg, Shanghai 200433, Peoples R China; [Jiang, Yi-Zhou; Peng, Wen-Ting; Yu, Ke-Da; Zhuang, Zhi-Gang; Shao, Zhi-Ming] Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xia, Chen; Zhuang, Zhi-Gang] Tongji Univ, Dept Breast Surg, Shanghai Matern & Infant Hosp 1, Sch Med, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Tongji University	Zhuang, ZG (corresponding author), Fudan Univ, Ctr Canc, Shanghai Med Coll, Dept Breast Surg, Shanghai 200433, Peoples R China.	zhigangzhuangFMIH@gmail.com; zhiminqshao@yahoo.com			National Natural Science Foundation of China [81001169]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Shanghai Key Laboratory of Breast Cancer [12DZ2260100]; Zhuo-Xue Project of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Shanghai Key Laboratory of Breast Cancer; Zhuo-Xue Project of Fudan University	This research was supported by grants from the National Natural Science Foundation of China (81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Shanghai Key Laboratory of Breast Cancer (12DZ2260100), and the Zhuo-Xue Project of Fudan University (For Y.K.D.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2008, J CANCER RES CLIN, V134, P1311, DOI 10.1007/s00432-008-0418-y; Blair S, 2006, J SURG ONCOL, V94, P220, DOI 10.1002/jso.20561; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Downes KJ, 2005, CANCER-AM CANCER SOC, V103, P906, DOI 10.1002/cncr.20851; Egner JR, 2010, JAMA-J AM MED ASSOC, V304, P1726, DOI DOI 10.1001/JAMA.2010.1525; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Grimsby GM, 2009, AM J SURG, V198, P500, DOI 10.1016/j.amjsurg.2009.07.012; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lampen-Sachar K, 2012, LUNG CANCER, V75, P332, DOI 10.1016/j.lungcan.2011.08.001; Ohsumi S, 2009, JPN J CLIN ONCOL, V39, P491, DOI 10.1093/jjco/hyp060; Onesti JK, 2008, AM J SURG, V196, P844, DOI 10.1016/j.amjsurg.2008.07.028; Sahdev A, 2007, INT J GYNECOL CANCER, V17, P629, DOI 10.1111/j.1525-1438.2007.00829.x; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284	13	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86676	10.1371/journal.pone.0086676	http://dx.doi.org/10.1371/journal.pone.0086676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489766	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000058
J	Li, LG; Li, DQ; You, HL; Dodson, P				Li, Li-Guo; Li, Da-Qing; You, Hai-Lu; Dodson, Peter			A New Titanosaurian Sauropod from the Hekou Group (Lower Cretaceous) of the Lanzhou-Minhe Basin, Gansu Province, China	PLOS ONE			English	Article							MORRISON FORMATION; DINOSAURIA; OSTEOLOGY; REDESCRIPTION; REEVALUATION; PATAGONIA; GENUS	Increased excavation of dinosaurs from China over the last two decades has enriched the record of Asian titanosauriform sauropods. However, the relationships of these sauropods remain contentious, and hinges on a few well-preserved taxa, such as Euhelopus zdanskyi. Here we describe a new sauropod, Yongjinglong datangi gen. nov. et sp. nov., from the Lower Cretaceous Hekou Group in the Lanzhou Basin of Gansu Province, northwestern China. Yongjinglong datangi is characterized by the following unique combination of characters, including seven autapomorphies: long-crowned, spoon-shaped premaxillary tooth; axially elongate parapophyses on the cervical vertebra; very deep lateral pneumatic foramina on the lateral surfaces of the cervical and cranial dorsal vertebral centra; low, unbifurcated neural spine fused with the postzygapophyses to form a cranially-pointing, triangular plate in a middle dorsal vertebra; an "XI"-shaped configuration of the laminae on the arches of the middle dorsal vertebrae; a very long scapular blade with straight cranial and caudal edges; and a tall, deep groove on the lateral surface of the distal shaft of the radius. The new specimen shares several features with other sauropods: a pronounced M. triceps longus tubercle on the scapula and ventrolaterally elongated parapophyses in its cervical vertebra as in Euhelopodidae. Based on phylogenetic analyses Yongjinglong datangi is highly derived within Titanosauria, which suggests either a remarkable convergence with more basal titanosauriform sauropods in the Early Cretaceous or a retention of plesiomorphic features that were lost in other titanosaurians. The morphology and remarkable length of the scapulocoracoid reveal an unusual relationship between the shoulder and the middle trunk: the scapulocoracoid spans over half of the length of the trunk. The medial, notch-shaped coracoid foramen and the partially fused scapulocoracoid synostosis suggest that the specimen is a subadult individual. This specimen sheds new light on the diversity of Early Cretaceous Titanosauriformes in China.	[Li, Li-Guo] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China; [Li, Li-Guo; Dodson, Peter] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Li, Da-Qing] Gansu Geol Museum, Lanzhou, Peoples R China; [You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China	China University of Geosciences; University of Pennsylvania; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Li, LG (corresponding author), China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China.	dinoliguo@gmail.com		You, Hai-Lu/0000-0003-2203-6461	National Natural Science Foundation of China; Hundred Talents Project of the Chinese Academy of Sciences; Gansu Bureau of Geology and Mineral Resources; NSF EAR [1024671]; Division Of Earth Sciences [1024671] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); Gansu Bureau of Geology and Mineral Resources; NSF EAR(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the National Natural Science Foundation of China and the Hundred Talents Project of the Chinese Academy of Sciences to YHL, and by the Gansu Bureau of Geology and Mineral Resources to Li DQ. The authors acknowledge the support of NSF EAR 1024671 to PD (YHL and LDQ co-PIs) for research in the Early Cretaceous of Gansu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco JL, 2005, PALEONTOLOGIA NATURA, V15, P1; Barrett Paul M., 2007, Palaeoworld, V16, P265, DOI 10.1016/j.palwor.2007.07.001; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Carballido JL, 2011, J VERTEBR PALEONTOL, V31, P93, DOI 10.1080/02724634.2011.539651; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Curtice Brian D., 1996, Museum of Northern Arizona Bulletin, V60, P87; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; D'Emic MD, 2012, J VERTEBR PALEONTOL, V32, P883, DOI 10.1080/02724634.2012.671204; Dong ZM, 1997, GIGANTIC SAUROPOD HU, P102; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gilmore C. W., 1925, Memoirs of the Carnegie Museum, V10, P347; Gilmore CW., 1946, US DEP INTERGEOL SUR, V210-C, P29, DOI DOI 10.3133/PP210C; Goloboff P., 2013, TNT TREE ANAL USING; Hallett M, 1987, DINOSAURS PRESENT, V1, P97; Harris JD, 2006, PALAEONTOLOGY, V49, P1091, DOI 10.1111/j.1475-4983.2006.00577.x; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; He XL, 1988, MIDDLE JURASSIC DINO, VIV, P143; He XL, 1984, VERTEBRATE FOSSILS S, P168; Hirasawa T, 2013, J ANAT, P1, DOI [10.1111/joa.12037, DOI 10.1111/J0A.12037]; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; JENSEN JA, 1985, GREAT BASIN NAT, V45, P697; Ksepka DT, 2010, AM MUS NOVIT, P1, DOI 10.1206/3700.2; Lovelace David M., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P527; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Mannion PD, 2011, J SYST PALAEONTOL, V9, P355, DOI 10.1080/14772019.2010.527379; MARTIN V, 1994, CR ACAD SCI II, V319, P1085; McIntosh J.S., 1990, P345; McIntosh JS, 2005, LIFE O PAST, P38; Meers MB, 2003, ANAT REC PART A, V274A, P891, DOI 10.1002/ar.a.10097; Osborn H. F., 1921, MEMOIRS AM MUSEUM NA, V3, P249; Ouyang H, 2002, 1 MAMENCHISAURIAN SK, P111; Parrish J. M, 2002, J VERTEBR PALEONTO S, V22, p95A; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Romer A.S, 1956, OSTEOLOGY REPTILES; Romer AS, 1962, VERTEBRATE BODY, P592; Schwarz D, 2007, ANAT REC, V290, P32, DOI 10.1002/ar.20405; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wilhite R, 2003, THESIS LOUISIANA STA, P225; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 1998, SOC VERTEBRATE PALEO, V5, P168; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Wilson Jeffrey A., 2012, Contributions from the Museum of Paleontology University of Michigan, V32, P1; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; You HL, 2009, P ROY SOC B-BIOL SCI, V276, P4077, DOI 10.1098/rspb.2009.1278; You Hailu, 2006, Geological Review (Beijing), V52, P668; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P424; You HL., 2008, GANSU GEOLOGY, V17, P1; Young C. C., 1939, Bulletin of the Geological Society of China, V19, P279; YOUNG C. C., 1935, BULL GEOL SOC CHINA, V14, P519; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young C.-C., 1954, SCI SINICA, V3, P491; YOUNG CHUNG-CHIEN, 1958, VERTEBR PALASIAT [CHINA], V2, P1; Zhang Y, 1984, J CHENGDU COLL GEOLO, V2, P1; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; Zhang YH, 1988, MIDDLE JURASSIC DINO, VII, P89	62	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85979	10.1371/journal.pone.0085979	http://dx.doi.org/10.1371/journal.pone.0085979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489684	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000021
J	Maesani, A; Fernando, PR; Floreano, D				Maesani, Andrea; Fernando, Pradeep Ruben; Floreano, Dario			Artificial Evolution by Viability Rather than Competition	PLOS ONE			English	Article							COVARIANCE-MATRIX ADAPTATION; GENETIC ALGORITHM; MULTIOBJECTIVE OPTIMIZATION; DIVERSITY; POPULATIONS; DESIGN	Evolutionary algorithms are widespread heuristic methods inspired by natural evolution to solve difficult problems for which analytical approaches are not suitable. In many domains experimenters are not only interested in discovering optimal solutions, but also in finding the largest number of different solutions satisfying minimal requirements. However, the formulation of an effective performance measure describing these requirements, also known as fitness function, represents a major challenge. The difficulty of combining and weighting multiple problem objectives and constraints of possibly varying nature and scale into a single fitness function often leads to unsatisfactory solutions. Furthermore, selective reproduction of the fittest solutions, which is inspired by competition-based selection in nature, leads to loss of diversity within the evolving population and premature convergence of the algorithm, hindering the discovery of many different solutions. Here we present an alternative abstraction of artificial evolution, which does not require the formulation of a composite fitness function. Inspired from viability theory in dynamical systems, natural evolution and ethology, the proposed method puts emphasis on the elimination of individuals that do not meet a set of changing criteria, which are defined on the problem objectives and constraints. Experimental results show that the proposed method maintains higher diversity in the evolving population and generates more unique solutions when compared to classical competition-based evolutionary algorithms. Our findings suggest that incorporating viability principles into evolutionary algorithms can significantly improve the applicability and effectiveness of evolutionary methods to numerous complex problems of science and engineering, ranging from protein structure prediction to aircraft wing design.	[Maesani, Andrea; Fernando, Pradeep Ruben; Floreano, Dario] Ecole Polytech Fed Lausanne, LIS, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Floreano, D (corresponding author), Ecole Polytech Fed Lausanne, LIS, Lausanne, Switzerland.	dario.floreano@epfl.ch			Swiss National Science Foundation [200021_127143]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research has been supported by the Swiss National Science Foundation, grant number 200021_127143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2006, NAT REV GENET, V7, P109, DOI 10.1038/nrg1771; Adra SF, 2011, IEEE T EVOLUT COMPUT, V15, P183, DOI 10.1109/TEVC.2010.2058117; Arnold DV, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P297, DOI 10.1145/2330163.2330207; Ashby W. R., 1956, INTRO CYBERNETICS; Ashby W. R., 1960, DESIGN BRAIN; ATMAR W, 1994, IEEE T NEURAL NETWOR, V5, P130, DOI 10.1109/72.265967; Aubin J.P., 1991, VIABILITY THEORY; Back T., 1996, EVOLUTIONARY ALGORIT; Baum EB, 2001, EVOL COMPUT, V9, P93, DOI 10.1162/10636560151075130; Beer RD, 1997, ROBOT AUTON SYST, V20, P257, DOI 10.1016/S0921-8890(96)00063-2; Bongard J, 2011, P NATL ACAD SCI USA, V108, P1234, DOI 10.1073/pnas.1015390108; Cannon W.B., 1932, WISDOM BODY; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Coello CAC, 2002, COMPUT METHOD APPL M, V191, P1245, DOI 10.1016/S0045-7825(01)00323-1; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Darwin C, 1859, ORIGIN SPECIES MEANS; DEB K, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P42; Deb K, 2002, IEEE C EVOL COMPUTAT, P825, DOI 10.1109/CEC.2002.1007032; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014; Eiben A. E., 1997, HDB EVOLUTIONARY COM; Eiben AE, 2002, INFORM PROCESS LETT, V82, P1, DOI 10.1016/S0020-0190(02)00204-1; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Eiben AE, 1997, EVOL COMPUT, V5, P347, DOI 10.1162/evco.1997.5.3.347; Floreano D., 2008, BIOINSPIRED ARTIFICI; Fogel D. B., 1995, EVOLUTIONARY COMPUTA; FOGEL DB, 1994, IEEE T NEURAL NETWOR, V5, P3, DOI 10.1109/72.265956; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; GEIGER RL, 1985, IEEE CIRCUITS DEVICE, V1, P20, DOI 10.1109/MCD.1985.6311946; Goldberg D.E., 1987, P 2 INT C GEN ALG GE; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gomes J, 2012, LECT NOTES ARTIF INT, V7637, P281, DOI 10.1007/978-3-642-34654-5_29; Hansen N, 2003, EVOL COMPUT, V11, P1, DOI 10.1162/106365603321828970; Igel C, 2007, EVOL COMPUT, V15, P1, DOI 10.1162/evco.2007.15.1.1; Jin Y, 2005, IEEE T EVOLUT COMPUT, V9, P303, DOI 10.1109/TEVC.2005.846356; Juric M., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P619, DOI 10.1109/ICEC.1994.349988; Kallel L, 2001, NAT COMPUT SER, P175; Konak A, 2006, RELIAB ENG SYST SAFE, V91, P992, DOI 10.1016/j.ress.2005.11.018; KUMAR V, 1992, AI MAG, V13, P32; Lassig J, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046702; Lassig J, 2008, P 2008 GECCO C COMP, P2181, DOI [10.1145/1388969.1389044, DOI 10.1145/1388969.1389044]; Lehman J., 2011, P GEN EV COMP C GECC; Lehman J, 2010, P GEN EV COMP C GECC; LEHMAN J, 2008, ARTIF LIFE, V11, P329; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Li JP, 2002, EVOL COMPUT, V10, P207, DOI 10.1162/106365602760234081; Marin J, 1999, IEEE T EVOLUT COMPUT, V3, P272, DOI 10.1109/4235.797970; Mattiussi C, 2004, EVOL COMPUT, V12, P495, DOI 10.1162/1063656043138923; Mattiussi C, 2003, TECHNICAL REPORT; Mc Ginley B, 2011, IEEE T EVOLUT COMPUT, V15, P692, DOI 10.1109/TEVC.2010.2046173; Mezura-Montes E, 2011, SWARM EVOL COMPUT, V1, P173, DOI 10.1016/j.swevo.2011.10.001; Muhlenbein H, 1993, EVOL COMPUT, V1, P335, DOI 10.1162/evco.1993.1.4.335; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Park T, 2010, IEEE T EVOLUT COMPUT, V14, P865, DOI 10.1109/TEVC.2010.2043362; Petrowski A, 1996, P 1996 IEEE INT C EV; Ray TS, 1991, SCI EXCELLENCE SUPER, P489; Ronikkonen J, 2008, LECT NOTES COMPUT SC, V5361, P239; Shir OF, 2006, LECT NOTES COMPUT SC, V4193, P142; Singh G, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1305; Storn R, 1999, IEEE T EVOLUT COMPUT, V3, P22, DOI 10.1109/4235.752918; Toffolo A, 2003, EVOL COMPUT, V11, P151, DOI 10.1162/106365603766646816; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; WHITLEY D, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P116; Wineberg M, 2003, LECT NOTES COMPUT SC, V2724, P1493; Wischmann S, 2012, P NATL ACAD SCI USA, V109, P864, DOI 10.1073/pnas.1104267109; Woldesenbet YG, 2009, IEEE T EVOLUT COMPUT, V13, P514, DOI 10.1109/TEVC.2008.2009032	67	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86831	10.1371/journal.pone.0086831	http://dx.doi.org/10.1371/journal.pone.0086831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489790	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000072
J	Maman, S; van Rooyen, H; Stankard, P; Chingono, A; Muravha, T; Ntogwisangu, J; Phakathi, Z; Srirak, N; Morin, SF				Maman, Suzanne; van Rooyen, Heidi; Stankard, Petra; Chingono, Alfred; Muravha, Tshifhiwa; Ntogwisangu, Jacob; Phakathi, Zipho; Srirak, Namtip; Morin, Stephen F.		NIMH Project Accept HPTN 043 Study	NIMH Project Accept (HPTN 043): Results from In-Depth Interviews with a Longitudinal Cohort of Community Members	PLOS ONE			English	Article							HIV; INTERVENTION; STIGMA; DISCRIMINATION; PREVENTION; ADHERENCE; TANZANIA; AFRICA; IMPACT; TRIAL	Introduction: NIMH Project Accept (HPTN 043) is a community-randomized trial to test the safety and efficacy of a community-level intervention designed to increase testing and lower HIV incidence in Tanzania, Zimbabwe, South Africa and Thailand. The evaluation design included a longitudinal study with community members to assess attitudinal and behavioral changes in study outcomes including HIV testing norms, HIV-related discussions, and HIV-related stigma. Methods: A cohort of 657 individuals across all sites was selected to participate in a qualitative study that involved 4 interviews during the study period. Baseline and 30-month data were summarized according to each outcome, and a qualitative assessment of changes was made at the community level over time. Results: Members from intervention communities described fewer barriers and greater motivation for testing than those from comparison communities. HIV-related discussions in intervention communities were more grounded in personal testing experiences. A change in HIV-related stigma over time was most pronounced in Tanzania and Zimbabwe. Participants in the intervention communities from these two sites attributed community-level changes in attitudes to project specific activities. Discussion: The Project Accept intervention was associated with more favorable social norms regarding HIV testing, more personal content in HIV discussions in all study sites, and qualitative changes in HIV-related stigma in two of five sites.	[Maman, Suzanne; Stankard, Petra] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [van Rooyen, Heidi; Phakathi, Zipho] Human Sci Res Council, Social Behav & Biomed Intervent Unit, Pieternaritzburg, South Africa; [Chingono, Alfred] Univ Zimbabwe, Dept Psychiat, Harare, Zimbabwe; [Muravha, Tshifhiwa] Witswatersrand Univ, Perinatal HIV Res Unit, Soweto, South Africa; [Ntogwisangu, Jacob] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat & Mental Hlth, Dar Es Salaam, Tanzania; [Srirak, Namtip] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Morin, Stephen F.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Zimbabwe; University of Witwatersrand; Muhimbili University of Health & Allied Sciences; Chiang Mai University; University of California System; University of California San Francisco	Maman, S (corresponding author), Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA.	maman@email.unc.edu	Maman, Suzanne/A-3802-2016; Mulawa, Marta/T-3476-2019; Singh, Basant/AAR-9108-2020	Mulawa, Marta/0000-0001-9687-421X; Singh, Basant/0000-0002-7448-1906; Laeyendecker, Oliver/0000-0002-6429-4760; Donnell, Deborah/0000-0002-0587-7480; Kulich, Michal/0000-0002-2812-8968; McGrath, Nuala/0000-0002-1039-0159	U.S. National Institute of Mental Health [U01MH066687, U01MH066688, U01MH066701, U01MH066702]; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068613, U01AI068617, UM1A068619]; Office of AIDS Research of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068617, ZIAAI000361, U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066701, U01MH066702, U01MH066688, U01MH066687] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 (Johns Hopkins University - David Celentano, PI); U01MH066688 (Medical University of South Carolina - Michael Sweat, PI); U01MH066701 (University of California, Los Angeles - Thomas J. Coates, PI); and U01MH066702 (University of California, San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613 (HPTN Network Laboratory - Susan Eshleman, PI); U01AI068617 (SCHARP - Deborah Donnell, PI); and UM1A068619 (HIV Prevention Trials Network - Sten Vermund, PI) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; and by the Office of AIDS Research of the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arem H, 2011, AIDS PATIENT CARE ST, V25, P719, DOI 10.1089/apc.2010.0349; Coates T, OUTCOMES NI IN PRESS; Creswell W. C., 2011, DESIGNING CONDUCTING; Doherty T, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3481; Dworkin SL, 2007, ARCH SEX BEHAV, V36, P269, DOI 10.1007/s10508-006-9092-9; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Jewkes R, 2010, HEALTH EDUC RES, V25, P1074, DOI 10.1093/her/cyq062; Jurgensen M, 2013, SOC SCI MED, V81, P18, DOI 10.1016/j.socscimed.2013.01.011; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Low C, 2013, AIDS CARE, V25, pS97, DOI 10.1080/09540121.2012.748879; Maman S, 2009, SOC SCI MED, V68, P2271, DOI 10.1016/j.socscimed.2009.04.002; Maughan-Brown B, 2010, SOC SCI MED, V70, P368, DOI 10.1016/j.socscimed.2009.09.041; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Plummer ML, 2010, AIDS CARE, V22, P499, DOI 10.1080/09540120903202889; Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Squires A, 2008, INT NURS REV, V55, P265, DOI 10.1111/j.1466-7657.2008.00652.x; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; *WHO, UN ACC SCAL PRIOR HI; Wight D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-788; World Health Organization, 2006, PROGR GLOB ACC HIV A; World Health Organization, 2005, WORLD HLTH STAT	24	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87091	10.1371/journal.pone.0087091	http://dx.doi.org/10.1371/journal.pone.0087091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489841	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330570000099
J	Mensen, A; Poryazova, R; Schwartz, S; Khatami, R				Mensen, Armand; Poryazova, Rositsa; Schwartz, Sophie; Khatami, Ramin			Humor as a Reward Mechanism: Event-Related Potentials in the Healthy and Diseased Brain	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; FACIAL EMOTION RECOGNITION; PARKINSONS-DISEASE; DOPAMINERGIC MODULATION; COGNITIVE FUNCTION; HUMAN NARCOLEPSY; DECISION-MAKING; FUNCTIONAL MRI; AMYGDALA; CATAPLEXY	Humor processing involves distinct processing stages including incongruity detection, emotional response, and engagement of mesolimbic reward regions. Dysfunctional reward processing and clinical symptoms in response to humor have been previously described in both hypocretin deficient narcolepsy-cataplexy (NC) and in idiopathic Parkinson disease (PD). For NC patients, humor is the strongest trigger for cataplexy, a transient loss of muscle tone, whereas dopamine-deficient PD-patients show blunted emotional responses to humor. To better understand the role of reward system and the various contributions of hypocretinergic and dopaminergic mechanisms to different stages of humor processing we examined the electrophysiological response to humorous and neutral pictures when given as reward feedback in PD, NC and healthy controls. Humor compared to neutral feedback demonstrated modulation of early ERP amplitudes likely corresponding to visual processing stages, with no group differences. At 270 ms post-feedback, conditions showed topographical and amplitudinal differences for frontal and left posterior electrodes, in that humor feedback was absent in PD patients but increased in NC patients. We suggest that this effect relates to a relatively early affective response, reminiscent of increased amygdala response reported in NC patients. Later ERP differences, corresponding to the late positive potential, revealed a lack of sustained activation in PD, likely due to altered dopamine regulation in reward structures in these patients. This research provides new insights into the temporal dynamics and underlying mechanisms of humor detection and appreciation in health and disease.	[Mensen, Armand; Khatami, Ramin] Clin Barmelweid, Dept Sleep Med, Barmelweid, Switzerland; [Poryazova, Rositsa] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland	University of Zurich; University Zurich Hospital; University of Geneva	Khatami, R (corresponding author), Clin Barmelweid, Dept Sleep Med, Barmelweid, Switzerland.	Ramin.Khatami@Barmelweid.ch		Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [32003B-124763]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by Swiss National Science Foundation Grant-No: 32003B-124763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Bassetti C, 1997, SLEEP, V20, P630, DOI 10.1093/sleep/20.8.630; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Calipari ES, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00054; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Coulson S, 2005, J COGNITIVE NEUROSCI, V17, P494, DOI 10.1162/0898929053279568; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Euteneuer F, 2009, NEUROPSYCHOLOGIA, V47, P2882, DOI 10.1016/j.neuropsychologia.2009.06.014; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; GOTHAM AM, 1986, LANCET, V2, P970; Ibarretxe-Bilbao N, 2009, EUR J NEUROSCI, V30, P1162, DOI 10.1111/j.1460-9568.2009.06892.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kobayakawa M, 2008, MOVEMENT DISORD, V23, P547, DOI 10.1002/mds.21865; Korb S, 2012, SOC NEUROSCI-UK, V7, P510, DOI 10.1080/17470919.2012.667573; Korotkova TM, 2003, J NEUROSCI, V23, P7; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Nakashima T, 2008, NEUROSCI RES, V62, P225, DOI 10.1016/j.neures.2008.08.009; Overeem S, 2004, J SLEEP RES, V13, P257, DOI 10.1111/j.1365-2869.2004.00411.x; Overeem S, 2004, PSYCHOPHYSIOLOGY, V41, P254, DOI 10.1111/j.1469-8986.2003.00145.x; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Ponz A, 2010, ANN NEUROL, V67, P394, DOI 10.1002/ana.21881; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Raggi A, 2011, NEUROSCI BIOBEHAV R, V35, P1144, DOI 10.1016/j.neubiorev.2010.12.001; Ramachandran VS, 1998, MED HYPOTHESES, V51, P351, DOI 10.1016/S0306-9877(98)90061-5; Sabatinelli D, 2013, BIOL PSYCHOL, V92, P513, DOI 10.1016/j.biopsycho.2012.04.005; Saletu M, 2008, CLIN NEUROPHYSIOL, V119, P1782, DOI 10.1016/j.clinph.2008.04.297; Samson AC, 2008, SOC NEUROSCI-UK, V3, P125, DOI 10.1080/17470910701745858; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Schwartz S, 2008, BRAIN, V131, P514, DOI 10.1093/brain/awm292; Sinha N, 2013, J NEUROPSYCHOL, V7, P255, DOI 10.1111/jnp.12013; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tobimatsu Shozo, 2012, Brain and Nerve (Tokyo), V64, P717; Tucci V, 2003, SLEEP, V26, P558, DOI 10.1093/sleep/26.5.558; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; van Wouwe NC, 2012, NEUROPSYCHOLOGIA, V50, P583, DOI 10.1016/j.neuropsychologia.2011.12.012; Watson KK, 2007, CEREB CORTEX, V17, P314, DOI 10.1093/cercor/bhj149; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Yoshimura N, 2005, NEUROSCIENCE, V131, P523, DOI 10.1016/j.neuroscience.2004.09.054; Young JW, 2010, BIOL PSYCHIAT, V67, P784, DOI 10.1016/j.biopsych.2009.12.015; Zinbarg RE, 2010, J ABNORM PSYCHOL, V119, P307, DOI 10.1037/a0017552	65	18	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85978	10.1371/journal.pone.0085978	http://dx.doi.org/10.1371/journal.pone.0085978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489683	Green Accepted, gold, Green Published			2022-12-27	WOS:000330570000020
J	Tsuruta, JK; Klauber-DeMore, N; Streeter, J; Samples, J; Patterson, C; Mumper, RJ; Ketelsen, D; Dayton, P				Tsuruta, James K.; Klauber-DeMore, Nancy; Streeter, Jason; Samples, Jennifer; Patterson, Cam; Mumper, Russell J.; Ketelsen, David; Dayton, Paul			Ultrasound Molecular Imaging of Secreted Frizzled Related Protein-2 Expression in Murine Angiosarcoma	PLOS ONE			English	Article							BREAST-CANCER; TUMOR; ANGIOGENESIS; SFRP2; CELLS; HYPERMETHYLATION; APOPTOSIS; GROWTH; GENES	Angiosarcoma is a biologically aggressive vascular malignancy with a high metastatic potential. In the era of targeted medicine, knowledge of specific molecular tumor characteristics has become more important. Molecular imaging using targeted ultrasound contrast agents can monitor tumor progression non-invasively. Secreted frizzled related protein 2 (SFRP2) is a tumor endothelial marker expressed in angiosarcoma. We hypothesize that SFRP2-directed imaging could be a novel approach to imaging the tumor vasculature. To develop an SFRP2 contrast agent, SFRP2 polyclonal antibody was biotinylated and incubated with streptavidin-coated microbubbles. SVR angiosarcoma cells were injected into nude mice, and when tumors were established the mice were injected intravenously with the SFRP2 -targeted contrast agent, or a control streptavidin-coated contrast agent. SFRP2 -targeted contrast agent detected tumor vasculature with significantly more signal intensity than control contrast agent: the normalized fold-change was 1.6+/-0.27 (n = 13, p = 0.0032). The kidney was largely devoid of echogenicity with no significant difference between the control contrast agent and the SFRP2-targeted contrast agent demonstrating that the SFRP2-targeted contrast agent was specific to tumor vessels. Plotting average pixel intensity obtained from SFRP2-targeted contrast agent against tumor volume showed that the average pixel intensity increased as tumor volume increased. In conclusion, molecularly-targeted imaging of SFRP2 visualizes angiosarcoma vessels, but not normal vessels, and intensity increases with tumor size. Molecular imaging of SFRP2 expression may provide a rapid, non-invasive method to monitor tumor regression during therapy for angiosarcoma and other SFRP2 expressing cancers, and contribute to our understanding of the biology of SFRP2 during tumor development and progression.	[Tsuruta, James K.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Klauber-DeMore, Nancy; Samples, Jennifer; Ketelsen, David] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Klauber-DeMore, Nancy; Patterson, Cam] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC USA; [Tsuruta, James K.; Streeter, Jason; Mumper, Russell J.; Dayton, Paul] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Tsuruta, James K.; Streeter, Jason; Mumper, Russell J.; Dayton, Paul] N Carolina State Univ, Raleigh, NC 27695 USA; [Mumper, Russell J.; Dayton, Paul] UNC Eshelman Sch Pharm, Div Mol Pharmaceut, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Klauber-DeMore, N (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA.	nancy_demore@med.unc.edu	Streeter, Jason/ABA-4809-2020; , Animal Studies Core/AAF-4432-2022; , Animal Studies Core/ADK-4234-2022		National Institute of Health [1R01CA142657-01A1, R01 HL61656, R01 EB009066]; University Cancer Research Fund; Nancy DeMore Research Foundation; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009066] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund; Nancy DeMore Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institute of Health 1R01CA142657-01A1 to NK-D, R01 HL61656 to CP, and R01 EB009066 to PD; University Cancer Research Fund to CP, Nancy DeMore Research Foundation to NK-D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbiser JL, 2009, CURR MOL MED, V9, P929, DOI 10.2174/156652409789712828; Banerjee P, 2013, CANCER LETT, V338, P292, DOI 10.1016/j.canlet.2013.05.036; Bensch F, 2013, EUR J PHARMACOL, V717, P2, DOI 10.1016/j.ejphar.2013.01.079; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z; Espat N J, 2000, Sarcoma, V4, P173, DOI 10.1080/13577140020025896; Esteve P, 2011, DEVELOPMENT, V138, P4179, DOI 10.1242/dev.065839; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Fontenot E, 2013, MOL CANCER THER, V12, P685, DOI 10.1158/1535-7163.MCT-12-1066; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022; Kinoshita T, 2011, HEPATO-GASTROENTEROL, V58, P1051; Lee JL, 2004, J BIOL CHEM, V279, P14602, DOI 10.1074/jbc.M309008200; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Martin KH, 2013, WIRES NANOMED NANOBI, V5, P329, DOI 10.1002/wnan.1219; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Munson J, 2013, CELL CYCLE, V12, P2200, DOI 10.4161/cc.25334; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Siamakpour-Reihani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020412; Streeter JE, 2011, MOL IMAGING, V10, P460, DOI 10.2310/7290.2011.00015; Streeter JE, 2010, MOL IMAGING, V9, P87, DOI 10.2310/7290.2010.00005; Tanaka J, 2008, HEPATO-GASTROENTEROL, V55, P1265; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Yamamura S, 2010, MOL CANCER THER, V9, P1680, DOI 10.1158/1535-7163.MCT-10-0012	28	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86642	10.1371/journal.pone.0086642	http://dx.doi.org/10.1371/journal.pone.0086642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489757	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000053
J	Zhang, Y; Hu, LQ; Cui, Y; Qi, ZG; Huang, XP; Cai, LY; Zhang, T; Yin, YX; Lu, ZY; Xiang, JY				Zhang, Yan; Hu, Lingqing; Cui, Yan; Qi, Zhigang; Huang, Xiaoping; Cai, Liyi; Zhang, Ting; Yin, Yongxiang; Lu, Zhiyi; Xiang, Jingying			Roles of PPAR gamma/NF-kappa B Signaling Pathway in the Pathogenesis of Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; HUMAN GESTATIONAL TISSUES; PROINFLAMMATORY CYTOKINES; LIPID-METABOLISM; BILE-ACIDS; INFLAMMATION; ALPHA; INTERLEUKIN-6; INHIBITION; EXPRESSION	Background: Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent pregnancy specific liver disease. However, the pathogenesis and etiology of ICP is poorly understood. Aim: To assess the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and nuclear factor kappa B (NF-kappa B) in placenta and HTR-8/SVneo cell, and evaluate the serum levels of cytokines, bile acids, hepatic function and lipids in control and ICP patients and the fetal outcome, in order to explore the role of PPAR gamma/NF-kappa B signaling pathway in the possible mechanism of ICP. Methods: Clinical data of the pregnant women were collected and serum levels of cytokines, bile acids, hepatic function and lipids were measured. Expressions of PPAR gamma and NF-kappa B in placenta and HTR-8/SVneo cell were determined. The newborn information was collected to demonstrate the relationship between PPAR gamma/NF-kappa B signaling pathway and ICP. Results: The serum levels of bile acids, hepatic function, triglycerides (TG), total cholesterol (TC), IL-6, IL-12 and TNF-alpha in ICP group were significantly increased (P < 0.01), and serum level of IL-4 was significantly decreased (P, 0.01). PPAR gamma and NF-kappa B staining were found in the membrane and cytoplasm of placental trophoblast cell. The expression of PPAR gamma and NF-kappa B were significantly higher in ICP group and taurocholate acid (TCA) treated HTR-8/SVneo cell (P<0.01). The new-born information in severe ICP group were significantly different as compared to that in control group (P<0.05), and part of information in mild ICP group were also difference to that in control group (P<0.05). Conclusions: The higher expressions of PPAR gamma and NF-kappa B in ICP placenta and TCA treated HTR-8/SVneo cell, together with the abnormal serum levels of cytokines, might induced by the imbalance of inflammatory and immune reaction, and then disturb placental bile acid and serum lipids transportation, finally result in fatal cholestasis which probably be one of the mechanism of ICP.	[Zhang, Yan; Hu, Lingqing; Huang, Xiaoping; Cai, Liyi; Zhang, Ting; Yin, Yongxiang; Xiang, Jingying] Nanjing Med Univ, Affiliated Hosp, Wuxi Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China; [Zhang, Yan; Cui, Yan] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Qi, Zhigang] Wuxi Peoples Hosp, Dept Pharmaceut, Wuxi, Jiangsu, Peoples R China; [Lu, Zhiyi] Wuxi Hosp Tradit Chinese Med, Dept Obstet & Gynecol, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; Jiangnan University	Zhang, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp, Wuxi Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Wuxi, Jiangsu, Peoples R China.	2004zhangshanshi@163.com; wxxjy89@163.com	hu, ling/GWC-1104-2022		joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City [YGZX1204]	joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City	This work was supported by the joint research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City (No. YGZX1204). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2013, HEPATOLOGY, V57, P716, DOI 10.1002/hep.26055; Ai Ying, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P322; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Borel V., 2008, PPAR RES, V2008, P1; Calleja-Agius J, 2012, HUM REPROD, V27, P349, DOI 10.1093/humrep/der402; Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chaouat G, 2004, IMMUNOL LETT, V92, P207, DOI 10.1016/j.imlet.2004.01.011; Chen JB, 2013, INT J GYNECOL OBSTET, V122, P5, DOI 10.1016/j.ijgo.2013.02.015; Dann AT, 2006, OBSTET GYNECOL, V107, P106, DOI 10.1097/01.AOG.0000189096.94874.9c; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Diken Z, 2013, AM J PERINATOL; Du Q, 2013, HEPATOL RES; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Fitzgerald K.A., 2001, CYTOKINE FACTSBOOK, P515; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Fournier T, 2011, J REPROD IMMUNOL, V90, P41, DOI 10.1016/j.jri.2011.05.003; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Greig PC, 1997, OBSTET GYNECOL, V90, P465, DOI 10.1016/S0029-7844(97)00294-9; Hadfield KA, 2011, J REPROD IMMUNOL, V89, P1, DOI 10.1016/j.jri.2010.11.008; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; Hu Y, 2010, AM J REPROD IMMUNOL, V63, P267, DOI 10.1111/j.1600-0897.2009.00798.x; Hutter S, 2013, PPAR RES, V2013, DOI 10.1155/2013/970276; Joshi D, 2010, LANCET, V375, P594, DOI 10.1016/S0140-6736(09)61495-1; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kenyon AP, 2011, OBSTETRICSCHOLESTASI; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lappas M, 2002, J CLIN ENDOCR METAB, V87, P4667, DOI 10.1210/jc.2002-020613; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Ling B, 2007, CELL MOL IMMUNOL, V4, P71; Liu Xing-hui, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P321; Liu ZJ, 2008, ZHONGHUA FU CHAN KE, V43, P292; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Mandard S, 2013, PPAR RES, V2013, DOI 10.1155/2013/613864; Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488; Martinez N, 2008, REPRODUCTION, V136, P95, DOI 10.1530/REP-08-0028; McCracken SA, 2004, J IMMUNOL, V172, P4583, DOI 10.4049/jimmunol.172.7.4583; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Murthi P, 2013, PLACENTA, V34, P299, DOI 10.1016/j.placenta.2013.01.005; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Painter JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/sj.ejhg.5201355; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Reyes H, 2008, HEPATOLOGY, V47, P376, DOI 10.1002/hep.22139; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rieger L, 2002, MOL HUM REPROD, V8, P255, DOI 10.1093/molehr/8.3.255; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Savander M, 2003, GUT, V52, P1025, DOI 10.1136/gut.52.7.1025; Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009; Shalom-Barak T, 2012, DEV BIOL, V372, P143, DOI 10.1016/j.ydbio.2012.08.021; Shemer EW, 2012, PLACENTA, V33, P914, DOI 10.1016/j.placenta.2012.08.005; Shi Q, 1998, ZHONGHUA FU CHAN KE, V33, P292; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416739; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Wang LH, 2007, BLOOD, V110, P4373, DOI 10.1182/blood-2006-07-038026; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WEGMANN TG, 1992, DEV COMP IMMUNOL, V16, P425, DOI 10.1016/0145-305X(92)90026-9; Wei J, 2010, ARCH GYNECOL OBSTET, V281, P801, DOI 10.1007/s00404-009-1156-3; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065; Zeng C, 2011, MOLECULES, V16, P8552, DOI 10.3390/molecules16108552; Zhou F, 2013, PLACENTA, V34, P401, DOI 10.1016/j.placenta.2013.02.006	77	15	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87343	10.1371/journal.pone.0087343	http://dx.doi.org/10.1371/journal.pone.0087343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489901	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000135
J	Zhou, W; Lv, R; Qi, WL; Wu, D; Xu, YY; Liu, W; Mou, YP; Wang, LW				Zhou, Wei; Lv, Ran; Qi, Weilin; Wu, Di; Xu, Yunyun; Liu, Wei; Mou, Yiping; Wang, Liewei			Snail Contributes to the Maintenance of Stem Cell-Like Phenotype Cells in Human Pancreatic Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGNOSTIC-SIGNIFICANCE; METASTASIS; NANOG; TWIST; OVEREXPRESSION; IDENTIFICATION; COEXPRESSION; EXPRESSION; SLUG	Snail, a potent repressor of E-cadherin expression, plays a key role in epithelial-to-mesenchymal transition (EMT) in epithelial cancer. Recently, EMT and stemness programs are found linked together. In the current study, the expression of Snail and its contribution to cancer stem cell (CSC) marker expression, invasiveness, self-renewal, clonogenicity, and tumorigenicity of pancreatic cancer cells were studied. Our results showed that Snail was highly expressed in CSChigh cell line Panc-1. Stable, short hairpin RNA (shRNA)-mediated Snail knockdown decreased invasion in Panc-1 cells, in line with increased E-cadherin expression and its translocation from the nucleus to the membrane. Snail silencing in Panc-1 also inhibited CSC marker ALDH expression, together with decreased sphere and colony forming capacity, which was highly consistent with the expression of stem cell associated transcription factors like Sox2 and Oct4. In mouse xenograft models, knockdown of Snail led to a reduced number of tumor-bearing mice and a reduced average size of tumors, which had a stronger membrane staining of E-cadherin and lighter staining of Oct4. Collectively, these findings implicate Snail is required for the maintenance of stem cell-like phenotype in pancreatic cancer, and inhibition of Snail could be an efficient strategy to treat pancreatic cancer by targeting CSCs.	[Zhou, Wei; Qi, Weilin; Wu, Di; Xu, Yunyun; Liu, Wei; Mou, Yiping] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Lv, Ran] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Zhejiang University; Zhejiang University; Mayo Clinic	Zhou, W (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou 310003, Zhejiang, Peoples R China.	nuzwlvran@aliyun.com			National Natural Science Foundation of China [81001095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [81001095]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jones RJ, 2004, JNCI-J NATL CANCER I, V96, P583, DOI 10.1093/jnci/djh095; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kuo KT, 2012, ANN SURG ONCOL, V19, pS549, DOI 10.1245/s10434-011-2043-2; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nishioka R, 2010, EXP MOL PATHOL, V89, P149, DOI 10.1016/j.yexmp.2010.05.008; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhu JH, 2012, J PROTEOME RES, V11, P2272, DOI 10.1021/pr201059g	40	62	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87409	10.1371/journal.pone.0087409	http://dx.doi.org/10.1371/journal.pone.0087409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489910	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000142
J	Dalio, RJD; Fleischmann, F; Humez, M; Osswald, W				Dalio, Ronaldo J. D.; Fleischmann, Frank; Humez, Martina; Osswald, Wolfgang			Phosphite Protects Fagus sylvatica Seedlings towards Phytophthora plurivora via Local Toxicity, Priming and Facilitation of Pathogen Recognition	PLOS ONE			English	Article							EUCALYPTUS-MARGINATA; DEFENSE RESPONSES; CINNAMOMI; PHOTOSYNTHESIS; SENSITIVITY; PHOSPHORUS; CITRICOLA; FUNGICIDE; OAK	Phytophthora plurivora causes severe damage on Fagus sylvatica and is responsible for the extensive decline of European Beech throughout Europe. Unfortunately, no effective treatment against this disease is available. Phosphite (Phi) is known to protect plants against Phytophthora species; however, its mode of action towards P. plurivora is still unknown. To discover the effect of Phi on root infection, leaves were sprayed with Phi and roots were subsequently inoculated with P. plurivora zoospores. Seedling physiology, defense responses, colonization of root tissue by the pathogen and mortality were monitored. Additionally the Phi concentration in roots was quantified. Finally, the effect of Phi on mycelial growth and zoospore formation was recorded. Phi treatment was remarkably efficient in protecting beech against P. plurivora; all Phi treated plants survived infection. Phi treated and infected seedlings showed a strong up-regulation of several defense genes in jasmonate, salicylic acid and ethylene pathways. Moreover, all physiological parameters measured were comparable to control plants. The local Phi concentration detected in roots was high enough to inhibit pathogen growth. Phi treatment alone did not harm seedling physiology or induce defense responses. The up-regulation of defense genes could be explained either by priming or by facilitation of pathogen recognition of the host.	[Dalio, Ronaldo J. D.; Fleischmann, Frank; Humez, Martina; Osswald, Wolfgang] Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany	Technical University of Munich	Osswald, W (corresponding author), Tech Univ Munich, Sect Pathol Woody Plants, Freising Weihenstephan, Germany.	osswald@tum.de	Dalio, Ronaldo J. D./E-8151-2015	Dalio, Ronaldo J. D./0000-0002-1457-4828	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, has granted Dr. Ronaldo J.D. Dalio a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm J, 1999, J PHYTOPATHOL, V147, P409, DOI 10.1111/j.1439-0434.1999.tb03842.x; COFFEY MD, 1985, PHYTOPATHOLOGY, V75, P1042, DOI 10.1094/Phyto-75-1042; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Daniel R, 2006, PHYTOPATHOLOGY, V96, pS28; Dobrowolski MP, 2008, PLANT PATHOL, V57, P928, DOI 10.1111/j.1365-3059.2008.01883.x; Ellsworth DS, 2004, GLOBAL CHANGE BIOL, V10, P2121, DOI 10.1111/j.1365-2486.2004.00867.x; Eshraghi L, 2011, PLANT PATHOL, V60, P1086, DOI 10.1111/j.1365-3059.2011.02471.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Fleischmann F, 2005, PLANT BIOLOGY, V7, P650, DOI 10.1055/s-2005-872891; Machinandiarena MF, 2012, J PLANT PHYSIOL, V169, P1417, DOI 10.1016/j.jplph.2012.05.005; Garbelotto M., 2007, Arboriculture & Urban Forestry, V33, P309; GUEST D, 1991, BIOL REV, V66, P159, DOI 10.1111/j.1469-185X.1991.tb01139.x; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Hardy GES, 2001, AUSTRALAS PLANT PATH, V30, P133, DOI 10.1071/AP01012; Jackson TJ, 2000, PLANT PATHOL, V49, P147, DOI 10.1046/j.1365-3059.2000.00422.x; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; King M, 2010, MOL GENET GENOMICS, V284, P425, DOI 10.1007/s00438-010-0579-7; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; Massoud K, 2012, PLANT PHYSIOL, V159, P286, DOI 10.1104/pp.112.194647; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Osswald W, 2012, ECOL STUD-ANAL SYNTH, V220, P53, DOI 10.1007/978-3-642-30645-7_3; OUIMETTE D, 1985, PHYTOPATHOLOGY, V75, P1330; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pilbeam RA, 2011, TREES-STRUCT FUNCT, V25, P1121, DOI 10.1007/s00468-011-0587-1; Portz RL, 2011, FOREST PATHOL, V41, P202, DOI 10.1111/j.1439-0329.2010.00667.x; Roos GHP, 1999, COMMUN SOIL SCI PLAN, V30, P2323, DOI 10.1080/00103629909370376; RYDER DS, 1986, J CHROMATOGR, V354, P438, DOI 10.1016/S0021-9673(01)87045-X; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Shearer BL, 2006, FOREST PATHOL, V36, P119, DOI 10.1111/j.1439-0329.2006.00440.x; Van Wees Saskia C M, 2013, Methods Mol Biol, V1011, P35, DOI 10.1007/978-1-62703-414-2_4; Werres S, 1995, EUR J FOREST PATHOL, V25, P381; Wilkinson CJ, 2001, PLANT PATHOL, V50, P587, DOI 10.1046/j.1365-3059.2001.00605.x; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037	37	53	58	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87860	10.1371/journal.pone.0087860	http://dx.doi.org/10.1371/journal.pone.0087860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489973	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000154
J	Levy, JI; Fabian, MP; Peters, JL				Levy, Jonathan I.; Fabian, Maria Patricia; Peters, Junenette L.			Community-Wide Health Risk Assessment Using Geographically Resolved Demographic Data: A Synthetic Population Approach	PLOS ONE			English	Article							MICRODATA; EXPOSURE; SMOKING; BLOOD; SITE	Background: Evaluating environmental health risks in communities requires models characterizing geographic and demographic patterns of exposure to multiple stressors. These exposure models can be constructed from multivariable regression analyses using individual-level predictors (microdata), but these microdata are not typically available with sufficient geographic resolution for community risk analyses given privacy concerns. Methods: We developed synthetic geographically-resolved microdata for a low-income community (New Bedford, Massachusetts) facing multiple environmental stressors. We first applied probabilistic reweighting using simulated annealing to data from the 2006-2010 American Community Survey, combining 9,135 microdata samples from the New Bedford area with census tract-level constraints for individual and household characteristics. We then evaluated the synthetic microdata using goodness-of-fit tests and by examining spatial patterns of microdata fields not used as constraints. As a demonstration, we developed a multivariable regression model predicting smoking behavior as a function of individual-level microdata fields using New Bedford-specific data from the 2006-2010 Behavioral Risk Factor Surveillance System, linking this model with the synthetic microdata to predict demographic and geographic smoking patterns in New Bedford. Results: Our simulation produced microdata representing all 94,944 individuals living in New Bedford in 2006-2010. Variables in the synthetic population matched the constraints well at the census tract level (e. g., ancestry, gender, age, education, household income) and reproduced the census-derived spatial patterns of non-constraint microdata. Smoking in New Bedford was significantly associated with numerous demographic variables found in the microdata, with estimated tract-level smoking rates varying from 20% (95% CI: 17%, 22%) to 37% (95% CI: 30%, 45%). Conclusions: We used simulation methods to create geographically-resolved individual-level microdata that can be used in community-wide exposure and risk assessment studies. This approach provides insights regarding community-scale exposure and vulnerability patterns, valuable in settings where policy can be informed by characterization of multi-stressor exposures and health risks at high resolution.	[Levy, Jonathan I.; Fabian, Maria Patricia; Peters, Junenette L.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA	Boston University	Levy, JI (corresponding author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.	jonlevy@bu.edu	Levy, Jon/B-4542-2011	Levy, Jon/0000-0002-1116-4006; Fabian, M. Patricia/0000-0002-1658-3349; /0000-0003-4542-4563	U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program; U.S. Environmental Protection Agency's STAR program [RD83457702]	U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program(United States Environmental Protection Agency); U.S. Environmental Protection Agency's STAR program(United States Environmental Protection Agency)	This research has been supported by a grant from the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program. Although the research described in the article has been funded wholly or in part by the U.S. Environmental Protection Agency's STAR program through grant RD83457702, it has not been subjected to any EPA review and therefore does not necessarily reflect the views of the Agency, and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Chahine T, 2011, SOC SCI MED, V73, P752, DOI 10.1016/j.socscimed.2011.06.032; Choi AL, 2006, ENVIRON HEALTH PERSP, V114, P1092, DOI 10.1289/ehp.8827; Committee on Improving Risk Analysis Approaches Used by the U.S. EPA, 2008, SCI DEC ADV RISK ASS; Committee on the Health Risks of Phthalates National Research Council, 2008, PHTHAL CUM RISK ASS; Hanaoka K, 2007, COMPUT ENVIRON URBAN, V31, P162, DOI 10.1016/j.compenvurbsys.2006.06.003; Harland K, 2012, JASSS-J ARTIF SOC S, V15; Hermes K, 2012, COMPUT ENVIRON URBAN, V36, P281, DOI 10.1016/j.compenvurbsys.2012.03.005; Hermes K, 2012, HEALTH PLACE, V18, P630, DOI 10.1016/j.healthplace.2011.12.010; Korrick SA, 2000, J EXPO ANAL ENV EPID, V10, P743, DOI 10.1038/sj.jea.7500120; Mahaffey KR, 2009, ENVIRON HEALTH PERSP, V117, P47, DOI 10.1289/ehp.11674; Massachusetts Community Health Information Profile, 2010, SMOK REP NEW BEDF; Massachusetts Department of Public Health, 2009, BRFSS SPEC REP CHRON; Massachusetts Department of Public Health, 2009, MASSCHIP KIDS COUNT; Massachusetts Department of Public Health, 2009, BRFSS SPEC REP RISK; Miranda ML, 2002, ENVIRON HEALTH PERSP, V110, P947, DOI 10.1289/ehp.02110947; Sagiv SK, 2008, ENVIRON HEALTH PERSP, V116, P666, DOI 10.1289/ehp.10553; Sagiv SK, 2007, EPIDEMIOLOGY, V18, P120, DOI 10.1097/01.ede.0000249769.15001.7c; Sexton K, 2011, AM J PUBLIC HEALTH, V101, pS81, DOI 10.2105/AJPH.2011.300118; Smith DM, 2011, HEALTH PLACE, V17, P618, DOI 10.1016/j.healthplace.2011.01.001; U.S EPA (United States Environmental Protection Agency), 2003, EPA630P02001F RISK A; US Environmental Protection Agency, 2009, ENVIROMAPPER; Williamson P, 1998, ENVIRON PLANN A, V30, P785, DOI 10.1068/a300785; Williamson P., 2007, 20071 U LIV DEP GEOG	24	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87144	10.1371/journal.pone.0087144	http://dx.doi.org/10.1371/journal.pone.0087144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489855	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000111
J	Lombardo, FL; Maggini, M; De Bellis, A; Seghieri, G; Anichini, R				Lombardo, Flavia L.; Maggini, Marina; De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto			Lower Extremity Amputations in Persons with and without Diabetes in Italy: 2001-2010	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; FOOT CARE; DECREASING INCIDENCE; MAJOR AMPUTATIONS; POPULATION; PEOPLE; INDIVIDUALS; REDUCTION; ENGLAND; DISEASE	Objective: To analyze hospitalization for lower extremity amputations (LEAs) and amputee rates in persons with and without diabetes in Italy. Research Design and Methods: All patients with LEAs in the period 2001-2010 were identified analyzing the National Hospital Discharge Record database. For each year, amputee and hospitalization rates for LEAs were calculated either for persons with diabetes or without. Time trend for major and minor amputations were analysed. Results: From 2001 to 2010 a mean annual number of 11,639 individuals underwent a lower extremity amputation: 58.6% had diabetes accounting for 60.7% of total hospitalizations. In 2010, the crude amputee rate for LEAs was 20.4 per 100,000 inhabitants: 247.2 for 100.000 persons with diabetes, and 8.6 for those without diabetes. Having diabetes was associated to an increased risk of amputation (Poisson estimated RR 10.9, 95% CI 9.4-12.8). Over the whole period, a progressive reduction of amputee rates was observed for major amputations either among persons with diabetes (-30.7%) or without diabetes (-12.5%), while the rates of minor amputations increased progressively (+22.4%) among people without diabetes and were nearly stable in people with diabetes (-4.6%). A greater number of minor amputations were performed among persons with than without diabetes: in 2010, the minor-to-major ratio among persons with diabetes (2.5) was more than twice than in those without diabetes (1.0). Conclusions: The nationwide analyses confirm a progressive reduction of hospitalization and amputee rates for major LEAs, suggesting an earlier and more diffuse approach aimed at limb salvage.	[Lombardo, Flavia L.; Maggini, Marina] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto] Gen Hosp Pistoia, Dept Internal Med, Diabet Unit, Pistoia, Italy; [De Bellis, Alessandra; Seghieri, Giuseppe; Anichini, Roberto] Gen Hosp Pistoia, Dept Internal Med, Diabet Foot Unit, Pistoia, Italy	Istituto Superiore di Sanita (ISS)	Anichini, R (corresponding author), Gen Hosp Pistoia, Dept Internal Med, Diabet Unit, Pistoia, Italy.	r.anichini@usl3.toscana.it	anichini, roberto/U-4181-2017; SEGHIERI, GIUSEPPE/AAF-1161-2019; Lombardo, Flavia/AAA-9723-2021	anichini, roberto/0000-0002-8227-9388; SEGHIERI, GIUSEPPE/0000-0002-7599-4455; Lombardo, Flavia Lucia/0000-0001-6183-0735				Anichini R, 2007, DIABETES RES CLIN PR, V75, P153, DOI 10.1016/j.diabres.2006.05.014; [Anonymous], 1990, Diabet Med, V7, P360; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Buckley CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041492; Faglia E, 2002, J INTERN MED, V252, P225, DOI 10.1046/j.1365-2796.2002.01015.x; Faglia E, 2009, DIABETES CARE, V32, P822, DOI 10.2337/dc08-1223; Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x; Graziani L, 2010, CATHETER CARDIO INTE, V75, P433, DOI 10.1002/ccd.22287; Holstein P, 2000, DIABETOLOGIA, V43, P844, DOI 10.1007/s001250051459; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Jeffcoate WJ, 2005, ACTA CHIR BELG, V105, P140, DOI 10.1080/00015458.2005.11679687; Jeffcoate WJ, 2004, DIABETOLOGIA, V47, P2051, DOI 10.1007/s00125-004-1584-3; Krishnan S, 2008, DIABETES CARE, V31, P99, DOI 10.2337/dc07-1178; LARSSON J, 1995, DIABETIC MED, V12, P770, DOI 10.1111/j.1464-5491.1995.tb02078.x; Layden J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4947; Li YF, 2012, DIABETES CARE, V35, P273, DOI 10.2337/dc11-1360; Lopez-de-Andres A, 2011, DIABETES CARE, V34, P1570, DOI 10.2337/dc11-0077; Lupattelli T, 2010, J ENDOVASC THER, V17, P366, DOI 10.1583/09-2960.1; Manzi M, 2012, J ENDOVASC THER, V19, P461, DOI 10.1583/12-3854L12-3867L12-3867L.461; Margolis DJ, 2011, DATA POINTS PUBLICAT; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; Moxey PW, 2010, BRIT J SURG, V97, P1348, DOI 10.1002/bjs.7092; Rayman G, 2004, DIABETES CARE, V27, P1892, DOI 10.2337/diacare.27.8.1892; Romagnoli F, 2003, DIABETES NUTR METAB, V16, P155; Schofield CJ, 2009, DIABETIC MED, V26, P773, DOI 10.1111/j.1464-5491.2009.02770.x; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; Vaccaro O, 2002, NUTR METAB CARDIOVAS, V12, P331; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; van Battum P, 2011, DIABETIC MED, V28, P199, DOI 10.1111/j.1464-5491.2010.03192.x; van Houtum WH, 2004, DIABETES CARE, V27, P1042, DOI 10.2337/diacare.27.5.1042; Werneck CCF, 2009, ANN VASC SURG, V23, P554, DOI 10.1016/j.avsg.2009.05.007	32	85	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86405	10.1371/journal.pone.0086405	http://dx.doi.org/10.1371/journal.pone.0086405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489723	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000049
J	Tsai, JC; Lin, YW; Huang, CY; Lin, CY; Tsai, YT; Shih, CM; Lee, CY; Chen, YH; Li, CY; Chang, NC; Lin, FY; Tsai, CS				Tsai, Jui-Chi; Lin, Yi-Wen; Huang, Chun-Yao; Lin, Chih-Yuan; Tsai, Yi-Ting; Shih, Chun-Min; Lee, Chung-Yi; Chen, Yung-Hsiang; Li, Chi-Yuan; Chang, Nen-Chung; Lin, Feng-Yen; Tsai, Chien-Sung			The Role of Calpain-Myosin 9-Rab7b Pathway in Mediating the Expression of Toll-Like Receptor 4 in Platelets: A Novel Mechanism Involved in alpha-Granules Trafficking	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; THROMBIN RECEPTOR; ACTIVATED PLATELETS; LIPOPOLYSACCHARIDE; TLR4; AGGREGATION; KINASE; PHOSPHORYLATION; THROMBOCYTOPENIA; LOCALIZATION	Toll-like receptors (TLRs) plays a critical role in innate immunity. In 2004, Aslam R. and Shiraki R. first determined that murine and human platelets express functional TLRs. Additionally, Andonegui G. demonstrated that platelets express TLR4, which contributes to thrombocytopenia. However, the underlying mechanisms of TLR4 expression by platelets have been rarely explored until now. The aim of this study was to identify the mechanism of TLR4 expression underlying thrombin treatment. The human washed platelets were used in this study. According to flowcytometry and western blot analysis, the surface levels of TLR4 were significantly enhanced in thrombin-activated human platelets and decreased by TMB-8, calpeptin, and U73122, but not Y27632 (a Rho-associated protein kinase ROCK inhibitor) indicating that thrombin-mediated TLR4 expression was modulated by PAR/PLC pathway, calcium and calpain. Co-immunoprecipitation (co-IP) assay demonstrated that the interaction between TLR4 and myosin-9 (a substrate of calpain) was regulated by calpain; cleavage of myosin-9 enhanced TLR4 expression in thrombin treated platelets. Transmission electron microscope data indicated that human platelets used alpha-granules to control TLR4 expression; the co-IP experiment suggested that myosin-9 did not coordinate with Rab7b to negatively regulate TLR4 trafficking in thrombin treated platelets. In summary, phospholipase C gamma-calpain-myosin 9-Rab7b axis was responsible for the mechanism underlying the regulation of TLR4 containing alpha-granules trafficking in thrombin-stimulated platelets, which was involved in coagulation.	[Tsai, Jui-Chi] Triserv Gen Hosp, Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Yi-Wen; Lin, Chih-Yuan; Tsai, Yi-Ting; Lee, Chung-Yi; Tsai, Chien-Sung] Triserv Gen Hosp, Div Cardiovasc Surg, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Jui-Chi; Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ Hosp, Div Cardiol, Taipei, Taiwan; [Huang, Chun-Yao; Shih, Chun-Min; Chang, Nen-Chung; Lin, Feng-Yen] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, FY (corresponding author), Taipei Med Univ, Dept Internal Med, Taipei, Taiwan.	g870905@tmu.edu.tw; sung1500@mail.ndmctsgh.edu.tw	Chen, Yung-Hsiang/K-6766-2015	Chen, Yung-Hsiang/0000-0002-8756-5113; Li, Chi-Yuan/0000-0003-3390-7568	National Science Council [NSC 97-2314-B-038-035-MY2, NSC 101-2314-B-038-041-MY3, NSC 101-2314-B-016-007-MY2]; National Defense Medical Center, Taiwan [TSGH-C98-25]	National Science Council(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Taiwan	This work was supported by the National Science Council (NSC 97-2314-B-038-035-MY2, NSC 101-2314-B-038-041-MY3 and NSC 101-2314-B-016-007-MY2) and partial by the National Defense Medical Center (TSGH-C98-25), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2003, J ENDOTOXIN RES, V9, P322, DOI 10.1179/096805103225002593; Althaus K, 2009, SEMIN THROMB HEMOST, V35, P189, DOI 10.1055/s-0029-1220327; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Aslam R, 2004, PLATELETS, V15, P267; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BRASS LF, 1992, J BIOL CHEM, V267, P13795; Bucci Cecilia, 2010, Commun Integr Biol, V3, P401, DOI 10.4161/cib.3.5.12341; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cognasse F, 2008, BRIT J HAEMATOL, V141, P84, DOI 10.1111/j.1365-2141.2008.06999.x; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; ISHII H, 1991, DIABETOLOGIA, V34, P332, DOI 10.1007/BF00405005; Jayachandran M, 2007, J APPL PHYSIOL, V102, P429, DOI 10.1152/japplphysiol.01576.2005; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kato H, 2008, ARCH BIOCHEM BIOPHYS, V475, P80, DOI 10.1016/j.abb.2008.04.023; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Lin YW, 2011, INT J ANDROL, V34, pE368, DOI 10.1111/j.1365-2605.2010.01130.x; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; ODA M, 1985, J LIPID RES, V26, P1294; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Randriamboavonjy V, 2010, ADV PHARMACOL, V59, P235, DOI 10.1016/S1054-3589(10)59008-2; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Semple JW, 2007, BLOOD, V109, P4803, DOI 10.1182/blood-2006-12-062695; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; Solum NO, 1999, ARTERIOSCL THROM VAS, V19, P2841, DOI 10.1161/01.ATV.19.12.2841; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stohlawetz P, 1999, THROMB HAEMOSTASIS, V81, P613; Tavener SA, 2004, CIRC RES, V95, P700, DOI 10.1161/01.RES.0000144175.70140.8c; Tokuda H, 2012, INT J MOL MED, V30, P1387, DOI 10.3892/ijmm.2012.1146; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191; Yuan YP, 1997, J BIOL CHEM, V272, P21847, DOI 10.1074/jbc.272.35.21847; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884	55	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85833	10.1371/journal.pone.0085833	http://dx.doi.org/10.1371/journal.pone.0085833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489676	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000021
J	van de Ven, G; Draskovic, I; van Herpen, E; Koopmans, RTCM; Donders, R; Zuidema, SU; Adang, EMM; Vernooij-Dassen, MJFJ				van de Ven, Geertje; Draskovic, Irena; van Herpen, Elke; Koopmans, Raymond T. C. M.; Donders, Rogier; Zuidema, Sytse U.; Adang, Eddy M. M.; Vernooij-Dassen, Myrra J. F. J.			The Economics of Dementia-Care Mapping in Nursing Homes: A Cluster-Randomised Controlled Trial	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; INTERVENTIONS; FACILITIES; AGITATION; EFFICACY; QUALITY; FALLS	Background: Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric symptoms in people with dementia in nursing homes. Alongside an 18-month cluster-randomized controlled trial in which we studied the effectiveness of DCM on residents and staff outcomes, we investigated differences in costs of care between DCM and usual care in nursing homes. Methods: Dementia special care units were randomly assigned to DCM or usual care. Nurses from the intervention care homes received DCM training, a DCM organizational briefing day and conducted the 4-months DCM-intervention twice during the study. A single DCM cycle consists of observation, feedback to the staff, and action plans for the residents. We measured costs related to health care consumption, falls and psychotropic drug use at the resident level and absenteeism at the staff level. Data were extracted from resident files and the nursing home records. Prizes were determined using the Dutch manual of health care cost and the cost prices delivered by a pharmacy and a nursing home. Total costs were evaluated by means of linear mixed-effect models for longitudinal data, with the unit as a random effect to correct for dependencies within units. Results: 34 units from 11 nursing homes, including 318 residents and 376 nursing staff members participated in the cost analyses. Analyses showed no difference in total costs. However certain changes within costs could be noticed. The intervention group showed lower costs associated with outpatient hospital appointments over time (p = 0.05) than the control group. In both groups, the number of falls, costs associated with the elderly-care physician and nurse practitioner increased equally during the study (p<0.02). Conclusions: DCM is a cost-neutral intervention. It effectively reduces outpatient hospital appointments compared to usual care. Other considerations than costs, such as nursing homes' preferences, may determine whether they adopt the DCM method.	[van de Ven, Geertje; Draskovic, Irena; van Herpen, Elke; Koopmans, Raymond T. C. M.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Donders, Rogier; Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Zuidema, Sytse U.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Kalorama Fdn, Beek Ubbergen, Gelderland, Netherlands; [van de Ven, Geertje; Draskovic, Irena; Koopmans, Raymond T. C. M.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Alzheimer Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen	van de Ven, G (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	G.vandeVen@elg.umcn.nl	Donders, A.R.T./L-4277-2015; Koopmans, R.T.C.M./H-8062-2014; Vernooij-Dassen, M.J.F.J./H-8107-2014; Adang, E.M.M./L-4169-2015; Draskovic, Irena/GZG-9712-2022	Donders, A.R.T./0000-0002-0484-1419; Draskovic, Irena/0000-0002-1677-5543	The Netherlands Organization for Health Research and Development (ZonMw)	The Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Netherlands Organization for Health Research and Development (ZonMw) funded this study. The funding bodies financially supported GV and ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ballard C, 2002, INT J GERIATR PSYCH, V17, P140, DOI 10.1002/gps.543; Bostick JE, 2006, J AM MED DIR ASSOC, V7, P366, DOI 10.1016/j.jamda.2006.01.024; Brooker D, 1998, AGING MENT HEALTH, V2, P60, DOI 10.1080/13607869856957; Brooker D., 2004, WHAT IS PERSONCENTRE, V13, P215, DOI [DOI 10.1017/S095925980400108X, 10.1017/S095925980400108X]; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Cohen-Mansfield J, 2012, J CLIN PSYCHIAT, V73, P1255, DOI 10.4088/JCP.12m07918; Dijcks BPJ, 2005, NED TIJDSCHR GENEES, V149, P1043; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hoekstra J, 2008, KOSTEN ZIEKTEN NEDER; Kitwood T, 1998, J CLIN ETHIC, V9, P23; Kitwood Tom, 1992, Ageing Soc, V12, P269, DOI 10.1017/S0144686X0000502X; Neyens JC, 2011, J AM MED DIR ASSOC, V12, P410, DOI 10.1016/j.jamda.2010.07.018; Perry M, 2010, J CLIN EPIDEMIOL, V63, P1118, DOI 10.1016/j.jclinepi.2009.11.014; Ribbe MW, 1997, AGE AGEING, V26, P3, DOI 10.1093/ageing/26.suppl_2.3; Rokstad AMM, 2013, DEMENT GERIATR COGN, V36, P340, DOI 10.1159/000354366; Rovner BW, 1996, J AM GERIATR SOC, V44, P7, DOI 10.1111/j.1532-5415.1996.tb05631.x; van de Ven G, 2012, J AM GERIATR SOC, V12, P1; van de Ven G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067325; Wetzels RB, 2011, INT PSYCHOGERIATR, V23, P1249, DOI 10.1017/S1041610211000755; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Zuidema S, 2007, J GERIATR PSYCH NEUR, V20, P41, DOI 10.1177/0891988706292762	22	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86662	10.1371/journal.pone.0086662	http://dx.doi.org/10.1371/journal.pone.0086662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489762	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000070
J	Cunha, HA; Medeiros, BV; Barbosa, LA; Cremer, MJ; Marigo, J; Lailson-Brito, J; Azevedo, AF; Sole-Cava, AM				Cunha, Haydee A.; Medeiros, Bruna V.; Barbosa, Lupercio A.; Cremer, Marta J.; Marigo, Juliana; Lailson-Brito, Jose; Azevedo, Alexandre F.; Sole-Cava, Antonio M.			Population Structure of the Endangered Franciscana Dolphin (Pontoporia blainvillei): Reassessing Management Units	PLOS ONE			English	Article							INCIDENTALLY CAUGHT; GENETIC-STRUCTURE; SOUTHERN BRAZIL; CONSERVATION; CETACEA; EVOLUTION; ABUNDANCE; SOFTWARE; ECOLOGY	Franciscanas are the most endangered dolphins in the Southwestern Atlantic. Due to their coastal and estuarine habits, franciscanas suffer from extensive fisheries bycatch, as well as from habitat loss and degradation. Four Franciscana Management Areas (FMA), proposed based on biology, demography, morphology and genetic data, were incorporated into management planning and in the delineation of research efforts. We re-evaluated that proposal through the analysis of control region sequences from franciscanas throughout their distribution range (N = 162), including novel sequences from the northern limit of the species and two other previously unsampled localities in Brazil. A deep evolutionary break was observed between franciscanas from the northern and southern portions of the species distribution, indicating that they must be managed as two Evolutionarily Significant Units (ESU). Furthermore, additional FMAs should be recognised to accommodate the genetic differentiation found in each ESU. These results have immediate consequences for the conservation and management of this endangered species.	[Cunha, Haydee A.; Medeiros, Bruna V.; Sole-Cava, Antonio M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, Brazil; [Cunha, Haydee A.; Lailson-Brito, Jose; Azevedo, Alexandre F.] Univ Estado Rio de Janeiro, Fac Oceanografia, Lab Mamiferos Aquat & Bioindicadores, BR-20550011 Rio De Janeiro, Brazil; [Barbosa, Lupercio A.] Org Consciencia Ambiental, Vila Velha, ES, Brazil; [Cremer, Marta J.] Univ Regiao Joinville, Dept Ciencias Biol, Joinville, SC, Brazil; [Marigo, Juliana] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Patol Comparada Anim Selvagen, Sao Paulo, Brazil; [Marigo, Juliana] Projeto Biopesca, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade da Regiao de Joinville; Universidade de Sao Paulo	Cunha, HA (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Biodiversidade Mol, Rio De Janeiro, Brazil.	haydeecunha@yahoo.com.br	Cunha, Haydee/O-1940-2017; Azevedo, Alexandre/B-9660-2013; Cremer, Marta/T-2653-2019; Sole-Cava, Antonio M/G-4209-2011; AZEVEDO, ALEXANDRE/HII-5648-2022; Brito, Jose Lailson/B-3572-2013	Azevedo, Alexandre/0000-0002-3754-9035; Cremer, Marta/0000-0003-3521-1409; Sole-Cava, Antonio M/0000-0003-0363-5821; Brito, Jose Lailson/0000-0001-8366-458X; Marigo, Juliana/0000-0002-3279-2909; Vieira de Medeiros, Bruna/0000-0002-8830-0053	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was financially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/Brazil (www.cnpq.br) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MB, 2012, ENVIRON POLLUT, V170, P152, DOI 10.1016/j.envpol.2012.06.001; Alonso MB, 2012, ENVIRON INT, V47, P99, DOI 10.1016/j.envint.2012.06.010; Azevedo Alexandre F., 2002, Latin American Journal of Aquatic Mammals, V1, P191; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbato BHA, 2012, J MAR BIOL ASSOC UK, V92, P1645, DOI 10.1017/S0025315411000725; Barbosa, 2003, LAT AM J AQUAT MAMM, V2, P57, DOI DOI 10.5597/LAJAM00033; Bastida R, 2007, MAMIFEROS ACUATICOS; Bertozzi Carolina P., 2002, Latin American Journal of Aquatic Mammals, V1, P153; Botta S, 2010, J MAR BIOL ASSOC UK, V90, P1493, DOI 10.1017/S0025315410001141; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Costa-Urrutia P, 2012, J HERED, V103, P92, DOI 10.1093/jhered/esr103; Crespo EA, 2002, ENCY MARINE MAMMALS, P484; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; Crespo Enrique Alberto, 1994, Reports of the International Whaling Commission Special Issue, V15, P269; Danilewicz D, 2010, J MAR BIOL ASSOC UK, V90, P1649, DOI 10.1017/S0025315409991482; Danilewicz D, 2009, J MAR BIOL ASSOC UK, V89, P943, DOI 10.1017/S002531540900054X; Di Beneditto Ana Paula Madeira, 2003, Latin American Journal of Aquatic Mammals, V2, P79; Di Beneditto APM, 1998, BRAZ ARCH BIOL TECHN, V41, P296; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gago-Ferrero P, 2013, ENVIRON SCI TECHNOL, V47, P5619, DOI 10.1021/es400675y; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kajiwara N, 2004, ARCH ENVIRON CON TOX, V46, P124, DOI 10.1007/s00244-003-2239-y; KINAS PG, 2002, LATIN AM J AQUATIC M, V1, P43; Lailson-Brito J, 2007, ORGANOHALOGEN COMPOU, V69, P1741; Lailson-Brito J, 2011, CHEMOSPHERE, V84, P882, DOI 10.1016/j.chemosphere.2011.06.018; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Moreno Ignacio B., 2003, Latin American Journal of Aquatic Mammals, V2, P131; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Netto Ricardo de Freitas, 2007, Boletim do Museu de Biologia Mello Leitao, V21, P35; Ott P.H., 2002, THESIS U FEDERAL RIO; Ott PH, 2008, 13 REUN TRAB ESP MAM, P81; Pinedo MC, 1991, THESIS U CALIFORNIA; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Praderi R, 1997, 2 ENC COORD PESQ MAN, P42; Ramos Renata M.A., 2002, Latin American Journal of Aquatic Mammals, V1, P129; Rocha-Campos C.C, 2010, PLANO ACAO NACL CONS; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Ryman N., 1987, POPULATION GENETICS; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Secchi E.R., 2006, THESIS U OTAGO DUNED; Secchi Eduardo R., 2003, Journal of Cetacean Research and Management, V5, P61; Secchi ER, 2010, WILDL PROT DESTR EXT, P301; Secchi ER, 2010, WILDL PROT DESTR EXT, P323; Secchi Eduardo R., 1997, Report of the International Whaling Commission, V47, P653; Secchi Eduardo R., 2004, Latin American Journal of Aquatic Mammals, V3, P61; Secchi ER, 1998, CAN J ZOOL, V76, P1622, DOI 10.1139/cjz-76-9-1622; Secchi ER, 2001, LAT AM J AQUAT MAMM, V1, P11; Siciliano Salvatore, 1994, Reports of the International Whaling Commission Special Issue, V15, P241; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Panebianco MV, 2012, ANIM REPROD SCI, V131, P41, DOI 10.1016/j.anireprosci.2012.02.005; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x	59	40	43	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85633	10.1371/journal.pone.0085633	http://dx.doi.org/10.1371/journal.pone.0085633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497928	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900010
J	Hung, JE; Fogle, EJ; Garg, N; Chekan, JR; Nair, SK; van der Donk, WA				Hung, John E.; Fogle, Emily J.; Garg, Neha; Chekan, Jonathan R.; Nair, Satish K.; van der Donk, Wilfred A.			Chemical Rescue and Inhibition Studies to Determine the Role of Arg301 in Phosphite Dehydrogenase	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; BAEYER-VILLIGER MONOOXYGENASES; L-ASPARTATE OXIDASE; ACTIVE-SITE; GUANIDINE DERIVATIVES; IMP DEHYDROGENASE; STEADY-STATE; ARGININE; ENZYME; RESIDUES	Phosphite dehydrogenase (PTDH) catalyzes the NAD(+)-dependent oxidation of phosphite to phosphate. This reaction requires the deprotonation of a water nucleophile for attack on phosphite. A crystal structure was recently solved that identified Arg301 as a potential base given its proximity and orientation to the substrates and a water molecule within the active site. Mutants of this residue showed its importance for efficient catalysis, with about a 100-fold loss in k(cat) and substantially increased K-m,K-phosphite for the Ala mutant (R301A). The 2.35 angstrom resolution crystal structure of the R301A mutant with NAD(+) bound shows that removal of the guanidine group renders the active site solvent exposed, suggesting the possibility of chemical rescue of activity. We show that the catalytic activity of this mutant is restored to near wild-type levels by the addition of exogenous guanidinium analogues; Bronsted analysis of the rates of chemical rescue suggests that protonation of the rescue reagent is complete in the transition state of the rate-limiting step. Kinetic isotope effects on the reaction in the presence of rescue agents show that hydride transfer remains at least partially rate-limiting, and inhibition experiments show that K-i of sulfite with R301A is similar to 400-fold increased compared to the parent enzyme, similar to the increase in K-m for phosphite in this mutant. The results of our experiments indicate that Arg301 plays an important role in phosphite binding as well as catalysis, but that it is not likely to act as an active site base.	[Hung, John E.; Fogle, Emily J.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Garg, Neha; Chekan, Jonathan R.; Nair, Satish K.; van der Donk, Wilfred A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	vddonk@illinois.edu	Garg, Neha/L-3120-2018; Chekan, Jonathan/AAN-8499-2020; Nair, Satish/AAY-2510-2021; van der Donk, Wilfred/K-2961-2015	Garg, Neha/0000-0002-2760-7123; van der Donk, Wilfred/0000-0002-5467-7071; Chekan, Jonathan/0000-0003-4651-0594	National Science Foundation [NSF 0822536]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF 0822536 to WAvdD). WAvdD is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berkowitz O, 2011, ANAL BIOCHEM, V412, P74, DOI 10.1016/j.ab.2011.01.014; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Cook P. F., 2007, ENZYME KINETICS MECH; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Fogle EJ, 2007, BIOCHEMISTRY-US, V46, P13101, DOI 10.1021/bi701550c; Goedl C, 2008, FEBS J, V275, P903, DOI [10.1111/j.1742-4658.2008.06254.x, 10.1111/j.1742-4658.2007.06254.x]; Hansch C, 1979, SUBSTITUENT CONSTANT; HARPEL MR, 1994, BIOCHEMISTRY-US, V33, P5553, DOI 10.1021/bi00184a026; Hedstrom L, 2006, CURR OPIN CHEM BIOL, V10, P520, DOI 10.1016/j.cbpa.2006.08.005; Hirota R, 2012, J BIOSCI BIOENG, V113, P445, DOI 10.1016/j.jbiosc.2011.11.027; Hung JE, 2012, BIOCHEMISTRY-US, V51, P4254, DOI 10.1021/bi201691w; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Johannes TW, 2005, APPL ENVIRON MICROB, V71, P5728, DOI 10.1128/AEM.71.10.5728-5734.2005; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KLINMAN JP, 1985, J AM CHEM SOC, V107, P1058, DOI 10.1021/ja00290a052; Leatherbarrow RJ, 2009, GRAFIT VERSION 7 7 0; Lehoux IE, 2000, BIOCHEMISTRY-US, V39, P10055, DOI 10.1021/bi000161f; Liu DF, 2012, APPL BIOCHEM BIOTECH, V166, P1301, DOI 10.1007/s12010-011-9518-2; Martinez A, 2012, ENVIRON MICROBIOL, V14, P1363, DOI 10.1111/j.1462-2920.2011.02612.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pazmino DET, 2008, ANGEW CHEM INT EDIT, V47, P2275, DOI 10.1002/anie.200704630; Pazmino DET, 2009, CHEMBIOCHEM, V10, P2595, DOI 10.1002/cbic.200900480; Perrin DD, 1965, INT UNION PURE APPL; Relyea HA, 2005, BIOCHEMISTRY-US, V44, P6640, DOI 10.1021/bi047640p; Rioz-Martinez A, 2011, ORG BIOMOL CHEM, V9, P1337, DOI 10.1039/c0ob00988a; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; Sanchez-Torres P, 2003, BIOCHEM J, V370, P331, DOI 10.1042/BJ20021071; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P16695, DOI 10.1021/bi051603w; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; van Beek HL, 2012, CHEM COMMUN, V48, P3288, DOI 10.1039/c2cc17656d; van der Kamp MW, 2008, CHEM COMMUN, P1874, DOI 10.1039/b800496j; Vrtis JM, 2001, J AM CHEM SOC, V123, P2672, DOI 10.1021/ja004301k; Vrtis JM, 2002, ANGEW CHEM INT EDIT, V41, P3257, DOI 10.1002/1521-3773(20020902)41:17<3257::AID-ANIE3257>3.0.CO;2-N; Woodyer R, 2003, BIOCHEMISTRY-US, V42, P11604, DOI 10.1021/bi035018b; Woodyer R, 2005, BIOCHEMISTRY-US, V44, P4765, DOI 10.1021/bi047868c; Zou YZ, 2012, BIOCHEMISTRY-US, V51, P4263, DOI 10.1021/bi2016926	48	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87134	10.1371/journal.pone.0087134	http://dx.doi.org/10.1371/journal.pone.0087134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498026	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900069
J	Kojima, K; April, C; Canasto-Chibuque, C; Chen, XT; Deshmukh, M; Venkatesh, A; Tan, PS; Kobayashi, M; Kumada, H; Fan, JB; Hoshida, Y				Kojima, Kensuke; April, Craig; Canasto-Chibuque, Claudia; Chen, Xintong; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Kobayashi, Masahiro; Kumada, Hiromitsu; Fan, Jian-Bing; Hoshida, Yujin			Transcriptome Profiling of Archived Sectioned Formalin-Fixed Paraffin-Embedded (AS-FFPE) Tissue for Disease Classification	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; HEPATOCELLULAR-CARCINOMA; CANCER	Background: Archived tissues from previously completed prospective trials represent invaluable resource for biomarker development. However, such specimens are often stored as sections on glass slides, in which RNA is severely degraded due to prolonged air exposure. We evaluated whether a proportion of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissues yield transcriptome profiles comparable to freshly cut (FC) FFPE tissues, which can be used for retrospective class prediction analysis. Methods: Genome-wide transcriptome profiles of 6 to 7-year-old AS-FFPE tissue sections (generated from 5 to 16-year-old blocks) of 83 hepatocellular carcinoma (HCC) and 47 liver cirrhosis samples were generated by using whole-genome DASL assay (Illumina) and digital transcript counting (nCounter) assay (NanoString), and gene signature-based prediction of HCC subclasses and prognosis was compared with previously generated FC-FFPE profiles from the same tissue blocks. Results: RNA quality and assay reproducibility of AS-FFPE RNA were comparable to intermediate to poor quality FC-FFPE samples (RNA Integrity Number: up to 2.50, R-square for technical replicates: up to 0.93). Analyzable transcriptome profiles were obtained in 64 (77%) HCC and 36 (77%) cirrhosis samples. Statistically more confident predictions based on random resampling-based method (nearest template prediction) were obtained in 37 (58%) HCC and 13 (36%) cirrhosis samples. Predictions made in FC-FFPE profiles were reproduced in 36 (97%) HCC and 11 (85%) cirrhosis AS-FFPE profiles. nCounter assay was tested in 24 cirrhosis samples, which yielded confident prediction in 15 samples (63%), of which 10 samples (67%) showed concordant predictions with FC-FFPE profiles. Conclusions: AS-FFPE tissues yielded poorer quality RNA and transcriptome profiles compared to FC-FFPE tissues. Statistically more confident class prediction was feasible in 37 of 83 HCC samples and 13 of 47 cirrhosis samples. These results suggest that AS-FFPE tissues can be regarded as a resource for retrospective transcriptome-based class prediction analysis when they are the only available materials.	[Kojima, Kensuke; Canasto-Chibuque, Claudia; Chen, Xintong; Deshmukh, Manjeet; Venkatesh, Anu; Tan, Poh Seng; Hoshida, Yujin] Icahn Sch Med Mt Sinai, Liver Canc Program, Tisch Canc Inst, Div Liver Dis,Dept Med, New York, NY 10029 USA; [April, Craig; Fan, Jian-Bing] Illumina Inc, San Diego, CA USA; [Kobayashi, Masahiro; Kumada, Hiromitsu] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan	Icahn School of Medicine at Mount Sinai; Illumina; Toranomon Hospital	Hoshida, Y (corresponding author), Icahn Sch Med Mt Sinai, Liver Canc Program, Tisch Canc Inst, Div Liver Dis,Dept Med, New York, NY 10029 USA.	yujin.hoshida@mssm.edu	Chen, Xintong/I-4800-2019; Hoshida, Yujin/R-7513-2019	Chen, Xintong/0000-0002-2536-165X; 	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK099558]; European Commission-FP7 Framework (HEPTROMIC) [259744]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099558] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Commission-FP7 Framework (HEPTROMIC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	YH is supported by National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK099558) and European Commission-FP7 Framework (HEPTROMIC, No. 259744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Korbler T, 2003, EXP MOL PATHOL, V74, P336, DOI 10.1016/S0014-4800(03)00024-8; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Minguez B, 2011, J HEPATOL, V55, P1325, DOI 10.1016/j.jhep.2011.02.034; Nault JC, 2013, GASTROENTEROLOGY, V145, P176, DOI 10.1053/j.gastro.2013.03.051; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; RHEE Y, 1995, NUCLEIC ACIDS RES, V23, P3275, DOI 10.1093/nar/23.16.3275; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Tanabe KK, 2013, ANN SURG ONCOL, V20, P3707, DOI 10.1245/s10434-013-3071-x; Toffanin S, 2011, GASTROENTEROLOGY, V140, P1618, DOI 10.1053/j.gastro.2011.02.009; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waldron L, 2012, CLIN CANCER RES, V18, P6136, DOI 10.1158/1078-0432.CCR-12-1915; WORKMAN C, 2002, GENOME BIOL, V0003; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865	32	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86961	10.1371/journal.pone.0086961	http://dx.doi.org/10.1371/journal.pone.0086961			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498002	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100042
J	Park, HK; Jung, JW; Cho, SH; Min, KU; Kang, HR				Park, Han-Ki; Jung, Jae-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun			What Makes a Difference in Exercise-Induced Bronchoconstriction: An 8 Year Retrospective Analysis	PLOS ONE			English	Article							INDUCED ASTHMA; INDUCED BRONCHOSPASM; BRONCHIAL RESPONSIVENESS; COLD-AIR; METHACHOLINE; CHALLENGE; CHILDREN; PATHOGENESIS; SENSITIVITY; MECHANISMS	Background: Exercise-induced bronchoconstriction (EIB) was recently classified into EIB alone and EIB with asthma, based on the presence of concurrent asthma. Objective: Differences between EIB alone and EIB with asthma have not been fully described. Methods: We retrospectively reviewed who visited an allergy clinic for respiratory symptoms after exercise and underwent exercise bronchial provocation testing. More than a 15% decrease of forced expiratory volume in 1 second (FEV1) from baseline to the end of a 6 min free-running challenge test was interpreted as positive EIB. Results: EIB was observed in 66.9% of the study subjects (89/133). EIB-positive subjects showed higher positivity to methacholine provocation testing (61.4% vs. 18.9%, p<0.001) compared with EIB-negative subjects. In addition, sputum eosinophilia was more frequently observed in EIB-positive subjects than in EIB-negative subjects (56% vs. 23.5%, p = 0.037). The temperature and relative humidity on exercise test day were significantly related with the EIB-positive rate. Positive EIB status was correlated with both temperature (p = 0.001) and relative humidity (p = 0.038) in the methacholine-negative EIB group while such a correlation was not observed in the methacholine-positive EIB group. In the methacholine-positive EIB group the time to reach a 15% decrease in FEV1 during exercise was significantly shorter than that in the methacholine-negative EIB group (3.2 +/- 0.7 min vs. 8.6 +/- 1.6 min, p = 0.004). Conclusions: EIB alone may be a distinct clinical entity from EIB with asthma. Conditions such as temperature and humidity should be considered when performing exercise tests, especially in subjects with EIB alone.	[Park, Han-Ki; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Park, Han-Ki; Jung, Jae-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Jung, Jae-Woo] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital	Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	helenmed@snu.ac.kr	Park, Han-Ki/AAY-3102-2020; Park, Heung-Woo/AAW-7690-2020	Park, Heung-Woo/0000-0002-6970-3228; Park, Han-Ki/0000-0002-5460-9917	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 2012, J ASTHMA, V49, P480, DOI 10.3109/02770903.2012.676123; Anderson SD, 2008, J ALLERGY CLIN IMMUN, V122, P225, DOI 10.1016/j.jaci.2008.05.001; Anderson SD, 2008, CURR OPIN PULM MED, V14, P39, DOI 10.1097/MCP.0b013e3282f197f6; Anderson Sandra D, 2004, Treat Respir Med, V3, P365, DOI 10.2165/00151829-200403060-00004; ANDERSON SD, 1985, EUR J RESPIR DIS, V67, P20; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; Anderson SD, 2003, J ALLERGY CLIN IMMUN, V111, P45, DOI 10.1067/mai.2003.1; Anderson SD, 2013, IMMUNOLOGY ALLERGY C; Atkinson RW, 2001, AM J RESP CRIT CARE, V164, P1860, DOI 10.1164/ajrccm.164.10.2010138; Avital A, 2000, PEDIATR PULM, V30, P207, DOI 10.1002/1099-0496(200009)30:3<207::AID-PPUL5>3.0.CO;2-Z; BRUTSCHE M, 1995, ALLERGY, V50, P905, DOI 10.1111/j.1398-9995.1995.tb02497.x; Choi IS, 2012, ALLERGY ASTHMA IMMUN, V4, P192, DOI 10.4168/aair.2012.4.4.192; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Goldberg S, 2005, CHEST, V128, P2408, DOI 10.1378/chest.128.4.2408; Goldberg S, 2012, ALLERGY ASTHMA PROC, V33, P416, DOI 10.2500/aap.2012.33.3586; HAHN A, 1984, AM REV RESPIR DIS, V130, P575; Hallstrand TS, 2012, CURR OPIN ALLERGY CL, V12, P42, DOI 10.1097/ACI.0b013e32834ecc67; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Helenius IJ, 1998, BRIT J SPORT MED, V32, P125, DOI 10.1136/bjsm.32.2.125; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; Holz O, 2002, CLIN EXP ALLERGY, V32, P681, DOI 10.1046/j.1365-2222.2002.01358.x; Lazo-Velasquez JC, 2005, PEDIATR PULM, V40, P457, DOI 10.1002/ppul.20275; Lecomte J, 2002, Rev Med Brux, V23, pA206; MCFADDEN ER, 1990, LANCET, V335, P880, DOI 10.1016/0140-6736(90)90478-N; MCFADDEN ER, 1994, NEW ENGL J MED, V330, P1362, DOI 10.1056/NEJM199405123301907; Min KU, 2000, CLIN EXP ALLERGY, V30, P1129, DOI 10.1046/j.1365-2222.2000.00862.x; Park HW, 2007, ANN ALLERG ASTHMA IM, V98, P533, DOI 10.1016/S1081-1206(10)60731-4; Parsons JP, 2007, MED SCI SPORT EXER, V39, P1487, DOI 10.1249/mss.0b013e3180986e45; Parsons JP, 2013, AM J RESP CRIT CARE, V187, P1016, DOI 10.1164/rccm.201303-0437ST; Pohjantahti H, 2005, SCAND J MED SCI SPOR, V15, P324, DOI 10.1111/j.1600-0838.2004.00423.x; Randolph C, 2009, CURR ALLERGY ASTHM R, V9, P433, DOI 10.1007/s11882-009-0064-8; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; TABKA Z, 1988, CHEST, V94, P81, DOI 10.1378/chest.94.1.81; van Leeuwen JC, 2013, IMMUNOLOGY ALLERGY C; Van Schoor J, 2000, EUR RESPIR J, V16, P514, DOI 10.1034/j.1399-3003.2000.016003514.x; Weiler JM, 2007, J ALLERGY CLIN IMMUN, V119, P1349, DOI 10.1016/j.jaci.2007.02.041; Weiler John M, 2010, Ann Allergy Asthma Immunol, V105, pS1, DOI 10.1016/j.anai.2010.09.021	39	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87155	10.1371/journal.pone.0087155	http://dx.doi.org/10.1371/journal.pone.0087155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498034	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100054
J	Yoshida, S; Lee, JO; Nakamura, K; Suzuki, S; Hendon, DN; Kobayashi, M; Suzuki, F				Yoshida, Shohei; Lee, Jong O.; Nakamura, Kiwamu; Suzuki, Sumihiro; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio			Effect of Glycyrrhizin on Pseudomonal Skin Infections in Human-Mouse Chimeras	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVE COMPONENT; LICORICE ROOTS; CHRONIC HEPATITIS; CELLS; ACID; MACROPHAGES; EXPRESSION; PHAGOCYTOSIS; REPLICATION	In our previous studies, peripheral blood lineage(-)CD34(+)CD31(+) cells (CD31(+) IMC) appearing in severely burned patients have been characterized as inhibitor cells for the production of beta-defensins (HBDs) by human epidermal keratinocytes (NHEK). In this study, the effect of glycyrrhizin on pseudomonal skin infections was studied in a chimera model of thermal injury. Two different chimera models were utilized. Patient chimeras were created in murine antimicrobial peptide-depleted NOD-SCID IL-2r gamma(null) mice that were grafted with unburned skin tissues of severely burned patients and inoculated with the same patient peripheral blood CD31(+) IMC. Patient chimera substitutes were created in the same mice that were grafted with NHEK and inoculated with experimentally induced CD31(+) IMC. In the results, both groups of chimeras treated with glycyrrhizin resisted a 20 LD50 dose of P. aeruginosa skin infection, while all chimeras in both groups treated with saline died within 3 days of the infection. Human antimicrobial peptides were detected from the grafted site tissues of both groups of chimeras treated with glycyrrhizin, while the peptides were not detected in the same area tissues of controls. HBD-1 was produced by keratinocytes in transwell-cultures performed with CD31(+) IMC and glycyrrhizin. Also, inhibitors (IL-10 and CCL2) of HBD-1 production by keratinocytes were not detected in cultures of patient CD31(+) IMC treated with glycyrrhizin. These results indicate that sepsis stemming from pseudomonal grafted site infections in a chimera model of burn injury is controllable by glycyrrhizin. Impaired antimicrobial peptide production at the infection site of severely burned patients may be restored after treatment with glycyrrhizin.	[Yoshida, Shohei; Nakamura, Kiwamu; Kobayashi, Makiko; Suzuki, Fujio] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Lee, Jong O.; Hendon, David N.; Kobayashi, Makiko; Suzuki, Fujio] Shriners Hosp Children, Galveston, TX 77550 USA; [Suzuki, Sumihiro] Univ N Texas, Hlth Sci Ctr, Dept Biostat, Ft Worth, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of North Texas System; University of North Texas Health Science Center	Suzuki, F (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	fsuzuki@utmb.edu			Shriners Hospitals for Children [85110]	Shriners Hospitals for Children	This work was supported by the Shriners Hospitals for Children Grant #85110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE N, 1982, MICROBIOL IMMUNOL, V26, P535, DOI 10.1111/j.1348-0421.1982.tb00207.x; ARMANINI D, 1983, CLIN ENDOCRINOL, V19, P609, DOI 10.1111/j.1365-2265.1983.tb00038.x; Braff MH, 2006, CURR TOP MICROBIOL, V306, P91; Cherng JM, 2006, EUR J PHARMACOL, V547, P10, DOI 10.1016/j.ejphar.2006.06.080; Cherng JM, 2004, ANTIVIR RES, V62, P27, DOI 10.1016/j.antiviral.2003.11.005; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Dai JH, 2001, IMMUNOLOGY, V103, P235, DOI 10.1046/j.1365-2567.2001.01224.x; Di Paola R, 2009, INTENS CARE MED, V35, P687, DOI 10.1007/s00134-008-1334-y; FRAZIERJESSEN MR, 1995, J IMMUNOL, V154, P1838; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heggers JP., 2002, TOTAL BURN CARE, P120, DOI DOI 10.1038/SREP41441; Herndon DN., 2017, TOTAL BURN CARE, V5th; Honda H, 2012, J LEUKOCYTE BIOL, V91, P967, DOI 10.1189/jlb.0112038; Hunsicker LM, 2001, CLINICAL MANAGEMENT OF INFECTIONS IN IMMUNOCOMPROMISED INFANTS AND CHILDREN, P327; Iino S, 2001, HEPATOL RES, V19, P31, DOI 10.1016/S1386-6346(00)00079-6; ITO M, 1988, ANTIVIR RES, V10, P289, DOI 10.1016/0166-3542(88)90047-2; Itoh K., 1983, INT CONG SERIES EXCE, P460; Jones VC, 2010, J IMMUNOL, V184; Kobayashi M, 2008, J LEUKOCYTE BIOL, V83, P1354, DOI 10.1189/jlb.0807541; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEVEY RH, 1966, P NATL ACAD SCI USA, V56, P1130, DOI 10.1073/pnas.56.4.1130; Li M, 2011, J CLIN ENDOCR METAB, V96, P2502, DOI 10.1210/jc.2011-0055; Ma CH, 2013, J ETHNOPHARMACOL, V148, P755, DOI 10.1016/j.jep.2013.04.021; Maree AFM, 2008, J APPL PHYSIOL, V104, P157, DOI 10.1152/japplphysiol.00514.2007; Menegazzi M, 2008, PHARMACOL RES, V58, P22, DOI 10.1016/j.phrs.2008.05.012; Milner SM, 1999, BURNS, V25, P411, DOI 10.1016/S0305-4179(98)00192-2; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; MUKAIDA N, 1991, J IMMUNOL, V146, P1212; NUMAZAKI K, 1994, J LEUKOCYTE BIOL, V55, P24, DOI 10.1002/jlb.55.1.24; O'Brien BA, 2002, DIABETES, V51, P2481, DOI 10.2337/diabetes.51.8.2481; Ortega MR, 2000, BURNS, V26, P724, DOI 10.1016/S0305-4179(00)00052-8; Piganelli JD, 1998, DIABETES, V47, P1212, DOI 10.2337/diabetes.47.8.1212; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Sato H, 1996, ANTIVIR RES, V30, P171, DOI 10.1016/0166-3542(96)00942-4; Sawamura D, 2005, GENE THER, V12, P857, DOI 10.1038/sj.gt.3302472; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; STORMER FC, 1993, FOOD CHEM TOXICOL, V31, P303, DOI 10.1016/0278-6915(93)90080-I; SUZUKI F, 1974, P SOC EXP BIOL MED, V146, P78; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; Utsunomiya T, 1999, CLIN EXP IMMUNOL, V116, P291; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012; Yoshida S, 2013, PLOS ONE; Yoshida T, 2010, J LEUKOCYTE BIOL, V87, P35, DOI 10.1189/jlb.1208760	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e83747	10.1371/journal.pone.0083747	http://dx.doi.org/10.1371/journal.pone.0083747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497916	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100003
J	Cazzoletti, L; Corsico, AG; Albicini, F; Di Vincenzo, EMG; Gini, E; Grosso, A; Ronzoni, V; Bugiani, M; Pirina, P; Cerveri, I				Cazzoletti, Lucia; Corsico, Angelo Guido; Albicini, Federica; Di Vincenzo, Eti Maria Giulia; Gini, Erica; Grosso, Amelia; Ronzoni, Vanessa; Bugiani, Massimiliano; Pirina, Pietro; Cerveri, Isa			The Course of Asthma in Young Adults: A Population-Based Nine-Year Follow-Up on Asthma Remission and Control	PLOS ONE			English	Article							REAL-WORLD EVALUATION; NATURAL-HISTORY; ALLERGIC RHINITIS; CHILDHOOD; EUROPE; IMPACT; PREVALENCE; SEVERITY; CHILDREN; RELAPSE	Background: Only few longitudinal studies on the course of asthma among adults have been carried out. Objective: The aim of the present prospective study, carried out between 2000 and 2009 in Italy, is to assess asthma remission and control in adults with asthma, as well as their determinants. Methods: All the subjects with current asthma (21-47 years) identified in 2000 in the Italian Study on Asthma in Young Adults in 6 Italian centres were followed up. Asthma remission was assessed at follow-up in 2008-2009 (n = 214), asthma control at baseline and follow-up. Asthma remission and control were related to potential determinants by a binomial logistic and a multinomial logistic model. Separate models for remission were used for men and women. Results: The estimate of the proportion of subjects who were in remission was 29.7% (95% CI: 14.4%; 44.9%). Men who were not under control at baseline had a very low probability of being in remission at follow-up (OR = 0.06; 95% CI: 0.01; 0.33) when compared to women (OR = 0.40; 95% CI: 0.17; 0.94). The estimates of the proportion of subjects who were under control, partial control or who were not under control in our sample were 26.3% (95% CI: 21.2; 31.3%), 51.6% (95% CI: 44.6; 58.7%) and 22.1% (95% CI: 16.6; 27.6%), respectively. Female gender, increasing age, the presence of chronic cough and phlegm and partial or absent asthma control at baseline increased the risk of uncontrolled asthma at follow-up. Conclusion: Asthma remission was achieved in nearly 1/3 of the subjects with active asthma in the Italian adult population, whereas the proportion of the subjects with controlled asthma among the remaining subjects was still low.	[Cazzoletti, Lucia] Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Corsico, Angelo Guido] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Albicini, Federica; Di Vincenzo, Eti Maria Giulia; Gini, Erica; Grosso, Amelia; Ronzoni, Vanessa; Cerveri, Isa] Univ Pavia, Ist Ricovero & Cura Carattere Sci San Matteo Hosp, Div Resp Dis, I-27100 Pavia, Italy; [Bugiani, Massimiliano] Natl Hlth Serv, Resp Med Unit, Turin, Italy; [Pirina, Pietro] Univ Sassari, Inst Resp Dis, I-07100 Sassari, Italy	University of Verona; University of Pavia; University of Pavia; University of Sassari	Cazzoletti, L (corresponding author), Univ Verona, Unit Epidemiol & Med Stat, I-37100 Verona, Italy.	lucia.cazzoletti@univr.it	Grosso, Amelia/Y-9632-2019; Corsico, Angelo Guido/AAC-8138-2019	Corsico, Angelo Guido/0000-0002-8716-4694; Albicini, Federica/0000-0002-2319-1917; Ronzoni, Vanessa/0000-0002-2503-3656; Gini, Erica/0000-0003-4843-5890; Cerveri, Isa/0000-0003-0337-043X; Grosso, Amelia/0000-0002-4442-8522	Agenzia Italiana del Farmaco (AIFA) [FARM5JYS5A]	Agenzia Italiana del Farmaco (AIFA)	The Agenzia Italiana del Farmaco (AIFA) (FARM5JYS5A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Baldacci S, 2012, RESP MED, V106, P777, DOI 10.1016/j.rmed.2012.02.013; Bateman ED, 2008, ALLERGY, V63, P932, DOI 10.1111/j.1398-9995.2008.01724.x; Bottema RW, 2005, IMMUNOL ALLERGY CLIN, V25, P621, DOI 10.1016/j.iac.2005.07.002; Braido F, 2009, ALLERGY, V64, P937, DOI 10.1111/j.1398-9995.2008.01932.x; Braman Sidney S, 2010, Expert Rev Respir Med, V4, P239, DOI 10.1586/ers.10.12; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; BRONNIMANN S, 1986, CHEST, V90, P480, DOI 10.1378/chest.90.4.480; Burgess JA, 2011, THORAX, V66, P508, DOI 10.1136/thx.2010.146845; Cazzoletti L, 2007, J ALLERGY CLIN IMMUN, V120, P1360, DOI 10.1016/j.jaci.2007.09.019; Chaudhuri R, 2008, ALLERGY, V63, P132, DOI 10.1111/j.1398-9995.2007.01538.x; Combescure C, 2003, EUR RESPIR J, V22, P298, DOI 10.1183/09031936.03.00081102; Corsico AG, 2007, RESP MED, V101, P1363, DOI 10.1016/j.rmed.2006.11.012; de Marco R, 2005, INT ARCH ALLERGY IMM, V138, P225, DOI 10.1159/000088723; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; de Marco R, 2003, ALLERGY, V58, P221, DOI 10.1034/j.1398-9995.2003.00059.x; de Marco R, 2002, CLIN EXP ALLERGY, V32, P1405, DOI 10.1046/j.1365-2745.2002.01466.x; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; Demoly P, 2012, EUR RESPIR REV, V21, P66, DOI 10.1183/09059180.00008111; Ekerljung L, 2008, RESP MED, V102, P1730, DOI 10.1016/j.rmed.2008.07.011; Elliott M. R., 2000, J OFF STAT, V16, P191; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Global Initiative for Asthma, 2006, NAT HEART LUNG BLOOD, V02-3659; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Hofler M, 2005, SOC PSYCH PSYCH EPID, V40, P291, DOI 10.1007/s00127-005-0882-5; Holm M, 2007, EUR RESPIR J, V30, P62, DOI 10.1183/09031936.00121705; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Koster ES, 2011, PEDIAT ALLERG IMM-UK, V22, P776, DOI 10.1111/j.1399-3038.2011.01188.x; Lee JH, 2006, J ASTHMA, V43, P179, DOI 10.1080/02770900600566405; Leynaert B, 1997, AM J RESP CRIT CARE, V156, P1413, DOI 10.1164/ajrccm.156.5.9701060; Little R.J.A., 2002, STAT ANAL MISSING DA; Lundback B, 2007, ALLERGY, V62, P611, DOI 10.1111/j.1398-9995.2007.01399.x; Panhuysen CIM, 1997, AM J RESP CRIT CARE, V155, P1267, DOI 10.1164/ajrccm.155.4.9105065; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Ponte EV, 2008, ALLERGY, V63, P564, DOI 10.1111/j.1398-9995.2007.01624.x; Potter F., 1990, P SECT SURV RES METH, P225; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Ronmark E, 1999, THORAX, V54, P611, DOI 10.1136/thx.54.7.611; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Siroux V, 2009, J ALLERGY CLIN IMMUN, V124, P681, DOI 10.1016/j.jaci.2009.06.010; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Upham JW, 2011, PHARMACOL THERAPEUT, V130, P38, DOI 10.1016/j.pharmthera.2011.01.002; Vonk JM, 2004, THORAX, V59, P925, DOI 10.1136/thx.2003.016246; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	44	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86956	10.1371/journal.pone.0086956	http://dx.doi.org/10.1371/journal.pone.0086956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489813	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000084
J	Cunha, E; Magno, G; Goncalves, MA; Cambraia, C; Almeida, V				Cunha, Evandro; Magno, Gabriel; Goncalves, Marcos Andre; Cambraia, Cesar; Almeida, Virgilio			He Votes or She Votes? Female and Male Discursive Strategies in Twitter Political Hashtags	PLOS ONE			English	Article							GENDER-DIFFERENCES; PERSUASION	In this paper, we conduct a study about differences between female and male discursive strategies when posting in the microblogging service Twitter, with a particular focus on the hashtag designation process during political debate. The fact that men and women use language in distinct ways, reverberating practices linked to their expected roles in the social groups, is a linguistic phenomenon known to happen in several cultures and that can now be studied on the Web and on online social networks in a large scale enabled by computing power. Here, for instance, after analyzing tweets with political content posted during Brazilian presidential campaign, we found out that male Twitter users, when expressing their attitude toward a given candidate, are more prone to use imperative verbal forms in hashtags, while female users tend to employ declarative forms. This difference can be interpreted as a sign of distinct approaches in relation to other network members: for example, if political hashtags are seen as strategies of persuasion in Twitter, imperative tags could be understood as more overt ways of persuading and declarative tags as more indirect ones. Our findings help to understand human gendered behavior in social networks and contribute to research on the new fields of computer-enabled Internet linguistics and social computing, besides being useful for several computational tasks such as developing tag recommendation systems based on users' collective preferences and tailoring targeted advertising strategies, among others.	[Cunha, Evandro; Magno, Gabriel; Goncalves, Marcos Andre; Almeida, Virgilio] Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil; [Cunha, Evandro; Cambraia, Cesar] Univ Fed Minas Gerais, Coll Letters, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Cunha, E (corresponding author), Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil.	evandrocunha@dcc.ufmg.br	Magno, Gabriel/AAN-6212-2020; Cambraia, César Nardelli/A-2426-2013	Cambraia, César Nardelli/0000-0002-2403-3021; Almeida, Virgilio/0000-0001-6452-0361; Goncalves, Marcos Andre/0000-0002-2075-3363	MCT/CNPq/INCT Web Grant from the Brazilian Council for Scientific and Technological Development [573871/2008-6]	MCT/CNPq/INCT Web Grant from the Brazilian Council for Scientific and Technological Development	Authors were partially supported by MCT/CNPq/INCT Web Grant number 573871/2008-6 from the Brazilian Council for Scientific and Technological Development. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PH, 1987, HUM COMMUN RES, V13, P372, DOI 10.1111/j.1468-2958.1987.tb00110.x; Argamon S., 2003, TEXT TALK, V23, P321, DOI [10.1515/text.2003.014, DOI 10.1515/TEXT.2003.014]; Argamon S., 2007, MINING BLOGOSPHERE A; Bamman D., 2012, GENDER TWITTER STYLE; Beauvoir Simone de., 1973, 2 SEX; Bell C.M., 2012, APPL NATURAL LANGUAG, P545, DOI [10.4018/978-1-60960-741-8.ch032, DOI 10.4018/978-1-60960-741-8.CH032]; Biderman MTC, 1973, REV ALFA, V19, P339; Brown Roger, 1960, STYLE LANGUAGE, P253, DOI [10.1017/CBO9780511813085, DOI 10.1017/CBO9780511813085]; Brunel FF, 2003, J ADVERTISING RES, V43, P330, DOI 10.1017/S0021849903030320; Burger John D., 2011, P C EMP METH NAT LAN, P1301, DOI DOI 10.1007/S00256-005-0933-8; Carli L, 1978, J PERS SOC PSYCHOL, V85, P86; Ceron A., 2013, NEW MEDIA SOC; Chung J, 2003, J BUS ETHICS, V47, P133, DOI 10.1023/A:1026004716676; COATES Jennifer, 1986, WOMEN MEN LANGUAGE S; Condit CM, 1997, WOMENS STUDIES COMMU, V20, P91, DOI DOI 10.1080/07491409.1997.10162405; Corney M, 2002, P 18 ANN COMP SEC AP; Cunha Evandro, 2011, P WORKSH LANG SOC ME, P58; EAGLY AH, 1978, PSYCHOL BULL, V85, P86, DOI 10.1037/0033-2909.85.1.86; FISCHER JL, 1958, WORD, V14, P47, DOI 10.1080/00437956.1958.11659655; Guadagno RE, 2002, GROUP DYN-THEOR RES, V6, P38, DOI 10.1037/1089-2699.6.1.38; Guy G. R., 1981, THESIS U PENNSYLVANI; Herring SC, 2006, J SOCIOLING, V10, P439, DOI 10.1111/j.1467-9841.2006.00287.x; Horvath Barbara, 1985, VARIATION AUSTR ENGL; Labov, 2001, PRINCIPLES LINGUISTI; Lakoff Robin, 1975, LANGUAGE WOMANS PLAC; Larsson AO, 2012, NEW MEDIA SOC, V14, P729, DOI 10.1177/1461444811422894; Lin Y.-R, 2013, P 7 INT AAAI C WEBL; Liu B., 2012, SYNTHESIS LECT HUMAN; Manovich L, 2012, DEBATES IN THE DIGITAL HUMANITIES, P460; Mitchell T.M, 2003, MACH LEARN; Ottoni R., 2013, P 7 INT AAAI C WEBL; Romaine S, 2000, LANGUAGE SOC INTRO S, VSecond; Rossetti P, 1998, INTERNET TESL J, V4; SAGRESTANO LM, 1992, PSYCHOL WOMEN QUART, V16, P481, DOI 10.1111/j.1471-6402.1992.tb00270.x; Savicki V, 1999, COMPUT HUM BEHAV, V15, P185, DOI 10.1016/S0747-5632(99)00017-5; Schler Jonathan, 2006, P AAAI SPRING S COMP; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Tannen D., 2007, YOU JUST DONT UNDERS; Tannen D, 1996, GENDER DISCOURSE; Trudgill Peter, 1974, SOCIAL DIFFERENTIATI; Trudgill Peter, 1983, SOCIOLINGUISTICS INT; Tumasjan A., 2010, P INT AAAI C WEB SOC, V4; Weber I, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P523	43	18	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87041	10.1371/journal.pone.0087041	http://dx.doi.org/10.1371/journal.pone.0087041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489832	gold, Green Published			2022-12-27	WOS:000330570000095
J	Dennis, BB; Bawor, M; Thabane, L; Sohani, Z; Samaan, Z				Dennis, Brittany B.; Bawor, Monica; Thabane, Lehana; Sohani, Zahra; Samaan, Zainab			Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MAINTENANCE TREATMENT; WITHDRAWAL SYMPTOMS; DOSAGE REQUIREMENTS; N-DEMETHYLATION; PLASMA-LEVELS; ASSOCIATION; RISK; SUBSTITUTION; VARIABILITY; MORTALITY	Background: Genetic variability may influence methadone metabolism, dose requirements, and risk of relapse. Objectives: To determine whether the CYP2B6*6 or ABCB1 (rs1045642) polymorphisms are associated with variation in methadone response (plasma concentration, dose, or response to treatment). Methods: Two independent reviewers searched Medline, EMBASE, CINAHL, PsycINFO, and Web of Science databases. We included studies that reported methadone plasma concentration, methadone response, or methadone dose in relation to the CYP2B6*6 or ABCB1 polymorphisms. Results: We screened 182 articles and extracted 7 articles for inclusion in the meta-analysis. Considerable agreement was observed between the two independent raters on the title (kappa, 0.82), abstract (kappa, 0.43), and full text screening (kappa, 0.43). Trough (R) methadone plasma concentration was significantly higher in CYP2B6*6 homozygous carriers when compared to non-carriers (standardized mean difference [SMD] = 0.53, 95% confidence interval [CI], 0.05-1.00, p = 0.03) with minimal heterogeneity (I-2 = 0%). Similarly, trough (S) methadone plasma concentration was higher in homozygous carriers of the *6 haplotype when compared to non-carriers, (SMD = 1.44, 95% CI 0.27-2.61, p = 0.02) however significant heterogeneity was observed (I-2 = 69%). Carriers of the CYP2B6*6 haplotype were not found to be significantly different from non-carriers with respect to dose or response to treatment. We found no significant association between the ABCB1 polymorphism and the trough (R), (S) plasma concentrations, methadone dose, or methadone response. Conclusion: Although the number of studies included and sample size were modest, this is the first meta analysis to show participants homozygous for the CYP2B6*6 genotype have higher trough (R) and (S) methadone plasma concentrations, suggesting that methadone metabolism is significantly slower in *6 homozygous carriers.	[Dennis, Brittany B.; Thabane, Lehana; Sohani, Zahra; Samaan, Zainab] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Dennis, Brittany B.; Thabane, Lehana] St Josephs Healthcare, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Dennis, Brittany B.; Bawor, Monica; Thabane, Lehana; Sohani, Zahra; Samaan, Zainab] McMaster Univ, Populat Genom Program, Hamilton, ON, Canada; [Bawor, Monica; Samaan, Zainab] McMaster Univ, McMaster Integrat Neurosci Discovery & Study MiND, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Thabane, Lehana; Sohani, Zahra; Samaan, Zainab] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Samaan, Zainab] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University	Samaan, Z (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	samaanz@mcmaster.ca	samaan, z/J-4289-2012	Samaan, Zainab/0000-0002-5974-9361; Dennis, Brittany/0000-0002-3691-5400; Bawor, Monica/0000-0002-4878-716X	CIHR Drug Safety and Effectiveness Network (DSEN) grant [126639]	CIHR Drug Safety and Effectiveness Network (DSEN) grant(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR Drug Safety and Effectiveness Network (DSEN) grant (grant number: 126639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, JAMA, V280, P1936; Ansermot N, 2010, ARCH INTERN MED, V170, P529, DOI 10.1001/archinternmed.2010.26; Bao YP, 2009, AM J DRUG ALCOHOL AB, V35, P28, DOI 10.1080/00952990802342899; Barratt DT, 2012, PHARMACOGN PERS MED, V5, P53, DOI 10.2147/PGPM.S29272; Benyamina A, 2009, PROG NEURO-PSYCHOPH, V33, P1270, DOI 10.1016/j.pnpbp.2009.07.016; Bunten H, 2011, ADDICT BIOL, V16, P142, DOI 10.1111/j.1369-1600.2010.00274.x; Chen CH, 2011, PHARMACOGENOMICS, V12, P1397, DOI [10.2217/pgs.11.103, 10.2217/PGS.11.103]; Chen DY, 2011, AM J MED GENET B, V156B, P661, DOI 10.1002/ajmg.b.31208; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collaboration TC, 2011, COCHR HDB SYST REV I; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Coller JK, 2009, PHARMACOGN PERS MED, V2, P9; Cornish Rosie, 2010, BMJ, V341, pc5475, DOI 10.1136/bmj.c5475; Cousins G, 2011, J SUBST ABUSE TREAT, V41, P252, DOI 10.1016/j.jsat.2011.05.001; Crettol S, 2008, CLIN PHARMACOL THER, V83, P668, DOI 10.1038/sj.clpt.6100305; Crettol S, 2005, CLIN PHARMACOL THER, V78, P593, DOI 10.1016/j.clpt.2005.08.011; Crettol SE, 2007, HEROIN ADDICT REL CL, V9, P39; Crettol S, 2008, PROG NEURO-PSYCHOPH, V32, P1722, DOI 10.1016/j.pnpbp.2008.07.009; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; de Cid R, 2008, GENES BRAIN BEHAV, V7, P515, DOI 10.1111/j.1601-183X.2007.00386.x; Degenhardt L, 2009, DRUG ALCOHOL DEPEN, V105, P9, DOI 10.1016/j.drugalcdep.2009.05.021; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Eap CB, 2007, CLIN PHARMACOL THER, V81, P719, DOI 10.1038/sj.clpt.6100120; Eap CB, 2001, J CLIN PSYCHOPHARM, V21, P229, DOI 10.1097/00004714-200104000-00016; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Fonseca F, 2010, MOL DIAGN THER, V14, P171, DOI 10.2165/11537650-000000000-00000; Gadel S, 2013, DRUG METAB DISPOS, V41, P709, DOI 10.1124/dmd.112.050625; Gerber JG, 2004, CHIRALITY, V16, P36, DOI 10.1002/chir.10303; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Goldstein MF, 2002, DRUG ALCOHOL DEPEN, V66, P181, DOI 10.1016/S0376-8716(01)00199-5; Guyatt G OA, 2011, J CLIN EPIDEMIOLOGY; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang CLC, 2013, J SUBST ABUSE TREAT, V44, P295, DOI 10.1016/j.jsat.2012.08.003; Hung CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059419; Hung CC, 2011, PHARMACOGENOMICS, V12, P1525, DOI [10.2217/PGS.11.96, 10.2217/pgs.11.96]; Jimenez-Trevino L, 2011, ADDICT BEHAV, V36, P1184, DOI 10.1016/j.addbeh.2011.07.019; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Kurdyak P, 2012, ADDICTION, V107, P776, DOI 10.1111/j.1360-0443.2011.03707.x; Levran O, 2012, PHARMACOGENOMICS J, V12, P319, DOI 10.1038/tpj.2011.6; Levran O, 2011, ADDICT BIOL; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Li YF, 2008, MOL DIAGN THER, V12, P109, DOI 10.1007/BF03256276; Lin CR, 2009, CARDIOLOGY, V113, P59, DOI 10.1159/000167043; Lotsch J, 2006, CLIN PHARMACOL THER, V79, P72, DOI 10.1016/j.clpt.2005.09.010; Marian AJ, 2011, CIRC RES, V108, P1252, DOI 10.1161/CIRCRESAHA.110.236067; Marsch LA, 1998, ADDICTION, V93, P515, DOI 10.1046/j.1360-0443.1998.9345157.x; Mattick Richard P, 2009, COCHRANE DATABASE SY; Nosyk B, 2009, AM J EPIDEMIOL, V170, P783, DOI 10.1093/aje/kwp186; Okruhlica Lubomir, 2012, Cas Lek Cesk, V151, P389; Oneda B, 2011, PHARMACOGENOMICS J, V11, P258, DOI 10.1038/tpj.2010.37; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; de los Cobos JP, 2007, DRUG ALCOHOL DEPEN, V89, P190, DOI 10.1016/j.drugalcdep.2006.12.018; Sharif B, 2013, SUBST USE MISUSE, V48, P671, DOI 10.3109/10826084.2013.800119; Sheridan Janie, 2005, Harm Reduct J, V2, P25, DOI 10.1186/1477-7517-2-25; Somogyi AA, 2011, BAS CLIN PHARM TOX C, p[109, 132]; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; Tian JN, 2012, PHARMACOGENOMICS, V13, P879, DOI [10.2217/PGS.12.69, 10.2217/pgs.12.69]; Torrens M, 1996, DRUG ALCOHOL DEPEN, V41, P55, DOI 10.1016/0376-8716(96)01230-6; Totah RA, 2008, ANESTHESIOLOGY, V108, P363, DOI 10.1097/ALN.0b013e3181642938; Totah RA, 2007, J PHARMACOL EXP THER, V321, P389, DOI 10.1124/jpet.106.117580; Uehlinger C, 2007, J CLIN PSYCHOPHARM, V27, P273, DOI 10.1097/JCP.0b013e3180592ad2; Wang SC, 2011, J CLIN PSYCHOPHARM, V31, P463, DOI 10.1097/JCP.0b013e318222b5dd; Wells G. A., 2009, NEWCASTLE OTTAWA SCA	67	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86114	10.1371/journal.pone.0086114	http://dx.doi.org/10.1371/journal.pone.0086114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489693	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000024
J	Djonlagic, I; Guo, MS; Matteis, P; Carusona, A; Stickgold, R; Malhotra, A				Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul			Untreated Sleep-Disordered Breathing: Links to Aging-Related Decline in Sleep-Dependent Memory Consolidation	PLOS ONE			English	Article							SLOW-WAVE SLEEP; WAKING COGNITIVE PERFORMANCE; CARDIOVASCULAR RISK-FACTORS; MIDDLE-AGED ADULTS; OLDER-ADULTS; DECLARATIVE MEMORY; MOTOR SKILL; INTERMITTENT HYPOXIA; INSOMNIA COMPLAINTS; HEART HEALTH	Background: Increasing age is associated with a decline in cognition and motor skills, while at the same time exacerbating one's risk of developing obstructive sleep apnea (OSA). OSA-related cognitive deficits are highly prevalent and can affect various memory systems including overnight memory consolidation on a motor sequence task. Thus, the aim of our study was to examine the effect of aging on sleep-dependent motor memory consolidation in patients with and without OSA. Methods: We studied 44 patients (19-68 years) who had been referred by a physician for a baseline polysomnography (PSG) evaluation. Based on their PSG, patients were assigned either to the OSA group (AHI>5/h), or control (Non-OSA) group (AHI<5/h). All subjects performed the Psychomotor Vigilance Task (PVT) and the Motor Sequence Learning Task (MST) in the evening and again in the morning after their PSG. Results: Despite similar learning in the evening, OSA subjects showed significantly less overnight improvement on the MST, both for immediate (OSA -2.7%+/- 2.8% vs. controls 12.2%+/- 3.5%; p = 0.002) and plateau improvement (OSA 4.9%+/- 2.3% vs. controls 21.1%+/- 4.0%; p = 0.001). Within the OSA group, there was a significant negative correlation between overnight MST improvement and age (r(2) = 0.3; p = 0.01), an effect that was not observed in the Non-OSA group (r(2) = 0.08; p = 0.23) Conclusions: Consistent with previous research, healthy sleepers demonstrated a higher degree of sleep-dependent overnight improvement on the MST, an effect not mitigated by increasing age. However, the presence of untreated obstructive sleep apnea is associated with an aging-related cognitive deficit, otherwise not present in individuals without OSA. As other research has linked the presence of OSA to a higher likelihood of developing dementia, future studies are necessary to examine if the inhibition of memory consolidation is tied to the onset of neurodegenerative disease.	[Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Malhotra, Atul] Brigham & Womens Hosp, Div Sleep Med, Sleep Disorders Res Program, Boston, MA 02115 USA; [Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul] Harvard Univ, Sch Med, Boston, MA USA; [Djonlagic, Ina; Guo, Mengshuang; Matteis, Paul; Stickgold, Robert] Beth Israel Hosp, Dept Psychiat, Ctr Sleep & Cognit, Boston, MA USA; [Malhotra, Atul] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Diego	Djonlagic, I (corresponding author), Brigham & Womens Hosp, Div Sleep Med, Sleep Disorders Res Program, 75 Francis St, Boston, MA 02115 USA.	idonlagic@partners.org			American Board of Sleep Medicine Junior Faculty Research Award [K23 HL10385-01, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL103850, R01HL090897, P01HL095491, R01HL085188, K24HL093218] Funding Source: NIH RePORTER	American Board of Sleep Medicine Junior Faculty Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by K23 HL10385-01, American Board of Sleep Medicine Junior Faculty Research Award, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanatis M, 2008, SLEEP BREATH, V12, P17, DOI 10.1007/s11325-007-0133-y; Ancoli-Israel S, 1989, Clin Geriatr Med, V5, P347; Ancoli-Israel S, 2008, HARVARD REV PSYCHIAT, V16, P279, DOI 10.1080/10673220802432210; ANCOLIISRAEL S, 1993, SLEEP, V16, pS25, DOI 10.1093/sleep/16.suppl_8.S25; ANCOLIISRAEL S, 1995, AM J RESP CRIT CARE, V152, P1946, DOI 10.1164/ajrccm.152.6.8520760; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, BIOFEEDBACK SELF-REG, V16, P349, DOI 10.1007/BF00999989; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; Backhaus J, 2007, LEARN MEMORY, V14, P336, DOI 10.1101/lm.470507; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Boehlecke B A, 2000, Curr Opin Pulm Med, V6, P471, DOI 10.1097/00063198-200011000-00002; BONNET MH, 1993, SLEEP, V16, pS65, DOI 10.1093/sleep/16.suppl_8.S65; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Crenshaw MC, 1999, PHYSIOL BEHAV, V66, P485, DOI 10.1016/S0031-9384(98)00316-3; Crowley K, 2002, CLIN NEUROPHYSIOL, V113, P1615, DOI 10.1016/S1388-2457(02)00237-7; Dealberto MJ, 1996, J AM GERIATR SOC, V44, P1287, DOI 10.1111/j.1532-5415.1996.tb01397.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Edinger JD, 2000, PHYSIOL BEHAV, V70, P127, DOI 10.1016/S0031-9384(00)00238-9; Engleman HM, 2000, SLEEP, V23, pS102; Federal Interagency Forum on Aging-Related Statistics, 2010, OLD AM 2012 KEY IND; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; GRANAT P, 1990, J FAM PRACTICE, V30, P632; GRUNSTEIN RR, 1995, INT J OBESITY, V19, P410; HOCH CC, 1990, SLEEP, V13, P502, DOI 10.1093/sleep/13.6.502; Hornung OP, 2005, EXP GERONTOL, V40, P279, DOI 10.1016/j.exger.2005.02.001; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Iber C., 2007, AASM MANUAL SCORING; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lavie P, 2009, J SLEEP RES, V18, P397, DOI 10.1111/j.1365-2869.2009.00754.x; Malhotra A., 2006, AM J MED, V119, p72.; Manabe K, 2000, GERONTOLOGY, V46, P318, DOI 10.1159/000022184; Manoach DS, 2010, J PSYCHIATR RES, V44, P112, DOI 10.1016/j.jpsychires.2009.06.011; MANT A, 1995, SLEEP, V18, P433, DOI 10.1093/sleep/18.6.433; MCCANN UD, 1992, BIOL PSYCHIAT, V31, P1082, DOI 10.1016/0006-3223(92)90153-Q; Newman AB, 1997, J AM GERIATR SOC, V45, P1; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Rockwood K, 2001, J AM GERIATR SOC, V49, P639, DOI 10.1046/j.1532-5415.2001.49125.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Tucker M, 2011, J AM GERIATR SOC, V59, P603, DOI 10.1111/j.1532-5415.2011.03324.x; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yim-Yeh S, 2010, SLEEP, V33, P1177, DOI 10.1093/sleep/33.9.1177; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	64	33	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85918	10.1371/journal.pone.0085918	http://dx.doi.org/10.1371/journal.pone.0085918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489679	gold, Green Published			2022-12-27	WOS:000330570000019
J	Finkle, WD; Greenland, S; Ridgeway, GK; Adams, JL; Frasco, MA; Cook, MB; Fraumeni, JF; Hoover, RN				Finkle, William D.; Greenland, Sander; Ridgeway, Gregory K.; Adams, John L.; Frasco, Melissa A.; Cook, Michael B.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.			Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OLDER MEN; CARDIOVASCULAR EVENTS; HORMONE-THERAPY; METAANALYSIS; THROMBOSIS; AUTOPSY; BLOOD	Background: An association between testosterone therapy (TT) and cardiovascular disease has been reported and TT use is increasing rapidly. Methods: We conducted a cohort study of the risk of acute non-fatal myocardial infarction (MI) following an initial TT prescription (N = 55,593) in a large health-care database. We compared the incidence rate of MI in the 90 days following the initial prescription (post-prescription interval) with the rate in the one year prior to the initial prescription (pre-prescription interval) (post/pre). We also compared post/pre rates in a cohort of men prescribed phosphodiesterase type 5 inhibitors (PDE5I; sildenafil or tadalafil, N = 167,279), and compared TT prescription post/pre rates with the PDE5I post/pre rates, adjusting for potential confounders using doubly robust estimation. Results: In all subjects, the post/pre-prescription rate ratio (RR) for TT prescription was 1.36 (1.03, 1.81). In men aged 65 years and older, the RR was 2.19 (1.27, 3.77) for TT prescription and 1.15 (0.83, 1.59) for PDE5I, and the ratio of the rate ratios (RRR) for TT prescription relative to PDE5I was 1.90 (1.04, 3.49). The RR for TT prescription increased with age from 0.95 (0.54, 1.67) for men under age 55 years to 3.43 (1.54, 7.56) for those aged >= 75 years (p(trend) = 0.03), while no trend was seen for PDE5I (p(trend) = 0.18). In men under age 65 years, excess risk was confined to those with a prior history of heart disease, with RRs of 2.90 (1.49, 5.62) for TT prescription and 1.40 (0.91, 2.14) for PDE5I, and a RRR of 2.07 (1.05, 4.11). Discussion: In older men, and in younger men with pre-existing diagnosed heart disease, the risk of MI following initiation of TT prescription is substantially increased.	[Finkle, William D.; Ridgeway, Gregory K.; Adams, John L.; Frasco, Melissa A.] Consolidated Res Inc, Los Angeles, CA 90045 USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Greenland, Sander] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; [Cook, Michael B.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Finkle, WD (corresponding author), Consolidated Res Inc, Los Angeles, CA 90045 USA.	bill@consolidated-research.com; hooverr@mail.nih.gov	Cook, Michael B/A-5641-2009	Cook, Michael B/0000-0002-0533-7302; Frasco, Melissa/0000-0002-3437-1518; Ridgeway, Greg/0000-0001-6911-0804	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Intramural Research Program of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; Baillargeon J, 2013, JAMA INTERN MED, P1; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Baskurt OK, 2012, SEMIN THROMB HEMOST, V38, P854, DOI 10.1055/s-0032-1325616; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Corona G, 2011, EUR J ENDOCRINOL, V165, P687, DOI 10.1530/EJE-11-0447; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Hensen LG, 2010, HLTH RES DATA REAL W; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jackson G, 2006, UROLOGY, V68, P47, DOI 10.1016/j.urology.2006.05.047; JAMA, 1970, JAMA, V214, P1303, DOI DOI 10.1001/JAMA.1970.03180070069012; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; O'Connor A, 2013, MENS USE HORMONES RI; Oliva A, 2011, ATHEROSCLEROSIS, V218, P28, DOI 10.1016/j.atherosclerosis.2011.05.012; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Peerschke EI, 2007, AM J CLIN PATHOL, V127, P422, DOI 10.1309/B29E2AHMTQA1KAKJ; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Roger VL, 2001, AM J MED, V110, P267, DOI 10.1016/S0002-9343(00)00709-9; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Ruige JB, 2011, HEART, V97, P870, DOI 10.1136/hrt.2010.210757; Sandset PM, 2009, THROMB RES, V123, pS70, DOI 10.1016/S0049-3848(09)70015-5; Seeger JD, 2003, AM J CARDIOL, V92, P1447, DOI 10.1016/j.amjcard.2003.08.057; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Swerdloff RS, 2000, J CLIN ENDOCR METAB, V85, P4500, DOI 10.1210/jc.85.12.4500; Urhausen A, 2003, J STEROID BIOCHEM, V84, P369, DOI 10.1016/S0960-0760(03)00105-5; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	31	491	500	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85805	10.1371/journal.pone.0085805	http://dx.doi.org/10.1371/journal.pone.0085805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489673	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000017
J	Lohaus, G; Schwerdtfeger, M				Lohaus, Gertrud; Schwerdtfeger, Michael			Comparison of Sugars, Iridoid Glycosides and Amino Acids in Nectar and Phloem Sap of Maurandya barclayana, Lophospermum erubescens, and Brassica napus	PLOS ONE			English	Article							FLORAL NECTAR; CATALPA-SPECIOSA; TOXIC NECTAR; SCROPHULARIACEAE; PLANTS; TRANSPORT; SPINACH; ANATOMY; THIEVES; ORIGIN	Background: Floral nectar contains sugars and amino acids to attract pollinators. In addition, nectar also contains different secondary compounds, but little is understood about their origin or function. Does nectar composition reflect phloem composition, or is nectar synthesized and/or modified in nectaries? Studies where both, the nectar as well as the phloem sap taken from the same plant species were analyzed in parallel are rare. Therefore, phloem sap and nectar from different plant species (Maurandya barclayana, Lophospermum erubescens, and Brassica napus) were compared. Methodology and Principal Findings: Nectar was collected with microcapillary tubes and phloem sap with the laser-aphid-stylet technique. The nectar of all three plant species contained high amounts of sugars with different percentages of glucose, fructose, and sucrose, whereas phloem sap sugars consisted almost exclusively of sucrose. One possible reason for this could be the activity of invertases in the nectaries. The total concentration of amino acids was much lower in nectars than in phloem sap, indicating selective retention of nitrogenous solutes during nectar formation. Nectar amino acid concentrations were negatively correlated with the nectar volumes per flower of the different plant species. Both members of the tribe Antirrhineae (Plantaginaceae) M. barclayana and L. erubescens synthesized the iridoid glycoside antirrhinoside. High amounts of antirrhinoside were found in the phloem sap and lower amounts in the nectar of both plant species. Conclusions/Significance: The parallel analyses of nectar and phloem sap have shown that all metabolites which were found in nectar were also detectable in phloem sap with the exception of hexoses. Otherwise, the composition of both aqueous solutions was not the same. The concentration of several metabolites was lower in nectar than in phloem sap indicating selective retention of some metabolites. Furthermore, the existence of antirrhinoside in nectar could be based on passive secretion from the phloem.	[Lohaus, Gertrud] Berg Univ Wuppertal, Wuppertal, Germany; [Schwerdtfeger, Michael] Univ Gottingen, Albrecht von Haller Inst, D-37073 Gottingen, Germany	University of Wuppertal; University of Gottingen	Lohaus, G (corresponding author), Berg Univ Wuppertal, Wuppertal, Germany.	lohaus@uni-wuppertal.de						Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Baker H.G., 1983, P126; Baker H.G., 1983, P117; BAKER HG, 1986, PLANT SYST EVOL, V151, P175, DOI 10.1007/BF02430273; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; Beninger CW, 2007, J CHEM ECOL, V33, P731, DOI 10.1007/s10886-007-9253-x; Beninger CW, 2009, J CHEM ECOL, V35, P1363, DOI 10.1007/s10886-009-9715-4; BOWERS MD, 1989, ECOL ENTOMOL, V14, P247, DOI 10.1111/j.1365-2311.1989.tb00953.x; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; Davis AR, 1998, PLANTA, V205, P305, DOI 10.1007/s004250050325; De la Barrera E, 2004, TRENDS PLANT SCI, V9, P65, DOI 10.1016/j.tplants.2003.12.003; ELISENS WJ, 1988, AM J BOT, V75, P971, DOI 10.2307/2443763; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Irwin RE, 2008, ECOLOGY, V89, P2207, DOI 10.1890/07-1359.1; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Knop C, 2001, PLANTA, V213, P80, DOI 10.1007/s004250000465; Kram BW, 2009, SEX PLANT REPROD, V22, P235, DOI 10.1007/s00497-009-0112-5; Kromer T, 2008, PLANT BIOLOGY, V10, P502, DOI 10.1111/j.1438-8677.2008.00058.x; Lohaus G, 2000, PLANTA, V211, P833, DOI 10.1007/s004250000349; LOHAUS G, 1995, BOT ACTA, V108, P270, DOI 10.1111/j.1438-8677.1995.tb00860.x; LUTTGE U, 1961, PLANTA, V56, P189, DOI 10.1007/BF01895008; Nadwodnik J, 2008, PLANTA, V227, P1079, DOI 10.1007/s00425-007-0682-0; Orona-Tamayo D, 2013, PLANT J, V73, P546, DOI 10.1111/tpj.12052; PATE JS, 1985, PLANTA, V166, P28, DOI 10.1007/BF00397382; PERCIVAL MARY S., 1961, NEW PHYTOL, V60, P235, DOI 10.1111/j.1469-8137.1961.tb06255.x; Petanidou T, 2006, OIKOS, V115, P155, DOI 10.1111/j.2006.0030-1299.14487.x; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Schmidt-Lebuhn AN, 2007, FLORA, V202, P62, DOI 10.1016/j.flora.2006.02.005; STEPHENSON AG, 1982, J CHEM ECOL, V8, P1025, DOI 10.1007/BF00987883; STEPHENSON AG, 1981, AM MIDL NAT, V105, P381, DOI 10.2307/2424757; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Voitsekhovskaja OV, 2009, J EXP BOT, V60, P1873, DOI 10.1093/jxb/erp074; Voitsekhovskaja OV, 2006, PLANT PHYSIOL, V140, P383, DOI 10.1104/pp.105.068312; Wenzler M, 2008, J EXP BOT, V59, P3425, DOI 10.1093/jxb/ern191; ZIMMERMANN MARTIN, 1953, BER SCHWEIZ BOT GES, V63, P402	39	46	47	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87689	10.1371/journal.pone.0087689	http://dx.doi.org/10.1371/journal.pone.0087689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489951	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000170
J	Park, MH; Rhee, H; Park, JH; Woo, HM; Choi, BO; Kim, BY; Chung, KW; Cho, YB; Kim, HJ; Jung, JW; Koo, SK				Park, Mi-Hyun; Rhee, Hwanseok; Park, Jung Hoon; Woo, Hae-Mi; Choi, Byung-Ok; Kim, Bo-Young; Chung, Ki Wha; Cho, Yoo-Bok; Kim, Hyung Jin; Jung, Ji-Won; Koo, Soo Kyung			Comprehensive Analysis to Improve the Validation Rate for Single Nucleotide Variants Detected by Next-Generation Sequencing	PLOS ONE			English	Article							DISEASE; BIASES; ERROR; TOOL	Next-generation sequencing (NGS) has enabled the high-throughput discovery of germline and somatic mutations. However, NGS-based variant detection is still prone to errors, resulting in inaccurate variant calls. Here, we categorized the variants detected by NGS according to total read depth (TD) and SNP quality (SNPQ), and performed Sanger sequencing with 348 selected non-synonymous single nucleotide variants (SNVs) for validation. Using the SAMtools and GATK algorithms, the validation rate was positively correlated with SNPQ but showed no correlation with TD. In addition, common variants called by both programs had a higher validation rate than caller-specific variants. We further examined several parameters to improve the validation rate, and found that strand bias (SB) was a key parameter. SB in NGS data showed a strong difference between the variants passing validation and those that failed validation, showing a validation rate of more than 92% (filtering cutoff value: alternate allele forward [AF]>= 20 and AF<80 in SAMtools, SB<-10 in GATK). Moreover, the validation rate increased significantly (up to 97-99%) when the variant was filtered together with the suggested values of mapping quality (MQ), SNPQ and SB. This detailed and systematic study provides comprehensive recommendations for improving validation rates, saving time and lowering cost in NGS analyses.	[Park, Mi-Hyun; Woo, Hae-Mi; Kim, Bo-Young; Kim, Hyung Jin; Jung, Ji-Won; Koo, Soo Kyung] Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea; [Rhee, Hwanseok; Park, Jung Hoon] Macrogen Inc, Seoul, South Korea; [Choi, Byung-Ok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Chung, Ki Wha] Kongju Natl Univ, Dept Biol Sci, Gongju, South Korea; [Cho, Yoo-Bok] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Macrogen, Inc.; Sungkyunkwan University (SKKU); Samsung Medical Center; Kongju National University; Korea Advanced Institute of Science & Technology (KAIST)	Koo, SK (corresponding author), Natl Inst Hlth, Div Intractable Dis, Ctr Biomed Sci, Chungcheongbuk Do, South Korea.	skkoo@nih.go.kr			Korea National Institute of Health [4800-4845-302-210 (2012-N61001-00)]	Korea National Institute of Health	This work supported by the Korea National Institute of Health intramural research program 4800-4845-302-210 (2012-N61001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Choi BO, 2013, NEUROGENETICS, V14, P35, DOI 10.1007/s10048-012-0346-5; Choi BO, 2012, HUM MUTAT, V33, P1610, DOI 10.1002/humu.22143; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Jia PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038470; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Taub MA, 2010, GENOME MED, V2, DOI 10.1186/gm208; Valencia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053083	19	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86664	10.1371/journal.pone.0086664	http://dx.doi.org/10.1371/journal.pone.0086664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489763	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000056
J	Sims, RE; Dale, N				Sims, Robert Edward; Dale, Nicholas			Activity-Dependent Adenosine Release May Be Linked to Activation of Na+-K+ ATPase: An In Vitro Rat Study	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SLICES; ISCHEMIA; NEURONS; BRAIN; INHIBITION; EXPRESSION; KINASE; DEPOLARIZATION; WAKEFULNESS	In the brain, extracellular adenosine increases as a result of neuronal activity. The mechanisms by which this occurs are only incompletely understood. Here we investigate the hypothesis that the Na+ influxes associated with neuronal signalling activate the Na+-K+ ATPase which, by consuming ATP, generates intracellular adenosine that is then released via transporters. By measuring adenosine release directly with microelectrode biosensors, we have demonstrated that AMPA-receptor evoked adenosine release in basal forebrain and cortex depends on extracellular Na+. We have simultaneously imaged intracellular Na+ and measured adenosine release. The accumulation of intracellular Na+ during AMPA receptor activation preceded adenosine release by some 90 s. By removing extracellular Ca2+, and thus preventing indiscriminate neuronal activation, we used ouabain to test the role of the Na+-K+ ATPase in the release of adenosine. Under conditions which caused a Na+ influx, brief applications of ouabain increased the accumulation of intracellular Na+ but conversely rapidly reduced extracellular adenosine levels. In addition, ouabain greatly reduced the amount of adenosine released during application of AMPA. Our data therefore suggest that activity of the Na+-K+ ATPase is directly linked to the efflux of adenosine and could provide a universal mechanism that couples adenosine release to neuronal activity. The Na+-K+ ATPase-dependent adenosine efflux is likely to provide adenosine-mediated activity-dependent negative feedback that will be important in many diverse functional contexts including the regulation of sleep.	[Sims, Robert Edward; Dale, Nicholas] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Sims, RE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	r.e.sims@aston.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Sims, Robert/0000-0003-1373-7514	Wellcome Trust [WT087968MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust, grant WT087968MA, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Blom H, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-16; Boison D, 2006, TRENDS PHARMACOL SCI, V27, P652, DOI 10.1016/j.tips.2006.10.008; Brundege JM, 1998, NEUROREPORT, V9, P3007, DOI 10.1097/00001756-199809140-00016; Brundege JM, 1996, J NEUROSCI, V16, P5603; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Dale N, 2000, J PHYSIOL-LONDON, V526, P143, DOI 10.1111/j.1469-7793.2000.00143.x; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Dunwiddie T V, 1999, Adv Neurol, V79, P1001; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; Etherington LAV, 2009, NEUROPHARMACOLOGY, V56, P429, DOI 10.1016/j.neuropharm.2008.09.016; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Frenguelli BG, 2003, J NEUROCHEM, V86, P1506, DOI 10.1046/j.1471-4159.2003.01957.x; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Gourine AV, 2008, J PHYSIOL-LONDON, V586, P3963, DOI 10.1113/jphysiol.2008.154567; Hirsh AJ, 2007, BIOCHEMISTRY-US, V46, P10373, DOI 10.1021/bi7009647; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Klyuch BP, 2011, J PHYSIOL-LONDON, V589, P283, DOI 10.1113/jphysiol.2010.198986; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Ma YF, 2011, CEREB CORTEX, V21, P2639, DOI 10.1093/cercor/bhr051; Meier C, 2002, HISTOCHEM CELL BIOL, V117, P461, DOI 10.1007/s00418-002-0417-z; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Santos SD, 2010, J PROTEOME RES, V9, P1670, DOI 10.1021/pr900766r; Schmitt LI, 2012, J NEUROSCI, V32, P4417, DOI 10.1523/JNEUROSCI.5689-11.2012; Sims RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053814; Studer FE, 2006, NEUROSCIENCE, V142, P125, DOI 10.1016/j.neuroscience.2006.06.016; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Torok TL, 2007, PROG NEUROBIOL, V82, P287, DOI 10.1016/j.pneurobio.2007.06.003; Wall MJ, 2007, J PHYSIOL-LONDON, V581, P553, DOI 10.1113/jphysiol.2006.126417; Wall MJ, 2013, J PHYSIOL-LONDON, V591, P3853, DOI 10.1113/jphysiol.2013.253450; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; zur Nedden S, 2011, J NEUROSCI, V31, P6221, DOI 10.1523/JNEUROSCI.4039-10.2011	43	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87481	10.1371/journal.pone.0087481	http://dx.doi.org/10.1371/journal.pone.0087481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489921	Green Published, Green Accepted, gold			2022-12-27	WOS:000330570000148
J	Alaimo, A; Alberdi, A; Gomis-Perez, C; Fernandez-Orth, J; Bernardo-Seisdedos, G; Malo, C; Millet, O; Areso, P; Villarroel, A				Alaimo, Alessandro; Alberdi, Araitz; Gomis-Perez, Carolina; Fernandez-Orth, Juncal; Bernardo-Seisdedos, Ganeko; Malo, Covadonga; Millet, Oscar; Areso, Pilar; Villarroel, Alvaro			Pivoting between Calmodulin Lobes Triggered by Calcium in the Kv7.2/Calmodulin Complex	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN-PEPTIDE; APO-CALMODULIN; GATING DOMAIN; IQ MOTIF; BINDING; CHANNELS; RECOGNITION; CALCINEURIN; MODULATION	Kv7.2 (KCNQ2) is the principal molecular component of the slow voltage gated M-channel, which strongly influences neuronal excitability. Calmodulin (CaM) binds to two intracellular C-terminal segments of Kv7.2 channels, helices A and B, and it is required for exit from the endoplasmic reticulum. However, the molecular mechanisms by which CaM controls channel trafficking are currently unknown. Here we used two complementary approaches to explore the molecular events underlying the association between CaM and Kv7.2 and their regulation by Ca2+. First, we performed a fluorometric assay using dansylated calmodulin (D-CaM) to characterize the interaction of its individual lobes to the Kv7.2 CaM binding site (Q2AB). Second, we explored the association of Q2AB with CaM by NMR spectroscopy, using N-15-labeled CaM as a reporter. The combined data highlight the interdependency of the N- and C-lobes of CaM in the interaction with Q2AB, suggesting that when CaM binds Ca2+ the binding interface pivots between the N-lobe whose interactions are dominated by helix B and the C-lobe where the predominant interaction is with helix A. In addition, Ca2+ makes CaM binding to Q2AB more difficult and, reciprocally, the channel weakens the association of CaM with Ca2+.	[Alaimo, Alessandro; Alberdi, Araitz; Gomis-Perez, Carolina; Fernandez-Orth, Juncal; Bernardo-Seisdedos, Ganeko; Malo, Covadonga; Villarroel, Alvaro] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain; [Areso, Pilar] Univ Basque Country, UPV EHU, Dept Farmacol, Leioa, Spain; [Millet, Oscar] CICbioGUNE, Struct Biol Unit, Derio, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Villarroel, A (corresponding author), Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain.	alvaro.villarroel@csic.es	Bernardo-Seisdedos, Ganeko/C-6923-2016; Arco, Mariangeles/C-6181-2016; Alaimo, Alessandro/C-6334-2016; Millet, Oscar/F-9696-2011; Gomis-Perez, Carolina/J-6472-2012; Villarroel, Alvaro/H-5580-2015	Bernardo-Seisdedos, Ganeko/0000-0002-1372-3844; Arco, Mariangeles/0000-0002-0993-7460; Alaimo, Alessandro/0000-0002-5888-6268; Millet, Oscar/0000-0001-8748-4105; Gomis-Perez, Carolina/0000-0002-6818-4403; 	Spanish Ministry of Education [BFU2012-39883, BFU2009-07581]; Spanish Ion Channel Initiative Consolider project [CSD2008-00005]; Basque Government [SAIOTEK SA-2006/00023, 304211ENA9]; Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation [BES-2008-002314]; CSIC; European Social Funds; Basque Country Government [BFI-2011-159]	Spanish Ministry of Education(Spanish Government); Spanish Ion Channel Initiative Consolider project; Basque Government(Basque Government); Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; European Social Funds(European Social Fund (ESF)); Basque Country Government(Basque Government)	This work was supported by grants from the Spanish Ministry of Education (BFU2012-39883 and BFU2009-07581), the Spanish Ion Channel Initiative Consolider project (CSD2008-00005), and the Basque Government (SAIOTEK SA-2006/00023 and 304211ENA9). A. Alaimo and C. Malo were partially funded by Fundacion Biofisica Bizkaia. J. Fernandez-Orth held a FPI fellowship from the Spanish Ministry of Science and Innovation (BES-2008-002314). A. Alberdi holds a JAE-predoctoral CSIC fellowship cofinanced with European Social Funds. G. Bernardo-Seisdedos holds a fellowship from the Basque Country Government (BFI-2011-159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2012, METHOD MOL BIOL, V998, P217; Alaimo A, 2013, J CELL SCI, V126, P244, DOI 10.1242/jcs.114082; Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Bellini G, 2010, GENEREVIEWS; Black DJ, 2010, BIOCHEMISTRY-US, V49, P78, DOI 10.1021/bi901695p; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Gomez-Posada JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025508; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; KINCAID RL, 1982, J BIOL CHEM, V257, P638; LINSE S, 1991, J BIOL CHEM, V266, P8050; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Mruk K, 2012, P NATL ACAD SCI USA, V109, P13579, DOI 10.1073/pnas.1207606109; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Selyanko AA, 1996, NEURON, V16, P151, DOI 10.1016/S0896-6273(00)80032-X; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Ye QL, 2006, BIOCHEMISTRY-US, V45, P738, DOI 10.1021/bi0521801; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941	52	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86711	10.1371/journal.pone.0086711	http://dx.doi.org/10.1371/journal.pone.0086711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489773	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000074
J	Giannelli, M; Sghedoni, R; Iacconi, C; Iori, M; Traino, AC; Guerrisi, M; Mascalchi, M; Toschi, N; Diciotti, S				Giannelli, Marco; Sghedoni, Roberto; Iacconi, Chiara; Iori, Mauro; Traino, Antonio Claudio; Guerrisi, Maria; Mascalchi, Mario; Toschi, Nicola; Diciotti, Stefano			MR Scanner Systems Should Be Adequately Characterized in Diffusion-MRI of the Breast	PLOS ONE			English	Article							PRINCIPAL EIGENVECTOR MEASUREMENTS; CARCINOMA IN-SITU; FRACTIONAL ANISOTROPY; NEOADJUVANT CHEMOTHERAPY; WEIGHTED MRI; MEAN DIFFUSIVITY; DIFFERENTIAL-DIAGNOSIS; TENSOR MRI; COEFFICIENT MEASUREMENTS; HEALTHY-SUBJECTS	Breast imaging represents a relatively recent and promising field of application of quantitative diffusion-MRI techniques. In view of the importance of guaranteeing and assessing its reliability in clinical as well as research settings, the aim of this study was to specifically characterize how the main MR scanner system-related factors affect quantitative measurements in diffusion-MRI of the breast. In particular, phantom acquisitions were performed on three 1.5 T MR scanner systems by different manufacturers, all equipped with a dedicated multi-channel breast coil as well as acquisition sequences for diffusion-MRI of the breast. We assessed the accuracy, inter-scan and inter-scanner reproducibility of the mean apparent diffusion coefficient measured along the main orthogonal directions (<ADC>) as well as of diffusion-tensor imaging (DTI)-derived mean diffusivity (MD) measurements. Additionally, we estimated spatial non-uniformity of <ADC> (NU<ADC>) and MD (NUMD) maps. We showed that the signal-to-noise ratio as well as overall calibration of high strength diffusion gradients system in typical acquisition sequences for diffusion-MRI of the breast varied across MR scanner systems, introducing systematic bias in the measurements of diffusion indices. While <ADC> and MD values were not appreciably different from each other, they substantially varied across MR scanner systems. The mean of the accuracies of measured <ADC> and MD was in the range [-2.3%, 11.9%], and the mean of the coefficients of variation for <ADC> and MD measurements across MR scanner systems was 6.8%. The coefficient of variation for repeated measurements of both <ADC> and MD was <1%, while NU<ADC> and NUMD values were <4%. Our results highlight that MR scanner system-related factors can substantially affect quantitative diffusion-MRI of the breast. Therefore, a specific quality control program for assessing and monitoring the performance of MR scanner systems for diffusion-MRI of the breast is highly recommended at every site, especially in multicenter and longitudinal studies.	[Giannelli, Marco; Traino, Antonio Claudio] Pisa Univ Hosp Azienda Ospedaliero Univ Pisana, Med Phys Unit, Pisa, Italy; [Sghedoni, Roberto; Iori, Mauro] IRCCS Arcispedale Santa Maria Nuova, Dept Oncol & Adv Tech, Med Phys Unit, Reggio Emilia, Italy; [Iacconi, Chiara] Massa Hosp, Div Radiol, Breast Unit, Azienda USL Massa & Carrara, Massa, Italy; [Guerrisi, Maria; Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, Rome, Italy; [Mascalchi, Mario; Diciotti, Stefano] Univ Florence, Dept Clin & Expt Biomed Sci, Florence, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Univ, Sch Med, Boston, MA USA; [Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Cesena, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Arcispedale S. Maria Nuova; University of Rome Tor Vergata; University of Florence; Harvard University; Harvard Medical School; University of Bologna	Giannelli, M (corresponding author), Pisa Univ Hosp Azienda Ospedaliero Univ Pisana, Med Phys Unit, Pisa, Italy.	m.giannelli@ao-pisa.toscana.it	Diciotti, Stefano/C-4167-2008; Iori, Mauro/K-2393-2018; Toschi, Nicola/J-2555-2012; Jovicich, Jorge/D-2293-2010; Giannelli, Marco/AAO-5778-2020; iacconi, chiara/U-6266-2017	Diciotti, Stefano/0000-0001-8778-7819; Iori, Mauro/0000-0002-8738-3352; Toschi, Nicola/0000-0003-1929-5833; iacconi, chiara/0000-0002-0729-4166; GUERRISI, MARIA GIOVANNA/0000-0002-7456-4349; Giannelli, Marco/0000-0002-4061-0490				Alexander AL, 2006, NEUROIMAG CLIN N AM, V16, P299, DOI 10.1016/j.nic.2006.02.006; Pereira FPA, 2011, MAGN RESON IMAGING C, V19, P95, DOI 10.1016/j.mric.2010.09.001; Baltzer PAT, 2011, EUR RADIOL, V21, P1, DOI 10.1007/s00330-010-1901-9; Bammer R, 2003, MAGNET RESON MED, V50, P560, DOI 10.1002/mrm.10545; Baron CA, 2012, MAGN RESON MED, V68, P1190, DOI 10.1002/mrm.24120; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bilgili MYK, 2012, EUR J RADIOL, V81, P2066, DOI 10.1016/j.ejrad.2011.06.045; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Braithwaite AC, 2009, RADIOLOGY, V250, P459, DOI 10.1148/radiol.2502080849; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Chen X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-693; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; Chenevert Thomas L, 2002, Mol Imaging, V1, P336, DOI 10.1162/153535002321093945; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Cutajar M, 2011, EUR J RADIOL, V80, pE263, DOI 10.1016/j.ejrad.2010.12.018; Delakis I, 2004, PHYS MED BIOL, V49, P1409, DOI 10.1088/0031-9155/49/8/003; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Einstein A, 1956, INVESTIGATIONS THEOR; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; Evans CJ, 2012, MAGN RESON MED; Eyal E, 2012, INVEST RADIOL, V47, P284, DOI 10.1097/RLI.0b013e3182438e5d; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Giannelli M, 2011, MED PHYS, V38, P3205, DOI 10.1118/1.3592013; Gibbs P, 2007, MAGN RESON IMAGING, V25, P1423, DOI 10.1016/j.mri.2007.03.030; Goh V, 2012, J MAGN RESON IMAGING, V35, P820, DOI 10.1002/jmri.22873; Guo Y, 2002, J MAGN RESON IMAGING, V16, P172, DOI 10.1002/jmri.10140; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Huang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047684; Iacconi C, 2011, RADIOLOGY, V259, P303, DOI 10.1148/radiol.10102057; Iacconi C, 2010, EUR RADIOL, V20, P303, DOI 10.1007/s00330-009-1550-z; Iima M, 2011, RADIOLOGY, V260, P364, DOI 10.1148/radiol.11101892; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2010, DIFFUSION MRI THEORY; Kazama T, 2012, J MAGN RESON IMAGING, V36, P139, DOI 10.1002/jmri.23626; Kim SY, 2012, J MAGN RESON IMAGING, V36, P1131, DOI 10.1002/jmri.23744; Kim SY, 2010, RADIOLOGY, V255, P815, DOI 10.1148/radiol.10091706; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; Landman BA, 2008, MAGN RESON IMAGING, V26, P790, DOI 10.1016/j.mri.2008.01.034; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Lauzon CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061737; Le Bihan D., 1995, DIFFUSION PERFUSION, V1st; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Magnusson P, 2000, MED PHYS, V27, P1980, DOI 10.1118/1.1286593; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; Manton DJ, 2006, BRIT J CANCER, V94, P427, DOI 10.1038/sj.bjc.6602948; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Martincich L, 2012, EUR RADIOL, V22, P1519, DOI 10.1007/s00330-012-2403-8; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; Meier C, 2008, MAGN RESON MED, V60, P128, DOI 10.1002/mrm.21615; Miquel ME, 2012, BRIT J RADIOL, V85, P1507, DOI 10.1259/bjr/32269440; Mohammadi S, 2012, NEUROIMAGE, V60, P562, DOI 10.1016/j.neuroimage.2011.12.009; Nagy Z, 2007, MAGN RESON MED, V58, P763, DOI 10.1002/mrm.21379; O'Flynn EAM, 2012, EUR RADIOL, V22, P1512, DOI 10.1007/s00330-012-2399-0; OCH JG, 1992, MED PHYS, V19, P217, DOI 10.1118/1.596903; Pagani E, 2010, J MAGN RESON IMAGING, V31, P1458, DOI 10.1002/jmri.22186; Park SH, 2010, RADIOLOGY, V257, P56, DOI 10.1148/radiol.10092021; Partridge SC, 2010, MAGN RESON IMAGING, V28, P320, DOI 10.1016/j.mri.2009.10.003; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P339, DOI 10.1002/jmri.22045; Partridge SC, 2009, AM J ROENTGENOL, V193, P1716, DOI 10.2214/AJR.08.2139; Petralia G, 2011, RADIOL MED, V116, P466, DOI 10.1007/s11547-011-0616-z; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Pickles MD, 2006, MAGN RESON IMAGING, V24, P843, DOI 10.1016/j.mri.2005.11.005; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; PRICE RR, 1990, MED PHYS, V17, P287, DOI 10.1118/1.596566; Rahbar H, 2012, RADIOLOGY, V263, P374, DOI 10.1148/radiol.12111368; Rosenkrantz AB, 2011, J MAGN RESON IMAGING, V33, P128, DOI 10.1002/jmri.22395; Rubesova E, 2006, J MAGN RESON IMAGING, V24, P319, DOI 10.1002/jmri.20643; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Schmithorst VJ, 2002, MAGNET RESON MED, V47, P208, DOI 10.1002/mrm.10022; Sharma U, 2009, NMR BIOMED, V22, P104, DOI 10.1002/nbm.1245; Sinha S, 2002, J MAGN RESON IMAGING, V15, P693, DOI 10.1002/jmri.10116; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tagliafico A, 2012, RADIOL MED, V117, P992, DOI 10.1007/s11547-012-0831-9; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Theilmann RJ, 2004, NEOPLASIA, V6, P831, DOI 10.1593/neo.03343; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Walker L., 2012, HUM BRAIN MAPP; Wang ZYJ, 2011, MED PHYS, V38, P4415, DOI 10.1118/1.3595111; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Woodhams R, 2010, RADIOLOGY, V254, P357, DOI 10.1148/radiol.2542090405; Woodhams R, 2009, AM J ROENTGENOL, V193, P260, DOI 10.2214/AJR.08.1670; Wu YC, 2007, J COMPUT ASSIST TOMO, V31, P984, DOI 10.1097/rct.0b013e31805152fa; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010	95	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86280	10.1371/journal.pone.0086280	http://dx.doi.org/10.1371/journal.pone.0086280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489711	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000044
J	Lutay, N; Hakansson, G; Alaridah, N; Hallgren, O; Westergren-Thorsson, G; Godaly, G				Lutay, Nataliya; Hakansson, Gisela; Alaridah, Nader; Hallgren, Oskar; Westergren-Thorsson, Gunilla; Godaly, Gabriela			Mycobacteria Bypass Mucosal NF-kB Signalling to Induce an Epithelial Anti-Inflammatory IL-22 and IL-10 Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HEPARIN-BINDING HEMAGGLUTININ; CALMETTE-GUERIN INFECTION; COMPLETE GENOME SEQUENCE; FACTOR-KAPPA-B; INNATE IMMUNITY; TRANSCRIPTION FACTORS; HOST-DEFENSE; INTRACELLULAR PERSISTENCE; DENDRITIC CELLS	The mechanisms by which mycobacteria subvert the inflammatory defence to establish chronic infection remain an unresolved question in the pathogenesis of tuberculosis. Using primary epithelial cells, we have analysed mycobacteria induced epithelial signalling pathways from activation of TLRs to cytokine secretion. Mycobacterium bovis bacilli Calmette-Guerin induced phosphorylation of glycogen synthase kinase (GSK)3 by PI3K-Akt in the signalling pathway downstream of TLR2 and TLR4. Mycobacteria did not supress NF-kappa B by activating the peroxisome proliferator-activated receptor gamma. Instead the pro-inflammatory NF-kappa B was bypassed by mycobacteria induced GSK3 inhibition that promoted the anti-inflammatory transcription factor CREB. Mycobacterial infection did not thus induce mucosal pro-inflammatory response as measured by TNF alpha and IFN gamma secretion, but led to an anti-inflammatory IL-10 and IL-22 production. Apart from CREB, MAP3Ks p38 and ERK1/2 activated the transcription factor AP-1 leading to IL-6 production. Interestingly, blocking of TLR4 before infection decreased epithelial IL-6 secretion, but increased the CREB-activated IL-10 production. Our data indicate that mycobacteria supress epithelial pro-inflammatory production by supressing NF-kappa B activation thereby shifting the infection towards an anti-inflammatory state. This balance between the host immune response and the pathogen could determine the outcome of infection.	[Lutay, Nataliya; Hakansson, Gisela; Alaridah, Nader; Godaly, Gabriela] Lund Univ, Div Lab Med, Dept MIG, Lund, Sweden; [Hallgren, Oskar] Lund Univ, Dept Resp Med & Allergol, Div Clin Sci, Lund, Sweden; [Westergren-Thorsson, Gunilla] Lund Univ, Div Vasc & Resp Res Unit Lung Biol, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University; Lund University	Godaly, G (corresponding author), Lund Univ, Div Lab Med, Dept MIG, Lund, Sweden.	Gabriela.godaly@med.lu.se	Godaly, Gabriela/AAD-7545-2019; Godaly, Gabriela/C-8786-2014; Lutay, Nataliya/K-1733-2014	Godaly, Gabriela/0000-0002-3467-1350; Godaly, Gabriela/0000-0002-3467-1350; Lutay, Nataliya/0000-0003-1852-1288; Alaridah, Nader/0000-0003-3659-8203	Swedish Medical Research Council [2005-7364, 7364, 11550]; Crafoord Foundation; Heart and Lung Foundation; Evy and Gunnar Sandberg Foundation; Medical Faculty of Lund University, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Crafoord Foundation; Heart and Lung Foundation(Swedish Heart-Lung Foundation); Evy and Gunnar Sandberg Foundation; Medical Faculty of Lund University, Sweden	This study was supported by a Research Scientist Grant from the Swedish Medical Research Council (2005-7364, 7364, 11550); the Crafoord Foundation; the Heart and Lung Foundation; Evy and Gunnar Sandberg Foundation and the Medical Faculty of Lund University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, SCAND J IMMUNOL, V62, P16, DOI 10.1111/j.1365-3083.2005.01639.x; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersson M, 2012, INNATE IMMUN-LONDON, V18, P531, DOI 10.1177/1753425911426591; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Caceres N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029010; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Florio W, 2009, CAN J MICROBIOL, V55, P975, DOI [10.1139/W09-053, 10.1139/w09-053]; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Godaly G, 2005, CELL MICROBIOL, V7, P591, DOI 10.1111/j.1462-5822.2004.00489.x; Gopal R, 2013, MUCOSAL IMMUNOL; Gutierrez MG, 2008, J IMMUNOL, V181, P2651, DOI 10.4049/jimmunol.181.4.2651; Hakansson G, 2012, IMMUNOBIOLOGY; Hershko DD, 2002, AM J PHYSIOL-REG I, V283, pR1140, DOI 10.1152/ajpregu.00161.2002; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jacobs M, 2000, IMMUNOLOGY, V100, P494, DOI 10.1046/j.1365-2567.2000.00053.x; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight D, 2011, PULM PHARMACOL THER, V24, P193, DOI 10.1016/j.pupt.2010.10.005; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Li Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/791392; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matthews K, TUBERCULOSIS EDINB, V91, P587; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; Mehta PK, 1996, INFECT IMMUN, V64, P2673, DOI 10.1128/IAI.64.7.2673-2679.1996; Mendez-Samperio P, 2007, CELL IMMUNOL, V245, P111, DOI 10.1016/j.cellimm.2007.04.005; Menozzi FD, 2006, MICROBES INFECT, V8, P1, DOI 10.1016/j.micinf.2005.03.023; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Muhl H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00018; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Neufert C, 2001, J IMMUNOL, V167, P1542, DOI 10.4049/jimmunol.167.3.1542; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x; Quesniaux VJ, 2004, J IMMUNOL, V172, P4425, DOI 10.4049/jimmunol.172.7.4425; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SILVA MT, 1989, MICROB PATHOGENESIS, V6, P369, DOI 10.1016/0882-4010(89)90079-X; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Toossi Z, 1997, J IMMUNOL, V159, P4109; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	69	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86466	10.1371/journal.pone.0086466	http://dx.doi.org/10.1371/journal.pone.0086466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489729	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000052
J	Lee, WJ; Kim, SC; Lee, SJ; Lee, J; Park, JH; Yu, KS; Lim, J; Kwon, SW				Lee, Won Jun; Kim, Sang Cheol; Lee, Seul Ji; Lee, Jeongmi; Park, Jeong Hill; Yu, Kyung-Sang; Lim, Johan; Kwon, Sung Won			Investigating the Different Mechanisms of Genotoxic and Non-Genotoxic Carcinogens by a Gene Set Analysis	PLOS ONE			English	Article							CANCER; DISCRIMINATION; SENSITIVITY; CLASSIFICATION; ASSAYS; LIVER; HEPG2	Based on the process of carcinogenesis, carcinogens are classified as either genotoxic or non-genotoxic. In contrast to non-genotoxic carcinogens, many genotoxic carcinogens have been reported to cause tumor in carcinogenic bioassays in animals. Thus evaluating the genotoxicity potential of chemicals is important to discriminate genotoxic from non-genotoxic carcinogens for health care and pharmaceutical industry safety. Additionally, investigating the difference between the mechanisms of genotoxic and non-genotoxic carcinogens could provide the foundation for a mechanism-based classification for unknown compounds. In this study, we investigated the gene expression of HepG2 cells treated with genotoxic or non-genotoxic carcinogens and compared their mechanisms of action. To enhance our understanding of the differences in the mechanisms of genotoxic and non-genotoxic carcinogens, we implemented a gene set analysis using 12 compounds for the training set (12, 24, 48 h) and validated significant gene sets using 22 compounds for the test set (24, 48 h). For a direct biological translation, we conducted a gene set analysis using Globaltest and selected significant gene sets. To validate the results, training and test compounds were predicted by the significant gene sets using a prediction analysis for microarrays (PAM). Finally, we obtained 6 gene sets, including sets enriched for genes involved in the adherens junction, bladder cancer, p53 signaling pathway, pathways in cancer, peroxisome and RNA degradation. Among the 6 gene sets, the bladder cancer and p53 signaling pathway sets were significant at 12, 24 and 48 h. We also found that the DDB2, RRM2B and GADD45A, genes related to the repair and damage prevention of DNA, were consistently up-regulated for genotoxic carcinogens. Our results suggest that a gene set analysis could provide a robust tool in the investigation of the different mechanisms of genotoxic and non-genotoxic carcinogens and construct a more detailed understanding of the perturbation of significant pathways.	[Lee, Won Jun; Lee, Seul Ji; Park, Jeong Hill; Kwon, Sung Won] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Won Jun; Lee, Seul Ji; Park, Jeong Hill; Kwon, Sung Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Kim, Sang Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Lee, Jeongmi] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Yu, Kyung-Sang] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea; [Lim, Johan] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea.	sckim.sgi@gmail.com; swkwon@snu.ac.kr	Lee, Jeongmi/AAJ-7720-2020; Yu, Kyung-Sang/J-2770-2012	Lee, Jeongmi/0000-0002-9948-7554; 	National Research Foundation (NRF); Korean government (Ministry of Education, Science and Technology) [NRF- 2011-0019639]; NRF of Korea; Ministry of Education, Science and Technology [NRF-2011-0023057]; Korean government (MSIP) [NRF-2011-0030810]	National Research Foundation (NRF); Korean government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NRF of Korea; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean government (MSIP)	This research was supported by Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (Ministry of Education, Science and Technology) (NRF- 2011-0019639), Basic Science Research Program through the NRF of Korea funded by the Ministry of Education, Science and Technology (NRF-2011-0023057) and NRF of Korea grant funded by the Korean government (MSIP)(NRF-2011-0030810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; Barckhausen C, 2013, ONCOGENE; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bruin SC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-662; Bylesjo M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-106; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Gollapudi BB, 2011, ENVIRON MOL MUTAGEN, V52, DOI 10.1002/em.20611; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hulsegge Ina, 2009, BMC Proc, V3 Suppl 4, pS10, DOI 10.1186/1753-6561-3-S4-S10; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim HS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-348; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Magkoufopoulou C, 2012, CARCINOGENESIS, V33, P1421, DOI 10.1093/carcin/bgs182; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; Oberthuer A, 2007, CANCER LETT, V250, P250, DOI 10.1016/j.canlet.2006.10.016; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011; Westerink WMA, 2010, MUTAT RES-GEN TOX EN, V696, P21, DOI 10.1016/j.mrgentox.2009.12.007; Williams GM, 2001, TOXICOLOGY, V166, P3, DOI 10.1016/S0300-483X(01)00442-5	28	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86700	10.1371/journal.pone.0086700	http://dx.doi.org/10.1371/journal.pone.0086700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497971	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900037
J	Truong, T; Boshra, H; Embury-Hyatt, C; Nfon, C; Gerdts, V; Tikoo, S; Babiuk, LA; Kara, P; Chetty, T; Mather, A; Wallace, DB; Babiuk, S				Thang Truong; Boshra, Hani; Embury-Hyatt, Carissa; Nfon, Charles; Gerdts, Volker; Tikoo, Suresh; Babiuk, Lorne A.; Kara, Pravesh; Chetty, Thireshni; Mather, Arshad; Wallace, David B.; Babiuk, Shawn			Peste des Petits Ruminants Virus Tissue Tropism and Pathogenesis in Sheep and Goats following Experimental Infection	PLOS ONE			English	Article							LUMPY SKIN-DISEASE; HEMAGGLUTININ PROTEIN; RINDERPEST VIRUS; PROTECTION; VACCINE; FUSION; CATTLE; MORBILLIVIRUS; PREVALENCE; GENES	Peste des petits ruminants (PPR) is a viral disease which primarily affects small ruminants, causing significant economic losses for the livestock industry in developing countries. It is endemic in Saharan and sub-Saharan Africa, the Middle East and the Indian sub-continent. The primary hosts for peste des petits ruminants virus (PPRV) are goats and sheep; however recent models studying the pathology, disease progression and viremia of PPRV have focused primarily on goat models. This study evaluates the tissue tropism and pathogenesis of PPR following experimental infection of sheep and goats using a quantitative time-course study. Upon infection with a virulent strain of PPRV, both sheep and goats developed clinical signs and lesions typical of PPR, although sheep displayed milder clinical disease compared to goats. Tissue tropism of PPRV was evaluated by real-time RT-PCR and immunohistochemistry. Lymph nodes, lymphoid tissue and digestive tract organs were the predominant sites of virus replication. The results presented in this study provide models for the comparative evaluation of PPRV pathogenesis and tissue tropism in both sheep and goats. These models are suitable for the establishment of experimental parameters necessary for the evaluation of vaccines, as well as further studies into PPRV-host interactions.	[Thang Truong; Boshra, Hani; Embury-Hyatt, Carissa; Nfon, Charles; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Gerdts, Volker; Tikoo, Suresh] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Tikoo, Suresh] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada; [Babiuk, Lorne A.] Univ Alberta, Edmonton, AB, Canada; [Kara, Pravesh; Chetty, Thireshni; Mather, Arshad; Wallace, David B.] ARC Onderstepoort Vet Inst, Onderstepoort, South Africa; [Wallace, David B.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Babiuk, Shawn] Univ Manitoba, Winnipeg, MB, Canada	Canadian Food Inspection Agency; University of Saskatchewan; University of Saskatchewan; University of Alberta; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Manitoba	Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	shawn.babiuk@inspection.gc.ca	Mather, Arshad/AAW-9138-2021; Truong, Thang/HGF-0213-2022; Boshra, Hani/M-2619-2014	Truong, Thang/0000-0002-0707-7452; Boshra, Hani/0000-0001-9924-8126; kara, Pravesh/0000-0002-0468-7896; Mather, Arshad/0000-0001-7455-2738; Chetty, Thireshni/0000-0003-4770-6476; Gerdts, Volker/0000-0001-8229-1611	Canadian International Development Research Centre (IDRC) [106930]; Canadian International Development Agency (CIDA)	Canadian International Development Research Centre (IDRC); Canadian International Development Agency (CIDA)	This work was funded from a Canadian International Food Security Research Fund (CIFSRF) grant (no. 106930: Livestock vaccines against viral diseases for sub-Saharan Africa) by the Canadian International Development Research Centre (IDRC) and Canadian International Development Agency (CIDA) and is supported by the respective research institutions to which the authors belong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Union International Bureau for Animal Resources, 2012, IMP LIV DIS AFR; Ayari-Fakhfakh E, 2011, VET J, V187, P402, DOI 10.1016/j.tvjl.2010.01.007; Ba JY, 2008, J VIROL METHODS, V148, P232, DOI 10.1016/j.jviromet.2007.12.003; Babiuk S, 2009, J GEN VIROL, V90, P105, DOI 10.1099/vir.0.004507-0; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Balamurugan V, 2012, J VET SCI, V13, P279, DOI 10.4142/jvs.2012.13.3.279; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Boshra H, 2013, ANTIVIR RES, V98, P217, DOI 10.1016/j.antiviral.2013.02.016; BUNDZA A, 1988, CAN J VET RES, V52, P46; Chandran D, 2010, INDIAN J MICROBIOL, V50, P266, DOI 10.1007/s12088-010-0026-9; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; de Vries RD, 2012, CURR OPIN VIROL, V2, P248, DOI 10.1016/j.coviro.2012.03.005; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; Diallo A., 2003, VVolume 114, P113; Diallo A, 2002, ANN NY ACAD SCI, V969, P88, DOI 10.1111/j.1749-6632.2002.tb04356.x; El Harrak M, 2012, J CLIN MICROBIOL, V50, P3738, DOI 10.1128/JCM.01785-12; Emikpe BO, 2010, VET RES COMMUN, V34, P569, DOI 10.1007/s11259-010-9425-y; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; Hammouchi M, 2012, VET MICROBIOL, V160, P240, DOI 10.1016/j.vetmic.2012.04.043; JANIGAN DT, 1961, CAN MED ASSOC J, V85, P741; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Malik YS, 2011, TRANSBOUND EMERG DIS, V58, P268, DOI 10.1111/j.1865-1682.2011.01201.x; NAWATHE DR, 1979, TROP ANIM HEALTH PRO, V11, P120, DOI 10.1007/BF02237785; Ngichabe CK, 2002, EPIDEMIOL INFECT, V128, P343, DOI 10.1017/S0950268801006513; Pope RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055830; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; ROMERO CH, 1995, VACCINE, V13, P36, DOI 10.1016/0264-410X(95)80008-2; ROMERO CH, 1994, VIROLOGY, V204, P425, DOI 10.1006/viro.1994.1548; ROMERO CH, 1994, VET REC, V135, P152, DOI 10.1136/vr.135.7.152; Saravanan P, 2004, ACTA VIROL, V48, P249; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; TAYLOR WP, 1979, RES VET SCI, V26, P236, DOI 10.1016/S0034-5288(18)32924-2; TAYLOR WP, 1979, RES VET SCI, V27, P321, DOI 10.1016/S0034-5288(18)32800-5; Toplu N, 2004, J COMP PATHOL, V131, P135, DOI 10.1016/j.jcpa.2004.02.004; Tourais-Esteves I, 2008, DEV COMP IMMUNOL, V32, P1231, DOI 10.1016/j.dci.2008.03.011; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817	41	84	86	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87145	10.1371/journal.pone.0087145	http://dx.doi.org/10.1371/journal.pone.0087145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498032	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100053
J	Dacheux, L; Cervantes-Gonzalez, M; Guigon, G; Thiberge, JM; Vandenbogaert, M; Maufrais, C; Caro, V; Bourhy, H				Dacheux, Laurent; Cervantes-Gonzalez, Minerva; Guigon, Ghislaine; Thiberge, Jean-Michel; Vandenbogaert, Mathias; Maufrais, Corinne; Caro, Valerie; Bourhy, Herve			A Preliminary Study of Viral Metagenomics of French Bat Species in Contact with Humans: Identification of New Mammalian Viruses	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; BORNA-DISEASE; GENETIC DIVERSITY; GENOME ANALYSIS; GENOGROUP-I; FRUIT BATS; PICOBIRNAVIRUSES; CORONAVIRUS; ORTHOREOVIRUS; ASTROVIRUSES	The prediction of viral zoonosis epidemics has become a major public health issue. A profound understanding of the viral population in key animal species acting as reservoirs represents an important step towards this goal. Bats harbor diverse viruses, some of which are of particular interest because they cause severe human diseases. However, little is known about the diversity of the global population of viruses found in bats (virome). We determined the viral diversity of five different French insectivorous bat species (nine specimens in total) in close contact with humans. Sequence-independent amplification, high-throughput sequencing with Illumina technology and a dedicated bioinformatics analysis pipeline were used on pooled tissues (brain, liver and lungs). Comparisons of the sequences of contigs and unassembled reads provided a global taxonomic distribution of virus-related sequences for each sample, highlighting differences both within and between bat species. Many viral families were present in these viromes, including viruses known to infect bacteria, plants/fungi, insects or vertebrates, the most relevant being those infecting mammals (Retroviridae, Herpesviridae, Bunyaviridae, Poxviridae, Flaviviridae, Reoviridae, Bornaviridae, Picobirnaviridae). In particular, we detected several new mammalian viruses, including rotaviruses, gammaretroviruses, bornaviruses and bunyaviruses with the identification of the first bat nairovirus. These observations demonstrate that bats naturally harbor viruses from many different families, most of which infect mammals. They may therefore constitute a major reservoir of viral diversity that should be analyzed carefully, to determine the role played by bats in the spread of zoonotic viral infections.	[Dacheux, Laurent; Cervantes-Gonzalez, Minerva; Bourhy, Herve] Inst Pasteur, Lyssavirus Dynam & Host Adaptat Unit, Natl Reference Ctr Rabies, WHO Reference Ctr Reference & Res Rabies, Paris, France; [Guigon, Ghislaine; Thiberge, Jean-Michel; Vandenbogaert, Mathias; Caro, Valerie] Inst Pasteur, Genotyping Pathogens & Publ Hlth Platform, Paris, France; [Maufrais, Corinne] Inst Pasteur, Comp Ctr Biol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dacheux, L (corresponding author), Inst Pasteur, Lyssavirus Dynam & Host Adaptat Unit, Natl Reference Ctr Rabies, WHO Reference Ctr Reference & Res Rabies, Paris, France.	laurent.dacheux@pasteur.fr	Dacheux, Laurent/AAJ-5372-2020	Vandenbogaert, Mathias/0000-0002-3073-9688; Dacheux, Laurent/0000-0002-4401-3706	Direction Generale de la Sante, France; PREDEMICS UE [278433]	Direction Generale de la Sante, France; PREDEMICS UE	This work was financed by the Direction Generale de la Sante, France, and PREDEMICS UE project No. 278433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Banyai K, 2008, J GEN VIROL, V89, P534, DOI 10.1099/vir.0.83134-0; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; BOURHY H, 1989, J CLIN MICROBIOL, V27, P519, DOI 10.1128/JCM.27.3.519-523.1989; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; BRUSSOW H, 1992, J CLIN MICROBIOL, V30, P67; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chu DKW, 2008, J VIROL, V82, P9107, DOI 10.1128/JVI.00857-08; Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104; Chua KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003803; Coffin J, 1997, RETROVIRUSES; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Cui J, 2012, J GEN VIROL, V93, P2037, DOI 10.1099/vir.0.043760-0; Cui J, 2012, J VIROL, V86, P4288, DOI 10.1128/JVI.06624-11; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2006, INFECT GENET EVOL, V6, P464, DOI 10.1016/j.meegid.2006.02.007; DELATORRE JC, 1990, VIROLOGY, V179, P853, DOI 10.1016/0042-6822(90)90154-J; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Estes MK, 2001, NOVART FDN SYMP, V238, P82; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Fenaux M, 2006, J VIROL, V80, P5219, DOI 10.1128/JVI.02664-05; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Ganesh B, 2012, REV MED VIROL, V22, P245, DOI 10.1002/rmv.1707; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ghosh S, 2011, J GEN VIROL, V92, P2201, DOI 10.1099/vir.0.033001-0; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Giordano MO, 2011, J INFECTION, V62, P45, DOI 10.1016/j.jinf.2010.09.031; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; He B, 2013, J VIROL; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Joffret ML, 2013, J GEN VIROL; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Kim HJ, 2011, VET MICROBIOL, V152, P291, DOI 10.1016/j.vetmic.2011.05.017; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lelli D, 2013, ZOONOSES PUBLIC HLTH, V60, P84, DOI 10.1111/zph.12001; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Lipkin WI, 2007, FIELDS VIROLOGY, P1449; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mackenzie JS, 2005, J NEUROVIROL, V11, P434, DOI 10.1080/13550280591002487; Maeda K, 2008, EMERG INFECT DIS, V14, P347, DOI 10.3201/eid1402.070932; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2006, J VIROL, V80, P3801, DOI 10.1128/JVI.80.8.3801-3810.2006; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; NICHOL ST, 2001, FIELDS VIROLOGY, V2, P1603; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Poon LLM, 2005, J VIROL, V79, P2001, DOI 10.1128/JVI.79.4.2001-2009.2005; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Smits SL, 2012, EMERG INFECT DIS, V18, P1539, DOI 10.3201/eid1809.120507; Smits SL, 2011, EMERG INFECT DIS, V17, P2328, DOI 10.3201/eid1712.110934; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Walter CT, 2011, J GEN VIROL, V92, P80, DOI 10.1099/vir.0.024240-0; Watanabe S, 2010, EMERG INFECT DIS, V16, P986, DOI 10.3201/eid1606.091567; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu HC, 2009, J GEN VIROL, V90, P883, DOI 10.1099/vir.0.007732-0	86	79	79	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87194	10.1371/journal.pone.0087194	http://dx.doi.org/10.1371/journal.pone.0087194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489870	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000119
J	Salvadori, MR; Ando, RA; do Nascimento, CAO; Correa, B				Salvadori, Marcia R.; Ando, Romulo A.; Oller do Nascimento, Claudio A.; Correa, Benedito			Intracellular Biosynthesis and Removal of Copper Nanoparticles by Dead Biomass of Yeast Isolated from the Wastewater of a Mine in the Brazilian Amazonia	PLOS ONE			English	Article							BIOLOGICAL SYNTHESIS; AQUEOUS-SOLUTION; HEAVY-METAL; MICROBIAL SYNTHESIS; BIOSORPTION; CADMIUM; OXIDE; IONS; FABRICATION; ADSORPTION	In this study was developed a natural process using a biological system for the biosynthesis of nanoparticles (NPs) and possible removal of copper from wastewater by dead biomass of the yeast Rhodotorula mucilaginosa. Dead and live biomass of Rhodotorula mucilaginosa was used to analyze the equilibrium and kinetics of copper biosorption by the yeast in function of the initial metal concentration, contact time, pH, temperature, agitation and inoculum volume. Dead biomass exhibited the highest biosorption capacity of copper, 26.2 mg g(-1), which was achieved within 60 min of contact, at pH 5.0, temperature of 30 degrees C, and agitation speed of 150 rpm. The equilibrium data were best described by the Langmuir isotherm and Kinetic analysis indicated a pseudo-second-order model. The average size, morphology and location of NPs biosynthesized by the yeast were determined by scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDS) and transmission electron microscopy (TEM). The shape of the intracellularly synthesized NPs was mainly spherical, with an average size of 10.5 nm. The X-ray photoelectron spectroscopy (XPS) analysis of the copper NPs confirmed the formation of metallic copper. The dead biomass of Rhodotorula mucilaginosa may be considered an efficiently bioprocess, being fast and low-cost to production of copper nanoparticles and also a probably nano-adsorbent of this metal ion in wastewater in bioremediation process.	[Salvadori, Marcia R.; Correa, Benedito] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Sao Paulo, Brazil; [Ando, Romulo A.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil; [Oller do Nascimento, Claudio A.] Univ Sao Paulo, Dept Engn Quim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Salvadori, MR (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed 2, Sao Paulo, Brazil.	mrsal@usp.br	Ando, Romulo Augusto/C-9665-2012; Nascimento, Claudio A.O./G-8565-2014	Ando, Romulo Augusto/0000-0002-3872-8094; Nascimento, Claudio A.O./0000-0001-6110-0249; Correa, Benedito/0000-0003-4314-0751; Salvadori, Marcia Regina/0000-0001-6771-5447	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri M, 2009, MATER LETT, V63, P1231, DOI 10.1016/j.matlet.2009.02.042; Ahmad Iqbal, 2006, Indian J Exp Biol, V44, P73; Aizpurua J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057401; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Bharde AA, 2008, LANGMUIR, V24, P5787, DOI 10.1021/la704019p; Bishnoi NR, 2005, J SCI IND RES INDIA, V64, P93; Briggs D., 1990, PRATICAL SURFACE ANA, V1; Cho DH, 2003, BIOPROC BIOSYST ENG, V25, P271, DOI 10.1007/s00449-002-0315-8; Cho DH, 2002, THEORIES APPL CHEM E, V8, P4037; DAMERON CT, 1989, NATURE, V338, P596, DOI 10.1038/338596a0; Du AX, 2009, WATER AIR SOIL POLL, V201, P99, DOI 10.1007/s11270-008-9930-6; Elmaci A, 2007, WATER ENVIRON RES, V79, P1000, DOI 10.2175/106143007X183961; Evans P, 2008, NAT NANOTECHNOL, V3, P577, DOI 10.1038/nnano.2008.286; Faryal R, 2006, PAK J BOT, V38, P817; FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; Gericke M, 2006, GOLD BULL, V39, P22, DOI 10.1007/BF03215529; Ghodselahi T, 2008, APPL SURF SCI, V255, P2730, DOI 10.1016/j.apsusc.2008.08.110; Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Grimm A, 2008, BIORESOURCE TECHNOL, V99, P2559, DOI 10.1016/j.biortech.2007.04.036; Guo ZH, 2007, COMPOS SCI TECHNOL, V67, P2036, DOI 10.1016/j.compscitech.2006.11.017; Hasan SS, 2008, J NANOSCI NANOTECHNO, V8, P3191, DOI 10.1166/jnn.2008.095; He SY, 2008, BIOTECHNOL PROGR, V24, P476, DOI 10.1021/bp0703174; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Honary S, 2012, DIG J NANOMATER BIOS, V7, P999; Jeong S, 2008, ADV FUNCT MATER, V18, P679, DOI 10.1002/adfm.200700902; Jha AK, 2009, BIOCHEM ENG J, V43, P303, DOI 10.1016/j.bej.2008.10.016; Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321; Kowshik M, 2002, ADV MATER, V14, P815, DOI 10.1002/1521-4095(20020605)14:11<815::AID-ADMA815>3.0.CO;2-K; Kowshik M, 2002, BIOTECHNOL BIOENG, V78, P583, DOI 10.1002/bit.10233; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kumar BN, 2011, SEP SCI TECHNOL, V46, P997, DOI 10.1080/01496395.2010.537727; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Li YM, 2008, MATER RES BULL, V43, P2380, DOI 10.1016/j.materresbull.2007.07.045; Li Z, 2008, BIORESOURCE TECHNOL, V99, P1339, DOI 10.1016/j.biortech.2007.02.004; Li ZJ, 2006, APPL MICROBIOL BIOT, V73, P458, DOI 10.1007/s00253-006-0473-8; Liu YG, 2006, T NONFERR METAL SOC, V16, P681, DOI 10.1016/S1003-6326(06)60121-0; Machado MD, 2010, J HAZARD MATER, V180, P347, DOI 10.1016/j.jhazmat.2010.04.037; Nakajima A, 2001, WORLD J MICROB BIOT, V17, P343, DOI 10.1023/A:1016638230043; Naumkin A. V., 2012, 20 NIST; Neter J., 1996, APPL LINEAR STAT MOD; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; Nimrichter L, 2005, MICROBES INFECT, V7, P789, DOI 10.1016/j.micinf.2005.03.002; PANDAY KK, 1986, WATER AIR SOIL POLL, V27, P287, DOI 10.1007/BF00649410; Rai A, 2006, LANGMUIR, V22, P736, DOI 10.1021/la052055q; Ramanathan R, 2013, NANOSCALE, V5, P2300, DOI 10.1039/c2nr32887a; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989; ROME L, 1987, APPL MICROBIOL BIOT, V26, P84, DOI DOI 10.1007/BF00282153; Sanghi R, 2009, BIORESOURCE TECHNOL, V100, P501, DOI 10.1016/j.biortech.2008.05.048; Selatnia A, 2004, BIOCHEM ENG J, V19, P127, DOI 10.1016/j.bej.2003.12.007; Singh AV, 2010, CURR NANOSCI, V6, P365; Tortora G., 1998, MICROBIOLOGY INTRO; Varshney R., 2012, NANO BIOMED ENG, V4, P99, DOI [10.5101/nbe.v4i2.p99-106, DOI 10.5101/NBE.V4I2.P99-106]; Veit MT, 2005, PROCESS BIOCHEM, V40, P3303, DOI 10.1016/j.procbio.2005.03.029; Villegas LB, 2005, J BASIC MICROB, V45, P381, DOI 10.1002/jobm.200510569; Volesky B, 2003, HYDROMETALLURGY, V71, P179, DOI 10.1016/S0304-386X(03)00155-5; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104; Yilmazer P, 2009, J CHEM TECHNOL BIOT, V84, P604, DOI 10.1002/jctb.2088; Zhang DL, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159551	64	59	59	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87968	10.1371/journal.pone.0087968	http://dx.doi.org/10.1371/journal.pone.0087968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489975	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000185
J	Testini, M; Gurrado, A; Portincasa, P; Scacco, S; Marzullo, A; Piccinni, G; Lissidini, G; Greco, L; De Salvia, MA; Bonfrate, L; Debellis, L; Sardaro, N; Staffieri, F; Carratu, MR; Crovace, A				Testini, Mario; Gurrado, Angela; Portincasa, Piero; Scacco, Salvatore; Marzullo, Andrea; Piccinni, Giuseppe; Lissidini, Germana; Greco, Luigi; De Salvia, Maria Antonietta; Bonfrate, Leonilde; Debellis, Lucantonio; Sardaro, Nicola; Staffieri, Francesco; Carratu, Maria Rosaria; Crovace, Antonio			Bovine Pericardium Patch Wrapping Intestinal Anastomosis Improves Healing Process and Prevents Leakage in a Pig Model	PLOS ONE			English	Article							STAPLE-LINES; COLORECTAL SURGERY; BURST PRESSURE; IN-VITRO; REINFORCEMENT; COLON; BUTTRESS; BOWEL; RAT	Failure of intestinal anastomosis is a major complication following abdominal surgery. Biological materials have been introduced as reinforcement of abdominal wall hernia in contaminated setting. An innovative application of biological patch is its use as reinforcement of gastrointestinal anastomosis. The aim of study was to verify whether the bovine pericardium patch improves the healing of anastomosis, when in vivo wrapping the suture line of pig intestinal anastomosis, avoiding leakage in the event of deliberately incomplete suture. Forty-three pigs were randomly divided: Group 1 (control, n = 14): hand-sewn ileo-ileal and colo-colic anastomosis; Group 2 (n = 14): standard anastomosis wrapped by pericardium bovine patch; Group 3 (n = 1) and 4 (n = 14): one suture was deliberately incomplete and also wrapped by patch in the last one. Intraoperative evaluation, histological, biochemical, tensiometric and electrophysiological studies of intestinal specimens were performed at 48 h, 7 and 90 days after. In groups 2 and 4, no leak, stenosis, abscess, peritonitis, mesh displacement or shrinkage were found and adhesion rate decreased compared to control. Biochemical studies showed mitochondrial function improvement in colic wrapped anastomosis. Tensiometric evaluations suggested that the patch preserves the colic contractility similar to the controls. Electrophysiological results demonstrated that the patch also improves the mucosal function restoring almost normal transport properties. Use of pericardium bovine patch as reinforcement of intestinal anastomosis is safe and effective, significantly improving the healing process. Data of prevention of acute peritonitis and leakage in cases of iatrogenic perforation of anastomoses, covered with patch, is unpublished.	[Testini, Mario; Gurrado, Angela; Piccinni, Giuseppe; Lissidini, Germana] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Endocrine Digest & Emergency Surg, Bari, Italy; [Portincasa, Piero; Bonfrate, Leonilde] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Med A Murri, Bari, Italy; [Scacco, Salvatore; Sardaro, Nicola] Univ Med Sch A Moro, Dept Basic Med Sci, Bari, Italy; [Marzullo, Andrea] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Unit Pathol, Bari, Italy; [Greco, Luigi] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Unit Gen Surg & Liver Transplantat, Bari, Italy; [De Salvia, Maria Antonietta; Carratu, Maria Rosaria] Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Sect Pharmachol, Bari, Italy; [Debellis, Lucantonio] Univ Med Sch A Moro, Dept Biosci Biotechnol & Pharmacol Sci, Bari, Italy; [Staffieri, Francesco; Crovace, Antonio] Univ Med Sch A Moro, Dept Emergency Surg & Organ Transplantat, Div Vet Clin & Anim Prod, Bari, Italy		Testini, M (corresponding author), Univ Med Sch A Moro, Dept Biomed Sci & Human Oncol, Unit Endocrine Digest & Emergency Surg, Bari, Italy.	mario.testini@uniba.it	Bonfrate, Leonilde/ABH-1835-2021; Scacco, Salvatore/AAC-7406-2022; Lissidini, Germana/AAP-7189-2020; Staffieri, Francesco/K-4230-2016; crovace, antonio/K-6375-2016	Scacco, Salvatore/0000-0003-2717-2489; Debellis, Lucantonio/0000-0002-7571-0969; De Salvia, Maria Antonietta/0000-0001-5326-792X; Staffieri, Francesco/0000-0002-2085-376X; crovace, antonio/0000-0002-1391-339X; portincasa, piero/0000-0001-5359-1471; Testini, Mario/0000-0002-9297-4894; Carratu, Maria/0000-0002-9709-6533				Arnold W, 2005, OBES SURG, V15, P164, DOI 10.1381/0960892053268309; BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P395, DOI 10.1016/0006-2944(78)90089-3; CRAWFORD FA, 1986, ANN THORAC SURG, V41, P602, DOI 10.1016/S0003-4975(10)63068-8; Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074; Dilek ON, 1996, ACTA CHIR BELG, V96, P261; DOCHERTY JG, 1995, ANN SURG, V221, P176, DOI 10.1097/00000658-199502000-00008; Downey DM, 2005, OBES SURG, V15, P1379, DOI 10.1381/096089205774859254; Enestvedt CK, 2006, MICROSURG, V26, P137, DOI 10.1002/micr.20198; Gaertner WB, 2010, J BIOMED MATER RES B, V92B, P48, DOI 10.1002/jbm.b.31488; Hagerman GF, 2007, DIS COLON RECTUM, V50, P1053, DOI 10.1007/s10350-007-0212-y; Hoeppner J, 2010, EUR SURG RES, V45, P68, DOI 10.1159/000318856; Hoeppner J, 2010, J GASTROINTEST SURG, V14, P977, DOI 10.1007/s11605-010-1191-1; Hoeppner J, 2009, INT J COLORECTAL DIS, V24, P543, DOI 10.1007/s00384-009-0637-y; HUTSON JM, 1985, ANN ROY COLL SURG, V67, P107; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Kimberger O, 2007, ANESTH ANALG, V105, P773, DOI 10.1213/01.ane.0000277490.90387.96; Kosmidis C, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-6; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG647, DOI 10.1152/ajpgi.00183.2006; Morell VO, 2007, ANN THORAC SURG, V84, P1312, DOI 10.1016/j.athoracsur.2007.05.036; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; Nocca D, 2009, J LAPAROENDOSC ADV S, V19, P79, DOI 10.1089/lap.2008.0028; Portillo G, 2010, J LAPAROENDOSC ADV S, V20, P323, DOI 10.1089/lap.2009.0201; Schreinemacher MH, 2011, INT J COLORECTAL DIS, V26, P729, DOI 10.1007/s00384-011-1158-z; Shikora SA, 2003, OBES SURG, V13, P37, DOI 10.1381/096089203321136566; Telem DA, 2010, ARCH SURG-CHICAGO, V145, P371, DOI 10.1001/archsurg.2010.40; Testini M, 1998, EUR SURG RES, V30, P1, DOI 10.1159/000008551; Testini M, 2002, WORLD J SURG, V26, P493, DOI 10.1007/s00268-001-0255-5; Testini M, 2003, ANN ITAL CHIR, V74, P247; van Tuil Cornelia, 2006, Hernia, V10, P41; Zacharakis E, 2007, J INVEST SURG, V20, P9, DOI 10.1080/08941930601126074; Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3	33	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86627	10.1371/journal.pone.0086627	http://dx.doi.org/10.1371/journal.pone.0086627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489752	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000052
J	He, DX; Jin, D; Baquero, C; Liu, DY				He, Dongxiao; Jin, Di; Baquero, Carlos; Liu, Dayou			Link Community Detection Using Generative Model and Nonnegative Matrix Factorization	PLOS ONE			English	Article							COMPLEX NETWORKS	Discovery of communities in complex networks is a fundamental data analysis problem with applications in various domains. While most of the existing approaches have focused on discovering communities of nodes, recent studies have shown the advantages and uses of link community discovery in networks. Generative models provide a promising class of techniques for the identification of modular structures in networks, but most generative models mainly focus on the detection of node communities rather than link communities. In this work, we propose a generative model, which is based on the importance of each node when forming links in each community, to describe the structure of link communities. We proceed to fit the model parameters by taking it as an optimization problem, and solve it using nonnegative matrix factorization. Thereafter, in order to automatically determine the number of communities, we extend the above method by introducing a strategy of iterative bipartition. This extended method not only finds the number of communities all by itself, but also obtains high efficiency, and thus it is more suitable to deal with large and unexplored real networks. We test this approach on both synthetic benchmarks and real-world networks including an application on a large biological network, and compare it with two highly related methods. Results demonstrate the superior performance of our approach over competing methods for the detection of link communities.	[He, Dongxiao; Liu, Dayou] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [He, Dongxiao; Jin, Di; Liu, Dayou] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Jin, Di] Tianjin Univ, Sch Comp Sci & Technol, Tianjin 300072, Peoples R China; [Jin, Di] Bournemouth Univ, Sch Design Engn & Comp, Poole BH12 5BB, Dorset, England; [Baquero, Carlos] INESC TEC, HASLab, Braga, Portugal; [Baquero, Carlos] Univ Minho, Braga, Portugal	Jilin University; Jilin University; Tianjin University; Bournemouth University; INESC TEC; Universidade do Minho	Jin, D (corresponding author), Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	jindi@tju.edu.cn; liudy@jlu.edu.cn	Jin, Di/AAC-3716-2019; Baquero, Carlos/AAA-2371-2021	Baquero, Carlos/0000-0002-3933-6850	Major State Basic Research Development Program of China [2013CB329301]; National Natural Science Foundation of China [61303110, 61133011, 61373053, 61070089, 61373165, 61202308]; PhD Programs Foundation of Ministry of Education of China [20130032120043]; Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education [93K172013K02]; Innovation Foundation of Tianjin University [60302034]; TECHNO II project within Erasmus Mundus Programme of European Union; China Scholarship Council	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education; Innovation Foundation of Tianjin University; TECHNO II project within Erasmus Mundus Programme of European Union; China Scholarship Council(China Scholarship Council)	This work is supported by Major State Basic Research Development Program of China (2013CB329301), National Natural Science Foundation of China (61303110, 61133011, 61373053, 61070089, 61373165, 61202308), PhD Programs Foundation of Ministry of Education of China (20130032120043), Open Project Program of Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education (93K172013K02), Innovation Foundation of Tianjin University (60302034), the TECHNO II project within Erasmus Mundus Programme of European Union, and the China Scholarship Council (award to Dongxiao He for one year's study abroad at Washington University in St Louis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Altman DG., 1999, PRACTICAL STAT MED R; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Boyd S., 2004, CONVEX OPTIMIZATION; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grunwald P. D., 2007, MINIMUM DESCRIPTION; He DX, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/10/P10015; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kim Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026110; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pan L, 2011, PROC INT C TOOLS ART, P884, DOI 10.1109/ICTAI.2011.140; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Ren W, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036111; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shen HW, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056111; Tan VYF, 2013, IEEE T PATTERN ANAL, V35, P1592, DOI 10.1109/TPAMI.2012.240; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Xie JR, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2501654.2501657; Zhang Y., 2012, P 18 ACM SIGKDD INT, P606, DOI [DOI 10.1145/2339530.2339629, 10.1145/2339530.2339629]; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803	31	14	16	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86899	10.1371/journal.pone.0086899	http://dx.doi.org/10.1371/journal.pone.0086899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489803	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000088
J	Leonard, SM; Perry, T; Woodman, CB; Kearns, P				Leonard, Sarah M.; Perry, Tracey; Woodman, Ciaran B.; Kearns, Pamela			Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia	PLOS ONE			English	Article							LOW-DOSE DECITABINE; DNA METHYLATION; PHASE-II; 5-AZA-2'-DEOXYCYTIDINE; MULTICENTER; COMBINATION; INHIBITORS; CELLS	The current interest in epigenetic priming is underpinned by the belief that remodelling of the epigenetic landscape will sensitise tumours to subsequent therapy. In this pre-clinical study, paediatric AML cells expanded in culture and primary AML xenografts were treated with decitabine, a DNA demethylating agent, and cytarabine, a frontline cytotoxic agent used in the treatment of AML, either alone or in combination. Sequential treatment with decitabine and cytarabine was found to be more effective in reducing tumour burden than treatment with cytarabine alone suggesting that the sequential delivery of these agents may a have real clinical advantage in the treatment of paediatric AML. However we found no evidence to suggest that this outcome was dependent on priming with a hypomethylating agent, as the benefits observed were independent of the order in which these drugs were administered.	[Leonard, Sarah M.; Perry, Tracey; Woodman, Ciaran B.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England; [Kearns, Pamela] Univ Birmingham, Sch Canc Sci, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England	University of Birmingham; Cancer Research UK; University of Birmingham	Woodman, CB (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England.	c.b.woodman@bham.ac.uk; p.r.kearns@bham.ac.uk	Kearns, Pamela/AAD-6011-2021	Kearns, Pamela/0000-0003-2756-5813	Leukemia and Lymphoma Research UK; Janssen Research and Development	Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); Janssen Research and Development	This work was supported by Leukemia and Lymphoma Research UK and by Janssen Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salihi M, 2011, EPIGENETICS-US, V6, P1021, DOI 10.4161/epi.6.8.16064; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; BOEHM TLJ, 1982, CANCER RES, V42, P1537; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Claus R, 2013, LEUKEMIA RES, V37, P190, DOI 10.1016/j.leukres.2012.10.015; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Link PA, 2008, CANCER RES, V68, P9358, DOI 10.1158/0008-5472.CAN-08-1860; Mims A, 2013, LEUKEMIA, V27, P871, DOI 10.1038/leu.2012.342; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Phillips CL, 2013, BRIT J HAEMATOL, V161, P406, DOI 10.1111/bjh.12268; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Ricart AD, 2011, CLIN CANCER RES, V17, P6417, DOI 10.1158/1078-0432.CCR-11-0486; Scandura JM, 2011, BLOOD, V118, P1472, DOI 10.1182/blood-2010-11-320093; Schuringa Jan Jacob, 2009, V538, P287, DOI 10.1007/978-1-59745-418-6_14; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; van Gosliga D, 2007, EXP HEMATOL, V35, P1538, DOI 10.1016/j.exphem.2007.07.001; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956	21	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87475	10.1371/journal.pone.0087475	http://dx.doi.org/10.1371/journal.pone.0087475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489920	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000137
J	Zhao, F; Pan, SL; Gu, Y; Guo, SY; Dai, QC; Yu, YY; Zhang, W				Zhao, Feng; Pan, Shengli; Gu, Yan; Guo, Shanyu; Dai, Qiancheng; Yu, Yingyan; Zhang, Wei			Small Activating RNA Restores the Activity of the Tumor Suppressor HIC-1 on Breast Cancer	PLOS ONE			English	Article							INDUCE TRANSCRIPTIONAL ACTIVATION; MAMMALIAN-CELLS; BINDING PROTEIN; UP-REGULATION; EXPRESSION; GENE; KINASE; OVEREXPRESSION; APOPTOSIS; INVASION	HIC-1 is a gene that is hypermethylated in cancer, and commonly downregulated in human breast cancer. However, the precise mechanisms and molecular pathways regulated by HIC-1 remain unclear. We assessed HIC-1 expression on a tissue microarray containing 80 cases of breast cancer. We also analyzed its biological function by restoring HIC-1 expression using 5-aza-2' deoxycytidine (5-CdR) and small-activating RNAs for the reversal of HIC-1 tumor suppressive effects on MCF-7 and MDA-MB-231 cell lines. An Agilent Q44h global expressing microarray was probed after restoring the expression of HIC-1. Data demonstrated that HIC-1 expression was reduced significantly in breast cancer tissues. HIC-1 immunohistochemistry resulted in mean staining scores in cancer tissue and normal ductal epithelia of 3.54 and 8.2, respectively (p < 0.01). 5-CdR partially reversed HIC-1 expression, and modulated cell growth and apoptosis. dsHIC1-2998, an saRNA, showed activating efficacy in breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray. Upon saRNA treatment, genes upregulated included those involved in immune activation, cell cycle interference, the induction of apoptosis, anti-metastasis, and cell differentiation. Downregulated genes included oncogenes and those that play roles in cell invasion, cell growth, and cell division. Our findings may provide valuable resources not only for gene functional studies, but also for potential clinical applications to develop novel drug targets.	[Zhao, Feng; Gu, Yan; Guo, Shanyu; Dai, Qiancheng; Zhang, Wei] Shanghai Jiao Tong Univ, Dept Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yu, Yingyan] Shanghai Jiao Tong Univ, Dept Surg, Shanghai Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, W (corresponding author), Shanghai Jiao Tong Univ, Dept Surg, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China.	weizh1518@hotmail.com	Gu, Yan/AFQ-1163-2022		National High Tech Program [2012AA02A504, 2012AA02A203]; National Natural Science Foundation of China [81172329, 81372644]; Shanghai Science and Technology Commission [12410706400]	National High Tech Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was partly supported by the National High Tech Program (2012AA02A504, 2012AA02A203); National Natural Science Foundation of China (81172329 and 81372644), and the International Cooperative Project from Shanghai Science and Technology Commission (12410706400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann V, 2001, J PATHOL, V195, P191, DOI 10.1002/path.941; Bando Hiroko, 2007, Breast Cancer, V14, P163, DOI 10.2325/jbcs.968; Berlingieri MT, 2007, EUR J CANCER, V43, P2729, DOI 10.1016/j.ejca.2007.09.003; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen Z, 2008, MOL CANCER THER, V7, P698, DOI 10.1158/1535-7163.MCT-07-2312; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Fujita T, 2009, CANCER SCI, V100, P238, DOI 10.1111/j.1349-7006.2008.01026.x; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Hall CL, 1995, J NEURO-ONCOL, V26, P221, DOI 10.1007/BF01052625; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hassan ZK, 2012, ASIAN PAC J CANCER P, V13, P3259, DOI 10.7314/APJCP.2012.13.7.3259; Hirata A, 2005, CANCER RES, V65, P4253, DOI 10.1158/0008-5472.CAN-04-2748; Hu J, 2012, BIOCHEM J, V447, P407, DOI 10.1042/BJ20120256; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Hur JY, 2004, P NATL ACAD SCI USA, V101, P2351, DOI 10.1073/pnas.0307337101; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kang MR, 2012, CANCER RES, V72, P5069, DOI 10.1158/0008-5472.CAN-12-1871; Krishnan A, 2008, BIOCHEM PHARMACOL, V75, P1924, DOI 10.1016/j.bcp.2008.02.013; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Lopez-Munoz E, 2012, CLIN TRANSL ONCOL, V14, P586, DOI 10.1007/s12094-012-0845-8; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Mao QQ, 2008, BIOCHEM BIOPH RES CO, V375, P566, DOI 10.1016/j.bbrc.2008.08.059; Mao ZG, 2010, APOPTOSIS, V15, P1211, DOI 10.1007/s10495-010-0513-9; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Nicoll G, 2001, BRIT J CANCER, V85, P1878, DOI 10.1054/bjoc.2001.2163; O'Donovan N, 2007, ANTICANCER RES, V27, P1285; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Pan SL, 2013, GENE, V527, P102, DOI 10.1016/j.gene.2013.05.034; Parrella P, 2005, CANCER LETT, V222, P75, DOI 10.1016/j.canlet.2004.08.026; Place RF, 2010, CURR PHARM BIOTECHNO, V11, P518; Portnoy V, 2011, WIRES RNA, V2, P748, DOI 10.1002/wrna.90; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Pushparaj PN, 2008, BIOINFORMATION, V2, P235, DOI 10.6026/97320630002235; Qin Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-11; Radetzki S, 2002, ONCOGENE, V21, P227, DOI 10.1038/sj/onc/1205010; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Rood BR, 2013, EXPERT OPIN THER TAR, V17, P811, DOI 10.1517/14728222.2013.788152; Sankaran D, 2012, J BIOL CHEM, V287, P5483, DOI 10.1074/jbc.M111.324632; Shen DY, 2010, LIVER INT, V30, P119, DOI 10.1111/j.1478-3231.2009.02106.x; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Slotky M, 2005, BREAST CANCER RES, V7, pR737, DOI 10.1186/bcr1278; Soung YH, 2008, HUM PATHOL, V39, P895, DOI 10.1016/j.humpath.2007.10.015; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Tokuda Y, 2009, BREAST CANCER-TOKYO, V16, P295, DOI 10.1007/s12282-009-0142-8; Ueda S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-384; URIA JA, 1994, CANCER RES, V54, P2091; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Wall NR, 2003, LANCET, V362, P1401, DOI 10.1016/S0140-6736(03)14637-5; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Ward S, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13suppl1/01; Wei JX, 2010, CANCER SCI, V101, P1790, DOI 10.1111/j.1349-7006.2010.01594.x; Westbrook L, 2007, CANCER RES, V67, P11393, DOI 10.1158/0008-5472.CAN-06-4173; Westbrook L, 2009, INT J ONCOL, V34, P1425, DOI 10.3892/ijo_00000271; Yang SX, 2011, INT J ONCOL, V38, P1445, DOI 10.3892/ijo.2011.966; Yang SX, 2009, EXPERT REV ANTICANC, V9, P1715, DOI 10.1586/ERA.09.153; Yuan Y, 2011, DIAGN CYTOPATHOL, V39, P562, DOI 10.1002/dc.21424; Zhang W, 2011, INT J MOL SCI, V12, P5672, DOI 10.3390/ijms12095672; Zheng JH, 2013, CLIN CANCER RES, V19, P1400, DOI 10.1158/1078-0432.CCR-12-2888; Zhou RX, 2002, J NEURO-ONCOL, V59, P15, DOI 10.1023/A:1016373015569; Zou YY, 2002, CANCER RES, V62, P8	68	15	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86486	10.1371/journal.pone.0086486	http://dx.doi.org/10.1371/journal.pone.0086486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489730	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000053
J	Huang, YY; Wille, M; Dobbin, A; Walzthoni, NM; Robertson, GJ; Ojkic, D; Whitney, H; Lang, AS				Huang, Yanyan; Wille, Michelle; Dobbin, Ashley; Walzthoeni, Natasha M.; Robertson, Gregory J.; Ojkic, Davor; Whitney, Hugh; Lang, Andrew S.			Genetic Structure of Avian Influenza Viruses from Ducks of the Atlantic Flyway of North America	PLOS ONE			English	Article							WATER-BORNE TRANSMISSION; A VIRUSES; INTERSPECIES TRANSMISSION; PERSISTENCE; EVOLUTION; ALASKA; AMPLIFICATION; REASSORTMENT; PREVALENCE; DIVERSITY	Wild birds, including waterfowl such as ducks, are reservoir hosts of influenza A viruses. Despite the increased number of avian influenza virus (AIV) genome sequences available, our understanding of AIV genetic structure and transmission through space and time in waterfowl in North America is still limited. In particular, AIVs in ducks of the Atlantic flyway of North America have not been thoroughly investigated. To begin to address this gap, we analyzed 109 AIV genome sequences from ducks in the Atlantic flyway to determine their genetic structure and to document the extent of gene flow in the context of sequences from other locations and other avian and mammalian host groups. The analyses included 25 AIVs from ducks from Newfoundland, Canada, from 2008-2011 and 84 available reference duck AIVs from the Atlantic flyway from 2006-2011. A vast diversity of viral genes and genomes was identified in the 109 viruses. The genetic structure differed amongst the 8 viral segments with predominant single lineages found for the PB2, PB1 and M segments, increased diversity found for the PA, NP and NS segments (2, 3 and 3 lineages, respectively), and the highest diversity found for the HA and NA segments (12 and 9 lineages, respectively). Identification of inter-hemispheric transmissions was rare with only 2% of the genes of Eurasian origin. Virus transmission between ducks and other bird groups was investigated, with 57.3% of the genes having highly similar (>= 99% nucleotide identity) genes detected in birds other than ducks. Transmission between North American flyways has been frequent and 75.8% of the genes were highly similar to genes found in other North American flyways. However, the duck AIV genes did display spatial distribution bias, which was demonstrated by the different population sizes of specific viral genes in one or two neighbouring flyways compared to more distant flyways.	[Huang, Yanyan; Wille, Michelle; Dobbin, Ashley; Walzthoeni, Natasha M.; Lang, Andrew S.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Robertson, Gregory J.] Environm Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Ojkic, Davor] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada; [Whitney, Hugh] Newfoundland & Labrador Dept Nat Resources, St John, NF, Canada	Memorial University Newfoundland; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; University of Guelph	Lang, AS (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	aslang@mun.ca	Robertson, Greg/AAI-5849-2020; Wille, Michelle/F-4819-2013; huang, yan/GWM-4747-2022	Robertson, Greg/0000-0001-8452-5506; Wille, Michelle/0000-0002-5629-0196; Lang, Andrew/0000-0002-4510-7683	Newfoundland and Labrador Department of Natural Resources; Environment Canada's Strategic Technology Applications of Genomics in the Environment program; Wildlife and Landscape Science Directorate; Natural Sciences and Engineering Research Council (NSERC); Canada Foundation for Innovation; Memorial University School of Graduate Studies; Postgraduate Study Abroad Program from the China Scholarship Council; CGS-M fellowship from NSERC; Memorial University Biology Department Honours program	Newfoundland and Labrador Department of Natural Resources; Environment Canada's Strategic Technology Applications of Genomics in the Environment program; Wildlife and Landscape Science Directorate; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Memorial University School of Graduate Studies; Postgraduate Study Abroad Program from the China Scholarship Council; CGS-M fellowship from NSERC; Memorial University Biology Department Honours program	Funding from the Newfoundland and Labrador Department of Natural Resources (www.nr.gov.nl.ca/nr/), Environment Canada's Strategic Technology Applications of Genomics in the Environment program (www.ec.gc.ca/scitech/) and Wildlife and Landscape Science Directorate (http://www.ec.gc.ca/faunescience-wildlifescience/), the Natural Sciences and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca/Index_eng.asp), and the Canada Foundation for Innovation (www.innovation.ca/en) supported this research. YH was also supported by a fellowship from Memorial University School of Graduate Studies(http://www.mun.ca/sgs/) and by the Postgraduate Study Abroad Program from the China Scholarship Council (http://en.csc.edu.cn/). MW was supported by a CGS-M fellowship from NSERC and a merit fellowship from Memorial University School of Graduate Studies. AD and NMW's research was supported in part by funding from the Memorial University Biology Department (www.mun.ca/biology/) Honours program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Girard YA, 2012, VIRUS GENES, V44, P415, DOI 10.1007/s11262-011-0706-5; Gonzalez-Reiche AS, 2012, AVIAN DIS, V56, P1025, DOI 10.1637/10203-041412-Reg.1; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081842; Huang YY, 2013, CAN J MICROBIOL, V59, P701, DOI 10.1139/cjm-2013-0507; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lam TTY, 2012, ECOL LETT, V15, P24, DOI 10.1111/j.1461-0248.2011.01703.x; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lebarbenchon C, 2012, P ROY SOC B-BIOL SCI, V279, P3967, DOI 10.1098/rspb.2012.1271; Lu G, 2007, NUCLEIC ACIDS RES, V35, pW275, DOI 10.1093/nar/gkm365; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Pereda AJ, 2008, VIROLOGY, V378, P363, DOI 10.1016/j.virol.2008.06.010; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; Reeves AB, 2011, INFECT GENET EVOL, V11, P2004, DOI 10.1016/j.meegid.2011.09.011; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Spackman E, 2005, VIRUS RES, V114, P89, DOI 10.1016/j.virusres.2005.05.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Borm S, 2012, ARCH VIROL, V157, P1509, DOI 10.1007/s00705-012-1323-x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1	45	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86999	10.1371/journal.pone.0086999	http://dx.doi.org/10.1371/journal.pone.0086999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498009	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330617100044
J	Mora, A; Dahbi, G; Lopez, C; Mamani, R; Marzoa, J; Dion, S; Picard, B; Blanco, M; Alonso, MP; Denamur, E; Blanco, J				Mora, Azucena; Dahbi, Ghizlane; Lopez, Cecilia; Mamani, Rosalia; Marzoa, Juan; Dion, Sara; Picard, Bertrand; Blanco, Miguel; Pilar Alonso, Maria; Denamur, Erick; Blanco, Jorge			Virulence Patterns in a Murine Sepsis Model of ST131 Escherichia coli Clinical Isolates Belonging to Serotypes O25b:H4 and O16:H5 Are Associated to Specific Virotypes	PLOS ONE			English	Article							SEQUENCE TYPE ST131; SPECTRUM BETA-LACTAMASES; EXTENDED-SPECTRUM; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC GROUP; CLONAL GROUP; EMERGENCE; CTX-M-15; RESISTANCE; STRAINS	Escherichia coli sequence type (ST) 131 is an emerging disseminated public health threat implicated in multidrug-resistant extraintestinal infections worldwide. Although the majority of ST131 isolates belong to O25b:H4 serotype, new variants with different serotypes, STs using the discriminative multilocus sequence typing scheme of Pasteur Institute, and virulence-gene profiles (virotypes) have been reported with unknown implications on the pattern of spread, persistence and virulence. The aim of the present study was to compare virulence in a mouse subcutaneous sepsis model of representative ST131 clinical isolates belonging to 2 serotypes (O25b:H4, O16:H5) and nine virotypes and subtypes (A, B, C, D1, D2, D3, D4, D5 and E). Fourteen out of the 23 ST131 isolates tested (61%) killed 90 to 100% of mice challenged, and 18 of 23 (78%) at least 50%. Interestingly, different virulence patterns in association with virotypes were observed, from highly rapid lethality (death in less than 24 h) to low final lethality (death at 7 days) but with presence of an acute inflammation. This is the first study to assess virulence of ST131 isolates belonging to serotype O16:H5, which exhibited virotype C. In spite of their low virulence-gene score, O16:H5 isolates did not show significant differences in final lethality compared with highly virulent O25b:H4 isolates of virotypes A, B and C, but killed mice less rapidly. Significant differences were found, however, between virotypes A, B, C (final lethality >= 80% of mice challenged) and virotypes D, E. Particularly unexpected was the low lethality of the newly assigned virotype E taking into account that it exhibited high virulence-gene score, and the same clonotype H30 as highly virulent O25b:H4 isolates of virotypes A, B and C. In vivo virulence diversity reported in this study would reflect the genetic variability within ST131 clonal group evidenced by molecular typing.	[Mora, Azucena; Dahbi, Ghizlane; Lopez, Cecilia; Mamani, Rosalia; Marzoa, Juan; Blanco, Miguel; Blanco, Jorge] USC, LREC, Dept Microbiol & Parasitoloxia, Fac Vet, Lugo, Spain; [Dion, Sara; Picard, Bertrand; Denamur, Erick] INSERM, IAME, UMR 1137, Paris, France; [Dion, Sara; Denamur, Erick] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Picard, Bertrand] Univ Paris 13, Sorbonne Paris Cite, Paris, France; [Pilar Alonso, Maria] HULA, Unidade Microbiol Clin, Lugo, Spain	Universidade de Santiago de Compostela; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Hospital Universitario Lucus Augusti-Lugo	Mora, A (corresponding author), USC, LREC, Dept Microbiol & Parasitoloxia, Fac Vet, Lugo, Spain.	azucena.mora@usc.es	Marzoa Fandiño, Juan/F-8993-2016; ALVAREZ, JORGE BLANCO/C-7161-2013; López, Cecilia/T-3281-2019; Gutiérrez, Azucena Mora/F-4612-2016	Marzoa Fandiño, Juan/0000-0001-6866-600X; ALVAREZ, JORGE BLANCO/0000-0003-0264-4136; López, Cecilia/0000-0002-4290-9250; Gutiérrez, Azucena Mora/0000-0002-0785-5795; Blanco Alvarez, Miguel/0000-0002-0572-0571; Alonso Garcia, Maria Pilar/0000-0002-6094-3903	Red Espanola de Investigacion en Patologia Infecciosa [REIPI RD06/0008/1018-1016]; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana [PI09/01273]; FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF); (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) [CN2012/303]; ERDF	Red Espanola de Investigacion en Patologia Infecciosa; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana; FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF); (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia); ERDF(European Commission)	This work was partially supported by the Red Espanola de Investigacion en Patologia Infecciosa (REIPI RD06/0008/1018-1016) and grants PI09/01273 (Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria, Ministerio de Economia y Competitividad, Gobierno de Espana), FEDER-INNTERCONECTA-COLIVAC (CDTI, Ministerio de Economia y Competitividad, Gobierno de Espana; Conselleria de Economia e Industria, Xunta de Galicia; The European Regional Development Fund, ERDF) and CN2012/303 (Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia and the ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2013, ANTIMICROB AGENTS CH, V57, P6385, DOI 10.1128/AAC.01604-13; Blanco J, 2013, J CLIN MICROBIOL, V51, P3358, DOI 10.1128/JCM.01555-13; Blanco M, 2009, J ANTIMICROB CHEMOTH, V63, P1135, DOI 10.1093/jac/dkp122; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Dahbi G, 2013, INT J ANTIMICROB AG, V42, P347, DOI 10.1016/j.ijantimicag.2013.06.017; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2003, ANTIMICROB AGENTS CH, V47, P2161, DOI 10.1128/AAC.47.7.2161-2168.2003; Kudinha T, 2013, CLIN MICROBIOL INFEC, V19, pE173, DOI 10.1111/1469-0691.12123; Kudinha T, 2013, J CLIN MICROBIOL, V51, P3270, DOI 10.1128/JCM.01315-13; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Matsumura Y, 2012, J ANTIMICROB CHEMOTH, V67, P2612, DOI 10.1093/jac/dks278; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Tchesnokova V, 2013, J CLIN MICROBIOL, V51, P2991, DOI 10.1128/JCM.00984-13; Vredenburg J, 2013, ENVIRON MICROBIOL, V1, DOI [10.1111/1462-2920.12231, DOI 10.1111/1462-2920.12231.[]; Weissman SJ, 2012, APPL ENVIRON MICROB, V78, P1353, DOI 10.1128/AEM.06663-11	26	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87025	10.1371/journal.pone.0087025	http://dx.doi.org/10.1371/journal.pone.0087025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498015	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100046
J	Wang, F; Zhao, SC; Li, F; Zhang, B; Qu, Y; Sun, TL; Luo, T; Li, DP				Wang, Fei; Zhao, Shancang; Li, Feng; Zhang, Bo; Qu, Yi; Sun, Tianlei; Luo, Ting; Li, Dapeng			Investigation of Antioxidant Interactions between Radix Astragali and Cimicifuga foetida and Identification of Synergistic Antioxidant Compounds	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; LIQUID-CHROMATOGRAPHY; METHANOL EXTRACTS; IN-VITRO; ACID; MONGHOLICUS; FLAVONOIDS; LEAF	The medicinal plants of Huang-qi (Radix Astragali) and Sheng-ma (Cimicifuga foetida) demonstrate significantly better antioxidant effects when used in combination than when used alone. However, the bioactive components and interactional mechanism underlying this synergistic action are still not well understood. In the present study, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay was employed to investigate the antioxidant capacity of single herbs and their combination with the purpose of screening synergistic antioxidant compounds from them. Chromatographic isolation was performed on silica gel, Sephadex LH-20 columns and HPLC, and consequently to yield formononetin, calycosin, ferulic acid and isoferulic acid, which were identified by their retention time, UV lambda(max), MS and MS/MS data. The combination of isoferulic acid and calycosin at a dose ratio of 1:1 resulted in significant synergy in scavenging DPPH radicals and ferric reducing antioxidant power (FRAP) assay. Furthermore, the protective effects of these four potential synergistic compounds were examined using H2O2-induced HepG2 Cells bioassay. Results revealed that the similar synergy was observed in the combination of isoferulic acid and calycosin. These findings might provide some theoretical basis for the purported synergistic efficiency of Huang-qi and Sheng-ma as functional foods, dietary supplements and medicinal drugs.	[Wang, Fei; Li, Feng; Zhang, Bo; Qu, Yi; Sun, Tianlei; Luo, Ting; Li, Dapeng] Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China; [Zhao, Shancang] Shandong Acad Agr Sci, Shandong Prov Key Lab Test Technol Food Qual & Sa, Jinan, Shandong, Peoples R China; [Zhao, Shancang] Shandong Acad Agr Sci, Cent Lab, Jinan, Shandong, Peoples R China	Shandong Agricultural University; Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Li, DP (corresponding author), Shandong Agr Univ, Dept Food Sci, Tai An, Shandong, Peoples R China.	dpli73@sdau.edu.cn	li, dapeng/G-4166-2010; DaPeng, Li/G-4164-2010	li, dapeng/0000-0002-1816-3217; DaPeng, Li/0000-0002-1816-3217	National Key Technology R&D Program in the 12th five-year Plan of China [2012BAK17B05]; Shandong Provincial Natural Science Foundation [2009ZRB019PD]; National Natural Science Foundation of China [31201417]	National Key Technology R&D Program in the 12th five-year Plan of China(National Key Technology R&D Program); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Technology R&D Program in the 12th five-year Plan of China (2012BAK17B05), Shandong Provincial Natural Science Foundation (2009ZRB019PD), and National Natural Science Foundation of China (31201417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cai YZ, 2006, LIFE SCI, V78, P2872, DOI 10.1016/j.lfs.2005.11.004; Costa RM, 2009, FOOD CHEM TOXICOL, V47, P860, DOI 10.1016/j.fct.2009.01.019; Dai F, 2008, BIOCHIMIE, V90, P1499, DOI 10.1016/j.biochi.2008.05.007; Facino RM, 1998, PLANTA MED, V64, P343, DOI 10.1055/s-2006-957448; Freeman BL, 2010, J FOOD SCI, V75, pC570, DOI 10.1111/j.1750-3841.2010.01717.x; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fu SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019604; Goupy P, 2007, FREE RADICAL BIO MED, V43, P933, DOI 10.1016/j.freeradbiomed.2007.06.013; Guo FQ, 2006, J PHARMACEUT BIOMED, V40, P623, DOI 10.1016/j.jpba.2005.07.034; HUDSON BJF, 1983, FOOD CHEM, V10, P111, DOI 10.1016/0308-8146(83)90027-4; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; Li HB, 2008, LWT-FOOD SCI TECHNOL, V41, P385, DOI 10.1016/j.lwt.2007.03.011; Li M, 2011, LWT FOOD SCI TECHNOL; Li XC, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-140; Lin LZ, 2000, J CHROMATOGR A, V876, P87, DOI 10.1016/S0021-9673(00)00149-7; Liu DH, 2008, LWT-FOOD SCI TECHNOL, V41, P1344, DOI 10.1016/j.lwt.2007.08.001; Lopez-Alarcon C, 2012, ANAL CHIMICA ACTA; Palafox-Carlos H, 2012, MOLECULES, V17, P12657, DOI 10.3390/molecules171112657; Pan RL, 2009, ARCH PHARM RES, V32, P185, DOI 10.1007/s12272-009-1133-1; Peng ZF, 2003, PHYTOCHEMISTRY, V62, P219, DOI 10.1016/S0031-9422(02)00504-6; Peyrat-Maillard MN, 2003, J AM OIL CHEM SOC, V80, P1007, DOI 10.1007/s11746-003-0812-z; Prior R. L., 2013, AM J BIOMEDICAL SCI, V5, P126, DOI DOI 10.5099/AJ130200126; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Wang CC, 2010, FOOD CHEM, V120, P184, DOI 10.1016/j.foodchem.2009.10.005; Wang XZ, 2011, NAT PROD COMMUN, V6, P1285; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yu DH, 2005, BIOMED ENVIRON SCI, V18, P297	32	31	32	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87221	10.1371/journal.pone.0087221	http://dx.doi.org/10.1371/journal.pone.0087221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498048	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100063
J	Bernsmeier, C; Meyer-Gerspach, AC; Blaser, LS; Jeker, L; Steinert, RE; Heim, MH; Beglinger, C				Bernsmeier, Christine; Meyer-Gerspach, Anne C.; Blaser, Lea S.; Jeker, Lia; Steinert, Robert E.; Heim, Markus H.; Beglinger, Christoph			Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; HEPATIC STEATOSIS; ENERGY-INTAKE; GLP-1 ANALOG; INCRETIN; RESPONSES; RECEPTOR; ASSOCIATION; SENSITIVITY; OVERWEIGHT	Background & Aims: The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gastrointestinal peptide hormones regulating postprandial insulin release from pancreatic beta-cells. GLP-1 agonism is a treatment strategy in Type 2 diabetes and is evaluated in Non-alcoholic fatty liver disease (NAFLD). However, the role of incretins in its pathophysiology is insufficiently understood. Studies in mice suggest improvement of hepatic steatosis by GLP-1 agonism. We determined the secretion of incretins after oral glucose administration in non-diabetic NAFLD patients. Methods: N = 52 patients (n = 16 NAFLD and n = 36 Non-alcoholic steatohepatitis (NASH) patients) and n = 50 matched healthy controls were included. Standardized oral glucose tolerance test was performed. Glucose, insulin, glucagon, GLP-1 and GIP plasma levels were measured sequentially for 120 minutes after glucose administration. Results: Glucose induced GLP-1 secretion was significantly decreased in patients compared to controls (p < 0.001). In contrast, GIP secretion was unchanged. There was no difference in GLP-1 and GIP secretion between NAFLD and NASH subgroups. All patients were insulin resistant, however HOMA2-IR was highest in the NASH subgroup. Fasting and glucose-induced insulin secretion was higher in NAFLD and NASH compared to controls, while the glucose lowering effect was diminished. Concomitantly, fasting glucagon secretion was significantly elevated in NAFLD and NASH. Conclusions: Glucose-induced GLP-1 secretion is deficient in patients with NAFLD and NASH. GIP secretion is contrarily preserved. Insulin resistance, with hyperinsulinemia and hyperglucagonemia, is present in all patients, and is more severe in NASH compared to NAFLD. These pathophysiologic findings endorse the current evaluation of GLP-1 agonism for the treatment of NAFLD.	[Bernsmeier, Christine; Heim, Markus H.; Beglinger, Christoph] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland; [Bernsmeier, Christine; Meyer-Gerspach, Anne C.; Blaser, Lea S.; Jeker, Lia; Steinert, Robert E.; Heim, Markus H.; Beglinger, Christoph] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Bernsmeier, C (corresponding author), Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland.	c.bernsmeier@unibas.ch	Meyer-Gerspach, Anne Christin/A-9865-2012; Heim, Markus/A-7526-2008	Meyer-Gerspach, Anne Christin/0000-0003-4104-8812; Heim, Markus/0000-0002-7523-4894; Bernsmeier, Christine/0000-0002-5558-0503; Steinert, Robert E/0000-0001-7884-5036	Astra-Altana research funding; Swiss National Science Foundation [320030-132960/1]; Stiftung zur Forderung der Gastroenterologischen Forschung; Hoffmann-La Roche	Astra-Altana research funding; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung zur Forderung der Gastroenterologischen Forschung; Hoffmann-La Roche(Hoffmann-La Roche)	The Basel NAFLD cohort is supported by an Astra-Altana research funding. The current work has further been supported by the Swiss National Science Foundation (Grant No. 320030-132960/1), the Stiftung zur Forderung der Gastroenterologischen Forschung, and an unrestricted grant from Hoffmann-La Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003995; Bagger JI, 2011, J CLIN ENDOCR METAB, V96, P737, DOI 10.1210/jc.2010-2435; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Cuthbertson DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050117; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Feinle C, 2002, PEPTIDES, V23, P1491, DOI 10.1016/S0196-9781(02)00087-6; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; MacIntosh CG, 1999, AM J CLIN NUTR, V69, P999; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Miyazaki M, 2012, MOL MED REP, V5, P729, DOI 10.3892/mmr.2011.707; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rizzo M, 2009, EXPERT OPIN INV DRUG, V18, P1495, DOI 10.1517/14728220903241633; Seimon RV, 2013, AM J PHYSIOL-ENDOC M, V304, pE294, DOI 10.1152/ajpendo.00533.2012; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025269; Steinert RE, 2009, CLIN PHARMACOL THER, V86, P644, DOI 10.1038/clpt.2009.159; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tomas E, 2011, REGUL PEPTIDES, V169, P43, DOI 10.1016/j.regpep.2011.04.006; Trahair LG, 2012, J CLIN ENDOCR METAB, V97, P844, DOI 10.1210/jc.2011-2583; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Roque MIV, 2006, GASTROENTEROLOGY, V131, P1717, DOI 10.1053/j.gastro.2006.10.025; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vilsboll T, 2003, REGUL PEPTIDES, V114, P115, DOI 10.1016/S0167-0115(03)00111-3; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046; Zhang LL, 2013, LIVER INT, V33, P794, DOI 10.1111/liv.12120	42	73	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87488	10.1371/journal.pone.0087488	http://dx.doi.org/10.1371/journal.pone.0087488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489924	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330570000151
J	Carrier, G; Garnier, M; Le Cunff, L; Bougaran, G; Probert, I; De Vargas, C; Corre, E; Cadoret, JP; Saint-Jean, B				Carrier, Gregory; Garnier, Matthieu; Le Cunff, Loic; Bougaran, Gael; Probert, Ian; De Vargas, Colomban; Corre, Erwan; Cadoret, Jean-Paul; Saint-Jean, Bruno			Comparative Transcriptome of Wild Type and Selected Strains of the Microalgae Tisochrysis lutea Provides Insights into the Genetic Basis, Lipid Metabolism and the Life Cycle	PLOS ONE			English	Article							BIOFUEL PRODUCTION; GENOME REVEALS; RNA-SEQ; SEXUAL REPRODUCTION; PROTEINS; FAMILY; COCCOLITHOPHORES; COMPONENTS; ADAPTATION; PREDICTION	The applied exploitation of microalgae cultures has to date almost exclusively involved the use of wild type strains, deposited over decades in dedicated culture collections. Concomitantly, the concept of improving algae with selection programs for particular specific purposes is slowly emerging. Studying since a decade an economically and ecologically important haptophyte Tisochrysis lutea (Tiso), we took advantage of the availability of wild type (Tiso-Wt) and selected (Tiso-S2M2) strains to conduct a molecular variations study. This endeavour presented substantial challenges: the genome assembly was not yet available, the life cycle unknown and genetic diversity of Tiso-Wt poorly documented. This study brings the first molecular data in order to set up a selection strategy for that microalgae. Following high-throughput Illumina sequencing, transcriptomes of Tiso-Wt and Tiso-S2M2 were de novo assembled and annotated. Genetic diversity between both strains was analyzed and revealed a clear conservation, while a comparison of transcriptomes allowed identification of polymorphisms resulting from the selection program. Of 34,374 transcripts, 291 were differentially expressed and 165 contained positional polymorphisms (SNP, Indel). We focused on lipid over-accumulation of the Tiso-S2M2 strain and 8 candidate genes were identified by combining analysis of positional polymorphism, differential expression levels, selection signature and by study of putative gene function. Moreover, genetic analysis also suggests the existence of a sexual cycle and genetic recombination in Tisochrysis lutea.	[Carrier, Gregory; Garnier, Matthieu; Bougaran, Gael; Cadoret, Jean-Paul; Saint-Jean, Bruno] IFREMER, Ctr Nantes, PBA, F-44311 Nantes 3, France; [Probert, Ian; De Vargas, Colomban] CNRS UPMC, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Le Cunff, Loic] UMT Genovigne, Montpellier, France; [Corre, Erwan] CNRS UPMC, ABiMS, Stn Biol Roscoff, Roscoff, France	Ifremer; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Saint-Jean, B (corresponding author), IFREMER, Ctr Nantes, PBA, F-44311 Nantes 3, France.	Bruno.Saintjean@ifremer.fr	corre, erwan/O-4669-2019; Probert, Ian/M-9807-2019	corre, erwan/0000-0001-6354-2278; Bougaran, Gael/0000-0002-3463-7590; Garnier, Matthieu/0000-0001-7391-547X; Probert, Ian/0000-0002-1643-1759; carrier, gregory/0000-0001-6859-5707; de Vargas, Colomban/0000-0002-6476-6019; Cadoret, Jean-Paul/0000-0001-7542-5474; Saint-Jean, Bruno/0000-0003-3915-5440	region of Pays de Loire "Nouvelle equipes, nouvelles thematique" program; Agence National de la Recherche, Facteur 4 project	region of Pays de Loire "Nouvelle equipes, nouvelles thematique" program; Agence National de la Recherche, Facteur 4 project	This work was partly funded by region of Pays de Loire "Nouvelle equipes, nouvelles thematique" program and by the Agence National de la Recherche, Facteur 4 project. There are no non-financial competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bendif E, 2013, J APPL PHYCOL, V25, P1763, DOI 10.1007/s10811-013-0037-0; Bendif E, 2011, PROTIST, V162, P738, DOI 10.1016/j.protis.2011.05.001; Blanc G, 2010, PLANT CELL, V22, P2943, DOI 10.1105/tpc.110.076406; Bougaran G, 2012, BIOTECHNOL BIOENG, V109, P2737, DOI 10.1002/bit.24560; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cadoret JP, 2008, M S-MED SCI, V24, P375, DOI 10.1051/medsci/2008244375; Cadoret JP, 2012, ADV BOT RES, V64, P285, DOI 10.1016/B978-0-12-391499-6.00008-6; Cadoret Jean-Paul, 2008, Journal de la Societe de Biologie, V202, P201, DOI 10.1051/jbio:2008022; Carrier G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032973; Chao A, 2010, SPADE SPECIES PREDIC; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Chepurnov VA, 2011, CELL ORIG LIFE EXTRE, V19, P167, DOI 10.1007/978-94-007-1327-7_7; Cracraft J., 2004, ASSEMBLING TREE LIFE; Darwin C, 1859, ORIGIN SPECIES MEANS; De la Jara A, 2009, CHARACTERIZATION DUN; de Vargas C, 2004, MICROPALEONTOLOGY, V50, P45, DOI 10.2113/50.Suppl_1.45; Del Campo JA, 2007, APPL MICROBIOL BIOT, V74, P1163, DOI 10.1007/s00253-007-0844-9; Demontis D, 2009, MOL ECOL, V18, P4551, DOI 10.1111/j.1365-294X.2009.04366.x; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Evans KM, 2009, PROTIST, V160, P386, DOI 10.1016/j.protis.2009.02.001; Evans KM, 2005, J PHYCOL, V41, P506, DOI 10.1111/j.1529-8817.2005.00084.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Fox JM, 2010, DNA RES, V17, P185, DOI 10.1093/dnares/dsq012; FU L, 2012, BIOINFORMATICS; Gong N, 2011, CHEMOSPHERE, V83, P510, DOI 10.1016/j.chemosphere.2010.12.059; Grabherr MG, 2011, NAT BIOTECHNOL, P1087; Groot P H, 1976, Adv Lipid Res, V14, P75; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hermisson J, 2002, THEOR POPUL BIOL, V62, P9, DOI 10.1006/tpbi.2002.1582; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Jordan RW, 2004, MICROPALEONTOLOGY, V50, P55, DOI 10.2113/50.Suppl_1.55; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Kim SJ, 2008, J MICROBIOL, V46, P183, DOI 10.1007/s12275-008-0037-y; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kristensen TN, 2005, J EVOLUTION BIOL, V18, P763, DOI 10.1111/j.1420-9101.2005.00883.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martin M, 2011, EMBNET J, V17; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Guzman HM, 2012, J APPL PHYCOL, V24, P1237, DOI 10.1007/s10811-011-9768-y; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Misra N, 2012, EVOL BIOINFORM, V8, P545, DOI 10.4137/EBO.S10159; Morgan TH, 1917, AM NAT, V51, P513, DOI 10.1086/279629; Mouget JL, 2009, FEMS MICROBIOL ECOL, V69, P194, DOI 10.1111/j.1574-6941.2009.00700.x; Muller A, 2012, BBA-BIOMEMBRANES, V1818, P117, DOI 10.1016/j.bbamem.2011.10.009; Nozaki H, 2009, MOL PHYLOGENET EVOL, V53, P872, DOI 10.1016/j.ympev.2009.08.015; Perrier X, 2003, DATA ANAL METHODS GE, P43; Puerta MVS, 2004, DNA RES, V11, P1, DOI 10.1093/dnares/11.1.1; Reed DH, 2009, MOL ECOL, V18, P4521, DOI 10.1111/j.1365-294X.2009.04367.x; ROUXEL C., 2011, Novel isochrysis sp tahitian clone and uses therefore, Patent No. [EP 11006712.1, 11006712]; Saei AA, 2012, MOL BIOL REP, V39, P9931, DOI 10.1007/s11033-012-1861-z; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Sili C., 2012, ECOLOGY CYANOBACTERI, P677, DOI DOI 10.1007/978-94-007-3855-3_25; Singh R.S., 2000, EVOLUTIONARY GENETIC; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Taylor R, 1998, J APPL PHYCOL, V10, P481, DOI 10.1023/A:1008094622412; Doan TTY, 2012, ALGAL RES, V1, P17, DOI 10.1016/j.algal.2012.03.001; Walne P, 1966, EXPT LARGE SCALE CUL, V25, P53970; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Wuitschick JD, 1999, J EUKARYOT MICROBIOL, V46, P239, DOI 10.1111/j.1550-7408.1999.tb05120.x; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	77	34	34	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86889	10.1371/journal.pone.0086889	http://dx.doi.org/10.1371/journal.pone.0086889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489800	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000078
J	Cowan, GJM; Bockau, U; Eleni-Muus, J; Aldag, I; Samuel, K; Creasey, AM; Hartmann, MWW; Cavanagh, DR				Cowan, Graeme J. M.; Bockau, Ulrike; Eleni-Muus, Janna; Aldag, Ingo; Samuel, Kay; Creasey, Alison M.; Hartmann, Marcus W. W.; Cavanagh, David R.			A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PARASITE PLASMODIUM-FALCIPARUM; C-TERMINAL FRAGMENT; INTRINSICALLY UNSTRUCTURED PROTEINS; BLOOD-STAGE VACCINE; GROWTH IN-VITRO; ESCHERICHIA-COLI; ERYTHROCYTE INVASION; SEQUENCE DIVERSITY; ANTIBODY EPITOPES	Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components. We have investigated the use of a novel ciliate expression system, Tetrahymena thermophila, as a P. falciparum vaccine antigen platform. A synthetic vaccine antigen composed of N-terminal and C-terminal regions of merozoite surface protein-1 (MSP-1) was expressed in Tetrahymena thermophila. The recombinant antigen was secreted into the culture medium and purified by monoclonal antibody (mAb) affinity chromatography. The vaccine was immunogenic in MF1 mice, eliciting high antibody titers against both N- and C-terminal components. Sera from immunized animals reacted strongly with P. falciparum parasites from three antigenically different strains by immunofluorescence assays, confirming that the antibodies produced are able to recognize parasite antigens in their native form. Epitope mapping of serum reactivity with a peptide library derived from all three MSP-1 Block 2 serotypes confirmed that the MSP-1 Block 2 hybrid component of the vaccine had effectively targeted all three serotypes of this polymorphic region of MSP-1. This study has successfully demonstrated the use of Tetrahymena thermophila as a recombinant protein expression platform for the production of malaria vaccine antigens.	[Cowan, Graeme J. M.; Creasey, Alison M.; Cavanagh, David R.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Bockau, Ulrike; Eleni-Muus, Janna; Aldag, Ingo; Hartmann, Marcus W. W.] Cilian AG, Munster, Germany; [Samuel, Kay] Scottish Natl Blood Transfus Serv, Cell Therapy Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh	Cavanagh, DR (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.	david.cavanagh@ed.ac.uk	Cowan, Graeme/F-2842-2011; Cavanagh, David R/A-1828-2008	Cowan, Graeme/0000-0002-1949-4253; Cavanagh, David/0000-0003-4360-2637	EU [LSHP-CT-2007-037304]	EU(European Commission)	This project was funded by an EU Framework 6 STREP grant (CILMALVAC), awarded jointly to Cilian AG, Germany, The University of Edinburgh, UK and the Centre for Medical Parasitology, University of Copenhagen, Denmark (LSHP-CT-2007-037304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Aldag I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-11; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Babon JJ, 2007, MOL BIOCHEM PARASIT, V153, P31, DOI 10.1016/j.molbiopara.2007.01.015; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; CassidyHanley D, 1997, GENETICS, V146, P135; Cavanagh DR, 1997, MOL BIOCHEM PARASIT, V85, P197, DOI 10.1016/S0166-6851(96)02826-5; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Cowan GJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026616; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Gaertig J, 2000, METHOD CELL BIOL, V62, P485; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Gaertig J, 1999, NAT BIOTECHNOL, V17, P462, DOI 10.1038/8638; Galamo CD, 2009, J INFECT DIS, V199, P1151, DOI 10.1086/597426; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garrity RR, 1997, J IMMUNOL, V159, P279; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Hellenbroich D, 1999, APPL MICROBIOL BIOT, V51, P447, DOI 10.1007/s002530051415; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Huckriede A, 2003, VACCINE, V21, P925, DOI 10.1016/S0264-410X(02)00542-X; Jayaram J, 2010, BIOPHARM INT S; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Keitel WA, 1999, VACCINE, V18, P531, DOI 10.1016/S0264-410X(99)00221-2; Khan F, 2012, BIOTECHNOL J, V7, P133, DOI 10.1002/biot.201100331; KIY T, 1992, APPL MICROBIOL BIOT, V38, P141; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau OS, 2010, PLANT BIOTECHNOL J, V8, P994, DOI 10.1111/j.1467-7652.2010.00526.x; Mawili-Mboumba DP, 2003, J INFECT DIS, V187, P1137, DOI 10.1086/368414; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; MCBRIDE JS, 1985, J EXP MED, V161, P160, DOI 10.1084/jem.161.1.160; Milich DR, 2001, VACCINE, V20, P771, DOI 10.1016/S0264-410X(01)00400-5; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Morgan WD, 2004, MOL BIOCHEM PARASIT, V138, P29, DOI 10.1016/j.molbiopara.2004.06.014; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Parra M, 2000, INFECT IMMUN, V68, P2685, DOI 10.1128/IAI.68.5.2685-2691.2000; Peterson DS, 2002, MOL BIOCHEM PARASIT, V122, P119, DOI 10.1016/S0166-6851(02)00079-8; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; POLLACK Y, 1982, NUCLEIC ACIDS RES, V10, P539, DOI 10.1093/nar/10.2.539; Polley SD, 2003, INFECT IMMUN, V71, P1833, DOI 10.1128/IAI.71.4.1833-1842.2003; QUAKYI IA, 1994, J IMMUNOL, V153, P2082; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Victor ME, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-325; Weide T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-19; Weide T, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-12; WHO, 2011, QUEST ANSW MAL VACC	72	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87198	10.1371/journal.pone.0087198	http://dx.doi.org/10.1371/journal.pone.0087198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489871	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000120
J	De Gaetano, A; Panunzi, S; Eliopoulos, D; Hardy, T; Mingrone, G				De Gaetano, Andrea; Panunzi, Simona; Eliopoulos, Dimitris; Hardy, Thomas; Mingrone, Geltrude			Mathematical Modeling of Renal Tubular Glucose Absorption after Glucose Load	PLOS ONE			English	Article							DIABETES-MELLITUS; TRANSPORT; THRESHOLD; MECHANISM; HOMEOSTASIS; GLYCOSURIA; EXCRETION; GLYCEMIA; KIDNEY; SGLT2	A partial differential Progressive Tubular Reabsorption (PTR) model, describing renal tubular glucose reabsorption and urinary glucose excretion following a glucose load perturbation, is proposed and fitted to experimental data from five subjects. For each subject the Glomerular Filtration Rate was estimated and both blood and urine glucose were sampled following an Intra-Venous glucose bolus. The PTR model was compared with a model representing the conventional Renal Threshold Hypothesis (RTH). A delay bladder compartment was introduced in both formulations. For the RTH model, the average threshold for glycosuria varied between 9.90 +/- 4.50 mmol/L and 10.63 +/- 3.64 mmol/L (mean +/- Standard Deviation) under different hypotheses; the corresponding average maximal transport rates varied between 0.48 +/- 0.45 mmol/min (86.29 +/- 81.22 mg/min) and 0.50 +/- 0.42 mmol/min (90.62 +/- 76.15 mg/min). For the PTR Model, the average maximal transports rates varied between 0.61 +/- 0.52 mmol/min (109.57 +/- 93.77 mg/min) and 0.83 +/- 0.95 mmol/min (150.13 +/- 171.85 mg/min). The time spent by glucose inside the tubules before entering the bladder compartment varied between 1.66 +/- 0.73 min and 2.45 +/- 1.01 min. The PTR model proved much better than RTH at fitting observations, by correctly reproducing the delay of variations of glycosuria with respect to the driving glycemia, and by predicting non-zero urinary glucose elimination at low glycemias. This model is useful when studying both transients and steady-state glucose elimination as well as in assessing drug-related changes in renal glucose excretion.	[De Gaetano, Andrea; Panunzi, Simona] CNR, Inst Syst Anal & Comp Sci IASI, BioMatLab, Rome, Italy; [Eliopoulos, Dimitris] Univ Athens Med Sch, Dept Internal Med 2, Hippokration, Greece; [Hardy, Thomas] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Mingrone, Geltrude] Univ Cattolica S Cuore, Dept Internal Med, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Eli Lilly; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Panunzi, S (corresponding author), CNR, Inst Syst Anal & Comp Sci IASI, BioMatLab, Rome, Italy.	simona.panunzi@biomatematica.it	Mingrone, Geltrude/AAB-9681-2019; Panunzi, Simona/AAK-9337-2020; De Gaetano, Andrea/AAC-4805-2021	De Gaetano, Andrea/0000-0001-7712-056X; Mingrone, Geltrude/0000-0003-2021-528X; Panunzi, Simona/0000-0003-0956-8578				Benedict S, 1918, J BIOL CHEM, V34, P217; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bernard C, 1877, LECONS DIABETE GLYCO; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Faber K, 1926, J CLIN INVEST, V3, P203, DOI 10.1172/JCI100075; Faber K, 1921, ACTA MED SCAND, VLIV; Faber K, 1921, ACTA MED SCAND, VLIII; Frank E, 1913, ARCH EXP PATHOL PHAR, V72, P387, DOI 10.1007/BF01863106; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; GLAUBER H, 1987, DIABETES, V36, P1187, DOI 10.2337/diabetes.36.10.1187; Hansen KM, 1923, INVESTIGATIONS BLOOD; Himsworth HP, 1931, BIOCHEM J, V25, P1128, DOI 10.1042/bj0251128; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Jacobsen AT, 1917, BLODSUKKERINDHOLDET; JOHANSEN K, 1984, DIABETOLOGIA, V26, P180; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; KOUSHANPOUR E, 1971, J THEOR BIOL, V31, P177, DOI 10.1016/0022-5193(71)90182-2; Leibniz G.W., 1765, OEUVRES PHILOS LATIN; Ni TG, 1930, BIOCHEM J, V24, P1039, DOI 10.1042/bj0241039; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; R Core Team, 2018, R LANG ENV STAT COMP; Rave K, 2006, NEPHROL DIAL TRANSPL, V21, P2166, DOI 10.1093/ndt/gfl175; RICHARDS AN, 1929, METHODS RESULTS DIRE; Ruhnau B, 1997, DIABETES RES CLIN PR, V36, P27, DOI 10.1016/S0168-8227(97)01389-2; Triplitt Curtis L, 2012, Am J Manag Care, V18, pS4; Weinstein AM, 2007, AM J PHYSIOL-RENAL, V292, pF1164, DOI 10.1152/ajprenal.00392.2006; WEINSTEIN AM, 1994, ANNU REV PHYSIOL, V56, P691, DOI 10.1146/annurev.ph.56.030194.003355	28	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86963	10.1371/journal.pone.0086963	http://dx.doi.org/10.1371/journal.pone.0086963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489817	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000086
J	Li, ST; Meng, FY; Liao, XL; Wang, YM; Sun, ZX; Guo, FC; Li, XX; Meng, M; Li, Y; Sun, CH				Li, Songtao; Meng, Fanyu; Liao, Xilu; Wang, Yemei; Sun, Zongxiang; Guo, Fuchuan; Li, Xiaoxia; Meng, Man; Li, Ying; Sun, Changhao			Therapeutic Role of Ursolic Acid on Ameliorating Hepatic Steatosis and Improving Metabolic Disorders in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Rats	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PPAR-ALPHA; PENTACYCLIC TRITERPENE; INSULIN-RESISTANCE; LIPID-METABOLISM; LDL RECEPTOR; STEATOHEPATITIS; INFLAMMATION; AGONIST; HYPERLIPIDEMIA	Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases around the world, and is closely associated with obesity, diabetes, and insulin resistance. Ursolic acid (UA), an ubiquitous triterpenoid with multifold biological roles, is distributed in various plants. This study was conducted to investigate the therapeutic effect and potential mechanisms of UA against hepatic steatosis in a high-fat diet (HFD)-induced obese non-alcoholic fatty liver disease (NAFLD) rat model. Methodology/Principal Findings: Obese NAFLD model was established in Sprague-Dawley rats by 8-week HFD feeding. Therapeutic role of UA was evaluated using 0.125%, 0.25%, 0.5% UA-supplemented diet for another 6 weeks. The results from both morphologic and histological detections indicated that UA significantly reversed HFD-induced hepatic steatosis and liver injury. Besides, hepatic peroxisome proliferator-activated receptor (PPAR)-alpha was markedly up-regulated at both mRNA and protein levels by UA. Knocking down PPAR-alpha significantly inhibited the anti-steatosis role of UA in vitro. HFD-induced adverse changes in the key genes, which participated in hepatic lipid metabolism, were also alleviated by UA treatment. Furthermore, UA significantly ameliorated HFD-induced metabolic disorders, including insulin resistance, inflammation and oxidative stress. Conclusions/Significance: These results demonstrated that UA effectively ameliorated HFD-induced hepatic steatosis through a PPAR-alpha involved pathway, via improving key enzymes in the controlling of lipids metabolism. The metabolic disorders were accordingly improved with the decrease of hepatic steatosis. Thereby, UA could be a promising candidate for the treatment of NAFLD.	[Li, Songtao; Meng, Fanyu; Liao, Xilu; Wang, Yemei; Sun, Zongxiang; Guo, Fuchuan; Li, Xiaoxia; Meng, Man; Li, Ying; Sun, Changhao] Harbin Med Univ, Dept Nutr & Food Hyg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Harbin, Heilongjiang Pr, Peoples R China.	sun2002changhao@yahoo.com	SUN, CHANG/GXM-3680-2022; Li, Songtao/I-1490-2019	Li, Songtao/0000-0002-2926-673X	National High Technology Research and Development Program of China (863 program) [2010AA023002]; National 12th Five-Year Scientific and Technical Support Program of China [2012BAI02B02]; NSFC [81130049, 81102111, 81202185]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National 12th Five-Year Scientific and Technical Support Program of China; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the grant of National High Technology Research and Development Program of China (863 program, No. 2010AA023002) the National 12th Five-Year Scientific and Technical Support Program of China (2012BAI02B02) and NSFC (81130049 and 81102111 and 81202185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chen XS, 2011, EXP DIABETES RES, DOI 10.1155/2011/853501; Choudhury Jayanta, 2004, Clin Liver Dis, V8, P575, DOI 10.1016/j.cld.2004.04.006; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Erickson SK, 2009, J LIPID RES, V50, pS412, DOI 10.1194/jlr.R800089-JLR200; Ferreira DD, 2010, PARASITOL RES, V106, P985, DOI 10.1007/s00436-010-1740-2; Fiorucci S, 2005, J PHARMACOL EXP THER, V315, P58, DOI 10.1124/jpet.105.085597; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Guo FC, 2011, MOL NUTR FOOD RES, V55, P1809, DOI 10.1002/mnfr.201100392; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; James OFW, 1998, J HEPATOL, V29, P495, DOI 10.1016/S0168-8278(98)80073-1; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Jia Y, 2011, BIOORG MED CHEM LETT, V21, P5876, DOI 10.1016/j.bmcl.2011.07.095; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Laurent A, 2004, HEPATOLOGY, V39, P1277, DOI 10.1002/hep.20177; Le May C, 2005, J NUTR, V135, P2313, DOI 10.1093/jn/135.10.2313; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li ST, 2013, INT J CARDIOL, V168, P2548, DOI 10.1016/j.ijcard.2013.03.057; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Lu N, 2008, J AGR FOOD CHEM, V56, P11526, DOI 10.1021/jf802607x; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191; Rafiq N, 2008, SEMIN LIVER DIS, V28, P427, DOI 10.1055/s-0028-1091986; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; Rao VS, 2011, J MED FOOD, V14, P1375, DOI 10.1089/jmf.2010.0267; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Sun F, 2010, PHYTOMEDICINE, V17, P669, DOI 10.1016/j.phymed.2009.10.021; Sundaresan A, 2012, GEN PHYSIOL BIOPHYS, V31, P323, DOI 10.4149/gpb_2012_037; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tailleux A, 2011, BIOCH BIOPHYS ACTA; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	51	53	60	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86724	10.1371/journal.pone.0086724	http://dx.doi.org/10.1371/journal.pone.0086724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489777	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000064
J	Watkins, SC; Smith, JR; Hayes, PK; Watts, JEM				Watkins, Siobhan C.; Smith, James R.; Hayes, Paul K.; Watts, Joy E. M.			Characterisation of Host Growth after Infection with a Broad-Range Freshwater Cyanopodophage	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS-AERUGINOSA; GENETIC DIVERSITY; MARINE; CYANOPHAGES; PHAGE; BACTERIOPHAGE; GENOME; SEQUENCES; PROCHLOROCOCCUS; IDENTIFICATION	Freshwater cyanophages are poorly characterised in comparison to their marine counterparts, however, the level of genetic diversity that exists in freshwater cyanophage communities is likely to exceed that found in marine environments, due to the habitat heterogeneity within freshwater systems. Many cyanophages are specialists, infecting a single host species or strain; however, some are less fastidious and infect a number of different host genotypes within the same species or even hosts from different genera. Few instances of host growth characterisation after infection by broad host-range phages have been described. Here we provide an initial characterisation of interactions between a cyanophage isolated from a freshwater fishing lake in the south of England and its hosts. Designated Phi MHI42, the phage is able to infect isolates from two genera of freshwater cyanobacteria, Planktothrix and Microcystis. Transmission Electron Microscopy and Atomic Force Microscopy indicate that Phi MHI42 is a member of the Podoviridae, albeit with a larger than expected capsid. The kinetics of host growth after infection with Phi MHI42 differed across host genera, species and strains in a way that was not related to the growth rate of the uninfected host. To our knowledge, this is the first characterisation of the growth of cyanobacteria in the presence of a broad host-range freshwater cyanophage.	[Watkins, Siobhan C.; Hayes, Paul K.; Watts, Joy E. M.] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; [Smith, James R.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	University of Portsmouth; University of Portsmouth	Watts, JEM (corresponding author), Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England.	joy.watts@port.ac.uk	Smith, James R/D-2350-2011; Smith, James R/F-1108-2014	Smith, James R/0000-0001-8805-3788; Smith, James R/0000-0001-8805-3788; Watts, Joy/0000-0001-9595-0540	EU FP7 KBBE award [265409]	EU FP7 KBBE award	Funding provided by EU FP7 KBBE award 265409: MicroAqua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2003, APPL ENVIRON MICROB, V69, P7499, DOI 10.1128/AEM.69.12.7499-7506.2003; Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Ackermann Hans-W, 2012, Bacteriophage, V2, P122; Ackermann HW, 2009, BACTERIOPHAGES METHO, V1, P175; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Ankrah NYD, 2013, ISME J; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Baker AC, 2006, APPL ENVIRON MICROB, V72, P5713, DOI 10.1128/AEM.00270-06; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BOOKER MJ, 1979, BRIT PHYCOL J, V14, P141, DOI 10.1080/00071617900650161; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Chenard C, 2008, APPL ENVIRON MICROB, V74, P5317, DOI 10.1128/AEM.02480-07; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cook A., 2003, THESIS U WARWICK UK; Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Dreher TW, 2011, ENVIRON MICROBIOL, V13, P1858, DOI 10.1111/j.1462-2920.2011.02502.x; Dunbar J, 1997, APPL ENVIRON MICROB, V63, P1326, DOI 10.1128/AEM.63.4.1326-1331.1997; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Hadas H, 1997, MICROBIOL-UK, V143, P179, DOI 10.1099/00221287-143-1-179; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; Huang SJ, 2012, ENVIRON MICROBIOL, V14, P540, DOI 10.1111/j.1462-2920.2011.02667.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Humbert JF, 2005, MICROB ECOL, V49, P308, DOI 10.1007/s00248-004-0004-z; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Jenkins CA, 2006, J MAR BIOL ASSOC UK, V86, P529, DOI 10.1017/S0025315406013439; Kimura S, 2013, APPL ENVIRON MICROB, V79, P2789, DOI 10.1128/AEM.03751-12; Kuno S, 2012, APPL ENVIRON MICROB, V78, P5353, DOI 10.1128/AEM.00626-12; Kuznetsov YG, 2012, MICRON, V43, P1336, DOI 10.1016/j.micron.2012.02.013; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Labrie SJ, 2013, ENVIRON MICROBIOL, V15, P1356, DOI 10.1111/1462-2920.12053; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Lu J, 2001, APPL ENVIRON MICROB, V67, P3285, DOI 10.1128/AEM.67.7.3285-3290.2001; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Marston MF, 2003, APPL ENVIRON MICROB, V69, P4639, DOI 10.1128/AEM.69.8.4639-4647.2003; McDaniel L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003263; Middelboe M, 2000, MICROBIAL ECOL, V40, P114; Miller R.V., 2008, BACTERIOPHAGE ECOLOG, P114, DOI DOI 10.1017/CBO9780511541483.008; Nelissen B, 1996, J MOL EVOL, V42, P194, DOI 10.1007/BF02198845; Paerl H W, 2001, ScientificWorldJournal, V1, P76; Pepe-Ranney C, 2012, ENVIRON MICROBIOL, V14, P1182, DOI 10.1111/j.1462-2920.2012.02698.x; Petrov VM, 2006, J MOL BIOL, V361, P46, DOI 10.1016/j.jmb.2006.05.071; Ponsero AJ, 2013, GENOME ANNOUNC, V1, P3; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Shan J, 2008, FEMS MICROBIOL LETT, V283, P154, DOI 10.1111/j.1574-6968.2008.01148.x; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Sikora AE, 2012, SOFT MATTER, V8, P6358, DOI 10.1039/c2sm07213k; SNYDER L, 1995, MOL MICROBIOL, V15, P415, DOI 10.1111/j.1365-2958.1995.tb02255.x; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sullivan MB, 2008, ENVIRON MICROBIOL, V10, P2810, DOI 10.1111/j.1462-2920.2008.01702.x; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993; Yoshida T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zhao FQ, 2006, PHYSIOL GENOMICS, V24, P181, DOI 10.1152/physiolgenomics.00255.2005; Zhong F, 2011, WATER RES, V45, P6479, DOI 10.1016/j.watres.2011.09.044	70	19	20	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87339	10.1371/journal.pone.0087339	http://dx.doi.org/10.1371/journal.pone.0087339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489900	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000134
J	Xiao, WB; Hong, H; Awadallah, A; Zhou, L; Xin, W				Xiao, Wenbin; Hong, Hong; Awadallah, Amad; Zhou, Lan; Xin, Wei			Utilization of CDX2 Expression in Diagnosing Pancreatic Ductal Adenocarcinoma and Predicting Prognosis	PLOS ONE			English	Article							HOMEOBOX GENE CDX2; INTESTINAL METAPLASIA; IMMUNOHISTOCHEMICAL SURVEY; GASTRIC CARCINOMAS; TRANSGENIC MICE; CANCER; MICROARRAYS; MUCOSA; MARKER; TUMORS	CDX2, a master transcriptional regulator of intestinal cell differentiation and survival, has been used as a marker to indicate colorectal lineage in adenocarcinomas of unknown origin. Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes for adenocarcinomas of unknown origin, but CDX2 expression in pancreatic disease remains unclear. In this study, we systemically and extensively investigated the expression and role of CDX2 in PDAC. We reported that CDX2 expression is weak and heterogeneous is all normal pancreas and chronic pancreatitis. It is largely expressed in epithelial-lining cells of pancreatic ducts including main ducts, inter-lobular ducts, intra-lobular ducts, intercalated ducts and centroacinar cells, but not in acinar cells or islet cells. CDX2 expression is down regulated during the transformation process from PanIN to PDAC. Only one third of PDACs retain some degree of CDX2 expression, and this group of PDACs have reduced median survival time compared to that of CDX2 negative group (308 days vs. 586 days, p = 0.0065). Metastatic PDACs remain similar expression pattern to that of the primary sites. Our study clearly demonstrates CDX2 expression in pancreatic diseases including PDAC, which is practically important when CDX2 is used to establish the primary sites of adenocarcinomas of unknown origin. In addition, our study also provides CDX2 as a prognostic marker for PDAC and implicates an important role of CDX2 in the development of normal pancreas and PDAC.	[Xiao, Wenbin; Hong, Hong; Awadallah, Amad; Zhou, Lan; Xin, Wei] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Xiao, Wenbin; Hong, Hong; Zhou, Lan; Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Xin, W (corresponding author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	wei.xin@case.edu		Hong, Hong/0000-0002-1009-3621; Xiao, Wenbin/0000-0001-8586-8500	Case Western Reserve University faculty startup fund; University Hospital Case Medical Center Pathology small research grant; NATIONAL CANCER INSTITUTE [P50CA150964] Funding Source: NIH RePORTER	Case Western Reserve University faculty startup fund; University Hospital Case Medical Center Pathology small research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by Case Western Reserve University faculty startup fund, and University Hospital Case Medical Center Pathology small research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Chang YT, 2007, J GASTROEN HEPATOL, V22, P389, DOI 10.1111/j.1440-1746.2006.04487.x; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chu PG, 2005, AM J SURG PATHOL, V29, P359, DOI 10.1097/01.pas.0000149708.12335.6a; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Huang LP, 2012, INT J GYNECOL CANCER, V22, P1170, DOI 10.1097/IGC.0b013e318261d89c; Li QL, 2011, PATHOL ONCOL RES, V17, P561, DOI 10.1007/s12253-010-9346-7; Liu HY, 2012, ARCH PATHOL LAB MED, V136, P601, DOI 10.5858/arpa.2011-0326-OA; Logsdon CD, 2003, CANCER RES, V63, P2649; Matsumoto K, 2004, ONCOL REP, V12, P1239; Mizoshita T, 2001, Gastric Cancer, V4, P185, DOI 10.1007/PL00011741; Mizoshita T, 2003, J CANCER RES CLIN, V129, P727, DOI 10.1007/s00432-003-0499-6; Moskaluk CA, 2003, MODERN PATHOL, V16, P913, DOI 10.1097/01.MP.0000086073.92773.55; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Roessler K, 2005, WORLD J GASTROENTERO, V11, P3182, DOI 10.3748/wjg.v11.i21.3182; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Satoh K, 2002, HELICOBACTER, V7, P192, DOI 10.1046/j.1523-5378.2002.00080.x; Seno H, 2002, INT J ONCOL, V21, P769; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Takahashi K, 2009, PANCREAS, V38, P49, DOI 10.1097/MPA.0b013e31817fa2ba; Tamai Y, 1999, CANCER RES, V59, P2965; Thoene S, 2009, LEUKEMIA, V23, P649, DOI 10.1038/leu.2008.355; van den Akker E, 2002, DEVELOPMENT, V129, P2181; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Werling RW, 2003, AM J SURG PATHOL, V27, P303, DOI 10.1097/00000478-200303000-00003	28	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86853	10.1371/journal.pone.0086853	http://dx.doi.org/10.1371/journal.pone.0086853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489794	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000073
J	Beurel, E; Harrington, LE; Buchser, W; Lemmon, V; Jope, RS				Beurel, Eleonore; Harrington, Laurie E.; Buchser, William; Lemmon, Vance; Jope, Richard S.			Astrocytes Modulate the Polarization of CD4(+) T Cells to Th1 Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; GLUTAMATE RECEPTORS; MULTIPLE-SCLEROSIS; EMERGING EVIDENCE; DENDRITIC CELLS; IMMUNE CELLS; IFN-GAMMA; LYMPHOCYTES; ACTIVATION	T-cell characteristics are dynamic and influenced by multiple factors. To test whether cells and the environment in the central nervous system (CNS) can influence T-cells, we tested if culturing mouse CD4(+) T-cells on mouse primary astrocytes, compared with standard feeder cells, modified T-cell polarization to Th1 and Treg subtypes. Astrocytes supported the production of Th1 cells and Tregs, which was diminished by inflammatory activation of astrocytes, and glutamate accumulation that may result from impaired glutamate uptake by astrocytes strongly promoted Th1 production. These results demonstrate that astrocytes and the environment in the CNS have the capacity to regulate T-cell characteristics.	[Beurel, Eleonore; Jope, Richard S.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Beurel, Eleonore; Jope, Richard S.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Harrington, Laurie E.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Buchser, William] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Lemmon, Vance] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA	University of Miami; University of Miami; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Miami	Beurel, E (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.	ebeurel@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Buchser, William/0000-0002-6675-6359	NIH [MH090236, MH095380]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095380, R00MH090236, K99MH090236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the NIH (MH090236 and MH095380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Aloisi F, 1999, EUR J IMMUNOL, V29, P2705, DOI 10.1002/(SICI)1521-4141(199909)29:09<2705::AID-IMMU2705>3.0.CO;2-1; Aloisi F, 1998, J IMMUNOL, V160, P4671; Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Boldyrev AA, 2005, J NEUROCHEM, V95, P913, DOI 10.1111/j.1471-4159.2005.03456.x; Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008; Buchser WJ, 2012, CANCER RES, V72, P2970, DOI 10.1158/0008-5472.CAN-11-3396; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; FRASCA D, 1985, J IMMUNOL, V134, P3907; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kipnis J, 2008, TRENDS IMMUNOL, V29, P455, DOI 10.1016/j.it.2008.07.007; Kvaratskhelia E, 2009, NEUROIMMUNOMODULAT, V16, P201, DOI 10.1159/000204234; Levite M, 2001, TRENDS IMMUNOL, V22, P2, DOI 10.1016/S1471-4906(00)01799-3; Lindblad SS, 2012, NEUROSIGNALS, V20, P61, DOI 10.1159/000329551; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lombardi G, 2001, BRIT J PHARMACOL, V133, P936, DOI 10.1038/sj.bjp.0704134; Mashkina AP, 2007, NEUROCHEM INT, V51, P356, DOI 10.1016/j.neuint.2007.04.009; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miglio G, 2007, BIOCHEM BIOPH RES CO, V361, P404, DOI 10.1016/j.bbrc.2007.07.015; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nikcevich KM, 1997, J IMMUNOL, V158, P614; Ontaneda D, 2012, ANNU REV MED, V63, P389, DOI 10.1146/annurev-med-042910-135833; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Pacheco R, 2007, J NEUROIMMUNOL, V185, P9, DOI 10.1016/j.jneuroim.2007.01.003; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Poulopoulou C, 2005, MOL PHARMACOL, V67, P856, DOI 10.1124/mol.67.3.856; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ron-Hare N, 2011, BRAIN BEHAV IMMUN, V25, P1036, DOI 10.1016/j.bbi.2010.12.011; Ron-Harel N, 2008, REJUV RES, V11, P903, DOI 10.1089/rej.2008.0755; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Schwartz M, 2010, NAT REV NEUROL, V6, P405, DOI 10.1038/nrneurol.2010.71; Stuve O, 2010, ARCH NEUROL-CHICAGO, V67, P1307, DOI 10.1001/archneurol.2010.158; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	50	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86257	10.1371/journal.pone.0086257	http://dx.doi.org/10.1371/journal.pone.0086257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489707	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000040
J	Cooper, DL; Harirforoosh, S				Cooper, Dustin L.; Harirforoosh, Sam			Design and Optimization of PLGA-Based Diclofenac Loaded Nanoparticles	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; CONTROLLED DRUG-DELIVERY; BEHAVIOR IN-VITRO; ORAL DELIVERY; BIODEGRADABLE NANOPARTICLES; TOPICAL APPLICATION; CONTROLLED-RELEASE; SODIUM; MICROSPHERES; FORMULATION	Drug based nanoparticle (NP) formulations have gained considerable attention over the past decade for their use in various drug formulations. NPs have been shown to increase bioavailability, decrease side effects of highly toxic drugs, and prolong drug release. Nonsteroidal anti-inflammatory drugs such as diclofenac block cyclooxygenase expression and reduce prostaglandin synthesis, which can lead to several side effects such as gastrointestinal bleeding and renal insufficiency. The aim of this study was to formulate and characterize diclofenac entrapped poly(lactide-co-glycolide) (PLGA) based nanoparticles. Nanoparticles were formulated using an emulsion-diffusion-evaporation technique with varying concentrations of poly vinyl alcohol (PVA) (0.1, 0.25, 0.5, or 1%) or didodecyldimethylammonium bromide (DMAB) (0.1, 0.25, 0.5, 0.75, or 1%) stabilizers centrifuged at 8,800 rpm or 12,000 rpm. The resultant nanoparticles were evaluated based on particle size, zeta potential, and entrapment efficacy. DMAB formulated NPs showed the lowest particle size (108 +/- 2.1 nm) and highest zeta potential (-27.71 +/- 0.6 mV) at 0.1 and 0.25% respectively, after centrifugation at 12,000 rpm. Results of the PVA based NP formulation showed the smallest particle size (92.4 +/- 7.6 nm) and highest zeta potential (-11.14 +/- 0.5 mV) at 0.25% and 1% w/v, respectively, after centrifugation at 12,000 rpm. Drug entrapment reached 77.3 +/- 3.5% and 80.2 +/- 1.2% efficiency with DMAB and PVA formulations, respectively. The results of our study indicate the use of DMAB for increased nanoparticle stability during formulation. Our study supports the effective utilization of PLGA based nanoparticle formulation for diclofenac.	[Cooper, Dustin L.; Harirforoosh, Sam] E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA	East Tennessee State University	Harirforoosh, S (corresponding author), E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	harirfor@etsu.edu	Harirforoosh, Sam/J-9493-2013	Harirforoosh, Sam/0000-0002-2631-3756	Research and Development Committee Major Grant, East Tennessee State University	Research and Development Committee Major Grant, East Tennessee State University	This study was funded by a Research and Development Committee Major Grant, East Tennessee State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri SM, 2009, NANOMED-NANOTECHNOL, V5, P90, DOI 10.1016/j.nano.2008.07.003; Ahuja M, 2011, J MICROENCAPSUL, V28, P37, DOI 10.3109/02652048.2010.523794; Attama AA, 2008, INT J PHARM, V355, P307, DOI 10.1016/j.ijpharm.2007.12.007; Barbucci R, 2012, ACTA BIOMATER, V8, P4244, DOI 10.1016/j.actbio.2012.09.006; Barzegar-Jalali M, 2012, POWDER TECHNOL, V219, P211, DOI 10.1016/j.powtec.2011.12.046; Caldwell FJ, 2004, AM J VET RES, V65, P271, DOI 10.2460/ajvr.2004.65.271; Cetin M, 2010, AAPS PHARMSCITECH, V11, P1250, DOI 10.1208/s12249-010-9489-6; Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013; Chawla V, 2000, DRUG DEV IND PHARM, V26, P675, DOI 10.1081/DDC-100101283; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dehar N, 2012, INT J APPL BASIC MED, V2, P25, DOI DOI 10.4103/2229-516X.96799; El-Sousi S, 2013, J PHARM PHARMACOL, V65, P193, DOI 10.1111/j.2042-7158.2012.01587.x; Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3; Gavini E, 2011, J PHARM PHARMACOL, V63, P472, DOI 10.1111/j.2042-7158.2010.01220.x; Gohel MC, 1998, J CONTROL RELEASE, V51, P115, DOI 10.1016/S0168-3659(97)00102-8; Gohel MC, 1999, DRUG DEV IND PHARM, V25, P247, DOI 10.1081/DDC-100102167; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Gursoy A, 2000, J MICROENCAPSUL, V17, P565; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Huanbutta K, 2013, EUR J PHARM SCI, V50, P303, DOI 10.1016/j.ejps.2013.07.010; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Italia JL, 2009, PHARM RES-DORDR, V26, P1324, DOI 10.1007/s11095-009-9841-2; Jain A, 2013, BIOMATTER, V3; Konan YN, 2003, EUR J PHARM BIOPHARM, V55, P115, DOI 10.1016/S0939-6411(02)00128-5; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Levine DG, 2009, AM J VET RES, V70, P1323, DOI 10.2460/ajvr.70.11.1323; Liu D, 2013, J LIPOSOME RES; Liu DF, 2010, J MICROENCAPSUL, V27, P726, DOI 10.3109/02652048.2010.513456; Mathew A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032616; Mittal G, 2007, J CONTROL RELEASE, V119, P77, DOI 10.1016/j.jconrel.2007.01.016; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; National Center for Biotechnology Information, PUBCHEM COMP DAT; Park H, 2008, SMALL, V4, P192, DOI 10.1002/smll.200700807; Patricio B F de Carvalho, 2013, World J Nucl Med, V12, P24, DOI 10.4103/1450-1147.113946; RODRIGUES JM, 1994, TROP MED PARASITOL, V45, P223; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Saxena V, 2004, INT J PHARMACEUT, V278, P293, DOI 10.1016/j.ijpharm.2004.03.032; Sena MM, 2004, J PHARMACEUT BIOMED, V36, P743, DOI 10.1016/j.jpba.2004.08.001; SETH BL, 1992, ARZNEIMITTEL-FORSCH, V42-1, P120; Sonaje K, 2007, PHARM RES-DORDR, V24, P899, DOI 10.1007/s11095-006-9207-y; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wohlfart S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019121; Zacher J, 2008, CURR MED RES OPIN, V24, P925, DOI [10.1185/030079908X273066, 10.1185/030079908X273066 ]	44	57	61	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87326	10.1371/journal.pone.0087326	http://dx.doi.org/10.1371/journal.pone.0087326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489896	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000129
J	Hou, SK; Ding, H; Lv, Q; Yin, XF; Song, JQ; Landen, NX; Fan, HJ				Hou, Shike; Ding, Hui; Lv, Qi; Yin, Xiaofeng; Song, Jianqi; Landen, Ning Xu; Fan, Haojun			Therapeutic Effect of Intravenous Infusion of Perfluorocarbon Emulsion on LPS-Induced Acute Lung Injury in Rats	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LIQUID VENTILATION; OXYGEN CARRIERS; IN-VITRO; INHIBITION; RELEASE; ARDS	Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS) are the leading causes of death in critical care. Despite extensive efforts in research and clinical medicine, mortality remains high in these diseases. Perfluorocarbon (PFC), a chemical compound known as liquid ventilation medium, is capable of dissolving large amounts of physiologically important gases (mainly oxygen and carbon dioxide). In this study we aimed to investigate the effect of intravenous infusion of PFC emulsion on lipopolysaccharide (LPS) induced ALI in rats and elucidate its mechanism of action. Forty two Wistar rats were randomly divided into three groups: 6 rats were treated with saline solution by intratracheal instillation (control group), 18 rats were treated with LPS by intratracheal instillation (LPS group) and the other 18 rats received PFC through femoral vein prior to LPS instillation (LPS+ PFC group). The rats in the control group were sacrificed 6 hours later after saline instillation. At 2, 4 and 6 hours of exposure to LPS, 6 rats in the LPS group and 6 rats in LPS+ PFC group were sacrificed at each time point. By analyzing pulmonary pathology, partial pressure of oxygen in the blood (PaO2) and lung wet-dry weight ratio (W/D) of each rat, we found that intravenous infusion of PFC significantly alleviated acute lung injury induced by LPS. Moreover, we showed that the expression of pulmonary myeloperoxidase (MPO), intercellular adhesion molecule-1 (ICAM-1) of endothelial cells and CD11b of polymorphonuclear neutrophils (PMN) induced by LPS were significantly decreased by PFC treatment in vivo. Our results indicate that intravenous infusion of PFC inhibits the infiltration of PMNs into lung tissue, which has been shown as the core pathogenesis of ALI/ARDS. Thus, our study provides a theoretical foundation for using intravenous infusion of PFC to prevent and treat ALI/ARDS in clinical practice.	[Hou, Shike; Ding, Hui; Lv, Qi; Yin, Xiaofeng; Song, Jianqi; Fan, Haojun] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, Peoples R China; [Landen, Ning Xu] Karolinska Univ Hosp, Mol Dermatol Res Grp, CMM, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Fan, HJ (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Rescue Med Res Inst, Tianjin, Peoples R China.	haojunfan86@163.com	Landén, Ning Xu/AFL-2883-2022	Landén, Ning Xu/0000-0003-4868-3798; Fan, Haojun/0000-0003-1111-0232; Lv, Qi/0000-0001-9076-7042	capital development fund [2009-3091]; Key program of PAPF [WJHQ2010-08]	capital development fund; Key program of PAPF	This work was supported by grants from the capital development fund (2009-3091), Key program of PAPF (WJHQ2010-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi AS, 2010, RESUSCITATION, V81, P353, DOI 10.1016/j.resuscitation.2009.11.018; Angus DC, 2006, CRIT CARE MED, V34, P2885, DOI 10.1097/01.CCM.0000248727.29055.25; ASHBAUGH DG, 1967, LANCET, V2, P319; Baba A, 2000, CRIT CARE MED, V28, P1113, DOI 10.1097/00003246-200004000-00034; Bernard GR, 1999, CHEST, V116, p260S; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Brower RG, 2004, NEW ENGL J MED, V351, P327; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x; Chang H, 2005, INTENS CARE MED, V31, P977, DOI 10.1007/s00134-005-2652-y; Chopra M, 2009, EXP BIOL MED, V234, P361, DOI 10.3181/0811-MR-318; Dickinson S, 2011, CRIT CARE CLIN, V27, P511, DOI 10.1016/j.ccc.2011.05.010; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Faithfull NS, 1998, VOX SANG, V74, P243, DOI 10.1111/j.1423-0410.1998.tb05426.x; Gale SC, 2007, J SURG RES, V138, P135, DOI 10.1016/j.jss.2006.08.029; Garber BG, 1996, CRIT CARE MED, V24, P687, DOI 10.1097/00003246-199604000-00023; Gardinali M, 2000, AM J RESP CRIT CARE, V161, P1022, DOI 10.1164/ajrccm.161.3.9901066; GREENSPAN JS, 1990, J PEDIATR-US, V117, P106, DOI 10.1016/S0022-3476(05)82457-6; Greenspan JS, 2000, SEMIN PERINATOL, V24, P396, DOI 10.1053/sper.2000.20092; Hadjiliadis D, 2000, SEM RESP CRIT CARE M, V21, P175, DOI 10.1055/s-2000-9852; Hale DF, 2012, J TRAUMA ACUTE CARE, V72, P1634, DOI 10.1097/TA.0b013e318247cd4f; Keipert PE, 2001, ANASTH INTENSIV NOTF, V36, pS104; KERINS DM, 1994, AM J MED SCI, V307, P218, DOI 10.1097/00000441-199403000-00009; Lu YM, 2004, INTENS CARE MED, V30, P2197, DOI 10.1007/s00134-004-2479-y; [马希刚 MA Xigang], 2006, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V26, P363; Michetti C, 2003, J SURG RES, V115, P92, DOI 10.1016/S0022-4804(03)00219-1; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; Sharma J, 2009, J IMMUNOL METHODS, V351, P30, DOI 10.1016/j.jim.2009.09.008; Shashikant BN, 2005, CRIT CARE MED, V33, P1096, DOI 10.1097/01.CCM.0000163218.79770.29; Shen Y, 2011, EXPERT REV RESP MED, V5, P107, DOI [10.1586/ers.10.80, 10.1586/ERS.10.80]; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Spahn DR, 1999, CRIT CARE, V3, pR93, DOI 10.1186/cc364; Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008; Taut FJH, 2008, CHEST, V134, P724, DOI 10.1378/chest.08-0362; Taylor RW, 2004, JAMA-J AM MED ASSOC, V291, P1603, DOI 10.1001/jama.291.13.1603; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; Wang X, 2013, CLIN RESPIR  J, DOI [10.1111/crj.12053, DOI 10.1111/CRJ.12053.[]; Wolfson MR, 2004, PAEDIATR ANAESTH, V14, P15, DOI 10.1046/j.1460-9592.2003.01206.x; Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001; Young D, 2013, NEW ENGL J MED, V368, P806, DOI 10.1056/NEJMoa1215716; Yoxall CW, 1997, THORAX, V52, pS3, DOI 10.1136/thx.52.2008.S3; Zhang XP, 2009, J PANCREAS, V10, P8; Zhou XH, 2012, FRONT BIOSCI-LANDMRK, V17, P2278, DOI 10.2741/4051	47	29	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87826	10.1371/journal.pone.0087826	http://dx.doi.org/10.1371/journal.pone.0087826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489970	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000152
J	Tsumuraya, T; Matsushita, M				Tsumuraya, Tomoyuki; Matsushita, Masayuki			COPA and SLC4A4 are Required for Cellular Entry of Arginine-Rich Peptides	PLOS ONE			English	Article							TAT-FUSION PROTEINS; FUNCTIONAL EXPRESSION; PENETRATING PEPTIDES; IN-VIVO; TRANSDUCTION; ENDOCYTOSIS; DELIVERY; INTERNALIZATION; MECHANISM; COATOMER	Cell-penetrating peptides (CPPs) have gained attention as promising tools to enable the delivery of various molecules in a non-invasive manner. Among the CPPs, TAT and poly-arginine have been extensively utilized in numerous studies for the delivery of functional proteins, peptides, and macromolecules to analyze cellular signaling. However, the molecular mechanisms of cellular entry remain largely unknown. Here, we applied siRNA library screening to identify the regulatory genes for the cellular entry of poly-arginine peptide based on microscopic observation of the entry of fluorescent peptides in siRNA-treated cells. In this screening, we identified the cell membrane gene SLC4A4 and the trafficking regulator gene COPA, which also plays an important role in early endosome maturation. These results demonstrated that cellular entry of poly-arginine requires at least two different steps, probably binding on the cell surface and endosomal entry. The identification of genes for cellular entry of poly-arginine provides insights into its mechanisms and should further aid in the development of highly efficient cell-penetrating peptides.	[Tsumuraya, Tomoyuki; Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa, Japan	University of the Ryukyus	Matsushita, M (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Mol & Cellular Physiol, Okinawa, Japan.	masayuki@med.u-ryukyu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Uehara Memorial Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). This research was also supported by the Uehara Memorial Foundation and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Choi I, 2003, AM J PHYSIOL-RENAL, V284, pF1199, DOI 10.1152/ajprenal.00131.2002; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Katayama S, 2013, BBA-BIOMEMBRANES, V1828, P2134, DOI 10.1016/j.bbamem.2013.05.016; Kondo E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1952; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Matsushita M, 2004, FEBS LETT, V572, P221, DOI 10.1016/j.febslet.2004.07.033; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Perry C, 2007, AM J PHYSIOL-RENAL, V293, pF68, DOI 10.1152/ajprenal.00454.2006; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86639	10.1371/journal.pone.0086639	http://dx.doi.org/10.1371/journal.pone.0086639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489756	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000067
J	Zughaier, SM; Kandler, JL; Shafer, WM				Zughaier, Susu M.; Kandler, Justin L.; Shafer, William M.			Neisseria gonorrhoeae Modulates Iron-Limiting Innate Immune Defenses in Macrophages	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GONOCOCCAL-INFECTION; EPITHELIAL-CELLS; MEDIATED IRON; HEPCIDIN 20; RESISTANCE; EXPRESSION; LIPOCALIN-2; METABOLISM; EFFLUX	Neisseria gonorrhoeae is a strict human pathogen that causes the sexually transmitted infection termed gonorrhea. The gonococcus can survive extracellularly and intracellularly, but in both environments the bacteria must acquire iron from host proteins for survival. However, upon infection the host uses a defensive response by limiting the bioavailability of iron by a number of mechanisms including the enhanced expression of hepcidin, the master iron-regulating hormone, which reduces iron uptake from the gut and retains iron in macrophages. The host also secretes the antibacterial protein NGAL, which sequesters bacterial siderophores and therefore inhibits bacterial growth. To learn whether intracellular gonococci can subvert this defensive response, we examined expression of host genes that encode proteins involved in modulating levels of intracellular iron. We found that N. gonorrhoeae can survive in association (tightly adherent and intracellular) with monocytes and macrophages and upregulates a panel of its iron-responsive genes in this environment. We also found that gonococcal infection of human monocytes or murine macrophages resulted in the upregulation of hepcidin, NGAL, and NRAMP1 as well as downregulation of the expression of the gene encoding the short chain 3-hydroxybutyrate dehydrogenase (BDH2); BDH2 catalyzes the production of the mammalian siderophore 2,5-DHBA involved in chelating and detoxifying iron. Based on these findings, we propose that N. gonorrhoeae can subvert the iron-limiting innate immune defenses to facilitate iron acquisition and intracellular survival.	[Zughaier, Susu M.; Kandler, Justin L.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] Dept Vet Affairs Med Ctr, Labs Microbial Pathogenesis, Decatur, GA USA	Emory University	Zughaier, SM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	szughai@emory.edu	Zughaier, Susu/N-3185-2019; Zughaier, Susu/GLQ-9288-2022	Zughaier, Susu/0000-0001-7487-8770; 	Emory-Egleston Children's Research Center; NIH [U19 AI0131496]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI131496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000112] Funding Source: NIH RePORTER	Emory-Egleston Children's Research Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by an Emory-Egleston Children's Research Center grant to S.M.Z., NIH grant U19 AI0131496 (P. F. Sparling, PI, University of North Carolina School of Medicine, W. M. S., Co-Investigator) and by a VA Merit Award grant to W. M. S. from the Medical Research Service of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Cabantchik ZI, 2002, ADV EXP MED BIOL, V509, P55; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; Criss AK, 2006, CELL MICROBIOL, V8, P1430, DOI 10.1111/j.1462-5822.2006.00722.x; Criss AK, 2012, NAT REV MICROBIOL, V10, P178, DOI 10.1038/nrmicro2713; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Ganz T, 2002, ISRAEL MED ASSOC J, V4, P1043; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Hollander A, 2011, INFECT IMMUN, V79, P4764, DOI 10.1128/IAI.05806-11; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Jackson LA, 2010, J BACTERIOL, V192, P77, DOI 10.1128/JB.00741-09; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Johnson MB, 2013, CELL MICROBIOL, V15, P1323, DOI 10.1111/cmi.12117; Johnson MB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00077; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Layoun A, 2012, INFLAMMATION, V35, P1500, DOI 10.1007/s10753-012-9463-4; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Lipinski Pawel, 2010, Postepy Biochem, V56, P305; Liu Y, 2012, MUCOSAL IMMUNOL, V5, P320, DOI 10.1038/mi.2012.12; Liu ZM, 2012, J MOL MED, V90, P1209, DOI 10.1007/s00109-012-0899-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288; Maisetta G, 2010, PEPTIDES, V31, P1995, DOI 10.1016/j.peptides.2010.08.007; Mercante AD, 2012, ANTIMICROB AGENTS CH, V56, P1491, DOI 10.1128/AAC.06112-11; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; NIELSEN H, 1987, ACTA PATH MICRO IM C, V95, P81; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Rodrigues PN, 2011, IMMUNOBIOLOGY, V216, P1127, DOI 10.1016/j.imbio.2011.04.004; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; SHAFER WM, 1984, J INFECT DIS, V149, P175, DOI 10.1093/infdis/149.2.175; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; World Health Organization Department of Reproductive Health and Research, 2011, WHORHR1114 DEP REPR; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	56	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87688	10.1371/journal.pone.0087688	http://dx.doi.org/10.1371/journal.pone.0087688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489950	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000145
J	Barnett, WH; Cymbalyuk, GS				Barnett, William H.; Cymbalyuk, Gennady S.			A Codimension-2 Bifurcation Controlling Endogenous Bursting Activity and Pulse-Triggered Responses of a Neuron Model	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; INTERSEGMENTAL COORDINATION; HEART INTERNEURONS; I-H; OSCILLATORY ACTIVITY; LIMB MOVEMENTS; PHASE; LEECH; MECHANISMS; DYNAMICS	The dynamics of individual neurons are crucial for producing functional activity in neuronal networks. An open question is how temporal characteristics can be controlled in bursting activity and in transient neuronal responses to synaptic input. Bifurcation theory provides a framework to discover generic mechanisms addressing this question. We present a family of mechanisms organized around a global codimension-2 bifurcation. The cornerstone bifurcation is located at the intersection of the border between bursting and spiking and the border between bursting and silence. These borders correspond to the blue sky catastrophe bifurcation and the saddle-node bifurcation on an invariant circle (SNIC) curves, respectively. The cornerstone bifurcation satisfies the conditions for both the blue sky catastrophe and SNIC. The burst duration and interburst interval increase as the inverse of the square root of the difference between the corresponding bifurcation parameter and its bifurcation value. For a given set of burst duration and interburst interval, one can find the parameter values supporting these temporal characteristics. The cornerstone bifurcation also determines the responses of silent and spiking neurons. In a silent neuron with parameters close to the SNIC, a pulse of current triggers a single burst. In a spiking neuron with parameters close to the blue sky catastrophe, a pulse of current temporarily silences the neuron. These responses are stereotypical: the durations of the transient intervals-the duration of the burst and the duration of latency to spiking-are governed by the inverse-square-root laws. The mechanisms described here could be used to coordinate neuromuscular control in central pattern generators. As proof of principle, we construct small networks that control metachronal-wave motor pattern exhibited in locomotion. This pattern is determined by the phase relations of bursting neurons in a simple central pattern generator modeled by a chain of oscillators.	[Barnett, William H.; Cymbalyuk, Gennady S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Cymbalyuk, GS (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	gcymbalyuk@gsu.edu	Barnett, William/GWU-7996-2022		National Science Foundation [PHY-0750456]; Division Of Physics [0750456] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by National Science Foundation grant PHY-0750456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola J, 2012, J NEUROSCI, V32, P2166, DOI 10.1523/JNEUROSCI.5297-11.2012; ANGSTADT JD, 1991, J NEUROPHYSIOL, V66, P1858, DOI 10.1152/jn.1991.66.6.1858; [Anonymous], 1998, METHODS QUALITATIVE; ARBAS EA, 1984, J COMP PHYSIOL, V155, P783, DOI 10.1007/BF00611595; BAL T, 1988, J COMP PHYSIOL A, V163, P715, DOI 10.1007/BF00604049; Berge P, 1987, ORDER CHAOS DETERMIN; Booth V, 1997, SIAM J APPL MATH, V57, P1406, DOI 10.1137/S0036139995295104; Butera RJ, 1997, BIOL CYBERN, V77, P307, DOI 10.1007/s004220050392; Cao XJ, 2011, J NEUROPHYSIOL, V106, P630, DOI 10.1152/jn.00015.2010; Channell P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.134101; COHEN AH, 1992, TRENDS NEUROSCI, V15, P434, DOI 10.1016/0166-2236(92)90006-T; Cymbalyuk G, 2005, J COMPUT NEUROSCI, V18, P255, DOI 10.1007/s10827-005-0354-7; Cymbalyuk GS, 2002, J NEUROSCI, V22, P10580; Cymbalyuk GS, 2001, NEUROCOMPUTING, V38, P159, DOI 10.1016/S0925-2312(01)00414-3; DiCaprio RA, 1997, J EXP BIOL, V200, P963; Doiron B, 2002, J COMPUT NEUROSCI, V12, P5, DOI 10.1023/A:1014921628797; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; ERMENTROUT B, 1994, NEURAL COMPUT, V6, P225, DOI 10.1162/neco.1994.6.2.225; Ermentrout B, 2004, SIAM; ERMENTROUT GB, 1994, SIAM J APPL MATH, V54, P478, DOI 10.1137/S0036139992231964; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Friesen W.O., 1993, Seminars in the Neurosciences, V5, P41, DOI 10.1016/S1044-5765(05)80023-5; Ghigliazza RM, 2004, SIAM J APPL DYN SYST, V3, P636, DOI 10.1137/030602307; Ghosh A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041930; Guckenheimer J, 1997, J COMPUT NEUROSCI, V4, P257, DOI 10.1023/A:1008871803040; Gutkin BS, 1998, NEURAL COMPUT, V10, P1047, DOI 10.1162/089976698300017331; HARRISWARRICK RM, 1987, J NEUROSCI, V7, P2113; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; HOOPER SL, 1987, J NEUROSCI, V7, P2097; Hooper SL, 2002, NAT NEUROSCI, V5, P552, DOI 10.1038/nn838; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; Hoppensteadt FC, 1997, APPL MATH SCI, V126; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jones SR, 2003, J NEUROSCI, V23, P3457; KHIBNIK AI, 1993, PHYSICA D, V62, P360, DOI 10.1016/0167-2789(93)90294-B; Khorkova O, 2007, J NEUROSCI, V27, P8709, DOI 10.1523/JNEUROSCI.1274-07.2007; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; KOPELL N, 1988, MATH BIOSCI, V90, P87, DOI 10.1016/0025-5564(88)90059-4; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Kozlov A, 2009, P NATL ACAD SCI USA, V106, P20027, DOI 10.1073/pnas.0906722106; KRISTAN WB, 1974, J COMP PHYSIOL, V94, P97, DOI 10.1007/BF00617837; Laing CR, 2003, J COMPUT NEUROSCI, V14, P329, DOI 10.1023/A:1023269128622; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Malashchenko T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041910; Malashchenko T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021782; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; Meng XY, 2011, J COMPUT NEUROSCI, V31, P117, DOI 10.1007/s10827-010-0297-5; Mouser C, 2008, J MATH BIOL, V57, P161, DOI 10.1007/s00285-007-0150-2; Mullins OJ, 2011, PROG NEUROBIOL, V93, P244, DOI 10.1016/j.pneurobio.2010.11.001; Nadim F, 1997, J NEUROSCI, V17, P4461; Norris BJ, 2007, J NEUROPHYSIOL, V98, P2983, DOI 10.1152/jn.00407.2007; OPDYKE CA, 1994, J COMP PHYSIOL A, V175, P781; POMEAU Y, 1980, COMMUN MATH PHYS, V74, P189, DOI 10.1007/BF01197757; Pontryagin L. S., 1960, SOV MATH DOKL, V1, P611; Popovych OV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.228102; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Pulver S, 2012, FRONT BEH NEUR C 10; Ramirez JM, 2011, J BIOL PHYS, V37, P241, DOI 10.1007/s10867-011-9214-z; RINZEL J, 1978, FED PROC, V37, P2793; Rinzel J, 1987, LECT NOTES BIOMATH, V71; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Roa MAD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021911; Rodgers EW, 2011, J NEUROSCI, V31, P16387, DOI 10.1523/JNEUROSCI.3770-11.2011; Rodgers EW, 2011, J NEUROSCI, V31, P13046, DOI 10.1523/JNEUROSCI.2194-11.2011; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; Shilnikov L, 2001, METHODS QUALITATIVE, V2; Shilnikov L. P., 2000, METHODS QUALITATIVE, V200, P165; Simoni ME, 2004, IEEE T BIO-MED ENG, V51, P342, DOI 10.1109/TBME.2003.820390; Skinner FK, 1998, J NEUROSCI, V18, P3831; Smarandache C, 2009, J NEUROSCI, V29, P9351, DOI 10.1523/JNEUROSCI.1744-09.2009; Soofi W, 2012, J COMPUT NEUROSCI, V33, P77, DOI 10.1007/s10827-011-0375-3; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; Teka W, 2011, B MATH BIOL, V73, P1292, DOI 10.1007/s11538-010-9559-7; Tobin AE, 2005, J NEUROPHYSIOL, V94, P3938, DOI 10.1152/jn.00340.2005; Varkonyi PL, 2008, J COMPUT NEUROSCI, V25, P245, DOI 10.1007/s10827-008-0076-8; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WILLIAMS TL, 1989, J EXP BIOL, V143, P559; Yanchuk S, 2011, CHAOS, V21, DOI 10.1063/1.3665200	96	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85451	10.1371/journal.pone.0085451	http://dx.doi.org/10.1371/journal.pone.0085451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497927	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900009
J	Gauvin, L; Panisson, A; Cattuto, C				Gauvin, Laetitia; Panisson, Andre; Cattuto, Ciro			Detecting the Community Structure and Activity Patterns of Temporal Networks: A Non-Negative Tensor Factorization Approach	PLOS ONE			English	Article							DECOMPOSITIONS	The increasing availability of temporal network data is calling for more research on extracting and characterizing mesoscopic structures in temporal networks and on relating such structure to specific functions or properties of the system. An outstanding challenge is the extension of the results achieved for static networks to time-varying networks, where the topological structure of the system and the temporal activity patterns of its components are intertwined. Here we investigate the use of a latent factor decomposition technique, non-negative tensor factorization, to extract the community-activity structure of temporal networks. The method is intrinsically temporal and allows to simultaneously identify communities and to track their activity over time. We represent the time-varying adjacency matrix of a temporal network as a three-way tensor and approximate this tensor as a sum of terms that can be interpreted as communities of nodes with an associated activity time series. We summarize known computational techniques for tensor decomposition and discuss some quality metrics that can be used to tune the complexity of the factorized representation. We subsequently apply tensor factorization to a temporal network for which a ground truth is available for both the community structure and the temporal activity patterns. The data we use describe the social interactions of students in a school, the associations between students and school classes, and the spatio-temporal trajectories of students over time. We show that non-negative tensor factorization is capable of recovering the class structure with high accuracy. In particular, the extracted tensor components can be validated either as known school classes, or in terms of correlated activity patterns, i.e., of spatial and temporal coincidences that are determined by the known school activity schedule.	[Gauvin, Laetitia; Panisson, Andre; Cattuto, Ciro] ISI Fdn, Data Sci Lab, Turin, Italy		Gauvin, L (corresponding author), ISI Fdn, Data Sci Lab, Turin, Italy.	laetitia.gauvin@isi.it		Panisson, Andre/0000-0002-3336-0374	Lagrange Project; CRT Foundation; Q-ARACNE project; Fondazione Compagnia di San Paolo; FET Multiplex Project [EU-FET-317532]; European Commission	Lagrange Project; CRT Foundation; Q-ARACNE project; Fondazione Compagnia di San Paolo(Compagnia di San Paolo); FET Multiplex Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge partial support from the Lagrange Project funded by the CRT Foundation, the Q-ARACNE project funded by the Fondazione Compagnia di San Paolo, and the FET Multiplex Project (EU-FET-317532) funded by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Phan AH, 2012, NEURAL COMPUT APPL, V21, P623, DOI 10.1007/s00521-011-0652-0; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chen Y., 2013, ARXIV13037226; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; De Domenico M, 2013, ARXIV13074977; Dunlavy DM, 2011, ACM T KNOWL DISCOV D, V5, DOI 10.1145/1921632.1921636; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Greene D, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P176, DOI 10.1109/ASONAM.2010.17; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Kim J., 2012, HIGH PERFORMANCE SCI, P311, DOI DOI 10.1007/978-1-4471-2437-5_16; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Morup M, 2011, WIRES DATA MIN KNOWL, V1, P24, DOI 10.1002/widm.1; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nickel M., 2011, P 28 INT C MACH LEAR, P809, DOI DOI 10.5555/3104482.3104584; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Ronhovde P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00329; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shashua A., 2005, P 22 INT C MACHINE L, P792, DOI [10.1145/1102351.1102451, DOI 10.1145/1102351.1102451]; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Sun J., 2006, P 12 ACM SIGKDD INT, P374, DOI DOI 10.1145/1150402.1150445; Van de Cruys Tim, 2009, P WORKSHOP GEOMETRIC, P83; Wang F, 2011, DATA MIN KNOWL DISC, V22, P493, DOI 10.1007/s10618-010-0181-y; Wang Y, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P1145; Yang Jaewon, 2013, P 6 ACM INT C WEB SE, P587, DOI [DOI 10.1145/2433396.2433471, 10.1145/2433396.2433471]	36	134	139	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86028	10.1371/journal.pone.0086028	http://dx.doi.org/10.1371/journal.pone.0086028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497935	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900015
J	Lehmann, D; Spanholtz, J; Sturtzel, C; Tordoir, M; Schlechta, B; Groenewegen, D; Hofer, E				Lehmann, Dorit; Spanholtz, Jan; Sturtzel, Caterina; Tordoir, Marleen; Schlechta, Bernhard; Groenewegen, Dirk; Hofer, Erhard			IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR; L-SELECTIN; MANNOSE RECEPTOR; GENE-EXPRESSION; CD56(BRIGHT); IMMUNOTHERAPY; CYTOTOXICITY; BIOLOGY; DISPLAY	The possibility to modulate ex vivo human NK cell differentiation towards specific phenotypes will contribute to a better understanding of NK cell differentiation and facilitate tailored production of NK cells for immunotherapy. In this study, we show that addition of a specific low dose of IL-12 to an ex vivo NK cell differentiation system from cord blood CD34(+) stem cells will result in significantly increased proportions of cells with expression of CD62L as well as KIRs and CD16 which are preferentially expressed on mature CD56(dim) peripheral blood NK cells. In addition, the cells displayed decreased expression of receptors such as CCR6 and CXCR3, which are typically expressed to a lower extent by CD56(dim) than CD56(bright) peripheral blood NK cells. The increased number of CD62L and KIR positive cells prevailed in a population of CD33(+)NKG2A(+) NK cells, supporting that maturation occurs via this subtype. Among a series of transcription factors tested we found Gata3 and TOX to be significantly downregulated, whereas ID3 was upregulated in the IL-12-modulated ex vivo NK cells, implicating these factors in the observed changes. Importantly, the cells differentiated in the presence of IL-12 showed enhanced cytokine production and cytolytic activity against MHC class I negative and positive targets. Moreover, in line with the enhanced CD16 expression, these cells exhibited improved antibody-dependent cellular cytotoxicity for B-cell leukemia target cells in the presence of the clinically applied antibody rituximab. Altogether, these data provide evidence that IL-12 directs human ex vivo NK cell differentiation towards more mature NK cells with improved properties for potential cancer therapies.	[Lehmann, Dorit; Sturtzel, Caterina; Hofer, Erhard] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria; [Spanholtz, Jan; Tordoir, Marleen; Groenewegen, Dirk] Glycostem Therapeut, Nijmegen, Netherlands; [Schlechta, Bernhard] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Hofer, E (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	erhard.hofer@meduniwien.ac.at		Sturtzel, Caterina/0000-0003-1002-5634; Spanholtz, Jan/0000-0001-7152-6956	Marie Curie research training network grants of the EC [MRTN-CT-2005-019248, FP7-People-2012-ITN-317013]	Marie Curie research training network grants of the EC	This work was supported by Marie Curie research training network grants of the EC to EH (MRTN-CT-2005-019248 and FP7-People-2012-ITN-317013). DL was a Marie Curie fellow in the network MRTN-CT-2005-019248. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bennett IM, 1996, J EXP MED, V184, P1845, DOI 10.1084/jem.184.5.1845; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Billot K, 2009, LEUKEMIA RES, V34, P289; Binyamin L, 2008, J IMMUNOL, V180, P6392, DOI 10.4049/jimmunol.180.9.6392; BLOMBERG K, 1986, J IMMUNOL METHODS, V86, P225, DOI 10.1016/0022-1759(86)90457-6; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Di Santo JP, 2008, NAT IMMUNOL, V9, P473, DOI 10.1038/ni.f.201; Eissens DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030930; Galon J, 1999, J IMMUNOL, V162, P7256; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Heemskerk MHM, 1997, J EXP MED, V186, P1597, DOI 10.1084/jem.186.9.1597; Ikawa T, 2001, P NATL ACAD SCI USA, V98, P5164, DOI 10.1073/pnas.091537598; Irjala H, 2001, J EXP MED, V194, P1033, DOI 10.1084/jem.194.8.1033; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Lehmann D, 2012, STEM CELLS DEV, V21, P2926, DOI 10.1089/scd.2011.0659; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Loza MJ, 2004, J IMMUNOL, V172, P88, DOI 10.4049/jimmunol.172.1.88; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Marttila-Ichihara F, 2008, BLOOD, V112, P64, DOI 10.1182/blood-2007-10-118984; Marusina AI, 2005, J IMMUNOL, V174, P2152, DOI 10.4049/jimmunol.174.4.2152; McDyer JF, 1998, J ALLERGY CLIN IMMUN, V102, P11; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Niederleithner H, 2012, J INVEST DERMATOL, V132, P2235, DOI 10.1038/jid.2012.138; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Saez-Borderias A, 2009, J IMMUNOL, V182, P829, DOI 10.4049/jimmunol.182.2.829; Samson SI, 2003, IMMUNITY, V19, P701, DOI 10.1016/S1074-7613(03)00294-2; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Takahashi E, 2007, SCAND J IMMUNOL, V65, P126, DOI 10.1111/j.1365-3083.2006.01883.x; Tayade C, 2005, J LEUKOCYTE BIOL, V78, P1347, DOI 10.1189/jlb.0305142; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; WOJTA J, 1989, J BIOL CHEM, V264, P2846; Yamamoto K, 2002, BIOCHEM BIOPH RES CO, V297, P1245, DOI 10.1016/S0006-291X(02)02378-1; Yun S, 2011, IMMUNOL LETT, V136, P29, DOI 10.1016/j.imlet.2010.11.008	47	25	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87131	10.1371/journal.pone.0087131	http://dx.doi.org/10.1371/journal.pone.0087131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498025	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900068
J	Li, J; Gao, GZ; Xu, K; Chen, BY; Yan, GX; Li, F; Qiao, JW; Zhang, TY; Wu, XM				Li, Jun; Gao, Guizhen; Xu, Kun; Chen, Biyun; Yan, Guixin; Li, Feng; Qiao, Jiangwei; Zhang, Tianyao; Wu, Xiaoming			Genome-Wide Survey and Expression Analysis of the Putative Non-Specific Lipid Transfer Proteins in Brassica rapa L	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; INTRACELLULAR EXCHANGE; POLLEN DEVELOPMENT; BINDING PROTEINS; DROUGHT STRESS; GENE FAMILIES; C GENOMES; ARABIDOPSIS; NAPUS; IDENTIFICATION	Background: Plant non-specific lipid transfer proteins (nsLtps) are small, basic proteins encoded by multigene families and have reported functions in many physiological processes such as mediating phospholipid transfer, defense reactions against phytopathogens, the adaptation of plants to various environmental conditions, and sexual reproduction. To date, no genome-wide overview of the Brassica rapa nsLtp (BrnsLtp) gene family has been performed. Therefore, as the first step and as a helpful strategy to elucidate the functions of BrnsLtps, a genome-wide study for this gene family is necessary. Methodology/Principal Finding: In this study, a total of 63 putative BrnsLtp genes were identified through a comprehensive in silico analysis of the whole genome of B. rapa. Based on the sequence similarities, these BrnsLtps was grouped into nine types (I, II, III, IV, V, VI, VIII, IX, and XI). There is no type VII nsLtps in B. rapa, and a new type, XI nsLtps, was identified in B. rapa. Furthermore, nine type II AtLtps have no homologous genes in B. rapa. Gene duplication analysis demonstrated that the conserved collinear block of each BrnsLtp is highly identical to those in Arabidopsis and that both segmental duplications and tandem duplications seem to play equal roles in the diversification of this gene family. Expression analysis indicated that 29 out of the 63 BrnsLtps showed specific expression patterns. After careful comparison and analysis, we hypothesize that some of the type I BrnsLtps may function like Arabidopsis pathogenesis-related-14 (PR-14) proteins to protect the plant from phytopathogen attack. Eleven BrnsLtps with inflorescence-specific expression may play important roles in sexual reproduction. Additionally, BrnsLtpI.3 may have functions similar to Arabidopsis LTP1. Conclusions/Significance: The genome-wide identification, bioinformatic analysis and expression analysis of BrnsLtp genes should facilitate research of this gene family and polyploidy evolution and provide new insight towards elucidating their biological functions in plants.	[Li, Jun; Gao, Guizhen; Xu, Kun; Chen, Biyun; Yan, Guixin; Li, Feng; Qiao, Jiangwei; Zhang, Tianyao; Wu, Xiaoming] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wu, XM (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wuxm@oilcrops.cn		Li, Jun/0000-0002-1285-6514	Chinese National Basic Research and Development Program [2011CB109302]; National Natural Science Foundation of China [31100236]; Wuhan Youth Science and Technology Chen Guang Program [201271031402]	Chinese National Basic Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Youth Science and Technology Chen Guang Program	This study was supported by the Chinese National Basic Research and Development Program (2011CB109302), the National Natural Science Foundation of China (31100236), and the Wuhan Youth Science and Technology Chen Guang Program (201271031402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2001, BIOCHEMISTRY-US, V40, P4229, DOI 10.1021/bi002537v; ARONDEL V, 1990, MOL CELL BIOCHEM, V98, P49; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Blein JP, 2002, TRENDS PLANT SCI, V7, P293, DOI 10.1016/S1360-1385(02)02284-7; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Bohuon EJR, 1996, THEOR APPL GENET, V93, P833, DOI 10.1007/BF00224083; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Brotman Y, 2012, MICROBIOL-SGM, V158, P139, DOI 10.1099/mic.0.052621-0; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cardoza V, 2004, IN VITRO CELL DEV-PL, V40, P542, DOI 10.1079/IVP2004568; Carvalho AD, 2007, PEPTIDES, V28, P1144, DOI 10.1016/j.peptides.2007.03.004; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chae K, 2010, J EXP BOT, V61, P4277, DOI 10.1093/jxb/erq228; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Champigny MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00230; Champigny MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-125; Chen CM, 2011, PLANT SCI, V181, P439, DOI 10.1016/j.plantsci.2011.07.003; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Choi YE, 2012, PLANT J, V70, P480, DOI 10.1111/j.1365-313X.2011.04886.x; COUTOSTHEVENOT P, 1993, EUR J BIOCHEM, V217, P885, DOI 10.1111/j.1432-1033.1993.tb18317.x; Douliez JP, 2000, J CEREAL SCI, V32, P1, DOI 10.1006/jcrs.2000.0315; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Ellerstrom M, 1996, PLANT MOL BIOL, V32, P1019, DOI 10.1007/BF00041385; EVANS DE, 1992, PLANTA, V186, P343, DOI 10.1007/BF00195314; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FOSTER GD, 1992, PLANT SCI, V84, P187, DOI 10.1016/0168-9452(92)90133-7; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; GUERCHE P, 1990, PLANT CELL, V2, P469, DOI 10.1105/tpc.2.5.469; Guiderdoni E, 2002, PLANT MOL BIOL, V49, P683, DOI 10.1023/A:1015595100145; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo CK, 2013, PLANT MOL BIOL, V82, P239, DOI 10.1007/s11103-013-0057-9; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Jose-Estanyol M, 2000, PLANT PHYSIOL BIOCH, V38, P97, DOI 10.1016/S0981-9428(00)00165-0; Jung HW, 2003, PLANT CELL ENVIRON, V26, P915, DOI 10.1046/j.1365-3040.2003.01024.x; KADER JC, 1984, EUR J BIOCHEM, V139, P411, DOI 10.1111/j.1432-1033.1984.tb08020.x; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; KADER JC, 1975, BIOCHIM BIOPHYS ACTA, V380, P31, DOI 10.1016/0005-2760(75)90042-9; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim TH, 2008, J PLANT PHYSIOL, V165, P345, DOI 10.1016/j.jplph.2007.06.004; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; LEHMANN MS, 1989, J MOL BIOL, V210, P235, DOI 10.1016/0022-2836(89)90303-3; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Lim GAC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-40; Lin P, 2007, PEPTIDES, V28, P1514, DOI 10.1016/j.peptides.2007.06.028; Liu Wanfei, 2010, Genomics Proteomics & Bioinformatics, V8, P229, DOI 10.1016/S1672-0229(10)60024-1; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Lukens L, 2003, GENETICS, V164, P359; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Molina A, 1997, PLANT J, V12, P669, DOI 10.1046/j.1365-313X.1997.00669.x; Molina A, 1996, MOL GEN GENET, V252, P162, DOI 10.1007/BF02173216; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nieuwland J, 2005, PLANT CELL, V17, P2009, DOI 10.1105/tpc.105.032094; OSTERGAARD J, 1993, BIOCHIM BIOPHYS ACTA, V1170, P109, DOI 10.1016/0005-2760(93)90059-I; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Park SY, 2003, PLANT MOL BIOL, V51, P183, DOI 10.1023/A:1021139502947; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piffanelli P, 1997, PLANT J, V11, P549, DOI 10.1046/j.1365-313X.1997.11030549.x; Pii Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24836; Pii Y, 2010, PLANT SIGNAL BEHAV, V5, P594, DOI 10.4161/psb.11499; Potocka I, 2012, PLANT CELL REP, V31, P2031, DOI 10.1007/s00299-012-1314-0; Rogers HJ, 2001, PLANT MOL BIOL, V45, P577, DOI 10.1023/A:1010695226241; Sarowar S, 2009, PLANT CELL REP, V28, P419, DOI 10.1007/s00299-008-0653-3; Sawano Y, 2008, PLANT PHYSIOL, V146, P1909, DOI 10.1104/pp.107.111500; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SHIN DH, 1995, STRUCTURE, V3, P189, DOI 10.1016/S0969-2126(01)00149-6; SLEIGHT RG, 1987, ANNU REV PHYSIOL, V49, P193; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stalberg K, 1996, PLANTA, V199, P515, DOI 10.1007/BF00195181; STERK P, 1991, PLANT CELL, V3, P907, DOI 10.1105/tpc.3.9.907; Suwabe K, 2008, GENOME, V51, P169, DOI 10.1139/G07-113; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia G, 2013, PLANT MOL BIOL, V82, P485, DOI 10.1007/s11103-013-0080-x; Tassin S, 1998, BIOCHEMISTRY-US, V37, P3623, DOI 10.1021/bi9723515; THOMA S, 1994, PLANT PHYSIOL, V105, P35, DOI 10.1104/pp.105.1.35; Tian AM, 2009, MOL BIOL REP, V36, P307, DOI 10.1007/s11033-007-9180-5; TSUBOI S, 1992, J BIOCHEM-TOKYO, V111, P500, DOI 10.1093/oxfordjournals.jbchem.a123787; U. N., 1935, Japanese Journal of Botany, V7, P389; VANCE JE, 1991, J BIOL CHEM, V266, P8241; VERGNOLLE C, 1992, METHOD ENZYMOL, V209, P522; Wang CM, 2008, PLANT CELL REP, V27, P159, DOI 10.1007/s00299-007-0434-4; Wang HW, 2012, DNA RES, V19, P179, DOI 10.1093/dnares/dss003; Wang NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S9; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2005, FEBS LETT, V579, P1683, DOI 10.1016/j.febslet.2005.02.024; Yuan J, 2008, PLANT PHYSIOL, V146, P1637, DOI 10.1104/pp.107.110304; Zhang DS, 2010, PLANT PHYSIOL, V154, P149, DOI 10.1104/pp.110.158865; Zhou ZF, 2012, J EXP BOT, V63, P2041, DOI 10.1093/jxb/err405	102	27	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e84556	10.1371/journal.pone.0084556	http://dx.doi.org/10.1371/journal.pone.0084556			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497919	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900006
J	de Andrade, L; Vissoci, JRN; Rodrigues, CG; Finato, K; Carvalho, E; Pietrobon, R; de Souza, EM; Nihei, OK; Lynch, C; Carvalho, MDD				de Andrade, Luciano; Nickenig Vissoci, Joao Ricardo; Rodrigues, Clarissa Garcia; Finato, Karen; Carvalho, Elias; Pietrobon, Ricardo; de Souza, Eniuce Menezes; Nihei, Oscar Kenji; Lynch, Catherine; de Barros Carvalho, Maria Dalva			Brazilian Road Traffic Fatalities: A Spatial and Environmental Analysis	PLOS ONE			English	Article							ACCIDENTS; HOTSPOTS; CRASHES; SAFETY; TRENDS; RISK	Background: Road traffic injuries (RTI) are a major public health epidemic killing thousands of people daily. Low and middle-income countries, such as Brazil, have the highest annual rates of road traffic fatalities. In order to improve road safety, this study mapped road traffic fatalities on a Brazilian highway to determine the main environmental factors affecting road traffic fatalities. Methods and Findings: Four techniques were utilized to identify and analyze RTI hotspots. We used spatial analysis by points by applying kernel density estimator, and wavelet analysis to identify the main hot regions. Additionally, built environment analysis, and principal component analysis were conducted to verify patterns contributing to crash occurrence in the hotspots. Between 2007 and 2009, 379 crashes were notified, with 466 fatalities on BR277. Higher incidence of crashes occurred on sections of highway with double lanes (ratio 2: 1). The hotspot analysis demonstrated that both the eastern and western regions had higher incidences of crashes when compared to the central region. Through the built environment analysis, we have identified five different patterns, demonstrating that specific environmental characteristics are associated with different types of fatal crashes. Patterns 2 and 4 are constituted mainly by predominantly urban characteristics and have frequent fatal pedestrian crashes. Patterns 1, 3 and 5 display mainly rural characteristics and have higher prevalence of vehicular collisions. In the built environment analysis, the variables length of road in urban area, limited lighting, double lanes roadways, and less auxiliary lanes were associated with a higher incidence of fatal crashes. Conclusions: By combining different techniques of analyses, we have identified numerous hotspots and environmental characteristics, which governmental or regulatory agencies could make use to plan strategies to reduce RTI and support life-saving policies.	[de Andrade, Luciano; Finato, Karen; Nihei, Oscar Kenji] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil; [de Andrade, Luciano; Pietrobon, Ricardo; Lynch, Catherine] Duke Univ Hlth Syst, Dept Surg, Durham, NC 27710 USA; [de Andrade, Luciano; Nickenig Vissoci, Joao Ricardo; Rodrigues, Clarissa Garcia; Carvalho, Elias; Lynch, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Rodrigues, Clarissa Garcia] RS Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil; [Carvalho, Elias] PUC PR, Grad Program Informat PPGIA, Curitiba, Parana, Brazil; [Carvalho, Elias; de Souza, Eniuce Menezes; de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil	Universidade Estadual do Oeste do Parana; Duke University; Duke University; Centro Universitario Inga (UNINGA); Fundacao Universitaria de Cardiologia; Universidade Estadual de Maringa	Lynch, C (corresponding author), Duke Univ Hlth Syst, Dept Surg, Durham, NC 27710 USA.	catherine.lynch@duke.edu	Carvalho, Maria Dalva/AAK-8411-2021; Souza, Eniuce/Q-1421-2019; Carvalho, Elias/J-7086-2012	Carvalho, Maria Dalva/0000-0002-1377-3331; Souza, Eniuce/0000-0003-0265-7586; Staton, Catherine/0000-0002-6468-2894; Carvalho, Elias/0000-0002-2638-7202	Science Without Borders Program, Brazilian Government	Science Without Borders Program, Brazilian Government	LA and JRNV were funded by Science Without Borders Program, Brazilian Government (http://www.cienciasemfronteiras.gov.br/web/csf-eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hemoud AM, 2010, J SAFETY RES, V41, P307, DOI 10.1016/j.jsr.2010.06.001; American Traffic Safety Services Association, 2008, LOW COST LOC ROAD SA; Anderson T, 2007, J MAPS, P55, DOI 10.4113/jom.2007.72; Anderson TK, 2009, ACCIDENT ANAL PREV, V41, P359, DOI 10.1016/j.aap.2008.12.014; [Anonymous], 1995, LECT NOTES STAT; Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069; Bailey T, 1995, INTERACTIVE SPATIAL; Bates D, 2013, R PROJECT STAT COMPU; Brazil Ministry of Health, 2008, HLTH INF NOT; Brugmann Jeb, 2009, WELCOME URBAN REVOLU; Cafiso S, 2010, ACCIDENT ANAL PREV, V42, P1072, DOI 10.1016/j.aap.2009.12.015; Camara G, 2002, ANALISE ESPACIAL EVE; Cho GY, 2009, ACCIDENT ANAL PREV, V41, P692, DOI 10.1016/j.aap.2009.03.008; Clifton KJ, 2009, TRANSPORT RES D-TR E, V14, P425, DOI 10.1016/j.trd.2009.01.001; Coll B, 2013, ACCIDENT ANAL PREV, V59, P604, DOI 10.1016/j.aap.2013.07.012; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; Almeida LVC, 2009, CAD SAUDE PUBLICA, V25, P303, DOI 10.1590/S0102-311X2009000200008; Neto OLD, 2012, CIENC SAUDE COLETIVA, V17, P2223; Erdogan S, 2008, ACCIDENT ANAL PREV, V40, P174, DOI 10.1016/j.aap.2007.05.004; Ewing R, 2009, J PLAN LIT, V23, P347, DOI 10.1177/0885412209335553; Koehlmoos TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001464; Kwon OH, 2013, ACCIDENT ANAL PREV, V51, P141, DOI 10.1016/j.aap.2012.10.019; Lockhart PA, 2013, TRAFFIC INJ PREV, V14, P509, DOI 10.1080/15389588.2012.732718; Lopez R, 2008, J HEALTH POLIT POLIC, V33, P617, DOI 10.1215/03616878-2008-010; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luoma J, 2013, ACCIDENT ANAL PREV, V50, P1207, DOI 10.1016/j.aap.2012.09.023; Montella A, 2010, ACCIDENT ANAL PREV, V42, P571, DOI 10.1016/j.aap.2009.09.025; Noland RB, 2004, ACCIDENT ANAL PREV, V36, P525, DOI 10.1016/S0001-4575(03)00058-7; Paun S, 2011, CHIRURGIA-BUCHAREST, V106, P439; Redelmeier DA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001463; Rzeznikiewiz D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1125; Sutton T, 2011, DOCUMENTATION QGIS 1; The PLoS Medicine Editors, 2010, PLOS MED, V7; Wang Y., 2008, COST EFFECTIVE SAFET; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2004, WORLD REPORT ROAD TR; Xie Z, 2008, COMPUT ENV URBAN SYS, V32, P5396; Yan XD, 2008, TRAFFIC INJ PREV, V9, P173, DOI 10.1080/15389580701869356; Zegeer CV, 2012, ACCIDENT ANAL PREV, V44, P3, DOI 10.1016/j.aap.2010.12.007	39	14	16	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87244	10.1371/journal.pone.0087244	http://dx.doi.org/10.1371/journal.pone.0087244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498051	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100065
J	Chen, J; Cai, YY; Cong, EZ; Liu, Y; Gao, JF; Li, YH; Tao, M; Zhang, KR; Wang, XM; Gao, CG; Yang, LJ; Li, K; Shi, JG; Wang, G; Liu, LF; Zhang, JB; Du, B; Jiang, GQ; Shen, JH; Zhang, Z; Liang, W; Sun, J; Hu, J; Liu, TB; Wang, XY; Miao, GD; Meng, HQ; Li, Y; Hu, CM; Li, Y; Huang, GP; Li, GY; Ha, BW; Deng, H; Mei, QY; Zhong, H; Gao, SG; Sang, H; Zhang, YT; Fang, X; Yu, FY; Yang, DL; Liu, TQ; Chen, YC; Hong, XH; Wu, WY; Chen, GB; Cai, M; Song, Y; Pan, JY; Dong, JC; Pan, RD; Zhang, W; Shen, ZM; Liu, ZR; Gu, DH; Wang, XP; Liu, XJ; Zhang, QW; Li, YH; Chen, YP; Kendler, KS; Shi, SX; Flint, J				Chen, Jing; Cai, Yiyun; Cong, Enzhao; Liu, Ying; Gao, Jingfang; Li, Youhui; Tao, Ming; Zhang, Kerang; Wang, Xumei; Gao, Chengge; Yang, Lijun; Li, Kan; Shi, Jianguo; Wang, Gang; Liu, Lanfen; Zhang, Jinbei; Du, Bo; Jiang, Guoqing; Shen, Jianhua; Zhang, Zhen; Liang, Wei; Sun, Jing; Hu, Jian; Liu, Tiebang; Wang, Xueyi; Miao, Guodong; Meng, Huaqing; Li, Yi; Hu, Chunmei; Li, Yi; Huang, Guoping; Li, Gongying; Ha, Baowei; Deng, Hong; Mei, Qiyi; Zhong, Hui; Gao, Shugui; Sang, Hong; Zhang, Yutang; Fang, Xiang; Yu, Fengyu; Yang, Donglin; Liu, Tieqiao; Chen, Yunchun; Hong, Xiaohong; Wu, Wenyuan; Chen, Guibing; Cai, Min; Song, Yan; Pan, Jiyang; Dong, Jicheng; Pan, Runde; Zhang, Wei; Shen, Zhenming; Liu, Zhengrong; Gu, Danhua; Wang, Xiaoping; Liu, Xiaojuan; Zhang, Qiwen; Li, Yihan; Chen, Yiping; Kendler, Kenneth S.; Shi, Shenxun; Flint, Jonathan			Childhood Sexual Abuse and the Development of Recurrent Major Depression in Chinese Women	PLOS ONE			English	Article							MENTAL-HEALTH; SUICIDAL-BEHAVIOR; PHYSICAL ABUSE; BODILY SHAME; RISK; PSYCHOPATHOLOGY; ASSOCIATION; DISORDERS; CHILDREN; HISTORY	Background: Our prior study in Han Chinese women has shown that women with a history of childhood sexual abuse (CSA) are at increased risk for developing major depression (MD). Would this relationship be found in our whole data set? Method: Three levels of CSA (non-genital, genital, and intercourse) were assessed by self-report in two groups of Han Chinese women: 6017 clinically ascertained with recurrent MD and 5983 matched controls. Diagnostic and other risk factor information was assessed at personal interview. Odds ratios (ORs) were calculated by logistic regression. Results: We confirmed earlier results by replicating prior analyses in 3,950 new recurrent MD cases. There were no significant differences between the two data sets. Any form of CSA was significantly associated with recurrent MD (OR 4.06, 95% confidence interval (CI) [3.19-5.24]). This association strengthened with increasing CSA severity: non-genital (OR 2.21, 95% CI 1.58-3.15), genital (OR 5.24, 95% CI 3.52-8.15) and intercourse (OR 10.65, 95% CI 5.56-23.71). Among the depressed women, those with CSA had an earlier age of onset, longer depressive episodes. Recurrent MD patients those with CSA had an increased risk for dysthymia (OR 1.60, 95% CI 1.11-2.27) and phobia (OR 1.41, 95% CI 1.09-1.80). Any form of CSA was significantly associated with suicidal ideation or attempt (OR 1.50, 95% CI 1.20-1.89) and feelings of worthlessness or guilt (OR 1.41, 95% CI 1.02-2.02). Intercourse (OR 3.47, 95% CI 1.66-8.22), use of force and threats (OR 1.95, 95% CI 1.05-3.82) and how strongly the victims were affected at the time (OR 1.39, 95% CI 1.20-1.64) were significantly associated with recurrent MD. Conclusions: In Chinese women CSA is strongly associated with recurrent MD and this association increases with greater severity of CSA. Depressed women with CSA have some specific clinical traits. Some features of CSA were associated with greater likelihood of developing recurrent MD.	[Cong, Enzhao; Shi, Shenxun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Chen, Jing; Cai, Yiyun; Shi, Shenxun] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; [Liu, Ying] China Med Univ, Hosp 1, Shenyang, Liaoning, Peoples R China; [Gao, Jingfang] Chinese Tradit Hosp Zhejiang, Hangzhou, Zhejiang, Peoples R China; [Li, Youhui] Zhengzhou Univ, Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Tao, Ming] Xinhua Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Kerang] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Xumei] China Med Univ, ShengJing Hosp, Shenyang, Liaoning, Peoples R China; [Gao, Chengge] Xi An Jiao Tong Univ, Coll Med, Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Yang, Lijun] Jilin Brain Hosp, Siping, Jilin, Peoples R China; [Li, Kan] Mental Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China; [Shi, Jianguo] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Wang, Gang] Capital Univ Med Sci, Beijing Anding Hosp, Beijing, Peoples R China; [Liu, Lanfen] Shandong Mental Hlth Ctr, Jinan, Shandong, Peoples R China; [Zhang, Jinbei] Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Du, Bo] Hebei Mental Hlth Ctr, Baoding, Hebei, Peoples R China; [Jiang, Guoqing] Chongqing Mental Hlth Ctr, Chongqing, Peoples R China; [Shen, Jianhua] Tianjin Anding Hosp, Tianjin, Peoples R China; [Zhang, Zhen] Jiangsu Univ, Hosp 4, Zhenjiang, Jiangsu, Peoples R China; [Liang, Wei] Psychiat Hosp Henan Prov, Xinxiang, Henan, Peoples R China; [Sun, Jing] Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Hu, Jian] Harbin Med Univ, Haerbin, Heilongjiang, Peoples R China; [Liu, Tiebang] Shenzhen Kang Ning Hosp, Shenzhen, Guangdong, Peoples R China; [Wang, Xueyi] Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China; [Miao, Guodong] Guangzhou Psychiat Hosp, Guangzhou Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Meng, Huaqing] Chongqing Med Univ, Hosp 1, Chongqing, Peoples R China; [Li, Yi] Dalian 7 Hosp, Dalian, Liaoning, Peoples R China; [Hu, Chunmei] 3 Hosp Heilongjiang Prov, Beian, Heilongjiang, Peoples R China; [Li, Yi] Wuhan Mental Hlth Ctr, Wuhan, Hubei, Peoples R China; [Huang, Guoping] Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China; [Li, Gongying] Jining Med Coll, Mental Hlth Inst, Jining, Shandong, Peoples R China; [Ha, Baowei] Liaocheng 4 Hosp, Liaocheng, Shandong, Peoples R China; [Deng, Hong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Mei, Qiyi] Suzhou Guangji Hosp, Suzhou, Jiangsu, Peoples R China; [Zhong, Hui] Anhui Mental Hlth Ctr, Hefei, Anhui, Peoples R China; [Gao, Shugui] Ningbo Kang Ning Hosp, Ningbo, Zhejiang, Peoples R China; [Sang, Hong] Changchun Mental Hosp, Changchun, Jilin, Peoples R China; [Zhang, Yutang] Lanzhou Univ, Hosp 2, Lanzhou 730000, Gansu, Peoples R China; [Fang, Xiang] Fuzhou Psychiat Hosp, Fuzhou, Fujian, Peoples R China; [Yu, Fengyu] Harbin 1 Special Hosp, Haerbin, Heilongjiang, Peoples R China; [Yang, Donglin] Jining Psychiat Hosp, Jining, Shandong, Peoples R China; [Liu, Tieqiao] Zhongnan Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Chen, Yunchun] 4 Mil Med Univ, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Hong, Xiaohong] Shantou Univ, Mental Hlth Ctr, Shantou, Guangdong, Peoples R China; [Wu, Wenyuan] Tongji Univ Hosp, Shanghai, Peoples R China; [Chen, Guibing] Huaian 3 Hosp, Huaian, Jiangsu, Peoples R China; [Cai, Min] Huzhou 3 Hosp, Huzhou, Zhejiang, Peoples R China; [Song, Yan] Mudanjiang Psychiat Hosp Heilongjiang Prov, Mudanjiang, Heilongjiang, Peoples R China; [Pan, Jiyang] Jinan Univ, Hosp 1, Guangzhou, Guangdong, Peoples R China; [Dong, Jicheng] Qingdao Mental Hlth Ctr, Qingdao, Shandong, Peoples R China; [Pan, Runde] Guangxi Longquanshan Hosp, Liuzhou, Guangxi, Peoples R China; [Zhang, Wei] Daqing 3 Hosp Heilongjiang Prov, Daqing, Heilongjiang, Peoples R China; [Shen, Zhenming] Tangshan 5 Hosp, Tangshan, Hebei, Peoples R China; [Liu, Zhengrong] Anshan Psychiat Rehabil Hosp, Anshan, Liaoning, Peoples R China; [Gu, Danhua] Weihai Mental Hlth Ctr, Weihai, Shandong, Peoples R China; [Wang, Xiaoping] Wuhan Univ, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Liu, Xiaojuan] Tianjin First Ctr Hosp, Tianjin, Peoples R China; [Zhang, Qiwen] Hainan Anning Hosp, Haikou, Hainan, Peoples R China; [Li, Yihan; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford, England; [Chen, Yiping] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA	Shanghai Jiao Tong University; Fudan University; China Medical University; Zhengzhou University; Zhejiang Chinese Medical University; Shanxi Medical University; China Medical University; Xi'an Jiaotong University; Capital Medical University; Sun Yat Sen University; Jiangsu University; Harbin Medical University; Hebei Medical University; Chongqing Medical University; Jining Medical University; Sichuan University; Lanzhou University; Central South University; Air Force Military Medical University; Shantou University; Tongji University; Jinan University; Wuhan University; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; Virginia Commonwealth University	Shi, SX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	shishenxun@163.com; jf@well.ox.ac.uk	Chen, Yi/HIR-2608-2022; liu, tieqiao/GSE-2327-2022; Kendler, Kenneth/AAF-2876-2019	Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust [083240/Z/07/2]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100549] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Wellcome Trust (083240/Z/07/2): http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS B, 1995, J ABNORM PSYCHOL, V104, P277, DOI 10.1037/0021-843X.104.2.277; Andrews B, 1997, BRIT J CLIN PSYCHOL, V36, P41, DOI 10.1111/j.2044-8260.1997.tb01229.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, COMP INT DIAGN INT C; APA, 1994, DIAGN STAT MAN MENT; Basile KC, 2006, J ADOLESC HLTH, V39; Bedi S, 2011, SUICIDE LIFE-THREAT, V41, P406, DOI 10.1111/j.1943-278X.2011.00040.x; Bonomi AE, 2008, CHILD ABUSE NEGLECT, V32, P693, DOI 10.1016/j.chiabu.2007.10.004; Brodsky BS, 2001, AM J PSYCHIAT, V158, P1871, DOI 10.1176/appi.ajp.158.11.1871; Bulik CM, 2001, BRIT J PSYCHIAT, V179, P444, DOI 10.1192/bjp.179.5.444; Carey PD, 2008, EUR CHILD ADOLES PSY, V17, P93, DOI 10.1007/s00787-007-0641-0; CAVAIOLA AA, 1989, CHILD ABUSE NEGLECT, V13, P327, DOI 10.1016/0145-2134(89)90072-0; Chen Jing-qi, 2004, Zhonghua Er Ke Za Zhi, V42, P39; Chen JQ, 2006, J ADOLESCENT HEALTH, V38, P544, DOI 10.1016/j.jadohealth.2005.04.001; Chen JQ, 2004, CHILD ABUSE NEGLECT, V28, P1171, DOI 10.1016/j.chiabu.2004.07.003; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Cohen P, 2001, DEV PSYCHOPATHOL, V13, P981, DOI 10.1017/S0954579401004126; Cong E, 2012, PSYCHOL MED, V42, P409, DOI 10.1017/S0033291711001462; Davidson JRT, 1996, ARCH GEN PSYCHIAT, V53, P550; Draper B, 2008, J AM GERIATR SOC, V56, P262, DOI 10.1111/j.1532-5415.2007.01537.x; Dube SR, 2005, AM J PREV MED, V28, P430, DOI 10.1016/j.amepre.2005.01.015; Endicott J., 1992, FAMILY HIST RES DIAG; Epstein JN, 1997, J TRAUMA STRESS, V10, P573, DOI 10.1023/A:1024841718677; Fergusson D., 1999, CHILDHOOD SEXUAL ABU; Fergusson DM, 2008, CHILD ABUSE NEGLECT, V32, P607, DOI 10.1016/j.chiabu.2006.12.018; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Gamble SA, 2006, J NERV MENT DIS, V194, P382, DOI 10.1097/01.nmd.0000218058.96252.ac; Gan ZY, 2012, J AFFECT DISORDERS, V136, P988, DOI 10.1016/j.jad.2011.06.046; Gao J., 2011, P 2011 INT C EL MACH, P1; Gladstone G, 1999, AM J PSYCHIAT, V156, P431; JUMPER SA, 1995, CHILD ABUSE NEGLECT, V19, P715, DOI 10.1016/0145-2134(95)00029-8; Kaplow JB, 2007, J ABNORM PSYCHOL, V116, P176, DOI 10.1037/0021-843X.116.1.176; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kendler KS, 1996, AM J PSYCHIAT, V153, P11; Kendler KS, 2013, PSYCHOL MED, V13, P1; KENDLER KS, 2006, ENV PSYCHOPATHOLOGY; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Liu RT, 2012, CHILD ABUSE NEGLECT, V36, P323, DOI 10.1016/j.chiabu.2011.11.007; Martin G, 2004, CHILD ABUSE NEGLECT, V28, P491, DOI 10.1016/j.chiabu.2003.08.006; MARTIN J, 1993, CHILD ABUSE NEGLECT, V17, P383, DOI 10.1016/0145-2134(93)90061-9; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; MENNEN FE, 1995, J INTERPERS VIOLENCE, V10, P259, DOI 10.1177/088626095010003002; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; Neumann DA, 1996, CHILD MALTREATMENT, V1, P6, DOI [10.1177/1077559596001001002, DOI 10.1177/1077559596001001002]; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PETERS DK, 1995, CHILD ABUSE NEGLECT, V19, P335, DOI 10.1016/S0145-2134(94)00133-2; Powers A, 2009, DEPRESS ANXIETY, V26, P46, DOI 10.1002/da.20534; Rind B, 1997, J SEX RES, V34, P237, DOI 10.1080/00224499709551891; Rodriguez N, 1996, CHILD ABUSE NEGLECT, V20, P943, DOI 10.1016/0145-2134(96)00083-X; ROESLER TA, 1994, J NERV MENT DIS, V182, P145, DOI 10.1097/00005053-199403000-00003; Rohde P, 2008, CHILD ABUSE NEGLECT, V32, P878, DOI 10.1016/j.chiabu.2007.11.004; Sarchiapone M, 2007, DEPRESS ANXIETY, V24, P268, DOI 10.1002/da.20243; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Spinhoven P, 2010, J AFFECT DISORDERS, V126, P103, DOI 10.1016/j.jad.2010.02.132; Sun YP, 2008, WORLD J PEDIATR, V4, P285, DOI 10.1007/s12519-008-0052-4; Tao M, 2011, J AFFECT DISORDERS, V135, P95, DOI 10.1016/j.jad.2011.06.054; TONG L, 1987, CHILD ABUSE NEGLECT, V11, P371, DOI 10.1016/0145-2134(87)90011-1; Ullman SE, 2009, SUICIDE LIFE-THREAT, V39, P47, DOI 10.1521/suli.2009.39.1.47; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; WOZENCRAFT T, 1991, CHILD ABUSE NEGLECT, V15, P505, DOI 10.1016/0145-2134(91)90034-B; Young MS, 2007, J INTERPERS VIOLENCE, V22, P1315, DOI 10.1177/0886260507304552; Zlotnick C, 2001, CHILD ABUSE NEGLECT, V25, P357, DOI 10.1016/S0145-2134(00)00251-9	66	19	20	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87569	10.1371/journal.pone.0087569	http://dx.doi.org/10.1371/journal.pone.0087569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489940	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000161
J	Cordoni, G; Norscia, I				Cordoni, Giada; Norscia, Ivan			Peace-Making in Marsupials: The First Study in the Red-Necked Wallaby (Macropus rufogriseus)	PLOS ONE			English	Article							POST-CONFLICT BEHAVIOR; SELF-DIRECTED BEHAVIOR; CHIMPANZEES PAN-TROGLODYTES; PLACENTAL MAMMAL PHYLOGENY; MACAQUES MACACA-FUSCATA; GORILLA-GORILLA-GORILLA; LONG-TAILED MACAQUES; POSTCONFLICT AFFILIATION; REPRODUCTIVE SUCCESS; RELATIONSHIP QUALITY	The issue of reconciliation has been widely investigated in many eutherian mammal species. Nevertheless, no data are available for marsupial mammals. Indeed, the majority of reports focus on group dynamics from an ecological and reproductive perspective, but no study has investigated them from a social point of view. We observed the red-necked wallaby colony (Macropus rufogriseus) hosted at the Tierparc Zoo Berlin (Germany) and collected data on aggressive and post-conflict interactions between group members. We found that the phenomenon of reconciliation is present in the study species (mean group CCT 27.40% +/-8.89% SE). Therefore, we demonstrated, for the first time, the occurrence of reconciliation in a gregarious marsupial mammal. Post-conflict reunion was not affected by the relationship quality between individuals (friendship or kinship) but it was fine-tuned according to the aggression intensity. For example, low intensity conflicts were reconciled whereas high intensity ones were not. Reconciliation reduced anxiety-related scratching in both of the former opponents and limited further attacks towards the victim during the post-conflict period. These findings suggest that the red-necked wallaby, like many eutherian species, can evaluate the costs of reconciliation and engage in peacemaking behavior in the right contexts, in order to maximize its pay-offs.	[Cordoni, Giada; Norscia, Ivan] Univ Pisa, Museo Storia Nat, Pisa, Italy	University of Pisa	Cordoni, G (corresponding author), Univ Pisa, Museo Storia Nat, Pisa, Italy.	cordoni@vademecos.eu	Cordoni, Giada/ABE-2242-2020; Norscia, Ivan/J-3321-2015	Cordoni, Giada/0000-0001-7093-0025; Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2006, HDB NEUROCHEMISTRY M; Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Arnold K, 2007, PRIMATES PERSPECTIVE, P592; Arnold Kate, 2007, P592; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Aureli F, 2002, BEHAV BRAIN SCI, V25, P23, DOI 10.1017/S0140525X02250013; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli Filippo, 2000, P199; Barros M, 2000, BEHAV BRAIN RES, V108, P205, DOI 10.1016/S0166-4328(99)00153-9; Blumstein Daniel T., 2003, Acta Ethologica, V5, P95, DOI 10.1007/s10211-002-0070-5; Butovskaya M, 1996, PRIMATES, V37, P261, DOI 10.1007/BF02381858; Byers JA, 1999, J ZOOL, V247, P349, DOI 10.1017/S0952836999003064; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Castles DL, 1998, ETHOLOGY, V104, P148; CHAUVET MT, 1983, GEN COMP ENDOCR, V51, P309, DOI 10.1016/0016-6480(83)90086-2; Cilia J, 1997, PHARMACOL BIOCHEM BE, V58, P85, DOI 10.1016/S0091-3057(96)00376-0; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cooper MA, 2007, ETHOLOGY, V113, P26, DOI 10.1111/j.1439-0310.2006.01287.x; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; Cordoni G, 2007, J COMP PSYCHOL, V121, P171, DOI 10.1037/0735-7036.121.2.171; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Cords M., 2000, NATURAL CONFLICT RES, P177; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; DeWaal FBM, 1997, ANN NY ACAD SCI, V807, P317; DeWaal Frans B. M., 1996, GOOD NATURED ORIGINS; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Fraser ON, 2008, ETHOLOGY, V114, P834, DOI 10.1111/j.1439-0310.2008.01527.x; Fraser ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018118; FRIED RG, 1994, J AM ACAD DERMATOL, V30, P993, DOI 10.1016/S0190-9622(94)70125-3; Fujisawa KK, 2005, AGGRESSIVE BEHAV, V31, P138, DOI 10.1002/ab.20076; Gemmell RT, 2002, REPRODUCTION, V123, P301, DOI 10.1530/rep.0.1230301; Higginbottom K, 2000, WILDLIFE BIOL, V6, P129, DOI 10.2981/wlb.2000.008; Higginbottom Karen, 1999, Symposia of the Zoological Society of London, V72, P80; Isler K, 2011, BIOESSAYS, V33, P173, DOI 10.1002/bies.201000123; Jarman PJ, 2000, PRIMATE MALES, P21; JARMAN PJ, 1991, ADV STUD BEHAV, V20, P1, DOI 10.1016/S0065-3454(08)60318-6; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P125, DOI 10.1071/WR9870125; JOHNSON CN, 1989, J MAMMAL, V70, P18, DOI 10.2307/1381665; JOHNSON CN, 1986, BEHAV ECOL SOCIOBIOL, V19, P143, DOI 10.1007/BF00299949; JOHNSON CN, 1985, THESIS U NEW ENGLAND; Judge PG, 2013, ANIM BEHAV, V85, P881, DOI 10.1016/j.anbehav.2013.02.011; KAPPELER PM, 1993, ANIM BEHAV, V45, P901, DOI 10.1006/anbe.1993.1110; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Karlen SJ, 2007, PROG NEUROBIOL, V82, P122, DOI 10.1016/j.pneurobio.2007.03.003; Koo J. Y. M., 2003, PSYCHOCUTANEOUS MED, P139; Koyama NF, 2001, ETHOLOGY, V107, P975, DOI 10.1046/j.1439-0310.2001.00731.x; KRAUSE L, 1983, BRIT MED J, V287, P1199, DOI 10.1136/bmj.287.6400.1199; Kutsukake N, 2003, BEHAVIOUR, V140, P1153, DOI 10.1163/156853903322589687; Kutsukake N, 2001, ANIM COGN, V4, P59; Kutsukake N, 2009, ECOL RES, V24, P521, DOI 10.1007/s11284-008-0563-4; Leca JB, 2002, INT J PRIMATOL, V23, P979, DOI 10.1023/A:1019641830918; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Martin P., 2007, MEASURING BEHAV INTR, V3; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Morris Desmond, 1977, MANWATCHING FIELD GU; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nunn CL, 2004, BEHAV ECOL SOCIOBIOL, V57, P50, DOI 10.1007/s00265-004-0830-5; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2008, AM J PRIMATOL, V70, P949, DOI 10.1002/ajp.20587; Palagi E, 2011, STRESS, V14, P93, DOI 10.3109/10253890.2010.505272; Palagi E, 2009, ANIM BEHAV, V78, P979, DOI 10.1016/j.anbehav.2009.07.017; Parry LJ, 2000, EXP PHYSIOL, V85, p91S, DOI 10.1111/j.1469-445X.2000.tb00012.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rothman S, 1941, PHYSIOL REV, V21, P357, DOI 10.1152/physrev.1941.21.2.357; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 1998, BEHAVIOUR, V135, P343, DOI 10.1163/156853998793066302; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; SHANLEY KJ, 1988, VET CLIN N AM-SMALL, V18, P971, DOI 10.1016/S0195-5616(88)50101-8; Stangier U, 2003, BEHAV RES THER, V41, P991, DOI 10.1016/S0005-7967(02)00176-6; Tran BW, 2010, ACTA DERM-VENEREOL, V90, P354, DOI 10.2340/00015555-0890; Troisi A, 2000, J NERV MENT DIS, V188, P13, DOI 10.1097/00005053-200001000-00003; Van Hooff Jan A.R.A.M., 2001, P67; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; WATSON DM, 1993, ETHOLOGY, V94, P1; Watson DM, 1996, ETHOLOGY, V102, P336; Watson DM, 1990, THESIS U NEW S WALES; Watts DP, 2006, INT J PRIMATOL, V27, P1337, DOI 10.1007/s10764-006-9081-9; Weaver A, 2003, MAR MAMMAL SCI, V19, P836, DOI 10.1111/j.1748-7692.2003.tb01134.x; Wittig RM, 2003, BEHAVIOUR, V140, P1527, DOI 10.1163/156853903771980701; Zar JH, 1999, BIOSTATISTICAL ANAL	91	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86859	10.1371/journal.pone.0086859	http://dx.doi.org/10.1371/journal.pone.0086859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489796	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000075
J	Hu, XQ; Wu, XL; Xu, C; Zheng, XH; Jin, YL; Wu, LJ; Wang, XY; Xu, HZ; Tian, NF				Hu, Xu-Qi; Wu, Xin-Lei; Xu, Cong; Zheng, Xu-Hao; Jin, Yong-Long; Wu, Li-Jun; Wang, Xiang-Yang; Xu, Hua-Zi; Tian, Nai-Feng			A Systematic Review and Meta-Analysis of Unilateral versus Bilateral Pedicle Screw Fixation in Transforaminal Lumbar Interbody Fusion	PLOS ONE			English	Article							CLINICAL ARTICLE; POSTERIOR; SPONDYLOLISTHESIS; INSTRUMENTATION; DISEASE	Background: Transforaminal lumbar interbody fusion (TLIF) has become one of the most widely used procedures for lumbar spinal disorders. However, it is still unclear whether TLIF with unilateral pedicle screw (PS) fixation is as effective as that with bilateral PS fixation. We performed a meta-analysis of the literatures and aimed to gain a better understanding of whether TLIF with unilateral PS fixation was safe and effective for lumbar diseases. Methodology/Principal Findings: We systematically searched Ovid, Springer, and Medline databases for relevant randomized controlled trials (RCTs) that compared the clinical and radiological outcomes of unilateral versus bilateral PS fixation in TLIF. Risk of bias in included studies was assessed using the Cochrane Risk of Bias tool. We generated pooled risk ratios or weighted mean differences across studies. According to our predefined inclusion criteria, seven RCTs with a total of 441 patients were included in this study. Baseline characteristics were similar between the unilateral and bilateral groups. Our meta-analysis showed that no significant difference was detected between the two groups in terms of postoperative clinical function, fusion status, reoperation rate, complication rate, and hospital stay (p > 0.05). Pooled estimates revealed that the unilateral group was associated with significantly reduced implant cost, operative time and blood loss (p < 0.05). Conclusions/Significances: Our meta-analysis suggested TLIF with unilateral PS fixation was as safe and effective as that with bilateral PS fixation for lumbar diseases in selected patients. Despite these findings, our meta-analysis was based on studies with small sample size and different study characteristics that might lead to the inconsistent results such as various functional outcomes among the included studies. Therefore, high-quality randomized controlled trials with larger sample size are also needed to further clarify these issues and to provide the long-term outcomes.	[Hu, Xu-Qi; Xu, Cong; Zheng, Xu-Hao; Jin, Yong-Long; Wang, Xiang-Yang; Xu, Hua-Zi; Tian, Nai-Feng] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Wenzhou, Zhejiang, Peoples R China; [Wu, Xin-Lei; Wu, Li-Jun] Wenzhou Med Univ, Inst Digitized Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Xu, HZ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Wenzhou, Zhejiang, Peoples R China.	spine-xu@163.com; tiannaifeng@163.com		Wu, Xinlei/0000-0001-7383-8961	National Natural Science Foundation of China [81371988]; Natural Science Foundation of Zhejiang Province for Distinguished Young Scholars [LR12H06001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province for Distinguished Young Scholars	This work is supported by grants of National Natural Science Foundation of China (No. 81371988), Natural Science Foundation of Zhejiang Province for Distinguished Young Scholars (No. LR12H06001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2012, J NEUROSURG-SPINE, V17, P153, DOI 10.3171/2012.5.SPINE111044; Aoki Y, 2010, J NEUROSURG-SPINE, V13, P381, DOI 10.3171/2010.3.SPINE09590; Beringer Will F, 2006, Neurosurg Focus, V20, pE4; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Chen Yi-Heng, 2010, Zhonghua Wai Ke Za Zhi, V48, P989; Choi UY, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.2.FOCUS12398; Crandall DG, 2013, SPINE, V38, P1128, DOI 10.1097/BRS.0b013e31828864e6; Dahdaleh NS, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13171; Deutsch Harel, 2006, Neurosurg Focus, V20, pE10; Feng Zhen-Zhou, 2011, Orthopedics, V34, P364, DOI 10.3928/01477447-20110317-05; HA KY, 1993, J SPINAL DISORD, V6, P99; Hackenberg L, 2005, EUR SPINE J, V14, P551, DOI 10.1007/s00586-004-0830-1; HARMS J, 1982, Z ORTHOP GRENZGEB, V120, P343, DOI 10.1055/s-2008-1051624; Harris BM, 2004, SPINE, V29, pE65, DOI 10.1097/01.BRS.0000113034.74567.86; Humphreys SC, 2001, SPINE, V26, P567; Kai Z, 2013, INT ORTHOP; Lauber S, 2006, SPINE, V31, P1693, DOI 10.1097/01.brs.0000224530.08481.4e; Park P, 2004, SPINE, V29, P1938, DOI 10.1097/01.brs.0000137069.88904.03; Parker SL, 2012, PROF CASE MANAG, V17, P229, DOI 10.1097/NCM.0b013e3182529c05; Potter BK, 2005, J SPINAL DISORD TECH, V18, P337, DOI 10.1097/01.bsd.0000166642.69189.45; Quante M, 2012, ORTHOPADE, V41, P153, DOI 10.1007/s00132-011-1832-4; Salehi SA, 2004, NEUROSURGERY, V54, P368, DOI 10.1227/01.NEU.0000103493.25162.18; Sethi A, 2011, SPINE J, V11, P863, DOI 10.1016/j.spinee.2011.06.015; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; Suk KS, 2000, SPINE, V25, P1843; Toyone T, 2010, SPINE S; Tuttle Jonathan, 2006, Neurosurg Focus, V20, pE5; Xie YZ, 2012, ORTHOPEDICS, V35, pE1517, DOI 10.3928/01477447-20120919-22; Xue HM, 2012, SPINE J, V12, P209, DOI 10.1016/j.spinee.2012.01.010	29	17	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87501	10.1371/journal.pone.0087501	http://dx.doi.org/10.1371/journal.pone.0087501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489929	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000155
J	Li, XW; Jiang, HX; Zhang, XC; Shelton, AM; Feng, JN				Li, Xiao-Wei; Jiang, Hong-Xue; Zhang, Xiao-Chen; Shelton, Anthony M.; Feng, Ji-Nian			Post-Mating Interactions and Their Effects on Fitness of Female and Male Echinothrips americanus (Thysanoptera: Thripidae), a New Insect Pest in China	PLOS ONE			English	Article							SEXUAL-HARASSMENT; CALLOSOBRUCHUS-MACULATUS; MATE CHOICE; COSTS; LONGEVITY; FECUNDITY; BEHAVIOR; FLY; REPRODUCTION; FREQUENCY	Post-mating, sexual interactions of opposite sexes differ considerably in different organisms. Post-mating interactions such as re-mating behavior and male harassment can affect the fitness of both sexes. Echinothrips americanus is a new insect pest in Mainland China, and little is known about its post-mating interactions. In this study, we observed re-mating frequency and male harassment frequency and their effects on fitness parameters and offspring sex ratios of E. americanus females. Furthermore, we tested the impact of mating and post-mating interactions on fitness parameters of males. Our results revealed that the re-mating frequency in female adults was extremely low during a 30-day period. However, post-mating interactions between females and males, consisting mainly of male harassment and female resistance, did occur and significantly reduced female longevity and fecundity. Interestingly, increased access to males did not affect the ratio of female offspring. For males, mating dramatically reduced their longevity. However, post-mating interactions with females had no effects on the longevity of mated males. These results enrich our basic knowledge about female and male mating and post-mating behaviors in this species and provide important information about factors that may influence population regulation of this important pest species.	[Li, Xiao-Wei; Jiang, Hong-Xue; Zhang, Xiao-Chen; Feng, Ji-Nian] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China; [Li, Xiao-Wei; Shelton, Anthony M.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Northwest A&F University - China; Cornell University	Feng, JN (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Yangling, Shaanxi, Peoples R China.	jinianf@nwsuaf.edu.cn			National Science Foundation of China [3127344]; Doctoral Fund of Ministry of Education of China [20090204110003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	The project was supported by the National Science Foundation of China (3127344) and Doctoral Fund of Ministry of Education of China (20090204110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GR, 1994, ANIM BEHAV, V48, P635, DOI 10.1006/anbe.1994.1283; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Blanckenhorn WU, 2002, BEHAV ECOL, V13, P353, DOI 10.1093/beheco/13.3.353; Burton-Chellew MN, 2007, EVOL ECOL RES, V9, P921; Cheng LI, 2004, J INSECT BEHAV, V17, P227, DOI 10.1023/B:JOIR.0000028572.76021.d9; CluttonBrock T, 1997, BEHAV ECOL, V8, P392, DOI 10.1093/beheco/8.4.392; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; CRESPI BJ, 1986, ECOL ENTOMOL, V11, P119, DOI 10.1111/j.1365-2311.1986.tb00286.x; CRESPI BJ, 1988, AM MIDL NAT, V119, P83, DOI 10.2307/2426056; CRESPI BJ, 1988, BEHAV ECOL SOCIOBIOL, V22, P293, DOI 10.1007/BF00299845; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; den Hollander M, 2009, ANIM BEHAV, V78, P1061, DOI 10.1016/j.anbehav.2009.06.036; EBERHARD WG, 1995, TRENDS ECOL EVOL, V10, P493, DOI 10.1016/S0169-5347(00)89205-8; Edvardsson M, 2007, ANIM BEHAV, V74, P183, DOI 10.1016/j.anbehav.2006.07.018; Gay L, 2009, PHYSIOL ENTOMOL, V34, P86, DOI 10.1111/j.1365-3032.2008.00656.x; Gilbert JDJ, 2013, BIOL J LINN SOC, V109, P802, DOI 10.1111/bij.12100; Gosden TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000580; HEADY SE, 1993, PHYSIOL ENTOMOL, V18, P263, DOI 10.1111/j.1365-3032.1993.tb00598.x; Helinski MEH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1131, DOI 10.1007/s00265-012-1365-9; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kotiaho JS, 2003, J INSECT PHYSIOL, V49, P817, DOI 10.1016/S0022-1910(03)00117-3; KRAINACKER DA, 1990, EXP APPL ACAROL, V9, P169, DOI 10.1007/BF01193426; Lachmann AD, 2000, INVERTEBR REPROD DEV, V37, P233, DOI 10.1080/07924259.2000.9652423; Li XW, 2012, ENVIRON ENTOMOL, V41, P706, DOI 10.1603/EN11325; Macke E, 2012, AM NAT, V179, pE147, DOI 10.1086/665002; Maklakov AA, 2009, ANIM BEHAV, V77, P1375, DOI 10.1016/j.anbehav.2009.03.005; McLain DK, 1999, BEHAV ECOL SOCIOBIOL, V46, P164, DOI 10.1007/s002650050606; Milne M, 1997, THESIS U QUEENSLAND; Mirab-Balou Majid, 2010, Acta Zootaxonomica Sinica, V35, P674; Muhlhauser C, 2002, BEHAV ECOL, V13, P359, DOI 10.1093/beheco/13.3.359; Oetting Ronald D., 1993, Zoology (Journal of Pure and Applied Zoology), V4, P307; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Parker G. A., 1979, SEXUAL SELECTION REP; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Ringo J, 1996, ANNU REV ENTOMOL, V41, P473, DOI 10.1146/annurev.en.41.010196.002353; Ronn J, 2006, ANIM BEHAV, V72, P335, DOI 10.1016/j.anbehav.2005.10.024; Rossi BH, 2010, ANIM BEHAV, V79, P165, DOI 10.1016/j.anbehav.2009.10.023; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Sakurai G, 2008, ANIM BEHAV, V75, P1367, DOI 10.1016/j.anbehav.2007.09.010; Shuker DM, 2006, ANIM BEHAV, V72, P313, DOI 10.1016/j.anbehav.2005.10.020; Simmons LW, 2007, J EVOLUTION BIOL, V20, P488, DOI 10.1111/j.1420-9101.2006.01274.x; Sirot LK, 2001, ANIM BEHAV, V61, P415, DOI 10.1006/anbe.2000.1605; SMITH AF, 1990, J INSECT PHYSIOL, V36, P369, DOI 10.1016/0022-1910(90)90019-C; SPENCER JL, 1992, J INSECT BEHAV, V5, P689, DOI 10.1007/BF01047980; STONE GN, 1995, ANIM BEHAV, V50, P405, DOI 10.1006/anbe.1995.0255; Takahashi Y, 2009, ENTOMOL SCI, V12, P219, DOI 10.1111/j.1479-8298.2009.00326.x; Terry I., 1993, Zoology (Journal of Pure and Applied Zoology), V4, P339; Thornhill R., 1983, pi; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; VARADARASAN S, 1982, Proceedings of the Indian National Science Academy Part B Biological Sciences, V48, P35; Wagner WE, 2001, EVOLUTION, V55, P994, DOI 10.1554/0014-3820(2001)055[0994:FRALSB]2.0.CO;2; WALKER WF, 1980, AM NAT, V115, P780, DOI 10.1086/283600; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101	57	16	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87725	10.1371/journal.pone.0087725	http://dx.doi.org/10.1371/journal.pone.0087725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489956	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000174
J	Xu, GG; McMahan, CA; Walter, CA				Xu, Guogang; McMahan, C. Alex; Walter, Christi A.			Early-Life Exposure to Benzo[a]pyrene Increases Mutant Frequency in Spermatogenic Cells in Adulthood	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-ADDUCTS; CHILDRENS HEALTH; GERM-CELLS; SPONTANEOUS MUTATION; PHAGOCYTIC FUNCTION; GENE-EXPRESSION; SERTOLI-CELLS; TOBACCO-SMOKE; DIOL EPOXIDE	Children are vulnerable to environmental mutagens, and the developing germline could also be affected. However, little is known about whether exposure to environmental mutagens in childhood will result in increased germline mutations in subsequent adult life. In the present study, male transgenic lacI mice at different ages (7, 25 and 60 days old) were treated with a known environmental mutagen (benzo[a]pyrene, B[a]P) at different doses (0, 50, 200 or 300 mg/kg body weight). Mutant frequency was then determined in a meiotic cell type (pachytene spermatocyte), a post-meiotic cell type (round spermatid) and epididymal spermatozoa after at least one cycle of spermatogenesis. Our results show that 1) mice treated with B[a]P at 7 or 25 days old, both being pre-adult ages, had significantly increased mutant frequencies in all spermatogenic cell types tested when they were 60 days old; 2) spermatogenic cells from mice treated before puberty were more susceptible to B[a]P-associated mutagenesis compared to adult mice; and 3) unexpectedly, epididymal spermatozoa had the highest mutant frequency among the spermatogenic cell types tested. These data show that pre-adult exposure to B[a]P increases the male germline mutant frequency in young adulthood. The data demonstrate that exposure to environmental genotoxins at different life phases (e.g., pre-adult and adult) can have differential effects on reproductive health.	[Xu, Guogang; Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [McMahan, C. Alex] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Sci, San Antonio, TX 78229 USA; [Walter, Christi A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Walter, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	walter@uthscsa.edu			 [AG021163]; NATIONAL INSTITUTE ON AGING [R01AG021163] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by AG021163, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2000, ENVIRON HEALTH PERSP, V108, P573, DOI 10.2307/3454549; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barton HA, 2005, ENVIRON HEALTH PERSP, V113, P1125, DOI 10.1289/ehp.7667; Bartsch H, 1996, MUTAT RES-REV GENET, V340, P67, DOI 10.1016/S0165-1110(96)90040-8; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bieche I, 2007, PHARMACOGENET GENOM, V17, P731, DOI 10.1097/FPC.0b013e32810f2e58; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Braun RE, 1998, NAT GENET, V18, P202, DOI 10.1038/ng0398-202; CHEMES H, 1986, ENDOCRINOLOGY, V119, P1673, DOI 10.1210/endo-119-4-1673; CONNEY AH, 1994, DRUG METAB REV, V26, P125, DOI 10.3109/03602539409029788; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dym M, 1970, Biology Reprod., V3, P308; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; GENEROSO WM, 1982, MUTAT RES, V94, P155, DOI 10.1016/0027-5107(82)90178-6; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Grandjean V, 1997, DEV BIOL, V184, P165, DOI 10.1006/dbio.1997.8518; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hill KA, 1999, MUTAT RES-REV MUTAT, V436, P11, DOI 10.1016/S1383-5742(98)00024-6; Hill KA, 2004, ENVIRON MOL MUTAGEN, V43, P110, DOI 10.1002/em.20004; Hill KA, 1999, MUTAT RES-FUND MOL M, V425, P47, DOI 10.1016/S0027-5107(98)00248-6; IARC, 1983, POL AR COMP 1; Jansen J, 2001, NUCLEIC ACIDS RES, V29, P1791, DOI 10.1093/nar/29.8.1791; KADLUBAR FF, 1980, CHEM-BIOL INTERACT, V31, P255, DOI 10.1016/0009-2797(80)90014-9; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Landrigan PJ, 2011, MT SINAI J MED, V78, P1, DOI 10.1002/msj.20236; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; Leavitt SA, 2008, MUTAGENESIS, V23, P445, DOI 10.1093/mutage/gen033; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; MACKENZIE KM, 1981, BIOL REPROD, V24, P183, DOI 10.1095/biolreprod24.1.183; Marchetti F, 2011, P NATL ACAD SCI USA, V108, P12811, DOI 10.1073/pnas.1106896108; McCullagh P, 1989, GEN STAT MODELS; Mohamed ESA, 2010, HUM REPROD, V25, P2427, DOI 10.1093/humrep/deq205; Nishino H, 1996, ENVIRON MOL MUTAGEN, V28, P299; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Oh SM, 2009, ENVIRON TOXICOL, V24, P225, DOI 10.1002/tox.20422; Olivo-Marston SE, 2009, CANCER EPIDEM BIOMAR, V18, P3375, DOI 10.1158/1055-9965.EPI-09-0986; Olsen AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011349; PANIAGUA R, 1984, J ANAT, V139, P535; PINEAU C, 1991, CELL TISSUE RES, V264, P589, DOI 10.1007/BF00319048; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; RUSSELL LD, 1977, ANAT RECORD, V187, P347, DOI 10.1002/ar.1091870307; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Shane BS, 2000, CARCINOGENESIS, V21, P715, DOI 10.1093/carcin/21.4.715; Somers CM, 2004, SCIENCE, V304, P1008, DOI 10.1126/science.1095815; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325; Verhofstad N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-333; Verhofstad N, 2010, ENVIRON MOL MUTAGEN, V51, P123, DOI 10.1002/em.20516; Walter CA, 2004, DNA REPAIR, V3, P495, DOI 10.1016/j.dnarep.2004.01.005; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Wei QY, 2000, J NATL CANCER I, V92, P1764; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wijker CA, 1996, MUTAT RES-FUND MOL M, V349, P229, DOI 10.1016/0027-5107(95)00187-5; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Xu GG, 2008, MUTAT RES-GEN TOX EN, V654, P150, DOI 10.1016/j.mrgentox.2008.05.012; Yauk CL, 1996, P NATL ACAD SCI USA, V93, P12137, DOI 10.1073/pnas.93.22.12137; Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87439	10.1371/journal.pone.0087439	http://dx.doi.org/10.1371/journal.pone.0087439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489914	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000145
J	Cardoso, DC; Pompolo, SD; Cristiano, MP; Tavares, MG				Cardoso, Danon Clemes; Pompolo, Silvia das Gracas; Cristiano, Maykon Passos; Tavares, Mara Garcia			The Role of Fusion in Ant Chromosome Evolution: Insights from Cytogenetic Analysis Using a Molecular Phylogenetic Approach in the Genus Mycetophylax	PLOS ONE			English	Article							KARYOTYPE EVOLUTION; HYMENOPTERA-FORMICIDAE; SPECIATION; EMERY; ORTHOPTERA; INFERENCE; PATTERNS; ORIGIN; BASES	Among insect taxa, ants exhibit one of the most variable chromosome numbers ranging from n=1 to n=60. This high karyotype diversity is suggested to be correlated to ants diversification. The karyotype evolution of ants is usually understood in terms of Robertsonian rearrangements towards an increase in chromosome numbers. The ant genus Mycetophylax is a small monogynous basal Attini ant (Formicidae: Myrmicinae), endemic to sand dunes along the Brazilian coastlines. A recent taxonomic revision validates three species, Mycetophylax morschi, M. conformis and M. simplex. In this paper, we cytogenetically characterized all species that belongs to the genus and analyzed the karyotypic evolution of Mycetophylax in the context of a molecular phylogeny and ancestral character state reconstruction. M. morschi showed a polymorphic number of chromosomes, with colonies showing 2n = 26 and 2n = 30 chromosomes. M. conformis presented a diploid chromosome number of 30 chromosomes, while M. simplex showed 36 chromosomes. The probabilistic models suggest that the ancestral haploid chromosome number of Mycetophylax was 17 (Likelihood framework) or 18 (Bayesian framework). The analysis also suggested that fusions were responsible for the evolutionary reduction in chromosome numbers of M. conformis and M. morschi karyotypes whereas fission may determines the M. simplex karyotype. These results obtained show the importance of fusions in chromosome changes towards a chromosome number reduction in Formicidae and how a phylogenetic background can be used to reconstruct hypotheses about chromosomes evolution.	[Cardoso, Danon Clemes; Pompolo, Silvia das Gracas; Cristiano, Maykon Passos; Tavares, Mara Garcia] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil	Universidade Federal de Vicosa	Cardoso, DC (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil.	danon.cardoso@ufv.br	Cristiano, Maykon Passos/H-7723-2012; Cardoso, Danon Clemes/D-2313-2009	Cristiano, Maykon Passos/0000-0001-7850-9155; Cardoso, Danon Clemes/0000-0002-2811-2536	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CRA-APQ-00540-11, CBB-22004-11]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by a Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), process numbers: CRA-APQ-00540-11 and CBB-22004-11. Financial support was also provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros LAC, 2010, SOCIOBIOLOGY, V56, P57; Cardoso DC, 2011, INSECT SOC, V58, P427, DOI 10.1007/s00040-011-0160-3; Cardoso DC, 2014, MOL PHYLOGENET EVOL, V70, P378, DOI 10.1016/j.ympev.2013.10.012; Cardoso DC, 2012, CR BIOL, V335, P619, DOI 10.1016/j.crvi.2012.09.012; Cardoso DC, 2012, MYRMECOL NEWS, V16, P57; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; de Freitas TRO, 2006, GENETICA, V126, P227, DOI 10.1007/s10709-005-1451-2; Dillenburg SR, 2009, LECT NOTES EARTH SCI, V107, P1, DOI 10.1007/978-3-540-44771-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Gokhman VE, 2009, KARYOTYPES PARASITIC, DOI 10.1007/978-1-4020-9807-9; Guerra M, 2012, PLANT BIOSYST, V146, P703, DOI 10.1080/11263504.2012.717973; Hemp C, 2013, ORG DIVERS EVOL, V13, P521, DOI 10.1007/s13127-013-0133-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IMAI HT, 1989, CHROMOSOMA, V98, P456, DOI 10.1007/BF00292792; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; IMAI HT, 1977, CHROMOSOMA, V59, P341, DOI 10.1007/BF00327974; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; KEMPF W W, 1972, Studia Entomologica, V15, P3; King M., 1993, SPECIES EVOLUTION; Klingenberg C, 2007, STUD NEOTROP FAUNA E, V42, P121, DOI 10.1080/01650520601065509; Klingenberg C, 2009, ZOOTAXA, P1; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Livingstone K, 2004, NEW PHYTOL, V161, P107, DOI 10.1046/j.1469-8137.2003.00942.x; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Lukhtanov VA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-109; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; POMPOLO SG, 1990, INSECT SOC, V37, P251, DOI 10.1007/BF02224052; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rodrigues LSRR, 2003, CARYOLOGIA, V56, P413, DOI 10.1080/00087114.2003.10589352; Santos IS, 2010, ANN ENTOMOL SOC AM, V103, P424, DOI 10.1603/AN09101; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Sosa-Calvo J, 2010, ANN ENTOMOL SOC AM, V103, P181, DOI 10.1603/AN09108; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Warchalowska-Sliwa E, 2013, EUR J ENTOMOL, V110, P1, DOI 10.14411/eje.2013.001; WHITE M J D, 1973, P961	44	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87473	10.1371/journal.pone.0087473	http://dx.doi.org/10.1371/journal.pone.0087473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489918	Green Published, gold			2022-12-27	WOS:000330510000135
J	Zhou, W; Stojanovic, A				Zhou, Wen; Stojanovic, Aleksandar			Comparison of Corneal Epithelial and Stromal Thickness Distributions between Eyes with Keratoconus and Healthy Eyes with Corneal Astigmatism >= 2.0 D	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FREQUENCY DIGITAL ULTRASOUND; TOPOGRAPHY-GUIDED ABLATION; 3-DIMENSIONAL DISPLAY; BOWMANS LAYER; ARTEMIS; PROFILES; DIAGNOSIS; ECTASIA; LASIK	Purpose: To identify corneal epithelial-and stromal-thickness distribution patterns in keratoconus using spectral-domain optical coherence tomography (SD-OCT). Patients and Methods: We analyzed SD-OCT findings in 20 confirmed cases of keratoconus (group 1) and in 20 healthy subjects with corneal astigmatism >= 2 D (group 2). Epithelial and stromal thicknesses were measured at 11 strategic locations along the steepest and flattest meridians, previously located by corneal topography. Vertical mirrored symmetry superimposition was used in the statistical analysis. Results: The mean maximum keratometry measurements in groups 1 and 2 were 47.9+/-2.9 D (range, 41.8-52.8) and 45.6+/-1.1 D (range, 42.3-47.5), respectively, with mean corneal cylinders of 3.3+/-2.2 D (range, 0.5-9.5) and 3.6+/-1.2 D (range, 2.0-6.4), respectively. The mean epithelial thickness along the steepest meridian in group 1 was the lowest (37.4+/-4.4 mu m) at 1.2 mm inferotemporally and the highest (59.3+/-4.4 mu m) at 1.4 mm supranasally from the corneal vertex. There was only a small deviation in thickness along the steepest meridian in group 2, as well as along the flattest meridians in both groups. The stromal thickness distribution in the two groups was similar to the epithelial, while the stromal thickness was generally lower in group 1 than in group 2. Conclusions: SD-OCT provides details about the distribution of corneal epithelial and stromal thicknesses. The epithelium and stroma in keratoconic eyes were thinner inferotemporally and thicker supranasally compared with control eyes. The distribution pattern was more distinct in epithelium than in stroma. This finding may help improve the early diagnosis of keratoconus.	[Zhou, Wen; Stojanovic, Aleksandar] SynsLaser Kirurgi AS, Tromso, Troms, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Troms, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway	Stojanovic, A (corresponding author), SynsLaser Kirurgi AS, Tromso, Troms, Norway.	aleks@online.no	Stojanovic, Aleksandar/AAG-9933-2019		SynsLaser AS; Norwegian Research Council	SynsLaser AS; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was supported by the SynsLaser AS and the Norwegian Research Council and that no additional external funding was received for this study. The funders had no role n study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XJ, 2012, J REFRACT SURG, V28, P120, DOI 10.3928/1081597X-20110926-01; Correa-Perez ME, 2012, INVEST OPHTH VIS SCI, V53, P1752, DOI 10.1167/iovs.11-9033; Du CX, 2012, CORNEA, V31, P1036, DOI 10.1097/ICO.0b013e31823f8d56; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Haque S, 2006, J REFRACT SURG, V22, P486, DOI 10.3928/1081-597X-20060501-11; Haque S, 2008, OPTOMETRY VISION SCI, V85, P963, DOI 10.1097/OPX.0b013e318188892c; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kanellopoulos AJ, 2012, CLIN OPHTHALMOL, V6, P789, DOI 10.2147/OPTH.S31524; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Li Y, 2008, OPHTHALMOLOGY, V115, P2159, DOI 10.1016/j.ophtha.2008.08.004; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Prakash G, 2012, INVEST OPHTH VIS SCI, V53, P2580, DOI 10.1167/iovs.11-8981; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Reinstein DZ, 2012, J REFRACT SURG, V28, P657, DOI 10.3928/1081597X-20120815-02; Reinstein DZ, 2011, J REFRACT SURG, V27, P356, DOI 10.3928/1081597X-20100930-01; Reinstein DZ, 2010, J REFRACT SURG, V26, P259, DOI 10.3928/1081597X-20100218-01; Reinstein DZ, 2009, J REFRACT SURG, V25, P604, DOI 10.3928/1081597X-20090610-06; Reinstein DZ, 2009, J REFRACT SURG, V25, P444, DOI 10.3928/1081597X-20090422-07; Rocha KM, 2013, J REFRACT SURG, V29, P173, DOI 10.3928/1081597X-20130129-08; Schlegel Z, 2008, J CATARACT REFR SURG, V34, P789, DOI 10.1016/j.jcrs.2007.12.036; Schmoll T, 2012, OPTOMETRY VISION SCI, V89, pE795, DOI 10.1097/OPX.0b013e3182504346; Sin S, 2006, OPTOMETRY VISION SCI, V83, P360, DOI 10.1097/01.opx.0000221388.26031.23	23	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85994	10.1371/journal.pone.0085994	http://dx.doi.org/10.1371/journal.pone.0085994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489687	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000029
J	Hatamoto, Y; Yamada, Y; Sagayama, H; Higaki, Y; Kiyonaga, A; Tanaka, H				Hatamoto, Yoichi; Yamada, Yosuke; Sagayama, Hiroyuki; Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki			The Relationship between Running Velocity and the Energy Cost of Turning during Running	PLOS ONE			English	Article							DIRECTIONAL CHANGES; SOCCER PLAYERS; OXYGEN-UPTAKE; FATIGUE; PERFORMANCE; PHYSIOLOGY; EXERCISE; DEMANDS; UPDATE	Ball game players frequently perform changes of direction (CODs) while running; however, there has been little research on the physiological impact of CODs. In particular, the effect of running velocity on the physiological and energy demands of CODs while running has not been clearly determined. The purpose of this study was to examine the relationship between running velocity and the energy cost of a 180 degrees COD and to quantify the energy cost of a 180 degrees COD. Nine male university students (aged 18-22 years) participated in the study. Five shuttle trials were performed in which the subjects were required to run at different velocities (3, 4, 5, 6, 7, and 8 km/h). Each trial consisted of four stages with different turn frequencies (13, 18, 24 and 30 per minute), and each stage lasted 3 minutes. Oxygen consumption was measured during the trial. The energy cost of a COD significantly increased with running velocity (except between 7 and 8 km/h, p=0.110). The relationship between running velocity and the energy cost of a 180 degrees COD is best represented by a quadratic function (y=-0.012+0.066x+0.008x(2), [r=0.994, p=0.001]), but is also well represented by a linear (y=-0.228+0.152x, [r=0.991, p<0.001]). These data suggest that even low running velocities have relatively high physiological demands if the COD frequency increases, and that running velocities affect the physiological demands of CODs. These results also showed that the energy expenditure of COD can be evaluated using only two data points. These results may be useful for estimating the energy expenditure of players during a match and designing shuttle exercise training programs.	[Hatamoto, Yoichi; Sagayama, Hiroyuki] Fukuoka Univ, Grad Sch Sports & Hlth Sci, Fukuoka 81401, Japan; [Yamada, Yosuke; Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki] Fukuoka Univ, Inst Phys Act, Fukuoka 81401, Japan; [Yamada, Yosuke] Kyoto Prefectural Univ Med, Lab Appl Hlth Sci, Kyoto, Japan; [Yamada, Yosuke] Japan Soc Promot Sci, Tokyo, Japan; [Higaki, Yasuki; Kiyonaga, Akira; Tanaka, Hiroaki] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Kyoto Prefectural University of Medicine; Japan Society for the Promotion of Science; Fukuoka University	Tanaka, H (corresponding author), Fukuoka Univ, Inst Phys Act, Fukuoka 81401, Japan.	htanaka@fukuoka-u.ac.jp	Sagayama, Hiroyuki/AHB-8387-2022; Yamada, Yosuke/AAX-7073-2020	Sagayama, Hiroyuki/0000-0002-9040-7650; Yamada, Yosuke/0000-0002-4284-6317	Fukuoka University Institute for Physical Activity; Japanese Government's Ministry of Education, Culture, Sports, Science and Technology [A19200049]; Fukuoka University	Fukuoka University Institute for Physical Activity; Japanese Government's Ministry of Education, Culture, Sports, Science and Technology; Fukuoka University	This study was carried out with the support of the Fukuoka University Institute for Physical Activity, a Technology Scientific Research Budget Basic Research Grant (A19200049 Strategic Research Infrastructure) from the Japanese Government's Ministry of Education, Culture, Sports, Science and Technology, and a Global FU Program grant from Fukuoka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsbo Jens, 1994, Journal of Sports Sciences, V12, pS5; Bekraoui N, 2012, APPL PHYSIOL NUTR ME, V37, P982, DOI [10.1139/h2012-082, 10.1139/H2012-082]; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Buchheit M, 2010, INT J SPORTS MED, V31, P402, DOI 10.1055/s-0030-1249620; Buchheit M, 2012, J SPORT SCI, V30, P555, DOI 10.1080/02640414.2012.658079; Buchheit M, 2011, INT J SPORT PHYSIOL, V6, P380, DOI 10.1123/ijspp.6.3.380; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; EKBLOM B, 1986, SPORTS MED, V3, P50, DOI 10.2165/00007256-198603010-00005; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Hatamoto Y, 2013, OPEN ACCESS J SPORTS, V4, P117, DOI 10.2147/OAJSM.S39206; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; LEGER L, 1984, SPORTS MED, V1, P270, DOI 10.2165/00007256-198401040-00003; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Rand MK, 2000, GAIT POSTURE, V12, P169, DOI 10.1016/S0966-6362(00)00073-4; Reilly T, 1997, J SPORT SCI, V15, P257, DOI 10.1080/026404197367263; Reilly T, 2005, J SPORT SCI, V23, P561, DOI 10.1080/02640410400021245; REILLY T, 1984, RES Q EXERCISE SPORT, V55, P267, DOI 10.1080/02701367.1984.10609363; REILLY T, 1979, ERGONOMICS, V22, P541, DOI 10.1080/00140137908924638; SCHOT P, 1995, J ORTHOP SPORT PHYS, V22, P254, DOI 10.2519/jospt.1995.22.6.254; Shephard RJ, 1999, J SPORT SCI, V17, P757, DOI 10.1080/026404199365498; SHEPHARD RJ, 1992, CLIN J SPORT MED, V2, P62; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Stolen T, 2005, SPORTS MED, V35, P501; Thompson D, 1999, J SPORT SCI, V17, P387, DOI 10.1080/026404199365902; Zadro I, 2011, J STRENGTH COND RES, V25, P1767, DOI 10.1519/JSC.0b013e3181da85d1	31	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e81850	10.1371/journal.pone.0081850	http://dx.doi.org/10.1371/journal.pone.0081850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497913	gold, Green Submitted, Green Published			2022-12-27	WOS:000330621900002
J	Park, C; Ahn, J; Kim, H; Park, S				Park, Chihyun; Ahn, Jaegyoon; Kim, Hyunjin; Park, Sanghyun			Integrative Gene Network Construction to Analyze Cancer Recurrence Using Semi-Supervised Learning	PLOS ONE			English	Article							EXPRESSION; METASTASIS; PREDICTION; CYTOSCAPE	Background: The prognosis of cancer recurrence is an important research area in bioinformatics and is challenging due to the small sample sizes compared to the vast number of genes. There have been several attempts to predict cancer recurrence. Most studies employed a supervised approach, which uses only a few labeled samples. Semi-supervised learning can be a great alternative to solve this problem. There have been few attempts based on manifold assumptions to reveal the detailed roles of identified cancer genes in recurrence. Results: In order to predict cancer recurrence, we proposed a novel semi-supervised learning algorithm based on a graph regularization approach. We transformed the gene expression data into a graph structure for semi-supervised learning and integrated protein interaction data with the gene expression data to select functionally-related gene pairs. Then, we predicted the recurrence of cancer by applying a regularization approach to the constructed graph containing both labeled and unlabeled nodes. Conclusions: The average improvement rate of accuracy for three different cancer datasets was 24.9% compared to existing supervised and semi-supervised methods. We performed functional enrichment on the gene networks used for learning. We identified that those gene networks are significantly associated with cancer-recurrence-related biological functions. Our algorithm was developed with standard C++ and is available in Linux and MS Windows formats in the STL library. The executable program is freely available at: http://embio.yonsei.ac.kr/Park/ssl.php.	[Park, Chihyun; Ahn, Jaegyoon; Kim, Hyunjin; Park, Sanghyun] Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea	Yonsei University	Park, S (corresponding author), Yonsei Univ, Dept Comp Sci, Seoul 120749, South Korea.	sanghyun@cs.yonsei.ac.kr			National Research Foundation of Korea(NRF); Korea government(MSIP) [NRF-2012R1A2A1A01010775]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea); Korea government(MSIP)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) NRF-2012R1A2A1A01010775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOINFORMATICS, V27, P1846, DOI 10.1093/bioinformatics/btr283; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bonato V, 2011, BIOINFORMATICS, V27, P359, DOI 10.1093/bioinformatics/btq660; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chapelle O, 2008, J MACH LEARN RES, V9, P203; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Hu JH, 2007, BIOMETRICS, V63, P41, DOI 10.1111/j.1541-0420.2006.00675.x; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi M, 2011, BIOINFORMATICS, V27, P3017, DOI 10.1093/bioinformatics/btr502; Shu XO, 2005, CANCER EPIDEM BIOMAR, V14, P91; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Nguyen TP, 2012, ARTIF INTELL MED, V54, P63, DOI 10.1016/j.artmed.2011.09.003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; You ZH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-343; Yu LB, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1701; Zhu X., 2003, P INT C MACH LEARN I, V3	23	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86309	10.1371/journal.pone.0086309	http://dx.doi.org/10.1371/journal.pone.0086309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497942	Green Submitted, gold, Green Published			2022-12-27	WOS:000330621900021
J	Sasportas, LS; Gambhir, SS				Sasportas, Laura Sarah; Gambhir, Sanjiv Sam			Imaging Circulating Tumor Cells in Freely Moving Awake Small Animals Using a Miniaturized Intravital Microscope	PLOS ONE			English	Article							IN-VIVO; BREAST-CANCER; METASTASIS; HALLMARKS; MARKERS	Metastasis, the cause for 90% of cancer mortality, is a complex and poorly understood process involving the invasion of circulating tumor cells (CTCs) into blood vessels. These cells have potential prognostic value as biomarkers for early metastatic risk. But their rarity and the lack of specificity and sensitivity in measuring them render their interrogation by current techniques very challenging. How and when these cells are circulating in the blood, on their way to potentially give rise to metastasis, is a question that remains largely unanswered. In order to provide an insight into this "black box" using non-invasive imaging, we developed a novel miniature intravital microscopy (mIVM) strategy capable of real-time long-term monitoring of CTCs in awake small animals. We established an experimental 4T1-GL mouse model of metastatic breast cancer, in which tumor cells express both fluorescent and bioluminescent reporter genes to enable both single cell and whole body tumor imaging. Using mIVM, we monitored blood vessels of different diameters in awake mice in an experimental model of metastasis. Using an in-house software algorithm we developed, we demonstrated in vivo CTC enumeration and computation of CTC trajectory and speed. These data represent the first reported use we know of for a miniature mountable intravital microscopy setup for in vivo imaging of CTCs in awake animals.	[Sasportas, Laura Sarah; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA; [Sasportas, Laura Sarah; Gambhir, Sanjiv Sam] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program, Stanford, CA 94305 USA.	sgambhir@stanford.edu			Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Society for Nuclear Medicine; Howard Hughes Medical Institute; National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence [U54 U54CA151459]; NCI ICMIC [P50CA114747]; Canary Foundation; NATIONAL CANCER INSTITUTE [P50CA114747, U54CA151459] Funding Source: NIH RePORTER	Fulbright Science and Technology Fellowship; Stanford Weiland Fellowship; Society for Nuclear Medicine; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence; NCI ICMIC; Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Fulbright Science and Technology Fellowship, a Stanford Weiland Fellowship, a Student Fellowship from the Society for Nuclear Medicine, an International Student Fellowship from the Howard Hughes Medical Institute, a National Cancer Institute (NCI) Center for Cancer Nanotechnology Excellence grant U54 U54CA151459 (SSG), NCI ICMIC P50CA114747 (SSG), and the Canary Foundation (SSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2012, CLIN CHEM; Balic M, 2005, CYTOM PART B-CLIN CY, V68B, P25, DOI 10.1002/cyto.b.20065; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brown E, 2010, COLD SPRING HARB PRO, P5452; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Eifler RL, 2010, CYTOMETRY B; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Georgakoudi I, 2004, CANCER RES, V64, P5044, DOI 10.1158/0008-5472.CAN-04-1058; Gervasoni A, 2011, ONCOL REP, V25, P1669, DOI 10.3892/or.2011.1231; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Gradilone A, 2011, J CELL MOL MED, V15, P1066, DOI 10.1111/j.1582-4934.2011.01285.x; Gray JW, 2003, CANCER CELL, V4, P4, DOI 10.1016/S1535-6108(03)00167-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N., 2011, INT J CLIN ONCOL; He W, 2007, P NATL ACAD SCI USA, V104, P11760, DOI 10.1073/pnas.0703875104; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kraeft Stine-Kathrein, 2003, Methods Mol Med, V75, P423; Krebs MG, 2011, J THORACIC ONCOLOGY; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Paterlini-Brechot P, 2011, FUTURE ONCOL, V7, P849, DOI [10.2217/FON.11.32, 10.2217/fon.11.32]; Pierga JY, 2011, ANN ONCOL; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Van der Auwera I, 2010, BRIT J CANCER, V102, P276, DOI 10.1038/sj.bjc.6605472; Vaska P, 2004, IEEE T NUCL SCI, V51, P2718, DOI 10.1109/TNS.2004.835740; Weigert R, 2010, HISTOCHEM CELL BIOL, V133, P481, DOI 10.1007/s00418-010-0692-z; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Witz IP, 2008, CANCER METAST REV, V27, P19, DOI 10.1007/s10555-007-9101-z; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yew NS, 2001, MOL THER, V4, P75, DOI 10.1006/mthe.2001.0415	38	28	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86759	10.1371/journal.pone.0086759	http://dx.doi.org/10.1371/journal.pone.0086759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497977	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900038
J	Simonson, MA; McQueen, MB; Keller, MC				Simonson, Matthew A.; McQueen, Matthew B.; Keller, Matthew C.			Whole-Genome Pathway Analysis on 132,497 Individuals Identifies Novel Gene-Sets Associated with Body Mass Index	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; WIDE ASSOCIATION; COMMON SNPS; ADIPOCYTE DIFFERENTIATION; CARDIOVASCULAR-DISEASE; ENRICHMENT ANALYSIS; COMPLEX TRAITS; OBESITY; RISK; SCHIZOPHRENIA	Whole genome pathway analysis is a powerful tool for the exploration of the combined effects of gene-sets within biological pathways. This study applied Interval Based Enrichment Analysis (INRICH) to perform whole-genome pathway analysis of body-mass index (BMI). We used a discovery set composed of summary statistics from a meta-analysis of 123,865 subjects performed by the GIANT Consortium, and an independent sample of 8,632 subjects to assess replication of significant pathways. We examined SNPs within nominally significant pathways using linear mixed models to estimate their contribution to overall BMI heritability. Six pathways replicated as having significant enrichment for association after correcting for multiple testing, including the previously unknown relationships between BMI and the Reactome regulation of ornithine decarboxylase pathway, the KEGG lysosome pathway, and the Reactome stabilization of P53 pathway. Two non-overlapping sets of genes emerged from the six significant pathways. The clustering of shared genes based on previously identified protein-protein interactions listed in PubMed and OMIM supported the relatively independent biological effects of these two gene-sets. We estimate that the SNPs located in examined pathways explain similar to 20% of the heritability for BMI that is tagged by common SNPs (3.35% of the 16.93% total).	[Simonson, Matthew A.] Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [McQueen, Matthew B.] Univ Colorado, Inst Behav Genet, Dept Integrat Physiol, Boulder, CO 80309 USA; [Keller, Matthew C.] Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Simonson, Matthew A.] Mayo Clin, Dept Hlth Sci, Div Biomed Stat & Informat, Rochester, MN USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Mayo Clinic	Simonson, MA (corresponding author), Univ Colorado, Inst Behav Genet, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	simonson.matthew@mayo.edu	McQueen, Matthew/X-5845-2019	KELLER, MATTHEW/0000-0002-6075-9882	National Institute of Child Health and Human Development [T32 HD 7289-28, R01HD060726]; National Institutes of Mental Health [K01MH085812, R01MH100141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726, T32HD007289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH085812, R01MH100141] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Contributions by MAS were partially supported by two institutional training grants from the National Institute of Child Health and Human Development (T32 HD 7289-28, Michael C. Stallings, Director) and (T32 HD 7289-28, Michael C. Stallings, Director). Contributions by MCK were supported by National Institutes of Mental Health Grants K01MH085812 and R01MH100141. MBM was supported by a grant from the National Institute of Child Health and Human Development (R01HD060726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], CARDIA COR RISK DEV; Benyamin B., 2013, MOL PSYCHIAT, DOI 10.1038/mp.2012.184; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Haby MM, 2012, HEALTH PROMOT INT, V27, P250, DOI 10.1093/heapro/dar036; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jia PL, 2012, J MED GENET, V49, P96, DOI 10.1136/jmedgenet-2011-100397; Jia PL, 2011, INT J NEUROPSYCHOPH, V14, P567, DOI 10.1017/S1461145710001446; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lee PH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.95; Lee PH, 2011, INTERVAL ENRICHMENT; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee SH, 2006, GENET SEL EVOL, V38, P25, DOI 10.1051/gse:2005025; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Liu YF, 2013, STAT INTERFACE, V6, P1; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Molchadsky A, 2013, CELL DEATH DIFFER; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Penman Alan D, 2006, Prev Chronic Dis, V3, pA74; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Simonson MA, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-146; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stewart SE, 2013, MOL PSYCHIAT; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; *TEAM TDC, 2008, R LANG ENV STAT COMP; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	72	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e78546	10.1371/journal.pone.0078546	http://dx.doi.org/10.1371/journal.pone.0078546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497910	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900001
J	Li, A; Liu, YN; Zhao, QH; Feng, HQ; Harris, L; Wang, MH				Li, Ao; Liu, Yuanning; Zhao, Qihong; Feng, Huanqing; Harris, Lyndsay; Wang, Minghui			Genome-Wide Identification of Somatic Aberrations from Paired Normal-Tumor Samples	PLOS ONE			English	Article							COPY NUMBER ALTERATIONS; HIDDEN MARKOV MODEL; CHROMOSOMAL-ABERRATIONS; EXPRESSION ANALYSES; CANCER-CELLS; SINGLE; HETEROZYGOSITY; TOOL; REARRANGEMENT; LANDSCAPE	Genomic copy number alteration and allelic imbalance are distinct features of cancer cells, and recent advances in the genotyping technology have greatly boosted the research in the cancer genome. However, the complicated nature of tumor usually hampers the dissection of the SNP arrays. In this study, we describe a bioinformatic tool, named GIANT, for genome-wide identification of somatic aberrations from paired normal-tumor samples measured with SNP arrays. By efficiently incorporating genotype information of matched normal sample, it accurately detects different types of aberrations in cancer genome, even for aneuploid tumor samples with severe normal cell contamination. Furthermore, it allows for discovery of recurrent aberrations with critical biological properties in tumorigenesis by using statistical significance test. We demonstrate the superior performance of the proposed method on various datasets including tumor replicate pairs, simulated SNP arrays and dilution series of normal-cancer cell lines. Results show that GIANT has the potential to detect the genomic aberration even when the cancer cell proportion is as low as 5 similar to 10%. Application on a large number of paired tumor samples delivers a genome-wide profile of the statistical significance of the various aberrations, including amplification, deletion and LOH. We believe that GIANT represents a powerful bioinformatic tool for interpreting the complex genomic aberration, and thus assisting both academic study and the clinical treatment of cancer.	[Li, Ao; Wang, Minghui] Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230026, Peoples R China; [Li, Ao; Liu, Yuanning; Feng, Huanqing; Wang, Minghui] Univ Sci & Technol China, Sch Informat Sci & Technol, Hefei 230026, Peoples R China; [Zhao, Qihong] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China; [Harris, Lyndsay] Case Western Reserve Univ, Sch Med, Seidman Canc Ctr, Cleveland, OH USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Case Western Reserve University	Li, A (corresponding author), Univ Sci & Technol China, Ctr Biomed Engn, Hefei 230026, Peoples R China.	aoli@ustc.edu.cn	Li, Ao/GRR-5311-2022; Li, aoyu/GXV-4925-2022		National Natural Science Foundation of China [31100955, 61101061]; Fundamental Research Funds for the Central Universities [WK2100230007]; United States Department of Defense [W81XWH-04-1-0 549]; Breast Cancer Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); United States Department of Defense(United States Department of Defense); Breast Cancer Research Foundation	This work was supported by grants from National Natural Science Foundation of China [31100955 and 61101061], and Fundamental Research Funds for the Central Universities (WK2100230007), United States Department of Defense (W81XWH-04-1-0 549) and the Breast Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Attiyeh EF, 2009, GENOME RES, V19, P276, DOI 10.1101/gr.075671.107; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001060; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Li A, 2011, NUCLEIC ACIDS RES, V39, P4928, DOI 10.1093/nar/gkr014; Liu ZZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010909; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Olshen AB, 2011, BIOINFORMATICS, V27, P2038, DOI 10.1093/bioinformatics/btr329; Ortiz-Estevez M, 2012, BIOINFORMATICS, V28, P1793, DOI 10.1093/bioinformatics/bts248; Park P, 2008, CANCER INVEST, V26, P923, DOI 10.1080/07357900801993432; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rasmussen M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r108; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Staaf J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3075; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun W, 2009, NUCLEIC ACIDS RES, V37, P5365, DOI 10.1093/nar/gkp493; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92; Yuan XG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-342	40	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87212	10.1371/journal.pone.0087212	http://dx.doi.org/10.1371/journal.pone.0087212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498045	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100060
J	Witham, MD; Donnan, PT; Vadiveloo, T; Sniehotta, FF; Crombie, IK; Feng, ZQ; McMurdo, MET				Witham, Miles D.; Donnan, Peter T.; Vadiveloo, Thenmalar; Sniehotta, Falko F.; Crombie, Iain K.; Feng, Zhiqiang; McMurdo, Marion E. T.			Association of Day Length and Weather Conditions with Physical Activity Levels in Older Community Dwelling People	PLOS ONE			English	Article							ADULTS; HEALTH; ACCELEROMETER; VALIDITY; GENDER; AGE	Background: Weather is a potentially important determinant of physical activity. Little work has been done examining the relationship between weather and physical activity, and potential modifiers of any relationship in older people. We therefore examined the relationship between weather and physical activity in a cohort of older community-dwelling people. Methods: We analysed prospectively collected cross-sectional activity data from community-dwelling people aged 65 and over in the Physical Activity Cohort Scotland. We correlated seven day triaxial accelerometry data with daily weather data (temperature, day length, sunshine, snow, rain), and a series of potential effect modifiers were tested in mixed models: environmental variables (urban vs rural dwelling, percentage of green space), psychological variables (anxiety, depression, perceived behavioural control), social variables (number of close contacts) and health status measured using the SF-36 questionnaire. Results: 547 participants, mean age 78.5 years, were included in this analysis. Higher minimum daily temperature and longer day length were associated with higher activity levels; these associations remained robust to adjustment for other significant associates of activity: age, perceived behavioural control, number of social contacts and physical function. Of the potential effect modifier variables, only urban vs rural dwelling and the SF-36 measure of social functioning enhanced the association between day length and activity; no variable modified the association between minimum temperature and activity. Conclusions: In older community dwelling people, minimum temperature and day length were associated with objectively measured activity. There was little evidence for moderation of these associations through potentially modifiable health, environmental, social or psychological variables.	[Witham, Miles D.; McMurdo, Marion E. T.] Univ Dundee, Dundee, Scotland; [Donnan, Peter T.; Vadiveloo, Thenmalar] Univ Dundee, Dundee Epidemiol & Biostat Unit, Dundee, Scotland; [Sniehotta, Falko F.] Newcastle Univ, Dept Hlth Psychol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Crombie, Iain K.] Univ Dundee, Dept Publ Hlth, Dundee, Scotland; [Feng, Zhiqiang] Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews, Fife, Scotland	University of Dundee; University of Dundee; Newcastle University - UK; University of Dundee; University of St Andrews	Witham, MD (corresponding author), Univ Dundee, Dundee, Scotland.	m.witham@dundee.ac.uk	Sniehotta, Falko/ABF-7131-2021; Sniehotta, Falko F/C-5481-2008	Sniehotta, Falko/0000-0003-1738-4269; Sniehotta, Falko F/0000-0003-1738-4269; Donnan, Peter/0000-0001-7828-0610; Witham, Miles/0000-0002-1967-0990; Vadiveloo, Thenmalar/0000-0001-5531-6289	Scottish Executive grant [CZH/4/518]; University of Dundee; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Scottish Executive grant; University of Dundee; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Scottish Executive grant CZH/4/518. The sponsor was the University of Dundee. Neither funder nor sponsor had a role in the design, conduct or interpretation of the study.	Badland HM, 2011, HEALTH PLACE, V17, P1084, DOI 10.1016/j.healthplace.2011.06.003; Baker PRA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub2; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Brandon CA, 2009, APPL PHYSIOL NUTR ME, V34, P182, DOI 10.1139/H09-004; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Feinglass J, 2011, J PHYS ACT HEALTH, V8, P934, DOI 10.1123/jpah.8.7.934; Flowerdew R, 2007, COMPUT ENVIRON URBAN, V31, P76, DOI 10.1016/j.compenvurbsys.2005.07.008; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Hagger MS, 2002, BRIT J HEALTH PSYCH, V7, P283, DOI 10.1348/135910702760213689; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Harper R, 2003, MEASURING SOCIAL CAP; Kochersberger G, 1996, ARCH PHYS MED REHAB, V77, P793, DOI 10.1016/S0003-9993(96)90258-0; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; McMurdo MET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031878; McMurdo MET, 2010, J AM GERIATR SOC, V58, P2099, DOI 10.1111/j.1532-5415.2010.03127.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Pivarnik JM, 2003, MED SCI SPORT EXER, V35, P1004, DOI 10.1249/01.MSS.0000069747.55950.B1; Pollard B, 2001, SOC SCI MED, V52, P921, DOI 10.1016/S0277-9536(00)00194-5; Richardson EA, 2010, SOC SCI MED, V71, P568, DOI 10.1016/j.socscimed.2010.04.015; Scottish Government, URB RUR CLASS 2009 2; Sumukadas D, 2009, J EPIDEMIOL COMMUN H, V63, P305, DOI 10.1136/jech.2008.080838; Sumukadas D, 2008, AGING CLIN EXP RES, V20, P15; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Talbot LA, 2002, AM J CARDIOL, V89, P1187, DOI 10.1016/S0002-9149(02)02302-0; Togo F, 2005, INT J BIOMETEOROL, V50, P83, DOI 10.1007/s00484-005-0277-z; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Tudor-Locke C, 2004, ANN BEHAV MED, V28, P158, DOI 10.1207/s15324796abm2803_3; Witham MD, 2005, AM J CARDIOL, V95, P1120, DOI 10.1016/j.amjcard.2005.01.031; Yildirim M, 2013, J PHYS ACT HLTH	30	43	43	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85331	10.1371/journal.pone.0085331	http://dx.doi.org/10.1371/journal.pone.0085331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24497925	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100008
J	Tin, ST; Woodward, A; Ameratunga, S				Tin, Sandar Tin; Woodward, Alistair; Ameratunga, Shanthi			What Influences the Association between Previous and Future Crashes among Cyclists? A Propensity Score Analysis	PLOS ONE			English	Article							INJURY PREVENTION; ACCIDENT PRONENESS; EMERGENCY-MEDICINE; BICYCLE CRASHES; RISK-FACTOR; SUBCLASSIFICATION; ACCURACY; HELMET; COHORT; BIAS	Background: It is known that experience of a previous crash is related to incidence of future crashes in a cohort of New Zealand cyclists. This paper investigated if the strength of such association differed by crash involvement propensity and by the need for medical care in the previous crash. Methods: The Taupo Bicycle Study involved 2590 adult cyclists recruited in 2006 and followed over a median period of 4.6 years through linkage to four national databases. The crash involvement propensity was estimated using propensity scores based on the participants' demographic, cycling and residential characteristics. Cox regression modelling for repeated events was performed with multivariate and propensity score adjustments. Analyses were then stratified by quintiles of the propensity score. Results: A total of 801 (31.0%) participants reported having experienced at least one bicycle crash in the twelve months prior to the baseline survey. They had a higher risk of experiencing crash events during follow-up (hazard ratio (HR): 1.43; 95% CI: 1.28, 1.60) but in the stratified analysis, this association was significant only in the highest two quintiles of the propensity score where the likelihood of having experienced a crash was more than 33%. The association was stronger for previous crashes that had received medical care (HR 1.63; 95% CI: 1.41, 1.88) compared to those that had not (HR 1.30; 95% CI: 1.14, 1.49). Conclusions: Previous crash experience increased the risk of future crash involvement in high-risk cyclists and the association was stronger for previous crashes attended medically. What distinguishes the high risk group warrants closer investigation, and the findings indicate also that health service providers could play an important role in prevention of bicycle crash injuries.	[Tin, Sandar Tin; Woodward, Alistair; Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand	University of Auckland	Tin, ST (corresponding author), Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand.	s.tintin@auckland.ac.nz	Tin, Sandar Tin/I-6392-2019	Tin, Sandar Tin/0000-0002-7303-061X; Woodward, Alistair/0000-0001-5425-6018; Ameratunga, Shanthi/0000-0001-8042-2251	Health Research Council of New Zealand [09/142]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand [grant number 09/142], URL: http://www.hrc.govt.nz/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accident Compensation Corporation, 2012, ANN REP 2012; af Wahlberg AE, 2010, TRANSPORT RES F-TRAF, V13, P106, DOI 10.1016/j.trf.2009.11.004; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Baren J, 2000, ACAD EMERG MED, V7, P1424, DOI 10.1111/j.1553-2712.2000.tb00502.x; Bishai D, 2003, ACAD EMERG MED, V10, P1371, DOI 10.1197/S1069-6563(03)00540-2; BOYCE WT, 1989, AM J DIS CHILD, V143, P338, DOI 10.1001/archpedi.1989.02150150096024; Chandraratna S, 2006, ACCIDENT ANAL PREV, V38, P532, DOI 10.1016/j.aap.2005.11.011; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Cryer C, 2008, DEV INDICATORS INJUR; Cummings GE, 2000, J EMERG MED, V18, P299, DOI 10.1016/S0736-4679(99)00218-8; Davie G, 2011, INJURY PREV, V17, P338, DOI 10.1136/injuryprev-2011-040090; Day AJ, 2012, ACCIDENT ANAL PREV, V49, P532, DOI 10.1016/j.aap.2012.03.028; ENGEL HO, 1991, J ROY SOC MED, V84, P163, DOI 10.1177/014107689108400316; Farmer E, 1926, 38 IND FAT RES BOARD; Garrettson M, 2008, J EMERG NURS, V34, P61, DOI 10.1016/j.jen.2007.10.013; Garrison HG, 1997, ANN EMERG MED, V30, P84, DOI 10.1016/S0196-0644(97)70116-1; Greenwood M., 1919, 4 IND FAT RES BOARD; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Jansson B, 2004, EUR J PUBLIC HEALTH, V14, P161, DOI 10.1093/eurpub/14.2.161; Jaslow D, 2003, J EMERG MED, V25, P167, DOI 10.1016/S0736-4679(03)00165-3; Jenkins P, 2002, AM J IND MED, V41, P98, DOI 10.1002/ajim.10035; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; KUNE JB, 1985, BRIT J IND MED, V42, P336; Lash TL, 2009, APPL QUANTITATIVE BI; Manheimer D I, 1997, Inj Prev, V3, P135, DOI 10.1136/ip.3.2.135; McDonald EM, 2007, INJURY, V38, P538, DOI 10.1016/j.injury.2006.11.020; Ministry of Health, 2012, NAT MIN DAT HOSP INP; Ministry of Health, 2009, MORT COLL DAT DICT V; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Neeleman J, 2001, INT J EPIDEMIOL, V30, P154, DOI 10.1093/ije/30.1.154; Ponsford J., 2013, TRAUMATIC BRAIN INJU, V2nd ed; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; RUTHERFORD WH, 1986, ARCH EMERG MED, V3, P163; Sasidharan L, 2013, ACCIDENT ANAL PREV, V50, P539, DOI 10.1016/j.aap.2012.05.036; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Stiffler KA, 2006, EMERG MED CLIN N AM, V24, P849, DOI 10.1016/j.emc.2006.06.010; Thornley SJ, 2008, INJURY PREV, V14, P11, DOI 10.1136/ip.2007.016675; Tin ST, 2013, PREV MED, V57, P152, DOI 10.1016/j.ypmed.2013.05.001; Tin ST, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-420; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; Visser E, 2007, ACCIDENT ANAL PREV, V39, P556, DOI 10.1016/j.aap.2006.09.012; Wilk KE., 2012, PHYS REHABILITATION, P232, DOI [DOI 10.1016/B978-1-4377-2411-0.00013-7, 10.1016/B978-1-4377-2411-0.00013-7]; Wu BC, 2005, PEDIATR EMERG CARE, V21, P730, DOI 10.1097/01.pec.0000186426.69517.24; Yancey Arthur H 2nd, 2002, Prehosp Emerg Care, V6, P204, DOI 10.1080/10903120290938553	52	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87633	10.1371/journal.pone.0087633	http://dx.doi.org/10.1371/journal.pone.0087633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489945	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000165
J	Campbell, EM; Chao, L				Campbell, Ellsworth M.; Chao, Lin			A Population Model Evaluating the Consequences of the Evolution of Double-Resistance and Tradeoffs on the Benefits of Two-Drug Antibiotic Treatments	PLOS ONE			English	Article							CROSS-RESISTANCE; DRUG-RESISTANCE	The evolution of antibiotic resistance in microbes poses one of the greatest challenges to the management of human health. Because addressing the problem experimentally has been difficult, research on strategies to slow the evolution of resistance through the rational use of antibiotics has resorted to mathematical and computational models. However, despite many advances, several questions remain unsettled. Here we present a population model for rational antibiotic usage by adding three key features that have been overlooked: 1) the maximization of the frequency of uninfected patients in the human population rather than the minimization of antibiotic resistance in the bacterial population, 2) the use of cocktails containing antibiotic pairs, and 3) the imposition of tradeoff constraints on bacterial resistance to multiple drugs. Because of tradeoffs, bacterial resistance does not evolve directionally and the system reaches an equilibrium state. When considering the equilibrium frequency of uninfected patients, both cycling and mixing improve upon single-drug treatment strategies. Mixing outperforms optimal cycling regimens. Cocktails further improve upon aforementioned strategies. Moreover, conditions that increase the population frequency of uninfected patients also increase the recovery rate of infected individual patients. Thus, a rational strategy does not necessarily result in a tragedy of the commons because benefits to the individual patient and general public are not in conflict. Our identification of cocktails as the best strategy when tradeoffs between multiple-resistance are operating could also be extended to other host-pathogen systems. Cocktails or other multiple-drug treatments are additionally attractive because they allow re-using antibiotics whose utility has been negated by the evolution of single resistance.	[Campbell, Ellsworth M.; Chao, Lin] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Campbell, EM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	ells@psu.edu						Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bacon CW, 1996, APPL ENV MICROBIOLOG; Baquero F, 2003, Rev Esp Quimioter, V16, P11; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bochner BR, 1980, J BACTERIOLOGY; Bollenbach T, 2011, MOL CELL, V42, P413, DOI 10.1016/j.molcel.2011.04.016; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Chait R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015179; Chao L, 1986, ANBURY REPORT 24 ANT, P71; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Dumon L, 1979, ANTIMICROBIAL AGENTS; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Falconer D. S., 1981, INTRO QUANTITATIVE G; Foster K, 2006, PLOS MED, P1; Hall AR, 2011, GENETICS, V187, P817, DOI 10.1534/genetics.110.124628; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Kunin CM, 1993, ANN INTERNAL MED; Maloy SR, 1981, J BACTERIOLOGY; Michel JB, 2008, DRUG INTERACTIONS MO; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Palmer AC, 2010, NATURE CHEM BIOL; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; RANK GH, 1975, GENETICS, V80, P483; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Reading C, 1977, ANTIMICROBIAL AGENTS; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Reluga TC, 2005, MATH MED BIOL, V22, P187, DOI 10.1093/imammb/dqi002; Resistance ITFOA, 2012, PUBL HLTH ACT PLAN C, P1; RISKA B, 1986, EVOLUTION, V40, P1303, DOI 10.1111/j.1558-5646.1986.tb05753.x; Roff DA, 2012, EVOLUTION, V66, P2461, DOI 10.1111/j.1558-5646.2012.01634.x; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN, P274; Spagnolo F, 2011, Q REV BIOL, V86, P366, DOI 10.1086/662513; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Yeh PJ, 2009, NATURE REV MICROBIOL; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	42	8	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86971	10.1371/journal.pone.0086971	http://dx.doi.org/10.1371/journal.pone.0086971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498003	gold, Green Published			2022-12-27	WOS:000330621900052
J	Seifers, DL; Haber, S; Martin, TJ; McCallum, BD				Seifers, Dallas L.; Haber, Steve; Martin, Terry J.; McCallum, Brent D.			Heritable, De Novo Resistance to Leaf Rust and Other Novel Traits in Selfed Descendants of Wheat Responding to Inoculation with Wheat Streak Mosaic Virus	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; ABERRANT RATIO; PLANT; METHYLATION; INHERITANCE; EFFICACY; GENOME	Stable resistance to infection with Wheat streak mosaic virus (WSMV) can be evolved de novo in selfing bread wheat lines subjected to cycles of WSMV inoculation and selection of best-performing plants or tillers. To learn whether this phenomenon might be applied to evolve resistance de novo to pathogens unrelated to WSMV, we examined the responses to leaf rust of succeeding generations of the rust-and WSMV-susceptible cultivar 'Lakin' following WSMV inoculation and derived rust-resistant sublines. After three cycles of the iterative protocol five plants, in contrast to all others, expressed resistance to leaf and stripe rust. A subset of descendant sublines of one of these, 'R1', heritably and uniformly expressed the new trait of resistance to leaf rust. Such sublines, into which no genes from a known source of resistance had been introgressed, conferred resistance to progeny of crosses with susceptible parents. The F-1 populations produced from crosses between, respectively, susceptible and resistant 'Lakin' sublines 4-3-3 and 4-12-3 were not all uniform in their response to seedling inoculation with race TDBG. In seedling tests against TDBG and MKPS races the F(2)s from F-1 populations that were uniformly resistant had 3: 1 ratios of resistant to susceptible individuals but the F(2)s from susceptible F-1 progenitors were uniformly susceptible. True-breeding lines derived from resistant individuals in F-2 populations were resistant to natural stripe and leaf rust inoculum in the field, while the 'Lakin' progenitor was susceptible. The next generation of six of the 'Lakin'-derived lines exhibited moderate to strong de novo resistance to stem rust races TPMK, QFCS and RKQQ in seedling tests while the 'Lakin' progenitor was susceptible. These apparently epigenetic effects in response to virus infection may help researchers fashion a new tool that expands the range of genetic resources already available in adapted germplasm.	[Seifers, Dallas L.; Martin, Terry J.] Kansas State Univ, Agr Res Ctr Hays, Hays, KS USA; [Haber, Steve; McCallum, Brent D.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada	Kansas State University; Agriculture & Agri Food Canada	Haber, S (corresponding author), Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada.	Steve.Haber@AGR.GC.CA						Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; ALI I, 1994, PLANT DIS, V78, P383, DOI 10.1094/PD-78-0383; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; BRAKKE MK, 1981, PHYTOPATHOLOGY, V71, P823, DOI 10.1094/Phyto-71-823; BRAKKE MK, 1984, ANNU REV PHYTOPATHOL, V22, P77, DOI 10.1146/annurev.py.22.090184.000453; Browder LE, 1971, USDA AGR RES SERV TE; Brown GN, 1997, EUPHYTICA, V95, P67, DOI 10.1023/A:1002985326256; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Comeau A, 2010, GEN-RES ISSUES, P401; Haber S., 2011, AM J PLANT SCI BIOTE, V5, P95; Haber S, 1993, ANN WHEAT NEWSLETTER, V39, P121; Haber S, 2008, CEREAL RES COMMUN, V36, P63, DOI 10.1556/CRC.36.2008.Suppl.B.10; Harper G, 2002, ANNU REV PHYTOPATHOL, V40, P119, DOI 10.1146/annurev.phyto.40.120301.105642; Hauben M, 2009, P NATL ACAD SCI USA, V106, P20109, DOI 10.1073/pnas.0908755106; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; LONG DL, 1989, PHYTOPATHOLOGY, V79, P525, DOI 10.1094/Phyto-79-525; Lu H, 2002, THEOR APPL GENET, V105, P622, DOI 10.1007/s00122-002-0970-9; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Martin TJ, 2002, APPL PLANT IN PRESS; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Seifers DL, 2008, PLANT DIS, V92, P808, DOI 10.1094/PDIS-92-5-0808; Seifers DL, 2006, PLANT DIS, V90, P623, DOI 10.1094/PD-90-0623; SEIFERS DL, 1988, PHYTOPATHOLOGY, V78, P703, DOI 10.1094/Phyto-78-703; SEIFERS DL, 1995, PLANT DIS, V79, P1104, DOI 10.1094/PD-79-1104; Shelton DR, 1993, ANN WHEAT NEWSLETTER, V39, P321; Snedecor G.W., 1989, AMES IOWA STATE U PR; SPRAGUE GF, 1963, SCIENCE, V141, P1052, DOI 10.1126/science.141.3585.1052; SPRAGUE GF, 1971, GENETICS, V67, P533; SPRAGUE GF, 1966, GENETICS, V54, P1287; Springer NM, 2013, TRENDS GENET, V29, P241, DOI 10.1016/j.tig.2012.10.009; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Wu SY, 2009, CROP SCI, V49, P1681, DOI 10.2135/cropsci2008.11.0666	36	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86307	10.1371/journal.pone.0086307	http://dx.doi.org/10.1371/journal.pone.0086307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497941	gold, Green Submitted, Green Published			2022-12-27	WOS:000330621900020
J	Wang, X; Sundquist, J; Zoller, B; Memon, AA; Palmer, K; Sundquist, K; Bennet, L				Wang, Xiao; Sundquist, Jan; Zoller, Bengt; Memon, Ashfaque A.; Palmer, Karolina; Sundquist, Kristina; Bennet, Louise			Determination of 14 Circulating microRNAs in Swedes and Iraqis with and without Diabetes Mellitus Type 2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MIDDLE-EAST; IMMIGRANTS; PLASMA; EXPRESSION; CANCER; RISK; POPULATION; PREVALENCE; BIOMARKERS	Background: Recent reports suggest that immigrants from Middle Eastern countries are a high-risk group for type 2 diabetes (T2D) compared with Swedes, and that the pathogenesis of T2D may be ethnicity-specific. Deregulation of microRNA (miRNA) expression has been demonstrated to be associated with T2D but ethnic differences in miRNA have not been investigated. The aim of this study was to explore the ethnic specific expression (Swedish and Iraqi) of a panel of 14 previously identified miRNAs in patients without T2D (including those with prediabetes) and T2D. Methods: A total of 152 individuals were included in the study (84 Iraqis and 68 Swedes). Nineteen Iraqis and 14 Swedes were diagnosed with T2D. Expression of the 14 selected miRNAs (miR-15a, miR-20, miR-21, miR-24, miR-29b, miR-126, miR-144, miR-150, miR-197, miR-223, miR-191, miR-320a, miR-486-5p, and miR-28-3p) in plasma samples was measured by real-time PCR. Results: In the whole study population, the expression of miR-24 and miR-29b was significantly different between T2D patients and controls after adjustment for age, sex, waist circumference, family history of T2D, and a sedentary lifestyle. Interestingly, when stratifying the study population according to country of birth, we found that higher expression of miR-144 was significantly associated with T2D in Swedes (OR = 2.43, p = 0.035), but not in Iraqis (OR = 0.54, p = 0.169). The interaction test was significant (p = 0.017). Conclusion: This study suggests that the association between plasma miR-144 expression and T2D differs between Swedes and Iraqis.	[Wang, Xiao; Sundquist, Jan; Zoller, Bengt; Memon, Ashfaque A.; Palmer, Karolina; Sundquist, Kristina; Bennet, Louise] Lund Univ Reg Skane, Ctr Primary Hlth Care Res, Lund, Sweden; [Sundquist, Jan; Sundquist, Kristina] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Lund University; Stanford University	Wang, X (corresponding author), Lund Univ Reg Skane, Ctr Primary Hlth Care Res, Lund, Sweden.	xiao.wang@med.lu.se	Zöller, Bengt/M-3217-2019; Zöller, Bengt/H-8856-2012	Zöller, Bengt/0000-0002-8250-5613; Zöller, Bengt/0000-0002-8250-5613; Bennet, Louise/0000-0001-7101-1290; Memon, Ashfaque/0000-0002-1081-3553	Swedish Society of Medicine; Swedish Research Council; ALF; FoU from Region Skane	Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF; FoU from Region Skane	This study was funded by ALF funding, FoU grants from Region Skane, and a grant from the Swedish Society of Medicine awarded to LB; grants awarded to JS and KS by the Swedish Research Council; and an ALF project grant (Drs Bennet; Jan Sundquist and Kristina Sundquist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bener A, 2005, CROAT MED J, V46, P302; Bennet L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-303; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Faskunger J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-304; Feng Biao, 2012, ISRN Endocrinol, V2012, P549875, DOI 10.5402/2012/549875; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Glans F, 2008, DIABETIC MED, V25, P303, DOI 10.1111/j.1464-5491.2007.02366.x; Guay C, 2013, NAT REV ENDOCRINOL; Jonsson LS, 2013, J PUBLIC HEALTH-UK, V35, P270, DOI 10.1093/pubmed/fds091; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kim YJ, 2012, STEM CELLS DEV, V21, P1749, DOI 10.1089/scd.2011.0429; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Ling HY, 2012, EXP CLIN ENDOCR DIAB, V120, P553, DOI 10.1055/s-0032-1311644; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Park SY, 2013, ARCH PHARM RES, V36, P154, DOI 10.1007/s12272-013-0017-6; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Sun LL, 2011, DIABETES RES CLIN PR, V91, P94, DOI 10.1016/j.diabres.2010.11.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wandell PE, 2008, DIABETES METAB, V34, P328, DOI 10.1016/j.diabet.2008.01.012; Wang YL, 2009, CURR OPIN MOL THER, V11, P292; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WMA, 2008, DECLARATION HELSINKI; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	45	58	62	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86792	10.1371/journal.pone.0086792	http://dx.doi.org/10.1371/journal.pone.0086792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497980	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100032
J	Helfer, M; Koppensteiner, H; Schneider, M; Rebensburg, S; Forcisi, S; Muller, C; Schmitt-Kopplin, P; Schindler, M; Brack-Werner, R				Helfer, Markus; Koppensteiner, Herwig; Schneider, Martha; Rebensburg, Stephanie; Forcisi, Sara; Mueller, Constanze; Schmitt-Kopplin, Philippe; Schindler, Michael; Brack-Werner, Ruth			The Root Extract of the Medicinal Plant Pelargonium sidoides Is a Potent HIV-1 Attachment Inhibitor	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; (-)-EPIGALLOCATECHIN GALLATE; ANTIRETROVIRAL THERAPY; CHEMOKINE RECEPTOR; ENTRY INHIBITORS; REPLICATION; INFECTION; SAFETY; PHARMACOKINETICS; IDENTIFICATION	Global HIV-1 treatment would benefit greatly from safe herbal medicines with scientifically validated novel anti-HIV-1 activities. The root extract from the medicinal plant Pelargonium sidoides (PS) is licensed in Germany as the herbal medicine EPs (R) 7630, with numerous clinical trials supporting its safety in humans. Here we provide evidence from multiple cell culture experiments that PS extract displays potent anti-HIV-1 activity. We show that PS extract protects peripheral blood mononuclear cells and macrophages from infection with various X4 and R5 tropic HIV-1 strains, including clinical isolates. Functional studies revealed that the extract from PS has a novel mode-of-action. It interferes directly with viral infectivity and blocks the attachment of HIV-1 particles to target cells, protecting them from virus entry. Analysis of the chemical footprint of anti-HIV activity indicates that HIV-1 inhibition is mediated by multiple polyphenolic compounds with low cytotoxicity and can be separated from other extract components with higher cytotoxicity. Based on our data and its excellent safety profile, we propose that PS extract represents a lead candidate for the development of a scientifically validated herbal medicine for anti-HIV-1 therapy with a mode-of-action different from and complementary to current single-molecule drugs.	[Helfer, Markus; Koppensteiner, Herwig; Schneider, Martha; Rebensburg, Stephanie; Schindler, Michael; Brack-Werner, Ruth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany; [Forcisi, Sara; Mueller, Constanze; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Analyt BioGeoChem, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Brack-Werner, R (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Virol, Neuherberg, Germany.	brack@helmholtz-muenchen.de	Brack-Werner, Ruth/M-4615-2014; Schindler, Michael/C-1647-2015; Schmitt-Kopplin, Philippe/H-6271-2011	Brack-Werner, Ruth/0000-0002-8651-9318; Schindler, Michael/0000-0001-8989-5813; Schmitt-Kopplin, Philippe/0000-0003-0824-2664	Helmholtz Zentrum Munchen	Helmholtz Zentrum Munchen(Helmholtz Association)	Financial support for this study was provided by intramural funding of the Helmholtz Zentrum Munchen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo USDoHaHSH, 2012, HIV ITS TREATM FDA A; Alexandre KB, 2011, J VIROL, V85, P9039, DOI 10.1128/JVI.02675-10; Brendler T, 2008, J ETHNOPHARMACOL, V119, P420, DOI 10.1016/j.jep.2008.07.037; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Cos P, 2008, PLANTA MED, V74, P1323, DOI 10.1055/s-2008-1081314; Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Forcisi S, 2013, J CHROMATOGR A, V1292, P51, DOI 10.1016/j.chroma.2013.04.017; Francois K, 2010, MED RES REV, V32, P349; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Fuss IJ., 2009, CURRENT PROTOCOLS IM; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Gibson RM, 2012, CURR HIV RES, V10, P19, DOI 10.2174/157016212799304616; Hamza A, 2006, J PHYS CHEM B, V110, P2910, DOI 10.1021/jp0550762; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hertje M, 2010, CHEMMEDCHEM, V5, P1825, DOI 10.1002/cmdc.201000292; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Jones J, 2007, BIOTECHNIQUES, V43, P589, DOI 10.2144/000112624; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kolodziej H, 2007, PHYTOMEDICINE, V14, P9, DOI 10.1016/j.phymed.2006.11.021; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Kremb S, 2010, ANTIMICROB AGENTS CH, V54, P5257, DOI 10.1128/AAC.00515-10; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; Magalhaes PJ, 2010, J CHROMATOGR A, V1217, P3258, DOI 10.1016/j.chroma.2009.10.068; Marcus KA, 2012, CURR OPIN HIV AIDS, V7, P292, DOI 10.1097/COH.0b013e328354dcac; Michaelis M, 2011, PHYTOMEDICINE, V18, P384, DOI 10.1016/j.phymed.2010.09.008; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Mukhtar M, 2008, VIRUS RES, V131, P111, DOI 10.1016/j.virusres.2007.09.008; Overy DP, 2008, NAT PROTOC, V3, P471, DOI 10.1038/nprot.2007.512; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Schnitzler P, 2008, PHYTOMEDICINE, V15, P1108, DOI 10.1016/j.phymed.2008.06.009; Singh IP, 2010, NAT PROD REP, V27, P1781, DOI 10.1039/c0np00025f; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Stadeli KM, 2012, ANTIVIRAL THERAPY; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Theisen LL, 2012, ANTIVIRAL RES; Timmer A, 2008, COCHRANE DATABASE SY, V3; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9; Yang J, 2011, FITOTERAPIA	48	49	53	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87487	10.1371/journal.pone.0087487	http://dx.doi.org/10.1371/journal.pone.0087487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489923	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000150
J	Jani, PK; Kajdacsi, E; Megyeri, M; Dobo, J; Doleschall, Z; Futosi, K; Timar, CI; Mocsai, A; Mako, V; Gal, P; Cervenak, L				Jani, Peter K.; Kajdacsi, Erika; Megyeri, Marton; Dobo, Jozsef; Doleschall, Zoltan; Futosi, Krisztina; Timar, Csaba I.; Mocsai, Attila; Mako, Veronika; Gal, Peter; Cervenak, Laszlo			MASP-1 Induces a Unique Cytokine Pattern in Endothelial Cells: A Novel Link between Complement System and Neutrophil Granulocytes	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SERINE PROTEASE-1 MASP-1; NF-KAPPA-B; LECTIN-PATHWAY; KINASE PATHWAYS; ACTIVATION; EXPRESSION; GENE; INTERLEUKIN-8; INITIATION	Microbial infection urges prompt intervention by the immune system. The complement cascade and neutrophil granulocytes are the predominant contributors to this immediate anti-microbial action. We have previously shown that mannan-binding lectin-associated serine protease-1 (MASP-1), the most abundant enzyme of the complement lectin pathway, can induce p38-MAPK activation, NFkappaB signaling, and Ca2+-mobilization in endothelial cells. Since neutrophil chemotaxis and transmigration depends on endothelial cell activation, we aimed to explore whether recombinant MASP-1 (rMASP-1) is able to induce cytokine production and subsequent neutrophil chemotaxis in human umbilical vein endothelial cells (HUVEC). We found that HUVECs activated by rMASP-1 secreted IL-6 and IL-8, but not IL-1alpha, IL-1ra, TNFalpha and MCP-1. rMASP-1 induced dose-dependent IL-6 and IL-8 production with different kinetics. rMASP-1 triggered IL-6 and IL-8 production was regulated predominantly by the p38-MAPK pathway. Moreover, the supernatant of rMASP-1-stimulated HUVECs activated the chemotaxis of neutrophil granulocytes as an integrated effect of cytokine production. Our results implicate that besides initializing the complement lectin pathway, MASP-1 may activate neutrophils indirectly, via the endothelial cells, which link these effective antimicrobial host defense mechanisms.	[Jani, Peter K.; Kajdacsi, Erika; Mako, Veronika; Cervenak, Laszlo] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary; [Megyeri, Marton; Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Doleschall, Zoltan] Natl Inst Oncol, Dept Pathogenet, Budapest, Hungary; [Futosi, Krisztina; Timar, Csaba I.; Mocsai, Attila] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; National Institute of Oncology Hungary; Semmelweis University	Jani, PK (corresponding author), Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary.	jani.peter@med.semmelweis-univ.hu	Timar, Csaba/N-9948-2017; Dobo, Jozsef/C-7331-2014; Mocsai, Attila/B-2792-2008; Cervenak, Laszlo/F-1672-2010; Gal, Peter/B-5886-2011	Kajdacsi, Erika/0000-0003-0739-2193; Cervenak, Laszlo/0000-0003-0166-8697; Futosi, Krisztina/0000-0002-1661-4635; Timar, Csaba/0000-0001-8472-0897; Mocsai, Attila/0000-0002-0512-1157; Dobo, Jozsef/0000-0001-9187-8502	'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences [BO/00218/10]; Hungarian Scientific Research Fund (OTKA) [K100684, K75084, K81277, NK100834, NK77978]; European Research Council (Starting Independent Investigator [206283]; Wellcome Trust [087782]; 'Jedlik Anyos' [TAMOP 4.2.4.A/1-11-1-2012-0001]	'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Research Council (Starting Independent Investigator; Wellcome Trust(Wellcome TrustEuropean Commission); 'Jedlik Anyos'	This work was supported by 'Janos Bolyai' Research Fellowship of the Hungarian Academy of Sciences to L. C. (research fellowship number BO/00218/10, http://mta.hu/osztondijak); and grants No. K100684 (to L. C.), K75084 and K81277 (to E. L.), NK100834 and NK77978 (to P. G.) from The Hungarian Scientific Research Fund (OTKA, http://www.otka.hu/en); grant No. 206283 (to A. M.) from European Research Council (Starting Independent Investigator, http://erc.europa.eu). A. M. is also a recipient of International Senior Research Fellowships (087782) of the Wellcome Trust(http://www.wellcome.ac.uk/). K. F. is a recipient of 'Jedlik Anyos' predoctoral fellowship (TAMOP 4.2.4.A/1-11-1-2012-0001, http://www.nfu.hu/?lang= en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Cherla RP, 2006, J LEUKOCYTE BIOL, V79, P397, DOI 10.1189/jlb.0605313; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Futosi K, 2012, BLOOD, V119, P4981, DOI 10.1182/blood-2011-07-369041; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Hippenstiel S, 2000, BLOOD, V95, P3044; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Knipe L, 2010, BLOOD, V116, P2183, DOI 10.1182/blood-2010-03-276170; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; LUKACS NW, 1995, BLOOD, V86, P2767; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Niu QX, 2008, CLIN EXP PHARMACOL P, V35, P89, DOI 10.1111/j.1440-1681.2007.04755.x; Oie CI, 2011, J HEPATOL, V55, P1346, DOI 10.1016/j.jhep.2011.03.013; Oroszlan M, 2006, INT IMMUNOL, V18, P871, DOI 10.1093/intimm/dxl023; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Oynebraten I, 2004, BLOOD, V104, P314, DOI 10.1182/blood-2003-08-2891; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; SHREENIWAS R, 1992, J CLIN INVEST, V90, P2333, DOI 10.1172/JCI116122; Storm D, 1997, J BIOL CHEM, V272, P31043, DOI 10.1074/jbc.272.49.31043; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Szabo-Fresnais N, 2008, MOL CELL ENDOCRINOL, V284, P28, DOI 10.1016/j.mce.2007.12.017; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; Yuen DYC, 2009, DIABETES, V58, P1086, DOI 10.2337/db08-0775	42	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87104	10.1371/journal.pone.0087104	http://dx.doi.org/10.1371/journal.pone.0087104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489848	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330570000104
J	Jonas, JB; Wang, NL; Wang, YX; You, QS; Xie, XB; Yang, DY; Xu, L				Jonas, Jost B.; Wang, Ningli; Wang, Ya Xing; You, Qi Sheng; Xie, Xiaobin; Yang, Diya; Xu, Liang			Body Height, Estimated Cerebrospinal Fluid Pressure and Open-Angle Glaucoma. The Beijing Eye Study 2011	PLOS ONE			English	Article							OCULAR DIMENSIONS; ADULT-POPULATION; LAMINA-CRIBROSA; MASS INDEX; TANJONG PAGAR; PARAMETERS; STATURE; CHINA; ASSOCIATIONS; PREVALENCE	Purpose: To examine potential associations between body height, cerebrospinal fluid pressure (CSFP), trans-lamina cribrosa pressure difference (TLCPD) and prevalence of open-angle glaucoma (OAG) in a population-based setting. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6+/-9.8 years (range: 50-93 years). A detailed ophthalmic examination was performed. Based on a previous study with lumbar cerebrospinal fluid pressure (CSFP) measurements, CSFP was calculated as CSFP[mmHg] = 0.44xBody Mass Index[kg/m(2)]+0.16xDiastolic Blood Pressure[mmHg]-0.18xAge[Years]-1.91 Results: Data of IOP and CSFP were available for 3353 (96.7%) subjects. Taller body height was associated with higher CSFP (P < 0.001; standardized correlation coefficient beta: 0.13; regression coefficient B:0.29; 95% confidence interval (CI): 0.25,0.33) after adjusting for male gender, urban region of habitation, higher educational level, and pulse rate. If TLCPD instead of CSFP was added, taller body height was associated with lower TLCPD (P < 0.001; beta: -0.10; B: -0.20; 95% CI: -0.25,-0.15). Correspondingly, higher CSFP was associated with taller body height (P = 0.003; beta: 0.02;B:0.01;95%CI:0.00,0.02), after adjusting for age, gender, body mass index, pulse, systolic blood pressure, and blood concentration of cholesterol. If IOP was added to the model, higher CSFP was associated with higher IOP (P < 0.001; beta: 0.02; B: 0.02; 95% CI: 0.01,0.03). TLCPD was associated with lower body height (P = 0.003; beta: -0.04; B -0.02,95%CI:-0.04,-0.01) after adjusting for age, body mass index, systolic blood pressure, pulse, blood concentrations of triglycerides, axial length, central corneal thickness, corneal curvature radius, and anterior chamber depth. Adding the prevalence of OAG to the multivariate analysis revealed, that taller body height was associated with a lower OAG prevalence (P = 0.03; beta:-0.03;B:-1.20; 95% CI:-2.28,-0.12) after adjusting for educational level and gender. Conclusions: Taller body height was associated with higher CSFP and lower TLCPD (and vice versa), after adjusting for systemic and ocular parameters. Parallel to the associations between a higher prevalence of glaucoma with a lower CSFP or higher TLCPD, taller body height was associated with a lower prevalence of OAG.	[Jonas, Jost B.; Wang, Ya Xing; You, Qi Sheng; Xu, Liang] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany; [Wang, Ningli; Xie, Xiaobin; Yang, Diya] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing Tongren Hosp, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Xu, L (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@yahoo.cn	You, Qisheng/AAG-7153-2020; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81770890]; Beijing NOVA Program [2011058]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This work was supported by National Natural Science Foundation of China 81770890; Beijing NOVA Program 2011058 and by National Key Technology R&D Program of the Ministry of Science and Technology (No. 2012BAH05F05 and 2013BAH19F04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bourne RRA, 2008, BRIT J OPHTHALMOL, V92, P310, DOI 10.1136/bjo.2007.123349; Chang L, 2009, EYE, V23, P1775, DOI 10.1038/eye.2008.375; Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Nangia V, 2010, GRAEF ARCH CLIN EXP, V248, P1657, DOI 10.1007/s00417-010-1448-0; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1237; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Xie XW, 2009, GRAEF ARCH CLIN EXP, V247, P1651, DOI 10.1007/s00417-009-1161-z; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, ACTA OPHTHALMOL SCAN, V85, P914, DOI 10.1111/j.1600-0420.2007.00966.x; Xu L, 2011, ACTA OPHTHALMOL, V89, P442, DOI 10.1111/j.1755-3768.2009.01734.x; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	26	36	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86678	10.1371/journal.pone.0086678	http://dx.doi.org/10.1371/journal.pone.0086678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489767	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000059
J	Lu, XL; Li, Y; Wang, WQ; Chen, SC; Liu, T; Jia, D; Quan, XP; Sun, DL; Chang, AK; Gao, B				Lu, Xiuli; Li, Yang; Wang, Weiqi; Chen, Shuchao; Liu, Ting; Jia, Dan; Quan, Xiaoping; Sun, Deliang; Chang, Alan K.; Gao, Bing			3 beta-Hydroxysteroid-Delta 24 Reductase (DHCR24) Protects Neuronal Cells from Apoptotic Cell Death Induced by Endoplasmic Reticulum (ER) Stress	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INSULIN; MECHANISMS; SELADIN-1; IMPAIRMENT; EXPRESSION; CAVEOLAE; RECEPTOR; HOMOLOG	3 beta-Hydroxysteroid-Delta 24 reductase (DHCR24) is an endoplasmic reticulum (ER)-localized multifunctional enzyme that possesses anti-apoptotic and cholesterol-synthesizing activities. Accumulating evidence suggests that ER stress is involved in the pathogenesis of neurodegenerative disease. In this study, we investigated whether DHCR24 may function as a neuroprotective protein under ER stress. Neuroblastoma N2A cells were infected with adenovirus expressing myc-tagged DHCR24 (Ad-DHCR24) or lacZ (Ad-lacZ, serving as a control) and subjected to ER-stress, induced with Tunicamycin (TM). Cells infected with Ad-DHCR24-myc were resistant to TM-induced apoptosis, and showed weaker level of caspase-12 activity. These cells also exhibited lower levels of Bip and CHOP proteins than Ad-LacZ-infected cells. Moreover, a stronger and rapid activation of PERK, and a prolonged activation of JNK and p38 were observed in Ad-LacZ-infected cells. The generation of intracellular reactive oxygen species from ER stress was also diminished by the overexpression of DHCR24. Additionally, intracellular cholesterol level was also elevated in the Ad-DHCR24-infected cells, accompanied by a well-organized formation of caveolae (cholesterol-rich microdomain) on the plasma membrane, and improved colocalization of caveolin-1 and insulin-like growth factor 1 receptor. These results demonstrated for the first time that DHCR24 could protect neuronal cells from apoptosis induced by ER stress.	[Lu, Xiuli; Li, Yang; Wang, Weiqi; Chen, Shuchao; Liu, Ting; Jia, Dan; Quan, Xiaoping; Sun, Deliang; Chang, Alan K.] Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China; [Gao, Bing] Shenyang Med Coll, Sch Basic Med Sci, Shenyang, Peoples R China	Liaoning University; Shenyang Medical College	Lu, XL (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang 110036, Peoples R China.	luxiulidr@gmail.com; gaobingdr@gmail.com		Lu, Xiuli/0000-0003-4267-1112	National Natural Science Foundation of China [31271494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China to Q. C. (No. 31271494) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dandona P, 2011, J CLIN ENDOCR METAB, V96, P1783, DOI 10.1210/jc.2010-2961; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Fujita E, 2002, CELL DEATH DIFFER, V9, P1108, DOI 10.1038/sj.cdd.4401080; Gasparini L, 2003, TRENDS NEUROSCI, V26, P404, DOI 10.1016/S0166-2236(03)00163-2; Greeve I, 2000, J NEUROSCI, V20, P7345; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huo HR, 2003, J BIOL CHEM, V278, P11561, DOI 10.1074/jbc.M211785200; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Kondo T., 2013, CELL STEM CELL; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamsa R, 2007, AM J MED GENET B, V144B, P906, DOI 10.1002/ajmg.b.30532; Lu X, 2008, EXP CELL RES, V314, P342, DOI 10.1016/j.yexcr.2007.10.013; Lu X, 2008, ENDOCRINOLOGY, V149, P3267, DOI 10.1210/en.2008-0024; Lu XL, 2006, ENDOCRINOLOGY, V147, P3123, DOI 10.1210/en.2005-1426; Lu XL, 2011, CELL STRESS CHAPERON, V16, P539, DOI 10.1007/s12192-011-0265-7; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sarkar D, 2001, J CLIN ENDOCR METAB, V86, P5130, DOI 10.1210/jc.86.11.5130; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharpe LJ, 2012, J ALZHEIMERS DIS, V30, P35, DOI 10.3233/JAD-2012-111955; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x	41	24	26	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86753	10.1371/journal.pone.0086753	http://dx.doi.org/10.1371/journal.pone.0086753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489783	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000069
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			Influence of Protein - Micelle Ratios and Cysteine Residues on the Kinetic Stability and Unfolding Rates of Human Mitochondrial VDAC-2	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; OUTER-MEMBRANE PROTEIN; BETA-BARREL; THERMODYNAMIC STABILITY; STRUCTURAL STABILITY; LIPID INTERACTIONS; PARALLEL PATHWAYS; APOPTOSIS; ISOFORMS; DYNAMICS	Delineating the kinetic and thermodynamic factors which contribute to the stability of transmembrane beta-barrels is critical to gain an in-depth understanding of membrane protein behavior. Human mitochondrial voltage-dependent anion channel isoform 2 (hVDAC-2), one of the key anti-apoptotic eukaryotic beta-barrel proteins, is of paramount importance, owing to its indispensable role in cell survival. We demonstrate here that the stability of hVDAC-2 bears a strong kinetic contribution that is dependent on the absolute micellar concentration used for barrel folding. The refolding efficiency and ensuing stability is sensitive to the lipid-to-protein (LPR) ratio, and displays a non-linear relationship, with both low and high micellar amounts being detrimental to hVDAC-2 structure. Unfolding and aggregation process are sequential events and show strong temperature dependence. We demonstrate that an optimal lipid-to-protein ratio of 2600:1 - 13000:1 offers the highest protection against thermal denaturation. Activation energies derived only for lower LPRs are similar to 17 kcal mol(-1) for full-length hVDAC-2 and similar to 23 kcal mol(-1) for the Cys-less mutant, suggesting that the nine cysteine residues of hVDAC-2 impart additional malleability to the barrel scaffold. Our studies reveal that cysteine residues play a key role in the kinetic stability of the protein, determine barrel rigidity and thereby give rise to strong micellar association of hVDAC-2. Non-linearity of the Arrhenius plot at high LPRs coupled with observation of protein aggregation upon thermal denaturation indicates that contributions from both kinetic and thermodynamic components stabilize the 19-stranded beta-barrel. Lipid-protein interaction and the linked kinetic contribution to free energy of the folded protein are together expected to play a key role in hVDAC-2 recycling and the functional switch at the onset of apoptosis.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India.	maha@iiserb.ac.in	Mahalakshmi, Radhakrishnan/B-3143-2008; Maurya, Svetlana/H-3664-2018	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550; Maurya, Svetlana/0000-0002-4700-2711	Department of Biotechnology (DBT), Govt. of India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research, India; DBT, Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); DBT, Govt. of India(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT), Govt. of India award number BT/01/IYBA/2009. S.R.M. is supported by a senior research fellowship from Council of Scientific and Industrial Research, India. R. M. is a recipient of the Ramalingaswami Fellowship from DBT, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Chaturvedi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079351; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 1996, Ion Channels, V4, P169; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; Garbuzynskiy SO, 2013, P NATL ACAD SCI USA, V110, P147, DOI 10.1073/pnas.1210180110; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jayaraman S, 2005, BIOPHYS J, V88, P2907, DOI 10.1529/biophysj.104.055921; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Palazzo G, 2010, BBA-PROTEINS PROTEOM, V1804, P137, DOI 10.1016/j.bbapap.2009.09.021; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saccone C, 2003, J MOL EVOL, V57, pS277, DOI 10.1007/s00239-003-0037-9; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schlebach JP, 2012, PROTEIN SCI, V21, P97, DOI 10.1002/pro.766; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Tan EHL, 1996, BIOPHYS J, V70, P2385, DOI 10.1016/S0006-3495(96)79806-5; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859	56	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87701	10.1371/journal.pone.0087701	http://dx.doi.org/10.1371/journal.pone.0087701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24494036	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000171
J	Park, S; Park, MS; Jung, KH; Song, J; Kim, YA; Cho, HJ; Min, BI; Bae, H				Park, Soojin; Park, Min-Sun; Jung, Kyung-Hwa; Song, Joohyun; Kim, You Ah; Cho, Hi Jae; Min, Byung-Il; Bae, Hyunsu			Treatment with Pyranopyran-1, 8-Dione Attenuates Airway Responses in Cockroach Allergen Sensitized Asthma in Mice	PLOS ONE			English	Article							UNRESTRAINED PLETHYSMOGRAPHY; INHALED CORTICOSTEROIDS; STRUCTURAL-CHANGES; IL-4 RECEPTOR; MODEL; INFLAMMATION; CHILDREN; DISEASE; CELLS; RESPONSIVENESS	Chronic allergic asthma is characterized by Th2-typed inflammation, and contributes to airway remodeling and the deterioration of lung function. Viticis Fructus (VF) has long been used in China and Korea as a traditional herbal remedy for treating various inflammatory diseases. Previously, we have isolated a novel phytochemical, pyranopyran-1, 8-dione (PPY), from VF. This study was conducted to evaluate the ability of PPY to prevent airway inflammation and to attenuate airway responses in a cockroach allergen-induced asthma model in mice. The mice sensitized to and challenged with cockroach allergen were treated with oral administration of PPY. The infiltration of total cells, eosinophils and lymphocytes into the BAL fluid was significantly inhibited in cockroach allergen-induced asthma mice treated with PPY (1, 2, or 10 mg/kg). Th2 cytokines and chemokine, such as IL-4, IL-5, IL-13 and eotaxin in BAL fluid were also reduced to normal levels following treatment with PPY. In addition, the levels of IgE were also markedly suppressed after PPY treatment. Histopathological examination demonstrated that PPY substantially inhibited eosinophil infiltration into the airway, goblet cell hyperplasia and smooth muscle hypertrophy. Taken together, these results demonstrate that PPY possesses a potent efficacy on controlling allergic asthma response such as airway inflammation and remodeling.	[Park, Soojin; Jung, Kyung-Hwa; Song, Joohyun; Bae, Hyunsu] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Park, Min-Sun; Min, Byung-Il] Kyung Hee Univ, Dept East West Med, Seoul, South Korea; [Kim, You Ah; Cho, Hi Jae] Korea Promot Inst Tradit Med Ind, Dept Nat Prod, Kyungbuk, South Korea	Kyung Hee University; Kyung Hee University	Bae, H (corresponding author), Kyung Hee Univ, Coll Korean Med, Seoul, South Korea.	hbae@khu.ac.kr	JUNG, KYOUNGHWA/AAL-3317-2021; Bae, Hyunsu/ABH-6248-2020	Bae, Hyunsu/0000-0002-0299-3582; Kim, You Ah/0000-0002-6744-2490	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0006220]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No. 2011-0006220). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Michael J, 2003, Am J Respir Med, V2, P287; Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; Bates J, 2004, AM J RESP CELL MOL, V31, P373, DOI 10.1165/ajrcmb.31.3.1; Bergeron C, 2006, CHEST, V129, P1068, DOI 10.1378/chest.129.4.1068; Berlin AA, 2005, AM J RESP CRIT CARE, V171, P35, DOI 10.1164/rccm.200403-385OC; Blaeser F, 2003, J EXP MED, V198, P1189, DOI 10.1084/jem.20030471; Busse PJ, 2010, ANN ALLERG ASTHMA IM, V104, P236, DOI 10.1016/j.anai.2009.12.006; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Choi MS, 2013, CYTOKINE, V61, P256, DOI 10.1016/j.cyto.2012.10.005; Ci XX, 2012, INFLAMM RES, V61, P749, DOI 10.1007/s00011-012-0470-6; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Corry DB, 2002, NAT REV DRUG DISCOV, V1, P55, DOI 10.1038/nrd702; Finn PW, 2000, J ALLERGY CLIN IMMUN, V105, P933, DOI 10.1067/mai.2000.106546; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gorman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067823; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kariyawasam HH, 2007, CURR OPIN IMMUNOL, V19, P681, DOI 10.1016/j.coi.2007.07.021; Katherine L., 2011, PHARMACOTHERAPY; Kelly HW, 2003, J ALLERGY CLIN IMMUN, V112, P469, DOI 10.1067/mai.2003.1718; Kim DY, 2011, J ETHNOPHARMACOL, V136, P230, DOI 10.1016/j.jep.2011.04.048; Kim J, 2007, J ETHNOPHARMACOL, V114, P186, DOI 10.1016/j.jep.2007.07.038; Kim SR, 2013, J ALLERGY CLIN IMMUN; Kips JC, 2001, EUR RESPIR J, V18, p24S, DOI 10.1183/09031936.01.00229601; Korenblat PE, 2001, ANN ALLERG ASTHMA IM, V86, P31, DOI 10.1016/S1081-1206(10)62309-5; Laviolette M, 1999, AM J RESP CRIT CARE, V160, P1862, DOI 10.1164/ajrccm.160.6.9803042; Lederlin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048493; Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6; Lee H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/769830; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P205, DOI 10.4168/aair.2011.3.3.205; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; Lemanske Robert F. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS502; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; LUNDGREN JD, 1990, J ALLERGY CLIN IMMUN, V85, P399, DOI 10.1016/0091-6749(90)90147-V; Maecker HT, 2001, J IMMUNOL, V166, P959, DOI 10.4049/jimmunol.166.2.959; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Nagai T, 2004, INT IMMUNOPHARMACOL, V4, P1353, DOI 10.1016/j.intimp.2004.05.021; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Oh BG, 2009, PHYTOMEDICINE, V16, P814, DOI 10.1016/j.phymed.2009.01.009; Patterson ML, 2002, CLIN EXP ALLERGY, V32, P721, DOI 10.1046/j.1365-2222.2002.01397.x; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; RENZ H, 1995, INT ARCH ALLERGY IMM, V106, P46, DOI 10.1159/000236889; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Royce SG, 2012, ARCH IMMUNOL THER EX, V60, P295, DOI 10.1007/s00005-012-0180-3; SAETTA M, 1991, AM REV RESPIR DIS, V143, P138, DOI 10.1164/ajrccm/143.1.138; Scalabrin DMF, 1996, J ASTHMA, V33, P407, DOI 10.3109/02770909609068185; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Shin TY, 2000, J ETHNOPHARMACOL, V72, P443, DOI 10.1016/S0378-8741(00)00258-0; Tanaka H, 2000, CLIN EXP ALLERGY, V30, P874; Tsujiyama I, 2013, ORIENTAL PHARM EXP M, V13, P175, DOI 10.1007/s13596-012-0093-z; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142	70	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87558	10.1371/journal.pone.0087558	http://dx.doi.org/10.1371/journal.pone.0087558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489937	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000158
J	Sommer, B; Waege, I; Pollmann, D; Seitz, T; Thomm, M; Sterner, R; Hausner, W				Sommer, Bettina; Waege, Ingrid; Poellmann, David; Seitz, Tobias; Thomm, Michael; Sterner, Reinhard; Hausner, Winfried			Activation of a Chimeric Rpb5/RpoH Subunit Using Library Selection	PLOS ONE			English	Article							RNA-POLYMERASE-II; SITE-DIRECTED MUTAGENESIS; VIRUS X-PROTEIN; IN-VIVO; ARCHAEAL TRANSCRIPTION; COMPLEX STRUCTURE; CRYSTAL-STRUCTURE; RPB5; YEAST; ENZYME	Rpb5 is a general subunit of all eukaryotic RNA polymerases which consists of a N-terminal and a C-terminal domain. The corresponding archaeal subunit RpoH contains only the conserved C-terminal domain without any N-terminal extensions. A chimeric construct, termed rp5H, which encodes the N-terminal yeast domain and the C-terminal domain from Pyrococcus furiosus is unable to complement the lethal phenotype of a yeast rpb5 deletion strain (Delta rpb5). By applying a random mutagenesis approach we found that the amino acid exchange E197K in the C-terminal domain of the chimeric Rp5H, either alone or with additional exchanges in the N-terminal domain, leads to heterospecific complementation of the growth deficiency of Delta rpb5. Moreover, using a recently described genetic system for Pyrococcus we could demonstrate that the corresponding exchange E62K in the archaeal RpoH subunit alone without the eukaryotic N-terminal extension was stable, and growth experiments indicated no obvious impairment in vivo. In vitro transcription experiments with purified RNA polymerases showed an identical activity of the wild type and the mutant Pyrococcus RNA polymerase. A multiple alignment of RpoH sequences demonstrated that E62 is present in only a few archaeal species, whereas the great majority of sequences within archaea and eukarya contain a positively charged amino acid at this position. The crystal structures of the Sulfolobus and yeast RNA polymerases show that the positively charged arginine residues in subunits RpoH and Rpb5 most likely form salt bridges with negatively charged residues from subunit RpoK and Rpb1, respectively. A similar salt bridge might stabilize the interaction of Rp5H-E197K with a neighboring subunit of yeast RNA polymerase and thus lead to complementation of Delta rpb5.	[Sommer, Bettina; Seitz, Tobias; Sterner, Reinhard] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Waege, Ingrid; Poellmann, David; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Waege, Ingrid; Poellmann, David; Thomm, Michael; Hausner, Winfried] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Sterner, R (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	Reinhard.Sterner@biologie.uni-regensburg.de; Winfried.Hausner@biologie.uni-regensburg.de	Sterner, Reinhard/ABI-6781-2020	Sterner, Reinhard/0000-0001-8177-8460	Deutsche Forschungsgemeinschaft [TH422/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (TH422/13-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; Goede B, 2006, J BIOL CHEM, V281, P30581, DOI 10.1074/jbc.M605209200; Grunberg S, 2010, NUCLEIC ACIDS RES, V38, P1950, DOI 10.1093/nar/gkp1190; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jun SH, 2011, CRIT REV BIOCHEM MOL, V46, P27, DOI 10.3109/10409238.2010.538662; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-38; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kreuzer M, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-9; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; LANGER D, 1995, P NATL ACAD SCI USA, V92, P5768, DOI 10.1073/pnas.92.13.5768; Lin Y, 1997, J BIOL CHEM, V272, P7132, DOI 10.1074/jbc.272.11.7132; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Miyao T, 1998, P NATL ACAD SCI USA, V95, P15281, DOI 10.1073/pnas.95.26.15281; Miyao T, 1998, MOL GEN GENET, V259, P123, DOI 10.1007/s004380050796; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; Navarro F, 2000, RNA, V6, P103, DOI 10.1017/S1355838200991714; Ochs SM, 2012, J BIOL CHEM, V287, P18863, DOI 10.1074/jbc.M112.365742; Reich C, 2009, MOL MICROBIOL, V71, P989, DOI 10.1111/j.1365-2958.2008.06577.x; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Schwab T, 2011, CHEMBIOCHEM, V12, P1581, DOI 10.1002/cbic.201000770; SHPAKOVSKI GV, 1995, MOL CELL BIOL, V15, P4702; Thiru A, 1999, J MOL BIOL, V287, P753, DOI 10.1006/jmbi.1999.2638; Thomm M, 2009, BIOCHEM SOC T, V37, P18, DOI 10.1042/BST0370018; Todone F, 2000, P NATL ACAD SCI USA, V97, P6306, DOI 10.1073/pnas.97.12.6306; Waege I, 2010, APPL ENVIRON MICROB, V76, P3308, DOI 10.1128/AEM.01951-09; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Widlund PO, 2005, YEAST, V22, P769, DOI 10.1002/yea.1244; Wojtas MN, 2013, BIOCHEM SOC T, V41, P356, DOI 10.1042/BST20120305; Wojtas MN, 2012, NUCLEIC ACIDS RES, V40, P9941, DOI 10.1093/nar/gks692; Yee A, 2000, P NATL ACAD SCI USA, V97, P6311, DOI 10.1073/pnas.97.12.6311; Zaros C, 2007, NUCLEIC ACIDS RES, V35, P634, DOI 10.1093/nar/gkl686	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87485	10.1371/journal.pone.0087485	http://dx.doi.org/10.1371/journal.pone.0087485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489922	Green Published, gold			2022-12-27	WOS:000330570000149
J	Winer-Jones, JP; Vahidi, B; Arquilevich, N; Fang, C; Ferguson, S; Harkins, D; Hill, C; Klem, E; Pagano, PC; Peasley, C; Romero, J; Shartle, R; Vasko, RC; Strauss, WM; Dempsey, PW				Winer-Jones, Jessamine P.; Vahidi, Behrad; Arquilevich, Norma; Fang, Cong; Ferguson, Samuel; Harkins, Darren; Hill, Cory; Klem, Erich; Pagano, Paul C.; Peasley, Chrissy; Romero, Juan; Shartle, Robert; Vasko, Robert C.; Strauss, William M.; Dempsey, Paul W.			Circulating Tumor Cells: Clinically Relevant Molecular Access Based on a Novel CTC Flow Cell	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EPITHELIAL-CELLS; BREAST-CANCER; HEALTHY-SUBJECTS; SURVIVAL; PROGRESSION; POPULATION; CARCINOMA	Background: Contemporary cancer diagnostics are becoming increasing reliant upon sophisticated new molecular methods for analyzing genetic information. Limiting the scope of these new technologies is the lack of adequate solid tumor tissue samples. Patients may present with tumors that are not accessible to biopsy or adequate for longitudinal monitoring. One attractive alternate source is cancer cells in the peripheral blood. These rare circulating tumor cells (CTC) require enrichment and isolation before molecular analysis can be performed. Current CTC platforms lack either the throughput or reliability to use in a clinical setting or they provide CTC samples at purities that restrict molecular access by limiting the molecular tools available. Methodology/Principal Findings: Recent advances in magetophoresis and microfluidics have been employed to produce an automated platform called LiquidBiopsyH. This platform uses high throughput sheath flow microfluidics for the positive selection of CTC populations. Furthermore the platform quantitatively isolates cells useful for molecular methods such as detection of mutations. CTC recovery was characterized and validated with an accuracy (<20% error) and a precision (CV<25%) down to at least 9 CTC/ml. Using anti-EpCAM antibodies as the capture agent, the platform recovers 78% of MCF7 cells within the linear range. Non specific recovery of background cells is independent of target cell density and averages 55 cells/mL. 10% purity can be achieved with as low as 6 CTCs/mL and better than 1% purity can be achieved with 1 CTC/mL. Conclusions/Significance: The LiquidBiopsy platform is an automated validated platform that provides high throughput molecular access to the CTC population. It can be validated and integrated into the lab flow enabling CTC enumeration as well as recovery of consistently high purity samples for molecular analysis such as quantitative PCR and Next Generation Sequencing. This tool opens the way for clinically relevant genetic profiling of CTCs.	[Winer-Jones, Jessamine P.; Arquilevich, Norma; Fang, Cong; Harkins, Darren; Hill, Cory; Klem, Erich; Pagano, Paul C.; Peasley, Chrissy; Romero, Juan; Vasko, Robert C.; Strauss, William M.; Dempsey, Paul W.] Cynvenio Biosyst, Res & Dev, Westlake Village, CA USA; [Vahidi, Behrad; Ferguson, Samuel; Shartle, Robert] Cynvenio Biosyst, Engn, Westlake Village, CA USA		Winer-Jones, JP (corresponding author), Cynvenio Biosyst, Res & Dev, Westlake Village, CA USA.	jwinerjones@cynvenio.com	Winer-Jones, Jessamine P/N-7458-2013	Winer-Jones, Jessamine P/0000-0002-6412-4139	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261201100115C, HHSN261201100109C]; Cynvenio Biosystems	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cynvenio Biosystems	This study was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract Nos. HHSN261201100115C and HHSN261201100109C. Additional funding was provided by Cynvenio Biosystems. All authors are employees of Cynvenio Biosystems and Cynvenio Biosystems played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bhatia S, 2012, NAT BIOTECHNOL, V30, P604, DOI 10.1038/nbt.2294; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; De Giorgi V, 2010, J INVEST DERMATOL, V130, P2440, DOI 10.1038/jid.2010.141; Elshal MF, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-29; Fiegl M, 2003, CLIN CANCER RES, V9, P1224; Franken B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3333; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; HANCOCK JP, 1993, J IMMUNOL METHODS, V164, P51, DOI 10.1016/0022-1759(93)90275-C; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Irwin PL, 2010, ANAL BIOANAL CHEM, V398, P895, DOI 10.1007/s00216-010-3967-2; Marrinucci D, 2010, J ONCOL, V2010, P1, DOI DOI 10.1016/S1470-2045(07)70140-7; McCloskey KE, 2003, ANAL CHEM, V75, P6868, DOI 10.1021/ac034315j; Mikolajczyk S. D., 2011, J ONCOL, V2011, P1, DOI [DOI 10.1186/1477-7819-4-67, 10.1186/1477-7819-4-67]; Mostert B, 2012, CANCER LETT, V319, P49, DOI 10.1016/j.canlet.2011.12.031; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; Ring AE, 2005, BRIT J CANCER, V92, P906, DOI 10.1038/sj.bjc.6602418; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; You FL, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-2	27	55	60	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86717	10.1371/journal.pone.0086717	http://dx.doi.org/10.1371/journal.pone.0086717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489774	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000063
J	Wyszko, E; Mueller, F; Gabryelska, M; Bondzio, A; Popenda, M; Barciszewski, J; Erdmann, VA				Wyszko, Eliza; Mueller, Florian; Gabryelska, Marta; Bondzio, Angelika; Popenda, Mariusz; Barciszewski, Jan; Erdmann, Volker A.			Spiegelzymes (R) Mirror-Image Hammerhead Ribozymes and Mirror-Image DNAzymes, an Alternative to siRNAs and microRNAs to Cleave mRNAs In Vivo?	PLOS ONE			English	Article							DNA; DESIGN; OLIGONUCLEOTIDES; ANTICOAGULANT; THERAPEUTICS; APTAMER	With the discovery of small non-coding RNA (ncRNA) molecules as regulators for cellular processes, it became intriguing to develop technologies by which these regulators can be applied in molecular biology and molecular medicine. The application of ncRNAs has significantly increased our knowledge about the regulation and functions of a number of proteins in the cell. It is surprising that similar successes in applying these small ncRNAs in biotechnology and molecular medicine have so far been very limited. The reasons for these observations may lie in the high complexity in which these RNA regulators function in the cells and problems with their delivery, stability and specificity. Recently, we have described mirror-image hammerhead ribozymes and DNAzymes (Spiegelzymes (R)) which can sequence-specifically hydrolyse mirror-image nucleic acids, such as our mirror-image aptamers (Spiegelmers) discovered earlier. In this paper, we show for the first time that Spiegelzymes are capable of recognising complementary enantiomeric substrates (D-nucleic acids), and that they efficiently hydrolyse them at submillimolar magnesium concentrations and at physiologically relevant conditions. The Spiegelzymes are very stable in human sera, and do not require any protein factors for their function. They have the additional advantages of being non-toxic and non-immunogenic. The Spiegelzymes can be used for RNA silencing and also as therapeutic and diagnostic tools in medicine. We performed extensive three-dimensional molecular modelling experiments with mirror-image hammerhead ribozymes and DNAzymes interacting with D-RNA targets. We propose a model in which L/D-double helix structures can be formed by natural Watson-Crick base pairs, but where the nucleosides of one of the two strands will occur in an anticlinal conformation. Interestingly enough, the duplexes (L-RNA/D-RNA and L-DNA/D-RNA) in these models can show either right-or left-handedness. This is a very new observation, suggesting that molecular symmetry of enantiomeric nucleic acids is broken down.	[Wyszko, Eliza; Gabryelska, Marta; Popenda, Mariusz; Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Mueller, Florian] Pentafolium Soft, Rosengarten, Germany; [Bondzio, Angelika] Free Univ Berlin, Inst Biochem, Berlin, Germany; [Erdmann, Volker A.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Erdmann, Volker A.] Erdmann Technol GmbH, Berlin, Germany	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Free University of Berlin; Free University of Berlin	Erdmann, VA (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.	vae@zedat.fu-berlin.de	Barciszewski, Jan/N-9283-2019	Barciszewski, Jan/0000-0001-7766-5594; Gabryelska, Marta/0000-0002-4433-282X; Popenda, Mariusz/0000-0001-9965-0430; Wyszko, Eliza/0000-0001-9524-0960	Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsches Zentrum fur Luft- und Raumfahrt (DLR); Deutsche Forschungsgemeinschaft [SFB Transregio 19]; Polish Ministry of Sciences of Higher Education; NCN; Foreign Office of the Free University of Berlin	Berlin RNA Network; Federal Ministry of Science (BMBF); Deutsches Zentrum fur Luft- und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Polish Ministry of Sciences of Higher Education; NCN; Foreign Office of the Free University of Berlin	The authors are grateful for financial support from the Berlin RNA Network, the Federal Ministry of Science (BMBF), Deutsches Zentrum fur Luft- und Raumfahrt (DLR), The Deutsche Forschungsgemeinschaft for funding of the SFB Transregio 19 (project C1), the Polish Ministry of Sciences of Higher Education, and NCN. The financial support from the Foreign Office of the Free University of Berlin is also appreciated. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley GW, 1992, J AM CHEM SOC, V114, P9721; Becker R C, 2007, Hamostaseologie, V27, P378; BLOMMERS MJJ, 1994, BIOCHEMISTRY-US, V33, P7886, DOI 10.1021/bi00191a016; Boeckel CAA, 1987, J MOL EVOL, V25, P100; Burgess DJ, 2012, NAT REV CANCER, V12, P508, DOI 10.1038/nrc3328; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; DAMHA MJ, 1994, BIOCHEMISTRY-US, V33, P7877, DOI 10.1021/bi00191a015; Eulberg D, 2006, APTAMER HDB FUNCTION; FUJIMORI S, 1990, J AM CHEM SOC, V112, P7436, DOI 10.1021/ja00176a077; Gaglione M, 2010, MINI-REV MED CHEM, V10, P578, DOI 10.2174/138955710791384036; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P4159, DOI 10.1093/nar/21.18.4159; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scott WG, 2010, RNA TECHNOL, P305, DOI 10.1007/978-3-642-12168-5_14; URATA H, 1993, J AM CHEM SOC, V115, P9852, DOI 10.1021/ja00074a083; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Wang J, 2009, CHEMBIOCHEM, V10, P2171, DOI 10.1002/cbic.200900408; Wyszko E, 2013, PLOS ONE, V1, pe5471	25	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86673	10.1371/journal.pone.0086673	http://dx.doi.org/10.1371/journal.pone.0086673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489764	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000057
J	Anglani, R; Creanza, TM; Liuzzi, VC; Piepoli, A; Panza, A; Andriulli, A; Ancona, N				Anglani, Roberto; Creanza, Teresa M.; Liuzzi, Vania C.; Piepoli, Ada; Panza, Anna; Andriulli, Angelo; Ancona, Nicola			Loss of Connectivity in Cancer Co-Expression Networks	PLOS ONE			English	Article							MOLECULAR-ORIGINS; TUMOR-SUPPRESSOR; MICROARRAY DATA; GENE; EXPRESSION; MUTATIONS; PATHWAYS; BREAST; SET; CELLS	Differential gene expression profiling studies have lead to the identification of several disease biomarkers. However, the oncogenic alterations in coding regions can modify the gene functions without affecting their own expression profiles. Moreover, post-translational modifications can modify the activity of the coded protein without altering the expression levels of the coding gene, but eliciting variations to the expression levels of the regulated genes. These considerations motivate the study of the rewiring of networks co-expressed genes as a consequence of the aforementioned alterations in order to complement the informative content of differential expression. We analyzed 339 mRNAomes of five distinct cancer types to find single genes that presented co-expression patterns strongly differentiated between normal and tumor phenotypes. Our analysis of differentially connected genes indicates the loss of connectivity as a common topological trait of cancer networks, and unveils novel candidate cancer genes. Moreover, our integrated approach that combines the differential expression together with the differential connectivity improves the classic enrichment pathway analysis providing novel insights on putative cancer gene biosystems not still fully investigated.	[Anglani, Roberto; Creanza, Teresa M.; Liuzzi, Vania C.; Ancona, Nicola] CNR ISSIA, Inst Intelligent Syst Automat, Natl Res Council, Bari, Italy; [Creanza, Teresa M.] Univ Turin, Ctr Complex Syst Mol Biol & Med, Turin, Italy; [Piepoli, Ada; Panza, Anna; Andriulli, Angelo] IRCCS Casa Sollievo Sofferenza, Dept Med Sci, Div & Lab Gastroenterol, San Giovanni Rotondo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Studi sui Sistemi Intelligenti per l'Automazione (ISSIA-CNR); University of Turin; IRCCS Casa Sollievo Della Sofferenza	Ancona, N (corresponding author), CNR ISSIA, Inst Intelligent Syst Automat, Natl Res Council, Bari, Italy.	ancona@ba.issia.cnr.it	Ancona, Nicola/AAD-4772-2022; Piepoli, Ada/K-9299-2016; Andriulli, Angelo/B-5027-2017; Panza, Anna/K-1989-2016; CREANZA, TERESA MARIA/AAX-6584-2020; Ancona, Nicola/E-9971-2013	Piepoli, Ada/0000-0001-7487-8754; Andriulli, Angelo/0000-0001-8862-7083; Panza, Anna/0000-0001-5840-0849; CREANZA, TERESA MARIA/0000-0003-4926-6451; Ancona, Nicola/0000-0003-0065-0321; Anglani, Roberto/0000-0002-7175-5991	Regione Puglia PO FESR Progetto BISIMANE [44]; Progetto FIRB [RBAP11B2SX]; Progetto di Ricerca Finalizzata [RF/2009-1471624]	Regione Puglia PO FESR Progetto BISIMANE; Progetto FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetto di Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was partially supported by grants from Regione Puglia PO FESR 2007--2013 Progetto BISIMANE (Cod. n. 44), Progetto FIRB RBAP11B2SX, Progetto di Ricerca Finalizzata 2009 RF/2009-1471624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benz CC, 1998, ENDOCR-RELAT CANCER, V5, P271, DOI 10.1677/erc.0.0050271; Califano A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.117; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen LM, 2011, J CELL BIOCHEM, V112, P933, DOI 10.1002/jcb.23009; Cheng XX, 2005, CANCER LETT, V223, P339, DOI 10.1016/j.canlet.2004.11.013; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 1999, CURR BIOL, V9, pR62, DOI 10.1016/S0960-9822(99)80012-8; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giaccone G, 2008, ANN ONCOL, V19, P1219, DOI 10.1093/annonc/mdn048; Good P., 2013, PERMUTATION TESTS PR; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hollander M., 2014, WILEY SERIES PROBABI, V3rd; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2012, LECT NOTES COMPUTER, P1; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shin SM, 2006, GASTROENTEROLOGY, V130, P2074, DOI 10.1053/j.gastro.2006.03.055; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Stern HM, 2010, CLIN CANCER RES, V16, P1587, DOI 10.1158/1078-0432.CCR-09-3108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thibodeau J, 2012, ONCOIMMUNOLOGY, V1, P908, DOI 10.4161/onci.21205; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wei P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046887; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	54	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87075	10.1371/journal.pone.0087075	http://dx.doi.org/10.1371/journal.pone.0087075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489837	Green Published, gold			2022-12-27	WOS:000330510000104
J	Ducas, VC; Rhoades, E				Ducas, Vanessa C.; Rhoades, Elizabeth			Investigation of Intramolecular Dynamics and Conformations of alpha-, beta- and gamma-Synuclein	PLOS ONE			English	Article							SECONDARY STRUCTURE; LOOP FORMATION; AGGREGATION; MUTATION; PROTEINS; DEMENTIA; BINDING; HELIX; MODEL; LOCALIZATION	The synucleins are a family of natively unstructured proteins consisting of alpha-, beta-, and gamma-synuclein which are primarily expressed in neurons. They have been linked to a wide variety of pathologies, including neurological disorders, such as Parkinson's disease (alpha-synuclein) and dementia with Lewy bodies (alpha- and beta-synuclein), as well as various types of cancers (gamma-synuclein). Self-association is a key pathological feature of many of these disorders, with alpha-synuclein having the highest propensity to form aggregates, while beta-synuclein is the least prone. Here, we used a combination of fluorescence correlation spectroscopy and single molecule Forster resonance energy transfer to compare the intrinsic dynamics of different regions of all three synuclein proteins to investigate any correlation with putative functional or dysfunctional interactions. Despite a relatively high degree of sequence homology, we find that individual regions sample a broad range of diffusion coefficients, differing by almost a factor of four. At low pH, a condition that accelerates aggregation of alpha-synuclein, on average smaller diffusion coefficients are measured, supporting a hypothesis that slower intrachain dynamics may be correlated with self-association. Moreover, there is a surprising inverse correlation between dynamics and bulkiness of the segments. Aside from this observation, we could not discern any clear relationship between the physico-chemical properties of the constructs and their intrinsic dynamics. This work suggests that while protein dynamics may play a role in modulating self-association or interactions with other binding partners, other factors, particularly the local cellular environment, may be more important.	[Ducas, Vanessa C.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rhoades, Elizabeth] Yale Univ, Dept Phys, New Haven, CT USA	Yale University; Yale University	Rhoades, E (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	elizabeth.rhoades@yale.edu			National Institutes of Health [GM102815, NS079955, GM067543, GM008283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102815, T32GM067543, T32GM008283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health GM102815 and NS079955 (to ER) and predoctoral training grants GM067543 and GM008283 (to VCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bradbury J, 2003, LANCET NEUROL, V2, P715, DOI 10.1016/S1474-4422(03)00601-X; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; CHAZIN WJ, 1989, P NATL ACAD SCI USA, V86, P2195, DOI 10.1073/pnas.86.7.2195; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; Das RK, 2013, P NATL ACAD SCI; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Ducas VC, 2012, J MOL BIOL, V423, P528, DOI 10.1016/j.jmb.2012.08.008; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fujita M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1101; Fujita M, 2009, J NEUROL, V256, pS286, DOI 10.1007/s00415-009-5246-8; George JM, 2002, GENOME BIOL, V3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gregersen N, 2005, MOL BIOTECHNOL, V31, P141, DOI 10.1385/MB:31:2:141; Grupi A, 2011, J MOL BIOL, V405, P1267, DOI 10.1016/j.jmb.2010.11.011; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lavedan C, 1998, GENOME RES, V8, P871, DOI 10.1101/gr.8.9.871; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Manivel P, 2011, J MOL MODEL, V17, P251, DOI 10.1007/s00894-010-0718-4; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Pan ZZ, 2006, INT J ONCOL, V29, P1201; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Schweyer Paul, 1909; SEGREST JP, 1992, J LIPID RES, V33, P141; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh VK, 2007, CANCER RES, V67, P626, DOI 10.1158/0008-5472.CAN-06-1820; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1009, DOI 10.1007/s10571-005-8471-4; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei J, 2007, J BIOL CHEM, V282, P28904, DOI 10.1074/jbc.M703711200; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	74	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86983	10.1371/journal.pone.0086983	http://dx.doi.org/10.1371/journal.pone.0086983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489820	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000096
J	Harmon, KJ; Bennett, EE; Gomella, AA; Wen, H				Harmon, Katherine J.; Bennett, Eric E.; Gomella, Andrew A.; Wen, Han			Efficient Decoding of 2D Structured Illumination with Linear Phase Stepping in X-Ray Phase Contrast and Dark-Field Imaging	PLOS ONE			English	Article							SCATTER CORRECTION METHOD; FRINGE-PATTERN ANALYSIS; FRESNEL ZONE-PLATE; WAVE-FRONT; PRIMARY MODULATION; INTERFEROMETER	The ability to map the phase distribution and lateral coherence of an x-ray wavefront offers the potential for imaging the human body through phase contrast, without the need to deposit significant radiation energy. The classic means to achieve this goal is structured illumination, in which a periodic intensity modulation is introduced into the image, and changes in the phase distribution of the wavefront are detected as distortions of the modulation pattern. Two-dimensional periodic patterns are needed to fully characterize a transverse wavefront. Traditionally, the information in a 2D pattern is retrieved at high resolution by acquiring multiple images while shifting the pattern over a 2D matrix of positions. Here we describe a method to decode 2D periodic patterns with single-axis phase stepping, without either a loss of information or increasing the number of sampling steps. The method is created to reduce the instrumentation complexity of high-resolution 2D wavefront sensing in general. It is demonstrated with motionless electromagnetic phase stepping and a flexible processing algorithm in x-ray dark-field and phase contrast imaging.	[Harmon, Katherine J.; Bennett, Eric E.; Gomella, Andrew A.; Wen, Han] NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wen, H (corresponding author), NHLBI, Imaging Phys Lab, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	wenh@nhlbi.nih.gov	Wen, Han/G-3081-2010; Bennett, Eric/Q-6451-2019; Bennett, Eric/A-2551-2013; Bennett, Eric E/F-1070-2018	Wen, Han/0000-0001-6844-2997; Bennett, Eric/0000-0001-6577-9869; Bennett, Eric/0000-0001-6577-9869; Bennett, Eric E/0000-0001-6577-9869; Gomella, Andrew/0000-0003-0319-2434; Harmon, Katherine/0000-0001-6427-7971	Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH), part of the Health and Human Services Department of the US Federal Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004606, ZIGHL006020] Funding Source: NIH RePORTER	Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH), part of the Health and Human Services Department of the US Federal Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work is funded by the Division of Intramural Research of the National Heart, Lung and Blood Institute, National Institutes of Health (NIH), which is part of the Health and Human Services Department of the US Federal Government. All authors are affiliated with NIH. The work is performed as official duty in fulfilling the general mission of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EE, 2010, MED PHYS, V37, P6047, DOI 10.1118/1.3501311; Berujon S, 2012, OPT LETT, V37, P1622, DOI 10.1364/OL.37.001622; Berujon S, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063813; BONE DJ, 1986, APPL OPTICS, V25, P1653, DOI 10.1364/AO.25.001653; BRUNING JH, 1974, APPL OPTICS, V13, P2693, DOI 10.1364/AO.13.002693; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Clauser, 1998, United States patent, Patent No. [5812629, US 5,812,629]; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; Hartmann J., 1900, Z INSTRUMENTENKD, V20, P47; Jensen TH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214103; LIANG JZ, 1994, J OPT SOC AM A, V11, P1949, DOI 10.1364/JOSAA.11.001949; Miao HX, 2013, P NATL ACAD SCI USA, V110, P19268, DOI 10.1073/pnas.1311053110; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9; Morgan KS, 2011, OPT EXPRESS, V19, P19781, DOI 10.1364/OE.19.019781; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Platt B.C., 1971, OPT SCI NEWSLETTER, V5, P15; Rueckel M, 2006, P NATL ACAD SCI USA, V103, P17137, DOI 10.1073/pnas.0604791103; Rutishauser S, 2013, J SYNCHROTRON RADIAT, V20, P300, DOI 10.1107/S0909049513001817; Rutishauser S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1950; Sato G, 2011, OPT LETT, V36, P3551, DOI 10.1364/OL.36.003551; Schorner K, 2012, IEEE T NUCL SCI, V59, P3278, DOI 10.1109/TNS.2012.2218127; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Wang HC, 2013, OPT LETT, V38, P827, DOI 10.1364/OL.38.000827; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wen H, 2008, IEEE T MED IMAGING, V27, P997, DOI 10.1109/TMI.2007.912393; Wen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078276; Wen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3659; Wen H, 2009, RADIOLOGY, V251, P910, DOI 10.1148/radiol.2521081903; Wen HH, 2010, OPT LETT, V35, P1932, DOI 10.1364/OL.35.001932; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zanette I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248102; Zhu L, 2006, IEEE T MED IMAGING, V25, P1573, DOI 10.1109/TMI.2006.884636	35	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87127	10.1371/journal.pone.0087127	http://dx.doi.org/10.1371/journal.pone.0087127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489853	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000110
J	Liu, T; Zhang, XY; He, XH; Geng, JS; Liu, Y; Kong, DJ; Shi, QY; Liu, F; Wei, W; Pang, D				Liu, Tong; Zhang, Xian-Yu; He, Xiao-Hui; Geng, Jing-Shu; Liu, Yang; Kong, De-Jia; Shi, Qing-Yu; Liu, Feng; Wei, Wei; Pang, Da			High Levels of BCOX1 Expression Are Associated with Poor Prognosis in Patients with Invasive Ductal Carcinomas of the Breast	PLOS ONE			English	Article							AFRICAN-AMERICAN; CANCER; PATTERNS; BIOLOGY; WOMEN; HER2	This study was to examine the breast cancer-overexpressed gene 1 (BCOX1) expression in invasive ductal carcinomas (IDC) of the breast and its value in the prognosis of the disease. The levels of BCOX1 expression in 491 paired IDC and surrounding non-tumor breast tissues as well as 40 paired fresh specimens were evaluated by tissue microarray, immunohistochemistry and quantitative RT-PCR. The potential associations of high BCOX1 expression with clinicopathological variables and the overall survival of these patients were analyzed. The relative levels of BCOX1 mRNA transcripts in the IDC breast tissues were significantly higher than that in the corresponding non-tumor tissues (P = 0.005). The anti-BCOX1 was predominantly stained in the cytoplasm of breast tissue cells and the levels of BCOX1 expression in the majority of breast cancer tissues were obviously higher than that in the corresponding non-tumor breast tissues. High levels of BCOX1 expression were found in 59.5% (292/491) of breast cancer tissues. The high BCOX1 expression was significantly associated with high histological grade (P = 0.037), positive expression of human epidermal growth factor receptor 2 (HER2, P = 0.031) and triple negative breast cancer (P = 0.027). The high BCOX1 expression in breast cancers was significantly associated with a shorter overall survival of these patients (P = 0.023), particularly in patients with triple negative breast cancer (P = 0.005). Therefore, the high BCOX1 expression may serve as a novel marker of poor prognosis and a potential therapeutic target for patients with IDC of the breast.	[Liu, Tong; Zhang, Xian-Yu; Liu, Yang; Kong, De-Jia; Shi, Qing-Yu; Liu, Feng; Wei, Wei; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [He, Xiao-Hui] Harbin Med Univ, Affiliated Hosp 3, Dept Med Records, Harbin, Peoples R China; [Geng, Jing-Shu] Harbin Med Univ, Affiliated Tumor Hosp, Dept Pathol, Harbin, Peoples R China; [Geng, Jing-Shu] Harbin Med Univ, Dept Med Genet, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China.	pangda@ems.hrbmu.edu.cn		LIU, TONG/0000-0001-9234-1328	Heilongjiang Provincial Finance Department [2011-14]	Heilongjiang Provincial Finance Department	This study was supported by the fund of Heilongjiang Provincial Finance Department(Da Pang, Grant no. 2011-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2007, ANN ONCOL, V18, P1904, DOI 10.1093/annonc/mdm487; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Ang KK, 2002, CANCER RES, V62, P7350; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Ma KK, 2012, ASIAN PAC J CANCER P, V13, P2109, DOI 10.7314/APJCP.2012.13.5.2109; Mishra DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057967; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Nagase T, 1995, DNA Res, V2, P51, DOI 10.1093/dnares/2.1.51; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song J, 2006, BBA-GEN SUBJECTS, V1760, P62, DOI 10.1016/j.bbagen.2005.09.017; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Yarden Y, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055396	16	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86952	10.1371/journal.pone.0086952	http://dx.doi.org/10.1371/journal.pone.0086952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489812	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000092
J	Liu, XF; Yang, WT; Xu, R; Liu, JT; Zheng, PS				Liu, Xiao-Fang; Yang, Wen-Ting; Xu, Rui; Liu, Jun-Tian; Zheng, Peng-Sheng			Cervical Cancer Cells with Positive Sox2 Expression Exhibit the Properties of Cancer Stem Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; PROSPECTIVE IDENTIFICATION; PANCREATIC-CANCER; PROSTATE-CANCER; DOWN-REGULATION; METASTASIS; CARCINOMA; SUBPOPULATION; LEUKEMIA	Background: Although Sox2 expression has been found in several types of cancer, it has not yet been used to identify or isolate CSCs in somatic carcinoma. Methods: SiHa and C33A cells stably transfected with a plasmid containing human Sox2 transcriptional elements driving the enhanced green fluorescent protein (EGFP) reporter were sorted into the Sox2-positive and the Sox2-negative populations by FACS, and Sox2 expression was detected by western blot and immunohistochemistry. The differentiation, self-renewal and tumor formation abilities, as well as the expression of the stemness and the EMT related genes of the Sox2-positive and the Sox2-negative cervical cancer cells were characterized in vitro and in vivo. Results: A pSox2/EGFP system was used to separate the Sox2-positive and the Sox2-negative cells from cervical cancer cell lines, SiHa and C33A cells. Compared with the Sox2-negative cells, the Sox2-positive SiHa and C33A cells exhibited greater capacities for self-renewal, differentiation and tumor formation. Furthermore, Sox2-positive SiHa and C33A cells expressed higher levels of stemness-related genes, such as Sox2/Bmi-1/Oct4/ALDH1, and EMT-related genes, such as vimentin/snail/beta-catenin. Taken together, all these results indicated that cells expressing endogenous Sox2 are CSCs in cervical carcinomas. Conclusion: This study is the first to establish a functional link between endogenous Sox2 expression and CSCs in cervical carcinomas. Additionally, this study demonstrated that it is feasible to develop a tool to isolate CSCs from somatic tumors based on the expression of the endogenous nuclear protein Sox2 instead of cell surface markers.	[Liu, Xiao-Fang; Yang, Wen-Ting; Xu, Rui; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China; [Liu, Xiao-Fang; Liu, Jun-Tian] Xi An Jiao Tong Univ, Dept Pharmacol, Sch Med, Xian 710049, Peoples R China; [Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Dept Biochem & Mol Biol, Sch Med, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Div Canc Stem Cell Res, Sch Med, Key Lab Environm & Genes Related Dis,Minist Educ, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [30571951]; special scientific Distinguished Young Scientists Fund grant [30725043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special scientific Distinguished Young Scientists Fund grant	This work was supported by a general grant from the National Natural Science Foundation of China to Prof. Peng-Sheng Zheng (No. 30571951), a special scientific Distinguished Young Scientists Fund grant (No. 30725043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Giakoumopoulos M, 2010, REPROD SCI, V17, P798, DOI 10.1177/1933719110371853; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Leis O, 2011, ONCOGENE; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Madka V, 2011, INDIAN J EXP BIOL, V49, P826; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sakashita Hiroyuki, 2007, Gan To Kagaku Ryoho, V34, P1721; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun SY, 2010, BIOCHEM BIOPH RES CO, V396, P843, DOI 10.1016/j.bbrc.2010.04.170; Tomuleasa C, 2011, J GASTROINTEST LIVER, V20, P443; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Xu R, 2013, HUM PATHOL, V44, P208, DOI 10.1016/j.humpath.2012.02.020; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856	35	76	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87092	10.1371/journal.pone.0087092	http://dx.doi.org/10.1371/journal.pone.0087092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489842	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000106
J	Lui, JLC; Chen, WP; Cheung, CSF; Baron, J				Lui, Julian C.; Chen, Weiping; Cheung, Crystal S. F.; Baron, Jeffrey			Broad Shifts in Gene Expression during Early Postnatal Life Are Associated with Shifts in Histone Methylation Patterns	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTOME ANALYSIS; CHROMATIN STATE; GENOME; DIFFERENTIATION; REVEALS; H3K4ME3; DISEASE; LISTS; CHIP	During early postnatal life, extensive changes in gene expression occur concomitantly in multiple major organs, indicating the existence of a common core developmental genetic program. This program includes hundreds of growth-promoting genes that are downregulated with age in liver, kidney, lung, and heart, and there is evidence that this component of the program drives the widespread decline in cell proliferation that occurs in juvenile life, as organs approach adult sizes. To investigate epigenetic changes that might orchestrate this program, we performed chromatin immunoprecipitation-promoter tiling array to assess temporal changes in histone H3K4 and H3K27 trimethylation (me3) at promoter regions throughout the genome in kidney and lung, comparing 1- to 4-wk-old mice. We found extensive genome-wide shifts in H3K4me3 and H3K27me3 occurring with age in both kidney and lung. The number of genes with concordant changes in the two organs was far greater than expected by chance. Temporal changes in H3K4me3 showed a strong, positive association with changes in gene expression, assessed by microarray, whereas changes in H3K27me3 showed a negative association. Gene ontology analysis indicated that shifts in specific histone methylation marks were associated with specific developmental functions. Of particular interest, genes with decreases in H3K4me3 with age in both organs were strongly implicated in cell cycle and cell proliferation functions. Taken together, the findings suggest that the common core developmental program of gene expression which occurs in multiple organs during juvenile life is associated with a common core developmental program of histone methylation. In particular, declining H3K4me3 is strongly associated with gene downregulation and occurs in the promoter regions of many growth-regulating genes, suggesting that this change in histone methylation may contribute to the component of the genetic program that drives juvenile body growth deceleration.	[Lui, Julian C.; Cheung, Crystal S. F.; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Microarray Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Lui, JLC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	luichunk@mail.nih.gov	Chen, Wei/GZK-7348-2022; Lui, Julian/E-2253-2012	Lui, Julian/0000-0002-0611-4901	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JI, 2004, DEV BIOL, V265, P491, DOI 10.1016/j.ydbio.2003.09.041; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Herlofsen SR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-105; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86957	10.1371/journal.pone.0086957	http://dx.doi.org/10.1371/journal.pone.0086957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489814	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000093
J	Bekrater-Bodmann, R; Foell, J; Diers, M; Kamping, S; Rance, M; Kirsch, P; Trojan, J; Fuchs, X; Bach, F; Cakmak, HK; Maass, H; Flor, H				Bekrater-Bodmann, Robin; Foell, Jens; Diers, Martin; Kamping, Sandra; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Bach, Felix; Cakmak, Hueseyin Kemal; Maass, Heiko; Flor, Herta			The Importance of Synchrony and Temporal Order of Visual and Tactile Input for Illusory Limb Ownership Experiences - An fMRI Study Applying Virtual Reality	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; VENTRAL PREMOTOR CORTEX; EXTRASTRIATE BODY AREA; RUBBER HAND ILLUSION; MULTISENSORY REPRESENTATION; SOMATOSENSORY HOMUNCULUS; ATTENTIONAL MODULATION; PERIPERSONAL SPACE; SELF-ATTRIBUTION; BRAIN	In the so-called rubber hand illusion, synchronous visuotactile stimulation of a visible rubber hand together with one's own hidden hand elicits ownership experiences for the artificial limb. Recently, advanced virtual reality setups were developed to induce a virtual hand illusion (VHI). Here, we present functional imaging data from a sample of 25 healthy participants using a new device to induce the VHI in the environment of a magnetic resonance imaging (MRI) system. In order to evaluate the neuronal robustness of the illusion, we varied the degree of synchrony between visual and tactile events in five steps: in two conditions, the tactile stimulation was applied prior to visual stimulation (asynchrony of -300 ms or -600 ms), whereas in another two conditions, the tactile stimulation was applied after visual stimulation (asynchrony of +300 ms or +600 ms). In the fifth condition, tactile and visual stimulation was applied synchronously. On a subjective level, the VHI was successfully induced by synchronous visuotactile stimulation. Asynchronies between visual and tactile input of +/- 300 ms did not significantly diminish the vividness of illusion, whereas asynchronies of +/- 600 ms did. The temporal order of visual and tactile stimulation had no effect on VHI vividness. Conjunction analyses of functional MRI data across all conditions revealed significant activation in bilateral ventral premotor cortex (PMv). Further characteristic activation patterns included bilateral activity in the motion-sensitive medial superior temporal area as well as in the bilateral Rolandic operculum, suggesting their involvement in the processing of bodily awareness through the integration of visual and tactile events. A comparison of the VHI-inducing conditions with asynchronous control conditions of +/- 600 ms yielded significant PMv activity only contralateral to the stimulation site. These results underline the temporal limits of the induction of limb ownership related to multisensory body-related input.	[Bekrater-Bodmann, Robin; Foell, Jens; Diers, Martin; Kamping, Sandra; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Flor, Herta] Heidelberg Univ, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Mannheim, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Trojan, Joerg] Univ Koblenz Landau, Dept Psychol, Landau, Germany; [Bach, Felix; Cakmak, Hueseyin Kemal; Maass, Heiko] Karlsruhe Inst Technol, Inst Appl Comp Sci, Eggenstein Leopoldshafen, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; State University System of Florida; Florida State University; University of Koblenz & Landau; Helmholtz Association; Karlsruhe Institute of Technology	Flor, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Mannheim, Germany.	herta.flor@zi-mannheim.de	Fuchs, Xaver/HCI-1160-2022; Diers, Martin/M-9155-2013; Trojan, Jörg/C-1616-2009; Çakmak, Hüseyin Kemâl/G-1507-2018; Bach, Felix/AAR-4792-2020	Diers, Martin/0000-0002-3257-7299; Trojan, Jörg/0000-0003-4110-2647; Çakmak, Hüseyin Kemâl/0000-0002-1463-7606; Bach, Felix/0000-0002-5035-7978; Kamping, Sandra/0000-0001-5389-0455; Flor, Herta/0000-0003-4809-5398	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project; European Community [230249]; Deutsche Forschungsgemeinschaft [KFO 256, FL 156/35-1]	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project; European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the 'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)' project, which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249 (http://erc.europa.eu/) awarded to HF, as well as the clinical research unit KFO 256 'Mechanisms of disturbed emotion processing in borderline personality disorder' funded by the Deutsche Forschungsgemeinschaft (FL 156/35-1) (http://www.dfg.de/en/research_funding/programmes/coordinated_programmes/clinical_research_units/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bach F, 2012, BIOMED ENG-BIOMED TE, V57, P718, DOI 10.1515/bmt-2012-4084; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Cakmak H, 2005, MINIM INVASIV THER, V14, P134, DOI 10.1080/13645700510033958; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Huk AC, 2002, J NEUROSCI, V22, P7195; Inoue K, 2001, NEUROIMAGE, V14, P1469, DOI 10.1006/nimg.2001.0942; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kida T, 2007, J NEUROPHYSIOL, V97, P3585, DOI 10.1152/jn.00007.2007; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Limanowski J, 2013, NEUROIMAGE, DOI [10.1016/j.neuro-image.2013.10.035, DOI 10.1016/J.NEUR0-IMAGE.2013.10.035.]; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Macaluso E, 2002, CEREB CORTEX, V12, P357, DOI 10.1093/cercor/12.4.357; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Meehan SK, 2009, HUM BRAIN MAPP, V30, P484, DOI 10.1002/hbm.20520; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Rhee T, 2006, COMPUT GRAPH FORUM, V25, P439, DOI 10.1111/j.1467-8659.2006.00963.x; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; Schaefer M, 2007, NEUROIMAGE, V36, P700, DOI 10.1016/j.neuroimage.2007.03.046; Schaefer M, 2009, HUM BRAIN MAPP, V30, P1413, DOI 10.1002/hbm.20609; Schubotz RI, 2004, J NEUROSCI, V24, P5467, DOI 10.1523/JNEUROSCI.1169-04.2004; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Shimada S, 2010, EXP BRAIN RES, V201, P359, DOI 10.1007/s00221-009-2028-6; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Tal N, 2009, EXP BRAIN RES, V198, P165, DOI 10.1007/s00221-009-1949-4; Tipper SP, 2001, EXP BRAIN RES, V139, P160, DOI 10.1007/s002210100743; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Weber O, 2007, COMPUT GRAPH FORUM, V26, P265, DOI 10.1111/j.1467-8659.2007.01048.x; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	63	50	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87013	10.1371/journal.pone.0087013	http://dx.doi.org/10.1371/journal.pone.0087013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498012	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900058
J	Helvik, AS; Skancke, RH; Selbaek, G; Engedal, K				Helvik, Anne-Sofie; Skancke, Randi Helene; Selbaek, Geir; Engedal, Knut			Nursing Home Admission during the First Year after Hospitalization - The Contribution of Cognitive Impairment	PLOS ONE			English	Article							MINI-MENTAL-STATE; OLDER-PEOPLE; PREDICTORS; DEMENTIA; CARE; PREVALENCE; CRITERIA; POPULATION; PLACEMENT; SYMPTOMS	Objective: The importance of cognitive and physical functioning for nursing home admission among medically hospitalized older patients is rarely studied in a one-year follow-up perspective. This study aims to explore the association between patient characteristics and nursing home admission within one year after hospitalization in persons 65 years or more. Design: A one-year longitudinal study. Methods: We included 463 (234 women) persons aged 65 years or more from internal medical wards in a rural area of Norway. Cognitive function was assessed using the Mini Mental State Examination; physical and instrumental functional status was assessed using the physical self-maintenance scale and instrumental activities of daily living scale of Lawton and Brody. Comorbidity was measured with the Charlson index. Admission to nursing home within one year (yes versus no) was analyzed using logistic regression analysis and Cox proportional hazard regression analysis. Results: The mean age of the sample was 80.5 (SD 7.4) years, mean Mini Mental State Examination score was 24.1 (SD 3.8) (maximum score is 30). In adjusted analysis participants with cognitive impairment (a Mini Mental State Examination score,25) or impaired physical functioning at baseline had higher risk of admission to nursing home within one year (OR 3.0, 95% CI 1.5-6.2 and OR 3.5, 95% CI 1.8-9.6, respectively). The time before admission was also associated with cognitive impairment and impaired physical functioning in the adjusted analysis (HR 2.6 95% CI 1.4-4.8 and HR 3.7, 95% CI 1.5-8.9, respectively). Conclusion: Impaired cognitive and physical functioning increased the risk for nursing home admission within one year after hospitalization. However, putative regressors, such as education and social network were not included in the analysis.	[Helvik, Anne-Sofie; Skancke, Randi Helene] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Helvik, Anne-Sofie] St Olavs Univ Hosp, Trondheim, Norway; [Helvik, Anne-Sofie; Skancke, Randi Helene] Innlandet Hosp Trust, Div Tynset, Tynset, Norway; [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway; [Selbaek, Geir] Akershus Univ Hosp, Lorenskog, Norway; [Selbaek, Geir; Engedal, Knut] Oslo Univ Hosp, Norwegian Ctr Dementia Res, Ullevaal, Norway; [Engedal, Knut] Univ Oslo, Fac Med, Oslo, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Innlandet Hospital Trust; Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo	Helvik, AS (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	Anne-Sofie.Helvik@ntnu.no		Selbaek, Geir/0000-0001-6511-8219	Norwegian Ministry of Health and Care Services; Innlandet Hospital Trust	Norwegian Ministry of Health and Care Services; Innlandet Hospital Trust	The research was funded by collaboration between the Norwegian Ministry of Health and Care Services, and Innlandet Hospital Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg W, 1999, Tijdschr Gerontol Geriatr, V30, P264; Alladi S, 2006, PSYCHOL MED, V36, P507, DOI 10.1017/S0033291705006744; Bilotta C, 2009, HEALTH SOC CARE COMM, V17, P543, DOI 10.1111/j.1365-2524.2009.00853.x; Brevik I, 2010, NEW HOME CARE SERVIC; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; De Saint-Hubert M, 2010, J NUTR HEALTH AGING, V14, P394, DOI 10.1007/s12603-010-0086-x; Drame M, 2011, J NUTR HEALTH AGING, V15, P399, DOI 10.1007/s12603-011-0004-x; Eaker ED, 2002, J CLIN EPIDEMIOL, V55, P462, DOI 10.1016/S0895-4356(01)00498-X; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Engedal K, 1988, Compr Gerontol A, V2, P87; Fjaertoft H, 2005, CEREBROVASC DIS, V19, P376, DOI 10.1159/000085543; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fullerton CA, 2009, PSYCHIAT SERV, V60, P965, DOI 10.1176/appi.ps.60.7.965; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Harris Y, 2006, J AM GERIATR SOC, V54, P593, DOI 10.1111/j.1532-5415.2006.00687.x; Helvik AS, 2011, NORD J PSYCHIAT, V65, P338, DOI 10.3109/08039488.2011.560684; Helvik AS, 2010, AGING MENT HEALTH, V14, P861, DOI 10.1080/13607861003801003; Helvik AS, 2010, INT J GERIATR PSYCH, V25, P150, DOI 10.1002/gps.2312; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Hirdes JP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-9; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HUNT, 2009, HLTH STUD NORD TROND; Inouye SK, 2006, J GEN INTERN MED, V21, P1276, DOI 10.1111/j.1525-1497.2006.00613.x; Kirkevold O, 2004, SCAND J CARING SCI, V18, P281, DOI 10.1111/j.1471-6712.2004.00278.x; Kivela S L, 1985, Scand J Prim Health Care, V3, P39, DOI 10.3109/02813438509017736; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; McCusker J, 2002, J GERONTOL A-BIOL, V57, pM569, DOI 10.1093/gerona/57.9.M569; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; Mora Fernandez Jesus, 2009, Rev Esp Geriatr Gerontol, V44, P186, DOI 10.1016/j.regg.2009.03.008; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nygaard H A, 2000, Tidsskr Nor Laegeforen, V120, P3113; NYGAARD H A, 1992, Scandinavian Journal of Primary Health Care, V10, P128, DOI 10.3109/02813439209014049; Portegijs E, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.04.003; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Romoren T, 1999, PATIENTS RESIDENTS N; RUBENSTEIN LZ, 1986, HEALTH SERV RES, V20, P881; RUBENSTEIN LZ, 1984, J AM GERIATR SOC, V32, P503, DOI 10.1111/j.1532-5415.1984.tb02235.x; Satish S, 1996, J AM GERIATR SOC, V44, P914, DOI 10.1111/j.1532-5415.1996.tb01860.x; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Smith GE, 2001, NEUROLOGY, V57, P1467, DOI 10.1212/WNL.57.8.1467; Snaith RP., 1994, HOSP ANXIETY DEPRESS; Sorbye LW, 2010, J MULTIDISCIP HEALTH, V3, P11; Thygesen E, 2009, INT J OLDER PEOPLE N, V4, P12, DOI 10.1111/j.1748-3743.2008.00132.x; Tropea J, 2008, AUSTRALAS J AGEING, V27, P150, DOI 10.1111/j.1741-6612.2008.00301.x; Tsai ACH, 2011, ARCH GERONTOL GERIAT, V53, P298, DOI 10.1016/j.archger.2010.12.003; Tuokko H, 2000, CLIN NEUROPSYCHOL, V14, P504, DOI 10.1076/clin.14.4.504.7200; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Wilson RS, 2012, NEUROLOGY, V78, P950, DOI 10.1212/WNL.0b013e31824d5894; WINOGRAD CH, 1991, J AM GERIATR SOC, V39, P778, DOI 10.1111/j.1532-5415.1991.tb02700.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86116	10.1371/journal.pone.0086116	http://dx.doi.org/10.1371/journal.pone.0086116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497936	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900016
J	Hensley, PJ; Desiniotis, A; Wang, C; Stromberg, A; Chen, CS; Kyprianou, N				Hensley, Patrick J.; Desiniotis, Andreas; Wang, Chi; Stromberg, Arnold; Chen, Ching-Shih; Kyprianou, Natasha			Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; ANOIKIS; PROGRESSION; EXPRESSION; DOXAZOSIN; APOPTOSIS; METASTASIS; INTEGRINS	Cancer cell resistance to anoikis driven by aberrant signaling sustained by the tumor microenvironment confers high invasive potential and therapeutic resistance. We recently generated a novel lead quinazoline-based Doxazosin (R) derivative, DZ-50, which impairs tumor growth and metastasis via anoikis. Genome-wide analysis in the human prostate cancer cell line DU-145 identified primary downregulated targets of DZ-50, including genes involved in focal adhesion integrity (fibronectin, integrin-alpha 6 and talin), tight junction formation (claudin-11) as well as insulin growth factor binding protein 3 (IGFBP-3) and the angiogenesis modulator thrombospondin 1 (TSP-1). Confocal microscopy demonstrated structural disruption of both focal adhesions and tight junctions by the downregulation of these gene targets, resulting in decreased cell survival, migration and adhesion to extracellular matrix (ECM) components in two androgen-independent human prostate cancer cell lines, PC-3 and DU-145. Stabilization of cell-ECM interactions by overexpression of talin-1 and/or exposing cells to a fibronectin-rich environment mitigated the effect of DZ-50. Loss of expression of the intracellular focal adhesion signaling effectors talin-1 and integrin linked kinase (ILK) sensitized human prostate cancer to anoikis. Our findings suggest that DZ-50 exerts its antitumor effect by targeting the key functional intercellular interactions, focal adhesions and tight junctions, supporting the therapeutic significance of this agent for the treatment of advanced prostate cancer.	[Hensley, Patrick J.; Desiniotis, Andreas; Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Urol, Lexington, KY 40536 USA; [Hensley, Patrick J.; Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Pathol, Lexington, KY USA; [Wang, Chi] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA; [Stromberg, Arnold] Univ Kentucky, Dept Stat, Lexington, KY USA; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY USA; [Kyprianou, Natasha] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University System of Ohio; Ohio State University; University of Kentucky; University of Kentucky	Kyprianou, N (corresponding author), Univ Kentucky, Coll Med, Dept Urol, Lexington, KY 40536 USA.	nkypr2@email.uky.edu		Hensley, Patrick/0000-0002-8098-901X	National Institutes of Health [R01-GRANT00491815]; National Center for Research Resources; National Center for Advancing Translational Sciences [UL1RR033173]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health, R01-GRANT00491815 and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, UL1RR033173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chon JK, 1999, J UROLOGY, V161, P2002, DOI 10.1016/S0022-5347(05)68873-8; Desiniotis A, 2011, INT REV CEL MOL BIO, V289, P117, DOI 10.1016/B978-0-12-386039-2.00004-3; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Fanning AS, 2007, MOL BIOL CELL, V18, P721, DOI 10.1091/mbc.E06-08-0764; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Garrison JB, 2007, CANCER RES, V67, P11344, DOI 10.1158/0008-5472.CAN-07-1662; Garrison JB, 2006, CANCER RES, V66, P464, DOI 10.1158/0008-5472.CAN-05-2039; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Hall CL, 2006, CANCER RES, V66, P8648, DOI 10.1158/0008-5472.CAN-06-1544; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kyprianou N, 2003, J UROLOGY, V169, P1520, DOI 10.1097/01.ju.0000033280.29453.72; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Logothetis CJ, 2013, CANCER DISCOV, V3, P849, DOI 10.1158/2159-8290.CD-12-0460; MacVicar GR, 2013, CURR OPIN ONCOL, V25, P252, DOI 10.1097/CCO.0b013e32835ff161; Matuszak EA, 2011, EXPERT REV ENDOCRINO, V6, P469, DOI 10.1586/EEM.11.32; Miloszewska J, 2013, CELL PROLIFERAT, V46, P146, DOI 10.1111/cpr.12015; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Park SH, 2013, APOPTOSIS, V18, P949, DOI 10.1007/s10495-013-0847-1; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Sakamoto S, 2011, EUR UROL, V59, P734, DOI 10.1016/j.eururo.2010.12.038; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Shaw YJ, 2004, J MED CHEM, V47, P4453, DOI 10.1021/jm049752k; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh AB, 2012, CARCINOGENESIS, V33, P2538, DOI 10.1093/carcin/bgs275; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	40	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86238	10.1371/journal.pone.0086238	http://dx.doi.org/10.1371/journal.pone.0086238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497940	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900019
J	Liu, CP; Tsuda, Y; Shen, HL; Hu, LJ; Saito, Y; Ide, Y				Liu, Chunping; Tsuda, Yoshiaki; Shen, Hailong; Hu, Lijiang; Saito, Yoko; Ide, Yuji			Genetic Structure and Hierarchical Population Divergence History of Acer mono var. mono in South and Northeast China	PLOS ONE			English	Article							MICROSATELLITE MARKERS; EVOLUTIONARY PROCESSES; FRAXINUS-MANDSHURICA; DIVERSITY; FOREST; TREE; NUCLEAR; CONSERVATION; DIFFERENTIATION; PHYLOGEOGRAPHY	Knowledge of the genetic structure and evolutionary history of tree species across their ranges is essential for the development of effective conservation and forest management strategies. Acer mono var. mono, an economically and ecologically important maple species, is extensively distributed in Northeast China (NE), whereas it has a scattered and patchy distribution in South China (SC). In this study, the genetic structure and demographic history of 56 natural populations of A. mono var. mono were evaluated using seven nuclear microsatellite markers. Neighbor-joining tree and STRUCTURE analysis clearly separated populations into NE and SC groups with two admixed-like populations. Allelic richness significantly decreased with increasing latitude within the NE group while both allelic richness and expected heterozygosity showed significant positive correlation with latitude within the SC group. Especially in the NE region, previous studies in Quercus mongolica and Fraxinus mandshurica have also detected reductions in genetic diversity with increases in latitude, suggesting this pattern may be common for tree species in this region, probably due to expansion from single refugium following the last glacial maximum (LGM). Approximate Bayesian Computation-based analysis revealed two major features of hierarchical population divergence in the species' evolutionary history. Recent divergence between the NE group and the admixed-like group corresponded to the LGM period and ancient divergence of SC groups took place during mid-late Pleistocene period. The level of genetic differentiation was moderate (F-ST = 0.073; G(ST)' = 0.278) among all populations, but significantly higher in the SC group than the NE group, mirroring the species' more scattered distribution in SC. Conservation measures for this species are proposed, taking into account the genetic structure and past demographic history identified in this study.	[Liu, Chunping; Shen, Hailong; Hu, Lijiang] Northeast Forestry Univ, State Key Lab Forest Genet & Breeding, Harbin, Heilongjiang Pr, Peoples R China; [Liu, Chunping; Saito, Yoko; Ide, Yuji] Univ Tokyo, Lab Forest Ecosyst Studies, Dept Ecosyst Studies, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tsuda, Yoshiaki] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Program Plant Ecol & Evolut, Uppsala, Sweden	Northeast Forestry University - China; University of Tokyo; Uppsala University	Shen, HL (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China.	shenhl-cf@nefu.edu.cn			Heilongjiang Provincial Key Technologies R D Program [GA09B202-06]; Support Plan for Distinguished Researchers in Northeast Forestry University, China	Heilongjiang Provincial Key Technologies R D Program; Support Plan for Distinguished Researchers in Northeast Forestry University, China	This study was partially supported by Heilongjiang Provincial Key Technologies R & D Program (GA09B202-06) and by the Special Funding from the Support Plan for Distinguished Researchers in Northeast Forestry University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Baucom RS, 2005, CONSERV GENET, V6, P39, DOI 10.1007/s10592-004-7718-9; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Buiteveld J, 2007, FOREST ECOL MANAG, V247, P98, DOI 10.1016/j.foreco.2007.04.018; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dong SL, 1985, B BOT RES, V5, P97; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Escudero A, 2003, BIOL CONSERV, V113, P351, DOI 10.1016/S0006-3207(03)00122-8; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; FRANKEL OH, 1974, GENETICS, V78, P53; Fu LG, 1992, CHINA PLANT RED DATA, V1, P385; Geburek T, 1997, BIODIVERS CONSERV, V6, P1639, DOI 10.1023/A:1018330906758; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heuertz M, 2004, EVOLUTION, V58, P976; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hsu T., 1992, GUIHAIA, V12, P229; Hsu T, 1988, RESOURCE DEV MARKET, V4, P51; Hu LJ, 2008, ANN BOT-LONDON, V102, P195, DOI 10.1093/aob/mcn074; Hu LJ, 2010, CONSERV GENET, V11, P77, DOI 10.1007/s10592-009-0004-0; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kikuchi S, 2008, MOL ECOL RESOUR, V8, P339, DOI 10.1111/j.1471-8286.2007.01948.x; Kikuchi S, 2009, PLANT ECOL, V204, P43, DOI 10.1007/s11258-008-9564-1; Langella O., 2007, POPULATIONS 1 2 30 P; Lascoux M, 2008, PLANT ECOL DIVERS, V1, P209, DOI 10.1080/17550870802328439; Li WenYing, 2003, Scientia Silvae Sinicae, V39, P29; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Lin NF, 1999, QUATERNARY SCI, V5, P448; Liu Jian-feng, 2005, Forest Research, V18, P222; Logossa ZA, 2011, MOL ECOL, V20, P4009, DOI 10.1111/j.1365-294X.2011.05249.x; Lu ZX, 2006, PLANT SCI, V170, P407, DOI 10.1016/j.plantsci.2005.09.009; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Matsui K, 2010, PLANT SPEC BIOL, V6, P117; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mu Li-Qiang, 2007, Zhiwu Shengtai Xuebao, V31, P1190; Naydenov KD, 2011, NEW FOREST, V42, P179, DOI 10.1007/s11056-010-9245-5; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Pandey M, 2004, MOL ECOL NOTES, V4, P253, DOI 10.1111/j.1471-8286.2004.00633.x; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; Peakall R, 2007, GEN ANAL EXCEL POPU; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Satake G, 1993, WILD FLOWERS JAPAN W; Segarra-Moragues JG, 2008, CONSERV GENET, V9, P1059, DOI 10.1007/s10592-007-9451-7; Shibata M, 2009, ECOL RES, V24, P1, DOI 10.1007/s11284-008-0474-4; *SPSS INC, 2004, SPSS WIND REL 13 0 S; Steinitz O, 2012, MOL ECOL, V21, P300, DOI 10.1111/j.1365-294X.2011.05394.x; Terui H, 2006, MOL ECOL NOTES, V6, P77, DOI 10.1111/j.1471-8286.2005.01144.x; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; Xia Ming, 2001, Scientia Silvae Sinicae, V37, P126; [薛祥煦 Xue Xiangxu], 2004, [第四纪研究, Quaternary Sciences], V24, P82; [薛祥煦 Xue Xiangxu], 2002, [西北大学学报. 自然科学版, Journal of Northwest University], V32, P451; Yan ZhiFeng, 2006, Biodiversity Science, V14, P488, DOI 10.1360/biodiv.060041; Yu G, 1998, J BIOGEOGR, V25, P1055, DOI 10.1046/j.1365-2699.1998.00237.x; Zhang Jie, 2007, Shengwu Duoyangxing, V15, P292, DOI 10.1360/biodiv.060133; Zhang YQ, 2003, J GEOMECH, V4, P313; Zheng W, 2004, SYLVA SINICA, V4, P4258; Zhu JJ, 2007, J FOREST RES-JPN, V12, P403, DOI 10.1007/s10310-007-0033-9	78	32	35	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87187	10.1371/journal.pone.0087187	http://dx.doi.org/10.1371/journal.pone.0087187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498039	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900075
J	Revermann, M; Neofitidou, S; Kirschning, T; Schloss, M; Brandes, RP; Hofstetter, C				Revermann, Marc; Neofitidou, Skevi; Kirschning, Thomas; Schloss, Manuel; Brandes, Ralf P.; Hofstetter, Christian			Inhalation of the BKCa-Opener NS1619 Attenuates Right Ventricular Pressure and Improves Oxygenation in the Rat Monocrotaline Model of Pulmonary Hypertension	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; DEPENDENT POTASSIUM CHANNELS; ARTERIAL SMOOTH-MUSCLE; GROWTH-FACTOR EXPRESSION; CELL-PROLIFERATION; PROTEIN-KINASE; NITRIC-OXIDE; MITOCHONDRIAL-MEMBRANE; INHIBITION; VASODILATORS	Background: Right heart failure is a fatal consequence of chronic pulmonary hypertension (PH). The development of PH is characterized by increased proliferation of vascular cells, in particular pulmonary artery smooth muscle cells (PASMCs) and pulmonary artery endothelial cells. In the course of PH, an escalated right ventricular (RV) afterload occurs, which leads to increased perioperative morbidity and mortality. BKCa channels are ubiquitously expressed in vascular smooth muscle cells and their opening induces cell membrane hyperpolarization followed by vasodilation. Moreover, BK activation induces anti-proliferative effects in a multitude of cell types. On this basis, we hypothesized that treatment with the nebulized BK channel opener NS1619 might be a therapy option for pulmonary hypertension and tested this in rats. Methods: (1) Rats received monocrotaline injection for PH induction. Twenty-four days later, rats were anesthetized and NS1619 or the solvent was administered by inhalation. Systemic hemodynamic parameters, RV hemodynamic parameters, and blood gas analyses were measured before as well as 30 and 120 minutes after inhalation. (2) Rat PASMCs were stimulated with PDGF-BB in the presence and absence of NS1619. AKT, ERK1 and ERK2 activation were investigated by western blot analyses, and relative cell number was determined 48 hours after stimulation. Results: Inhalation of a 12 mu M and 100 mu M NS1619 solution significantly reduced RV pressure without affecting systemic arterial pressure. Blood gas analyses demonstrated significantly reduced carbon dioxide and improved oxygenation in NS1619-treated animals pointing towards a considerable pulmonary shunt-reducing effect. In PASMC's, NS1619 (100 mu M) significantly attenuated PASMC proliferation by a pathway independent of AKT and ERK1/2 activation. Conclusion: NS1619 inhalation reduces RV pressure and improves oxygen supply and its application inhibits PASMC proliferation in vitro. Hence, BK opening might be a novel option for the treatment of pulmonary hypertension.	[Revermann, Marc; Neofitidou, Skevi; Kirschning, Thomas; Hofstetter, Christian] Heidelberg Univ, Dept Anesthesiol & Crit Care Med, Univ Hosp Mannheim, Fac Med, Heidelberg, Germany; [Revermann, Marc; Schloss, Manuel; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Cardiovasc Physiol, Fac Med, D-60054 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Revermann, M (corresponding author), Heidelberg Univ, Dept Anesthesiol & Crit Care Med, Univ Hosp Mannheim, Fac Med, Heidelberg, Germany.	marc.revermann@umm.de	Brandes, Ralf P/L-3058-2017	Brandes, Ralf P/0000-0002-8035-0048	Medical Faculty of Mannheim; Medical Faculty of Frankfurt; B. Braun foundation	Medical Faculty of Mannheim; Medical Faculty of Frankfurt; B. Braun foundation	The Medical Faculties of Mannheim and Frankfurt and the B. Braun foundation supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda M, 1999, ANESTH ANALG, V89, P152, DOI 10.1097/00000539-199907000-00027; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bae YM, 1999, J PHYSIOL-LONDON, V514, P747, DOI 10.1111/j.1469-7793.1999.747ad.x; Barman SA, 2003, AM J PHYSIOL-LUNG C, V284, pL1004, DOI 10.1152/ajplung.00295.2002; BARNES PJ, 1995, PHARMACOL REV, V47, P87; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Bonnet S, 2003, CARDIOVASC RES, V60, P326, DOI 10.1016/S0008-6363(03)00527-3; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; BOWRING NE, 1993, BRIT J PHARMACOL, V109, P1133, DOI 10.1111/j.1476-5381.1993.tb13740.x; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Carlino C, 2010, AM J MED SCI, V339, P55, DOI 10.1097/MAJ.0b013e3181c078d7; Chang H, 2011, J CELL PHYSIOL, V226, P1660, DOI 10.1002/jcp.22497; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Costa RSA, 2005, NITRIC OXIDE-BIOL CH, V13, P145, DOI 10.1016/j.niox.2005.05.010; Cui B, 2009, CLIN EXP PHARMACOL P, V36, P169, DOI 10.1111/j.1440-1681.2008.05044.x; Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC; Dick GM, 2010, EXP BIOL MED, V235, P10, DOI 10.1258/ebm.2009.009201; Dimitropoulou C, 2005, AM J RESP CELL MOL, V32, P239, DOI 10.1165/rcmb.2004-0331OC; EDWARDS G, 1994, BRIT J PHARMACOL, V113, P1538, DOI 10.1111/j.1476-5381.1994.tb17171.x; Falcao-Pires I, 2009, AM J PHYSIOL-HEART C, V296, pH2007, DOI 10.1152/ajpheart.00089.2009; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Humbert M, 1998, EUR RESPIR J, V11, P554; Krick S, 2001, AM J PHYSIOL-LUNG C, V281, pL887, DOI 10.1152/ajplung.2001.281.4.L887; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002; Nagaoka T, 2005, AM J RESP CRIT CARE, V171, P494, DOI 10.1164/rccm.200405-637OC; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Revermann M, 2009, J HYPERTENS, V27, P322, DOI 10.1097/HJH.0b013e32831aedfa; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Tuder RM, 2009, J AM COLL CARDIOL, V54, pS3, DOI 10.1016/j.jacc.2009.04.009; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001; Yun J, 2010, SKIN PHARMACOL PHYS, V23, P91, DOI 10.1159/000265680; Zhao YJ, 1998, EXP LUNG RES, V24, P71, DOI 10.3109/01902149809046055	46	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86636	10.1371/journal.pone.0086636	http://dx.doi.org/10.1371/journal.pone.0086636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497961	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900030
J	Agroskin, D; Klackl, J; Jonas, E				Agroskin, Dmitrij; Klackl, Johannes; Jonas, Eva			The Self-Liking Brain: A VBM Study on the Structural Substrate of Self-Esteem	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; MAJOR DEPRESSIVE DISORDER; EMOTION REGULATION; MATTER VOLUME; HIPPOCAMPAL VOLUME; SOCIAL-BEHAVIOR; NEURAL BASES; STRESS; ANXIETY; GRAY	Abundant evidence suggests that self-esteem is an important personality resource for emotion regulation in response to stressful experiences. It was thus hypothesized that the relative grey matter volume of brain regions involved in responding to and coping with stress is related to individual differences in trait self-esteem. Using structural magnetic resonance imaging of 48 healthy adults in conjunction with voxel-based morphometry and diffeomorphic anatomical registration using exponentiated lie algebra (VBM-DARTEL), positive associations between self-esteem and regional grey matter volume were indeed found in the anterior cingulate cortex (ACC), right lateral prefrontal cortex (LPFC), right hippocampus, and left hypothalamus. In addition, self-esteem positively covaried with grey matter volume in the right temporo-parietal junction (TPJ), which has been implicated in pride and theory of mind. The results suggest that persons with low self-esteem have reduced grey matter volume in brain regions that contribute to emotion/stress regulation, pride, and theory of mind. The findings provide novel neuroanatomical evidence for the view that self-esteem constitutes a vital coping resource.	[Agroskin, Dmitrij; Klackl, Johannes; Jonas, Eva] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria	Salzburg University	Agroskin, D (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.	dmitrij.agroskin@sbg.ac.at	Jonas, Eva/B-1500-2017; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018	Jonas, Eva/0000-0003-1016-3076; Klackl, Johannes/0000-0003-2619-4715	Doctoral College "Imaging the Mind"; Austrian Science Fund [FWF-W1233]	Doctoral College "Imaging the Mind"; Austrian Science Fund(Austrian Science Fund (FWF))	This research was supported by the Doctoral College "Imaging the Mind," funded by the Austrian Science Fund (FWF-W1233) (http://www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2010, VBM TUTORIAL; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baroncini M, 2012, NEUROIMAGE, V59, P168, DOI 10.1016/j.neuroimage.2011.07.013; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bielau H, 2005, EUR ARCH PSY CLIN N, V255, P401, DOI 10.1007/s00406-005-0581-y; Blair RJR, 2010, CURR PSYCHIAT REP, V12, P76, DOI 10.1007/s11920-009-0086-x; Blairy S, 2004, J AFFECT DISORDERS, V79, P97, DOI 10.1016/S0165-0327(02)00347-6; Blascovich J., 1991, MEAS PERSONALITY SOC, VVolume 1, P115, DOI DOI 10.1002/JTS.20680; Bradley R, 2005, J TRAUMA STRESS, V18, P685, DOI 10.1002/jts.20077; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Brooks JO, 2009, PSYCHIAT RES-NEUROIM, V172, P200, DOI 10.1016/j.pscychresns.2008.06.007; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cahill KR, 2007, SOC DEV, V16, P45, DOI 10.1111/j.1467-9507.2007.00371.x; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Collani G., 2003, Z DIFFERENTIELLE DIA, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Creswell JD, 2005, PSYCHOL SCI, V16, P846, DOI 10.1111/j.1467-9280.2005.01624.x; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; Donnellan MB, 2005, PSYCHOL SCI, V16, P328, DOI 10.1111/j.0956-7976.2005.01535.x; Dori GA, 1999, SUICIDE LIFE-THREAT, V29, P309; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fava GA, 2001, J AFFECT DISORDERS, V65, P185, DOI 10.1016/S0165-0327(00)00267-6; Ferring D, 1996, DIAGNOSTICA, V42, P284; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Giuliani NR, 2011, BIOL PSYCHOL, V86, P379, DOI 10.1016/j.biopsycho.2010.11.010; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hadland KA, 2003, NEUROPSYCHOLOGIA, V41, P919, DOI 10.1016/S0028-3932(02)00325-1; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Klackl J, 2014, SOC COGN AFFECT NEUR, V9, P1754, DOI 10.1093/scan/nst167; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; Kuhn S, 2012, J AFFECT DISORDERS, V141, P352, DOI 10.1016/j.jad.2012.03.024; Kuster F, 2012, PERS SOC PSYCHOL B, V38, P747, DOI 10.1177/0146167212437250; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leary MR, 2003, HANDBOOK OF SELF AND IDENTITY, P401; Levesque J, 2004, NEUROSCIENCE, V129, P361, DOI 10.1016/j.neuroscience.2004.07.032; Lewis PA, 2011, NEUROIMAGE, V57, P1624, DOI 10.1016/j.neuroimage.2011.05.030; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lochhead RA, 2004, BIOL PSYCHIAT, V55, P1154, DOI 10.1016/j.biopsych.2004.02.026; Lopez-Larson MP, 2002, BIOL PSYCHIAT, V52, P93, DOI 10.1016/S0006-3223(02)01350-1; LORR M, 1988, J CLIN PSYCHOL, V44, P36, DOI 10.1002/1097-4679(198801)44:1<36::AID-JCLP2270440107>3.0.CO;2-B; Mak AKY, 2009, PROG NEURO-PSYCHOPH, V33, P1184, DOI 10.1016/j.pnpbp.2009.06.025; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marenco S, 2010, NEUROPSYCHOPHARMACOL, V35, P1708, DOI 10.1038/npp.2010.35; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Merali Z, 2004, J NEUROSCI, V24, P1478, DOI 10.1523/JNEUROSCI.4734-03.2004; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mundy P, 2003, J CHILD PSYCHOL PSYC, V44, P793, DOI 10.1111/1469-7610.00165; Neiss MB, 2009, J PERS, V77, P327, DOI 10.1111/j.1467-6494.2008.00549.x; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OCHSNER KN, 2006, SOCIAL NEUROSCIENCE, P245; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Ridgway GR, GET TOTALS; Roberts JE, 1996, J PERS SOC PSYCHOL, V70, P310, DOI 10.1037/0022-3514.70.2.310; Romeo RD, 2010, ENCYCLOPEDIA OF BEHAVIORAL NEUROSCIENCE, VOL 3: P-Z, P304; Rosenberg M., 1979, CONCEIVING SELF; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Sapolsky R., 2007, HDB EMOTION REGULATI, P606; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R., HDB COGNITIVE NEUROS; Saxe R, 2010, RIGHT TEMPORO PARIET; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Silverstone Peter H, 2003, Ann Gen Hosp Psychiatry, V2, P2, DOI 10.1186/1475-2832-2-2; SILVERSTONE PH, 1991, BRIT J CLIN PSYCHOL, V30, P185, DOI 10.1111/j.2044-8260.1991.tb00936.x; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Takahashi H, 2008, CEREB CORTEX, V18, P898, DOI 10.1093/cercor/bhm120; Taylor SE, 2003, J PERS SOC PSYCHOL, V85, P605, DOI 10.1037/0022-3514.85.4.605; Taylor SE, 2003, J PERS SOC PSYCHOL, V84, P165, DOI 10.1037//0022-3514.84.1.165; Taylor SE, 2008, J PERS SOC PSYCHOL, V95, P197, DOI 10.1037/0022-3514.95.1.197; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Marle HJF, 2010, NEUROIMAGE, V53, P348, DOI 10.1016/j.neuroimage.2010.05.070; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x	108	24	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86430	10.1371/journal.pone.0086430	http://dx.doi.org/10.1371/journal.pone.0086430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489727	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000040
J	Brenneman, KE; Willingham, C; Kilbourne, JA; Curtiss, R; Roland, KL				Brenneman, Karen E.; Willingham, Crystal; Kilbourne, Jacquelyn A.; Curtiss, Roy, III; Roland, Kenneth L.			A Low Gastric pH Mouse Model to Evaluate Live Attenuated Bacterial Vaccines	PLOS ONE			English	Article							ACID TOLERANCE RESPONSE; ORAL TYPHOID VACCINE; ENTERICA SEROVAR TYPHIMURIUM; PROBIOTIC ESCHERICHIA-COLI; CONTROLLED FIELD TRIAL; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; ANTIGEN-EXPRESSION; SHIGELLA-FLEXNERI; IMMUNE-RESPONSE	The low pH of the stomach serves as a barrier to ingested microbes and must be overcome or bypassed when delivering live bacteria for vaccine or probiotic applications. Typically, the impact of stomach acidity on bacterial survival is evaluated in vitro, as there are no small animal models to evaluate these effects in vivo. To better understand the effect of this low pH barrier to live attenuated Salmonella vaccines, which are often very sensitive to low pH, we investigated the value of the histamine mouse model for this application. A low pH gastric compartment was transiently induced in mice by the injection of histamine. This resulted in a gastric compartment of approximately pH 1.5 that was capable of distinguishing between acid-sensitive and acid-resistant microbes. Survival of enteric microbes during gastric transit in this model directly correlated with their in vitro acid resistance. Because many Salmonella enterica serotype Typhi vaccine strains are sensitive to acid, we have been investigating systems to enhance the acid resistance of these bacteria. Using the histamine mouse model, we demonstrate that the in vivo survival of S. Typhi vaccine strains increased approximately 10-fold when they carried a sugar-inducible arginine decarboxylase system. We conclude that this model will be a useful for evaluating live bacterial preparations prior to clinical trials.	[Brenneman, Karen E.; Willingham, Crystal; Kilbourne, Jacquelyn A.; Curtiss, Roy, III; Roland, Kenneth L.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Curtiss, Roy, III] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Roland, KL (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	kenneth.roland@asu.edu			National Institutes of Health [AI092307, R01 AI60557-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557, R01AI093348, R21AI092307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the R21 grant AI092307 from the National Institutes of Health (http://www.nih.gov). The authors would like to acknowledge additional funding support from grant R01 AI60557-08 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini B, 2010, EUR J PHARM SCI, V40, P359, DOI 10.1016/j.ejps.2010.04.011; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Berk PA, 2005, J APPL MICROBIOL, V99, P859, DOI 10.1111/j.1365-2672.2005.02658.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bhagwat AA, 2005, INFECT IMMUN, V73, P4993, DOI 10.1128/IAI.73.8.4993-5003.2005; Bhagwat AA, 2004, FEMS MICROBIOL LETT, V234, P139, DOI [10.1111/j.1574-6968.2004.tb09525.x, 10.1016/j.femsle.2004.03.020]; BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BLACK R, 1982, DEV BIOLOGICALS, V53, P9; Borza AD, 2010, J MICROENCAPSUL, V27, P387, DOI 10.3109/02652040903367293; Brenneman KE, 2013, J BACTERIOL, V195, P3062, DOI 10.1128/JB.00104-13; BUTTERTON JR, 1995, INFECT IMMUN, V63, P2689, DOI 10.1128/IAI.63.7.2689-2696.1995; Casalino M, 2010, INT J MED MICROBIOL, V300, P289, DOI 10.1016/j.ijmm.2009.10.008; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; CURTISS R, 1991, COLONIZATION CONTROL, P169; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; Durant JA, 2000, J FOOD PROTECT, V63, P573, DOI 10.4315/0362-028X-63.5.573; Erdem AL, 2007, J BACTERIOL, V189, P7426, DOI 10.1128/JB.00464-07; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; FORMAL SB, 1958, J BACTERIOL, V75, P604, DOI 10.1128/JB.75.5.604-610.1958; Foster JW, 1999, CURR OPIN MICROBIOL, V2, P170, DOI 10.1016/S1369-5274(99)80030-7; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Furutani K, 2003, J PHARMACOL EXP THER, V307, P331, DOI 10.1124/jpet.103.052019; Gahan ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006062; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; HONE DM, 1994, VACCINE, V12, P895, DOI 10.1016/0264-410X(94)90031-0; HOWDEN CW, 1987, GUT, V28, P96, DOI 10.1136/gut.28.1.96; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Kirkpatrick BD, 2005, J INFECT DIS, V192, P360, DOI 10.1086/431605; KOELZ HR, 1992, SCAND J GASTROENTERO, V27, P2, DOI 10.3109/00365529209095998; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; LEE IS, 1995, MOL MICROBIOL, V17, P155; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1990, LANCET, V336, P891; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Nguyen NV, 2004, GASTROENTEROLOGY, V127, P145, DOI 10.1053/j.gastro.2004.04.016; NWOKOLO CU, 1994, EUR J GASTROEN HEPAT, V6, P697, DOI 10.1097/00042737-199408000-00009; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Robbe-Saule V, 1999, FEMS MICROBIOL LETT, V170, P141, DOI 10.1111/j.1574-6968.1999.tb13366.x; Russell DW S. J., 2001, MOL CLONING LAB MANU; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; Tennant SM, 2008, INFECT IMMUN, V76, P639, DOI 10.1128/IAI.01138-07; Tiwari RP, 2004, J BASIC MICROB, V44, P137, DOI 10.1002/jobm.200310333; VERDU E, 1994, GUT, V35, P455, DOI 10.1136/gut.35.4.455; Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAHDAN MH, 1980, B WORLD HEALTH ORGAN, V58, P469; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Waterman SR, 1996, INFECT IMMUN, V64, P2808, DOI 10.1128/IAI.64.7.2808-2811.1996; WilmesRiesenberg MR, 1997, INFECT IMMUN, V65, P203, DOI 10.1128/IAI.65.1.203-210.1997; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]; ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402	71	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87411	10.1371/journal.pone.0087411	http://dx.doi.org/10.1371/journal.pone.0087411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489912	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000143
J	Degtyarev, M; Reichelt, M; Lin, K				Degtyarev, Michael; Reichelt, Mike; Lin, Kui			Novel Quantitative Autophagy Analysis by Organelle Flow Cytometry after Cell Sonication	PLOS ONE			English	Article							SUBCELLULAR FRACTIONATION; RAT-LIVER; PROTEIN; DEGRADATION; VACUOLES; IDENTIFICATION; COMPARTMENTS; GUIDELINES; INHIBITOR; ASSAYS	Autophagy is a dynamic process of bulk degradation of cellular proteins and organelles in lysosomes. Current methods of autophagy measurement include microscopy-based counting of autophagic vacuoles (AVs) in cells. We have developed a novel method to quantitatively analyze individual AVs using flow cytometry. This method, OFACS (organelle flow after cell sonication), takes advantage of efficient cell disruption with a brief sonication, generating cell homogenates with fluorescently labeled AVs that retain their integrity as confirmed with light and electron microscopy analysis. These AVs could be detected directly in the sonicated cell homogenates on a flow cytometer as a distinct population of expected organelle size on a cytometry plot. Treatment of cells with inhibitors of autophagic flux, such as chloroquine or lysosomal protease inhibitors, increased the number of particles in this population under autophagy inducing conditions, while inhibition of autophagy induction with 3-methyladenine or knockdown of ATG proteins prevented this accumulation. This assay can be easily performed in a high-throughput format and opens up previously unexplored avenues for autophagy analysis.	[Degtyarev, Michael; Lin, Kui] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Reichelt, Mike] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Lin, K (corresponding author), Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA.	klin@gene.com			Genentech, Inc; Roche group	Genentech, Inc(Roche HoldingGenentech); Roche group	This study was funded by Genentech, Inc., a member of the Roche group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Degtyarev M, 2009, AUTOPHAGY, V5, P415, DOI 10.4161/auto.5.3.7827; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Gauthier DJ, 2008, EXPERT REV PROTEOMIC, V5, P603, DOI 10.1586/14789450.5.4.603; GLAUMANN H, 1986, EXP CELL RES, V163, P151, DOI 10.1016/0014-4827(86)90567-7; GRAY RH, 1981, EXP MOL PATHOL, V34, P72, DOI 10.1016/0014-4800(81)90037-X; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; MURPHY RF, 1985, P NATL ACAD SCI USA, V82, P8523, DOI 10.1073/pnas.82.24.8523; Paglin S, 2001, CANCER RES, V61, P439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rajotte D, 2003, CYTOM PART A, V55A, P94, DOI 10.1002/cyto.a.10065; Seglen PO, 1996, ADV EXP MED BIOL, V389, P103; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Silva R, 2011, BIOMACROMOLECULES, V12, P3353, DOI 10.1021/bm200658b; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; WILSON RB, 1989, METHOD CELL BIOL, V31, P293	33	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87707	10.1371/journal.pone.0087707	http://dx.doi.org/10.1371/journal.pone.0087707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489953	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000173
J	Inoue, M; Kuroda, T; Honda, A; Komabayashi-Suzuki, M; Komai, T; Shinkai, Y; Mizutani, KI				Inoue, Mayuko; Kuroda, Takao; Honda, Aya; Komabayashi-Suzuki, Mariko; Komai, Tae; Shinkai, Yoichi; Mizutani, Ken-ichi			Prdm8 Regulates the Morphological Transition at Multipolar Phase during Neocortical Development	PLOS ONE			English	Article							INTERMEDIATE PROGENITOR CELLS; RADIAL NEURONAL MIGRATION; BIPOLAR TRANSITION; SUBVENTRICULAR ZONE; GUIDANCE CUES; STEM-CELLS; EXPRESSION; GLIA; NEUROGENESIS; INTEGRATION	Here, we found that the PR domain protein Prdm8 serves as a key regulator of the length of the multipolar phase by controlling the timing of morphological transition. We used a mouse line with expression of Prdm8-mVenus reporter and found that Prdm8 is predominantly expressed in the middle and upper intermediate zone during both the late and terminal multipolar phases. Prdm8 expression was almost coincident with Unc5D expression, a marker for the late multipolar phase, although the expression of Unc5D was found to be gradually down-regulated to the point at which mVenus expression was gradually up-regulated. This expression pattern suggests the possible involvement of Prdm8 in the control of the late and terminal multipolar phases, which controls the timing for morphological transition. To test this hypothesis, we performed gain-and loss-of-function analysis of neocortical development by using in utero electroporation. We found that the knockdown of Prdm8 results in premature change from multipolar to bipolar morphology, whereas the overexpression of Prdm8 maintained the multipolar morphology. Additionally, the postnatal analysis showed that the Prdm8 knockdown stimulated the number of early born neurons, and differentiated neurons located more deeply in the neocortex, however, majority of those cells could not acquire molecular features consistent with laminar location. Furthermore, we found the candidate genes that were predominantly utilized in both the late and terminal multipolar phases, and these candidate genes included those encoding for guidance molecules. In addition, we also found that the expression level of these guidance molecules was inhibited by the introduction of the Prdm8 expression vector. These results indicate that the Prdm8-mediated regulation of morphological changes that normally occur during the late and terminal multipolar phases plays an important role in neocortical development.	[Inoue, Mayuko; Kuroda, Takao; Honda, Aya; Komabayashi-Suzuki, Mariko; Mizutani, Ken-ichi] Doshisha Univ, Lab Neural Differentiat, Grad Sch Brain Sci, Kyoto 602, Japan; [Inoue, Mayuko; Komai, Tae] Kyoto Univ, Dept Mol & Cellular Biol, Grad Sch Biostudies, Kyoto, Japan; [Shinkai, Yoichi] RIKEN, Cellular Memory Lab, Saitama, Japan; [Mizutani, Ken-ichi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan	Doshisha University; Kyoto University; RIKEN; Japan Science & Technology Agency (JST)	Mizutani, KI (corresponding author), Doshisha Univ, Lab Neural Differentiat, Grad Sch Brain Sci, Kyoto 602, Japan.	kmizutan@mail.doshisha.ac.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	JST, PRESTO "Development and Function of Neural Networks"; MEXT of Japan	JST, PRESTO "Development and Function of Neural Networks"; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by JST, PRESTO "Development and Function of Neural Networks", and a Grant-in-Aid for Scientific Research on Innovative Areas "Neurovascular" from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub AE, 2011, P NATL ACAD SCI USA, V108, P14950, DOI 10.1073/pnas.1112213108; Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Cameron DA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-90; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Diez-Rouz G, 2008, PLOS BIOL, V9; DOBYNS WB, 1995, NEUROPEDIATRICS, V26, P132, DOI 10.1055/s-2007-979744; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Evsyukova I, 2013, ANNU REV CELL DEV BI, V29, P299, DOI 10.1146/annurev-cellbio-101512-122400; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hinck L, 2004, DEV CELL, V7, P783, DOI 10.1016/j.devcel.2004.11.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; Jossin Y, 2011, NAT NEUROSCI, V79, P1123; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karaulanov E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005742; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Komai T, 2009, GENE EXPR PATTERNS, V9, P503, DOI 10.1016/j.gep.2009.07.005; Li QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065703; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Melani M, 2010, ANNU REV CELL DEV BI, V26, P639, DOI 10.1146/annurev.cellbio.093008.093324; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oeschger FM, 2012, CEREB CORTEX, V22, P1343, DOI 10.1093/cercor/bhr197; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Ohtaka-Maruyama C, 2012, NEUROSCIENCE, V201, P67, DOI 10.1016/j.neuroscience.2011.11.006; Ohtaka-Maruyama C, 2013, CELL REP, V3, P458, DOI 10.1016/j.celrep.2013.01.012; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Ross SE, 2012, NEURON, V73, P292, DOI 10.1016/j.neuron.2011.09.035; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Sicca F, 2003, NEUROLOGY, V61, P1042, DOI 10.1212/WNL.61.8.1042; Stanco A, 2009, P NATL ACAD SCI USA, V106, P7595, DOI 10.1073/pnas.0811343106; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Sun YM, 2010, J BIOL CHEM, V285, P39039, DOI 10.1074/jbc.M110.168351; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2009, CEREB CORTEX, V19, P2092, DOI 10.1093/cercor/bhn227; Takemoto M, 2011, CEREB CORTEX, V21, P1925, DOI 10.1093/cercor/bhq265; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Torii M, 2009, NATURE, V461, P524, DOI 10.1038/nature08362; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189	57	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86356	10.1371/journal.pone.0086356	http://dx.doi.org/10.1371/journal.pone.0086356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489718	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000034
J	Killick, E; Tymrakiewicz, M; Cieza-Borrella, C; Smith, P; Thompson, DJ; Pooley, KA; Easton, DF; Bancroft, E; Page, E; Leongamornlert, D; Kote-Jarai, Z; Eeles, RA				Killick, Emma; Tymrakiewicz, Malgorzata; Cieza-Borrella, Clara; Smith, Paula; Thompson, Deborah J.; Pooley, Karen A.; Easton, Doug F.; Bancroft, Elizabeth; Page, Elizabeth; Leongamornlert, Daniel; Kote-Jarai, Zsofia; Eeles, Rosalind A.		IMPACT Collaborators	Telomere Length Shows No Association with BRCA1 and BRCA2 Mutation Status	PLOS ONE			English	Article							BREAST-CANCER RISK; CIGARETTE-SMOKING; CELLS; DNA; SURVIVAL; CARRIERS; DISEASE; BLOOD; WOMEN	This study aimed to determine whether telomere length (TL) is a marker of cancer risk or genetic status amongst two cohorts of BRCA1 and BRCA2 mutation carriers and controls. The first group was a prospective set of 665 male BRCA1/2 mutation carriers and controls (mean age 53 years), all healthy at time of enrolment and blood donation, 21 of whom have developed prostate cancer whilst on study. The second group consisted of 283 female BRCA1/2 mutation carriers and controls (mean age 48 years), half of whom had been diagnosed with breast cancer prior to enrolment. TL was quantified by qPCR from DNA extracted from peripheral blood lymphocytes. Weighted and unweighted Cox regressions and linear regression analyses were used to assess whether TL was associated with BRCA1/2 mutation status or cancer risk. We found no evidence for association between developing cancer or being a BRCA1 or BRCA2 mutation carrier and telomere length. It is the first study investigating TL in a cohort of genetically predisposed males and although TL and BRCA status was previously studied in females our results don't support the previous finding of association between hereditary breast cancer and shorter TL.	[Killick, Emma] Univ Hosp Southampton NHS Fdn Trust, Div Med Oncol, Southampton, Hants, England; [Killick, Emma; Tymrakiewicz, Malgorzata; Page, Elizabeth; Leongamornlert, Daniel; Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, Surrey, England; [Cieza-Borrella, Clara] Univ Salamanca, Unidad Med Mol, E-37008 Salamanca, Spain; [Smith, Paula; Thompson, Deborah J.; Pooley, Karen A.; Easton, Doug F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Cambridge, England; [Bancroft, Elizabeth] Royal Marsden Hosp NHS Trust, London, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Salamanca; University of Cambridge; Royal Marsden NHS Foundation Trust	Killick, E (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Div Med Oncol, Southampton, Hants, England.	emma.killick@uhs.nhs.uk	Valdagni, Riccardo/K-1361-2016; Thong, Meow-Keong/B-9960-2010; Foulkes, William D./AAR-9586-2021; Kiemeney, Lambertus A./D-3357-2009; Amor, David J/A-6478-2018; Nicolai, Nicola/D-1091-2017; Tischkowitz, Marc/O-4452-2018; balmaña, judith/AAH-1908-2019; Evans, D Gareth/AAB-4308-2022; Blanco, Ignacio/AAN-5426-2021; Petelin, Lara/I-3954-2015	Valdagni, Riccardo/0000-0001-5140-9728; Thong, Meow-Keong/0000-0002-7288-7910; Foulkes, William D./0000-0001-7427-4651; Kiemeney, Lambertus A./0000-0002-2368-1326; Amor, David J/0000-0001-7191-8511; Nicolai, Nicola/0000-0002-5718-2699; Tischkowitz, Marc/0000-0002-7880-0628; Evans, D Gareth/0000-0002-8482-5784; Blanco, Ignacio/0000-0002-7414-7481; Osther, Palle Jorn Sloth/0000-0001-7962-1640; Cornford, Philip/0000-0002-7146-9258; Leongamornlert, Daniel/0000-0002-3486-3168; Cieza-Borrella, Clara/0000-0003-2739-1040; catto, james/0000-0003-2787-8828; Balmana, Judith/0000-0002-0762-6415; Bancroft, Elizabeth/0000-0002-5482-5660; Skytte, Anne-Bine/0000-0002-0067-9557; Gerdes, Anne-Marie/0000-0002-0328-3320; McGaughran, Julie/0000-0002-0926-7858; Petelin, Lara/0000-0003-3245-8895; Eeles, Rosalind/0000-0002-3698-6241	Annabel Evans Memorial Fund; CRUK [C5047/A13232, C5047/A15007]; NIHR; Ronald and Rita McAulay foundation; Cancer Research UK [15007, 10118, 13232, 11022, 16563] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER	Annabel Evans Memorial Fund; CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); Ronald and Rita McAulay foundation; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding from the Annabel Evans Memorial Fund, CRUK (grant numbers C5047/A13232 and C5047/A15007), NIHR support to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust and the Ronald and Rita McAulay foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodvarsdottir SK, 2012, MUTAT RES-FUND MOL M, V729, P90, DOI 10.1016/j.mrfmmm.2011.10.002; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Diker-Cohen T, 2013, LEUK LYMPHOMA; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Guinan EM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-138; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu H, 2010, J CANCER RES CLIN, V136, P1407, DOI 10.1007/s00432-010-0795-x; Killick E, 2012, CLIN ONCOL R COLL RA; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Maeda T, 2012, INT J RAD BIOL; Martinez-Delgado B, 2012, J MED GENET, V49, P341, DOI 10.1136/jmedgenet-2012-100807; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Min J, 2012, J BIOL CHEM, V287, P5091, DOI 10.1074/jbc.M111.278994; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Murillo-Ortiz B, 2012, AGING MALE, V15, P54, DOI 10.3109/13685538.2011.593658; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005	32	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86659	10.1371/journal.pone.0086659	http://dx.doi.org/10.1371/journal.pone.0086659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489760	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330570000054
J	Kinung'hi, SM; Magnussen, P; Kaatano, GM; Kishamawe, C; Vennervald, BJ				Kinung'hi, Safari M.; Magnussen, Pascal; Kaatano, Godfrey M.; Kishamawe, Coleman; Vennervald, Birgitte J.			Malaria and Helminth Co-Infections in School and Preschool Children: A Cross-Sectional Study in Magu District, North-Western Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SCHISTOSOMA-MANSONI INFECTION; HOOKWORM INFECTION; KENYAN SCHOOLCHILDREN; URINARY SCHISTOSOMIASIS; PARASITIC INFECTIONS; PANGANI DISTRICT; PREGNANT-WOMEN; MWERA DIVISION; EAST-AFRICA	Background: Malaria, schistosomiasis and soil transmitted helminth infections (STH) are important parasitic infections in Sub-Saharan Africa where a significant proportion of people are exposed to co-infections of more than one parasite. In Tanzania, these infections are a major public health problem particularly in school and pre-school children. The current study investigated malaria and helminth co-infections and anaemia in school and pre-school children in Magu district, Tanzania. Methodology: School and pre-school children were enrolled in a cross-sectional study. Stool samples were examined for Schistosoma mansoni and STH infections using Kato Katz technique. Urine samples were examined for Schistosoma haematobium using the urine filtration method. Blood samples were examined for malaria parasites and haemoglobin concentrations using the Giemsa stain and Haemoque methods, respectively. Principal Findings: Out of 1,546 children examined, 1,079 (69.8%) were infected with one or more parasites. Malaria-helminth co-infections were observed in 276 children (60% of all children with P. falciparum infection). Malaria parasites were significantly more prevalent in hookworm infected children than in hookworm free children (p = 0.046). However, this association was non-significant on multivariate logistic regression analysis (OR = 1.320, p = 0.064). Malaria parasite density decreased with increasing infection intensity of S. mansoni and with increasing number of co-infecting helminth species. Anaemia prevalence was 34.4% and was significantly associated with malaria infection, S. haematobium infection and with multiple parasite infections. Whereas S. mansoni infection was a significant predictor of malaria parasite density, P. falciparum and S. haematobium infections were significant predictors of anaemia. Conclusions/Significance: These findings suggest that multiple parasite infections are common in school and pre-school children in Magu district. Concurrent P. falciparum, S. mansoni and S. haematobium infections increase the risk of lower Hb levels and anaemia, which in turn calls for integrated disease control interventions. The associations between malaria and helminth infections detected in this study need further investigation.	[Kinung'hi, Safari M.; Kaatano, Godfrey M.; Kishamawe, Coleman] Mwanza Ctr, NIMR, Mwanza, Tanzania; [Magnussen, Pascal; Vennervald, Birgitte J.] Univ Copenhagen, DBL Ctr Hlth Res & Dev, Dept Vet Dis Biol, Copenhagen, Denmark	National Institute of Medical Research; University of Copenhagen	Kinung'hi, SM (corresponding author), Mwanza Ctr, NIMR, Mwanza, Tanzania.	kinunghi_csm@hotmail.com		Vennervald, Birgitte/0000-0001-5721-3494; Magnussen, Pascal/0000-0001-7372-0250	Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark	Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark	Financial support for this study was provided by the Danish Development Assistance (DANIDA) through the DBL-Centre for Heath Research and Development, Faculty of Life Sciences, University of Copenhagen and Denmark, and formed part of PhD training for SMK. The funding agency (DANIDA) had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ajanga A, 2006, T ROY SOC TROP MED H, V100, P59, DOI 10.1016/j.trstmh.2005.06.024; Archie CAC, 2006, TROP MED INT HEALTH, V4, P490; Bhargava Alok, 2003, Food and Nutrition Bulletin, V24, P332; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; Booth M, 2004, T ROY SOC TROP MED H, V98, P125, DOI 10.1016/S0035-9203(03)00018-X; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2000, E AFR MED J, V77, P157; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Bustinduy AL, 2013, AM J TROP MED HYG, P12; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Egwunyenga AO, 2001, MEM I OSWALDO CRUZ, V96, P1055, DOI 10.1590/S0074-02762001000800005; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Helmby H, 2007, TRENDS PARASITOL, V23, P88, DOI 10.1016/j.pt.2007.01.001; Hillier SD, 2008, J INFECT DIS, V198, P920, DOI 10.1086/591183; Hopkins DR, 2008, ANN NY ACAD SCI, V1136, P45, DOI 10.1196/annals.1425.015; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Howard SC, 2002, ACTA TROP, V83, P141, DOI 10.1016/S0001-706X(02)00093-1; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Kabatereine NB, 2004, T ROY SOC TROP MED H, V98, P711, DOI 10.1016/j.trstmh.2004.06.003; Keiser J, 2002, J PARASITOL, V88, P461, DOI 10.2307/3285432; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Lwambo NJS, 1999, T ROY SOC TROP MED H, V93, P497, DOI 10.1016/S0035-9203(99)90349-8; LWAMBO NJS, 1992, EPIDEMIOL INFECT, V108, P469, DOI 10.1017/S0950268800049980; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Magnussen P, 2002, ANN TROP MED PARASIT, V96, P843, DOI 10.1179/000349802125002329; Magnussen P, 2001, T ROY SOC TROP MED H, V95, P58, DOI 10.1016/S0035-9203(01)90333-5; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Mboera LE, 2001, AFR J HLTH SCI, V8, P14; Mboera LEG, 2004, TANZANIA HLTH RES B, V6, P11; MCCULLOUGH FS, 1972, TROP GEOGR MED, V24, P199; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Mwatha JK, 2003, J INFECT DIS, V187, P1337, DOI 10.1086/368362; Nacher M, 2001, AM J TROP MED HYG, V65, P644, DOI 10.4269/ajtmh.2001.65.644; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Naus CWA, 2003, J INFECT DIS, V187, P1272, DOI 10.1086/368361; NBS (National Bureau of Statistics), 2002, POP HOUS CENS; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; Olsen A, 1998, T ROY SOC TROP MED H, V92, P643, DOI 10.1016/S0035-9203(98)90795-7; Petney Trevor N., 1998, International Journal for Parasitology, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Pierrot C, 2006, INFECT IMMUN, V74, P3347, DOI 10.1128/IAI.01724-05; Pradhan P, 2009, J VECTOR DIS, V46, P100; Rugemalila JB, 1991, HLTH DIS TANZANIA, P144; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; STEPHENSON LS, 1993, J NUTR, V123, P1036; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Tchuem Tchuente LA, 2003, TROP MED INT HEALTH, V8, P975, DOI 10.1046/j.1360-2276.2003.01120.x; Tshikuka JG, 1996, ANN TROP MED PARASIT, V90, P277, DOI 10.1080/00034983.1996.11813053; Warrell DA, 2002, ESSENTIAL MALARIOLOG, V4th, P236; WEBBE G, 1962, B WORLD HEALTH ORGAN, V27, P59; Wilson S, 2007, TROP MED INT HEALTH, V12, P1442, DOI 10.1111/j.1365-3156.2007.01950.x; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT; Yatich NJ, 2009, AM J TROP MED HYG, V80, P896, DOI 10.4269/ajtmh.2009.80.896	66	52	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86510	10.1371/journal.pone.0086510	http://dx.doi.org/10.1371/journal.pone.0086510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489732	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000042
J	Rentsch, C; Bebu, I; Guest, JL; Rimland, D; Agan, BK; Marconi, V				Rentsch, Christopher; Bebu, Ionut; Guest, Jodie L.; Rimland, David; Agan, Brian K.; Marconi, Vincent			Combining Epidemiologic and Biostatistical Tools to Enhance Variable Selection in HIV Cohort Analyses	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; AIC MODEL SELECTION; AKAIKE INFORMATION CRITERION; INFERENCE; SURVIVAL; ACCESS	Background: Variable selection is an important step in building a multivariate regression model for which several methods and statistical packages are available. A comprehensive approach for variable selection in complex multivariate regression analyses within HIV cohorts is explored by utilizing both epidemiological and biostatistical procedures. Methods: Three different methods for variable selection were illustrated in a study comparing survival time between subjects in the Department of Defense's National History Study and the Atlanta Veterans Affairs Medical Center's HIV Atlanta VA Cohort Study. The first two methods were stepwise selection procedures, based either on significance tests (Score test), or on information theory (Akaike Information Criterion), while the third method employed a Bayesian argument (Bayesian Model Averaging). Results: All three methods resulted in a similar parsimonious survival model. Three of the covariates previously used in the multivariate model were not included in the final model suggested by the three approaches. When comparing the parsimonious model to the previously published model, there was evidence of less variance in the main survival estimates. Conclusions: The variable selection approaches considered in this study allowed building a model based on significance tests, on an information criterion, and on averaging models using their posterior probabilities. A parsimonious model that balanced these three approaches was found to provide a better fit than the previously reported model.	[Rentsch, Christopher; Guest, Jodie L.; Rimland, David; Marconi, Vincent] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Guest, Jodie L.; Rimland, David; Marconi, Vincent] Emory Univ, Sch Med, Atlanta, GA USA; [Guest, Jodie L.; Marconi, Vincent] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Bebu, Ionut; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Emory University; Rollins School Public Health; Uniformed Services University of the Health Sciences - USA	Marconi, V (corresponding author), Atlanta Vet Affairs Med Ctr, Decatur, GA USA.	vcmarco@emory.edu	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Rentsch, Christopher/0000-0002-1408-7907; Guest, Jodie/0000-0002-3650-3975; Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program (IDCRP) [IDCRP-000-24]; Department of Defense program through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; Emory University's Center for AIDS Research [CFAR P30-AI50409]; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP); Department of Defense program through the Uniformed Services University of the Health Sciences(United States Department of Defense); National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory University's Center for AIDS Research; IDCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by [IDCRP-000-24] the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement [Y1-AI-5072]. The content of this publication is the sole responsibility of the authors and does not necessarily reflect the views or policies of the NIH, Department of Health and Human Services, Department of Defense, Department of Veterans Affairs, or the departments of the Army, Navy, or Air Force. Mention of trade names, or commercial products, or organizations does not imply endorsement by the U. S. Government. This collaboration is funded by a grant from Emory University's Center for AIDS Research [CFAR P30-AI50409] and by the IDCRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Breslow NE, 1980, STAT METHODS CANC RE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; DALES LG, 1978, INT J EPIDEMIOL, V7, P373, DOI 10.1093/ije/7.4.373; FURNIVAL GM, 1974, TECHNOMETRICS, V16, P499, DOI 10.2307/1267601; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GREENLAND S, 1980, INT J EPIDEMIOL, V9, P361, DOI 10.1093/ije/9.4.361; Guest JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062273; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Johnson BR., 1997, EDUCATION, V118, P282, DOI DOI 10.1016/J.CEDPSYCH.2016.09.005; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; KLEINBAUM DG, 1982, COMMUN STAT A-THEOR, V11, P485, DOI 10.1080/03610928208828251; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lehmann E, 2009, ELEMENTS LARGE SAMPL; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; REGAL RR, 1991, STAT MED, V10, P717, DOI 10.1002/sim.4780100506; ROBINS JM, 1986, AM J EPIDEMIOL, V123, P392, DOI 10.1093/oxfordjournals.aje.a114254; ROTHMAN KJ, 1977, CANCER, V39, P1771, DOI 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; SAS Institute Inc, 2012, SAS GUID PERS COMP; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Therneau T.M., 2000, MODELING SURVIVAL DA; Volinsky CT, 1997, J R STAT SOC C-APPL, V46, P433, DOI 10.1111/1467-9876.00082; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weintrob AC, 2009, JAIDS-J ACQ IMM DEF, V52, P574, DOI 10.1097/QAI.0b013e3181b98537	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87352	10.1371/journal.pone.0087352	http://dx.doi.org/10.1371/journal.pone.0087352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489902	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000330570000136
J	Smith, T; Quesnel, F; De Ploeg, G; De Franceschi, D; Metais, G; De Bast, E; Sole, F; Folie, A; Boura, A; Claude, J; Dupuis, C; Gagnaison, C; Iakovleva, A; Martin, J; Maubert, F; Prieur, J; Roche, E; Storme, JY; Thomas, R; Tong, H; Yans, J; Buffetaut, E				Smith, Thierry; Quesnel, Florence; De Ploeeg, Gael; De Franceschi, Dario; Metais, Gregoire; De Bast, Eric; Sole, Floreal; Folie, Annelise; Boura, Anais; Claude, Julien; Dupuis, Christian; Gagnaison, Cyril; Iakovleva, Alina; Martin, Jeremy; Maubert, Francois; Prieur, Judicael; Roche, Emile; Storme, Jean-Yves; Thomas, Romain; Tong, Haiyan; Yans, Johan; Buffetaut, Eric			First Clarkforkian Equivalent Land Mammal Age in the Latest Paleocene Basal Sparnacian Facies of Europe: Fauna, Flora, Paleoenvironment and (Bio)stratigraphy	PLOS ONE			English	Article							EARLIEST EOCENE; MIDDLE EOCENE; EARLY PALEOGENE; ORGANIC-CARBON; MORPHOLOGY; VERTEBRATES; EVOLUTION; EXCURSION; BOUNDARY; SECTION	The Paleocene-Eocene Thermal Maximum (PETM) is correlated with the first occurrences of earliest modern mammals in the Northern Hemisphere. The latest Paleocene Clarkforkian North American Land Mammal Age, that has yielded rodents and carnivorans, is the only exception to this rule. However, until now no pre-PETM localities have yielded modern mammals in Europe or Asia. We report the first Clarkforkian equivalent Land Mammal Age in the latest Paleocene deposits of the basal Sparnacian facies at Rivecourt, in the north-central part of the Paris Basin. The new terrestrial vertebrate and macroflora assemblages are analyzed through a multidisciplinary study including sedimentologic, stratigraphic, isotopic, and palynological aspects in order to reconstruct the paleoenvironment and to evaluate biochronologic and paleogeographic implications. The mammals are moderately diverse and not abundant, contrary to turtles and champsosaurs. The macroflora is exceptional in preservation and diversity with numerous angiosperms represented by flowers, fruits, seeds and wood preserved as lignite material, revealing an abundance of Arecaceae, Betulaceae, Icacinaceae, Menispermaceae, Vitaceae and probably Cornaceae. Results indicate a Late Paleocene age based on carbon isotope data, palynology and vertebrate occurrences such as the choristoderan Champsosaurus, the arctocyonid Arctocyon, and the plesiadapid Plesiadapis tricuspidens. However, several mammal species compare better with the earliest Eocene. Among these, the particular louisinid Teilhardimys musculus, also recorded from the latest Paleocene of the Spanish Pyrenees, suggests a younger age than the typical MP6 reference level. Nevertheless, the most important aspect of the Rivecourt fauna is the presence of dental remains of a rodent and a "miacid" carnivoran, attesting to the presence of two modern mammalian orders in the latest Paleocene of Europe. Interestingly, these two groups are also the only modern groups recorded from the latest Paleocene of North America, making Rivecourt the first direct equivalent to the Clarkforkian Land Mammal Age outside of North America.	[Smith, Thierry; De Bast, Eric; Sole, Floreal; Folie, Annelise] Inst Royal Sci Nat Belg, Direct Operat Terre & Hist Vie, Brussels, Belgium; [Quesnel, Florence] Univ Orleans, CNRS, BRGM, DGR GAT,Bur Rech Geol & Minieres French Geol Surv, Orleans, France; [De Ploeeg, Gael; Prieur, Judicael] Ctr Permanent Initiat Environm Pays Oise, Verberie, France; [De Franceschi, Dario; Metais, Gregoire; Boura, Anais; Thomas, Romain] CNRS MNHN UPMC, Ctr Rech Paleobiodiversite & Paleoenvironm, Museum Natl Hist Nat, Paris, France; [De Franceschi, Dario; Metais, Gregoire; Boura, Anais; Thomas, Romain] Univ Paris 06, Paris, France; [Claude, Julien] Univ Montpellier 2, Inst Sci Evolut Montpellier, F-34059 Montpellier, France; [Dupuis, Christian] Univ Mons, Geol GFA, Fac Polytech, B-7000 Mons, Belgium; [Gagnaison, Cyril] Inst Polytech LaSalle Beauvais, Beauvais, France; [Iakovleva, Alina] Russian Acad Sci, Inst Geol, Moscow V71, Russia; [Martin, Jeremy] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Maubert, Francois] Lafarge Granulats Seine Nord, Paris, France; [Roche, Emile] Univ Liege, Dept Geol, Liege, Belgium; [Storme, Jean-Yves; Yans, Johan] Univ Namur, Dept Geol, Namur, Belgium; [Tong, Haiyan] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantarawichai, Thailand; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris, France	Bureau de Recherches Geologiques et Minieres (BRGM); Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Mons; UniLaSalle; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences; University of Bristol; University of Liege; University of Namur; Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Smith, T (corresponding author), Inst Royal Sci Nat Belg, Direct Operat Terre & Hist Vie, Brussels, Belgium.	thierry.smith@naturalsciences.be	Claude, julien/G-7411-2016; Martin, Jeremy/L-4542-2016; Anaïs, Boura/ABB-7025-2021; QUESNEL, Florence/AAR-9253-2021; IAKOVLEVA, ALINA/ABH-9243-2020	Claude, julien/0000-0002-9267-1228; Martin, Jeremy/0000-0001-9159-645X; Anaïs, Boura/0000-0002-3144-8217; QUESNEL, Florence/0000-0002-4081-1911; IAKOVLEVA, ALINA/0000-0001-8569-1880; Folie, Annelise/0000-0002-5839-4212; Smith, Thierry/0000-0002-1795-2564	Federal Science Policy Office of Belgium [MO/36/020, BR/121/A3/PALEURAFRICA]; BRGM	Federal Science Policy Office of Belgium; BRGM	This work was supported by projects MO/36/020 and BR/121/A3/PALEURAFRICA of the Federal Science Policy Office of Belgium (to TS; http://www.belspo.be), and Research cooperation contract funded by the BRGM ("Regolithe" and "Paleosurface eocene-PETM" research projects; to FQ, TS, CD, AI, ER and JYS; http://www.brgm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRL, 1964, SEDIMENTOLOGY, V3, P163, DOI 10.1111/j.1365-3091.1964.tb00459.x; [Anonymous], 1997, MEMOIRES TRAVAUX EPH, V21, P769; [Anonymous], 1977, PALAEONTOGR ABT B; Aubry M.P., 2005, STRATIGRAPHY, V2, P65; Aubry MP, 2007, EPISODES, V30, P271, DOI 10.18814/epiiugs/2007/v30i4/003; BLONDEAU A., 1976, B INF GEOL BASS PARI, V13, P3; Boyer DM, 2012, AM J PHYS ANTHROPOL, V149, P329, DOI 10.1002/ajpa.22119; BRIDGE JS, 1986, SEDIMENTOLOGY, V33, P851, DOI 10.1111/j.1365-3091.1986.tb00987.x; Broin F de, 1977, NOUVELLE C, V33; Brunet M., 1987, MUNCHNER GEOWISSEN A, V10, P13, DOI DOI 10.1111/GCB.12846; Buffetaut E, 2002, GEOL SOC AM SPEC PAP, V356, P303; Cavagnetto Carla, 2000, Palaeontographica Abteilung B Palaeophytologie, V255, P147; Cavelier C, 1968, MEM BRGM, V59, P13; Chateauneuf J.J., 1968, MEMOIRE BUREAU RECHE, V59, P113; Collinson J D, 1996, SEDIMENTARY ENV FACI, P37, DOI DOI 10.2307/3514634; Collinson ME, 2007, J GEOL SOC LONDON, V164, P87, DOI 10.1144/0016-76492005-185; de Coninck J., 1981, Bulletin de la Societe Belge de Geologie, V90, P121; De Franceschi Dario, 2003, Geodiversitas, V25, P633; de Ploeg G., 1998, Strata Series 1 Communications, V9, P108; Delfino M, 2012, J VERTEBR PALEONTOL, V32, P1358, DOI 10.1080/02724634.2012.699484; Delfino M, 2009, ZOOL J LINN SOC-LOND, V156, P140, DOI 10.1111/j.1096-3642.2008.00478.x; Estes R., 1988, P119; Fensom RA, 2004, AASP CONTRIBUTION SE, V42; Feugueur L., 1963, MEMOIRE SERVIR EXPLI; Folie A, 2013, GEOL BELG, V16, P227; Folk R. L., 1957, J SEDIMENT PETROL, V27, P3, DOI [10.1306/74d70646-2b21-11d7-8648000102c1865, 10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D]; Gagnaison Cyril, 2009, Bulletin d'Information des Geologues du Bassin de Paris, V46, P3; Gheerbrant E, 1999, ECLOGAE GEOL HELV, V92, P517; Gingerich P.D., 1976, U MICHIGAN PAPERS PA, V15; Gingerich P. D., 1983, CONTRIB MUS PALEONTO, V26, P187; GINGERICH PD, 2001, PAPERS PALEONTOLOGY, V33, P1; Godinot M., 1980, PALAEOVERTEBRATA MEM, P167; Graves L., 1847, ESSAI TOPOGRAPHIE GE; Gruas-Cavagnetto C., 1976, Bulletin d'Information des Geologues du Bassin de Paris, V13, P11; Gruas-Cavagnetto C, 1968, MEM SOC GEOL FRANCE, V110, P1; Heilmann-Clausen C., 1985, DANMARKS GEOLOGISK A, V7, P1, DOI DOI 10.34194/SERIEA.V7.7026; Heinrich RE, 2008, J PALEONTOL, V82, P154, DOI 10.1666/05-118.1; Herre W., 1950, Zoologischer Anzeiger, V145, P286; Hooker JJ, 2012, ZOOL J LINN SOC-LOND, V164, P856, DOI 10.1111/j.1096-3642.2011.00787.x; Jacques FMB, 2005, REV PALAEOBOT PALYNO, V135, P61, DOI 10.1016/j.revpalbo.2005.02.005; Jehle Martin, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P487, DOI 10.1007/s12549-012-0100-x; Johnson H D, 1996, SEDIMENTARY ENV PROC, P232; Knox R., 2010, PETROLEUM GEOLOGICAL, P210; Krutzsch W., 1958, Z ANGEW GEOL, V11, P509; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Lopez-Martinez N, 1999, B SOC GEOL FR, V170, P681; Maas MC, 2001, J VERTEBR PALEONTOL, V21, P578, DOI 10.1671/0272-4634(2001)021[0578:ENUFTE]2.0.CO;2; Magioncalda R, 2004, GEOLOGY, V32, P553, DOI 10.1130/G20476.1; Magioncalda R, 2001, B SOC GEOL FR, V172, P349, DOI 10.2113/172.3.349; Martin Larry D., 1992, Natural History Museum of Los Angeles County Science Series, V36, P97; MARTINI E., 1970, P 2 PLANKT C ROM, V2, P739; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Metais Gregoire, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P477, DOI 10.1007/s12549-012-0095-3; Nel A, 1999, CR ACAD SCI II A, V329, P65, DOI 10.1016/S1251-8050(99)80229-8; Perez-Garcia A, 2012, J VERTEBR PALEONTOL, V32, P545, DOI 10.1080/02724634.2012.658933; Pflug H.D., 1953, PALAEONTOGR ABT B, V95, P60; PFLUG HANS, 1952, PALAEONTOL ZEITSCHR, V26, P112; PLINT AG, 1983, SEDIMENTOLOGY, V30, P625, DOI 10.1111/j.1365-3091.1983.tb00699.x; Plint AG, 1988, TERTIARY RES, V10, P107; Quesnel F, 2006, GEOLOGIE TERRITOIRE; Rage J.-C., 2001, PART 2 BOIDAE PALAEO, V30, P111, DOI DOI 10.18563/pv.36.1-4.37-73; Reineck H.E., 1980, DEPOSITIONAL SEDIMEN, P5; Roche E, 1973, MEMOIRES SERVIR EXPL, V13, P13; Roche E, 2009, GNS SCI MISCELLANEOU, V16, P122; ROSE K D, 1981, Museum of Paleontology Papers on Paleontology, P1; Rouvillois A, 1960, MEMOIRE MUSEUM HIST, VVIII; Russell D. E, 1980, PALAEOVERTEBRATA MEM; RUSSELL DONALD E., 1964, MEM MUS NAT HIST NATUR NOW SER SER C SCI TERRE, V13, P1; Sanchiz B., 1998, HDB PALAOHERPETOLOGI, V4, P275; Schumm S. A., 1977, FLUVIAL SYSTEM; SIGOGNEAU-RUSSEL D, 1979, Annales de Paleontologie Vertebres, V65, P93; Smith T, 2000, GFF, V122, P148, DOI 10.1080/11035890001221148; Smith T, 1996, B SOC BELG GEOL, V104, P119; Smith T, 2006, P NATL ACAD SCI USA, V103, P11223, DOI 10.1073/pnas.0511296103; Smith T, 2011, CR PALEVOL, V10, P11, DOI 10.1016/j.crpv.2010.11.004; Sole F, J VERTEBRATE PALEONT; Sole F, 2011, PALAEONTOL ELECTRON, V14; Steurbaut E., 2003, Geological Society of America Special Paper, V369, P291; Steurbaut Etienne, 1998, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P91; Storme JY, 2012, TERRA NOVA, V24, P114, DOI 10.1111/j.1365-3121.2011.01044.x; STOTT LD, 1996, GEOLOGICAL SOC SPECI, V0101; Sukhanov Vladimir B., 2000, P309; Tabuce R, 2006, ACTA PALAEONTOL POL, V51, P37; Teilhard de Chardin P, 1927, MEMOIRES MUSEE ROYAL, V6, P1; THIRY M., 2006, STRATIGRAPHY, V3, P119; Vitek N. S., 2012, PALAEONTOL ELECTRON, V15, P1; Wellnhofer P., 1983, HDB PALAOHERPETOLOGI, P1; Woodburne Michael O., 2009, Denver Museum of Nature & Science Annals, V1, P1; Yans J, 2006, AM J SCI, V306, P712, DOI 10.2475/09.2006.02; Yans J, 2010, PALAEOGEOGR PALAEOCL, V291, P85, DOI 10.1016/j.palaeo.2010.01.014; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	91	44	45	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86229	10.1371/journal.pone.0086229	http://dx.doi.org/10.1371/journal.pone.0086229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489703	Green Published, gold			2022-12-27	WOS:000330570000029
J	Tabone, M; Lioy, VS; Ayora, S; Machon, C; Alonso, JC				Tabone, Mariangela; Lioy, Virginia S.; Ayora, Silvia; Machon, Cristina; Alonso, Juan C.			Role of Toxin zeta and Starvation Responses in the Sensitivity to Antimicrobials	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; FUNCTIONAL-ANALYSIS; ANTIBIOTIC TOLERANCE; ADDICTION SYSTEM; (P)PPGPP; RESISTANCE; STRESS; CELLS	A fraction of otherwise antimicrobial-sensitive Bacillus subtilis cells, called persisters, are phenotypically tolerant of antimicrobial treatment. We report that, independently of B. subtilis' growth phase, transient zeta toxin expression induces a dormant state and alters cellular responses so that cells are more sensitive to antimicrobials with different modes of action. This outcome is modulated by fine tuning (p) ppGpp and GTP levels: i) in the presence of low "dysregulated" (p) ppGpp levels (as in relA(-) cells) hyper-tolerance to both toxin and antimicrobials was observed; ii) physiological or low (p) ppGpp levels (as in the wild-type, sasA(-), sasB(-) and relA(-) sasA(-) context) show a normal toxin and antimicrobial tolerance; and iii) lower levels (in relA(-) sasB(-)) or absence of (p) ppGpp (in the relA(-) sasA(-) sasB(-) context), in concert with elevated GTP levels, potentiate the efficacy of both toxin and antimicrobial action, rendering tolerance vulnerable to eradication.	[Tabone, Mariangela; Lioy, Virginia S.; Ayora, Silvia; Machon, Cristina; Alonso, Juan C.] CSIC, CNB, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CSIC, CNB, Dept Biotecnol Microbiana, Madrid, Spain.	jcalonso@cnb.csic.es	Tabone, Mariangela/ABG-3195-2020; Ayora, Silvia/D-2552-2009; Lioy, Vicky S./AAL-9782-2021; Sobrado, Cristina Machón/K-1634-2014; Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky/AAE-4039-2022	Ayora, Silvia/0000-0003-3121-1786; Lioy, Vicky S./0000-0002-5366-0462; Sobrado, Cristina Machón/0000-0001-5363-2958; Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky/0000-0002-5366-0462; Tabone, Mariangela/0000-0003-2688-6922	European Union [Health-F3-2009-223111]; Ministerio de Economia y Competividad (MINECO) [BFU2012-39879-C02-01]; MINECO [BFU2012-39879-C02-02]; Comunidad de Madrid [CM-BIO0260-2006]	European Union(European Commission); Ministerio de Economia y Competividad (MINECO)(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	The research was partially financed by the European Union (Grant Health-F3-2009-223111) and by the Ministerio de Economia y Competividad (MINECO) (BFU2012-39879-C02-01) to J.C.A., by the MINECO (BFU2012-39879-C02-02) and by the Comunidad de Madrid (CM-BIO0260-2006) to S. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2009, J BACTERIOL, V191, P2248, DOI 10.1128/JB.01726-08; Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Belda E, 2013, MICROBIOL-SGM, V159, P757, DOI 10.1099/mic.0.064691-0; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1994, J BACTERIOL, V176, P4081, DOI 10.1128/JB.176.13.4081-4091.1994; Bokinsky G, 2013, J BACTERIOL, V195, P3173, DOI 10.1128/JB.02210-12; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Drlica K, 2009, CURR TOP MED CHEM; ECDC-EMEA, 2009, JOINT TECHN REP BACT; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Germain E, 2013, MOL CELL; Goldman Robert C., 2004, Current Drug Targets - Infectious Disorders, V4, P241, DOI 10.2174/1568005043340812; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030282; Lioy VS, 2010, PLASMID, V63, P31, DOI 10.1016/j.plasmid.2009.09.005; Lioy VS, 2010, SISTEMA TOXINA ANTIT; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Meinhart A, 2001, ACTA CRYSTALLOGR D, V57, P745, DOI 10.1107/S0907444901004176; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Pellegrini O, 2005, MOL MICROBIOL, V56, P1139, DOI 10.1111/j.1365-2958.2005.04606.x; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Viducic D, 2006, MICROBIOL IMMUNOL, V50, P349, DOI 10.1111/j.1348-0421.2006.tb03793.x; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Wu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023909; XIAO H, 1991, J BIOL CHEM, V266, P5980; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	54	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86615	10.1371/journal.pone.0086615	http://dx.doi.org/10.1371/journal.pone.0086615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489751	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000051
J	Manley, H; Dayan, P; Diedrichsen, J				Manley, Harry; Dayan, Peter; Diedrichsen, Joern			When Money Is Not Enough: Awareness, Success, and Variability in Motor Learning	PLOS ONE			English	Article							MOVEMENT; ADAPTATION; MODEL; REPRESENTATION; UNCERTAINTY; ATTENTION; SYSTEMS; CORTEX; MEMORY	When performing a skill such as throwing a dart, many different combinations of joint motions suffice to hit the target. The motor system adapts rapidly to reduce bias in the desired outcome (i.e., the first-order moment of the error); however, the essence of skill is to produce movements with less variability (i.e., to reduce the second-order moment). It is easy to see how feedback about success or failure could sculpt performance to achieve this aim. However, it is unclear whether the dimensions responsible for success or failure need to be known explicitly by the subjects, or whether learning can proceed without explicit awareness of the movement parameters that need to change. Here, we designed a redundant, two-dimensional reaching task in which we could selectively manipulate task success and the variability of action outcomes, whilst also manipulating awareness of the dimension along which performance could be improved. Variability was manipulated either by amplifying natural errors, leaving the correlation between the executed movement and the visual feedback intact, or by adding extrinsic noise, decorrelating movement and feedback. We found that explicit, binary, feedback about success or failure was only sufficient for learning when participants were aware of the dimension along which motor behavior had to change. Without such awareness, learning was only present when extrinsic noise was added to the feedback, but not when task success or variability was manipulated in isolation; learning was also much slower. Our results highlight the importance of conscious awareness of the relevant dimension during motor learning, and suggest that higher-order moments of outcome signals are likely to play a significant role in skill learning in complex tasks.	[Manley, Harry; Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England; [Manley, Harry] Bangor Univ, Inst Psychol Elite Performance, Bangor, Gwynedd, Wales	University of London; University College London; University of London; University College London; Bangor University	Diedrichsen, J (corresponding author), UCL, Inst Cognit Neurosci, London, England.	j.diedrichsen@ucl.ac.uk	Diedrichsen, Jörn/A-7789-2010; Diedrichsen, Jörn/AAQ-2242-2020	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532	Wellcome Trust [094874/Z/10/Z]; James S. McDonnell Foundation; Gatsby Charitable Foundation; BBSRC [BB/E009174/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009174/2] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); James S. McDonnell Foundation; Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was supported by Grants from the Wellcome Trust (094874/Z/10/Z) and the James S. McDonnell Foundation (both to JD) and a strategic award by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Dam G, 2009, COGNITIVE SCI, V33, P530, DOI 10.1111/j.1551-6709.2009.01021.x; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Debicki DB, 2004, EXP BRAIN RES, V154, P382, DOI 10.1007/s00221-003-1673-4; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Donchin O, 2003, J NEUROSCI, V23, P9032; Gepshtein S, 2007, J VISION, V7, DOI 10.1167/7.5.13; GITTINS JC, 1979, J ROY STAT SOC B MET, V41, P148; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hore J, 2005, J NEUROPHYSIOL, V93, P3189, DOI 10.1152/jn.01268.2004; HORE J, 1995, EXP BRAIN RES, V103, P277; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Izawa J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002012; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kruschke JK, 2001, J MATH PSYCHOL, V45, P812, DOI 10.1006/jmps.2000.1354; Landy MS, 2012, J NEUROSCI, V32, P12702, DOI 10.1523/JNEUROSCI.6160-11.2012; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Liu XL, 2011, J NEUROPHYSIOL, V105, P454, DOI 10.1152/jn.00247.2010; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Mosier KM, 2005, J NEUROPHYSIOL, V94, P4362, DOI 10.1152/jn.00380.2005; Muller H, 2009, ADV EXP MED BIOL, V629, P439, DOI 10.1007/978-0-387-77064-2_23; Mussa-Ivaldi FA, 2011, PROG BRAIN RES, V191, P45, DOI 10.1016/B978-0-444-53752-2.00014-X; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Peters J, 2007, USING REWARD WEIGHTE, P262; Peters J, 2008, NEURAL NETWORKS, V21, P682, DOI 10.1016/j.neunet.2008.02.003; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Schaefer SY, 2012, J NEUROPHYSIOL, V107, P1247, DOI 10.1152/jn.00273.2011; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Stanley J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00503; Sternad D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002159; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; Trommershauser J, 2003, J OPT SOC AM A, V20, P1419, DOI 10.1364/JOSAA.20.001419; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 2013, J NEUROPHYSIOL, V109, P969, DOI 10.1152/jn.00706.2012; Vetter P, 2002, CURR BIOL, V12, P488, DOI 10.1016/S0960-9822(02)00715-7; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112	55	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86580	10.1371/journal.pone.0086580	http://dx.doi.org/10.1371/journal.pone.0086580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489746	Green Published, gold			2022-12-27	WOS:000330510000061
J	Takasu, M; Tamura, T; Kaichi, Y; Tanitame, K; Akiyama, Y; Date, S; Sakai, A; Kuroda, Y; Awai, K				Takasu, Miyuki; Tamura, Takayuki; Kaichi, Yoko; Tanitame, Keizo; Akiyama, Yuji; Date, Shuji; Sakai, Akira; Kuroda, Yoshiaki; Awai, Kazuo			Magnetic Resonance Evaluation of Multiple Myeloma at 3.0 Tesla: How Do Bone Marrow Plasma Cell Percentage and Selection of Protocols Affect Lesion Conspicuity?	PLOS ONE			English	Article							WATER-FAT DECOMPOSITION; 3-POINT DIXON TECHNIQUE; WORKING GROUP; SUPPRESSION; SEPARATION; DIAGNOSIS; SPINE; IDEAL; MRI	Purpose: To compare various pulse sequences in terms of percent contrast and contrast-to-noise ratio (CNR) for detection of focal multiple myeloma lesions and to assess the dependence of lesion conspicuity on the bone marrow plasma cell percent (BMPC%). Materials and Methods: Sagittal T-1-weighted FSE, fat-suppressed T-2-weighted FSE (FS-T-2 FSE), fast STIR and iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of the lumbar spine were performed (n = 45). Bone marrow (BM)-focal myeloma lesion percent contrast and CNR were calculated. Spearman rank correlation coefficients were obtained between percent contrast, CNR and BMPC%. Percent contrasts and CNRs were compared among the three imaging sequences. Results: BM-focal lesion percent contrasts, CNRs and BMPC% showed significant negative correlations in the three fat-suppression techniques. Percent contrast and CNRs were significantly higher for FS-T2 FSE than for STIR (P < 0.01, P < 0.05, respectively), but no significant differences were found among the three fat-suppression methods in the low tumor load BM group. Conclusion: The higher BMPC% was within BM, the less conspicuous the focal lesion was on fat-suppressed MRI. The most effective protocol for detecting focal lesions was FS-T-2 FSE. In the high tumor load BM group, no significant differences in lesion conspicuity were identified among the three fat-suppression techniques.	[Takasu, Miyuki; Tamura, Takayuki; Kaichi, Yoko; Tanitame, Keizo; Akiyama, Yuji; Date, Shuji; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Sakai, Akira] Fukushima Med Univ Sch Med, Dept Radiat Life Sci, Fukushima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan	Hiroshima University; Fukushima Medical University; Hiroshima University	Takasu, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan.	my-takasu@syd.odn.ne.jp	Takasu, Miyuki/AAG-7737-2019	Takasu, Miyuki/0000-0001-7375-6501	International Myeloma Foundation Japan's Research Grants; Grants-in-Aid for Scientific Research [23591768] Funding Source: KAKEN	International Myeloma Foundation Japan's Research Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.T. was supported by International Myeloma Foundation Japan's Research Grants 2012, which provided funding for the Japan Myeloma Study Group. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur-Melnyk A, 2005, EUR J RADIOL, V55, P56, DOI 10.1016/j.ejrad.2005.01.017; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Durie Brian G M, 2003, Hematol J, V4, P379; FLECKENSTEIN JL, 1991, RADIOLOGY, V179, P499, DOI 10.1148/radiology.179.2.2014300; Gerdes CM, 2007, AM J ROENTGENOL, V189, pW284, DOI 10.2214/AJR.07.2593; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hanrahan CJ, 2010, RADIOGRAPHICS, V30, P127, DOI 10.1148/rg.301095066; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Ma JF, 2004, J MAGN RESON IMAGING, V20, P1025, DOI 10.1002/jmri.20201; Moulopoulos LA, 2005, ANN ONCOL, V16, P1824, DOI 10.1093/annonc/mdi362; Nakatsu M, 2000, JMRI-J MAGN RESON IM, V11, P56, DOI 10.1002/(SICI)1522-2586(200001)11:1<56::AID-JMRI8>3.0.CO;2-D; RAHMOUNI A, 1993, AM J ROENTGENOL, V160, P1049, DOI 10.2214/ajr.160.5.8470574; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; RICCI C, 1990, RADIOLOGY, V177, P83, DOI 10.1148/radiology.177.1.2399343; Sommer G, 2011, EUR RADIOL, V21, P857, DOI 10.1007/s00330-010-1950-0; Sormaala MJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-128; Tagliafico A, 2011, SKELETAL RADIOL, V40, P717, DOI 10.1007/s00256-010-1050-x; Takasu M, 2012, EUR RADIOL, V22, P1114, DOI 10.1007/s00330-011-2351-8; Terpos E, 2005, ANN ONCOL, V16, P1223, DOI 10.1093/annonc/mdi235; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Walker R, 2007, J CLIN ONCOL, V25, P1121, DOI 10.1200/JCO.2006.08.5803; YEUNG HN, 1986, RADIOLOGY, V159, P783, DOI 10.1148/radiology.159.3.3704157; Yu HZ, 2005, MAGN RESON MED, V54, P1032, DOI 10.1002/mrm.20654	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85931	10.1371/journal.pone.0085931	http://dx.doi.org/10.1371/journal.pone.0085931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489680	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000024
J	Moore, C; Cumming, GS; Slingsby, J; Grewar, J				Moore, Christine; Cumming, Graeme S.; Slingsby, Jasper; Grewar, John			Tracking Socioeconomic Vulnerability Using Network Analysis: Insights from an Avian Influenza Outbreak in an Ostrich Production Network	PLOS ONE			English	Article							INFECTIOUS-DISEASE; CONTACT NETWORKS; MOUTH-DISEASE; MOVEMENTS; CATTLE; TRANSMISSION; EPIDEMICS; TOPOLOGY; RESOURCE; ECOLOGY	Background: The focus of management in many complex systems is shifting towards facilitation, adaptation, building resilience, and reducing vulnerability. Resilience management requires the development and application of general heuristics and methods for tracking changes in both resilience and vulnerability. We explored the emergence of vulnerability in the South African domestic ostrich industry, an animal production system which typically involves 3-4 movements of each bird during its lifetime. This system has experienced several disease outbreaks, and the aim of this study was to investigate whether these movements have contributed to the vulnerability of this system to large disease outbreaks. Methodology/Principal Findings: The ostrich production system requires numerous movements of birds between different farm types associated with growth (i.e. Hatchery to juvenile rearing farm to adult rearing farm). We used 5 years of movement records between 2005 and 2011 prior to an outbreak of Highly Pathogenic Avian Influenza (H5N2). These data were analyzed using a network analysis in which the farms were represented as nodes and the movements of birds as links. We tested the hypothesis that increasing economic efficiency in the domestic ostrich industry in South Africa made the system more vulnerable to outbreak of Highly Pathogenic Avian Influenza (H5N2). Our results indicated that as time progressed, the network became increasingly vulnerable to pathogen outbreaks. The farms that became infected during the outbreak displayed network qualities, such as significantly higher connectivity and centrality, which predisposed them to be more vulnerable to disease outbreak. Conclusions/Significance: Taken in the context of previous research, our results provide strong support for the application of network analysis to track vulnerability, while also providing useful practical implications for system monitoring and management.	[Moore, Christine; Cumming, Graeme S.] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa; [Slingsby, Jasper] South African Environm Observat Network, Cape Town, South Africa; [Grewar, John] Govt Western Cape, Dept Agr, Elsenburg, South Africa	National Research Foundation - South Africa; University of Cape Town; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON)	Moore, C (corresponding author), Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa.	christine.moore9@gmail.com	Slingsby, Jasper/AAU-7259-2021; Cumming, Graeme S./B-6551-2008	Slingsby, Jasper/0000-0003-1246-1181; Cumming, Graeme S./0000-0002-3678-1326; Grewar, John/0000-0002-4496-8051	National Research Foundation of South Africa; James S. McDonnell Foundation	National Research Foundation of South Africa(National Research Foundation - South Africa); James S. McDonnell Foundation	Funding for this project was provided by the National Research Foundation of South Africa and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2012, AVIAN DIS, V56, P865, DOI 10.1637/10171-041012-Reg.1; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Burns TE, 2011, TRANSBOUND EMERG DIS, V58, P510, DOI 10.1111/j.1865-1682.2011.01232.x; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cumming G. S., 2008, COMPLEXITY THEORY SU, P246; Cumming GS., 2008, COMPLEXITY THEORY SU, P15; Cundill G, 2012, CONSERV BIOL, V26, P13, DOI 10.1111/j.1523-1739.2011.01755.x; Danon Leon, 2011, Interdiscip Perspect Infect Dis, V2011, P284909, DOI 10.1155/2011/284909; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, REV SCI TECH OIE, V30, P425; Ferrari Matthew J, 2011, Interdiscip Perspect Infect Dis, V2011, P267049, DOI 10.1155/2011/267049; Frossling J, 2012, PREV VET MED, V105, P202, DOI 10.1016/j.prevetmed.2011.12.011; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Jonkers ART, 2010, J R SOC INTERFACE, V7, P695, DOI 10.1098/rsif.2009.0304; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; LARKIN PA, 1977, T AM FISH SOC, V106, P1, DOI 10.1577/1548-8659(1977)106<1:AEFTCO>2.0.CO;2; Leibler JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009888; Mather C, 2011, AGR HUM VALUES, V28, P153, DOI 10.1007/s10460-010-9271-0; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nickbakhsh S, 2011, BMC VET RES, V7, DOI [10.1186/1746-6148-7-66, 10.1186/1746-6148-8-51]; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; RCore Team, 2020, R LANG ENV STAT COMP; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosato V, 2008, PHYSICA A, V387, P1689, DOI 10.1016/j.physa.2007.10.065; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Sharkey KJ, 2008, P ROY SOC B-BIOL SCI, V275, P19, DOI 10.1098/rspb.2007.1100; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; South Africa Department of Agriculture Forestry & Fisheries, 2011, PROF S AFR OSTR MARK; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Western Cape Department of Agriculture, 2011, 1 W CAP DEP AGR; Wilcox Bruce A., 2005, Environmental Health and Preventive Medicine, V10, P263, DOI 10.1007/BF02897701; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799	49	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86973	10.1371/journal.pone.0086973	http://dx.doi.org/10.1371/journal.pone.0086973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498004	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330621900053
J	Shi, JG; Zhang, Y; Liu, FH; Li, YJ; Wang, JH; Flint, J; Gao, JF; Li, YH; Tao, M; Zhang, KR; Wang, XM; Gao, CG; Yang, LJ; Li, K; Shi, SX; Wang, G; Liu, LF; Zhang, JB; Du, B; Jiang, GQ; Shen, JH; Zhang, Z; Liang, W; Sun, J; Hu, J; Liu, TB; Wang, XY; Miao, GD; Meng, HQ; Li, Y; Hu, CM; Li, Y; Huang, GP; Li, GY; Ha, BW; Deng, H; Mei, QY; Zhong, H; Gao, SG; Sang, H; Zhang, YT; Fang, X; Yu, FY; Yang, DL; Liu, TQ; Chen, YC; Hong, XH; Wu, WY; Chen, GB; Cai, M; Song, Y; Pan, JY; Dong, JC; Pan, RD; Zhang, W; Shen, ZM; Liu, ZR; Gu, DH; Wang, XP; Liu, XJ; Zhang, QW; Li, YH; Chen, YP; Kendler, KS				Shi, Jianguo; Zhang, Yan; Liu, Feihu; Li, Yajuan; Wang, Junhui; Flint, Jonathan; Gao, Jingfang; Li, Youhui; Tao, Ming; Zhang, Kerang; Wang, Xumei; Gao, Chengge; Yang, Lijun; Li, Kan; Shi, Shenxun; Wang, Gang; Liu, Lanfen; Zhang, Jinbei; Du, Bo; Jiang, Guoqing; Shen, Jianhua; Zhang, Zhen; Liang, Wei; Sun, Jing; Hu, Jian; Liu, Tiebang; Wang, Xueyi; Miao, Guodong; Meng, Huaqing; Li, Yi; Hu, Chunmei; Li, Yi; Huang, Guoping; Li, Gongying; Ha, Baowei; Deng, Hong; Mei, Qiyi; Zhong, Hui; Gao, Shugui; Sang, Hong; Zhang, Yutang; Fang, Xiang; Yu, Fengyu; Yang, Donglin; Liu, Tieqiao; Chen, Yunchun; Hong, Xiaohong; Wu, Wenyuan; Chen, Guibing; Cai, Min; Song, Yan; Pan, Jiyang; Dong, Jicheng; Pan, Runde; Zhang, Wei; Shen, Zhenming; Liu, Zhengrong; Gu, Danhua; Wang, Xiaoping; Liu, Xiaojuan; Zhang, Qiwen; Li, Yihan; Chen, Yiping; Kendler, Kenneth S.			Associations of Educational Attainment, Occupation, Social Class and Major Depressive Disorder among Han Chinese Women	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; SOCIOECONOMIC-STATUS; UNITED-STATES; PSYCHIATRIC-DISORDERS; PREVALENCE; SELECTION; POPULATION; CAUSATION; POVERTY	Background: The prevalence of major depressive disorder (MDD) is higher in those with low levels of educational attainment, the unemployed and those with low social status. However the extent to which these factors cause MDD is unclear. Most of the available data comes from studies in developed countries, and these findings may not extrapolate to developing countries. Examining the relationship between MDD and socio economic status in China is likely to add to the debate because of the radical economic and social changes occurring in China over the last 30 years. Principal findings: We report results from 3,639 Chinese women with recurrent MDD and 3,800 controls. Highly significant odds ratios (ORs) were observed between MDD and full time employment (OR = 0.36, 95% CI = 0.25-0.46, logP = 78), social status (OR = 0.83, 95% CI = 0.77-0.87, logP = 13.3) and education attainment (OR = 0.90, 95% CI = 0.86-0.90, logP = 6.8). We found a monotonic relationship between increasing age and increasing levels of educational attainment. Those with only primary school education have significantly more episodes of MDD (mean 6.5, P-value = 0.009) and have a clinically more severe disorder, while those with higher educational attainment are likely to manifest more comorbid anxiety disorders. Conclusions: In China lower socioeconomic position is associated with increased rates of MDD, as it is elsewhere in the world. Significantly more episodes of MDD occur among those with lower educational attainment (rather than longer episodes of disease), consistent with the hypothesis that the lower socioeconomic position increases the likelihood of developing MDD. The phenomenology of MDD varies according to the degree of educational attainment: higher educational attainment not only appears to protect against MDD but alters its presentation, to a more anxious phenotype.	[Shi, Jianguo; Zhang, Yan; Liu, Feihu; Li, Yajuan; Wang, Junhui] Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China; [Shi, Jianguo; Zhang, Yan; Liu, Feihu; Li, Yajuan; Wang, Junhui] Xian Sch Med, Affiliated Mental Hlth Inst, Xian, Shaanxi, Peoples R China; [Flint, Jonathan; Li, Yihan] Wellcome Trust Ctr Human Genet, Oxford, England; [Gao, Jingfang] Chinese Tradit Hosp Zhejiang, Hangzhou, Zhejiang, Peoples R China; [Li, Youhui] Zhengzhou Univ, Hosp 1, Zhengzhou, Henan, Peoples R China; [Tao, Ming] Xinhua Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Zhang, Kerang] Shanxi Med Univ, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Xumei] China Med Univ, ShengJing Hosp, Shenyang, Liaoning, Peoples R China; [Gao, Chengge] Xi An Jiao Tong Univ, Coll Med, Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Yang, Lijun] Jilin Brain Hosp, Siping, Jilin, Peoples R China; [Li, Kan] Mental Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China; [Shi, Shenxun] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Wang, Gang] Capital Univ Med Sci, Beijing Anding Hosp, Beijing, Peoples R China; [Liu, Lanfen] Shandong Mental Hlth Ctr, Jinan, Shandong, Peoples R China; [Zhang, Jinbei] Sun Yat Sen Univ, Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Du, Bo] Hebei Mental Hlth Ctr, Baoding, Hebei, Peoples R China; [Jiang, Guoqing] Chongqing Mental Hlth Ctr, Chongqing, Peoples R China; [Shen, Jianhua] Tianjin Anding Hosp, Tianjin, Peoples R China; [Zhang, Zhen] Jiangsu Univ, Hosp 4, Zhenjiang, Jiangsu, Peoples R China; [Liang, Wei] Psychiat Hosp Henan Prov, Xinxiang, Henan, Peoples R China; [Sun, Jing] Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China; [Hu, Jian] Harbin Med Univ, Haerbin, Heilongjiang, Peoples R China; [Liu, Tiebang] Shenzhen Kang Ning Hosp, Shenzhen, Guangdong, Peoples R China; [Wang, Xueyi] Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China; [Miao, Guodong] Guangzhou Psychiat Hosp, Guangzhou Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Meng, Huaqing] Chongqing Med Univ, Hosp 1, Chongqing, Peoples R China; [Li, Yi] Dalian 7 Hosp, Dalian, Liaoning, Peoples R China; [Hu, Chunmei] 3 Hosp Heilongjiang Prov, Beian, Heilongjiang, Peoples R China; [Li, Yi] Wuhan Mental Hlth Ctr, Wuhan, Hubei, Peoples R China; [Huang, Guoping] Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China; [Li, Gongying] Jining Med Coll, Mental Hlth Inst, Jining, Shandong, Peoples R China; [Ha, Baowei] Liaocheng 4 Hosp, Liaocheng, Shandong, Peoples R China; [Deng, Hong] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Mei, Qiyi] Suzhou Guangji Hosp, Suzhou, Jiangsu, Peoples R China; [Zhong, Hui] Anhui Mental Hlth Ctr, Hefei, Anhui, Peoples R China; [Gao, Shugui] Ningbo Kang Ning Hosp, Ningbo, Zhejiang, Peoples R China; [Sang, Hong] Changchun Mental Hosp, Changchun, Jilin, Peoples R China; [Zhang, Yutang] Lanzhou Univ, Hosp 2, Lanzhou 730000, Gansu, Peoples R China; [Fang, Xiang] Fuzhou Psychiat Hosp, Fuzhou, Fujian, Peoples R China; [Yu, Fengyu] Harbin 1 Special Hosp, Haerbin, Heilongjiang, Peoples R China; [Yang, Donglin] Jining Psychiat Hosp, Jining, Shandong, Peoples R China; [Liu, Tieqiao] Zhongnan Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Chen, Yunchun] 4 Mil Med Univ, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Hong, Xiaohong] Shantou Univ, Mental Hlth Ctr, Shantou, Guangdong, Peoples R China; [Wu, Wenyuan] Tongji Univ Hosp, Shanghai, Peoples R China; [Chen, Guibing] Huaian 3 Hosp, Huaian, Jiangsu, Peoples R China; [Cai, Min] Huzhou 3 Hosp, Huzhou, Zhejiang, Peoples R China; [Song, Yan] Mudanjiang Psychiat Hosp Heilongjiang Prov, Mudanjiang, Heilongjiang, Peoples R China; [Pan, Jiyang] Jinan Univ, Hosp 1, Guangzhou, Guangdong, Peoples R China; [Dong, Jicheng] Qingdao Mental Hlth Ctr, Qingdao, Shandong, Peoples R China; [Pan, Runde] Guangxi Longquanshan Hosp, Yufeng Dist, Liuzhou, Peoples R China; [Zhang, Wei] Daqing 3 Hosp Heilongjiang Prov, Daqing, Heilongjiang, Peoples R China; [Shen, Zhenming] Tangshan 5 Hosp, Tangshan, Hebei, Peoples R China; [Liu, Zhengrong] Anshan Psychiat Rehabil Hosp, Anshan, Liaoning, Peoples R China; [Gu, Danhua] ETDZ, Weihai Mental Hlth Ctr, Weihai, Shandong, Peoples R China; [Wang, Xiaoping] Wuhan Univ, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Liu, Xiaojuan] Tianjin First Ctr Hosp, Tianjin, Peoples R China; [Zhang, Qiwen] Hainan Anning Hosp, Haikou, Hainan, Peoples R China; [Chen, Yiping] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA	University of Oxford; Wellcome Centre for Human Genetics; Zhengzhou University; Zhejiang Chinese Medical University; Shanxi Medical University; China Medical University; Xi'an Jiaotong University; Capital Medical University; Sun Yat Sen University; Jiangsu University; Harbin Medical University; Hebei Medical University; Chongqing Medical University; Jining Medical University; Sichuan University; Lanzhou University; Central South University; Air Force Military Medical University; Shantou University; Tongji University; Jinan University; Wuhan University; Radcliffe Infirmary; University of Oxford; Virginia Commonwealth University	Shi, JG (corresponding author), Xian Mental Hlth Ctr, Xian, Shaanxi, Peoples R China.	zhan_777@gmail.com	Chen, Yi/HIR-2608-2022; liu, tieqiao/GSE-2327-2022; Kendler, Kenneth/AAF-2876-2019	Flint, Jonathan/0000-0002-9427-4429	Wellcome Trust [090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100549] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Wellcome Trust (090532/Z/09/Z, 083573/Z/07/Z, 089269/Z/09/Z): http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1994, DIAGN STAT MAN MENT, V4th; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; BRUCE ML, 1991, ARCH GEN PSYCHIAT, V48, P470; Chen SL, 2012, J AFFECT DISORDERS, V141, P86, DOI 10.1016/j.jad.2012.02.027; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; EATON WW, 1980, AM J SOCIOL, V86, P149, DOI 10.1086/227207; Gan ZY, 2012, J AFFECT DISORDERS, V136, P988, DOI 10.1016/j.jad.2011.06.046; Inaba A, 2005, SOC SCI MED, V61, P2280, DOI 10.1016/j.socscimed.2005.07.014; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; KENDLER KS, 2006, ENV PSYCHOPATHOLOGY; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; LAPOUSE R, 1956, AM J PUBLIC HEALTH N, V46, P978, DOI 10.2105/AJPH.46.8.978; LEE RPL, 1976, INT J SOC PSYCHIATR, V22, P1, DOI 10.1177/002076407602200101; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Lu J, 2008, J AFFECT DISORDERS, V111, P221, DOI 10.1016/j.jad.2008.02.018; MURPHY JM, 1991, ARCH GEN PSYCHIAT, V48, P223; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Qin XX, 2008, J AFFECT DISORDERS, V110, P46, DOI 10.1016/j.jad.2007.12.237; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Rai D, 2013, BRIT J PSYCHIAT, V202, P195, DOI 10.1192/bjp.bp.112.112482; Sewell WilliamH., 1976, SCH ACHIEVEMENT AM S; Skapinakis P, 2006, BRIT J PSYCHIAT, V189, P109, DOI 10.1192/bjp.bp.105.014449; TURNER RJ, 1967, AM SOCIOL REV, V32, P104, DOI 10.2307/2091723; Wang JL, 2010, J EPIDEMIOL COMMUN H, V64, P447, DOI 10.1136/jech.2009.090910; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; World Health Organization, 2008, GLOB BURD DIS 2004 U	29	18	19	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86674	10.1371/journal.pone.0086674	http://dx.doi.org/10.1371/journal.pone.0086674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497966	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900033
J	Cheng, ZY; Tian, X; Gao, J; Li, HM; Jia, LJ; Qiao, HL				Cheng, Zhen-Yu; Tian, Xin; Gao, Jie; Li, Hong-Meng; Jia, Lin-Jing; Qiao, Hai-Ling			Contribution of Baicalin on the Plasma Protein Binding Displacement and CYP3A Activity Inhibition to the Pharmacokinetic Changes of Nifedipine in Rats In Vivo and In Vitro	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; INDUCED LIVER-INJURY; SCUTELLARIA-BAICALENSIS; METABOLISM; PREDICTION; MIDAZOLAM; PROBE; HUMANS; DISPOSITION; EXPRESSION	Baicalin purified from the root of Radix scutellariae is widely used in clinical practices. This study aimed to evaluate the effect of baicalin on the pharmacokinetics of nifedipine, a CYP3A probe substrate, in rats in vivo and in vitro. In a randomised, three-period crossover study, significant changes in the pharmacokinetics of nifedipine (2 mg/kg) were observed after treatment with a low (0.225 g/kg) or high (0.45 g/kg) dose of baicalin in rats. In the low- and high-dose groups of baicalin-treated rats, C-max of total nifedipine decreased by 40%+/- 14% (P<0.01) and 65%+/- 14% (P<0.01), AUC(0-infinity) decreased by 41%+/- 8% (P<0.01) and 63%+/- 7% (P<0.01), V-d increased by 85%+/- 43% (P<0.01) and 224%+/- 231% (P<0.01), and CL increased by 97%+/- 78% (P<0.01) and 242%+/- 135% (P<0.01), respectively. Plasma protein binding experiments in vivo showed that C-max of unbound nifedipine significantly increased by 25%+/- 19% (P<0.01) and 44%+/- 29% (P<0.01), respectively, and there was a good correlation between the unbound nifedipine (%) and baicalin concentrations (P<0.01). Furthermore, in vitro results revealed that baicalin was a competitive displacer of nifedipine from plasma proteins. In vitro incubation experiments demonstrated that baicalin could also competitively inhibit CYP3A activity in rat liver microsomes in a concentration-dependent manner. In conclusion, the pharmacokinetic changes of nifedipine may be modulated by the inhibitory effects of baicalin on plasma protein binding and CYP3A-mediated metabolism.	[Cheng, Zhen-Yu; Tian, Xin; Gao, Jie; Li, Hong-Meng; Jia, Lin-Jing; Qiao, Hai-Ling] Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou 450052, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Sch Med, Dept Clin Pharmacol, Zhengzhou 450052, Peoples R China.	qiaohl@zzu.edu.cn	Gao, Jie/U-4696-2017	Gao, Jie/0000-0002-4648-7956	National Natural Science Foundation of China [81041113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81041113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison RS, 2000, EUR J CLIN PHARMACOL, V56, P715, DOI 10.1007/s002280000211; Akabane T, 2010, DRUG METAB DISPOS, V38, P308, DOI 10.1124/dmd.109.028829; Aoki M, 2010, DRUG METAB DISPOS, V38, P1183, DOI 10.1124/dmd.110.032227; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Buur JL, 2009, RES VET SCI, V86, P293, DOI 10.1016/j.rvsc.2008.07.003; Choi YH, 2012, XENOBIOTICA, V42, P483, DOI 10.3109/00498254.2011.633177; Christensen H, 2006, J PHARM SCI-US, V95, P2778, DOI 10.1002/jps.20733; de Jonge H, 2011, CLIN PHARMACOL THER, V90, P414, DOI 10.1038/clpt.2011.130; Dhillon S, 1998, BRIT J CLIN PHARMACO, V13, P553; Fan L, 2009, EUR J CLIN PHARMACOL, V65, P403, DOI 10.1007/s00228-008-0594-3; Foti RS, 2010, DRUG METAB DISPOS, V38, P981, DOI 10.1124/dmd.110.032094; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053038; Gao ZH, 2001, PHARMACOL RES, V43, P173, DOI 10.1006/phrs.2000.0761; Gonzalez-Perez V, 2012, DRUG METAB DISPOS, V40, P2136, DOI 10.1124/dmd.112.047134; Grundy JS, 1997, BIOPHARM DRUG DISPOS, V18, P509, DOI 10.1002/(SICI)1099-081X(199708)18:6<509::AID-BDD38>3.0.CO;2-5; Guo YZ, 2007, INT J PHARMACEUT, V341, P91, DOI 10.1016/j.ijpharm.2007.03.053; Hoch M, 2013, EUR J CLIN PHARMACOL, V69, P523, DOI 10.1007/s00228-012-1403-6; Ito K, 2004, BRIT J CLIN PHARMACO, V57, P473, DOI 10.1111/j.1365-2125.2003.02041.x; Iwatsubo T, 1996, BIOPHARM DRUG DISPOS, V17, P273, DOI 10.1002/(SICI)1099-081X(199605)17:4<273::AID-BDD961>3.0.CO;2-R; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kenworthy KE, 1999, BRIT J CLIN PHARMACO, V48, P716; Kim RB, 1999, PHARMACEUT RES, V16, P408; Lai MY, 2004, PLANTA MED, V70, P132, DOI 10.1055/s-2004-815489; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Lee KJ, 2004, ARCH PHARM RES, V27, P978, DOI 10.1007/BF02975854; Lehr T, 2010, CLIN PHARMACOKINET, V49, P53, DOI 10.2165/11317210-000000000-00000; Li LL, 2012, INT IMMUNOPHARMACOL, V13, P15, DOI 10.1016/j.intimp.2012.03.001; Li Y, 2010, EUR J PHARMACOL, V640, P46, DOI 10.1016/j.ejphar.2010.05.017; Lilja JJ, 2005, BRIT J CLIN PHARMACO, V59, P433, DOI 10.1111/j.1365-2125.2004.02323.x; LINDUP WE, 1981, BRIT MED J, V282, P212, DOI 10.1136/bmj.282.6259.212; LITTERST CL, 1975, LIFE SCI, V17, P813, DOI 10.1016/0024-3205(75)90539-1; Liu H, 2010, J PHYS CHEM B, V114, P12938, DOI 10.1021/jp102053x; Lombardo F, 2002, J MED CHEM, V45, P2867, DOI 10.1021/jm0200409; MACKICHAN JJ, 1989, CLIN PHARMACOKINET, V16, P65, DOI 10.2165/00003088-198916020-00001; Miyazaki M, 2008, DRUG METAB DISPOS, V36, P2287, DOI 10.1124/dmd.108.021816; Mohri K, 2000, DRUG METAB DISPOS, V28, P482; Poor M, 2012, LUMINESCENC IN PRESS; Qiao HX, 2011, PHARM BIOL, V49, P38, DOI 10.3109/13880209.2010.493179; Reilly PEB, 1999, COMP BIOCHEM PHYS C, V122, P197, DOI 10.1016/S0742-8413(98)10106-8; RENWICK AG, 1992, BRIT J CLIN PHARMACO, V34, P332, DOI 10.1111/j.1365-2125.1992.tb05639.x; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; Soligard HT, 2010, PEDIATR RES, V67, P614, DOI 10.1203/PDR.0b013e3181da7578; Tang YH, 2006, BIOMED CHROMATOGR, V20, P1116, DOI 10.1002/bmc.655; Tian X, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/179643; Tian X, 2013, CHEM-BIOL INTERACT, V203, P522, DOI 10.1016/j.cbi.2013.02.005; Uchiyama Y, 2005, BBA-GEN SUBJECTS, V1725, P298, DOI 10.1016/j.bbagen.2005.06.017; Wan JY, 2008, EUR J PHARMACOL, V587, P302, DOI 10.1016/j.ejphar.2008.02.081; Wang Y, 2011, J FOOD SCI, V76, pT30, DOI 10.1111/j.1750-3841.2010.01960.x; Wolniak M, 2008, MAGN RESON CHEM, V46, P215, DOI 10.1002/mrc.2165; Wright JD, 1996, CLIN PHARMACOKINET, V30, P445, DOI 10.2165/00003088-199630060-00003; Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031312; Zamuner S, 2010, BRIT J CLIN PHARMACO, V70, P537, DOI 10.1111/j.1365-2125.2010.03729.x; Zeng MF, 2010, FITOTERAPIA, V81, P490, DOI 10.1016/j.fitote.2010.01.004	53	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87234	10.1371/journal.pone.0087234	http://dx.doi.org/10.1371/journal.pone.0087234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498050	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100064
J	Prodam, F; Savastio, S; Genoni, G; Babu, D; Giordano, M; Ricotti, R; Aimaretti, G; Bona, G; Bellone, S				Prodam, Flavia; Savastio, Silvia; Genoni, Giulia; Babu, Deepak; Giordano, Mara; Ricotti, Roberta; Aimaretti, Gianluca; Bona, Gianni; Bellone, Simonetta			Effects of Growth Hormone (GH) Therapy Withdrawal on Glucose Metabolism in Not Confirmed GH Deficient Adolescents at Final Height	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL FUNCTION; INSULIN SENSITIVITY; REPLACEMENT THERAPY; BODY-COMPOSITION; BASE-LINE; GH/IGF-I; IGF-I; RECEPTOR; CHILDREN	Context, objective: Growth hormone deficiency (GHD) is associated with insulin resistance and diabetes, in particular after treatment in children and adults with pre-existing metabolic risk factors. Our aims were. i) to evaluate the effect on glucose metabolism of rhGH treatment and withdrawal in not confirmed GHD adolescents at the achievement of adult height; ii) to investigate the impact of GH receptor gene genomic deletion of exon 3 (d3GHR). Design, setting: We performed a longitudinal study (1 year) in a tertiary care center. Methods: 23 GHD adolescent were followed in the last year of rhGH treatment (T0), 6 (T6) and 12 (T12) months after rhGH withdrawal with fasting and post-OGTT evaluations. 40 healthy adolescents were used as controls. HOMA-IR, HOMA%beta, insulinogenic (INS) and disposition (DI) indexes were calculated. GHR genotypes were determined by multiplex PCR. Results: In the group as a whole, fasting insulin (p<0.05), HOMA-IR (p<0.05), insulin and glucose levels during OGTT (p<0.01) progressively decreased from T0 to T12 becoming similar to controls. During rhGH, a compensatory insulin secretion with a stable DI was recorded, and, then, HOMA beta and INS decreased at T6 and T12 (p<0.05). By evaluating the GHR genotype, nDel GHD showed a decrease from T0 to T12 in HOMA-IR, HOMAb, INS (p<0.05) and DI. Del GHD showed a gradual increase in DI (p<0.05) and INS with a stable HOMA-IR and higher HDL-cholesterol (p<0.01). Conclusions: In not confirmed GHD adolescents the fasting deterioration in glucose homeostasis during rhGH is efficaciously coupled with a compensatory insulin secretion and activity at OGTT. The presence of at least one d3GHR allele is associated with lower glucose levels and higher HOMA-beta and DI after rhGH withdrawal. Screening for the d3GHR in the pediatric age may help physicians to follow and phenotype GHD patients also by a metabolic point of view.	[Prodam, Flavia; Savastio, Silvia; Genoni, Giulia; Ricotti, Roberta; Bona, Gianni; Bellone, Simonetta] Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy; [Prodam, Flavia; Aimaretti, Gianluca; Bellone, Simonetta] Univ Piemonte Orientale, Dept Clin & Expt Med, Novara, Italy; [Prodam, Flavia; Giordano, Mara; Bona, Gianni; Bellone, Simonetta] ICOS, Novara, Italy; [Babu, Deepak; Giordano, Mara] Univ Piemonte Orientale, Dept Hlth Sci, Lab Human Genet, Novara, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Prodam, F (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dept Hlth Sci, Div Pediat, Novara, Italy.	flavia.prodam@med.unipmn.it	Savastio, Silvia/AAC-6475-2022; GIORDANO, Mara/AAB-1379-2019; Bellone, Simonetta/K-2196-2016	Savastio, Silvia/0000-0002-5867-3246; GIORDANO, Mara/0000-0001-6686-4600; Prodam, Flavia/0000-0001-9660-5335; BELLONE, Simonetta/0000-0001-8521-497X	Regione Piemonte [2827]; Universita del Piemonte Orientale "A. Avogadro"; Ministero dell'Universita e della Ricerca Scientifica (MIUR) [20082P8CCE]	Regione Piemonte(Regione Piemonte); Universita del Piemonte Orientale "A. Avogadro"; Ministero dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by Regione Piemonte (grant no 2827, 2008), Universita del Piemonte Orientale "A. Avogadro", Ministero dell'Universita e della Ricerca Scientifica (MIUR, grant no 20082P8CCE, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Appelman-Dijkstra NM, 2013, EUR J ENDOCRINOL, V169, pR1, DOI 10.1530/EJE-12-1088; Arafat AM, 2010, DIABETOLOGIA, V53, P1304, DOI 10.1007/s00125-010-1738-4; Bramnert M, 2003, J CLIN ENDOCR METAB, V88, P1455, DOI 10.1210/jc.2002-020542; Bulow B, 1999, CLIN ENDOCRINOL, V50, P45, DOI 10.1046/j.1365-2265.1999.00595.x; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Carroll PV, 2004, J CLIN ENDOCR METAB, V89, P3890, DOI 10.1210/jc.2003-031588; Child CJ, 2011, J CLIN ENDOCR METAB, V96, pE1025, DOI 10.1210/jc.2010-3023; Corneli G, 2007, EUR J ENDOCRINOL, V157, P701, DOI 10.1530/EJE-07-0384; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Dos Santos C, 2004, NAT GENET, V36, P720, DOI 10.1038/ng1379; Filopanti M, 2011, J ENDOCRINOL INVEST, V34, P861, DOI 10.1007/BF03346731; Gao LL, 2011, PEDIATR DIABETES, V12, P429, DOI 10.1111/j.1399-5448.2010.00747.x; Giannini C, 2012, DIABETES, V61, P606, DOI 10.2337/db11-1111; Giavoli C, 2010, EUR J ENDOCRINOL, V163, P361, DOI 10.1530/EJE-10-0317; Gungor N, 2004, J PEDIATR-US, V144, P656, DOI 10.1016/j.jpeds.2003.12.045; Heptulla RA, 1997, J CLIN ENDOCR METAB, V82, P3234, DOI 10.1210/jc.82.10.3234; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Horan M, 2006, HUM GENET, V119, P527, DOI 10.1007/s00439-006-0166-5; JORGENSEN JOL, 1993, J CLIN ENDOCR METAB, V77, P1589, DOI 10.1210/jc.77.6.1589; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Lee SJ, 2008, J PEDIATR-US, V152, P177, DOI 10.1016/j.jpeds.2007.07.053; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MOLLER N, 1989, DIABETOLOGIA, V32, P105, DOI 10.1007/BF00505182; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Norrelund H, 2000, J CLIN ENDOCR METAB, V85, P1912, DOI 10.1210/jc.85.5.1912; Oliveira CRP, 2011, ARQ BRAS CARDIOL, V97, P434, DOI 10.1590/S0066-782X2011001400012; Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200; Radetti G, 2004, CLIN ENDOCRINOL, V61, P473, DOI 10.1111/j.1365-2265.2004.02113.x; Rosenfalck AM, 2000, J CLIN ENDOCR METAB, V85, P4173, DOI 10.1210/jc.85.11.4173; Schneider HJ, 2011, EUR J ENDOCRINOL, V164, P223, DOI 10.1530/EJE-10-0963; Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813; Seminara S, 1998, CLIN ENDOCRINOL, V49, P125, DOI 10.1046/j.1365-2265.1998.00502.x; Smith TR, 1997, AM J PHYSIOL-ENDOC M, V272, pE1071, DOI 10.1152/ajpendo.1997.272.6.E1071; Sorensen K, 2009, J CLIN ENDOCR METAB, V94, P2966, DOI 10.1210/jc.2009-0313; Strawbridge RJ, 2007, GROWTH HORM IGF RES, V17, P392, DOI 10.1016/j.ghir.2007.04.005; Svensson J, 2002, J CLIN ENDOCR METAB, V87, P2121, DOI 10.1210/jc.87.5.2121; Takada D, 2003, AM J MED GENET A, V121A, P136, DOI 10.1002/ajmg.a.20172; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; van der Kaay D, 2010, EUR J ENDOCRINOL, V162, P887, DOI 10.1530/EJE-09-1113; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	46	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87157	10.1371/journal.pone.0087157	http://dx.doi.org/10.1371/journal.pone.0087157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498035	Green Submitted, gold, Green Published			2022-12-27	WOS:000330617100055
J	Xu, AM; Huang, L; Liu, W; Gao, S; Han, WX; Wei, ZJ				Xu, A-Man; Huang, Lei; Liu, Wei; Gao, Shuang; Han, Wen-Xiu; Wei, Zhi-Jian			Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							PHASE-II TRIAL; PREOPERATIVE CHEMOTHERAPY; PLUS CISPLATIN; PERIOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; D2 GASTRECTOMY; CANCER; S-1; PACLITAXEL; MULTICENTER	Background: The effect of neoadjuvant chemotherapy (NAC) on Gastric carcinoma (GC) has been extensively studied, while its survival and surgical benefits remain controversial. This study aims to perform a meta-analysis of high-quality randomized controlled trials (RCTs), comparing efficacy, safety and other outcomes of NAC followed by surgery with surgery alone (SA) for GC. Methods: We systematically searched databases of MEDLINE, EMBASE, The Cochrane Library and Springer for RCTs comparing NAC with SA when treating GC. Reference lists of relevant articles and reviews, conference proceedings and ongoing trial databases were also searched. Primary outcomes were 3-year and 5-year survival rates, survival time, and total and perioperative mortalities. Secondary outcomes included down-staging effects, R0 resection rate, and postoperative complications. Meta-analysis was conducted where possible comparing items using relative risks (RRs) and weighted mean differences (WMDs) according to type of data. NAC-related objective response, safety and toxicity were also specifically analyzed. Results: A total of 9 RCTs comparing NAC (n = 511) with SA (n = 545) published from 1995 to 2010 were identified. SA tended to be accompanied with higher overall mortality rate than NAC (46.03% vs 40.61%, RR: 0.83, 95% CI: 0.65-1.06, P = 0.14). Significantly, higher incidence of cases without regional lymph node metastasis observed upon resection were achieved among patients receiving NAC than those undergoing SA (25.68% vs 16.95%, RR: 1.92, 95% CI: 1.20-3.06, P = 0.006). All other parameters were comparable. Of the evaluable patients, 43.0% demonstrated either complete or partial response. The comprehensive NAC-related side-effect rate was 18.2% among patients available for safety assessment. Conclusions: NAC contributes to lowering nodal stages, and potentially reduces overall mortality. Response rate may be an important influential factor impacting advantages, with chemotherapy-related adverse effects as a drawback. This level 1a evidence doesn't support NAC to outweigh SA in terms of survival and surgical benefits when dealing with GC.	[Xu, A-Man; Huang, Lei; Gao, Shuang; Han, Wen-Xiu; Wei, Zhi-Jian] Anhui Med Univ, Hefei, Peoples R China; [Xu, A-Man; Huang, Lei; Han, Wen-Xiu; Wei, Zhi-Jian] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China; [Liu, Wei] Sun Yat Sen Univ, Guangdong Prov Key Lab Liver Dis Res, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Shuang] Anhui Med Univ, Dept Med Oncol, Affiliated Hosp 1, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Sun Yat Sen University; Anhui Medical University	Huang, L (corresponding author), Anhui Med Univ, Hefei, Peoples R China.	huangleizhenting@126.com	Huang, Lei/AFJ-8406-2022; Liu, Wei/AAH-5037-2020	Huang, Lei/0000-0002-4225-9200; Liu, Wei/0000-0002-4935-7591	State 973 National Basic Research Program of China [2009CB522404]; National Natural Science Foundation of China [81172036, 81170451, 81170452]; 985 Project [82000-3281901]; Doctoral Fund of Ministry of Education of China [20100171120107, 20120171110082]; Foundation of Anhui Science and Technology Agency [12070403061]; Natural Science Foundation of Guangdong Province [10151008901000208]	State 973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 985 Project(Jilin UniversityXiamen University); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Foundation of Anhui Science and Technology Agency; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by State 973 National Basic Research Program of China (2009CB522404), National Natural Science Foundation of China (81172036, 81170451, 81170452), 985 Project (82000-3281901), Doctoral Fund of Ministry of Education of China (20100171120107, 20120171110082), Foundation of Anhui Science and Technology Agency (12070403061), as well as Natural Science Foundation of Guangdong Province (10151008901000208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Biffi R, 2010, WORLD J GASTROENTERO, V16, P868, DOI 10.3748/wjg.v16.i7.868; Bolke E, 2011, DEUT MED WOCHENSCHR, V136, P2205, DOI 10.1055/s-0031-1292034; Chau I, 2009, ANN ONCOL, V20, P885, DOI 10.1093/annonc/mdn716; Chen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045388; Chen MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039655; Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dikken JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-329; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Fushida S, 2012, JPN J CLIN ONCOL, V42, P131, DOI 10.1093/jjco/hyr183; Ge L, 2012, WORLD J GASTROENTERO, V18, P7384, DOI 10.3748/wjg.v18.i48.7384; Hartgrink HH, 2004, EJSO-EUR J SURG ONC, V30, P643, DOI 10.1016/j.ejso.2004.04.013; Hasegawa S, 2013, ANN SURG ONCOL, V20, P2016, DOI 10.1245/s10434-012-2817-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Imano M, 2010, EJSO-EUR J SURG ONC, V36, P963, DOI 10.1016/j.ejso.2010.06.012; Inoue K, 2012, EJSO-EUR J SURG ONC, V38, P143, DOI 10.1016/j.ejso.2011.11.009; Iwase H, 2011, ONCOLOGY-BASEL, V80, P76, DOI 10.1159/000328746; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang YK, 1996, ASCO ANN M; Kim JY, 2011, CANCER CHEMOTH PHARM, V67, P527, DOI 10.1007/s00280-010-1353-6; Kinoshita T, 2009, GASTRIC CANCER, V12, P37, DOI 10.1007/s10120-008-0496-1; Kobayashi T, 2000, Gan To Kagaku Ryoho, V27, P1521; Kodera Y, 2012, GASTRIC CANCER, V15, P335, DOI 10.1007/s10120-012-0156-3; Kodera Y, 2010, GASTRIC CANCER, V13, P197, DOI 10.1007/s10120-010-0559-y; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Li QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053403; Li W, 2010, WORLD J GASTROENTERO, V16, P5621, DOI 10.3748/wjg.v16.i44.5621; Liao Y, 2013, J GASTROEN HEPATOL, V28, P777, DOI 10.1111/jgh.12152; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lygidakis NJ, 1999, HEPATO-GASTROENTEROL, V46, P2035; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Misra S, 2012, J SURG RES, V178, P623, DOI 10.1016/j.jss.2012.04.062; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nashimoto A, 2009, ANTICANCER RES, V29, P4689; Nio Y, 2004, ANTICANCER RES, V24, P1879; Nishikawa K, 2012, GASTRIC CANCER, V15, P363, DOI 10.1007/s10120-011-0124-3; Nishiyama M, 2009, GASTRIC CANCER, V12, P132, DOI 10.1007/s10120-009-0521-z; Okines A, 2010, ANN ONCOL, V21, pv50, DOI 10.1093/annonc/mdq164; Ott K, 2011, LANGENBECK ARCH SURG, V396, P743, DOI 10.1007/s00423-010-0738-7; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Sakamoto J, 2009, GASTRIC CANCER, V12, P69, DOI 10.1007/s10120-009-0505-z; Sant M, 2009, EUR J CANCER, V45, P931, DOI 10.1016/j.ejca.2008.11.018; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Schuhmacher C, 2010, J CLIN ONCOL, V28, P5210, DOI 10.1200/JCO.2009.26.6114; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; SHCHEPOTIN IB, 1995, ONCOL REP, V2, P473; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takahari D, 2011, CANCER CHEMOTH PHARM, V67, P1423, DOI 10.1007/s00280-010-1432-8; Tsuburaya A, 2013, CANCER CHEMOTH PHARM, V71, P1309, DOI 10.1007/s00280-013-2130-0; Untch M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2227; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wang LB, 2012, J SURG ONCOL, V105, P293, DOI 10.1002/jso.22085; Wang XL, 2000, ONCOL REP, V7, P241; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261; Zhao WH, 2006, WORLD J GASTROENTERO, V12, P1356, DOI 10.3748/wjg.v12.i9.1356; WILKE H, 1989, J CLIN ONCOL, V7, P1318, DOI 10.1200/JCO.1989.7.9.1318; Wu A., 2007, COCHRANE DATABASE SY; Wu AW, 2012, WORLD J GASTRO SURG, V4, P27, DOI 10.4240/wjgs.v4.i2.27; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; YONEMURA Y, 1993, WORLD J SURG, V17, P256, DOI 10.1007/BF01658939; Yoshikawa T, 2010, EJSO-EUR J SURG ONC, V36, P546, DOI 10.1016/j.ejso.2010.04.011; Yoshikawa T, 2009, BRIT J SURG, V96, P1015, DOI 10.1002/bjs.6665; Yoshikawa T, 2012, NAT REV CLIN ONCOL, V9, P192, DOI 10.1038/nrclinonc.2012.23; Yoshikawa T, 2010, JPN J CLIN ONCOL, V40, P369, DOI 10.1093/jjco/hyp178; Zhang CW, 2004, WORLD J GASTROENTERO, V10, P3070	80	60	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86941	10.1371/journal.pone.0086941	http://dx.doi.org/10.1371/journal.pone.0086941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497999	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100041
J	Abarca, N; Jahn, R; Zimmermann, J; Enke, N				Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela			Does the Cosmopolitan Diatom Gomphonema parvulum (Kutzing) Kutzing Have a Biogeography?	PLOS ONE			English	Article							BACILLARIOPHYTA; TYPIFICATION; DISPERSAL; DIVERSITY; PATTERNS; PROVIDE; AFRICA; TAXA	Diatom cultures of the G. parvulum species complex were established from seven different sites in the Faroe Islands, Sweden, Germany, Mexico and Korea, and were studied in detail. Eight morphodemes were identified which corresponded to the descriptions of the cosmopolitan taxon G. parvulum (Kutzing) Kutzing sensu lato: its nominate variety (var. parvulum), G. parvulum var. exilissimum Grunow and G. parvulum f. saprophilum Lange-Bertalot & Reichardt, G. [parvulum var.] lagenula Kutzing plus four unidentifiable morphodemes. The concatenated analysis of the sequences of the markers 18SV4, rbcL, and ITS as well as morphological data resulted in a separation of four taxa based on their biogeography in Mexico, Korea, central Continental Europe and Northern Atlantic Europe. Mantel tests showed a significant correlation between molecular and geographical distances. The diagnoses of two taxa, G. parvulum sensu stricto, and G. lagenula, were emended, G. saprophilum elevated to species rank and epitypes designated. One species was newly described.	[Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela] Free Univ Berlin, Bot Garten, Berlin, Germany; [Abarca, Nelida; Jahn, Regine; Zimmermann, Jonas; Enke, Neela] Free Univ Berlin, Bot Museum Berlin Dahlem, Berlin, Germany; [Zimmermann, Jonas] Univ Giessen, AG Spezielle Bot, D-35390 Giessen, Germany	Free University of Berlin; Free University of Berlin; Justus Liebig University Giessen	Abarca, N (corresponding author), Free Univ Berlin, Bot Garten, Berlin, Germany.	n.abarca@bgbm.org		Zimmermann, Jonas/0000-0002-0522-0569	Verein der Freunde des Botanischen Gartens Berlin	Verein der Freunde des Botanischen Gartens Berlin	The authors thank the Verein der Freunde des Botanischen Gartens Berlin for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algal Flora of Korea, 2011, FRESHW DIAT 4, V3; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Bellinger BJ, 2006, HYDROBIOLOGIA, V573, P75, DOI 10.1007/s10750-006-0262-5; Besse-Lototskaya A, 2011, ECOL INDIC, V11, P456, DOI 10.1016/j.ecolind.2010.06.017; Boo SM, 2010, MOL ECOL, V19, P4328, DOI 10.1111/j.1365-294X.2010.04813.x; Carter JR, 1960, J QUEKETT MICROSCOPI, V12, P255; Cermeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010037; Chao A, 2006, OIKOS, V114, P479, DOI 10.1111/j.2006.0030-1299.14814.x; Chen GF, 2007, EUR J PHYCOL, V42, P163, DOI 10.1080/09670260601149784; Cleve PT, 1894, KONGL SVENSKA VETENS, V26; Cocquyt C, 2007, CRYPTOGAMIE ALGOL, V28, P107; Dawson PA, 1972, BRIT PHYCOL J, V7, P255, DOI DOI 10.1080/00071617200650261; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Ettl H., 1991, SUSSWASSERFLORA MITT, V2/3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlay BJ, 2002, PROTIST, V153, P261, DOI 10.1078/1434-4610-00103; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Frenguelli J, 1923, B ACAD NAC CIENC COR, V32, P11; GEITLER LOTHAR, 1932, ARCH PROTISTENK, V78, P1; Grunow A, 1878, ABH ZOOL BOT GES WIE, V10; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heiberg P.A.C., 1863, CONSPECTUS CRITICUS; Hofmann G, 2011, DIATOMEEN SUSSWASSER; HOHN MATTHEW H., 1959, NOTULAE NATURAE [PHILADELPHIA], V316, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hustedt F., 1930, S WASSER FLORA MITTE, V10; Hustedt F, 1985, KIESELALGEN DEUTSCHL, V7; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jahn R., 1986, P 8 INT DIATOM S, P191; Juttner I, 2013, DIATOM RES, V28, P303, DOI 10.1080/0269249X.2013.797924; Kaczmarska I, 2009, EUR J PHYCOL, V44, P461, DOI 10.1080/09670260902855873; Kermarrec L, 2013, PROTIST, V164, P686, DOI 10.1016/j.protis.2013.07.005; Klemencic AK, 2010, PERIOD BIOL, V112, P179; Kobayasi H, 2006, H KOBAYASISS ATLAS J, V1; Krammer K., 1986, SUSSWASSERFLORA MITT, V2/1, P1; Krienitz L, 2012, FOTTEA, V12, P231, DOI 10.5507/fot.2012.017; Kutzing F. T., 1844, KIESELSCHALIGEN BACI; KUTZING F.T., 1849, SPECIES ALGARUM; Lange-Bertalot H., 1993, BIBLIOTHECA DIATOMOL, V27, P1; Lange-Bertalot H., 1996, ICONOGR DIATOMOL, V2; Lange-Bertalot H, 1999, ICONOGR DIATOMOL, V6; LANGEBERTALOT H, 2007, P 1 CENTR EUR DIAT M, P107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mann DG, 2004, PHYCOLOGIA, V43, P459, DOI 10.2216/i0031-8884-43-4-459.1; MANTEL N, 1967, CANCER RES, V27, P209; Mayer, 1928, DENKSCHR K BAYER BOT, VXI, P83; McBride Stacy A., 1998, Diatom Research, V13, P293; Metzeltin Ditmar, 2005, V15, P7; Michels-Estrada A, 2003, THESIS TU MUNCHEN; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moser G., 1998, BIBLIOTHECA DIATOMOL, V38, P464; Mpawenayo B, 2005, BELG J BOT, V138, P152; Muller K., 2005, PHYDE 0 995 PHYLOGEN; PADISAK J, 2009, ENCY INLAND WATERS, V1, P219, DOI DOI 10.1016/B978-012370626-3.00256-8; Patrick R., 1975, ACAD NATURAL SCI PHI, V13; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulickova A, 2010, PROTIST, V161, P353, DOI 10.1016/j.protis.2009.12.003; R Core Team, 2021, R LANGUAGE ENV STAT; Rabenhorst L, 1864, FLORA EUROPACA ALGAR, V1; Rambaut A., 2008, FIGTREE V1 2 2; Reichardt E, 1999, ICONOGR DIATOMOL, V9; Romero OE, 2013, DIATOM RES, V28, P175, DOI 10.1080/0269249X.2013.770801; Ross R, 1979, NOVA HEDWIGIA S, V64, P513; Round FE, 1990, DIATOMS BIOL MORPHOL; Souffreau C, 2013, PROTIST, V164, P101, DOI 10.1016/j.protis.2012.04.001; Souffreau C, 2011, MOL PHYLOGENET EVOL, V61, P866, DOI 10.1016/j.ympev.2011.08.031; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Van Heurck H., 1896, TREATISE DIATOMACEAE; VANDAM H, 1994, NETHERLANDS J AQUATI, V28, P117, DOI DOI 10.1007/BF02334251; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; WALLACE JOHN H., 1950, BUTLER UNIV BOT STUD, V9, P227; Walley WJ, 2001, WATER RES, V35, P4285, DOI 10.1016/S0043-1354(01)00162-2; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	84	73	80	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86885	10.1371/journal.pone.0086885	http://dx.doi.org/10.1371/journal.pone.0086885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489799	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000077
J	Hilbert, A; Baldofski, S; Zenger, M; Lowe, B; Kersting, A; Braehler, E				Hilbert, Anja; Baldofski, Sabrina; Zenger, Markus; Loewe, Bernd; Kersting, Anette; Braehler, Elmar			Weight Bias Internalization Scale: Psychometric Properties and Population Norms	PLOS ONE			English	Article							PERCEIVED DISCRIMINATION; OBESITY; HEALTH; ADULTS; OVERWEIGHT; STIGMA; ASSOCIATIONS; SAMPLE	Objective: Internalizing the pervasive weight bias commonly directed towards individuals with overweight and obesity, co-occurs with increased psychopathology and impaired quality of life. This study sought to establish population norms and psychometric properties of the most widely used self-report questionnaire, the Weight Bias Internalization Scale (WBIS), in a representative community sample. Design and Methods: In a survey of the German population, N = 1158 individuals with overweight and obesity were assessed with the WBIS and self-report measures for convergent validation. Results: Item analysis revealed favorable item-total correlation of all but one WBIS item. With this item removed, item homogeneity and internal consistency were excellent. The one-factor structure of the WBIS was confirmed using confirmatory factor analysis. Convergent validity was shown through significant associations with measures of depressive and somatoform symptoms. The WBIS contributed to the explanation of variance in depressive and somatoform symptoms over and above body mass index. Higher WBIS scores were found in women than in men, in individuals with obesity than in individuals with overweight, and in those with lower education or income than those with higher education or income. Sex-specific norms were provided. Conclusions: The results showed good psychometric properties of the WBIS after removal of one item. Future research is warranted on further indicators of reliability and validity, for example, retest reliability, sensitivity to change, and prognostic validity.	[Hilbert, Anja; Baldofski, Sabrina] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr AdiposityDis, D-04109 Leipzig, Germany; [Hilbert, Anja; Baldofski, Sabrina; Zenger, Markus; Braehler, Elmar] Univ Leipzig, Med Ctr, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Loewe, Bernd] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Kersting, Anette] Univ Leipzig, Med Ctr, Clin Psychosomat Med & Psychotherapy, D-04109 Leipzig, Germany; [Braehler, Elmar] Univ Clin Giessen Marburg, Clin Psychosomat & Psychotherapy, Giessen, Germany	Leipzig University; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; University Hospital of Giessen & Marburg	Hilbert, A (corresponding author), Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr AdiposityDis, D-04109 Leipzig, Germany.	anja.hilbert@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009; Löwe, Bernd/AAG-4038-2020	Braehler, Elmar/0000-0002-2648-2728; Lowe, Bernd/0000-0003-4220-3378	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research [01EO1001]; German Research Foundation; Leipzig University	Department of Medical Psychology and Medical Sociology at the University of Leipzig; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Leipzig University	This research was supported by internal funds by the Department of Medical Psychology and Medical Sociology at the University of Leipzig and by grant 01EO1001 from the German Federal Ministry of Education and Research. We acknowledge support from the German Research Foundation and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; BOLLEN KA, 1992, SOCIOL METHOD RES, V21, P205, DOI 10.1177/0049124192021002004; Carels RA, 2010, EAT BEHAV, V11, P180, DOI 10.1016/j.eatbeh.2010.03.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; DESTATIS (Federal Statistical Office), 2013, POP 2013; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Durso LE, 2012, OBESITY FACTS, V5, P869, DOI 10.1159/000345931; Durso LE, 2012, INT J EAT DISORDER, V45, P423, DOI 10.1002/eat.20933; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Gierk B, JAMA INTERN IN PRESS; Han E, 2011, ECON HUM BIOL, V9, P381, DOI 10.1016/j.ehb.2011.07.002; Hansson LM, 2010, SCAND J PUBLIC HEALT, V38, P587, DOI 10.1177/1403494810372266; Hilbert A, 2013, OBESITY, DOI [10.1002/oby.20561, DOI 10.1002/0BY.20561.[]; Hilbert A, 2010, ESSANFAELLE ADIPOSIT; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kurth BM, 2012, BUNDESGESUNDHEITSBLA, V55, P980, DOI 10.1007/s00103-012-1504-5; Latner JD, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-3; Li W, 2009, OBES REV, V10, P87, DOI 10.1111/j.1467-789X.2008.00528.x; Lillis J, 2010, OBESITY, V18, P971, DOI 10.1038/oby.2009.353; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Pearl RL, 2013, BODY IMAGE, DOI [10.1016/j.bodyim.2013.09.005, DOI 10.1016/J.B0DYIM.2013.09.005.[]; Puhl RM, 2007, OBESITY, V15, P19, DOI 10.1038/oby.2007.521; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Roberto CA, 2012, OBESITY, V20, P533, DOI 10.1038/oby.2011.123; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schollgen I, 2011, HEALTH PSYCHOL, V30, P326, DOI 10.1037/a0022514; Visscher TLS, 2006, OBESITY, V14, P2054, DOI 10.1038/oby.2006.240	31	85	86	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86303	10.1371/journal.pone.0086303	http://dx.doi.org/10.1371/journal.pone.0086303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489713	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000031
J	Huang, AH; Xu, SZ; Cai, XD				Huang, Anhui; Xu, Shizhong; Cai, Xiaodong			Whole-Genome Quantitative Trait Locus Mapping Reveals Major Role of Epistasis on Yield of Rice	PLOS ONE			English	Article							EMPIRICAL BAYESIAN LASSO; FUNCTIONAL GENOMICS; DRAFT SEQUENCE; GENETIC-BASIS; HYBRID; POPULATION; SELECTION; QTLS; REGRESSION; HETEROSIS	Although rice yield has been doubled in most parts of the world since 1960s, thanks to the advancements in breeding technologies, the biological mechanisms controlling yield are largely unknown. To understand the genetic basis of rice yield, a number of quantitative trait locus (QTL) mapping studies have been carried out, but whole-genome QTL mapping incorporating all interaction effects is still lacking. In this paper, we exploited whole-genome markers of an immortalized F-2 population derived from an elite rice hybrid to perform QTL mapping for rice yield characterized by yield per plant and three yield component traits. Our QTL model includes additive and dominance main effects of 1,619 markers and all pair-wise interactions, with a total of more than 5 million possible effects. The QTL mapping identified 54, 5, 28 and 4 significant effects involving 103, 9, 52 and 7 QTLs for the four traits, namely the number of panicles per plant, the number of grains per panicle, grain weight, and yield per plant. Most identified QTLs are involved in digenic interactions. An extensive literature survey of experimentally characterized genes related to crop yield shows that 19 of 54 effects, 4 of 5 effects, 12 of 28 effects and 2 of 4 effects for the four traits, respectively, involve at least one QTL that locates within 2 cM distance to at least one yield-related gene. This study not only reveals the major role of epistasis influencing rice yield, but also provides a set of candidate genetic loci for further experimental investigation.	[Huang, Anhui; Cai, Xiaodong] Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; [Xu, Shizhong] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of Miami; University of California System; University of California Riverside	Cai, XD (corresponding author), Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA.	x.cai@miami.edu			National Science Foundation (NSF) [0746882]; Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program [2007-35300-18285]; Division of Computing and Communication Foundations [0746882] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (NSF) under NSF CAREER Award no. 0746882 to XC and by the Agriculture and Food Research Initiative (AFRI) of the USDA National Institute of Food and Agriculture under the Plant Genome, Genetics and Breeding Program 2007-35300-18285 to SX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; de Los Campos Gustavo, 2013, Methods Mol Biol, V1019, P299, DOI 10.1007/978-1-62703-447-0_12; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Huang AH, 2013, BMC GENET, V13, DOI 10.1186/1471-2156-14-5; Ikeda M, 2013, CURR OPIN PLANT BIOL, V16, P213, DOI 10.1016/j.pbi.2013.02.002; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jiang YH, 2012, BIOTECHNOL ADV, V30, P1059, DOI 10.1016/j.biotechadv.2011.08.013; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; LANDER ES, 1989, GENETICS, V121, P185; Li F, 2010, CELL RES, V20, P838, DOI 10.1038/cr.2010.69; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; R Development Core Team, 2012, R LANG ENV STAT COMP; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Song XJ, 2008, RICE, V1, P135, DOI 10.1007/s12284-008-9018-3; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang ET, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-108; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu SZ, 2003, GENETICS, V163, P789; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yi NJ, 2009, GENETICS, V181, P1101, DOI 10.1534/genetics.108.099556; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZENG ZB, 1994, GENETICS, V136, P1457; Zha XJ, 2009, PLANT BIOTECHNOL J, V7, P611, DOI 10.1111/j.1467-7652.2009.00428.x; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	47	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87330	10.1371/journal.pone.0087330	http://dx.doi.org/10.1371/journal.pone.0087330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489897	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000132
J	Kahn, JG; Jiwani, A; Gomez, GB; Hawkes, SJ; Chesson, HW; Broutet, N; Kamb, ML; Newman, LM				Kahn, James G.; Jiwani, Aliya; Gomez, Gabriela B.; Hawkes, Sarah J.; Chesson, Harrell W.; Broutet, Nathalie; Kamb, Mary L.; Newman, Lori M.			The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUALLY-TRANSMITTED INFECTIONS; ANTENATAL SYPHILIS; CONGENITAL-SYPHILIS; DIAGNOSTIC-ACCURACY; MATERNAL SYPHILIS; CARE; OUTCOMES; METAANALYSIS; PREVALENCE	Background: Syphilis in pregnancy imposes a significant global health and economic burden. More than half of cases result in serious adverse events, including infant mortality and infection. The annual global burden from mother-to-child transmission (MTCT) of syphilis is estimated at 3.6 million disability-adjusted life years (DALYs) and $309 million in medical costs. Syphilis screening and treatment is simple, effective, and affordable, yet, worldwide, most pregnant women do not receive these services. We assessed cost-effectiveness of scaling-up syphilis screening and treatment in existing antenatal care (ANC) programs in various programmatic, epidemiologic, and economic contexts. Methods and Findings: We modeled the cost, health impact, and cost-effectiveness of expanded syphilis screening and treatment in ANC, compared to current services, for 1,000,000 pregnancies per year over four years. We defined eight generic country scenarios by systematically varying three factors: current maternal syphilis testing and treatment coverage, syphilis prevalence in pregnant women, and the cost of healthcare. We calculated program and net costs, DALYs averted, and net costs per DALY averted over four years in each scenario. Program costs are estimated at $4,142,287 - $8,235,796 per million pregnant women (2010 USD). Net costs, adjusted for averted medical care and current services, range from net savings of $12,261,250 to net costs of $1,736,807. The program averts an estimated 5,754 - 93,484 DALYs, yielding net savings in four scenarios, and a cost per DALY averted of $24 - $111 in the four scenarios with net costs. Results were robust in sensitivity analyses. Conclusions: Eliminating MTCT of syphilis through expanded screening and treatment in ANC is likely to be highly cost-effective by WHO-defined thresholds in a wide range of settings. Countries with high prevalence, low current service coverage, and high healthcare cost would benefit most. Future analyses can be tailored to countries using local epidemiologic and programmatic data.	[Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kahn, James G.] Super Models Global Hlth, Berkeley, CA USA; [Jiwani, Aliya] Super Models Global Hlth, Arlington, VA 22203 USA; [Gomez, Gabriela B.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hawkes, Sarah J.] UCL, UCL Inst Global Hlth, London, England; [Chesson, Harrell W.; Kamb, Mary L.] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA; [Broutet, Nathalie; Newman, Lori M.] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Centers for Disease Control & Prevention - USA; World Health Organization	Jiwani, A (corresponding author), Super Models Global Hlth, Arlington, VA 22203 USA.	ajiwani@gmail.com	Hawkes, Sarah/AAK-7375-2020	Hawkes, Sarah/0000-0003-1062-3538	World Health Organization; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by a grant from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X; [Anonymous], 2012, CHOOS INT AR COST EF; Blandford JM, 2007, SEX TRANSM DIS, V34, pS61, DOI 10.1097/01.olq.0000258314.20752.5f; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Hossain M, 2007, SEX TRANSM DIS, V34, pS22, DOI 10.1097/01.olq.0000261049.84824.40; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Jamison DT, 2006, GLOBAL BURDEN DIS RI; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lujan J, 2008, SAMJ S AFR MED J, V98, P49; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Mehta SD, 2006, JAIDS-J ACQ IMM DEF, V42, P116, DOI 10.1097/01.qai.0000200662.40215.34; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P997, DOI 10.1097/OLQ.0b013e3182260987; Peeling RW, 2006, SEX TRANSM INFECT, V82, P425, DOI 10.1136/sti.2005.017251; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; STIGMA, 2019, GUID MAN SEX TRANSM; Terris-Prestholt F, 2003, SEX TRANSM INFECT, V79, P375, DOI 10.1136/sti.79.5.375; Tinajeros F, 2006, SEX TRANSM INFECT, V82, pV17, DOI 10.1136/sti.2006.022640; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; World Bank, 2010, GDP PER CAP CURR US; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2008, COUNTD 2015 TRACK PR; World Health Organization, 2013, WHO CHOICE COUNTR SP; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2008, GLOB HLTH OBS DAT RE; World Health Organization, 2012, INV CAS EL MOTH TO C; World Health Organization, 2011, CHOOSING INT AR COST	35	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87510	10.1371/journal.pone.0087510	http://dx.doi.org/10.1371/journal.pone.0087510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489931	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330570000156
J	Leitner, NR; Lassnig, C; Rom, R; Heider, S; Bago-Horvath, Z; Eferl, R; Muller, S; Kolbe, T; Kenner, L; Rulicke, T; Strobl, B; Muller, M				Leitner, Nicole R.; Lassnig, Caroline; Rom, Rita; Heider, Susanne; Bago-Horvath, Zsuzsanna; Eferl, Robert; Mueller, Simone; Kolbe, Thomas; Kenner, Lukas; Ruelicke, Thomas; Strobl, Birgit; Mueller, Mathias			Inducible, Dose-Adjustable and Time-Restricted Reconstitution of Stat1 Deficiency In Vivo	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; ENCEPHALOMYOCARDITIS VIRUS; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; TARGETED DISRUPTION; GENE-EXPRESSION; TRANSGENIC MICE; VIRAL DISEASE; INTERFERON; MUTATIONS	Signal transducer and activator of transcription (STAT) 1 is a key player in interferon (IFN) signaling, essential in mediating host defense against viruses and other pathogens. STAT1 levels are tightly regulated and loss-or gain-of-function mutations in mice and men lead to severe diseases. We have generated a doxycycline (dox) -inducible, FLAG-tagged Stat1 expression system in mice lacking endogenous STAT1 (i.e. Stat1(ind) mice). We show that STAT1 expression depends on the time and dose of dox treatment in primary cells and a variety of organs isolated from Stat1(ind) mice. In bone marrow-derived macrophages, a fraction of the amount of STAT1 present in WT cells is sufficient for full expression of IFN-induced genes. Dox-induced STAT1 established protection against virus infections in primary cells and mice. The availability of the Stat1(ind) mouse model will enable an examination of the consequences of variable amounts of STAT1. The model will also permit the study of STAT1 dose-dependent and reversible functions as well as of STAT1's contributions to the development, progression and resolution of disease.	[Leitner, Nicole R.; Lassnig, Caroline; Rom, Rita; Bago-Horvath, Zsuzsanna; Mueller, Simone; Strobl, Birgit; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Lassnig, Caroline; Kolbe, Thomas; Mueller, Mathias] Univ Vet Med Vienna, Univ Ctr Biomodels Austria BIAT, Vienna, Austria; [Heider, Susanne; Bago-Horvath, Zsuzsanna; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Heider, Susanne; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Bago-Horvath, Zsuzsanna] Univ Vet Med Vienna, Inst Pharmacol & Toxicol, Vienna, Austria; [Eferl, Robert] Med Univ Vienna, Inst Canc Res, Dept Internal Med 1, Ctr Comprehens Canc, Vienna, Austria; [Kolbe, Thomas] Univ Nat Resources & Appl Life Sci, Dept IFA Tulln, Tulln, Austria; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna	Leitner, NR (corresponding author), Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria.	nicole.leitner@vetmeduni.ac.at; mathias.mueller@vetmeduni.ac.at	Kolbe, Thomas/H-8215-2018	Kolbe, Thomas/0000-0003-2974-8066; Muller, Mathias/0000-0002-7879-3552; Eferl, Robert/0000-0002-6074-7144; Strobl, Birgit/0000-0001-5716-3212; Kenner, Lukas/0000-0003-2184-1338; LASSNIG, Caroline/0000-0001-7905-3620	Austrian Science Fund [SFB-F28]; Austrian Genome Research Programme GEN-AU II and III "Austromouse"	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Genome Research Programme GEN-AU II and III "Austromouse"	This work was supported by the Austrian Science Fund SFB-F28 "JAK-STAT" and the Austrian Genome Research Programme GEN-AU II and III "Austromouse." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders K, 2012, TRANSGENIC RES, V21, P1099, DOI 10.1007/s11248-011-9580-0; Averbuch D, 2011, PEDIATR INFECT DIS J, V30, P352, DOI 10.1097/INF.0b013e3181fdff4a; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Baran-Marszak F, 2004, BLOOD, V104, P2475, DOI 10.1182/blood-2003-10-3508; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BOCKER R, 1984, ARZNEIMITTEL-FORSCH, V34-1, P446; BOCKER R, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2116; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Chen LS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-22; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Choi J, 2013, BREAST CANCER RES TR, V137, P417, DOI 10.1007/s10549-012-2383-z; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Doi K, 2011, J COMP PATHOL, V144, P25, DOI 10.1016/j.jcpa.2010.05.001; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Gil MP, 2006, BLOOD, V107, P987, DOI 10.1182/blood-2005-07-2834; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Guleria A, 2011, J BIOSCIENCES, V36, P929, DOI 10.1007/s12038-011-9164-4; Hannesdottir L, 2012, INT J DEV BIOL, V56, P279, DOI 10.1387/ijdb.113397lh; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hori T, 2012, J CLIN IMMUNOL, V32, P1213, DOI 10.1007/s10875-012-9744-6; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Klover PJ, 2010, NEOPLASIA, V12, P899, DOI 10.1593/neo.10716; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; Kong XF, 2010, BLOOD, V116, P5895, DOI 10.1182/blood-2010-04-280586; Koromilas Antonis E, 2013, JAKSTAT, V2, pe23353, DOI 10.4161/jkst.23353; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Kristensen IA, 2011, J CLIN IMMUNOL, V31, P265, DOI 10.1007/s10875-010-9480-8; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; Leitner NR, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-48; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Meyer T, 2002, EMBO J, V21, P344, DOI 10.1093/emboj/21.3.344; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Ohtaki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00367; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Prchal-Murphy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039141; Raven JF, 2011, CELL CYCLE, V10, P794, DOI 10.4161/cc.10.5.14956; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Romberg N, 2013, J ALLERGY CLIN IMMUN, V131, P1691, DOI 10.1016/j.jaci.2013.01.004; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Schneckenleithner C, 2011, ONCOTARGET, V2, P1043; Schonig K, 2013, TRANSGENIC RES, V22, P251, DOI 10.1007/s11248-012-9660-9; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Takiguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054009; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; VOGEL SN, 1987, J VIROL, V61, P812, DOI 10.1128/JVI.61.3.812-818.1987; Wallner B, 2012, TRANSGENIC RES, V21, P217, DOI 10.1007/s11248-011-9519-5; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114	77	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86608	10.1371/journal.pone.0086608	http://dx.doi.org/10.1371/journal.pone.0086608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489749	Green Submitted, gold, Green Published			2022-12-27	WOS:000330570000050
J	Priest, HD; Fox, SE; Rowley, ER; Murray, JR; Michael, TP; Mockler, TC				Priest, Henry D.; Fox, Samuel E.; Rowley, Erik R.; Murray, Jessica R.; Michael, Todd P.; Mockler, Todd C.			Analysis of Global Gene Expression in Brachypodium distachyon Reveals Extensive Network Plasticity in Response to Abiotic Stress	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; HIGH-SALINITY; COLD STRESS; RUBISCO ACTIVASE; PLANT-RESPONSES; GENOME SEQUENCE; DOWN-REGULATION; LOW-TEMPERATURE; ARABIDOPSIS; DROUGHT	Brachypodium distachyon is a close relative of many important cereal crops. Abiotic stress tolerance has a significant impact on productivity of agriculturally important food and feedstock crops. Analysis of the transcriptome of Brachypodium after chilling, high-salinity, drought, and heat stresses revealed diverse differential expression of many transcripts. Weighted Gene Co-Expression Network Analysis revealed 22 distinct gene modules with specific profiles of expression under each stress. Promoter analysis implicated short DNA sequences directly upstream of module members in the regulation of 21 of 22 modules. Functional analysis of module members revealed enrichment in functional terms for 10 of 22 network modules. Analysis of condition-specific correlations between differentially expressed gene pairs revealed extensive plasticity in the expression relationships of gene pairs. Photosynthesis, cell cycle, and cell wall expression modules were down-regulated by all abiotic stresses. Modules which were up-regulated by each abiotic stress fell into diverse and unique gene ontology GO categories. This study provides genomics resources and improves our understanding of abiotic stress responses of Brachypodium.	[Priest, Henry D.; Rowley, Erik R.; Murray, Jessica R.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Priest, Henry D.; Mockler, Todd C.] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Fox, Samuel E.; Rowley, Erik R.; Mockler, Todd C.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Fox, Samuel E.; Rowley, Erik R.; Mockler, Todd C.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst, New Brunswick, NJ 08903 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Donald Danforth Plant Science Center; Washington University (WUSTL); Oregon State University; Oregon State University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Mockler, TC (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	tmockler@danforthcenter.org	Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Priest, Henry/0000-0002-0998-8137	TCM from the DOE - Plant Feedstock Genomics for Bioenergy Program [DE-FG02-08ER64630]; Direct For Biological Sciences [1025965] Funding Source: National Science Foundation	TCM from the DOE - Plant Feedstock Genomics for Bioenergy Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant to TCM (DE-FG02-08ER64630) from the DOE - Plant Feedstock Genomics for Bioenergy Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranjuelo I, 2011, J EXP BOT, V62, P111, DOI 10.1093/jxb/erq249; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Ashraf M, 2010, J MED PLANTS RES, V4, P112; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Chew YH, 2011, CURR OPIN BIOTECH, V22, P281, DOI 10.1016/j.copbio.2010.11.011; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feltus FA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-44; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fisher R.A., 1963, STAT TABLES BIOL AGR, V6th; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haga N, 2011, PLANT PHYSIOL, V157, P706, DOI 10.1104/pp.111.180836; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janska A, 2011, FUNCT INTEGR GENOMIC, V11, P307, DOI 10.1007/s10142-011-0213-8; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim K, 2005, PLANT CELL PHYSIOL, V46, P522, DOI 10.1093/pcp/pci052; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lauria M, 2011, BBA-GENE REGUL MECH, V1809, P369, DOI 10.1016/j.bbagrm.2011.03.002; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-65; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim H, 2009, MOL CELLS, V27, P641, DOI 10.1007/s10059-009-0085-0; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; LOPUSHINSKY W, 1969, BOT GAZ, V130, P258, DOI 10.1086/336501; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Marino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2479; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Mukhopadhyay P, 2013, PLANT CELL PHYSIOL, V54, P528, DOI 10.1093/pcp/pct012; Oliveira G, 2004, PLANT ECOL, V175, P179, DOI 10.1007/s11258-005-4876-x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parre E, 2007, PLANT PHYSIOL, V144, P503, DOI 10.1104/pp.106.095281; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Rowley ER, 2011, INTECH OPEN ACCESS J; Salvucci ME, 2001, PLANT PHYSIOL, V127, P1053, DOI 10.1104/pp.010357; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Turano FJ, 1998, PLANT PHYSIOL, V117, P1411, DOI 10.1104/pp.117.4.1411; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Witcombe JR, 2008, PHILOS T R SOC B, V363, P703, DOI 10.1098/rstb.2007.2179; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yazaki J, 2004, PHYSIOL GENOMICS, V17, P87, DOI 10.1152/physiolgenomics.00201.2003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhao HJ, 2005, PHOTOSYNTHETICA, V43, P473, DOI 10.1007/s11099-005-0076-0; Zhong L, 2009, AFR J BIOTECHNOL, V8, P6201; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	71	63	64	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87499	10.1371/journal.pone.0087499	http://dx.doi.org/10.1371/journal.pone.0087499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489928	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000154
J	Rojo-Arreola, L; Long, T; Asarnow, D; Suzuki, BM; Singh, R; Caffrey, CR				Rojo-Arreola, Liliana; Long, Thavy; Asarnow, Dan; Suzuki, Brian M.; Singh, Rahul; Caffrey, Conor R.			Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis	PLOS ONE			English	Article							HMG-COA REDUCTASE; MEVALONATE PATHWAY; IN-VITRO; PROTEIN PRENYLATION; ANTISCHISTOSOMAL ACTION; MOLECULAR-MECHANISMS; MANSONI; CANCER; INHIBITORS; PARASITE	The mevalonate pathway is essential in eukaryotes and responsible for a diversity of fundamental synthetic activities. 3-hydroxy- 3-methylglutaryl coenzyme A reductase (HMGR) is the rate-limiting enzyme in the pathway and is targeted by the ubiquitous statin drugs to treat hypercholesterolemia. Independent reports have indicated the cidal effects of statins against the flatworm parasite, S. mansoni, and the possibility that SmHMGR is a useful drug target to develop new statin-based anti-schistosome therapies. For six commercially available statins, we demonstrate concentration-and time-dependent killing of immature (somule) and adult S. mansoni in vitro at sub-micromolar and micromolar concentrations, respectively. Cidal activity trends with statin lipophilicity whereby simvastatin and pravastatin are the most and least active, respectively. Worm death is preventable by excess mevalonate, the product of HMGR. Statin activity against somules was quantified both manually and automatically using a new, machine learning-based automated algorithm with congruent results. In addition, to chemical targeting, RNA interference (RNAi) of HMGR also kills somules in vitro and, again, lethality is blocked by excess mevalonate. Further, RNAi of HMGR of somules in vitro subsequently limits parasite survival in a mouse model of infection by up to 80%. Parasite death, either via statins or specific RNAi of HMGR, is associated with activation of apoptotic caspase activity. Together, our genetic and chemical data confirm that S. mansoni HMGR is an essential gene and the relevant target of statin drugs. We discuss our findings in context of a potential drug development program and the desired product profile for a new schistosomiasis drug.	[Rojo-Arreola, Liliana; Long, Thavy; Suzuki, Brian M.; Singh, Rahul; Caffrey, Conor R.] Univ Calif San Francisco, Dept Pathol, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94140 USA; [Asarnow, Dan; Singh, Rahul] San Francisco State Univ, Dept Comp Sci, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University	Caffrey, CR (corresponding author), Univ Calif San Francisco, Dept Pathol, Ctr Discovery & Innovat Parasit Dis, San Francisco, CA 94140 USA.	conor.caffrey@ucsf.edu		Asarnow, Daniel/0000-0001-7870-5308; Rojo-Arreola, Liliana/0000-0002-4163-0506	UC MEXUS-CONACYT; National Institute of Allergy And Infectious Diseases of the National Institutes of Health [1R01AI089896, R21AI107390]; National Science Foundation [IIS 0644418]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089896, R21AI107390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	LR-A was supported by a UC MEXUS-CONACYT Postdoctoral Research Fellowship. The research reported was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award numbers 1R01AI089896 (BMS, CRC, DA, and RS) and R21AI107390 (CRC), and by the National Science Foundation through grant IIS 0644418 (DA and RS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Abdulla MH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000478; Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Andersson M, 1996, J INTERF CYTOK RES, V16, P435, DOI 10.1089/jir.1996.16.435; ANDREWS P, 1985, PHARMACOL THERAPEUT, V29, P129, DOI 10.1016/0163-7258(85)90020-8; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Araújo Neusa, 2002, Rev. Soc. Bras. Med. Trop., V35, P35, DOI 10.1590/S0037-86822002000100007; Asarnow DE, 2013, IEEE T MED IMAGING, V32, P1007, DOI 10.1109/TMI.2013.2247412; Barrios-Gonzalez J, 2010, APPL MICROBIOL BIOT, V85, P869, DOI 10.1007/s00253-009-2239-6; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Berndt N, 2011, NAT PROTOC, V6, P1775, DOI 10.1038/nprot.2011.387; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Caffrey CR, 2011, CURR OPIN INFECT DIS, V24, P410, DOI 10.1097/QCO.0b013e328349156f; Chang HL, 2013, BBA-GEN SUBJECTS, V1830, P4053, DOI 10.1016/j.bbagen.2013.04.011; CHEN GZ, 1990, N-S ARCH PHARMACOL, V342, P477; CHEN GZ, 1993, MOL BIOCHEM PARASIT, V59, P287, DOI 10.1016/0166-6851(93)90226-N; CHEN GZ, 1991, EXP PARASITOL, V73, P82, DOI 10.1016/0014-4894(91)90010-T; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; Corcos L, 2013, DIGEST LIVER DIS, V45, P795, DOI 10.1016/j.dld.2013.02.002; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COXON FP, 2008, IBMS BONEKEY, V5, P357; Crowther GJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000804; de Hostos E. L., 2012, PARASITIC HELMINTHS, P217, DOI [10.1002/9783527652969.ch13, DOI 10.1002/9783527652969.CH13]; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Doenhoff MJ, 2009, PARASITOLOGY, V136, P1825, DOI 10.1017/S0031182009000493; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Dvorak J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000449; Eastman RT, 2006, J LIPID RES, V47, P233, DOI 10.1194/jlr.R500016-JLR200; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; ENDO A, 1992, J LIPID RES, V33, P1569; Garzoni LR, 2004, INT J ANTIMICROB AG, V23, P273, DOI 10.1016/j.ijantimicag.2003.07.020; GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450; GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Henneman L, 2011, BBA-MOL CELL BIOL L, V1811, P227, DOI 10.1016/j.bbalip.2011.01.002; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jolly ER, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r65; Joshi Hemant N., 1999, Pharmacy and Pharmacology Communications, V5, P269; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lee H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S4; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; Manzoni M, 2002, APPL MICROBIOL BIOT, V58, P555, DOI 10.1007/s00253-002-0932-9; MEYER F, 1970, BIOCHIM BIOPHYS ACTA, V210, P257, DOI 10.1016/0005-2760(70)90170-0; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Mo HB, 2004, EXP BIOL MED, V229, P567, DOI 10.1177/153537020422900701; Montalvetti A, 2000, BIOCHEM J, V349, P27, DOI 10.1042/0264-6021:3490027; Montalvetti A, 2001, J BIOL CHEM, V276, P33930, DOI 10.1074/jbc.M103950200; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ochocki JD, 2013, MEDCHEMCOMM, V4, P476, DOI 10.1039/c2md20299a; Olliaro P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001138; Osman A, 1999, MOL BIOCHEM PARASIT, V100, P27, DOI 10.1016/S0166-6851(99)00029-8; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Paveley RA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001762; Platt J., 1998, SEQUENTIAL MINIMAL O; Pradines B, 2007, ANTIMICROB AGENTS CH, V51, P2654, DOI 10.1128/AAC.01330-06; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; RAJKOVIC A, 1989, P NATL ACAD SCI USA, V86, P8217, DOI 10.1073/pnas.86.21.8217; Rauthan M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-243; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Rozen S, 2000, Methods Mol Biol, V132, P365; SABAH AA, 1986, EXP PARASITOL, V61, P294, DOI 10.1016/0014-4894(86)90184-0; Sashank Singhvi R., 2009, 2009 INT C CONTR AUT, P1; Soliman MFM, 2005, ACTA TROP, V93, P1, DOI 10.1016/j.actatropica.2004.08.006; Stefanic S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000850; Tamarozzi F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-53; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; URBINA JA, 1993, ANTIMICROB AGENTS CH, V37, P580, DOI 10.1128/AAC.37.3.580; VANDEWAA EA, 1989, AM J PHYSIOL, V257, pR618, DOI 10.1152/ajpregu.1989.257.3.R618; Vermeire JJ, 2003, INT J PARASITOL, V33, P721, DOI 10.1016/S0020-7519(03)00046-8; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; Wasko BM, 2011, J PHARMACOL EXP THER, V337, P540, DOI 10.1124/jpet.110.175521; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	86	52	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87594	10.1371/journal.pone.0087594	http://dx.doi.org/10.1371/journal.pone.0087594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489942	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000162
J	von Borstel, UK; Glissman, C				von Borstel, Uta Koenig; Glissman, Chantal			Alternatives to Conventional Evaluation of Rideability in Horse Performance Tests: Suitability of Rein Tension and Behavioural Parameters	PLOS ONE			English	Article							BREEDING OBJECTIVES; PERSONALITY-TRAITS; TEMPERAMENT TESTS; PRACTICAL GUIDE; REPEATABILITY; EQUITATION; SITUATION; RESPONSES; HANDLER; RIDDEN	Rideability, i.e. the ease and comfort with which a horse can be ridden, is considered to be one of the most important traits in riding horses. However, at present rideability is evaluated rather subjectively in breeding horse performance tests. The aim of the present study was to evaluate the role horse behaviour as well as degree and quality of rein tension might play in judges' evaluation of horses' rideability. Mares (n = 33) and stallions (n = 13) from two different mare-and one stallion-testing station were observed twice during their performance test dressage training. During these rides, rein tension was measured continuously, and frequency of behaviour patterns such as head-tossing, tail swishing, and snorting was recorded. Rein tension parameters showed reasonable repeatabilities within horse-rider pairs (e. g. mean rein tension: r(2) = 0.61 +/- 0.11; variance of rein tension: r(2) = 0.52 +/- 0.14). Regression analysis revealed that a larger proportion of variance in rideability scores could be explained by maximum (17%), mean (16%) and variance (15%) of rein tension compared to horses' or riders' behavioural parameters (tail-swishing: 5% and rider's use of hands: 5%, respectively). According to mixed model analysis, rideability scores dropped (all P<0.05) with increasing mean, maximum and variability in rein tension (e. g. -0.37 +/- 0.14 scores per additional 10 Newton in mean tension). However, mean rein tension differed between testing stations (P<0.0001) ranging between 9.1 +/- 1.6 N in one station and 21.7 +/- 1.3 N in another station. These results indicate that quantity and consistency of rein tension is either directly or indirectly an important factor for judges to derive rideability scores. Given the importance of rein tension parameters to both rider comfort and horse welfare, potentially, measurements of rein tension along with behaviour observations assessing the quality of rein contact (e. g. distinguishing a light contact from attempts to evade contact) might be used to make the assessment of rideability more impartial.	[von Borstel, Uta Koenig; Glissman, Chantal] Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany	University of Gottingen	von Borstel, UK (corresponding author), Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany.	koenigvb@gwdg.de	von Borstel, Uta U. König/H-6747-2012	Konig von Borstel, Uta/0000-0002-7313-1197	EU via the European Funds for Regional Development; German Research Foundation; Open Access Publication Funds of the Gottingen University	EU via the European Funds for Regional Development; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the EU via the European Funds for Regional Development, the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner M, 2010, SCHWEIZ ARCH TIERH, V152, P194; Beer N, 1993, THESIS U MUNICH GERM; BMVEL (Federal Ministry of Food Agriculture and Consumer Protection), 2003, LEITL VER HENGST DTS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROWN JS, 1951, J EXP PSYCHOL, V41, P317, DOI 10.1037/h0060166; Christensen JW, 2011, EQUINE VET J, V43, P223, DOI 10.1111/j.2042-3306.2010.00151.x; Clayton HM, 2003, EXP TECHNIQUES, V27, P34, DOI 10.1111/j.1747-1567.2003.tb00112.x; Egenvall A, 2012, J VET BEHAV, V7, P157, DOI 10.1016/j.jveb.2011.08.006; Falconer D. S., 1984, EINFUHRUNG QUANTITAT, P184; Glissmann C, 2012, 8 INT EQ SCI C 2012, P20; Gorecka-Bruzda A, 2011, ANTHROZOOS, V24, P379, DOI 10.2752/175303711X13159027359827; Gorecka-Bruzda A, 2011, APPL ANIM BEHAV SCI, V133, P207, DOI 10.1016/j.applanim.2011.05.011; Gorecka-Bruzda A, 2010, ANIM SCI PAP REP, V28, P27; Graf P, 2013, J VET BEHAV, V8, P316, DOI 10.1016/j.jveb.2013.05.006; Graf P, 2013, ZUCHTUNGSKUNDE, V85, P129; Hawson LA, 2010, J VET BEHAV, V5, P170, DOI 10.1016/j.jveb.2009.12.010; Heleski CR, 2009, VET J, V181, P56, DOI 10.1016/j.tvjl.2009.03.011; Janssens S, 2010, 44 INT C INT SOC APP, P207; Koenen EPC, 2004, LIVEST PROD SCI, V88, P77, DOI 10.1016/j.livprodsci.2003.10.011; Konig v. Borstel U., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138006; Konig von Borstel U, 2012, 8 INT EQ SCI C 2012, P129; Kuhnke S, 2010, COMP EXERC PHYSIOL, V7, P57, DOI 10.1017/S1755254010000243; Larose C, 2006, LATERALITY, V11, P355, DOI 10.1080/13576500600624221; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Lewczuk D, 2004, ANIM SCI PAP REP, P125; Ludewig AK, 2013, J VET BEHAV, V8, P15; McGreevy PD, 2009, J VET BEHAV, V4, P193, DOI 10.1016/j.jveb.2008.08.001; Miesner S., 2000, RICHTLINIEN REITEN F, V1; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Oki H, 2007, J ANIM BREED GENET, V124, P185, DOI 10.1111/j.1439-0388.2007.00659.x; Pasing S, 2012, 8 INT EQ SCI C 2012, P125; Pasing S, 2011, 62 ANN M EUR ASS AN, P142; Peeters M, 2012, J VET BEHAV, V7, P311, DOI 10.1016/j.jveb.2011.10.008; Randle H, 2013, 9 INT EQ SCI C 2013, P37; Roberds JH, 2006, FOREST ECOL MANAG, V228, P215, DOI 10.1016/j.foreco.2006.03.005; Rothmann J, 2010, 61 ANN M EUR ASS AN, P151; Teegen R, 2008, ZUCHTUNGSKUNDE, V80, P99; Visser EK, 2003, APPL ANIM BEHAV SCI, V82, P279, DOI 10.1016/S0168-1591(03)00083-2; von Borstel UK, 2011, PHYSIOL BEHAV, V104, P454, DOI 10.1016/j.physbeh.2011.05.010; von Borstel UK, 2013, J VET BEHAV, V8, P326, DOI 10.1016/j.jveb.2013.04.066; von Borstel UK, 2012, APPL ANIM BEHAV SCI, V139, P251, DOI 10.1016/j.applanim.2012.04.007; von Borstel UK, 2011, APPL ANIM BEHAV SCI, V135, P277, DOI 10.1016/j.applanim.2011.10.007; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; von Velsen-Zerweck A, 1998, INTEGRIERTE ZUCHTWER; Warren-Smith AK, 2007, APPL ANIM BEHAV SCI, V108, P157, DOI 10.1016/j.applanim.2006.11.017; Wejer J, 2013, J EQUINE VET SCI, V33, P483, DOI 10.1016/j.jevs.2012.07.009	46	33	33	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87285	10.1371/journal.pone.0087285	http://dx.doi.org/10.1371/journal.pone.0087285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489890	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000130
J	Zhang, J; Chen, J; Yang, J; Xu, CW; Ding, JW; Yang, J; Guo, Q; Hu, Q; Jiang, H				Zhang, Jing; Chen, Jing; Yang, Jian; Xu, Changwu; Ding, Jiawang; Yang, Jun; Guo, Qing; Hu, Qi; Jiang, Hong			Sodium Ferulate Inhibits Neointimal Hyperplasia in Rat Balloon Injury Model	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; DRUG-ELUTING STENTS; BARE-METAL STENTS; ANGIOTENSIN-CONVERTING ENZYME; OXIDATIVE STRESS; VASCULAR INJURY; NADPH OXIDASE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; DEPENDENT PATHWAY	Background/Aim: Neointimal formation after vessel injury is a complex process involving multiple cellular and molecular processes. Inhibition of intimal hyperplasia plays an important role in preventing proliferative vascular diseases, such as restenosis. In this study, we intended to identify whether sodium ferulate could inhibit neointimal formation and further explore potential mechanisms involved. Methods: Cultured vascular smooth muscle cells (VSMCs) isolated from rat thoracic aorta were pre-treated with 200 mu mol/L sodium ferulate for 1 hour and then stimulated with 1 mu mol/L angiotensin II (Ang II) for 1 hour or 10% serum for 48 hours. Male Sprague-Dawley rats subjected to balloon catheter insertion were administrated with 200 mg/kg sodium ferulate (or saline) for 7 days before sacrificed. Results: In presence of sodium ferulate, VSMCs exhibited decreased proliferation and migration, suppressed intracellular reactive oxidative species production and NADPH oxidase activity, increased SOD activation and down-regulated p38 phosphorylation compared to Ang II-stimulated alone. Meanwhile, VSMCs treated with sodium ferulate showed significantly increased protein expression of smooth muscle alpha-actin and smooth muscle myosin heavy chain protein. The components of Notch pathway, including nuclear Notch-1 protein, Jagged-1, Hey-1 and Hey-2 mRNA, as well as total beta-catenin protein and Cyclin D1 mRNA of Wnt signaling, were all significantly decreased by sodium ferulate in cells under serum stimulation. The levels of serum 8-iso-PGF2 alpha and arterial collagen formation in vessel wall were decreased, while the expression of contractile markers was increased in sodium ferulate treated rats. A decline of neointimal area, as well as lower ratio of intimal to medial area was observed in sodium ferulate group. Conclusion: Sodium ferulate attenuated neointimal hyperplasia through suppressing oxidative stress and phenotypic switching of VSMCs.	[Zhang, Jing; Chen, Jing; Xu, Changwu; Hu, Qi; Jiang, Hong] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Yang, Jian; Ding, Jiawang; Yang, Jun] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yichang, Hubei, Peoples R China; [Guo, Qing] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Ophthalmol, Yichang, Hubei, Peoples R China	Wuhan University; China Three Gorges University; China Three Gorges University	Jiang, H (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China.	jianghongmed@126.com			National Natural Science Foundation of the People's Republic of China [81170195, 81200088, 81200156]; Fundamental Research Funds for the Central Universities [20103020201000203, 201130202020014, 302274023]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of the People's Republic of China (NO. 81170195, 81200088 and 81200156) and the Fundamental Research Funds for the Central Universities (20103020201000203, 201130202020014; 302274023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmar AE, 2009, INT J CARDIOL, V132, P398, DOI 10.1016/j.ijcard.2008.03.001; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Barone E, 2009, BIOGERONTOLOGY, V10, P97, DOI 10.1007/s10522-008-9160-8; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Chen GP, 2009, LIFE SCI, V84, P81, DOI 10.1016/j.lfs.2008.11.003; Chen LL, 2009, J PHARMACEUT BIOMED, V50, P127, DOI 10.1016/j.jpba.2009.03.039; Chen YL, 2013, INT J MOL MED, V31, P597, DOI 10.3892/ijmm.2013.1256; Choi R, 2011, EXP MOL MED, V43, P676, DOI 10.3858/emm.2011.43.12.078; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; De Labriolle A, 2009, ARCH CARDIOVASC DIS, V102, P209, DOI 10.1016/j.acvd.2009.01.004; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; FERNANDEZORTIZ A, 1994, J AM COLL CARDIOL, V23, P1562, DOI 10.1016/0735-1097(94)90657-2; Forman HJ, 2002, MOL CELL BIOCHEM, V234, P49, DOI 10.1023/A:1015913229650; Frid MG, 1997, ARTERIOSCL THROM VAS, V17, P1203, DOI 10.1161/01.ATV.17.7.1203; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Gao LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062489; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Hou YZ, 2004, EUR J PHARMACOL, V499, P85, DOI 10.1016/j.ejphar.2004.07.107; HUANG HC, 1992, EUR J PHARMACOL, V221, P381; Jin Y, 2005, ACTA PHARMACOL SIN, V26, P943, DOI 10.1111/j.1745-7254.2005.00158.x; Jin Y, 2007, ACTA PHARMACOL SIN, V28, P1881, DOI 10.1111/j.1745-7254.2007.00634.x; Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010; Kibos A, 2007, Acute Card Care, V9, P111, DOI 10.1080/17482940701263285; Kim SR, 2013, J MED FOOD, V16, P95, DOI 10.1089/jmf.2013.1602.com; Kochiadakis GE, 2010, INT J CARDIOL, V142, P33, DOI 10.1016/j.ijcard.2008.12.105; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Landmesser U, 2001, CORONARY ARTERY DIS, V12, P455, DOI 10.1097/00019501-200109000-00004; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Lyon C, 2011, FRONT BIOSCI-LANDMRK, V16, P644, DOI 10.2741/3711; Ma ZC, 2010, BIOL PHARM BULL, V33, P752, DOI 10.1248/bpb.33.752; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Mill C, 2012, CARDIOVASC RES, V95, P233, DOI 10.1093/cvr/cvs141; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Nikol S, 1996, ATHEROSCLEROSIS, V123, P17, DOI 10.1016/0021-9150(96)05807-8; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Papafaklis MI, 2012, PHARMACOL THERAPEUT, V134, P43, DOI 10.1016/j.pharmthera.2011.12.006; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhyu MR, 2005, J CARDIOVASC PHARM, V46, P99, DOI 10.1097/01.fjc.0000164092.88821.49; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Sorescu D, 2001, FREE RADICAL BIO MED, V30, P603, DOI 10.1016/S0891-5849(00)00507-4; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Wang BH, 2005, CARDIOVASC DRUG REV, V23, P161; Zargham R, 2008, CLIN SCI, V114, P257, DOI 10.1042/CS20070228; Zhang DX, 2009, J CARDIOVASC PHARM T, V14, P302, DOI 10.1177/1074248409347986; Zhu LH, 2013, MOL CELL BIOCHEM, V373, P53, DOI 10.1007/s11010-012-1474-9	58	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87561	10.1371/journal.pone.0087561	http://dx.doi.org/10.1371/journal.pone.0087561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489938	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000159
J	Borziak, K; Posner, MG; Upadhyay, A; Danson, MJ; Bagby, S; Dorus, S				Borziak, Kirill; Posner, Mareike G.; Upadhyay, Abhishek; Danson, Michael J.; Bagby, Stefan; Dorus, Steve			Comparative Genomic Analysis Reveals 2-Oxoacid Dehydrogenase Complex Lipoylation Correlation with Aerobiosis in Archaea	PLOS ONE			English	Article							PROTEIN LIGASE-A; LIPOIC ACID METABOLISM; ESCHERICHIA-COLI; POSTTRANSLATIONAL MODIFICATION; GENES; COMMUNITY; LPLA; ATTACHMENT; EVOLUTION; INSIGHTS	Metagenomic analyses have advanced our understanding of ecological microbial diversity, but to what extent can metagenomic data be used to predict the metabolic capacity of difficult-to-study organisms and their abiotic environmental interactions? We tackle this question, using a comparative genomic approach, by considering the molecular basis of aerobiosis within archaea. Lipoylation, the covalent attachment of lipoic acid to 2-oxoacid dehydrogenase multienzyme complexes (OADHCs), is essential for metabolism in aerobic bacteria and eukarya. Lipoylation is catalysed either by lipoate protein ligase (LplA), which in archaea is typically encoded by two genes (LplA-N and LplA-C), or by a lipoyl(octanoyl) transferase (LipB or LipM) plus a lipoic acid synthetase (LipA). Does the genomic presence of lipoylation and OADHC genes across archaea from diverse habitats correlate with aerobiosis? First, analyses of 11,826 biotin protein ligase (BPL)-LplA-LipB transferase family members and 147 archaeal genomes identified 85 species with lipoylation capabilities and provided support for multiple ancestral acquisitions of lipoylation pathways during archaeal evolution. Second, with the exception of the Sulfolobales order, the majority of species possessing lipoylation systems exclusively retain LplA, or either LipB or LipM, consistent with archaeal genome streamlining. Third, obligate anaerobic archaea display widespread loss of lipoylation and OADHC genes. Conversely, a high level of correspondence is observed between aerobiosis and the presence of LplA/LipB/LipM, LipA and OADHC E2, consistent with the role of lipoylation in aerobic metabolism. This correspondence between OADHC lipoylation capacity and aerobiosis indicates that genomic pathway profiling in archaea is informative and that well characterized pathways may be predictive in relation to abiotic conditions in difficult-to-study extremophiles. Given the highly variable retention of gene repertoires across the archaea, the extension of comparative genomic pathway profiling to broader metabolic and homeostasis networks should be useful in revealing characteristics from metagenomic datasets related to adaptations to diverse environments.	[Borziak, Kirill; Dorus, Steve] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Posner, Mareike G.; Upadhyay, Abhishek; Danson, Michael J.; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Claverton Down, England; [Danson, Michael J.] Univ Bath, Ctr Extremophile Res, Claverton Down, England	Syracuse University; University of Bath; University of Bath	Bagby, S (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, England.	s.bagby@bath.ac.uk; sdorus@syr.edu	Posner, Mareike/AGK-4002-2022	Posner, Mareike/0000-0002-3156-3071; Bagby, Stefan/0000-0003-2302-9511				Amo Taku, 2002, Archaea, V1, P113, DOI 10.1155/2002/616075; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Antunes A, 2008, INT J SYST EVOL MICR, V58, P215, DOI 10.1099/ijs.0.65316-0; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cavicchioli R, 2011, NAT REV MICROBIOL, V9, P51, DOI 10.1038/nrmicro2482; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Christensen QH, 2012, BIOCHEMISTRY-US, V49, P10024; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Csuros M, 2009, MOL BIOL EVOL, V26, P2087, DOI 10.1093/molbev/msp123; Davis JJ, 2011, MOL BIOL EVOL, V28, P211, DOI 10.1093/molbev/msq185; Davis JJ, 2010, MOL BIOL EVOL, V27, P800, DOI 10.1093/molbev/msp281; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Kang SG, 2007, GENE, V393, P53, DOI 10.1016/j.gene.2007.01.011; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Kennedy J, 2010, MAR DRUGS, V8, P608, DOI 10.3390/md8030608; Kratzer C, 2011, FEBS J, V278, P442, DOI 10.1111/j.1742-4658.2010.07964.x; Lombard J, 2012, MOL BIOL EVOL, V29, P3261, DOI 10.1093/molbev/mss160; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; Marx CJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001487; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Posner MG, 2013, BIOCHEM J, V449, P415, DOI 10.1042/BJ20121150; Posner MG, 2009, FEBS J, V276, P4012, DOI 10.1111/j.1742-4658.2009.07110.x; Punta M, NUCL ACIDS RES, V40, pD290; Reche PA, 2000, PROTEIN SCI, V9, P1922, DOI 10.1110/ps.9.10.1922; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; SELIG M, 1994, ARCH MICROBIOL, V162, P286, DOI 10.1007/BF00301853; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Tully BJ, 2012, ENVIRON MICROBIOL, V14, P254, DOI 10.1111/j.1462-2920.2011.02628.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wheeler TJ, 2009, LECT N BIOINFORMAT, V5724, P375, DOI 10.1007/978-3-642-04241-6_31; Wilmes P, 2009, FEMS MICROBIOL REV, V33, P109, DOI 10.1111/j.1574-6976.2008.00144.x; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Wolf YI, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-46; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Yuan YL, 2011, ENV MICROBIOL REP, V3, P320, DOI 10.1111/j.1758-2229.2010.00228.x	57	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87063	10.1371/journal.pone.0087063	http://dx.doi.org/10.1371/journal.pone.0087063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489835	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000103
J	Boyle, PM; Park, CJ; Arevalo, HJ; Vigmond, EJ; Trayanova, NA				Boyle, Patrick M.; Park, Carolyn J.; Arevalo, Hermenegild J.; Vigmond, Edward J.; Trayanova, Natalia A.			Sodium Current Reduction Unmasks a Structure-Dependent Substrate for Arrhythmogenesis in the Normal Ventricles	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; BRUGADA-SYNDROME; CARDIAC TISSUE; IMPULSE PROPAGATION; IONIC MECHANISMS; SLOW CONDUCTION; DEATH-SYNDROME; HEART; REPOLARIZATION; RABBIT	Background: Organ-scale arrhythmogenic consequences of source-sink mismatch caused by impaired excitability remain unknown, hindering the understanding of pathophysiology in disease states like Brugada syndrome and ischemia. Objective: We sought to determine whether sodium current (I-Na) reduction in the structurally normal heart unmasks a regionally heterogeneous substrate for the induction of sustained arrhythmia by premature ventricular contractions (PVCs). Methods: We conducted simulations in rabbit ventricular computer models with 930 unique combinations of PVC location (10 sites) and coupling interval (250-400 ms), I-Na reduction (30 or 40% of normal levels), and post-PVC sinus rhythm (arrested or persistent). Geometric characteristics and source-sink mismatch were quantitatively analyzed by calculating ventricular wall thickness and a newly formulated 3D safety factor (SF), respectively. Results: Reducing I-Na to 30% of its normal level created a substrate for sustained arrhythmia induction by establishing large regions of critical source-sink mismatch (SF<1) for ectopic wavefronts propagating from thin to thick tissue. In the same simulations but with 40% of normal I-Na, PVCs did not induce reentry because the volume of tissue with SF<1 was >95% smaller. Likewise, when post-PVC sinus activations were persistent instead of arrested, no ectopic excitations initiated sustained reentry because sinus activation breakthroughs engulfed the excitable gap. Conclusion: Our new SF formulation can quantify ectopic wavefront propagation robustness in geometrically complex 3D tissue with impaired excitability. This novel methodology was applied to show that I-Na reduction precipitates source-sink mismatch, creating a potent substrate for sustained arrhythmia induction by PVCs originating near regions of ventricular wall expansion, such as the RV outflow tract.	[Boyle, Patrick M.; Park, Carolyn J.; Arevalo, Hermenegild J.; Trayanova, Natalia A.] Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA; [Vigmond, Edward J.] Univ Bordeaux 1, Inst LIRYC, Bordeaux, France	Johns Hopkins University; UDICE-French Research Universities; Universite de Bordeaux	Trayanova, NA (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Inst Computat Med, Baltimore, MD 21218 USA.	ntrayanova@jhu.edu	Boyle, Patrick/HDN-7133-2022	Boyle, Patrick/0000-0001-9048-1239; Park, Carolyn/0000-0002-0877-2959; Trayanova, Natalia/0000-0002-8661-063X	National Science and Engineering Research Council of Canada; US National Institutes of Health [NIH-R01-HL103428, NIH-DP1-HL123271]; US National Science Foundation [NSF-CDI-1124804, NSF-OCI-108849]; French National Research Agency [ANR-10-IAHU-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL123271, R01HL103428] Funding Source: NIH RePORTER; Direct For Biological Sciences [1124804] Funding Source: National Science Foundation	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); French National Research Agency(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a postdoctoral fellowship from the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), US National Institutes of Health (http://www.nih.gov) grants NIH-R01-HL103428 and NIH-DP1-HL123271, US National Science Foundation (http://www.nsf.gov) grants NSF-CDI-1124804 and NSF-OCI-108849, and French National Research Agency (http://www.agence-nationale-recherche.fr/Intl) grant ANR-10-IAHU-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo H, 2007, CHAOS, V17, DOI 10.1063/1.2430637; Baroudi G, 2000, FEBS LETT, V467, P12, DOI 10.1016/S0014-5793(00)01099-1; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Boukens BJ, 2013, CIRC RES, V113, P137, DOI 10.1161/CIRCRESAHA.113.301565; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; Boyle PM, 2010, ANN BIOMED ENG, V38, P456, DOI 10.1007/s10439-009-9829-4; Bueno-Orovio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052234; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Ciaccio EJ, 2000, CIRCULATION, V102, P464; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; FAST VG, 1995, CARDIOVASC RES, V30, P449, DOI 10.1016/0008-6363(95)00071-2; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; Hoogendijk MG, 2011, HEART RHYTHM, V8, P111, DOI 10.1016/j.hrthm.2010.09.066; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lambiase PD, 2009, CIRCULATION, V120, P106, DOI 10.1161/CIRCULATIONAHA.108.771401; LOBO FV, 1992, CAN J CARDIOL, V8, P261; Lukas A, 1996, CARDIOVASC RES, V32, P593, DOI 10.1016/0008-6363(96)00115-0; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; MENDEZ C, 1970, CIRC RES, V26, P135, DOI 10.1161/01.RES.26.2.135; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Morita H, 2003, J CARDIOVASC ELECTR, V14, P373, DOI 10.1046/j.1540-8167.2003.02365.x; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Postema PG, 2010, J AM COLL CARDIOL, V55, P789, DOI 10.1016/j.jacc.2009.11.033; Postema PG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P379, DOI 10.1161/CIRCEP.108.790543; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Rodriguez B, 2005, CIRC RES, V97, P168, DOI 10.1161/01.RES.0000174429.00987.17; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Shaw RM, 1997, CIRC RES, V81, P727; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Tada H, 1998, AM J CARDIOL, V81, P519, DOI 10.1016/S0002-9149(97)00942-9; Tan BH, 2006, AM J PHYSIOL-HEART C, V291, pH1822, DOI 10.1152/ajpheart.00101.2006; Trayanova N, 2002, CHAOS, V12, P962, DOI 10.1063/1.1483955; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Veeraraghavan R, 2008, CARDIOVASC RES, V77, P749, DOI 10.1093/cvr/cvm090; Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Volders PGA, 1999, CIRCULATION, V99, P206, DOI 10.1161/01.CIR.99.2.206; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660	46	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86947	10.1371/journal.pone.0086947	http://dx.doi.org/10.1371/journal.pone.0086947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489810	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000091
J	de Moraes, FR; Neshich, IAP; Mazoni, I; Yano, IH; Pereira, JGC; Salim, JA; Jardine, JG; Neshich, G				de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Yano, Inacio H.; Pereira, Jose G. C.; Salim, Jose A.; Jardine, Jose G.; Neshich, Goran			Improving Predictions of Protein-Protein Interfaces by Combining Amino Acid-Specific Classifiers Based on Structural and Physicochemical Descriptors with Their Weighted Neighbor Averages	PLOS ONE			English	Article							WEB-BASED APPLICATION; SITE PREDICTION; BINDING-SITE; GENOMICS; SERVER; IDENTIFICATION; CONSERVATION; COMPLEXES; ALGORITHM; RESIDUES	Protein-protein interactions are involved in nearly all regulatory processes in the cell and are considered one of the most important issues in molecular biology and pharmaceutical sciences but are still not fully understood. Structural and computational biology contributed greatly to the elucidation of the mechanism of protein interactions. In this paper, we present a collection of the physicochemical and structural characteristics that distinguish interface-forming residues (IFR) from free surface residues (FSR). We formulated a linear discriminative analysis (LDA) classifier to assess whether chosen descriptors from the BlueStar STING database (http://www.cbi.cnptia.embrapa.br/SMS/) are suitable for such a task. Receiver operating characteristic (ROC) analysis indicates that the particular physicochemical and structural descriptors used for building the linear classifier perform much better than a random classifier and in fact, successfully outperform some of the previously published procedures, whose performance indicators were recently compared by other research groups. The results presented here show that the selected set of descriptors can be utilized to predict IFRs, even when homologue proteins are missing (particularly important for orphan proteins where no homologue is available for comparative analysis/indication) or, when certain conformational changes accompany interface formation. The development of amino acid type specific classifiers is shown to increase IFR classification performance. Also, we found that the addition of an amino acid conservation attribute did not improve the classification prediction. This result indicates that the increase in predictive power associated with amino acid conservation is exhausted by adequate use of an extensive list of independent physicochemical and structural parameters that, by themselves, fully describe the nano-environment at protein-protein interfaces. The IFR classifier developed in this study is now integrated into the BlueStar STING suite of programs. Consequently, the prediction of protein-protein interfaces for all proteins available in the PDB is possible through STING_interfaces module, accessible at the following website: (http://www.cbi.cnptia.embrapa.br/SMS/predictions/index.html).	[de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Pereira, Jose G. C.] Univ Estadual Campinas, Inst Biol, Sao Paulo, Brazil; [de Moraes, Fabio R.; Neshich, Izabella A. P.; Mazoni, Ivan; Yano, Inacio H.; Pereira, Jose G. C.; Jardine, Jose G.; Neshich, Goran] Natl Ctr Agr Informat, Brazilian Agr Res Corp EMBRAPA, Sao Paulo, Brazil; [Salim, Jose A.] Univ Estadual Campinas, Sch Elect & Comp Engn, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Campinas	Neshich, G (corresponding author), Natl Ctr Agr Informat, Brazilian Agr Res Corp EMBRAPA, Sao Paulo, Brazil.	Goran.Neshich@cnptia.embrapa.br	de Moraes, Fábio R/B-8331-2017; Salim, José Augusto/AAY-4366-2020; Yano, Inacio H/F-3109-2013; Pena, Izabella/P-6345-2017	de Moraes, Fábio R/0000-0002-0425-0352; Salim, José Augusto/0000-0002-8675-7068; Pena, Izabella/0000-0001-5242-3724; Yano, Inacio/0000-0003-2698-6309	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03108-1, 2009/16376-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grants #2009/03108-1 and #2009/16376-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Borro LC, 2006, GENET MOL RES, V5, P193; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Chen CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037706; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen HL, 2008, BIOPHYS J, V94, P918, DOI 10.1529/biophysj.107.114280; da Silveira CH, 2009, PROTEINS, V74, P727, DOI 10.1002/prot.22187; deFreitas SM, 1997, FEBS LETT, V409, P121, DOI 10.1016/S0014-5793(97)00419-5; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fernandez JH, 2003, BIOCHEM BIOPH RES CO, V308, P219, DOI 10.1016/S0006-291X(03)01363-9; Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792; Higa RH, 2004, BIOINFORMATICS, V20, P1983, DOI 10.1093/bioinformatics/bth185; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Johnson D., 1998, APPL MULTIVARIATE ME; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Mancini AL, 2004, BIOINFORMATICS, V20, P2145, DOI 10.1093/bioinformatics/bth203; Marcellino LH, 1996, FEBS LETT, V385, P154, DOI 10.1016/0014-5793(96)00375-4; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Melo RC, 2007, GENET MOL RES, V6, P946; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neshich G, 2006, GENET MOL RES, V5, P717; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pW29, DOI 10.1093/nar/gki397; Neshich IAP, SURFACE HYD IN PRESS; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Poupon A, 2010, METHODS MOL BIOL, V609, P349, DOI 10.1007/978-1-60327-241-4_20; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Schneider M, 2009, PROTEINS, V77, P97, DOI 10.1002/prot.22421; Simoes M, 2007, MOL BIOCHEM PARASIT, V154, P134, DOI 10.1016/j.molbiopara.2007.04.003; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SRIDHARAN S, 1992, FASEB J, V6, pA174; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Terwilliger TC, 2000, NAT STRUCT BIOL, V7, P935, DOI 10.1038/80700; Tsuchiya Y, 2006, PROTEIN ENG DES SEL, V19, P421, DOI 10.1093/protein/gzl026; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013; Xenarios L, 2001, CURR OPIN BIOTECH, V12, P334, DOI 10.1016/S0958-1669(00)00224-X; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang QC, 2011, NUCLEIC ACIDS RES, V39, pW283, DOI 10.1093/nar/gkr311; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	60	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87107	10.1371/journal.pone.0087107	http://dx.doi.org/10.1371/journal.pone.0087107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489849	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000108
J	Margolis, DJ; Gartland, AJ; Singer, JH; Detwiler, PB				Margolis, David J.; Gartland, Andrew J.; Singer, Joshua H.; Detwiler, Peter B.			Network Oscillations Drive Correlated Spiking of ON and OFF Ganglion Cells in the rd1 Mouse Model of Retinal Degeneration	PLOS ONE			English	Article							VISUAL FUNCTION; RESPONSES; SIGNALS; MICE; MECHANISMS; GENERATION; CHANNELS	Following photoreceptor degeneration, ON and OFF retinal ganglion cells (RGCs) in the rd-1/rd-1 mouse receive rhythmic synaptic input that elicits bursts of action potentials at similar to 10 Hz. To characterize the properties of this activity, RGCs were targeted for paired recording and morphological classification as either ON alpha, OFF alpha or non-alpha RGCs using two-photon imaging. Identified cell types exhibited rhythmic spike activity. Cross-correlation of spike trains recorded simultaneously from pairs of RGCs revealed that activity was correlated more strongly between alpha RGCs than between alpha and non-alpha cell pairs. Bursts of action potentials in alpha RGC pairs of the same type, i.e. two ON or two OFF cells, were in phase, while bursts in dissimilar alpha cell types, i.e. an ON and an OFF RGC, were 180 degrees out of phase. This result is consistent with RGC activity being driven by an input that provides correlated excitation to ON cells and inhibition to OFF cells. A2 amacrine cells were investigated as a candidate cellular mechanism and found to display 10 Hz oscillations in membrane voltage and current that persisted in the presence of antagonists of fast synaptic transmission and were eliminated by tetrodotoxin. Results support the conclusion that the rhythmic RGC activity originates in a presynaptic network of electrically coupled cells including A2s via a Na+-channel dependent mechanism. Network activity drives out of phase oscillations in ON and OFF cone bipolar cells, entraining similar frequency fluctuations in RGC spike activity over an area of retina that migrates with changes in the spatial locus of the cellular oscillator.	[Margolis, David J.] Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Gartland, Andrew J.; Detwiler, Peter B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Gartland, Andrew J.; Detwiler, Peter B.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Singer, Joshua H.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Rutgers State University New Brunswick; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland College Park	Margolis, DJ (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA.	david.margolis@rutgers.edu; detwiler@uw.edu			NIH [EY002048, EY-017836, 5 T32 GM007108]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001730, R01EY002048, R01EY017836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants: EY002048 (PBD), EY-017836 (JHS), and 5 T32 GM007108 (AJG). JHS was a Special Scholar for Retinitis Pigmentosa sponsored by Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bloomfield SA, 2004, VISION RES, V44, P3297, DOI 10.1016/j.visres.2004.07.012; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Cembrowski MS, 2012, CELL REP, V1, P155, DOI 10.1016/j.celrep.2011.12.006; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Jones Bryan W, 2005, Clin Exp Optom, V88, P282; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; Margolis DJ, 2010, J NEUROSCI, V30, P7127, DOI 10.1523/JNEUROSCI.5694-09.2010; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Murphy GJ, 2008, NAT NEUROSCI, V11, P318, DOI 10.1038/nn2045; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; PEICHL L, 1987, J COMP NEUROL, V263, P25, DOI 10.1002/cne.902630103; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Tian M, 2010, J NEUROSCI, V30, P4650, DOI 10.1523/JNEUROSCI.4212-09.2010; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Weiland JD, 2005, ANNU REV BIOMED ENG, V7, P361, DOI 10.1146/annurev.bioeng.7.060804.100435; Ye JH, 2007, PHYSIOL MEAS, V28, P1079, DOI 10.1088/0967-3334/28/9/009; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	31	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86253	10.1371/journal.pone.0086253	http://dx.doi.org/10.1371/journal.pone.0086253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489706	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000039
J	Pischedda, A; Shahandeh, MP; Cochrane, WG; Cochrane, VA; Turner, TL				Pischedda, Alison; Shahandeh, Michael P.; Cochrane, Wesley G.; Cochrane, Veronica A.; Turner, Thomas L.			Natural Variation in the Strength and Direction of Male Mating Preferences for Female Pheromones in Drosophila melanogaster	PLOS ONE			English	Article							MUTUAL SEXUAL SELECTION; CUTICULAR HYDROCARBONS; PREMATING ISOLATION; FORCED COPULATIONS; GENETIC-ANALYSIS; COURTSHIP; POPULATION; ATTRACTIVENESS; DESICCATION; RECOGNITION	Many animal species communicate using chemical signals. In Drosophila, cuticular hydrocarbons (CHCs) are involved in species and sexual identification, and have long been thought to act as stimulatory pheromones as well. However, a previous study reported that D. melanogaster males were more attracted to females that were lacking CHCs. This surprising result is consistent with several evolutionary hypotheses but is at odds with other work demonstrating that female CHCs are attractive to males. Here, we investigated natural variation in male preferences for female pheromones using transgenic flies that cannot produce CHCs. By perfuming females with CHCs and performing mate choice tests, we found that some male genotypes prefer females with pheromones, some have no apparent preference, and at least one male genotype prefers females without pheromones. This variation provides an excellent opportunity to further investigate the mechanistic causes and evolutionary implications of divergent pheromone preferences in D. melanogaster males.	[Pischedda, Alison; Shahandeh, Michael P.; Cochrane, Wesley G.; Cochrane, Veronica A.; Turner, Thomas L.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Cochrane, Veronica A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	University of California System; University of California Santa Barbara; Oregon Health & Science University	Pischedda, A (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	alison.pischedda@lifesci.ucsb.edu	Shahandeh, Michael/AAM-6045-2021	Cochrane, Wesley/0000-0002-3325-6921	National Institutes of Health [R01 GM098614]; MRSEC Program of the NSF [DMR 1121053]; NSF-Materials Research Facilities Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRSEC Program of the NSF(National Science Foundation (NSF)); NSF-Materials Research Facilities Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (R01 GM098614). The MRL Shared Experimental Facilities are supported by the MRSEC Program of the NSF under Award No. DMR 1121053, a member of the NSF-funded Materials Research Facilities Network (www.mrfn.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Chenoweth SF, 2003, EVOLUTION, V57, P2326; Chenoweth SF, 2005, AM NAT, V165, P281, DOI 10.1086/427271; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dukas R, 2004, BEHAV ECOL, V15, P695, DOI 10.1093/beheco/arh068; Dukas R, 2012, ANIM BEHAV, V84, P1501, DOI 10.1016/j.anbehav.2012.09.023; Dukas R, 2012, ANIM BEHAV, V84, P1177, DOI 10.1016/j.anbehav.2012.08.021; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Fang S, 2002, GENETICS, V162, P781; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, GENETICA, V97, P73, DOI 10.1007/BF00132583; Foley BR, 2011, HEREDITY, V106, P68, DOI 10.1038/hdy.2010.40; Friberg U, 2006, ANIM BEHAV, V72, P1259, DOI 10.1016/j.anbehav.2006.03.021; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Grillet M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00224; Havens JA, 2013, J EVOLUTION BIOL, V26, P562, DOI 10.1111/jeb.12073; HOLM S, 1979, SCAND J STAT, V6, P65; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Long TAF, 2007, P ROY SOC B-BIOL SCI, V274, P3105, DOI 10.1098/rspb.2007.1140; Lu BK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002587; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; MANNING A., 1959, ANIMAL BEHAVIOR, V7, P60, DOI 10.1016/0003-3472(59)90031-4; Marcillac F, 2004, J EXP BIOL, V207, P3927, DOI 10.1242/jeb.01236; Markow TA, 2000, AM NAT, V156, P100, DOI 10.1086/303368; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Rouault J, 2000, GENETICA, V110, P117, DOI 10.1023/A:1017987220814; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Toda H, 2012, CELL REP, V1, P599, DOI 10.1016/j.celrep.2012.05.007; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1981, J INSECT PHYSIOL, V27, P17, DOI 10.1016/0022-1910(81)90026-3; Turner TL, 2012, GENETICS, V191, P633, DOI 10.1534/genetics.112.139337; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	54	13	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87509	10.1371/journal.pone.0087509	http://dx.doi.org/10.1371/journal.pone.0087509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489930	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000139
J	Ravi, VK; Swain, T; Chandra, N; Swaminathan, R				Ravi, Vijay Kumar; Swain, Tulsi; Chandra, Nividh; Swaminathan, Rajaram			On the Characterization of Intermediates in the Isodesmic Aggregation Pathway of Hen Lysozyme at Alkaline pH	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FLUORESCENCE ANISOTROPY; AMYLOID FIBRILS; SIMULATIONS; MODEL; TRYPTOPHAN; MECHANISM	Protein aggregation leading to formation of amyloid fibrils is a symptom of several diseases like Alzheimer's, type 2 diabetes and so on. Elucidating the poorly understood mechanism of such phenomena entails the difficult task of characterizing the species involved at each of the multiple steps in the aggregation pathway. It was previously shown by us that spontaneous aggregation of hen-eggwhite lysozyme (HEWL) at room temperature in pH 12.2 is a good model to study aggregation. Here in this paper we investigate the growth kinetics, structure, function and dynamics of multiple intermediate species populating the aggregation pathway of HEWL at pH 12.2. The different intermediates were isolated by varying the HEWL monomer concentration in the 300 nM-0.12 mM range. The intermediates were characterized using techniques like steady-state and nanosecond time-resolved fluorescence, atomic force microscopy and dynamic light scattering. Growth kinetics of non-fibrillar HEWL aggregates were fitted to the von Bertalanffy equation to yield a HEWL concentration independent rate constant (k = (6.6+/-0.6) x 10(-5) s(-1)). Our results reveal stepwise changes in size, molecular packing and enzymatic activity among growing HEWL aggregates consistent with an isodesmic aggregation model. Formation of disulphide bonds that crosslink the monomers in the aggregate appear as a unique feature of this aggregation. AFM images of multiple amyloid fibrils emanating radially from amorphous aggregates directly confirmed that on-pathway fibril formation was feasible under isodesmic polymerization. The isolated HEWL aggregates are revealed as polycationic protein nanoparticles that are robust at neutral pH with ability to take up non-polar molecules like ANS.	[Ravi, Vijay Kumar; Swain, Tulsi; Chandra, Nividh; Swaminathan, Rajaram] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Swaminathan, R (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	rsw@iitg.ernet.in	Swaminathan, Rajaram/I-2250-2019; Swaminathan, Rajaram/B-1230-2008	Swaminathan, Rajaram/0000-0003-1294-8379; Ravi, Vijay/0000-0003-3772-0573	Department of Science and Technology, New Delhi [SR/SO/BB-48/2009]; RGNF fellowship from UGC, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); RGNF fellowship from UGC, New Delhi	RS acknowledges funding support from Department of Science and Technology, New Delhi under project SR/SO/BB-48/2009. VKR acknowledges RGNF fellowship from UGC, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M., 2010, MATH BIOL SCI; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; Carlsson F, 2001, J PHYS CHEM B, V105, P12189, DOI 10.1021/jp012235i; Chan HY, 2012, BIOPHYS J, V102, P1934, DOI [10.1016/j.bpj.2012.03.025, 10.1016/j.bpj.2012.03.1125]; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; DAVIES RC, 1969, BIOCHIM BIOPHYS ACTA, V178, P294, DOI 10.1016/0005-2744(69)90397-0; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Homchaudhuri L, 2006, FEBS LETT, V580, P2097, DOI 10.1016/j.febslet.2006.03.012; Homchaudhuri L, 2006, THESIS INDIAN I TECH; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Kumar S, 2010, CURR SCI INDIA, V98, P639; Kumar S, 2008, BIOCHEM J, V415, P275, DOI 10.1042/BJ20071499; Kumar S, 2007, J CHEM SCI, V119, P141, DOI 10.1007/s12039-007-0021-9; Kumar S, 2009, BBA-PROTEINS PROTEOM, V1794, P913, DOI 10.1016/j.bbapap.2009.01.009; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lund M, 2003, BIOPHYS J, V85, P2940, DOI 10.1016/S0006-3495(03)74714-6; Ma BY, 2006, CURR OPIN CHEM BIOL, V10, P445, DOI 10.1016/j.cbpa.2006.08.018; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Nishimoto E, 1998, BIOCHEMISTRY-US, V37, P5599, DOI 10.1021/bi9718651; OOI T, 1962, ARCH BIOCHEM BIOPHYS, V98, P1, DOI 10.1016/0003-9861(62)90138-8; Pellicane G, 2012, J PHYS CHEM B, V116, P2114, DOI 10.1021/jp212048j; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Price WS, 1999, J AM CHEM SOC, V121, P11503, DOI 10.1021/ja992265n; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Ravi VK, 2012, BIOPHYS J, V102, p255A, DOI 10.1016/j.bpj.2011.11.1406; Ravi VK, 2014, PLOS ONE, DOI [10.1371/journal.pone.0087012, DOI 10.1371/J0URNAL.P0NE.0087012]; Scheinost J.C., 2010, PROTEIN MISFOLDING D, P615; Sekhar A, 2011, BIOCHEMISTRY-US, V50, P805, DOI 10.1021/bi101312h; SOPHIANOPOULOS A, 1961, J BIOL CHEM, V236, pPC82; SOPHIANOPOULOS AJ, 1964, J BIOL CHEM, V239, P2516; Steiner R. F., 1991, TOPICS FLUORESCENCE, V2, P1, DOI DOI 10.1007/0-306-47058-6_; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Wei GH, 2007, PRION, V1, P3, DOI 10.4161/pri.1.1.3969; WETTER LR, 1951, J BIOL CHEM, V192, P237; Zhang J, 2003, J CHEM PHYS, V119, P10972, DOI 10.1063/1.1622380; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c	44	17	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87256	10.1371/journal.pone.0087256	http://dx.doi.org/10.1371/journal.pone.0087256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489883	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000121
J	Selvarajah, V; Pasea, L; Ojha, S; Wilkinson, IB; Tomlinson, LA				Selvarajah, Viknesh; Pasea, Laura; Ojha, Sanjay; Wilkinson, Ian B.; Tomlinson, Laurie A.			Pre-Dialysis Systolic Blood Pressure-Variability Is Independently Associated with All-Cause Mortality in Incident Haemodialysis Patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK; DISEASE PATIENTS	Systolic blood pressure variability is an independent risk factor for mortality and cardiovascular events. Standard measures of blood pressure predict outcome poorly in haemodialysis patients. We investigated whether systolic blood pressure variability was associated with mortality in incident haemodialysis patients. We performed a longitudinal observational study of patients commencing haemodialysis between 2005 and 2011 in East Anglia, UK, excluding patients with cardiovascular events within 6 months of starting haemodialysis. The main exposure was variability independent of the mean (VIM) of systolic blood pressure from short-gap, pre-dialysis blood pressure readings between 3 and 6 months after commencing haemodialysis, and the outcome was all-cause mortality. Of 203 patients, 37 (18.2%) patients died during a mean follow-up of 2.0 (SD 1.3) years. The age and sex-adjusted hazard ratio (HR) for mortality was 1.09 (95% confidence interval (CI) 1.02-1.17) for a one-unit increase of VIM. This was not altered by adjustment for diabetes, prior cardiovascular disease and mean systolic blood pressure (HR 1.09, 95% CI 1.02-1.16). Patients with VIM of systolic blood pressure above the median were 2.4 (95% CI 1.17-4.74) times more likely to die during follow-up than those below the median. Results were similar for all measures of blood pressure variability and further adjustment for type of dialysis access, use of antihypertensives and absolute or variability of fluid intake did not alter these findings. Diastolic blood pressure variability showed no association with all cause mortality. Our study shows that variability of systolic blood pressure is a strong and independent predictor of all-cause mortality in incident haemodialysis patients. Further research is needed to understand the mechanism as this may form a therapeutic target or focus for management.	[Selvarajah, Viknesh] Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Selvarajah, Viknesh; Ojha, Sanjay] Cambridge Univ Hosp NHS Fdn Trust, Dept Nephrol, Cambridge, England; [Pasea, Laura] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 2QQ, England; [Wilkinson, Ian B.; Tomlinson, Laurie A.] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Selvarajah, V (corresponding author), Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	vs321@cam.ac.uk		wilkinson, ian/0000-0001-6598-9399; Tomlinson, Laurie/0000-0001-8848-9493	British Heart Foundation; Cambridge Biomedical Research Centre; British Heart Foundation [FS/12/8/29377] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cambridge Biomedical Research Centre(General Electric); British Heart Foundation(British Heart Foundation)	IBW and VS are supported by the British Heart Foundation and the Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2007, SEMIN DIALYSIS, V20, P498, DOI 10.1111/j.1525-139X.2007.00340.x; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Brunelli SM, 2008, AM J KIDNEY DIS, V52, P716, DOI 10.1053/j.ajkd.2008.04.032; Chang TI, 2014, J HUM HYPERTENS, V28, P18, DOI 10.1038/jhh.2013.49; Chang TI, 2011, CURR HYPERTENS REP, V13, P362, DOI 10.1007/s11906-011-0223-x; Di Iorio B, 2013, J NEPHROL, V26, P173, DOI 10.5301/jn.5000108; Flythe JE, 2013, AJKD, P1; Lacy P, 2006, CLIN SCI, V110, P101, DOI 10.1042/CS20050192; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mallamaci F, 2013, BLOOD PURIFICAT, V36, P58, DOI 10.1159/000351004; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; Raimann JG, 2012, KIDNEY INT, V81, P548, DOI 10.1038/ki.2011.426; Rohrscheib MR, 2008, CLIN J AM SOC NEPHRO, V3, P1407, DOI 10.2215/CJN.00110108; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Vita G, 1999, KIDNEY INT, V56, P232, DOI 10.1046/j.1523-1755.1999.00511.x; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8	21	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86514	10.1371/journal.pone.0086514	http://dx.doi.org/10.1371/journal.pone.0086514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489735	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000055
J	Zhang, DP; Meng, SN; Xu, P; Lu, HY; Zhuang, MH; Wu, GH; Liu, YL; Pan, XH; Yan, HJ; Chen, X; Fan, LR; Li, CM; Fu, XJ; Qi, JL; Han, L; Ma, FC; Lv, F; Sun, JP				Zhang, Dapeng; Meng, Sining; Xu, Peng; Lu, Hongyan; Zhuang, Minghua; Wu, Guohui; Liu, Yanling; Pan, Xiaohong; Yan, Hongjing; Chen, Xi; Fan, Lirui; Li, Chengmei; Fu, Xiaojing; Qi, Jinlei; Han, Lei; Ma, Fuchang; Lv, Fan; Sun, Jiangping			Experience of Offering HIV Rapid Testing to At-Risk Patients in Community Health Centers in Eight Chinese Cities	PLOS ONE			English	Article							COST-EFFECTIVENESS; CARE; PROGRAM	Objective: To explore the feasibility of offering HIV counseling and testing in community health centers (CHCs) and to provide evidence for the HIV/AIDS response in China. Methods: Forty-two CHCs were selected from the eight cities that participated in the study. Rapid testing was mainly provided to: clients seeking HIV testing and counseling (HTC); outpatients with high-risk behavior of contracting HIV; inpatients and outpatients of key departments. Aggregate administrative data were collected in CHCs and general hospitals and differences between the two categories were compared. Results: There were 23,609 patients who underwent HIV testing, accounting for 0.37% of all estimated clinic visits at the 42 sites (0.03%-4.35% by site). Overall, positive screening prevalence was 0.41% (95% confidence interval [CI] 0.33%-0.49%, range 0.00%-0.98%), which is higher than in general hospitals (0.17%). The identification efficiency was 0.22% (95% CI: 0.16%-0.27%) in pilot CHCs, 3.5 times higher than in general hospitals (0.06%) (Chi square test = 95.196, p<0.001). The percentage of those receiving confirmatory tests among those who screened positive was slightly lower in CHCs (73.7%) than in general hospitals (80.1%) (Chi-square test = 17.472, p<0.001). Composition of clients mobilized for testing was consistent with the usage of basic public health and medical services in CHCs. The rate of patients testing HIV positive was higher among patients from key CHC departments (0.68%) than among high-risk Voluntary Counseling and Testing (VCT) clients (0.56%), those participating in outreach activities (0.41%), pregnant women (0.05%), and surgical patients (0.00%). Conclusion: This project demonstrates that providing HIV testing services for patients who exhibit high risk behavior has a high HIV case detection rate and that CHCs have the capacity to integrate HTC into routine work. It provides concrete evidence supporting the involvement of CHCs in the expansion of HIV/AIDS testing and case finding.	[Zhang, Dapeng; Meng, Sining; Xu, Peng; Li, Chengmei; Fu, Xiaojing; Qi, Jinlei; Ma, Fuchang; Lv, Fan; Sun, Jiangping] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Lu, Hongyan] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhuang, Minghua] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Liu, Yanling] Harbin Ctr Dis Control & Prevent, Harbin, Peoples R China; [Pan, Xiaohong] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Yan, Hongjing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Xi] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Fan, Lirui] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Han, Lei] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022		China-Gates Foundation HIV Cooperation Program [Opp49277]	China-Gates Foundation HIV Cooperation Program	This work was supported by the China-Gates Foundation HIV Cooperation Program (grant number Opp49277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WHO RAP HIV TESTS GU; Arthur GR, 2005, JAIDS-J ACQ IMM DEF, V40, P329, DOI 10.1097/01.qai.0000166376.23846.38; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chao TT, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/841979; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chinese Center for Diseae Control and Prevention, 2009, NAT GUILD DET HIV AI; Chinese Center for Diseae Control and Prevention, 2009, NAT GUID HIV VOL TES; Choi KH, 2006, AIDS EDUC PREV, V18, P33, DOI 10.1521/aeap.2006.18.1.33; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Guenter D, 2008, AIDS PATIENT CARE ST, V22, P195, DOI 10.1089/apc.2007.0137; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Lu H, 2008, CAPITAL J PUBLIC HLT, V2, P61; Martin EG, 2011, J CLIN VIROL, V52, P7; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; Pan XL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-93; Ramesh M, 2013, HLTH GOVERNANCE HEAL; Roberts KJ, 2007, AIDS PATIENT CARE ST, V21, P621, DOI 10.1089/apc.2006.0196; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Waheed U, 2013, J CLIN VIROL, V56, P367, DOI 10.1016/j.jcv.2012.12.012; Wang HF, 2011, HEALTH POLICY, V99, P37, DOI 10.1016/j.healthpol.2010.07.003; Wang SH, 2011, ASIA-PAC J PUBLIC HE, V23, P620, DOI 10.1177/1010539511412576; Weis KE, 2009, AIDS PATIENT CARE ST, V23, P251, DOI 10.1089/apc.2008.0167; WU Z, 2010, INT J EPIDEMIOL S2, V39, P1, DOI DOI 10.1093/IJE/DYQ220; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431; 吴尊友, 2011, [中国公共卫生, China Public Health], V27, P1505	34	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86609	10.1371/journal.pone.0086609	http://dx.doi.org/10.1371/journal.pone.0086609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489750	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000063
J	Howard, TP; Hayward, AP; Tordillos, A; Fragoso, C; Moreno, MA; Tohme, J; Kausch, AP; Mottinger, JP; Dellaporta, SL				Howard, Thomas P., III; Hayward, Andrew P.; Tordillos, Anthony; Fragoso, Christopher; Moreno, Maria A.; Tohme, Joe; Kausch, Albert P.; Mottinger, John P.; Dellaporta, Stephen L.			Identification of the Maize Gravitropism Gene lazy plant1 by a Transposon-Tagging Genome Resequencing Strategy	PLOS ONE			English	Article							ELEMENT SYSTEM; COPY NUMBER; NUCLEOTIDE-SEQUENCE; SHOOT GRAVITROPISM; READ ALIGNMENT; CLONING; INSERTION; LAZY1; MUTAGENESIS; ALLELE	Since their initial discovery, transposons have been widely used as mutagens for forward and reverse genetic screens in a range of organisms. The problems of high copy number and sequence divergence among related transposons have often limited the efficiency at which tagged genes can be identified. A method was developed to identity the locations of Mutator (Mu) transposons in the Zea mays genome using a simple enrichment method combined with genome resequencing to identify transposon junction fragments. The sequencing library was prepared from genomic DNA by digesting with a restriction enzyme that cuts within a perfectly conserved motif of the Mu terminal inverted repeats (TIR). Paired-end reads containing Mu TIR sequences were computationally identified and chromosomal sequences flanking the transposon were mapped to the maize reference genome. This method has been used to identify Mu insertions in a number of alleles and to isolate the previously unidentified lazy plant1 (la1) gene. The la1 gene is required for the negatively gravitropic response of shoots and mutant plants lack the ability to sense gravity. Using bioinformatic and fluorescence microscopy approaches, we show that the la1 gene encodes a cell membrane and nuclear localized protein. Our Mu-Taq method is readily adaptable to identify the genomic locations of any insertion of a known sequence in any organism using any sequencing platform.	[Howard, Thomas P., III; Hayward, Andrew P.; Tordillos, Anthony; Fragoso, Christopher; Moreno, Maria A.; Dellaporta, Stephen L.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Tohme, Joe] Ctr Int Agr Trop, Cali, Colombia; [Kausch, Albert P.; Mottinger, John P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA	Yale University; Alliance; International Center for Tropical Agriculture - CIAT; University of Rhode Island	Dellaporta, SL (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	stephen.dellaporta@yale.edu		Howard, Thomas/0000-0002-3438-2831	National Science Foundation [0965420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by a grant to SLD, MAM and JT from the National Science Foundation (0965420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; ALLEMAN M, 1986, GENETICS, V112, P107; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARKER RF, 1984, NUCLEIC ACIDS RES, V12, P5955, DOI 10.1093/nar/12.15.5955; Benito MI, 1997, MOL CELL BIOL, V17, P5165, DOI 10.1128/MCB.17.9.5165; BENNETZEN J L, 1984, Journal of Molecular and Applied Genetics, V2, P519; Bennetzen JL, 1996, CURR TOP MICROBIOL, V204, P195; BENNETZEN JL, 1993, CRIT REV PLANT SCI, V12, P57, DOI 10.1080/713608042; BENNETZEN JL, 1984, P NATL ACAD SCI-BIOL, V81, P4125, DOI 10.1073/pnas.81.13.4125; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CHEN CH, 1987, GENETICS, V116, P469; Chen J., 1993, MAIZE HAND BOOK, P526; CHOMET P, 1991, GENETICS, V129, P261; CRESSE AD, 1995, GENETICS, V140, P315; Darwin C, 1880, POWER MOVEMENT PLANT; DAS L, 1995, PLANT CELL, V7, P287, DOI 10.1105/tpc.7.3.287; Dietrich CR, 2002, GENETICS, V160, P697; Dong ZB, 2013, PLANT PHYSIOL, V163, P1306, DOI 10.1104/pp.113.227314; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; FLEENOR D, 1990, NUCLEIC ACIDS RES, V18, P6725, DOI 10.1093/nar/18.22.6725; Frey M, 1998, PLANT J, V13, P717, DOI 10.1046/j.1365-313X.1998.00091.x; Hanley S, 2000, PLANT J, V23, P557, DOI 10.1046/j.1365-313x.2000.00830.x; Hayward A, 2011, METHODS MOL BIOL, V678, P55, DOI 10.1007/978-1-60761-682-5_5; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Illumina, 2010, GEN SEQ; JAMES MG, 1993, PLANT MOL BIOL, V21, P1181, DOI 10.1007/BF00023614; Jenkins M., 1931, IOWA AGIC EXP STA RE, V138, P121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; May BP, 2003, P NATL ACAD SCI USA, V100, P11541, DOI 10.1073/pnas.1831119100; McCarty DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077172; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; MCLAUGHLIN M, 1987, GENETICS, V117, P771; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; OREILLY C, 1985, EMBO J, V4, P877, DOI 10.1002/j.1460-2075.1985.tb03713.x; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Pooma W, 2002, GENETICS, V161, P793; Project TUM, 2011, PROJ DOC PROT; Raizada MN, 2001, PLANT CELL, V13, P1587, DOI 10.1105/tpc.13.7.1587; Raizada MN, 2003, METH MOL B, V236, P37; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCHNABLE PS, 1989, MOL GEN GENET, V217, P459, DOI 10.1007/BF02464917; Settles AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-116; Settles AM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh052; Shafer J, 1939, BOT GAZ, V101, P68, DOI 10.1086/334851; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; TALBERT LE, 1989, J MOL EVOL, V29, P28, DOI 10.1007/BF02106179; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; TAYLOR LP, 1987, GENETICS, V117, P297; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Van Overbeek J, 1938, J HERED, V29, P339, DOI 10.1093/oxfordjournals.jhered.a104536; van Overbeek J, 1936, J HERED, V29, P339; WALBOT V, 1988, MOL GEN GENET, V211, P27, DOI 10.1007/BF00338389; Walbot Virginia, 2002, P533; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yoshihara T, 2013, PLANT J, V74, P267, DOI 10.1111/tpj.12118; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	68	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87053	10.1371/journal.pone.0087053	http://dx.doi.org/10.1371/journal.pone.0087053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498020	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900064
J	Zoufaly, A; Cozzi-Lepri, A; Reekie, J; Kirk, O; Lundgren, J; Reiss, P; Jevtovic, D; Machala, L; Zangerle, R; Mocroft, A; Van Lunzen, J				Zoufaly, Alexander; Cozzi-Lepri, Alessandro; Reekie, Joanne; Kirk, Ole; Lundgren, Jens; Reiss, Peter; Jevtovic, Djordje; Machala, Ladislav; Zangerle, Robert; Mocroft, Amanda; Van Lunzen, Jan		EuroSIDA EuroCoord	Immuno-Virological Discordance and the Risk of Non-AIDS and AIDS Events in a Large Observational Cohort of HIV-Patients in Europe	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; INFECTED PATIENTS; CLINICAL-TRIALS; IMMUNODEFICIENCY; MORTALITY; SUPPRESSION; PROGRESSION; RESPONSES	Background: The impact of immunosuppression despite virological suppression (immuno-virological discordance, ID) on the risk of developing fatal and non-fatal AIDS/non-AIDS events is unclear and remains to be elucidated. Methods: Patients in EuroSIDA starting at least 1 new antiretroviral drug with CD4<350 cells/mu l and viral load (VL)>500 copies/mL were followed-up from the first day of VL<=50 copies/ml until a new fatal/non-fatal non-AIDS/AIDS event. Considered non-AIDS events included non-AIDS malignancies, pancreatitis, severe liver disease with hepatic encephalopathy (>grade 3), cardio-and cerebrovascular events, and end-stage renal disease. Patients were classified over time according to whether current CD4 count was above (non-ID) or below (ID) baseline level. Relative rates (RR) of events were calculated for ID vs. non-ID using adjusted Poisson regression models. Results: 2,913 patients contributed 11,491 person-years for the analysis of non-AIDS. 241 pre-specified non-AIDS events (including 84 deaths) and 89 AIDS events (including 10 deaths) occurred. The RR of developing pre-specified non-AIDS events for ID vs. non-ID was 1.96 (95% CI 1.37-2.81, p<0.001) in unadjusted analysis and 1.43 (0.94-2.17, p = 0.095) after controlling for current CD4 count. ID was not associated with the risk of AIDS events (aRR 0.76, 95% CI 0.41-1.38, p = 0.361). Conclusion: Compared to CD4 responders, patients with immuno-virological discordance may be at increased risk of developing non-AIDS events. Further studies are warranted to establish whether in patients with ID, strategies to directly modify CD4 count response may be needed besides the use of ART.	[Zoufaly, Alexander; Van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Dept Med 1, Hamburg, Germany; [Cozzi-Lepri, Alessandro; Reekie, Joanne; Mocroft, Amanda] UCL, Dept Infect & Populat Hlth, London, England; [Kirk, Ole; Lundgren, Jens] Univ Copenhagen, Rigshosp, Copenhagen HIV Programme, Dept Infect Dis & Rheumatol,Sect 8632, DK-2100 Copenhagen, Denmark; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth & Stichting HIV Monitoring, NL-1105 AZ Amsterdam, Netherlands; [Jevtovic, Djordje] Univ Belgrade, Sch Med, Infect Dis Hosp, HIV AIDS Dept, Belgrade, Serbia; [Machala, Ladislav] Charles Univ Prague, Dept Infect Dis, Fac Med 3, Prague, Czech Republic; [Zangerle, Robert] Med Univ Innsbruck, Dept Dermatol & Venereal Dis, A-6020 Innsbruck, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Rigshospitalet; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of Belgrade; Charles University Prague; Medical University of Innsbruck	Zoufaly, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Dept Med 1, Hamburg, Germany.	alex_zoufaly@yahoo.com	Begovac, Josip/AAI-5672-2021; Lundgren, Jens/AAE-6876-2019; Vandekerckhove, Linos/J-6420-2013; kirk, ole/ABB-4746-2021; Castagna, Antonella/K-3280-2018; VELLA, STEFANO/V-8440-2019; Soriano, Vicente/O-5730-2018; Mitsura, Viktar/G-2457-2017; Ostergaard, Lars/AAA-3020-2020; Flisiak, Robert/S-5356-2018; LAZZARIN, Adriano/K-3607-2018; Grzeszczuk, Anna/R-7844-2018	Begovac, Josip/0000-0003-2641-4327; Vandekerckhove, Linos/0000-0002-8600-1631; Castagna, Antonella/0000-0002-8338-9714; VELLA, STEFANO/0000-0003-2347-5984; Soriano, Vicente/0000-0002-4624-5199; Mitsura, Viktar/0000-0002-0449-5026; Ostergaard, Lars/0000-0003-2459-0511; Flisiak, Robert/0000-0003-3394-1635; LAZZARIN, Adriano/0000-0003-2551-7754; Colebunders, Robert/0000-0002-1919-1340; Lundgren, Jens/0000-0001-8901-7850; Johnson, Anne/0000-0003-1330-7100; Jevtovic, Dorde/0000-0003-1127-6072; Anna, Vassilenko/0000-0003-1907-2322; Gianotti, Nicola/0000-0002-7182-5080; Ostergaard, Lars/0000-0002-7619-605X; Grzeszczuk, Anna/0000-0002-6420-5545; Benfield, Thomas/0000-0003-0698-9385; Katzenstein, Terese L/0000-0002-2233-500X; Leen, Clifford/0000-0001-8439-7719; Ristola, Matti/0000-0001-5115-2811	European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632, 260694]; Gilead; Pfizer; Merck and Co.; Swiss National Science Foundation [108787]; MSD SHARP DOHME GmbH	European Commission(European CommissionEuropean Commission Joint Research Centre); Gilead(Gilead Sciences); Pfizer(Pfizer); Merck and Co.(Merck & Company); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MSD SHARP DOHME GmbH	Primary support is provided by the European Commission BIOMED 1 (CT94-1637), BIOMED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773), the 6th Framework (LSHP-CT-2006-018632), and the 7th Framework (FP7/2007-2013, EuroCoord no. 260694) programmes. Current support also includes unrestricted grants by Gilead, Pfizer, and Merck and Co. The participation of centres from Switzerland was supported by The Swiss National Science Foundation (Grant 108787). AZ received a grant from MSD SHARP & DOHME GmbH for the performance of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; [Anonymous], MMWR RECOMM REP, V17, P1; Babiker A, 2002, INT J EPIDEMIOL, V31, P951, DOI 10.1093/ije/31.5.951; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Hatano H, 2012, J INFECT DIS; Helleberg M, 2013, AIDS, V27, P1021, DOI 10.1097/QAD.0b013e32835cba4c; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kesselring A, 2011, CLIN INFECT DIS, V52, P1458, DOI 10.1093/cid/cir207; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Lanzafame M, 2009, AIDS, V23, P869, DOI 10.1097/QAD.0b013e3283262aa0; Lapadula G, 2013, AIDS, V27, P769, DOI 10.1097/QAD.0b013e32835cb747; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2012, ANTIVIR THER; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Moore RD, 2008, CLIN INFECT DIS, V47, P1102, DOI 10.1086/592115; Nies-Kraske E, 2009, J INFECT DIS, V199, P1648, DOI 10.1086/598980; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Wolbers M, 2008, HIV MED, V9, P397, DOI 10.1111/j.1468-1293.2008.00566.x; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	28	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87160	10.1371/journal.pone.0087160	http://dx.doi.org/10.1371/journal.pone.0087160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498036	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900072
J	Huang, YK; Lee, WF; Wang, MJ; Chang, YHS; Tchaou, WS; Chang, WJ; Lee, SY; Sheu, JR; Teng, NC				Huang, Yung-Kai; Lee, Wei-Fang; Wang, Meng-Jiy; Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Chang, Wei-Jen; Lee, Sheng-Yang; Sheu, Joen-Rong; Teng, Nai-Chia			Chair-Side Quantitative Oral-Microflora Screening for Assessing Familial Correlation of Periodontal Status and Caries Prevalence	PLOS ONE			English	Article							MUTANS STREPTOCOCCI; DENTAL-CARIES; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; CHILDREN; PLAQUE; TRANSMISSION; SUBGINGIVAL; HEALTH; RISK	Aim: Our goal was to investigate the relationship between clinical status and the presence of carious or periodontal pathogens among parent-child familial pairs. Clinical practices of risk assessment with consideration of familial pathogen interaction might reduce the need for therapy, improve patient outcomes, and ultimately reduce oral disease burden. Materials and Methods: In this study, we enrolled 30 parent-child pairs, with the children exhibiting complete deciduous dentition or mixed dentition with only permanent first molars. Clinical statuses were evaluated using caries and periodontal disease indicators, including the sum of decay and the number of missing or filled teeth (DMFT) for adults, decay, extraction caused by dental disease, and filled teeth (deft), for children, probing depth, and plaque control record (PCR). Supra-and sub-gingival bacteria were determined based on semi-quantitative measurements of microbial infection by using data from the Dentocult (R) SM test (caries-related organisms) and the PerioCheck (R) test (periodontal disease-related organisms). Results: No statistically significant relationship was detected between the prevalence of periodontal pathogens and that of cariogenic pathogens in the oral cavity. However, the clinical status of caries (DMFT) was negatively correlated with the clinical status of periodontal disease (pocket depth) in parents who were infected with dominant periodontal pathogens (r = 20.59, p<0.01). Parents' DMFT scores were positively correlated with children's deft and PCR scores. PCR and deft scores of children appeared to decrease significantly with the parent's pocket depth. Conclusion: The study showed that the quantity of caries pathogens were not significant related to periodontal pathogens, but the caries clinical outcome is negative related with periodontal clinical outcome between familial pairs.	[Huang, Yung-Kai] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Lee, Wei-Fang] Taipei Med Univ, Sch Dent Technol, Coll Oral Med, Taipei, Taiwan; [Wang, Meng-Jiy] Natl Taiwan Univ Sci & Technol, Dept Chem Engn, Taipei, Taiwan; [Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Teng, Nai-Chia] Taipei Med Univ Hosp, Div Oral Rehabil, Dept Dent, Taipei, Taiwan; [Chang, Yus-Han Sophie; Tchaou, Wen-Shiun; Teng, Nai-Chia] Taipei Med Univ Hosp, Ctr Pediat Dent, Dept Dent, Taipei, Taiwan; [Chang, Wei-Jen; Lee, Sheng-Yang; Teng, Nai-Chia] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Lee, Sheng-Yang] Taipei Med Univ, Dept Dent, Wan Fang Hosp, Taipei, Taiwan; [Sheu, Joen-Rong] Taipei Med Univ, Dept Pharmacol, Sch Med, Coll Med, Taipei, Taiwan; [Sheu, Joen-Rong] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Taiwan University of Science & Technology; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Teng, NC (corresponding author), Taipei Med Univ Hosp, Div Oral Rehabil, Dept Dent, Taipei, Taiwan.	dianaten@tmu.edu.tw	Huang, Yung-Kai/C-7868-2012	Huang, Yung-Kai/0000-0002-4467-0300	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program [TMU-NTUST-100-01]	Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program	This study was supported by a research grant from the Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program (TMU-NTUST-100-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; BOWERS J E, 1989, Journal of Clinical Dentistry, V1, P106; Dalwai F, 2007, J CLIN MICROBIOL, V45, P3072, DOI 10.1128/JCM.01131-07; Dogan B, 2008, J PERIODONTOL, V79, P307, DOI [10.1902/jop.2008.070270, 10.1902/jop.2008.070270 ]; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; ELEY BM, 1995, BRIT DENT J, V178, P133, DOI 10.1038/sj.bdj.4808681; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FIEHN NE, 1992, J PERIODONTAL RES, V27, P609, DOI 10.1111/j.1600-0765.1992.tb01744.x; Haffajee AD, 1994, PERIODONTOL, V5, P78, DOI DOI 10.1111/J.1600-0757.1994.TB00020.X; HASSELL TM, 1995, CRIT REV ORAL BIOL M, V6, P319, DOI 10.1177/10454411950060040401; Hemmings KW, 1997, J CLIN PERIODONTOL, V24, P110, DOI 10.1111/j.1600-051X.1997.tb00475.x; HILLMAN JD, 1985, ARCH ORAL BIOL, V30, P791, DOI 10.1016/0003-9969(85)90133-5; Iwano Y, 2010, J PERIODONTAL RES, V45, P165, DOI 10.1111/j.1600-0765.2009.01213.x; Karjalainen S, 2004, ACTA ODONTOL SCAND, V62, P153, DOI 10.1080/00016350410001559; KONONEN E, 1994, ORAL MICROBIOL IMMUN, V9, P310, DOI 10.1111/j.1399-302X.1994.tb00077.x; Kuramitsu HK, 2003, CRIT REV ORAL BIOL M, V14, P331, DOI 10.1177/154411130301400504; Lee Y, 2006, J DENT RES, V85, P182, DOI 10.1177/154405910608500213; Loesche W, 2007, INFECT DIS CLIN N AM, V21, P471, DOI 10.1016/j.idc.2007.03.006; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Morinushi T, 2000, J PERIODONTOL, V71, P403, DOI 10.1902/jop.2000.71.3.403; Olak J, 2007, INT J PAEDIATR DENT, V17, P92, DOI 10.1111/j.1365-263X.2006.00788.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; PIENIHAKKINEN K, 1995, EUR J ORAL SCI, V103, P61, DOI 10.1111/j.1600-0722.1995.tb00012.x; Quirynen M, 1999, J CLIN PERIODONTOL, V26, P322, DOI 10.1034/j.1600-051X.1999.260511.x; RUDNEY JD, 1994, ARCH ORAL BIOL, V39, P513, DOI 10.1016/0003-9969(94)90148-1; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Sheiham A, 2000, COMMUNITY DENT ORAL, V28, P399, DOI 10.1034/j.1600-0528.2000.028006399.x; Tanner ACR, 2006, J DENT RES, V85, P318, DOI 10.1177/154405910608500407; Thenisch NL, 2006, CARIES RES, V40, P366, DOI 10.1159/000094280; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; van der Reijden WA, 2001, J CLIN PERIODONTOL, V28, P686, DOI 10.1034/j.1600-051x.2001.028007686.x; van Loveren C, 2000, CARIES RES, V34, P481, DOI 10.1159/000016627; WATSON MR, 1991, J DENT RES, V70, P1052, DOI 10.1177/00220345910700070701; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	36	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87100	10.1371/journal.pone.0087100	http://dx.doi.org/10.1371/journal.pone.0087100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498022	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100048
J	Luo, JQ; Wen, JG; Zhou, HH; Chen, XP; Zhang, W				Luo, Jian-Quan; Wen, Jia-Gen; Zhou, Hong-Hao; Chen, Xiao-Ping; Zhang, Wei			Endothelial Nitric Oxide Synthase Gene G894T Polymorphism and Myocardial Infarction: A Meta-Analysis of 34 Studies Involving 21068 Subjects	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MISSENSE GLU298ASP VARIANT; HEART-DISEASE; RISK-FACTOR; EXON 7; ASSOCIATION; GENOTYPE; MUTATION; ALLELE; COMMON	Background: Researches have revealed that the endothelial nitric oxide synthase (eNOS) gene G894T polymorphism is associated with the risk of Myocardial infarction (MI), but the results remain conflicting. Objective and Methods: A meta-analysis was conducted to investigate the association between eNOS G894T polymorphism and MI. Published studies from PubMed, Embase, CNKI and CBM databases were retrieved. The pooled odds ratios (ORs) for the association between eNOS G894T polymorphism and MI and their corresponding 95% confidence intervals (CIs) were estimated using the random-or fixed-effect model. Results: A total of 34 studies including 8229 cases and 12839 controls were identified for the meta-analysis. The eNOS G894T polymorphism was significantly associated with MI under a homozygous genetic model (OR = 1.41, 95% CI = 1.08-1.84; P = 0.012), a recessive genetic model (OR = 1.35, 95% CI = 1.06-1.70; P = 0.014), a dominant genetic model (OR = 1.18, 95% CI = 1.04-1.34; P = 0.009). In the subgroup analysis by ethnicity (non-Asian and Asian), no significant association was observed between eNOS G894T polymorphism and MI risk among non-Asians (P > 0.05), but a positive significant association was found among Asians (P < 0.05). Conclusions: The eNOS G894T polymorphism is associated with increased MI risk in Asians. The results indicate that ethnicity plays important roles in the association between eNOS G894T polymorphism and MI.	[Luo, Jian-Quan; Wen, Jia-Gen; Zhou, Hong-Hao; Chen, Xiao-Ping; Zhang, Wei] Cent South Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China	Central South University	Chen, XP (corresponding author), Cent South Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China.	chenxp74@hotmail.com; yjsd2003@163.com	Luo, Jianquan/AAE-7795-2019		National Scientific Foundation of China [81273595, 81202594, 81001445]; "863" Project [2012AA02A518]; Scientific Foundation of Hunan [11K073, 10JJ4020]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); "863" Project(National High Technology Research and Development Program of China); Scientific Foundation of Hunan	The work was supported by the National Scientific Foundation of China (No. 81273595, 81202594, 81001445), the "863" Project (No. 2012AA02A518), the Scientific Foundation of Hunan (No. 11K073, 10JJ4020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agema WRP, 2004, CLIN SCI, V107, P255, DOI 10.1042/CS20030360; Andrikopoulos GK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-43; Angeline T, 2010, EXP MOL PATHOL, V89, P205, DOI 10.1016/j.yexmp.2010.08.009; Antoniades C, 2005, J AM COLL CARDIOL, V46, P1101, DOI 10.1016/j.jacc.2005.05.072; Aras O, 2002, THROMB HAEMOSTASIS, V87, P347; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cai H, 1999, J MOL MED, V77, P511, DOI 10.1007/s001099900020; Cai H, 1998, DIABETES CARE, V21, P2195, DOI 10.2337/diacare.21.12.2195; Casas JP, 2004, CIRCULATION, V109, P1359, DOI 10.1161/01.CIR.0000121357.76910.A3; Chao YX, 2006, ASS ENDOTHELIAL NITR; Chien YH, 2004, FREE RADICAL BIO MED, V36, P1011, DOI 10.1016/j.freeradbiomed.2004.01.011; Dafni C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-133; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Franco E, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-27; Gad MZ, 2012, GENET TEST MOL BIOMA, V16, P695, DOI 10.1089/gtmb.2011.0342; Gardemann A, 2002, ATHEROSCLEROSIS, V160, P167, DOI 10.1016/S0021-9150(01)00554-8; Gluba A, 2009, ANGIOLOGY, V60, P588, DOI 10.1177/0003319709335031; Gong LL, 2012, THROMB RES, V130, pE43, DOI 10.1016/j.thromres.2012.06.015; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Isordia-Salas I, 2010, CLIN CHIM ACTA, V411, P553, DOI 10.1016/j.cca.2010.01.013; Jo I, 2006, CLIN CHIM ACTA, V365, P86, DOI 10.1016/j.cca.2005.07.029; Katakami N, 2010, ATHEROSCLEROSIS, V212, P534, DOI 10.1016/j.atherosclerosis.2010.06.010; Kumar ASA, 2013, MOL BIOL REP, V40, P1275, DOI 10.1007/s11033-012-2170-2; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Narne P, 2013, J DIABETES COMPLICAT, V27, P255, DOI 10.1016/j.jdiacomp.2012.10.009; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; Odeberg J, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-36; Poirier O, 1999, EUR J CLIN INVEST, V29, P284; [齐霁 Qi Ji], 2003, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V23, P470; Rankinen T, 2000, HYPERTENSION, V36, P885, DOI 10.1161/01.HYP.36.5.885; Sampalo MF, 2007, CLIN CHIM ACTA, V377, P154, DOI 10.1016/j.cca.2006.09.013; Schmoelzer I, 2003, EUR J CLIN INVEST, V33, P191, DOI 10.1046/j.1365-2362.2003.01108.x; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Song C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060454; Song J, 2000, ASS STUD AL REP INS; Szabo GV, 2009, PATHOL ONCOL RES, V15, P631, DOI 10.1007/s12253-009-9163-z; Vasilakou M, 2008, ACTA CARDIOL, V63, P609, DOI 10.2143/AC.63.5.2033229; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262; Wang CL, 2001, J FORMOS MED ASSOC, V100, P736; Wei Danhong, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P471; Yoshimura M, 1998, HUM GENET, V103, P65, DOI 10.1007/s004390050785; Yu H, 2006, RELATIONS GENE POLYM; Zhan Y, 2005, CHINESE J CLIN REHAB, V9, P177; Zhang K, 2012, THROMB RES, V130, P192, DOI 10.1016/j.thromres.2012.02.015; Zigra AM, 2013, DIS MARKERS, V34, P431, DOI [10.1155/2013/235056, 10.3233/DMA-130987]	51	24	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87196	10.1371/journal.pone.0087196	http://dx.doi.org/10.1371/journal.pone.0087196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498040	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100056
J	Carvalho, HH; Brustolini, OJB; Pimenta, MR; Mendes, GC; Gouveia, BC; Silva, PA; Silva, JCF; Mota, CS; Soares-Ramos, JRL; Fontes, EPB				Carvalho, Humberto H.; Brustolini, Otavio J. B.; Pimenta, Maiana R.; Mendes, Giselle C.; Gouveia, Bianca C.; Silva, Priscila A.; Silva, Jose Cleydson F.; Mota, Clenilso S.; Soares-Ramos, Juliana R. L.; Fontes, Elizabeth P. B.			The Molecular Chaperone Binding Protein BiP Prevents Leaf Dehydration-Induced Cellular Homeostasis Disruption	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; VACUOLAR PROCESSING ENZYME; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; MESSENGER-RNA; SIGNALING PATHWAY; DROUGHT TOLERANCE; TRANSLOCON PORE	BiP overexpression improves leaf water relations during droughts and delays drought-induced leaf senescence. However, whether BiP controls cellular homeostasis under drought conditions or simply delays dehydration-induced leaf senescence as the primary cause for water stress tolerance remains to be determined. To address this issue, we examined the drought-induced transcriptomes of BiP-overexpressing lines and wild-type (WT) lines under similar leaf water potential (psi(w)) values. In the WT leaves, a psi(w) reduction of -1.0 resulted in 1339 up-regulated and 2710 down-regulated genes; in the BiP-overexpressing line 35S::BiP-4, only 334 and 420 genes were induced and repressed, respectively, at a similar leaf psi(w) = -1.0 MPa. This level of leaf dehydration was low enough to induce a repertory of typical drought-responsive genes in WT leaves but not in 35S::BiP-4 dehydrated leaves. The responders included hormone-related genes, functional and regulatory genes involved in drought protection and senescence-associated genes. The number of differentially expressed genes in the 35S::BiP-4 line approached the wild type number at a leaf psi(w) = -1.6 MPa. However, N-rich protein (NRP)-mediated cell death signaling genes and unfolded protein response (UPR) genes were induced to a much lower extent in the 35S::BiP-4 line than in the WT even at psi(w) = -1.6 MPa. The heatmaps for UPR, ERAD (ER-associated degradation protein system), drought-responsive and cell death-associated genes revealed that the leaf transcriptome of 35S::BiP-4 at psi(w) = -1.0 MPa clustered together with the transcriptome of well-watered leaves and they diverged considerably from the drought-induced transcriptome of the WT (psi(w) = -1.0, 21.7 and 22.0 MPa) and 35S::BiP-4 leaves at psi(w) = -1.6 MPa. Taken together, our data revealed that BiP-overexpressing lines requires a much higher level of stress (psi(w) = -1.6 MPa) to respond to drought than that of WT (psi(w) = -1.0). Therefore, BiP overexpression maintains cellular homeostasis under water stress conditions and thus ameliorates endogenous osmotic stress.	[Carvalho, Humberto H.; Brustolini, Otavio J. B.; Mendes, Giselle C.; Gouveia, Bianca C.; Silva, Priscila A.; Mota, Clenilso S.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, Vicosa, MG, Brazil; [Brustolini, Otavio J. B.; Gouveia, Bianca C.; Silva, Priscila A.; Soares-Ramos, Juliana R. L.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol Bioagro, Vicosa, MG, Brazil; [Carvalho, Humberto H.; Pimenta, Maiana R.; Mendes, Giselle C.; Silva, Jose Cleydson F.] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Fontes, EPB (corresponding author), Univ Fed Vicosa, Natl Inst Sci & Technol Plant Pest Interact, Vicosa, MG, Brazil.	bbfontes@ufv.br	Mendes, Giselle/F-4277-2016; Silva, Cleydson/AAR-8163-2020; Mendes, Giselle/AFV-6426-2022; da Silva, Priscila Alves/C-6614-2016; Fontes, Elizabeth/K-3159-2012	Mendes, Giselle/0000-0003-4361-9359; da Silva, Priscila Alves/0000-0002-4505-2248; Fontes, Elizabeth/0000-0002-7986-1369; Silva, Jose Cleydson F/0000-0001-5435-702X	CNPq [573600/2008-2, 470287/2011-0]; FAPEMIG [CBB-APQ-00070-09]; FINEP [01.09.0625.00]; CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was funded through the following grants from Brazilian Government Agencies: CNPq grants 573600/2008-2 and 470287/2011-0 (to EPBF); FAPEMIG grant CBB-APQ-00070-09; and FINEP grant 01.09.0625.00 (to EPBF). GCM and PAAR were supported by CNPq graduate fellowships, and HHC was supported by a FAPEMIG graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirrezabal L, 2006, PLANT CELL ENVIRON, V29, P2216, DOI 10.1111/j.1365-3040.2006.01595.x; Al-Asbahi A. A., 2012, Journal of Stress Physiology & Biochemistry, V8, P179; Alves MS, 2011, J BIOL CHEM, V286, P20020, DOI 10.1074/jbc.M111.233494; Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Anderson JV, 1994, PLANT PHYSL ROCKV, V104, P1395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; Carvalho HH, 2014, PLANT PHYSIOL, V164, P654, DOI 10.1104/pp.113.231928; Cascardo JCM, 2001, PLANT SCI, V160, P273, DOI 10.1016/S0168-9452(00)00384-8; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Costa MDL, 2008, J BIOL CHEM, V283, P20209, DOI 10.1074/jbc.M802654200; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Fanata WID, 2013, J PROTEOMICS, V93, P356, DOI 10.1016/j.jprot.2013.04.023; Faria JAQA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-129; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; KAISER WM, 1987, PHYSIOL PLANTARUM, V71, P142, DOI 10.1111/j.1399-3054.1987.tb04631.x; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Li J, 2001, Genome Inform, V12, P3; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Lu SJ, 2012, MOL PLANT, V5, P504, DOI 10.1093/mp/ssr115; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Mendes GC, 2013, P NATL ACAD SCI USA, V110, P19627, DOI 10.1073/pnas.1311729110; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Noh SJ, 2002, BBA-GENE STRUCT EXPR, V1575, P130, DOI 10.1016/S0167-4781(02)00237-3; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Reis PAB, 2012, PLANT SIGNAL BEHAV, V7, P628, DOI 10.4161/psb.20111; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Srivastava R, 2013, PLANT CELL, V25, P1416, DOI 10.1105/tpc.113.110684; Srivastava R, 2012, PLANT J, V70, P1033, DOI 10.1111/j.1365-313X.2012.04943.x; Sung DY, 2001, PHYSIOL PLANTARUM, V113, P443, DOI 10.1034/j.1399-3054.2001.1130402.x; Tajima H, 2008, BIOCHEM BIOPH RES CO, V374, P242, DOI 10.1016/j.bbrc.2008.07.021; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Urade R, 2009, BIOFACTORS, V35, P326, DOI 10.1002/biof.45; Valente MAS, 2009, J EXP BOT, V60, P533, DOI 10.1093/jxb/ern296; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang B, 2012, MOL BIOL REP, V39, P6319, DOI 10.1007/s11033-012-1453-y; Xu FX, 1999, PLANT J, V17, P321, DOI 10.1046/j.1365-313X.1999.00370.x; Xu W, 2000, FEBS L, V474, P11	63	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86661	10.1371/journal.pone.0086661	http://dx.doi.org/10.1371/journal.pone.0086661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489761	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000055
J	Lahti, J; Lahti, M; Pesonen, AK; Heinonen, K; Kajantie, E; Forsen, T; Wahlbeck, K; Osmond, C; Barker, DJP; Eriksson, JG; Raikkonen, K				Lahti, Jari; Lahti, Marius; Pesonen, Anu-Katriina; Heinonen, Kati; Kajantie, Eero; Forsen, Tom; Wahlbeck, Kristian; Osmond, Clive; Barker, David J. P.; Eriksson, Johan G.; Raikkonen, Katri			Prenatal and Childhood Growth, and Hospitalization for Alcohol Use Disorders in Adulthood: The Helsinki Birth Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-LIFE; DEVELOPMENTAL ORIGINS; PERSONALITY-DISORDERS; PSYCHIATRIC-DISORDER; SUBSTANCE DEPENDENCE; BEHAVIORAL SYMPTOMS; GENERAL-POPULATION; FOLLOW-UP; WEIGHT	Background: Small birth size - an indicator of a sub-optimal prenatal environment - and variation in growth after birth have been associated with non-communicable diseases in later life. We tested whether birth size or growth in childhood associated with the risk of hospital admission for alcohol use disorders (AUDs) from early to late adulthood. Methods: The sample comprised 6544 men and 6050 women born between 1934 and 1944 in Helsinki, Finland. Data on anthropometric measures were extracted from medical records and diagnoses of AUD from the Finnish Hospital Discharge Register and Causes of Death Register covering a 40-year period from 1969 to 2008. Results: Altogether 171 women (2.8%) and 657 men (10.0%) were diagnosed at a hospital with AUD. After adjusting for major confounders, shorter length at birth, shorter height up to two years of age, and lower weight at two years associated with hospitalization for AUD in women. In men, slower growth in height, particularly from 2 to 7 years, and slower weight gain from 7 to 11 years as well as shorter height and lower weight at 7 and 11 years associated with a diagnosis of AUD in men. Conclusions: Pre-and postnatal growth associates with the risk for AUD later in life differently in women than in men: the fetal period and infancy seem to be the sensitive periods for women, whereas those for men the occur from toddlerhood onwards.	[Lahti, Jari; Lahti, Marius; Pesonen, Anu-Katriina; Heinonen, Kati; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Kajantie, Eero; Forsen, Tom; Wahlbeck, Kristian; Eriksson, Johan G.] Natl Publ Hlth Inst, Helsinki, Finland; [Osmond, Clive; Barker, David J. P.] Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton SO9 5NH, Hants, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland	University of Helsinki; Finland National Institute for Health & Welfare; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Helsinki	Lahti, J (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	jari.lahti@helsinki.fi	Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Wahlbeck, Kristian/F-8394-2011; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Heinonen, Kati/0000-0002-1262-5599; Pesonen, Anu-Katriina/0000-0002-0662-6261; Osmond, Clive/0000-0002-9054-4655; Wahlbeck, Kristian/0000-0003-3754-3933; Eriksson, Johan/0000-0002-2516-2060; Lahti-Pulkkinen, Marius/0000-0002-5244-5525	Academy of Finland; Doctoral Programme of Psychology; Alfred Kordelin foundation; Ella and Georg Ehrnrooths Stiftelse; Yrjo Jahnsson Foundation; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	Academy of Finland(Academy of Finland); Doctoral Programme of Psychology; Alfred Kordelin foundation; Ella and Georg Ehrnrooths Stiftelse; Yrjo Jahnsson Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Academy of Finland, Doctoral Programme of Psychology, Alfred Kordelin foundation, Ella and Georg Ehrnrooths Stiftelse, and Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Alati R, 2007, AM J EPIDEMIOL, V165, P575, DOI 10.1093/aje/kwk036; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Anderson SE, 2006, ARCH PEDIAT ADOL MED, V160, P285, DOI 10.1001/archpedi.160.3.285; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Bowman RE, 2004, ENDOCRINOLOGY, V145, P3778, DOI 10.1210/en.2003-1759; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Disney ER, 2008, PEDIATRICS, V122, pE1225, DOI 10.1542/peds.2008-1380; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Evans BE, 2012, ADDICTION, V107, P312, DOI 10.1111/j.1360-0443.2011.03568.x; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Green AI, 2006, J CLIN PSYCHIAT, V67, P31; Gustafsson WM, 2009, ACTA PSYCHIAT SCAND, V119, P54, DOI 10.1111/j.1600-0447.2008.01267.x; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hallin AL, 2011, SCAND J PSYCHOL, V52, P251, DOI 10.1111/j.1467-9450.2010.00850.x; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Kelly YJ, 2001, INT J EPIDEMIOL, V30, P88, DOI 10.1093/ije/30.1.88; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lahti J, 2010, ACTA PSYCHIAT SCAND, V121, P227, DOI 10.1111/j.1600-0447.2009.01432.x; Lahti J, 2009, BRIT J PSYCHIAT, V195, P132, DOI 10.1192/bjp.bp.108.054387; Lahti M, 2011, J PERS DISORD, V25, P620, DOI 10.1521/pedi.2011.25.5.620; Lahti M, 2010, PSYCHIAT RES, V179, P226, DOI 10.1016/j.psychres.2009.08.024; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lumeng JC, 2003, PEDIATRICS, V112, P1138, DOI 10.1542/peds.112.5.1138; Makela P, 2008, J EPIDEMIOL COMMUN H, V62, P728, DOI 10.1136/jech.2007.065672; Makikyro T, 1998, EUR PSYCHIAT, V13, P57, DOI 10.1016/S0924-9338(98)80019-9; Manjarrez G, 2005, J PEDIATR-US, V147, P592, DOI 10.1016/j.jpeds.2005.06.025; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; Mikkonen M, MOTHERS MARITA UNPUB; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Ohlmeier MD, 2008, ALCOHOL ALCOHOLISM, V43, P300, DOI 10.1093/alcalc/agn014; Osler M, 2008, ANN EPIDEMIOL, V18, P422, DOI 10.1016/j.annepidem.2007.12.008; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Perrin MA, 2007, BRIT J PSYCHIAT, V191, P512, DOI 10.1192/bjp.bp.106.034694; Pirkola SP, 2006, ALCOHOL ALCOHOLISM, V41, P315, DOI 10.1093/alcalc/agh240; POIKOLAINEN K, 1983, DRUG ALCOHOL DEPEN, V12, P315, DOI 10.1016/0376-8716(83)90002-9; Raikkonen K, 2012, BEST PRACT RES CL EN, V26, P599, DOI 10.1016/j.beem.2012.03.001; Raikkonen K, 2011, J PSYCHIATR RES, V45, P332, DOI 10.1016/j.jpsychires.2010.07.003; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rice F, 2007, ACTA PSYCHIAT SCAND, V115, P171, DOI 10.1111/j.1600-0447.2006.00895.x; Roza SJ, 2008, NEUROIMAGE, V39, P1491, DOI 10.1016/j.neuroimage.2007.11.004; SAMPSON PD, 1994, AM J PUBLIC HEALTH, V84, P1421, DOI 10.2105/AJPH.84.9.1421; Schlotz W, 2007, PEDIATRICS, V120, pE1237, DOI 10.1542/peds.2006-3277; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Schulte MT, 2009, CLIN PSYCHOL REV, V29, P535, DOI 10.1016/j.cpr.2009.06.003; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Slotkin TA, 2006, NEUROPSYCHOPHARMACOL, V31, P904, DOI 10.1038/sj.npp.1300892; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; STEWART AL, 1983, AM J PUBLIC HEALTH, V73, P171, DOI 10.2105/AJPH.73.2.171; Strang-Karlsson S, 2008, AM J PSYCHIAT, V165, P1345, DOI 10.1176/appi.ajp.2008.08010085; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; Veijola J, 2008, SOC PSYCH PSYCH EPID, V43, P11, DOI 10.1007/s00127-007-0268-y; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; Weinstock M, 2011, STRESS, V14, P604, DOI 10.3109/10253890.2011.588294; Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21	74	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87404	10.1371/journal.pone.0087404	http://dx.doi.org/10.1371/journal.pone.0087404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489908	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330570000140
J	Mannironi, C; Proietto, M; Bufalieri, F; Cundari, E; Alagia, A; Danovska, S; Rinaldi, T; Famiglini, V; Coluccia, A; La Regina, G; Silvestri, R; Negri, R				Mannironi, Cecilia; Proietto, Marco; Bufalieri, Francesca; Cundari, Enrico; Alagia, Angela; Danovska, Svetlana; Rinaldi, Teresa; Famiglini, Valeria; Coluccia, Antonio; La Regina, Giuseppe; Silvestri, Romano; Negri, Rodolfo			An High-Throughput In Vivo Screening System to Select H3K4-Specific Histone Demethylase Inhibitors	PLOS ONE			English	Article							JUMONJI C DOMAIN; H3K4 DEMETHYLATION; METHYLATION; CHROMATIN; CANCER; TRIMETHYLATION; IDENTIFICATION; TRANSCRIPTION; METHYLTRANSFERASE; BINDING	Background: Histone demethylases (HDMs) have a prominent role in epigenetic regulation and are emerging as potential therapeutic cancer targets. The search for small molecules able to inhibit HDMs in vivo is very active but at the present few compounds were found to be specific for defined classes of these enzymes. Methodology/Principal Findings: In order to discover inhibitors specific for H3K4 histone demethylation we set up a screening system which tests the effects of candidate small molecule inhibitors on a S. cerevisiae strain which requires Jhd2 demethylase activity to efficiently grow in the presence of rapamycin. In order to validate the system we screened a library of 45 structurally different compounds designed as competitive inhibitors of alpha -ketoglutarate (alpha-KG) cofactor of the enzyme, and found that one of them inhibited Jhd2 activity in vitro and in vivo. The same compound effectively inhibits human Jumonji AT-Rich Interactive Domain (JARID) 1B and 1D in vitro and increases H3K4 tri-methylation in HeLa cell nuclear extracts (NEs). When added in vivo to HeLa cells, the compound leads to an increase of tri-methyl-H3K4 (H3K4me3) but does not affect H3K9 tri-methylation. We describe the cytostatic and toxic effects of the compound on HeLa cells at concentrations compatible with its inhibitory activity. Conclusions/Significance: Our screening system is proved to be very useful in testing putative H3K4-specific HDM inhibitors for the capacity of acting in vivo without significantly altering the activity of other important 2-oxoglutarate oxygenases.	[Mannironi, Cecilia; Cundari, Enrico] CNR, Ist Biol & Patol Mol, Rome, Italy; [Proietto, Marco; Bufalieri, Francesca; Alagia, Angela; Danovska, Svetlana; Rinaldi, Teresa; Negri, Rodolfo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Famiglini, Valeria; Coluccia, Antonio; La Regina, Giuseppe; Silvestri, Romano] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Negri, R (corresponding author), Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	rodolfo.negri@uniroma1.it	Proietto, Marco/AAQ-2915-2020; mannironi, cecilia/D-5745-2017; La Regina, Giuseppe/I-2161-2012; Rinaldi, Teresa/AAC-9710-2020; Bufalieri, Francesca/AAT-3937-2020; Coluccia, Antonio/K-3114-2018	mannironi, cecilia/0000-0001-6934-8425; La Regina, Giuseppe/0000-0003-3252-1161; Rinaldi, Teresa/0000-0001-6291-245X; Bufalieri, Francesca/0000-0002-9571-318X; Coluccia, Antonio/0000-0002-7940-8206; Silvestri, Romano/0000-0003-2489-0178; PROIETTO, Marco/0000-0001-5681-3199	FIRB [RBIN06E9Z8]; PRIN [2010W7YRLZ]; Progetti di Ricerca di Ateneo [C26A1139XY]; Progetti di Ricerca di Universita, Sapienza Universita di Roma; Bando Futuro in Ricerca [RBFR10ZJQT]; Regione Lazio	FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Progetti di Ricerca di Ateneo; Progetti di Ricerca di Universita, Sapienza Universita di Roma; Bando Futuro in Ricerca; Regione Lazio(Regione Lazio)	This work has been supported by: FIRB 2011-2013 (grant no. RBIN06E9Z8) "Molecular Bases of Diseases"; PRIN 2009 "Role of S. cerevisiae General Regulatory Factors in chromatin organization and dynamics" and Progetti di Ricerca di Ateneo (grant no. C26A1139XY) to RN and: PRIN 2010 (grant no. 2010W7YRLZ); Progetti di Ricerca di Universita, Sapienza Universita di Roma 2012 and Bando Futuro in Ricerca 2010 (grant no. RBFR10ZJQT) to RS. VL fellowship is sponsored by Regione Lazio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz N, 2010, RNA, V15, P277; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hou JL, 2012, AM J TRANSL RES, V4, P247; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Korb O, 2006, ANT COL OPT SWARM IN; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kristensen LH, 2012, FEBS J, V279, P1905, DOI 10.1111/j.1742-4658.2012.08567.x; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; Luo XL, 2011, J AM CHEM SOC, V133, P9451, DOI 10.1021/ja201597b; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Mishra BP, 2009, FEBS J, V276, P1629, DOI 10.1111/j.1742-4658.2009.06895.x; Mitra D, 2011, J BIOL CHEM, V286, P40531, DOI 10.1074/jbc.M111.304865; Nielsen AL, 2012, FEBS LETT, V586, P1190, DOI 10.1016/j.febslet.2012.03.001; Noma A, 2010, J BIOL CHEM, V285, P34503, DOI 10.1074/jbc.M110.156398; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Zee BM, 2012, MOL CELL BIOL, V32, P2503, DOI 10.1128/MCB.06673-11; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhou BO, 2011, J BIOL CHEM, V286, P34770, DOI 10.1074/jbc.M111.273128	51	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86002	10.1371/journal.pone.0086002	http://dx.doi.org/10.1371/journal.pone.0086002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489688	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000022
J	Misuno, K; Tran, SD; Khalili, S; Huang, JW; Liu, YN; Hu, S				Misuno, Kaori; Tran, Simon D.; Khalili, Saeed; Huang, Junwei; Liu, Younan; Hu, Shen			Quantitative Analysis of Protein and Gene Expression in Salivary Glands of Sjogren's-Like Disease NOD Mice Treated by Bone Marrow Soup	PLOS ONE			English	Article							STEM-CELLS; IDENTIFICATION; BIOMARKERS; ACTIVATION; KALLIKREIN; DIFFERENTIATION; ORGANIZATION; PATHWAYS; LYMPHOMA; SYSTEM	Background: Bone marrow cell extract (termed as BM Soup) has been demonstrated to repair irradiated salivary glands (SGs) and restore saliva secretion in our previous study. In the present study, we aim to investigate if the function of damaged SGs in non-obese diabetic (NOD) mice can be restored by BM Soup treatment and the molecular alterations associated with the treatment. Methods: Whole BM cells were lysed and soluble intracellular contents ("BM Soup") were injected I. V. into NOD mice. Tandem mass tagging with 2-D liquid chromatography-mass spectrometry was used to quantify proteins in the submandibular glands (SMGs) between untreated and BM Soup-treated mice. Quantitative PCR was used to identify genes with altered expression in the treated mice. Results BM Soup: restored salivary flow rates to normal levels and significantly reduced the focus scores of SMGs in NOD mice. More than 1800 proteins in SMG cells were quantified by the proteomic approach. Many SMG proteins involved in inflammation and apoptosis were found to be down-regulated whereas those involved in salivary gland biology and development/regeneration were up-regulated in the BM Soup-treated mice. qPCR analysis also revealed expression changes of growth factors and cytokines in the SMGs of the treated NOD mice. Conclusion: BM Soup treatment is effective to restore the function of damaged SGs in NOD mice. Through gene/protein expression analysis, we have found that BM Soup treatment might effectuate via inhibiting apoptosis, focal adhesion and inflammation whereas promoting development, regeneration and differentiation of the SG cells in NOD mice. These findings provide important insights on the potential mechanisms underlying the BM Soup treatment for functional restoration of damaged SGs in NOD mice. Additional studies are needed to further confirm the identified target genes and their related signaling pathways that are responsible for the BM Soup treatment.	[Misuno, Kaori; Huang, Junwei; Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Tran, Simon D.; Khalili, Saeed; Liu, Younan] McGill Univ, Fac Dent, Craniofacial Tissue Engn & Stem Cells Lab, Montreal, PQ, Canada	University of California System; University of California Los Angeles; McGill University	Tran, SD (corresponding author), McGill Univ, Fac Dent, Craniofacial Tissue Engn & Stem Cells Lab, Montreal, PQ, Canada.	simon.tran@mcgill.ca; shenhu@ucla.edu	Hu, Steve/B-3799-2011		Canadian Institutes of Health Research (CIHR); Canada Research Chairs (CRC); Sjogren's Syndrome Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs (CRC)(Canada Research Chairs); Sjogren's Syndrome Foundation	This study was supported in part by the Canadian Institutes of Health Research (CIHR, ST) and Canada Research Chairs (CRC, ST), and partially supported by the Sjogren's Syndrome Foundation (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Beroukas D, 2002, LAB INVEST, V82, P1547, DOI 10.1097/01.LAB.0000038502.42845.9E; Berridge MJ, 1997, J EXP BIOL, V200, P315; Bhoola K, 2001, BIOL CHEM, V382, P77, DOI 10.1515/BC.2001.013; CAMACHO P, 1995, CELL, V82, P765, DOI 10.1016/0092-8674(95)90473-5; Castro A, 1996, CELL CALCIUM, V20, P493, DOI 10.1016/S0143-4160(96)90091-3; Colomer J, 2008, CALCIUM SIGNALLING D, P169; Coppes RP, 2011, ORAL DIS, V17, P143, DOI 10.1111/j.1601-0825.2010.01723.x; DANIELS TE, 1992, RHEUM DIS CLIN N AM, V18, P571; Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012; FISHLEDER A, 1987, NEW ENGL J MED, V316, P1118, DOI 10.1056/NEJM198704303161803; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Hjelmervik TOR, 2009, ORAL DIS, V15, P342, DOI 10.1111/j.1601-0825.2009.01531.x; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2011, PROTEOMICS, V11, P1499, DOI 10.1002/pmic.201000206; Hu S, 2010, ARTHRIT CARE RES, V62, P1633, DOI 10.1002/acr.20289; Hu S, 2009, ARTHRITIS RHEUM-US, V60, P81, DOI 10.1002/art.24150; Humphreys-Beher MG, 1999, CLIN EXP IMMUNOL, V116, P383; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; KAWANO S, 1995, J PHYSIOL-LONDON, V486, P593, DOI 10.1113/jphysiol.1995.sp020837; Khalili S, 2013, CYTOTHERAPY IN PRESS; Khalili S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038615; Khalili S, 2010, INT J BIOCHEM CELL B, V42, P1893, DOI 10.1016/j.biocel.2010.08.008; Khovidhunkit W, 2005, AM J PHYSIOL-REG I, V288, pR1306, DOI 10.1152/ajpregu.00007.2004; KOHSAKA H, 1990, J CLIN INVEST, V85, P1566, DOI 10.1172/JCI114606; Kuo J-C, 2013, J CELLULAR MOL MED; Lam K, 2005, J CELL PHYSIOL, V203, P353, DOI 10.1002/jcp.20247; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Liu XB, 2000, P SOC EXP BIOL MED, V225, P211, DOI 10.1046/j.1525-1373.2000.22527.x; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Lombaert IMA, 2008, CLIN CANCER RES, V14, P7741, DOI 10.1158/1078-0432.CCR-08-1449; Maria OM, 2007, ORAL DIS, V13, P11, DOI 10.1111/j.1601-0825.2006.01324.x; MARSHALL ICB, 1993, J EXP BIOL, V184, P161; Mishra J, 2002, BIOPHYS J, V83, P1298, DOI 10.1016/S0006-3495(02)73901-5; Olsson AY, 2002, BIOCHEM BIOPH RES CO, V299, P305; Peluso G, 2007, ARTHRITIS RHEUM, V56, P2216, DOI 10.1002/art.22738; Ring T, 2006, CLIN RHEUMATOL, V25, P891, DOI 10.1007/s10067-005-0086-0; Robinson CP, 1997, P NATL ACAD SCI USA, V94, P5767, DOI 10.1073/pnas.94.11.5767; ROYCE LS, 1993, DIFFERENTIATION, V52, P247, DOI 10.1111/j.1432-0436.1993.tb00637.x; Ryu OH, 2006, RHEUMATOLOGY, V45, P1077, DOI 10.1093/rheumatology/kei212; Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010; Sipsas NV, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3262; Sisto M, 2006, J AUTOIMMUN, V27, P38, DOI 10.1016/j.jaut.2006.05.001; Sumida T, 2010, AUTOIMMUN REV, V9, P615, DOI 10.1016/j.autrev.2010.05.008; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Takada K, 2005, J BIOL CHEM, V280, P3982, DOI 10.1074/jbc.M410157200; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Tran SD, 2011, BIOL BLOOD MARROW TR, V17, P429, DOI 10.1016/j.bbmt.2010.09.021; Tran SD, 2011, INT J BIOCHEM CELL B, V43, P5, DOI 10.1016/j.biocel.2010.10.010; Ulbricht KU, 2003, AUTOIMMUN REV, V2, P109, DOI 10.1016/S1568-9972(03)00002-8; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; You S, 2012, INVEST OPHTH VIS SCI, V53, P126, DOI 10.1167/iovs.11-7893; You S, 2011, INVEST OPHTH VIS SCI, V52, P2087, DOI 10.1167/iovs.10-5686; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zheng CY, 1998, J CELL PHYSIOL, V177, P628, DOI 10.1002/(SICI)1097-4652(199812)177:4<628::AID-JCP13>3.0.CO;2-L	64	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87158	10.1371/journal.pone.0087158	http://dx.doi.org/10.1371/journal.pone.0087158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489858	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000110
J	Parker, HL; Rylott, EL; Hunt, AJ; Dodson, JR; Taylor, AF; Bruce, NC; Clark, JH				Parker, Helen L.; Rylott, Elizabeth L.; Hunt, Andrew J.; Dodson, Jennifer R.; Taylor, Andrew F.; Bruce, Neil C.; Clark, James H.			Supported Palladium Nanoparticles Synthesized by Living Plants as a Catalyst for Suzuki-Miyaura Reactions	PLOS ONE			English	Article							GOLD NANOPARTICLES; COUPLING REACTIONS; HETEROGENEOUS CATALYST; HYDROGENATION; OXIDATION; EFFICIENT; BIOMASS; COPPER; SILVER; PD	The metal accumulating ability of plants has previously been used to capture metal contaminants from the environment; however, the full potential of this process is yet to be realized. Herein, the first use of living plants to recover palladium and produce catalytically active palladium nanoparticles is reported. This process eliminates the necessity for nanoparticle extraction from the plant and reduces the number of production steps compared to traditional catalyst palladium on carbon. These heterogeneous plant catalysts have demonstrated high catalytic activity in Suzuki coupling reactions between phenylboronic acid and a range of aryl halides containing iodo-, bromo- and chloro- moieties.	[Parker, Helen L.; Hunt, Andrew J.; Dodson, Jennifer R.; Clark, James H.] Univ York, Dept Chem, Green Chem Ctr Excellence, York YO10 5DD, N Yorkshire, England; [Rylott, Elizabeth L.; Taylor, Andrew F.; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Bruce, NC (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	neil.bruce@york.ac.uk; james.clark@york.ac.uk	Clark, James/C-2064-2012; Rylott, Elizabeth L/A-6059-2012	Clark, James/0000-0002-5860-2480; Rylott, Elizabeth L/0000-0002-1609-414X; Bruce, Neil Charles/0000-0003-0398-2997; Taylor, Andrew/0000-0003-1689-5737; Dodson, Jennifer/0000-0001-6233-2252; /0000-0003-3983-8313	EPSRC [EP/P505178/1, EP/K022482/1]; Engineering and Physical Sciences Research Council [EP/K022482/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from EPSRC, grant code: EP/P505178/1. Funding was also received from "The G8 Research Councils Initiative on Multilateral Research Funding" (funds came from EPSRC) grant code: EP/K022482/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak L, 2009, J ORG CHEM, V74, P3982, DOI 10.1021/jo9003037; Anderson CWN, 2013, ACS SUSTAIN CHEM ENG, V1, P640, DOI 10.1021/sc400011s; Anderson CWN, 1998, NATURE, V395, P553, DOI 10.1038/26875; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Badone D, 1997, J ORG CHEM, V62, P7170, DOI 10.1021/jo970439i; Bennett JA, 2010, CHEM ENG SCI, V65, P282, DOI 10.1016/j.ces.2009.06.069; Brooks RR, 1998, PLANTS THAT HYPERACCUMULATE HEAVY METALS: THEIR ROLE IN PHYTOREMEDIATION, MICROBIOLOGY, ARCHAEOLOGY, MINERAL EXPLORATION AND PHYTOMINING, P1; Coker VS, 2010, ACS NANO, V4, P2577, DOI 10.1021/nn9017944; Datye AK, 2006, CATAL TODAY, V111, P59, DOI 10.1016/j.cattod.2005.10.013; De Corte S, 2012, MICROB BIOTECHNOL, V5, P5, DOI 10.1111/j.1751-7915.2011.00265.x; Dodson J, 2013, RSC GREEN CHEM SER, V22, P220, DOI 10.1039/9781849737340-00220; Foulkes JM, 2011, ACS CATAL, V1, P1589, DOI 10.1021/cs200400t; FOX B, 1982, J BIOL CHEM, V257, P2498; Harris AT, 2008, J NANOPART RES, V10, P691, DOI 10.1007/s11051-007-9288-5; Haverkamp RG, 2009, J NANOPART RES, V11, P1453, DOI 10.1007/s11051-008-9533-6; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jiang L, 2009, J ELECTROCHEM SOC, V156, pB643, DOI 10.1149/1.3098478; Joo SH, 2009, NAT MATER, V8, P126, DOI 10.1038/NMAT2329; Karami K, 2013, CATAL COMMUN, V38, P10, DOI 10.1016/j.catcom.2013.04.003; Losfeld G, 2012, CATAL TODAY, V189, P111, DOI 10.1016/j.cattod.2012.02.044; Manceau A, 2008, ENVIRON SCI TECHNOL, V42, P1766, DOI 10.1021/es072017o; Mandal S, 2004, CHEM MATER, V16, P3714, DOI 10.1021/cm0352504; Nemutandani T., 2006, Toxicological and Environmental Chemistry, V88, P175, DOI 10.1080/02772240600585842; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; SALT DE, 1995, BIO-TECHNOL, V13, P468, DOI 10.1038/nbt0595-468; Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a; Singaravelu G, 2007, COLLOID SURFACE B, V57, P97, DOI 10.1016/j.colsurfb.2007.01.010; Sobjerg LS, 2009, GREEN CHEM, V11, P2041, DOI 10.1039/b918351p; Torborg C, 2009, ADV SYNTH CATAL, V351, P3027, DOI 10.1002/adsc.200900587; Wolfe JP, 1999, J AM CHEM SOC, V121, P9550, DOI 10.1021/ja992130h; Yang CX, 2011, J MATER CHEM, V21, P187, DOI 10.1039/c0jm03145c; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2	32	67	69	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87192	10.1371/journal.pone.0087192	http://dx.doi.org/10.1371/journal.pone.0087192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489869	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000118
J	Wong, HR; Weiss, SL; Giuliano, JS; Wainwright, MS; Cvijanovich, NZ; Thomas, NJ; Allen, GL; Anas, N; Bigham, MT; Hall, M; Freishtat, RJ; Sen, A; Meyer, K; Checchia, PA; Shanley, TP; Nowak, J; Quasney, M; Chopra, A; Fitzgerald, JC; Gedeit, R; Banschbach, S; Beckman, E; Lahni, P; Hart, K; Lindsell, CJ				Wong, Hector R.; Weiss, Scott L.; Giuliano, John S., Jr.; Wainwright, Mark S.; Cvijanovich, Natalie Z.; Thomas, Neal J.; Allen, Geoffrey L.; Anas, Nick; Bigham, Michael T.; Hall, Mark; Freishtat, Robert J.; Sen, Anita; Meyer, Keith; Checchia, Paul A.; Shanley, Thomas P.; Nowak, Jeffrey; Quasney, Michael; Chopra, Arun; Fitzgerald, Julie C.; Gedeit, Rainer; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick; Hart, Kimberly; Lindsell, Christopher J.			Testing the Prognostic Accuracy of the Updated Pediatric Sepsis Biomarker Risk Model	PLOS ONE			English	Article							EXPRESSION PROFILES; IDENTIFICATION	Background: We previously derived and validated a risk model to estimate mortality probability in children with septic shock (PERSEVERE; PEdiatRic SEpsis biomarkEr Risk modEl). PERSEVERE uses five biomarkers and age to estimate mortality probability. After the initial derivation and validation of PERSEVERE, we combined the derivation and validation cohorts (n = 355) and updated PERSEVERE. An important step in the development of updated risk models is to test their accuracy using an independent test cohort. Objective: To test the prognostic accuracy of the updated version PERSEVERE in an independent test cohort. Methods: Study subjects were recruited from multiple pediatric intensive care units in the United States. Biomarkers were measured in 182 pediatric subjects with septic shock using serum samples obtained during the first 24 hours of presentation. The accuracy of PERSEVERE 28-day mortality risk estimate was tested using diagnostic test statistics, and the net reclassification improvement (NRI) was used to test whether PERSEVERE adds information to a physiology-based scoring system. Results: Mortality in the test cohort was 13.2%. Using a risk cut-off of 2.5%, the sensitivity of PERSEVERE for mortality was 83% (95% CI 62-95), specificity was 75% (68-82), positive predictive value was 34% (22-47), and negative predictive value was 97% (91-99). The area under the receiver operating characteristic curve was 0.81 (0.70-0.92). The false positive subjects had a greater degree of organ failure burden and longer intensive care unit length of stay, compared to the true negative subjects. When adding PERSEVERE to a physiology-based scoring system, the net reclassification improvement was 0.91 (0.47-1.35; p<0.001). Conclusions: The updated version of PERSEVERE estimates mortality probability reliably in a heterogeneous test cohort of children with septic shock and provides information over and above a physiology-based scoring system.	[Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA; [Wong, Hector R.; Banschbach, Sharon; Beckman, Eileen; Lahni, Patrick] Cincinnati Childrens Res Fdn, Cincinnati, OH 45229 USA; [Wong, Hector R.] Univ Cincinnati Coll Med, Dept Pediat, Cincinnati, OH USA; [Weiss, Scott L.; Fitzgerald, Julie C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, Div Crit Care Med, New Haven, CT USA; [Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL USA; [Cvijanovich, Natalie Z.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Thomas, Neal J.] Penn State Hershey Childrens Hosp, Hershey, PA USA; [Allen, Geoffrey L.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Anas, Nick] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Bigham, Michael T.] Akron Childrens Hosp, Akron, OH USA; [Hall, Mark] Nationwide Childrens Hosp, Columbus, OH USA; [Freishtat, Robert J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sen, Anita] Columbia Univ, Med Ctr, Morgan Stanley Childrens Hosp, New York, NY USA; [Meyer, Keith] Miami Childrens Hosp, Miami, FL USA; [Checchia, Paul A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Shanley, Thomas P.; Quasney, Michael] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Nowak, Jeffrey] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Chopra, Arun] St Christophers Hosp Children, Philadelphia, PA 19133 USA; [Gedeit, Rainer] Childrens Hosp Wisconsin, Milwaukee, WI USA; [Hart, Kimberly; Lindsell, Christopher J.] Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Children's Mercy Hospital; Childrens Hospital of Orange County; Akron Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Baylor College of Medicine; University of Michigan System; University of Michigan; Children's Hospitals & Clinics of Minnesota; Children's Hospital of Wisconsin; University System of Ohio; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	Hall, Mark/E-3193-2011; Chopra, Arun/AAA-6983-2019	Freishtat, Robert/0000-0002-7411-2342; Gedeit, Rainer/0000-0003-2420-9493; Weiss, Scott/0000-0002-7040-3281; Thomas, Neal/0000-0002-7991-7510; Wong, Hector/0000-0001-7989-1173; Meyer, Keith/0000-0001-7354-5552; Chopra, Arun/0000-0002-1418-6470; Lindsell, Christopher/0000-0002-3297-2811; Giuliano, John/0000-0003-2753-8460; Fitzgerald, Julie/0000-0001-9936-9569; Shanley, Thomas/0000-0001-8936-377X	National Institutes of Health [RC1HL100474, RO1GM064619, RO1GM099773]; Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR [8UL1 TR000077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, R01GM064619, R01GM099773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation; Institutional Clinical and Translational Science Award, NIH/NCRR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RC1HL100474, RO1GM064619, and RO1GM099773, and an Innovation Award from the Center for Technology Commercialization at the Cincinnati Children's Hospital Research Foundation. This work was also supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR 8UL1 TR000077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulebda A, 2013, CRIT CARE MED; Basu RK, 2011, CRIT CARE, V15, DOI 10.1186/cc10554; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Che DS, 2011, ADV EXP MED BIOL, V696, P191, DOI 10.1007/978-1-4419-7046-6_19; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; Giuliano Jr JS, 2013, PEDIAT CRIT CARE MED; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hanna W, 2013, CRIT CARE CLIN, V29, P203, DOI 10.1016/j.ccc.2012.11.003; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Lowry R., 2013, VASSARSTATS WEBSITE; Muller R, 2008, CLIN CHIM ACTA, V394, P1, DOI 10.1016/j.cca.2008.04.007; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; Wong HR, 2011, CRIT CARE MED, V39, P2511, DOI 10.1097/CCM.0b013e3182257675; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Wong HR, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-34; Wynn J, 2010, PEDIATRICS, V125, P1031, DOI 10.1542/peds.2009-3301; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	26	45	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86242	10.1371/journal.pone.0086242	http://dx.doi.org/10.1371/journal.pone.0086242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489704	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000030
J	Chen, P; Zhang, L; Weng, TJ; Zhang, SC; Sun, SJ; Chang, MT; Li, Y; Zhang, B; Zhang, LY				Chen, Peng; Zhang, Li; Weng, Tujun; Zhang, Shichang; Sun, Shijin; Chang, Mingtao; Li, Yang; Zhang, Bo; Zhang, Lianyang			A Ser252Trp Mutation in Fibroblast Growth Factor Receptor 2 (FGFR2) Mimicking Human Apert Syndrome Reveals an Essential Role for FGF Signaling in the Regulation of Endochondral Bone Formation	PLOS ONE			English	Article							OF-FUNCTION MUTATION; PROTEIN-KINASE-C; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; MOUSE; MICE; CRANIOSYNOSTOSIS; ACTIVATION; P38; ABNORMALITIES	A S252W mutation of fibroblast growth factor receptor 2 (FGFR2), which is responsible for nearly two-thirds of Apert syndrome (AS) cases, causes retarded development of the skeleton and skull malformation resulting from premature fusion of the craniofacial sutures. We utilized a Fgfr2(+/S252W) mouse (a knock-in mouse model mimicking human AS) to demonstrate decreased bone mass due to reduced trabecular bone volume, reduced bone mineral density, and shortened growth plates in the long bones. In vitro bone mesenchymal stem cells (BMSCs) culture studies revealed that the mutant mice showed reduced BMSC proliferation, a reduction in chondrogenic differentiation, and reduced mineralization. Our results suggest that these phenomena are caused by up-regulation of p38 and Erk1/2 phosphorylation. Treatment of cultured mutant bone rudiments with SB203580 or PD98059 resulted in partial rescue of the bone growth retardation. The p38 signaling pathway especially was found to be responsible for the retarded long bone development. Our data indicate that the S252W mutation in FGFR2 directly affects endochondral ossification, resulting in growth retardation of the long bone. We also show that the p38 and Erk1/2 signaling pathways partially mediate the effects of the S252W mutation of FGFR2 on long bone development.	[Chen, Peng; Zhang, Li; Weng, Tujun; Zhang, Shichang; Sun, Shijin; Chang, Mingtao; Li, Yang; Zhang, Bo; Zhang, Lianyang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Chen, Peng] PLA 324 Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University	Zhang, B (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	zhangbo67184@163.com; dpzhangly@163.com	Zhang, Shichang/K-1715-2019	Zhang, Shichang/0000-0002-6587-2518; Li, Yang/0000-0003-2327-0444	Special Funds for Major State Basic Research Program of China (973 program) [2011CB964701]; National Natural Science Foundation of China [81000422]	Special Funds for Major State Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Special Funds for Major State Basic Research Program of China (973 program) (No. 2011CB964701) and National Natural Science Foundation of China (No. 81000422). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; COHEN MM, 1993, AM J MED GENET, V47, P624, DOI 10.1002/ajmg.1320470509; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jin M, 2012, HUM MOL GENET, V21, P5443, DOI 10.1093/hmg/dds390; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Lemonnier J, 2001, AM J PATHOL, V158, P1833, DOI 10.1016/S0002-9440(10)64139-9; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Li CL, 1999, HUM MOL GENET, V8, P35, DOI 10.1093/hmg/8.1.35; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Nagata M, 2011, BONE, V48, P847, DOI 10.1016/j.bone.2010.11.014; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; PARK WJ, 1995, AM J HUM GENET, V57, P321; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Raucci A, 2004, J BIOL CHEM, V279, P1747, DOI 10.1074/jbc.M310384200; Rice DPC, 2003, BONE, V33, P14, DOI 10.1016/S8756-3282(03)00163-7; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; So N, 2008, BIOCHEM BIOPH RES CO, V376, P454, DOI 10.1016/j.bbrc.2008.08.165; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang YL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-22; Wang YL, 2005, DEVELOPMENT, V132, P3537, DOI 10.1242/dev.01914; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yin L, 2008, BONE, V42, P631, DOI 10.1016/j.bone.2007.11.019; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu K, 2001, P NATL ACAD SCI USA, V98, P3641, DOI 10.1073/pnas.081082498	46	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87311	10.1371/journal.pone.0087311	http://dx.doi.org/10.1371/journal.pone.0087311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489893	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000127
J	Evans, SE; Groenke, JR; Jones, MEH; Turner, AH; Krause, DW				Evans, Susan E.; Groenke, Joseph R.; Jones, Marc E. H.; Turner, Alan H.; Krause, David W.			New Material of Beelzebufo, a Hyperossified Frog (Amphibia: Anura) from the Late Cretaceous of Madagascar	PLOS ONE			English	Article							PALEOGENE PIPID FROG; MORPHOLOGICAL EVOLUTION; MAHAJANGA BASIN; SOUTH-AMERICA; MOLECULAR PHYLOGENY; MAEVARANO FORMATION; CO-OSSIFICATION; FOSSIL RECORD; ORIGIN; GENUS	The extant anuran fauna of Madagascar is exceptionally rich and almost completely endemic. In recent years, many new species have been described and understanding of the history and relationships of this fauna has been greatly advanced by molecular studies, but very little is known of the fossil history of frogs on the island. Beelzebufo ampinga, the first named pre-Holocene frog from Madagascar, was described in 2008 on the basis of numerous disarticulated cranial and postcranial elements from the Upper Cretaceous (Maastrichtian) Maevarano Formation of Madagascar. These specimens documented the presence of a hyperossified taxon that differed strikingly from extant Malagasy frogs in its large size and heavy coarse cranial exostosis. Here we describe and analyse new, articulated, and more complete material of the skull, vertebral column, and hind limb, as well as additional isolated elements discovered since 2008. mu CT scans allow a detailed understanding of both internal and external morphology and permit a more accurate reconstruction. The new material shows Beelzebufo to have been even more bizarre than originally interpreted, with large posterolateral skull flanges and sculptured vertebral spine tables. The apparent absence of a tympanic membrane, the strong cranial exostosis, and vertebral morphology suggest it may have burrowed during seasonally arid conditions, which have been interpreted for the Maevarano Formation from independent sedimentological and taphonomic evidence. New phylogenetic analyses, incorporating both morphological and molecular data, continue to place Beelzebufo with hyloid rather than ranoid frogs. Within Hyloidea, Beelzebufo still groups with the South American Ceratophryidae thus continuing to pose difficulties with both biogeographic interpretations and prior molecular divergence dates.	[Evans, Susan E.; Jones, Marc E. H.] UCL, Dept Cell & Dev Biol, London, England; [Groenke, Joseph R.; Turner, Alan H.; Krause, David W.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Jones, Marc E. H.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Adelaide	Evans, SE (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	ucgasue@ucl.ac.uk	Huw, Emyr/C-1516-2010; Evans, Susan/C-1888-2008	Huw, Emyr/0000-0002-0146-9623; Evans, Susan/0000-0002-0799-4154; Groenke, Joseph/0000-0002-9527-1887	National Science Foundation [DEB-9224396, EAR-9418816, EAR-9706302, DEB-9904045, EAR-0106477, EAR-0116517, EAR-0446488]; National Geographic Society; NSF; Directorate For Geosciences [1123642] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially funded by grants from the National Science Foundation ((DEB-9224396, EAR-9418816, EAR-9706302, DEB-9904045, EAR-0106477, EAR-0116517, EAR-0446488, EAR-0116517) and the National Geographic Society (1999, 2001, 2004, 2009) to David W. Krause. NSF (www.nsf.gov) funded fieldwork expeditions to the Mahajanga Basin (including return travel for JG,DK,AT); laboratory preparation costs, travel for SEE to visit SBU, shipment of specimens to and from U. K., computer upgrade to efficiently run Avizo software. NG (www.nationalgeographic.com) funded fieldwork expeditions to the Mahajanga Basin (including return travel for JG, DK, AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin Federico L., 2005, Studia Geologica Salmanticensia, V41, P45; Ali JR, 2008, EARTH-SCI REV, V88, P145, DOI 10.1016/j.earscirev.2008.01.007; Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Ali JR, 2009, J BIOGEOGR, V36, P1778, DOI 10.1111/j.1365-2699.2009.02105.x; AmphibiaWeb, 2013, INF AMPH BIOL CONS; Andreone F, 2008, PLOS BIOL, V6, P943, DOI 10.1371/journal.pbio.0060118; [Anonymous], 2014, TRACER V1 6; Asher RJ, 1998, J VERTEBR PALEONTOL, V18, P696, DOI 10.1080/02724634.1998.10011098; BAEZ A M, 1990, Ameghiniana, V27, P379; Baez A.M, 1977, Acta Geologica Lilloana, V14, P149; BAEZ A M, 1981, Ameghiniana, V18, P127; BAEZ A M, 1989, Anais da Academia Brasileira de Ciencias, V61, P447; Baez A.M., 2005, B RESUMOS MUSEU NACL, P45; Baez A.M., 1996, AMEGHINIANA, V33, P460; Baez AM, 2005, PALAEONTOLOGY, V48, P723, DOI 10.1111/j.1475-4983.2005.00477.x; Baez AM, 1998, PALAEONTOLOGY, V41, P669; Baez AM, 2003, ZOOL J LINN SOC-LOND, V139, P439, DOI 10.1046/j.1096-3642.2003.00085.x; Baez AM, 2000, J VERTEBR PALEONTOL, V20, P490, DOI 10.1671/0272-4634(2000)020[0490:TEKPFF]2.0.CO;2; Baez AM, 1998, J VERTEBR PALEONTOL, V18, P511, DOI 10.1080/02724634.1998.10011078; Baez AM, 2007, CRETACEOUS RES, V28, P1005, DOI 10.1016/j.cretres.2007.01.004; Baez AM, 2012, GONDWANA RES, V22, P1141, DOI 10.1016/j.gr.2012.02.021; Baez AM, 2009, CRETACEOUS RES, V30, P829, DOI 10.1016/j.cretres.2009.01.002; Baez Ana Maria, 2000, Amphibian Biology, V4, P1388; Besairie H., 1972, ANN GEOL MADAGASCAR, V35, P1; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Brandley MC, 2006, SYST BIOL, V55, P138, DOI 10.1080/10635150500431155; Buckley GA, 2000, NATURE, V405, P941, DOI 10.1038/35016061; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Casamiquela R.M., 1963, AMEGHINIANA, V5, P141; Case Judd A., 2002, Journal of Vertebrate Paleontology, V22, p42A; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Clemente-Carvalho RBG, 2011, J HERPETOL, V45, P94, DOI 10.1670/09-164.1; Clemente-Carvalho RBG, 2009, J MORPHOL, V270, P1285, DOI 10.1002/jmor.10755; CODDINGTON J, 1994, CLADISTICS, V10, P415; Colbert EH, 1981, GONDWANA 5, P277; Colbert EH, 1971, IMPLICATIONS CONTINE, P395; Contreras Victor Hugo, 1998, Boletin de la Sociedad de Biologia de Concepcion, V69, P83; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Crowley BE, 2013, HOLOCENE, V23, P1066, DOI 10.1177/0959683613484675; Davies Margaret, 1993, P15; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W. E., 1986, BIOL AMPHIBIANS; DUELLMAN WE, 1994, HERPETOLOGICA, V50, P51; DUNLAP DONALD G., 1960, JOUR MORPHOL, V106, P1, DOI 10.1002/jmor.1051060102; Dutta SK, 2004, CURR SCI INDIA, V86, P211; EMERSON SB, 1985, HERPETOLOGICA, V41, P177; EMERSON SB, 1976, J MORPHOL, V149, P437, DOI 10.1002/jmor.1051490402; EMERSON SB, 1979, BIOL J LINN SOC, V11, P153, DOI 10.1111/j.1095-8312.1979.tb00032.x; Evans F. G., 1939, Annals of the New York Academy of Sciences, V39, P29; Evans SE, 2008, P NATL ACAD SCI USA, V105, P2951, DOI 10.1073/pnas.0707599105; Fabrezi M, 2006, J ZOOL SYST EVOL RES, V44, P153, DOI 10.1111/j.1439-0469.2005.00349.x; Fabrezi M, 2003, J ZOOL, V260, P41, DOI 10.1017/S0952836903003479; Fabrezi M, 2011, EVOL BIOL, V38, P390, DOI 10.1007/s11692-011-9128-5; Fabrezi M, 2008, ZOOL J LINN SOC-LOND, V154, P752, DOI 10.1111/j.1096-3642.2008.00420.x; Fabrezi Marissa, 1993, Alytes (Paris), V11, P47; Feller AE, 1998, MOL PHYLOGENET EVOL, V9, P509, DOI 10.1006/mpev.1998.0500; Fernicola JC, 2001, AMEGHINIANA, V38, P385; Fischer von Waldheim G, 1813, ZOOGNOSIA TABULIS SY, V1; Flynn L.J., 1988, J VERTEBR PALEONTOL, V7, P469; Ford Linda S., 1993, Herpetological Monographs, V7, P94, DOI 10.2307/1466954; Forster CA, 1996, NATURE, V382, P532, DOI 10.1038/382532a0; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaffney ES, 2011, AM MUS NOVIT, P1; Gaupp E., 1896, ANATOMIE FROSCHES; Gayer S.M.P., 1984, Revista Brasileira de Zoologia, V2, P113; Glaw F., 2003, P883; Glaw F., 1994, FIELD GUIDE AMPHIBIA; Glaw F, 2006, ZOOTAXA, P27, DOI 10.11646/zootaxa.1334.1.2; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2008, CLADISTICS, V24, P758, DOI 10.1111/j.1096-0031.2008.00209.x; Goloboff Pablo A., 2005, P148; Gomez RO, 2011, J VERTEBR PALEONTOL, V31, P50, DOI 10.1080/02724634.2011.539654; Gomez-Mestre I, 2010, J EVOLUTION BIOL, V23, P1364, DOI 10.1111/j.1420-9101.2010.02016.x; GRIFFITHS I, 1963, BIOL REV, V38, P241, DOI 10.1111/j.1469-185X.1963.tb00784.x; Hay WW, 1999, GEOL S AM S, P1; HAYES T, 1992, J EXP ZOOL, V264, P130, DOI 10.1002/jez.1402640203; Heinicke MP, 2009, ZOOTAXA, P1; Henrici AC, 2002, ANN CARNEGIE MUS, V71, P241; Hoffstetter R., 1961, Bull Mus Hist nat Paris, V33, P152; Huene F.V., 1933, MEMOIRS GEOLOGICAL S, V21, P1; Huene F. von, 1929, Anales del Museo de La Plata, V3, P1; Irisarri I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-626; JACOBS LL, 1990, NATL GEOGR RES, V6, P196; Jared C, 2005, J ZOOL, V265, P1, DOI 10.1017/S0952836904005953; Johnston P, 2011, J MORPHOL, V272, P1492, DOI 10.1002/jmor.10998; Jones MEH, 2003, ANN CARNEGIE MUS, V72, P65; Karche JP, 1967, ITINERAIRE GEOLOGIQU; Kosuch J, 2001, MOL PHYLOGENET EVOL, V21, P398, DOI 10.1006/mpev.2001.1034; Krause D, 2003, J VERTEBR PALEONTOL, V23, p69A; Krause D, 2012, J VERTEBR PALEONTOL, V32, P123; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Krause DW, 2010, J VERTEBR PALEONTOL, V30, P4, DOI 10.1080/02724634.2010.516784; Krause DW, 2003, J VERTEBR PALEONTOL, V23, P842, DOI 10.1671/9; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1999, GSA TODAY, V9, P1; Krause DW, 2010, SOC VERTEBR PALEONTO, V10; Kurabayashi A, 2008, MOL BIOL EVOL, V25, P874, DOI 10.1093/molbev/msn031; Laduke TC, 2010, J VERTEBR PALEONTOL, V30, P109, DOI 10.1080/02724630903409188; Laloy F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074874; Lynch J. D., 1971, Misc Publs Mus nat Hist Univ Kansas, VNo. 53, P1; LYNCH JD, 1982, SYST ZOOL, V31, P166, DOI 10.2307/2413035; MACPHEE RDE, 1985, INT J PRIMATOL, V6, P463, DOI 10.1007/BF02735571; Mahler L, 2005, J VERTEBR PALEONTOL, V25, P236, DOI 10.1671/0272-4634(2005)025[0236:ROADTF]2.0.CO;2; Markwick PJ, 2004, PALAEOGEOGR PALAEOCL, V213, P37, DOI 10.1016/j.palaeo.2004.06.015; MAXSON LR, 1988, J HERPETOL, V22, P228, DOI 10.2307/1564003; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Muzzopappa P, 2010, ACTA PALAEONTOL POL, V55, P645, DOI 10.4202/app.2009.0093; Nomura F, 2009, J ETHOL, V27, P195, DOI 10.1007/s10164-008-0112-1; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Papini M, 1998, J AFR EARTH SCI, V26, P229, DOI 10.1016/S0899-5362(98)00007-4; Parker HW, 1934, MONOGRAPH FROGS FAMI; Prasad Guntupalli V. R., 2004, Revue de Paleobiologie, V23, P99; Prasad GVR, 2009, B SOC GEOL FR, V180, P369, DOI 10.2113/gssgfbull.180.4.369; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Quinzio S, 2012, ANAT REC, V295, P2089, DOI 10.1002/ar.22601; Quinzio Silvia I., 2006, South American Journal of Herpetology, V1, P202, DOI 10.2994/1808-9798(2006)1[202:ROTTOC]2.0.CO;2; Radhakrishnan C, 2007, CURR SCI INDIA, V92, P213; RAGE J-C, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V206, P1; Rakotoarison A, 2012, ZOOTAXA, P1; REIG O A, 1963, Physis (Buenos Aires), V24, P113; Reig O. A., 1963, Physis, V24, P181; Reig O.A., 1972, EVOLUTION GENUS BUFO, P14; REIG OA, 1959, ACTAS TRAB PRIMER C, V4, P133; REIG OSVALDO A., 1958, PHYSIS, V21, P109; Reilly SM, 2011, J MORPHOL, V272, P149, DOI 10.1002/jmor.10902; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; RITLAND RICHARD MARTIN, 1955, J MORPH, V97, P215, DOI 10.1002/jmor.1050970203; Rocek Z, 1995, J VERTEBR PALEONTOL, V15, P506; Rocek Z, 2008, CRETACEOUS RES, V29, P577, DOI 10.1016/j.cretres.2008.01.005; Rocek Zbynek, 2000, Amphibian Biology, V4, P1332; Rocek Zbynek, 2000, Amphibian Biology, V4, P1295; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers RR, 2007, J VERTEBR PALEONTOL, V27, P21, DOI 10.1671/0272-4634(2007)27[21:PAPOMC]2.0.CO;2; Rogers RR, 2007, SCI AM, V296, P42, DOI 10.1038/scientificamerican0207-42; Rogers RR, 2013, CRETACEOUS RES, V44, P12, DOI 10.1016/j.cretres.2013.03.008; Rogers RR, 2005, GEOLOGY, V33, P297, DOI 10.1130/G21036.1; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROYER JY, 1992, AM GEOPHYS UNION GEO, V70, P471; Ruane S, 2011, J EVOLUTION BIOL, V24, P274, DOI 10.1111/j.1420-9101.2010.02164.x; RUIBAL R, 1984, J HERPETOL, V18, P313, DOI 10.2307/1564085; RUIBAL R, 1988, COPEIA, P591; RUSSELL D, 1976, COMPTES RENDUS SOMMA, V5, P205; Sahni A., 2010, P91; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2007, SOC VERTEBR PALEONTO, V8; San Mauro D, 2005, AM NAT, V165, P590, DOI 10.1086/429523; Sanchiz B., 1998, ENCY PALEOHERPETOL 4; Scotese C.R., 1998, CONTINENTAL DRIFT 0; Scott E, 2005, CLADISTICS, V21, P507, DOI 10.1111/j.1096-0031.2005.00079.x; SEIBERT EA, 1974, PHYSIOL ZOOL, V47, P261, DOI 10.1086/physzool.47.4.30152529; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 2009, ZOOKEYS, P1, DOI 10.3897/zookeys.28.325; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Sheil CA, 1999, J MORPHOL, V240, P49, DOI 10.1002/(SICI)1097-4687(199904)240:1<49::AID-JMOR5>3.0.CO;2-Z; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Spinar Z.V., 1986, Journal of Vertebrate Paleontology, V6, P113; SPINAR Z V, 1985, Amphibia-Reptilia, V6, P363, DOI 10.1163/156853885X00353; Stigall AL, 2008, PALAEONTOLOGY, V51, P1053, DOI 10.1111/j.1475-4983.2008.00799.x; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Tejedo M, 2010, CLIM RES, V43, P31, DOI 10.3354/cr00878; Tomassini RL, 2011, J VERTEBR PALEONTOL, V31, P1005, DOI 10.1080/02724634.2011.596602; Trueb L, 2006, J VERTEBR PALEONTOL, V26, P44, DOI 10.1671/0272-4634(2006)26[44:ROTECC]2.0.CO;2; Trueb L, 2005, J VERTEBR PALEONTOL, V25, P533, DOI 10.1671/0272-4634(2005)025[0533:ANPAFT]2.0.CO;2; Trueb L., 1973, P65; TRUEB L, 1978, COPEIA, P498; Trueb L., 1970, U KANS PUBL MUS NAT, V18, P547; Trueb Linda, 1993, P255; Turner AH., 2006, HIST BIOL, V18, P255, DOI [10.1080/08912960500516112, DOI 10.1080/08912960500516112]; Turner AH, 2008, J VERTEBR PALEONTOL, V28, P382, DOI 10.1671/0272-4634(2008)28[382:MICMCA]2.0.CO;2; TURNER FREDERICK B., 1960, AMER MIDLAND NAT, V64, P327, DOI 10.2307/2422665; Tyler M., 1998, AUSTR FROGS NATURAL; U. S. Geological Survey, 2013, NON AQ SPEC DAT; van der Meijden A, 2007, MOL PHYLOGENET EVOL, V44, P1017, DOI 10.1016/j.ympev.2007.02.008; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Vences M, 2004, J BIOGEOGR, V31, P593, DOI 10.1046/j.1365-2699.2003.01031.x; Vences M, 2001, J BIOGEOGR, V28, P1091, DOI 10.1046/j.1365-2699.2001.00624.x; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vences M, 2004, ITAL J ZOOL, V71, P217, DOI 10.1080/11250000409356639; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Vences Miguel, 2001, Spixiana, V24, P85; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; von Huene F, 1929, GEOL RUNDSCH, V20, P89; von HUENE FRIEDRICH, 1927, BOL ACRID NACION CIENC ARGENTINA, V30, P231; Wells N, 2003, NATURAL HIST MADAGAS, P16; Wever E. G., 1985, AMPHIBIAN EAR; Wiens JJ, 2011, EVOLUTION, V65, P1283, DOI 10.1111/j.1558-5646.2011.01221.x; Wild ER, 1999, J MORPHOL, V242, P229, DOI 10.1002/(SICI)1097-4687(199912)242:3<229::AID-JMOR3>3.0.CO;2-N; Wild ER, 1997, J MORPHOL, V232, P169, DOI 10.1002/(SICI)1097-4687(199705)232:2<169::AID-JMOR4>3.0.CO;2-5; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; ZUG G.R., 1979, SMITHSON CONTRIB ZOO, V284, P1	202	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87236	10.1371/journal.pone.0087236	http://dx.doi.org/10.1371/journal.pone.0087236			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489877	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000119
J	Mascaro, J; Asner, GP; Knapp, DE; Kennedy-Bowdoin, T; Martin, RE; Anderson, C; Higgins, M; Chadwick, KD				Mascaro, Joseph; Asner, Gregory P.; Knapp, David E.; Kennedy-Bowdoin, Ty; Martin, Roberta E.; Anderson, Christopher; Higgins, Mark; Chadwick, K. Dana			A Tale of Two "Forests": Random Forest Machine Learning Aids Tropical Forest Carbon Mapping	PLOS ONE			English	Article							BIOMASS ESTIMATION; STOCKS; PATTERNS; CLASSIFICATION; EMISSIONS; ACCURACY; DENSITY; LEVEL	Accurate and spatially-explicit maps of tropical forest carbon stocks are needed to implement carbon offset mechanisms such as REDD+ (Reduced Deforestation and Degradation Plus). The Random Forest machine learning algorithm may aid carbon mapping applications using remotely-sensed data. However, Random Forest has never been compared to traditional and potentially more reliable techniques such as regionally stratified sampling and upscaling, and it has rarely been employed with spatial data. Here, we evaluated the performance of Random Forest in upscaling airborne LiDAR (Light Detection and Ranging)-based carbon estimates compared to the stratification approach over a 16-million hectare focal area of the Western Amazon. We considered two runs of Random Forest, both with and without spatial contextual modeling by including-in the latter case-x, and y position directly in the model. In each case, we set aside 8 million hectares (i.e., half of the focal area) for validation; this rigorous test of Random Forest went above and beyond the internal validation normally compiled by the algorithm (i.e., called "out-of-bag"), which proved insufficient for this spatial application. In this heterogeneous region of Northern Peru, the model with spatial context was the best preforming run of Random Forest, and explained 59% of LiDAR-based carbon estimates within the validation area, compared to 37% for stratification or 43% by Random Forest without spatial context. With the 60% improvement in explained variation, RMSE against validation LiDAR samples improved from 33 to 26 Mg C ha(-1) when using Random Forest with spatial context. Our results suggest that spatial context should be considered when using Random Forest, and that doing so may result in substantially improved carbon stock modeling for purposes of climate change mitigation.	[Mascaro, Joseph; Asner, Gregory P.; Knapp, David E.; Kennedy-Bowdoin, Ty; Martin, Roberta E.; Anderson, Christopher; Higgins, Mark; Chadwick, K. Dana] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	Carnegie Institution for Science	Mascaro, J (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	jmascaro@carnegiescience.edu	Asner, Gregory/G-9268-2013; Chadwick, K. Dana/AGN-9988-2022; Chadwick, K. Dana/G-4643-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Chadwick, K. Dana/0000-0002-5633-4865; Anderson, Christopher/0000-0001-7392-4368; Martin, Roberta/0000-0003-3509-8530	John D. and Catherine T. MacArthur Foundation; endowment of the Carnegie Institution for Science	John D. and Catherine T. MacArthur Foundation; endowment of the Carnegie Institution for Science	This study was supported by the John D. and Catherine T. MacArthur Foundation and the endowment of the Carnegie Institution for Science. The Carnegie Airborne Observatory is made possible by the Avatar Alliance Foundation, Gordon and Betty Moore Foundation, W. M. Keck Foundation, Margaret A. Cargill Foundation, Grantham Foundation for the Protection of the Environment, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelsen Arild, 2008, MOVING AHEAD REDD IS; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2012, CARBON BAL MANAGE, V7, DOI [10.1186/1750-0680-1187-1182, DOI 10.1186/1750-0680-1187-1182]; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Asner Gregory P, 2013, Carbon Balance Manag, V8, P7, DOI 10.1186/1750-0680-8-7; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2011, FRONT ECOL ENVIRON, V9, P434, DOI 10.1890/100179; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; Asner GP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034009; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Colgan MS, 2013, ECOL APPL, V23, P1170, DOI 10.1890/12-0922.1; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dahlin KM, 2013, P NATL ACAD SCI USA, V110, P6895, DOI 10.1073/pnas.1215513110; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Ene LT, 2012, REMOTE SENS ENVIRON, V123, P579, DOI 10.1016/j.rse.2012.04.017; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Fabbri R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1322432.1322434; Fanelli G, 2011, PROC CVPR IEEE, P617, DOI 10.1109/CVPR.2011.5995458; Herold M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014002; Higgins MA, 2011, J BIOGEOGR, V38, P2136, DOI 10.1111/j.1365-2699.2011.02585.x; Higgins MA, 2012, REMOTE SENS-BASEL, V4, P2401, DOI 10.3390/rs4082401; Hudak AT, 2008, REMOTE SENS ENVIRON, V112, P2232, DOI 10.1016/j.rse.2007.10.009; Hudak AT, 2012, REMOTE SENS ENVIRON, V123, P25, DOI 10.1016/j.rse.2012.02.023; INGEMMET, 2000, GEOL PER; Jarvis A, 2008, HOLE FILLED SEAMLESS; Josse C, 2007, ECOLOGICAL SYSTEMS A; Legendre P., 1998, DEV ENV MODELLING, V20; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Galiano VF, 2011, PROCEDIA ENVIRON SCI, V3, P44, DOI 10.1016/j.proenv.2011.02.009; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Triebel R, 2013, WORKSH ACT LEARN ROB; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037	44	87	87	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85993	10.1371/journal.pone.0085993	http://dx.doi.org/10.1371/journal.pone.0085993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489686	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000028
J	Matsumura, H; Miyagi, N; Taniai, N; Fukushima, M; Tarora, K; Shudo, A; Urasaki, N				Matsumura, Hideo; Miyagi, Norimichi; Taniai, Naoki; Fukushima, Mai; Tarora, Kazuhiko; Shudo, Ayano; Urasaki, Naoya			Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis	PLOS ONE			English	Article							CUCUMIS-SATIVUS L.; SNP DISCOVERY; CUCURBITACEAE; PLANTS; INHERITANCE; EXPRESSION; MARKERS; GENES; FEMALENESS; GENETICS	Momordica charantia is a monoecious plant of the Cucurbitaceae family that has both male and female unisexual flowers. Its unique gynoecious line, OHB61-5, is essential as a maternal parent in the production of F-1 cultivars. To identify the DNA markers for this gynoecy, a RAD-seq (restriction-associated DNA tag sequencing) analysis was employed to reveal genome-wide DNA polymorphisms and to genotype the F-2 progeny from a cross between OHB61-5 and a monoecious line. Based on a RAD-seq analysis of F-2 individuals, a linkage map was constructed using 552 co-dominant markers. In addition, after analyzing the pooled genomic DNA from monoecious or gynoecious F-2 plants, several SNP loci that are genetically linked to gynoecy were identified. GTFL-1, the closest SNP locus to the putative gynoecious locus, was converted to a conventional DNA marker using invader assay technology, which is applicable to the marker-assisted selection of gynoecy in M. charantia breeding.	[Matsumura, Hideo; Fukushima, Mai] Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan; [Miyagi, Norimichi; Taniai, Naoki; Tarora, Kazuhiko; Shudo, Ayano; Urasaki, Naoya] Okinawa Prefectural Agr Res Ctr, Itoman, Okinawa, Japan	Shinshu University	Matsumura, H (corresponding author), Shinshu Univ, Ctr Gene Res, Ueda, Nagano, Japan.	hideoma@shinshu-u.ac.jp	wang, chen/F-7230-2011	Tarora, Kazuhiko/0000-0003-1448-976X; Matsumura, Hideo/0000-0003-4849-1016	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal G, 2012, PLANT SIGNAL BEHAV, V7, P827, DOI 10.4161/psb.20321; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Bharathi LK, 2011, J GENET, V90, P21, DOI 10.1007/s12041-011-0026-5; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Briggs Adrian W, 2009, J Vis Exp, P1573, DOI 10.3791/1573; Chou LS, 2010, CLIN CHEM, V56, P62, DOI 10.1373/clinchem.2009.132639; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; GALUN E, 1961, GENETICA, V32, P134, DOI 10.1007/BF01816091; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Guo DL, 2012, AM J BOT, V99, pE182, DOI 10.3732/ajb.1100277; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hegarty M, 2013, PLANT BIOTECHNOL J, V11, P572, DOI 10.1111/pbi.12045; Hossain MA, 1996, EUPHYTICA, V90, P121; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Kim DW, 2010, GENOME, V53, P568, DOI [10.1139/G10-025, 10.1139/g10-025]; KUBICKI B, 1969, GENET POL, V10, P69; Kwiatkowski RW, 1999, MOL DIAGN, V4, P353, DOI 10.1016/S1084-8592(99)80012-5; Li Z, 2012, J EXP BOT, V63, P4475, DOI 10.1093/jxb/ers123; Li Z, 2009, GENETICS, V182, P1381, DOI 10.1534/genetics.109.104737; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Mibus H, 2004, THEOR APPL GENET, V109, P1669, DOI 10.1007/s00122-004-1793-7; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; MITCHELL WD, 1962, SCIENCE, V136, P880, DOI 10.1126/science.136.3519.880; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Olivier M, 2005, MUTAT RES-FUND MOL M, V573, P103, DOI 10.1016/j.mrfmmm.2004.08.016; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Poole CF, 1939, J HERED, V30, P21, DOI 10.1093/oxfordjournals.jhered.a104626; Ram D, 2006, J HERED, V97, P294, DOI 10.1093/jhered/esj028; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; ROBINSON RW, 1976, HORTSCIENCE, V11, P554; Schaefer H, 2010, MOL PHYLOGENET EVOL, V54, P553, DOI 10.1016/j.ympev.2009.08.006; TAKAHASHI H, 1984, PHYTON-INT J EXP BOT, V44, P81; Wang SZ, 2010, AM J BOT, V97, pE75, DOI 10.3732/ajb.1000153; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318	45	36	36	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87138	10.1371/journal.pone.0087138	http://dx.doi.org/10.1371/journal.pone.0087138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498029	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100050
J	Prommer, J; Wanek, W; Hofhansl, F; Trojan, D; Offre, P; Urich, T; Schleper, C; Sassmann, S; Kitzler, B; Soja, G; Hood-Nowotny, RC				Prommer, Judith; Wanek, Wolfgang; Hofhansl, Florian; Trojan, Daniela; Offre, Pierre; Urich, Tim; Schleper, Christa; Sassmann, Stefan; Kitzler, Barbara; Soja, Gerhard; Hood-Nowotny, Rebecca Clare			Biochar Decelerates Soil Organic Nitrogen Cycling but Stimulates Soil Nitrification in a Temperate Arable Field Trial	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; FAST-PYROLYSIS BIOCHAR; FILLED PORE-SPACE; MICROBIAL COMMUNITY; OXIDE PRODUCTION; NUMERICAL ABUNDANCE; AGRICULTURAL SOIL; PONDEROSA PINE; N2O EMISSIONS; BLACK CARBON	Biochar production and subsequent soil incorporation could provide carbon farming solutions to global climate change and escalating food demand. There is evidence that biochar amendment causes fundamental changes in soil nutrient cycles, often resulting in marked increases in crop production, particularly in acidic and in infertile soils with low soil organic matter contents, although comparable outcomes in temperate soils are variable. We offer insight into the mechanisms underlying these findings by focusing attention on the soil nitrogen (N) cycle, specifically on hitherto unmeasured processes of organic N cycling in arable soils. We here investigated the impacts of biochar addition on soil organic and inorganic N pools and on gross transformation rates of both pools in a biochar field trial on arable land (Chernozem) in Traismauer, Lower Austria. We found that biochar increased total soil organic carbon but decreased the extractable organic C pool and soil nitrate. While gross rates of organic N transformation processes were reduced by 50-80%, gross N mineralization of organic N was not affected. In contrast, biochar promoted soil ammonia-oxidizer populations (bacterial and archaeal nitrifiers) and accelerated gross nitrification rates more than two-fold. Our findings indicate a de-coupling of the soil organic and inorganic N cycles, with a build-up of organic N, and deceleration of inorganic N release from this pool. The results therefore suggest that addition of inorganic fertilizer-N in combination with biochar could compensate for the reduction in organic N mineralization, with plants and microbes drawing on fertilizer-N for growth, in turn fuelling the belowground build-up of organic N. We conclude that combined addition of biochar with fertilizer-N may increase soil organic N in turn enhancing soil carbon sequestration and thereby could play a fundamental role in future soil management strategies.	[Prommer, Judith; Wanek, Wolfgang; Hofhansl, Florian; Hood-Nowotny, Rebecca Clare] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Trojan, Daniela; Offre, Pierre; Urich, Tim; Schleper, Christa] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria; [Sassmann, Stefan] Univ Vienna, Core Facil Cell Imaging & Ultrastruct Res, Vienna, Austria; [Kitzler, Barbara] Fed Res & Training Ctr Forests Nat Hazards & Land, Inst Forest Ecol & Soil, Vienna, Austria; [Soja, Gerhard] Austrian Inst Technol, Dept Hlth & Environm, Tulln, Austria	University of Vienna; University of Vienna; University of Vienna	Wanek, W (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria.	wolfgang.wanek@univie.ac.at; rebecca.clare.hood-nowotny@univie.ac.at	Soja, Gerhard/A-9657-2008; Schleper, Christa M/C-2567-2013; Hofhansl, Florian/E-6656-2012; Urich, Tim/J-8241-2016; Offre, Pierre/S-3382-2019; Kitzler, Barbara/ACM-1987-2022; Wanek, Wolfgang/E-7001-2012; Kitzler, Barbara/HGF-0438-2022	Soja, Gerhard/0000-0001-7391-4899; Hofhansl, Florian/0000-0003-0073-0946; Urich, Tim/0000-0002-5718-1354; Wanek, Wolfgang/0000-0003-2178-8258; Hood-Nowotny, Rebecca/0000-0002-4398-3233; Kitzler, Barbara/0000-0002-1617-9186; Schleper, Christa/0000-0002-1918-2735; Trojan, Daniela/0000-0001-6748-5311	FWF Project [V138-B17]; FFG Project [825438]; Austrian Science Fund (FWF) [I 487, V 138] Funding Source: researchfish	FWF Project(Austrian Science Fund (FWF)); FFG Project; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors highly appreciate the funding through FWF Project V138-B17 (to RCHN) as well as the FFG Project 825438 (to GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RJE, 2013, ISME J, V7, P1620, DOI 10.1038/ismej.2013.35; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; BAATH E, 1979, OIKOS, V33, P11, DOI 10.2307/3544505; Bailey VL, 2011, SOIL BIOL BIOCHEM, V43, P296, DOI 10.1016/j.soilbio.2010.10.014; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Ball PN, 2010, J ENVIRON QUAL, V39, P1243, DOI 10.2134/jeq2009.0082; BARRACLOUGH D, 1991, PLANT SOIL, V131, P89, DOI 10.1007/BF00010423; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Bergeron SP, 2013, SOIL BIOL BIOCHEM, V58, P140, DOI 10.1016/j.soilbio.2012.11.017; Berglund LM, 2004, SOIL BIOL BIOCHEM, V36, P2067, DOI 10.1016/j.soilbio.2004.06.005; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Bruun EW, 2011, EUR J SOIL SCI, V62, P581, DOI 10.1111/j.1365-2389.2011.01377.x; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Busscher WJ, 2010, SOIL SCI, V175, P10, DOI 10.1097/SS.0b013e3181cb7f46; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; Chen Y, 2010, AUST J SOIL RES, V48, P526, DOI 10.1071/SR10011; Cheng Y, 2012, BIOL FERT SOILS, V48, P941, DOI 10.1007/s00374-012-0687-0; Clough TJ, 2013, AGRONOMY-BASEL, V3, P275, DOI 10.3390/agronomy3020275; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; COLEMAN DC, 1994, MICROBIAL ECOL, V28, P245, DOI 10.1007/BF00166814; Daum M, 1998, CURR MICROBIOL, V37, P281, DOI 10.1007/s002849900379; DeLuca T.H., 2015, BIOCHAR ENV MANAGEME, P453, DOI DOI 10.4324/9781849770552; DeLuca TH, 2006, SOIL SCI SOC AM J, V70, P448, DOI 10.2136/sssaj2005.0096; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; Dempster DN, 2012, SOIL BIOL BIOCHEM, V48, P47, DOI 10.1016/j.soilbio.2012.01.013; Dempster DN, 2012, SOIL RES, V50, P216, DOI 10.1071/SR11316; Di HJ, 2000, AUST J SOIL RES, V38, P213, DOI 10.1071/SR99005; Downie A., 2009, BIOCHAR ENV MANAGEME; Doyle A, 2004, SOIL SCI SOC AM J, V68, P669, DOI 10.2136/sssaj2004.0669; Farrell M, 2013, ECOSYSTEMS, V16, P133, DOI 10.1007/s10021-012-9601-8; Finlay BJ, 2000, PROTIST, V151, P69, DOI 10.1078/1434-4610-00008; Foissner W, 1999, AGR ECOSYST ENVIRON, V74, P95, DOI 10.1016/S0167-8809(99)00032-8; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gryc V., 2008, Journal of Forest Science (Prague), V54, P418, DOI 10.17221/59/2008-JFS; Gundale MJ, 2006, FOREST ECOL MANAG, V231, P86, DOI 10.1016/j.foreco.2006.05.004; HASLAM E, 1974, BIOCHEM J, V139, P285, DOI 10.1042/bj1390285; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; HYNES RK, 1982, CAN J MICROBIOL, V28, P334, DOI 10.1139/m82-049; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P1893, DOI 10.1016/S0038-0717(02)00203-1; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Kasozi GN, 2010, ENVIRON SCI TECHNOL, V44, P6189, DOI 10.1021/es1014423; Kelleher BP, 2006, GEOCHIM COSMOCHIM AC, V70, P4080, DOI 10.1016/j.gca.2006.06.012; Khan SA, 2000, SOIL SCI SOC AM J, V64, P1083, DOI 10.2136/sssaj2000.6431083x; KIRKHAM DON, 1954, SOIL SCI SOC AMER PROC, V18, P33; Knicker H, 2011, SOIL BIOL BIOCHEM, V43, P1118, DOI 10.1016/j.soilbio.2011.02.020; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Lachouani P, 2010, RAPID COMMUN MASS SP, V24, P3615, DOI 10.1002/rcm.4798; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Ma Li, 2012, Xinjiang Agricultural Sciences, V49, P589; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Mooshammer M, 2012, ECOLOGY, V93, P770, DOI 10.1890/11-0721.1; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; Mulder C, 2005, ECOL LETT, V8, P80, DOI 10.1111/j.1461-0248.2004.00704.x; Mullen CA, 2010, BIOMASS BIOENERG, V34, P67, DOI 10.1016/j.biombioe.2009.09.012; Murphy DV, 2003, ADV AGRON, V79, P69, DOI 10.1016/S0065-2113(02)79002-0; Nakajima Y, 2005, NUTR CYCL AGROECOSYS, V71, P33, DOI 10.1007/s10705-004-1196-9; Nelissen V, 2012, SOIL BIOL BIOCHEM, V55, P20, DOI 10.1016/j.soilbio.2012.05.019; Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Quilliam RS, 2013, SOIL BIOL BIOCHEM, V65, P287, DOI 10.1016/j.soilbio.2013.06.004; Read D., 2000, MYCORRHIZAL SYMBIOSI; Roberts P, 2008, SOIL BIOL BIOCHEM, V40, P1485, DOI 10.1016/j.soilbio.2008.01.001; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schleper C, 2010, ISME J, V4, P1092, DOI 10.1038/ismej.2010.111; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Singh B, 2010, AUST J SOIL RES, V48, P516, DOI 10.1071/SR10058; Singh BP, 2012, ENVIRON SCI TECHNOL, V46, P11770, DOI 10.1021/es302545b; SORENSEN P, 1991, ANAL CHIM ACTA, V252, P201, DOI 10.1016/0003-2670(91)87215-S; STIENSTRA AW, 1994, FEMS MICROBIOL ECOL, V14, P45, DOI 10.1111/j.1574-6941.1994.tb00089.x; Strong DT, 1998, AUST J SOIL RES, V36, P855, DOI 10.1071/S97103; Taghizadeh-Toosi A, 2012, PLANT SOIL, V353, P73, DOI 10.1007/s11104-011-1010-9; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; van Zwieten L, 2010, AUST J SOIL RES, V48, P555, DOI 10.1071/SR10004; Ventura M, 2013, J ENVIRON QUAL, V42, P76, DOI 10.2134/jeq2012.0250; Wanek W, 2010, SOIL BIOL BIOCHEM, V42, P1293, DOI 10.1016/j.soilbio.2010.04.001; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang LF, 2008, SOIL SCI PLANT NUTR, V54, P786, DOI 10.1111/j.1747-0765.2008.00297.x; Wang T, 2012, ORG GEOCHEM, V51, P45, DOI 10.1016/j.orggeochem.2012.07.009; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Zheng H, 2013, GEODERMA, V206, P32, DOI 10.1016/j.geoderma.2013.04.018; Zimmerman AR, 2004, ENVIRON SCI TECHNOL, V38, P4542, DOI 10.1021/es035340+	101	186	202	26	317	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86388	10.1371/journal.pone.0086388	http://dx.doi.org/10.1371/journal.pone.0086388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497947	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100015
J	Ben-Dov, IZ; Tan, YC; Morozov, P; Wilson, PD; Rennert, H; Blumenfeld, JD; Tuschl, T				Ben-Dov, Iddo Z.; Tan, Ying-Cai; Morozov, Pavel; Wilson, Patricia D.; Rennert, Hanna; Blumenfeld, Jon D.; Tuschl, Thomas			Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at Baseline	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CDNA LIBRARIES; RNA; CANCER; EPITHELIA; PATHOGENESIS; CULTURE; TARGETS; PLASMA; GROWTH	Background: Autosomal dominant polycystic kidney disease (ADPKD) is clinically heterogenic. Biomarkers are needed to predict prognosis and guide management. We aimed to profile microRNA (miRNA) in ADPKD to gain molecular insight and evaluate biomarker potential. Methods: Small-RNA libraries were generated from urine specimens of ADPKD patients (N = 20) and patients with chronic kidney disease of other etiologies (CKD, N = 20). In this report, we describe the miRNA profiles and baseline characteristics. For reference, we also examined the miRNA transcriptome in primary cultures of ADPKD cyst epithelia (N = 10), normal adult tubule (N = 8) and fetal tubule (N = 7) epithelia. Results: In primary cultures of ADPKD kidney cells, miRNA cistrons mir-143(2) (9.2-fold), let-7i(1) (2.3-fold) and mir-3619(1) (12.1-fold) were significantly elevated compared to normal tubule epithelia, whereas mir-1(4) members (19.7-fold), mir-133b(2) (21.1-fold) and mir-205(1) (3.0-fold) were downregulated (P < 0.01). Expression of the dysregulated miRNA in fetal tubule epithelia resembled ADPKD better than normal adult cells, except let-7i, which was lower in fetal cells. In patient biofluid specimens, mir-143(2) members were 2.9-fold higher in urine cells from ADPKD compared to other CKD patients, while expression levels of mir-133b(2) (4.9-fold) and mir-1(4) (4.4-fold) were lower in ADPKD. We also noted increased abundance mir-223(1) (5.6-fold), mir-199a(3) (1.4-fold) and mir-199b(1) (1.8-fold) (P < 0.01) in ADPKD urine cells. In ADPKD urine microvesicles, miR-1(2) (7.2-fold) and miR-133a(2) (11.8-fold) were less abundant compared to other CKD patients (P, 0.01). Conclusions: We found that in ADPKD urine specimens, miRNA previously implicated as kidney tumor suppressors (miR-1 and miR-133), as well as miRNA of presumed inflammatory and fibroblast cell origin (miR-223/miR-199), are dysregulated when compared to other CKD patients. Concordant with findings in the primary tubule epithelial cell model, this suggests roles for dysregulated miRNA in ADPKD pathogenesis and potential use as biomarkers. We intend to assess prognostic potential of miRNA in a followup analysis.	[Ben-Dov, Iddo Z.; Morozov, Pavel; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; [Tan, Ying-Cai; Rennert, Hanna] Cornell Univ, Mol Pathol Lab, New York Presbyterian Hosp, New York, NY 10021 USA; [Tan, Ying-Cai; Rennert, Hanna] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Wilson, Patricia D.] UCL, Sch Med, Ctr Nephrol, London W1N 8AA, England; [Blumenfeld, Jon D.] Cornell Univ, Rogosin Inst, Weill Med Coll, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; University of London; University College London; UCL Medical School; Cornell University	Ben-Dov, IZ (corresponding author), Hadassah Hebrew Univ, Med Ctr, Serv Nephrol, Jerusalem, Israel.	iddo@hadassah.org.il	Ben-Dov, Iddo/F-3282-2010; Wilson, Patricia/AAW-8481-2021; Morozov, Pavel/GQP-7206-2022; Blumenfeld, Jon/ABC-1107-2021	Ben-Dov, Iddo/0000-0002-9180-3604; Wilson, Patricia/0000-0003-0902-188X; 	National Center for Research Resources, a component of the National Institutes of Health (NIH) [UL1RR024143]; NIH Roadmap for Medical Research; American Physicians Fellowship for Medicine in Israel; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director;  [UH2TR000933]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000933] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	National Center for Research Resources, a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Physicians Fellowship for Medicine in Israel; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	IZB was supported by Grant Award Number UL1RR024143 from the National Center for Research Resources, a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. IZB was also supported in part by a fellowship from the American Physicians Fellowship for Medicine in Israel. The work described in this manuscript was also supported in part by grant number UH2TR000933 awarded by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Burrow CR, 1999, AM J PHYSIOL-RENAL, V277, pF391, DOI 10.1152/ajprenal.1999.277.3.F391; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fleissner F, 2012, AM J TRANSPLANT, V12, P289, DOI 10.1111/j.1600-6143.2011.03790.x; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Gronwald W, 2011, KIDNEY INT, V79, P1244, DOI 10.1038/ki.2011.30; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hanke M, 2007, CLIN CHEM, V53, P2070, DOI 10.1373/clinchem.2007.091363; Jilg CA, 2013, NEPHRON CLIN PRACT, V123, P13, DOI 10.1159/000351049; Karihaloo A, 2011, J AM SOC NEPHROL, V22, P1809, DOI 10.1681/ASN.2011010084; Kawakami K, 2012, EUR J CANCER, V48, P827, DOI 10.1016/j.ejca.2011.06.030; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kistler AD, 2009, KIDNEY INT, V76, P89, DOI 10.1038/ki.2009.93; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meder B, 2008, GENE DEV, V22, P3227, DOI 10.1101/gad.1753508; Meijer E, 2010, AM J KIDNEY DIS, V56, P883, DOI 10.1053/j.ajkd.2010.06.023; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Myrvang Helene, 2011, Nat Rev Nephrol, V7, P244, DOI 10.1038/nrneph.2011.33; Orskov B, 2012, NEPHROL DIAL TRANSPL, V27, P1607, DOI 10.1093/ndt/gfr467; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohatgi R, 2008, AM J PHYSIOL-RENAL, V294, pF890, DOI 10.1152/ajprenal.00341.2007; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Ta MHT, 2013, NEPHROLOGY, V18, P317, DOI 10.1111/nep.12045; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wilson P. D., 2009, PEDIAT NEPHROLOGY; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wilson PD, 2000, AM J PATHOL, V156, P253, DOI 10.1016/S0002-9440(10)64726-8; WILSON PD, 1985, AM J PHYSIOL, V248, pF436, DOI 10.1152/ajprenal.1985.248.3.F436; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; WILSON PD, 1986, KIDNEY INT, V30, P371, DOI 10.1038/ki.1986.194; Wilson PD, 1991, J TISSUE CULT METHOD, V13, P137; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19	43	73	78	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86856	10.1371/journal.pone.0086856	http://dx.doi.org/10.1371/journal.pone.0086856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489795	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000074
J	Johnell, K; Laflamme, L; Moller, J; Monarrez-Espino, J				Johnell, Kristina; Laflamme, Lucie; Moller, Jette; Monarrez-Espino, Joel			The Role of Marital Status in the Association between Benzodiazepines, Psychotropics and Injurious Road Traffic Crashes: A Register-Based Nationwide Study of Senior Drivers in Sweden	PLOS ONE			English	Article							OLDER DRIVERS; VEHICLE CRASHES; RISK; ACCIDENTS; DRUGS; HOSPITALIZATION; POLYPHARMACY; MEDICATIONS; PERFORMANCE; ADULTS	Background: Among senior drivers, benzodiazepines (BZDs) have a documented effect on the risk of road traffic crashes (RTCs). It remains unclear however if BZDs play the same role when considering marital status. Therefore, we aimed to investigate the role of marital status in the association between BZD use and injurious RTCs among senior drivers. Methods: Matched case-control study based on five national Swedish registers (n = 154 225). Cases comprised the first non-alcohol-related injurious RTC sustained by drivers aged 50-80 years from July 2005 to December 2009 and controls included registered residents with a valid license who did not crash during that period. Four controls were matched to each case by sex, age and place of residence. Conditional logistic regression analysis for injurious RTC was performed with adjustment for occupation and number of medications. The main exposure was dispensation of BZDs, alone or in combination with other psychotropic medications, 1-30 days prior to the crash date stratified by marital status. Results: BZD use, alone or in combination with other psychotropic medications, increased the risk of being involved in an RTC (BZD only: adjusted OR: 1.26, 95% CI: 1.17-1.36; BZDs and other psychotropics: adjusted OR: 1.25, 95% CI: 1.12-1.41). Compared to married drivers, those divorced (1.48, 1.43-1.53) and widowed (1.54; 1.45-1.63) had higher adjusted ORs. Marital status modified the association between BZDs and RTCs, particularly among younger male drivers. Conclusions: Both BZDs and marital status independently affect the risk for senior drivers to be involved in an RTC. However, marital status plays a role in the association between BZD use and RTCs and this may have implications for targeting risk populations for RTCs among senior drivers.	[Johnell, Kristina] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Johnell, Kristina] Stockholm Univ, S-10691 Stockholm, Sweden; [Laflamme, Lucie; Moller, Jette; Monarrez-Espino, Joel] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Johnell, K (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	Kristina.Johnell@ki.se	Laflamme, Lucie/T-2953-2019	Laflamme, Lucie/0000-0002-6443-1307; Moller, Jette/0000-0001-9513-5896	Petrus and Augusta Hedlund's Foundation; Swedish Transport Agency; Swedish Research Council [2007-5870, 2007-5681]	Petrus and Augusta Hedlund's Foundation; Swedish Transport Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by different project specific and individual grants, including the Petrus and Augusta Hedlund's Foundation, the Swedish Transport Agency and the Swedish Research Council (2007-5870 and 2007-5681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Wahlberg AE, 2007, J SAFETY RES, V38, P453, DOI 10.1016/j.jsr.2007.01.013; Akalanka EC, 2012, ASIA-PAC J PUBLIC HE, V24, P91, DOI 10.1177/1010539510376304; Barbone F, 1998, LANCET, V352, P1331, DOI 10.1016/S0140-6736(98)04087-2; Betz ME, 2010, J AM GERIATR SOC, V58, P1931, DOI 10.1111/j.1532-5415.2010.03010.x; Cheung YB, 1998, SOC SCI MED, V47, P1325, DOI 10.1016/S0277-9536(98)00210-X; Cooper L, 2011, ASIA-PAC J PUBLIC HE, V23, P443, DOI 10.1177/1010539511407661; Dassanayake T, 2011, DRUG SAFETY, V34, P125, DOI 10.2165/11539050-000000000-00000; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Eaker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018040; Engeland A, 2007, ANN EPIDEMIOL, V17, P597, DOI 10.1016/j.annepidem.2007.03.009; Farley JF, 2006, AM J MANAG CARE, V12, P110; Ferrer A, 2013, J AM GERIATR SOC, V61, P294, DOI 10.1111/jgs.12154; Fildes BN, 2008, TRAFFIC INJ PREV, V9, P387, DOI 10.1080/15389580802272435; French DD, 2005, PHARMACOEPIDEM DR S, V14, P17, DOI 10.1002/pds.967; Grube Joel W, 2004, Traffic Inj Prev, V5, P199, DOI 10.1080/15389580490465229; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Hemmelgarn B, 1997, JAMA-J AM MED ASSOC, V278, P27, DOI 10.1001/jama.278.1.27; Johnell K, 2013, DEMENT GERIATR COGN, V35, P239, DOI 10.1159/000348408; Johnell K, 2009, INT J GERIATR PSYCH, V24, P731, DOI 10.1002/gps.2189; Lader M, 2012, BR J CLIN PHARM; Lagarde E, 2004, EPIDEMIOLOGY, V15, P762, DOI 10.1097/01.ede.0000142140.77194.ad; Madhusoodanan Subramoniam, 2004, Expert Opin Drug Saf, V3, P485, DOI 10.1517/14740338.3.5.485; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Meuleners LB, 2011, J AM GERIATR SOC, V59, P1575, DOI 10.1111/j.1532-5415.2011.03561.x; Mitchell CGB, 2013, ACCIDENT ANAL PREV, V50, P732, DOI 10.1016/j.aap.2012.06.027; Moden B, 2012, EUR J PUBLIC HEALTH, V22, P726, DOI 10.1093/eurpub/ckr110; Moller J, 2011, AGING MENT HEALTH, V15, P259, DOI 10.1080/13607863.2010.513041; Monarrez-Espino J, INJ PREV IN PRESS; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Organisation for Economic Cooperation and Development (OECD), 2001, AG TRANSP MOB NEEDS; RAY WA, 1992, AM J EPIDEMIOL, V136, P873, DOI 10.1093/aje/136.7.873; Razmpa E, 2011, INDIAN J OTOLARYNGOL, V63, P269, DOI 10.1007/s12070-011-0235-5; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sims RV, 2000, J GERONTOL A-BIOL, V55, pM22; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Vanakoski J, 2000, EUR J CLIN PHARMACOL, V56, P453, DOI 10.1007/s002280000167; Vaughn MG, 2011, J PSYCHIATR RES, V45, P347, DOI 10.1016/j.jpsychires.2010.06.016; Vollmer WM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-155; Wang CC, 2004, J AM GERIATR SOC, V52, P143, DOI 10.1111/j.1532-5415.2004.52025.x; Whitlock G, 2004, INJURY PREV, V10, P33, DOI 10.1136/ip.2003.003020; Wolinsky FD, 2010, J GERONTOL A-BIOL, V65, P769, DOI 10.1093/gerona/glq003	43	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86742	10.1371/journal.pone.0086742	http://dx.doi.org/10.1371/journal.pone.0086742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489781	gold, Green Published			2022-12-27	WOS:000330570000067
J	Luo, Z; Dong, XC; Li, YX; Zhang, Q; Kim, C; Song, Y; Kang, L; Liu, YL; Wu, KL; Wu, JG				Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo			PolyC-Binding Protein 1 Interacts with 5 '-Untranslated Region of Enterovirus 71 RNA in Membrane-Associated Complex to Facilitate Viral Replication	PLOS ONE			English	Article							POLY(RC) BINDING-PROTEIN; RIBOSOMAL ENTRY SITE; VIRUS-RNA; GENE-EXPRESSION; POLIOVIRUS RNA; ELEMENT; TRANSLATION; SEQUENCE; CLOVERLEAF; INITIATION	Enterovirus 71 (EV71) is one causative agent of hand, foot, and mouth disease (HFMD), which may lead to severe neurological disorders and mortality in children. EV71 genome is a positive single-stranded RNA containing a single open reading frame (ORF) flanked by 5'-untranslated region (5'UTR) and 3'UTR. The 5'UTR is fundamentally important for virus replication by interacting with cellular proteins. Here, we revealed that poly(C)-binding protein 1 (PCBP1) specifically binds to the 5'UTR of EV71. Detailed studies indicated that the RNA-binding K-homologous 1 (KH1) domain of PCBP1 is responsible for its binding to the stem-loop I and IV of EV71 5'UTR. Interestingly, we revealed that PCBP1 is distributed in the nucleus and cytoplasm of uninfected cells, but mainly localized in the cytoplasm of EV71-infected cells due to interaction and co-localization with the viral RNA. Furthermore, sub-cellular distribution analysis showed that PCBP1 is located in ER-derived membrane, in where virus replication occurred in the cytoplasm of EV71-infected cells, suggesting PCBP1 is recruited in a membrane-associated replication complex. In addition, we found that the binding of PCBP1 to 5'UTR resulted in enhancing EV71 viral protein expression and virus production so as to facilitate viral replication. Thus, we revealed a novel mechanism in which PCBP1 as a positive regulator involved in regulation of EV71 replication in the host specialized membrane-associated replication complex, which provides an insight into cellular factors involved in EV71 replication.	[Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Luo, Zhen; Dong, Xingchen; Li, Youxing; Zhang, Qi; Kim, Cholho; Song, Yu; Kang, Lei; Liu, Yingle; Wu, Kailang; Wu, Jianguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Jianguo] Wuhan Univ, Zhongnan Hosp, Chinese French Liver Dis Res Inst, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Wu, KL (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	wukailang@whu.edu.cn; jwu@whu.edu.cn		Zhen, Luo/0000-0002-1142-2845; Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from Major State Basic Research Development Program (973 Program) (2012CB518900), National Natural Science Foundation of China (31230005 and 81171525), National Mega Project on Major Infectious Disease Prevention (2012ZX10004-207), National Mega Project on Major Drug Development (2011ZX09401-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bailey JM, 2007, J VIROL, V81, P650, DOI 10.1128/JVI.01327-06; Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; Beura LK, 2011, J VIROL, V85, P12939, DOI 10.1128/JVI.05177-11; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Fernandez N, 2010, VIROLOGY; GutierrezEscolano L, 1996, ARCH MED RES, V27, P413; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Huo LR, 2010, BBA-PROTEINS PROTEOM, V1804, P1954, DOI 10.1016/j.bbapap.2010.07.002; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; LIU YT, 2010, J ACCOUNT RES, V3, P3; Lyons T, 2001, J VIROL, V75, P10696, DOI 10.1128/JVI.75.22.10696-10708.2001; Magliano D, 1998, VIROLOGY, V240, P57, DOI 10.1006/viro.1997.8906; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Maul A, 1991, ASPECTS STAT METHODE, P143; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Nishimura K, 2004, VIROLOGY, V325, P364, DOI 10.1016/j.virol.2004.04.041; Ogram SA, 2010, VIROLOGY, V397, P14, DOI 10.1016/j.virol.2009.11.006; Perera R, 2007, J VIROL, V81, P8919, DOI 10.1128/JVI.01013-07; Qu J, 2011, FEBS LETT, V585, P4002, DOI 10.1016/j.febslet.2011.11.008; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Salonen A, 2005, CURR TOP MICROBIOL, V285, P139; Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Sharma N, 2009, VIROLOGY, V393, P238, DOI 10.1016/j.virol.2009.07.039; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Silvera D, 1999, J BIOL CHEM, V274, P38163, DOI 10.1074/jbc.274.53.38163; Spear A, 2008, VIROLOGY, V374, P280, DOI 10.1016/j.virol.2007.12.039; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Toyoda H, 2007, J VIROL, V81, P10017, DOI 10.1128/JVI.00516-07; Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936; Wang Li-chun, 2010, Virologica Sinica, V25, P98, DOI 10.1007/s12250-010-3102-8; Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Xia M, 2012, CELL CYCLE, V11, P2833, DOI 10.4161/cc.21169; Zhou X, 2012, CELL RES, V22, P717, DOI 10.1038/cr.2011.184	51	37	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87491	10.1371/journal.pone.0087491	http://dx.doi.org/10.1371/journal.pone.0087491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489926	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000152
J	Sasaoka, N; Sakamoto, M; Kanemori, S; Kan, M; Tsukano, C; Takemoto, Y; Kakizuka, A				Sasaoka, Norio; Sakamoto, Megumi; Kanemori, Shoko; Kan, Michiru; Tsukano, Chihiro; Takemoto, Yoshiji; Kakizuka, Akira			Long-Term Oral Administration of Hop Flower Extracts Mitigates Alzheimer Phenotypes in Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALLEVIATE MENOPAUSAL DISCOMFORTS; HUMULUS-LUPULUS L.; GAMMA-SECRETASE; BETA-PROTEIN; COGNITIVE DECLINE; ACID RECEPTOR; DOUBLE-BLIND; DISEASE; MUTATION	Coincident with the expanding population of aged people, the incidence of Alzheimer disease (AD) is rapidly increasing in most advanced countries. At present, no effective prophylactics are available. Among several pathological mechanisms proposed for AD, the "amyloid hypothesis" has been most widely accepted, in which accumulation or deposition of A beta is considered to be the initial event. Thus, prevention of A beta production would be an ideal strategy for the treatment or prevention of AD. A beta is produced via the proteolytic cleavage of its precursor protein, APP (amyloid precursor protein), by two different enzymes, beta and gamma-secretases. Indeed, inhibitors against either or both enzymes have been developed and tested for clinical efficacy. Based on the "amyloid hypothesis", we developed a luciferase-based screening method to monitor gamma-secretase activity, screened more than 1,600 plant extracts, most of which have long been used in Chinese medicine, and observed that Hop extracts significantly inhibit A beta production in cultured cells. A major component of the inhibitory activity was purified, and its chemical identity was determined by NMR to be Garcinielliptone HC. In vivo, oral administration of Hop extracts to AD model mice decreased A beta depositions in the cerebral cortex of the parietal lobe, hippocampus, and artery walls (amyloid angiopathy) in the brains. In a Morris water maze test, AD model mice that had daily consumed Hop extracts in their drinking water showed significant mitigation of memory impairment at ages of 9 and 12 months. Moreover, in the open field test oral administration of Hop extracts also prevented an emotional disturbance that appeared in the AD mice at 18 months. Despite lifelong consumption of Hop extracts, no deleterious side effects were observed at any age. These results support the "amyloid hypothesis", and indicate that Hop extract is a promising candidate for an effective prophylactic for AD.	[Sasaoka, Norio; Sakamoto, Megumi; Kanemori, Shoko; Kan, Michiru; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Sakyo Ku, Kyoto, Japan; [Tsukano, Chihiro; Takemoto, Yoshiji] Kyoto Univ, Dept Organ Chem, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan	Kyoto University; Kyoto University	Kakizuka, A (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Sakyo Ku, Kyoto, Japan.	kakizuka@lif.kyoto-u.ac.jp	Takemoto, Yoshiji/C-7099-2009; Tsukano, Chihiro/B-7697-2014	Tsukano, Chihiro/0000-0002-9361-0857	Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan	Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants from Solution-Oriented Research for Science and Technology of the Japan Science and Technology Agency and the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2012, CHEM BIODIVERS, V9, P1045, DOI 10.1002/cbdv.201100233; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Chadwick LR, 2006, PHYTOMEDICINE, V13, P119, DOI 10.1016/j.phymed.2004.07.006; Choi Y, 2008, COMB CHEM HIGH T SCR, V11, P1; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Desai A, 2012, ATHEROSCLEROSIS, V223, P130, DOI 10.1016/j.atherosclerosis.2012.05.004; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Erkkola R, 2010, PHYTOMEDICINE, V17, P389, DOI 10.1016/j.phymed.2010.01.007; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Martinez-Aguilar JF, 2009, J AGR FOOD CHEM, V57, P1933, DOI 10.1021/jf802141d; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Funato H, 1998, AM J PATHOL, V152, P1633; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Godbolt AK, 2004, ARCH NEUROL-CHICAGO, V61, P1743, DOI 10.1001/archneur.61.11.1743; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heyerick A, 2006, MATURITAS, V54, P164, DOI 10.1016/j.maturitas.2005.10.005; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kelleher RJ, 2010, SCIENCE, V330, P1055, DOI 10.1126/science.1198668; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Koike M, 2010, J BIOL CHEM, V285, P21736, DOI 10.1074/jbc.M109.099283; Kumari P, 2011, ANAL BIOCHEM, V415, P134, DOI 10.1016/j.ab.2011.04.010; Levine AJ, 2004, ARCH CLIN NEUROPSYCH, V19, P769, DOI 10.1016/j.acn.2003.09.004; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lu YH, 2008, PHYTOCHEMISTRY, V69, P225, DOI 10.1016/j.phytochem.2007.06.026; Morelli L, 2012, INT J ALZHEIMERS DIS, V2012; Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Neugroschl J, 2010, MT SINAI J MED, V77, P3, DOI 10.1002/msj.20165; Nilsson LNG, 2004, NEUROBIOL AGING, V25, P1153, DOI 10.1016/j.neurobiolaging.2003.12.011; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011; Raschetti R, 2005, EUR J CLIN PHARMACOL, V61, P361, DOI 10.1007/s00228-005-0946-1; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SAITOU M, 1994, J BIOL CHEM, V269, P19101; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Thomas P, 2007, MUTAGENESIS, V22, P15, DOI 10.1093/mutage/gel055; Van Cleemput M, 2009, J NAT PROD, V72, P1220, DOI 10.1021/np800740m; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; von Bernhardi R, 2010, J ALZHEIMERS DIS, V19, P405, DOI 10.3233/JAD-2010-1248; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang Xiao-Ping, 2008, Neurosci Bull, V24, P105, DOI 10.1007/s12264-008-0105-7; Wharton W, 2011, J ALZHEIMERS DIS, V26, P495, DOI 10.3233/JAD-2011-110341; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yamamoto Y, 2001, CELL DEATH DIFFER, V8, P871, DOI 10.1038/sj.cdd.4400901	64	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87185	10.1371/journal.pone.0087185	http://dx.doi.org/10.1371/journal.pone.0087185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489866	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000116
J	Tofik, R; Ohlsson, S; Bakoush, O				Tofik, Rafid; Ohlsson, Sophie; Bakoush, Omran			Urinary Concentration of Monocyte Chemoattractant Protein-1 in Idiopathic Glomerulonephritis: A Long-Term Follow-Up Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; LUPUS NEPHRITIS; CREATININE ASSAYS; RENAL-DISEASE; MCP-1; PROGRESSION; PREDICTION; EXCRETION; ALBUMIN	Background: Monocyte chemoattractant protein-1 (MCP-1), which is up regulated in kidney diseases, is considered a marker of kidney inflammation. We examined the value of urine MCP-1 in predicting the outcome in idiopathic glomerulonephritis. Methods: Between 1993 and 2004, 165 patients (68 females) diagnosed with idiopathic proteinuric glomerulopathy and with serum creatinine >150 mu mol/L at diagnosis were selected for the study. Urine concentrations of MCP-1 were analyzed by ELISA in early morning spot urine samples collected on the day of the diagnostic kidney biopsy. The patients were followed until 2009. The progression rate to end-stage kidney disease was calculated using Kaplan-Meier survival analysis. End-stage kidney disease (ESKD) was defined as the start of kidney replacement therapy during the study follow-up time. Results: Patients with proliferative glomerulonephritis had significantly higher urinary MCP-1 excretion levels than those with non-proliferative glomerulonephritis (p<0.001). The percentage of patients whose kidney function deteriorated significantly was 39.0% in the high MCP-1 excretion group and 29.9% in the low MCP-1 excretion group. However, after adjustment for confounding variables such as glomerular filtration rate (GFR) and proteinuria, there was no significant association between urine MCP-1 concentration and progression to ESKD, (HR = 1.75, 95% CI = 0.64-4.75, p = 0.27). Conclusion: Our findings indicate that progression to end-stage kidney disease in patients with idiopathic glomerulopathies is not associated with urine MCP-1 concentrations at the time of diagnosis.	[Tofik, Rafid; Ohlsson, Sophie; Bakoush, Omran] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden; [Bakoush, Omran] UAE Univ, Dept Internal Med, Al Ain, U Arab Emirates	Lund University; United Arab Emirates University	Bakoush, O (corresponding author), Lund Univ, Dept Nephrol, S-22101 Lund, Sweden.	Omran.Bakoush@uaeu.ac.ae	Bakoush, Omran/ABF-8443-2021; Ohlsson, Sophie/W-9495-2019; Bakoush, Omran/B-9395-2009	Bakoush, Omran/0000-0003-1447-9836; Ohlsson, Sophie/0000-0002-5253-1650; Bakoush, Omran/0000-0003-1447-9836	ALF grants from Lund University Research Fund	ALF grants from Lund University Research Fund	This study was supported by ALF grants from Lund University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bakoush O, 2001, KIDNEY INT, V60, P1904, DOI 10.1046/j.1523-1755.2001.00018.x; Barbado J, 2012, CYTOKINE, V60, P583, DOI 10.1016/j.cyto.2012.07.009; Bazzi C, 2012, J NEPHROL, V25, P810, DOI 10.5301/jn.5000069; Bjork J, 2007, SCAND J CLIN LAB INV, V67, P678, DOI 10.1080/00365510701326891; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Kim MJ, 2011, CLIN CHIM ACTA, V412, P2022, DOI 10.1016/j.cca.2011.07.023; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Lieberthal JG, 2013, J RHEUMATOL, V40, P674, DOI 10.3899/jrheum.120879; McQuarrie EP, 2011, NEPHROL DIAL TRANSPL, V26, P1563, DOI 10.1093/ndt/gfq605; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Murea M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-148; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Nyman U, 2006, SCAND J CLIN LAB INV, V66, P451, DOI 10.1080/00365510600902362; Ohlsson S, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/584916; PRICE CP, 1983, ANN CLIN BIOCHEM, V20, P1; Rosa RF, 2012, J RHEUMATOL, V39, P1948, DOI 10.3899/jrheum.110201; Rovin BH, 1996, AM J KIDNEY DIS, V27, P640, DOI 10.1016/S0272-6386(96)90097-9; Singh RG, 2012, LUPUS, V21, P1214, DOI 10.1177/0961203312452622; SVENDSEN P, 1991, DETERMINATION HUMAN; Tencer J, 1996, SCAND J CLIN LAB INV, V56, P691, DOI 10.3109/00365519609088816; Titan SM, 2012, J DIABETES COMPLICAT, V26, P546, DOI 10.1016/j.jdiacomp.2012.06.006; Tofik R, 2011, SCAND J CLIN LAB INV, V71, P123, DOI 10.3109/00365513.2010.542828; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Yu C, 2007, J AM SOC NEPHROL, V18, P750, DOI 10.1681/ASN.2006070770	28	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87857	10.1371/journal.pone.0087857	http://dx.doi.org/10.1371/journal.pone.0087857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489972	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000184
J	Vegvari, C; Foley, RA				Vegvari, Carolin; Foley, Robert A.			High Selection Pressure Promotes Increase in Cumulative Adaptive Culture	PLOS ONE			English	Article							MIDDLE STONE-AGE; POPULATION-GROWTH; HUMAN-BEHAVIOR; EVOLUTION; COMPLEXITY; DEMOGRAPHY; MODELS; ORIGIN; INTENSIFICATION; TECHNOLOGY	The evolution of cumulative adaptive culture has received widespread interest in recent years, especially the factors promoting its occurrence. Current evolutionary models suggest that an increase in population size may lead to an increase in cultural complexity via a higher rate of cultural transmission and innovation. However, relatively little attention has been paid to the role of natural selection in the evolution of cultural complexity. Here we use an agent-based simulation model to demonstrate that high selection pressure in the form of resource pressure promotes the accumulation of adaptive culture in spite of small population sizes and high innovation costs. We argue that the interaction of demography and selection is important, and that neither can be considered in isolation. We predict that an increase in cultural complexity is most likely to occur under conditions of population pressure relative to resource availability. Our model may help to explain why culture change can occur without major environmental change. We suggest that understanding the interaction between shifting selective pressures and demography is essential for explaining the evolution of cultural complexity.	[Vegvari, Carolin; Foley, Robert A.] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol & Anthropol, Cambridge, England	University of Cambridge	Vegvari, C (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol & Anthropol, Cambridge, England.	cv275@cam.ac.uk						Ambrose SH., 2022, SOCIAL ECOLOGICAL MO, P3, DOI [DOI 10.1515/9781474470957-003, 10.1515/9781474470957-003]; [Anonymous], 2005, CONDITIONS AGR GROWT; BEATON JM, 1991, ANTIQUITY, V65, P946, DOI 10.1017/S0003598X00080741; Bettinger RL, 2006, J ARCHAEOL SCI, V33, P538, DOI 10.1016/j.jas.2005.09.009; Bird DW, 2006, J ARCHAEOL RES, V14, P143, DOI 10.1007/s10814-006-9003-6; Boyd R, 2005, ORIGIN EVOLUTION CUL; Clark JL, 2011, J ANTHROPOL ARCHAEOL, V30, P273, DOI 10.1016/j.jaa.2011.04.002; Darwin C, 1859, ORIGIN SPECIES MEANS; Deacon HJ, 1989, HUMAN REVOLUTION BEH, P104; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Fitzhugh B, 2001, J ANTHROPOL ARCHAEOL, V20, P125, DOI 10.1006/jaar.2001.0380; Flannery K. V., 1969, The domestication and exploitation of plants and animals., P73; Ghirlanda S, 2007, QUAL QUANT, V41, P591, DOI 10.1007/s11135-007-9070-x; Ghirlanda S, 2010, THEOR POPUL BIOL, V77, P181, DOI 10.1016/j.tpb.2010.01.004; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jones R, 1977, PREHISTORY MAT CULTU, V12; Kandler A, 2009, THEOR POPUL BIOL, V76, P59, DOI 10.1016/j.tpb.2009.04.004; KEELEY LH, 1988, J ANTHROPOL ARCHAEOL, V7, P373, DOI 10.1016/0278-4165(88)90003-7; Kline MA, 2010, P ROY SOC B-BIOL SCI, V277, P2559, DOI 10.1098/rspb.2010.0452; Lee Richard, 1968, MAN HUNTER; Lycett SJ, 2010, QUATERN INT, V211, P55, DOI 10.1016/j.quaint.2008.12.001; Maher LA, 2011, CAMB ARCHAEOL J, V21, P1, DOI 10.1017/S0959774311000011; MARINARROYO ABM, 2009, FARMING, V2009, P00001, DOI DOI 10.3828/BFARM.2009.2.3; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2006, J HUM EVOL, V51, P429, DOI 10.1016/j.jhevol.2006.06.003; McGuire RH., 1983, ADV ARCHAEOL METH TH, V6, P91; Mesoudi A, 2004, EVOLUTION, V58, P1; Mesoudi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018239; Munro N, 2009, VERTEBR PALEOBIOL PA, P141, DOI 10.1007/978-1-4020-9699-0_10; MURDOCK GP, 1973, ETHNOLOGY, V12, P379, DOI 10.2307/3773367; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Pradhan GR, 2012, J HUM EVOL, V63, P180, DOI 10.1016/j.jhevol.2012.04.008; Read D, 2006, AM ANTIQUITY, V71, P164, DOI 10.2307/40035327; Read DW, 2003, CURR ANTHROPOL, V44, P59, DOI 10.1086/344616; Read D, 2008, AM ANTIQUITY, V73, P599, DOI 10.2307/25470520; Rendell L, 2011, PHILOS T R SOC B, V366, P1118, DOI 10.1098/rstb.2010.0376; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Shea JJ, 2007, J ANTHROPOL RES, V63, P449, DOI 10.3998/jar.0521004.0063.401; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Stiner MC, 2006, HUM ECOL, V34, P693, DOI 10.1007/s10745-006-9041-1; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stutz AJ, 2009, J HUM EVOL, V56, P294, DOI 10.1016/j.jhevol.2008.10.004; Ugan A, 2003, J ARCHAEOL SCI, V30, P1315, DOI 10.1016/S0305-4403(03)00022-0; Wilkinson R. G., 1973, POVERTY PROGR ECOLOG	51	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86406	10.1371/journal.pone.0086406	http://dx.doi.org/10.1371/journal.pone.0086406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	301ZC	24489724	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000038
J	de Santos-Sierra, D; Sendina-Nadal, I; Leyva, I; Almendral, JA; Anava, S; Ayali, A; Papo, D; Boccaletti, S				de Santos-Sierra, Daniel; Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.; Anava, Sarit; Ayali, Amir; Papo, David; Boccaletti, Stefano			Emergence of Small-World Anatomical Networks in Self-Organizing Clustered Neuronal Cultures	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NERVOUS-SYSTEM; DYNAMICS	In vitro primary cultures of dissociated invertebrate neurons from locust ganglia are used to experimentally investigate the morphological evolution of assemblies of living neurons, as they self-organize from collections of separated cells into elaborated, clustered, networks. At all the different stages of the culture's development, identification of neurons' and neurites' location by means of a dedicated software allows to ultimately extract an adjacency matrix from each image of the culture. In turn, a systematic statistical analysis of a group of topological observables grants us the possibility of quantifying and tracking the progression of the main network's characteristics during the self-organization process of the culture. Our results point to the existence of a particular state corresponding to a small-world network configuration, in which several relevant graph's micro-and meso-scale properties emerge. Finally, we identify the main physical processes ruling the culture's morphological transformations, and embed them into a simplified growth model qualitatively reproducing the overall set of experimental observations.	[de Santos-Sierra, Daniel; Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.; Papo, David] Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain; [Sendina-Nadal, Irene; Leyva, Inmaculada; Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Anava, Sarit; Ayali, Amir] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Florence, Italy; [Boccaletti, Stefano] Ist Nazl Fis Nucl, I-50125 Florence, Italy	Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Universidad Rey Juan Carlos; Tel Aviv University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	de Santos-Sierra, D (corresponding author), Univ Politecn Madrid, Ctr Biomed Technol, Madrid, Spain.	daniel.desantos@ctb.upm.es	Leyva, I./M-1820-2013; Ayali, Amir/B-1050-2008; Sendiña-Nadal, Irene/M-3083-2013; Almendral, Juan/ABC-8025-2021; Boccaletti, Stefano/U-7603-2019	Leyva, I./0000-0001-9634-5385; Ayali, Amir/0000-0001-6152-2927; Sendiña-Nadal, Irene/0000-0003-0432-235X; Almendral, Juan/0000-0003-1100-7446; Boccaletti, Stefano/0000-0002-5758-7012; Papo, David/0000-0003-1889-2791	Spanish Ministerio de Ciencia e Innovacion (Spain) [FIS2009-07072]; Comunidad de Madrid (Spain) [MODELICO-CM S2009ESP-1691]; Comunidad de Madrid through the R+D Activity Program [NEUROTEC-CM (2010/BMD-2460)]	Spanish Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid); Comunidad de Madrid through the R+D Activity Program	The authors acknowledge financial support from the Spanish Ministerio de Ciencia e Innovacion (Spain) under project FIS2009-07072, and from Comunidad de Madrid (Spain) under project MODELICO-CM S2009ESP-1691. DSS is supported by the Comunidad de Madrid through the R+D Activity Program NEUROTEC-CM (2010/BMD-2460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Anava S, 2013, INSECT MOL BIOL, V22, P457, DOI 10.1111/imb.12036; Anava S, 2009, BIOPHYS J, V96, P1661, DOI 10.1016/j.bpj.2008.10.058; Ayali A, 2004, COMPLEXITY, V9, P25, DOI 10.1002/cplx.20046; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 2001, RANDOM GRAPHS; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Downes JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002522; Eckmann JP, 2007, PHYS REP, V449, P54, DOI 10.1016/j.physrep.2007.02.014; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Li DQ, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/68004; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rad AA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Segev R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168101; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Shefi O, 2002, NEUROCOMPUTING, V44, P635, DOI 10.1016/S0925-2312(02)00451-4; van Pelt J, 2005, PROG BRAIN RES, V147, P173, DOI 10.1016/S0079-6123(04)47013-7; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Woiterski L, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025029	28	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85828	10.1371/journal.pone.0085828	http://dx.doi.org/10.1371/journal.pone.0085828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489675	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330510000020
J	Feng, SY; Xu, Y; Ma, RQ; Sun, YQ; Luo, X; Li, HB				Feng, Shaoyan; Xu, Ying; Ma, Renqiang; Sun, Yueqi; Luo, Xi; Li, Huabin			Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DOUBLE-BLIND; DERMATOPHAGOIDES-PTERONYSSINUS; THERAPEUTIC VACCINES; SAFETY; SCHEDULES; ASTHMA; EXTRACT; IMPROVEMENT; GRASS	Background: Although allergen specific immunotherapy (SIT) represents the only immune-modifying and curative option available for patients with allergic rhinitis (AR), the optimal schedule for specific subcutaneous immunotherapy (SCIT) is still unknown. The objective of this study is to systematically assess the efficacy and safety of cluster SCIT for patients with AR. Methods: By searching PubMed, EMBASE and the Cochrane clinical trials database from 1980 through May 10th, 2013, we collected and analyzed the randomized controlled trials (RCTs) of cluster SCIT to assess its efficacy and safety. Results: Eight trials involving 567 participants were included in this systematic review. Our meta-analysis showed that cluster SCIT have similar effect in reduction of both rhinitis symptoms and the requirement for anti-allergic medication compared with conventional SCIT, but when comparing cluster SCIT with placebo, no statistic significance were found in reduction of symptom scores or medication scores. Some caution is required in this interpretation as there was significant heterogeneity between studies. Data relating to Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in 3 included studies were analyzed, which consistently point to the efficacy of cluster SCIT in improving quality of life compared to placebo. To assess the safety of cluster SCIT, meta-analysis showed that no differences existed in the incidence of either local adverse reaction or systemic adverse reaction between the cluster group and control group. Conclusion: Based on the current limited evidence, we still could not conclude affirmatively that cluster SCIT was a safe and efficacious option for the treatment of AR patients. Further large-scale, well-designed RCTs on this topic are still needed.	[Feng, Shaoyan; Ma, Renqiang; Sun, Yueqi; Luo, Xi; Li, Huabin] Sun Yat Sen Univ, Otorhinolarygol Hosp, Allergy & Canc Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Feng, Shaoyan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Otolaryngol, Zhuhai, Peoples R China; [Xu, Ying] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Pharmaceutical University	Li, HB (corresponding author), Sun Yat Sen Univ, Otorhinolarygol Hosp, Allergy & Canc Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	allergyli@163.com	Sun, Yueqi/N-4528-2018	Sun, Yueqi/0000-0002-2382-0429	National Nature and Science Grant of China [81070771, 81271054]; Program for New Century Excellent Talents in University [NCET-10-0851]	National Nature and Science Grant of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study is supported by National Nature and Science Grant of China (No. 81070771, 81271054) and Program for New Century Excellent Talents in University (No. NCET-10-0851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Casanovas M, 2006, INT ARCH ALLERGY IMM, V139, P153, DOI 10.1159/000090392; Colas C, 2006, J ALLERGY CLIN IMMUN, V117, P810, DOI 10.1016/j.jaci.2005.11.039; Cox L, 2006, ANN ALLERG ASTHMA IM, V97, P126, DOI 10.1016/S1081-1206(10)60003-8; Cox L, 2013, CURR ALLERGY ASTHM R, V13, P178, DOI 10.1007/s11882-012-0335-7; Crimi Nunzio, 2004, Ann Ital Med Int, V19, P98; Fernandez-Tavora L, 2011, EXPERT OPIN DRUG SAF, V10, P947, DOI 10.1517/14740338.2011.603724; Freeman J, 1930, LANCET, V1, P744; Garde J, 2005, Allergol Immunopathol (Madr), V33, P100, DOI 10.1157/13072921; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Guardia P, 2004, Allergol Immunopathol (Madr), V32, P271, DOI 10.1157/13066304; Hansen I, 2003, LARYNGO RHINO OTOL, V82, P558; Hernandez N, 2011, ALLERGOL IMMUNOPATH, V39, P267, DOI 10.1016/j.aller.2010.09.002; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Juniper EF, 1999, J ALLERGY CLIN IMMUN, V104, P364, DOI 10.1016/S0091-6749(99)70380-5; Justicia JL, 2007, J INVEST ALLERG CLIN, V17, P386; Lou W, 2012, PEDIAT ALLERG IMM-UK, V23, P141, DOI 10.1111/j.1399-3038.2011.01249.x; MALLING HJ, 1993, ALLERGY, V14, P7; Martinez-Canavate A, 2005, Allergol Immunopathol (Madr), V33, P138, DOI 10.1157/13075696; More DR, 2002, ANN ALLERG ASTHMA IM, V88, P391, DOI 10.1016/S1081-1206(10)62370-8; Nanda A, 2004, J ALLERGY CLIN IMMUN, V114, P1339, DOI 10.1016/j.jaci.2004.08.049; Pfaar O, 2009, HNO, V57, P1099, DOI 10.1007/s00106-009-1946-8; Pfaar O, 2009, INT ARCH ALLERGY IMM, V150, P102, DOI 10.1159/000210436; Pfaar O, 2010, EUR ARCH OTO-RHINO-L, V267, P245, DOI 10.1007/s00405-009-1077-6; Pichler CE, 2001, ALLERGY, V56, P301, DOI 10.1034/j.1398-9995.2001.00834.x; Polosa R, 2004, ALLERGY, V59, P1224, DOI 10.1111/j.1398-9995.2004.00537.x; Rossi RE, 2004, INT ARCH ALLERGY IMM, V135, P44, DOI 10.1159/000080042; Serrano P, 2004, J INVEST ALLERG CLIN, V14, P312; Song FJ, 1998, BRIT MED J, V316, P471; Stokes JR, 2011, CURR OPIN IMMUNOL, V23, P808, DOI 10.1016/j.coi.2011.07.015; Subiza J, 2008, CLIN EXP ALLERGY, V38, P987, DOI 10.1111/j.1365-2222.2008.02995.x; Tabar AI, 2005, J ALLERGY CLIN IMMUN, V116, P109, DOI 10.1016/j.jaci.2005.05.005; Tabar AI, 2004, J INVEST ALLERG CLIN, V14, P193; Walker SM, 2001, J ALLERGY CLIN IMMUN, V107, P87, DOI 10.1067/mai.2001.112027; Zenner HP, 1997, J ALLERGY CLIN IMMUN, V100, P23, DOI 10.1016/S0091-6749(97)70190-8; Zhang L, 2009, INT ARCH ALLERGY IMM, V148, P161, DOI 10.1159/000155747	39	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86529	10.1371/journal.pone.0086529	http://dx.doi.org/10.1371/journal.pone.0086529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489740	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000058
J	Guo, YC; Kuhl, SJ; Pfister, AS; Cizelsky, W; Denk, S; Beer-Molz, L; Kuhl, M				Guo, Yanchun; Kuehl, Susanne J.; Pfister, Astrid S.; Cizelsky, Wiebke; Denk, Stephanie; Beer-Molz, Laura; Kuehl, Michael			Comparative Analysis Reveals Distinct and Overlapping Functions of Mef2c and Mef2d during Cardiogenesis in Xenopus laevis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2C; HEART FIELD; IN-VIVO; EXPRESSION; CELLS; MESODERM; DIFFERENTIATION; CARDIOMYOCYTES; MORPHOGENESIS; FIBROBLASTS	The family of vertebrate Mef2 transcription factors is comprised of four members named Mef2a, Mef2b, Mef2c, and Mef2d. These transcription factors are regulators of the myogenic programs with crucial roles in development of skeletal, cardiac and smooth muscle cells. Mef2a and Mef2c are essential for cardiac development in mice. In Xenopus, mef2c and mef2d but not mef2a were recently shown to be expressed during cardiogenesis. We here investigated the function of Mef2c and Mef2d during Xenopus laevis cardiogenesis. Knocking down either gene by corresponding antisense morpholino oligonucleotides led to profound heart defects including morphological abnormalities, pericardial edema, and brachycardia. Marker gene expression analyses and rescue experiments revealed that (i) both genes are required for proper cardiac gene expression, (ii) Mef2d can compensate for the loss of Mef2c but not vice versa, and (iii) the gamma domain of Mef2c is required for early cardiac development. Taken together, our data provide novel insights into the function of Mef2 during cardiogenesis, highlight evolutionary differences between species and might have an impact on attempts of direct reprogramming.	[Guo, Yanchun; Kuehl, Susanne J.; Pfister, Astrid S.; Cizelsky, Wiebke; Denk, Stephanie; Beer-Molz, Laura; Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany; [Guo, Yanchun; Cizelsky, Wiebke] Univ Ulm, Int Grad Sch Mol Med Ulm, D-89069 Ulm, Germany	Ulm University; Ulm University	Kuhl, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, D-89069 Ulm, Germany.	michael.kuehl@uni-ulm.de			DFG [Ku1166/3-2, GSC270]	DFG(German Research Foundation (DFG))	DFG (Ku1166/3-2), DFG (GSC270), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Di Lisi R, 1998, J BIOL CHEM, V273, P25371, DOI 10.1074/jbc.273.39.25371; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Garriock RJ, 2005, DEV DYNAM, V233, P1287, DOI 10.1002/dvdy.20460; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Herrmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046798; Herrmann F, 2011, DEV DYNAM, V240, P2634, DOI 10.1002/dvdy.22776; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Karamboulas Christina, 2006, J Cell Sci, V119, P4315, DOI 10.1242/jcs.03186; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P19512; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nieuwkoop P, 1975, EXTERNAL INTERNAL ST; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; SATER AK, 1990, DEVELOPMENT, V108, P461; SATER AK, 1989, DEVELOPMENT, V105, P821; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	37	8	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87294	10.1371/journal.pone.0087294	http://dx.doi.org/10.1371/journal.pone.0087294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489892	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000126
J	Herrero, A; Zamora, R				Herrero, Asier; Zamora, Regino			Plant Responses to Extreme Climatic Events: A Field Test of Resilience Capacity at the Southern Range Edge	PLOS ONE			English	Article							DROUGHT-INDUCED MORTALITY; SCOTS PINE; NORTHERN ARIZONA; TREE MORTALITY; CHANGE IMPACTS; NEEDLE GROWTH; VEGETATION; SYLVESTRIS; FORESTS; NIGRA	The expected and already observed increment in frequency of extreme climatic events may result in severe vegetation shifts. However, stabilizing mechanisms promoting community resilience can buffer the lasting impact of extreme events. The present work analyzes the resilience of a Mediterranean mountain ecosystem after an extreme drought in 2005, examining shoot-growth and needle-length resistance and resilience of dominant tree and shrub species (Pinus sylvestris vs Juniperus communis, and P. nigra vs J. oxycedrus) in two contrasting altitudinal ranges. Recorded high vegetative-resilience values indicate great tolerance to extreme droughts for the dominant species of pine-juniper woodlands. Observed tolerance could act as a stabilizing mechanism in rear range edges, such as the Mediterranean basin, where extreme events are predicted to be more detrimental and recurrent. However, resistance and resilience components vary across species, sites, and ontogenetic states: adult Pinus showed higher growth resistance than did adult Juniperus; saplings displayed higher recovery rates than did conspecific adults; and P. nigra saplings displayed higher resilience than did P. sylvestris saplings where the two species coexist. P. nigra and J. oxycedrus saplings at high and low elevations, respectively, were the most resilient at all the locations studied. Under recurrent extreme droughts, these species-specific differences in resistance and resilience could promote changes in vegetation structure and composition, even in areas with high tolerance to dry conditions.	[Herrero, Asier; Zamora, Regino] Univ Granada, Dept Ecol, Granada, Andalusia, Spain; [Herrero, Asier] Univ Alcala, Dept Life Sci, Madrid, Spain	University of Granada; Universidad de Alcala	Herrero, A (corresponding author), Univ Granada, Dept Ecol, Granada, Andalusia, Spain.	asier@ugr.es	Herrero, Asier/A-9746-2018; Zamora, Regino/B-3179-2010	Herrero, Asier/0000-0003-2932-5194; Zamora, Regino/0000-0002-5049-9968	Ministerio de Ciencia e Innovacion (Spanish Government) [CGL2008-04794, CGL2011-29910]; FPU-MEC [AP2005-1561]	Ministerio de Ciencia e Innovacion (Spanish Government)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU-MEC(Spanish Government)	This study was supported by Ministerio de Ciencia e Innovacion (Spanish Government) Projects CGL2008-04794 and CGL2011-29910 to R.Z.,and by grant FPU-MEC (AP2005-1561) to A.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2004, OECOLOGIA, V140, P217, DOI 10.1007/s00442-004-1585-4; Afzal-Rafii Z, 2007, MOL ECOL, V16, P723, DOI 10.1111/j.1365-294X.2006.03183.x; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Blanco E., 1997, BOSQUES IBERICOS INT; Boulant N, 2008, DIVERS DISTRIB, V14, P862, DOI 10.1111/j.1472-4642.2008.00494.x; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Linares JC, 2010, TREE PHYSIOL, V30, P795, DOI 10.1093/treephys/tpq052; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Day ME, 2011, TREE PHYSIOL-NETH, V4, P91, DOI 10.1007/978-94-007-1242-3_4; De Dato G, 2008, IFOREST, V1, P39, DOI 10.3832/ifor0418-0010039; Debain S, 2007, CAN J FOREST RES, V37, P705, DOI 10.1139/X06-265; DeClerck FAJ, 2006, ECOLOGY, V87, P2787, DOI 10.1890/0012-9658(2006)87[2787:SRASSI]2.0.CO;2; Della-Marta PM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008510; Dobbertin M, 2010, TREE PHYSIOL, V30, P346, DOI 10.1093/treephys/tpp123; EDENIUS L, 1995, CAN J FOREST RES, V25, P529, DOI 10.1139/x95-060; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; Garcia-Herrera R, 2007, J HYDROMETEOROL, V8, P483, DOI 10.1175/JHM578.1; GARRETT PW, 1973, ECOLOGY, V54, P1328, DOI 10.2307/1934195; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Herrero A, 2012, PLANT ECOL, V213, P459, DOI 10.1007/s11258-011-9993-0; Herrero A, 2013, OECOLOGIA, V173, P1613, DOI 10.1007/s00442-013-2707-7; Hodar JA, 2003, BIOL CONSERV, V110, P123, DOI 10.1016/S0006-3207(02)00183-0; Holling C.S., 1996, ENG ECOL CONSTRAINTS, V31, P32, DOI DOI 10.17226/4919.[; ISIK K, 1990, FOREST ECOL MANAG, V35, P261, DOI 10.1016/0378-1127(90)90007-X; Koepke DF, 2010, OECOLOGIA, V163, P1079, DOI 10.1007/s00442-010-1671-8; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lloret F, 2004, GLOBAL CHANGE BIOL, V10, P2092, DOI 10.1111/j.1365-2486.2004.00870.x; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Lloret F, 2011, OIKOS, V120, P1909, DOI 10.1111/j.1600-0706.2011.19372.x; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Mutke S, 2003, ANN FOREST SCI, V60, P527, DOI 10.1051/forest:2003046; Penuelas J, 2004, ECOSYSTEMS, V7, P598, DOI 10.1007/s10021-004-0179-7; PRUSGLOWACKI W, 1994, SILVAE GENET, V43, P7; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Richter S, 2012, OECOLOGIA, V169, P269, DOI 10.1007/s00442-011-2191-x; Royce EB, 2001, AM J BOT, V88, P919, DOI 10.2307/2657045; Slik JWF, 2004, OECOLOGIA, V141, P114, DOI 10.1007/s00442-004-1635-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Thabeet A, 2009, TREES-STRUCT FUNCT, V23, P843, DOI 10.1007/s00468-009-0326-z; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Willms J, 1998, TREES-STRUCT FUNCT, V12, P215, DOI 10.1007/s004680050143; Zamora R, 2001, FOREST ECOL MANAG, V144, P33, DOI 10.1016/S0378-1127(00)00362-5; Zweifel R, 2009, J VEG SCI, V20, P442, DOI 10.1111/j.1654-1103.2009.05701.x	58	39	40	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87842	10.1371/journal.pone.0087842	http://dx.doi.org/10.1371/journal.pone.0087842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489971	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000153
J	Hojland, DH; Jensen, KMV; Kristensen, M				Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael			Adaptation of Musca domestica L. Field Population to Laboratory Breeding Causes Transcriptional Alterations	PLOS ONE			English	Article							RESISTANT HOUSE-FLIES; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; CROSS-RESISTANCE; DROSOPHILA; GENES; P450; EXPRESSION; EVOLUTION; GENETICS	Background: The housefly, Musca domestica, has developed resistance to most insecticides applied for its control. Expression of genes coding for detoxification enzymes play a role in the response of the housefly when encountered by a xenobiotic. The highest level of constitutive gene expression of nine P450 genes was previously found in a newly-collected susceptible field population in comparison to three insecticide-resistant laboratory strains and a laboratory reference strain. Results: We compared gene expression of five P450s by qPCR as well as global gene expression by RNAseq in the newly-acquired field population (845b) in generation F-1, F-13 and F-29 to test how gene expression changes following laboratory adaption. Four (CYP6A1, CYP6A36, CYP6D3, CYP6G4) of five investigated P450 genes adapted to breeding by decreasing expression. CYP6D1 showed higher female expression in F-29 than in F-1. For males, about half of the genes accessed in the global gene expression were up-regulated in F-13 and F-29 in comparison with the F-1 population. In females, 60% of the genes were up-regulated in F-13 in comparison with F-1, while 33% were up-regulated in F-29. Forty potential P450 genes were identified. In most cases, P450 gene expression was decreased in F-13 flies in comparison with F-1. Gene expression then increased from F-13 to F-29 in males and decreased further in females. Conclusion: The global gene expression changes massively during adaptation to laboratory breeding. In general, global expression decreased as a result of laboratory adaption in males, while female expression was not unidirectional. Expression of P450 genes was in general down-regulated as a result of laboratory adaption. Expression of hexamerin, coding for a storage protein was increased, while gene expression of genes coding for amylases decreased. This suggests a major impact of the surrounding environment on gene response to xenobiotics and genetic composition of housefly strains.	[Hojland, Dorte H.; Jensen, Karl-Martin Vagn; Kristensen, Michael] Aarhus Univ, Dept Agroecol, Aarhus, Denmark	Aarhus University	Kristensen, M (corresponding author), Aarhus Univ, Dept Agroecol, Aarhus, Denmark.	michael.kristensen@agrsci.dk	Kristensen, Michael/F-5536-2016; Jensen, Karl-Martin Vagn/E-9756-2016	Kristensen, Michael/0000-0001-7332-3490; Hojland, Dorte H./0000-0002-9758-5783	Danish Agency for Science Technology and Innovation	Danish Agency for Science Technology and Innovation	This work was funded by a mobility stipend to Dorte H Hojland from the Danish Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2001, GENETICS, V157, P667; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capurro MD, 2000, INSECT MOL BIOL, V9, P169, DOI 10.1046/j.1365-2583.2000.00173.x; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Gao Q, 2012, PESTIC BIOCHEM PHYS, V104, P252, DOI 10.1016/j.pestbp.2012.09.006; Geng Hua, 2004, Acta Genetica Sinica, V31, P1344; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Hojland DH, 2014, PEST MANAG SCI, V70, P1237, DOI 10.1002/ps.3681; KAY MA, 1987, TRENDS GENET, V3, P347, DOI 10.1016/0168-9525(87)90295-2; Keiding J, 1986, VECTOR CONTROL SERIE; Kristensen M, 2004, PEST MANAG SCI, V60, P894, DOI 10.1002/ps.883; Kristensen M, 2008, PEST MANAG SCI, V64, P126, DOI 10.1002/ps.1481; Kristensen M, 2006, PEST MANAG SCI, V62, P738, DOI 10.1002/ps.1231; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; LEE SST, 1989, PESTIC BIOCHEM PHYS, V35, P1, DOI 10.1016/0048-3575(89)90096-5; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; Sawicki R.M., 1987, COMBATING RESISTANCE, P105; Schaub L, 2002, PEST MANAG SCI, V58, P959, DOI 10.1002/ps.561; Scott H.G., 1962, FLIES PUBLIC HLTH IM; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; SHONO T, 1990, J ECON ENTOMOL, V83, P686, DOI 10.1093/jee/83.3.686; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; White NM, 1997, INSECT MOL BIOL, V6, P329, DOI 10.1046/j.1365-2583.1997.00187.x; Zhang ML, 1996, PESTIC BIOCHEM PHYS, V55, P150, DOI 10.1006/pest.1996.0044; Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	28	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85965	10.1371/journal.pone.0085965	http://dx.doi.org/10.1371/journal.pone.0085965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489682	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000026
J	Jujo, T; Sakao, S; Tsukahara, M; Kantake, S; Maruoka, M; Tanabe, N; Masuda, M; Tatsumi, K				Jujo, Takayuki; Sakao, Seiichiro; Tsukahara, Masanori; Kantake, Seiji; Maruoka, Miki; Tanabe, Nobuhiro; Masuda, Masahisa; Tatsumi, Koichiro			The Role of Matrix Metalloproteinase in the Intimal Sarcoma-Like Cells Derived from Endarterectomized Tissues from a Chronic Thromboembolic Pulmonary Hypertension Patient	PLOS ONE			English	Article							INHIBITOR BATIMASTAT; PROGENITOR CELLS; TUMOR-GROWTH; INVASION; MT1-MMP; METASTASIS; SPREAD; ARTERY; MODEL; BB-94	Sarcoma-like cells (SCLs) were derived from endarterectomized tissue of a single chronic thromboembolic pulmonary hypertension (CTEPH) patient during incubation of those thrombi at second passage as described at our previous report. These cells had malignant potential, with an increased expression of matrix metalloproteinase-14 (MMP-14), leading to tumor emboli within pulmonary arteries in in vivo studies. The purpose of this study was to perform a more detailed evaluation of the characteristics of SCLs, and to elucidate the role of the increased expression of MMP-14 expression in the growth and death of these cells. In order to elucidate the characteristics of SCLs and to confirm the protein expression of MMP-14, three-dimentional culture, invasion assays, a Western blot analysis and immunohistochemical studies were performed. To examine the role of MMP-14 in tumorigenesis, the metalloproteinase inhibitor, batimastat, was administered to SCID mice which were subcutaneously injected with SCLs. Those mice were sacrificed on day 14 and the tumor volume was evaluated. A Western blot analysis showed the increased expression of MMP-14 in comparison to the expression in lung adenocarcinoma cells (A549). Immunohistochemistry showed that SCLs were positive for vimentin, MMP-14, MMP-2 and CD44. However, endothelial markers, such as CD31 and von Willebrand factor (vWF), were negative. The in vivo studies demonstrated that batimastat could suppress the growth of the subcutaneous tumors formed by the SCLs. This study suggested that MMPs had critical roles on the pathological activities of SCLs and that batimastat might have anti-proliferative and anti-invasive effects on these cells.	[Jujo, Takayuki; Sakao, Seiichiro; Tsukahara, Masanori; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol B2, Inohana Chuo Ku, Chiba, Japan; [Kantake, Seiji] Kimitsu Chuo Hosp, Kisarazu City, Japan; [Maruoka, Miki] Natl Hosp Org, Chiba Med Ctr, Chuo Ku, Chiba, Japan; [Masuda, Masahisa] Natl Hosp Org, Chiba Med Ctr, Chuo Ku, Chiba, Japan	Chiba University	Jujo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol B2, Inohana Chuo Ku, Chiba, Japan.	naikamo_resp19184@yahoo.co.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Cardiovascular Research Fund; Research Grants for the Respiratory Failure Research Group; Ministry of Health, Labour and Welfare, Japan [24-57]; Takeda Science Foundation	Cardiovascular Research Fund; Research Grants for the Respiratory Failure Research Group; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	Takayuki Jujo was supported by The Cardiovascular Research Fund. Seiichiro Sakao was supported by Research Grants for the Respiratory Failure Research Group and the Cardiovascular Diseases (24-57) from the Ministry of Health, Labour and Welfare, Japan and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NH, 1973, JOHNS HOPKINS MED J, V133, P214; Bloomberg RD, 2003, CAN J CARDIOL, V19, P843; Botos I, 1996, P NATL ACAD SCI USA, V93, P2749, DOI 10.1073/pnas.93.7.2749; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; CHIRIVI RGS, 1994, INT J CANCER, V58, P460, DOI 10.1002/ijc.2910580326; DAVIES B, 1993, CANCER RES, V53, P2087; Doyle C, 2006, CA-CANCER J CLIN, V56, P323, DOI 10.3322/canjclin.56.6.323; Firth AL, 2010, AM J PHYSIOL-CELL PH, V298, pC1217, DOI 10.1152/ajpcell.00416.2009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jujo T, 2012, INT J ONCOL, V41, P701, DOI 10.3892/ijo.2012.1493; Kadono Y, 1998, BIOCHEM BIOPH RES CO, V251, P681, DOI 10.1006/bbrc.1998.9531; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; SLEDGE GW, 1995, J NATL CANCER I, V87, P1546, DOI 10.1093/jnci/87.20.1546; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Ueda J, 2003, ONCOGENE, V22, P8716, DOI 10.1038/sj.onc.1206962; Vasuri F, 2012, HISTOPATHOLOGY, V61, P737, DOI 10.1111/j.1365-2559.2012.04241.x; WANG X, 1994, CANCER RES, V54, P4726; WATSON SA, 1995, CANCER RES, V55, P3629; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yao WJ, 2009, AM J PHYSIOL-LUNG C, V296, pL870, DOI 10.1152/ajplung.90413.2008; Zervos EE, 1997, J SURG RES, V69, P367, DOI 10.1006/jsre.1997.5086	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87489	10.1371/journal.pone.0087489	http://dx.doi.org/10.1371/journal.pone.0087489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489925	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000138
J	Kwon, YD; LaLonde, JM; Yang, YP; Elban, MA; Sugawara, A; Courter, JR; Jones, DM; Smith, AB; Debnath, AK; Kwong, PD				Kwon, Young Do; LaLonde, Judith M.; Yang, Yongping; Elban, Mark A.; Sugawara, Akihiro; Courter, Joel R.; Jones, David M.; Smith, Amos B., III; Debnath, Asim K.; Kwong, Peter D.			Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; STRUCTURE-BASED DESIGN; CD4-MIMETIC MINIPROTEIN; ANTIVIRAL ACTIVITY; ENTRY INHIBITORS; X-RAY; RECEPTOR; CCR5; BINDING; MECHANISM	Efforts to develop therapeutic agents that inhibit HIV-1 entry have led to the identification of several small molecule leads. One of the most promising is the NBD series, which binds within a conserved gp120 cavity and possesses para-halogen substituted aromatic rings, a central oxalamide linker, and a tetramethylpiperidine moiety. In this study, we characterized structurally the interactions of four NBD analogues containing meta-fluoro substitution on the aromatic ring and various heterocyclic ring replacements of the tetramethylpiperidine group. The addition of a meta-fluorine to the aromatic ring improved surface complementarity and did not alter the position of the analogue relative to gp120. By contrast, heterocyclic ring replacements of the tetramethylpiperidine moiety exhibited diverse positioning and interactions with the vestibule of the gp120 cavity. Overall, the biological profile of NBD-congeners was modulated by ligand interactions with the gp120-cavity vestibule. Herein, six co-crystal structures of NBD-analogues with gp120 provide a structural framework for continued small molecule-entry inhibitor optimization.	[Kwon, Young Do; Yang, Yongping; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [LaLonde, Judith M.] Bryn Mawr Coll, Dept Chem, Bryn Mawr, PA 19010 USA; [Elban, Mark A.; Sugawara, Akihiro; Courter, Joel R.; Jones, David M.; Smith, Amos B., III] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Debnath, Asim K.] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Mol Modeling & Drug Design, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Bryn Mawr College; University of Pennsylvania; New York Blood Center	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Sugawara, Akihiro/G-6120-2017; Do Kwon, Young/A-6957-2010	Sugawara, Akihiro/0000-0003-1266-7497; Do Kwon, Young/0000-0002-1188-7458	Intramural AIDS Targeted Antiviral Program; Intramural Research Program of the National Institutes of Health (NIH); NIH [GM 56550]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this work was provided by the Intramural AIDS Targeted Antiviral Program, by the Intramural Research Program of the National Institutes of Health (NIH), and by NIH GM 56550 to JL and ABS. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2013, STRUCTURE, V21, P1018, DOI 10.1016/j.str.2013.04.015; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Billick E, 2004, J VIROL, V78, P4134, DOI 10.1128/JVI.78.8.4134-4144.2004; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Curreli F, 2012, J MED CHEM, V55, P4764, DOI 10.1021/jm3002247; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lalezari JP, 2003, AIDS, V17, P691, DOI 10.1097/00002030-200303280-00007; LaLonde JM, 2013, ACS MED CHEM LETT, V4, P338, DOI 10.1021/ml300407y; LaLonde JM, 2012, J MED CHEM, V55, P4382, DOI 10.1021/jm300265j; LaLonde JM, 2011, BIOORGAN MED CHEM, V19, P91, DOI 10.1016/j.bmc.2010.11.049; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Morellato-Castillo L, 2013, J MED CHEM, V56, P5033, DOI 10.1021/jm4002988; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Tuzer F, 2013, PROTEINS, V81, P271, DOI 10.1002/prot.24184; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yoshimura K, 2010, J VIROL, V84, P7558, DOI 10.1128/JVI.00227-10; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	39	37	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85940	10.1371/journal.pone.0085940	http://dx.doi.org/10.1371/journal.pone.0085940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489681	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000025
J	Olack, B; Feikin, DR; Cosmas, LO; Odero, KO; Okoth, GO; Montgomery, JM; Breiman, RF				Olack, Beatrice; Feikin, Daniel R.; Cosmas, Leonard O.; Odero, Kennedy O.; Okoth, George O.; Montgomery, Joel M.; Breiman, Robert F.			Mortality Trends Observed in Population-Based Surveillance of an Urban Slum Settlement, Kibera, Kenya, 2007-2010	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NAIROBI	Background: We used population based infectious disease surveillance to characterize mortality rates in residents of an urban slum in Kenya. Methods: We analyzed biweekly household visit data collected two weeks before death for 749 cases who died during January 1, 2007 to December 31, 2010. We also selected controls matched by age, gender and having a biweekly household visit within two weeks before death of the corresponding case and compared the symptoms reported. Results: The overall mortality rate was 6.3 per 1,000 person years of observation (PYO) (females: 5.7; males: 6.8). Infant mortality rate was 50.2 per 1000 PYOs, and it was 15.1 per 1,000 PYOs for children < 5 years old. Poisson regression indicates a significant decrease over time in overall mortality from (6.0 in 2007 to 4.0 in 2010 per 1000 PYOs; p < 0.05) in persons >= 5 years old. This decrease was predominant in females (7.8 to 5.7 per 1000 PYOs; p < 0.05). Two weeks before death, significantly higher prevalence for cough (OR = 4.7 [95% CI: 3.7-5.9]), fever (OR = 8.1 [95% CI: 6.1-10.7]), and diarrhea (OR = 9.1 [95% CI: 6.4-13.2]) were reported among participants who died (cases) when compared to participants who did not die (controls). Diarrhea followed by fever were independently associated with deaths (OR = 14.4 [95% CI: 7.1-29.2]), and (OR = 11.4 [95% CI: 6.7-19.4]) respectively. Conclusions: Despite accessible health care, mortality rates are high among people living in this urban slum; infectious disease syndromes appear to be linked to a substantial proportion of deaths. Rapid urbanization poses an increasing challenge in national efforts to improve health outcomes, including reducing childhood mortality rates. Targeting impoverished people in urban slums with effective interventions such as water and sanitation interventions are needed to achieve national objectives for health.	[Olack, Beatrice; Odero, Kennedy O.; Okoth, George O.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Olack, Beatrice; Odero, Kennedy O.; Okoth, George O.] Ctr Dis Control & Prevent Collaborat KEMRI CDC, Nairobi, Kenya; [Feikin, Daniel R.; Cosmas, Leonard O.; Montgomery, Joel M.; Breiman, Robert F.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya	Kenya Medical Research Institute	Olack, B (corresponding author), Kenya Govt Med Res Ctr, Nairobi, Kenya.	bolack@kemricdc.org			Centers for Disease Control and Prevention (CDC US)	Centers for Disease Control and Prevention (CDC US)	This work was supported by the Centers for Disease Control and Prevention (CDC US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand G., PLANNING CITIES AFRI; Anand K, 2007, NATL MED J INDIA, V20, P115; Anyamele Okechukwu D, 2009, J Health Care Poor Underserved, V20, P90, DOI 10.1353/hpu.0.0199; APHRC (African Population and Health Research Centre), 2002, POP HLTH DYN NAIR IN; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Fotso JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-218; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Kanungo S, 2010, B WORLD HEALTH ORGAN, V88, P667, DOI 10.2471/BLT.09.073742; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; *UN, 2002, WORLD URB PROSP 2001; UN-HABITAT, 2010, STRAT URB DEV PLAN H; UN-HABITAT, 2008, UN HABITAT KEN SLUM; UN-HABITAT, 2008, STAT WORLDS CIT 2010; UNICEF, 2012, STAT WORLDS CHILDR 2; WHO, 2005, EC HUM WELL BEING HL; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933	20	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85913	10.1371/journal.pone.0085913	http://dx.doi.org/10.1371/journal.pone.0085913			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489678	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000023
J	Gong, L; Wei, LX; Ren, P; Zhang, WD; Liu, XY; Han, XJ; Yao, L; Zhu, SJ; Lan, M; Li, YH; Zhang, W				Gong, Li; Wei, Long-Xiao; Ren, Pin; Zhang, Wen-Dong; Liu, Xiao-Yan; Han, Xiu-Juan; Yao, Li; Zhu, Shao-Jun; Lan, Miao; Li, Yan-Hong; Zhang, Wei			Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-CELL DYSPLASIA; DIAGNOSTIC-VALUE; CD34 IMMUNOHISTOCHEMISTRY; ONCOFETAL PROTEIN; LESIONS; MARKER; EXPRESSION; CIRRHOSIS; UTILITY; BENIGN	Glypican-3 (GPC3) has been reported to be a novel serum and histochemical marker for HCC. The positivity or negativity for GPC3 in hepatic precancerous lesions, such as dysplastic nodules (DN), has also been described. Moreover, our previous studies have demonstrated that some DN in liver cirrhosis represent monoclonal hyperplasia, and confirmed their neoplastic nature. However, additional studies must be performed to investigate further the relationship between DN with GPC3 positivity and HCC. Thus, we first investigated the expression of GPC3 in 136 HCC and 103 small DN (less than 1 cm in diameter) by immunohistochemical staining and determined the clonality of 81 DN from female patients using X-chromosome inactivation mosaicism and polymorphism of androgen receptor (AR) gene. Then we examined these samples for chromosomal loss of heterozygosity (LOH) at 11 microsatellite polymorphism sites. The results demonstrated that GPC3 immunoreactivity was detected in 103 of 136 HCC (75.7%) and 19 of 103 DN (18.4%), and the positive ratio correlated with HBsAg positivity. Clonality assays showed that 15 GPC3-positive DN from female patients, including 12 high-grade DN (HGDN), and 28 (42.4%) of 66 GPC3-negative DN, were monoclonal. In addition, among 19 GPC3-positive DN, chromosomal LOH was found at loci D6S1008 (100%, 19/19), D8S262 (52.6%, 10/19) and D11S1301 (57.9%, 11/19). However, the LOH frequency in GPC3-negative DN was 5.95% (5/84), 23.8% (20/84), and 4.76% (4/84) in three loci, respectively. Thus, we concluded that GPC3-positive DN, especially GPC3-positive HGDN, was really a late premalignant lesion of HCC.	[Gong, Li; Ren, Pin; Zhang, Wen-Dong; Liu, Xiao-Yan; Han, Xiu-Juan; Yao, Li; Zhu, Shao-Jun; Lan, Miao; Li, Yan-Hong; Zhang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Helmholtz Sino German Lab Canc Res, Xian 710032, Peoples R China; [Wei, Long-Xiao] Fourth Mil Med Univ, Tangdu Hosp, Dept Nucl Med, Xian 710032, Peoples R China; [Li, Yan-Hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Gynaecol & Obstet, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, YH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Pathol, Helmholtz Sino German Lab Canc Res, Xian 710032, Peoples R China.	lyhzhw@fmmu.edu.cn; zhwlyh@fmmu.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [30800417, 30672013, 81372226]; National Basic Research Program (973 Program) of China [2009CB521705]; Shaanxi Province [2011KTCL03-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Shaanxi Province	The study was supported by the National Natural Science Foundation of China (No. 30800417; 30672013; 81372226), the National Basic Research Program (973 Program) of China (No. 2009CB521705), and Shaanxi Province Innovation Project Co-ordinator (No. 2011KTCL03-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatelli F, 2008, AM J CLIN PATHOL, V130, P219, DOI 10.1309/WMB5PX57Y4P8QCTY; ANTHONY PP, 1973, J CLIN PATHOL, V26, P217, DOI 10.1136/jcp.26.3.217; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Coston WMP, 2008, AM J SURG PATHOL, V32, P433, DOI 10.1097/PAS.0b013e318158142f; Di Tommaso L, 2007, HEPATOLOGY, V45, P725, DOI 10.1002/hep.21531; Du Jing-li, 2011, Chinese Journal of Pathology, V40, P11, DOI 10.3760/cma.j.issn.0529-5807.2011.01.004; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Gong L, 2008, PATHOLOGY, V40, P392, DOI 10.1080/00313020801911496; Gong L, 2010, HISTOPATHOLOGY, V56, P589, DOI 10.1111/j.1365-2559.2010.03523.x; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Hippo Y, 2004, CANCER RES, V64, P2418, DOI 10.1158/0008-5472.CAN-03-2191; Hirohashi S, 2000, PATHOLOGY GENETICS T, P159; Kojiro M, 2006, PATHOLOGY HEPATOCELL, P105; Libbrecht L, 2006, AM J SURG PATHOL, V30, P1405, DOI 10.1097/01.pas.0000213323.97294.9a; Ligato S, 2008, MODERN PATHOL, V21, P626, DOI 10.1038/modpathol.2008.26; Liu H, 2010, WORLD J GASTROENTERO, V16, P4410, DOI 10.3748/wjg.v16.i35.4410; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Park YN, 2011, ARCH PATHOL LAB MED, V135, P704, DOI 10.1043/2010-0524-RA.1; Plentz RR, 2007, HEPATOLOGY, V45, P968, DOI 10.1002/hep.21552; Shafizadeh N, 2008, MODERN PATHOL, V21, P1011, DOI 10.1038/modpathol.2008.85; Su N, 2011, MOL BIOL REP, V15, P162; Tangkijvanich P, 2010, J GASTROEN HEPATOL, V25, P129, DOI 10.1111/j.1440-1746.2009.05988.x; Tatrai P, 2009, AM J SURG PATHOL, V33, P874, DOI 10.1097/PAS.0b013e318194b3ea; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; WATANABE S, 1983, CANCER, V51, P2197, DOI 10.1002/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5; Yamauchi N, 2005, MODERN PATHOL, V18, P1591, DOI 10.1038/modpathol.3800436; Yan B, 2011, ANN DIAGN PATHOL, V15, P162, DOI 10.1016/j.anndiagpath.2010.10.004; Yao M, 2011, HEPATOB PANCREAT DIS, V10, P289, DOI 10.1016/S1499-3872(11)60048-9; Zhang LJ, 2012, ACTA HISTOCHEM, V114, P547, DOI 10.1016/j.acthis.2011.10.003	30	8	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87120	10.1371/journal.pone.0087120	http://dx.doi.org/10.1371/journal.pone.0087120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498024	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900067
J	Amin, L; Azad, MAK; Gausmian, MH; Zulkifli, F				Amin, Latifah; Azad, Md Abul Kalam; Gausmian, Mohd Hanafy; Zulkifli, Faizah			Determinants of Public Attitudes to Genetically Modified Salmon	PLOS ONE			English	Article							MODIFIED FOODS; ETHICAL PERCEPTION; FIT INDEXES; RISK PERCEPTION; BIOTECHNOLOGY; CONSUMER; ACCEPTANCE; KNOWLEDGE; SCIENCE; ISSUES	The objective of this paper is to assess the attitude of Malaysian stakeholders to genetically modified (GM) salmon and to identify the factors that influence their acceptance of GM salmon using a structural equation model. A survey was carried out on 434 representatives from various stakeholder groups in the Klang Valley region of Malaysia. Public attitude towards GM salmon was measured using self-developed questionnaires with seven-point Likert scales. The findings of this study have confirmed that public attitudes towards GM salmon is a complex issue and should be seen as a multi-faceted process. The most important direct predictors for the encouragement of GM salmon are the specific application-linked perceptions about religious acceptability of GM salmon followed by perceived risks and benefits, familiarity, and general promise of modern biotechnology. Encouragement of GM salmon also involves the interplay among other factors such as general concerns of biotechnology, threatening the natural order of things, the need for labeling, the need for patenting, confidence in regulation, and societal values. The research findings can serve as a database that will be useful for understanding the social construct of public attitude towards GM foods in a developing country.	[Amin, Latifah; Azad, Md Abul Kalam; Zulkifli, Faizah] Univ Kebangsaan Malaysia, Ctr Gen Studies, Bangi 43600, Selangor, Malaysia; [Azad, Md Abul Kalam] Khamarbari, Dept Agr Extens, Dhaka, Bangladesh; [Gausmian, Mohd Hanafy] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Amin, L (corresponding author), Univ Kebangsaan Malaysia, Ctr Gen Studies, Bangi 43600, Selangor, Malaysia.	nilam@ukm.my	abdullah, mohammed azad/ABB-7670-2020	abdullah, mohammed azad/0000-0002-7488-4019	Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia [11JC/010/2006]; Universiti Kebangsaan Malaysia [UKM-AP-CMNB-21-2009/1]	Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia; Universiti Kebangsaan Malaysia	The authors would like to thank the Food Safety and Quality Division, Department of Public Health, Ministry of Health, Malaysia, for supporting this research under the 11JC/010/2006 grant. Additional thanks to the Universiti Kebangsaan Malaysia for the UKM-AP-CMNB-21-2009/1 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerni P, 2004, AQUAT SCI, V66, P327, DOI 10.1007/s00027-004-0715-8; Aerni P, 1999, THESIS SWISS FEDERAL; Aiken L. R., 1994, PSYCHOL TESTING ASSE; Amin L., 2007, J PENGAJIAN UMUM, V8, P195; Amin L, 2012, SOCIAL SCI, V7, P502, DOI DOI 10.3923/SSCIENCE.2012.502.509; Amin L, 2006, J PENGAJIAN UMUM, V7, P87; Amin L, 2011, INT J SCI SOC, V2, P1; Amin L, 2011, AFR J BIOTECHNOL, V10, P12469; Amin L, 2011, AFR J BIOTECHNOL, V10, P12457; Amin L, 2011, AFR J BIOTECHNOL, V10, P12435; Amin L, 2011, PUBLIC UNDERST SCI, V20, P674, DOI 10.1177/0963662510369622; Arbuckle JL, 1999, AMOS 4 0 YSERS GUIDE; BABAS, 1999, ETH ASP AGR BIOT; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; Batiste JM, 2000, MODELOS ECUACIONES E; Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202; Bauer MW, 2002, PUBLIC UNDERST SCI, V11, P93, DOI 10.1088/0963-6625/11/2/301; Bentler P. M., 2002, EQS 6 STRUCTURAL EQU; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bertolini P, 2003, 7 ICABR INT COS AGR; Blume Y, 2008, BIOTECHNOL BIOTEC EQ, V22, P641, DOI 10.1080/13102818.2008.10817527; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Borcherding K, 1986, NEW DIRECTIONS RES D, P245; Bredahl L, 1999, APPETITE, V33, P343, DOI 10.1006/appe.1999.0267; Bredahl L., 2001, J CONSUMER POLICY, V24, P23, DOI [10.1023/A:1010950406128, DOI 10.1023/A:1010950406128]; BREDAHL L, 1998, CONSUMER POLICY, V21, P251; Bucchi M, 2004, SCIENCE, V304, P1749, DOI 10.1126/science.1095861; Bucchi M, 2002, NATURE, V416, P261, DOI 10.1038/416261a; Bukraba-Rylska I, 2003, GENTICALLY MODIFIED; Byrne B. M., 2001, STRUCTURAL EQUATION; Chen MF, 2007, FOOD QUAL PREFER, V18, P662, DOI 10.1016/j.foodqual.2006.10.002; Chern Wen S., 2002, AgBioForum, V5, P105; Comstock G, 2000, ETHICS GENETICALLY M; Connor M, 2010, SCI COMMUN, V32, P514, DOI 10.1177/1075547009358919; Costa-Font J, 2007, FOOD QUAL PREFER, V18, P173, DOI 10.1016/j.foodqual.2005.09.013; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Cowx IG., 2010, EFSA, V7, p69E, DOI [10.2903/sp.efsa.2010.EN-69, DOI 10.2903/SP.EFSA.2010.EN-69]; Demirci A, 2008, AFR J BIOTECHNOL, V7, P4321; Earle T.C., 1995, SOCIAL TRUST COSMOPO; Einsiedel EF, 2000, NAT BIOTECHNOL, V18, P943, DOI 10.1038/79419; Fischhoff B., 2004, PERCEPTION RISK RISK; FISHBEIN M, 1963, HUM RELAT, V16, P233, DOI 10.1177/001872676301600302; Fletcher G L, 1991, Genet Eng (N Y), V13, P331; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Frewer LJ, 1996, FOOD QUAL PREFER, V7, P61, DOI 10.1016/0950-3293(95)00017-8; Frewer LJ, 1998, PESTIC SCI, V52, P388, DOI 10.1002/(SICI)1096-9063(199804)52:4&lt;388::AID-PS740&gt;3.0.CO;2-F; Frewer LJ, 1997, SCI TECHNOL HUM VAL, V22, P98, DOI 10.1177/016224399702200105; Frewer LJ., 1994, BRIT FOOD J, V96, P26, DOI [10.1108/00070709410072562, DOI 10.1108/00070709410072562]; Fritz S., 2003, AgBioForum, V6, P178; Furedi F., 1997, CULTURE FEAR RISK TA; Ganiere P, 2006, J AGR RESOUR ECON, V31, P129; Gaskell G, 2000, NAT BIOTECHNOL, V18, P935, DOI 10.1038/79403; Gaskell G, 2004, RISK ANAL, V24, P185, DOI 10.1111/j.0272-4332.2004.00421.x; Gaskell G, 2003, EUROPEANS BIOTECHNOL; Gath M, 1998, POTENTIAL EFFECTS LA; Ghasemi S, 2013, SCI ENG ETHICS, V19, P1201, DOI 10.1007/s11948-012-9383-6; Glenn LM, 2004, ETHICAL ISSUES GENET; Goos H, 2001, P INT C PERSP COMP E; Gott M, 2004, ATLA-ALTERN LAB ANIM, V32, P391, DOI 10.1177/026119290403201s64; Grimsrud KM, 2002, AM AGR EC ASS ANN M; Grunert K. G., 2003, Innovative Food Science & Emerging Technologies, V4, P435, DOI 10.1016/S1466-8564(03)00035-3; Grunert K.G., 2000, 72 MAPP; Grunert K.G., 2004, INT C RES ADVERTISIN; Grunert KG, 2001, FOOD QUAL PREFER, V12, P527, DOI 10.1016/S0950-3293(01)00049-0; Gursoy D, 2004, ANN TOURISM RES, V31, P495, DOI 10.1016/j.annals.2003.08.008; Gutteling J, 2006, PUBLIC UNDERST SCI, V15, P103, DOI 10.1177/0963662506057479; Hair J.F., 2010, MULTIVARIATE DATA AN, P1; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Hair J.F., 1998, MULTIVARIATE DATA AN, V5, P207; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Haro MN, 2012, FNI REPORT, P1; HARRIS MM, 1990, J MANAGE, V16, P337, DOI 10.1177/014920639001600206; Henseler J, 2012, J ACAD MARKET SCI, V40, P402, DOI 10.1007/s11747-011-0298-6; Herren RV, 2005, INTRO BIOTECHNOLOGY; Hew CL, 1997, CHEM IND-LONDON, P311; Hossain F., 2004, INT J CONSUM STUD, V28, P255, DOI [DOI 10.1111/j.1470-6431.2004.00352.x, 10.1111/ijc.2004.28.issue-310.1111/j.1470-6431.2004.00352.x, DOI 10.1111/IJC.2004.28.ISSUE-310.1111/J.1470-6431.2004.00352.X]; House L., 2004, AgBioForum, V7, P113; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog K.G., 1996, LISREL 8 USERS REFER; Joreskog KG., 1986, LISREL 6 ANAL LINEAR; Kaiser M, 2005, REV SCI TECH OIE, V24, P75, DOI 10.20506/rst.24.1.1552; Kamaldeen S, 2000, 17 U GUELPH DEP PLAN; Kelley J, 1995, PUBLIC PERCEPTIONS G; Kiesel K, 2005, AM J AGR ECON, V87, P378, DOI 10.1111/j.1467-8276.2005.00729.x; Kirk SFL, 2002, APPETITE, V38, P189, DOI 10.1006/appe.2001.0478; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Koch K, 1998, C Q RES, V9, P761; Kuznesof S., 1996, British Food Journal, V98, P39, DOI 10.1108/00070709610119874; Lake Research Partners, 2010, ATT FDAS PLAN GEN EN; Leisinger KM, 2007, ANN REV SYNGENTA FDN; Levy J. P, 2003, ANALISIS MULTIVARIAB; Luque T, 2000, TECNICAS ANALISIS DA; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Macer D. R. J., 2000, International Journal of Biotechnology, V2, P313, DOI 10.1504/IJBT.2000.000142; MACER DRJ, 2000, INT J BIOTECHNOLOGY, V3, P116; Margulis C, 2006, ENVIRON HEALTH PERSP, V114, pA146, DOI 10.1289/ehp.114-a146; Marlier E., 1992, Biotechnology in public: a review of recent research., P52; Marlier E, 1993, EUROBAROMETER 39 1 B; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; McLeod C, 2006, SUPER SALMON IND FIS, P17; Menozzi D., 2012, AgBioForum, V15, P276; Ministry of Health Malaysia, 2006, GUID ETH REV CLIN RE; Monroe Jr JC, 1993, STAT PROBLEM SOLVING; Mora C., 2008, FOOD EC ACTA AGR S C, V5, P92, DOI [10.1080/16507540903034907, DOI 10.1080/16507540903034907]; Navin Srivastava, 2011, Biotechnology, V10, P136; Nep S, 2013, SOC NATUR RESOUR, V26, P506, DOI 10.1080/08941920.2012.716904; Nicholas B, 2000, ETHICAL ISSUES GENET; Olesen I, 2011, J AGR ENVIRON ETHIC, V24, P381, DOI 10.1007/s10806-010-9269-z; Pardo R, 2002, J BIOTECHNOL, V98, P9, DOI 10.1016/S0168-1656(02)00082-2; Persley GJ, 1999, APPL BIOTECHNOLOGY C; Pollara Research and Earnscliffe Research and Communications, 2000, PUBL OP RES BIOT ISS; Potrykus I, 2001, PLANT PHYSIOL, V125, P1157, DOI 10.1104/pp.125.3.1157; Priest SH, 2000, NAT BIOTECHNOL, V18, P939, DOI 10.1038/79412; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Qin W, 2006, SCI COMMUN, V28, P243, DOI 10.1177/1075547006294770; Ringle CM, 2012, MIS QUART, V36, pIII; Rogers W.L., 1976, QUALITY AM LIFE PERC; ROHRMANN B, 1994, AUST J PSYCHOL, V46, P150, DOI 10.1080/00049539408259490; Rohrmann B, 1999, RISK PERCEPTION RES; Rowe G, 2004, TRENDS BIOTECHNOL, V22, P107, DOI 10.1016/j.tibtech.2004.01.007; Sandman PeterM., 1987, EPA J, P21, DOI DOI 10.1177/0893318988002002006; Seralini GE, 2007, ARCH ENVIRON CON TOX, V52, P596, DOI 10.1007/s00244-006-0149-5; Sheehy H., 1998, J CONSUMER POLICY, V21, P359; Shrader-Frechette K, 2005, SCI ENG ETHICS, V11, P137, DOI 10.1007/s11948-005-0065-5; Siegrist M, 2000, RISK ANAL, V20, P195, DOI 10.1111/0272-4332.202020; Siegrist M, 1999, J APPL SOC PSYCHOL, V29, P2093, DOI 10.1111/j.1559-1816.1999.tb02297.x; Singh OV, 2006, APPL MICROBIOL BIOT, V71, P598, DOI 10.1007/s00253-006-0449-8; Singh R., 2009, MARKETING REV, V9, P199, DOI [DOI 10.1362/146934709X467767, 10.1362/146934709X467767]; Sjoberg L, 2004, EMBO REP, V5, pS47, DOI 10.1038/sj.embor.7400258; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Smith MD, 2010, SCIENCE, V330, P1052, DOI 10.1126/science.1197769; SPARKS P, 1994, RISK ANAL, V14, P799, DOI 10.1111/j.1539-6924.1994.tb00291.x; Straughan R, 2000, CURR OPIN PLANT BIOL, V3, P163, DOI 10.1016/S1369-5266(99)00056-4; Szczurowska T, 2005, POLES BIOTECHNOLOGY; Taylor SL, 2001, ALLERGY, V56, P64, DOI 10.1034/j.1398-9995.2001.00920.x; The Canadian Trade Commissioner Service, 2006, WELC KIT MAL; Traill W. B., 2006, Acta Agricultura Scandinavica. Section C, Food Economics, V3, P12, DOI 10.1080/16507540600733900; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Uzogara SG, 2000, BIOTECHNOL ADV, V18, P179, DOI 10.1016/S0734-9750(00)00033-1; Verdurme A., 2003, QUAL MARK RES INT J, V6, P95, DOI [10.1108/13522750310470109, DOI 10.1108/13522750310470109]; Wansink B, 2001, AM BEHAV SCI, V44, P1405, DOI 10.1177/00027640121956755; Weil V, 2002, SCI ENG ETHICS, V8, P223, DOI 10.1007/s11948-002-0023-4; Wynne B, 2006, COMMUNITY GENET, V9, P211, DOI 10.1159/000092659	144	32	32	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86174	10.1371/journal.pone.0086174	http://dx.doi.org/10.1371/journal.pone.0086174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489695	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000025
J	Cortes, LK; Scarcelli, JJ; Taron, CH				Cortes, Leslie K.; Scarcelli, John J.; Taron, Christopher H.			Complementation of Essential Yeast GPI Mannosyltransferase Mutations Suggests a Novel Specificity for Certain Trypanosoma and Plasmodium PigB Proteins	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; 4TH MANNOSE; BIOSYNTHESIS; CRUZI; GENES; IDENTIFICATION; GLYCOPROTEIN	The glycosylphosphatidylinositol (GPI) anchor is an essential glycolipid that tethers certain eukaryotic proteins to the cell surface. The core structure of the GPI anchor is remarkably well conserved across evolution and consists of NH2-CH2-CH2-PO4- 6Man alpha 1,2Man alpha 1,6Man alpha 1,4-GlcN alpha 1,6-myo-inositol-PO4-lipid. The glycan portion of this structure may be modified with various side-branching sugars or other compounds that are heterogeneous and differ from organism to organism. One such modification is an alpha(1,2)-linked fourth mannose (Man-IV) that is side-branched to the third mannose (Man-III) of the trimannosyl core. In fungi and mammals, addition of Man-III and Man-IV occurs by two distinct Family 22 alpha(1,2)-mannosyltransferases, Gpi10/PigB and Smp3/PigZ, respectively. However, in the five protozoan parasite genomes we examined, no genes encoding Smp3/PigZ proteins were observed, despite reports of tetramannosyl-GPI structures (Man(4)-GPIs) being produced by some parasites. In this study, we tested the hypothesis that the Gpi10/PigB proteins produced by protozoan parasites have the ability to add both Man-III and Man-IV to GPI precursors. We used yeast genetics to test the in vivo specificity of Gpi10/PigB proteins from several Plasmodium and Trypanosoma species by examining their ability to restore viability to Saccharomyces cerevisiae strains harboring lethal defects in Man-III (gpi10 Delta) or Man-IV (smp3 Delta) addition to GPI precursor lipids. We demonstrate that genes encoding PigB enzymes from T. cruzi, T. congolense and P. falciparum are each capable of separately complementing essential gpi10 Delta and smp3 Delta mutations, while PIGB genes from T. vivax and T. brucei only complement gpi10 Delta. Additionally, we show the ability of T. cruzi PIGB to robustly complement a gpi10 Delta/ smp3 Delta double mutant. Our data suggest that certain Plasmodium and Trypanosoma PigB mannosyltransferases can transfer more than one mannose to GPI precursors in vivo, and suggest a novel biosynthetic mechanism by which Man(4)-GPIs may be synthesized in these organisms.	[Cortes, Leslie K.; Scarcelli, John J.; Taron, Christopher H.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Taron, CH (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	taron@neb.com		Taron, Christopher/0000-0001-8149-4556	New England Biolabs, Inc	New England Biolabs, Inc	This research was privately funded by New England Biolabs, Inc. The funders had no role in experimental design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boutlis CS, 2005, CURR TOP MICROBIOL, V297, P145; BREWIS IA, 1995, J BIOL CHEM, V270, P22946, DOI 10.1074/jbc.270.39.22946; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cardoso MS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002369; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; Delorenzi M, 2002, INFECT IMMUN, V70, P4510, DOI 10.1128/IAI.70.8.4510-4522.2002; Rodriguez AE, 2010, VET PARASITOL, V167, P227, DOI 10.1016/j.vetpar.2009.09.024; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grimme SJ, 2001, J BIOL CHEM, V276, P27731, DOI 10.1074/jbc.M101986200; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Rudd PM, 1997, J BIOL CHEM, V272, P7229, DOI 10.1074/jbc.272.11.7229; SERRANO AA, 1995, J BIOL CHEM, V270, P27244, DOI 10.1074/jbc.270.45.27244; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sutterlin C, 1998, BIOCHEM J, V332, P153; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87673	10.1371/journal.pone.0087673	http://dx.doi.org/10.1371/journal.pone.0087673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489949	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000169
J	Han, K; Park, YM; Kwon, HS; Ko, SH; Lee, SH; Yim, HW; Lee, WC; Park, YG; Kim, MK; Park, YM				Han, Kyungdo; Park, Yu-Mi; Kwon, Hyuk-Sang; Ko, Seung-Hyun; Lee, Seung-Hwan; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong Gyu; Kim, Mee Kyoung; Park, Yong-Moon			Sarcopenia as a Determinant of Blood Pressure in Older Koreans: Findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; METABOLIC SYNDROME; ASSOCIATION; OBESITY; HYPERTENSION; PREVALENCE	Background: Blood pressure (BP) is directly and causally associated with body size in the general population. Whether muscle mass is an important factor that determines BP remains unclear. Objective: To investigate whether sarcopenia is associated with hypertension in older Koreans. Participants: We surveyed 2,099 males and 2,747 females aged 60 years or older. Measurements: Sarcopenia was defined as an appendicular skeletal muscle mass divided by body weight (ASM/Wt) that was <1 SD below the gender-specific mean for young adults. Obesity was defined as a body mass index (BMI) >= 25 kg/m(2). Subjects were divided into four groups based on presence or absence of obesity or sarcopenia. Hypertension was defined as a systolic BP (SBP) >= 140 mmHg, a diastolic BP (DBP) >= 90 mmHg, or a self-reported current use of antihypertensive medications. Results: The overall prevalence of hypertension in the four groups was as follows 49.7% for non-obese non-sarcopenia, 60.9% for non-obese sarcopenia, 66.2% for obese non-sarcopenia and 74.7% for obese sarcopenia. After adjustment for age, gender, regular activity, current smoking and alcohol use, the odds ratio (OR) for having hypertension was 1.5 (95% confidence interval (CI) = 1.23-1.84) in subjects in the non-obese sarcopenia group, 2.08 (95% CI = 1.68-2.57) in the obese non-sarcopenia group and 3.0 (95% CI = 2.48-3.63) in the obese sarcopenia group, compared with the non-obese non-sarcopenia group (p for trend <0.001). Controlling further for body weight and waist circumference did not change the association between hypertension and sarcopenia. The association between sarcopenia and hypertension was more robust in the subjects with diabetes mellitus. Conclusion: Body composition beyond BMI has a considerable impact on hypertension in elderly Koreans. Subjects with sarcopenic obesity appear to have a greater risk of hypertension than simply obese or sarcopenia subjects.	[Han, Kyungdo; Yim, Hyeon Woo; Lee, Won-Chul; Park, Yong-Moon] Catholic Univ Korea, Dept Prevent Med, Seoul, South Korea; [Han, Kyungdo; Park, Yong Gyu] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Park, Yu-Mi] Catholic Univ Korea, Sch Med, Seoul, South Korea; [Kwon, Hyuk-Sang; Ko, Seung-Hyun; Lee, Seung-Hwan; Kim, Mee Kyoung] Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kim, MK (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	makung@catholic.ac.kr; markYMpark@gmail.com	Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019; PARK, YONG-MOON ("MARK")/ABA-2765-2021	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Park, Yong Gyu/0000-0002-8721-3230				Adams V, 1999, J AM COLL CARDIOL, V33, P959, DOI 10.1016/S0735-1097(98)00626-3; Anker SD, 1997, CIRCULATION, V96, P526; Burton LA, 2011, CLIN ENDOCRINOL, V75, P725, DOI 10.1111/j.1365-2265.2011.04148.x; Cappuccio FP, 2008, EPIDEMIOLOGY, V19, P38, DOI 10.1097/EDE.0b013e31815c4d2c; Chin SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060119; Choi KM, 2003, DIABETIC MED, V20, P99, DOI 10.1046/j.1464-5491.2003.00890.x; Choi KM, 2013, ENDOCRINOL METAB, V28, P86, DOI 10.3803/EnM.2013.28.2.86; Choi YJ, 2011, DIABETES METAB J, V35, P587, DOI 10.4093/dmj.2011.35.6.587; Chokshi NP, 2013, HEART, V99, P577, DOI 10.1136/heartjnl-2012-302029; Dogan MH, 2012, ACTA CLIN BELG, V67, P328, DOI 10.2143/ACB.67.5.2062685; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Kim HA, 2013, DIABETES RES CLIN PR, V99, P54, DOI 10.1016/j.diabres.2012.10.011; Kim MK, 2010, CLIN ENDOCRINOL, V73, P330, DOI 10.1111/j.1365-2265.2010.03798.x; Ko SH, 2012, DIABETES RES CLIN PR, V97, P151, DOI 10.1016/j.diabres.2012.04.004; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Luke A, 2004, HYPERTENSION, V43, P555, DOI 10.1161/01.HYP.0000118020.44335.20; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Preedy VR, 2001, EUR J NEUROL, V8, P677, DOI 10.1046/j.1468-1331.2001.00303.x; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Snijder MB, 2004, J HYPERTENS, V22, P2339, DOI 10.1097/00004872-200412000-00016; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stellman Steven D., 1996, Yonsei Medical Journal, V37, P31; Walsh K, 2009, CIRC J, V73, P13, DOI 10.1253/circj.CJ-08-0961	27	72	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86902	10.1371/journal.pone.0086902	http://dx.doi.org/10.1371/journal.pone.0086902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489804	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000079
J	Lee, M; Narayanan, S; McGeer, EG; McGeer, PL				Lee, Moonhee; Narayanan, Sujaatha; McGeer, Edith G.; McGeer, Patrick L.			Aurin Tricarboxylic Acid Protects against Red Blood Cell Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinemia	PLOS ONE			English	Article							C9 DEFICIENCY; COMPLEMENT; MUTATION; DISEASE	Objectives: Paroxysmal nocturnal hemoglobinemia (PNH) is a rare but serious condition characterized by complement-mediated red blood cell (RBC) hemolysis and episodic thrombotic attack. It results from decay accelerating factor (CD55), and protectin (CD59), becoming attached to RBC and other cell surfaces. Absence of these protective proteins leaves such cells vulnerable to self attack at the C3 convertase and membrane attack complex (MAC) stages of complement activation. We have previously reported that aurin tricarboxylic acid (ATA) is an orally effective agent that selectively blocks complement activation at the C3 convertase stage as well as MAC formation at the C9 insertion stage. Design and Methods: We used a CH50 assay method and western blot analysis to investigate the vulnerability to complement attack of PNH RBCs compared with normal RBCs. Zymosan was used as the activator of normal serum and PNH serum. ATA was added to the sera to determine the concentration necessary to protect the RBCs from lysis by the zymosan-activated sera. Results: We found that erythrocytes from PNH patients on long term treatment with eculizumab were twice as vulnerable as normal erythrocytes to lysis induced by complement activated serum. Western blot data showed the presence of both C3 and C5 convertases on the PNH patient erythrocyte membranes. These data indicate persistent vulnerability of PNH erythrocytes to complement attack due to deficiencies in CD55 and CD59. ATA, when added to serum in vitro, protected PNH erythrocytes from complement attack, restoring their resistance to that of normal erythrocytes. Conclusions: We conclude that ATA, by protecting PNH erythrocytes from their decay accelerating factor (CD55) and protectin (CD59) deficiencies, may be an effective oral treatment in this disorder.	[Lee, Moonhee; McGeer, Edith G.; McGeer, Patrick L.] Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V5Z 1M9, Canada; [Narayanan, Sujaatha] BC Canc Agcy, Vancouver Gen Hosp, Div Hematol, Leukemia BMT Program BC, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency; University of British Columbia	McGeer, PL (corresponding author), Univ British Columbia, Kinsmen Lab Neurol Res, Vancouver, BC V5Z 1M9, Canada.	mcgeerpl@mail.ubc.ca			University of British Columbia	University of British Columbia	This work was supported by the University of British Columbia, with the resources directed to be utilized for medical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG C, 1992, J BIOL CHEM, V267, P25347; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Hill A, 2010, HAEMATOL-HEMATOL J, V95, P567, DOI 10.3324/haematol.2009.007229; HOLGUIN MH, 1989, J CLIN INVEST, V84, P1387, DOI 10.1172/JCI114311; Horiuchi T, 1998, J IMMUNOL, V160, P1509; Kang HJ, 2005, ANN CLIN LAB SCI, V35, P144; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Kira R, 1999, J HUM GENET, V44, P109, DOI 10.1007/s100380050119; Lee M, 2012, NEUROBIOL AGING, V34, P1451; Lee M, 2012, NEUROBIOL AGING, V33, P2237, DOI 10.1016/j.neurobiolaging.2011.12.005; Luzzatto L, 2006, CURR OPIN GENET DEV, V16, P317, DOI 10.1016/j.gde.2006.04.015; MATIS LA, 1995, NAT MED, V1, P839, DOI 10.1038/nm0895-839; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Moyo VM, 2004, BRIT J HAEMATOL, V126, P133, DOI 10.1111/j.1365-2141.2004.04992.x; NICHOLSONWELLER A, 1992, CURR TOP MICROBIOL, V178, P7; Parker CJ, 2012, CURR OPIN HEMATOL, V19, P141, DOI 10.1097/MOH.0b013e328351c348; Parker CJ, 2002, BRIT J HAEMATOL, V117, P3; Risitano AM, 2009, BLOOD, V113, P4094, DOI 10.1182/blood-2008-11-189944; TAKAHASHI M, 1993, J EXP MED, V177, P517, DOI 10.1084/jem.177.2.517	19	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87316	10.1371/journal.pone.0087316	http://dx.doi.org/10.1371/journal.pone.0087316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489894	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000131
J	Magliocca, NR; Brown, DG; Ellis, EC				Magliocca, Nicholas R.; Brown, Daniel G.; Ellis, Erle C.			Cross-Site Comparison of Land-Use Decision-Making and Its Consequences across Land Systems with a Generalized Agent-Based Model	PLOS ONE			English	Article							COVER CHANGE; COUPLED HUMAN; DYNAMICS; CHALLENGES; EMERGENCE; SCIENCE	Local changes in land use result from the decisions and actions of land-users within land systems, which are structured by local and global environmental, economic, political, and cultural contexts. Such cross-scale causation presents a major challenge for developing a general understanding of how local decision-making shapes land-use changes at the global scale. This paper implements a generalized agent-based model (ABM) as a virtual laboratory to explore how global and local processes influence the land-use and livelihood decisions of local land-users, operationalized as settlement-level agents, across the landscapes of six real-world test sites. Test sites were chosen in USA, Laos, and China to capture globally-significant variation in population density, market influence, and environmental conditions, with land systems ranging from swidden to commercial agriculture. Publicly available global data were integrated into the ABM to model cross-scale effects of economic globalization on local land-use decisions. A suite of statistics was developed to assess the accuracy of model-predicted land-use outcomes relative to observed and random (i.e. null model) landscapes. At four of six sites, where environmental and demographic forces were important constraints on land-use choices, modeled land-use outcomes were more similar to those observed across sites than the null model. At the two sites in which market forces significantly influenced land-use and livelihood decisions, the model was a poorer predictor of land-use outcomes than the null model. Model successes and failures in simulating real-world land-use patterns enabled the testing of hypotheses on land-use decision-making and yielded insights on the importance of missing mechanisms. The virtual laboratory approach provides a practical framework for systematic improvement of both theory and predictive skill in land change science based on a continual process of experimentation and model enhancement.	[Magliocca, Nicholas R.; Ellis, Erle C.] Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21228 USA; [Brown, Daniel G.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI USA; [Magliocca, Nicholas R.] Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD USA	University System of Maryland; University of Maryland Baltimore County; University of Michigan System; University of Michigan	Magliocca, NR (corresponding author), Univ Maryland Baltimore Cty, Dept Geog & Environm Syst, Baltimore, MD 21228 USA.	nmag1@umbc.edu	Ellis, Erle C./B-8264-2008; Brown, Dan/L-8089-2013	Ellis, Erle C./0000-0002-2006-3362; Magliocca, Nicholas/0000-0002-0971-0207; Brown, Dan/0000-0001-6023-5950	US National Science Foundation (NSF) under NSF Grant [0549469]; East Asia and Pacific Summer Institute (NSF Grant) [1208953]; GLOBE Project (NSF Grant) [1125210]; Direct For Computer & Info Scie & Enginr [1125210] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	US National Science Foundation (NSF) under NSF Grant(National Science Foundation (NSF)); East Asia and Pacific Summer Institute (NSF Grant); GLOBE Project (NSF Grant); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NRM was supported by the US National Science Foundation (NSF) under NSF Grant #0549469 as an IGERT trainee and through the East Asia and Pacific Summer Institute 2012 (NSF Grant #1208953), and both NRM and ECE were supported through the GLOBE Project (NSF Grant #1125210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADGER W, 2009, ENVIRON SCI POLICY, V12, P398; An L, 2012, ECOL MODEL, V229, P25, DOI 10.1016/j.ecolmodel.2011.07.010; [Anonymous], 2005, CONDITIONS AGR GROWT; Buck JL, 1937, LAND UTILITZATION CH; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Ellis EC, 2009, ECOSYSTEMS, V12, P279, DOI 10.1007/s10021-008-9222-4; Ellis F., 1993, PEASANT EC FARM HOUS; Geist H.J., 2001, LUCC REPORT SERIES, V4; Global Agro-Ecological Zones (GAEZ), 2011, TERR CONSTR; Global Agro-Ecological Zones (GAEZ), 2011, AGR CONSTR; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Heinimann A, 2007, MT RES DEV, V27, P232, DOI 10.1659/mrd.0875; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Latombe G, 2011, ECOL MODEL, V222, P1557, DOI 10.1016/j.ecolmodel.2011.02.020; Le QB, 2008, ECOL INFORM, V3, P135, DOI 10.1016/j.ecoinf.2008.04.003; Liverman DM, 2008, EARTH SURF PROC LAND, V33, P1458, DOI 10.1002/esp.1715; Magliocca NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073241; Magliocca NR, 2013, T GIS, V17, P883, DOI 10.1111/tgis.12012; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Multi-Resolution Land Characteristics (MRLC) Consortium, 2001, 2011 NAT LAND COV DA; Netting R. M., 1993, SMALLHOLDERS HOUSEHO, DOI DOI 10.1111/j.1558-5646.2009.00817.x; Parker DC, 2008, J LAND USE SCI, V3, P41, DOI 10.1080/17474230802048151; Railsback SF, 2001, ECOL MODEL, V139, P47, DOI 10.1016/S0304-3800(01)00228-9; Rindfuss RR, 2007, ANN ASSOC AM GEOGR, V97, P739, DOI 10.1111/j.1467-8306.2007.00580.x; Rindfuss RR, 2008, J LAND USE SCI, V3, P1, DOI 10.1080/17474230802047955; Rindfuss RR, 2004, P NATL ACAD SCI USA, V101, P13976, DOI 10.1073/pnas.0401545101; Rounsevell MDA, EARTH SYS D IN PRESS; Rudel TK, 2008, GLOBAL ENVIRON CHANG, V18, P18, DOI 10.1016/j.gloenvcha.2007.06.001; Rudel TK, 2007, LAND USE POLICY, V24, P35, DOI 10.1016/j.landusepol.2005.11.004; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Turner BL, 2007, P NATL ACAD SCI USA, V104, P20666, DOI 10.1073/pnas.0704119104; TURNER BL, 1977, ANN ASSOC AM GEOGR, V67, P384, DOI 10.1111/j.1467-8306.1977.tb01149.x; TURNER BL, 1994, AMBIO, V23, P91; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; Verburg PH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034019; Verburg PH, 2009, J ENVIRON MANAGE, V90, P1327, DOI 10.1016/j.jenvman.2008.08.005	39	23	23	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86179	10.1371/journal.pone.0086179	http://dx.doi.org/10.1371/journal.pone.0086179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489696	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000026
J	Manns, R; Schmandke, A; Schmandke, A; Jareonsettasin, P; Cook, G; Schwab, ME; Holt, C; Keynes, R				Manns, Richard; Schmandke, Andre; Schmandke, Antonio; Jareonsettasin, Prem; Cook, Geoffrey; Schwab, Martin E.; Holt, Christine; Keynes, Roger			Protein Synthesis Dependence of Growth Cone Collapse Induced by Different Nogo-A-Domains	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; SEMAPHORIN 3A; AXONAL REGENERATION; NEURITE OUTGROWTH; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; INHIBITION; RECEPTOR; IDENTIFICATION; EXPRESSION	Background: The protein Nogo-A regulates axon growth in the developing and mature nervous system, and this is carried out by two distinct domains in the protein, Nogo-A-Delta 20 and Nogo-66. The differences in the signalling pathways engaged in axon growth cones by these domains are not well characterized, and have been investigated in this study. Methodology/Principal Findings: We analyzed growth cone collapse induced by the Nogo-A domains Nogo-A-Delta 20 and Nogo-66 using explanted chick dorsal root ganglion neurons growing on laminin/poly-lysine substratum. Collapse induced by purified Nogo-A-Delta 20 peptide is dependent on protein synthesis whereas that induced by Nogo-66 peptide is not. Nogo-A-Delta 20-induced collapse is accompanied by a protein synthesis-dependent rise in RhoA expression in the growth cone, but is unaffected by proteasomal catalytic site inhibition. Conversely Nogo-66-induced collapse is inhibited similar to 50% by proteasomal catalytic site inhibition. Conclusion/Significance: Growth cone collapse induced by the Nogo-A domains Nogo-A-Delta 20 and Nogo-66 is mediated by signalling pathways with distinguishable characteristics concerning their dependence on protein synthesis and proteasomal function.	[Manns, Richard; Jareonsettasin, Prem; Cook, Geoffrey; Holt, Christine; Keynes, Roger] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Schmandke, Andre; Schmandke, Antonio; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Schmandke, Andre; Schmandke, Antonio; Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Cambridge; University of Zurich; ETH Zurich	Keynes, R (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	rjk10@cam.ac.uk	Schwab, Martin E/B-6818-2016	Holt, Christine Elizabeth/0000-0003-2829-121X	Wellcome Trust [08534/Z/08/Z]; Trinity College, Cambridge	Wellcome Trust(Wellcome TrustEuropean Commission); Trinity College, Cambridge	The Wellcome Trust (www.wellcome.ac.uk) project grant no. 08534/Z/08/Z. RM was funded by a graduate studentship from Trinity College, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Deng KW, 2010, J BIOL CHEM, V285, P6425, DOI 10.1074/jbc.M109.071548; Dickson HM, 2010, J NEUROSCI, V30, P13319, DOI 10.1523/JNEUROSCI.1324-10.2010; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Dontchev VD, 2002, J NEUROSCI, V22, P6659; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gao Y, 2010, STEM CELLS DEV, V19, P53, DOI 10.1089/scd.2008.0357; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Grunewald E, 2009, MOL CELL NEUROSCI, V42, P363, DOI 10.1016/j.mcn.2009.08.007; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Murthy R, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-30; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Niederost B, 2002, J NEUROSCI, V22, P10368; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Peng XM, 2011, J NEUROCHEM, V119, P1183, DOI 10.1111/j.1471-4159.2011.07520.x; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86820	10.1371/journal.pone.0086820	http://dx.doi.org/10.1371/journal.pone.0086820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489789	Green Published, gold, Green Accepted			2022-12-27	WOS:000330570000071
J	Perez-Hedo, M; Rivera-Perez, C; Noriega, FG				Perez-Hedo, Meritxell; Rivera-Perez, Crisalejandra; Noriega, Fernando G.			Starvation Increases Insulin Sensitivity and Reduces Juvenile Hormone Synthesis in Mosquitoes	PLOS ONE			English	Article							FEMALE AEDES-AEGYPTI; CORPORA-ALLATA; NUTRITIONAL REGULATION; OVARIAN DEVELOPMENT; FARNESOIC ACID; LIFE-SPAN; BIOSYNTHESIS; EXPRESSION; DROSOPHILA; PEPTIDES	Background: The interactions between the insulin signaling pathway (ISP) and juvenile hormone (JH) controlling reproductive trade-offs are well documented in insects. JH and insulin regulate reproductive output in mosquitoes; both hormones are involved in a complex regulatory network, in which they influence each other and in which the mosquito's nutritional status is a crucial determinant of the network's output. Previous studies reported that the insulin-TOR (target of rapamacyn) signaling pathway is involved in the nutritional regulation of JH synthesis in female mosquitoes. The present studies further investigate the regulatory circuitry that controls both JH synthesis and reproductive output in response to nutrient availability. Methods: We used a combination of diet restriction, RNA interference (RNAi) and insulin treatments to modify insulin signaling and study the cross-talk between insulin and JH in response to starvation. JH synthesis was analyzed using a newly developed assay utilizing fluorescent tags. Conclusions: Our results reveal that starvation decreased JH synthesis via a decrease in insulin signaling in the corpora allata (CA). Paradoxically, starvation-induced up regulation of insulin receptor transcripts and therefore "primed" the gland to respond rapidly to increases in insulin levels. During this response to starvation the synthetic potential of the CA remained unaffected, and the gland rapidly and efficiently responded to insulin stimulation by increasing JH synthesis to rates similar to those of CA from non-starved females.	[Perez-Hedo, Meritxell; Rivera-Perez, Crisalejandra; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Rivera-Perez, Crisalejandra/AAM-1269-2021; Perez-Hedo, Meritxell/O-6441-2019	Perez-Hedo, Meritxell/0000-0003-3411-0761; Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health (NIH) [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI 45545 to FGN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badisco L, 2013, FRONTIERS PHYSL, V4, P1; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; Briegel H, 2001, J MED ENTOMOL, V38, P557, DOI 10.1603/0022-2585-38.4.557; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005; Clifton ME, 2011, J INSECT PHYSIOL, V57, P1274, DOI 10.1016/j.jinsphys.2011.06.002; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hattori A, 2013, J EXP ZOOL PART B, V320B, P295, DOI 10.1002/jez.b.22501; Hernandez-Martinez S, 2007, J INSECT PHYSIOL, V53, P230, DOI 10.1016/j.jinsphys.2006.08.009; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Klowden MJ, 1997, ARCH INSECT BIOCHEM, V35, P491, DOI 10.1002/(SICI)1520-6327(1997)35:4<491::AID-ARCH10>3.3.CO;2-5; Li YP, 2006, J BIOL CHEM, V281, P34048, DOI 10.1074/jbc.M606341200; Li YP, 2004, REGUL PEPTIDES, V118, P175, DOI 10.1016/j.regpep.2003.12.004; Li YP, 2003, INSECT BIOCHEM MOLEC, V33, P1307, DOI 10.1016/j.ibmb.2003.07.003; Li YP, 2003, J EXP BIOL, V206, P1825, DOI 10.1242/jeb.00371; Libbrecht R, 2013, P NATL ACAD SCI USA, V110, P11050, DOI 10.1073/pnas.1221781110; Maestro JL, 2009, J BIOL CHEM, V284, P5506, DOI 10.1074/jbc.M807042200; Marquez AG, 2011, GEN COMP ENDOCR, V173, P303, DOI 10.1016/j.ygcen.2011.06.005; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Noriega F.G., 1993, Insect Molecular Biology, V2, P21, DOI 10.1111/j.1365-2583.1993.tb00121.x; Noriega FG, 2004, INSECT BIOCHEM MOLEC, V34, P687, DOI 10.1016/j.ibmb.2004.03.021; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Osawa N, 2005, EUR J ENTOMOL, V102, P503, DOI 10.14411/eje.2005.072; Perez-Hedo M, 2013, INSECT BIOCHEM MOLEC, V43, P495, DOI 10.1016/j.ibmb.2013.03.008; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rivera-Perez C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043784; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Shiao SH, 2008, J INSECT PHYSIOL, V54, P231, DOI 10.1016/j.jinsphys.2007.09.007; SIDDLE K, 2012, FRONT ENDOCRINOL, V3, P1, DOI DOI 10.3389/FEND0.2012.00034; Suren-Castillo S, 2012, INSECT BIOCHEM MOLEC, V42, P491, DOI 10.1016/j.ibmb.2012.03.006; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776	39	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86183	10.1371/journal.pone.0086183	http://dx.doi.org/10.1371/journal.pone.0086183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489697	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000027
J	Santin-Janin, H; Hugueny, B; Aubry, P; Fouchet, D; Gimenez, O; Pontier, D				Santin-Janin, Hugues; Hugueny, Bernard; Aubry, Philippe; Fouchet, David; Gimenez, Olivier; Pontier, Dominique			Accounting for Sampling Error When Inferring Population Synchrony from Time-Series Data: A Bayesian State-Space Modelling Approach with Applications	PLOS ONE			English	Article							ESTIMATING DENSITY-DEPENDENCE; SPATIAL SYNCHRONY; PROCESS NOISE; FLUCTUATIONS; DISPERSAL; ABUNDANCE; DYNAMICS; SCALE; VARIABILITY; VARIANCE	Background: Data collected to inform time variations in natural population size are tainted by sampling error. Ignoring sampling error in population dynamics models induces bias in parameter estimators, e.g., density-dependence. In particular, when sampling errors are independent among populations, the classical estimator of the synchrony strength (zero-lag correlation) is biased downward. However, this bias is rarely taken into account in synchrony studies although it may lead to overemphasizing the role of intrinsic factors (e.g., dispersal) with respect to extrinsic factors (the Moran effect) in generating population synchrony as well as to underestimating the extinction risk of a metapopulation. Methodology/Principal findings: The aim of this paper was first to illustrate the extent of the bias that can be encountered in empirical studies when sampling error is neglected. Second, we presented a space-state modelling approach that explicitly accounts for sampling error when quantifying population synchrony. Third, we exemplify our approach with datasets for which sampling variance (i) has been previously estimated, and (ii) has to be jointly estimated with population synchrony. Finally, we compared our results to those of a standard approach neglecting sampling variance. We showed that ignoring sampling variance can mask a synchrony pattern whatever its true value and that the common practice of averaging few replicates of population size estimates poorly performed at decreasing the bias of the classical estimator of the synchrony strength. Conclusion/Significance: The state-space model used in this study provides a flexible way of accurately quantifying the strength of synchrony patterns from most population size data encountered in field studies, including over-dispersed count data. We provided a user-friendly R-program and a tutorial example to encourage further studies aiming at quantifying the strength of population synchrony to account for uncertainty in population size estimates.	[Santin-Janin, Hugues; Aubry, Philippe] Direct Etud & Rech, Off Natl Chasse & Faune Sauvage, Le Perray En Yvelines, France; [Santin-Janin, Hugues; Fouchet, David; Pontier, Dominique] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; [Hugueny, Bernard] Museum Natl Hist Nat, MNHN IRD CNRS UPMC, UMR Biol Aquat Organims & Ecosyst, Paris, France; [Gimenez, Olivier] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Santin-Janin, H (corresponding author), Direct Etud & Rech, Off Natl Chasse & Faune Sauvage, Le Perray En Yvelines, France.	hugues_sj@yahoo.fr	Gimenez, Olivier/G-4281-2010	Pontier, Dominique/0000-0003-4700-3543; Gimenez, Olivier/0000-0001-7001-5142; Aubry, Philippe/0000-0002-0964-1942	World Health Organization (WHO) Onchocerciasis Control Programme (OCP); 'Centre National de Recherche Scientifique' (CNRS); Institut Paul Emile Victor (IPEV) [279]; Zone Atelier (ZA) Program 'Environnement, Vie et Societe'; French National Research Agency [ANR-09-PEXT-008]	World Health Organization (WHO) Onchocerciasis Control Programme (OCP); 'Centre National de Recherche Scientifique' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Paul Emile Victor (IPEV); Zone Atelier (ZA) Program 'Environnement, Vie et Societe'; French National Research Agency(French National Research Agency (ANR))	The authors thank the World Health Organization (WHO) Onchocerciasis Control Programme (OCP), the 'Centre National de Recherche Scientifique' (CNRS), the Institut Paul Emile Victor (IPEV, Programme 'Popchat' no. 279), the Zone Atelier (ZA) Program 'Environnement, Vie et Societe' and the French National Research Agency (ANR-09-PEXT-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry P, 2012, ECOL INDIC, V18, P599, DOI 10.1016/j.ecolind.2012.01.019; Buckland S.T., 2001, pi; Bull JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011635; Buonaccorsi JP, 2006, THEOR POPUL BIOL, V70, P322, DOI 10.1016/j.tpb.2006.02.002; Buonaccorsi JP, 2001, ECOLOGY, V82, P1668, DOI 10.2307/2679809; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Devillard S, 2011, MOL ECOL, V20, P5141, DOI 10.1111/j.1365-294X.2011.05329.x; EBERHARDT LL, 1991, ECOL MONOGR, V61, P53, DOI 10.2307/1942999; Engen S, 2005, AM NAT, V166, P603, DOI 10.1086/491690; Fewster RM, 2011, BIOMETRICS, V67, P1518, DOI 10.1111/j.1541-0420.2011.01604.x; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Gelman A., 2003, BAYESIAN DATA ANAL; Gimenez O, 2009, ENVIRON ECOL STAT SE, V3, P883, DOI 10.1007/978-0-387-78151-8_41; Grosbois V, 2009, ECOLOGY, V90, P2922, DOI 10.1890/08-1657.1; Grotan V, 2005, ECOLOGY, V86, P1472, DOI 10.1890/04-1502; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; Hugueny B, 2006, OIKOS, V115, P3, DOI 10.1111/j.2006.0030-1299.14686.x; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Koenig WD, 2002, ECOGRAPHY, V25, P283, DOI 10.1034/j.1600-0587.2002.250304.x; Lande R, 2002, PHILOS T ROY SOC B, V357, P1179, DOI 10.1098/rstb.2002.1120; Lande R, 1999, AM NAT, V154, P271, DOI 10.1086/303240; Lande R., 2003, OXFORD SERIES ECOLOG; Lebreton JD, 2013, J WILDLIFE MANAGE, V77, P12, DOI 10.1002/jwmg.425; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; LINK WA, 1994, ECOLOGY, V75, P1097, DOI 10.2307/1939433; LINK WA, 1994, OIKOS, V69, P539, DOI 10.2307/3545869; Monkkonen M, 1998, ANN ZOOL FENN, V35, P47; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; Pardo-Iguzquiza E, 1999, MATH GEOL, V31, P47, DOI 10.1023/A:1007522230013; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M, 2010, RJAGS BAYESIAN GRAPH; Pontier D, 2005, POLAR BIOL, V28, P268, DOI 10.1007/s00300-004-0692-3; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; Royama T, 2005, ECOL MONOGR, V75, P277, DOI 10.1890/04-0770; Royama T., 1992, ANAL POPULATION ECOL; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Santin-Janin H, 2009, POLAR BIOL, V32, P861, DOI 10.1007/s00300-009-0586-5; Santin-Janin H, 2010, THESIS U CLAUDE BERN; Say L, 2002, POLAR BIOL, V25, P90, DOI 10.1007/s003000100316; Solow AR, 2001, ECOLOGY, V82, P3263, DOI 10.1890/0012-9658(2001)082[3263:OEATDO]2.0.CO;2; Solow AR, 1998, ECOLOGY, V79, P1463, DOI 10.2307/176759; Solymos P, 2010, R J, V2, P29; Staples DF, 2004, ECOLOGY, V85, P923, DOI 10.1890/03-3101; Tedesco PA, 2004, J ANIM ECOL, V73, P693, DOI 10.1111/j.0021-8790.2004.00843.x; Yoccoz N. G., 2004, Animal Biodiversity and Conservation, V27, P427	52	8	8	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87084	10.1371/journal.pone.0087084	http://dx.doi.org/10.1371/journal.pone.0087084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489839	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000097
J	Schwarzberg, K; Le, R; Bharti, B; Lindsay, S; Casaburi, G; Salvatore, F; Saber, MH; Alonaizan, F; Slots, J; Gottlieb, RA; Caporaso, JG; Kelley, ST				Schwarzberg, Karen; Le, Rosalin; Bharti, Balambal; Lindsay, Suzanne; Casaburi, Giorgio; Salvatore, Francesco; Saber, Mohamed H.; Alonaizan, Faisal; Slots, Jorgen; Gottlieb, Roberta A.; Caporaso, J. Gregory; Kelley, Scott T.			The Personal Human Oral Microbiome Obscures the Effects of Treatment on Periodontal Disease	PLOS ONE			English	Article							SEQUENCES; DIVERSITY	Periodontitis is a progressive disease of the periodontium with a complex, polymicrobial etiology. Recent Next-Generation Sequencing (NGS) studies of the microbial diversity associated with periodontitis have revealed strong, community-level differences in bacterial assemblages associated with healthy or diseased periodontal sites. In this study, we used NGS approaches to characterize changes in periodontal pocket bacterial diversity after standard periodontal treatment. Despite consistent changes in the abundance of certain taxa in individuals whose condition improved with treatment, post-treatment samples retained the highest similarity to pre-treatment samples from the same individual. Deeper phylogenetic analysis of periodontal pathogen-containing genera Prevotella and Fusobacterium found both unexpected diversity and differential treatment response among species. Our results highlight how understanding interpersonal variability among microbiomes is necessary for determining how polymicrobial diseases respond to treatment and disturbance.	[Schwarzberg, Karen; Le, Rosalin; Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Bharti, Balambal; Lindsay, Suzanne] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Casaburi, Giorgio; Salvatore, Francesco] CEINGE Biotecnol Avanzate, Naples, Italy; [Casaburi, Giorgio; Salvatore, Francesco] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Saber, Mohamed H.; Alonaizan, Faisal] USC, Sect Endodont, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Slots, Jorgen] USC, Herman Ostrow Sch Dent, Los Angeles, CA USA; [Gottlieb, Roberta A.] San Diego State Univ, BioSci Ctr, San Diego, CA 92182 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Caporaso, J. Gregory] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	California State University System; San Diego State University; California State University System; San Diego State University; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Southern California; University of Southern California; California State University System; San Diego State University; Northern Arizona University; United States Department of Energy (DOE); Argonne National Laboratory	Kelley, ST (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	skelley@mail.sdsu.edu	; Salvatore, Francesco/A-1966-2011	Caporaso, Greg/0000-0002-8865-1670; Salvatore, Francesco/0000-0002-2346-3564; Gottlieb, Roberta/0000-0002-1432-006X	NIH [U26IHS300292]; Native American Research Centers for Health [NARCH5]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Native American Research Centers for Health	This work received financial support from the following sources: NIH Grant U26IHS300292 (PI: Calac; Project Leader: Gottlieb); "Native American Research Centers for Health (NARCH5): Periodontal Disease, Atherosclerosis, and the Oral Microbiome". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusleme L, 2013, ISME J, DOI 101038/ismej2012174; BADERSTEN A, 1981, J CLIN PERIODONTOL, V8, P57, DOI 10.1111/j.1600-051X.1981.tb02024.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cobb CM, 2002, J CLIN PERIODONTOL, V29, P6; Cullinan MP, 2013, PERIODONTOL 2000, V62, P271, DOI 10.1111/prd.12007; Dentino A, 2013, PERIODONTOL 2000, V61, P16, DOI 10.1111/j.1600-0757.2011.00397.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2013, SCIENCE, V341, DOI 10.1126/science.1237439; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/jour-nal.pone.0037919; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miller M.A., 2010, P GAT COMP ENV WORKS; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Saber MH, 2012, J ENDODONT, V38, P1484, DOI 10.1016/j.joen.2012.06.037; Skrepcinski FB, 2000, J PUBLIC HEALTH DENT, V60, P261; Slots J, 2013, PERIODONTOL 2000, V62, P7, DOI 10.1111/prd.12011; Slots J, 2012, PERIODONTOL 2000, V60, P110, DOI 10.1111/j.1600-0757.2011.00429.x; Team R. D. C., 2008, R LANG ENV STAT COMP; Teles R, 2013, PERIODONTOL 2000, V62, P95, DOI 10.1111/prd.12010; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	27	60	61	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86708	10.1371/journal.pone.0086708	http://dx.doi.org/10.1371/journal.pone.0086708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489772	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000062
J	Kim, S; Lee, HG; Park, SA; Kundu, JK; Keum, YS; Cha, YN; Na, HK; Surh, YJ				Kim, Sanghyun; Lee, Hee-Geum; Park, Sin-Aye; Kundu, Joydeb Kumar; Keum, Young-Sam; Cha, Young-Nam; Na, Hye-Kyung; Surh, Young-Joon			Keap1 Cysteine 288 as a Potential Target for Diallyl Trisulfide-Induced Nrf2 Activation	PLOS ONE			English	Article							OXIDATIVE STRESS; HEME OXYGENASE-1; REACTIVE OXYGEN; NAD(P)H-QUINONE OXIDOREDUCTASE-1; GENE-EXPRESSION; CELL-LINE; INDUCTION; ANTIOXIDANT; CANCER; PROTEIN	Diallyl sulfide, diallyl disulfide, and daillyl trisulfide (DATS) are major volatile components of garlic oil. In this study, we assessed their relative potency in inducing antioxidant enzyme expression. Among the three organosulfur compounds, DATS was found to be most potent in inducing heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 (NQO1) in human gastric epithelial (AGS) cells. Furthermore, DATS administration by gavage increased the expression of HO-1 and NQO1 in C57BL/6 mouse stomach. Treatment with DATS increased the accumulation of nuclear factor-erythroid-2-related factor-2 (Nrf2) in the nucleus of cultured AGS cells and in mouse stomach in vivo. The DATS-induced expression of HO-1 and NQO1 was abrogated in the cells transiently transfected with Nrf2-siRNA or in the embryonic fibroblasts from Nrf2-null mice, indicating that Nrf2 is a key mediator of the cytoprotective effects of DATS. Pretreatment of AGS cells with N-acetylcysteine or dithiothreitol attenuated DATS-induced nuclear localization of Nrf2 and the expression of HO-1 and NQO1. Cysteine-151, -273 and -288 of Kelch-like ECH-associated protein-1 (Keap1), a cytosolic repressor of Nrf2, have been considered to act as a redox sensor and play a role in Nrf2 activation. To determine whether DATS could inactivate Keap1 through thiol modification, we established cell lines constitutively expressing wild type-Keap1 or three different mutant constructs in which cysteine-151, -273, or -288 of Keap1 was replaced with serine by retroviral gene transfer. DATS failed to activate Nrf2, and to induce expression of HO-1 and NQO1 only in Keap1-C288S mutant cells. LC-ESI-MS/MS analysis of recombinant Keap1 treated with DATS revealed that the peptide fragment containing Cys288 gained a molecular mass of 72.1 Da equivalent to the molecular weight of mono-allyl mono-sulfide. Taken together, these findings suggest that DATS may directly interact with the Cys288 residue of Keap1, which partly accounts for its ability to induce Nrf2 activation and upregulate defensive gene expression.	[Kim, Sanghyun; Lee, Hee-Geum; Park, Sin-Aye; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Kundu, Joydeb Kumar] Keimyung Univ, Coll Pharm, Taegu, South Korea; [Keum, Young-Sam] Dongguk Univ, Coll Pharm, Ilsan, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Inchon, South Korea; [Na, Hye-Kyung] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Surh, Young-Joon] Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Dongguk University; Inha University; Sungshin Women's University; Seoul National University (SNU); Seoul National University (SNU)	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea.	surh@plaza.snu.ac.kr	Park, Sin-Aye/E-2303-2019	Park, Sin-Aye/0000-0003-2456-3572; Kim, Sanghyun/0000-0001-9519-1994	Global Core Research Center grant from the National Research Foundation, Republic of Korea	Global Core Research Center grant from the National Research Foundation, Republic of Korea	This work was supported by the Global Core Research Center grant from the National Research Foundation, Republic of Korea. The funders have no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bartsch H, 2005, MUTAT RES-FUND MOL M, V591, P34, DOI 10.1016/j.mrfmmm.2005.04.013; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Cobbs CS, 2003, CANCER RES, V63, P8670; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Eggler AL, 2007, CHEM RES TOXICOL, V20, P1878, DOI 10.1021/tx700217c; Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340; Fukao T, 2004, BIOFACTORS, V21, P171, DOI 10.1002/biof.552210135; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; Hamajima Nobuyuki, 2002, Int J Clin Oncol, V7, P103; Hayashi S, 1999, CIRC RES, V85, P663, DOI 10.1161/01.RES.85.8.663; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hosono T, 2008, CARCINOGENESIS, V29, P1400, DOI 10.1093/carcin/bgn124; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kong ANT, 2001, DRUG METAB REV, V33, P255, DOI 10.1081/DMR-120000652; Kundu JK, 2010, PHARM RES-DORDR, V27, P999, DOI 10.1007/s11095-010-0096-8; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Long DJ, 2000, CANCER RES, V60, P5913; Malik MA, 2011, DNA CELL BIOL, V30, P297, DOI 10.1089/dna.2010.1115; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Munday R, 2003, FREE RADICAL BIO MED, V34, P1200, DOI 10.1016/S0891-5849(03)00144-8; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedraza-Chaverri J, 2003, EUR J PHARMACOL, V473, P71, DOI 10.1016/S0014-2999(03)01948-4; PROCHASKA HJ, 1987, J BIOL CHEM, V262, P1931; PRUTZ WA, 1993, FREE RADICAL RES COM, V18, P159, DOI 10.3109/10715769309147489; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WARGOVICH MJ, 1988, CANCER RES, V48, P6872; Was H, 2011, FREE RADICAL BIO MED, V51, P1717, DOI 10.1016/j.freeradbiomed.2011.07.025; WEFERS H, 1984, FEBS LETT, V169, P63, DOI 10.1016/0014-5793(84)80290-2; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	46	55	62	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85984	10.1371/journal.pone.0085984	http://dx.doi.org/10.1371/journal.pone.0085984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489685	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000027
J	Sha, K; Choi, SH; Im, J; Lee, GG; Loeffler, F; Park, JH				Sha, Kai; Choi, Seung-Hoon; Im, Jeongdae; Lee, Gyunghee G.; Loeffler, Frank; Park, Jae H.			Regulation of Ethanol-Related Behavior and Ethanol Metabolism by the Corazonin Neurons and Corazonin Receptor in Drosophila melanogaster	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE ALDH; PROTEIN-COUPLED-RECEPTORS; LIVER ALCOHOL-DEHYDROGENASE; NEUROPEPTIDE CORAZONIN; RAT-LIVER; DISULFIRAM TREATMENT; SIGNALING PATHWAY; GROWTH-HORMONE; BOMBYX-MORI; EXPRESSION	Impaired ethanol metabolism can lead to various alcohol-related health problems. Key enzymes in ethanol metabolism are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH); however, neuroendocrine pathways that regulate the activities of these enzymes are largely unexplored. Here we identified a neuroendocrine system involving Corazonin (Crz) neuropeptide and its receptor (CrzR) as important physiological regulators of ethanol metabolism in Drosophila. Crz-cell deficient (Crz-CD) flies displayed significantly delayed recovery from ethanol-induced sedation that we refer to as hangover-like phenotype. Newly generated mutant lacking Crz Receptor (CrzR(01)) and CrzR-knockdown flies showed even more severe hangover-like phenotype, which is causally associated with fast accumulation of acetaldehyde in the CrzR(01) mutant following ethanol exposure. Higher levels of acetaldehyde are likely due to 30% reduced ALDH activity in the mutants. Moreover, increased ADH activity was found in the CrzR(01) mutant, but not in the Crz-CD flies. Quantitative RT-PCR revealed transcriptional upregulation of Adh gene in the CrzR(01). Transgenic inhibition of cyclic AMP-dependent protein kinase (PKA) also results in significantly increased ADH activity and Adh mRNA levels, indicating PKA-dependent transcriptional regulation of Adh by CrzR. Furthermore, inhibition of PKA or cAMP response element binding protein (CREB) in CrzR cells leads to comparable hangover-like phenotype to the CrzR(01) mutant. These findings suggest that CrzR-associated signaling pathway is critical for ethanol detoxification via Crz-dependent regulation of ALDH activity and Crz-independent transcriptional regulation of ADH. Our study provides new insights into the neuroendocrine-associated ethanol-related behavior and metabolism.	[Sha, Kai; Choi, Seung-Hoon; Lee, Gyunghee G.; Park, Jae H.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Im, Jeongdae; Loeffler, Frank] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Park, Jae H.] Univ Tennessee, Genome Sci Technol, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Park, JH (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	jhpark@utk.edu	Im, Jeongdae/K-8500-2013	Im, Jeongdae/0000-0002-6871-5366; Park, Jae/0000-0002-4846-2197; Lee, Gyunghee/0000-0003-3108-1870	National Science Foundation (NSF) [IOS-0919797, IBN-0133538]; Fite fellowship from BCMB	National Science Foundation (NSF)(National Science Foundation (NSF)); Fite fellowship from BCMB	This work was supported by National Science Foundation (NSF) grants (IOS-0919797, IBN-0133538) (http://www.nsf.gov/) and a Fite fellowship from BCMB (K. S.) (http://web.bio.utk.edu/bcmb/grad/financial_support/advanced.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; BARBANCHO M, 1987, HEREDITY, V58, P443, DOI 10.1038/hdy.1987.73; Boccia S, 2009, CANCER EPIDEM BIOMAR, V18, P248, DOI 10.1158/1055-9965.EPI-08-0462; Broughton SJ, 1996, J CELL BIOCHEM, V60, P584, DOI 10.1002/(SICI)1097-4644(19960315)60:4<584::AID-JCB14>3.0.CO;2-H; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; CHICK J, 1992, BRIT J PSYCHIAT, V161, P84, DOI 10.1192/bjp.161.1.84; Choi SH, 2009, THESIS TENNESSEE RES; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; CRABB DW, 1989, J CLIN INVEST, V83, P314, DOI 10.1172/JCI113875; Crabb DW, 2001, ALCOHOL CLIN EXP RES, V25, P945, DOI 10.1097/00000374-200107000-00001; Dannenberg LO, 2005, DNA CELL BIOL, V24, P543, DOI 10.1089/dna.2005.24.543; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Fry JD, 2006, GENET RES, V87, P87, DOI 10.1017/S0016672306008032; GIBSON JB, 1981, OECOLOGIA, V51, P191, DOI 10.1007/BF00540600; HEINSTRA PWH, 1989, BIOCHEM J, V259, P791, DOI 10.1042/bj2590791; HILLBOM ME, 1970, BIOCHEM PHARMACOL, V19, P2097, DOI 10.1016/0006-2952(70)90308-4; ISRAEL Y, 1975, J PHARMACOL EXP THER, V192, P565; Isse T, 2002, PHARMACOGENETICS, V12, P621, DOI 10.1097/00008571-200211000-00006; Jelski W, 2008, CLIN CHIM ACTA, V395, P1, DOI 10.1016/j.cca.2008.05.001; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; LEAL JFM, 1993, INSECT BIOCHEM MOLEC, V23, P543, DOI 10.1016/0965-1748(93)90027-P; LEAL JFM, 1992, INSECT BIOCHEM MOLEC, V22, P885, DOI 10.1016/0965-1748(92)90115-U; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Lee GG, 2013, J COMP NEUROL, V521, P3972, DOI 10.1002/cne.23387; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McClure KD, 2013, J NEUROSCI, V33, P4044, DOI 10.1523/JNEUROSCI.3413-12.2013; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; MEZEY E, 1979, ENDOCRINOLOGY, V104, P1667, DOI 10.1210/endo-104-6-1667; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MOXON LN, 1985, COMP BIOCHEM PHYS B, V80, P525, DOI 10.1016/0305-0491(85)90285-8; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; POTTER JJ, 1989, ARCH BIOCHEM BIOPHYS, V274, P548, DOI 10.1016/0003-9861(89)90469-4; Rodan AR, 2002, J NEUROSCI, V22, P9490; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Sha K, 2012, GENE, V497, P191, DOI 10.1016/j.gene.2012.01.052; Simon FR, 2002, AM J PHYSIOL-GASTR L, V283, pG646, DOI 10.1152/ajpgi.00438.2001; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1111/j.1530-0277.2000.tb02075.x; Song BJ, 2011, J PROTEOMICS, V74, P2691, DOI 10.1016/j.jprot.2011.05.013; Swift R, 1998, ALCOHOL HEALTH RES W, V22, P54; Tanaka Y, 2002, J INSECT PHYSIOL, V48, P707, DOI 10.1016/S0022-1910(02)00094-X; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; WRIGHT C, 1990, AM J MED, V88, P647, DOI 10.1016/0002-9343(90)90534-K; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675; Yokoyama M, 2005, ALCOHOL CLIN EXP RES, V29, P1165, DOI 10.1097/01.ALC.0000172457.62535.EE; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; YU M, 1994, GENE, V141, P249, DOI 10.1016/0378-1119(94)90580-0; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	61	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87062	10.1371/journal.pone.0087062	http://dx.doi.org/10.1371/journal.pone.0087062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489834	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000102
J	Zhao, Y; Yu, YB; Tian, XL; Yang, X; Li, XQ; Jiang, F; Chen, YD; Shi, MW				Zhao, Ying; Yu, Yanbo; Tian, Xiaoli; Yang, Xi; Li, Xueqi; Jiang, Feng; Chen, Yundai; Shi, Maowei			Association Study to Evaluate FoxO1 and FoxO3 Gene in CHD in Han Chinese	PLOS ONE			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; FORKHEAD; ATHEROSCLEROSIS; LONGEVITY; DYSFUNCTION; MECHANISMS; EXPRESSION	Background: Coronary heart disease (CHD) is one of the leading causes of mortality and morbidity in China. Genetic factors that predispose individuals to CHD are unclear. In the present study, we aimed to determine whether the variation of FoxOs, a novel genetic factor associated with longevity, was associated with CHD in Han Chinese populations. Methods: 1271 CHD patients and 1287 age-and sex-matched controls from Beijing and Harbin were included. We selected four tagging single nucleotide polymorphisms (SNPs) of FoxO1 (rs2755209, rs2721072, rs4325427 and rs17592371) and two tagging SNPs of FoxO3 (rs768023 and rs1268165). And the genotypes of these SNPs were determined in both CHD patients and non-CHD controls. Results: For population from Beijing, four SNPs of FoxO1 and two SNPs of FoxO3 were found not to be associated with CHD (p>0.05). And this was validated in the other population from Harbin (p>0.05). After combining the two geographically isolated case-control populations, the results showed that the six SNPs did not necessarily predispose to CHD in Han Chinese(p>0.05). In stratified analysis according to gender, the history of smoking, hypertension, diabetes mellitus, hyperlipidemia and the metabolic syndrome, we further explored that neither the variants of FoxO1 nor the variants of FoxO3 might be associated with CHD (p>0.05). Conclusion: The variants of FoxO1 and FoxO3 may not increase the prevalence of CHD in Han Chinese population.	[Zhao, Ying; Shi, Maowei] Jinan Mil Gen Hosp, Dept Geriatr, Jinan, Peoples R China; [Yu, Yanbo] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Peoples R China; [Tian, Xiaoli; Yang, Xi] Peking Univ, Inst Mol Med, Dept Human Populat Genet, Beijing 100871, Peoples R China; [Li, Xueqi; Jiang, Feng] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin, Peoples R China; [Chen, Yundai] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China	Shandong University; Peking University; Harbin Medical University; Chinese People's Liberation Army General Hospital	Chen, YD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China.	ydchen301@163.com; jnshimw@163.com	chen, yundai/I-4353-2019; yu, yanbo/GZM-8474-2022	chen, yundai/0000-0003-2252-8992; Yang, Xi/0000-0002-1154-2919	Beijing Natural Science Foundation [7092099]; National Natural Science Foundation of China [81200270]; scientific research foundation for outstanding young scientist of Shandong Province [BS2012SW012]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific research foundation for outstanding young scientist of Shandong Province	This study was supported by Beijing Natural Science Foundation (7092099), National Natural Science Foundation of China (81200270) and the scientific research foundation for outstanding young scientist of Shandong Province (BS2012SW012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Bachschmid MM, 2013, ANN MED, V45, P17, DOI 10.3109/07853890.2011.645498; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Cai DS, 2009, CELL CYCLE, V8, P2542, DOI 10.4161/cc.8.16.9386; Calixto A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003141; Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; Cuaz-Perolin C, 2008, ARTERIOSCL THROM VAS, V28, P272, DOI 10.1161/ATVBAHA.107.155606; Dabek J, 2008, BIOCHEM GENET, V46, P241, DOI 10.1007/s10528-007-9137-3; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Frieri M, 2012, CURR ALLERGY ASTHM R, V12, P25, DOI 10.1007/s11882-011-0236-1; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Iwata H, 2012, CURR ATHEROSCLER REP, V14, P484, DOI 10.1007/s11883-012-0267-7; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kim M, 2012, DIABETES RES CLIN PR, V98, P132, DOI 10.1016/j.diabres.2012.04.013; Kuo CC, 2007, MOL MED, V13, P561, DOI 10.2119/2007-00021.Kuo; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Lytvyn Olena Ivanivna, 2004, Kardiol Pol, V61, P110; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Maiese K, 2009, ADV EXP MED BIOL, V665, P242; Maiese K, 2009, CLIN SCI, V116, P191, DOI 10.1042/CS20080113; Morris JB, 2005, ENDOCRINOLOGY, V146, P4370, DOI 10.1210/en.2005-0162; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; O'Rourke MF, 2007, VASC MED, V12, P329, DOI 10.1177/1358863x07083392; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Peng SL, 2007, AUTOIMMUNITY, V40, P462, DOI 10.1080/08916930701464913; Qiang L, 2012, J BIOL CHEM, V287, P13944, DOI 10.1074/jbc.M111.332767; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rossouw JE, 2008, ARCH INTERN MED, V168, P2245, DOI 10.1001/archinte.168.20.2245; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Tian Xiao-Li, 2006, V129, P69; Tilstra JS, 2011, AGING DIS, V2, P449; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yeagley D, 2001, J BIOL CHEM, V276, P33705, DOI 10.1074/jbc.M101215200	53	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86252	10.1371/journal.pone.0086252	http://dx.doi.org/10.1371/journal.pone.0086252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489705	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000038
J	Han, D; Kang, I; Ha, HK; Kim, HC; Kim, OS; Lee, BY; Cho, JC; Hur, HG; Lee, YK				Han, Dukki; Kang, Ilnam; Ha, Ho Kyung; Kim, Hyun Cheol; Kim, Ok-Sun; Lee, Bang Yong; Cho, Jang-Cheon; Hur, Hor-Gil; Lee, Yoo Kyung			Bacterial Communities of Surface Mixed Layer in the Pacific Sector of the Western Arctic Ocean during Sea-Ice Melting	PLOS ONE			English	Article							BIOMASS PRODUCTION; HETEROTROPHIC PRODUCTION; ARCHAEAL COMMUNITIES; DIVERSITY; BIOGEOGRAPHY; ASSEMBLAGES; ECOSYSTEM; SALINITY; LINEAGES; WATERS	From July to August 2010, the IBRV ARAON journeyed to the Pacific sector of the Arctic Ocean to monitor bacterial variation in Arctic summer surface-waters, and temperature, salinity, fluorescence, and nutrient concentrations were determined during the ice-melting season. Among the measured physicochemical parameters, we observed a strong negative correlation between temperature and salinity, and consequently hypothesized that the melting ice decreased water salinity. The bacterial community compositions of 15 samples, includicng seawater, sea-ice, and melting pond water, were determined using a pyrosequencing approach and were categorized into three habitats: (1) surface seawater, (2) ice core, and (3) melting pond. Analysis of these samples indicated the presence of local bacterial communities; a deduction that was further corroborated by the discovery of seawater- and ice-specific bacterial phylotypes. In all samples, the Alphaproteobacteria, Flavobacteria, and Gammaproteobacteria taxa composed the majority of the bacterial communities. Among these, Alphaproteobacteria was the most abundant and present in all samples, and its variation differed among the habitats studied. Linear regression analysis suggested that changes in salinity could affect the relative proportion of Alphaproteobacteria in the surface water. In addition, the species-sorting model was applied to evaluate the population dynamics and environmental heterogeneity in the bacterial communities of surface mixed layer in the Arctic Ocean during sea-ice melting.	[Han, Dukki; Ha, Ho Kyung; Kim, Hyun Cheol; Kim, Ok-Sun; Lee, Bang Yong; Lee, Yoo Kyung] KIOST, Korea Polar Res Inst, Inchon, South Korea; [Han, Dukki; Hur, Hor-Gil] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Kwangju, South Korea; [Kang, Ilnam; Cho, Jang-Cheon] Inha Univ, Div Biol & Ocean Sci, Inchon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Gwangju Institute of Science & Technology (GIST); Inha University	Lee, YK (corresponding author), KIOST, Korea Polar Res Inst, Inchon, South Korea.	yklee@kopri.re.kr	Kim, Hyun-Cheol/AAP-1250-2020; Ha, Ho Kyung/HCH-4138-2022	Kim, Hyun-Cheol/0000-0002-6831-9291; Cho, Jang-Cheon/0000-0002-0666-3791; Lee, Yoo Kyung/0000-0002-1271-5738	Korea Polar Research Institute (KOPRI) [PP10090, PP11020, PM11050, PD12010]; Gwanju Institute of Science and Technology; Inha University, Korea	Korea Polar Research Institute (KOPRI); Gwanju Institute of Science and Technology; Inha University, Korea	This research was supported by a grant from the Korea Polar Research Institute (KOPRI; http://www.kopri.re.kr) as K-Polar projects (PP10090; PP11020; PM11050). This study was also supported by the Polar Academic Program (PD12010) of the KOPRI, Gwanju Institute of Science and Technology and Inha University, Korea, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Cai WJ, 2010, SCIENCE, V329, P556, DOI 10.1126/science.1189338; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Carmack EC, 2002, ARCTIC, V55, P29; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Cooper LW, 1997, J GEOPHYS RES-OCEANS, V102, P12563, DOI 10.1029/97JC00015; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cottrell MT, 2003, LIMNOL OCEANOGR, V48, P168, DOI 10.4319/lo.2003.48.1.0168; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2008, LIMNOL OCEANOGR, V53, P813, DOI 10.4319/lo.2008.53.2.0813; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Garneau ME, 2006, AQUAT MICROB ECOL, V42, P27, DOI 10.3354/ame042027; Gosink JJ, 1997, SYST APPL MICROBIOL, V20, P356, DOI 10.1016/S0723-2020(97)80003-3; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; Kellogg CTE, 2009, AQUAT MICROB ECOL, V57, P1, DOI 10.3354/ame01317; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Larose C, 2010, EXTREMOPHILES, V14, P205, DOI 10.1007/s00792-009-0299-2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Li LN, 1999, BIODIVERS CONSERV, V8, P659, DOI 10.1023/A:1008848203739; Lim GE, 2004, APPL ENVIRON MICROB, V70, P4921, DOI 10.1128/AEM.70.8.4921-4929.2004; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Malmstrom RR, 2007, AQUAT MICROB ECOL, V47, P45, DOI 10.3354/ame047045; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Nishino S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004666; Palacios C, 2009, MICROB ECOL, V58, P737, DOI 10.1007/s00248-009-9538-4; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Proshutinsky A.Y., 2009, J GEOPHYS RES, V114; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Wilkins D, 2013, FEMS MICROBIOL REV, V37, P303, DOI 10.1111/1574-6976.12007; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233	51	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86887	10.1371/journal.pone.0086887	http://dx.doi.org/10.1371/journal.pone.0086887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497990	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900044
J	Xi, JX; Si, XHA; Gaide, R				Xi, Jinxiang; Si, Xiuhua A.; Gaide, Rachel			Electrophoretic Particle Guidance Significantly Enhances Olfactory Drug Delivery: A Feasibility Study	PLOS ONE			English	Article							SUBMICROMETER AEROSOL DEPOSITION; NASAL; AIRWAYS; VENTILATION; DYNAMICS; FLOW	Background: Intranasal olfactory drug delivery provides a non-invasive method that bypasses the Blood-Brain-Barrier and directly delivers medication to the brain and spinal cord. However, a device designed specifically for olfactory delivery has not yet been found. Methods: In this study, a new delivery method was proposed that utilized electrophoretic forces to guide drug particles to the olfactory region. The feasibility of this method was numerically evaluated in both idealized 2-D and anatomically accurate 3-D nose models. The influence of nasal airflow, electrode strength, and drug release position were also studied on the olfactory delivery efficiency. Findings: Results showed that by applying electrophoretic forces, the dosage to the olfactory region was significantly enhanced. In both 2-D and 3-D cases, electrophoretic-guided delivery achieved olfactory dosages nearly two orders of magnitude higher than that without electrophoretic forces. Furthermore, releasing drugs into the upper half of the nostril (i.e., partial release) led to olfactory dosages two times higher than releasing drugs over the entire area of the nostril. By combining the advantages of pointed drug release and appropriate electrophoretic guidance, olfactory dosages of more than 90% were observed as compared to the extremely low olfactory dosage (<1%) with conventional inhaler devices. Conclusion: Results of this study have important implications in developing personalized olfactory delivery protocols for the treatment of neurological disorders. Moreover, a high sensitivity of olfactory dosage was observed in relation to different pointed release positions, indicating the importance of precise particle guidance for effective olfactory delivery.	[Xi, Jinxiang] Cent Michigan Univ, Dept Mech & Biomed Engn, Mt Pleasant, MI 48859 USA; [Si, Xiuhua A.; Gaide, Rachel] Calvin Coll, Dept Engn, Grand Rapids, MI 49506 USA	Central Michigan University; Calvin University	Xi, JX (corresponding author), Cent Michigan Univ, Dept Mech & Biomed Engn, Mt Pleasant, MI 48859 USA.	xi1j@cmich.edu	Xi, Jinxiang/Y-1161-2019		Central Michigan University [P421071, P622911]; Calvin Summer Research Grant	Central Michigan University; Calvin Summer Research Grant	This work was funded by Central Michigan University Innovative Research Grant P421071 and Central Michigan University Early Career Grant P622911. RG was supported by Calvin Summer Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2012, INT J NANOMED, V7, P5705, DOI 10.2147/IJN.S35329; [Anonymous], 2009, J AEROSOL MED, DOI DOI 10.1089/JAM.1989.2.365; Bagger M, 2004, INT J PHARMACEUT, V269, P311, DOI 10.1016/j.ijpharm.2003.09.017; Chan T. L., 1978, Journal of Aerosol Science, V9, P463, DOI 10.1016/0021-8502(78)90009-5; CHEN YK, 1993, AEROSOL SCI TECH, V19, P389, DOI 10.1080/02786829308959646; CHENG KH, 1995, AEROSOL SCI TECH, V23, P465, DOI 10.1080/02786829508965329; CHENG YS, 1993, AEROSOL SCI TECH, V18, P359, DOI 10.1080/02786829308959610; COHEN BS, 1995, J AEROSOL SCI, V26, P1149, DOI 10.1016/0021-8502(95)00039-F; Covert D, 1997, AEROSOL SCI TECH, V27, P206, DOI 10.1080/02786829708965467; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dhand R, 2012, J AEROSOL MED PULM D, V25, P63, DOI 10.1089/jamp.2011.0929; Fry FA, 1970, J AEROSOL SCI, V1, P135; Geller David E, 2005, Respir Care, V50, P1313; Hanson LR, 2007, J NEUROIMMUNE PHARM, V2, P81, DOI 10.1007/s11481-006-9039-x; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Karner S, 2011, J AEROSOL SCI, V42, P428, DOI 10.1016/j.jaerosci.2011.02.010; Kelly JT, 2004, AEROSOL SCI TECH, V38, P1063, DOI 10.1080/027868290883360; Kwok PCL, 2005, J PHARM SCI-US, V94, P2789, DOI 10.1002/jps.20395; Kwok PCL, 2008, J AEROSOL SCI, V39, P211, DOI 10.1016/j.jaerosci.2007.11.004; Mancuso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036337; Misra A, 2012, CURR PHARM BIOTECHNO, V13, P2355, DOI 10.2174/138920112803341752; Mistry A, 2009, INT J PHARMACEUT, V379, P146, DOI 10.1016/j.ijpharm.2009.06.019; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Nava S, 2001, INTENS CARE MED, V27, P1627, DOI 10.1007/s001340101062; Petitot F, 2013, TOXICOL LETT, V217, P217, DOI 10.1016/j.toxlet.2012.12.022; Ribeiro P, 2012, ELECTRON ENG, P21; Schroeter JD, 2006, J AEROSOL MED, V19, P301, DOI 10.1089/jam.2006.19.301; Shi H, 2006, J BIOMECH ENG-T ASME, V128, P697, DOI 10.1115/1.2244574; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; Tao XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049304; Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Willis LD, 2012, RESP CARE, V57, P1234, DOI 10.4187/respcare.01518; Xi JX, 2008, INT J HEAT MASS TRAN, V51, P5562, DOI 10.1016/j.ijheatmasstransfer.2008.04.037; Xi JX, 2007, ANN BIOMED ENG, V35, P560, DOI 10.1007/s10439-006-9245-y; Xi JX, 2012, ANN BIOMED ENG, V40, P2579, DOI 10.1007/s10439-012-0603-7; Xi JX, 2010, SURFACTANT SCI SER, V148, P501; Xi JX, 2009, AEROSOL SCI TECH, V43, P808, DOI 10.1080/02786820902950887; Xi JX, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838039; Yaakov Y, 2007, CHEST, V132, P1219, DOI 10.1378/chest.06-2975; YU CP, 1977, B MATH BIOL, V39, P471, DOI 10.1007/BF02462925; Zeng Y, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/46/464125; Zhang L, 2002, BIOELECTROCHEMISTRY, V56, P233, DOI 10.1016/S1567-5394(02)00057-9	44	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86593	10.1371/journal.pone.0086593	http://dx.doi.org/10.1371/journal.pone.0086593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497957	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900028
J	Yi, X; Jia, W; Jin, Y; Zhen, S				Yi, Xiao; Jia, Wei; Jin, Yin; Zhen, Shang			Statin Use Is Associated with Reduced Risk of Haematological Malignancies: Evidence from a Meta-Analysis	PLOS ONE			English	Article							A REDUCTASE INHIBITORS; LOVASTATIN-INDUCED APOPTOSIS; LOWERING LDL CHOLESTEROL; NON-HODGKIN-LYMPHOMA; PRIMARY PREVENTION; MEDICAL CONDITIONS; CORONARY EVENTS; FOLLOW-UP; CANCER; CELL	Background: Several observational studies have shown that statin use may modify the risk of haematological malignancies. To quantify the association between statin use and risk for haematological malignancies, we performed a detailed meta-analysis of published studies regarding this subject. Methods: We conducted a systematic search of multiple databases including PubMed, Embase, and Cochrane Library Central database up to July 2013. Fixed-effect and random-effect models were used to estimate summary relative risks (RR) and the corresponding 95% confidence intervals (CIs). Potential sources of heterogeneity were detected by meta-regression. Subgroup analyses and sensitivity analysis were also performed. Results: A total of 20 eligible studies (ten case-control studies, four cohort studies, and six RCTs) reporting 1,139,584 subjects and 15,297 haematological malignancies cases were included. Meta-analysis showed that statin use was associated with a statistically significant 19% reduction in haematological malignancies incidence (RR = 0.81, 95% CI [0.70, 0.92]). During subgroup analyses, statin use was associated with a significantly reduced risk of haematological malignancies among observational studies (RR = 0.79, 95% CI [0.67, 0.93]), but not among RCTs (RR = 0.92, 95% CI [0.77, 1.09]). Conclusions: Based on this comprehensive meta-analysis, statin use may have chemopreventive effects against haematological malignancies. More studies, especially definitive, randomized chemoprevention trials are needed to confirm this association.	[Yi, Xiao; Jia, Wei; Jin, Yin; Zhen, Shang] Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yi, X (corresponding author), Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	dr_xiaoyi@126.com			Natural Science Foundation of Hubei Province [2012FFB02435]; central university special funding [2013QN191]	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); central university special funding	This work was supported by Natural Science Foundation of Hubei Province (No. 2012FFB02435) and the central university special funding (No. 2013QN191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046691; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Chao C, 2011, AIDS, V25, P1771, DOI 10.1097/QAD.0b013e328349c67a; Coogan PF, 2007, EPIDEMIOLOGY, V18, P213, DOI 10.1097/01.ede.0000254694.03027.a1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitroulakos J, 2002, NEOPLASIA, V4, P337, DOI 10.1038/sj.neo.7900247; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P921, DOI 10.1158/1055-9965.EPI-05-0866; Friedman GD, 2008, PHARMACOEPIDEM DR S, V17, P27, DOI 10.1002/pds.1507; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Griner LN, 2013, BRIT J HAEMATOL, V160, P177, DOI 10.1111/bjh.12103; Gronich N, 2004, J INVEST MED, V52, P335, DOI 10.1136/jim-52-05-34; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Iwata H, 2006, CANCER SCI, V97, P133, DOI 10.1111/j.1349-7006.2006.00153.x; Jacobs EJ, 2011, CANCER RES, V71, P1763, DOI 10.1158/0008-5472.CAN-10-2953; Kusama T, 2002, GASTROENTEROLOGY, V122, P308, DOI 10.1053/gast.2002.31093; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Landgren O, 2006, CANCER EPIDEM BIOMAR, V15, P2342, DOI 10.1158/1055-9965.EPI-06-0097; Lutski M, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120005; Matar P, 1999, CLIN EXP METASTAS, V17, P19; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Romano M, 2000, LAB INVEST, V80, P1095, DOI 10.1038/labinvest.3780115; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simes RJ, 2002, LANCET, V359, P1379; Singh S, 2013, GASTROENTEROLOGY, V144, P323, DOI 10.1053/j.gastro.2012.10.005; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Traversa G, 1998, PHARMACOEPIDEM DR S, V7, P113, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9; Vinogradova Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-409; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196; Zhang YW, 2004, CANCER CAUSE CONTROL, V15, P419, DOI 10.1023/B:CACO.0000027506.55846.5d	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87019	10.1371/journal.pone.0087019	http://dx.doi.org/10.1371/journal.pone.0087019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498014	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900060
J	Capitini, C; Conti, S; Perni, M; Guidi, F; Cascella, R; De Poli, A; Penco, A; Relini, A; Cecchi, C; Chiti, F				Capitini, Claudia; Conti, Simona; Perni, Michele; Guidi, Francesca; Cascella, Roberta; De Poli, Angela; Penco, Amanda; Relini, Annalisa; Cecchi, Cristina; Chiti, Fabrizio			TDP-43 Inclusion Bodies Formed in Bacteria Are Structurally Amorphous, Non-Amyloid and Inherently Toxic to Neuroblastoma Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; C-TERMINAL FRAGMENTS; PROTEIN AGGREGATION; ESCHERICHIA-COLI; NEURONAL INCLUSIONS; SECONDARY STRUCTURE; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ALS	Accumulation of ubiquitin-positive, tau-and a-synuclein-negative intracellular inclusions of TDP-43 in the central nervous system represents the major hallmark correlated to amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions. Such inclusions have variably been described as amorphous aggregates or more structured deposits having an amyloid structure. Following the observations that bacterial inclusion bodies generally consist of amyloid aggregates, we have overexpressed full-length TDP-43 and C-terminal TDP-43 in E. coli, purified the resulting full-length and C-terminal TDP-43 containing inclusion bodies (FL and Ct TDP-43 IBs) and subjected them to biophysical analyses to assess their structure/morphology. We show that both FL and Ct TDP-43 aggregates contained in the bacterial IBs do not bind amyloid dyes such as thioflavin T and Congo red, possess a disordered secondary structure, as inferred using circular dichroism and infrared spectroscopies, and are susceptible to proteinase K digestion, thus possessing none of the hallmarks for amyloid. Moreover, atomic force microscopy revealed an irregular structure for both types of TDP-43 IBs and confirmed the absence of amyloid-like species after proteinase K treatment. Cell biology experiments showed that FL TDP-43 IBs were able to impair the viability of cultured neuroblastoma cells when added to their extracellular medium and, more markedly, when transfected into their cytosol, where they are at least in part ubiquitinated and phosphorylated. These data reveal an inherently high propensity of TDP-43 to form amorphous aggregates, which possess, however, an inherently high ability to cause cell dysfunction. This indicates that a gain of toxic function caused by TDP-43 deposits is effective in TDP-43 pathologies, in addition to possible loss of function mechanisms originating from the cellular mistrafficking of the protein.	[Capitini, Claudia; Conti, Simona; Perni, Michele; Guidi, Francesca; Cascella, Roberta; De Poli, Angela; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Biochem Sect, Dept Biomed Expt & Clin Sci, Florence, Italy; [Penco, Amanda; Relini, Annalisa] Univ Genoa, Dept Phys, Genoa, Italy	University of Florence; University of Genoa	Chiti, F (corresponding author), Univ Florence, Biochem Sect, Dept Biomed Expt & Clin Sci, Florence, Italy.	fabrizio.chiti@unifi.it	Relini, Annalisa/AHC-3105-2022; Cascella, Roberta/K-5122-2016	Cecchi, Cristina/0000-0001-8387-7737; RELINI, ANNALISA/0000-0002-4040-9279; Capitini, Claudia/0000-0003-2834-1424; Cascella, Roberta/0000-0001-9856-6843	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA); "fondi di Ateneo" of the University of Genoa; Istituto Nazionale di Biostrutture e Biosistemi (INBB)	Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA); "fondi di Ateneo" of the University of Genoa; Istituto Nazionale di Biostrutture e Biosistemi (INBB)	This work was supported by a pilot grant from the Agenzia di Ricerca per la Sclerosi Laterale Amiotrofica (AriSLA) and by "fondi di Ateneo" of the University of Genoa. RC was supported by the Istituto Nazionale di Biostrutture e Biosistemi (INBB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Ami D, 2003, BBA-GEN SUBJECTS, V1624, P6, DOI 10.1016/j.bbagen.2003.09.008; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Duan W, 2010, NEUROSCIENCE, V169, P1621, DOI 10.1016/j.neuroscience.2010.06.018; Evangelisti E, 2013, CURR ALZHEIMER RES, V10, P143, DOI 10.2174/1567205011310020004; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x; Gatti-Lafranconi P, 2011, FEBS J, V278, P2408, DOI 10.1111/j.1742-4658.2011.08163.x; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jurgen B, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-41; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; MaachupalliReddy J, 1997, BIOTECHNOL PROGR, V13, P144, DOI 10.1021/bp970008l; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nyrkova IA, 2000, EUR PHYS J B, V17, P499, DOI 10.1007/s100510070128; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; PRZYBYCIEN TM, 1994, PROTEIN ENG, V7, P131, DOI 10.1093/protein/7.1.131; Ramshini H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016075; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Sabate R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-56; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sicorello A, 2009, BIOPHYS J, V96, P2289, DOI 10.1016/j.bpj.2008.11.042; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Umetsu M, 2004, FEBS LETT, V557, P49, DOI 10.1016/S0014-5793(03)01441-8; VALAX P, 1993, BIOTECHNOL PROGR, V9, P539, DOI 10.1021/bp00023a014; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Wang L, 2009, PRION, V3, P139, DOI 10.4161/pri.3.3.9922; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wasmer C, 2009, ANGEW CHEM INT EDIT, V48, P4858, DOI 10.1002/anie.200806100; Wright D, 2013, PHOTOCHEM PHOTOBIOL, V89, P442, DOI 10.1111/j.1751-1097.2012.01231.x; Zampagni M, 2011, J CELL MOL MED, V15, P2106, DOI 10.1111/j.1582-4934.2010.01239.x	49	56	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86720	10.1371/journal.pone.0086720	http://dx.doi.org/10.1371/journal.pone.0086720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497973	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100027
J	Jiang, ZY; Cai, Q; Chen, EZ				Jiang, Zhao-Yan; Cai, Qu; Chen, Er-Zhen			Association of Three Common Single Nucleotide Polymorphisms of ATP Binding Cassette G8 Gene with Gallstone Disease: A Meta-Analysis	PLOS ONE			English	Article							CHOLESTEROL TRANSPORTER ABCG8; RISK; EXPRESSION; VARIANT; LIVER; SUSCEPTIBILITY; METABOLISM; PROTEINS; SWEDISH; NPC1L1	Background: In this study, we evaluated the association between these polymorphisms and gallstone disease using meta-analysis and compared the hepatic ABCG5/G8 mRNA expression and biliary lipids composition in patients with different genotypes of T400K and Y54C. Methods: Data were analyzed using the Stata/SE 11.0 software and a random-effects model was applied irrespective of between-study heterogeneity. Hepatic mRNA expression of ABCG5/G8 genes in 182 patients with gallstone disease and 35 gallstone-free patients who underwent cholecystectomy were determined using real-time PCR. Genotypes of Y54C and T400K in the ABCG8 gene were determined by allelic discrimination using either genomic DNA or hepatic cDNA as template by Taqman assays. Biliary compostion in gallbladder bile was assayed in these patients as well. Results: Ten papers including 13 cohorts were included for the final analysis. In the genotype model, the overall association between genotype with gallstone was significant for D19H (OR = 2.43, 95%CI: 2.23-2.64, P < 0.001), and for Y54C (OR = 1.36, 95%CI: 1.01-1.83, P = 0.044), or T400K (OR = 1.17, 95%CI: 0.96-1.43. P = 0.110). In allele model, minor alleles of D19H polymorphism (allele D: OR = 2.25, 95%CI: 2.10-2.42, P < 0.001) and of T400K polymorphism (allele K: OR = 1.18, 95%CI: 1.06-1.31, P < 0.001) were related with an increased risk of gallstone disease. However, minor allele of Y54C polymorphism (allele Y, OR = 1.08, 95%CI: 0.96-1.21, P = 0.146) was not related with gallstone disease. I-2 statistics indicated no significant between-study heterogeneity for all genetic models for any of the three polymorphisms. Funnel plot and Egger's test suggested the absence of publication bias as well. However, no association of T400K and Y54C polymorphism with hepatic ABCG8/G5 mRNA expression or biliary lipids composition was found. Conclusions: Our study showed strong association of D19H polymorphism with gallstone disease. T400K and Y54C polymorphism, though to a less extent, may also relate with gallstone disease.	[Jiang, Zhao-Yan; Cai, Qu] Shanghai Inst Digest Surg, Dept Surg, Shanghai, Peoples R China; [Chen, Er-Zhen] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Jiang, ZY (corresponding author), Shanghai Inst Digest Surg, Dept Surg, Shanghai, Peoples R China.	zhaoyanjiang@gmail.com; chenerzhen@hotmail.com			National Natural Science Foundation [81070367, 81270537]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation (No. 81070367 and No. 81270537). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertomeu A, 1996, GASTROENTEROLOGY, V111, P1603, DOI 10.1016/S0016-5085(96)70023-9; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; CAREY MC, 1978, J LIPID RES, V19, P945; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Cui W, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-17; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grunhage F, 2007, HEPATOLOGY, V46, P793, DOI 10.1002/hep.21847; Gustafsson U, 2000, EUR J CLIN INVEST, V30, P1099, DOI 10.1046/j.1365-2362.2000.00740.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jaime SC, 2010, WORLD J GASTROENTERO, V16, P4685, DOI 10.3748/wjg.v16.i37.4685; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; Jiang ZY, 2009, BIOCHEM BIOPH RES CO, V379, P49, DOI 10.1016/j.bbrc.2008.11.131; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; Katsika D, 2010, J INTERN MED, V268, P279, DOI 10.1111/j.1365-2796.2010.02249.x; Klett EL, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-21; Kuo KK, 2008, BRIT J SURG, V95, P1005, DOI 10.1002/bjs.6178; Marschall HU, 2010, BIOCHEM BIOPH RES CO, V396, P58, DOI 10.1016/j.bbrc.2010.02.143; Plat J, 2005, J LIPID RES, V46, P68, DOI 10.1194/jlr.M400210-JLR200; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Siddapuram SP, 2010, J GASTROEN HEPATOL, V25, P1093, DOI 10.1111/j.1440-1746.2010.06309.x; Srivastava A, 2010, J GASTROEN HEPATOL, V25, P1758, DOI 10.1111/j.1440-1746.2010.06349.x; Stender S, 2011, HEPATOLOGY, V53, P640, DOI 10.1002/hep.24046; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; van Erpecum KJ, 2006, J LIPID RES, V47, P32, DOI 10.1194/jlr.M500180-JLR200; von Kampen O, 2013, HEPATOLOGY, V57, P2407, DOI 10.1002/hep.26009; Wang Y, 2007, CLIN CHIM ACTA, V384, P80, DOI 10.1016/j.cca.2007.06.004; Xu HL, 2011, CARCINOGENESIS, V32, P58, DOI 10.1093/carcin/bgq194; Xue P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045849; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	32	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87200	10.1371/journal.pone.0087200	http://dx.doi.org/10.1371/journal.pone.0087200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498041	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100057
J	Paul, NA; Svensson, CJ; de Nys, R; Steinberg, PD				Paul, Nicholas A.; Svensson, Carl Johan; de Nys, Rocky; Steinberg, Peter D.			Simple Growth Patterns Can Create Complex Trajectories for the Ontogeny of Constitutive Chemical Defences in Seaweeds	PLOS ONE			English	Article							ALGA ASPARAGOPSIS-ARMATA; LONG-DISTANCE TRANSPORT; NUTRIENT AVAILABILITY; PHLOROTANNIN PRODUCTION; HERBIVORY; RESISTANCE; ALLOCATION; CHEMISTRY; SELECTION; COSTS	All of the theory and most of the data on the ecology and evolution of chemical defences derive from terrestrial plants, which have considerable capacity for internal movement of resources. In contrast, most macroalgae - seaweeds - have no or very limited capacity for resource translocation, meaning that trade-offs between growth and defence, for example, should be localised rather than systemic. This may change the predictions of chemical defence theories for seaweeds. We developed a model that mimicked the simple growth pattern of the red seaweed Asparagopsis armata which is composed of repeating clusters of somatic cells and cells which contain deterrent secondary chemicals (gland cells). To do this we created a distinct growth curve for the somatic cells and another for the gland cells using empirical data. The somatic growth function was linked to the growth function for defence via differential equations modelling, which effectively generated a trade-off between growth and defence as these neighbouring cells develop. By treating growth and defence as separate functions we were also able to model a trade-off in growth of 2-3% under most circumstances. However, we found contrasting evidence for this trade-off in the empirical relationships between growth and defence, depending on the light level under which the alga was cultured. After developing a model that incorporated both branching and cell division rates, we formally demonstrated that positive correlations between growth and defence are predicted in many circumstances and also that allocation costs, if they exist, will be constrained by the intrinsic growth patterns of the seaweed. Growth patterns could therefore explain contrasting evidence for cost of constitutive chemical defence in many studies, highlighting the need to consider the fundamental biology and ontogeny of organisms when assessing the allocation theories for defence.	[Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Svensson, Carl Johan] Univ Gothenburg, Dept Marine Ecol, Gothenburg, Sweden; [Steinberg, Peter D.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Steinberg, Peter D.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	James Cook University; University of Gothenburg; University of New South Wales Sydney; University of New South Wales Sydney	Paul, NA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	nicholas.paul@jcu.edu.au	de Nys, Rocky/D-6741-2012; Paul, Nicholas/B-6496-2009	de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535; Svensson, Carl Johan/0000-0002-8265-9313; Steinberg, Peter/0000-0002-1781-0726	Australian Research Council; Swedish research council FORMAS [2007-449]	Australian Research Council(Australian Research Council); Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This study was jointly funded by the Australian Research Council ( P. D. S) and the Swedish research council FORMAS, project No. 2007-449. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Barton KE, 2007, AM J BOT, V94, P56, DOI 10.3732/ajb.94.1.56; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; BJORKMAN C, 1991, OECOLOGIA, V86, P202, DOI 10.1007/BF00317532; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; BRYANT JP, 1995, J CHEM ECOL, V21, P883, DOI 10.1007/BF02033796; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Cronin G, 2001, CRC MAR SCI, P325; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; DIOURIS M, 1984, MAR BIOL, V78, P199, DOI 10.1007/BF00394701; Dworjanyn SA, 2006, OIKOS, V113, P13; Elger A, 2009, OIKOS, V118, P767, DOI 10.1111/j.1600-0706.2009.17206.x; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Hay KB, 2011, J ECOL, V99, P1540, DOI 10.1111/j.1365-2745.2011.01874.x; HERMS DA, 1992, Q REV BIOL, V67, P478; Jasienski M, 1999, OIKOS, V84, P321, DOI 10.2307/3546729; Jormalainen V, 2004, J EVOLUTION BIOL, V17, P807, DOI 10.1111/j.1420-9101.2004.00715.x; Jormalainen V, 2009, OIKOS, V118, P713, DOI 10.1111/j.1600-0706.2008.17178.x; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Koricheva J, 1999, OECOLOGIA, V119, P467, DOI 10.1007/s004420050809; Luning K, 1981, BIOL SEAWEEDS, P326; Lynch M., 1998, GENETICS ANAL QUANTI; Mata L, 2006, AQUACULTURE, V252, P12, DOI 10.1016/j.aquaculture.2005.11.045; Mata L, 2010, J APPL PHYCOL, V22, P639, DOI 10.1007/s10811-010-9504-z; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; MCCONNELL O, 1977, PHYTOCHEMISTRY, V16, P367, DOI 10.1016/0031-9422(77)80067-8; McKey D., 1979, HERBIVORES THEIR INT, P55; Monro K, 2007, EVOL ECOL, V21, P765, DOI 10.1007/s10682-006-9150-8; Nylund GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061291; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Paul NA, 2006, J PHYCOL, V42, P637, DOI 10.1111/j.1529-8817.2006.00226.x; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Paul NA, 2006, MAR ECOL PROG SER, V323, P1, DOI 10.3354/meps323001; Pavia H, 1999, J ECOL, V87, P761, DOI 10.1046/j.1365-2745.1999.00397.x; Pavia H, 2002, ECOLOGY, V83, P891; Powers SJ, 2003, J THEOR BIOL, V222, P219, DOI 10.1016/S0022-5193(03)00030-4; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Raven JA, 2003, PLANT CELL ENVIRON, V26, P73, DOI 10.1046/j.1365-3040.2003.00920.x; Simms E. L., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P392; STEINBERG PD, 1984, SCIENCE, V223, P405, DOI 10.1126/science.223.4634.405; STEINBERG PD, 1995, OECOLOGIA, V102, P169, DOI 10.1007/BF00333248; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Toth GB, 2005, ECOLOGY, V86, P612, DOI 10.1890/04-0484; Verges A, 2008, ECOLOGY, V89, P1334, DOI 10.1890/07-0248.1; Wright JT, 2004, ECOLOGY, V85, P2946, DOI 10.1890/03-4041; YATES JL, 1993, ECOLOGY, V74, P1757, DOI 10.2307/1939934	48	5	5	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86893	10.1371/journal.pone.0086893	http://dx.doi.org/10.1371/journal.pone.0086893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497991	Green Accepted, Green Published, gold			2022-12-27	WOS:000330617100038
J	Pulcu, E; Lythe, K; Elliott, R; Green, S; Moll, J; Deakin, JFW; Zahn, R				Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Green, Sophie; Moll, Jorge; Deakin, John F. W.; Zahn, Roland			Increased Amygdala Response to Shame in Remitted Major Depressive Disorder	PLOS ONE			English	Article							NEURAL RESPONSE; ANTIDEPRESSANT TREATMENT; MORAL COGNITION; INSULAR CORTEX; MOOD STATE; GUILT; SELF; METAANALYSIS; BEHAVIOR; FACES	Proneness to self-blaming moral emotions such as shame and guilt is increased in major depressive disorder (MDD), and may play an important role in vulnerability even after symptoms have subsided. Social psychologists have argued that shame-proneness is relevant for depression vulnerability and is distinct from guilt. Shame depends on the imagined critical perception of others, whereas guilt results from one's own judgement. The neuroanatomy of shame in MDD is unknown. Using fMRI, we compared 21 participants with MDD remitted from symptoms with no current co-morbid axis-I disorders, and 18 control participants with no personal or family history of MDD. The MDD group exhibited higher activation of the right amygdala and posterior insula for shame relative to guilt (SPM8). This neural difference was observed despite equal levels of rated negative emotional valence and frequencies of induced shame and guilt experience across groups. These same results were found in the medication-free MDD subgroup (N = 15). Increased amygdala and posterior insula activations, known to be related to sensory perception of emotional stimuli, distinguish shame from guilt responses in remitted MDD. People with MDD thus exhibit changes in the neural response to shame after symptoms have subsided. This supports the hypothesis that shame and guilt play at least partly distinct roles in vulnerability to MDD. Shame-induction may be a more sensitive probe of residual amygdala hypersensitivity in MDD compared with facial emotion-evoked responses previously found to normalize on remission.	[Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Green, Sophie; Deakin, John F. W.; Zahn, Roland] Univ Manchester, Manchester, Lancs, England; [Pulcu, Erdem; Lythe, Karen; Elliott, Rebecca; Deakin, John F. W.] Manchester Acad Hlth Sci Ctr, Sch Med, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Lythe, Karen; Green, Sophie; Zahn, Roland] Manchester Acad Hlth Sci Ctr, Sch Psychol Sci, Neurosci & Aphasia Res Unit, Manchester, Lancs, England; [Moll, Jorge] DOr Inst Res & Educ IDOR, Cognit & Behav Neurosci Unit, Rio De Janeiro, Brazil; [Zahn, Roland] Kings Coll London, Inst Psychiat, Dept Psychol Med, Ctr Affect Disorders, London WC2R 2LS, England	University of Manchester; University of Manchester; University of Manchester; IDOR - Instituto D'Or de Ensino e Pesquisa; University of London; King's College London	Zahn, R (corresponding author), Univ Manchester, Manchester, Lancs, England.	roland.zahn@kcl.ac.uk	Moll, Jorge/AAF-8388-2021; Zahn, Roland/C-4665-2008; Zahn, Roland/O-8944-2019	Moll, Jorge/0000-0002-4297-591X; Zahn, Roland/0000-0002-8447-1453; Zahn, Roland/0000-0002-8447-1453; Elliott, Rebecca/0000-0002-7602-010X; Deakin, John/0000-0002-2750-962X; Pulcu, Erdem/0000-0002-2170-0677	Medical Research Council Clinician Scientist Fellowship [G0902304]; MRC [G0902304] Funding Source: UKRI; Medical Research Council [G0902304] Funding Source: researchfish	Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been funded by a Medical Research Council Clinician Scientist Fellowship to RZ (G0902304). http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnone D, 2012, AM J PSYCHIAT, V169, P841, DOI 10.1176/appi.ajp.2012.11121774; Basile B, 2011, HUM BRAIN MAPP, V32, P229, DOI 10.1002/hbm.21009; Berthoz S, 2006, NEUROIMAGE, V31, P945, DOI 10.1016/j.neuroimage.2005.12.039; Bhagwagar Z, 2008, PSYCHOL MED, V38, P307, DOI 10.1017/S0033291707001250; Bjornsdotter M, 2009, J NEUROSCI, V29, P9314, DOI 10.1523/JNEUROSCI.0400-09.2009; Brett M., 2002, 8 INT C FUNCT MAPP H; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Delvecchio G, 2012, EUR NEUROPSYCHOPHARM, V22, P100, DOI 10.1016/j.euroneuro.2011.07.003; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Eaton WW, 2008, ARCH GEN PSYCHIAT, V65, P513, DOI 10.1001/archpsyc.65.5.513; Ellison RH, 2010, NEW HISTORY OF THE SERMON: THE NINETEENTH CENTURY, P1, DOI 10.1163/ej.9789004185722.i-571.7; Fessler D. M. T., 1999, NATURE NURTURE BIOCU, P75; First MB, 2002, STRUCTURED CLIN INTE; Freud S, 1918, INT Z ARZTL PSYCHOAN, V4, P288; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gilbert P, 2009, PSYCHOL PSYCHOTHER-T, V82, P123, DOI 10.1348/147608308X379806; Green S, 2012, ARCH GEN PSYCHIAT, V173; Green S, 2013, PSYCHOPATHOLOGY; Green S, 2010, NEUROIMAGE, V52, P1720, DOI 10.1016/j.neuroimage.2010.05.038; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Groenewold NA, 2013, NEUROSCI BIOBEHAV R, V37, P152, DOI 10.1016/j.neubiorev.2012.11.015; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Kayhan G, 2002, J AFFECT DISORDERS, V68, P307, DOI 10.1016/S0165-0327(01)00335-4; Kedia G, 2008, J COGNITIVE NEUROSCI, V20, P1788, DOI 10.1162/jocn.2008.20070; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; Michl P, 2012, SOC COGN AFFECT NEUR; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Moll J, 2007, SOC NEUROSCI-UK, V2, P336, DOI 10.1080/17470910701392024; Morey RA, 2012, NEUROIMAGE, V60, P683, DOI 10.1016/j.neuroimage.2011.12.069; Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006; Neumeister A, 2006, NEUROPSYCHOPHARMACOL, V31, P1750, DOI 10.1038/sj.npp.1301010; Norbury R, 2010, PSYCHOL MED, V40, P425, DOI 10.1017/S0033291709990596; Northoff G, 2007, J AFFECT DISORDERS, V104, P1, DOI 10.1016/j.jad.2007.02.012; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; O'Connor LE, 2002, J AFFECT DISORDERS, V71, P19, DOI 10.1016/S0165-0327(01)00408-6; O'Connor LE, 2000, BRIT J MED PSYCHOL, V73, P519, DOI 10.1348/000711200160705; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ramel W, 2007, BIOL PSYCHIAT, V61, P231, DOI 10.1016/j.biopsych.2006.05.004; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; SROUFE LA, 1977, CHILD DEV, V48, P1184, DOI 10.1111/j.1467-8624.1977.tb03922.x; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thompson RJ, 2006, COGNITIVE THER RES, V30, P415, DOI 10.1007/s10608-006-9056-3; Tracy JL, 2006, PERS SOC PSYCHOL B, V32, P1339, DOI 10.1177/0146167206290212; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wagner U, 2011, CEREB CORTEX, V21, P2461, DOI 10.1093/cercor/bhr016; Wichers M, 2010, PSYCHOL MED, V40, P359, DOI 10.1017/S0033291709990420; Zahn R, 2011, HDB HUMAN AFFECTIVE; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, NEUROSCI LETT, V457, P107, DOI 10.1016/j.neulet.2009.03.090; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	67	33	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86900	10.1371/journal.pone.0086900	http://dx.doi.org/10.1371/journal.pone.0086900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497992	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100039
J	Nguyen, MT; Denniston, R; Nguyen, HTT; Hoang, TA; Ross, H; So, AD				Minh Thac Nguyen; Denniston, Ryan; Hien Thi Thu Nguyen; Tuan Anh Hoang; Ross, Hana; So, Anthony D.			The Empirical Analysis of Cigarette Tax Avoidance and Illicit Trade in Vietnam, 1998-2010	PLOS ONE			English	Article							UNITED-STATES; CONSUMPTION	Illicit trade carries the potential to magnify existing tobacco-related health care costs through increased availability of untaxed and inexpensive cigarettes. What is known with respect to the magnitude of illicit trade for Vietnam is produced primarily by the industry, and methodologies are typically opaque. Independent assessment of the illicit cigarette trade in Vietnam is vital to tobacco control policy. This paper measures the magnitude of illicit cigarette trade for Vietnam between 1998 and 2010 using two methods, discrepancies between legitimate domestic cigarette sales and domestic tobacco consumption estimated from surveys, and trade discrepancies as recorded by Vietnam and trade partners. The results indicate that Vietnam likely experienced net smuggling in during the period studied. With the inclusion of adjustments for survey respondent under-reporting, inward illicit trade likely occurred in three of the four years for which surveys were available. Discrepancies in trade records indicate that the value of smuggled cigarettes into Vietnam ranges from $100 million to $300 million between 2000 and 2010 and that these cigarettes primarily originate in Singapore, Hong Kong, Macao, Malaysia, and Australia. Notable differences in trends over time exist between the two methods, but by comparison, the industry estimates consistently place the magnitude of illicit trade at the upper bounds of what this study shows. The unavailability of annual, survey-based estimates of consumption may obscure the true, annual trend over time. Second, as surveys changed over time, estimates relying on them may be inconsistent with one another. Finally, these two methods measure different components of illicit trade, specifically consumption of illicit cigarettes regardless of origin and smuggling of cigarettes into a particular market. However, absent a gold standard, comparisons of different approaches to illicit trade measurement serve efforts to refine and improve measurement approaches and estimates.	[Minh Thac Nguyen] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Denniston, Ryan] Duke Univ, Sanford Sch Publ Policy, Program Global Hlth & Technol Access, Durham, NC USA; [Hien Thi Thu Nguyen; Tuan Anh Hoang] Vietnam Univ Commerce, Dept Econ, Hanoi, Vietnam; [Ross, Hana] Amer Canc Soc, Atlanta, GA 30329 USA; [So, Anthony D.] Duke Univ, Sanford Sch Publ Policy, Program Global Hlth & Technol Access, Durham, NC USA; [So, Anthony D.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Duke University; Thuongmai University; American Cancer Society; Duke University; Duke University	Nguyen, MT (corresponding author), Univ Illinois, Dept Econ, Chicago, IL 60680 USA.	mnguye43@uic.edu	Pavananunt, Pirudee/E-7537-2015	Ross, Hana/0000-0001-5799-1915	National Institutes of Health Fogarty International Center [R01TW007924]; Southeast Asian Tobacco Control Alliance; American Cancer Society; FOGARTY INTERNATIONAL CENTER [R01TW007924] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Southeast Asian Tobacco Control Alliance; American Cancer Society(American Cancer Society); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project received support from the National Institutes of Health Fogarty International Center (Grant Number R01TW007924), awarded to Duke University's Program on Global Health and Technology Access in collaboration with the Southeast Asian Tobacco Control Alliance and the American Cancer Society. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaglehole R., 2003, WORLD HLTH REPORT 20; Bhagwati J, 1964, OXFORD B ECON STAT, V27, P389, DOI [10.1111/j.1468-0084.1964.mp27004007.x, DOI 10.1111/J.1468-0084.1964.MP27004007.X]; Collin J, 2004, TOB CONTROL, V13, P104, DOI 10.1136/tc.2004.009357; Community Research and Development Services, 2009, UNPUB; Ferrantino MJ, 2008, CHINA ECON REV, V19, P502, DOI 10.1016/j.chieco.2008.02.002; Gallus S, 2011, TOB CONTROL, V20, P34, DOI 10.1136/tc.2009.034132; Guindon GE., 2010, TOBACCO TAXATION VIE; HATZIANDREU EJ, 1989, AM J PUBLIC HEALTH, V79, P1020, DOI 10.2105/AJPH.79.8.1020; JACKSON R, 1985, AM J EPIDEMIOL, V122, P341, DOI 10.1093/oxfordjournals.aje.a114106; Joosens L, 2009, ELIMINATING GLOBAL I; Joossens L, 2003, TOB CONTROL, V12, P119, DOI 10.1136/tc.12.2.119; Khue LN, 2011, J PRACTICAL MED, V4; Lee K, 2008, Glob Public Health, V3, P1, DOI 10.1080/17441690701589789; Merriman D, 2002, EC TOBACCO TOOLKIT; Ministry of Health, 2010, GLOB AD TOB SURV VIE; Nguyen TTH, 2005, CIGARETTE SMUGGLING; Southeast Asia Tobacco Control Alliance, 2012, ASEAN TOB TAX REP CA; Van Kinh H, 2003, EC SOCIAL HLTH ISSUE, P144; VINATABA, 2009, VIN NEWSL 1; Vincent JR, 2004, 3261 WORLD BANK, DOI [10.1596/1813-9450-3261., DOI 10.1596/1813-9450-3261]; WHO, 2011, JOINT NAT CAP ASS IM; World Health Organization, 1999, TOB US VIETN MAJ HLT	22	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87272	10.1371/journal.pone.0087272	http://dx.doi.org/10.1371/journal.pone.0087272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489886	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000128
J	Rieucau, G; Boswell, KM; De Robertis, A; Macaulay, GJ; Handegard, NO				Rieucau, Guillaume; Boswell, Kevin M.; De Robertis, Alex; Macaulay, Gavin J.; Handegard, Nils Olav			Experimental Evidence of Threat-Sensitive Collective Avoidance Responses in a Large Wild-Caught Herring School	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; PREDATOR-PREY INTERACTIONS; CLUPEA-HARENGUS; INFORMATION-TRANSFER; VISUAL INFORMATION; MULTIBEAM SONAR; ESCAPE BEHAVIOR; MULTIPLE CUES; SHOAL SIZE; FISH	Aggregation is commonly thought to improve animals' security. Within aquatic ecosystems, group-living prey can learn about immediate threats using cues perceived directly from predators, or from collective behaviours, for example, by reacting to the escape behaviours of companions. Combining cues from different modalities may improve the accuracy of prey antipredatory decisions. In this study, we explored the sensory modalities that mediate collective antipredatory responses of herring (Clupea harengus) when in a large school (approximately 60 000 individuals). By conducting a simulated predator encounter experiment in a semi-controlled environment (a sea cage), we tested the hypothesis that the collective responses of herring are threat-sensitive. We investigated whether cues from potential threats obtained visually or from the perception of water displacement, used independently or in an additive way, affected the strength of the collective avoidance reactions. We modified the sensory nature of the simulated threat by exposing the herring to 4 predator models differing in shape and transparency. The collective vertical avoidance response was observed and quantified using active acoustics. The combination of sensory cues elicited the strongest avoidance reactions, suggesting that collective antipredator responses in herring are mediated by the sensory modalities involved during threat detection in an additive fashion. Thus, this study provides evidence for magnitude-graded threat responses in a large school of wild-caught herring which is consistent with the "threat-sensitive hypothesis".	[Rieucau, Guillaume; Macaulay, Gavin J.; Handegard, Nils Olav] Inst Marine Res, N-5024 Bergen, Norway; [Boswell, Kevin M.] Florida Int Univ, North Miami, FL USA; [De Robertis, Alex] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	Institute of Marine Research - Norway; State University System of Florida; Florida International University; National Oceanic Atmospheric Admin (NOAA) - USA	Rieucau, G (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	guillaume.rieucau@imr.no	Boswell, Kevin M./B-6380-2016; Handegard, Nils Olav/I-3047-2012	Boswell, Kevin M./0000-0002-2037-1541; Handegard, Nils Olav/0000-0002-9708-9042; Macaulay, Gavin/0000-0003-2518-6537; Rieucau, Guillaume/0000-0002-8968-4992	Norwegian Research Council [204229/F20]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was financed by the Norwegian Research Council (grant 204229/F20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Axelsen BE, 2001, CAN J ZOOL, V79, P1586, DOI 10.1139/cjz-79-9-1586; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Brown GE, 2006, CAN J ZOOL, V84, P1, DOI 10.1139/Z05-166; Brown GE, 2003, ETHOLOGY, V109, P739, DOI 10.1046/j.1439-0310.2003.00919.x; BROWN GE, 1995, J FISH BIOL, V47, P387; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dionne M, 2002, CAN J ZOOL, V80, P2006, DOI 10.1139/Z02-176; Doksaeter L, 2012, J ACOUST SOC AM, V131, P1632, DOI 10.1121/1.3675944; Doksaeter L, 2009, J ACOUST SOC AM, V125, P554, DOI [10.1121/1.3021301, 10.1121/1.4784426]; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; DOMENICI P, 1994, J FISH BIOL, V45, P97, DOI 10.1111/j.1095-8649.1994.tb01086.x; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Ferno A, 1998, SARSIA, V83, P149; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V63, P113, DOI 10.1007/s00265-008-0641-1; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; Giske J, 1998, REV FISH BIOL FISHER, V8, P57, DOI 10.1023/A:1008864517488; GODIN JGJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P105, DOI 10.1007/BF00295142; GRAY JAB, 1991, J MAR BIOL ASSOC UK, V71, P83, DOI 10.1017/S0025315400037413; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hettyey A, 2012, BIOL J LINN SOC, V106, P820, DOI 10.1111/j.1095-8312.2012.01923.x; Holmin AJ, 2013, ANAL MULTIBEAM SONAR; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ioannou CC, 2008, BEHAV ECOL, V19, P126, DOI 10.1093/beheco/arm109; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kim JW, 2009, J FISH BIOL, V74, P1280, DOI 10.1111/j.1095-8649.2009.02199.x; Knudsen FR, 1997, J FISH BIOL, V51, P824, DOI 10.1006/jfbi.1997.0486; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Leduc AOHC, 2010, CAN J ZOOL, V88, P398, DOI 10.1139/Z10-016; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lima Steven L., 2005, P166; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; MAGURRAN AE, 1985, Z TIERPSYCHOL, V67, P167; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; MAGURRAN AE, 1986, J FISH BIOL, V29, P159, DOI 10.1111/j.1095-8649.1986.tb05007.x; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Marras S, 2012, ADAPT BEHAV, V20, P44, DOI 10.1177/1059712311426799; METCALFE NB, 1987, ANIM BEHAV, V35, P901, DOI 10.1016/S0003-3472(87)80125-2; MISUND OA, 1993, ICES J MAR SCI, V50, P145, DOI 10.1006/jmsc.1993.1016; Natale GS, 2011, ACTA ZOOL-STOCKHOLM, V92, P46, DOI 10.1111/j.1463-6395.2009.00445.x; Nottestad L, 1999, CAN J ZOOL, V77, P1540, DOI 10.1139/cjz-77-10-1540; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Pecor KW, 2003, ETHOLOGY, V109, P97, DOI 10.1046/j.1439-0310.2003.00834.x; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; Pitcher TJ, 1996, ICES J MAR SCI, V53, P449, DOI 10.1006/jmsc.1996.0063; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Radakov D. V., 1973, SCH ECOLOGY FISH; SEGHERS BH, 1981, ENVIRON BIOL FISH, V6, P21, DOI 10.1007/BF00001795; Skaret G, 2006, FISH RES, V78, P359, DOI 10.1016/j.fishres.2005.11.007; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Vabo R, 2002, FISH RES, V58, P59, DOI 10.1016/S0165-7836(01)00360-5; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; WEBB PW, 1982, J COMP PHYSIOL, V147, P371, DOI 10.1007/BF00609671; WEBB PW, 1980, COMP BIOCHEM PHYS A, V65, P231, DOI 10.1016/0300-9629(80)90230-3; Wilson B, 2002, CAN J FISH AQUAT SCI, V59, P542, DOI 10.1139/F02-029; Wilson M, 2011, J EXP BIOL, V214, P22, DOI 10.1242/jeb.043323; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668	63	21	21	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86726	10.1371/journal.pone.0086726	http://dx.doi.org/10.1371/journal.pone.0086726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489778	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000065
J	Sriram, U; Xu, J; Chain, RW; Varghese, L; Chakhtoura, M; Bennett, HL; Zoltick, PW; Gallucci, S				Sriram, Uma; Xu, Jun; Chain, Robert W.; Varghese, Linda; Chakhtoura, Marita; Bennett, Heather L.; Zoltick, Philip W.; Gallucci, Stefania			IL-4 Suppresses the Responses to TLR7 and TLR9 Stimulation and Increases the Permissiveness to Retroviral Infection of Murine Conventional Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CYTOKINE SIGNALING SOCS; SINGLE-STRANDED RNA; I INTERFERON; HIV-1 TRANSMISSION; IMMUNITY; VIRUS; RECOGNITION; EXPRESSION; DISTINCT	Th2-inducing pathological conditions such as parasitic diseases increase susceptibility to viral infections through yet unclear mechanisms. We have previously reported that IL-4, a pivotal Th2 cytokine, suppresses the response of murine bone-marrow- derived conventional dendritic cells (cDCs) and splenic DCs to Type I interferons (IFNs). Here, we analyzed cDC responses to TLR7 and TLR9 ligands, R848 and CpGs, respectively. We found that IL-4 suppressed the gene expression of IFN beta and IFN-responsive genes (IRGs) upon TLR7 and TLR9 stimulation. IL-4 also inhibited IFN-dependent MHC Class I expression and amplification of IFN signaling pathways triggered upon TLR stimulation, as indicated by the suppression of IRF7 and STAT2. Moreover, IL-4 suppressed TLR7-and TLR9-induced cDC production of pro-inflammatory cytokines such as TNF alpha, IL-12p70 and IL-6 by inhibiting IFN-dependent and NFkB-dependent responses. IL-4 similarly suppressed TLR responses in splenic DCs. IL-4 inhibition of IRGs and pro-inflammatory cytokine production upon TLR7 and TLR9 stimulation was STAT6-dependent, since DCs from STAT6-KO mice were resistant to the IL-4 suppression. Analysis of SOCS molecules (SOCS1, 22 and 23) showed that IL-4 induces SOCS1 and SOCS2 in a STAT6 dependent manner and suggest that IL-4 suppression could be mediated by SOCS molecules, in particular SOCS2. IL-4 also decreased the IFN response and increased permissiveness to viral infection of cDCs exposed to a HIV-based lentivirus. Our results indicate that IL-4 modulates and counteracts pro-inflammatory stimulation induced by TLR7 and TLR9 and it may negatively affect responses against viruses and intracellular parasites.	[Sriram, Uma; Xu, Jun; Chain, Robert W.; Varghese, Linda; Chakhtoura, Marita; Gallucci, Stefania] Temple Univ, Dept Microbiol & Immunol, Sch Med, Lab Dendrit Cell Biol, Philadelphia, PA 19122 USA; [Bennett, Heather L.] Childrens Hosp Philadelphia, Dept Pediat, Div Rheumatol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; [Zoltick, Philip W.] Childrens Hosp Philadelphia, Dept Surg, Childrens Ctr Fetal Res, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia	Sriram, U (corresponding author), Temple Univ, Dept Microbiol & Immunol, Sch Med, Lab Dendrit Cell Biol, Philadelphia, PA 19122 USA.	sriram@temple.edu; gallucci@temple.edu			National Institutes of Health; National Institute of Allergy and Infectious Diseases [RO1-AI076423]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant RO1-AI076423 and the Arthritis Foundation (www.arthritis.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Baetz A, 2004, J BIOL CHEM, V279, P54708, DOI 10.1074/jbc.M410992200; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boyer JD, 2002, INT J PARASITOL, V32, P543, DOI 10.1016/S0020-7519(01)00355-1; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Coleman CM, 2013, ADV EXP MED BIOL, V762, P109, DOI 10.1007/978-1-4614-4433-6_4; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Collman RG, 2003, J LEUKOCYTE BIOL, V74, P631, DOI 10.1189/jlb.0703357; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Dalpke AH, 2001, J IMMUNOL, V166, P7082, DOI 10.4049/jimmunol.166.12.7082; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Elkon KB, 2011, J INTERF CYTOK RES, V31, P803, DOI 10.1089/jir.2011.0045; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Eriksen KW, 2004, J BIOL CHEM, V279, P169, DOI 10.1074/jbc.M310472200; Fischer JE, 1997, J VIROL, V71, P8672, DOI 10.1128/JVI.71.11.8672-8677.1997; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; HORISBERGER MA, 1995, AM J RESP CRIT CARE, V152, pS67, DOI 10.1164/ajrccm/152.4_Pt_2.S67; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Labeur MS, 1999, J IMMUNOL, V162, P168; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Levings MK, 1999, J IMMUNOL, V162, P5224; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miyamoto R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3014; Moran TM, 1996, J VIROL, V70, P5230, DOI 10.1128/JVI.70.8.5230-5235.1996; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Sriram U, 2007, J IMMUNOL, V179, P6446, DOI 10.4049/jimmunol.179.10.6446; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Swiecki M, 2011, J LEUKOCYTE BIOL, V90, P691, DOI 10.1189/jlb.0311166; Tel J, 2011, J INVEST DERMATOL, V131, P900, DOI 10.1038/jid.2010.410; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Toscano MG, 2010, MOL THER, V18, P1035, DOI 10.1038/mt.2009.293; Yin JM, 2012, HUM VACC IMMUNOTHER, V8, P1555, DOI 10.4161/hv.22142; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhang MC, 2012, J IMMUNOL, V189, P2746, DOI 10.4049/jimmunol.1103129	71	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87668	10.1371/journal.pone.0087668	http://dx.doi.org/10.1371/journal.pone.0087668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489947	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000167
J	Bobrowski, L; Lukaszuk, T; Lindholm, B; Stenvinkel, P; Heimburger, O; Axelsson, J; Barany, P; Carrero, JJ; Qureshi, AR; Luttropp, K; Debowska, M; Nordfors, L; Schalling, M; Waniewski, J				Bobrowski, Leon; Lukaszuk, Tomasz; Lindholm, Bengt; Stenvinkel, Peter; Heimburger, Olof; Axelsson, Jonas; Barany, Peter; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Luttropp, Karin; Debowska, Malgorzata; Nordfors, Louise; Schalling, Martin; Waniewski, Jacek			Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method	PLOS ONE			English	Article							CANCER CLASSIFICATION; CLASSIFIERS; BIOMARKERS	Identification of risk factors in patients with a particular disease can be analyzed in clinical data sets by using feature selection procedures of pattern recognition and data mining methods. The applicability of the relaxed linear separability (RLS) method of feature subset selection was checked for high-dimensional and mixed type (genetic and phenotypic) clinical data of patients with end-stage renal disease. The RLS method allowed for substantial reduction of the dimensionality through omitting redundant features while maintaining the linear separability of data sets of patients with high and low levels of an inflammatory biomarker. The synergy between genetic and phenotypic features in differentiation between these two subgroups was demonstrated.	[Bobrowski, Leon; Debowska, Malgorzata; Waniewski, Jacek] Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Bobrowski, Leon; Lukaszuk, Tomasz] Bialystok Tech Univ, Bialystok, Poland; [Lindholm, Bengt; Stenvinkel, Peter; Heimburger, Olof; Axelsson, Jonas; Barany, Peter; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Luttropp, Karin; Debowska, Malgorzata; Nordfors, Louise; Schalling, Martin] Karolinska Inst, Baxter Novum & Renal Med, Stockholm, Sweden; [Carrero, Juan Jesus; Luttropp, Karin; Nordfors, Louise; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Bialystok University of Technology; Karolinska Institutet; Karolinska Institutet	Bobrowski, L (corresponding author), Inst Biocybernet & Biomed Engn, Warsaw, Poland.	l.bobrowski@pb.edu.pl	Łukaszuk, Tomasz/T-5454-2018; Bobrowski, Leon/T-9230-2018; Barany, Peter/I-6116-2019; Qureshi, Abdul Rashid Tony/G-1358-2010; Schalling, Martin/F-1518-2015; Debowska, Malgorzata/F-3035-2015; Lindholm, Bengt/P-1334-2017	Łukaszuk, Tomasz/0000-0003-0489-7567; Bobrowski, Leon/0000-0003-4735-2460; Barany, Peter/0000-0001-6501-8293; Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Schalling, Martin/0000-0001-5011-2922; Debowska, Malgorzata/0000-0001-8741-7930; Stenvinkel, Peter/0000-0002-8785-4820; Carrero, Juan Jesus/0000-0003-4763-2024; Lindholm, Bengt/0000-0003-4269-4293; Heimburger, Olof/0000-0003-0901-4145	Polish National Center for Research and Development [N R13 0014 04]; Institute of Biocybernetics and Biomedical Engineering PAS [4.2/St/2012]; Bialystok University of Technology [S/WI/2/2013]; GENECURE [LSHM-CT-2006-037697]; Swedish Research Council [Dnr 521-2012-2721]; Baxter Healthcare Corporation	Polish National Center for Research and Development; Institute of Biocybernetics and Biomedical Engineering PAS; Bialystok University of Technology; GENECURE(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Baxter Healthcare Corporation	This work was supported by Polish National Center for Research and Development [N R13 0014 04]; Institute of Biocybernetics and Biomedical Engineering PAS [4.2/St/2012]; Bialystok University of Technology [S/WI/2/2013]; GENECURE [grant LSHM-CT-2006-037697]; Swedish Research Council (Dnr 521-2012-2721). Baxter Novum is the result of a grant from Baxter Healthcare Corporation to Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Bobrowski L, 2001, ST HEAL T, V84, P1309; BOBROWSKI L, 1991, PATTERN RECOGN, V24, P863, DOI 10.1016/0031-3203(91)90005-P; Bobrowski L., 2005, DATA MINING BASED CO; Bobrowski L, 2011, SELECTED WORKS BIOIN; Bobrowski L, 2009, BIOCYBERN BIOMED ENG, V29, P43; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Demsar J, 2006, J MACH LEARN RES, V7, P1; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Ding SF, 2012, ARTIF INTELL REV, V37, P169, DOI 10.1007/s10462-011-9225-y; Duan KB, 2005, IEEE T NANOBIOSCI, V4, P228, DOI 10.1109/TNB.2005.853657; Duda R.O., 2006, PATTERN CLASSIFICATI; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M. A., 2000, P 17 INT C MACH LEAR; Hand D., 2001, ADAP COMP MACH LEARN; Johnson R.A., 1991, APPL MULTIVARIATE ST; KIRA K, 1992, MACHINE LEARNING /, P249; Kononenko I, 1994, MACH LEARN, V94; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Luttropp K, 2009, SEMIN DIALYSIS, V22, P417, DOI 10.1111/j.1525-139X.2009.00592.x; Minsky ML, 1987, PERCEPTRONS EXPANDED; Pecoits R, 2003, KIDNEY INT, V63, pS162, DOI 10.1046/j.1523-1755.63.s84.39.x; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V, 1988, STAT LEARNING THEORY; Witten I, 2000, DATA MINING PRACITCA; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86630	10.1371/journal.pone.0086630	http://dx.doi.org/10.1371/journal.pone.0086630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489753	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000064
J	Iqbal, M; Reddy, KB; Brookes, SM; Essen, SC; Brown, IH; McCauley, JW				Iqbal, Munir; Reddy, Kolli B.; Brookes, Sharon M.; Essen, Steve C.; Brown, Ian H.; McCauley, John W.			Virus Pathotype and Deep Sequencing of the HA Gene of a Low Pathogenicity H7N1 Avian Influenza Virus Causing Mortality in Turkeys	PLOS ONE			English	Article							HEMAGGLUTININ CLEAVAGE SITE; A VIRUS; CHICKENS; EMERGENCE; REPLICATION; ADAPTATION; GENERATION; EVOLUTION; INFECTION; SUBTYPE	Low pathogenicity avian influenza (LPAI) viruses of the H7 subtype generally cause mild disease in poultry. However the evolution of a LPAI virus into highly pathogenic avian influenza (HPAI) virus results in the generation of a virus that can cause severe disease and death. The classification of these two pathotypes is based, in part, on disease signs and death in chickens, as assessed in an intravenous pathogenicity test, but the effect of LPAI viruses in turkeys is less well understood. During an investigation of LPAI virus infection of turkeys, groups of three-week-old birds inoculated with A/chicken/Italy/1279/99 (H7N1) showed severe disease signs and died or were euthanised within seven days of infection. Virus was detected in many internal tissues and organs from culled birds. To examine the possible evolution of the infecting virus to a highly pathogenic form in these turkeys, sequence analysis of the haemagglutinin (HA) gene cleavage site was carried out by analysing multiple cDNA amplicons made from swabs and tissue sample extracts employing Sanger and Next Generation Sequencing. In addition, a RT-PCR assay to detect HPAI virus was developed. There was no evidence of the presence of HPAI virus in either the virus used as inoculum or from swabs taken from infected birds. However, a small proportion (<0.5%) of virus carried in individual tracheal or liver samples did contain a molecular signature typical of a HPAI virus at the HA cleavage site. All the signature sequences were identical and were similar to HPAI viruses collected during the Italian epizootic in 1999/2000. We assume that the detection of HPAI virus in tissue samples following infection with A/chicken/ Italy/1279/99 reflected amplification of a virus present at very low levels within the mixed inoculum but, strikingly, we observed no new HPAI virus signatures in the amplified DNA analysed by deep-sequencing.	[Iqbal, Munir; Reddy, Kolli B.] Pirbright Inst, Avian Viral Dis Programme, Compton Lab, Newbury, Berks, England; [Brookes, Sharon M.; Essen, Steve C.; Brown, Ian H.] Avian Virol Anim Hlth & Vet Labs Agcy Weybridge, Addlestone, Surrey, England; [McCauley, John W.] MRC Natl Inst Med Res, Div Virol, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; MRC National Institute for Medical Research	Iqbal, M (corresponding author), Pirbright Inst, Avian Viral Dis Programme, Compton Lab, Newbury, Berks, England.	Munir.iqbal@pirbright.ac.uk	Brown, Ian H/E-1119-2011; Brookes, Sharon M/C-8016-2011; Brookes, Sharon M/W-2128-2019; Essen, Stephen/E-9721-2011	Brookes, Sharon M/0000-0001-9207-6659; Brookes, Sharon M/0000-0001-9207-6659; Iqbal, Munir/0000-0001-5165-5339	Biotechnology and Biological Sciences Research Council [BBS/B/00093, BB/E010849/1]; Medical Research Council [U117585868]; Department for Environment, Food and Rural Affairs [SE0776, FT5094]; Biotechnology and Biological Sciences Research Council [BB/E010806/1, BBS/E/I/00001025, BBS/E/I/00001759, BBS/E/I/00001422, BB/L004240/1, BBS/E/I/00001708, BB/L026341/1] Funding Source: researchfish; Medical Research Council [MC_U117512723, MC_U117585868] Funding Source: researchfish; BBSRC [BB/E010806/1, BB/L004240/1, BBS/E/I/00001422, BBS/E/I/00001759, BB/E010849/1, BB/L026341/1, BBS/E/I/00001708] Funding Source: UKRI; MRC [MC_U117585868, MC_U117512723] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (award nos. BBS/B/00093 and BB/E010849/1), the Medical Research Council (programme U117585868) and the Department for Environment, Food and Rural Affairs (project SE0776 and FT5094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2008, ZOONOSES PUBLIC HLTH, V55, P16, DOI 10.1111/j.1863-2378.2007.01082.x; ALEXANDER DJ, 1979, RES VET SCI, V26, P17; ALLAN WH, 1977, AVIAN DIS, V21, P359, DOI 10.2307/1589318; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; BRUGH M, 1991, AVIAN DIS, V35, P824, DOI 10.2307/1591616; BRUGH M, 1992, AVIAN DIS, V36, P968, DOI 10.2307/1591557; BRUGH M, 1988, AVIAN DIS, V32, P695, DOI 10.2307/1590987; Brugh M, 1992, RECOVERY MINORITY SU, P166; Cannon RM, 1982, LIVESTOCK DIS SURVEY, Viii, P35; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; CEC, 2006, OFF J EUR COMMUNIT L, VL10, P16; Dundon WG, 2006, VIRUS RES, V119, P171, DOI 10.1016/j.virusres.2006.01.005; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Halvorson DA, 1992, INFLUENZA TURKEYS US, P33; HORIMOTO T, 1995, VIROLOGY, V206, P755, DOI 10.1016/S0042-6822(95)80004-2; Iqbal M, 2012, VIROLOGY, V433, P282, DOI 10.1016/j.virol.2012.08.001; Iqbal M, 2009, PHILOS T R SOC B, V364, P2739, DOI 10.1098/rstb.2009.0088; Ito T, 2001, J VIROL, V75, P4439, DOI 10.1128/JVI.75.9.4439-4443.2001; KAWAOKA Y, 1987, VIROLOGY, V158, P218, DOI 10.1016/0042-6822(87)90256-X; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Lee CW, 2007, AVIAN DIS, V51, P260, DOI 10.1637/7572-033106R.1; LI SQ, 1990, J VIROL, V64, P3297, DOI 10.1128/JVI.64.7.3297-3303.1990; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; Matrosovich Mikhail N., 2008, V27, P134; McCapes RH, 1986, AVIAN INFLUENZA CALI, P118; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Mutinelli E, 2003, AVIAN DIS, V47, P844, DOI 10.1637/0005-2086-47.s3.844; OIE, 2005, MAN DIAGN TESTS VACC; ORLICH M, 1990, VIROLOGY, V176, P531, DOI 10.1016/0042-6822(90)90023-K; PERDUE ML, 1990, VIRUS RES, V16, P137, DOI 10.1016/0168-1702(90)90018-7; Poss PE, 1987, P 2 INT S AV INFL, P112; ROTT R, 1992, VET MICROBIOL, V33, P303, DOI 10.1016/0378-1135(92)90058-2; ROTT R, 1980, ARCH VIROL, V65, P123, DOI 10.1007/BF01317323; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; SWAYNE DE, 1994, AVIAN PATHOL, V23, P345, DOI 10.1080/03079459408419002; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2004, AVIAN DIS, V48, P167, DOI 10.1637/7103; Villegras P, 2008, LAB MANUAL ISOLATION, P217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wood GW, 1996, AVIAN PATHOL, V25, P799, DOI 10.1080/03079459608419182; WOOD GW, 1993, ARCH VIROL, V130, P209, DOI 10.1007/BF01319010; Zanella A, 2001, AVIAN DIS, V45, P257, DOI 10.2307/1593038; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	46	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87076	10.1371/journal.pone.0087076	http://dx.doi.org/10.1371/journal.pone.0087076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489838	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000105
J	Ishizawa, K; Izawa-Ishizawa, Y; Yamano, N; Urushihara, M; Sakurada, T; Imanishi, M; Fujii, S; Nuno, A; Miyamoto, L; Kihira, Y; Ikeda, Y; Kagami, S; Kobori, H; Tsuchiya, K; Tamaki, T				Ishizawa, Keisuke; Izawa-Ishizawa, Yuki; Yamano, Noriko; Urushihara, Maki; Sakurada, Takumi; Imanishi, Masaki; Fujii, Shoko; Nuno, Asami; Miyamoto, Licht; Kihira, Yoshitaka; Ikeda, Yasumasa; Kagami, Shoji; Kobori, Hiroyuki; Tsuchiya, Koichiro; Tamaki, Toshiaki			Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PHOTODEGRADATION PRODUCT; ILLUMINATED NIFEDIPINE; ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; RENAL INJURY; COMPLICATIONS; PATHOGENESIS; RECEPTOR; RATS	Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a novel antioxidant with radical scavenging abilities and has the capacity to treat vascular dysfunction by exerting an endothelial protective effect. In the present study, we extended these findings by evaluating the efficacy of NO-NIF against DN and by clarifying the mechanisms of its antioxidative effect. In a model of type 2 DN (established in KKAy mice), NO-NIF administration reduced albuminuria and proteinuria as well as glomerular expansion without affecting glucose metabolism or systolic blood pressure. NO-NIF also suppressed renal and systemic oxidative stress and decreased the expression of intercellular adhesion molecule (ICAM)-1, a marker of endothelial cell injury, in the glomeruli of the KKAy mice. Similarly, NO-NIF reduced albuminuria, oxidative stress, and ICAM-1 expression in endothelial nitric oxide synthase (eNOS) knockout mice. Moreover, NO-NIF suppressed urinary angiotensinogen (AGT) excretion and intrarenal AGT protein expression in proximal tubular cells in the KKAy mice. On the other hand, hyperglycemia-induced mitochondrial superoxide production was not attenuated by NO-NIF in cultured endothelial cells. These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.	[Ishizawa, Keisuke; Fujii, Shoko; Nuno, Asami; Miyamoto, Licht; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan; [Izawa-Ishizawa, Yuki; Yamano, Noriko; Sakurada, Takumi; Imanishi, Masaki; Kihira, Yoshitaka; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Dept Pharmacol, Inst Hlth Biosci, Tokushima 770, Japan; [Urushihara, Maki; Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima 770, Japan; [Kobori, Hiroyuki] Kagawa Univ, Fac Med, Dept Pharmacol, Kagawa, Japan	Tokushima University; Tokushima University; Tokushima University; Kagawa University	Ishizawa, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan.	ishizawa@tokushima-u.ac.jp	Yamano-Adachi, Noriko/AAH-8605-2019; Kobori, Hiroyuki/F-1994-2014	Yamano-Adachi, Noriko/0000-0002-2167-5379; Kobori, Hiroyuki/0000-0001-5128-5059; Ikeda, Yasumasa/0000-0003-4318-7349; /0000-0003-2331-964X; Imanishi, Masaki/0000-0003-1305-5943	Grants for the Regional Innovation Cluster Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860063] Funding Source: KAKEN	Grants for the Regional Innovation Cluster Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for the Regional Innovation Cluster Program (to TT), Grants-in-Aid for Young Scientist B (to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mendoza MGA, 2008, NEPHROLOGY, V13, P218, DOI 10.1111/j.1440-1797.2007.00897.x; Atkins RC, 2010, NAT REV NEPHROL, V6, P134, DOI 10.1038/nrneph.2010.10; BAUER V, 1995, BRIT J PHARMACOL, V115, P871, DOI 10.1111/j.1476-5381.1995.tb15890.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fukuhara Y, 2011, J MED INVESTIG, V58, P118, DOI 10.2152/jmi.58.118; Hoogwerf BJ, 2000, CLEV CLIN J MED, V67, P287, DOI 10.3949/ccjm.67.4.287; Horinouchi Y, 2011, CHEM PHARM BULL, V59, P208, DOI 10.1248/cpb.59.208; Huang H, 2006, J ENDOCRINOL, V189, P643, DOI 10.1677/joe.1.06630; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Ishizawa K, 2005, HYPERTENSION, V46, P1046, DOI 10.1161/01.HYP.0000172622.51973.f5; Ishizawa K, 2009, J PHARMACOL SCI, V109, P14, DOI 10.1254/jphs.08R08FM; Kaida Y, 2013, DIABETES, V62, P3241, DOI 10.2337/db12-1608; Kobori H, 2008, AM J PHYSIOL-RENAL, V294, pF1257, DOI 10.1152/ajprenal.00588.2007; Kobori H, 2013, J INVEST MED, V61, P256, DOI 10.2310/JIM.0b013e31827c28bb; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mason RP, 1996, BIOCHEM PHARMACOL, V51, P653, DOI 10.1016/S0006-2952(95)02238-4; MISIK V, 1991, MOL PHARMACOL, V40, P435; Miyata K, 2008, CLIN EXP PHARMACOL P, V35, P922, DOI 10.1111/j.1440-1681.2008.04938.x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ogawa Susumu, 2009, Biomark Insights, V4, P97; OHKUBO T, 1992, J PHARMACEUT BIOMED, V10, P67, DOI 10.1016/0731-7085(92)80012-C; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Pomytkin IA, 2012, CURR NEUROPHARMACOL, V10, P311, DOI 10.2174/157015912804143559; Rossing P, 2013, NAT REV NEPHROL, V9, P128, DOI 10.1038/nrneph.2013.13; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Sakurada T, 2013, N-S ARCH PHARMACOL, V386, P29, DOI 10.1007/s00210-012-0810-7; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; STASKO A, 1994, FREE RADICAL BIO MED, V17, P545, DOI 10.1016/0891-5849(94)90094-9; Suzaki Y, 2007, INT J BIOL SCI, V3, P40; Usui M, 2000, CIRCULATION, V101, P305, DOI 10.1161/01.CIR.101.3.305; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yanez C, 2004, BIOORGAN MED CHEM, V12, P2459, DOI 10.1016/j.bmc.2004.01.050; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	37	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86335	10.1371/journal.pone.0086335	http://dx.doi.org/10.1371/journal.pone.0086335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489716	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000046
J	Mahalingaiah, PKS; Singh, KP				Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.			Chronic Oxidative Stress Increases Growth and Tumorigenic Potential of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TUMOR-GROWTH; STEM-CELLS; E-CADHERIN; ROS; ACTIVATION; APOPTOSIS; INFLAMMATION; METASTASIS; MECHANISMS	Accumulating evidence suggests that exposures to elevated levels of either endogenous estrogen or environmental estrogenic chemicals are associated with breast cancer development and progression. These natural or synthetic estrogens are known to produce reactive oxygen species (ROS) and increased ROS has been implicated in both cellular apoptosis and carcinogenesis. Though there are several studies on direct involvement of ROS in cellular apoptosis using short-term exposure model, there is no experimental evidence to directly implicate chronic exposure to ROS in increased growth and tumorigenicity of breast cancer cells. Therefore, the objective of this study was to evaluate the effects of chronic oxidative stress on growth, survival and tumorigenic potential of MCF-7 breast cancer cells. MCF-7 cells were exposed to exogenous hydrogen peroxide (H2O2) as a source of ROS at doses of 25 mu M and 250 mM for acute (24 hours) and chronic period (3 months) and their effects on cell growth/survival and tumorigenic potential were evaluated. The results of cell count, MTT and cell cycle analysis showed that while acute exposure inhibits the growth of MCF-7 cells in a dose-dependent manner, the chronic exposure to H2O2-induced ROS leads to increased cell growth and survival of MCF-7 cells. This was further confirmed by gene expression analysis of cell cycle and cell survival related genes. Significant increase in number of soft agar colonies, up-regulation of pro-metastatic genes VEGF, WNT1 and CD44, whereas down-regulation of anti-metastatic gene E-Cadherin in H2O2 treated MCF-7 cells observed in this study further suggests that persistent exposure to oxidative stress increases tumorigenic and metastatic potential of MCF-7 cells. Since many chemotherapeutic drugs are known to induce their cytotoxicity by increasing ROS levels, the results of this study are also highly significant in understanding the mechanism for adaptation to ROS-induced toxicity leading to acquired chemotherapeutic resistance in breast cancer cells.	[Mahalingaiah, Prathap Kumar S.; Singh, Kamaleshwar P.] Texas Tech Univ, Inst Environm & Human Hlth TIEHH, Dept Environm Toxicol, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Singh, KP (corresponding author), Texas Tech Univ, Inst Environm & Human Hlth TIEHH, Dept Environm Toxicol, Lubbock, TX 79409 USA.	kamaleshwar.singh@ttu.edu	Singh, Kamaleshwar Prasad/AAE-9166-2020					Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cavalieri EL, 2004, ANN NY ACAD SCI, V1028, P247, DOI 10.1196/annals.1322.029; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Deng YT, 2010, MOL CARCINOGEN, V49, P141, DOI 10.1002/mc.20583; Fenton SE, 2012, ANNU REV PHARMACOL, V52, P455, DOI 10.1146/annurev-pharmtox-010611-134659; Ferlini C, 1999, BRIT J CANCER, V79, P257, DOI 10.1038/sj.bjc.6690042; Florea AM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/159619; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Fujita T, 2002, AM J RESP CELL MOL, V27, P542, DOI 10.1165/rcmb.4775; Ganie SA, 2011, EUR REV MED PHARMACO, V15, P906; Geiser T, 2004, AM J PHYSIOL-LUNG C, V287, pL448, DOI 10.1152/ajplung.00177.2003; Goitre L, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/807682; Heirman I, 2006, FREE RADICAL BIO MED, V40, P285, DOI 10.1016/j.freeradbiomed.2005.08.033; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Hoshida Y, 2007, HEPATO-GASTROENTEROL, V54, P489; Hwang SL, 2008, J AGR FOOD CHEM, V56, P859, DOI 10.1021/jf072826r; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Jefcoate C R, 2000, J Natl Cancer Inst Monogr, P95; KUNDU N, 1995, CLIN EXP METASTAS, V13, P16, DOI 10.1007/BF00144014; Laden F, 2001, JNCI-J NATL CANCER I, V93, P768, DOI 10.1093/jnci/93.10.768; Lan T, 2013, INT J CLIN EXP PATHO, V6, P1799; Lerebours F, 2002, CRIT REV ONCOL HEMAT, V44, P121, DOI 10.1016/S1040-8428(01)00191-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YB, 2013, PHARMACOL REP, V65, P700, DOI 10.1016/S1734-1140(13)71048-X; Lin CH, 2013, INT J MOL SCI, V14, P13266, DOI 10.3390/ijms140713266; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073038; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui A, 2000, CANCER LETT, V151, P87, DOI 10.1016/S0304-3835(99)00424-3; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nickels S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003284; Niederacher D, 1999, ONCOLOGY-BASEL, V56, P59, DOI 10.1159/000011931; Nishikawa M, 2005, J CONTROL RELEASE, V109, P101, DOI 10.1016/j.jconrel.2005.09.017; Oesterreich S, 2003, CANCER RES, V63, P5203; Okada F, 2006, BRIT J CANCER, V94, P854, DOI 10.1038/sj.bjc.6603016; Okoh VO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054206; Owens TW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00225; Patel MM, 2004, J BIOCHEM MOL TOXIC, V18, P37, DOI 10.1002/jbt.20005; Paul S, 2012, NUTR CANCER, V64, P1087, DOI 10.1080/01635581.2012.712735; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2004, CURR PHARM DESIGN, V10, P1969, DOI 10.2174/1381612043384411; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244; Roy D, 2004, CURR GENOMICS, V5, P245, DOI 10.2174/1389202043349471; Roy SS, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/654698; Santner SJ, 1997, J CLIN ENDOCR METAB, V82, P200, DOI 10.1210/jc.82.1.200; Saud A, 2011, AFRICAN J BIOTECHNOL, V10, P3872; St-Hilaire S, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-32; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Sullivan R, 2008, CURR PHARM DESIGN, V14, P1113, DOI 10.2174/138161208784246225; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yue W, 2013, STEROIDS, V78, P161, DOI 10.1016/j.steroids.2012.11.001; Zhai Yubo, 2012, Drug Discov Today Dis Mech, V9, pe35; Zhao M, 2013, IEEE ENG MED BIO, P6433	70	91	94	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87371	10.1371/journal.pone.0087371	http://dx.doi.org/10.1371/journal.pone.0087371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489904	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000131
J	Raynaud, X; Nunan, N				Raynaud, Xavier; Nunan, Naoise			Spatial Ecology of Bacteria at the Microscale in Soil	PLOS ONE			English	Article							MICROBIAL DIVERSITY; COMMUNITIES; COMPETITION; PATTERNS; SCALE; BIODIVERSITY; RHIZOSPHERE; MAINTENANCE; COEXISTENCE; DYNAMICS	Despite an exceptional number of bacterial cells and species in soils, bacterial diversity seems to have little effect on soil processes, such as respiration or nitrification, that can be affected by interactions between bacterial cells. The aim of this study is to understand how bacterial cells are distributed in soil to better understand the scaling between cell-to-cell interactions and what can be measured in a few milligrams, or more, of soil. Based on the analysis of 744 images of observed bacterial distributions in soil thin sections taken at different depths, we found that the inter-cell distance was, on average 12.46 mu m and that these inter-cell distances were shorter near the soil surface (10.38 mu m) than at depth (>18 mu m), due to changes in cell densities. These images were also used to develop a spatial statistical model, based on Log Gaussian Cox Processes, to analyse the 2D distribution of cells and construct realistic 3D bacterial distributions. Our analyses suggest that despite the very high number of cells and species in soil, bacteria only interact with a few other individuals. For example, at bacterial densities commonly found in bulk soil (10(8) cells g(-1) soil), the number of neighbours a single bacterium has within an interaction distance of ca. 20 mu m is relatively limited (120 cells on average). Making conservative assumptions about the distribution of species, we show that such neighbourhoods contain less than 100 species. This value did not change appreciably as a function of the overall diversity in soil, suggesting that the diversity of soil bacterial communities may be species-saturated. All in all, this work provides precise data on bacterial distributions, a novel way to model them at the micrometer scale as well as some new insights on the degree of interactions between individual bacterial cells in soils.	[Raynaud, Xavier] Univ Paris 06, Sorbonne Univ, Inst Ecol & Environm Sci Paris, Paris, France; [Nunan, Naoise] CNRS, Inst Ecol & Environm Sci Paris, Campus AgroParisTech, Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Raynaud, X (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Ecol & Environm Sci Paris, Paris, France.	xavier.raynaud@upmc.fr	Nunan, Naoise/P-3135-2019; Nunan, Naoise/I-5297-2013; Raynaud, Xavier/C-2381-2009	Nunan, Naoise/0000-0003-3448-7171; Raynaud, Xavier/0000-0002-9065-2867	INSU EC2CO Microbiologie Environnementale; ANR Syscomm Programme MEPSOM	INSU EC2CO Microbiologie Environnementale; ANR Syscomm Programme MEPSOM(French National Research Agency (ANR))	This research was supported by the INSU EC2CO Microbiologie Environnementale and ANR Syscomm Programme MEPSOM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2004, J ANIM ECOL, V73, P128, DOI 10.1046/j.0021-8790.2004.00788.x; Andrey P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000853; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baveye PC, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c2; Bonami A, 2003, J FOURIER ANAL APPL, V9, P215, DOI 10.1007/s00041-003-0012-2; CHARLEY JL, 1975, J ECOL, V63, P945, DOI 10.2307/2258613; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Dechesne A, 2003, SOIL BIOL BIOCHEM, V35, P1537, DOI 10.1016/S0038-0717(03)00243-8; Dechesne A, 2008, FEMS MICROBIOL ECOL, V64, P1, DOI 10.1111/j.1574-6941.2008.00446.x; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Franklin RB, 2008, SPATIAL DISTRIBUTION, P1; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Gonod LV, 2003, SOIL BIOL BIOCHEM, V35, P373, DOI 10.1016/S0038-0717(02)00287-0; Goreaud F, 2002, ECOL MODEL, V158, P1, DOI 10.1016/S0304-3800(02)00058-3; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hodge A, 2003, NEW PHYTOL, V157, P303, DOI 10.1046/j.1469-8137.2003.00662.x; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kinkel LL, 2011, ANNU REV PHYTOPATHOL, V49, P47, DOI 10.1146/annurev-phyto-072910-095232; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; Moller J, 1998, SCAND J STAT, V25, P451, DOI 10.1111/1467-9469.00115; Moller J., 2003, STAT INFERENCE SIMUL; Ngom NF, 2011, GEODERMA, V163, P127, DOI 10.1016/j.geoderma.2011.04.013; Nunan N, 2002, MICROBIAL ECOL, V44, P296, DOI 10.1007/s00248-002-2021-0; Nunan N, 2003, FEMS MICROBIOL ECOL, V44, P203, DOI 10.1016/S0168-6496(03)00027-8; Nunan N, 2001, FEMS MICROBIOL ECOL, V37, P67, DOI 10.1111/j.1574-6941.2001.tb00854.x; Nunan Naoise, 2007, P61, DOI 10.1007/978-1-4020-6216-2_3; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Raynaud X, 2008, AM NAT, V171, P44, DOI 10.1086/523951; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2011, APPL ENVIRON MICROB, V77, P2791, DOI 10.1128/AEM.02870-10; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; SCHLATHER M, 2001, R NEWS, V1, P18; Stefanic P, 2009, J BACTERIOL, V191, P1756, DOI 10.1128/JB.01290-08; Stoyan D, 2006, CASE STUDIES SPATIAL, P3; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Van Groenigen JW, 2005, RAPID COMMUN MASS SP, V19, P1289, DOI 10.1002/rcm.1929; VanMarcke E., 1988, RANDOM FIELDS ANAL S, P138; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x	53	176	178	5	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87217	10.1371/journal.pone.0087217	http://dx.doi.org/10.1371/journal.pone.0087217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489873	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000117
J	Whiley, PJ; Parsons, MT; Leary, J; Tucker, K; Warwick, L; Dopita, B; Thorne, H; Lakhani, SR; Goldgar, DE; Brown, MA; Spurdle, AB				Whiley, Phillip J.; Parsons, Michael T.; Leary, Jennifer; Tucker, Kathy; Warwick, Linda; Dopita, Belinda; Thorne, Heather; Lakhani, Sunil R.; Goldgar, David E.; Brown, Melissa A.; Spurdle, Amanda B.			Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A > G(p.His41Arg) Is a Pathogenic Mutation	PLOS ONE			English	Article							UNKNOWN CLINICAL-SIGNIFICANCE; UBIQUITIN LIGASE ACTIVITY; FAMILIAL BREAST-CANCER; DNA-SEQUENCE VARIANTS; RING-DOMAIN; CLASSIFICATION; PROTEIN; GENES; MODEL; SUSCEPTIBILITY	Rare exonic, non-truncating variants in known cancer susceptibility genes such as BRCA1 and BRCA2 are problematic for genetic counseling and clinical management of relevant families. This study used multifactorial likelihood analysis and/or bioinformatically-directed mRNA assays to assess pathogenicity of 19 BRCA1 or BRCA2 variants identified following patient referral to clinical genetic services. Two variants were considered to be pathogenic (Class 5). BRCA1: c. 4484G>C(p. Arg1495Thr) was shown to result in aberrant mRNA transcripts predicted to encode truncated proteins. The BRCA1:c. 122A>G(p.His41Arg) RING-domain variant was found from multifactorial likelihood analysis to have a posterior probability of pathogenicity of 0.995, a result consistent with existing protein functional assay data indicating lost BARD1 binding and ubiquitin ligase activity. Of the remaining variants, seven were determined to be not clinically significant (Class 1), nine were likely not pathogenic (Class 2), and one was uncertain (Class 3). These results have implications for genetic counseling and medical management of families carrying these specific variants. They also provide additional multifactorial likelihood variant classifications as reference to evaluate the sensitivity and specificity of bioinformatic prediction tools and/or functional assay data in future studies.	[Whiley, Phillip J.; Parsons, Michael T.; Spurdle, Amanda B.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Whiley, Phillip J.; Brown, Melissa A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Leary, Jennifer] Westmead Hosp, Univ Sydney, Westmead Millennium Inst, Familial Canc Serv,Westmead Inst Canc Res, Sydney, NSW, Australia; [Tucker, Kathy] Prince Wales Hosp, Hereditary Canc Clin, Sydney, NSW, Australia; [Warwick, Linda; Dopita, Belinda] Canberra Hosp, Dept Genet, Canberra, ACT, Australia; [Thorne, Heather] KConFab, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Pathol Queensland, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Goldgar, David E.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Goldgar, David E.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA	QIMR Berghofer Medical Research Institute; University of Queensland; University of Sydney; Westmead Institute for Medical Research; Australian National University; Canberra Hospital; Peter Maccallum Cancer Center; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Spurdle, AB (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Amanda.Spurdle@qimrberghofer.edu.au	Brown, Melissa A/F-1451-2010; Spurdle, Amanda B/A-4978-2011; Lakhani, Sunil R/I-1970-2018	Spurdle, Amanda B/0000-0003-1337-7897; Lakhani, Sunil R/0000-0003-4067-2760; Thorne, Heather/0000-0003-3610-2511; Brown, Melissa/0000-0002-2830-9259; Parsons, Michael/0000-0003-3242-8477	NHMRC; National Breast Cancer Foundation; Cancer Australia [628333]; National Health and Medical Research Council (NHMRC) [ID442970, ID1010719]; Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; National Institutes of Health (NIH) [CA116167]; NIH Recovery Act supplement [CA116167Z]; NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA116201, U01CA116167] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Cancer Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Recovery Act supplement(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Clinical Follow Up Study was funded 2001-2009 by NHMRC (www.nhmrc.gov.au) and currently by the National Breast Cancer Foundation (www.nbcf.org.au) and Cancer Australia (www.canceraustralia.gov.au) # 628333. kConFab is supported by grants from the National Breast Cancer Foundation, the National Health and Medical Research Council (NHMRC) and by the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. This work was supported in part by project grants from The National Health and Medical Research Council (NHMRC, ID442970 & ID1010719) to Amanda B. Spurdle who is supported by an NHMRC Senior Research Fellowship. David E. Goldgar was supported by National Institutes of Health (NIH) (www.nih.gov) grant CA116167, an NIH Recovery Act supplement (CA116167Z) and an NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman JF, 1999, HUM MUTAT, V13, P311, DOI 10.1002/(SICI)1098-1004(1999)13:4<311::AID-HUMU8>3.3.CO;2-G; Bouwman P, 2013, CANC DISCOV; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Domchek SM, 2012, CANC DISCOV; Domchek SM, 2013, CANCER DISCOV, V3, P399, DOI 10.1158/2159-8290.CD-12-0421; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Guidugli L, 2013, CANCER RES, V73, P265, DOI 10.1158/0008-5472.CAN-12-2081; Hu YF, 2002, GENE DEV, V16, P1509, DOI 10.1101/gad.995502; Hu YF, 2000, J BIOL CHEM, V275, P40910, DOI 10.1074/jbc.C000607200; Lakhani SR, 2000, CLIN CANCER RES, V6, P782; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Mann GJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1377; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Orban TI, 2003, J CLIN PATHOL-MOL PA, V56, P191, DOI 10.1136/mp.56.4.191; Ozcelik H, 1999, HUM MUTAT, V14, P540, DOI 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.3.CO;2-3; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Raponi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037255; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sarkar M, 2008, MOL BIOSYST, V4, P599, DOI 10.1039/b802481b; Sevcik J, 2012, CELL SIGNAL, V24, P1023, DOI 10.1016/j.cellsig.2011.12.023; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Spurdle AB, 2010, CURR OPIN GENET DEV, V20, P315, DOI 10.1016/j.gde.2010.03.009; Sum EYM, 2002, J BIOL CHEM, V277, P7849, DOI 10.1074/jbc.M110603200; Sweet K, 2010, BREAST CANCER RES TR, V119, P737, DOI 10.1007/s10549-009-0438-6; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Vallee MP, 2012, HUM MUTAT, V33, P22, DOI 10.1002/humu.21629; Walker LC, 2013, HUM MUTAT, V34, P1424, DOI 10.1002/humu.22388; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Whiley P, 2013, CLIN CHEM; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang YP, 2003, HUM MOL GENET, V12, P2121, DOI 10.1093/hmg/ddg222; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	46	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86836	10.1371/journal.pone.0086836	http://dx.doi.org/10.1371/journal.pone.0086836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489791	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000082
J	Bandyopadhyay, D; Cyphersmith, A; Zapata, JA; Kim, YJ; Payne, CK				Bandyopadhyay, Debjyoti; Cyphersmith, Austin; Zapata, Jairo A.; Kim, Y. Joseph; Payne, Christine K.			Lysosome Transport as a Function of Lysosome Diameter	PLOS ONE			English	Article							CARGO TRANSPORT; LIVING CELLS; LIVE-CELL; IN-VIVO; MOTORS; CYTOPLASM; POLARIZATION; MICROTUBULES; TRAFFICKING; VISCOSITY	Lysosomes are membrane-bound organelles responsible for the transport and degradation of intracellular and extracellular cargo. The intracellular motion of lysosomes is both diffusive and active, mediated by motor proteins moving lysosomes along microtubules. We sought to determine how lysosome diameter influences lysosome transport. We used osmotic swelling to double the diameter of lysosomes, creating a population of enlarged lysosomes. This allowed us to directly examine the intracellular transport of the same organelle as a function of diameter. Lysosome transport was measured using live cell fluorescence microscopy and single particle tracking. We find, as expected, the diffusive component of intracellular transport is decreased proportional to the increased lysosome diameter. Active transport of the enlarged lysosomes is not affected by the increased lysosome diameter.	[Payne, Christine K.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Payne, CK (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	christine.payne@chemistry.gatech.edu			National Institutes of Health (NIH) [1DP2OD006470]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health (NIH) Director's New Innovator Award (to CKP, 1DP2OD006470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bakker AC, 1997, J CELL SCI, V110, P2227; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; COHN ZA, 1969, J EXP MED, V129, P201, DOI 10.1084/jem.129.1.201; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; DECOURCY K, 1991, EXP CELL RES, V192, P52, DOI 10.1016/0014-4827(91)90156-O; FERRIS AL, 1987, J CELL BIOL, V105, P2703, DOI 10.1083/jcb.105.6.2703; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Humphries WH, 2010, INTEGR BIOL-UK, V2, P536, DOI 10.1039/c0ib00035c; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Klumpp S, 2005, P NATL ACAD SCI USA, V102, P17284, DOI 10.1073/pnas.0507363102; Kole TP, 2004, MOL BIOL CELL, V15, P3475, DOI 10.1091/mbc.E04-03-0218; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Leduc C, 2011, ACS NANO, V5, P2587, DOI 10.1021/nn1023285; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Leijnse N, 2012, EUR PHYS J-SPEC TOP, V204, P75, DOI 10.1140/epjst/e2012-01553-y; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez JE, 2007, BIOCHEM BIOPH RES CO, V353, P835, DOI 10.1016/j.bbrc.2006.12.120; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Selhuber-Unkel C, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025015; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; Yum K, 2009, NANO LETT, V9, P2193, DOI 10.1021/nl901047u	35	82	84	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86847	10.1371/journal.pone.0086847	http://dx.doi.org/10.1371/journal.pone.0086847			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497985	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900042
J	Hotop, SK; Abd El Wahed, A; Beutling, U; Jentsch, D; Motzkus, D; Frank, R; Hunsmann, G; Stahl-Hennig, C; Fritz, HJ				Hotop, Sven-Kevin; Abd El Wahed, Ahmed; Beutling, Ulrike; Jentsch, Dieter; Motzkus, Dirk; Frank, Ronald; Hunsmann, Gerhard; Stahl-Hennig, Christiane; Fritz, Hans-Joachim			Multiple Antibody Targets on Herpes B Glycoproteins B and D Identified by Screening Sera of Infected Rhesus Macaques with Peptide Microarrays	PLOS ONE			English	Article							C-TERMINAL TAIL; VIRUS CERCOPITHECINE-HERPESVIRUS-1; DOMAIN; MONKEY; SEQUENCE; PROTEIN; REVEAL	Herpes B virus (or Herpesvirus simiae or Macacine herpesvirus 1) is endemic in many populations of macaques, both in the wild and in captivity. The virus elicits only mild clinical symptoms (if any) in monkeys, but can be transmitted by various routes, most commonly via bites, to humans where it causes viral encephalitis with a high mortality rate. Hence, herpes B constitutes a considerable occupational hazard for animal caretakers, veterinarians and laboratory personnel. Efforts are therefore being made to reduce the risk of zoonotic infection and to improve prognosis after accidental exposure. Among the measures envisaged are serological surveillance of monkey colonies and specific diagnosis of herpes B zoonosis against a background of antibodies recognizing the closely related human herpes simplex virus (HSV). 422 pentadecapeptides covering, in an overlapping fashion, the entire amino acid sequences of herpes B proteins gB and gD were synthesized and immobilized on glass slides. Antibodies present in monkey sera that bind to subsets of the peptide collection were detected by microserological techniques. With 42 different rhesus macaque sera, 114 individual responses to 18 different antibody target regions (ATRs) were recorded, 17 of which had not been described earlier. This finding may pave the way for a peptide-based, herpes B specific serological diagnostic test.	[Hotop, Sven-Kevin; Jentsch, Dieter; Motzkus, Dirk; Stahl-Hennig, Christiane] German Primate Ctr, Unit Infect Models, Gottingen, Germany; [Abd El Wahed, Ahmed; Hunsmann, Gerhard] Univ Gottingen, Univ Med Ctr, Dept Virol, D-37073 Gottingen, Germany; [Beutling, Ulrike; Frank, Ronald] Helmholtz Ctr Infect Res, Dept Chem Biol, Braunschweig, Germany; [Fritz, Hans-Joachim] Courant Res Ctr Geobiol, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research	Stahl-Hennig, C (corresponding author), German Primate Ctr, Unit Infect Models, Gottingen, Germany.	stahlh@dpz.eu		Abd El Wahed, Ahmed/0000-0003-3347-6075	EUPRIM-Net under the EU [262443]	EUPRIM-Net under the EU	The screening of monkey sera with ELISA was funded by EUPRIM-Net under the EU grant agreement 262443 of the 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; Coulibaly C, 2004, LAB ANIM-UK, V38, P432, DOI 10.1258/0023677041958891; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130; Elmore D, 2008, COMPARATIVE MED, V58, P11; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GILBERT R, 1994, J VIROL, V68, P2272, DOI 10.1128/JVI.68.4.2272-2285.1994; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Jainkittivong A, 1998, ORAL SURG ORAL MED O, V85, P399, DOI 10.1016/S1079-2104(98)90064-6; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lazear E, 2012, J VIROL, V86, P1563, DOI 10.1128/JVI.06480-11; Morton WR, 2008, ILAR J, V49, P137, DOI 10.1093/ilar.49.2.137; Perelygina L, 2005, J CLIN MICROBIOL, V43, P620, DOI 10.1128/JCM.43.2.620-628.2005; Perelygina L, 2003, J VIROL, V77, P6167, DOI 10.1128/JVI.77.11.6167-6177.2003; Perelygina L, 2002, J INFECT DIS, V186, P453, DOI 10.1086/341834; Perelygina L, 2002, ARCH VIROL, V147, P2057, DOI 10.1007/s00705-002-0889-0; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Sabin AB, 1934, J EXP MED, V59, P115, DOI 10.1084/jem.59.2.115; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Timmerman P, 2004, MOL DIVERS, V8, P61, DOI 10.1023/B:MODI.0000025650.94399.bb; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09	28	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86857	10.1371/journal.pone.0086857	http://dx.doi.org/10.1371/journal.pone.0086857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497986	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900043
J	Ibarra, A; Restrepo, T; Rojas, W; Castillo, A; Amorim, A; Martinez, B; Burgos, G; Ostos, H; Alvarez, K; Camacho, M; Suarez, Z; Pereira, R; Gusmao, L				Ibarra, Adriana; Restrepo, Tomas; Rojas, Winston; Castillo, Adriana; Amorim, Antonio; Martinez, Beatriz; Burgos, German; Ostos, Henry; Alvarez, Karen; Camacho, Mauricio; Suarez, Zuleyma; Pereira, Rui; Gusmao, Leonor			Evaluating the X Chromosome-Specific Diversity of Colombian Populations Using Insertion/Deletion Polymorphisms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; Y-CHROMOSOME; AMERICAN POPULATIONS; MITOCHONDRIAL-DNA; COMMON DISEASES; STR LOCI; ANCESTRY; MARKERS; RECOMMENDATIONS	The European and African contribution to the pre-existing Native American background has influenced the complex genetic pool of Colombia. Because colonisation was not homogeneous in this country, current populations are, therefore, expected to have different proportions of Native American, European and African ancestral contributions. The aim of this work was to examine 11 urban admixed populations and a Native American group, called Pastos, for 32 X chromosome indel markers to expand the current knowledge concerning the genetic background of Colombia. The results revealed a highly diverse genetic background comprising all admixed populations, harbouring important X chromosome contributions from all continental source populations. In addition, Colombia is genetically sub-structured, with different proportions of European and African influxes depending on the regions. The samples from the North Pacific and Caribbean coasts have a high African ancestry, showing the highest levels of diversity. The sample from the South Andean region showed the lowest diversity and significantly higher proportion of Native American ancestry than the other samples from the North Pacific and Caribbean coasts, Central-West and Central-East Andean regions, and the Orinoquian region. The results of admixture analysis using X-chromosomal markers suggest that the high proportion of African ancestry in the North Pacific coast was primarily male driven. These men have joined to females with higher Native American and European ancestry ( likely resulting from a classic colonial asymmetric mating type: European male x Amerindian female). This high proportion of male-mediated African contributions is atypical of colonial settings, suggesting that the admixture occurred during a period when African people were no longer enslaved. In the remaining regions, the African contribution was primarily female-mediated, whereas the European counterpart was primarily male driven and the Native American ancestry contribution was not gender biased.	[Ibarra, Adriana; Restrepo, Tomas; Alvarez, Karen] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, IdentiGEN Genet Identificat Lab, Medellin, Antioquia, Colombia; [Ibarra, Adriana; Restrepo, Tomas; Alvarez, Karen] Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, Res Grp Genet Identificat, Medellin, Antioquia, Colombia; [Rojas, Winston] Univ Antioquia, Inst Biol, Mol Genet Lab, Medellin, Antioquia, Colombia; [Castillo, Adriana] UIS, Genet Lab, Bucaramanga, Santander, Colombia; [Amorim, Antonio; Pereira, Rui; Gusmao, Leonor] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Amorim, Antonio] Univ Porto, FCUP Fac Sci, P-4100 Oporto, Portugal; [Martinez, Beatriz] Univ Cartagena, Immunol Res Inst, Mol Genet Lab, Cartagena, Bolivar, Colombia; [Burgos, German] Ecuadorian Red Cross, Cruz Vital, Mol Genet Lab, Quito, Ecuador; [Ostos, Henry] Surcolombiana Univ, Hlth Fac, Genom Med Lab, Neiva, Huila, Colombia; [Camacho, Mauricio] Inst Legal Med & Forens Sci, Arauca, Colombia; [Suarez, Zuleyma] Clin Lab Olga Zuleima Suarez Molina, Cucuta, Norte De Santan, Colombia; [Gusmao, Leonor] State Univ Rio de Janeiro UERJ, DNA Diagnost Lab LDD, Rio De Janeiro, Brazil	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidade do Porto; Universidade do Porto; Universidad de Cartagena; Universidade do Estado do Rio de Janeiro	Ibarra, A (corresponding author), Univ Antioquia, Sch Nat & Exact Sci FCEN, Inst Biol, IdentiGEN Genet Identificat Lab, Medellin, Antioquia, Colombia.	adriba@quimbaya.udea.edu.co	Pereira, Rui/B-1656-2013; Gusmao, Leonor/B-3122-2013; Gusmão, Leonor/L-8931-2019; Amorim, Antonio/A-7938-2008; Burgos Figueroa, German/S-3043-2017	Pereira, Rui/0000-0002-3889-798X; Gusmao, Leonor/0000-0003-0432-6481; Gusmão, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Burgos Figueroa, German/0000-0002-8400-2753; Rojas Montoya, Winston/0000-0002-7654-3998; Alvarez Diaz, Karen Dayanna/0000-0002-1968-4647	Portuguese Foundation for Science and Technology (FCT); FCT [SFRH/BPD/81986/2011]; Programa Sostenibilidad del Grupo Genetica Molecular	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Sostenibilidad del Grupo Genetica Molecular	IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, partially through funding from the Portuguese Foundation for Science and Technology (FCT). RP was supported through a postdoctoral fellowship from FCT (SFRH/BPD/81986/2011). WR was supported by "Programa Sostenibilidad del Grupo Genetica Molecular 2013-2014". The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Acosta MA, 2009, FORENSIC SCI INT-GEN, V3, pE59, DOI 10.1016/j.fsigen.2008.06.006; Alonso LA, 2013, HOMO, V64, P71, DOI 10.1016/j.jchb.2012.11.006; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bortolini MC, 1999, AM J HUM BIOL, V11, P551, DOI 10.1002/(SICI)1520-6300(1999)11:4<551::AID-AJHB15>3.0.CO;2-Z; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Falush D, 2003, GENETICS, V164, P1567; Gill P, 2012, FORENSIC SCI INT-GEN, V6, P679, DOI 10.1016/j.fsigen.2012.06.002; Gjertson DW, 2007, FORENSIC SCI INT-GEN, V1, P223, DOI 10.1016/j.fsigen.2007.06.006; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ibarra A, 2013, INT J LEGAL IN PRESS; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Lee JW, 2001, FORENSIC SCI INT, V116, P139, DOI 10.1016/S0379-0738(00)00356-X; Martinez B, 2007, INT ARCH ALLERGY IMM, V144, P105, DOI 10.1159/000103221; Martinez B, 2006, FORENSIC SCI INT, V160, P221, DOI 10.1016/j.forsciint.2005.05.035; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mutalib S, 2013, ADV SCI LETT, V19, P3391; Noguera MC, 2013, ANN HUM BIO IN PRESS; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Paredes M, 2003, FORENSIC SCI INT, V137, P67, DOI 10.1016/S0379-0738(03)00271-8; Pereira R, 2012, INT J LEGAL MED, V126, P97, DOI 10.1007/s00414-011-0593-2; Pereira V, 2012, AM J PHYS ANTHROPOL, V148, P389, DOI 10.1002/ajpa.22061; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Rodas C, 2003, HUM BIOL, V75, P13, DOI 10.1353/hub.2003.0026; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Yunis JJ, 2013, GENET MOL BIOL, V36, P329, DOI 10.1590/S1415-47572013000300005	42	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87202	10.1371/journal.pone.0087202	http://dx.doi.org/10.1371/journal.pone.0087202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498042	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900076
J	Murin, J; Naditch-Brule, L; Brette, S; Chiang, CE; O'Neill, J; Steg, PG				Murin, Jan; Naditch-Brule, Lisa; Brette, Sandrine; Chiang, Chern-En; O'Neill, James; Steg, P. Gabriel			Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey	PLOS ONE			English	Article							EURO HEART SURVEY; RHYTHM CONTROL; INCREASED MORTALITY; FOLLOW-UP; PREVALENCE; GUIDELINES; REGISTRY; PROGRESSION; PROGNOSIS; SYMPTOMS	Background: Atrial fibrillation can be categorized into nonpermanent and permanent atrial fibrillation. There is less information on permanent than on nonpermanent atrial fibrillation patients. This analysis aimed to describe the characteristics and current management, including the proportion of patients with successful atrial fibrillation control, of these atrial fibrillation subsets in a large, geographically diverse contemporary sample. Methods and Results: Data from RealiseAF, an international, observational, cross-sectional survey of 10,491 patients with atrial fibrillation, were used to characterize permanent atrial fibrillation (N = 4869) and nonpermanent atrial fibrillation (N = 5622) patients. Permanent atrial fibrillation patients were older, had a longer time since atrial fibrillation diagnosis, a higher symptom burden, and were more likely to be physically inactive. They also had a higher mean (SD) CHADS(2) score (2.2 [1.3] vs. 1.7 [1.3], p<0.001), and a higher frequency of CHADS(2) score >= 2 (67.3% vs. 53.0%, p<0.001) and comorbidities, most notably heart failure. Physicians indicated using a rate-control strategy in 84.2% of permanent atrial fibrillation patients (vs. 27.5% in nonpermanent atrial fibrillation). Only 50.2% (N = 2262/4508) of permanent atrial fibrillation patients were controlled. These patients had a longer time since atrial fibrillation diagnosis, a lower symptom burden, less obesity and physical inactivity, less severe heart failure, and fewer hospitalizations for acute heart failure than uncontrolled permanent atrial fibrillation patients, but with more arrhythmic events. The most frequent causes of hospitalization in the last 12 months were acute heart failure and stroke. Conclusion: Permanent atrial fibrillation is a high-risk subset of atrial fibrillation, representing half of all atrial fibrillation patients, yet rate control is only achieved in around half. Since control is associated with lower symptom burden and heart failure, adequate rate control is an important target for improving the management of permanent atrial fibrillation patients.	[Murin, Jan] Comenius Univ, Dept Internal Med & Cardiol, Bratislava, Slovakia; [Naditch-Brule, Lisa] Sanofi, Global Strateg Unit Cardiothrombosis, Paris, France; [Brette, Sandrine] Lincoln, Boulogne, France; [Chiang, Chern-En] Taipei Vet Gen Hosp, Gen Clin Res Ctr, Taipei, Taiwan; [Chiang, Chern-En] Natl Yang Ming Univ, Taipei 112, Taiwan; [O'Neill, James] Royal Coll Surgeons Ireland, Connolly Mater Hosp, Dublin 2, Ireland; [Steg, P. Gabriel] INSERM, U698, Paris, France; [Steg, P. Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, F-75877 Paris, France	Comenius University Bratislava; Sanofi-Aventis; Sanofi France; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Royal College of Surgeons - Ireland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Steg, PG (corresponding author), INSERM, U698, Paris, France.	gabriel.steg@bch.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019	STEG, Philippe Gabriel/0000-0001-6896-2941	sanofi	sanofi(Sanofi-Aventis)	The RealiseAF survey was funded by sanofi (http://en.sanofi.com). The funders had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript: the sanofi author assisted with the preparation of the manuscript and approved the manuscript for publication; sanofi had a role in data analysis via funding of the statistician at Lincoln; and PPSI was supported by sanofi.	Barrios V, 2012, REV ESP CARDIOL, V65, P47, DOI [10.1016/j.recesp.2011.08.008, 10.1016/j.rec.2011.09.004]; Camm AJ, 2012, J CARDIOVASC MED, V13, P97, DOI 10.2459/JCM.0b013e32834f23e1; Camm AJ, 2011, J AM COLL CARDIOL, V58, P493, DOI 10.1016/j.jacc.2011.03.034; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cohen A, 2010, ARCH CARDIOVASC DIS, V103, P376, DOI 10.1016/j.acvd.2010.06.001; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; De Ferrari GM, 2007, EUR J HEART FAIL, V9, P502, DOI 10.1016/j.ejheart.2006.10.021; FUNCKBRENTANO C, 1993, AM J CARDIOL, V72, pB17, DOI 10.1016/0002-9149(93)90035-B; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Gheorghiade M, 2013, EUR HEART J, V34, P1489, DOI 10.1093/eurheartj/eht120; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Kim MH, 2011, CLIN THER, V33, P1668, DOI 10.1016/j.clinthera.2011.10.005; Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Nieuwlaat R, 2008, EUR HEART J, V29, P1181, DOI 10.1093/eurheartj/ehn139; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Steg PG, 2012, HEART, V98, P195, DOI 10.1136/heartjnl-2011-300550; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Tebbe U, 2008, CLIN RES CARDIOL, V97, P389, DOI 10.1007/s00392-008-0644-y; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86443	10.1371/journal.pone.0086443	http://dx.doi.org/10.1371/journal.pone.0086443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497948	Green Published, gold			2022-12-27	WOS:000330621900024
J	Guo, M; Zhou, Q; Zhou, YZ; Yang, LF; Liu, TX; Yang, JL; Chen, YL; Su, LX; Xu, J; Chen, J; Liu, F; Chen, JP; Dai, WK; Ni, PX; Fang, CX; Yang, RF				Guo, Min; Zhou, Qian; Zhou, Yizhuang; Yang, Linfeng; Liu, Tianxiang; Yang, Jinlong; Chen, Yanling; Su, Longxiang; Xu, Jin; Chen, Jing; Liu, Feng; Chen, Jiapeng; Dai, Wenkui; Ni, Peixiang; Fang, Chengxiang; Yang, Ruifu			Genomic Evolution of 11 Type Strains within Family Planctomycetaceae	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FEATURE FREQUENCY PROFILES; DNA-DNA HYBRIDIZATION; SP-NOV.; GEN. NOV.; SEQUENCE; IDENTIFICATION; PIRELLULA; ALIGNMENT; ORDER	The species in family Planctomycetaceae are ideal groups for investigating the origin of eukaryotes. Their cells are divided by a lipidic intracytoplasmic membrane and they share a number of eukaryote-like molecular characteristics. However, their genomic structures, potential abilities, and evolutionary status are still unknown. In this study, we searched for common protein families and a core genome/pan genome based on 11 sequenced species in family Planctomycetaceae. Then, we constructed phylogenetic tree based on their 832 common protein families. We also annotated the 11 genomes using the Clusters of Orthologous Groups database. Moreover, we predicted and reconstructed their core/pan metabolic pathways using the KEGG (Kyoto Encyclopedia of Genes and Genomes) orthology system. Subsequently, we identified genomic islands (GIs) and structural variations (SVs) among the five complete genomes and we specifically investigated the integration of two Planctomycetaceae plasmids in all 11 genomes. The results indicate that Planctomycetaceae species share diverse genomic variations and unique genomic characteristics, as well as have huge potential for human applications.	[Guo, Min; Fang, Chengxiang; Yang, Ruifu] BGI Shenzhen, Shenzhen Key Lab Environm Microbial Genom & Appli, Shenzhen, Peoples R China; [Guo, Min; Zhou, Yizhuang; Yang, Jinlong; Chen, Jing; Fang, Chengxiang; Yang, Ruifu] BGI Shenzhen, Shenzhen Key Lab Bioenergy, Shenzhen, Peoples R China; [Guo, Min; Zhou, Qian; Zhou, Yizhuang; Yang, Linfeng; Liu, Tianxiang; Yang, Jinlong; Chen, Yanling; Xu, Jin; Chen, Jing; Liu, Feng; Chen, Jiapeng; Dai, Wenkui; Ni, Peixiang; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Su, Longxiang] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Fang, Chengxiang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Nankai University; Wuhan University; Beijing Institute of Microbiology & Epidemiology	Yang, RF (corresponding author), BGI Shenzhen, Shenzhen Key Lab Environm Microbial Genom & Appli, Shenzhen, Peoples R China.	ruifuyang@gmail.com	Yang, Linfeng/AAZ-8792-2020; xu, jin/O-6912-2019; chen, yanling/GRE-8287-2022; Yang, Ruifu/A-2273-2011; Su, Longxiang/I-6788-2019	xu, jin/0000-0003-2289-4896; Yang, Ruifu/0000-0003-3219-7269; Su, Longxiang/0000-0002-0942-2870; Chen, Jing/0000-0001-9481-9997; Chen, Jiapeng/0000-0002-9145-3018	Shenzhen Key Laboratory of Bioenergy [CXB201005240001A]; Shenzhen Key Laboratory of Environmental Microbial Genomics and Application [CXB201108250097A]; State Key Development Program for Basic Research of China [2009CB522600]; National Natural Science Foundation of China [30930001]	Shenzhen Key Laboratory of Bioenergy; Shenzhen Key Laboratory of Environmental Microbial Genomics and Application; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shenzhen Key Laboratory of Bioenergy (grant CXB201005240001A), Shenzhen Key Laboratory of Environmental Microbial Genomics and Application(grant CXB201108250097A) and by grants from the State Key Development Program for Basic Research of China (2009CB522600), the National Natural Science Foundation of China (Contract 30930001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao T, 2011, DNA RES, V18, P423, DOI 10.1093/dnares/dsr029; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Bondoso J, 2011, INT J SYST EVOL MICR, V61, P2844, DOI 10.1099/ijs.0.027474-0; Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Chavan A, 2012, BMJ CASE REP; Clum Alicia, 2010, Stand Genomic Sci, V2, P228, DOI 10.4056/sigs.881234; Clum A, 2009, STAND GENOMIC SCI, V1, P308, DOI 10.4056/sigs.51657; Cornell MJ, 2007, GENOME RES, V17, P1809, DOI 10.1101/gr.6531807; Damste JSS, 2005, FEBS J, V272, P4270, DOI 10.1111/j.1742-4658.2005.04842.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dhillon BK, 2013, NUCLEIC ACIDS RES, V41, pW129, DOI 10.1093/nar/gkt394; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ermolaeva MD, 2001, NUCLEIC ACIDS RES, V29, P1216, DOI 10.1093/nar/29.5.1216; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Gade D, 2005, PROTEOMICS, V5, P3672, DOI 10.1002/pmic.200401200; Gade D, 2004, MICROB ECOL, V47, P243, DOI 10.1007/s00248-003-1016-9; GIOVANNONI SJ, 1987, ARCH MICROBIOL, V147, P276, DOI 10.1007/BF00463488; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guo M, 2012, J BACTERIOL, V194, P3740, DOI 10.1128/JB.00639-12; Henrici AT, 1935, J BACTERIOL, V30, P61, DOI 10.1128/JB.30.1.61-93.1935; Hieu CX, 2008, PROTEOMICS, V8, P1608, DOI 10.1002/pmic.200701017; Jetten MSM, 2008, ENVIRON MICROBIOL, V10, P2903, DOI 10.1111/j.1462-2920.2008.01786.x; Jogler C, 2012, J BACTERIOL, V194, P6419, DOI 10.1128/JB.01325-12; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; KERGER BD, 1988, ARCH MICROBIOL, V149, P255, DOI 10.1007/BF00422014; Kleiner M, 2012, CURR OPIN MICROBIOL, V15, P621, DOI 10.1016/j.mib.2012.09.003; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kulichevskaya IS, 2008, INT J SYST EVOL MICR, V58, P1186, DOI 10.1099/ijs.0.65593-0; Kulichevskaya IS, 2007, INT J SYST EVOL MICR, V57, P2680, DOI 10.1099/ijs.0.65157-0; Kulichevskaya IS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00146; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LaButti K, 2010, STAND GENOMIC SCI, V3, P47, DOI 10.4056/sigs.1052813; LACASSE EC, 1993, ENDOCRINOLOGY, V133, P2760, DOI 10.1210/endo.133.6.8243301; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lango Zsuzsanna, 2005, Acta Microbiologica et Immunologica Hungarica, V52, P73, DOI 10.1556/AMicr.52.2005.1.3; Leary BA, 1998, GENE, V221, P151, DOI 10.1016/S0378-1119(98)00423-5; Lee HW, 2012, INT J SYST EVOL MICR; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Nardi E, 2011, CLIN NEPHROL, V76, P330, DOI 10.5414/CN106676; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; SCHMIDT JM, 1979, CURR MICROBIOL, V3, P187, DOI 10.1007/BF02601865; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	56	13	13	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86752	10.1371/journal.pone.0086752	http://dx.doi.org/10.1371/journal.pone.0086752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489782	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000068
J	Jacka, FN; Cherbuin, N; Anstey, KJ; Butterworth, P				Jacka, Felice N.; Cherbuin, Nicolas; Anstey, Kaarin J.; Butterworth, Peter			Dietary Patterns and Depressive Symptoms over Time: Examining the Relationships with Socioeconomic Position, Health Behaviours and Cardiovascular Risk	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; OXIDATIVE STRESS; ASSOCIATION; QUALITY; COHORT; WOMEN; LIFE; INEQUALITIES; INFLAMMATION; METAANALYSIS	Introduction: Recent research suggests that diet quality influences depression risk; however, a lack of experimental evidence leaves open the possibility that residual confounding explains the observed relationships. The aim of this study was to document the cross-sectional and longitudinal associations between dietary patterns and symptoms of depression and to undertake a detailed examination of potential explanatory factors, particularly socioeconomic circumstances, in the diet-depression relationship. Methods: Data were drawn from the Personality and Total Health (PATH) Through Life Study, a longitudinal community study following three age cohorts (20+; 40+; 60+ yrs) from south-eastern Australia over three assessment periods (n = 3663). Regression analyses evaluated the cross-sectional and longitudinal relationships between dietary patterns, depressive symptoms, age, detailed measures of socioeconomic circumstances, other health behaviours, and cardiovascular risk factors. Results: The lowest tertile of prudent (healthy) dietary pattern and the highest tertile of western (unhealthy) dietary pattern were associated with an increased likelihood of depressive symptoms. However, these contemporaneous associations were explained by adjustment for detailed measures of socioeconomic circumstances and physical activity. In prospective analyses, lower scores on the healthy dietary pattern and higher scores on the unhealthy dietary pattern independently predicted increased depressive symptoms across time, before and after adjustment for potential confounders and baseline depressive symptoms, but only for those in the oldest cohort. Dietary patterns did not explain the relationship between socioeconomic position and depressive symptoms. Conclusion: The results of this study confirm that the relationship between habitual dietary intake and depressive symptoms is somewhat explained by socioeconomic circumstances and other health behaviours, but suggest that long term exposure to unhealthy dietary habits independently predisposes to depression over the lifecourse.	[Jacka, Felice N.] Deakin Univ, IMPACT Strateg Res Ctr, Div Nutr Psychiat Res, Geelong, Vic 3217, Australia; [Jacka, Felice N.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Cherbuin, Nicolas; Anstey, Kaarin J.; Butterworth, Peter] Australian Natl Univ, Ctr Res Ageing Hlth & Well Being, Canberra, ACT, Australia	Deakin University; University of Melbourne; Australian National University	Jacka, FN (corresponding author), Deakin Univ, IMPACT Strateg Res Ctr, Div Nutr Psychiat Res, Geelong, Vic 3217, Australia.	felice@barwonhealth.org.au	Jacka, Felice N/D-9424-2012; Butterworth, Peter/AFK-2636-2022; Jacka, Felice N/ABE-6322-2020; Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Jacka, Felice N/0000-0002-9825-0328; Jacka, Felice N/0000-0002-9825-0328; Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748; Butterworth, Peter/0000-0002-1531-3881	NHMRC [973302, 157125, 1002560, 628912]; ARC [120100227];  [179805];  [350833]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); ; 	This study was supported by NHMRC Grant No. 973302, Program Grants No. 179805 and 350833, NHMRC project grant No. 157125. KJA is funded by NHMRC Research Fellowship No. 1002560. NC is funded by an ARC Future Fellowship No. 120100227. FNJ is funded by an NHMRC Postdoctoral Fellowship No. 628912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925; Ambrosini GL, 2003, PUBLIC HEALTH NUTR, V6, P415, DOI 10.1079/PHN2002434; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Anstey KJ, 2012, INT J EPIDEMIOL, V41, P951, DOI 10.1093/ije/dyr025; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Berk M, 2012, BRIT J PSYCHIAT, V201, P339, DOI 10.1192/bjp.bp.111.107797; Butterworth P, 2013, J AFFECT DISORDERS, V149, P75, DOI 10.1016/j.jad.2013.01.006; Butterworth P, 2012, AUST NZ J PSYCHIAT, V46, P364, DOI 10.1177/0004867411433215; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Chatzi L, 2011, PUBLIC HEALTH NUTR, V14, P1663, DOI 10.1017/S1368980010003629; Collins CE, 2008, J AM COLL NUTR, V27, P146, DOI 10.1080/07315724.2008.10719686; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Gerecke KM, 2013, BRAIN RES; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Guenther PM, 2007, DEV EVALUATION HLTH; Henderson L, 2002, NATL DIET NUTR SURVE; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacka FN, 2013, J AM ACAD CHILD PSY, V52, P1038, DOI 10.1016/j.jaac.2013.07.002; Jacka FN, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-149; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2011, J AFFECT DISORDERS, V129, P332, DOI 10.1016/j.jad.2010.09.004; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552; Lassale C, 2009, J HUM NUTR DIET, V22, P559, DOI 10.1111/j.1365-277X.2009.00990.x; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Maron David J, 2004, Curr Atheroscler Rep, V6, P73, DOI 10.1007/s11883-004-0119-1; Mila-Villarroel R, 2011, PUBLIC HEALTH NUTR, V14, P2338, DOI 10.1017/S1368980011002606; Mohanty P, 2002, AM J CLIN NUTR, V75, P767, DOI 10.1093/ajcn/75.4.767; Morris LJ, 2011, MENTAL HLTH WELLBEIN; Mulder M, 1998, INT J EPIDEMIOL, V27, P199, DOI 10.1093/ije/27.2.199; Nanri A, 2010, EUR J CLIN NUTR, V64, P832, DOI 10.1038/ejcn.2010.86; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Weng T T, 2011, PUBLIC HLTH NUT, V25, P1; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	43	101	101	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87657	10.1371/journal.pone.0087657	http://dx.doi.org/10.1371/journal.pone.0087657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489946	Green Published, gold			2022-12-27	WOS:000330570000166
J	Wan, PJ; Jia, S; Li, N; Fan, JM; Li, GQ				Wan, Pin-Jun; Jia, Shuang; Li, Na; Fan, Jin-Mei; Li, Guo-Qing			RNA Interference Depletion of the Halloween Gene Disembodied Implies its Potential Application for Management of Planthopper Sogatella furcifera and Laodelphax striatellus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; STEROID-HORMONE ECDYSONE; NILAPARVATA-LUGENS; ECDYSTEROID BIOSYNTHESIS; DROSOPHILA-MELANOGASTER; DSRNA INGESTION; P450 ENZYMES; CHLORPYRIFOS RESISTANCE; CYTOCHROME-P450 ENZYME; ANOPHELES-GAMBIAE	Sogatella furcifera and Laodelphax striatellus are economically important rice pests in China by acting as vectors of several rice viruses, sucking the phloem sap and blocking the phloem vessels. Ecdysteroid hormone 20-hydroxyecdysone regulates insect development and reproduction. A cytochrome P450 monooxygenase CYP302A1 (22-hydroxylase), encoded by the Halloween gene disembodied (dib), plays a critical role in ecdysteroidogenesis. The objective of this study is to test whether dib genes are potential targets for RNA interference-based management of S. furcifera and L. striatellus. We cloned and characterized Sfdib and Lsdib. The open reading frame regions of dib genes were generated and used for designing and constructing dsRNA fragments. Experiments were conducted using oral delivery of dsdib to investigate the effectiveness of RNAi in S. furcifera and L. striatellus nymphs. Real-time quantitative reverse transcriptase-PCR analysis demonstrated that continuous ingestion of dsdib at the concentration of 0.01, 0.05 and 0.50 mg/ml diminished Sfdib expression levels by 35.9%, 45.1% and 66.2%, and ecdysone receptor (SfEcR) gene mRNA levels by 34.0%, 36.2% and 58.5% respectively in S. furcifera, and decreased Lsdib expression level by 18.8%, 35.8% and 56.7%, and LsEcR mRNA levels by 25.2%, 46.8% and 68.8% respectively in L. striatellus. The reduction in dib and EcR transcript abundance resulted in observable phenotypes. The development of nymphs was impaired and the survival was negatively affected. Our data will enable the development of new insect control strategies and functional analysis of vital genes in S. furcifera and L. striatellus nymphs.	[Wan, Pin-Jun; Jia, Shuang; Li, Na; Fan, Jin-Mei; Li, Guo-Qing] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, GQ (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	ligq@njau.edu.cn			National Basic Research Program of China (973 Program) [2010CB126200]; National Natural Sciences Foundation of China [31360442]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (973 Program, No. 2010CB126200) and the National Natural Sciences Foundation of China (31360442). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bautista MAM, 2009, INSECT BIOCHEM MOLEC, V39, P38, DOI 10.1016/j.ibmb.2008.09.005; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRIENEISEN ML, 1993, INSECT BIOCHEM MOLEC, V23, P13, DOI 10.1016/0965-1748(93)90077-6; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Iga M, 2010, PEPTIDES, V31, P456, DOI 10.1016/j.peptides.2009.08.002; Jia S, 2013, GENE, V531, P168, DOI 10.1016/j.gene.2013.09.034; Jia S, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-19; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KAPPLER C, 1988, J STEROID BIOCHEM, V31, P891, DOI 10.1016/0022-4731(88)90330-5; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; KOBAYASHI M, 1989, PESTIC BIOCHEM PHYS, V34, P9, DOI 10.1016/0048-3575(89)90135-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Lu DH, 2013, PEST MANAG SCI, V69, P1034, DOI 10.1002/ps.3553; Luan JB, 2013, INSECT BIOCHEM MOLEC, V43, P740, DOI 10.1016/j.ibmb.2013.05.012; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Marchal E, 2011, J INSECT PHYSIOL, V57, P1240, DOI 10.1016/j.jinsphys.2011.05.009; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Nakao T, 2012, J PESTIC SCI, V37, P37, DOI 10.1584/jpestics.D11-018; Nelson David R., 2009, Human Genomics, V4, P59; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Ren XL, 2013, APPL ENVIRON MICROB, V79, P5576, DOI 10.1128/AEM.01519-13; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Sanada-Morimura S, 2011, APPL ENTOMOL ZOOL, V46, P65, DOI 10.1007/s13355-010-0009-7; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; Singh AD, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6901; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064026; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wan PJ, 2014, INSECT SCI, V21, P147, DOI 10.1111/1744-7917.12034; Wang LH, 2010, PEST MANAG SCI, V66, P1096, DOI 10.1002/ps.1984; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wu WJ, 2012, J INSECT PHYSIOL, V58, P420, DOI 10.1016/j.jinsphys.2012.01.012; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005; Yao JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070243; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhang XY, 2013, INSECT SCI, V20, P61, DOI 10.1111/j.1744-7917.2012.01539.x; Zhang YL, 2013, PESTIC BIOCHEM PHYS, V106, P8, DOI 10.1016/j.pestbp.2013.03.002; Zhang YL, 2012, PESTIC BIOCHEM PHYS, V104, P277, DOI 10.1016/j.pestbp.2012.10.002; Zhou LT, 2013, J INSECT PHYSIOL, V59, P1049, DOI 10.1016/j.jinsphys.2013.08.002; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	72	38	39	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86675	10.1371/journal.pone.0086675	http://dx.doi.org/10.1371/journal.pone.0086675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489765	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000071
J	McDermott, AM; Miller, N; Wall, D; Martyn, LM; Ball, G; Sweeney, KJ; Kerin, MJ				McDermott, Ailbhe M.; Miller, Nicola; Wall, Deirdre; Martyn, Lorcan M.; Ball, Graham; Sweeney, Karl J.; Kerin, Michael J.			Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; ESTROGEN-RECEPTOR; EXPRESSION; ANTIGEN; STAGE; PROFILES; METASTASIS; PROGNOSIS; DIAGNOSIS	Introduction: Breast cancer is a common disease with distinct tumor subtypes phenotypically characterized by ER and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression, and altered miRNA expression has been demonstrated in a variety of cancer states presenting the potential for exploitation as cancer biomarkers. Blood provides an excellent medium for biomarker discovery. This study investigated systemic miRNAs differentially expressed in Luminal A-like (ER+PR+HER2/neu-) breast cancer and their effectiveness as oncologic biomarkers in the clinical setting. Methods: Blood samples were prospectively collected from patients with Luminal A-like breast cancer (n = 54) and controls (n = 56). RNA was extracted, reverse transcribed and subjected to microarray analysis (n = 10 Luminal A-like; n = 10 Control). Differentially expressed miRNAs were identified by artificial neural network (ANN) data-mining algorithms. Expression of specific miRNAs was validated by RQ-PCR (n = 44 Luminal A; n = 46 Control) and potential relationships between circulating miRNA levels and clinicopathological features of breast cancer were investigated. Results: Microarray analysis identified 76 differentially expressed miRNAs. ANN revealed 10 miRNAs for further analysis (miR-19b, miR-29a, miR-93, miR-181a, miR-182, miR-223, miR-301a, miR-423-5p, miR-486-5 and miR-652). The biomarker potential of 4 miRNAs (miR-29a, miR-181a, miR-223 and miR-652) was confirmed by RQ-PCR, with significantly reduced expression in blood of women with Luminal A-like breast tumors compared to healthy controls (p = 0.001, 0.004, 0.009 and 0.004 respectively). Binary logistic regression confirmed that combination of 3 of these miRNAs (miR-29a, miR-181a and miR-652) could reliably differentiate between cancers and controls with an AUC of 0.80. Conclusion: This study provides insight into the underlying molecular portrait of Luminal A-like breast cancer subtype. From an initial 76 miRNAs, 4 were validated with altered expression in the blood of women with Luminal A-like breast cancer. The expression profiles of these 3 miRNAs, in combination with mammography, has potential to facilitate accurate subtype-specific breast tumor detection.	[McDermott, Ailbhe M.; Miller, Nicola; Martyn, Lorcan M.; Sweeney, Karl J.; Kerin, Michael J.] Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland; [Wall, Deirdre] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Ball, Graham] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Nottingham Trent University	Miller, N (corresponding author), Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland.	nicola.miller@nuigalway.ie	Miller, Nicola/F-4009-2018	Miller, Nicola/0000-0002-5416-7047; Ball, Graham/0000-0001-5828-7129; Kerin, Michael/0000-0003-4164-5561; Wall, Deirdre/0000-0001-6510-6082	National Breast Cancer Research Institute (NBCRI), Ireland	National Breast Cancer Research Institute (NBCRI), Ireland	A.M. McDermott received a research scholarship from the National Breast Cancer Research Institute (NBCRI), Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Endo Y, 2013, ENDOCR-RELAT CANCER, V20, P91, DOI 10.1530/ERC-12-0207; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Garcia M, 2007, GLOBAL CANC FACT FIG; Guo LJ, 2012, INT J MOL MED, V30, P680, DOI 10.3892/ijmm.2012.1021; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JACOBS I, 1989, HUM REPROD, V4, P1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Lin Y, 2012, CARCINOGENESIS, V10, P10; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Mar-Aguilar F, 2012, ASIA-PAC J CLIN ONCO, V23, P1743; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Nishimura J, 2012, ONCOL REP, V28, P2221, DOI 10.3892/or.2012.2059; Ogawa R, 2010, BIOCHEM BIOPH RES CO, V398, P723, DOI 10.1016/j.bbrc.2010.07.008; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waters PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050459; Weissmann-Brenner A, 2012, INT J ONCOL, V40, P2097, DOI 10.3892/ijo.2012.1403; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yang S., 2012, ONCOGENE, V24, P1; Zeng X, 2012, PLOS ONE, V7; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	46	72	76	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87032	10.1371/journal.pone.0087032	http://dx.doi.org/10.1371/journal.pone.0087032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498016	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330621900061
J	Ooi, JLS; Van Niel, KP; Kendrick, GA; Holmes, KW				Ooi, Jillian L. S.; Van Niel, Kimberly P.; Kendrick, Gary A.; Holmes, Karen W.			Spatial Structure of Seagrass Suggests That Size-Dependent Plant Traits Have a Strong Influence on the Distribution and Maintenance of Tropical Multispecies Meadows	PLOS ONE			English	Article							SE ASIAN SEAGRASSES; POSIDONIA-OCEANICA; SOIL PROPERTIES; GEOSTATISTICAL TOOLS; THALASSIA-HEMPRICHII; LANDSCAPE PATTERN; GROWTH DYNAMICS; PRODUCTIVITY; AUTOCORRELATION; PHOTOSYNTHESIS	Background: Seagrass species in the tropics occur in multispecies meadows. How these meadows are maintained through species co-existence and what their ecological drivers may be has been an overarching question in seagrass biogeography. In this study, we quantify the spatial structure of four co-existing species and infer potential ecological processes from these structures. Methods and Results: Species presence/absence data were collected using underwater towed and dropped video cameras in Pulau Tinggi, Malaysia. The geostatistical method, utilizing semivariograms, was used to describe the spatial structure of Halophila spp, Halodule uninervis, Syringodium isoetifolium and Cymodocea serrulata. Species had spatial patterns that were oriented in the along-shore and across-shore directions, nested with larger species in meadow interiors, and consisted of multiple structures that indicate the influence of 2-3 underlying processes. The Linear Model of Coregionalization (LMC) was used to estimate the amount of variance contributing to the presence of a species at specific spatial scales. These distances were <2.5 m (micro-scale), 2.5-50 m (fine-scale) and >50 m (broad-scale) in the along-shore; and <2.5 m (micro-scale), 2.5-140 m (fine-scale) and >140 m (broad-scale) in the across-shore. The LMC suggests that smaller species (Halophila spp and H. uninervis) were most influenced by broad-scale processes such as hydrodynamics and water depth whereas large, localised species (S. isoetifolium and C. serrulata) were more influenced by finer-scale processes such as sediment burial, seagrass colonization and growth, and physical disturbance. Conclusion: In this study, we provide evidence that spatial structure is distinct even when species occur in well-mixed multispecies meadows, and we suggest that size-dependent plant traits have a strong influence on the distribution and maintenance of tropical marine plant communities. This study offers a contrast from previous spatial models of seagrasses which have largely focused on monospecific temperate meadows.	[Ooi, Jillian L. S.; Kendrick, Gary A.] Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Ooi, Jillian L. S.; Van Niel, Kimberly P.; Holmes, Karen W.] Univ Western Australia, Sch Earth & Environm, Fac Nat & Agr Sci, Perth, WA 6009, Australia; [Ooi, Jillian L. S.; Van Niel, Kimberly P.; Kendrick, Gary A.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Ooi, Jillian L. S.] Univ Malaya, Dept Geog, Fac Arts & Social Sci, Kuala Lumpur, Malaysia; [Holmes, Karen W.] Univ Western Australia, Ctr Ecohydrol, Sch Environm Engn, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; Universiti Malaya; University of Western Australia	Ooi, JLS (corresponding author), Univ Western Australia, Sch Plant Biol, Fac Nat & Agr Sci, Perth, WA 6009, Australia.	jillian_03@um.edu.my	OOI, JILLIAN/B-5252-2010; Holmes, karen/AAS-6809-2021; Kendrick, Gary Andrew/B-3460-2011	OOI, JILLIAN/0000-0002-1764-6495; Kendrick, Gary Andrew/0000-0002-0276-6064	MOSTI [04-01-03-SF0177]; Grant for Research Student Training (GRST, UWA); Endeavour International Postgraduate Research Scholarship; University Postgraduate Award; University of Western Australia; Universiti Malaya	MOSTI(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Grant for Research Student Training (GRST, UWA); Endeavour International Postgraduate Research Scholarship(Australian Government); University Postgraduate Award; University of Western Australia; Universiti Malaya(Universiti Malaya)	Fieldtrips were partly funded by the MOSTI E-Science grant (04-01-03-SF0177) and the Grant for Research Student Training (GRST, UWA) awarded to JLSO. JLSO was supported by the Endeavour International Postgraduate Research Scholarship, the University Postgraduate Award, the PhD Completion Scholarship (University of Western Australia) and the Hadiah Cuti Belajar program (Universiti Malaya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOVERRO T, 1995, MAR ECOL PROG SER, V120, P203, DOI 10.3354/meps120203; Balestri E, 2003, MAR ECOL PROG SER, V250, P51, DOI 10.3354/meps250051; BIRCH WR, 1984, AQUAT BOT, V19, P343, DOI 10.1016/0304-3770(84)90048-2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borg JA, 2005, ESTUAR COAST SHELF S, V62, P667, DOI 10.1016/j.ecss.2004.10.003; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; DOBERMANN A, 1995, GEODERMA, V68, P173, DOI 10.1016/0016-7061(95)00035-M; Duarte CM, 1997, MAR ECOL PROG SER, V147, P285, DOI 10.3354/meps147285; Duarte CM, 2000, MAR ECOL PROG SER, V197, P231, DOI 10.3354/meps197231; DUARTE CM, 1991, AQUAT BOT, V40, P363, DOI 10.1016/0304-3770(91)90081-F; DUARTE CM, 1991, MAR ECOL PROG SER, V77, P289, DOI 10.3354/meps077289; Fonseca M, 2002, ECOL APPL, V12, P218, DOI 10.1890/1051-0761(2002)012[0218:MSLPAA]2.0.CO;2; Fonseca MS, 2008, ESTUAR COAST SHELF S, V76, P163, DOI 10.1016/j.ecss.2007.06.014; Fonseca MS, 1998, MAR ECOL PROG SER, V171, P109, DOI 10.3354/meps171109; FONSECA MS, 1987, AQUAT BOT, V27, P59, DOI 10.1016/0304-3770(87)90086-6; Gobert S, 2003, OCEANOL ACTA, V26, P199, DOI 10.1016/S0399-1784(02)00009-9; GOOVAERTS P, 1992, J SOIL SCI, V43, P597, DOI 10.1111/j.1365-2389.1992.tb00163.x; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Hammerli A, 2003, HEREDITY, V91, P448, DOI 10.1038/sj.hdy.6800310; Holmes KW, 2007, AQUAT CONSERV, V17, P385, DOI 10.1002/aqc.772; Holmes KW, 2005, BIOGEOCHEMISTRY, V74, P173, DOI 10.1007/s10533-004-3544-x; Japar Sidik B, 2006, AQUAT ECOSYST HEALTH, V9, P1; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kendrick GA, 2008, ECOGRAPHY, V31, P191, DOI 10.1111/j.0906-7590.2008.5252.x; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Marba N, 1996, MAR ECOL PROG SER, V133, P203, DOI 10.3354/meps133203; Marba N, 2002, MAR ECOL PROG SER, V226, P287, DOI 10.3354/meps226287; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2006, OECOLOGIA, V150, P362, DOI 10.1007/s00442-006-0524-y; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Meadows PS, 2012, GEOMORPHOLOGY, V157, P31, DOI 10.1016/j.geomorph.2011.07.007; Migliaccio M, 2005, MAR ECOL PROG SER, V304, P55, DOI 10.3354/meps304055; Miller CJ, 2005, MAR ECOL PROG SER, V304, P45, DOI 10.3354/meps304045; NACORDA HM, 2008, BURROWING SHRIMPS SE; Nakaoka M, 2005, POPUL ECOL, V47, P167, DOI 10.1007/s10144-005-0226-z; Nakaoka M, 2000, ECOL RES, V15, P415, DOI 10.1046/j.1440-1703.2000.00362.x; OLIVER M, 1989, T I BRIT GEOGR, V14, P259, DOI 10.2307/622687; Ooi JLS, 2011, CONT SHELF RES, V31, P1945, DOI 10.1016/j.csr.2011.09.005; Ooi JLS, 2011, ESTUAR COAST SHELF S, V92, P118, DOI 10.1016/j.ecss.2010.12.021; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; Ralph PJ, 2007, J EXP MAR BIOL ECOL, V350, P176, DOI 10.1016/j.jembe.2007.06.017; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Terrados J, 1998, ESTUAR COAST SHELF S, V46, P757, DOI 10.1006/ecss.1997.0304; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; VERMAAT JE, 1995, MAR ECOL PROG SER, V124, P215, DOI 10.3354/meps124215; Wagner HH, 2003, ECOLOGY, V84, P1045, DOI 10.1890/0012-9658(2003)084[1045:SCIPCI]2.0.CO;2	51	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86782	10.1371/journal.pone.0086782	http://dx.doi.org/10.1371/journal.pone.0086782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497978	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900039
J	Soubeyrand, S; Tollenaere, C; Haon-Lasportes, E; Laine, AL				Soubeyrand, Samuel; Tollenaere, Charlotte; Haon-Lasportes, Emilie; Laine, Anna-Liisa			Regression-Based Ranking of Pathogen Strains with Respect to Their Contribution to Natural Epidemics	PLOS ONE			English	Article							PLANT-PATHOGEN; FITNESS; AGGRESSIVENESS; ADAPTATION; GENETICS; ECOLOGY	Genetic variation in pathogen populations may be an important factor driving heterogeneity in disease dynamics within their host populations. However, to date, we understand poorly how genetic diversity in diseases impact on epidemiological dynamics because data and tools required to answer this questions are lacking. Here, we combine pathogen genetic data with epidemiological monitoring of disease progression, and introduce a statistical exploratory method to investigate differences among pathogen strains in their performance in the field. The method exploits epidemiological data providing a measure of disease progress in time and space, and genetic data indicating the relative spatial patterns of the sampled pathogen strains. Applying this method allows to assign ranks to the pathogen strains with respect to their contributions to natural epidemics and to assess the significance of the ranking. This method was first tested on simulated data, including data obtained from an original, stochastic, multi-strain epidemic model. It was then applied to epidemiological and genetic data collected during one natural epidemic of powdery mildew occurring in its wild host population. Based on the simulation study, we conclude that the method can achieve its aim of ranking pathogen strains if the sampling effort is sufficient. For powdery mildew data, the method indicated that one of the sampled strains tends to have a higher fitness than the four other sampled strains, highlighting the importance of strain diversity for disease dynamics. Our approach allowing the comparison of pathogen strains in natural epidemic is complementary to the classical practice of using experimental infections in controlled conditions to estimate fitness of different pathogen strains. Our statistical tool, implemented in the R package StrainRanking, is mainly based on regression and does not rely on mechanistic assumptions on the pathogen dynamics. Thus, the method can be applied to a wide range of pathogens.	[Soubeyrand, Samuel; Haon-Lasportes, Emilie] INRA, Biostat & Spatial Proc UR546, Avignon, France; [Tollenaere, Charlotte; Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Helsinki, Finland	INRAE; University of Helsinki	Soubeyrand, S (corresponding author), INRA, Biostat & Spatial Proc UR546, Avignon, France.	Samuel.Soubeyrand@avignon.inra.fr	Tollenaere, Charlotte/ABB-6175-2020; Laine, Anna-Liisa/B-1398-2016	Tollenaere, Charlotte/0000-0003-2045-2824; Laine, Anna-Liisa/0000-0002-0703-5850; Soubeyrand, Samuel/0000-0003-2447-3067	Academy of Finland [250444, 136393, 133499]; European Research Council (PATHEVOL) [281517]; French National Research Agency (EMILE project); European Union Seventh Framework Programme (PLANTFOODSEC) [261752]	Academy of Finland(Academy of Finland); European Research Council (PATHEVOL); French National Research Agency (EMILE project)(French National Research Agency (ANR)); European Union Seventh Framework Programme (PLANTFOODSEC)	A-L Laine acknowledges funding from the Academy of Finland (Grant numbers 250444, 136393, 133499) and European Research Council (PATHEVOL; 281517). S Soubeyrand acknowledges funding from the French National Research Agency (EMILE project) and the European Union Seventh Framework Programme (PLANTFOODSEC, 261752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Bruns E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-135; Carroll R., 2006, MEASUREMENT ERROR NO, V105; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Frenkel O, 2012, PLANT PATHOL, V61, P106, DOI 10.1111/j.1365-3059.2011.02502.x; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Gilligan CA, 2002, ADV BOT RES, V38, P1, DOI 10.1016/S0065-2296(02)38027-3; Giraud T, 2008, PARASITE, V15, P449, DOI 10.1051/parasite/2008153449; Grech K, 2006, J EVOLUTION BIOL, V19, P1620, DOI 10.1111/j.1420-9101.2006.01116.x; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Laine AL, 2006, J ECOL, V94, P217, DOI 10.1111/j.1365-2745.2005.01075.x; Luijckx P, 2011, ECOL LETT, V14, P125, DOI 10.1111/j.1461-0248.2010.01561.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Ovaskainen O, 2006, ECOLOGY, V87, P880, DOI 10.1890/0012-9658(2006)87[880:IESFED]2.0.CO;2; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; Pullan RL, 2012, PARASITOLOGY, V139, P1870, DOI 10.1017/S0031182012000698; Qi WH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000580; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Salvaudon L, 2005, EVOLUTION, V59, P2518, DOI 10.1111/j.0014-3820.2005.tb00965.x; Shaw MW., 2002, PLANT PATHOLOGISTS P, P252; Silverman B.W., 1986, DENSITY ESTIMATION S; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Soubeyrand S, 2006, STAT METHODOL, V3, P464, DOI DOI 10.1016/J4.STAMET.2005.12.005; Soubeyrand S, 2007, COMPUT STAT DATA AN, V51, P6404, DOI 10.1016/j.csda.2007.02.008; Tack AJM, 2012, J EVOLUTION BIOL, V25, P1918, DOI 10.1111/j.1420-9101.2012.02588.x; Thrall PH, 2002, EVOLUTION, V56, P1340; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Vale PF, 2009, HEREDITY, V103, P102, DOI 10.1038/hdy.2009.54; Vojvodic S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025035; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	36	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86591	10.1371/journal.pone.0086591	http://dx.doi.org/10.1371/journal.pone.0086591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497956	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900027
J	VanBavel, E; Tuna, BG				VanBavel, Ed; Tuna, Bilge Guvenc			Integrative Modeling of Small Artery Structure and Function Uncovers Critical Parameters for Diameter Regulation	PLOS ONE			English	Article							MESENTERIC SMALL ARTERIES; RESISTANCE ARTERIES; BLOOD-FLOW; WALL TENSION; ACTIVATION; MUTATIONS; PRESSURE; VASOCONSTRICTION; BIOMECHANICS; DISSECTIONS	Organ perfusion is regulated by vasoactivity and structural adaptation of small arteries and arterioles. These resistance vessels are sensitive to pressure, flow and a range of vasoactive stimuli. Several strongly interacting control loops exist. As an example, the myogenic response to a change of pressure influences the endothelial shear stress, thereby altering the contribution of shear-dependent dilation to the vascular tone. In addition, acute responses change the stimulus for structural adaptation and vice versa. Such control loops are able to maintain resistance vessels in a functional and stable state, characterized by regulated wall stress, shear stress, matched active and passive biomechanics and presence of vascular reserve. In this modeling study, four adaptation processes are identified that together with biomechanical properties effectuate such integrated regulation: control of tone, smooth muscle cell length adaptation, eutrophic matrix rearrangement and trophic responses. Their combined action maintains arteries in their optimal state, ready to cope with new challenges, allowing continuous long-term vasoregulation. The exclusion of any of these processes results in a poorly regulated state and in some cases instability of vascular structure.	[VanBavel, Ed; Tuna, Bilge Guvenc] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	VanBavel, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.vanbavel@amc.uva.nl	Tuna, Bilge Guvenc/AAB-5827-2020; Tuna, Bilge Güvenç/O-2215-2014	Tuna, Bilge Guvenc/0000-0003-1348-1336; Tuna, Bilge Güvenç/0000-0003-1348-1336; van Bavel, Ed/0000-0001-8654-986X	European Commission [235711]	European Commission(European CommissionEuropean Commission Joint Research Centre)	BGT is supported by grant 235711 (Small Artery remodeling) of the Marie Curie program of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bakker ENTP, 2002, J VASC RES, V39, P12, DOI 10.1159/000048989; Bakker ENTP, 2008, CARDIOVASC RES, V78, P341, DOI 10.1093/cvr/cvn050; Bakker ENTP, 2008, J VASC RES, V45, P271, DOI 10.1159/000113599; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; BURROWS ME, 1981, AM J PHYSIOL, V241, pH829, DOI 10.1152/ajpheart.1981.241.6.H829; Buus CL, 2001, CIRC RES, V89, P180, DOI 10.1161/hh1401.093575; Chilian WM, 2012, J MOL CELL CARDIOL, V52, P905, DOI 10.1016/j.yjmcc.2011.12.006; Cornelissen AJM, 2002, AM J PHYSIOL-HEART C, V282, pH2224, DOI 10.1152/ajpheart.00491.2001; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Eftekhari A, 2011, J HYPERTENS, V29, P896, DOI 10.1097/HJH.0b013e3283447a1c; Fung Y.C., 1984, BIODYNAMICS CIRCULAT; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hacking WJG, 1996, AM J PHYSIOL-HEART C, V270, pH364, DOI 10.1152/ajpheart.1996.270.1.H364; Heeneman S, 2007, CIRC RES, V101, P441, DOI 10.1161/CIRCRESAHA.107.148338; Jacobsen JCB, 2008, AM J PHYSIOL-REG I, V294, pR1379, DOI 10.1152/ajpregu.00407.2007; KUO L, 1991, AM J PHYSIOL, V261, pH1706, DOI 10.1152/ajpheart.1991.261.6.H1706; Martinez-Lemus LA, 2004, FASEB J, V18, P708, DOI 10.1096/fj.03-0634fje; Martinez-Lemus LA, 2011, AM J PHYSIOL-HEART C, V300, pH2005, DOI 10.1152/ajpheart.01066.2010; Martinez-Lemus LA, 2009, PHYSIOLOGY, V24, P45, DOI 10.1152/physiol.00029.2008; McGrath JC, 2005, EXP PHYSIOL, V90, P469, DOI 10.1113/expphysiol.2005.030130; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Pourageaud F, 1997, AM J PHYSIOL-HEART C, V273, pH1699, DOI 10.1152/ajpheart.1997.273.4.H1699; Prewitt RL, 2002, MICROCIRCULATION, V9, P295, DOI 10.1038/sj.mn.7800143; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Smith N, 2011, PROG BIOPHYS MOL BIO, V104, P1, DOI 10.1016/j.pbiomolbio.2010.12.006; Sonoyama Kazuhiko, 2007, Ther Adv Cardiovasc Dis, V1, P129, DOI 10.1177/1753944707086358; Sorop O, 2003, CIRC RES, V92, P1344, DOI 10.1161/01.RES.0000078604.47063.2B; Sorop O, 2006, AM J PHYSIOL-HEART C, V291, pH1236, DOI 10.1152/ajpheart.00838.2005; Tuna BG, 2013, J VASCULAR IN PRESS; Tuna BG, 2013, J BIOMECH, V46, P1420, DOI 10.1016/j.jbiomech.2013.03.010; Tuna BG, 2012, BASIC CLIN PHARMACOL, V110, P35, DOI 10.1111/j.1742-7843.2011.00794.x; van den Akker J, 2010, J VASC RES, V47, P183, DOI 10.1159/000255962; VanBavel E, 1998, CIRC RES, V82, P210; VANBAVEL E, 1994, J PHYSIOL-LONDON, V477, P103, DOI 10.1113/jphysiol.1994.sp020175; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	38	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86901	10.1371/journal.pone.0086901	http://dx.doi.org/10.1371/journal.pone.0086901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497993	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900045
J	Whyteside, AR; Turner, AJ; Lambert, DW				Whyteside, Alison R.; Turner, Anthony J.; Lambert, Daniel W.			Endothelin-Converting Enzyme-1 (ECE-1) Is Post-Transcriptionally Regulated by Alternative Polyadenylation	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; CELL; MICRORNA; GROWTH; CLEAVAGE	Endothelin-converting enzyme-1 (ECE-1) is the enzyme predominantly responsible for producing active endothelin-1 (ET-1), a mitogenic peptide implicated in the aetiology of a number of diseases, including cancer. Elevated levels of ECE-1 have been observed in a range of malignancies, with high expression conferring poor prognosis and aiding the acquisition of androgen independence in prostate cancer. The mechanisms regulating the expression of ECE-1 in cancer cells are poorly understood, hampering the development of novel therapies targeting the endothelin axis. Here we provide evidence that the expression of ECE-1 is markedly inhibited by its 3'UTR, and that alternative polyadenylation (APA) results in the production of ECE-1 transcripts with truncated 3'UTRs which promote elevated protein expression. Abolition of the ECE-1 APA sites reduced protein expression from a reporter vector in prostate cancer cells, suggesting these sites are functional. This is the first study to identify ECE-1 as a target for APA, a regulatory mechanism aberrantly activated in cancer cells, and provides novel information about the mechanisms leading to ECE-1 overexpression in malignant cells.	[Whyteside, Alison R.; Turner, Anthony J.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Sch Clin Dent, Sheffield, S Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, CR UK YCR Sheffield Canc Ctr, Sheffield, S Yorkshire, England	University of Leeds; University of Sheffield; University of Sheffield	Turner, AJ (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England.	a.j.turner@leeds.ac.uk; d.w.lambert@sheffield.ac.uk			Yorkshire Cancer Research [L342]	Yorkshire Cancer Research	This study was financially supported by a project grant from Yorkshire Cancer Research (ref L342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bagnato A, 1998, TRENDS ENDOCRIN MET, V9, P378, DOI 10.1016/S1043-2760(98)00094-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATTISTINI B, 1993, PEPTIDES, V14, P385, DOI 10.1016/0196-9781(93)90057-N; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Dawson LA, 2004, BRIT J CANCER, V90, P1577, DOI 10.1038/sj.bjc.6601717; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Raoch V, 2011, ARTERIOSCL THROM VAS, V31, P2577, DOI 10.1161/ATVBAHA.111.232025; Rayhman O, 2008, CANCER RES, V68, P9265, DOI 10.1158/0008-5472.CAN-08-2093; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; ROSSI GP, 1995, BIOCHEM BIOPH RES CO, V211, P249, DOI 10.1006/bbrc.1995.1803; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Shao R, 2003, MOL BIOL CELL, V14, P2327, DOI 10.1091/mbc.02-06-0093; Smollich M, 2007, BREAST CANCER RES TR, V106, P361, DOI 10.1007/s10549-007-9516-9; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Valdenaire O, 1999, EUR J BIOCHEM, V264, P341, DOI 10.1046/j.1432-1327.1999.00602.x	21	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e83260	10.1371/journal.pone.0083260	http://dx.doi.org/10.1371/journal.pone.0083260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497914	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900003
J	Condori, B; Hijmans, RJ; Ledent, JF; Quiroz, R				Condori, Bruno; Hijmans, Robert J.; Ledent, Jean Francois; Quiroz, Roberto			Managing Potato Biodiversity to Cope with Frost Risk in the High Andes: A Modeling Perspective	PLOS ONE			English	Article							CLIMATE-CHANGE; GROWTH; TEMPERATURE; TUBEROSUM	Austral summer frosts in the Andean highlands are ubiquitous throughout the crop cycle, causing yield losses. In spite of the existing warming trend, climate change models forecast high variability, including freezing temperatures. As the potato center of origin, the region has a rich biodiversity which includes a set of frost resistant genotypes. Four contrasting potato genotypes-representing genetic variability-were considered in the present study: two species of frost resistant native potatoes (the bitter Solanum juzepczukii, var. Luki, and the non-bitter Solanum ajanhuiri, var. Ajanhuiri) and two commercial frost susceptible genotypes (Solanum tuberosum ssp. tuberosum var. Alpha and Solanum tuberosum ssp. andigenum var. Gendarme). The objective of the study was to conduct a comparative growth analysis of four genotypes and modeling their agronomic response under frost events. It included assessing their performance under Andean contrasting agroecological conditions. Independent subsets of data from four field experiments were used to parameterize, calibrate and validate a potato growth model. The validated model was used to ascertain the importance of biodiversity, represented by the four genotypes tested, as constituents of germplasm mixtures in single plots used by local farmers, a coping strategy in the face of climate variability. Also scenarios with a frost routine incorporated in the model were constructed. Luki and Ajanhuiri were the most frost resistant varieties whereas Alpha was the most susceptible. Luki and Ajanhuiri, as monoculture, outperformed the yield obtained with the mixtures under severe frosts. These results highlight the role played by local frost tolerant varieties, and featured the management importance-e. g. clean seed, strategic watering-to attain the yields reported in our experiments. The mixtures of local and introduced potatoes can thus not only provide the products demanded by the markets but also reduce the impact of frosts and thus the vulnerability of the system to abiotic stressors.	[Condori, Bruno] Int Potato Ctr, Liaison Off Bolivia, La Paz, Bolivia; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Ledent, Jean Francois] Catholic Univ Louvain, Unite Ecophysiol & Ameliorat Vegetale, B-1348 Louvain, Brabant, Belgium; [Quiroz, Roberto] Int Potato Ctr, Integrated Crops & Syst Res Program, Lima, Peru	CGIAR; International Potato Center (CIP); University of California System; University of California Davis; Universite Catholique Louvain; CGIAR; International Potato Center (CIP)	Quiroz, R (corresponding author), Int Potato Ctr, Integrated Crops & Syst Res Program, POB 5969, Lima, Peru.	r.quiroz@cgiar.org	Quiroz, Roberto/AAP-7726-2020; Condori, Bruno/E-7644-2013; Hijmans, Robert/N-3299-2016	Quiroz, Roberto/0000-0001-8401-2700; Condori, Bruno/0000-0001-6537-0625; Hijmans, Robert/0000-0001-5872-2872	Unit of Eco-physiology and Crop Breeding, Catholic University of Louvain in Belgium; Canadian International Development Agency (CIDA); Swiss Development Cooperation (SDC)	Unit of Eco-physiology and Crop Breeding, Catholic University of Louvain in Belgium; Canadian International Development Agency (CIDA); Swiss Development Cooperation (SDC)	This work has been made possible through the financial contribution of the following organizations: The Unit of Eco-physiology and Crop Breeding, Catholic University of Louvain in Belgium that granted the PhD scholarship of Bruno Condori under which the model was initially developed. The Canadian International Development Agency (CIDA) which funded the CIP conducted ALTAGRO project through which Bruno Condori's work was partially supported. The Swiss Development Cooperation (SDC) which funded the CIP conducted initiative PAPA ANDINA through which Bruno Condori's work was partially supported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrasco E, 1997, PROGRAM REPORT 1995, P227; Condori B, 2002, THESIS U CATHOLIQUE; Condori B, 2008, EUR J AGRON, V28, P526, DOI 10.1016/j.eja.2007.12.002; Condori B, 2010, FIELD CROP RES, V119, P135, DOI 10.1016/j.fcr.2010.07.003; de Haan S, 2010, J LAND USE SCI, V5, P179, DOI 10.1080/1747423X.2010.500681; Devaux A., 1997, REV LATINOAMERICANA, V9, P123; Estrada N, 1999, BIODIVERSIDAD MEJORA; Francois C, 1999, AGR FOREST METEOROL, V95, P113, DOI 10.1016/S0168-1923(99)00002-7; Gabriel JL, 2001, EXPERIENCIAS LOGROS, P169; Hijmans R. J., 1999, Impact on a changing world. International Potato Center Program Report 1997-1998., P373; Hijmans RJ, 2003, AM J POTATO RES, V80, P271, DOI 10.1007/BF02855363; Hijmans RJ, 2003, AGR SYST, V76, P895, DOI 10.1016/S0308-521X(02)00081-1; INE - Instituto Nacional de Estadisticas, 2009, ENC NAC AGR 2008; Iriarte V, 2001, REV LATINOAMERICANA, V12, P72; Kooman PL, 1995, CURR ISS PROD ECOL, V3, P41; Le Tacon P., 1989, MANIFESTATION RISQUE; Moriondo M, 2005, J AM SOC HORTIC SCI, V130, P799, DOI 10.21273/JASHS.130.6.799; OCHOA CM, 1990, POTATOES S AM; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Rea J, 1992, PAPA AMARGA PRIMERA, P15; SMA SDMA, 2018, SMA SIST ORG SECT; Spitters C.J.T, 1988, ACTA HORT, V214, P71, DOI [10.17660/ActaHortic.1988.214.5, DOI 10.17660/ACTAHORTIC.1988.214.5]; SPITTERS CJT, 1990, ACTA HORTIC, V267, P349, DOI 10.17660/ActaHortic.1990.267.42; Spooner DM, 2005, P NATL ACAD SCI USA, V102, P14694, DOI 10.1073/pnas.0507400102; Stol W, 1991, 155 CABODLO; Tapia N, 1997, BIODIVERSIDAD PAPAS; Terrazas F, 1998, PLANT GENET RESOUR N, V114, P9; Thibeault JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012718; Tourneux C, 2003, AGRONOMIE, V23, P169, DOI 10.1051/agro:2002079; VanDam J, 1996, POTATO RES, V39, P51, DOI 10.1007/BF02358206; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Woolfe JA, 1987, POTATO HUMAN DIET, DOI [10.1007/BF02360035, DOI 10.1007/BF02360035]	35	21	22	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e81510	10.1371/journal.pone.0081510	http://dx.doi.org/10.1371/journal.pone.0081510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497912	Green Submitted, gold, Green Published			2022-12-27	WOS:000330617100002
J	Cornwell, EW; Mirbod, A; Wu, CL; Kandarian, SC; Jackman, RW				Cornwell, Evangeline W.; Mirbod, Azadeh; Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.			C26 Cancer-Induced Muscle Wasting Is IKK beta-Dependent and NF-kappaB-Independent	PLOS ONE			English	Article							SKELETAL-MUSCLE; MESSENGER-RNA; GENE-TRANSFER; B ACTIVATION; INHIBITION; PATHWAY; EXPRESSION; ATROPHY; BINDING; SUBSET	Existing data suggest that NF-kappaB signaling is a key regulator of cancer-induced skeletal muscle wasting. However, identification of the components of this signaling pathway and of the NF-kappa B transcription factors that regulate wasting is far from complete. In muscles of C26 tumor bearing mice, overexpression of dominant negative (d.n.) IKK beta blocked muscle wasting by 69% and the I kappa B beta-super repressor blocked wasting by 41%. In contrast, overexpression of d.n. IKK alpha or d.n. NIK did not block C26-induced wasting. Surprisingly, overexpression of d.n. p65 or d.n. c-Rel did not significantly affect muscle wasting. Genome-wide mRNA expression arrays showed upregulation of many genes previously implicated in muscle atrophy. To test if these upregulated genes were direct targets of NF-kappa B transcription factors, we compared genome-wide p65 binding to DNA in control and cachectic muscle using ChIP-sequencing. Bioinformatic analysis of ChIP-sequencing data from control and C26 muscles showed very little p65 binding to genes in cachexia and little to suggest that upregulated p65 binding influences the gene expression associated with muscle based cachexia. The p65 ChIP-seq data are consistent with our finding of no significant change in protein binding to an NF-kappa B oligonucleotide in a gel shift assay, no activation of a NF-kappa B-dependent reporter, and no effect of d.n. p65 overexpression in muscles of tumor bearing mice. Taken together, these data support the idea that although inhibition of I kappa B alpha, and particularly IKK beta, blocks cancer-induced wasting, the alternative NF-kappa B signaling pathway is not required. In addition, the downstream NF-kappa B transcription factors, p65 and c-Rel do not appear to regulate the transcriptional changes induced by the C26 tumor. These data are consistent with the growing body of literature showing that there are NF-kappa B-independent substrates of IKK beta and I kappa B alpha that regulate physiological processes.	[Cornwell, Evangeline W.; Mirbod, Azadeh; Wu, Chia-Ling; Kandarian, Susan C.; Jackman, Robert W.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Jackman, RW (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	rjackman@bu.edu			National Institutes of Health (NIH) award [AR060217]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060217] Funding Source: NIH RePORTER	National Institutes of Health (NIH) award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) award AR060217. (http://grants.nih.gov/grants/oer.htm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Baracos VE, 2003, NES NUTR WS, V8, P1, DOI 10.1159/000072744; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bhatnagar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013262; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Busquets S, 2004, CANCER RES, V64, P6725, DOI 10.1158/0008-5472.CAN-04-0425; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Comb WC, 2011, ONCOGENE, V30, P1727, DOI 10.1038/onc.2010.553; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Gringhuis SI, 2005, MOL CELL BIOL, V25, P6454, DOI 10.1128/MCB.25.15.6454-6463.2005; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jackman RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051478; Jackman RW, 2009, EXP CELL RES, V315, P3242, DOI 10.1016/j.yexcr.2009.08.020; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rhoads MG, 2009, EUR J CANC; Rossini K, 2002, BASIC APPL MYOL, V12, P97; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Shadfar S, 2011, NUTR CANCER, V63, P749, DOI 10.1080/01635581.2011.563032; Taylor J, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-11; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xing YJ, 2013, FUNCT INTEGR GENOMIC, V13, P143, DOI 10.1007/s10142-012-0305-0; Yamaki T, 2012, AM J PHYSIOL-CELL PH, V303, pC135, DOI 10.1152/ajpcell.00111.2012; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87776	10.1371/journal.pone.0087776	http://dx.doi.org/10.1371/journal.pone.0087776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489962	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000179
J	Hoffman, JI; Krause, ET; Lehmann, K; Kruger, O				Hoffman, Joseph I.; Krause, E. Tobias; Lehmann, Katrin; Krueger, Oliver			MC1R Genotype and Plumage Colouration in the Zebra Finch (Taeniopygia guttata): Population Structure Generates Artefactual Associations	PLOS ONE			English	Article							GENETIC-BASIS; RECEPTOR GENE; POLYMORPHISM; EVOLUTION; ORNAMENTS; BIRDS; LOCI; MICE; WILD	Polymorphisms at the melanocortin-1 receptor (MC1R) gene have been linked to coloration in many vertebrate species. However, the potentially confounding influence of population structure has rarely been controlled for. We explored the role of the MC1R in a model avian system by sequencing the coding region in 162 zebra finches comprising 79 wild type and 83 white individuals from five stocks. Allelic counts differed significantly between the two plumage morphs at multiple segregating sites, but these were mostly synonymous. To provide a control, the birds were genotyped at eight microsatellites and subjected to Bayesian cluster analysis, revealing two distinct groups. We therefore crossed wild type with white individuals and backcrossed the F1s with white birds. No significant associations were detected in the resulting offspring, suggesting that our original findings were a byproduct of genome-wide divergence. Our results are consistent with a previous study that found no association between MC1R polymorphism and plumage coloration in leaf warblers. They also contribute towards a growing body of evidence suggesting that care should be taken to quantify, and where necessary control for, population structure in association studies.	[Hoffman, Joseph I.; Krause, E. Tobias; Lehmann, Katrin; Krueger, Oliver] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Krause, E. Tobias] Wageningen Univ, Behav Ecol Grp, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands	University of Bielefeld; Wageningen University & Research	Hoffman, JI (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	joseph.hoffman@uni-bielefeld.de	Krause, E. Tobias/A-9900-2009; Hoffman, Joseph i/K-7725-2012	Krause, E. Tobias/0000-0002-8327-3711; Hoffman, Joseph i/0000-0001-5895-8949	Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship [KR2089/2-1]	Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship(German Research Foundation (DFG))	O.K. was funded by the Deutsche 422 Forschungsgemeinschaft (DFG) through a Heisenberg-Professorship (KR2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bolund E, 2010, J EVOLUTION BIOL, V23, P586, DOI 10.1111/j.1420-9101.2009.01927.x; Bolund E, 2010, ANIM BEHAV, V79, P947, DOI 10.1016/j.anbehav.2010.01.014; Bradley BJ, 2013, J MAMM EVOL, V20, P263, DOI 10.1007/s10914-012-9212-3; Dawson DA, 2005, MOL ECOL NOTES, V5, P298, DOI 10.1111/j.1471-8286.2005.00907.x; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Dunn PO, 2001, EVOLUTION, V55, P161; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Forstmeier W, 2007, MOL ECOL NOTES, V7, P1026, DOI 10.1111/j.1471-8286.2007.01762.x; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Fowlie MK, 2003, J EVOLUTION BIOL, V16, P577, DOI 10.1046/j.1420-9101.2003.00564.x; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison C. J. O., 1963, Bird Study, V10, P219; Immelmann K., 1969, ZEBRAFINK TAENIOPYGI; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Krause ET, 2011, ANIM BEHAV, V81, P1295, DOI 10.1016/j.anbehav.2011.03.021; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Mayr E., 1963, ANIMAL SPECIES EVOLU, P12; Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Naguib M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000901; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SMYTH JR, 1990, POULTRY BREEDING GEN; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Xu HY, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S109; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Zann RA., 1996, ZEBRA FINCH SYNTHESI	46	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86519	10.1371/journal.pone.0086519	http://dx.doi.org/10.1371/journal.pone.0086519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489736	Green Published, gold			2022-12-27	WOS:000330570000044
J	Yamasaki, S; Taguchi, Y; Shimamoto, A; Mukasa, H; Tahara, H; Okamoto, T				Yamasaki, Sachiko; Taguchi, Yuki; Shimamoto, Akira; Mukasa, Hanae; Tahara, Hidetoshi; Okamoto, Tetsuji			Generation of Human Induced Pluripotent Stem (Ips) Cells in Serum- and Feeder-Free Defined Culture and TGF-B1 Regulation of Pluripotency	PLOS ONE			English	Article							SELF-RENEWAL; RECOMBINANT VITRONECTIN; MAINTAINS PLURIPOTENCY; SOMATIC-CELLS; MOUSE; INDUCTION; GROWTH; FIBROBLASTS; EFFICIENT; NANOG	Human Embryonic Stem cells (hESCs) and human induced Pluripotent Stem cells (hiPSCs) are commonly maintained on inactivated mouse embryonic fibroblast as feeder cells in medium supplemented with FBS or proprietary replacements. Use of culture medium containing undefined or unknown components has limited the development of applications for pluripotent cells because of the relative lack of knowledge regarding cell responses to differentiating growth factors. In addition, there is no consensus as to the optimal formulation, or the nature of the cytokine requirements of the cells to promote their self-renewal and inhibit their differentiation. In this study, we successfully generated hiPSCs from human dental pulp cells (DPCs) using Yamanaka's factors (Oct3/4, Sox2, Klf4, and c-Myc) with retroviral vectors in serum-and feeder-free defined culture conditions. These hiPSCs retained the property of self-renewal as evaluated by the expression of self-renewal marker genes and proteins, morphology, cell growth rates, and pluripotency evaluated by differentiation into derivatives of all three primary germ layers in vitro and in vivo. In this study, we found that TGF-beta 1 increased the expression levels of pluripotency markers in a dose-dependent manner. However, increasing doses of TGF-beta 1 suppressed the growth rate of hiPSCs cultured under the defined conditions. Furthermore, over short time periods the hiPSCs cultured in hESF9 or hESF9T exhibited similar morphology, but hiPSCs maintained in hESF9 could not survive beyond 30 passages. This result clearly confirmed that hiPSCs cultured in hESF9 medium absolutely required TGF-beta 1 to maintain pluripotency. This simple serum-free adherent monoculture system will allow us to elucidate the cell responses to growth factors under defined conditions and can eliminate the risk might be brought by undefined pathogens.	[Yamasaki, Sachiko; Taguchi, Yuki; Mukasa, Hanae; Okamoto, Tetsuji] Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan; [Shimamoto, Akira; Tahara, Hidetoshi] Hiroshima Univ, Dept Cellular & Mol Biol, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan	Hiroshima University; Hiroshima University	Okamoto, T (corresponding author), Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Grad Inst Biomed & Hlth Sci, Hiroshima 730, Japan.	tetsuok@hiroshima-u.ac.jp	Yamasaki, Sachiko/H-2333-2019; Tahara, Hidetoshi/G-7697-2019		Japanese Ministry of Education, Culture, Sports, Science and Technology [22659369, 24890139]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants (no. 22659369 and 24890139) from the Japanese Ministry of Education, Culture, Sports, Science and Technology to TO and SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hayashi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014099; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; MATSUO M, 1982, J GERONTOL, V37, P33, DOI 10.1093/geronj/37.1.33; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MYOKEN Y, 1989, IN VITRO CELL DEV B, V25, P477; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; SATO JD, 1987, J EXP MED, V165, P1761, DOI 10.1084/jem.165.6.1761; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	40	30	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87151	10.1371/journal.pone.0087151	http://dx.doi.org/10.1371/journal.pone.0087151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489856	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000108
J	Lakes-Harlan, R; deVries, T; Stolting, H; Stumpner, A				Lakes-Harlan, Reinhard; deVries, Thomas; Stoelting, Heiko; Stumpner, Andreas			Useless Hearing in Male Emblemasoma auditrix (Diptera, Sarcophagidae) - A Case of Intralocus Sexual Conflict during Evolution of a Complex Sense Organ?	PLOS ONE			English	Article							CICADA OKANAGANA-RIMOSA; ORMIA-OCHRACEA DIPTERA; PARASITOID FLY; ACOUSTIC COMMUNICATION; TYMPANAL HEARING; AUDITORY-SYSTEM; TACHINIDAE; BEHAVIOR; HOST; DIMORPHISM	Sensory modalities typically are important for both sexes, although sex-specific functional adaptations may occur frequently. This is true for hearing as well. Consequently, distinct behavioural functions were identified for the different insect hearing systems. Here we describe a first case, where a trait of an evolutionary novelty and a highly specialized hearing organ is adaptive in only one sex. The main function of hearing of the parasitoid fly Emblemasoma auditrix is to locate the host, males of the cicada species Okanagana rimosa, by their calling song. This task is performed by female flies, which deposit larvae into the host. We show that male E. auditrix possess a hearing sense as well. The morphology of the tympanal organ of male E. auditrix is rather similar to the female ear, which is 8% broader than the male ear. In both sexes the physiological hearing threshold is tuned to 5 kHz. Behavioural tests show that males are able to orient towards the host calling song, although phonotaxis often is incomplete. However, despite extensive observations in the field and substantial knowledge of the biology of E. auditrix, no potentially adaptive function of the male auditory sense has been identified. This unique hearing system might represent an intralocus sexual conflict, as the complex sense organ and the behavioural relevant neuronal network is adaptive for only one sex. The correlated evolution of the sense organ in both sexes might impose substantial constraints on the sensory properties of the ear. Similar constraints, although hidden, might also apply to other sensory systems in which behavioural functions differ between sexes.	[Lakes-Harlan, Reinhard; deVries, Thomas] Univ Giessen, Inst Anim Physiol, AG Integrat Sensory Physiol, D-35390 Giessen, Germany; [Stoelting, Heiko; Stumpner, Andreas] Univ Gottingen, Schwann Schleiden Forschungszentrum, D-37073 Gottingen, Germany	Justus Liebig University Giessen; University of Gottingen	Lakes-Harlan, R (corresponding author), Univ Giessen, Inst Anim Physiol, AG Integrat Sensory Physiol, D-35390 Giessen, Germany.	reinhard.lakes-harlan@physzool.bio.uni-giessen.de		Stumpner, Andreas/0000-0003-3349-4038	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Parts of the study were funded by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen GR, 1999, J INSECT BEHAV, V12, P67, DOI 10.1023/A:1020929231430; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; CARDONE B, 1988, PHYSIOL ENTOMOL, V13, P9, DOI 10.1111/j.1365-3032.1988.tb00903.x; de Vries T, 2005, ZOOLOGY, V108, P239, DOI 10.1016/j.zool.2005.04.004; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Egelhaaf M, 2002, CURR OPIN NEUROBIOL, V12, P699, DOI 10.1016/S0959-4388(02)00390-2; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; FORREST TG, 1994, AM ZOOL, V34, P644; FOWLER H G, 1987, Revista Brasileira de Biologia, V47, P371; Fullard JH, 2007, BIOL LETT-UK, V3, P26, DOI 10.1098/rsbl.2006.0550; FULLARD JH, 1994, J EVOLUTION BIOL, V7, P435, DOI 10.1046/j.1420-9101.1994.7040435.x; FULLARD JH, 1993, TRENDS ECOL EVOL, V8, P248, DOI 10.1016/0169-5347(93)90200-9; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gopfert MC, 1999, J EXP BIOL, V202, P2727; Gopfert MC, 2000, P ROY SOC B-BIOL SCI, V267, P453, DOI 10.1098/rspb.2000.1021; Gu JJ, 2012, P NATL ACAD SCI USA, V109, P3868, DOI 10.1073/pnas.1118372109; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; Hustert R, 1999, J COMP NEUROL, V410, P444, DOI 10.1002/(SICI)1096-9861(19990802)410:3<444::AID-CNE7>3.0.CO;2-E; Kohler U, 2001, J COMP PHYSIOL A, V187, P581, DOI 10.1007/s003590100230; Lakes-Harlan R, 2000, ZOOL-ANAL COMPLEX SY, V103, P31; Lakes-Harlan R, 1999, P ROY SOC B-BIOL SCI, V266, P1161, DOI 10.1098/rspb.1999.0758; LAKESHARLAN R, 1991, J EXP BIOL, V158, P307; Lane KA, 2008, J COMP NEUROL, V508, P677, DOI 10.1002/cne.21675; LEDERHOUSE RC, 1976, ANN ENTOMOL SOC AM, V69, P656, DOI 10.1093/aesa/69.4.656; Lehmann GUC, 2010, J COMP PHYSIOL A, V196, P807, DOI 10.1007/s00359-010-0560-2; Parsch J, 2013, NAT REV GENET, V14, P83, DOI 10.1038/nrg3376; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; ROBERT D, 1994, CELL TISSUE RES, V275, P63, DOI 10.1007/BF00305376; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Rust J, 1999, NATURE, V399, P650, DOI 10.1038/21356; Schniederkotter K, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.36; SOPER RS, 1976, CAN ENTOMOL, V108, P61, DOI 10.4039/Ent10861-1; Stolting H, 2004, ZOOLOGY, V107, P243, DOI 10.1016/j.zool.2004.07.003; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; Stumpner A, 1996, J COMP PHYSIOL A, V178, P227; Stumpner A, 2007, J COMP PHYSIOL A, V193, P113, DOI 10.1007/s00359-006-0174-x; Sueur J, 2005, J ACOUST SOC AM, V118, P530, DOI 10.1121/1.1932227; Sueur J, 2008, J EXP BIOL, V211, P2379, DOI 10.1242/jeb.018804; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P527, DOI 10.1098/rstb.1986.0017; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119; Warren B, 2009, CURR BIOL, V19, P485, DOI 10.1016/j.cub.2009.01.059; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; Yager DD, 2008, BIOL J LINN SOC, V94, P541, DOI 10.1111/j.1095-8312.2008.00996.x; Yager DD, 2012, CURR OPIN NEUROBIOL, V22, P201, DOI 10.1016/j.conb.2011.12.011; YAGER DD, 1990, J ZOOL, V221, P517, DOI 10.1111/j.1469-7998.1990.tb04017.x; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P	48	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87211	10.1371/journal.pone.0087211	http://dx.doi.org/10.1371/journal.pone.0087211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489872	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000116
J	Toju, H; Sato, H; Tanabe, AS				Toju, Hirokazu; Sato, Hirotoshi; Tanabe, Akifumi S.			Diversity and Spatial Structure of Belowground Plant-Fungal Symbiosis in a Mixed Subtropical Forest of Ectomycorrhizal and Arbuscular Mycorrhizal Plants	PLOS ONE			English	Article							COMMUNITY STRUCTURE; RAIN-FOREST; PATTERNS; COMPETITION; CARBON; ESTABLISHMENT; COLONIZATION; VARIABILITY; NUTRITION; PHOSPHATE	Plant-mycorrhizal fungal interactions are ubiquitous in forest ecosystems. While ectomycorrhizal plants and their fungi generally dominate temperate forests, arbuscular mycorrhizal symbiosis is common in the tropics. In subtropical regions, however, ectomycorrhizal and arbuscular mycorrhizal plants co-occur at comparable abundances in single forests, presumably generating complex community structures of root-associated fungi. To reveal root-associated fungal community structure in a mixed forest of ectomycorrhizal and arbuscular mycorrhizal plants, we conducted a massively-parallel pyrosequencing analysis, targeting fungi in the roots of 36 plant species that co-occur in a subtropical forest. In total, 580 fungal operational taxonomic units were detected, of which 132 and 58 were probably ectomycorrhizal and arbuscular mycorrhizal, respectively. As expected, the composition of fungal symbionts differed between fagaceous (ectomycorrhizal) and non-fagaceous (possibly arbuscular mycorrhizal) plants. However, non-fagaceous plants were associated with not only arbuscular mycorrhizal fungi but also several clades of ectomycorrhizal (e. g., Russula) and root-endophytic ascomycete fungi. Many of the ectomycorrhizal and root-endophytic fungi were detected from both fagaceous and non-fagaceous plants in the community. Interestingly, ectomycorrhizal and arbuscular mycorrhizal fungi were concurrently detected from tiny root fragments of non-fagaceous plants. The plant-fungal associations in the forest were spatially structured, and non-fagaceous plant roots hosted ectomycorrhizal fungi more often in the proximity of ectomycorrhizal plant roots. Overall, this study suggests that belowground plant-fungal symbiosis in subtropical forests is complex in that it includes "non-typical'' plant-fungal combinations (e. g., ectomycorrhizal fungi on possibly arbuscular mycorrhizal plants) that do not fall within the conventional classification of mycorrhizal symbioses, and in that associations with multiple functional (or phylogenetic) groups of fungi are ubiquitous among plants. Moreover, ectomycorrhizal fungal symbionts of fagaceous plants may "invade'' the roots of neighboring non-fagaceous plants, potentially influencing the interactions between non-fagaceous plants and their arbuscular-mycorrhizal fungal symbionts at a fine spatial scale.	[Toju, Hirokazu; Sato, Hirotoshi; Tanabe, Akifumi S.] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Toju, Hirokazu; Sato, Hirotoshi] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan	Kyoto University; Kyoto University; Japan Fisheries Research & Education Agency (FRA)	Toju, H (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan.	toju.hirokazu.4c@kyoto-u.ac.jp	Toju, Hirokazu/T-7355-2019; Sato, Hirotoshi/A-2429-2015; Toju, Hirokazu/S-7307-2017; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government [GS014]	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government	This work was financially supported by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government (to H. T.; GS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander I. J., 2005, P165, DOI 10.1017/CBO9780511541971.008; Bahram M, 2011, FEMS MICROBIOL ECOL, V75, P313, DOI 10.1111/j.1574-6941.2010.01000.x; Bever JD, 2001, BIOSCIENCE, V51, P923, DOI 10.1641/0006-3568(2001)051[0923:AMFMDT]2.0.CO;2; Bonneau L, 2013, NEW PHYTOL, V199, P188, DOI 10.1111/nph.12234; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caruso T, 2012, NEW PHYTOL, V194, P891, DOI 10.1111/j.1469-8137.2012.04163.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chen YL, 2000, NEW PHYTOL, V146, P545, DOI 10.1046/j.1469-8137.2000.00663.x; Comas LH, 2009, NEW PHYTOL, V182, P919, DOI 10.1111/j.1469-8137.2009.02799.x; Dickie IA, 2001, NEW PHYTOL, V151, P257, DOI 10.1046/j.1469-8137.2001.00148.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eguchi T, 1984, CONSERVATION REPORTS, V3-26; Enoki T, 2003, ECOL RES, V18, P103, DOI 10.1046/j.1440-1703.2003.00549.x; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; FINLAY RD, 1986, NEW PHYTOL, V103, P157, DOI 10.1111/j.1469-8137.1986.tb00604.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hogberg MN, 2002, NEW PHYTOL, V154, P791, DOI 10.1046/j.1469-8137.2002.00417.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; KAGEYAMA S.A., 2008, MYCORRHIZA STATE ART, P29, DOI DOI 10.1007/978-3-540-78826-3_2; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Mandyam K, 2005, STUD MYCOL, P173; McGuire KL, 2008, MYCORRHIZA, V18, P217, DOI 10.1007/s00572-008-0170-9; McHugh TA, 2006, NEW PHYTOL, V171, P171, DOI 10.1111/j.1469-8137.2006.01735.x; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Murata H, 2013, MYCORRHIZA, V23, P235, DOI 10.1007/s00572-012-0466-7; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Phillips RP, 2013, NEW PHYTOL, V199, P41, DOI 10.1111/nph.12221; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Selosse MA, 2002, NEW PHYTOL, V155, P183, DOI 10.1046/j.1469-8137.2002.00442.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Sokal R.R., 2012, BIOMETRY; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe AS, 2012, CLAIDENT V0 1 2012 1; Tanabe AS, 2013, ASSAMS V0 1 2013 01; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Toju H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078248; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wu BY, 2012, NEW PHYTOL, V194, P1070, DOI 10.1111/j.1469-8137.2012.04126.x; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Xie XA, 2013, NEW PHYTOL, V198, P836, DOI 10.1111/nph.12188; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao ZW, 2001, MYCORRHIZA, V11, P159, DOI 10.1007/s005720100117	73	56	57	13	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86566	10.1371/journal.pone.0086566	http://dx.doi.org/10.1371/journal.pone.0086566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489745	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000060
J	Yang, TL; Lin, L; Lou, PJ; Chang, TC; Young, TH				Yang, Tsung-Lin; Lin, Lin; Lou, Pei-Jen; Chang, Ta-Chau; Young, Tai-Horng			Detection of Cell Carcinogenic Transformation by a Quadruplex DNA Binding Fluorescent Probe	PLOS ONE			English	Article							BALB/C 3T3-CELL TRANSFORMATION; EXPERIMENTAL PARAMETERS; MOLECULAR-MECHANISMS; PREMALIGNANT LESIONS; CANCER; TELOMERASE; ASSAY; CHEMICALS; RISK; TUMORIGENICITY	Cancer can be easily treated when found early. A probe capable of detecting cell transformation may increase the success rate of early diagnosis of cancer. In this report we have tested the ability of a fluorescent, quadruplex DNA binding probe, 3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC), to detect cell transformation in vitro. BMVC was applied to living cells in several different models of cell transformation, and the fluorescence signals of BMVC were measured. The degrees of cell transformation in these models were characterized by alterations in cellular morphological phenotype and subcellular organization. When BMVC probes were applied, the number of BMVC-positive cells increased in accordance with the degree of transformation. BMVC was capable of significantly detecting formation of foci, increased cellular motility, cell proliferation, cell apoptosis, anchorage-independent growth, and increased invasiveness of transformed cells. These results demonstrate the ability of BMVC probes to detect cell transformation and indicate that BMVC is of promise for use as a probe in early cancer detection.	[Yang, Tsung-Lin; Lou, Pei-Jen] Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan; [Yang, Tsung-Lin; Lou, Pei-Jen] Coll Med, Taipei, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lin, Lin; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10764, Taiwan; [Lin, Lin; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Yang, TL (corresponding author), Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan.	yangtl@ntu.edu.tw; thyoung@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012	Chang, Ta-Chau/0000-0001-5878-8556; YANG, TSUNG-LIN/0000-0001-6521-8631; LOU, PEI-JEN/0000-0002-3383-8593	National Science Council of the Republic of China [98-2218-E-001-002-]; National Taiwan University Hospital [HCH101-18]; National Health Research Institutes (NHRI) [NHRI-EX99-9912EI]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); National Health Research Institutes (NHRI)(National Health Research Institutes - Taiwan)	The authors thank National Science Council of the Republic of China (98-2218-E-001-002-), National Taiwan University Hospital (HCH101-18), and National Health Research Institutes (NHRI, NHRI-EX99-9912EI) for their financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao L, 2010, TOXICOL IN VITRO, V24, P430, DOI 10.1016/j.tiv.2009.10.006; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; BARRETT JC, 1987, ENVIRON HEALTH PERSP, V76, P65, DOI 10.2307/3430466; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boukamp Petra, 2005, J Dtsch Dermatol Ges, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x; Chang C, 2003, FILM COMMENT, V39, P75; Chang CC, 2004, CHEM BIODIVERS, V1, P1377, DOI 10.1002/cbdv.200490100; Chang TC, 2010, METHODS MOL BIOL, V608, P183, DOI 10.1007/978-1-59745-363-9_12; Colacci A, 2011, TOXICOL IN VITRO; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Ebert MPA, 2006, J PROTEOME RES, V5, P19, DOI 10.1021/pr050271e; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanash SM, 2011, NAT REV CLIN ONCOL, V8, P142, DOI 10.1038/nrclinonc.2010.220; Hsiao YC, 2011, BIOMATERIALS, V32, P4424, DOI 10.1016/j.biomaterials.2011.02.057; Hsue SS, 2007, J ORAL PATHOL MED, V36, P25; Hurley LH, 2000, PHARMACOL THERAPEUT, V85, P141, DOI 10.1016/S0163-7258(99)00068-6; Kang CC, 2007, ANALYST, V132, P745, DOI 10.1039/b617733f; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Keshava N, 2000, MUTAT RES-FUND MOL M, V447, P281, DOI 10.1016/S0027-5107(99)00216-X; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; LeBoeuf RA, 1999, IARC SCI PUBL, P409; Liao LJ, 2011, HEAD NECK-J SCI SPEC, V33, P719, DOI 10.1002/hed.21531; Liao LJ, 2009, ANALYST, V134, P708, DOI 10.1039/b814417f; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; Luo HM, 2011, FASEB J, V25, P1865, DOI 10.1096/fj.10-174318; Mao L, 1996, CANCER RES, V56, P5600; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Maruvada P., 2005, BIOTECHNIQUES, V4, P9, DOI DOI 10.2144/05384SU04; Mascolo MG, 2010, TOXICOL IN VITRO, V24, P1292, DOI 10.1016/j.tiv.2010.03.003; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P347, DOI 10.2307/3431405; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P277, DOI 10.2307/3431401; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P311, DOI 10.2307/3431403; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P293, DOI 10.2307/3431402; MATTHEWS EJ, 1993, ENVIRON HEALTH PERSP, V101, P319, DOI 10.2307/3431404; MCCORMICK JJ, 1994, RISK ANAL, V14, P257, DOI 10.1111/j.1539-6924.1994.tb00240.x; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Redpath JL, 2004, CANCER METAST REV, V23, P333, DOI 10.1023/B:CANC.0000031771.56142.9b; Rosin MP, 2000, CLIN CANCER RES, V6, P357; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sagiv Idit, 2009, J Carcinog, V8, P16, DOI 10.4103/1477-3163.58372; Sakai A, 2007, MUTAT RES-GEN TOX EN, V630, P103, DOI 10.1016/j.mrgentox.2007.03.005; SAKAI N, 1994, INT J CANCER, V58, P309, DOI 10.1002/ijc.2910580227; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; SHEU CW, 1992, FOOD CHEM TOXICOL, V30, P307, DOI 10.1016/0278-6915(92)90008-9; Sudbo J, 2001, NEW ENGL J MED, V344, P1270, DOI 10.1056/NEJM200104263441702; Tsuchiya T, 2010, ATLA-ALTERN LAB ANIM, V38, P11, DOI 10.1177/026119291003800111; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; YAMASAKI H, 1985, CANCER RES, V45, P2395; Yang TL, 2008, HEAD NECK-J SCI SPEC, V30, P631, DOI 10.1002/hed.20758; Yang TL, 2011, ORAL ONCOL, V47, P720, DOI 10.1016/j.oraloncology.2011.04.006; Yang TL, 2010, BIOMATERIALS, V31, P288, DOI 10.1016/j.biomaterials.2009.09.052; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0	60	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86143	10.1371/journal.pone.0086143	http://dx.doi.org/10.1371/journal.pone.0086143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489694	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000033
J	De Spiegeleer, A; Wynendaele, E; Vandekerckhove, M; Stalmans, S; Boucart, M; Van den Noortgate, N; Venken, K; Van Calenbergh, S; Aspeslagh, S; Elewaut, D				De Spiegeleer, Anton; Wynendaele, Evelien; Vandekerckhove, Matthias; Stalmans, Sofie; Boucart, Maxime; Van den Noortgate, Nele; Venken, Koen; Van Calenbergh, Serge; Aspeslagh, Sandrine; Elewaut, Dirk			An In Silico Approach for Modelling T-Helper Polarizing iNKT Cell Agonists	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-SYSTEM; NKT CELLS; POLARIZATION; RECOGNITION; ACTIVATION; VARIANTS; PEPTIDES; ANTIGENS	Many analogues of the glycolipid alpha-galactosylceramide (alpha-GalCer) are known to activate iNKT cells through their interaction with CD1d-expressing antigen-presenting cells, inducing the release of Th1 and Th2 cytokines. Because of iNKT cell involvement and associated Th1/Th2 cytokine changes in a broad spectrum of human diseases, the design of iNKT cell ligands with selective Th1 and Th2 properties has been the subject of extensive research. This search for novel iNKT cell ligands requires refined structural insights. Here we will visualize the chemical space of 333 currently known iNKT cell activators, including several newly tested analogues, by more than 3000 chemical descriptors which were calculated for each individual analogue. To evaluate the immunological responses we analyzed five different cytokines in five different test-systems. We linked the chemical space to the immunological space using a system biology computational approach resulting in highly sensitive and specific predictive models. Moreover, these models correspond with the current insights of iNKT cell activation by alpha-GalCer analogues, explaining the Th1 and Th2 biased responses, downstream of iNKT cell activation. We anticipate that such models will be of great value for the future design of iNKT cell agonists.	[De Spiegeleer, Anton; Vandekerckhove, Matthias; Venken, Koen; Aspeslagh, Sandrine; Elewaut, Dirk] Univ Ghent, Lab Mol Immunol & Inflammat, Dept Rheumatol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Wynendaele, Evelien; Stalmans, Sofie; Boucart, Maxime] Univ Ghent, Drug Qual & Registrat DruQuaR Grp, Dept Pharmaceut Anal, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; [Van den Noortgate, Nele] Univ Ghent, Geriatr Unit, Dept Internal Med, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Van Calenbergh, Serge] Univ Ghent, Med Chem Lab, Dept Pharmaceut, Fac Pharmaceut Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Elewaut, D (corresponding author), Univ Ghent, Lab Mol Immunol & Inflammat, Dept Rheumatol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Dirk.Elewaut@ugent.be	Van Calenbergh, Serge/A-3167-2008; Elewaut, Dirk/K-6831-2014; De Spiegeleer, Anton/V-5417-2019	Van Calenbergh, Serge/0000-0002-4201-1264; De Spiegeleer, Anton/0000-0002-3681-2807; Elewaut, Dirk/0000-0002-7468-974X; Venken, Koen/0000-0002-4950-386X				Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Bai L, 2012, J IMMUNOL, V188, P3053, DOI 10.4049/jimmunol.1102414; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Berkers CR, 2005, TRENDS PHARMACOL SCI, V26, P252, DOI 10.1016/j.tips.2005.03.005; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; DERRINGER GC, 1994, QUAL PROG, V27, P51; Drennan MB, 2010, NAT REV RHEUMATOL, V6, P90, DOI 10.1038/nrrheum.2009.261; Eriksson L., 2006, MULTI MEGAVARIATE 1; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Jervis PJ, 2012, BIOORG MED CHEM LETT, V22, P4348, DOI 10.1016/j.bmcl.2012.05.009; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Schiefner A, 2009, J MOL BIOL, V394, P71, DOI 10.1016/j.jmb.2009.08.061; Smyth MJ, 2002, BLOOD, V99, P1259, DOI 10.1182/blood.V99.4.1259; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Van Dorpe S, 2010, J SEP SCI, V33, P728, DOI 10.1002/jssc.200900476; Van Dorpe S, 2011, J PEPT SCI, V17, P398, DOI 10.1002/psc.1323; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu TN, 2011, P NATL ACAD SCI USA, V108, P17275, DOI 10.1073/pnas.1114255108; Yu ED, 2011, J IMMUNOL, V187, P2079, DOI 10.4049/jimmunol.1101636	30	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87000	10.1371/journal.pone.0087000	http://dx.doi.org/10.1371/journal.pone.0087000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498010	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900057
J	McColeman, CM; Barnes, JI; Chen, LH; Meier, KM; Walshe, RC; Blair, MR				McColeman, Caitlyn M.; Barnes, Jordan I.; Chen, Lihan; Meier, Kimberly M.; Walshe, R. Calen; Blair, Mark R.			Learning-Induced Changes in Attentional Allocation during Categorization: A Sizable Catalog of Attention Change as Measured by Eye Movements	PLOS ONE			English	Article							SELECTIVE ATTENTION; MODEL; PERCEPTION; FEATURES; SYSTEMS; NETWORK; MEMORY; EXPERT; SCENES	Learning how to allocate attention properly is essential for success at many categorization tasks. Advances in our understanding of learned attention are stymied by a chicken-and-egg problem: there are no theoretical accounts of learned attention that predict patterns of eye movements, making data collection difficult to justify, and there are not enough datasets to support the development of a rich theory of learned attention. The present work addresses this by reporting five measures relating to the overt allocation of attention across 10 category learning experiments: accuracy, probability of fixating irrelevant information, number of fixations to category features, the amount of change in the allocation of attention (using a new measure called Time Proportion Shift-TIPS), and a measure of the relationship between attention change and erroneous responses. Using these measures, the data suggest that eye-movements are not substantially connected to error in most cases and that aggregate trial-by-trial attention change is generally stable across a number of changing task variables. The data presented here provide a target for computational models that aim to account for changes in overt attentional behaviors across learning.	[McColeman, Caitlyn M.; Barnes, Jordan I.; Blair, Mark R.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Chen, Lihan; Blair, Mark R.] Simon Fraser Univ, Cognit Sci Program, Burnaby, BC V5A 1S6, Canada; [Meier, Kimberly M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Walshe, R. Calen] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9YL, Midlothian, Scotland	Simon Fraser University; Simon Fraser University; University of British Columbia; University of Edinburgh	McColeman, CM (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	caitlyn_mccoleman@sfu.ca	Meier, Kimberly/AGL-1571-2022	Meier, Kimberly/0000-0002-7070-0753; McColeman, Caitlyn/0000-0002-3984-7706	Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by grants from the Canada Foundation for Innovation (http://www.innovation.ca/), the British Columbia Knowledge Development Fund (http://www.aved.gov.bc.ca/researchandinnovation/Funding/BCKDF/index.htm), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bates D. M., 2007, LME4 LINEAR MIXED EF; BIEDERMAN I, 1987, J EXP PSYCHOL LEARN, V13, P640, DOI 10.1037/0278-7393.13.4.640; Blair M, 2005, J EXP PSYCHOL LEARN, V31, P258, DOI 10.1037/0278-7393.31.2.258; Blair M. R., 2009, P 31 ANN C COGN SCI, P3127; Blair M. R., 2011, P ANN C COGN SCI SOC, V33, P1649; Blair MR, 2009, COGNITION, V112, P330, DOI 10.1016/j.cognition.2009.04.008; Blair MR, 2009, J EXP PSYCHOL LEARN, V35, P1196, DOI 10.1037/a0016272; BOSTER JS, 1989, AM ANTHROPOL, V91, P866, DOI 10.1525/aa.1989.91.4.02a00040; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Craig S, 2011, J EXP PSYCHOL LEARN, V37, P673, DOI 10.1037/a0022473; EPELBOIM J, 1995, VISION RES, V35, P3401, DOI 10.1016/0042-6989(95)00080-X; Foerster RM, 2011, J VISION, V11, DOI 10.1167/11.7.9; Greenaway R, 2005, PSYCHOL SCI, V16, P987, DOI 10.1111/j.1467-9280.2005.01648.x; Haider H, 1999, J EXP PSYCHOL LEARN, V25, P172, DOI 10.1037/0278-7393.25.1.172; Irwin DE, 2002, PERCEPT PSYCHOPHYS, V64, P882, DOI 10.3758/BF03196793; Kalenine S, 2012, J EXP PSYCHOL LEARN, V38, P1274, DOI 10.1037/a0027626; Kim S, 2011, MEM COGNITION, V39, P649, DOI 10.3758/s13421-010-0050-3; Kopp B, 2000, BIOL PSYCHOL, V51, P223, DOI 10.1016/S0301-0511(99)00039-3; Kruschke JK, 1999, J EXP PSYCHOL LEARN, V25, P1083, DOI 10.1037/0278-7393.25.5.1083; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Love BC, 2004, PSYCHOL REV, V111, P309, DOI 10.1037/0033-295X.111.2.309; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Maddox WT, 2004, J EXP PSYCHOL LEARN, V30, P227, DOI 10.1037/0278-7393.30.1.227; Maxwell, 1980, J ED STAT, V5, P269, DOI [10.3102/10769986005003269, DOI 10.3102/10769986005003269]; McColeman C.M., 2011, P 33 ANN M COGN SCI, P1661; Meier KM, 2013, COGNITION, V126, P319, DOI 10.1016/j.cognition.2012.09.014; Memmert D, 2006, CONSCIOUS COGN, V15, P620, DOI 10.1016/j.concog.2006.01.001; Rayner K, 2009, PERCEPTION, V38, P895, DOI 10.1068/ldmk-ray; Rehder B, 2005, COGNITIVE PSYCHOL, V51, P1, DOI 10.1016/j.cogpsych.2004.11.001; Rensink RA, 2000, VIS COGN, V7, P127, DOI 10.1080/135062800394720; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Tatler BW, 2009, VIS COGN, V17, P777, DOI 10.1080/13506280902869213; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Wills AJ, 2012, PSYCHOL BULL, V138, P102, DOI 10.1037/a0025715; Yarbus A. L., 1967, EYE MOVEMENTS VISION, V2	42	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e83302	10.1371/journal.pone.0083302	http://dx.doi.org/10.1371/journal.pone.0083302			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497915	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900004
J	Rolland-Debord, C; Lair, D; Roussey-Bihouee, T; Hassoun, D; Evrard, J; Cheminant, MA; Chesne, J; Braza, F; Mahay, G; Portero, V; Sagan, C; Pitard, B; Magnan, A				Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Evrard, Justine; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Sagan, Christine; Pitard, Bruno; Magnan, Antoine			Block Copolymer/DNA Vaccination Induces a Strong Allergen-Specific Local Response in a Mouse Model of House Dust Mite Asthma	PLOS ONE			English	Article							IN-VIVO; IMMUNOTHERAPY; NANOSPHERES; MECHANISMS; CELLS	Background: Allergic asthma is caused by abnormal immunoreactivity against allergens such as house dust mites among which Dermatophagoides farinae (Der f) is a common species. Currently, immunotherapy is based on allergen administration, which has variable effect from patient to patient and may cause serious side effects, principally the sustained risk of anaphylaxis. DNA vaccination is a promising approach by triggering a specific immune response with reduced allergenicity. Objective: The aim of the study is to evaluate the effects of DNA immunization with Der f1 allergen specific DNA on allergic sensitization, inflammation and respiratory function in mice. Methods: Mice were vaccinated 28 and 7 days before allergen exposure with a Der f1-encoding plasmid formulated with a block copolymer. Asthma was induced by skin sensitization followed by intra-nasal challenges with Der f extract. Total lung, broncho-alveolar lavage (BAL) and spleen cells were analyzed by flow cytometry for their surface antigen and cytokine expression. Splenocytes and lung cell IFN-gamma production by CD8+ cells in response to Der f CMH1-restricted peptides was assessed by ELISPOT. IgE, IgG1 and IgG2a were measured in serum by ELISA. Specific bronchial hyperresponsiveness was assessed by direct resistance measurements. Results: Compared to animals vaccinated with an irrelevant plasmid, pVAX-Der f1 vaccination induced an increase of B cells in BAL, and an elevation of IL-10 and IFN-gamma but also of IL-4, IL-13 and IL-17 producing CD4+ lymphocytes in lungs and of IL-4 and IL-5 in spleen. In response to CD8-restricted peptides an increase of IFN-gamma was observed among lung cells. IgG2a levels non-specifically increased following block copolymer/DNA vaccination although IgE, IgG1 levels and airways resistances were not impacted. Conclusions & Clinical Relevance: DNA vaccination using a plasmid coding for Der f1 formulated with the block copolymer 704 induces a specific immune response in the model of asthma used herein.	[Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Evrard, Justine; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Pitard, Bruno; Magnan, Antoine] Ctr Natl Rech Sci 6291, INSERM, U1087, Unite Mixte Rech, Nantes, France; [Rolland-Debord, Camille; Lair, David; Roussey-Bihouee, Tiphaine; Hassoun, Dorian; Cheminant, Marie-Aude; Chesne, Julie; Braza, Faouzi; Mahay, Guillaume; Portero, Vincent; Magnan, Antoine] Univ Nantes, Nantes, France; [Sagan, Christine] Ctr Hosp Univ, Serv Anat & Cytol Pathol, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Magnan, A (corresponding author), Ctr Natl Rech Sci 6291, INSERM, U1087, Unite Mixte Rech, Nantes, France.	Antoine.Magnan@univ-nantes.fr	MAGNAN, ANTOINE/GVT-4308-2022; Magnan, Antoine/D-4100-2015; Pitard, Bruno F/K-9270-2015	Braza, Faouzi/0000-0003-1182-1413; Hassoun, Dorian/0000-0002-2154-0474; Chesne, Julie/0000-0001-8831-4386; Portero, Vincent/0000-0002-7221-859X	Societe Francaise d'Allergologie; Societe de Pneumologie de Langue Francaise; Fondation Recherche Medicale; Fondation Genavie (Nantes, France); Region Pays de La Loire	Societe Francaise d'Allergologie; Societe de Pneumologie de Langue Francaise; Fondation Recherche Medicale; Fondation Genavie (Nantes, France); Region Pays de La Loire(Region Pays de la Loire)	This work was supported by grants from the Societe Francaise d'Allergologie, Societe de Pneumologie de Langue Francaise, Fondation Recherche Medicale, Fondation Genavie (Nantes, France), and Region Pays de La Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2010, CLIN VACCINE IMMUNOL, V17, P36, DOI 10.1128/CVI.00275-09; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Beilvert F, 2012, HUM GENE THER, V23, P597, DOI 10.1089/hum.2012.024; Biliczki P, 2009, HEART RHYTHM, V6, P1792, DOI 10.1016/j.hrthm.2009.08.009; Fonseca DM, 2012, CLIN EXP ALLERGY, V42, P131, DOI 10.1111/j.1365-2222.2011.03845.x; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Jarman ER, 2004, IMMUNOLOGY, V112, P631, DOI 10.1111/j.1365-2567.2004.01927.x; Jin HL, 2008, EUR J IMMUNOL, V38, P2451, DOI 10.1002/eji.200737899; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kim CH, 2006, J ASTHMA, V43, P345, DOI 10.1080/02770900600701424; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Mamessier E, 2006, CLIN EXP ALLERGY, V36, P704, DOI 10.1111/j.1365-2222.2006.02487.x; McIlroy D, 2009, MOL THER, V17, P1473, DOI 10.1038/mt.2009.84; Peng HJ, 2002, VACCINE, V20, P1761, DOI 10.1016/S0264-410X(02)00029-4; Pipe A, 2009, RESP MED, V103, P800, DOI 10.1016/j.rmed.2009.01.008; Pitard B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh153; Richard P, 2005, J GENE MED, V7, P80, DOI 10.1002/jgm.631; Richard P, 2005, HUM GENE THER, V16, P1318, DOI 10.1089/hum.2005.16.1318; SECRIST H, 1993, J EXP MED, V178, P2123, DOI 10.1084/jem.178.6.2123	20	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85976	10.1371/journal.pone.0085976	http://dx.doi.org/10.1371/journal.pone.0085976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497934	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900014
J	Schecklmann, M; Landgrebe, M; Langguth, B				Schecklmann, Martin; Landgrebe, Michael; Langguth, Berthold		TRI Database Study Grp	Phenotypic Characteristics of Hyperacusis in Tinnitus	PLOS ONE			English	Article							GENERALIZED HYPERVIGILANCE; DISORDERS; SOUND; NOISE; HYPERSENSITIVITY; INDIVIDUALS; ASSOCIATION; PREVALENCE	Background: Many people with tinnitus also suffer from hyperacusis. Both clinical and basic scientific data indicate an overlap in pathophysiologic mechanisms. In order to further elucidate the interplay between tinnitus and hyperacusis we compared clinical and demographic characteristics of tinnitus patients with and without hyperacusis by analyzing a large sample from an international tinnitus patient database. Materials: The default dataset import [November 1st, 2012] from the Tinnitus Research Initiative [TRI] Database was used for analyses. Hyperacusis was defined by the question "Do sounds cause you pain or physical discomfort?" of the Tinnitus Sample Case History Questionnaire. Patients who answered this question with "yes" were contrasted with "no"-responders with respect to 41 variables. Results: 935 [55%] out of 1713 patients were characterized as hyperacusis patients. Hyperacusis in tinnitus was associated with younger age, higher tinnitus-related, mental and general distress; and higher rates of pain disorders and vertigo. In relation to objective audiological assessment patients with hyperacusis rated their subjective hearing function worse than those without hyperacusis. Similarly the tinnitus pitch was rated higher by hyperacusis patients in relation to the audiometrically determined tinnitus pitch. Among patients with tinnitus and hyperacusis the tinnitus was more frequently modulated by external noise and somatic maneuvers, i.e., exposure to environmental sounds and head and neck movements change the tinnitus percept. Conclusions: Our findings suggest that the comorbidity of hyperacusis is a useful criterion for defining a sub-type of tinnitus which is characterized by greater need of treatment. The higher sensitivity to auditory, somatosensory and vestibular input confirms the notion of an overactivation of an unspecific hypervigilance network in tinnitus patients with hyperacusis.	[Schecklmann, Martin; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Landgrebe, Michael] Social Fdn Bamberg, Dept Psychiat & Psychotherapy, Bamberg, Germany	University of Regensburg	Schecklmann, M (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	martin.schecklmann@medbo.de	Coelho, Claudia/J-6250-2016; Langguth, Berthold/AAP-2638-2021; Kleinjung, Tobias/AAJ-3141-2020; Heyning, Paul H Vande/I-8278-2017	Coelho, Claudia/0000-0002-2441-0739; Kleinjung, Tobias/0000-0003-3867-234X; Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative (TRI)	Tinnitus Research Initiative (TRI)	The study was supported by the Tinnitus Research Initiative (TRI; www.tinnitusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Basura GJ, 2012, BRAIN RES, V1485, P95, DOI 10.1016/j.brainres.2012.08.037; Blasing L, 2010, INT J AUDIOL, V49, P518, DOI 10.3109/14992021003724996; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Ridder D, NEUROSCI BI IN PRESS; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Fioretti AB, 2013, NOISE HEALTH, V15, P91, DOI 10.4103/1463-1741.110287; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Hebert S, 2013, J NEUROSCI, V33, P2356, DOI 10.1523/JNEUROSCI.3461-12.2013; Hollins M, 2009, PAIN, V141, P215, DOI 10.1016/j.pain.2008.10.003; Hwang JH, 2009, AM J OTOLARYNG, V30, P432, DOI 10.1016/j.amjoto.2008.08.005; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; KLEIN AJ, 1990, J SPEECH HEAR DISORD, V55, P339, DOI 10.1044/jshd.5502.339; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2008, NEUROIMAGE, V41, P1336, DOI 10.1016/j.neuroimage.2008.04.171; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Landgrebe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005026; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus OM, 2010, INT J AUDIOL, V49, P7, DOI 10.3109/14992020903160868; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Schecklmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034878; Sereda M, 2013, HEARING RES, V302, P50, DOI 10.1016/j.heares.2013.04.006; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Song JJ, BRAIN STRUC IN PRESS; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Tuz HH, 2003, AM J ORTHOD DENTOFAC, V123, P620, DOI 10.1016/S0889-5406(03)00153-7; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	42	114	117	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86944	10.1371/journal.pone.0086944	http://dx.doi.org/10.1371/journal.pone.0086944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498000	gold, Green Published			2022-12-27	WOS:000330621900050
J	Xu, JS; Calhoun, VD; Pearlson, GD; Potenza, MN				Xu, Jiansong; Calhoun, Vince D.; Pearlson, Godfrey D.; Potenza, Marc N.			Opposite Modulation of Brain Functional Networks Implicated at Low vs. High Demand of Attention and Working Memory	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PREFRONTAL CORTEX AREA-10; DEFAULT-MODE; VENTRAL ATTENTION; RESPONSE FUNCTIONS; BLIND SEPARATION; FMRI; CONNECTIVITY; SCHIZOPHRENIA; ACTIVATION	Background: Functional magnetic resonance imaging (fMRI) studies indicate that the brain organizes its activity into multiple functional networks (FNs) during either resting condition or task-performance. However, the functions of these FNs are not fully understood yet. Methodology/Principal Findings: To investigate the operation of these FNs, spatial independent component analysis (sICA) was used to extract FNs from fMRI data acquired from healthy participants performing a visual task with two levels of attention and working memory load. The task-related modulations of extracted FNs were assessed. A group of FNs showed increased activity at low-load conditions and reduced activity at high-load conditions. These FNs together involve the left lateral frontoparietal cortex, insula, and ventromedial prefrontal cortex. A second group of FNs showed increased activity at high-load conditions and reduced activity at low-load conditions. These FNs together involve the intraparietal sulcus, frontal eye field, lateral frontoparietal cortex, insula, and dorsal anterior cingulate, bilaterally. Though the two groups of FNs showed opposite task-related modulations, they overlapped extensively at both the lateral and medial frontoparietal cortex and insula. Such an overlap of FNs would not likely be revealed using standard general-linear-model-based analyses. Conclusions: By assessing task-related modulations, this study differentiated the functional roles of overlapping FNs. Several FNs including the left frontoparietal network are implicated in task conditions of low attentional load, while another set of FNs including the dorsal attentional network is implicated in task conditions involving high attentional demands.	[Xu, Jiansong; Calhoun, Vince D.; Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Pearlson, Godfrey D.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Pearlson, Godfrey D.] Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT USA; [Calhoun, Vince D.] Univ New Mexico, Dept ECE, Albuquerque, NM 87131 USA	Yale University; Yale University; Yale University; Lovelace Respiratory Research Institute; University of New Mexico	Xu, JS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Jiansong.xu@yale.edu	Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747	National Institute On Drug Abuse (NIDA) grants [K01 DA027750, P20 DA027844]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027750, P20DA027844] Funding Source: NIH RePORTER	National Institute On Drug Abuse (NIDA) grants; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the following grants: National Institute On Drug Abuse (NIDA) grants K01 DA027750 (Xu) and P20 DA027844 (Potenza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; Asplund CL, 2010, J EXP PSYCHOL HUMAN, V36, P1372, DOI 10.1037/a0020551; Asplund CL, 2010, NAT NEUROSCI, V13, P507, DOI 10.1038/nn.2509; Assaf M, 2009, BRAIN COGNITION, V70, P238, DOI 10.1016/j.bandc.2009.02.007; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beldzik E, 2013, NEUROIMAGE, V76, P304, DOI 10.1016/j.neuroimage.2013.03.014; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2012, TRENDS COGN SCI, V16, P255, DOI 10.1016/j.tics.2012.03.008; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daselaar SM, 2010, NEUROIMAGE, V52, P677, DOI 10.1016/j.neuroimage.2010.04.239; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Domagalik A, 2012, NEUROIMAGE, V62, P1325, DOI 10.1016/j.neuroimage.2012.06.006; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Esposito F, 2011, CURR OPIN NEUROL, V24, P378, DOI 10.1097/WCO.0b013e32834897a5; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gilbert SJ, 2006, J EXP PSYCHOL HUMAN, V32, P45, DOI 10.1037/0096-1523.32.1.45; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Juarez M, 2012, HUM BRAIN MAPP; Kalcher K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00301; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kim DI, 2009, SCHIZOPHRENIA BULL, V35, P67, DOI 10.1093/schbul/sbn133; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Laird AR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00154; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leung HC, 2007, NEUROIMAGE, V35, P368, DOI 10.1016/j.neuroimage.2006.12.012; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Meda SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007911; Menz MM, 2009, HUM BRAIN MAPP, V30, P3339, DOI 10.1002/hbm.20756; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nygard M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00149; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; St Jacques PL, 2011, NEUROIMAGE, V57, P608, DOI 10.1016/j.neuroimage.2011.04.039; Stevens MC, 2009, HUM BRAIN MAPP, V30, P24, DOI 10.1002/hbm.20478; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Wageningen H, 2009, HUM BRAIN MAPP, V30, P3616, DOI 10.1002/hbm.20789; Verduzco-Flores S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006399; Vossel S, 2013, NEUROSCIENTIST; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; White TP, 2010, SCHIZOPHR RES, V123, P105, DOI 10.1016/j.schres.2010.07.020; Wu X, 2009, NEUROIMAGE, V45, P1347, DOI 10.1016/j.neuroimage.2008.12.050; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038; Xu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014552; Yan XD, 2011, J NEUROSCI METH, V199, P108, DOI 10.1016/j.jneumeth.2011.05.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zsigmond TK, 2008, IDEGGYOGY SZEMLE, V61, P280; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	76	39	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87078	10.1371/journal.pone.0087078	http://dx.doi.org/10.1371/journal.pone.0087078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498021	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900065
J	Banerjee, D; Burkard, L; Panepinto, JC				Banerjee, Dithi; Burkard, Lauren; Panepinto, John C.			Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; IN-VITRO; CANDIDA-ALBICANS; PYRIMIDINE BIOSYNTHESIS; 5-FLUOROCYTOSINE; COMBINATION; FLUCYTOSINE; MENINGITIS; AGENTS; ASPERGILLUS	The polyene antifungal agent Amphotericin B exhibits potent and broad spectrum fungicidal activity. However, high nephrotoxicity can hinder its administration in resource poor settings. Quantification of early fungicidal activity in studies of HIV patients with cryptococcosis demonstrate that 5-Fluorocytosine therapy in combination with Amphotericin B results in faster clearance than with Amphotericin B alone. In vitro synergy between the two drugs has also been reported but the mechanism by which 5-Fluorocytosine synergizes with Amphotericin B has not been delineated. In this study we set out to investigate the effect of genetic mutation or pharmacologic repression of de novo pyrimidine and purine biosynthesis pathways on the Amphotericin B susceptibility of Cryptococcus neoformans. We demonstrate that a ura- derivative of wild type Cryptococcus neoformans strain H99 is hypersensitive to Amphotericin B. This sensitivity is remediated by reintroduction of a wild type URA5 gene, but not by addition of exogenous uracil to supplement the auxotrophy. Repression of guanine biosynthesis by treatment with the inosine monophosphate dehydrogenase inhibitor, mycophenolic acid, was synergistic with Amphotericin B as determined by checkerboard analysis. As in Cryptococcus neoformans, a ura(-) derivative of Candida albicans was also hypersensitive to Amphotericin B, and treatment of Candida albicans with mycophenolic acid was likewise synergistic with Amphotericin B. In contrast, neither mycophenolic acid nor 5-FC had an effect on the Amphotericin B susceptibility of Aspergillus fumigatus. These studies suggest that pharmacological targeting of nucleotide biosynthesis pathways has potential to lower the effective dose of Amphotericin B for both C. neoformans and C. albicans. Given the requirement of nucleotide and nucleotide sugars for growth and pathogenesis of Cryptococcus neoformans, disrupting nucleotide metabolic pathways might thus be an effective mechanism for the development of novel antifungal drugs.	[Banerjee, Dithi; Burkard, Lauren; Panepinto, John C.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Panepinto, JC (corresponding author), SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.	jcp25@buffalo.edu			Public Health Service (PHS) [1R01 AI089920]; University at Buffalo, the State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089920] Funding Source: NIH RePORTER	Public Health Service (PHS)(United States Department of Health & Human ServicesUnited States Public Health Service); University at Buffalo, the State University of New York; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Public Health Service (PHS) Grant 1R01 AI089920 to JCP and Startup Funds from the University at Buffalo, the State University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole VT, 1999, J ANTIMICROB CHEMOTH, V44, P151, DOI 10.1093/jac/44.2.151; Aoun M, 2000, INT J ANTIMICROB AG, V16, P143, DOI 10.1016/S0924-8579(00)00220-X; Balish E, 2009, J MED MICROBIOL, V58, P290, DOI 10.1099/jmm.0.004846-0; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; CHESNEY PJ, 1976, J PEDIATR-US, V89, P1017, DOI 10.1016/S0022-3476(76)80624-5; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; DiDomenico B, 1999, CURR OPIN MICROBIOL, V2, P509, DOI 10.1016/S1369-5274(99)00009-0; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Dromer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002870; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Engl T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-4; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; GHANNOUM MA, 1995, ANTIMICROB AGENTS CH, V39, P2459, DOI 10.1128/AAC.39.11.2459; HUGHES CE, 1984, ANTIMICROB AGENTS CH, V25, P560, DOI 10.1128/AAC.25.5.560; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; ITTARAT I, 1995, ANTIMICROB AGENTS CH, V39, P325, DOI 10.1128/AAC.39.2.325; Kagan S, 2012, ANTIMICROB AGENTS CH, V56, P5603, DOI 10.1128/AAC.00612-12; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LAUER BA, 1978, J ANTIMICROB CHEMOTH, V4, P375, DOI 10.1093/jac/4.4.375; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; ODDS FC, 1982, ANTIMICROB AGENTS CH, V22, P763, DOI 10.1128/AAC.22.5.763; Panepinto JC, 2007, INFECT IMMUN, V75, P4769, DOI 10.1128/IAI.00536-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pfaller MA, 2002, ANTIMICROB AGENTS CH, V46, P3518, DOI 10.1128/AAC.46.11.3518-3521.2002; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Schwarz P, 2003, ANTIMICROB AGENTS CH, V47, P3361, DOI 10.1128/AAC.47.10.3361-3364.2003; SNELLER MR, 1977, ANTIMICROB AGENTS CH, V12, P390, DOI 10.1128/AAC.12.3.390; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS188, DOI 10.1086/376524; Thompson GR, 2009, CLIN CHEST MED, V30, P203, DOI 10.1016/j.ccm.2009.02.001; TITSWORTH E, 1973, ANTIMICROB AGENTS CH, V4, P306, DOI 10.1128/AAC.4.3.306; VARMA A, 1992, INFECT IMMUN, V60, P1101, DOI 10.1128/IAI.60.3.1101-1108.1992; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	45	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87246	10.1371/journal.pone.0087246	http://dx.doi.org/10.1371/journal.pone.0087246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498052	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100066
J	Low, ETL; Rosli, R; Jayanthi, N; Mohd-Amin, A; Azizi, N; Chan, KL; Maqbool, NJ; Maclean, P; Brauning, R; McCulloch, A; Moraga, R; Ong-Abdullah, M; Singh, R				Low, Eng-Ti L.; Rosli, Rozana; Jayanthi, Nagappan; Mohd-Amin, Ab Halim; Azizi, Norazah; Chan, Kuang-Lim; Maqbool, Nauman J.; Maclean, Paul; Brauning, Rudi; McCulloch, Alan; Moraga, Roger; Ong-Abdullah, Meilina; Singh, Rajinder			Analyses of Hypomethylated Oil Palm Gene Space	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ELAEIS-GUINEENSIS JACQ.; DISEASE RESISTANCE GENES; EXPRESSED SEQUENCE TAGS; SSR MARKERS; DIFFERENTIAL METHYLATION; TRANSCRIPTOME ANALYSIS; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; DRAFT SEQUENCE	Demand for palm oil has been increasing by an average of similar to 8% the past decade and currently accounts for about 59% of the world's vegetable oil market. This drives the need to increase palm oil production. Nevertheless, due to the increasing need for sustainable production, it is imperative to increase productivity rather than the area cultivated. Studies on the oil palm genome are essential to help identify genes or markers that are associated with important processes or traits, such as flowering, yield and disease resistance. To achieve this, 294,115 and 150,744 sequences from the hypomethylated or gene-rich regions of Elaeis guineensis and E. oleifera genome were sequenced and assembled into contigs. An additional 16,427 shot-gun sequences and 176 bacterial artificial chromosomes (BAC) were also generated to check the quality of libraries constructed. Comparison of these sequences revealed that although the methylation-filtered libraries were sequenced at low coverage, they still tagged at least 66% of the RefSeq supported genes in the BAC and had a filtration power of at least 2.0. A total 33,752 microsatellites and 40,820 high-quality single nucleotide polymorphism (SNP) markers were identified. These represent the most comprehensive collection of microsatellites and SNPs to date and would be an important resource for genetic mapping and association studies. The gene models predicted from the assembled contigs were mined for genes of interest, and 242, 65 and 14 oil palm transcription factors, resistance genes and miRNAs were identified respectively. Examples of the transcriptional factors tagged include those associated with floral development and tissue culture, such as homeodomain proteins, MADS, Squamosa and Apetala2. The E. guineensis and E. oleifera hypomethylated sequences provide an important resource to understand the molecular mechanisms associated with important agronomic traits in oil palm.	[Low, Eng-Ti L.; Rosli, Rozana; Jayanthi, Nagappan; Mohd-Amin, Ab Halim; Azizi, Norazah; Chan, Kuang-Lim; Ong-Abdullah, Meilina; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Maqbool, Nauman J.; Maclean, Paul] AgRes Ruakura Res Ctr, Hamilton, New Zealand; [Brauning, Rudi; McCulloch, Alan] AgRes Invermay Agr Ctr, Mosgiel, New Zealand; [Moraga, Roger] AgRes Grasslands Res Ctr, Palmerston North, New Zealand	Malaysian Palm Oil Board; AgResearch - New Zealand; AgResearch - New Zealand; AgResearch - New Zealand	Singh, R (corresponding author), Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia.	rajinder@mpob.gov.my	Low, Eng Ti Leslie/AHD-7011-2022; Singh, Rajinder/P-9179-2015; Moraga, Roger/AAW-2660-2021	Low, Eng Ti Leslie/0000-0003-3414-8401; Singh, Rajinder/0000-0001-9933-4884; Azizi, Norazah/0000-0001-5023-9763; Chan, Kuang-Lim/0000-0002-8419-0432; Maqbool, Nauman/0000-0002-9404-3647; Brauning, Rudiger/0000-0001-5068-9166; Maclean, Paul/0000-0001-8898-8276; Ong-Abdullah, Meilina/0000-0003-4825-5021	MPOB [R001702000-RB01-J]	MPOB	This work was supported by special MPOB grant (R001702000-RB01-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alwee SS, 2006, PLANT CELL TISS ORG, V85, P331, DOI 10.1007/s11240-006-9084-4; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barbosa-Da-Silva A, 2005, GENET MOL BIOL, V28, P562, DOI 10.1590/S1415-47572005000400011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bent AF, 1996, PLANT CELL, V8, P1757, DOI 10.1105/tpc.8.10.1757; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Billotte N, 2001, GENOME, V44, P413, DOI 10.1139/g01-017; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Budiman M. A., 2005, P 2005 PIPOC INT PAL, P628; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chan PL, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-14; Chandrasekar A, 2009, BIOINFORMATION, V4, P119, DOI 10.6026/97320630004119; Corley R., 2003, OIL PALM; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dransfield J., 2008, GENERA PALMARUM THE; Feng SP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/373768; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Giorgetti L, 2007, CARYOLOGIA, V60, P279, DOI 10.1080/00087114.2007.10797949; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish VF, 1999, DEV BIOL, V209, P211, DOI 10.1006/dbio.1999.9226; Itaya A, 2008, BBA-GENE REGUL MECH, V1779, P99, DOI 10.1016/j.bbagrm.2007.09.003; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Joslyn CA, 2004, BIOINFORMATICS, V20, P169, DOI 10.1093/bioinformatics/bth921; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDER E S, 1988, Genomics, V2, P231; Latiff A., 2000, ADV OIL PALM RES, V1, P19; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; Martienssen RA, 2004, CURR OPIN PLANT BIOL, V7, P102, DOI 10.1016/j.pbi.2004.01.010; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Mitsuda N, 2009, PLANT CELL PHYSIOL, V50, P1232, DOI 10.1093/pcp/pcp075; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Molesini B, 2012, TRENDS BIOTECHNOL, V30, P80, DOI 10.1016/j.tibtech.2011.07.005; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Ooi LCL, 2007, INT PLANT AN GEN 15, P177; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Ragupathy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-217; Riju A, 2009, NATURE PRECEDINGS; Riju A, 2009, J GENET, V88, P217, DOI 10.1007/s12041-009-0030-1; Riju A, 2007, BIOINFORMATION, V2, P128, DOI 10.6026/97320630002128; Rival A, 1997, PLANT CELL REP, V16, P884, DOI 10.1007/s002990050339; Sakai H, 2011, PLANT J, V66, P796, DOI 10.1111/j.1365-313X.2011.04539.x; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356; Singhal D, 2011, AFR J BIOTECHNOL, V10, P580; Soleimani VD, 2003, PLANT MOL BIOL REP, V21, P281, DOI 10.1007/BF02772803; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tameling WIL, 2008, EUR J PLANT PATHOL, V121, P243, DOI 10.1007/s10658-007-9187-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timko MP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-103; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Tranbarger TJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-1; van der Linden CG, 2004, THEOR APPL GENET, V109, P384, DOI 10.1007/s00122-004-1642-8; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vijayraghavan U, 2001, CURR SCI INDIA, V80, P233; Wanderley-Nogueira AC, 2007, GENET MOL RES, V6, P866; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yonemaru J, 2009, DNA RES, V16, P187, DOI 10.1093/dnares/dsp005; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan DaoJun, 2012, African Journal of Biotechnology, V11, P13269; Yun ChoongHyo, 1999, Plant Pathology Journal, V15, P105; Zaki NM, 2012, INT J MOL SCI, V13, P4069, DOI 10.3390/ijms13044069; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036	116	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86728	10.1371/journal.pone.0086728	http://dx.doi.org/10.1371/journal.pone.0086728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497974	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100028
J	Osler, M; Martensson, S; Prescott, E; Carlsen, K				Osler, Merete; Martensson, Solvej; Prescott, Eva; Carlsen, Kathrine			Impact of Gender, Co-Morbidity and Social Factors on Labour Market Affiliation after First Admission for Acute Coronary Syndrome. A Cohort Study of Danish Patients 2001-2009	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FOLLOW-UP; BYPASS-SURGERY; RETURN; WORK; MORTALITY; REGISTRY; DISEASE; ANGIOPLASTY; COMORBIDITY	Background: Over the last decades survival after acute coronary syndrome (ACS) has improved, leading to an increasing number of patients returning to work, but little is known about factors that may influence their labour market affiliation. This study examines the impact of gender, co-morbidity and socio-economic position on subsequent labour market affiliation and transition between various social services in patients admitted for the first time with ACS. Methods: From 2001 to 2009 all first-time hospitalisations for ACS were identified in the Danish National Patient Registry (n = 79,714). For this population, data on sick leave, unemployment and retirement were obtained from an administrative register covering all citizens. The 21,926 patients, aged 18-63 years, who had survived 30 days and were part of the workforce at the time of diagnosis were included in the analyses where subsequent transition between the above labour market states was examined using Kaplan-Meier estimates and Cox proportional hazards models. Findings: A total of 37% of patients were in work 30 days after first ACS diagnosis, while 55% were on sick leave and 8% were unemployed. Seventy-nine per cent returned to work once during follow-up. This probability was highest among males, those below 50 years, living with a partner, the highest educated, with higher occupations, having specific events (NSTEMI, and percutaneous coronary intervention) and with no co-morbidity. During five years follow-up, 43% retired due to disability or voluntary early pension. Female gender, low education, basic occupation, co-morbidity and having a severer event (invasive procedures) and receiving sickness benefits or being unemployed 30 days after admission were associated with increased probability of early retirement. Conclusion: About half of patients with first-time ACS stay in or return to work shortly after the event. Women, the socially disadvantaged, those with presumed severer events and co-morbidity have lower rates of return.	[Osler, Merete; Martensson, Solvej; Carlsen, Kathrine] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol Y, DK-2400 Copenhagen, Denmark; [Osler, Merete] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Osler, M (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	merete.osler@regionh.dk	Osler, Merete/AAF-7885-2019; Prescott, Eva/AAJ-7441-2020	Prescott, Eva/0000-0002-4134-0349; Osler, Merete/0000-0002-6921-220X	Danish Heart Association [1104-R83-A3441-22623]	Danish Heart Association	The study was funded by the Danish Heart Association (jr nr. 1104-R83-A3441-22623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; [Anonymous], 2006, IDA INT DAT LAB MARK; Boudrez H, 2000, ACTA CARDIOL, V55, P341, DOI 10.2143/AC.55.6.2005765; Hallberg V, 2009, SCAND CARDIOVASC J, V43, P277, DOI 10.1080/14017430802506601; Hamalainen H, 2004, EUR J PUBLIC HEALTH, V14, P350, DOI 10.1093/eurpub/14.4.350; Hjollund NH, 2007, SCAND J PUBLIC HEALT, V35, P497, DOI 10.1080/14034940701271882; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; MARK DB, 1992, CIRCULATION, V86, P1485, DOI 10.1161/01.CIR.86.5.1485; Mital Anil, 2004, J Cardiopulm Rehabil, V24, P365, DOI 10.1097/00008483-200411000-00001; Mittag O, 2001, SOC SCI MED, V52, P1441, DOI 10.1016/S0277-9536(00)00250-1; Nielsen FE, 2004, J CLIN EPIDEMIOL, V57, P837, DOI 10.1016/j.jclinepi.2003.12.022; Pedersen J, 2012, SCAND J WORK ENV HEA, V38, P516, DOI 10.5271/sjweh.3293; Perk J, 2004, SCAND J PUBLIC HEALT, V32, P181, DOI 10.1080/14034950410021880; Pinto Nigel, 2012, Asian Cardiovasc Thorac Ann, V20, P387, DOI 10.1177/0218492312437881; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Voss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040952	23	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86758	10.1371/journal.pone.0086758	http://dx.doi.org/10.1371/journal.pone.0086758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302PJ	24497976	gold, Green Submitted, Green Published			2022-12-27	WOS:000330617100030
J	Wang, XT; Dai, Y; Zhao, S; Tang, JX; Li, HJ; Xing, YT; Qu, GL; Li, XS; Dai, JR; Zhu, YC; Zhang, XG				Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Li, Hongjun; Xing, Yuntian; Qu, Guoli; Li, Xinsong; Dai, Jianrong; Zhu, Yinchang; Zhang, Xueguang			PAMAM-Lys, a Novel Vaccine Delivery Vector, Enhances the Protective Effects of the SjC23 DNA Vaccine against Schistosoma japonicum Infection	PLOS ONE			English	Article							PLASMID DNA; GENE DELIVERY; MOUSE MUSCLE; CHINA; EXPRESSION; PIGS; EXPERIENCES; PARAMYOSIN; CHALLENGE; DENDRIMER	Background: Schistosomiasis japonica remains a major public-health concern in China. Praziquantel-based chemotherapy effectively reduces both infections and intensity; however, it can not prevent re-infection. Furthermore, there is an increasing concern about praziquantel resistance following long-term repeated use of the drug in endemic areas. Therefore, development of a schistosomiasis vaccine, as a strategy to prevent and control schistosomiasis japonica, has been given high priority. The present study was conducted to develop PAMAM dendrimers as a novel vaccine delivery vector for a schistosomiasis japonica DNA vaccine and evaluate its ability to enhance protective effects against Schistosoma japonicum infection. Methodology/Principal Findings: Lysine was used to modify 4.0G PAMAM, and the modified product PAMAM-Lys was synthesized. PAMAM-Lys showed both high transfection and low cytotocity for gene delivery in vitro. DNA vaccines combined with PAMAM-Lys produced higher level of protection compare with naked DNA vaccines against S. japonicum infection in a mouse model. Futhermore, antibodies from mice immunized with PAMAM-Lys combined DNA vaccines were significantly higher than those of mice immunized with the naked DNA vaccines. The PAMAM-Lys vector elicited a predominantly IgG2a antibody response and a tremendously increase in the production of IL-2 and IFN-gamma. Conclusion/Significance: Lysine-modified PAMAM-Lys is an excellent vector. PAMAM-Lys may enhance the immunoreactivity of DNA vaccine and increase the protective effect of the SjC23 DNA vaccine against S. japonicum infection.	[Wang, Xiaoting; Zhang, Xueguang] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Clin Immunol,Med Coll, Jiangsu Stem Cell Key Lab,Inst Med Biotechnol, Suzhou, Peoples R China; [Wang, Xiaoting; Dai, Yang; Zhao, Song; Tang, Jianxia; Li, Hongjun; Xing, Yuntian; Qu, Guoli; Dai, Jianrong; Zhu, Yinchang] Jiangsu Prov Key Lab Mol Biol Parasites, Minist Hlth, Jiangsu Inst Parasit Dis, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China; [Li, Xinsong] Southeast Univ, Sch Chem & Chem Engn, Biomat & Drug Delivery Labs, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Southeast University - China	Zhu, YC (corresponding author), Jiangsu Prov Key Lab Mol Biol Parasites, Minist Hlth, Jiangsu Inst Parasit Dis, Key Lab Technol Parasit Dis Prevent & Control, Wuxi, Jiangsu, Peoples R China.	yczhu2006@aliyun.com; xueguangzh@126.com.cn	Wang, Xiaoting/AAI-3159-2020		National Program on Key Basic Research Project(973 Program) [2013CB530501]; Chinese National Natural Science Foundation of China [81000749, 81000748]; Jiangsu Provincial Nature Science Foundation [BK2010152]; Chinese Ministry of Health [LW201005]; Jiangsu Province's Outstanding Medical Academic Leader program [LJ201132]	National Program on Key Basic Research Project(973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Nature Science Foundation; Chinese Ministry of Health; Jiangsu Province's Outstanding Medical Academic Leader program	The study has been financially supported by the following grants: National Program on Key Basic Research Project(973 Program, Grant No. 2013CB530501); Chinese National Natural Science Foundation of China (No: 81000749 and 81000748); Jiangsu Provincial Nature Science Foundation (BK2010152); Scientific Research Project from Chinese Ministry of Health (LW201005); and Jiangsu Province's Outstanding Medical Academic Leader program (LJ201132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickle QD, 2001, VET PARASITOL, V100, P51, DOI 10.1016/S0304-4017(01)00483-6; Choi JS, 2004, J CONTROL RELEASE, V99, P445, DOI 10.1016/j.jconrel.2004.07.027; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dai Y, 2009, CLIN VACCINE IMMUNOL, V16, P1796, DOI 10.1128/CVI.00231-09; Dennig Jorg, 2002, J Biotechnol, V90, P339; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Eberl M, 2001, INFECT IMMUN, V69, P5352, DOI 10.1128/IAI.69.9.5352-5362.2001; Fenwick A, 2006, CURR OPIN INFECT DIS, V19, P577, DOI 10.1097/01.qco.0000247591.13671.6a; Gao Q, 2007, CHEM RES, V18, P41; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hao Yang, 2008, Chinese Journal of Schistosomiasis Control, V20, P401; Hogg KG, 2003, INFECT IMMUN, V71, P3563, DOI 10.1128/IAI.71.6.3563-3571.2003; Hu Y, 2007, EXP PARASITOL, V115, P379, DOI 10.1016/j.exppara.2006.09.022; Jain K, 2010, INT J PHARMACEUT, V394, P122, DOI 10.1016/j.ijpharm.2010.04.027; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Li CY, 2006, CELL MOL BIOL LETT, V11, P449, DOI 10.2478/s11658-006-0036-0; LIU SX, 1995, VACCINE, V13, P603, DOI 10.1016/0264-410X(94)00045-O; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McManus DP, 2000, INT J PARASITOL, V30, P265, DOI 10.1016/S0020-7519(99)00200-3; McManus DP, 1998, INT J PARASITOL, V28, P1739, DOI 10.1016/S0020-7519(98)00151-9; Ren JianGong, 2002, Chinese Journal of Schistosomiasis Control, V14, P98; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; SHI YE, 1990, EXP PARASITOL, V71, P100, DOI 10.1016/0014-4894(90)90012-2; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sun WY, 1999, PROTEIN EXPRES PURIF, V17, P410, DOI 10.1006/prep.1999.1140; Sun XL, 2010, MINI-REV MED CHEM, V10, P108, DOI 10.2174/138955710791185109; Taylor MG, 1998, VACCINE, V16, P1290, DOI 10.1016/S0264-410X(98)00055-3; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang Shi-Ping, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P402; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Zheng Hao, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P621; Zhou SH, 2000, VACCINE, V18, P3196, DOI 10.1016/S0264-410X(99)00555-1; Zhu Y, 2006, PARASITOLOGY, V132, P67, DOI 10.1017/S0031182005008644; Zhu YC, 2004, VACCINE, V23, P78, DOI 10.1016/j.vaccine.2004.04.031; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu Yinchang, 2002, Southeast Asian J Trop Med Public Health, V33, P207; Zhu Yingchang, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P697	41	11	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86578	10.1371/journal.pone.0086578	http://dx.doi.org/10.1371/journal.pone.0086578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497955	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100020
J	Acevedo, A; Aroca, G; Conejeros, R				Acevedo, Alejandro; Aroca, German; Conejeros, Raul			Genome-Scale NAD(H/(+)) Availability Patterns as a Differentiating Feature between Saccharomyces cerevisiae and Scheffersomyces stipitis in Relation to Fermentative Metabolism	PLOS ONE			English	Article							YEAST PICHIA-STIPITIS; OXYGEN AVAILABILITY; ETHANOL-PRODUCTION; NADH AVAILABILITY; ESCHERICHIA-COLI; RESPIRATION; XYLOSE; MODELS; RECONSTRUCTION; IDENTIFICATION	Scheffersomyces stipitis is a yeast able to ferment pentoses to ethanol, unlike Saccharomyces cerevisiae, it does not present the so-called overflow phenomenon. Metabolic features characterizing the presence or not of this phenomenon have not been fully elucidated. This work proposes that genome-scale metabolic response to variations in NAD(H/(+)) availability characterizes fermentative behavior in both yeasts. Thus, differentiating features in S. stipitis and S. cerevisiae were determined analyzing growth sensitivity response to changes in available reducing capacity in relation to ethanol production capacity and overall metabolic flux span. Using genome-scale constraint-based metabolic models, phenotypic phase planes and shadow price analyses, an excess of available reducing capacity for growth was found in S. cerevisiae at every metabolic phenotype where growth is limited by oxygen uptake, while in S. stipitis this was observed only for a subset of those phenotypes. Moreover, by using flux variability analysis, an increased metabolic flux span was found in S. cerevisiae at growth limited by oxygen uptake, while in S. stipitis flux span was invariant. Therefore, each yeast can be characterized by a significantly different metabolic response and flux span when growth is limited by oxygen uptake, both features suggesting a higher metabolic flexibility in S. cerevisiae. By applying an optimization-based approach on the genome-scale models, three single reaction deletions were found to generate in S. stipitis the reducing capacity availability pattern found in S. cerevisiae, two of them correspond to reactions involved in the overflow phenomenon. These results show a close relationship between the growth sensitivity response given by the metabolic network and fermentative behavior.	[Acevedo, Alejandro; Aroca, German; Conejeros, Raul] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Acevedo, Alejandro; Aroca, German; Conejeros, Raul] Barrio Univ, Bioenercel SA, Concepcion, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Concepcion	Conejeros, R (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile.	rconejer@ucv.cl	Conejeros, Raul/ABG-5517-2020; Conejeros, Raul/A-2466-2011; Aroca, German/ABG-6714-2020; Aroca, German/B-3798-2011	Conejeros, Raul/0000-0002-1273-535X; Aroca, German/0000-0003-1376-7940	CONICYT; PUCV [DI 037.424]; INNOVA CHILE Project Technological Consortium Bioenercel S.A. [208-7320]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); PUCV; INNOVA CHILE Project Technological Consortium Bioenercel S.A.	Financial support granted to A. Acevedo by CONICYT's Doctoral Scholarship is gratefully acknowledged. The authors would like to acknowledge the financial support of PUCV research grant DI 037.424 and the support of INNOVA CHILE Project 208-7320, Technological Consortium Bioenercel S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagurunathan B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-27; Berrios-Rivera SJ, 2002, METAB ENG, V4, P217, DOI 10.1006/mben.2002.0227; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Diano A, 2006, BIOTECHNOL BIOENG, V94, P899, DOI 10.1002/bit.20915; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Freese S, 2011, YEAST, V28, P309, DOI 10.1002/yea.1840; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; FURLAN SA, 1994, PROCESS BIOCHEM, V29, P657, DOI 10.1016/0032-9592(94)80043-X; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027316; Goldemberg J, 2007, SCIENCE, V315, P808, DOI 10.1126/science.1137013; Gombert AK, 2001, J BACTERIOL, V183, P1441, DOI 10.1128/JB.183.4.1441-1451.2001; Hanly TJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-44; Hanly TJ, 2013, BIOTECHNOL BIOENG, DOI 101002/bit25101; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hou J, 2010, APPL ENVIRON MICROB, V76, P851, DOI 10.1128/AEM.02040-09; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Jeffries TW, 2009, FEMS YEAST RES, V9, P793, DOI 10.1111/j.1567-1364.2009.00525.x; Laluce C, 2012, APPL BIOCHEM BIOTECH, V166, P1908, DOI 10.1007/s12010-012-9619-6; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; Passoth V, 1996, APPL BIOCHEM BIOTECH, V57-8, P201, DOI 10.1007/BF02941701; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reznik E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003195; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Silva JPA, 2010, APPL BIOCHEM BIOTECH, V162, P1306, DOI 10.1007/s12010-009-8867-6; SKOOG K, 1990, APPL ENVIRON MICROB, V56, P3389, DOI 10.1128/AEM.56.11.3389-3394.1990; SKOOG K, 1992, APPL BIOCHEM BIOTECH, V34-5, P369, DOI 10.1007/BF02920560; SONNLEITNER B, 1986, BIOTECHNOL BIOENG, V28, P927, DOI 10.1002/bit.260280620; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Unrean P, 2012, APPL MICROBIOL BIOT, V94, P1387, DOI 10.1007/s00253-012-4059-3; VARMA A, 1993, J THEOR BIOL, V165, P477, DOI 10.1006/jtbi.1993.1202; Veiga A, 2003, FEMS YEAST RES, V3, P239, DOI 10.1016/S1567-1356(03)00036-9; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; Wang Y, 2013, CURRENT OPI IN PRESS	47	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87494	10.1371/journal.pone.0087494	http://dx.doi.org/10.1371/journal.pone.0087494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489927	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000153
J	Bomtorin, AD; Mackert, A; Rosa, GCC; Moda, LM; Martins, JR; Bitondi, MMG; Hartfelder, K; Simoes, ZLP				Bomtorin, Ana Durvalina; Mackert, Aline; Couto Rosa, Gustavo Conrado; Moda, Livia Maria; Martins, Juliana Ramos; Gentile Bitondi, Marcia Maria; Hartfelder, Klaus; Paulino Simoes, Zila Luz			Juvenile Hormone Biosynthesis Gene Expression in the corpora allata of Honey Bee (Apis mellifera L.) Female Castes	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEHAVIORAL-DEVELOPMENT; METHYL FARNESOATE; HEMOLYMPH TITERS; VITELLOGENIN; WORKER; METHYLTRANSFERASE; LIFE; PRECURSOR; ESTERASE	Juvenile hormone (JH) controls key events in the honey bee life cycle, viz. caste development and age polyethism. We quantified transcript abundance of 24 genes involved in the JH biosynthetic pathway in the corpora allata-corpora cardiaca (CA-CC) complex. The expression of six of these genes showing relatively high transcript abundance was contrasted with CA size, hemolymph JH titer, as well as JH degradation rates and JH esterase (jhe) transcript levels. Gene expression did not match the contrasting JH titers in queen and worker fourth instar larvae, but jhe transcript abundance and JH degradation rates were significantly lower in queen larvae. Consequently, transcriptional control of JHE is of importance in regulating larval JH titers and caste development. In contrast, the same analyses applied to adult worker bees allowed us inferring that the high JH levels in foragers are due to increased JH synthesis. Upon RNAi-mediated silencing of the methyl farnesoate epoxidase gene (mfe) encoding the enzyme that catalyzes methyl farnesoate-to-JH conversion, the JH titer was decreased, thus corroborating that JH titer regulation in adult honey bees depends on this final JH biosynthesis step. The molecular pathway differences underlying JH titer regulation in larval caste development versus adult age polyethism lead us to propose that mfe and jhe genes be assayed when addressing questions on the role(s) of JH in social evolution.	[Bomtorin, Ana Durvalina; Mackert, Aline; Moda, Livia Maria; Martins, Juliana Ramos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Mackert, Aline] Univ Fed Mato Grosso do Sul, Dept Ciencias Ambiente, Corumba, Brazil; [Couto Rosa, Gustavo Conrado; Gentile Bitondi, Marcia Maria; Paulino Simoes, Zila Luz] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, Brazil; [Hartfelder, Klaus] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol Bioagentes Patogen, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo	Simoes, ZLP (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, Brazil.	zlpsimoe@usp.br	Hartfelder, Klaus/L-2300-2019; Martins, Juliana Ramos/AAD-4694-2021; Moda, Livia M/I-6451-2012; Martins, Juliana Ramos/F-6726-2012; Hartfelder, Klaus/A-4293-2009; Bomtorin, Ana/I-8817-2012; Simoes, Zila Luz Paulino/H-7314-2014; Bitondi, Marcia MG/E-8014-2012	Hartfelder, Klaus/0000-0001-7981-8427; Martins, Juliana Ramos/0000-0002-7185-6477; Moda, Livia M/0000-0001-6381-7788; Hartfelder, Klaus/0000-0001-7981-8427; Bomtorin, Ana/0000-0002-3331-7843; Bitondi, Marcia MG/0000-0002-5619-6378; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [05/03926-5, 11/03171-5, 09/05675-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [research grant numbers 05/03926-5, 11/03171-5], which also provided a fellowship [09/05675-0] to ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2005, INSECT SOC, V52, P316, DOI 10.1007/s00040-005-0812-2; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Bitondi MMG, 2006, J APICULT RES, V35, P27; Burtenshaw SM, 2008, PEPTIDES, V29, P242, DOI 10.1016/j.peptides.2007.10.030; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Cusson M, 2006, PROTEINS, V65, P742, DOI 10.1002/prot.21057; de Sousa CS, 2013, GENET MOL BIOL, V36, P292, DOI [10.1590/S1415-47572013000200022, 10.1590/s1415-47572013000200022]; Denlinger D.L., 2012, INSECT ENDOCRINOLOGY, P430, DOI DOI 10.1016/B978-0-12-384749-2.10010-X; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; GOODMAN WG, 1990, INSECT BIOCHEM, V20, P357, DOI 10.1016/0020-1790(90)90055-Y; GRANGER NA, 1979, MOL CELL ENDOCRINOL, V16, P1, DOI 10.1016/0303-7207(79)90002-9; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hartfelder K., 2012, INSECT ENDOCRINOLOGY, P464, DOI [10.1016/B978-0-12-384749-2.10011-1, DOI 10.1016/B978-0-12-384749-2.10011-1]; Hartfelder K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.06; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; LAUFER H, 1987, INSECT BIOCHEM, V17, P1129, DOI 10.1016/0020-1790(87)90134-X; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; Mackert A, 2010, J INSECT PHYSIOL, V56, P1139, DOI 10.1016/j.jinsphys.2010.03.007; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Antonio DSM, 2008, NATURWISSENSCHAFTEN, V95, P953, DOI 10.1007/s00114-008-0413-9; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nijhout H.F., 1994, INSECT HORMONES; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; RACHINSKY A, 1990, J INSECT PHYSIOL, V36, P189, DOI 10.1016/0022-1910(90)90121-U; RACHINSKY A, 1990, GEN COMP ENDOCR, V79, P31, DOI 10.1016/0016-6480(90)90085-Z; RACHINSKY A, 1991, NATURWISSENSCHAFTEN, V78, P270, DOI 10.1007/BF01134355; Rachinsky A, 2000, INSECT BIOCHEM MOLEC, V30, P729, DOI 10.1016/S0965-1748(00)00044-8; Rachinsky A, 2000, J INSECT PHYSIOL, V46, P41, DOI 10.1016/S0022-1910(99)00100-6; REMBOLD H, 1987, INSECT BIOCHEM, V17, P1003, DOI 10.1016/0020-1790(87)90110-7; ROBINSON GE, 1991, J INSECT PHYSIOL, V37, P929, DOI 10.1016/0022-1910(91)90008-N; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; SHARE MR, 1988, ANAL BIOCHEM, V169, P81, DOI 10.1016/0003-2697(88)90257-6; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Ueda H, 2009, J INSECT PHYSIOL, V55, P798, DOI 10.1016/j.jinsphys.2009.04.013; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston M.L., 1987, P1	59	47	48	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86923	10.1371/journal.pone.0086923	http://dx.doi.org/10.1371/journal.pone.0086923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489805	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000080
J	Cailotto, C; Gomez-Pinilla, PJ; Costes, LM; van der Vliet, J; Di Giovangiulio, M; Nemethova, A; Matteoli, G; Boeckxstaens, GE				Cailotto, Cathy; Gomez-Pinilla, Pedro J.; Costes, Lea M.; van der Vliet, Jan; Di Giovangiulio, Martina; Nemethova, Andrea; Matteoli, Gianluca; Boeckxstaens, Guy E.			Neuro-Anatomical Evidence Indicating Indirect Modulation of Macrophages by Vagal Efferents in the Intestine but Not in the Spleen	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGUS NERVE; GASTROINTESTINAL-TRACT; KAPPA-B; STIMULATION; RAT; INNERVATION; ACTIVATION; ANTIBODIES; MOUSE	Background: Electrical stimulation of the vagus nerve suppresses intestinal inflammation and normalizes gut motility in a mouse model of postoperative ileus. The exact anatomical interaction between the vagus nerve and the intestinal immune system remains however a matter of debate. In the present study, we provide additional evidence on the direct and indirect vagal innervation of the spleen and analyzed the anatomical evidence for neuroimmune modulation of macrophages by vagal preganglionic and enteric postganglionic nerve fibers within the intestine. Methods: Dextran conjugates were used to label vagal preganglionic (motor) fibers projecting to the small intestine and spleen. Moreover, identification of the neurochemical phenotype of the vagal efferent fibers and enteric neurons was performed by immunofluorescent labeling. F4/80 antibody was used to label resident macrophages. Results: Our anterograde tracing experiments did not reveal dextran-labeled vagal fibers or terminals in the mesenteric ganglion or spleen. Vagal efferent fibers were confined within the myenteric plexus region of the small intestine and mainly endings around nNOS, VIP and ChAT positive enteric neurons. nNOS, VIP and ChAT positive fibers were found in close proximity of intestinal resident macrophages carrying alpha 7 nicotinic receptors. Of note, VIP receptors were found on resident macrophages located in close proximity of VIP positive nerve fibers. Conclusion: In the present study, we show that the vagus nerve does not directly interact with resident macrophages in the gut or spleen. Instead, the vagus nerve preferentially interacts with nNOS, VIP and ChAT enteric neurons located within the gut muscularis with nerve endings in close proximity of the resident macrophages.	[Cailotto, Cathy; Costes, Lea M.; van der Vliet, Jan] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Gomez-Pinilla, Pedro J.; Di Giovangiulio, Martina; Nemethova, Andrea; Matteoli, Gianluca; Boeckxstaens, Guy E.] Catholic Univ Louvain, Dept Gastroenterol, Univ Hosp Leuven, B-3000 Louvain, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	Cailotto, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.cailotto@amc.uva.nl	Boeckxstaens, Guy/AAP-2502-2020	Matteoli, Gianluca/0000-0002-2902-4976; Di Giovangiulio, Martina/0000-0003-3004-578X	Research Foundation - Flanders (FWO) (Odysseus program); FWO; FWO Ph.D. fellowship; European Union 7th Framework Program; Netherlands Organization for Scientific Research (NWO Vici grant) [918-76 623]; Maag Lever Darm Stichting [W09-30]	Research Foundation - Flanders (FWO) (Odysseus program)(FWO); FWO(FWO); FWO Ph.D. fellowship(FWO); European Union 7th Framework Program(European Commission); Netherlands Organization for Scientific Research (NWO Vici grant)(Netherlands Organization for Scientific Research (NWO)); Maag Lever Darm Stichting	This work was supported by grants from the Research Foundation - Flanders (FWO) (Odysseus program to G.E.B.), by a FWO postdoctoral research fellowship (to G.M. and P.J.G.), and by FWO Ph.D. fellowship (to M.D.G.). This work was partly supported by grant from the European Union 7th Framework Program (to A.N.), by the Netherlands Organization for Scientific Research (NWO Vici grant 918-76 623), and by the Maag Lever Darm Stichting (W09-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Berthoud HR, 1996, MICROSC RES TECHNIQ, V35, P80, DOI 10.1002/(SICI)1097-0029(19960901)35:1<80::AID-JEMT7>3.0.CO;2-W; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Cailotto C, 2012, NEUROGASTROENT MOTIL, V24, P191, DOI 10.1111/j.1365-2982.2011.01824.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Delgado M, 1999, J IMMUNOL, V162, P4685; Delgado M, 1999, J IMMUNOL, V162, P1707; Gautron L, 2013, J COMP NEUROL, V521, P3741, DOI 10.1002/cne.23376; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG560, DOI 10.1152/ajpgi.00098.2007; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Lanciego JL, 2000, J NEUROSCI METH, V103, P127, DOI 10.1016/S0165-0270(00)00302-2; Maouche K, 2013, P NATL ACAD SCI USA, V110, P4099, DOI 10.1073/pnas.1216939110; Matteoli G, 2013, DISTINCT VAGAL ANTII; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; RAJAKUMAR N, 1992, ANAT EMBRYOL, V185, P25, DOI 10.1007/BF00213598; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; Tsuchida Y, 2011, GUT, V60, P638, DOI 10.1136/gut.2010.227546; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Walter GC, 2009, J NEUROSCI METH, V178, P1, DOI 10.1016/j.jneumeth.2008.11.003; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x	33	78	79	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87785	10.1371/journal.pone.0087785	http://dx.doi.org/10.1371/journal.pone.0087785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489965	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000181
J	Koh, YW; Park, CS; Yoon, DH; Suh, C; Huh, J				Koh, Young Wha; Park, Chan-Sik; Yoon, Dok Hyun; Suh, Cheolwon; Huh, Jooryung			CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; EPSTEIN-BARR-VIRUS; CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; CHI-SQUARE STATISTICS; ADVANCED-STAGE; FACTOR VEGF; INFILTRATING MACROPHAGES; ANTIANGIOGENIC THERAPY	Background: Recent studies have reported the prognostic value of tissue-associated magrophages (TAMs) in classical Hodgkin lymphoma (cHL). In addition, TAMs are implicated in the tumor angiogenesis. In this study, we examined the prognostic relevance of TAMs in relation to vascular endothelial growth factor (VEGF) expression and angiogenesis in uniformly treated cases of cHL. Methods: Diagnostic tissue from 116 patients with ABVD-treated cHL was evaluated retrospectively by immunohistochemical analysis for CD68, CD163 and VEGF expression and for CD31 expression as a measure of microvessel density (MVD). Results: High CD163 expression (>= 35% of cellularity) correlated with VEGF expression (Pearson's Chi-square test, P = 0.008) and MVD (Spearman correlation coefficient 0.310, P<0.001). High CD163 expression was associated with inferior event-free survival (EFS, P = 0.005) and overall survival (OS, P<0.001) in univariate analysis. In multivariate analysis, high CD163 expression was strongly associated with inferior EFS (P = 0.043) and OS (P = 0.008). Patients with high MVD had a lower OS than those with low MVD, but the difference was not significant (P = 0.071, respectively). While high expression of CD68 was also associated with inferior EFS (P = 0.007), it showed no correlation with VEGF or MVD. Conclusions: Our data confirms that CD163 expression provides independent prognostic information in cHL. The correlation of CD163 with VEGF expression and MVD suggests the role of CD163-positive cells in tumor angiogenesis of cHL.	[Koh, Young Wha] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Pathol, Ulsan 680749, South Korea; [Park, Chan-Sik; Huh, Jooryung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Yoon, Dok Hyun; Suh, Cheolwon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Huh, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	jrhuh@amc.seoul.kr			Asan Institute for Life Sciences, Seoul, Korea [2011-090]	Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant (2011-090) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RH, 2012, LEUKEMIA LYMPHOMA, V53, P718, DOI 10.3109/10428194.2011.623256; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Casulo C, 2013, LEUKEMIA RES, V37, P1178, DOI 10.1016/j.leukres.2013.03.021; Chen JJW, 2003, CLIN CANCER RES, V9, P729; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Doussis-Anagnostopoulou IA, 2002, J PATHOL, V197, P677, DOI 10.1002/path.1151; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; Enblad G, 1999, ACTA ONCOL, V38, P425, DOI 10.1080/028418699431942; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gratzinger D, 2007, AM J PATHOL, V170, P1362, DOI 10.2353/ajpath.2007.060901; Greaves P, 2013, J CLIN ONCOL, V31, P256, DOI 10.1200/JCO.2011.39.9881; Guzman-Medrano R, 2012, PATHOL RES PRACT, V208, P672, DOI 10.1016/j.prp.2012.09.001; Habermann TM, 2013, CONNS CURRENT THERAP, P810; HALPERN J, 1982, BIOMETRICS, V38, P1017, DOI 10.2307/2529882; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Huh J, 1999, AM J HEMATOL, V60, P205, DOI 10.1002/(SICI)1096-8652(199903)60:3<205::AID-AJH7>3.0.CO;2-J; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishigami SI, 1998, BRIT J CANCER, V78, P1379, DOI 10.1038/bjc.1998.688; Jakovic LR, 2012, ONKOLOGIE, V35, P733, DOI 10.1159/000343664; Jakovic LR, 2011, LEUKEMIA LYMPHOMA, V52, P1913, DOI 10.3109/10428194.2011.580026; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koh YW, 2012, ANN HEMATOL, V91, P1403, DOI 10.1007/s00277-012-1464-8; Koh YW, 2012, ONCOLOGIST, V17, P871, DOI 10.1634/theoncologist.2012-0034; Korkolopoulou P, 2005, LEUKEMIA, V19, P894, DOI 10.1038/sj.leu.2403690; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; Mainou-Fowler T, 2006, LEUKEMIA LYMPHOMA, V47, P223, DOI 10.1080/01674820500305838; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ohri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021874; Panico L, 2013, LEUKEMIA LYMPHOMA, V54, P2418, DOI 10.3109/10428194.2013.778405; Passam FH, 2009, PATHOL RES PRACT, V205, P11, DOI 10.1016/j.prp.2008.07.007; Porrata LF, 2012, HAEMATOL-HEMATOL J, V97, P262, DOI 10.3324/haematol.2011.050138; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Quddus F, 2009, CANCER J, V15, P161, DOI 10.1097/PPO.0b013e3181a1438a; Reiners KS, 2009, J IMMUNOTHER, V32, P508, DOI 10.1097/CJI.0b013e3181a25daf; Ruan J, 2009, ANN ONCOL, V20, P413, DOI 10.1093/annonc/mdn666; Ruan J, 2006, CLIN CANCER RES, V12, P5622, DOI 10.1158/1078-0432.CCR-06-1204; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Schmidt T, 2010, NATURE, V465, P697, DOI 10.1038/465697a; Shieh YS, 2009, ANN SURG ONCOL, V16, P751, DOI 10.1245/s10434-008-0259-6; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stopeck AT, 2012, BLOOD, V120, P1210, DOI 10.1182/blood-2012-04-423079; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Torroella-Kouri M, 2009, CANCER RES, V69, P4800, DOI 10.1158/0008-5472.CAN-08-3427; Uchida S, 1998, BRIT J CANCER, V77, P1704, DOI 10.1038/bjc.1998.281; Watkins SK, 2009, EUR J IMMUNOL, V39, P2126, DOI 10.1002/eji.200839010; WEIDNER N, 1993, AM J PATHOL, V143, P401; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Won YW, 2012, ANN HEMATOL, V91, P223, DOI 10.1007/s00277-011-1297-x; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yahalom Joachim, 2006, J Natl Compr Canc Netw, V4, P233; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8	67	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87066	10.1371/journal.pone.0087066	http://dx.doi.org/10.1371/journal.pone.0087066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489836	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000096
J	Koido, S; Ohkusa, T; Kajiura, T; Shinozaki, J; Suzuki, M; Saito, K; Takakura, K; Tsukinaga, S; Odahara, S; Yukawa, T; Mitobe, J; Kajihara, M; Uchiyama, K; Arakawa, H; Tajiri, H				Koido, Shigeo; Ohkusa, Toshifumi; Kajiura, Takayuki; Shinozaki, Junko; Suzuki, Manabu; Saito, Keisuke; Takakura, Kazuki; Tsukinaga, Shintaro; Odahara, Shunichi; Yukawa, Toyokazu; Mitobe, Jimi; Kajihara, Mikio; Uchiyama, Kan; Arakawa, Hiroshi; Tajiri, Hisao			Long-Term Alteration of Intestinal Microbiota in Patients with Ulcerative Colitis by Antibiotic Combination Therapy	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; COLONIC-MUCOSA; PHYLOGENETIC ANALYSIS; BACTERIA; ETIOPATHOGENESIS; DISEASE	Previous work has demonstrated that intestinal bacteria, such as Fusobacterium varium (F. varium), contribute to the clinical activity in ulcerative colitis (UC); thus, an antibiotic combination therapy (amoxicillin, tetracycline, and metronidazole (ATM)) against F. varium can induce and maintain UC remission. Therefore, we investigated whether ATM therapy induces a long-term alteration of intestinal microbiota in patients with UC. Patients with UC were enrolled in a multicenter, randomized, double-blind, placebo-controlled study. Biopsy samples at the beginning of the trial and again at 3 months after treatment completion were randomly obtained from 20 patients. The terminal restriction fragment length polymorphism (T-RFLP) in mucosa-associated bacterial components was examined to assess the alteration of the intestinal microbiota. Profile changes of T-RFLP in mucosa-associated bacterial components were found in 10 of 12 patients in the treatment group and in none of 8 in the placebo group. Dice similarity coefficients using the unweighted pair group method with arithmetic averages (Dice-UPGMA) confirmed that the similarity of mucosal microbiota from the descending colon was significantly decreased after the ATM therapy, and this change was maintained for at least 3 months. Moreover, at 3 months after treatment completion, the F. varium/beta-actin ratio, examined by real-time PCR using nested PCR products from biopsy samples, was reduced less than 40% in 8 of 12 treated patients, which was higher, but not significantly, than in 4 of 8 patients in the placebo group. Together, these results suggest that ATM therapy induces long-term alterations in the intestinal microbiota of patients with UC, which may be associated, at least in part, with clinical effects of the therapy.	[Koido, Shigeo; Ohkusa, Toshifumi; Saito, Keisuke; Takakura, Kazuki; Tsukinaga, Shintaro; Odahara, Shunichi; Yukawa, Toyokazu; Mitobe, Jimi; Kajihara, Mikio; Uchiyama, Kan; Arakawa, Hiroshi; Tajiri, Hisao] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Kajiura, Takayuki; Shinozaki, Junko] Ajinomoto Co Inc, Frontier Res Labs, Inst Innovat, Kawasaki, Kanagawa, Japan; [Kajiura, Takayuki; Shinozaki, Junko; Suzuki, Manabu] Ajinomoto Co Inc, Pharmaceut Labs, Kawasaki, Kanagawa, Japan	Jikei University; Ajinomoto Co Inc; Ajinomoto Co Inc	Ohkusa, T (corresponding author), Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan.	ohkusa@jikei.ac.jp	大草, 敏史/HGD-2376-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AJG, 2004, GUT, V53, P1801, DOI 10.1136/gut.2003.026807; Clement BG, 2000, BIOTECHNIQUES, V28, P640, DOI 10.2144/00284bm06; COLLINS MD, 1991, INT J SYST BACTERIOL, V41, P240, DOI 10.1099/00207713-41-2-240; Danese S, 2006, WORLD J GASTROENTERO, V12, P4807; Felliet H, 2004, CURR OPIN GASTROEN, V20, P560; Furrie E, 2004, GUT, V53, P91, DOI 10.1136/gut.53.1.91; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Imler J L, 2000, Rev Immunogenet, V2, P294; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; MATTS SG, 1961, Q J MED, V30, P393; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Nomura T, 2005, ALIMENT PHARM THER, V21, P1017, DOI 10.1111/j.1365-2036.2005.02428.x; Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Ohkusa T, 2010, AM J GASTROENTEROL, V105, P1820, DOI 10.1038/ajg.2010.84; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Okayasu I, 2012, PATHOL INT, V62, P368, DOI 10.1111/j.1440-1827.2012.02807.x; Oliva-Hemker M, 2002, INFLAMM BOWEL DIS, V8, P112, DOI 10.1097/00054725-200203000-00008; Sartor RB, 2001, CURR OPIN GASTROEN, V17, P324, DOI 10.1097/00001574-200107000-00005; Scheidegger EMD, 2009, MEM I OSWALDO CRUZ, V104, P1003, DOI 10.1590/S0074-02762009000700011; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang RF, 1996, APPL ENVIRON MICROB, V62, P1242, DOI 10.1128/AEM.62.4.1242-1247.1996; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	26	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86702	10.1371/journal.pone.0086702	http://dx.doi.org/10.1371/journal.pone.0086702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489770	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000061
J	Kung, D; Bigler, L; Davis, LR; Gratwicke, B; Griffith, E; Woodhams, DC				Kueng, Denise; Bigler, Laurent; Davis, Leyla R.; Gratwicke, Brian; Griffith, Edgardo; Woodhams, Douglas C.			Stability of Microbiota Facilitated by Host Immune Regulation: Informing Probiotic Strategies to Manage Amphibian Disease	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; ANTIMICROBIAL PEPTIDES; POPULATION DECLINES; CUTANEOUS BACTERIA; GUT MICROBIOTA; SKIN PEPTIDES; T-RFLP; CHYTRIDIOMYCOSIS; ECOLOGY; COMMUNITIES	Microbial communities can augment host immune responses and probiotic therapies are under development to prevent or treat diseases of humans, crops, livestock, and wildlife including an emerging fungal disease of amphibians, chytridiomycosis. However, little is known about the stability of host-associated microbiota, or how the microbiota is structured by innate immune factors including antimicrobial peptides (AMPs) abundant in the skin secretions of many amphibians. Thus, conservation medicine including therapies targeting the skin will benefit from investigations of amphibian microbial ecology that provide a model for vertebrate host-symbiont interactions on mucosal surfaces. Here, we tested whether the cutaneous microbiota of Panamanian rocket frogs, Colostethus panamansis, was resistant to colonization or altered by treatment. Under semi-natural outdoor mesocosm conditions in Panama, we exposed frogs to one of three treatments including: (1) probiotic - the potentially beneficial bacterium Lysinibacillus fusiformis, (2) transplant - skin washes from the chytridiomycosis-resistant glass frog Espadarana prosoblepon, and (3) control - sterile water. Microbial assemblages were analyzed by a culture-independent T-RFLP analysis. We found that skin microbiota of C. panamansis was resistant to colonization and did not differ among treatments, but shifted through time in the mesocosms. We describe regulation of host AMPs that may function to maintain microbial community stability. Colonization resistance was metabolically costly and microbe-treated frogs lost 7-12% of body mass. The discovery of strong colonization resistance of skin microbiota suggests a well-regulated, rather than dynamic, host-symbiont relationship, and suggests that probiotic therapies aiming to enhance host immunity may require an approach that circumvents host mechanisms maintaining equilibrium in microbial communities.	[Kueng, Denise; Davis, Leyla R.; Woodhams, Douglas C.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, Zurich, Switzerland; [Gratwicke, Brian] Smithsonian Inst, Natl Zool Pk, Ctr Species Survival Conservat & Sci, Washington, DC 20008 USA; [Griffith, Edgardo] El Valle Amphibian Conservat Ctr, El Valle, Panama; [Woodhams, Douglas C.] Smithsonian Trop Res Inst, Panama City, Panama	University of Zurich; University of Zurich; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian Tropical Research Institute	Woodhams, DC (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	dwoodhams@gmail.com	Bigler, Laurent/AAP-3799-2020; Woodhams, Douglas/B-1962-2012	Bigler, Laurent/0000-0003-3548-3594; Woodhams, Douglas/0000-0003-4559-1046; Gratwicke, Brian/0000-0002-7332-4060	Swiss National Science Foundation [31-125099]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided through Swiss National Science Foundation grant 31-125099 to D. C. W. and fieldwork was supported by SCNAT (Akademie der Naturwissenschaften Schweiz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Apponyi MA, 2004, PEPTIDES, V25, P1035, DOI 10.1016/j.peptides.2004.03.006; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; CHAN RCY, 1985, INFECT IMMUN, V47, P84, DOI 10.1128/IAI.47.1.84-89.1985; Chinchar VG, 2001, VIROLOGY, V288, P351, DOI 10.1006/viro.2001.1080; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; DALY JW, 1994, TOXICON, V32, P279, DOI 10.1016/0041-0101(94)90081-7; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Fierer N, 2012, ANNU REV ECOL EVOL S, V43, P137, DOI 10.1146/annurev-ecolsys-110411-160307; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Flechas SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044832; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hartmann M, 2005, J MICROBIOL METH, V61, P349, DOI 10.1016/j.mimet.2004.12.011; Hartmann M, 2008, FEMS MICROBIOL ECOL, V63, P249, DOI 10.1111/j.1574-6941.2007.00427.x; Hartmann M, 2006, APPL ENVIRON MICROB, V72, P7804, DOI 10.1128/AEM.01464-06; Irianto A, 2002, J FISH DIS, V25, P633, DOI 10.1046/j.1365-2761.2002.00422.x; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kelly CP, 2013, NEW ENGL J MED, V368, P474, DOI 10.1056/NEJMe1214816; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Matutte B, 2000, FEBS LETT, V483, P135, DOI 10.1016/S0014-5793(00)02102-5; MCCLANAH.L, 1969, COMP BIOCHEM PHYSIOL, V28, P381, DOI 10.1016/0010-406X(69)91351-6; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Miele R, 1998, FEBS LETT, V431, P23, DOI 10.1016/S0014-5793(98)00718-2; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Pask JD, 2012, GLOBAL CHANGE BIOL, V18, P1231, DOI 10.1111/j.1365-2486.2011.02622.x; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reid G, 2011, NAT REV MICROBIOL, V9, P27, DOI 10.1038/nrmicro2473; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Rollins-Smith L. A., 2012, ECOIMMUNOLOGY, P92; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rosenberg E, 2011, BIRTH DEFECTS RES C, V93, P56, DOI 10.1002/bdrc.20196; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schadich Ermin, 2009, Australasian Journal of Ecotoxicology, V15, P17; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Simmaco M, 1997, FEBS LETT, V416, P273, DOI 10.1016/S0014-5793(97)01216-7; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Taylor Sharon K., 2001, P159; Tennessen JA, 2009, DEV COMP IMMUNOL, V33, P1247, DOI 10.1016/j.dci.2009.07.004; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vredenburg V.T., 2011, FUNGAL DIS EMERGING, P342; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Wang J, 2010, TOXICON, V56, P640, DOI 10.1016/j.toxicon.2010.05.011; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Widmer F, 2006, APPL SOIL ECOL, V33, P294, DOI 10.1016/j.apsoil.2005.09.007; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-197; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Woodhams DC, 2008, ECOHEALTH, V5, P268, DOI 10.1007/s10393-008-0190-0; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	85	50	51	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87101	10.1371/journal.pone.0087101	http://dx.doi.org/10.1371/journal.pone.0087101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489847	Green Published, gold, Green Accepted			2022-12-27	WOS:000330570000103
J	Lara-Romero, C; Robledo-Arnuncio, JJ; Garcia-Fernandez, A; Iriondo, JM				Lara-Romero, Carlos; Robledo-Arnuncio, Juan J.; Garcia-Fernandez, Alfredo; Iriondo, Jose M.			Assessing Intraspecific Variation in Effective Dispersal Along an Altitudinal Gradient: A Test in Two Mediterranean High-Mountain Plants	PLOS ONE			English	Article							MODELING SEED DISPERSAL; ARMERIA-CAESPITOSA; PINUS-SYLVESTRIS; GENE FLOW; RECRUITMENT LIMITATION; REPRODUCTIVE SUCCESS; TEMPERATE FOREST; LOCAL ADAPTATION; POLLEN DISPERSAL; CLIMATE	Background: Plant recruitment depends among other factors on environmental conditions and their variation at different spatial scales. Characterizing dispersal in contrasting environments may thus be necessary to understand natural intraspecific variation in the processes underlying recruitment. Silene ciliata and Armeria caespitosa are two representative species of cryophilic pastures above the tree line in Mediterranean high mountains. No explicit estimations of dispersal kernels have been made so far for these or other high-mountain plants. Such data could help to predict their dispersal and recruitment patterns in a context of changing environments under ongoing global warming. Methods: We used an inverse modelling approach to analyse effective seed dispersal patterns in five populations of both Silene ciliata and Armeria caespitosa along an altitudinal gradient in Sierra de Guadarrama (Madrid, Spain). We considered four commonly employed two-dimensional seedling dispersal kernels exponential-power, 2Dt, WALD and log-normal. Key Results: No single kernel function provided the best fit across all populations, although estimated mean dispersal distances were short (<1 m) in all cases. S. ciliata did not exhibit significant among-population variation in mean dispersal distance, whereas significant differences in mean dispersal distance were found in A. caespitosa. Both S. ciliata and A. caespitosa exhibited among-population variation in the fecundity parameter and lacked significant variation in kernel shape. Conclusions: This study illustrates the complexity of intraspecific variation in the processes underlying recruitment, showing that effective dispersal kernels can remain relatively invariant across populations within particular species, even if there are strong variations in demographic structure and/or physical environment among populations, while the invariant dispersal assumption may not hold for other species in the same environment. Our results call for a case-by-case analysis in a wider range of plant taxa and environments to assess the prevalence and magnitude of intraspecific dispersal variation.	[Lara-Romero, Carlos; Garcia-Fernandez, Alfredo; Iriondo, Jose M.] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain; [Robledo-Arnuncio, Juan J.] INIA CIFOR, Dept Ecol & Forest Genet, Madrid, Spain; [Garcia-Fernandez, Alfredo] IBB CSIC IQUB, Inst Bot Barcelona, Barcelona, Spain	Universidad Rey Juan Carlos; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB)	Lara-Romero, C (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain.	carlos.lara.romero@gmail.com	Romero, Carlos Lara/E-5549-2012; Garcia, Alfredo/I-2772-2015; Iriondo, Jose M./B-3112-2008; Robledo-Arnuncio, Juan/G-6792-2012; García-Fernández, Alfredo/AAE-2520-2022	Romero, Carlos Lara/0000-0003-0962-0567; Garcia, Alfredo/0000-0002-5185-559X; Iriondo, Jose M./0000-0003-2710-3889; Robledo-Arnuncio, Juan/0000-0002-3909-8928; García-Fernández, Alfredo/0000-0002-7672-9872	Spanish Ministry of Science and Innovation [ISLAS-CGL2009-13190-C03-01, LIMITES-CGL2009-07229]; Spanish Ministry of Economy and Competitiveness [AdAptA-CGL2012-33528, CGL2009-09428]; Government of Autonomous Region of Madrid; F. P. I. fellowship (Spanish Ministry of Science);  [CGL2010-22234-C02/BOS]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Autonomous Region of Madrid; F. P. I. fellowship (Spanish Ministry of Science); 	This work was supported by the Spanish Ministry of Science and Innovation (http://micinn.es): ISLAS-CGL2009-13190-C03-01 and LIMITES-CGL2009-07229; the Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es): AdAptA-CGL2012-33528; and the Government of Autonomous Region of Madrid (http://madrid.org): REMEDINAL2. CLR and AG were supported by a F. P. I. fellowship (Spanish Ministry of Science). AG is also supported by a postdoctoral contract (CGL2010-22234-C02/BOS). JJRA was supported by CGL2009-09428 project from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Blanquart F, 2012, J EVOLUTION BIOL, V25, P1351, DOI 10.1111/j.1420-9101.2012.02524.x; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Caspersen JP, 2005, CAN J FOREST RES, V35, P978, DOI 10.1139/X05-024; Castro J, 2005, PLANT ECOL, V181, P191, DOI 10.1007/s11258-005-6626-5; Castroviejo S., 1990, FLORA IBERICA PLANTA, VII; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Debain S, 2007, CAN J FOREST RES, V37, P705, DOI 10.1139/X06-265; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Dullinger S, 2011, ECOGRAPHY, V34, P576, DOI 10.1111/j.1600-0587.2010.06601.x; Edwards AWF, 1992, LIKELIHOOD; Elle E, 2000, AM NAT, V156, P622, DOI 10.1086/316997; Escribano-Avila G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046993; Garcia-Camacho R, 2009, PLANT BIOLOGY, V11, P515, DOI 10.1111/j.1438-8677.2008.00151.x; Garcia-Camacho R, 2012, PLANT ECOL DIVERS, V5, P37, DOI 10.1080/17550874.2012.662534; Garcia-Camacho R, 2010, AM J BOT, V97, P1791, DOI 10.3732/ajb.1000248; Garcia-Fernandez A, 2013, AM J BOT, V100, P1641, DOI 10.3732/ajb.1200653; Garcia-Fernandez A, 2012, OIKOS, V121, P1435, DOI 10.1111/j.1600-0706.2011.20219.x; Garcia-Fernandez A, 2012, AM J BOT, V99, pE292, DOI 10.3732/ajb.1200006; Garcia-Romero A, 2010, CLIMATIC CHANGE, V100, P645, DOI 10.1007/s10584-009-9727-7; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; Gimenez-Benavides L, 2005, ECOL RES, V20, P433, DOI 10.1007/s11284-005-0059-4; Gimenez-Benavides L, 2008, ECOGRAPHY, V31, P731, DOI 10.1111/j.0906-7590.2008.05509.x; Gimenez-Benavides L, 2007, OIKOS, V116, P1461, DOI 10.1111/j.2007.0030-1299.15644.x; Gimenez-Benavides L, 2007, ANN BOT-LONDON, V99, P723, DOI [10.1093/aol/mcm007, 10.1093/aob/mcm007]; Gimenez-Benavides L, 2011, EVOL ECOL, V25, P777, DOI 10.1007/s10682-010-9440-z; Gimenez-Benavides L, 2011, ECOGRAPHY, V34, P85, DOI 10.1111/j.1600-0587.2010.06250.x; Gonzalo-Jimenez J, 2011, DIAGNOSIS FITOCLIMAT; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; GOVINDARAJU DR, 1988, OIKOS, V52, P31, DOI 10.2307/3565978; Greene DF, 2004, J ECOL, V92, P758, DOI 10.1111/j.0022-0477.2004.00921.x; Hanski Ilkka, 2001, P283; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson P. L., 2013, MOUNTAIN WEAR RES, P121, DOI DOI 10.1007/978-94-007-4098-3_3; Jongejans E, 1999, OIKOS, V87, P362, DOI 10.2307/3546752; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Klein EK, 2011, MOL ECOL, V20, P1077, DOI 10.1111/j.1365-294X.2011.05020.x; Larcher W, 2000, PLANT BIOSYST, V134, P279, DOI 10.1080/11263500012331350455; LePage PT, 2000, CAN J FOREST RES, V30, P415, DOI 10.1139/cjfr-30-3-415; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Martinez I, 2009, OECOLOGIA, V159, P389, DOI 10.1007/s00442-008-1218-4; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Moran EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036492; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Ouborg NJ, 1999, J ECOL, V87, P551, DOI 10.1046/j.1365-2745.1999.00389.x; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; PHILIPP M, 1992, HEREDITY, V69, P32, DOI 10.1038/hdy.1992.91; R Core Team, 2021, R LANGUAGE ENV STAT; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Robledo-Arnuncio JJ, 2007, MOL ECOL, V16, P5098, DOI 10.1111/j.1365-294X.2007.03427.x; Sagnard F, 2007, ECOL MODEL, V203, P464, DOI 10.1016/j.ecolmodel.2006.12.008; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; Schurr FM, 2010, ANNU PLANT REV, V38, P204, DOI 10.1002/9781444314557.ch6; Smouse PE, 1999, J EVOLUTION BIOL, V12, P1069; Stoyan D, 2001, ECOL MODEL, V145, P35, DOI 10.1016/S0304-3800(01)00385-4; Tackenberg O, 2008, J VEG SCI, V19, P109, DOI 10.3170/2007-8-18338; Tautenhahn S, 2012, ECOL MODEL, V233, P90, DOI 10.1016/j.ecolmodel.2012.03.009; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tutin T.G., 1995, FLORA EUROPAEA; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; Whiteman DC, 2000, TERRAIN FORCES FLOW, P141	81	15	15	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87189	10.1371/journal.pone.0087189	http://dx.doi.org/10.1371/journal.pone.0087189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489867	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000117
J	Lohse, K; Grafenhain, M; Behne, T; Rakoczy, H				Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes			Young Children Understand the Normative Implications of Future-Directed Speech Acts	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; EPISODIC MEMORY; EVENTS; FORESIGHT; EVOLUTION; YESTERDAY; TOMORROW; REMEMBER; HUMANS; SENSE	Much recent research has shown that the capacity for mental time travel and temporal reasoning emerges during the preschool years. Nothing is known so far, however, about young children's grasp of the normative dimension of future-directed thought and speech. The present study is the first to show that children from age 4 understand the normative outreach of such future-directed speech acts: subjects at time 1 witnessed a speaker make future-directed speech acts about/towards an actor A, either in imperative mode ("A, do X!") or as a prediction ("the actor A will do X"). When at time 2 the actor A performed an action that did not match the content of the speech act at time 1, children identified the speaker as the source of a mistake in the prediction case, and the actor as the source of the mistake in the imperative case and leveled criticism accordingly. These findings add to our knowledge about the emergence and development of temporal cognition in revealing an early sensitivity to the normative aspects of future-orientation.	[Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany; [Lohse, Karoline; Graefenhain, Maria; Behne, Tanya; Rakoczy, Hannes] Univ Gottingen, Courant Res Ctr, D-37073 Gottingen, Germany; [Graefenhain, Maria] Univ Leipzig, Dept Child & Adolescent Psychiat Psychotherapy &, D-04109 Leipzig, Germany	University of Gottingen; University of Gottingen; Leipzig University	Lohse, K (corresponding author), Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany.	klohse@uni-goettingen.de		rakoczy, hannes/0000-0003-3296-0551	Volkswagen Foundation; Fritz Thyssen Foundation; German Initiative of Excellence	Volkswagen Foundation(Volkswagen); Fritz Thyssen Foundation; German Initiative of Excellence	This work was supported by a "Dilthey Fellowship" of the Volkswagen Foundation and the Fritz Thyssen Foundation to HR and by the German Initiative of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; ASTINGTON JW, 1990, CHILD LANG, V7, P223; ASTINGTON JW, 1988, J CHILD LANG, V15, P157, DOI 10.1017/S0305000900012101; BISCHOFKOHLER D, 2000, KINDER ZEITREISE THE; BRATMAN M, 1984, PHILOS REV, V93, P375, DOI 10.2307/2184542; Busby J, 2005, COGNITIVE DEV, V20, P362, DOI 10.1016/j.cogdev.2005.05.002; Clayton NS, 2009, NEUROPSYCHOLOGIA, V47, P2330, DOI 10.1016/j.neuropsychologia.2008.10.011; Diessel H, 2001, COGN LINGUIST, V12, P97, DOI 10.1515/cogl.12.2.97; FODOR JA, 1985, MIND, V94, P76; Friedman WJ, 2005, LEARN MOTIV, V36, P145, DOI 10.1016/j.lmot.2005.02.005; Friedman WJ, 2003, ADV CHILD DEV BEHAV, V31, P229; HARNER L, 1975, DEV PSYCHOL, V11, P864, DOI 10.1037/0012-1649.11.6.864; Hayne H, 2011, COGNITIVE DEV, V26, P343, DOI 10.1016/j.cogdev.2011.09.006; Hoerl C., 2011, OXFORD HDB PHILOS TI, P439; Hoerl C, 2008, PHENOMENOL COGN SCI, V7, P485, DOI 10.1007/s11097-008-9089-z; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Lemmon K, 2001, SELF IN TIME: DEVELOPMENTAL PERSPECTIVES, P163; Maas FK, 1998, J CHILD LANG, V25, P203, DOI 10.1017/S0305000997003346; Malcolm N, 1991, J SEARLE HIS CRITICS; McColgan KL, 2008, CHILD DEV, V79, P1477, DOI 10.1111/j.1467-8624.2008.01200.x; McCormack T, 2007, J EXP CHILD PSYCHOL, V98, P168, DOI 10.1016/j.jecp.2007.06.001; McCormack T, 2011, COGNITIVE DEV, V26, P299, DOI 10.1016/j.cogdev.2011.10.001; McCormack T, 2011, DEV REV, V31, P1, DOI 10.1016/j.dr.2011.02.002; Metcalf JL, 2011, COGNITIVE DEV, V26, P371, DOI 10.1016/j.cogdev.2011.09.003; NELSON K, 1993, PSYCHOL SCI, V4, P7, DOI 10.1111/j.1467-9280.1993.tb00548.x; Perner J, 2000, OXFORD HDB MEMORY, P297; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.2307/1131717; Povinelli DJ, 1999, DEV PSYCHOL, V35, P1426, DOI 10.1037/0012-1649.35.6.1426; Putnam H., 1960, DIMENSIONS MIND, P57; Rakoczy H, 2009, COGNITION, V113, P205, DOI 10.1016/j.cognition.2009.07.013; Russell J, 2012, MIND LANG, V27, P29, DOI 10.1111/j.1468-0017.2011.01434.x; Searle John, 1969, SPEECH ACTS, P33; Searle John, 1983, INTENTIONALITY; SELLARS W, 1956, MINN STUD PHILOS SCI, V1, P253; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2011, DEVELOPMENTAL SCI, V14, P26, DOI 10.1111/j.1467-7687.2010.00950.x; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; Zelazo PD, 1999, DEV PSYCHOL, V35, P1059, DOI 10.1037/0012-1649.35.4.1059	40	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86958	10.1371/journal.pone.0086958	http://dx.doi.org/10.1371/journal.pone.0086958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489815	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000085
J	Norton, JE; Lytle, AG; Shen, SX; Tzvetkov, EP; Dorfmeier, CL; McGettigan, JP				Norton, James E., Jr.; Lytle, Andrew G.; Shen, Shixue; Tzvetkov, Evgeni P.; Dorfmeier, Corin L.; McGettigan, James P.			ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo	PLOS ONE			English	Article							ANTIGEN LFA-1; TYPE-1; RHABDOVIRUS; INDUCTION; LIVE; LYMPHOCYTES; EXPRESSION; PROTECTION; ADHESION; RECEPTOR	We have previously shown that live-attenuated rabies virus (RABV)-based vaccines infect and directly activate murine and human primary B cells in-vitro, which we propose can be exploited to help develop a single-dose RABV-based vaccine. Here we report on a novel approach to utilize the binding of Intracellular Adhesion Molecule-1 (ICAM-1) to its binding partner, Lymphocyte Function-associated Antigen-1 (LFA-1), on B cells to enhance B cell activation and RABV-specific antibody responses. We used a reverse genetics approach to clone, recover, and characterize a live-attenuated recombinant RABV-based vaccine expressing the murine Icam1 gene (rRABV-mICAM-1). We show that the murine ICAM-1 gene product is incorporated into virus particles, potentially exposing ICAM-1 to extracellular binding partners. While rRABV-mICAM-1 showed 10-100-fold decrease in viral titers on baby hamster kidney cells compared to the parental virus (rRABV), rRABV-mICAM-1 infected and activated primary murine B cells in-vitro more efficiently than rRABV, as indicated by significant upregulation of CD69, CD40, and MHCII on the surface of infected B cells. ICAM-1 expression on the virus surface was responsible for enhanced B cell infection since pre-treating rRABV-mICAM-1 with a neutralizing anti-ICAM-1 antibody reduced B cell infection to levels observed with rRABV alone. Furthermore, 100-fold less rRABV-mICAM-1 was needed to induce antibody titers in immunized mice equivalent to antibody titers observed in rRABV-immunized mice. Of note, only 10 3 focus forming units (ffu)/mouse of rRABV-mICAM-1 was needed to induce significant anti-RABV antibody titers as early as five days post-immunization. As both speed and potency of antibody responses are important in controlling human RABV infection in a post-exposure setting, these data show that expression of Icam1 from the RABV genome, which is then incorporated into the virus particle, is a promising strategy for the development of a single-dose RABV vaccine that requires only a minimum of virus.	[Norton, James E., Jr.; Lytle, Andrew G.; Shen, Shixue; Tzvetkov, Evgeni P.; Dorfmeier, Corin L.; McGettigan, James P.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [McGettigan, James P.] Thomas Jefferson Univ, Jefferson Med Coll, Jefferson Vaccine Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	McGettigan, JP (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	james.mcgettigan@jefferson.edu			NIH/NIAID [R01AI079211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079211] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grant R01AI079211 to JPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaney JE, 2011, J VIROL, V85, P10605, DOI 10.1128/JVI.00558-11; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Cantin R, 2005, J VIROL, V79, P6577, DOI 10.1128/JVI.79.11.6577-6587.2005; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; Cenna J, 2008, VACCINE, V26, P6405, DOI 10.1016/j.vaccine.2008.08.069; Cenna J, 2009, J INFECT DIS, V200, P1251, DOI 10.1086/605949; CONZELMANN KK, 1990, VIROLOGY, V175, P485, DOI 10.1016/0042-6822(90)90433-R; DENNIG D, 1994, CELL IMMUNOL, V156, P414, DOI 10.1006/cimm.1994.1186; Dorfmeier CL, 2013, J VIROL, V87, P9217, DOI 10.1128/JVI.00995-13; Dorfmeier CL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002129; Dorfmeier CL, 2012, J VIROL, V86, P11533, DOI 10.1128/JVI.00615-12; DUBEY C, 1995, J IMMUNOL, V155, P45; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Ertl HCJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000515; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Grewal IS, 1996, SCIENCE, V273, P1864, DOI 10.1126/science.273.5283.1864; Kondo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044827; KURZINGER K, 1981, J IMMUNOL, V127, P596; Lackay SN, 2008, VET CLIN N AM-SMALL, V38, P851, DOI 10.1016/j.cvsm.2008.03.003; Lytle AG, 2013, B CELL INFECT ACTIVA; McGettigan JP, 2010, EXPERT REV VACCINES, V9, P1177, DOI 10.1586/ERV.10.105; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P11366, DOI 10.1073/pnas.93.21.11366; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; Moore SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000595; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Rupprecht Charles E., 2010, Morbidity and Mortality Weekly Report, V59, P1; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; Schnell MJ, 2000, P NATL ACAD SCI USA, V97, P3544, DOI 10.1073/pnas.050589197; Shinde S, 1996, J IMMUNOL, V157, P2764; Siler CA, 2002, VIROLOGY, V292, P24, DOI 10.1006/viro.2001.1212; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Strady C, 2009, T ROY SOC TROP MED H, V103, P1159, DOI 10.1016/j.trstmh.2009.03.007; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; *WHO, 1997, WHO REC RAB POST TRE; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	41	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87098	10.1371/journal.pone.0087098	http://dx.doi.org/10.1371/journal.pone.0087098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489846	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000102
J	Komorita, T; Kajihara, R; Tsutsumi, H; Shibanuma, S; Yamada, T; Montani, S				Komorita, Tomohiro; Kajihara, Rumiko; Tsutsumi, Hiroaki; Shibanuma, Seiichiro; Yamada, Toshiro; Montani, Shigeru			Food Sources for Ruditapes philippinarum in a Coastal Lagoon Determined by Mass Balance and Stable Isotope Approaches	PLOS ONE			English	Article							ENERGY BUDGET; TIDAL-FLAT; CERASTODERMA-EDULE; HICHIRIPPU LAGOON; MYTILUS-EDULIS; SHALLOW LAGOON; ARIAKE SOUND; POPULATION; CARBON; HOKKAIDO	The relationship between the food demand of a clam population (Ruditapes philippinarum (Adams & Reeve 1850)) and the isotopic contributions of potential food sources (phytoplankton, benthic diatoms, and organic matter derived from the sediment surface, seagrass, and seaweeds) to the clam diet were investigated. In particular, we investigated the manner in which dense patches of clams with high secondary productivity are sustained in a coastal lagoon ecosystem (Hichirippu Lagoon) in Hokkaido, Japan. Clam feeding behavior should affect material circulation in this lagoon owing to their high secondary productivity (ca. 130 g C m(-2) yr(-1)). Phytoplankton were initially found to constitute 14-77% of the clam diet, although phytoplankton nitrogen content (1.79-4.48 kmol N) and the food demand of the clam (16.2 kmol N d(-1)) suggest that phytoplankton can constitute only up to 28% of clam dietary demands. However, use of isotopic signatures alone may be misleading. For example, the contribution of microphytobenthos (MPB) were estimated to be 0-68% on the basis of isotopic signatures but was subsequently shown to be 35 +/- 13% (mean +/- S.D.) and 64 +/- 4% (mean +/- S.D.) on the basis of phytoplankton biomass and clam food demand respectively, suggesting that MPB are the primary food source for clams. Thus, in the present study, the abundant MPB in the subtidal area appear to be a key food source for clams, suggesting that these MPB may sustain the high secondary production of the clam.	[Komorita, Tomohiro; Kajihara, Rumiko; Shibanuma, Seiichiro; Montani, Shigeru] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Komorita, Tomohiro; Tsutsumi, Hiroaki] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Tsukide, Kumamoto, Japan; [Yamada, Toshiro] Nishimuragumi Co Ltd, Mombetsu, Hokkaido, Japan	Hokkaido University	Komorita, T (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	komorita@pu-kumamoto.ac.jp	Komorita, Tomohiro/J-8817-2019	Komorita, Tomohiro/0000-0002-9469-5602	MEXT [22380102, 15201001]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by MEXT Grants-in-Aid for Scientific Research, Nos. 22380102 (to SM) and 15201001 (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brey T., 2001, POPULATION DYNAMICS; Cahoon LB, 1999, OCEANOGR MAR BIOL, V37, P47; COUCH CA, 1989, ESTUAR COAST SHELF S, V28, P433, DOI 10.1016/0272-7714(89)90090-5; Crisp D, 1984, IBP HDB, V16, P416; Dang C, 2009, MAR ECOL PROG SER, V387, P167, DOI 10.3354/meps08100; DEJONGE VN, 1980, MAR ECOL PROG SER, V2, P345, DOI 10.3354/meps002345; EPPLEY RW, 1968, LIMNOL OCEANOGR, V13, P574, DOI 10.4319/lo.1968.13.4.0574; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; GRIFFITHS RJ, 1981, ESTUAR COAST SHELF S, V13, P477, DOI 10.1016/S0302-3524(81)80053-9; Hicks DW, 2001, MAR ECOL PROG SER, V211, P181, DOI 10.3354/meps211181; HUGHES RN, 1970, J ANIM ECOL, V39, P357, DOI 10.2307/2976; HUMMEL H, 1985, NETH J SEA RES, V19, P84, DOI 10.1016/0077-7579(85)90045-6; Jonge V De, 1992, NETHERLANDS J SEA RE, V22, P445; Kach DJ, 2008, MAR BIOL, V153, P797, DOI 10.1007/s00227-007-0852-4; Kajihara Rumiko, 2010, Plankton & Benthos Research, V5, P90; Kanaya G, 2005, MAR ECOL PROG SER, V299, P67, DOI 10.3354/meps299067; Kanaya G, 2007, MAR ECOL PROG SER, V345, P117, DOI 10.3354/meps07025; Kanaya G, 2013, MAR POLLUT BULL, V71, P179, DOI 10.1016/j.marpolbul.2013.03.018; Kang CK, 1999, MAR ECOL PROG SER, V187, P147, DOI 10.3354/meps187147; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Koh CH, 2006, MAR ECOL PROG SER, V312, P85, DOI 10.3354/meps312085; Komorita T, 2012, MAR ECOL PROG SER, V446, P161, DOI 10.3354/meps09459; Komorita T, 2010, J EXP MAR BIOL ECOL, V383, P8, DOI 10.1016/j.jembe.2009.10.018; Komorita Tomohiro, 2009, Plankton & Benthos Research, V4, P31; LANGTON RW, 1977, AQUACULTURE, V12, P283, DOI 10.1016/0044-8486(77)90207-1; Laudien J, 2003, ESTUAR COAST SHELF S, V58, P105, DOI 10.1016/S0272-7714(03)00044-1; Loo LO, 1996, J SEA RES, V35, P199, DOI 10.1016/S1385-1101(96)90747-9; Lorenzen C., 1967, LIMNOL OCEANOGR, V22, P1096; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Montani S, 2003, MAR ECOL PROG SER, V249, P79, DOI 10.3354/meps249079; Nakamura Y, 2001, J EXP MAR BIOL ECOL, V266, P181, DOI 10.1016/S0022-0981(01)00354-9; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Ponurovsky S, 1992, J SHELLFISH RES, V22, P814; Garcia-March JR, 2008, MAR BIOL, V153, P689, DOI 10.1007/s00227-007-0842-6; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rodland DL, 2006, J EXP MAR BIOL ECOL, V334, P316, DOI 10.1016/j.jembe.2006.02.012; SHAFEE MS, 1992, J EXP MAR BIOL ECOL, V163, P183, DOI 10.1016/0022-0981(92)90048-F; Suga Natsumi, 2011, Plankton & Benthos Research, V6, P115; THOMPSON RJ, 1984, MAR ECOL PROG SER, V16, P249, DOI 10.3354/meps016249; TREVALLION A, 1971, Journal of Experimental Marine Biology and Ecology, V7, P95, DOI 10.1016/0022-0981(71)90006-2; Tsutsumi Hiroaki, 1994, Benthos Research, V46, P1; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Watanabe S, 2009, FISHERIES SCI, V75, P937, DOI 10.1007/s12562-009-0113-1; Yamaguchi Hitomi, 2004, Benthos Research, V59, P67; Yokoyama H, 2005, MAR ECOL PROG SER, V304, P101, DOI 10.3354/meps304101; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Yokoyama H, 2009, ESTUAR COAST SHELF S, V82, P243, DOI 10.1016/j.ecss.2009.01.010; Yoshino K, 2012, ESTUAR COAST SHELF S, V109, P138, DOI 10.1016/j.ecss.2012.05.021	50	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86732	10.1371/journal.pone.0086732	http://dx.doi.org/10.1371/journal.pone.0086732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489779	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000077
J	Olson, AD; Meyer, L; Prins, M; Thiebaut, R; Gurdasani, D; Guiguet, M; Chaix, ML; Amornkul, P; Babiker, A; Sandhu, MS; Porter, K				Olson, Ashley D.; Meyer, Laurence; Prins, Maria; Thiebaut, Rodolphe; Gurdasani, Deepti; Guiguet, Marguerite; Chaix, Marie-Laure; Amornkul, Pauli; Babiker, Abdel; Sandhu, Manjinder S.; Porter, Kholoud		C A S C A D E Collaboration EuroCo	An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; VIRAL LOAD; INFECTION; PROGRESSION; ABSENCE; COUNT; INDIVIDUALS; ACTIVATION	Background: Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype. Methods: We assessed a number of EC definitions used in the literature using CASCADE data of 25,692 HIV seroconverters. We estimated proportions maintaining EC of total ART-naive follow-up time, and disease progression, comparing to non-EC. We also examined HIV-RNA and CD4 values and CD4 slope during EC and beyond (while ART naive). Results: Most definitions classify, similar to 1% as ECs with median HIV-RNA 43-903 copies/ml and median CD4>500 cells/mm(3). Beyond EC status, median HIV-RNA levels remained low, although often detectable, and CD4 values high but with strong evidence of decline for all definitions. Median % ART-naive time as EC was >= 92% although overlap between definitions was low. EC definitions with consecutive HIV-RNA measurements <75 copies/ml with follow-up >= six months, or with 90% of measurements <400 copies/ml over >= 10 year follow-up preformed best overall. Individuals thus defined were less likely to progress to endpoint (hazard ratios ranged from 12.5-19.0 for non-ECs compared to ECs). Conclusions: ECs are rare, less likely to progress to clinical disease, but may eventually lose control. We suggest definitions requiring individuals to have consecutive undetectable HIV-RNA measurements for >= six months or otherwise with >90% of measurements <400 copies/ml over >= 10 years be used to define this phenotype.	[Olson, Ashley D.; Babiker, Abdel; Porter, Kholoud] UCL, Med Res Council Clin Trials Unit, London, England; [Meyer, Laurence] Univ Paris 11, INSERM, U1018, Le Kremlin Bicetre, France; [Prins, Maria] Amsterdam Publ Hlth Serv, Amsterdam, Netherlands; [Thiebaut, Rodolphe] Univ Bordeaux Segalen, INSERM, U897, Bordeaux, France; [Gurdasani, Deepti; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Gurdasani, Deepti; Sandhu, Manjinder S.] Univ Cambridge, Cambridge, England; [Guiguet, Marguerite] INSERM, U943, Paris, France; [Guiguet, Marguerite] Univ Paris 06, S943, Paris, France; [Chaix, Marie-Laure] Univ Paris 05, Hop Necker Enfants Malad, EA 3620, Paris, France; [Amornkul, Pauli] Int AIDS Vaccine Initiat, San Francisco, CA USA	Medical Research Council Clinical Trials Unit; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Public Health Service Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Wellcome Trust Sanger Institute; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; International AIDS Vaccine Initiative	Olson, AD (corresponding author), UCL, Med Res Council Clin Trials Unit, London, England.	a.olson@ucl.ac.uk	lutsar, irja/H-3177-2015; rezza, giovanni/D-4393-2016; Perez Hoyos, Santiago/O-1075-2019; DORRUCCI, MARIA/C-6485-2016; Guiguet, Marguerite/L-8480-2018; Muga, Roberto/AAY-8655-2021; DEL AMO VALERO, JULIA/M-7020-2015; Thiebaut, Rodolphe/T-6803-2019	rezza, giovanni/0000-0003-0268-6790; Perez Hoyos, Santiago/0000-0001-9797-4917; DORRUCCI, MARIA/0000-0002-8543-6430; Muga, Roberto/0000-0001-6301-431X; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Thiebaut, Rodolphe/0000-0002-5235-3962; Sabin, Miriam/0000-0002-7758-8338; Gurdasani, Deepti/0000-0001-9996-6929; Porter, Kholoud/0000-0002-9226-6206; GIAQUINTO, CARLO/0000-0001-9365-0413	European Union Seventh Framework Programme under EuroCoord grant [260694]; MRC [MC_U122886352, MC_UU_12023/15, MC_UU_12023/16] Funding Source: UKRI; Medical Research Council [MC_UU_12023/16, MC_U122886352, MC_UU_12023/15] Funding Source: researchfish	European Union Seventh Framework Programme under EuroCoord grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Boufassa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018726; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Gurdasani D, 2013, AIDS IN PRESS; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Julg B, 2010, CLIN INFECT DIS, V51, P233, DOI 10.1086/653677; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lopez M, 2011, AIDS RES HUM RETROV, V27, P157, DOI 10.1089/aid.2010.0107; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Madec Y, 2005, CLIN INFECT DIS, V40, P1350, DOI 10.1086/429318; Mandalia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029844; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Okulicz JF, 2012, J AIDS CLIN RES; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Sajadi MM, 2009, JAIDS-J ACQ IMM DEF, V50, P403, DOI 10.1097/QAI.0b013e3181945f1e; Strathdee SA, 1996, AIDS, V10, P959, DOI 10.1097/00002030-199610090-00005; Thiebaut R, 2005, STAT MED, V24, P65, DOI 10.1002/sim.1923; Thiebaut R, 2011, AIDS, V25, P865, DOI 10.1097/QAD.0b013e328344892e; Walker Bruce D, 2007, Top HIV Med, V15, P134; Wolf F. de, 2012, Clinical Investigation, V2, P255, DOI 10.4155/cli.12.3	33	61	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86719	10.1371/journal.pone.0086719	http://dx.doi.org/10.1371/journal.pone.0086719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489776	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000076
J	Tonosaki, M; Itoh, K; Umekage, M; Kishimoto, T; Yaoi, T; Lemmon, VP; Fushiki, S				Tonosaki, Madoka; Itoh, Kyoko; Umekage, Masafumi; Kishimoto, Tomokazu; Yaoi, Takeshi; Lemmon, Vance P.; Fushiki, Shinji			L1cam Is Crucial for Cell Locomotion and Terminal Translocation of the Soma in Radial Migration during Murine Corticogenesis	PLOS ONE			English	Article							ADHESION MOLECULE L1; NEURONAL MIGRATION; NERVOUS-SYSTEM; BRAIN-DEVELOPMENT; GENE-EXPRESSION; CEREBRAL-CORTEX; KNOCKOUT MICE; AXON GUIDANCE; OUTGROWTH; NEOCORTEX	L1cam (L1) is a cell adhesion molecule associated with a spectrum of human neurological diseases, the most well-known being X-linked hydrocephalus. Although we recently demonstrated that L1 plays an important role in neuronal migration during cortical histogenesis, the mechanisms of delayed migration have still not been clarified. In this study, we found that cell locomotion in the intermediate zone and terminal translocation in the primitive cortical zone (PCZ) were affected by L1-knockdown (L1-KD). Time-lapse analyses revealed that L1-KD neurons produced by in utero electroporation of shRNA targeting L1 (L1-shRNAs) molecules showed decreased locomotion velocity in the intermediate zone, compared with control neurons. Furthermore, L1-KD neurons showed longer and more undulated leading processes during translocation through the primitive cortical zone. The curvature index, a quantitative index for curvilinearity, as well as the length of the leading process, were increased, whereas the somal movement was decreased in L1-KD neurons during terminal translocation in the PCZ. These results suggest that L1 has a role in radial migration of cortical neurons.	[Tonosaki, Madoka; Itoh, Kyoko; Umekage, Masafumi; Kishimoto, Tomokazu; Yaoi, Takeshi; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto, Japan; [Kishimoto, Tomokazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto, Japan; [Lemmon, Vance P.] Univ Miami, Sch Med, Lois Pope LIFE Ctr, Miami Project Cure Paralysis, Miami, FL USA	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; University of Miami	Itoh, K (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto, Japan.	kxi14@koto.kpu-m.ac.jp	çè, æ/CAJ-4397-2022; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576	JSPS (KAKENHI) [18390308, 22390214]	JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS (KAKENHI) Grants-in-Aid for Scientific Research (B) (18390308, 22390214 to KI). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Britto JM, 2011, CEREB CORTEX, V21, P1018, DOI 10.1093/cercor/bhq168; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; FISCHER G, 1986, J NEUROSCI, V6, P605; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Itoh K, 2005, MOL CELL NEUROSCI, V30, P624, DOI 10.1016/j.mcn.2005.06.012; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Kamiguchi H, 1998, ANNU REV NEUROSCI, V21, P97, DOI 10.1146/annurev.neuro.21.1.97; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Kishimoto T, 2013, J NEUROSCI RES, V91, P42, DOI 10.1002/jnr.23141; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Marchetti G, 2010, EUR J NEUROSCI, V31, P399, DOI 10.1111/j.1460-9568.2009.07072.x; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Miyata T, 2002, J NEUROSCI RES, V69, P861, DOI 10.1002/jnr.10335; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Quach TT, 2008, FASEB J, V22, P401, DOI 10.1096/fj.07-9012com; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Sekine K, 2011, J NEUROSCI, V31, P9426, DOI 10.1523/JNEUROSCI.0650-11.2011; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86186	10.1371/journal.pone.0086186	http://dx.doi.org/10.1371/journal.pone.0086186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489698	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000034
J	Velasquez, NA; Opazo, D; Diaz, J; Penna, M				Velasquez, Nelson A.; Opazo, Daniel; Diaz, Javier; Penna, Mario			Divergence of Acoustic Signals in a Widely Distributed Frog: Relevance of Inter-Male Interactions	PLOS ONE			English	Article							PLEURODEMA-THAUL AMPHIBIA; SOUTHERN TEMPERATE FOREST; GEOGRAPHIC-VARIATION; SEXUAL SELECTION; FEMALE PREFERENCES; RECEIVER BIASES; CALL; DISCRIMINATION; EVOLUTION; RESPONSES	Divergence of acoustic signals in a geographic scale results from diverse evolutionary forces acting in parallel and affecting directly inter-male vocal interactions among disjunct populations. Pleurodema thaul is a frog having an extensive latitudinal distribution in Chile along which males' advertisement calls exhibit an important variation. Using the playback paradigm we studied the evoked vocal responses of males of three populations of P. thaul in Chile, from northern, central and southern distribution. In each population, males were stimulated with standard synthetic calls having the acoustic structure of local and foreign populations. Males of both northern and central populations displayed strong vocal responses when were confronted with the synthetic call of their own populations, giving weaker responses to the call of the southern population. The southern population gave stronger responses to calls of the northern population than to the local call. Furthermore, males in all populations were stimulated with synthetic calls for which the dominant frequency, pulse rate and modulation depth were varied parametrically. Individuals from the northern and central populations gave lower responses to a synthetic call devoid of amplitude modulation relative to stimuli containing modulation depths between 30-100%, whereas the southern population responded similarly to all stimuli in this series. Geographic variation in the evoked vocal responses of males of P. thaul underlines the importance of inter-male interactions in driving the divergence of the acoustic traits and contributes evidence for a role of intra-sexual selection in the evolution of the sound communication system of this anuran.	[Velasquez, Nelson A.; Opazo, Daniel; Diaz, Javier; Penna, Mario] Univ Chile, Fac Med, ICBM, Programa Fisiol & Biofis, Santiago 7, Chile; [Opazo, Daniel] Univ Chile, Fac Ciencias, Dept Biol, Lab Neurobiol & Biol Conocer, Santiago, Chile	Universidad de Chile; Universidad de Chile	Velasquez, NA (corresponding author), Univ Chile, Fac Med, ICBM, Programa Fisiol & Biofis, Santiago 7, Chile.	nelson.velasquez@gmail.com	Velasquez, Nelson A./S-7106-2019		CONICYT [AT24080118]; Guillermo Puelma Foundation; FONDECYT [3120208, 1080459]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Guillermo Puelma Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a Fellowship for Doctoral thesis CONICYT AT24080118, a Fellowship for Doctoral thesis from the Guillermo Puelma Foundation, postdoctoral FONDECYT grant 3120208, and FONDECYT grant 1080459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson M, 1994, SEXUAL SELECTION; [Anonymous], 1953, SOCIAL BEHAV ANIMALS; Bee MA, 1996, BEHAVIOUR, V133, P283, DOI 10.1163/156853996X00152; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Bosch J, 2002, ETHOL ECOL EVOL, V14, P217; Bosch J, 2000, BEHAV ECOL SOCIOBIOL, V49, P62, DOI 10.1007/s002650000280; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Burley NT, 1998, AM NAT, V152, P792, DOI 10.1086/286209; Byrne PG, 2004, BEHAV ECOL, V15, P872, DOI 10.1093/beheco/arh100; Castellano S, 2000, ETHOLOGY, V106, P1129, DOI 10.1046/j.1439-0310.2000.00639.x; Correa C, 2008, HERPETOL J, V18, P77; Correa Q. Claudio L., 2007, Check List, V3, P267; Coyne J.A., 2004, SPECIATION; Coyne JA, 1998, NATURE, V396, P35, DOI 10.1038/23856; Darwin C., 1871, P423; Endler J. A., 1999, GEOGRAPHIC VARIATION; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Hair J. F., 1999, ANALISIS MULTIVARIAN; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Kwiatkowski MA, 2002, EVOLUTION, V56, P2039; Parker G.A., 1982, P173; Parker G.A., 1983, P141; Penna M, 1997, J COMP PHYSIOL A, V180, P313, DOI 10.1007/s003590050051; Penna M, 2008, J COMP PHYSIOL A, V194, P361, DOI 10.1007/s00359-007-0312-0; Penna M, 2011, ETHOLOGY, V117, P1147, DOI 10.1111/j.1439-0310.2011.01973.x; Penna M, 2011, ETHOLOGY, V117, P63, DOI 10.1111/j.1439-0310.2010.01847.x; Podos J, 2007, ANIM BEHAV, V73, P833, DOI 10.1016/j.anbehav.2006.11.001; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Prohl H, 2007, ETHOLOGY, V113, P825, DOI 10.1111/j.1439-0310.2007.01396.x; Prohl H, 2006, EVOLUTION, V60, P1669; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quispe R, 2009, ETHOLOGY, V115, P465, DOI 10.1111/j.1439-0310.2009.01621.x; RATCLIFFE LM, 1985, ANIM BEHAV, V33, P290, DOI 10.1016/S0003-3472(85)80143-3; Ryan MJ, 2010, CURR ZOOL, V56, P343, DOI 10.1093/czoolo/56.3.343; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Searcy W, 2009, ENCY NEUROSCIENCE, P769; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; ten Cate C, 2002, ADV STUD BEHAV, V31, P31; van Dongen WFD, 2010, BEHAV ECOL, V21, P1243, DOI 10.1093/beheco/arq145; Velasquez NA, 2013, BIOL J LINN SOC, DOI 10.1111-bij.12113.; Veloso A, 2006, MACROFITAS VERTEBRAD; VICTORIANO P, 1995, COMP BIOCHEM PHYS B, V112, P487, DOI 10.1016/0305-0491(95)00071-2; Villagra CA, 2011, B ENTOMOL RES, V101, P573, DOI 10.1017/S0007485311000174; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Zahavi A, 1999, HANDICAP PRINCIPLE M	59	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87732	10.1371/journal.pone.0087732	http://dx.doi.org/10.1371/journal.pone.0087732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489957	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000148
J	Wang, J; Chen, DJ; Lei, Y; Chang, JW; Hao, BH; Xing, F; Li, S; Xu, Q; Deng, XX; Chen, LL				Wang, Jia; Chen, Dijun; Lei, Yang; Chang, Ji-Wei; Hao, Bao-Hai; Xing, Feng; Li, Sen; Xu, Qiang; Deng, Xiu-Xin; Chen, Ling-Ling			Citrus sinensis Annotation Project (CAP): A Comprehensive Database for Sweet Orange Genome	PLOS ONE			English	Article							GENE ANNOTATION; WEB; INTEGRATION; PLATFORM	Citrus is one of the most important and widely grown fruit crop with global production ranking firstly among all the fruit crops in the world. Sweet orange accounts for more than half of the Citrus production both in fresh fruit and processed juice. We have sequenced the draft genome of a double-haploid sweet orange (C. sinensis cv. Valencia), and constructed the Citrus sinensis annotation project (CAP) to store and visualize the sequenced genomic and transcriptome data. CAP provides GBrowse-based organization of sweet orange genomic data, which integrates ab initio gene prediction, EST, RNA-seq and RNA-paired end tag (RNA-PET) evidence-based gene annotation. Furthermore, we provide a user-friendly web interface to show the predicted protein-protein interactions (PPIs) and metabolic pathways in sweet orange. CAP provides comprehensive information beneficial to the researchers of sweet orange and other woody plants, which is freely available at http://citrus.hzau.edu.cn/.	[Wang, Jia; Chen, Dijun; Lei, Yang; Chang, Ji-Wei; Hao, Bao-Hai; Xing, Feng; Li, Sen; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China; [Wang, Jia] Huazhong Agr Univ, Sch Sci, Wuhan, Peoples R China; [Xu, Qiang; Deng, Xiu-Xin] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chen, LL (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Bioinformat, Wuhan, Peoples R China.	llchen@mail.hzau.edu.cn	Chen, Dijun/P-3877-2014; Chen, Ling-Ling/AAY-3547-2021	Chen, Dijun/0000-0002-7456-2511; Xiuxin, Deng/0000-0003-4490-4514	National Basic Research Program of China [2012AA10A304]; National Natural Science Foundation of China [31271406, 31222047]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the National Basic Research Program of China (2012AA10A304) and the National Natural Science Foundation of China (31271406 and 31222047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Attwood TK, 2012, DATABASE OXFORD, V2012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanco E, 2009, METHODS MOL BIOL, V537, P243, DOI 10.1007/978-1-59745-251-9_12; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Ding YD, 2014, PREDICTION FUN UNPUB; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Stein LD, 2013, BRIEF BIOINFORM, V14, P162, DOI 10.1093/bib/bbt001; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	24	14	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87723	10.1371/journal.pone.0087723	http://dx.doi.org/10.1371/journal.pone.0087723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489955	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000147
J	Al-Salam, S; Hashmi, S				Al-Salam, Suhail; Hashmi, Satwat			Galectin-1 in Early Acute Myocardial Infarction	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; BINDING PROTEIN; HYPOXIA; ISCHEMIA; FAMILY; MICE; HIF-1-ALPHA; ROLES	Myocardial infarction (MI) is the most serious manifestation of coronary artery disease and the cause of significant mortality and morbidity worldwide. Galectin-1(GAL-1), a divalent 14.5-kDa protein, is present both inside and outside cells, and has both intracellular and extracellular functions. Hypoxia inducible factor-1 alpha (HIF-1 alpha) is a transcription factor mediating early and late responses to myocardial ischemia. Identification of the pattern of expression of GAL-1 and HIF-1 alpha in the heart during the first 24 hours following acute MI will help in understanding early molecular changes in this event and may provide methods to overcome serious complications. Mouse model of MI was used and heart samples were processed for immunohistochemical and immunofluorescent labeling and Enzyme linked immunosorbent assay to identify GAL-1 and HIF 1 alpha levels in the heart during the first 24 hours following MI. There was significant increase in left ventricular GAL-1 at 20 (p = 0.001) and 30 minutes (p = 0.004) following MI. There was also a significant increase in plasma GAL-1 at 4 hours (p = 0.012) and 24 hours (p = 0.001) following MI. A significant increase in left ventricular HIF-1 alpha was seen at 20 minutes (p = 0.047) following MI. In conclusion, we show for the first time that GAL-1 level in the left ventricle is increased in early ischemic period. We also report for the first time that HIF-1 alpha is significantly increased at 20 minutes following MI. In addition we report for the first time that mouse plasma GAL-1 level is significantly raised as early as 4 hours following MI.	[Al-Salam, Suhail; Hashmi, Satwat] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates	United Arab Emirates University	Al-Salam, S (corresponding author), United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Abu Dhabi, U Arab Emirates.	suhaila@uaeu.ac.ae		Al-Salam, Suhail/0000-0003-0109-5964	UAEU-National Research Foundation [21MO73]	UAEU-National Research Foundation	This work was supported by UAEU-National Research Foundation grant 21MO73. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2009, GLYCOCONJUGATE J, V26, P277, DOI 10.1007/s10719-008-9178-9; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Case D, 2007, AM J PHYSIOL-LUNG C, V292, pL154, DOI 10.1152/ajplung.00192.2006; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Colnot C, 1996, BIOCHEM SOC T, V24, P141, DOI 10.1042/bst0240141; Dias-Baruffi M, 2010, GLYCOBIOLOGY, V20, P507, DOI 10.1093/glycob/cwp203; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; Hashmi S, 2013, INT J CLIN EXP PATHO, V6, P249; Hashmi S, 2012, CARDIOL REV, V20, P268, DOI 10.1097/CRD.0b013e31826287f6; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; HUGHES RC, 1994, GLYCOBIOLOGY, V4, P5, DOI 10.1093/glycob/4.1.5; Iwamoto M, 2010, GLYCOCONJUGATE J, V27, P419, DOI 10.1007/s10719-010-9288-z; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; Kumar Aka V., 2007, BASIC PATHOLOGY, V8th edn; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; LIPKE DW, 1993, AM J RESP CELL MOL, V9, P418, DOI 10.1165/ajrcmb/9.4.418; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Merklinger SL, 2005, CIRC RES, V97, P596, DOI 10.1161/01.RES.0000182425.49768.8a; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Michael LH, 1999, AM J PHYSIOL-HEART C, V277, pH660, DOI 10.1152/ajpheart.1999.277.2.H660; Mitani Y, 2001, EUR RESPIR J, V17, P316, DOI 10.1183/09031936.01.17203160; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; OFFNER H, 1990, J NEUROIMMUNOL, V28, P177, DOI 10.1016/0165-5728(90)90032-I; Parisi Q, 2005, INT J CARDIOL, V99, P337, DOI 10.1016/j.ijcard.2003.11.038; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; POIRIER F, 1993, DEVELOPMENT, V119, P1229; POIRIER F, 1992, DEVELOPMENT, V115, P143; Poirier F, 2002, BIOCHEM SOC SYMP, V69, P95; Qu WS, 2011, J NEUROCHEM, V116, P217, DOI 10.1111/j.1471-4159.2010.07095.x; Qu WS, 2010, NEUROCHEM RES, V35, P1716, DOI 10.1007/s11064-010-0234-z; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Seropian IM, 2013, AM J PATHOL, V182, P29, DOI 10.1016/j.ajpath.2012.09.022; Shao HF, 2009, BIOCHEM BIOPH RES CO, V378, P750, DOI 10.1016/j.bbrc.2008.11.134; Stillman BN, 2005, BRAIN PATHOL, V15, P124; Vansthertem D, 2010, HISTOL HISTOPATHOL, V25, P1417, DOI 10.14670/HH-25.1417; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xue WL, 2010, AM J PATHOL, V177, P97, DOI 10.2353/ajpath.2010.091091; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116	52	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86994	10.1371/journal.pone.0086994	http://dx.doi.org/10.1371/journal.pone.0086994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498007	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900055
J	Ishikawa, T; Kokura, S; Enoki, T; Sakamoto, N; Okayama, T; Ideno, M; Mineno, J; Uno, K; Yoshida, N; Kamada, K; Katada, K; Uchiyama, K; Handa, O; Takagi, T; Konishi, H; Yagi, N; Naito, Y; Itoh, Y; Yoshikawa, T				Ishikawa, Takeshi; Kokura, Satoshi; Enoki, Tatsuji; Sakamoto, Naoyuki; Okayama, Tetsuya; Ideno, Mitsuko; Mineno, Junichi; Uno, Kazuko; Yoshida, Naohisa; Kamada, Kazuhiro; Katada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Konishi, Hideyuki; Yagi, Nobuaki; Naito, Yuji; Itoh, Yoshito; Yoshikawa, Toshikazu			Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; VIVO PERSISTENCE; MEMORY; REGRESSION; DIFFERENTIATION; IMMUNOTHERAPY; STIMULATION; LIGATION; LENGTH; BLOOD	Background: Previous studies have demonstrated that less-differentiated T cells are ideal for adoptive T cell transfer therapy (ACT) and that fibronectin CH296 (FN-CH296) together with anti-CD3 resulted in cultured cells that contain higher amounts of less-differentiated T cells. In this phase I clinical trial, we build on these prior results by assessing the safety and efficacy of FN-CH296 stimulated T cell therapy in patients with advanced cancer. Methods: Patients underwent fibronectin CH296-stimulated T cell therapy up to six times every two weeks and the safety and antitumor activity of the ACT were assessed. In order to determine immune function, whole blood cytokine levels and the number of peripheral regulatory T cells were analyzed prior to ACT and during the follow up. Results: Transferred cells contained numerous less-differentiated T cells greatly represented by CD27+CD45RA+ or CD28+CD45RA+ cell, which accounted for approximately 65% and 70% of the total, respectively. No ACT related severe or unexpected toxicities were observed. The response rate among patients was 22.2% and the disease control rate was 66.7%. Conclusions: The results obtained in this phase I trial, indicate that FN-CH296 stimulated T cell therapy was very well tolerated with a level of efficacy that is quite promising. We also surmise that expanding T cell using CH296 is a method that can be applied to other T-cell-based therapies.	[Ishikawa, Takeshi; Kokura, Satoshi; Sakamoto, Naoyuki; Okayama, Tetsuya; Yoshida, Naohisa; Kamada, Kazuhiro; Katada, Kazuhiro; Uchiyama, Kazuhiko; Handa, Osamu; Takagi, Tomohisa; Konishi, Hideyuki; Yagi, Nobuaki; Naito, Yuji; Itoh, Yoshito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan; [Ishikawa, Takeshi; Kokura, Satoshi; Okayama, Tetsuya; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Dept Canc ImmunoCell Regulat, Kyoto, Japan; [Enoki, Tatsuji; Ideno, Mitsuko; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Otsu, Shiga, Japan; [Uno, Kazuko] Louis Pasteur Ctr Med Res, Basic Res Div, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Takara Bio Inc.	Kokura, S (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, Japan.	s-kokura@koto.kpu-m.ac.jp	半田, 修/GQA-9627-2022; Handa, Osamu/AEW-4869-2022; Sakamoto, Naoyuki/ABD-4871-2020	Handa, Osamu/0000-0003-2228-0405	JSPS KAKENHI [23590891]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by JSPS KAKENHI Grant Number 23590891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Childs RW, 2004, ANNU REV MED, V55, P459, DOI 10.1146/annurev.med.55.091902.104511; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ishikawa T, 2013, INT J CANC; Ishikawa T, 2012, CLIN BIOCHEM, V45, P207, DOI 10.1016/j.clinbiochem.2011.09.007; Ishikawa T, 2011, EXP THER MED, V2, P737, DOI 10.3892/etm.2011.271; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Matsumoto T, 2011, ONCOL RES, V19, P543, DOI 10.3727/096504012X13340632812596; METCALF D, 1986, BLOOD, V67, P37; NOJIMA Y, 1992, J EXP MED, V175, P1045, DOI 10.1084/jem.175.4.1045; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SATO T, 1995, J IMMUNOL, V155, P2938; Stroncek DF, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-48; Turtle CJ, 2012, CURR OPIN IMMUNOL, V24, P633, DOI 10.1016/j.coi.2012.06.004; Uno K, 1996, J INTERF CYTOK RES, V16, P911, DOI 10.1089/jir.1996.16.911; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Yu S, 2008, CANCER GENE THER, V15, P508, DOI 10.1038/cgt.2008.21; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046	30	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e83786	10.1371/journal.pone.0083786	http://dx.doi.org/10.1371/journal.pone.0083786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497917	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900005
J	Kaess, BM; Jozwiak, J; Nelson, CP; Lukas, W; Mastej, M; Windak, A; Tomasik, T; Grzeszczak, W; Tykarski, A; Gasowski, J; Slezak-Prochazka, I; Slezak, A; Charchar, FJ; Sattar, N; Thompson, JR; Samani, NJ; Tomaszewski, M				Kaess, Bernhard M.; Jozwiak, Jacek; Nelson, Christopher P.; Lukas, Witold; Mastej, Miroslaw; Windak, Adam; Tomasik, Tomasz; Grzeszczak, Wladyslaw; Tykarski, Andrzej; Gasowski, Jerzy; Slezak-Prochazka, Izabella; Slezak, Andrzej; Charchar, Fadi J.; Sattar, Naveed; Thompson, John R.; Samani, Nilesh J.; Tomaszewski, Maciej			The Relation of Rapid Changes in Obesity Measures to Lipid Profile - Insights from a Nationwide Metabolic Health Survey in 444 Polish Cities	PLOS ONE			English	Article							DISEASE RISK-FACTORS; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; HEART-DISEASE; WEIGHT CHANGE; ASSOCIATION; CHOLESTEROL; PREVENTION; ADIPOSITY; TRENDS	Objective: The impact of fast changes in obesity indices on other measures of metabolic health is poorly defined in the general population. Using the Polish accession to the European Union as a model of political and social transformation we examined how an expected rapid increase in body mass index (BMI) and waist circumference relates to changes in lipid profile, both at the population and personal level. Methods: Through primary care centres in 444 Polish cities, two cross-sectional nationwide population-based surveys (LIPIDOGRAM 2004 and LIPIDOGRAM 2006) examined 15,404 and 15,453 adult individuals in 2004 and 2006, respectively. A separate prospective sample of 1,840 individuals recruited in 2004 had a follow-up in 2006 (LIPIDOGRAM PLUS). Results: Two years after Polish accession to European Union, mean population BMI and waist circumference increased by 0.6% and 0.9%, respectively. This tracked with a 7.6% drop in HDL-cholesterol and a 2.1% increase in triglycerides (all p < 0.001) nationwide. The direction and magnitude of the population changes were replicated at the personal level in LIPIDOGRAM PLUS (0.7%, 0.3%, 8.6% and 1.8%, respectively). However, increases in BMI and waist circumference were both only weakly associated with HDL-cholesterol and triglycerides changes prospectively. The relation of BMI to the magnitude of change in both lipid fractions was comparable to that of waist circumference. Conclusions: Moderate changes in obesity measures tracked with a significant deterioration in measures of pro-atherogenic dyslipidaemia at both personal and population level. These associations were predominantly driven by factors not measureable directly through either BMI or waist circumference.	[Kaess, Bernhard M.; Nelson, Christopher P.; Charchar, Fadi J.; Samani, Nilesh J.; Tomaszewski, Maciej] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Kaess, Bernhard M.] Tech Univ Munich, Deutsch Herzzentrum, D-80290 Munich, Germany; [Kaess, Bernhard M.] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Jozwiak, Jacek; Slezak-Prochazka, Izabella; Slezak, Andrzej] Czestochowa Tech Univ, Dept Publ Hlth, Czestochowa, Poland; [Jozwiak, Jacek; Mastej, Miroslaw] Silesian Analyt Labs, Katowice, Poland; [Nelson, Christopher P.; Thompson, John R.; Samani, Nilesh J.; Tomaszewski, Maciej] NIHR Leicester Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Lukas, Witold] Med Univ Silesia, Dept Family Med, Zabrze, Poland; [Windak, Adam; Tomasik, Tomasz] Jagiellonian Univ, Coll Med, Dept Family Med, Krakow, Poland; [Grzeszczak, Wladyslaw] Med Univ Silesia, Dept Internal Dis Diabetol & Nephrol, Zabrze, Poland; [Tykarski, Andrzej] Univ Med Sci, Dept Hypertens Vasc Dis & Internal Dis, Poznan, Poland; [Gasowski, Jerzy] Jagiellonian Univ, Dept Internal Med & Gerontol, Coll Med, Krakow, Poland; [Charchar, Fadi J.] Univ Ballarat, Sch Hlth Sci, Ballarat, Vic 3353, Australia; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Regensburg; Technical University Czestochowa; Medical University Silesia; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University Silesia; Jagiellonian University; Collegium Medicum Jagiellonian University; Federation University Australia; University of Glasgow; University of Leicester	Tomaszewski, M (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	mt142@le.ac.uk	Jóźwiak, Jacek/AAN-6351-2020; Charchar, Fadi/I-6656-2017; Slezak-Prochazka, Izabella/F-7674-2019; Gąsowski, Jerzy/GPC-8774-2022; Gąsowski, Jerzy/CAF-0671-2022	Jóźwiak, Jacek/0000-0002-2645-7274; Charchar, Fadi/0000-0002-6164-9941; Slezak-Prochazka, Izabella/0000-0002-0707-2213; Gąsowski, Jerzy/0000-0002-8025-5323; Grzeszczak, Wladyslaw/0000-0003-1947-3783; Tomaszewski, Maciej/0000-0001-8215-6567; Sattar, Naveed/0000-0002-1604-2593; Windak, Adam/0000-0001-9844-8935; Lukas, Witold/0000-0003-2692-9611; Slezak, Andrzej/0000-0001-6818-2099; Nelson, Christopher/0000-0001-8025-2897; Tomasik, Tomasz/0000-0002-9109-4174	Schwarz Pharma; Silesian Analytical Laboratories; College of Family Physicians in Poland; European Union [LSHM-CT-2006-037593]	Schwarz Pharma; Silesian Analytical Laboratories; College of Family Physicians in Poland; European Union(European Commission)	LIPIDOGRAM project was supported by a research grant from Schwarz Pharma, Silesian Analytical Laboratories (the executive medical faculty of the study) and the The College of Family Physicians in Poland. BK's research fellowship in the Department of Cardiovascular Sciences, University of Leicester, was supported by the Cardiogenics project of the European Union (LSHM-CT-2006-037593). The funding bodies had no role in study design, collection, analysis and interpretation of data, writing the report, or submitting the paper for publication.	Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Brown JR, 2010, NEW ENGL J MED, V362, P2150, DOI 10.1056/NEJMp1003880; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Derby CA, 1998, ANN EPIDEMIOL, V8, P84, DOI 10.1016/S1047-2797(97)00130-0; Desroches S, 2006, J NUTR, V136, P1005, DOI 10.1093/jn/136.4.1005; Fletcher B, 2005, CIRCULATION, V112, P3184, DOI 10.1161/CIRCULATIONAHA.105.169180; Hillier TA, 2006, INT J EPIDEMIOL, V35, P190, DOI 10.1093/ije/dyi281; Ingelsson E, 2009, ARCH INTERN MED, V169, P279, DOI 10.1001/archinternmed.2008.561; Kaess BM, 2010, HEART, V96, P131, DOI 10.1136/hrt.2009.171520; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee DC, 2012, J AM COLL CARDIOL, V59, P665, DOI 10.1016/j.jacc.2011.11.013; Norman JE, 2003, INT J OBESITY, V27, P369, DOI 10.1038/sj.ijo.0802243; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Sinaiko AR, 2006, HYPERTENSION, V48, P730, DOI 10.1161/01.HYP.0000237863.24000.50; SOPKO G, 1985, METABOLISM, V34, P227, DOI 10.1016/0026-0495(85)90005-8; SPRAFKA JM, 1990, AM J EPIDEMIOL, V132, P489, DOI 10.1093/oxfordjournals.aje.a115685; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Williams PT, 2008, OBESITY, V16, P2163, DOI 10.1038/oby.2008.299; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86837	10.1371/journal.pone.0086837	http://dx.doi.org/10.1371/journal.pone.0086837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497983	gold, Green Published, Green Accepted			2022-12-27	WOS:000330621900041
J	Mukonzo, JK; Owen, JS; Ogwal-Okeng, J; Kuteesa, RB; Nanzigu, S; Sewankambo, N; Thabane, L; Gustafsson, LL; Ross, C; Aklillu, E				Mukonzo, Jackson K.; Owen, Joel S.; Ogwal-Okeng, Jasper; Kuteesa, Ronald B.; Nanzigu, Sarah; Sewankambo, Nelson; Thabane, Lehana; Gustafsson, Lars L.; Ross, Colin; Aklillu, Eleni			Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes	PLOS ONE			English	Article							PHARMACOKINETICS; THERAPY; PLASMA; INDIVIDUALS; FAILURE	Background: Pharmacogenetics contributes to inter-individual variability in pharmacokinetics (PK) of efavirenz (EFV), leading to variations in both efficacy and toxicity. The purpose of this study was to assess the effect of genetic factors on EFV pharmacokinetics, treatment outcomes and genotype based EFV dose recommendations for adult HIV-1 infected Ugandans. Methods: In total, 556 steady-state plasma EFV concentrations from 99 HIV infected patients (64 female) treated with EFV/lamivudine/zidovidine were analyzed. Patient genotypes for CYP2B6 (*6 & *11), CYP3A5 (*3,*6 & *7) and ABCB1 c.4046A>G, baseline biochemistries and CD4 and viral load change from baseline were determined. A one-compartment population PK model with first-order absorption (NONMEM) was used to estimate genotype effects on EFV pharmacokinetics. PK simulations were performed based upon population genotype frequencies. Predicted AUCs were compared between the product label and simulations for doses of 300 mg, 450 mg, and 600 mg. Results: EFV apparent clearance (CL/F) was 2.2 and 1.74 fold higher in CYP2B6*6 (*1/*1) and CYP2B6*6 (*1/*6) compared CYP2B6*6 (*6/*6) carriers, while a 22% increase in F1 was observed for carriers of ABCB1 c.4046A>G variant allele. Higher mean AUC was attained in CYP2B6 *6/*6 genotypes compared to CYP2B6 *1/*1 (p < 0.0001). Simulation based AUCs for 600 mg doses were 1.25 and 2.10 times the product label mean AUC for the Ugandan population in general and CYP2B6*6/*6 genotypes respectively. Simulated exposures for EFV daily doses of 300 mg and 450 mg are comparable to the product label. Viral load fell precipitously on treatment, with only six patients having HIV RNA >40 copies/mL after 84 days of treatment. No trend with exposure was noted for these six patients. Conclusion: Results of this study suggest that daily doses of 450 mg and 300 mg might meet the EFV treatment needs of HIV-1 infected Ugandans in general and individuals homozygous for CYP2B6*6 mutation, respectively.	[Mukonzo, Jackson K.; Ogwal-Okeng, Jasper; Kuteesa, Ronald B.; Nanzigu, Sarah; Sewankambo, Nelson] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Mukonzo, Jackson K.] Canadian HIV Trials Network, CIHR, Vancouver, BC, Canada; [Owen, Joel S.] Union Univ, Sch Pharm, Jackson, TN 38305 USA; [Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Anaesthesia, Hamilton, ON, Canada; [Gustafsson, Lars L.; Aklillu, Eleni] Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Ross, Colin] Univ British Columbia, Div Translat Therapeut, Vancouver, BC V5Z 1M9, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada	Makerere University; McMaster University; McMaster University; McMaster University; Karolinska Institutet; Karolinska University Hospital; University of British Columbia; McMaster University	Mukonzo, JK (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda.	mukojack@yahoo.co.uk	Nanzigu, Sarah/HGA-3602-2022; Aklillu, Eleni/ABG-3461-2021	Ross, Colin/0000-0003-1476-7037; Bisaso, Kuteesa R/0000-0001-7721-4005; Gustafsson, Lars Lennart/0000-0002-0063-552X; Mukonzo, Jackson/0000-0002-0573-1908; Aklillu, Eleni/0000-0002-9788-0790; Sewankambo, Nelson/0000-0001-9362-053X	CIHR Canadian HIV Trials Network (Clinical Trials Network); SIDA/SAREC [SWE 2007-270]	CIHR Canadian HIV Trials Network (Clinical Trials Network)(Canadian Institutes of Health Research (CIHR)); SIDA/SAREC	This study was funded in-part through a CIHR Canadian HIV Trials Network (Clinical Trials Network) international HIV postdoctoral grant and through a SIDA/SAREC, grant No. SWE 2007-270 to Makerere University-Karolinska Institutet research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Arab-Alameddine M, 2009, CLIN PHARMACOL THER, V85, P485, DOI 10.1038/clpt.2008.271; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Csajka C, 2003, CLIN PHARMACOL THER, V73, P20, DOI 10.1067/mcp.2003.22; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Gatanaga H, 2007, CLIN INFECT DIS, V45, P1230, DOI 10.1086/522175; Haas DW, 2004, AIDS, V18, P2391; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Leutscher PD, 2013, SCAND J INFECT DIS; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Mello AF, 2011, ANTIVIR THER, V16, P189, DOI 10.3851/IMP1742; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Puls R, 2013, IAS 2013; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rotger Margalida, 2006, Curr HIV/AIDS Rep, V3, P118, DOI 10.1007/BF02696655; Sanchez A, 2011, ANTIMICROB AGENTS CH, V55, P5314, DOI 10.1128/AAC.00194-11; Solas C, 2011, THERAPIE, V66, P197, DOI 10.2515/therapie/2011033; Stohr W, 2008, ANTIVIR THER, V13, P675; Torno MS, 2008, PHARMACOTHERAPY, V28, P782, DOI 10.1592/phco.28.6.782; WADE JR, 1993, J PHARMACOKINET BIOP, V21, P209, DOI 10.1007/BF01059771; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; World Health Organization (WHO), 2009, WHOHTMTB2009420; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34	28	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86919	10.1371/journal.pone.0086919	http://dx.doi.org/10.1371/journal.pone.0086919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497997	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900048
J	Seddon, JM; Reynolds, R; Yu, Y; Rosner, B				Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi; Rosner, Bernard			Three New Genetic Loci (R1210C in CFH, Variants in COL8A1 and RAD51B) Are Independently Related to Progression to Advanced Macular Degeneration	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK PREDICTION MODELS; COMPLEMENT FACTOR-H; APOLIPOPROTEIN-E; SUSCEPTIBILITY; POLYMORPHISM; ROLES	Objectives: To assess the independent impact of new genetic variants on conversion to advanced stages of AMD, controlling for established risk factors, and to determine the contribution of genes in predictive models. Methods: In this prospective longitudinal study of 2765 individuals, 777 subjects progressed to neovascular disease (NV) or geographic atrophy (GA) in either eye over 12 years. Recently reported genetic loci were assessed for their independent effects on incident advanced AMD after controlling for 6 established loci in 5 genes, and demographic, behavioral, and macular characteristics. New variants which remained significantly related to progression were then added to a final multivariate model to assess their independent effects. The contribution of genes to risk models was assessed using reclassification tables by determining risk within cross-classified quintiles for alternative models. Results: Three new genetic variants were significantly related to progression: rare variant R1210C in CFH (hazard ratio (HR) 2.5, 95% confidence interval [CI] 1.2-5.3, P = 0.01), and common variants in genes COL8A1 (HR 2.0, 95% CI 1.1-3.5, P = 0.02) and RAD51B (HR 0.8, 95% CI 0.60-0.97, P = 0.03). The area under the curve statistic (AUC) was significantly higher for the 9 gene model (. 884) vs the 0 gene model (. 873), P = .01. AUC's for the 9 vs 6 gene models were not significantly different, but reclassification analyses indicated significant added information for more genes, with adjusted odds ratios (OR) for progression within 5 years per one quintile increase in risk score of 2.7, P<0.001 for the 9 vs 6 loci model, and OR 3.5, P<0.001 for the 9 vs. 0 gene model. Similar results were seen for NV and GA. Conclusions: Rare variant CFH R1210C and common variants in COL8A1 and RAD51B plus six genes in previous models contribute additional predictive information for advanced AMD beyond macular and behavioral phenotypes.	[Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi] Tufts Univ, Sch Med, Ophthalm Epidemiol & Genet Serv, Boston, MA 02111 USA; [Seddon, Johanna M.; Reynolds, Robyn; Yu, Yi] New England Eye Ctr, Tufts Med Ctr, Boston, MA USA; [Seddon, Johanna M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA; [Rosner, Bernard] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Rosner, Bernard] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Tufts University; Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Seddon, JM (corresponding author), Tufts Univ, Sch Med, Ophthalm Epidemiol & Genet Serv, Boston, MA 02111 USA.	jseddon@tuftsmedicalcenter.org			National Institutes of Health [RO1-EY11309]; Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness; Research to Prevent Blindness; American Macular Degeneration Foundation; Macula Vision Research Foundation; Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA; NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); American Macular Degeneration Foundation; Macula Vision Research Foundation; Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grant RO1-EY11309 from the National Institutes of Health; Massachusetts Lions Eye Research Fund; Foundation Fighting Blindness; unrestricted grants from Research to Prevent Blindness; American Macular Degeneration Foundation; Macula Vision Research Foundation; and the Macular Degeneration Research Fund, Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosner B, 2009, BIOMETRICS, V65, P188, DOI 10.1111/j.1541-0420.2008.01062.x; Rosner B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2110; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Seddon JM, 2013, JAMA OPHTHALMOL, V131, P448, DOI 10.1001/jamaophthalmol.2013.2578; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Seddon JM, 2013, FARADAY DISCUSS, V161, P9, DOI 10.1039/c2fd90045a; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; TAMURA Y, 1991, INVEST OPHTH VIS SCI, V32, P2636; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270	34	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87047	10.1371/journal.pone.0087047	http://dx.doi.org/10.1371/journal.pone.0087047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498017	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900062
J	Vytlacil, J; Kayser, A; Miyakawa, A; D'Esposito, M				Vytlacil, Jason; Kayser, Andrew; Miyakawa, Asako; D'Esposito, Mark			An Approach for Identifying Brainstem Dopaminergic Pathways Using Resting State Functional MRI	PLOS ONE			English	Article							WORKING-MEMORY; CONNECTIVITY	Here, we present an approach for identifying brainstem dopaminergic pathways using resting state functional MRI. In a group of healthy individuals, we searched for significant functional connectivity between dopamine-rich midbrain areas (substantia nigra; ventral tegmental area) and a striatal region (caudate) that was modulated by both a pharmacological challenge (the administration of the dopaminergic agonist bromocriptine) and a dopamine-sensitive cognitive trait (an individual's working memory capacity). A significant inverted-U shaped connectivity pattern was found in a subset of midbrain-striatal connections, demonstrating that resting state fMRI data is sufficiently powerful to identify brainstem neuromodulatory brain networks.	[Vytlacil, Jason; Miyakawa, Asako; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Vytlacil, Jason; D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kayser, Andrew] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Vytlacil, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	jvytlacil@berkeley.edu			National Institutes of Health Grants [MH63901, NS40813, DA02060]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants MH63901, NS40813, and DA02060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Cools R, 2009, DOPAMINE HDB, P249; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; Dodds CM, 2009, PSYCHOPHARMACOLOGY, V207, P35, DOI 10.1007/s00213-009-1634-0; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox PT, 2005, HUM BRAIN MAPP, V25, P1, DOI 10.1002/hbm.20139; Fox PT, 2002, NAT REV NEUROSCI, V3, P319, DOI 10.1038/nrn789; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haber SN, 2000, J NEUROSCI, V20, P2369; Honey GD, 2003, BRAIN, V126, P1767, DOI 10.1093/brain/awg184; Jenkins GM, 1968, SPECTRAL ANAL ITS AP; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Nagano-Saito A, 2008, J NEUROSCI, V28, P3697, DOI 10.1523/JNEUROSCI.3921-07.2008; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Wallace DL, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00032	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87109	10.1371/journal.pone.0087109	http://dx.doi.org/10.1371/journal.pone.0087109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498023	Green Submitted, Green Published, gold			2022-12-27	WOS:000330621900066
J	Hayat, T; Awais, M; Alsaedi, A; Safdar, A				Hayat, T.; Awais, M.; Alsaedi, A.; Safdar, Ambreen			On Computations for Thermal Radiation in MHD Channel Flow with Heat and Mass Transfer	PLOS ONE			English	Article							HOMOTOPY ANALYSIS METHOD; MOVING POROUS WALLS; 3RD GRADE FLUID; VISCOUS-FLOW; PLATE	This study examines the simultaneous effects of heat and mass transfer on the three-dimensional boundary layer flow of viscous fluid between two infinite parallel plates. Magnetohydrodynamic (MHD) and thermal radiation effects are present. The governing problems are first modeled and then solved by homotopy analysis method (HAM). Influence of several embedded parameters on the velocity, concentration and temperature fields are described.	[Hayat, T.; Safdar, Ambreen] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Dept Math, Jeddah 21413, Saudi Arabia; [Awais, M.] COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan	Quaid I Azam University; King Abdulaziz University; COMSATS University Islamabad (CUI)	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan.	awais_mm@yahoo.com	Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	The research of Dr. Alsaedi was partially supported by Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia. No addition external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P3140, DOI 10.1016/j.cnsns.2010.11.018; Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P112, DOI 10.1016/j.cnsns.2010.04.004; Akulenko LD, 2008, PMM-J APPL MATH MEC+, V72, P296, DOI 10.1016/j.jappmathmech.2008.07.007; Awais M, 2013, INT J NUMER IN PRESS; Bataineh AS, 2009, COMMUN NONLINEAR SCI, V14, P409, DOI 10.1016/j.cnsns.2007.10.007; Bataineh AS, 2008, COMPUT MATH APPL, V55, P2913, DOI 10.1016/j.camwa.2007.11.022; Dinarvand S, 2010, NONLINEAR ANAL-REAL, V11, P1502, DOI 10.1016/j.nonrwa.2009.03.006; Hayat T, 2013, PROG COMPUT FLUID DY, V13, P48, DOI 10.1504/PCFD.2013.050650; Hayat T, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12128-5; Hayat T, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4006032; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1378, DOI 10.1016/j.cnsns.2010.07.004; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Martinez DM, 2008, CHEM ENG SCI, V63, P1882, DOI 10.1016/j.ces.2007.12.015; Mehmood A, 2007, ACTA MECH SINICA-PRC, V23, P503, DOI 10.1007/s10409-007-0106-1; Nestor RM, 2010, COMPUT METHOD APPL M, V199, P2249, DOI 10.1016/j.cma.2010.03.015; Rashidi MM, 2012, COMPUT FLUIDS, V54, P1, DOI 10.1016/j.compfluid.2011.08.001; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; Sahoo B, 2010, INT COMMUN HEAT MASS, V37, P1064, DOI 10.1016/j.icheatmasstransfer.2010.06.018; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Zhang SY, 2005, APPL MATH COMPUT, V171, P1081, DOI 10.1016/j.amc.2005.01.111	20	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86695	10.1371/journal.pone.0086695	http://dx.doi.org/10.1371/journal.pone.0086695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497968	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100025
J	Kanai, T; Seki, S; Jenks, JA; Kohli, A; Kawli, T; Martin, DP; Snyder, M; Bacchetta, R; Nadeau, KC				Kanai, Takahiro; Seki, Scott; Jenks, Jennifer A.; Kohli, Arunima; Kawli, Trupti; Martin, Dorrelyn Patacsil; Snyder, Michael; Bacchetta, Rosa; Nadeau, Kari C.			Identification of STAT5A and STAT5B Target Genes in Human T Cells	PLOS ONE			English	Article							GROWTH-HORMONE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; FAMILY CYTOKINES; MESSENGER-RNA; ALPHA-CHAIN; EXPRESSION; MUTATION; IMMUNODEFICIENCY; DEFICIENCY	Signal transducer and activator of transcription (STAT) comprises a family of universal transcription factors that help cells sense and respond to environmental signals. STAT5 refers to two highly related proteins, STAT5A and STAT5B, with critical function: their complete deficiency is lethal in mice; in humans, STAT5B deficiency alone leads to endocrine and immunological problems, while STAT5A deficiency has not been reported. STAT5A and STAT5B show peptide sequence similarities greater than 90%, but subtle structural differences suggest possible non-redundant roles in gene regulation. However, these roles remain unclear in humans. We applied chromatin immunoprecipitation followed by DNA sequencing using human CD4(+) T cells to detect candidate genes regulated by STAT5A and/or STAT5B, and quantitative-PCR in STAT5A or STAT5B knock-down (KD) human CD4(+) T cells to validate the findings. Our data show STAT5A and STAT5B play redundant roles in cell proliferation and apoptosis via SGK1 interaction. Interestingly, we found a novel, unique role for STAT5A in binding to genes involved in neural development and function (NDRG1, DNAJC6, and SSH2), while STAT5B appears to play a distinct role in T cell development and function via DOCK8, SNX9, FOXP3 and IL2RA binding. Our results also suggest that one or more co-activators for STAT5A and/or STAT5B may play important roles in establishing different binding abilities and gene regulation behaviors. The new identification of these genes regulated by STAT5A and/or STAT5B has major implications for understanding the pathophysiology of cancer progression, neural disorders, and immune abnormalities.	[Kanai, Takahiro; Seki, Scott; Jenks, Jennifer A.; Kohli, Arunima; Bacchetta, Rosa; Nadeau, Kari C.] Stanford Univ, Dept Pediat, Sch Med, Div Immunol & Allergy, Stanford, CA 94305 USA; [Kawli, Trupti; Martin, Dorrelyn Patacsil; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bacchetta, Rosa] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy	Stanford University; Stanford University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kanai, T (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Immunol & Allergy, Stanford, CA 94305 USA.	tkanai@jichi.ac.jp		Bacchetta, Rosa/0000-0002-0606-6268; Snyder, Michael/0000-0003-0784-7987; Jenks, Jennifer/0000-0002-6865-5615	Clinical Immunological Society Jr. Faculty Award; Fondazione Telethon Funding Source: Custom	Clinical Immunological Society Jr. Faculty Award; Fondazione Telethon(Fondazione Telethon)	Clinical Immunological Society Jr. Faculty Award funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Goudy K, 2013, CLIN IMMUNOL, V146, P248, DOI 10.1016/j.clim.2013.01.004; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Jenks JA, 2013, CLIN IMMUNOL, V148, P227, DOI 10.1016/j.clim.2013.04.014; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Kelly J, 2003, J IMMUNOL, V170, P210, DOI 10.4049/jimmunol.170.1.210; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Laloraya M, 2006, DIABETES, V55, P734, DOI 10.2337/diabetes.55.03.06.db05-1059; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Lin FR, 2012, BLOOD, V120, P1039, DOI 10.1182/blood-2011-12-399808; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Markham K, 2007, MOL CELL NEUROSCI, V35, P272, DOI 10.1016/j.mcn.2007.03.001; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Messner MC, 2010, ADV EXP MED BIOL, V688, P156; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; NUNEZ G, 1994, IMMUNOL TODAY, V15, P582, DOI 10.1016/0167-5699(94)90221-6; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; Peng B, 2002, MOL ENDOCRINOL, V16, P2019, DOI 10.1210/me.2002-0108; Pugliese-Pires PN, 2010, EUR J ENDOCRINOL, V163, P349, DOI 10.1530/EJE-10-0272; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ronchi CL, 2012, J CLIN ENDOCR METAB, V97, pE2251, DOI 10.1210/jc.2012-2669; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Tran TH, 2010, CANCER RES, V70, P1711, DOI 10.1158/0008-5472.CAN-09-2314; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Van Dyken SJ, 2007, MOL CELL BIOL, V27, P1096, DOI 10.1128/MCB.01750-06; Vauthier V, 2012, MOL GENET METAB, V106, P345, DOI 10.1016/j.ymgme.2012.04.026; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	55	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86790	10.1371/journal.pone.0086790	http://dx.doi.org/10.1371/journal.pone.0086790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497979	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100031
J	Stoczynska-Fidelus, E; Piaskowski, S; Bienkowski, M; Banaszczyk, M; Hulas-Bigoszewska, K; Winiecka-Klimek, M; Radomiak-Zaluska, A; Och, W; Borowiec, M; Zieba, J; Treda, C; Rieske, P				Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester; Bienkowski, Michal; Banaszczyk, Mateusz; Hulas-Bigoszewska, Krystyna; Winiecka-Klimek, Marta; Radomiak-Zaluska, Anna; Och, Waldemar; Borowiec, Maciej; Zieba, Jolanta; Treda, Cezary; Rieske, Piotr			The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; INTEGRATED GENOMIC ANALYSIS; HUMAN GLIOMA-CELLS; MITOTIC CATASTROPHE; SELF-RENEWAL; STEM-CELLS; CANCER; EGFR; EXPRESSION; MULTIFORME	Cell line analysis is an important element of cancer research. Despite the progress in glioblastoma cell culturing, the cells isolated from the majority of specimens cannot be propagated infinitely in vitro. The aim of this study was to identify the processes responsible for the stabilization failure. Therefore, we analyzed 56 primary GB cultures, 7 of which were stabilized. Our results indicate that senescence is primarily responsible for the glioblastoma cell line stabilization failure, while mitotic catastrophe and apoptosis play a minor role. Moreover, a new technical approach allowed for a more profound analysis of the senescent cells in primary cultures, including the distinction between tumor and normal cells. In addition, we observed that glioblastoma cells in primary cultures have a varied potential to undergo spontaneous in vitro senescence, which is often higher than that of the normal cells infiltrating the tumor. Thus, this is the first report of GB cells in primary cell cultures (including both monolayer and spheroid conditions) rapidly and spontaneously becoming senescent. Intriguingly, our data also suggest that nearly half of GB cell lines have a combination of TP53 mutation and CDKN2A homozygous deletion, which are considered as mutually exclusive in glioblastoma. Moreover, recognition of the mechanisms of senescence and mitotic catastrophe in glioblastoma cells may be a step towards a potential new therapeutic approach.	[Stoczynska-Fidelus, Ewelina; Piaskowski, Sylwester; Banaszczyk, Mateusz; Winiecka-Klimek, Marta; Zieba, Jolanta; Treda, Cezary; Rieske, Piotr] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland; [Bienkowski, Michal; Hulas-Bigoszewska, Krystyna] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland; [Radomiak-Zaluska, Anna] Maria Sklodowska Curie Reg Specialist Hosp Zgierz, Lodz, Poland; [Och, Waldemar] Voivodal Specialist Hosp Olsztyn, Clin Dept Neurosurg, Olsztyn, Warmia, Poland; [Och, Waldemar] Voivodal Specialist Hosp Olsztyn, Clin Dept Neurosurg, Olsztyn, Masuria, Poland; [Borowiec, Maciej] Med Univ Lodz, Dept Paediat Oncol Haematol & Diabetol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Stoczynska-Fidelus, E (corresponding author), Med Univ Lodz, Dept Tumor Biol, Lodz, Poland.	ewelina.stoczynska-fidelus@umed.lodz.pl	Stoczynska-Fidelus, Ewelina/S-9948-2016; Bieńkowski, Michał/H-3046-2019; Rieske, Piotr/M-4821-2015; Borowiec, Maciej/S-9220-2016; Stoczynska-Fidelus, Ewelina/M-4871-2015	Bieńkowski, Michał/0000-0002-9291-3928; Rieske, Piotr/0000-0002-2970-0970; Borowiec, Maciej/0000-0003-2812-5676; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075; Och, Waldemar/0000-0001-7006-872X	National Science Centre [2011/03/N/NZ1/06534]; Polpharma Science Foundation	National Science Centre(National Science Centre, Poland); Polpharma Science Foundation	This study was sponsored by National Science Centre Grant No. 2011/03/N/NZ1/06534 (analyses of senescence) and by Polpharma Science Foundation (other analyses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; [Anonymous], 2008, NATURE, V455, P1061; Bienkowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065444; BIGNER SH, 1990, CANCER RES, V50, P8017; Bottger K, 2012, MATH MODEL NAT PHENO, V7, P105, DOI 10.1051/mmnp/20127106; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Clavreul A, 2012, J NEURO-ONCOL, V106, P493, DOI 10.1007/s11060-011-0701-7; Clement V, 2009, INT J CANCER, V125, P244, DOI 10.1002/ijc.24352; Angelini PD, 2013, CANCER RES, V73, P450, DOI 10.1158/0008-5472.CAN-12-2301; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Dhruv HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072134; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Firat E, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-71; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hirose Y, 2001, CANCER RES, V61, P5843; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Nomura M, 2004, J CELL PHYSIOL, V201, P374, DOI 10.1002/jcp.20090; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rajaraman R, 2005, CELL BIOL INT, V29, P1084, DOI 10.1016/j.cellbi.2005.10.003; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Rieske P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-54; SAUTER G, 1994, INT J CANCER, V57, P508, DOI 10.1002/ijc.2910570412; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Svensson S, 2003, CANCER RES, V63, P1737; Ueki K, 2002, CLIN CANCER RES, V8, P196; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Witusik-Perkowska M, 2011, J NEURO-ONCOL, V102, P395, DOI 10.1007/s11060-010-0352-0; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zupanska A, 2005, NEUROCHEM INT, V47, P430, DOI 10.1016/j.neuint.2005.05.010	50	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87136	10.1371/journal.pone.0087136	http://dx.doi.org/10.1371/journal.pone.0087136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498027	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100049
J	Xiong, XL; Qi, Y; Jiao, J; Gong, WP; Duan, CS; Wen, BH				Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Gong, Wenping; Duan, Changsong; Wen, Bohai			Exploratory Study on Th1 Epitope-Induced Protective Immunity against Coxiella burnetii Infection	PLOS ONE			English	Article							Q-FEVER; BACTERIAL CLEARANCE; PROTEIN MICROARRAY; BALB/C MICE; T-CELLS; VACCINE; INTERFERON; MATURATION; RESPONSES; PATHOGEN	Coxiella burnetii is a Gram-negative bacterium that causes Q fever in humans. In the present study, 131 candidate peptides were selected from the major immunodominant proteins (MIPs) of C. burnetii due to their high-affinity binding capacity for the MHC class II molecule H2 I-A(b) based on bioinformatic analyses. Twenty-two of the candidate peptides with distinct MIP epitopes were well recognized by the IFN-gamma recall responses of CD4(+) T cells from mice immunized with parental proteins in an ELISPOT assay. In addition, 7 of the 22 peptides could efficiently induce CD4(+) T cells from mice immunized with C. burnetii to rapidly proliferate and significantly increase IFN-gamma production. Significantly higher levels of IL-2, IL-12p70, IFN-gamma, and TNF-alpha were also detected in serum from mice immunized with a pool of the 7 peptides. Immunization with the pool of 7 peptides, but not the individual peptides, conferred a significant protection against C. burnetii infection in mice, suggesting that these Th1 peptides could work together to efficiently activate CD4(+) T cells to produce the Th1-type immune response against C. burnetii infection. These observations could contribute to the rational design of molecular vaccines for Q fever.	[Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Gong, Wenping; Duan, Changsong; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Jiao, Jun/ABE-7519-2021; Qi, Yong/AAK-8798-2021; Gong, Wenping/B-8183-2018	Qi, Yong/0000-0001-6186-9023; Gong, Wenping/0000-0002-0333-890X	National Natural Science Foundation of China [81371767, 31170161]; National Basic Research Program of China [2010CB530200/2010CB530205]; National Science and Technology Major Project of China [2013ZX10004803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project of China	This research was supported by grants (81371767 and 31170161) from the National Natural Science Foundation of China, a grant (2010CB530200/2010CB530205) from the National Basic Research Program of China, and a grant (2013ZX10004803) from the National Science and Technology Major Project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017712; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Gidding HF, 2009, VACCINE, V27, P2037, DOI 10.1016/j.vaccine.2009.02.007; HACKSTADT T, 1985, INFECT IMMUN, V48, P359, DOI 10.1128/IAI.48.2.359-365.1985; Hendrix LR, 2012, ADV EXP MED BIOL, V984, P299, DOI 10.1007/978-94-007-4315-1_16; Howe D, 2002, INFECT IMMUN, V70, P5140, DOI 10.1128/IAI.70.9.5140-5147.2002; Lockhart M, 2012, FEMS IMMUNOL MED MIC, V64, P61, DOI 10.1111/j.1574-695X.2011.00898.x; MARMION BP, 1984, LANCET, V2, P1411; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Maybeno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043481; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Peng Y, 2012, J IMMUNOL, V189, P4909, DOI 10.4049/jimmunol.1201622; Qi Y, 2013, VACCINE; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Sarchielli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068428; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shannon JG, 2009, IMMUNOL RES, V43, P138, DOI 10.1007/s12026-008-8059-4; TURCO J, 1984, INFECT IMMUN, V45, P781, DOI 10.1128/IAI.45.3.781-783.1984; Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064; Wei Y, 2011, J INFECT DIS, V203, P283, DOI 10.1093/infdis/jiq037; WEN BH, 1991, ACTA VIROL, V35, P538; WILLIAMS JC, 1981, INFECT IMMUN, V32, P840, DOI 10.1128/IAI.32.2.840-851.1981; Xiong XL, 2012, VACCINE, V30, P6809, DOI 10.1016/j.vaccine.2012.09.017; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35; Zhang GQ, 2004, INFECT IMMUN, V72, P844, DOI 10.1128/IAI.72.2.844-852.2004; Zhang GQ, 2007, J IMMUNOL, V179, P8372, DOI 10.4049/jimmunol.179.12.8372; Zhang Guoquan, 2004, Expert Rev Vaccines, V3, P577, DOI 10.1586/14760584.3.5.577; Zhang GQ, 2012, ADV EXP MED BIOL, V984, P91, DOI 10.1007/978-94-007-4315-1_5	32	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87206	10.1371/journal.pone.0087206	http://dx.doi.org/10.1371/journal.pone.0087206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498044	gold, Green Published, Green Submitted			2022-12-27	WOS:000330617100059
J	Yu, Y; Wei, JK; Zhang, XJ; Liu, JW; Liu, CZ; Li, FH; Xiang, JH				Yu, Yang; Wei, Jiankai; Zhang, Xiaojun; Liu, Jingwen; Liu, Chengzhang; Li, Fuhua; Xiang, Jianhai			SNP Discovery in the Transcriptome of White Pacific Shrimp Litopenaeus vannamei by Next Generation Sequencing	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE MAP; ATLANTIC COD; MICROSATELLITE; IDENTIFICATION; MARKERS; SUSCEPTIBILITY; ANNOTATION; RESOURCE	The application of next generation sequencing technology has greatly facilitated high throughput single nucleotide polymorphism (SNP) discovery and genotyping in genetic research. In the present study, SNPs were discovered based on two transcriptomes of Litopenaeus vannamei (L. vannamei) generated from Illumina sequencing platform HiSeq 2000. One transcriptome of L. vannamei was obtained through sequencing on the RNA from larvae at mysis stage and its reference sequence was de novo assembled. The data from another transcriptome were downloaded from NCBI and the reads of the two transcriptomes were mapped separately to the assembled reference by BWA. SNP calling was performed using SAMtools. A total of 58,717 and 36,277 SNPs with high quality were predicted from the two transcriptomes, respectively. SNP calling was also performed using the reads of two transcriptomes together, and a total of 96,040 SNPs with high quality were predicted. Among these 96,040 SNPs, 5,242 and 29,129 were predicted as non-synonymous and synonymous SNPs respectively. Characterization analysis of the predicted SNPs in L. vannamei showed that the estimated SNP frequency was 0.21% (one SNP per 476 bp) and the estimated ratio for transition to transversion was 2.0. Fifty SNPs were randomly selected for validation by Sanger sequencing after PCR amplification and 76% of SNPs were confirmed, which indicated that the SNPs predicted in this study were reliable. These SNPs will be very useful for genetic study in L. vannamei, especially for the high density linkage map construction and genome-wide association studies.	[Yu, Yang; Wei, Jiankai; Zhang, Xiaojun; Liu, Jingwen; Liu, Chengzhang; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yu, Yang; Wei, Jiankai; Liu, Jingwen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, FH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	fhli@qdio.ac.cn	zhang, jin/GXV-9154-2022; jingwen, liu/B-5167-2014; xiang, jianhai/A-4767-2012	jingwen, liu/0000-0002-9863-1235; xiang, jianhai/0000-0001-5395-7787	National High Technology Research and Development Program (863 Program) of China [2012AA10A404, 2012AA092205]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China)	This work is supported by National High Technology Research and Development Program (863 Program) of China (2012AA10A404, 2012AA092205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcivar-Warren A, 2007, J SHELLFISH RES, V26, P1259, DOI 10.2983/0730-8000(2007)26[1259:SALMLM]2.0.CO;2; An HS, 2011, INT J MOL SCI, V12, P9189, DOI 10.3390/ijms12129189; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Ciobanu DC, 2010, ANIM GENET, V41, P39, DOI 10.1111/j.1365-2052.2009.01961.x; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Glenn KL, 2005, ANIM GENET, V36, P235, DOI 10.1111/j.1365-2052.2005.01274.x; Gorbach DM, 2009, ANIM GENET, V40, P106, DOI 10.1111/j.1365-2052.2008.01792.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Liu CZ, 2012, CHIN J OCEANOL LIMN, V30, P713, DOI 10.1007/s00343-012-1252-2; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Matsunaga E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025272; Miller NJ, 2012, ENVIRON ENTOMOL, V41, P997, DOI 10.1603/EN11216; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moen T, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-18; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Perez F, 2004, AQUACULTURE, V242, P105, DOI 10.1016/j.aquaculture.2004.09.002; Prudence M, 2006, ANIM GENET, V37, P348, DOI 10.1111/j.1365-2052.2006.01481.x; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sha Z, 2010, J FISH BIOL, V76, P1190, DOI 10.1111/j.1095-8649.2010.02592.x; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tseng MC, 2012, INT J MOL SCI, V13, P4281, DOI 10.3390/ijms13044281; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Zakas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031613; Zeng DG, 2013, PLOS ONE, V8; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; Zhang LS, 2010, AQUACULTURE, V302, P124, DOI 10.1016/j.aquaculture.2010.02.012; Zhang X, 2010, 7 INT CRUST C QINGD, pP361	46	40	53	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87218	10.1371/journal.pone.0087218	http://dx.doi.org/10.1371/journal.pone.0087218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498047	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100062
J	Nguyen, MD; Lee, ST; Ross, AE; Ryals, M; Choudhry, VI; Venton, BJ				Nguyen, Michael D.; Lee, Scott T.; Ross, Ashley E.; Ryals, Matthew; Choudhry, Vishesh I.; Venton, B. Jill			Characterization of Spontaneous, Transient Adenosine Release in the Caudate-Putamen and Prefrontal Cortex	PLOS ONE			English	Article							CARBON-FIBER MICROELECTRODES; INTERSTITIAL FLUID ADENOSINE; EXTRACELLULAR ADENOSINE; NERVOUS-SYSTEM; BRAIN-SLICES; RAT-BRAIN; DOPAMINE; RECEPTORS; INCREASES; NEUROTRANSMISSION	Adenosine is a neuroprotective agent that inhibits neuronal activity and modulates neurotransmission. Previous researchhas shown adenosine gradually accumulates during pathologies such as stroke and regulates neurotransmission on the minute-to-hour time scale. Our lab developed a method using carbon-fiber microelectrodes to directly measure adenosine changes on a sub-second time scale with fast-scan cyclic voltammetry (FSCV). Recently, adenosine release lasting a couple of seconds has been found in murine spinal cord slices. In this study, we characterized spontaneous, transient adenosine release in vivo, in the caudate-putamen and prefrontal cortex of anesthetized rats. The average concentration of adenosine release was 0.17 +/- 0.01 mu M in the caudate and 0.19 +/- 0.01 mu M in the prefrontal cortex, although the range was large, from 0.04 to 3.2 mu M. The average duration of spontaneous adenosine release was 2.9 +/- 0.1 seconds and 2.8 +/- 0.1 seconds in the caudate and prefrontal cortex, respectively. The concentration and number of transients detected do not change over a four hour period, suggesting spontaneous events are not caused by electrode implantation. The frequency of adenosine transients was higher in the prefrontal cortex than the caudate-putamen and was modulated by A(1) receptors. The A(1) antagonist DPCPX (8-cyclopentyl-1,3-dipropylxanthine, 6 mg/kg i.p.) increased the frequency of spontaneous adenosine release, while the A(1) agonist CPA (N-6-cyclopentyladenosine, 1 mg/kg i.p.) decreased the frequency. These findings are a paradigm shift for understanding the time course of adenosine signaling, demonstrating that there is a rapid mode of adenosine signaling that could cause transient, local neuromodulation.	[Nguyen, Michael D.; Lee, Scott T.; Ross, Ashley E.; Ryals, Matthew; Choudhry, Vishesh I.; Venton, B. Jill] Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA	University of Virginia	Venton, BJ (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22903 USA.	bjv2n@virginia.edu	Venton, B. Jill/A-2902-2008	Venton, B. Jill/0000-0002-5096-9309; Ross, Ashley/0000-0003-2456-3636	National Institute of Health [R01NS076875]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076875] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This reasearch was supported by the National Institute of Health (R01NS076875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula KK, 2008, J CHROMATOGR A, V1209, P230, DOI 10.1016/j.chroma.2008.08.086; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; Cechova S, 2010, NEUROSCIENCE, V171, P1006, DOI 10.1016/j.neuroscience.2010.09.063; Cechova S, 2008, J NEUROCHEM, V105, P1253, DOI 10.1111/j.1471-4159.2008.05223.x; Chang SY, 2012, MAYO CLIN PROC, V87, P760, DOI 10.1016/j.mayocp.2012.05.006; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dryhurst G, 1977, ELECTROCHEMISTRY BIO, P71; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; DUNWIDDIE TV, 1994, J PHARMACOL EXP THER, V268, P537; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; FASTBOM J, 1987, NEUROSCIENCE, V22, P813, DOI 10.1016/0306-4522(87)92961-7; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Garris PA, 1997, J NEUROCHEM, V68, P152; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Huffman ML, 2008, ELECTROANAL, V20, P2422, DOI 10.1002/elan.200804343; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; KAKU T, 1994, BRAIN RES, V658, P39, DOI 10.1016/S0006-8993(09)90008-7; Karcz-Kubicha M, 2003, NEUROPSYCHOPHARMACOL, V28, P1281, DOI 10.1038/sj.npp.1300167; Keithley RB, 2009, TRAC-TREND ANAL CHEM, V28, P1127, DOI 10.1016/j.trac.2009.07.002; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Kobayashi T, 1998, BRAIN RES, V787, P211, DOI 10.1016/S0006-8993(97)01481-9; Kovacs Z, 2010, NEUROCHEM RES, V35, P452, DOI 10.1007/s11064-009-0080-z; LASLEY RD, 1995, AM J PHYSIOL-HEART C, V269, pH1460, DOI 10.1152/ajpheart.1995.269.4.H1460; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; MALINOWSKI ER, 1977, ANAL CHEM, V49, P606, DOI 10.1021/ac50012a026; Milton JS, 2003, INTRO PROBABILITY ST; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; NAYEBPOUR M, 1993, CIRCULATION, V88, P2632, DOI 10.1161/01.CIR.88.6.2632; Pajski ML, 2013, PURINERG SIGNAL, V9, P167, DOI 10.1007/s11302-012-9343-2; Pajski ML, 2010, ACS CHEM NEUROSCI, V1, P775, DOI 10.1021/cn100037d; Paxinos G, 2007, RAT BRAIN STEREOTAXI, V6; Peairs MJ, 2011, ANAL METHODS-UK, V3, P2379, DOI 10.1039/c1ay05348e; PHILLIS JW, 1987, J CEREBR BLOOD F MET, V7, P679, DOI 10.1038/jcbfm.1987.122; PIHEL K, 1995, ANAL CHEM, V67, P4514, DOI 10.1021/ac00120a014; Prediger RDS, 2004, EUR J PHARMACOL, V499, P147, DOI 10.1016/j.ejphar.2004.07.106; Ross AE, 2012, ANALYST, V137, P3045, DOI 10.1039/c2an35297d; Sanford AL, 2010, ANAL CHEM, V82, P5205, DOI 10.1021/ac100536s; Sharma R, 2010, ALCOHOL CLIN EXP RES, V34, P813, DOI 10.1111/j.1530-0277.2010.01153.x; SORICELLI A, 1995, STROKE, V26, P1572, DOI 10.1161/01.STR.26.9.1572; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; Strand AM, 2008, ANAL CHEM, V80, P3708, DOI 10.1021/ac8001275; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Swamy BEK, 2007, ANAL CHEM, V79, P744, DOI 10.1021/ac061820i; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; Venton BJ, 2003, J NEUROCHEM, V84, P373, DOI 10.1046/j.1471-4159.2003.01527.x; WATT AH, 1985, BRIT J CLIN PHARMACO, V20, P503, DOI 10.1111/j.1365-2125.1985.tb05108.x; Wei Z, 2006, J AM CHEM SOC, V128, P3134, DOI 10.1021/ja053950z; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; WINN HR, 1985, ANN BIOMED ENG, V13, P321, DOI 10.1007/BF02584250; Xu YD, 2010, PHYS CHEM CHEM PHYS, V12, P10027, DOI 10.1039/c0cp00294a; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X	58	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87165	10.1371/journal.pone.0087165	http://dx.doi.org/10.1371/journal.pone.0087165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24494035	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000112
J	Bekaert, M; Conant, GC				Bekaert, Michael; Conant, Gavin C.			Gene Duplication and Phenotypic Changes in the Evolution of Mammalian Metabolic Networks	PLOS ONE			English	Article							CALORIE RESTRICTION; ENERGY-METABOLISM; LONGEVITY; LIFE; TEMPERATURE; RECONSTRUCTION; MECHANISMS; RECEPTOR; DATABASE; HISTORY	Metabolic networks attempt to describe the complete suite of biochemical reactions available to an organism. One notable feature of these networks in mammals is the large number of distinct proteins that catalyze the same reaction. While the existence of these isoenzymes has long been known, their evolutionary significance is still unclear. Using a phylogenetically-aware comparative genomics approach, we infer enzyme orthology networks for sixteen mammals as well as for their common ancestors. We find that the pattern of isoenzymes copy-number alterations (CNAs) in these networks is suggestive of natural selection acting on the retention of certain gene duplications. When further analyzing these data with a machine-learning approach, we found that that the pattern of CNAs is also predictive of several important phenotypic traits, including milk composition and geographic range. Integrating tools from network analyses, phylogenetics and comparative genomics both allows the prediction of phenotypes from genetic data and represents a means of unifying distinct biological disciplines.	[Bekaert, Michael] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Conant, Gavin C.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Conant, Gavin C.] Univ Missouri, Inst Informat, Columbia, MO USA	University of Stirling; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Conant, GC (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	conantg@missouri.edu	Conant, Gavin/R-7022-2019	Conant, Gavin/0000-0002-8677-4933; Bekaert, Michael/0000-0002-1206-7654	University of Missouri; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri	University of Missouri; Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri	This work was supported by a Research Board grant from the University of Missouri (MB) and the Reproductive Biology Group of the Food for the 21st Century program at the University of Missouri (GCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter Paul S, 2004, Theor Biol Med Model, V1, P13, DOI 10.1186/1742-4682-1-13; Basler G, 2011, BIOINFORMATICS, V27, P1397, DOI 10.1093/bioinformatics/btr145; Bekaert M, 2011, MOL BIOL EVOL, V28, P1111, DOI 10.1093/molbev/msq296; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Chautard E, 2010, BIOGERONTOLOGY, V11, P463, DOI 10.1007/s10522-010-9268-5; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ebenhoh O, 2006, IEE P SYST BIOL, V153, P354, DOI 10.1049/ip-syb:20060014; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GREGORY TR, 2011, ANIMAL GENOME SIZE D; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hall M. A., 1998, CORRELATION BASED FE; Hao T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-393; Hedges SB, 2009, TIMETREE LIFE, Vxxi; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kondrashov FA, 2006, J THEOR BIOL, V239, P141, DOI 10.1016/j.jtbi.2005.08.033; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Messer M, 2002, TRENDS GLYCOSCI GLYC, V14, P153, DOI 10.4052/tigg.14.153; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Nakamura T, 2003, COMP BIOCHEM PHYS B, V135, P439, DOI 10.1016/S1096-4959(03)00093-9; Oftedal O. T., 1995, HDB MILK COMPOSITION, P749; Oksanen J., 2016, R PACKAG; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Park YW, 2006, HDB MILK NONBOVINE M, Vx; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; ROUSSEEUW PJ, 1987, WILEY SERIES PROBABI, V14, P329; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Selvarasu S, 2010, MOL BIOSYST, V6, P152, DOI 10.1039/b912865d; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Wagner A, 2008, BIOESSAYS, V30, P367, DOI 10.1002/bies.20728; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Witten I. H., 2005, DATA MINING PRACTICA; Wooden KM, 2002, J EXP BIOL, V205, P2099	69	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87115	10.1371/journal.pone.0087115	http://dx.doi.org/10.1371/journal.pone.0087115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489850	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000109
J	Liu, Z; Lebrin, F; Maring, JA; van den Driesche, S; van der Brink, S; van Dinther, M; Thorikay, M; Martin, S; Kobayashi, K; Hawinkels, LJAC; van Meeteren, LA; Pardali, E; Korving, J; Letarte, M; Arthur, HM; Theuer, C; Goumans, MJ; Mummery, C; ten Dijke, P				Liu, Zhen; Lebrin, Franck; Maring, Janita A.; van den Driesche, Sander; van der Brink, Stieneke; van Dinther, Maarten; Thorikay, Midory; Martin, Sabrina; Kobayashi, Kazuki; Hawinkels, Lukas J. A. C.; van Meeteren, Laurens A.; Pardali, Evangelia; Korving, Jeroen; Letarte, Michelle; Arthur, Helen M.; Theuer, Charles; Goumans, Marie-Jose; Mummery, Christine; ten Dijke, Peter			ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; EMBRYONIC STEM-CELLS; BLOOD-VESSEL DEVELOPMENT; BETA RECEPTOR COMPLEX; MOUSE BONE EXPLANTS; TGF-BETA; IN-VITRO; SIGNAL-TRANSDUCTION; BINDING-PROTEIN; KINASE	ENDOGLIN (ENG) is a co-receptor for transforming growth factor-beta (TGF-beta) family members that is highly expressed in endothelial cells and has a critical function in the development of the vascular system. Mutations in Eng are associated with the vascular disease known as hereditary hemorrhagic telangiectasia type l. Using mouse embryonic stem cells we observed that angiogenic factors, including vascular endothelial growth factor (VEGF), induce vasculogenesis in embryoid bodies even when Eng deficient cells or cells depleted of Eng using shRNA are used. However, ENG is required for the stem cell-derived endothelial cells to organize effectively into tubular structures. Consistent with this finding, fetal metatarsals isolated from E17.5 Eng heterozygous mouse embryos showed reduced VEGF-induced vascular network formation. Moreover, shRNA-mediated depletion and pharmacological inhibition of ENG in human umbilical vein cells mitigated VEGF-induced angiogenesis. In summary, we demonstrate that ENG is required for efficient VEGF-induced angiogenesis.	[Liu, Zhen; Maring, Janita A.; van Dinther, Maarten; Thorikay, Midory; Kobayashi, Kazuki; Hawinkels, Lukas J. A. C.; van Meeteren, Laurens A.; Pardali, Evangelia; Goumans, Marie-Jose; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol,Canc Gen Ctr, Leiden, Netherlands; [Lebrin, Franck; van den Driesche, Sander; van der Brink, Stieneke; Korving, Jeroen; Mummery, Christine] Hubrecht Inst, Utrecht, Netherlands; [Mummery, Christine] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Lebrin, Franck; Martin, Sabrina] Coll France, Ctr Interdisciplinary Res Biol CIRB, CNRS, UMR 7241,INSERM,U1050, F-75231 Paris, France; [Letarte, Michelle] Univ Toronto, Hosp Sick Children, Mol Struct & Funct Program, Dept Immunol, Toronto, ON, Canada; [Letarte, Michelle] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; [Arthur, Helen M.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Theuer, Charles] Tracon Pharmaceut, San Diego, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Newcastle University - UK	Goumans, MJ (corresponding author), Leiden Univ, Med Ctr, Ctr Biomed Genet, Dept Mol Cell Biol,Canc Gen Ctr, Leiden, Netherlands.	M.J.T.H.Goumans@lumc.nl; C.L.Mummery@lumc.nl; p.ten_dijke@lumc.nl	van Meeteren, Laurens/A-9890-2008; Hawinkels, Lukas/Q-5098-2019; Van Meeteren, Laurens A./AGQ-6139-2022; Arthur, Helen/C-7808-2009; van den Driesche, Sander/H-7094-2019; Goumans, Marie Jose/U-1455-2019; Dijke, Peter ten/AAG-4660-2021; Goumans, Marie-José/AAG-4994-2021	van Meeteren, Laurens/0000-0001-9885-0668; Hawinkels, Lukas/0000-0002-2274-9325; Goumans, Marie Jose/0000-0001-9344-6746; Dijke, Peter ten/0000-0002-7234-342X; Mummery, Christine/0000-0002-4549-6535; van Dinther, Maarten/0000-0002-9451-8884; Arthur, Helen/0000-0001-6522-1363; van den Driesche, Sander/0000-0002-8092-6588; lebrin, franck/0000-0002-1650-6757	Dutch Cancer Society [UL2011-5051]; Leducq Foundation; Royal Netherlands Academy of Arts and Sciences; Netherlands Institute for Regenerative Medicine (NIRM); Centre for Biomedical Genetics; British Heart Foundation [RG/12/2/29416] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); Leducq Foundation(Leducq Foundation); Royal Netherlands Academy of Arts and Sciences; Netherlands Institute for Regenerative Medicine (NIRM); Centre for Biomedical Genetics; British Heart Foundation(British Heart Foundation)	This study was supported by grants from Dutch Cancer Society (UL2011-5051), Leducq Foundation, the Royal Netherlands Academy of Arts and Sciences, Netherlands Institute for Regenerative Medicine (NIRM) and Centre for Biomedical Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9312; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Baik J, 2012, EXP HEMATOL, V40, P837, DOI 10.1016/j.exphem.2012.06.007; Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Bot PTG, 2009, STROKE, V40, P439, DOI 10.1161/STROKEAHA.108.522284; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Cho SK, 2001, BLOOD, V98, P3635, DOI 10.1182/blood.V98.13.3635; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deckers M, 2001, LAB INVEST, V81, P5, DOI 10.1038/labinvest.3780207; Feraud O, 2003, HISTOL HISTOPATHOL, V18, P191, DOI 10.14670/HH-18.191; Feraud O, 2001, LAB INVEST, V81, P1669, DOI 10.1038/labinvest.3780380; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; GOUGOS A, 1988, J IMMUNOL, V141, P1925; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 1999, DEVELOPMENT, V126, P3473; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Korff T, 1999, J CELL SCI, V112, P3249; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li X, 2009, J THROMB HAEMOST, V7, P53, DOI 10.1111/j.1538-7836.2009.03427.x; Liu Z, 2012, PREGNANCY HYPERTENS, V2, P358, DOI 10.1016/j.preghy.2012.06.003; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Nomura-Kitabayashi A, 2009, DEV BIOL, V335, P66, DOI 10.1016/j.ydbio.2009.08.016; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pardali E, 2011, ONCOGENE, V30, P334, DOI 10.1038/onc.2010.418; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Park S, 2013, J CELL SCI, V126, P1392, DOI 10.1242/jcs.117275; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Perlingeiro RCR, 2007, DEVELOPMENT, V134, P3041, DOI 10.1242/dev.002907; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROELEN BAJ, 1994, DEV BIOL, V166, P716, DOI 10.1006/dbio.1994.1350; Sambrook J., 2002, MOL CLONING LAB MANU; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; She XW, 2004, INT J CANCER, V108, P251, DOI 10.1002/ijc.11551; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SLAGER HG, 1993, J CELL PHYSIOL, V156, P247, DOI 10.1002/jcp.1041560205; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; VANDERPLUIJM G, 1991, J BONE MINER RES, V6, P1203; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; WANG R, 1992, DEVELOPMENT, V114, P303; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51	64	123	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86273	10.1371/journal.pone.0086273	http://dx.doi.org/10.1371/journal.pone.0086273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489709	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000042
J	Oyeyemi, AL; Umar, M; Oguche, F; Aliyu, SU; Oyeyemi, AY				Oyeyemi, Adewale L.; Umar, Maimuna; Oguche, Friday; Aliyu, Salamatu U.; Oyeyemi, Adetoyeje Y.			Accelerometer-Determined Physical Activity and Its Comparison with the International Physical Activity Questionnaire in a Sample of Nigerian Adults	PLOS ONE			English	Article							COMPUTER-SCIENCE; SELF-REPORT; FIELD-EVALUATION; LOW-INCOME; VALIDITY; RELIABILITY; POPULATION; IPAQ; INC.; VALIDATION	Introduction: Accurate assessment of physical activity to identify current levels and changes within the population is dependent on the precision of the measurement tools. The aim of this study was to compare components of physical activity measured with an adapted version of the International Physical Activity Questionnaire (Hausa IPAQ-SF) and the accelerometer in a sample of Nigeria adults. Methods: One hundred and forty-four participants (Mean age = 32.6+/-9.9 years, 40.3% women) in a cross-sectional study wore an accelerometer for seven consecutive days and completed the Hausa IPAQ-SF questionnaire on the eighth day. Total physical activity, time spent in moderate-to-vigorous activity (MVPA) and sedentary time assessed by Hausa IPAQ-SF and accelerometer were compared. The absolute and criterion-related validity of the Hausa IPAQ-SF was assessed by Bland-Altman analysis and Spearman Correlation Coefficients, respectively. Specificity and sensitivity were calculated to classify individuals according to the global standard guideline for sufficient physical activity. Results: Compared with the accelerometer, higher time in MVPA and total physical activity were reported on the Hausa IPAQ-SF (p < 0.001), while low to moderate correlations (Rs = 0.03-0.38) were found between the two methods. The 95% limits of agreement were wide between methods for total physical activity (-23019 to 20375 METmin.d(-1)) and sedentary time (-510 to 150 min.d(-1)). The sensitivity (76.2%) of Hausa IPAQ-SF to identify insufficiently active people was good, but its specificity (33.3%) to correctly classify sufficiently active people was low. Conclusions: The Hausa IPAQ-SF overestimated components of physical activity among Nigerian adults, and demonstrated poor to moderate evidence of absolute and criterion validity. Further evaluation of IPAQ and other self-report physical activity instruments in other Africa populations could enhance accurate evaluation of physical activity data in the region countries.	[Oyeyemi, Adewale L.; Aliyu, Salamatu U.; Oyeyemi, Adetoyeje Y.] Univ Maiduguri, Dept Physiotherapy, Coll Med Sci, Maiduguri, Nigeria; [Umar, Maimuna] Univ Maiduguri, Dept Physiotherapy, Teaching Hosp, Maiduguri, Nigeria; [Oguche, Friday] Univ Jos, Dept Physiotherapy, Teaching Hosp, Jos, Nigeria	University of Jos	Oyeyemi, AL (corresponding author), Univ Maiduguri, Dept Physiotherapy, Coll Med Sci, Maiduguri, Nigeria.	alaoyeyemi@yahoo.com	Oyeyemi, Adewale/AAA-2792-2019; Oyeyemi, Adetoyeje/AER-0978-2022	Oyeyemi, Adetoyeje/0000-0003-4395-443X; Oyeyemi, Adewale/0000-0002-3737-2911				[Anonymous], 2000, WHO TECH REP SER, P894; Bassett DR, 2000, RES Q EXERCISE SPORT, V71, pS30, DOI 10.1080/02701367.2000.11082783; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Bull FC, 2005, COMP QUANTIFICATION, P729; Chu AH, 2013, ASIA-PAC J PUBLIC HE, DOI 1010539512444120; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Cocker K, 2007, RES Q EXERCISE SPORT, V78, P429, DOI 10.5641/193250307X13082505158615; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Graff-Iversen S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-13; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2010, J PHYS ACT HEALTH, V7, P402, DOI 10.1123/jpah.7.3.402; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Johnson-Kozlow M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-7; Kerr J, 2013, J PHYS ACT IN PRESS; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kurtze N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-63; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Loney T, 2011, J PHYS ACT HEALTH, V8, P62, DOI 10.1123/jpah.8.1.62; Mackay LM, 2011, OPEN J PREV MED, V1, P13, DOI DOI 10.4236/0JPM.2011.12003; MELANSON EL, 1995, MED SCI SPORT EXER, V27, P934; Napolitano MA, 2010, CONTEMP CLIN TRIALS, V31, P514, DOI 10.1016/j.cct.2010.08.004; National African Language Resources Center, 2010, HAUS LANG CULT; National Bureau of Statistics, 2008, STAT FACT SHEET POP; National Population Commission (NPC) [Nigeria] and ORC Macro, 2004, NIG DEM HLTH SURV 20; Nicaise V, 2011, J PHYS ACT HEALTH, V8, P881, DOI 10.1123/jpah.8.7.881; Nichols JF, 2000, RES Q EXERCISE SPORT, V71, P36, DOI 10.1080/02701367.2000.10608878; Oyeyemi AL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-156; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Sirard JR, 2000, MED SCI SPORT EXER, V32, P695, DOI 10.1097/00005768-200003000-00022; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Sobngwi E, 2001, INT J EPIDEMIOL, V30, P1361, DOI 10.1093/ije/30.6.1361; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Washburn RA, 2000, RES Q EXERCISE SPORT, V71, pS104, DOI 10.1080/02701367.2000.11082793; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	48	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87233	10.1371/journal.pone.0087233	http://dx.doi.org/10.1371/journal.pone.0087233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489876	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000118
J	Weingartl, HM; Zhang, SZ; Marszal, P; McGreevy, A; Burton, L; Wilson, WC				Weingartl, Hana M.; Zhang, Shunzhen; Marszal, Peter; McGreevy, Alan; Burton, Lynn; Wilson, William C.			Rift Valley Fever Virus Incorporates the 78 kDa Glycoprotein into Virions Matured in Mosquito C6/36 Cells	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; EXPRESSION STRATEGY; DENDRITIC CELLS; M SEGMENT; DC-SIGN; PHLEBOVIRUS; NSM; ALPHAVIRUSES; REPLICATION; INFECTION	Rift Valley fever virus (RVFV), genus Phlebovirus, family Bunyaviridae is a zoonotic arthropod-borne virus able to transition between distant host species, causing potentially severe disease in humans and ruminants. Viral proteins are encoded by three genomic segments, with the medium M segment coding for four proteins: nonstructural NSm protein, two glycoproteins Gn and Gc and large 78 kDa glycoprotein (LGp) of unknown function. Goat anti-RVFV polyclonal antibody and mouse monoclonal antibody, generated against a polypeptide unique to the LGp within the RVFV proteome, detected this protein in gradient purified RVFV ZH501 virions harvested from mosquito C6/36 cells but not in virions harvested from the mammalian Vero E6 cells. The incorporation of LGp into the mosquito cell line - matured virions was confirmed by immune-electron microscopy. The LGp was incorporated into the virions immediately during the first passage in C6/36 cells of Vero E6 derived virus. Our data indicate that LGp is a structural protein in C6/36 mosquito cell generated virions. The protein may aid the transmission from the mosquitoes to the ruminant host, with a possible role in replication of RVFV in the mosquito host. To our knowledge, this is a first report of different protein composition between virions formed in insect C6/36 versus mammalian Vero E6 cells.	[Weingartl, Hana M.; Zhang, Shunzhen; Marszal, Peter; Burton, Lynn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Weingartl, Hana M.; McGreevy, Alan] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Wilson, William C.] USDA, Arthropod Borne Anim Dis Res Unit, Manhattan, KS USA	Canadian Food Inspection Agency; University of Manitoba; United States Department of Agriculture (USDA)	Weingartl, HM (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	hana.weingartl@inspection.gc.ca	Wilson, William/Y-8857-2019	Wilson, William/0000-0002-7877-9224	CFIA; USDA; ARS CRIS [5430-32000-005-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-07-00982];  [CRTI-06-0138RD]	CFIA; USDA(United States Department of Agriculture (USDA)); ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); 	The funding for the project was provided from the CRTI-06-0138RD project, by CFIA, the USDA, ARS CRIS project #5430-32000-005-00D, and through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-07-00982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSELAAR TG, 1991, ARCH VIROL, V121, P111, DOI 10.1007/BF01316748; Brennan B, 2011, J VITOL, V85; COLLETT MS, 1985, VIROLOGY, V144, P228, DOI 10.1016/0042-6822(85)90320-4; Crabtree MB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001639; Darpel KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017545; Drolet BS, 2012, J VIROL METHODS, V179, P373, DOI 10.1016/j.jviromet.2011.11.025; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; Fernandez JC, 2012, CLIN VACCINE IMMUNOL, V19, P5, DOI 10.1128/CVI.05420-11; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; He LL, 2010, J VIROL, V84, P5270, DOI 10.1128/JVI.00044-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Ikegami T, 2005, J VIROL, V79; KAKACH LT, 1989, VIROLOGY, V170, P505, DOI 10.1016/0042-6822(89)90442-X; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kumar M, 2011, MOL BIOSYST, V7, P1629, DOI 10.1039/c0mb00259c; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Nfon CK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001623; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Rusu M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00254; Shabman RS, 2007, J VIROL, V81, P237, DOI 10.1128/JVI.01590-06; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; STRUTHERS JK, 1984, VIROLOGY, V134, P118, DOI 10.1016/0042-6822(84)90277-0; SUZICH JA, 1990, J VIROL, V64, P1549, DOI 10.1128/JVI.64.4.1549-1555.1990; Vaughn VM, 2010, VIRUSES-BASEL, V2, P655, DOI 10.3390/v2020655; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06	29	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87385	10.1371/journal.pone.0087385	http://dx.doi.org/10.1371/journal.pone.0087385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489907	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000132
J	Zanotti, S; Kalajzic, I; Aguila, HL; Canalis, E				Zanotti, Stefano; Kalajzic, Ivo; Aguila, Hector Leonardo; Canalis, Ernesto			Sex and Genetic Factors Determine Osteoblastic Differentiation Potential of Murine Bone Marrow Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; GROWTH-FACTOR; MICE; MUSCLE; MOUSE; ACTIVATION; FATE; ARCHITECTURE; OSTEOCLASTS; DIMORPHISM	Sex and genetic factors determine skeletal mass, and we tested whether bone histomorphometric parameters were sexually dimorphic in femurs from 1 to 6 month old C57BL/6 mice. Trabecular bone volume declined more rapidly in female mice than in male littermates because of enhanced bone resorption. Although bone formation was not different between sexes, female mice exhibited a higher number of osteoblasts than male littermates, suggesting that osteoblasts from female mice may have a reduced ability to form bone. To determine the impact of sex on osteoblastogenesis, we investigated the potential for osteoblastic differentiation of bone marrow stromal cells from C57BL/6, Friend leukemia virus-B (FVB), C3H/HeJ and BALB/c mice of both sexes. Bone marrow stromal cells from female FVB, C57BL/6 and C3H/HeJ mice exhibited lower Alpl and Osteocalcin expression and alkaline phosphatase activity, and formed fewer mineralized nodules than cells from male littermates. Proliferative capacity was greater in cells from male than female C57BL/6, but not FVB, mice. Sorting of bone marrow stromal cells from mice expressing an alpha-Smooth muscle actin-green fluorescent protein transgene, revealed a higher yield of mesenchymal stem cells in cultures from male mice than in those from female littermates. Sex had a modest impact on osteoblastic differentiation of mesenchymal stem cells. To determine the influence of sex and genetic factors on osteoblast function, calvarial osteoblasts were harvested from C57BL/6, FVB, C3H/HeJ and BALB/c mice. Alpl expression and activity were lower in osteoblasts from C57BL/6 and C3H/HeJ, but not FVB or BALB/c, female mice than in cells from littermates. Sex had no effect on osteoclastogenesis of bone marrow cultures of C57BL/6 mice, but osteoblasts from female mice exhibited higher Rankl and lower Opg expression than cells from male littermates. In conclusion, osteoblastogenesis is sexually dimorphic and influenced by genetic factors.	[Zanotti, Stefano; Canalis, Ernesto] St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA; [Zanotti, Stefano; Canalis, Ernesto] Univ Connecticut, Sch Med, Ctr Hlth, Farmington, CT USA; [Kalajzic, Ivo] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT USA; [Aguila, Hector Leonardo] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA	Saint Francis Hospital & Medical Center; University of Connecticut; University of Connecticut; University of Connecticut	Zanotti, S (corresponding author), St Francis Hosp & Med Ctr, Dept Res, Hartford, CT 06105 USA.	szanotti@stfranciscare.org			Arthritis Foundation [5371]; National Institute of Diabetes, Digestive and Kidney Diseases [DK045227]; National Institute of Arthritis Musculoskeletal and Skin Diseases [AR021707, AR063049, AR055607]; National Heart, Lung, and Blood Institute, National Institutes of Health [HL100569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063049, R37AR021707, R01AR055607, R01AR021707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	Arthritis Foundation; National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by a Research Fellowship from the Arthritis Foundation (http://www.arthritis.org/), under Award Number 5371 (S.Z.), Grant from the National Institute of Diabetes, Digestive and Kidney Diseases, under Award Number DK045227 (E. C.), Grants from the National Institute of Arthritis Musculoskeletal and Skin Diseases, under Award Number AR021707, AR063049 (E. C.) and AR055607 (I. K.) and Grant from the National Heart, Lung, and Blood Institute, under Award Number HL100569 (H. L. A.), all part of the National Institutes of Health (http://www.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aksu AE, 2008, ANN PLAS SURG, V60, P306, DOI 10.1097/SAP.0b013e3180621ff0; Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Beamer WG, 2007, J BONE MINER RES, V22, P1187, DOI 10.1359/JBMR.070419; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Cahill L, 2012, ENDOCRINOLOGY, V153, P2541, DOI 10.1210/en.2011-2167; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; Canalis E, 2005, NEW ENGL J MED, V352, P2014, DOI 10.1056/NEJMe058080; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; Canalis E, 2010, ENDOCRINOLOGY, V151, P3490, DOI 10.1210/en.2010-0145; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Corsi KA, 2007, J BONE MINER RES, V22, P1592, DOI 10.1359/JBMR.070702; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; DeMambro VE, 2008, ENDOCRINOLOGY, V149, P2051, DOI 10.1210/en.2007-1068; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; HEFLEY T, 1981, AM J PHYSIOL, V240, pC234, DOI 10.1152/ajpcell.1981.240.5.C234; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; KAPLOW LS, 1955, BLOOD, V10, P1023, DOI 10.1182/blood.V10.10.1023.1023; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576; Sokal R. R, 1981, BIOMETRY; Strube P, 2009, BONE, V45, P1065, DOI 10.1016/j.bone.2009.08.005; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Wang JW, 1998, ENDOCRINOLOGY, V139, P2605, DOI 10.1210/en.139.5.2605; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; YATES AJ, 1991, J BONE MINER RES, V6, P473; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Zanotti S, 2013, J BIOL CHEM, V288, P21547, DOI 10.1074/jbc.M113.489435; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514	48	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86757	10.1371/journal.pone.0086757	http://dx.doi.org/10.1371/journal.pone.0086757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489784	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000078
J	Sawada, H; Oeda, T; Umemura, A; Tomita, S; Hayashi, R; Kohsaka, M; Yamamoto, K; Sudoh, S; Sugiyama, H				Sawada, Hideyuki; Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Hayashi, Ryutaro; Kohsaka, Masayuki; Yamamoto, Kenji; Sudoh, Shinji; Sugiyama, Hiroshi			Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson's Disease: Case-control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; PSYCHOSIS QUESTIONNAIRE; COGNITIVE IMPAIRMENT; HALLUCINATIONS; DEMENTIA; DIAGNOSIS; ASSOCIATION; MICROGLIA; MORTALITY	Background: Though infections are associated with psychotic symptoms, whether or not subclinical inflammation is associated with hallucinations is not known in Parkinson's disease (PD). Purpose: To investigate the association of illusions/hallucinations and plasma CRP levels in PD patients without symptomatic infections. Methods: PD patients not diagnosed as having infections were assessed for illusions and hallucinations using the Parkinson Psychosis Questionnaire (PPQ). It comprises four-domain questions: PPQ-A for sleep problems, PPQ-B for hallucinations/illusions, PPQ-C for delusions, and PPQ-D for disorientation. Assigning patients with >= 1 points in the PPQ-B score to be cases and others as controls, the association of hallucinations/illusions and clinical features (age, sex, duration of PD, Unified Parkinson's Disease Rating Scale part 3 (UPDRS-3), Mini-Mental State Examination (MMSE) score, sleep disturbance (PPQ-A score) as well as daily doses of L-Dopa, dopamine agonists, amantadine, and selegiline) were analyzed using a case-control design. Results: A total of 111 patients were examined and plasma CRP levels were <0.1-6.0 mg/L. Hallucinations or illusions were detected in 28 (25.2%). There were significant differences in age, UPDRS-3 score, MMSE score, PPQ-A, daily doses of L-Dopa and dopamine agonists and plasma CRP levels between cases and controls. A multivariate logistic regression model revealed that UPDRS-3 scores and plasma CRP levels were significantly associated with hallucinations/illusions with an adjusted odds ratio of 1.96 (95% confidence interval (CI) 1.20-3.20) per 10 points and 1.57 (95% confidence interval 1.13-2.16) per two-fold, respectively. Dividing patients into thirds by CRP levels (<= 0.2, 0.3-0.6, >= 0.7 mg/L), the prevalence of hallucinations/illusions was 13.2%, 21.6%, and 41.7%, in the bottom-, middle-, and top-thirds, respectively (for trend p=0.012). Conclusions: Subclinical elevation of plasma CRP levels was associated with hallucinations or illusions after adjustment for motor disability, suggesting that subclinical elevations of CRP levels might be an independent risk for hallucinations/illusions.	[Sawada, Hideyuki] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan; Natl Utano Hosp, Dept Neurol, Kyoto, Japan		Sawada, H (corresponding author), Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021; Yamamoto, Kenji/AAD-8766-2019	Umemura, Atsushi/0000-0001-8557-6014; Yamamoto, Kenji/0000-0003-1240-6369; Sawada, Hideyuki/0000-0002-5909-3366; Tomita, Satoshi/0000-0003-4410-6539	National Hospital Organization; National Hospital Organization, Japan	National Hospital Organization; National Hospital Organization, Japan	This study was supported by the National Hospital Organization. Drs Sawada, Oeda, Umemura, and Kohsaka have received grant support from National Hospital Organization, Japan. Dr Yamamoto has received a grant-in-aid from the Minister of Education, Science and Culture, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Brandstaedter D, 2005, J NEUROL, V252, P1060, DOI 10.1007/s00415-005-0816-x; Cao SW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-259; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; de Maindreville AD, 2005, MOVEMENT DISORD, V20, P212, DOI 10.1002/mds.20263; Factor SA, 2003, NEUROLOGY, V60, P1756, DOI 10.1212/01.WNL.0000068010.82167.CF; Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Fenelon G, 2010, MOVEMENT DISORD, V25, P763, DOI 10.1002/mds.22839; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Friedman JH, 2010, PARKINSONISM RELAT D, V16, P553, DOI 10.1016/j.parkreldis.2010.05.004; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; GOETZ CG, 1993, NEUROLOGY, V43, P2227, DOI 10.1212/WNL.43.11.2227; Goetz CG, 2001, NEUROLOGY, V57, P2078, DOI 10.1212/WNL.57.11.2078; Graham JM, 1997, J NEUROL NEUROSUR PS, V63, P434, DOI 10.1136/jnnp.63.4.434; Hassin-Baer S, 2011, J NEURAL TRANSM, V118, P539, DOI 10.1007/s00702-010-0535-z; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Lee AH, 2012, MOVEMENT DISORD, V27, P858, DOI 10.1002/mds.25003; Leroi I, 2006, J NEUROL SCI, V248, P104, DOI 10.1016/j.jns.2006.05.021; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; Lindqvist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047387; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Pacchetti C, 2005, MOVEMENT DISORD, V20, P1439, DOI 10.1002/mds.20582; Poewe Werner, 2008, Pract Neurol, V8, P238, DOI 10.1136/jnnp.2008.152579; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Ravina B, 2007, MOVEMENT DISORD, V22, P1061, DOI 10.1002/mds.21382; Sawada H, 2011, EUR J NEUROL, V18, P518; Sawada H, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-145; Sawada H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003533; Scalzo P, 2011, NEUROIMMUNOMODULAT, V18, P240, DOI 10.1159/000323779; Scalzo P, 2010, NEUROSCI LETT, V468, P56, DOI 10.1016/j.neulet.2009.10.062; Schrag A, 2006, PARKINSONISM RELAT D, V12, P35, DOI 10.1016/j.parkreldis.2005.06.011; Song IU, 2011, NEUROL SCI, V32, P31, DOI 10.1007/s10072-010-0335-0; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Suvisaari J, 2011, PSYCHIAT RES, V189, P305, DOI 10.1016/j.psychres.2011.07.006; Svetel M, 2012, ACTA NEUROL BELG, V112, P33, DOI 10.1007/s13760-012-0027-z; Voon Valerie, 2005, Adv Neurol, V96, P130; Williams DR, 2005, LANCET NEUROL, V4, P605, DOI 10.1016/S1474-4422(05)70146-0; Xu GL, 2009, J NEUROL SCI, V284, P77, DOI 10.1016/j.jns.2009.04.018	42	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85886	10.1371/journal.pone.0085886	http://dx.doi.org/10.1371/journal.pone.0085886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497930	Green Submitted, gold, Green Published			2022-12-27	WOS:000330621900011
J	Lian, PH; Sun, YF; Ji, ZG; Li, HZ; Peng, JX				Lian, Penghu; Sun, Yunfeng; Ji, Zhigang; Li, Hanzhong; Peng, Jiaxi			Moving Away from Exhaustion: How Core Self-Evaluations Influence Academic Burnout	PLOS ONE			English	Article							JOB-SATISFACTION; LIFE SATISFACTION; WORK SUCCESS; MODELS; PERSONALITY; ENGAGEMENT; MOTIVATION; RESOURCES; STUDENTS; COLLEGE	Background: Academic burnout refers to students who have low interest, lack of motivation, and tiredness in studying. Studies concerning how to prevent academic burnout are rare. Objective: The present study aimed to investigate the impact of core self-evaluations on the academic burnout of university students, and mainly focused on the confirmation of the mediator role of life satisfaction. Methods: A total of 470 university students accomplished the core self-evaluation scale, Satisfaction with Life, and academic burnout scale. Results: Both core self-evaluations and life satisfaction were significantly correlated with academic burnout. Structural equation modeling indicated that life satisfaction partially mediated the relationship between core self-evaluations and academic burnout. Conclusions: Core self-evaluations significantly influence academic burnout and are partially mediated by life satisfaction.	[Lian, Penghu; Ji, Zhigang; Li, Hanzhong] Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Lian, Penghu; Ji, Zhigang; Li, Hanzhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yunfeng] Natl Def Univ, Polit Work Acad Dept, Beijing, Peoples R China; [Peng, Jiaxi] Forth Mil Med Univ, Dept Psychol, Xian, Shaanxi, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Air Force Military Medical University	Li, HZ (corresponding author), Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	lihanzhong@medmail.com.cn; pengjx880124@sina.com						Anderson James C., 1988, PSYCHOL BULL, V103, P411, DOI [DOI 10.1037/0033-2909.103.3.411, 10.1037/0033-2909.103.3.411]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; BIELBY WT, 1977, ANNU REV SOCIOL, V3, P137, DOI 10.1146/annurev.so.03.080177.001033; Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649; Chamorro-Premuzic T, 2008, LEARN INDIVID DIFFER, V18, P258, DOI 10.1016/j.lindif.2007.09.002; CLOGG CC, 1992, J EDUC STAT, V17, P51, DOI 10.3102/10769986017001051; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Erez A, 2001, J APPL PSYCHOL, V86, P1270, DOI 10.1037/0021-9010.86.6.1270; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Haydock Deborah, 2011, Community Pract, V84, P19; Hobfoll SE, 2002, REV GEN PSYCHOL, V6, P307, DOI 10.1037//1089-2680.6.4.307; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JACOBS SR, 2003, J COLL STUDENT DEV, V44, P291, DOI DOI 10.1353/CSD.2003.0028; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Judge TA, 2008, J APPL PSYCHOL, V93, P849, DOI 10.1037/0021-9010.93.4.849; Judge TA, 2009, J APPL PSYCHOL, V94, P742, DOI 10.1037/a0015497; Judge TA, 2009, CURR DIR PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-8721.2009.01606.x; KAFRY D, 1980, HUM RELAT, V33, P477, DOI 10.1177/001872678003300703; Kline RB, 1998, J PSYCHOEDUC ASSESS, V16, P343, DOI 10.1177/073428299801600407; Kong Y, 2010, CHINESE J CLIN PSYCH, V19, P234; Lee J, 2010, STRESS HEALTH, V26, P404, DOI 10.1002/smi.1312; [连榕 Lian Rong], 2005, [心理学报, Acta Psychologica Sinica], V37, P632; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Ng TWH, 2008, J VOCAT BEHAV, V73, P268, DOI 10.1016/j.jvb.2008.05.004; Piccolo RF, 2005, J ORGAN BEHAV, V26, P965, DOI 10.1002/job.358; Ronen S, 2012, EUR J WORK ORGAN PSY, V21, P828, DOI 10.1080/1359432X.2011.595561; Rosopa PJ, 2009, PERS INDIV DIFFER, V47, P1003, DOI 10.1016/j.paid.2009.07.028; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Scott BA, 2009, J APPL PSYCHOL, V94, P20, DOI 10.1037/a0012951; Slivar B., 2001, HORIZONS PSYCHOL, V10, P21; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stumpp T, 2009, EUR J WORK ORGAN PSY, V18, P148, DOI 10.1080/13594320802281110; Taylor AB, 2008, ORGAN RES METHODS, V11, P241, DOI 10.1177/1094428107300344; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Visser MRM, 2003, CAN MED ASSOC J, V168, P271; Wanberg CR, 2005, J APPL PSYCHOL, V90, P411, DOI 10.1037/0021-9010.90.3.411; Williams J, 2008, STRUCT EQU MODELING, V15, P23, DOI 10.1080/10705510701758166; Yagil D, 2008, INT J SERV IND MANAG, V19, P575, DOI 10.1108/09564230810903479; Yang HJ, 2005, COMPUT HUM BEHAV, V21, P917, DOI 10.1016/j.chb.2004.03.001; Zhang JX, 2014, SOC INDIC RES, V116, P809, DOI 10.1007/s11205-013-0328-5; Zhang YW, 2007, PERS INDIV DIFFER, V43, P1529, DOI 10.1016/j.paid.2007.04.010	48	29	31	8	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87152	10.1371/journal.pone.0087152	http://dx.doi.org/10.1371/journal.pone.0087152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489857	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000109
J	Pollatos, O; Laubrock, J; Wittmann, M				Pollatos, Olga; Laubrock, Jochen; Wittmann, Marc			Interoceptive Focus Shapes the Experience of Time	PLOS ONE			English	Article							NEURAL MECHANISMS; AWARENESS; EMOTION; SENSITIVITY; REACTIVITY; PERCEPTION; ANXIETY; INSULA	The perception of time is a fundamental part of human experience. Recent research suggests that the experience of time emerges from emotional and interoceptive (bodily) states as processed in the insular cortex. Whether there is an interaction between the conscious awareness of interoceptive states and time distortions induced by emotions has rarely been investigated so far. We aimed to address this question by the use of a retrospective time estimation task comparing two groups of participants. One group had a focus on interoceptive states and one had a focus on exteroceptive information while watching film clips depicting fear, amusement and neutral content. Main results were that attention to interoceptive processes significantly affected subjective time experience. Fear was accompanied with subjective time dilation that was more pronounced in the group with interoceptive focus, while amusement led to a quicker passage of time which was also increased by interoceptive focus. We conclude that retrospective temporal distortions are directly influenced by attention to bodily responses. These effects might crucially interact with arousal levels. Sympathetic nervous system activation affecting memory build-up might be the decisive factor influencing retrospective time judgments. Our data substantially extend former research findings underscoring the relevance of interoception for the effects of emotional states on subjective time experience.	[Pollatos, Olga] Univ Ulm, Inst Psychol, D-89069 Ulm, Germany; [Laubrock, Jochen] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Wittmann, Marc] Inst Frontier Areas Psychol & Mental Hlth, Dept Empir & Analyt Psychophys, Freiburg, Germany	Ulm University; University of Potsdam	Pollatos, O (corresponding author), Univ Ulm, Inst Psychol, D-89069 Ulm, Germany.	olga.pollatos@uni-ulm.de	Wittmann, Marc/ABC-6363-2020; Laubrock, Jochen/B-8080-2008	Wittmann, Marc/0000-0002-4483-7334; Laubrock, Jochen/0000-0002-0798-8977	German Research Council (DFG); Research Group Computational Modeling of Behavioral, Cognitive, and Neural Dynamics [PO 1011/2-1, FOR 868]	German Research Council (DFG)(German Research Foundation (DFG)); Research Group Computational Modeling of Behavioral, Cognitive, and Neural Dynamics	This study was funded by the German Research Council (DFG) and a grant to Olga Pollatos (PO 1011/2-1) participating in the Research Group Computational Modeling of Behavioral, Cognitive, and Neural Dynamics (FOR 868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cocenas-Silva R, 2012, MEM COGNITION, V40, P161, DOI 10.3758/s13421-011-0145-5; Craig AD, 2009, PHILOS T R SOC B, V364, P1933, DOI 10.1098/rstb.2009.0008; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Droit-Volet S, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00033; Dunn BD, 2010, PSYCHOL SCI, V21, P1835, DOI 10.1177/0956797610389191; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2012, TOP COGN SCI, V4, P692, DOI 10.1111/j.1756-8765.2012.01189.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jones G.E., 1994, PERCEPTION VISCERAL; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Meissner K, 2011, BIOL PSYCHOL, V86, P289, DOI 10.1016/j.biopsycho.2011.01.001; Mella N, 2011, BRAIN COGNITION, V75, P182, DOI 10.1016/j.bandc.2010.11.012; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Pollatos O, 2008, COGNITION EMOTION, V22, P272, DOI 10.1080/02699930701357535; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2012, PAIN, V153, P1680, DOI 10.1016/j.pain.2012.04.030; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; Wittmann M, 2011, BRAIN RES, V1406, P43, DOI 10.1016/j.brainres.2011.06.048; Wittmann M, 2010, NEUROPSYCHOLOGIA, V48, P3110, DOI 10.1016/j.neuropsychologia.2010.06.023; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Wittmann M, 2009, PHILOS T R SOC B, V364, P1809, DOI 10.1098/rstb.2009.0025; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604	37	40	41	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86934	10.1371/journal.pone.0086934	http://dx.doi.org/10.1371/journal.pone.0086934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489807	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000081
J	Alistar, SS; Owens, DK; Brandeau, ML				Alistar, Sabina S.; Owens, Douglas K.; Brandeau, Margaret L.			Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; METHADONE-MAINTENANCE; AFRICAN WOMEN; INFECTION; UKRAINE; TRANSMISSION; MEN; RISK; SEX	Background: Pre-exposure prophylaxis with oral antiretroviral treatment (oral PrEP) for HIV-uninfected injection drug users (IDUs) is potentially useful in controlling HIV epidemics with a significant injection drug use component. We estimated the effectiveness and cost effectiveness of strategies for using oral PrEP in various combinations with methadone maintenance treatment (MMT) and antiretroviral treatment (ART) in Ukraine, a representative case for mixed HIV epidemics. Methods and Findings: We developed a dynamic compartmental model of the HIV epidemic in a population of non-IDUs, IDUs who inject opiates, and IDUs in MMT, adding an oral PrEP program (tenofovir/emtricitabine, 49% susceptibility reduction) for uninfected IDUs. We analyzed intervention portfolios consisting of oral PrEP (25% or 50% of uninfected IDUs), MMT (25% of IDUs), and ART (80% of all eligible patients). We measured health care costs, quality-adjusted life years (QALYs), HIV prevalence, HIV infections averted, and incremental cost effectiveness. A combination of PrEP for 50% of IDUs and MMT lowered HIV prevalence the most in both IDUs and the general population. ART combined with MMT and PrEP (50% access) averted the most infections (14,267). For a PrEP cost of $950, the most cost-effective strategy was MMT, at $520/QALY gained versus no intervention. The next most cost-effective strategy consisted of MMT and ART, costing $1,000/QALY gained compared to MMT alone. Further adding PrEP (25% access) was also cost effective by World Health Organization standards, at $1,700/QALY gained. PrEP alone became as cost effective as MMT at a cost of $650, and cost saving at $370 or less. Conclusions: Oral PrEP for IDUs can be part of an effective and cost-effective strategy to control HIV in regions where injection drug use is a significant driver of the epidemic. Where budgets are limited, focusing on MMT and ART access should be the priority, unless PrEP has low cost.	[Alistar, Sabina S.; Brandeau, Margaret L.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Owens, Douglas K.] Vet Affairs Palo Healthcare Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Ctr Hlth Policy, Program Clin Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University	Alistar, SS (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	ssabina@stanford.edu			National Institute on Drug Abuse [R01DA15612]; Department of Veterans Affairs; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Grant Number R01DA15612 from the National Institute on Drug Abuse. Dr. Owens is supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; [Anonymous], 2013, E CAT ARVS; [Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], 2008, GUIDELINES USE ANTIR; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barcal Katerina, 2005, Harm Reduct J, V2, P16, DOI 10.1186/1477-7517-2-16; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Booth RE, 2006, DRUG ALCOHOL DEPEN, V82, pS49, DOI 10.1016/S0376-8716(06)80009-8; Bruce RD, 2007, INT J DRUG POLICY, V18, P326, DOI 10.1016/j.drugpo.2006.12.011; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Celentano DD, 2008, HIV CENTRAL ASIA TAJ, P557; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connock M, 2007, METHADONE BUPRENORPH; Cremin I, 2013, AIDS, V27, P447, DOI 10.1097/QAD.0b013e32835ca2dd; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dvoriak S, 2007, 4 IAS C HIV PATH TRE; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gold MR, 1996, COST EFFECTIVENESS H; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Gomez GB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001323; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; GRONBLADH L, 1989, DRUG ALCOHOL DEPEN, V24, P31, DOI 10.1016/0376-8716(89)90005-7; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; International HIV/AIDS Alliance in Ukraine, 2008, METH SUBST THER STAR; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, UKR NAT REP MON PROG; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008, UKR COUNTR SIT FACT; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Long EF, 2013, J GEN INT MED; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; MacArthur GJ, BMJ, V345, pe5945; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health of Ukraine, 2012, UKR HARM AIDS RESP P; Murray C. J., 2002, WORLD HLTH REPORT 20; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Nichols BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059549; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Pinkerton SD, 1997, SOC SCI MED, V44, P1303, DOI 10.1016/S0277-9536(96)00258-4; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; The World Bank, 2013, GDP PER CAP PPP CURR; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2012, UNAIDS GLOB REP AIDS; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, EP FACTSH HIV AIDS C; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; WHO, 2013, DAT HIV AIDS RESP AN; WHO, 2003, MAKING CHOICES HLTH; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organization, 2009, GLOB PRIC REP MECH; World Health Organization, 2006, ANT THER HIV INF AD; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zaric GS, 2000, MANAGE SCI, V46, P1013, DOI 10.1287/mnsc.46.8.1013.12025	62	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86584	10.1371/journal.pone.0086584	http://dx.doi.org/10.1371/journal.pone.0086584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489747	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000062
J	Ashlock, BM; Ma, Q; Issac, B; Mesri, EA				Ashlock, Brittany M.; Ma, Qi; Issac, Biju; Mesri, Enrique A.			Productively Infected Murine Kaposi's Sarcoma-Like Tumors Define New Animal Models for Studying and Targeting KSHV Oncogenesis and Replication	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; GENE-EXPRESSION; HERPESVIRUS REPLICATION; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS; PRECURSOR CELLS; DNA-SEQUENCES; DOUBLE-BLIND; STEM-CELLS; IN-VIVO	Kaposi's sarcoma (KS) is an AIDS-defining cancer caused by the KS-associated herpesvirus (KSHV). KS tumors are composed of KSHV-infected spindle cells of vascular origin with aberrant neovascularization and erythrocyte extravasation. KSHV genes expressed during both latent and lytic replicative cycles play important roles in viral oncogenesis. Animal models able to recapitulate both viral and host biological characteristics of KS are needed to elucidate oncogenic mechanisms, for developing targeted therapies, and to trace cellular components of KS ontogeny. Herein, we describe two new murine models of Kaposi's sarcoma. We found that murine bone marrow-derived cells, whether established in culture or isolated from fresh murine bone marrow, were infectable with rKSHV.219, formed KS-like tumors in immunocompromised mice and produced mature herpesvirus-like virions in vivo. Further, we show in vivo that the histone deacetylase (HDAC) inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) enhanced viral lytic reactivation. We propose that these novel models are ideal for studying both viral and host contributions to KSHV-induced oncogenesis as well as for testing virally-targeted antitumor strategies for the treatment of Kaposi's sarcoma. Furthermore, our isolation of bone marrow-derived cell populations containing a cell type that, when infected with KSHV, renders a tumorigenic KS-like spindle cell, should facilitate systematic identification of KS progenitor cells.	[Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami Ctr AIDS Res, Miami, FL 33136 USA; [Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Ashlock, Brittany M.; Ma, Qi; Mesri, Enrique A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Viral Oncol Program, Miami, FL 33136 USA; [Issac, Biju] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Bioinformat,Biostat & Bioinformat Core, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Mesri, EA (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami Ctr AIDS Res, Miami, FL 33136 USA.	emesri@med.miami.edu		Issac, Biju/0000-0002-7311-678X	National Institutes of Health (NIH) [CA75918, CA136387]; National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) from Miami CFAR; Miami CFAR Grant [5P30AI073961]; Florida Biomedical Foundation BankHead Coley Grant [3BB05]; NATIONAL CANCER INSTITUTE [R01CA136387, R01CA075918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) from Miami CFAR; Miami CFAR Grant; Florida Biomedical Foundation BankHead Coley Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants CA75918 and CA136387, by National Cancer Institute/Office of HIV and AIDS Malignancy (NCI/OHAM) supplements from the Miami CFAR grant, and by the Miami CFAR Grant 5P30AI073961, and by a Florida Biomedical Foundation BankHead Coley Grant 3BB05 to EAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austgen K, 2012, J VIROL, V86, P1877, DOI 10.1128/JVI.06600-11; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bhatt S, 2013, J CLIN INVEST, V123, P2616, DOI 10.1172/JCI64503; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; Cancian L, 2013, TRENDS CELL BIOL, V23, P421, DOI 10.1016/j.tcb.2013.04.001; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Casper C, 2004, BLOOD, V103, P1632, DOI 10.1182/blood-2003-05-1721; Casper C, 2008, J INFECT DIS, V198, P23, DOI 10.1086/588820; Cattelan Anna M, 2002, Am J Clin Dermatol, V3, P451, DOI 10.2165/00128071-200203070-00002; Chang H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000606; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Cooley T, 2007, ONCOLOGIST, V12, P114, DOI 10.1634/theoncologist.12-1-114; Cornali E, 1996, AM J PATHOL, V149, P1851; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Dittmer D, 1999, J EXP MED, V190, P1857, DOI 10.1084/jem.190.12.1857; Fonseca AV, 2008, BLOOD CELL MOL DIS, V41, P194, DOI 10.1016/j.bcmd.2008.04.004; Fu DX, 2008, NAT MED, V14, P1118, DOI 10.1038/nm.1864; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Ghosh SK, 2012, BLOOD, V119, P1008, DOI 10.1182/blood-2011-06-362434; GOTTLIEB GJ, 1981, AM J DERMATOPATH, V3, P111, DOI 10.1097/00000372-198100320-00002; Grayson W, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-31; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530; Krishnan HH, 2005, J VIROL, V79, P10952, DOI 10.1128/JVI.79.17.10952-10967.2005; Lee HR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00044; Leung HJ, 2012, ANTIMICROB AGENTS CH, V56, P5794, DOI 10.1128/AAC.01126-12; Liu R, 2010, BLOOD, V115, P887, DOI 10.1182/blood-2009-08-236745; Ma T, 2010, P NATL ACAD SCI USA, V107, P14363, DOI 10.1073/pnas.1001065107; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Maskew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064392; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Nguyen HQ, 2008, AIDS, V22, P937, DOI 10.1097/QAD.0b013e3282ff6275; Orenstein JM, 1997, AIDS, V11, pF35, DOI 10.1097/00002030-199705000-00001; Parsons CH, 2004, BLOOD, V104, P2736, DOI 10.1182/blood-2004-02-0693; Parsons CH, 2006, J CLIN INVEST, V116, P1963, DOI 10.1172/JCI27249; Paul AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024379; Perrine SR, 2007, BLOOD, V109, P2571, DOI 10.1182/blood-2006-01-024703; Picchio GR, 1997, VIROLOGY, V238, P22, DOI 10.1006/viro.1997.8822; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Simonart T, 2000, BRIT J DERMATOL, V143, P557, DOI 10.1111/j.1365-2133.2000.03709.x; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staudt MR, 2004, CANCER RES, V64, P4790, DOI 10.1158/0008-5472.CAN-03-3835; Sternbach George, 1995, Journal of Emergency Medicine, V13, P671, DOI 10.1016/0736-4679(95)00077-N; Sullivan RJ, 2009, BIODRUGS, V23, P69, DOI 10.2165/00063030-200923020-00001; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yakushko Y, 2011, J VIROL, V85, P4612, DOI 10.1128/JVI.02068-10; Yu XZ, 2011, CURR COLORECT CANC R, V7, P253, DOI 10.1007/s11888-011-0106-1; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	58	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87324	10.1371/journal.pone.0087324	http://dx.doi.org/10.1371/journal.pone.0087324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489895	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000128
J	Barrett, DJK; Zobay, O				Barrett, Doug J. K.; Zobay, Oliver			Attentional Control via Parallel Target-Templates in Dual-Target Search	PLOS ONE			English	Article							WORKING-MEMORY; VISUAL-SEARCH; CONTROL SETTINGS; SET-SIZE; INFORMATION; STIMULUS; COST	Simultaneous search for two targets has been shown to be slower and less accurate than independent searches for the same two targets. Recent research suggests this 'dual-target cost' may be attributable to a limit in the number of target-templates than can guide search at any one time. The current study investigated this possibility by comparing behavioural responses during single-and dual-target searches for targets defined by their orientation. The results revealed an increase in reaction times for dual-compared to single-target searches that was largely independent of the number of items in the display. Response accuracy also decreased on dual-compared to single-target searches: dual-target accuracy was higher than predicted by a model restricting search guidance to a single target-template and lower than predicted by a model simulating two independent single-target searches. These results are consistent with a parallel model of dual-target search in which attentional control is exerted by more than one target-template at a time. The requirement to maintain two target-templates simultaneously, however, appears to impose a reduction in the specificity of the memory representation that guides search for each target.	[Barrett, Doug J. K.] Univ Leicester, Sch Psychol, Coll Biol & Med Sci, Leicester, Leics, England; [Zobay, Oliver] MRC, Inst Hearing Res, Nottingham, England	University of Leicester	Barrett, DJK (corresponding author), Univ Leicester, Sch Psychol, Coll Biol & Med Sci, Leicester, Leics, England.	djkb1@le.ac.uk		Barrett, Douglas/0000-0002-0351-6809; Zobay, Oliver/0000-0002-0229-0668	University of Leicester	University of Leicester	This work was supported by the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Beck VM, 2012, PSYCHOL SCI, V23, P887, DOI 10.1177/0956797612439068; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Burmester A, 2012, PERCEPTION, V41, P505, DOI 10.1068/p7176; Cameron EL, 2004, SPATIAL VISION, V17, P259; Carlisle NB, 2011, J NEUROSCI, V31, P9315, DOI 10.1523/JNEUROSCI.1097-11.2011; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Caspi A, 2004, P NATL ACAD SCI USA, V101, P13086, DOI 10.1073/pnas.0305329101; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Garavan H, 1998, MEM COGNITION, V26, P263, DOI 10.3758/BF03201138; Godwin HJ, 2010, ACTA PSYCHOL, V134, P79, DOI 10.1016/j.actpsy.2009.12.009; Houtkamp R, 2009, PSYCHOL RES-PSYCH FO, V73, P317, DOI 10.1007/s00426-008-0157-3; Irons JL, 2012, J EXP PSYCHOL HUMAN, V38, P758, DOI 10.1037/a0026578; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Menneer T, 2007, APPL COGNITIVE PSYCH, V21, P915, DOI 10.1002/acp.1305; Menneer T, 2012, J EXP PSYCHOL-APPL, V18, P404, DOI 10.1037/a0031032; Menneer T, 2009, J EXP PSYCHOL-APPL, V15, P125, DOI 10.1037/a0015331; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; Roper ZJJ, 2012, PSYCHON B REV, V19, P1114, DOI 10.3758/s13423-012-0297-8; Salmela VR, 2013, VISION RES, V76, P17, DOI 10.1016/j.visres.2012.10.003; SHAW ML, 1982, COGNITIVE PSYCHOL, V14, P353, DOI 10.1016/0010-0285(82)90014-7; Smith P.L., 2010, TUTORIALS VISUAL COG, P211; Solman GJF, 2011, VISION RES, V51, P1185, DOI 10.1016/j.visres.2011.03.009; STERNBERG S, 1969, AM SCI, V57, P421; Stroud MJ, 2012, J EXP PSYCHOL HUMAN, V38, P113, DOI 10.1037/a0025887; Tollenaar N, 2003, BRIT J MATH STAT PSY, V56, P271, DOI 10.1348/000711003770480048; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016; Woodman GF, 2011, VIS COGN, V19, P1, DOI 10.1080/13506285.2010.521140; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Wright R, 1998, VISUAL ATTENTION, P295	40	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86848	10.1371/journal.pone.0086848	http://dx.doi.org/10.1371/journal.pone.0086848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489793	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000084
J	Cunniff, J; Wilkinson, S; Charles, M; Jones, G; Rees, M; Osborne, CP				Cunniff, Jennifer; Wilkinson, Sarah; Charles, Michael; Jones, Glynis; Rees, Mark; Osborne, Colin P.			Functional Traits Differ between Cereal Crop Progenitors and Other Wild Grasses Gathered in the Neolithic Fertile Crescent	PLOS ONE			English	Article							RELATIVE GROWTH-RATE; NET ASSIMILATION RATE; SEED SIZE; LEAF-AREA; TRADE-OFFS; PLANT SIZE; OHALO-II; DOMESTICATION; ORIGINS; MASS	The reasons why some plant species were selected as crops and others were abandoned during the Neolithic emergence of agriculture are poorly understood. We tested the hypothesis that the traits of Fertile Crescent crop progenitors were advantageous in the fertile, disturbed habitats surrounding early settlements and in cultivated fields. We screened functional traits related to competition and disturbance in a group of grass species that were increasingly exploited by early plant gatherers, and that were later domesticated (crop progenitors); and in a set of grass species for which there is archaeological evidence of gathering, but which were never domesticated (wild species). We hypothesised that crop progenitors would have greater seed mass, growth rate, height and yield than wild species, as these traits are indicative of greater competitive ability, and that crop progenitors would be more resilient to defoliation. Our results show that crop progenitors have larger seed mass than wild species, germinate faster and have greater seedling size. Increased seed size is weakly but positively correlated with a higher growth rate, which is primarily driven by greater biomass assimilation per unit leaf area. Crop progenitors also tend to have a taller stature, greater grain yield and higher resilience to defoliation. Collectively, the data are consistent with the hypothesis that adaptations to competition and disturbance gave crop progenitors a selective advantage in the areas surrounding early human settlements and in cultivated environments, leading to their adoption as crops through processes of unconscious selection.	[Cunniff, Jennifer; Wilkinson, Sarah; Rees, Mark; Osborne, Colin P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Charles, Michael] Univ Oxford, Sch Archaeol, Oxford, England; [Jones, Glynis] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England	University of Sheffield; University of Oxford; University of Sheffield	Cunniff, J (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	jennifer.cunniff@rothamsted.ac.uk		Swarbrick, Jennifer/0000-0003-3669-3665	University of Sheffield; NERC [NE/H022716/1]; ERC [269830-EOA]; Natural Environment Research Council [NE/H022716/1] Funding Source: researchfish	University of Sheffield; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a post graduate scholarship from the University of Sheffield to Jennifer Cunniff; a NERC standard grant (NE/H022716/1) awarded to Colin P Osborne, Glynis Jones and Michael Charles; and an ERC advanced research grant (269830-EOA) awarded to Glynis Jones. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo S, 2005, GENET RESOUR CROP EV, V52, P491, DOI 10.1007/s10722-004-7069-x; Anderson E, 1952, MANS ROLE CHANGING F, P763; [Anonymous], 1999, PREHISTORY FOOD APPE; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; Asouti E, 2013, CURR ANTHROPOL, V54, P299, DOI 10.1086/670679; Blackman VH, 1919, ANN BOT-LONDON, V33, P353, DOI 10.1093/oxfordjournals.aob.a089727; BLUMLER MA, 1991, CURR ANTHROPOL, V32, P23, DOI 10.1086/203912; Cohen MN, 2009, CURR ANTHROPOL, V50, P591, DOI 10.1086/603548; Colledge S, 1998, ORIGINS AGR CROP DOM, P121; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; Engelbrecht T.H., 1916, GEOGR Z, V22, P328; Fairbairn A, 2007, VEG HIST ARCHAEOBOT, V16, P467, DOI 10.1007/s00334-006-0069-3; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; HAMMER K, 1984, Kulturpflanze, V32, P11; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; HARLAN JR, 1973, EVOLUTION, V27, P311, DOI [10.2307/2406971, 10.1111/j.1558-5646.1973.tb00676.x]; Harlan JR, 1992, CROPS MAN, V2nd; Harms KE, 1997, J TROP ECOL, V13, P617, DOI 10.1017/S0266467400010750; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hawkes J. G., 1969, The domestication and exploitation of plants and animals., P17; Hayden B, 2009, CURR ANTHROPOL, V50, P597, DOI 10.1086/605110; Hendry GAF, 1993, METHODS COMP PLANT E, P9; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Hunt R, 1997, NEW PHYTOL, V135, P395, DOI 10.1046/j.1469-8137.1997.00671.x; Kidson R, 2000, OECOLOGIA, V125, P11, DOI 10.1007/PL00008882; KISLEV ME, 1992, REV PALAEOBOT PALYNO, V73, P161, DOI 10.1016/0034-6667(92)90054-K; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Leibniz-Institut Fur Pflanzengenetik und Kulturpflanzenforschung (IPK), 2013, GEN INT IPK GAT; Li Q, 2010, THEOR APPL GENET, V120, P753, DOI 10.1007/s00122-009-1196-x; MARANON T, 1993, FUNCT ECOL, V7, P591, DOI 10.2307/2390136; Metcalf CJE, 2006, FUNCT ECOL, V20, P217, DOI 10.1111/j.1365-2435.2006.01084.x; Nesbitt M., 2002, DAWN FARMING NEAR E, P113; Noy-Meir I, 2002, J APPL ECOL, V39, P259, DOI 10.1046/j.1365-2664.2002.00707.x; POORTER H, 1989, PHYSIOL PLANTARUM, V75, P237, DOI 10.1111/j.1399-3054.1989.tb06175.x; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Poorter L, 2005, OECOLOGIA, V142, P378, DOI 10.1007/s00442-004-1732-y; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; RINDOS D, 1980, CURR ANTHROPOL, V21, P751, DOI 10.1086/202569; Rindos D., 1984, ORIGINS AGR EVOLUTIO; Rose KE, 2009, ECOL LETT, V12, P1379, DOI 10.1111/j.1461-0248.2009.01394.x; Ryser R, 2001, PLANT BIOLOGY, V3, P426; Savard M., 2003, PALEORIENT, V29, P93, DOI [DOI 10.3406/paleo.2003.4756, DOI 10.3406/PALEO.2003.4756]; Savard M, 2006, WORLD ARCHAEOL, V38, P179, DOI 10.1080/00438240600689016; Shipley B, 2006, FUNCT ECOL, V20, P565, DOI 10.1111/j.1365-2435.2006.01135.x; Shipley B, 2002, FUNCT ECOL, V16, P682, DOI 10.1046/j.1365-2435.2002.00672.x; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Taylor SH, 2010, NEW PHYTOL, V185, P780, DOI 10.1111/j.1469-8137.2009.03102.x; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thompson K, 2001, SEED SCI RES, V11, P345; Tilman D., 1998, PLANT STRATEGIES DYN; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Turnbull LA, 2012, ECOLOGY, V93, P1283, DOI 10.1890/11-0261.1; Van Zeist W., 1984, PALAEOHISTORIA, V26, P171; Vesk PA, 2004, FUNCT ECOL, V18, P939, DOI 10.1111/j.0269-8463.2004.00899.x; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; Vesk PA, 2004, OIKOS, V106, P200, DOI 10.1111/j.0030-1299.2004.13204.x; Vesk PA, 2006, J ECOL, V94, P1027, DOI 10.1111/j.1365-2745.2006.01154.x; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Weiss E, 2004, ECON BOT, V58, pS125, DOI 10.1663/0013-0001(2004)58[S125:SWGASF]2.0.CO;2; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Willcox G, 2008, VEG HIST ARCHAEOBOT, V17, P313, DOI 10.1007/s00334-007-0121-y; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zeder MA, 2009, J ARCHAEOL RES, V17, P1, DOI 10.1007/s10814-008-9025-3	76	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87586	10.1371/journal.pone.0087586	http://dx.doi.org/10.1371/journal.pone.0087586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489941	gold, Green Accepted, Green Published			2022-12-27	WOS:000330510000144
J	Jin, XL; Feng, HK; Zhu, XK; Li, ZH; Song, SN; Song, XY; Yang, GJ; Xu, XG; Guo, WS				Jin, Xiu-liang; Feng, Hai-kuan; Zhu, Xin-kai; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang; Guo, Wen-shan			Assessment of the AquaCrop Model for Use in Simulation of Irrigated Winter Wheat Canopy Cover, Biomass, and Grain Yield in the North China Plain	PLOS ONE			English	Article							WATER-USE EFFICIENCY; FAO CROP MODEL; SUPPLEMENTAL IRRIGATION; PRODUCTIVITY; MANAGEMENT; DEFICIENT; PARAMETERIZATION; OPTIMIZATION; ADAPTATION; STRESS	Improving winter wheat water use efficiency in the North China Plain (NCP), China is essential in light of current irrigation water shortages. In this study, the AquaCrop model was used to calibrate, and validate winter wheat crop performance under various planting dates and irrigation application rates. All experiments were conducted at the Xiaotangshan experimental site in Beijing, China, during seasons of 2008/2009, 2009/2010, 2010/2011 and 2011/2012. This model was first calibrated using data from 2008/2009 and 2009/2010, and subsequently validated using data from 2010/2011 and 2011/2012. The results showed that the simulated canopy cover (CC), biomass yield (BY) and grain yield (GY) were consistent with the measured CC, BY and GY, with corresponding coefficients of determination (R-2) of 0.93, 0.91 and 0.93, respectively. In addition, relationships between BY, GY and transpiration (T), (R-2 = 0.57 and 0.71, respectively) was observed. These results suggest that frequent irrigation with a small amount of water significantly improved BY and GY. Collectively, these results indicate that the AquaCrop model can be used in the evaluation of various winter wheat irrigation strategies. The AquaCrop model predicted winter wheat CC, BY and GY with acceptable accuracy. Therefore, we concluded that AquaCrop is a useful decision-making tool for use in efforts to optimize wheat winter planting dates, and irrigation strategies.	[Jin, Xiu-liang; Zhu, Xin-kai; Song, Sen-nan; Guo, Wen-shan] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Peoples R China; [Jin, Xiu-liang; Feng, Hai-kuan; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China; [Jin, Xiu-liang; Feng, Hai-kuan; Li, Zhen-hai; Song, Sen-nan; Song, Xiao-yu; Yang, Gui-jun; Xu, Xin-gang] Natl Engn Res Ctr Informat Technol Agr, Beijing, Peoples R China	Yangzhou University; Beijing Academy of Agriculture & Forestry; Beijing Academy of Agriculture & Forestry	Xu, XG (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Informat Technol Agr, Beijing, Peoples R China.	xxgpaper@126.com; guows@yzu.edu.cn	Jin, Xiuliang/L-2802-2019; Song, xiaoyu/AHE-19540-2022; Li, Zhenhai/AAU-3396-2020	Jin, Xiuliang/0000-0003-2720-6247; Li, Zhenhai/0000-0001-9878-3274; Yang, Guijun/0000-0002-6425-8321; Feng, Haikuan/0000-0003-3312-6200; Xu, Xingang/0000-0002-8473-5631	National Natural Science Foundation of China [41001244, 41271415]; Beijing Nova Program [2011036]; 8th Six Talents Peak Project of Jiangsu Province [2011-NY039]; Key Projects in the National Science & Technology Pillar Program [2012BAH27B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); 8th Six Talents Peak Project of Jiangsu Province; Key Projects in the National Science & Technology Pillar Program	The National Natural Science Foundation of China (Grant No. 41001244, 41271415), Beijing Nova Program (Grant No. 2011036), the 8th Six Talents Peak Project of Jiangsu Province (2011-NY039) and the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (Grant No. 2012BAH27B04). The authors are grateful to Mr. Weiguo Li, Mrs. Zhihong Ma and Hong Chang for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinpour M, 2012, AGR WATER MANAGE, V110, P55, DOI 10.1016/j.agwat.2012.04.001; Abrha B, 2012, EXP AGR, V48, P252, DOI 10.1017/S0014479711001190; Ali MH, 2008, AGR WATER MANAGE, V95, P1201, DOI 10.1016/j.agwat.2008.06.008; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Anac M. S., 1999, Crop yield response to deficit irrigation., P196; Araya A, 2010, AGR WATER MANAGE, V97, P1838, DOI 10.1016/j.agwat.2010.06.021; Araya A, 2010, FIELD CROP RES, V116, P196, DOI 10.1016/j.fcr.2009.12.010; Behera SK, 2009, AGR WATER MANAGE, V96, P1532, DOI 10.1016/j.agwat.2009.06.016; Blank H., 1975, THESIS COLORADO STAT; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Dawney Z., 1972, J IRR DRAIN DIV-ASCE, V98, P107, DOI [10.1061/JRCEA4.0000853, DOI 10.1061/JRCEA4.0000853]; De Nys E, 2001, P 4 INT REG C ENV WA, P235; DE WIT C. T., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Trebon, [Czechoslovakia], 14-21 September, 1969, P17; Debaeke P, 2004, EUR J AGRON, V21, P433, DOI 10.1016/j.eja.2004.07.006; deVries F. W. T.Penning, 1989, SIMULATION MONOGRAPH, P82; Doorenbos J., 1979, YIELD RESPONSE WATER; Fang QuanXiao, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P34; FAO, 2009, EVAP REF SURF; Farahani HJ, 2009, AGRON J, V101, P469, DOI 10.2134/agronj2008.0182s; Farre I, 2009, AGR WATER MANAGE, V96, P383, DOI 10.1016/j.agwat.2008.07.002; Garcia-Vila M, 2009, AGRON J, V101, P477, DOI 10.2134/agronj2008.0179s; Garcia-Vila M, 2012, EUR J AGRON, V36, P21, DOI 10.1016/j.eja.2011.08.003; Geerts S, 2009, AGRON J, V101, P499, DOI 10.2134/agronj2008.0137s; Hedge DM, 1987, HORTIC SCI, V62, P507; Heng LK, 2009, AGRON J, V101, P488, DOI 10.2134/agronj2008.0029xs; Hill R. W., 1996, Water Reports, P69; Hsiao TC, 2009, AGRON J, V101, P448, DOI 10.2134/agronj2008.0218s; JENSEN M. E., 1968, Water Deficits and Plant Growth., V2, P1; Kang ShaoZhong, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P1; Kar G, 2006, AGR WATER MANAGE, V79, P280, DOI 10.1016/j.agwat.2005.03.001; Karunaratne AS, 2011, EXP AGR, V47, P509, DOI 10.1017/S0014479711000111; Katerji N, 2013, AGR WATER MANAGE, V130, P14, DOI 10.1016/j.agwat.2013.08.005; KIPKORIR EC, 2002, THESIS KU LEUVEN U B; Legesse A, 2006, THESIS KU LEUVEN U L; Li ZiZhong, 2011, Journal of China Agricultural University, V16, P59; MINHAS BS, 1974, WATER RESOUR RES, V10, P383, DOI 10.1029/WR010i003p00383; Molden D, 2003, COMP ASSESS WAT MAN, V1, P1, DOI 10.1079/9780851996691.0001; Oweis T, 2006, AGR WATER MANAGE, V80, P57, DOI 10.1016/j.agwat.2005.07.004; Raer D, 2010, REFERENCE MANUAL; Raes D., 2000, Irrigation and Drainage Systems, V14, P343, DOI 10.1023/A:1006412031535; Raes D, 2006, AGR WATER MANAGE, V81, P335, DOI 10.1016/j.agwat.2005.04.006; Raes D, 2009, CROP WATER PRODUCTIV; Raes D., 2009, AQUACROP FAO CROP MO; RAO NH, 1988, AGR WATER MANAGE, V15, P165, DOI 10.1016/0378-3774(88)90109-6; RAO NH, 1992, AGR WATER MANAGE, V20, P267, DOI 10.1016/0378-3774(92)90002-E; Salemi H, 2011, AFR J AGR RES, V6, P2204; [杜文勇 Du Wenyong], 2011, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V42, P174; Soddu A, 2013, PROCEDIA ENVIRON SCI, V19, P830, DOI 10.1016/j.proenv.2013.06.092; Steduto P, 2009, AGRON J, V101, P426, DOI 10.2134/agronj2008.0139s; Stewart JI, 1976, PRODUCTION FUNCTIONS, P80; Stricevic R, 2011, AGR WATER MANAGE, V98, P1615, DOI 10.1016/j.agwat.2011.05.011; Todorovic M, 2009, AGRON J, V101, P509, DOI 10.2134/agronj2008.0166s; Vanuytrecht E, 2011, AGR FOREST METEOROL, V151, P1753, DOI 10.1016/j.agrformet.2011.07.011; Wang JP, 2001, IRRIG DRAIN, V2, P76; Wang XX, 2013, AGR WATER MANAGE, V129, P95, DOI 10.1016/j.agwat.2013.07.010; Yuan M, 2013, AGR WATER MANAGE, V122, P28, DOI 10.1016/j.agwat.2013.02.006; Zhang HongCheng, 2000, Jiangsu Agricultural Sciences, P2; Zinyengere N, 2011, AGR FOREST METEOROL, V151, P1792, DOI 10.1016/j.agrformet.2011.07.015; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	59	57	61	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86938	10.1371/journal.pone.0086938	http://dx.doi.org/10.1371/journal.pone.0086938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489808	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000090
J	Koningstein, M; van der Bij, AK; de Kraker, MEA; Monen, JC; Muilwijk, J; de Greeff, SC; Geerlings, SE; Leverstein-van Hall, MA				Koningstein, Maike; van der Bij, Akke K.; de Kraker, Marlieke E. A.; Monen, Jos C.; Muilwijk, Jan; de Greeff, Sabine C.; Geerlings, Suzanne E.; Leverstein-van Hall, Maurine A.		ISIS-AR Study Grp	Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; SUSCEPTIBILITY; OUTPATIENTS; WOMEN	Background: Complicated urinary tract infections (c-UTIs) are among the most common nosocomial infections and a substantial part of the antimicrobial agents used in hospitals is for the treatment of c-UTIs. Data from surveillance can be used to guide the empirical treatment choices of clinicians when treating c-UTIs. We therefore used nation-wide surveillance data to evaluate antimicrobial coverage of agents for the treatment of c-UTI in the Netherlands. Methods: We included the first isolate per patient of urine samples of hospitalised patients collected by the Infectious Disease Surveillance Information System for Antibiotic Resistance (ISIS-AR) in 2012, and determined the probability of inadequate coverage for antimicrobial agents based on species distribution and susceptibility. Analyses were repeated for various patient groups and hospital settings. Results: The most prevalent bacteria in 27,922 isolates of 23,357 patients were Escherichia coli (47%), Enterococcus spp. (14%), Proteus mirabilis (8%), and Klebsiella pneumoniae (7%). For all species combined, the probability of inadequate coverage was <5% for amoxicillin or amoxicillin-clavulanic acid combined with gentamicin and the carbapenems. When including gram-negative bacteria only, the probability of inadequate coverage was 4.0%, 2.7%, 2.3% and 1.7%, respectively, for amoxicillin, amoxicillin-clavulanic acid, a second or a third generation cephalosporin in combination with gentamicin, and the carbapenems (0.4%). There were only small variations in results among different patient groups and hospital settings. Conclusions: When excluding Enterococcus spp., considered as less virulent, and the carbapenems, considered as last-resort drugs, empirical treatment for c-UTI with the best chance of adequate coverage are one of the studied beta-lactam-gentamicin combinations. This study demonstrates the applicability of routine surveillance data for up-to-date clinical practice guidelines on empirical antimicrobial therapy, essential in patient care given the evolving bacterial susceptibility.	[Koningstein, Maike; van der Bij, Akke K.; de Kraker, Marlieke E. A.; Monen, Jos C.; Muilwijk, Jan; de Greeff, Sabine C.; Leverstein-van Hall, Maurine A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Bij, Akke K.] Reinier Graaf Grp, Dept Med Microbiol, Delft, Netherlands; [Geerlings, Suzanne E.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Leverstein-van Hall, Maurine A.] Bronovo Hosp, Dept Med Microbiol & Infect Prevent, The Hague, Netherlands	Netherlands National Institute for Public Health & the Environment; Reinier de Graaf Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Haaglanden Medical Center; Bronovo Hospital	van der Bij, AK (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	akke.van.der.bij@rivm.nl		de Kraker, Marlieke/0000-0003-0903-8614	Dutch Ministry of Health	Dutch Ministry of Health	ISIS-AR is supported by the Dutch Ministry of Health. This study was conducted as part of our routine work and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; Edson RS, 1999, MAYO CLIN PROC, V74, P519, DOI 10.4065/74.5.519; European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in europe, 2012, ANN REP EUR ANT RES; Fluit AC, 2000, CLIN INFECT DIS, V30, P454, DOI 10.1086/313710; Fridkin SK, 1999, CLIN CHEST MED, V20, P303, DOI 10.1016/S0272-5231(05)70143-X; Geerlings S E, 2006, Ned Tijdschr Geneeskd, V150, P2370; Gonzalez LS, 1998, AM FAM PHYSICIAN, V58, P1811; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Johnson JR, 2004, J INFECT DIS, V190, P1739, DOI 10.1086/425018; Kahlmeter G, 2003, INT J ANTIMICROB AG, V22, pS49, DOI 10.1016/S0924-8579(03)00229-2; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Masterton R, 2008, CLIN INFECT DIS, V47, pS21, DOI 10.1086/590063; Nicolle LE, 2013, CRIT CARE CLIN, V29, P699, DOI 10.1016/j.ccc.2013.03.014; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Orenstein R, 1999, AM FAM PHYSICIAN, V59, P1225; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Paterson DL, 2000, CLIN INFECT DIS, V30, P473, DOI 10.1086/313719; Pitout JD., 2009, F1000 MED REP, V1; Stichting Werkgroep Antibiotica Beleid & National Insitute for Public Health and the Environment, 2013, NETHM 2013 CONS ANT; Stichting Werkgroep Antibioticabeleid, 2013, OPT ANT POL NETH SWA; van der Bij AK, 2012, CLIN MICROBIOL INFEC, V18, pE466, DOI 10.1111/j.1469-0691.2012.03996.x; van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020; Wagenlehner FME, 2006, EUR UROL, V49, P235, DOI 10.1016/j.eururo.2005.12.017; Zuschneid I, 2010, INFECT CONT HOSP EP, V31, P934, DOI 10.1086/655462	29	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86634	10.1371/journal.pone.0086634	http://dx.doi.org/10.1371/journal.pone.0086634			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489755	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000066
J	Lombarts, KMJMH; Heineman, MJ; Scherpbier, AJJA; Arah, OA				Lombarts, Kiki M. J. M. H.; Heineman, Maas Jan; Scherpbier, Albert J. J. A.; Arah, Onyebuchi A.			Effect of the Learning Climate of Residency Programs on Faculty's Teaching Performance as Evaluated by Residents	PLOS ONE			English	Article							EDUCATIONAL ENVIRONMENT; MEDICAL-EDUCATION; SAFETY CLIMATE; PERCEPTIONS; VALIDATION; INSTRUMENT; CURRICULUM; QUALITIES	Background: To understand teaching performance of individual faculty, the climate in which residents' learning takes place, the learning climate, may be important. There is emerging evidence that specific climates do predict specific outcomes. Until now, the effect of learning climate on the performance of the individual faculty who actually do the teaching was unknown. Objectives: This study: (i) tested the hypothesis that a positive learning climate was associated with better teaching performance of individual faculty as evaluated by residents, and (ii) explored which dimensions of learning climate were associated with faculty's teaching performance. Methods and Materials: We conducted two cross-sectional questionnaire surveys amongst residents from 45 residency training programs and multiple specialties in 17 hospitals in the Netherlands. Residents evaluated the teaching performance of individual faculty using the robust System for Evaluating Teaching Qualities (SETQ) and evaluated the learning climate of residency programs using the Dutch Residency Educational Climate Test (D-RECT). The validated D-RECT questionnaire consisted of 11 subscales of learning climate. Main outcome measure was faculty's overall teaching (SETQ) score. We used multivariable adjusted linear mixed models to estimate the separate associations of overall learning climate and each of its subscales with faculty's teaching performance. Results: In total 451 residents completed 3569 SETQ evaluations of 502 faculty. Residents also evaluated the learning climate of 45 residency programs in 17 hospitals in the Netherlands. Overall learning climate was positively associated with faculty's teaching performance (regression coefficient 0.54, 95% confidence interval: 0.37 to 0.71; P<0.001). Three out of 11 learning climate subscales were substantially associated with better teaching performance: 'coaching and assessment', 'work is adapted to residents' competence', and 'formal education'. Conclusions: Individual faculty's teaching performance evaluations are positively affected by better learning climate of residency programs.	[Lombarts, Kiki M. J. M. H.; Heineman, Maas Jan; Arah, Onyebuchi A.] Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, NL-1105 AZ Amsterdam, Netherlands; [Heineman, Maas Jan] Univ Amsterdam, Acad Med Ctr, Board Directors, NL-1105 AZ Amsterdam, Netherlands; [Scherpbier, Albert J. J. A.] Univ Maastricht, Off Dean, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Ctr Global & Immigrant Hlth, Los Angeles, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lombarts, KMJMH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Evidence Based Educ, Profess Performance Res Grp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.lombarts@amc.uva.nl		Lombarts, Kiki/0000-0001-6167-0620; Arah, Onyebuchi/0000-0002-9067-1697	Dutch Ministry of Health and Welfare; Academic Medical Center of the University of Amsterdam; Faculty of Health, Medicine and Life Sciences of the Maastricht University; Netherlands Organization for Scientific Research (NWO) [916.96.059]	Dutch Ministry of Health and Welfare; Academic Medical Center of the University of Amsterdam; Faculty of Health, Medicine and Life Sciences of the Maastricht University; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The project was funded by the Dutch Ministry of Health and Welfare and is co-financed by the Academic Medical Center of the University of Amsterdam and the Faculty of Health, Medicine and Life Sciences of the Maastricht University. Prof. Arah was supported by a Veni career grant (number 916.96.059) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-20; Arah OA, 2012, MED EDUC, V46, P381, DOI 10.1111/j.1365-2923.2011.04176.x; Arah OA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025983; Bassaw B, 2003, MED TEACH, V25, P522, DOI 10.1080/0142159031000137409; BOEREBACH BC, 2012, J SURG EDUC, P69511; Boerebach BCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069449; Boerebach BCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032089; BOOR K, 2009, THESIS VU MED CTR; Boor K, 2011, MED TEACH, V33, P820, DOI 10.3109/0142159X.2010.541533; Carr JZ, 2003, J APPL PSYCHOL, V88, P605, DOI 10.1037/0021-9010.88.4.605; Chang Y, 2011, NURS RES, V60, P32, DOI 10.1097/NNR.0b013e3181ff73cc; Colla JB, 2005, QUAL SAF HEALTH CARE, V14, P364, DOI 10.1136/qshc.2005.014217; Dyrbye LN, 2009, MED EDUC, V43, P274, DOI 10.1111/j.1365-2923.2008.03282.x; Flin R, 2006, QUAL SAF HEALTH CARE, V15, P109, DOI 10.1136/qshc.2005.014761; Gelman A., 2007, DATA ANAL USING REGR; Genn JM, 2001, MED TEACH, V23, P445, DOI 10.1080/01421590120075661; Genn JM, 2001, MED TEACH, V23, P337, DOI 10.1080/01421590120063330; Kanashiro J, 2006, SURGERY, V139, P150, DOI 10.1016/j.surg.2005.07.005; Litzelman DK, 1998, ACAD MED, V73, P688, DOI 10.1097/00001888-199806000-00016; Lombarts KMJMH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015202; Lombarts KMJMH, 2009, ANESTHESIOLOGY, V111, P709, DOI 10.1097/ALN.0b013e3181b76516; Lombarts M J M H, 2007, Ned Tijdschr Geneeskd, V151, P2004; Lombarts M J M H Kiki, 2010, Ned Tijdschr Geneeskd, V154, pA1222; LUCAS CA, 1993, ACAD MED, V68, P811, DOI 10.1097/00001888-199310000-00025; PARKER CP, 2004, J ORG BEH, V24, P389; Patterson M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14510; Roff S, 2005, MED TEACH, V27, P353, DOI 10.1080/01421590500151039; Saito A, 2010, INT J DENT HYG, V8, P134, DOI 10.1111/j.1601-5037.2009.00411.x; SKEFF KM, 1992, ARCH INTERN MED, V152, P1156, DOI 10.1001/archinte.1992.00400180028004; van der Leeuw R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019142; Williams BC, 2002, ACAD MED, V77, P177, DOI 10.1097/00001888-200202000-00020	31	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86512	10.1371/journal.pone.0086512	http://dx.doi.org/10.1371/journal.pone.0086512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489734	Green Published, gold			2022-12-27	WOS:000330510000054
J	Lu, HY; Lu, QX; Gaddipati, S; Kasetti, RB; Wang, W; Pasparakis, M; Kaplan, HJ; Li, QT				Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Pasparakis, Manolis; Kaplan, Henry J.; Li, Qiutang			IKK2 Inhibition Attenuates Laser-Induced Choroidal Neovascularization	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; ALPHA-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; MACULAR DEGENERATION; CANCER-CELLS; TRANSCRIPTIONAL REGULATION; INCREASED EXPRESSION; MOUSE MODEL	Choroidal neovascularization (CNV) is aberrant angiogenesis associated with exudative age-related macular degeneration (AMD), a leading cause of blindness in the elderly. Inflammation has been suggested as a risk factor for AMD. The IKK2/NF-kappa B pathway plays a key role in the inflammatory response through regulation of the transcription of cytokines, chemokines, growth factors and angiogenic factors. We investigated the functional role of IKK2 in development of the laser-induced CNV using either Ikk2 conditional knockout mice or an IKK2 inhibitor. The retinal neuronal tissue and RPE deletion of IKK2 was generated by breeding Ikk2(-/flox) mice with Nestin-Cre mice. Deletion of Ikk2 in the retina caused no obvious defect in retinal development or function, but resulted in a significant reduction in laser-induced CNV. In addition, intravitreal or retrobulbar injection of an IKK2 specific chemical inhibitor, TPCA-1, also showed similar inhibition of CNV. Furthermore, in vitro inhibition of IKK2 in ARPE-19 cells significantly reduced heat shock-induced expression of NFKBIA, IL1B, CCL2, VEGFA, PDGFA, HIF1A, and MMP-2, suggesting that IKK2 may regulate multiple molecular pathways involved in laser-induced CNV. The in vivo laser-induced expression of VEGFA, and HIF1A in RPE and choroidal tissue was also blocked by TPCA-1 treatment. Thus, IKK2/NF-kappa B signaling appears responsible for production of pro-inflammatory and pro-angiogenic factors in laser-induced CNV, suggesting that this intracellular pathway may serve as an important therapeutic target for aberrant angiogenesis in exudative AMD.	[Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA; [Lu, Huayi; Lu, Qingxian; Gaddipati, Subhash; Kasetti, Ramesh Babu; Wang, Wei; Kaplan, Henry J.; Li, Qiutang] Univ Louisville, Sch Med, Dept Visual Sci, Louisville, KY 40292 USA; [Lu, Qingxian; Gaddipati, Subhash; Li, Qiutang] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Lu, Huayi] Jilin Univ, Hosp 2, Changchun, Jilin Province, Peoples R China; [Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany	University of Louisville; University of Louisville; University of Louisville; Jilin University; University of Cologne	Li, QT (corresponding author), Univ Louisville, Sch Med, Dept Ophthalmol, Louisville, KY 40292 USA.	q.li@louisville.edu	Pasparakis, Manolis/H-9292-2017; Pasparakis, Manolis/N-4350-2019; Kasetti, Ramesh Babu/H-5157-2019	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; KASETTI, RAMESH/0000-0001-7874-3988; Gaddipati, Subhash/0000-0002-5323-5466	National Institutes of Health [EY019891, EY021584]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY021584, R01EY019891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY019891 and EY021584 and Ernest & Elizabeth Althose Special Scholar Award to Qiutang Li from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 2012, OPHTH NOV ANT COMB A; Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dinh HKB, 2001, PHYSIOL GENOMICS, V7, P3, DOI 10.1152/physiolgenomics.2001.7.1.3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Grossniklaus HE, 2005, ARCH OPHTHALMOL-CHIC, V123, P914; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haines JL, 2007, P NATL ACAD SCI USA, V104, P16725, DOI 10.1073/pnas.0708151104; Hu WZ, 2005, RETINA-J RET VIT DIS, V25, P1054, DOI 10.1097/00006982-200512000-00015; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; Levine L, 2003, CANCER RES, V63, P3495; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liu J, 2011, J BIOL CHEM, V286, P20991, DOI 10.1074/jbc.M111.226266; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Mankan AK, 2011, P NATL ACAD SCI USA, V108, P6567, DOI 10.1073/pnas.1018331108; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Neuvians TAP, 2005, J BIOTECHNOL, V117, P163, DOI 10.1016/j.jbiotec.2005.01.011; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Shibata A, 2002, BREAST CANCER RES TR, V73, P237, DOI 10.1023/A:1015872531675; Shono T, 1996, MOL CELL BIOL, V16, P4231; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yasuda M, 2002, AM J PHYSIOL-CELL PH, V282, pC917, DOI 10.1152/ajpcell.00223.2001; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	67	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87530	10.1371/journal.pone.0087530	http://dx.doi.org/10.1371/journal.pone.0087530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489934	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000141
J	Oliveira, GF; Oliveira, TRR; Ikejiri, AT; Andraus, MP; Galvao, TF; Silva, MT; Pereira, MG				Oliveira, Geraldo F.; Oliveira, Teresinha R. R.; Ikejiri, Adauto T.; Andraus, Mariela P.; Galvao, Tais F.; Silva, Marcus T.; Pereira, Mauricio G.			Prevalence of Hypertension and Associated Factors in an Indigenous Community of Central Brazil: A Population-Based Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-MASS INDEX; METABOLIC SYNDROME; BLOOD-PRESSURE; WHITE	Objective: The aim of the present study was to assess the prevalence of hypertension and cardiovascular risk factors among the native indigenous of Jaguapiru village in Dourados, Mato Grosso do Sul, Brazil. Method: A cross-sectional, population-based study was conducted with adult indigenous aged 18 years or more. The subjects' blood pressure was measured twice, and the mean of the two measurements was calculated. Body weight, height, capillary blood glucose and waist circumference were measured. Pregnant women, individuals using glucocorticoids, and non-indigenous villagers and their offspring were excluded. Multivariate regression analyses were conducted on the socio-demographic and clinical independent variables. Interactions between independent variables were also tested. Results: We included 1,608 native indigenous eligible to the research. The prevalence of hypertension was 29.5% (95% CI: 27-31.5), with no significant difference between the genders. For both men and women, diastolic hypertension was more common than systolic hypertension. The prevalence of hypertension was higher among obese, diabetic, and older participants, as well as those who consumed alcohol, had a lower educational level, or had a family history of hypertension. There was no association between hypertension and tobacco smoking or family income. Conclusion: Hypertension among the indigenous from Jaguapiru village was similar to the prevalence in the Brazilians, but may have a more negative effect in such disadvantaged population. The associated factors we found can help drawing prevention policies.	[Oliveira, Geraldo F.; Oliveira, Teresinha R. R.; Ikejiri, Adauto T.] Fed Univ Grande Dourados, Dept Clin Med, Dourados, Brazil; [Andraus, Mariela P.] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil; [Galvao, Tais F.; Pereira, Mauricio G.] Univ Brasilia, Fac Med, Brasilia, DF, Brazil; [Galvao, Tais F.] Univ Fed Amazonas, Getulio Vargas Univ Hosp, Manaus, Amazonas, Brazil; [Silva, Marcus T.] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil	Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados; Universidade de Brasilia; Universidade Federal de Amazonas; Universidade Federal de Amazonas	Pereira, MG (corresponding author), Univ Brasilia, Fac Med, Brasilia, DF, Brazil.	mauriciogpereira@gmail.com	Silva, Marcus Tolentino/J-1791-2014; Oliveira, Geraldo Ferreira/A-5831-2018; Galvao, Tais F/E-4317-2010	Silva, Marcus Tolentino/0000-0002-7186-9075; Galvao, Tais F/0000-0003-2072-4834	Federal University of Grande Dourados	Federal University of Grande Dourados	The financing of transport and rapid test strips (glucose oxidase) was sponsored by the Federal University of Grande Dourados. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2004, HLTH CONS SMOK REP S; Australian Institute of Health and Welfare, 2019, NO TERR REM AB INV O; Brazil, 2012, VIG BRAZ 2011 TEL SU; Brazilian Society of Cardiology/Brazilian Society of Hypertension/Brazilian Society of Nephrology, 2010, ARQ BRAS CARDIOL S91, P91; Cardoso A M, 2001, Cad Saude Publica, V17, P345, DOI 10.1590/S0102-311X2001000200009; Coimbra Jr. C. E. A., 2003, EPIDEMIOLOGIA SAUDE; Correa TD, 2006, ARQ MED ABC, V31, P91; Costa E de A, 1990, Bull Pan Am Health Organ, V24, P159; Passos VMD, 2006, EPIDEMIOL SERV SAUDE, V15, P35; de Oliveira GF, 2011, ETHNIC DIS, V21, P301; de Oliveira GF, 2011, REV PANAM SALUD PUBL, V29, P315, DOI 10.1590/S1020-49892011000500003; Deurenberg P, 1999, INT J OBESITY, V23, P537, DOI 10.1038/sj.ijo.0800868; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Franklin SS, 2013, WHITE COAT HYPERTENS; Gimeno SGA, 2009, J EPIDEMIOL COMMUN H, V63, P299, DOI 10.1136/jech.2008.077966; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Gressler LA SL, 1988, ASPECTOS HIST POVOAM; Guerrero-Romero F, 2000, J HUM HYPERTENS, V14, P555, DOI 10.1038/sj.jhh.1001067; Hayashi T, 2003, CIRCULATION, V108, P1718, DOI 10.1161/01.CIR.0000087597.59169.8D; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hoy WE, 2010, AUST NZ J PUBL HEAL, V34, P11, DOI 10.1111/j.1753-6405.2010.00467.x; IBGE, 2012, CENS DEM 2010 RES GE; International Diabetes Federation, 2013, GLOB GUID TYP 2 DIAB; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kadonaga Y, 2009, PREV MED, V48, P567, DOI 10.1016/j.ypmed.2009.03.018; Matsuzawa Y, 2005, BEST PRACT RES CL EN, V19, P637, DOI 10.1016/j.beem.2005.07.001; Medina-Lezama J, 2008, REV PANAM SALUD PUBL, V24, P169, DOI 10.1590/S1020-49892008000900003; Murphy N J, 1997, Ethn Health, V2, P267; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Saad M, 2005, THESIS U FEDERAL MAT; Salvo VLMAd, 2009, REV BRAS EPIDEMIOL, V12, P458; Silva L C, 2001, Rev Panam Salud Publica, V10, P152; Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608; Waeber B, 2001, J HYPERTENS, V19, pS9; World Health Organization, 2011, NONCOMMUNICABLE DIS; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86278	10.1371/journal.pone.0086278	http://dx.doi.org/10.1371/journal.pone.0086278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489710	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000043
J	Thelemann, C; Eren, RO; Coutaz, M; Brasseit, J; Bouzourene, H; Rosa, M; Duval, A; Lavanchy, C; Mack, V; Mueller, C; Reith, W; Acha-Orbea, H				Thelemann, Christoph; Eren, Remzi Onur; Coutaz, Manuel; Brasseit, Jennifer; Bouzourene, Hanifa; Rosa, Muriel; Duval, Anais; Lavanchy, Christine; Mack, Vanessa; Mueller, Christoph; Reith, Walter; Acha-Orbea, Hans			Interferon-gamma Induces Expression of MHC Class II on Intestinal Epithelial Cells and Protects Mice from Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HEPATICUS-INDUCED COLITIS; INNATE LYMPHOID-CELLS; CD4+ T-CELLS; HELICOBACTER-HEPATICUS; INTERLEUKIN-10-DEFICIENT MICE; IMMUNODEFICIENT MICE; MESSENGER-RNA; IN-VIVO; ANTIGEN	Immune responses against intestinal microbiota contribute to the pathogenesis of inflammatory bowel diseases (IBD) and involve CD4(+) T cells, which are activated by major histocompatibility complex class II (MHCII) molecules on antigen-presenting cells (APCs). However, it is largely unexplored how inflammation-induced MHCII expression by intestinal epithelial cells (IEC) affects CD4(+) T cell-mediated immunity or tolerance induction in vivo. Here, we investigated how epithelial MHCII expression is induced and how a deficiency in inducible epithelial MHCII expression alters susceptibility to colitis and the outcome of colon-specific immune responses. Colitis was induced in mice that lacked inducible expression of MHCII molecules on all nonhematopoietic cells, or specifically on IECs, by continuous infection with Helicobacter hepaticus and administration of interleukin (IL)-10 receptor-blocking antibodies (anti-IL10R mAb). To assess the role of interferon (IFN)-gamma in inducing epithelial MHCII expression, the T cell adoptive transfer model of colitis was used. Abrogation of MHCII expression by nonhematopoietic cells or IECs induces colitis associated with increased colonic frequencies of innate immune cells and expression of proinflammatory cytokines. CD4(+) T-helper type (Th) 1 cells - but not group 3 innate lymphoid cells (ILCs) or Th17 cells - are elevated, resulting in an unfavourably altered ratio between CD4(+) T cells and forkhead box P3 (FoxP3)(+) regulatory T (Treg) cells. IFN-gamma produced mainly by CD4(+) T cells is required to upregulate MHCII expression by IECs. These results suggest that, in addition to its proinflammatory roles, IFN-gamma exerts a critical anti-inflammatory function in the intestine which protects against colitis by inducing MHCII expression on IECs. This may explain the failure of anti-IFN-gamma treatment to induce remission in IBD patients, despite the association of elevated IFN-gamma and IBD.	[Thelemann, Christoph; Eren, Remzi Onur; Coutaz, Manuel; Rosa, Muriel; Duval, Anais; Lavanchy, Christine; Mack, Vanessa; Acha-Orbea, Hans] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Brasseit, Jennifer; Mueller, Christoph] Univ Bern, Inst Pathol, Bern, Switzerland; [Bouzourene, Hanifa] Unilabs Pathol Suisse Romande, Epalinges, Switzerland; [Reith, Walter] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland	University of Lausanne; University of Bern; University of Geneva	Acha-Orbea, H (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	hans.acha-orbea@unil.ch	Eren, Remzi Onur/GNW-6605-2022; Mueller, Christoph/F-2233-2014	Eren, Remzi Onur/0000-0003-2795-0156; Mueller, Christoph/0000-0002-3921-8678	Swiss National Science Fellowship [310030_132492]	Swiss National Science Fellowship	The project was funded by a Swiss National Science Fellowship to HAO No 310030_132492, Website: http://www.snf.ch/E/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND PW, 1986, IMMUNOLOGY, V58, P1; Brown SJ, 2007, AM J GASTROENTEROL, V102, P2058, DOI 10.1111/j.1572-0241.2007.01343.x; Buning J, 2006, FASEB J, V20, P359, DOI 10.1096/fj.05-4807fje; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cottone M, 2010, EXPERT OPIN INV DRUG, V19, P1147, DOI 10.1517/13543784.2010.510513; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dotan I, 2007, AM J PHYSIOL-GASTR L, V292, pG1630, DOI 10.1152/ajpgi.00294.2006; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2003, CANCER RES, V63, P6042; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Framson PE, 1999, GASTROENTEROLOGY, V116, P1054, DOI 10.1016/S0016-5085(99)70008-9; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hershberg RM, 1998, J CLIN INVEST, V102, P792, DOI 10.1172/JCI3201; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; KAISERLIAN D, 1989, EUR J IMMUNOL, V19, P1513, DOI 10.1002/eji.1830190827; Krishnan K, 2011, INFLAMM BOWEL DIS, V17, P410, DOI 10.1002/ibd.21316; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lee HO, 2000, GASTROENTEROLOGY, V119, P129, DOI 10.1053/gast.2000.8542; Maggio-Price L, 2012, INFLAMM BOWEL DIS; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; MAYER L, 1987, J EXP MED, V166, P1471, DOI 10.1084/jem.166.5.1471; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morrison PJ, 2013, MUCOSAL IMMUNOL, DOI 10.1038/mi.2013.11; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Nakazawa A, 1999, GASTROENTEROLOGY, V117, P536, DOI 10.1016/S0016-5085(99)70446-4; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; SANDERSON IR, 1993, IMMUNOLOGY, V79, P434; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; Ward JM, 1996, LAB ANIM SCI, V46, P15; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480	49	72	72	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86844	10.1371/journal.pone.0086844	http://dx.doi.org/10.1371/journal.pone.0086844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489792	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000083
J	Tzou, WS; Chu, Y; Lin, TY; Hu, CH; Pai, TW; Liu, HF; Lin, HJ; Cases, I; Rojas, A; Sanchez, M; You, ZY; Hsu, MW				Tzou, Wen-Shyong; Chu, Ying; Lin, Tzung-Yi; Hu, Chin-Hwa; Pai, Tun-Wen; Liu, Hsin-Fu; Lin, Han-Jia; Cases, Ildeofonso; Rojas, Ana; Sanchez, Mayka; You, Zong-Ye; Hsu, Ming-Wei			Molecular Evolution of Multiple-Level Control of Heme Biosynthesis Pathway in Animal Kingdom	PLOS ONE			English	Article							ERYTHROID 5-AMINOLEVULINATE SYNTHASE; UROPORPHYRINOGEN-III SYNTHASE; TISSUE-SPECIFIC EXPRESSION; IRON-RESPONSIVE ELEMENT; PHYLOGENETIC ANALYSIS; REGULATORY MOTIF; PORPHOBILINOGEN DEAMINASE; GENOME BROWSER; ALTERNATIVE PROMOTERS; POSITIVE SELECTION	Adaptation of enzymes in a metabolic pathway can occur not only through changes in amino acid sequences but also through variations in transcriptional activation, mRNA splicing and mRNA translation. The heme biosynthesis pathway, a linear pathway comprised of eight consecutive enzymes in animals, provides researchers with ample information for multiple types of evolutionary analyses performed with respect to the position of each enzyme in the pathway. Through bioinformatics analysis, we found that the protein-coding sequences of all enzymes in this pathway are under strong purifying selection, from cnidarians to mammals. However, loose evolutionary constraints are observed for enzymes in which self-catalysis occurs. Through comparative genomics, we found that in animals, the first intron of the enzyme-encoding genes has been co-opted for transcriptional activation of the genes in this pathway. Organisms sense the cellular content of iron, and through iron-responsive elements in the 59 untranslated regions of mRNAs and the intron-exon boundary regions of pathway genes, translational inhibition and exon choice in enzymes may be enabled, respectively. Pathway product (heme)-mediated negative feedback control can affect the transport of pathway enzymes into the mitochondria as well as the ubiquitin-mediated stability of enzymes. Remarkably, the positions of these controls on pathway activity are not ubiquitous but are biased towards the enzymes in the upstream portion of the pathway. We revealed that multiple-level controls on the activity of the heme biosynthesis pathway depend on the linear depth of the enzymes in the pathway, indicating a new strategy for discovering the molecular constraints that shape the evolution of a metabolic pathway.	[Tzou, Wen-Shyong; Chu, Ying] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan; [Lin, Tzung-Yi; Hu, Chin-Hwa; Liu, Hsin-Fu; Lin, Han-Jia; You, Zong-Ye; Hsu, Ming-Wei] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Cases, Ildeofonso; Rojas, Ana] Inst Predict & Personalized Med Canc IMPPC, Computat Cell Biol Grp, Barcelona, Spain; [Sanchez, Mayka] Inst Predict & Personalized Med Canc IMPPC, Canc & Iron Grp, Barcelona, Spain	National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan Ocean University; Mackay Memorial Hospital	Tzou, WS (corresponding author), Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan.	wstzou@ntou.edu.tw	Rojas, Ana M/D-5777-2011; Liu, Hsin-Fu/AAR-5960-2020; Cases, Ildefonso/C-2998-2008; Rojas, Ana M./I-2882-2019; Sanchez, Mayka/F-5140-2010; Tzou, Wen-Shyong/H-4517-2014; Hu, Chin-Hwa/D-1178-2009; IBIS, BIOINFORMATICA/O-1882-2015	Rojas, Ana M/0000-0003-0750-9099; Liu, Hsin-Fu/0000-0003-0082-2269; Cases, Ildefonso/0000-0002-8784-5174; Rojas, Ana M./0000-0003-0750-9099; Sanchez, Mayka/0000-0002-6499-5989; Tzou, Wen-Shyong/0000-0002-6726-1390; Hu, Chin-Hwa/0000-0001-9582-2303; Lin, Han-Jia/0000-0002-4929-6573	National Science Council, Taiwan, R.O.C. [NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019 -001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019 -001 -]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This work was supported by the National Science Council, Taiwan, R.O.C. (Grant Nos. NSC 95-2113-M-019-003, NSC 96-2627-B-019-002, NSC 97-2627-B-019-002, NSC 98-2627-B-019-002, NSC 98-2313-B-019-004-MY3, NSC 101-2311-B-019 -001, NSC 102-2627-B-019-002-, NSC 102-2633-B-019 -001 -) and the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizencang G, 2000, GENOMICS, V70, P223, DOI 10.1006/geno.2000.6373; Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; BLOOMER JR, 1981, J INVEST DERMATOL, V77, P102, DOI 10.1111/1523-1747.ep12479280; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Campbell PK, 2011, LEUKEMIA RES, V35, P1321, DOI 10.1016/j.leukres.2011.05.004; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Dailey HA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011676; Dailey TA, 2005, BIOCHEM J, V386, P381, DOI 10.1042/BJ20040570; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Duncan R, 1999, MOL BIOL EVOL, V16, P383, DOI 10.1093/oxfordjournals.molbev.a026119; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graham PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002185; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Jiang J, 2012, BIOCHEM BIOPH RES CO, V421, P274, DOI 10.1016/j.bbrc.2012.03.151; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakanishi T, 2006, CANCER RES, V66, P5007, DOI 10.1158/0008-5472.CAN-05-4572; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Olson-Manning CF, 2013, MOL BIOL EVOL, V30, P14, DOI 10.1093/molbev/mss204; Philip S, 2012, MOL BIOL EVOL, V29, P3887, DOI 10.1093/molbev/mss194; Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOENHAUT DS, 1989, NUCLEIC ACIDS RES, V17, P7013, DOI 10.1093/nar/17.17.7013; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Taketani S, 1999, GENE, V227, P117, DOI 10.1016/S0378-1119(99)00011-6; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan JS, 2006, BLOOD, V107, P2557, DOI 10.1182/blood-2005-07-2957; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yang YH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-206; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang L, 2011, HEME BIOL SECRET LIF; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	84	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86718	10.1371/journal.pone.0086718	http://dx.doi.org/10.1371/journal.pone.0086718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489775	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000075
J	Wadford, DA; Kauffman, RC; Deere, JD; Aoki, ST; Stanton, RA; Higgins, J; Van Rompay, KKA; Villalobos, A; Nettles, JH; Schinazi, RF; Pedersen, NC; North, TW				Wadford, Debra A.; Kauffman, Robert C.; Deere, Jesse D.; Aoki, Scott T.; Stanton, Richard A.; Higgins, Joanne; Van Rompay, Koen K. A.; Villalobos, Andradi; Nettles, James H.; Schinazi, Raymond F.; Pedersen, Niels C.; North, Thomas W.			Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV	PLOS ONE			English	Article							HIV-1 NUCLEOCAPSID PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; RHESUS MACAQUES; SEQUENCE VARIATION; DRUG-RESISTANCE; VIRAL DYNAMICS; IN-VITRO; INFECTED MACAQUES; STRAND TRANSFER; M184V MUTATION	RT-SHIV is a chimera of simian immunodeficiency virus (SIV) containing the reverse transcriptase (RT)-encoding region of human immunodeficiency virus type 1 (HIV-1) within the backbone of SIVmac239. It has been used in a non-human primate model for studies of non-nucleoside RT inhibitors (NNRTI) and highly active antiretroviral therapy (HAART). We and others have identified several mutations that arise in the "foreign" HIV-1 RT of RT-SHIV during in vivo replication. In this study we catalogued amino acid substitutions in the HIV-1 RT and in regions of the SIV backbone with which RT interacts that emerged 30 weeks post-infection from seven RT-SHIV-infected rhesus macaques. The virus set points varied from relatively high virus load, moderate virus load, to undetectable virus load. The G196R substitution in RT was detected from 6 of 7 animals at week 4 post-infection and remained in virus from 4 of 6 animals at week 30. Virus from four high virus load animals showed several common mutations within RT, including L74V or V75L, G196R, L214F, and K275R. The foreign RT from high virus load isolates exhibited as much variation as that of the highly variable envelope surface glycoprotein, and 10-fold higher than that of the native RT of SIVmac239. Isolates from moderate virus load animals showed much less variation in the foreign RT than the high virus load isolates. No variation was found in SIVmac239 genes known to interact with RT. Our results demonstrate substantial adaptation of the foreign HIV-1 RT in RT-SHIV-infected macaques, which most likely reflects selective pressure upon the foreign RT to attain optimal activity within the context of the chimeric RT-SHIV and the rhesus macaque host.	[Wadford, Debra A.; Kauffman, Robert C.; Deere, Jesse D.; Aoki, Scott T.; Higgins, Joanne; Villalobos, Andradi; North, Thomas W.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Stanton, Richard A.; Nettles, James H.] Emory Univ, Sch Med, Dept Pediat, Childrens Ctr Drug Discovery CDD, Atlanta, GA USA; [Stanton, Richard A.; Nettles, James H.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA; [Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Schinazi, Raymond F.] Emory Univ, Sch Med, Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Pedersen, Niels C.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA; [North, Thomas W.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; Emory University; Emory University; University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Davis; University of California System; University of California Davis	North, TW (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	twnorth@ucdavis.edu	Deere, Jesse Dee/ABH-7940-2020; Schinazi, Raymond F/B-6777-2017	Deere, Jesse/0000-0002-2539-0338; Wadford, Debra/0000-0002-8630-427X	NIH-IMSD Fellowship [R25 GM 56765]; NIH R01 grants [AI47070, RR13967]; NIH [P01 AI058708]; National Center for Research Resources [P51RR000169]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169, R01RR013967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058708, R01AI047070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056765] Funding Source: NIH RePORTER	NIH-IMSD Fellowship; NIH R01 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DAW was supported in part by the NIH-IMSD Fellowship R25 GM 56765. This work was supported by NIH R01 grants AI47070 and RR13967 to TWN, by NIH Program Project grant P01 AI058708, and the National Center for Research Resources grant P51RR000169 to CNPRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; Arts EJ, 1996, P NATL ACAD SCI USA, V93, P10063, DOI 10.1073/pnas.93.19.10063; Balzarini J, 1997, J ACQ IMMUN DEF SYND, V15, P1, DOI 10.1097/00042560-199705010-00001; BARAT C, 1993, J MOL BIOL, V231, P185, DOI 10.1006/jmbi.1993.1273; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Beerens N, 2000, NUCLEIC ACIDS RES, V28, P4130, DOI 10.1093/nar/28.21.4130; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boyer PL, 1998, ANTIMICROB AGENTS CH, V42, P447; Buckley KA, 2003, VIROLOGY, V312, P470, DOI 10.1016/S0042-6822(03)00262-9; Burns D P, 1994, Curr Top Microbiol Immunol, V188, P185; BURNS DPW, 1991, J VIROL, V65, P1843, DOI 10.1128/JVI.65.4.1843-1854.1991; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; CAMPBELL BJ, 1994, J VIROL, V68, P3129, DOI 10.1128/JVI.68.5.3129-3137.1994; Capetti AF, 2005, AIDS, V19, P633, DOI 10.1097/01.aids.0000163943.31682.c8; Cen S, 1999, J VIROL, V73, P4485, DOI 10.1128/JVI.73.5.4485-4488.1999; Cen Shan, 2004, Retrovirology, V1, P33, DOI 10.1186/1742-4690-1-33; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHOI WS, 1994, J VIROL, V68, P5395, DOI 10.1128/JVI.68.9.5395-5402.1994; Clever JL, 1999, J VIROL, V73, P101, DOI 10.1128/JVI.73.1.101-109.1999; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Das AT, 1997, J GEN VIROL, V78, P837, DOI 10.1099/0022-1317-78-4-837; DECLERCQ E, 1992, AIDS RES HUM RETROV, V8, P119, DOI 10.1089/aid.1992.8.119; Deere JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011640; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; Druillennec S, 1999, J BIOL CHEM, V274, P11283, DOI 10.1074/jbc.274.16.11283; ESSINK BBO, 1995, J BIOL CHEM, V270, P23867, DOI 10.1074/jbc.270.40.23867; Finzi D, 1998, CELL, V93, P665, DOI 10.1016/S0092-8674(00)81427-0; GARDNER MB, 2004, AIDS OTHER MANIFESTA, P195; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Harrich D, 1997, EMBO J, V16, P1224, DOI 10.1093/emboj/16.6.1224; Harrich D, 1996, J VIROL, V70, P4017, DOI 10.1128/JVI.70.6.4017-4027.1996; Havlir DV, 1996, ANN INTERN MED, V124, P984, DOI 10.7326/0003-4819-124-11-199606010-00006; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ji XD, 1996, BIOCHEMISTRY-US, V35, P132, DOI 10.1021/bi951707e; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Joly V, 2004, ANTIMICROB AGENTS CH, V48, P172, DOI 10.1128/AAC.48.1.172-175.2004; Kameoka M, 2001, J VIROL, V75, P2675, DOI 10.1128/JVI.75.6.2675-2683.2001; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KODAMA T, 1993, J VIROL, V67, P6522, DOI 10.1128/JVI.67.11.6522-6534.1993; KODAMA T, 1991, J VIROL, V65, P2010, DOI 10.1128/JVI.65.4.2010-2018.1991; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; LOHMAN BL, 1991, J CLIN MICROBIOL, V29, P2187, DOI 10.1128/JCM.29.10.2187-2192.1991; MILLER MA, 1992, AIDS RES HUM RETROV, V8, P1153, DOI 10.1089/aid.1992.8.1153; Miller V, 1998, ANTIMICROB AGENTS CH, V42, P3123, DOI 10.1128/AAC.42.12.3123; MORI K, 1992, J VIROL, V66, P2067, DOI 10.1128/JVI.66.4.2067-2075.1992; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Murry JP, 2003, J VIROL, V77, P1120, DOI 10.1128/JVI.77.2.1120-1130.2003; NAJERA I, 1995, J VIROL, V69, P23; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QuinonesMateu M, 1996, AIDS RES HUM RETROV, V12, P1117, DOI 10.1089/aid.1996.12.1117; Riddler SA, 1997, AIDS, V11, pS141; RIZVI TA, 1993, J VIROL, V67, P2681, DOI 10.1128/JVI.67.5.2681-2688.1993; RODRIGUEZRODRIGUEZ L, 1995, J BIOL CHEM, V270, P15005, DOI 10.1074/jbc.270.25.15005; Rong LW, 2001, J BIOL CHEM, V276, P47725, DOI 10.1074/jbc.M105124200; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Ryzhova E, 2002, J VIROL, V76, P7903, DOI 10.1128/JVI.76.15.7903-7909.2002; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Shao W, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-101; Sharma PL, 1997, J VIROL, V71, P8846, DOI 10.1128/JVI.71.11.8846-8851.1997; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Svicher V, 2006, J VIROL, V80, P7186, DOI 10.1128/JVI.02084-05; Tisne C, 2004, J BIOL CHEM, V279, P3588, DOI 10.1074/jbc.M310368200; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wrobel JA, 1998, P NATL ACAD SCI USA, V95, P638, DOI 10.1073/pnas.95.2.638; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	81	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86997	10.1371/journal.pone.0086997	http://dx.doi.org/10.1371/journal.pone.0086997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498008	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900056
J	Zhu, FC; Huang, SJ; Wu, T; Zhang, XF; Wang, ZZ; Ai, X; Yan, Q; Yang, CL; Cai, JP; Jiang, HM; Wang, YJ; Ng, MH; Zhang, J; Xia, NS				Zhu, Feng-Cai; Huang, Shou-Jie; Wu, Ting; Zhang, Xue-Feng; Wang, Zhong-Ze; Ai, Xing; Yan, Qiang; Yang, Chang-Lin; Cai, Jia-Ping; Jiang, Han-Min; Wang, Yi-Jun; Ng, Mun-Hon; Zhang, Jun; Xia, Ning-Shao			Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Study in a Rural Population in China	PLOS ONE			English	Article							E VIRUS-INFECTION; NON-B HEPATITIS; BLOOD-DONORS; UNITED-STATES; NON-A; ANTIBODIES; ASSAYS; PREVALENCE; OUTBREAK; TRANSMISSION	Background: Hepatitis E is caused by two viral genotype groups: human types and zoonotic types. Current understanding of the epidemiology of the zoonotic hepatitis E disease is founded largely on hospital-based studies. Methods: The epidemiology of hepatitis E was investigated in a community-based surveillance study conducted over one year in a rural city in eastern China with a registered population of 400,162. Results: The seroprevalence of hepatitis E in the cohort was 38%. The incidence of hepatitis E was 2.8/10,000 person-years. Totally 93.5% of the infections were attributed to genotype 4 and the rest, to genotype 1. Hepatitis E accounted for 28.4% (102/359) of the acute hepatitis cases and 68.9% (102/148) of the acute viral hepatitis cases in this area of China. The disease occurred sporadically with a higher prevalence during the cold season and in men, with the male-to-female ratio of 3:1. Additionally, the incidence of hepatitis E increased with age. Hepatitis B virus carriers have an increased risk of contracting hepatitis E than the general population (OR = 2.5, 95% CI 1.5-4.2). Pre-existing immunity to hepatitis E lowered the risk (relative risk = 0.34, 95% CI 0.21-0.55) and reduced the severity of the disease. Conclusions: Hepatitis E in the rural population of China is essentially that of a zoonosis due to the genotype 4 virus, the epidemiology of which is similar to that due to the other zoonotic genotype 3 virus.	[Zhu, Feng-Cai; Zhang, Xue-Feng; Ai, Xing] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Huang, Shou-Jie; Wu, Ting; Yan, Qiang; Ng, Mun-Hon; Zhang, Jun; Xia, Ning-Shao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen, Peoples R China; [Wang, Zhong-Ze; Yang, Chang-Lin; Cai, Jia-Ping; Jiang, Han-Min; Wang, Yi-Jun] Dongtai Ctr Dis Control & Prevent, Dongtai, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Xiamen University	Zhang, J (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Sch Publ Hlth, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Zhang, Jun/G-4598-2010; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; wang, yixuan/GXW-2866-2022	Zhang, Jun/0000-0002-6601-9180; Wu, Ting/0000-0002-1806-3056; Xia, Ningshao/0000-0003-0179-5266	National Major Scientific and Technological Special Project for "Significant New Drugs Development'' [2013ZX09101017]; National High-tech Research & Development Program (863 Program) [2012AA02A408]; National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases'' [2012ZX10002001, 2011ZX10004-903]; Fujian Provincial Science Fund for Distinguished Young Scholars [2011J06015]; Jiangsu science and technology support plan project [BE2013723]	National Major Scientific and Technological Special Project for "Significant New Drugs Development''; National High-tech Research & Development Program (863 Program); National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases''; Fujian Provincial Science Fund for Distinguished Young Scholars; Jiangsu science and technology support plan project	The work was supported by National Major Scientific and Technological Special Project for "Significant New Drugs Development'' (2013ZX09101017); National High-tech Research & Development Program (863 Program) (2012AA02A408); National Major Scientific and Technological Special Project for "Prevention and Control of important infectious diseases'' (2012ZX10002001, 2011ZX10004-903) (http://www.most.gov.cn/); Fujian Provincial Science Fund for Distinguished Young Scholars (2011J06015) (http://www.fjkjt.gov.cn/) and Jiangsu science and technology support plan project (BE2013723). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kenji, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P90; Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Buti M, 2006, CLIN VACCINE IMMUNOL, V13, P1328, DOI 10.1128/CVI.00255-06; Chen HY, 2005, CLIN DIAGN LAB IMMUN, V12, P593, DOI 10.1128/CDLI.12.5.593-598.2005; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Corwin AL, 1996, AM J TROP MED HYG, V54, P559, DOI 10.4269/ajtmh.1996.54.559; Dalton HR, 2007, LANCET, V369, P1260, DOI 10.1016/S0140-6736(07)60595-9; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Huang SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013560; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Legrand-Abravanel F, 2009, CLIN VACCINE IMMUNOL, V16, P772, DOI 10.1128/CVI.00438-08; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2009, J CLIN VIROL, V44, P74, DOI 10.1016/j.jcv.2008.09.010; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Myint KSA, 2006, J CLIN MICROBIOL, V44, P1581, DOI 10.1128/JCM.44.4.1581-1583.2006; Myint KSA, 2005, AM J TROP MED HYG, V73, P942, DOI 10.4269/ajtmh.2005.73.942; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2005, VIRAL HEPATITIS, 3RD EDITION, P635, DOI 10.1002/9780470987131.ch42; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Seriwatana J, 2002, CLIN DIAGN LAB IMMUN, V9, P1072, DOI 10.1128/CDLI.9.5.1072-1078.2002; Taniguchi M, 2009, J INFECTION, V58, P232, DOI 10.1016/j.jinf.2009.01.011; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; Wedemeyer H, 2013, SEMIN LIVER DIS, V33, P71, DOI 10.1055/s-0033-1338118; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhang J, 2013, CLIN MICROBIOL INFEC; Zheng YJ, 2006, J INFECT DIS, V193, P1643, DOI 10.1086/504293; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; Zhuang H, 1999, CHIN MED SCI J, V14, P47	43	35	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87154	10.1371/journal.pone.0087154	http://dx.doi.org/10.1371/journal.pone.0087154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498033	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900071
J	Zomer-Kooijker, K; van der Ent, CK; Ermers, MJJ; Uiterwaal, CSPM; Rovers, MM; Bont, LJ				Zomer-Kooijker, Kim; van der Ent, Cornelis K.; Ermers, Marieke J. J.; Uiterwaal, Cuno S. P. M.; Rovers, Maroeska M.; Bont, Louis J.		RSV Corticosteroid Study Grp	Increased Risk of Wheeze and Decreased Lung Function after Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							BRONCHIOLITIS; ASTHMA; ALLERGY; AGE; INFANCY; INTERLEUKIN-10; PREVENTION; RATIONALE; SYMPTOMS; DESIGN	Background: A relationship between hospitalization for respiratory syncytial virus (RSV) bronchiolitis and asthma development has been suggested in case-control studies. Objective: The aim of this study was to assess the risk of current wheeze, asthma, and lung function at school age in infants previously hospitalized for RSV bronchiolitis compared to non-hospitalized children. Methods: For this study, data from a prospective birth cohort of unselected, term-born infants (n = 553), of whom 4 (0.7%) were hospitalized for RSV bronchiolitis, and a prospective patient cohort of 155 term infants hospitalized for RSV bronchiolitis were used. Respiratory outcomes at age 6 in children hospitalized for RSV bronchiolitis were compared to non-hospitalized children. Results: The risk of current wheeze was higher in hospitalized patients (n = 159) compared to non-hospitalized children (n = 549) (adjusted odds ratio (OR) 3.2 (95% CI 1.2-8.1). Similarly, the risk of current asthma, defined as a doctor's diagnosis of asthma plus current symptoms or medication use, was higher in hospitalized patients (adjusted OR 3.1 (95% CI 1.3-7.5). Compared to non-hospitalized children, RSV bronchiolitis hospitalization was associated with lower lung function (mean difference FEV1% predicted -6.8 l (95% CI (-10.2 to -3.4). Conclusions and Clinical Relevance: This is the first study showing that hospitalization for RSV bronchiolitis during infancy is associated with increased risk of wheezing, current asthma, and impaired lung function as compared to an unselected birth cohort at age 6.	[Zomer-Kooijker, Kim; van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Pulmonol & Allergol, Utrecht, Netherlands; [Ermers, Marieke J. J.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Epidemiol Biostat & HTA & Operating Rooms, NL-6525 ED Nijmegen, Netherlands; [Bont, Louis J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Bont, LJ (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands.	l.bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014; Bont, Louis/J-6370-2014	Rovers, Maroeska/0000-0002-3095-170X; Van der Ent, Cornelis/0000-0002-2501-4121	Teva Pharmaceutical industries inc.; Dutch Asthma Foundation; Abbott	Teva Pharmaceutical industries inc.; Dutch Asthma Foundation; Abbott(Abbott Laboratories)	LB received a grant for this study from Teva Pharmaceutical industries inc., and from the Dutch Asthma Foundation. MR received an educational grant from Abbott, to provide financial support without restrictions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher MI, 1998, EUR RESPIR J, V12, P315; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bont L, 2000, AM J RESP CRIT CARE, V161, P1518, DOI 10.1164/ajrccm.161.5.9904078; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Ermers MJJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b897; Fjaerli Hans-Olav, 2005, BMC Pediatr, V5, P31, DOI 10.1186/1471-2431-5-31; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Juntti H, 2003, ALLERGY, V58, P878, DOI 10.1034/j.1398-9995.2003.00233.x; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Korppi M, 2004, PEDIATR PULM, V38, P155, DOI 10.1002/ppul.20058; Mikalsen IB, 2012, PEDIAT ALLERG IMM-UK, V23, P391, DOI 10.1111/j.1399-3038.2012.01283.x; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; MURRAY M, 1992, ARCH DIS CHILD, V67, P482, DOI 10.1136/adc.67.4.482; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Regnier S, 2013, PEDIATR INFECT DIS J, P3; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6284; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stein RT, 2010, THORAX, V65, P1033, DOI 10.1136/thx.2009.133967; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Szabo SM, 2012, PAEDIATR RESPIR REV, V13, pS9; van der Zalm MM, 2011, AM J RESP CRIT CARE, V183, P262, DOI 10.1164/rccm.200905-0716OC; Verbeke M, 2006, STUD HLTH TECHNOL IN, V124; Zomer-Kooijker K, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-9	29	76	81	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87162	10.1371/journal.pone.0087162	http://dx.doi.org/10.1371/journal.pone.0087162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498037	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900073
J	Hojo, MK; Yamamoto, A; Akino, T; Tsuji, K; Yamaoka, R				Hojo, Masaru K.; Yamamoto, Ari; Akino, Toshiharu; Tsuji, Kazuki; Yamaoka, Ryohei			Ants Use Partner Specific Odors to Learn to Recognize a Mutualistic Partner	PLOS ONE			English	Article							BUTTERFLY MACULINEA-REBELI; CUTICULAR HYDROCARBONS; SUGAR COMPOSITION; HOST-SPECIFICITY; SOCIAL PARASITE; LYCAENID LARVAE; EVOLUTION; DISCRIMINATION; COOPERATION; SYMBIOSIS	Regulation via interspecific communication is an important for the maintenance of many mutualisms. However, mechanisms underlying the evolution of partner communication are poorly understood for many mutualisms. Here we show, in an ant-lycaenid butterfly mutualism, that attendant ants selectively learn to recognize and interact cooperatively with a partner. Workers of the ant Pristomyrmex punctatus learn to associate cuticular hydrocarbons of mutualistic Narathura japonica caterpillars with food rewards and, as a result, are more likely to tend the caterpillars. However, the workers do not learn to associate the cuticular hydrocarbons of caterpillars of a non-ant-associated lycaenid, Lycaena phlaeas, with artificial food rewards. Chemical analysis revealed cuticular hydrocarbon profiles of the mutualistic caterpillars were complex compared with those of non-ant-associated caterpillars. Our results suggest that partner-recognition based on partner-specific chemical signals and cognitive abilities of workers are important mechanisms underlying the evolution and maintenance of mutualism with ants.	[Hojo, Masaru K.; Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 90301, Japan; [Hojo, Masaru K.; Yamamoto, Ari; Akino, Toshiharu; Yamaoka, Ryohei] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 606, Japan; [Hojo, Masaru K.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Tsuji, Kazuki] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan	University of the Ryukyus; Kyoto Institute of Technology; Harvard University; Kagoshima University	Hojo, MK (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	m.k.hojo@gmail.com	Tsuji, Kazuki/D-6607-2014; Hojo, Masaru K/O-4909-2014	Tsuji, Kazuki/0000-0002-2027-8582; Hojo, Masaru K/0000-0002-1573-9356	JSPS;  [223146]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a Grant-in-Aid for JSPS Fellows (No. 223146). M. K. H. was supported by JSPS Research Fellowship for young scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, P ROY SOC B-BIOL SCI, V267, P1857, DOI 10.1098/rspb.2000.1221; Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Axen AH, 1996, ANIM BEHAV, V52, P321, DOI 10.1006/anbe.1996.0178; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Bos N, 2012, J INSECT PHYSIOL, V58, P138, DOI 10.1016/j.jinsphys.2011.10.010; Brandstaetter AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021383; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; BUCKLEY RC, 1987, ANNU REV ECOL SYST, V18, P111, DOI 10.1146/annurev.es.18.110187.000551; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; CUSHMAN JH, 1991, AM NAT, V138, P851, DOI 10.1086/285256; Daniels H, 2005, J CHEM ECOL, V31, P2805, DOI 10.1007/s10886-005-8395-y; FIEDLER K, 1995, OECOLOGIA, V104, P316, DOI 10.1007/BF00328367; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; FIEDLER K, 1992, OECOLOGIA, V91, P468, DOI 10.1007/BF00650318; Fiedler K, 1991, BONN ZOOL MONOGR, V31, P1; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hojo MK, 2008, J COMP PHYSIOL A, V194, P1043, DOI 10.1007/s00359-008-0375-6; Hojo MK, 2009, P ROY SOC B-BIOL SCI, V276, P551, DOI 10.1098/rspb.2008.1064; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Lang C, 2011, ANIM BEHAV, V82, P1245, DOI 10.1016/j.anbehav.2011.08.020; LEIMAR O, 1993, ANIM BEHAV, V46, P1177, DOI 10.1006/anbe.1993.1307; Leimar O, 1997, P ROY SOC B-BIOL SCI, V264, P1209, DOI 10.1098/rspb.1997.0167; Leimar O, 2003, DAHL WS ENV, P203; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; PIERCE NE, 1987, BEHAV ECOL SOCIOBIOL, V21, P237, DOI 10.1007/BF00292505; PIERCE NE, 1981, SCIENCE, V211, P1185, DOI 10.1126/science.211.4487.1185; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; ROBBINS RK, 1991, OIKOS, V62, P363, DOI 10.2307/3545502; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; Schlick-Steiner BC, 2004, NATURWISSENSCHAFTEN, V91, P209, DOI 10.1007/s00114-004-0518-8; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364; van Wilgenburg E, 2011, J EVOLUTION BIOL, V24, P1188, DOI 10.1111/j.1420-9101.2011.02248.x; van Wilgenburg E, 2012, BIOL LETTERS, V8, P17, DOI 10.1098/rsbl.2011.0643; Wada A, 2001, CHEM SENSES, V26, P983, DOI 10.1093/chemse/26.8.983; Yao I, 2001, OECOLOGIA, V128, P36, DOI 10.1007/s004420100633	52	25	27	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86054	10.1371/journal.pone.0086054	http://dx.doi.org/10.1371/journal.pone.0086054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489690	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000023
J	Myles, IA; Pincus, NB; Fontecilla, NM; Datta, SK				Myles, Ian A.; Pincus, Nathan B.; Fontecilla, Natalia M.; Datta, Sandip K.			Effects of Parental Omega-3 Fatty Acid Intake on Offspring Microbiome and Immunity	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; GUT MICROBIOTA; T-CELLS; N-3; EXPRESSION; RESOLVIN; DIFFERS; MODEL; VITRO	The "Western diet" is characterized by increased intake of saturated and omega-6 (n-6) fatty acids with a relative reduction in omega-3 (n-3) consumption. These fatty acids can directly and indirectly modulate the gut microbiome, resulting in altered host immunity. Omega-3 fatty acids can also directly modulate immunity through alterations in the phospholipid membranes of immune cells, inhibition of n-6 induced inflammation, down-regulation of inflammatory transcription factors, and by serving as pre-cursors to anti-inflammatory lipid mediators such as resolvins and protectins. We have previously shown that consumption by breeder mice of diets high in saturated and n-6 fatty acids have inflammatory and immune-modulating effects on offspring that are at least partially driven by vertical transmission of altered gut microbiota. To determine if parental diets high in n-3 fatty acids could also affect offspring microbiome and immunity, we fed breeding mice an n-3-rich diet with 40% calories from fat and measured immune outcomes in their offspring. We found offspring from mice fed diets high in n-3 had altered gut microbiomes and modestly enhanced anti-inflammatory IL-10 from both colonic and splenic tissue. Omega-3 pups were protected during peanut oral allergy challenge with small but measurable alterations in peanut-related serologies. However, n-3 pups displayed a tendency toward worsened responses during E. coli sepsis and had significantly worse outcomes during Staphylococcus aureus skin infection. Our results indicate excess parental n-3 fatty acid intake alters microbiome and immune response in offspring.	[Myles, Ian A.; Pincus, Nathan B.; Fontecilla, Natalia M.; Datta, Sandip K.] NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Myles, IA (corresponding author), NIAID, Bacterial Pathogenesis Unit, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mylesi@niaid.nih.gov	Myles, Ian/AAE-7623-2019	Myles, Ian/0000-0001-9316-3703; Pincus, Nathan/0000-0002-3134-7176; Datta, Sandip/0000-0003-0243-7815	National Institutes of Health; Office of Dietary Supplements; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also the funding was entirely from National Institutes of Health and the Office of Dietary Supplements. There are no current external funding sources for this study.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Calder PC, 2009, INT REV IMMUNOL, V28, P506, DOI 10.3109/08830180903197480; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Ghosh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055468; Halabi-Tawil M, 2009, BRIT J DERMATOL, V160, P645, DOI 10.1111/j.1365-2133.2008.08835.x; Heuer JG, 2005, J IMMUNOL, V174, P7141, DOI 10.4049/jimmunol.174.11.7141; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jones ML, 2013, J LIPID RES, V54, P2247, DOI 10.1194/jlr.M039842; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim T, 2012, INTEGR COMPUT-AID E, V19, P1, DOI 10.3233/ICA-2012-0394; Langerhuus SN, 2012, BRIT J NUTR, V107, P735, DOI 10.1017/S0007114511003503; Lee HM, 2009, J IMMUNOL, V183, P6839, DOI 10.4049/jimmunol.0901856; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Li JJ, 2013, AM J CLIN NUTR, V97, P173, DOI 10.3945/ajcn.112.041145; Mabrok HB, 2012, CARCINOGENESIS, V33, P203, DOI 10.1093/carcin/bgr256; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Saurer L, 2009, ALLERGY, V64, P505, DOI 10.1111/j.1398-9995.2009.01965.x; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shek LP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/730568; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Teague H, 2013, IMMUNOLOGY, V139, P386, DOI 10.1111/imm.12088; Thang CL, 2013, MOL NUTR FOOD RES; van den Elsen LWJ, 2013, CLIN EXP ALLERGY, V43, P798, DOI 10.1111/cea.12111; van den Elsen LWJ, 2013, BRIT J NUTR, V109, P1821, DOI 10.1017/S0007114512003959; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Wright GP, 2011, EXPERT REV CLIN IMMU, V7, P213, DOI [10.1586/eci.10.96, 10.1586/ECI.10.96]	37	35	37	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87181	10.1371/journal.pone.0087181	http://dx.doi.org/10.1371/journal.pone.0087181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489864	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000114
J	Ooi, JH; Waddell, A; Lin, YD; Albert, I; Rust, LT; Holden, V; Cantorna, MT				Ooi, Jot Hui; Waddell, Amanda; Lin, Yang-Ding; Albert, Istvan; Rust, Laura T.; Holden, Victoria; Cantorna, Margherita T.			Dominant Effects of the Diet on the Microbiome and the Local and Systemic Immune Response in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; GUT MICROBIOTA; MULTIPLE-SCLEROSIS; CROHNS-DISEASE; DOUBLE-BLIND; EPIDEMIOLOGY; MICROFLORA; DISORDERS	Outside the nutrition community the effects of diet on immune-mediated diseases and experimental outcomes have not been appreciated. Investigators that study immune-mediated diseases and/or the microbiome have overlooked the potential of diet to impact disease phenotype. We aimed to determine the effects of diet on the bacterial microbiota and immune-mediated diseases. Three different laboratory diets were fed to wild-type mice for 2 weeks and resulted in three distinct susceptibilities to dextran sodium sulfate (DSS)-induced colitis. Examination of the fecal microbiota demonstrated a diet-mediated effect on the bacteria found there. Broad-spectrum antibiotics disturbed the gut microbiome and partially eliminated the diet-mediated changes in DSS susceptibility. Dietary changes 2 days after DSS treatment were protective and suggested that the diet-mediated effect occurred quickly. There were no diet-mediated effects on DSS susceptibility in germ-free mice. In addition, the diet-mediated effects were evident in a gastrointestinal infection model (Citrobacter rodentium) and in experimental autoimmune encephalomyelitis. Taken together, our study demonstrates a dominant effect of diet on immune-mediated diseases that act rapidly by changing the microbiota. These findings highlight the potential of using dietary manipulation to control the microbiome and prevent/treat immune-mediated disease.	[Ooi, Jot Hui; Waddell, Amanda; Lin, Yang-Ding; Albert, Istvan; Rust, Laura T.; Holden, Victoria; Cantorna, Margherita T.] Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Biochem & Mol Biol, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cantorna, MT (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Biochem & Mol Biol, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	mxc69@psu.edu	Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X; Holden, Victoria/0000-0003-4584-068X	National Institutes of Health/National Institute of Neurologic and Stroke [NS067563]; National Institutes of Health/National Center for Complementary and Alternative Medicine; Office of Dietary Supplements [AT005378]; National Gnotobiotic Rodent Resource Center, National Institutes of Health [5-P39-DK034987, 5-P40-OD010995]; National Center for Complementary & Integrative Health [R01AT005378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067563] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurologic and Stroke; National Institutes of Health/National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Gnotobiotic Rodent Resource Center, National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by the National Institutes of Health/National Institute of Neurologic and Stroke Grant NS067563 and National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements AT005378 and the National Gnotobiotic Rodent Resource Center, National Institutes of Health grants 5-P39-DK034987 AND 5-P40-OD010995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein CN, 2008, GUT, V57, P1185, DOI 10.1136/gut.2007.122143; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chapman-Kiddell CA, 2010, INFLAMM BOWEL DIS, V16, P137, DOI 10.1002/ibd.20968; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hugot JP, 2004, BEST PRACT RES CL GA, V18, P451, DOI 10.1016/j.bpg.2004.01.001; Hunter JO, 2008, INFLAMM BOWEL DIS, V14, pS35, DOI 10.1002/ibd.20547; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; King TS, 1997, ALIMENT PHARM THER, V11, P17, DOI 10.1046/j.1365-2036.1997.90262000.x; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ooi JH, 2013, J NUTR, V143, P1679, DOI 10.3945/jn.113.180794; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Steinhoff U, 2005, IMMUNOL LETT, V99, P12, DOI 10.1016/j.imlet.2004.12.013; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Varshney J, 2013, J NUTR, V143, P526, DOI 10.3945/jn.112.171355; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	30	32	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86366	10.1371/journal.pone.0086366	http://dx.doi.org/10.1371/journal.pone.0086366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489720	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000035
J	Selfe, J; Alexander, J; Costello, JT; May, K; Garratt, N; Atkins, S; Dillon, S; Hurst, H; Davison, M; Przybyla, D; Coley, A; Bitcon, M; Littler, G; Richards, J				Selfe, James; Alexander, Jill; Costello, Joseph T.; May, Karen; Garratt, Nigel; Atkins, Stephen; Dillon, Stephanie; Hurst, Howard; Davison, Matthew; Przybyla, Daria; Coley, Andrew; Bitcon, Mark; Littler, Greg; Richards, Jim			The Effect of Three Different (-135 degrees C) Whole Body Cryotherapy Exposure Durations on Elite Rugby League Players	PLOS ONE			English	Article							ANTERIOR KNEE; TEMPERATURE; MUSCLE; CRYOSTIMULATION	Background: Whole body cryotherapy (WBC) is the therapeutic application of extreme cold air for a short duration. Minimal evidence is available for determining optimal exposure time. Purpose: To explore whether the length of WBC exposure induces differential changes in inflammatory markers, tissue oxygenation, skin and core temperature, thermal sensation and comfort. Method: This study was a randomised cross over design with participants acting as their own control. Fourteen male professional first team super league rugby players were exposed to 1, 2, and 3 minutes of WBC at -135 degrees C. Testing took place the day after a competitive league fixture, each exposure separated by seven days. Results: No significant changes were found in the inflammatory cytokine interleukin six. Significant reductions (p<0.05) in deoxyhaemoglobin for gastrocnemius and vastus lateralis were found. In vastus lateralis significant reductions (p<0.05) in oxyhaemoglobin and tissue oxygenation index (p<0.05) were demonstrated. Significant reductions (p<0.05) in skin temperature were recorded. No significant changes were recorded in core temperature. Significant reductions (p<0.05) in thermal sensation and comfort were recorded. Conclusion: Three brief exposures to WBC separated by 1 week are not sufficient to induce physiological changes in IL-6 or core temperature. There are however significant changes in tissue oxyhaemoglobin, deoxyhaemoglobin, tissue oxygenation index, skin temperature and thermal sensation. We conclude that a 2 minute WBC exposure was the optimum exposure length at temperatures of -135 degrees C and could be applied as the basis for future studies.	[Selfe, James] Univ Cent Lancashire, Allied Hlth Res Unit, Preston PR1 2HE, Lancs, England; [Alexander, Jill; May, Karen; Littler, Greg; Richards, Jim] Univ Cent Lancashire, AHRu, Preston PR1 2HE, Lancs, England; [Costello, Joseph T.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Garratt, Nigel] Univ Cent Lancashire, SSTO, Preston PR1 2HE, Lancs, England; [Atkins, Stephen; Dillon, Stephanie; Hurst, Howard; Davison, Matthew; Przybyla, Daria] Univ Cent Lancashire, SENS, Preston PR1 2HE, Lancs, England; [Coley, Andrew; Bitcon, Mark] Wigan Warriors Rugby League, Wigan, England	University of Central Lancashire; University of Central Lancashire; Queensland University of Technology (QUT); University of Central Lancashire; University of Central Lancashire	Alexander, J (corresponding author), Univ Cent Lancashire, AHRu, Preston PR1 2HE, Lancs, England.	jalexander3@uclan.ac.uk	Costello, Joseph/AAW-8764-2020; Costello, Joseph/G-6294-2011; Costello, Joseph/J-1374-2012; Richards, Jim/AAI-7331-2020	Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Richards, Jim/0000-0002-4004-3115; Alexander, Jill/0000-0002-6492-1621; Littler, Greg/0000-0002-2575-0874; Selfe, James/0000-0001-9931-4998	University of Central Lancashire	University of Central Lancashire	Jill Alexander was funded to work on the project by a University of Central Lancashire innovation voucher. The use of the mobile Cryochamber, liquid nitrogen and specialist operator were provided free of charge by BOC Linde throughout the testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, ERG THERM ENV ASS IN; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Austin DJ, 2011, J STRENGTH COND RES, V25, P1898, DOI 10.1519/JSC.0b013e3181e83a5b; Banfi G, 2010, SPORTS MED, V7, P1; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Costello J, 2012, PLOS ONE, V7, P1; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2012, J THERM BIOL, V37, P103, DOI 10.1016/j.jtherbio.2011.11.008; Costello JT, 2013, ACSM; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Flouris AD, 2008, EUR J APPL PHYSIOL, V104, P491, DOI 10.1007/s00421-008-0798-3; Flouris AD, 2009, J APPL PHYSIOL, V106, P1264, DOI 10.1152/japplphysiol.91426.2008; Fonda B, 2013, SCAND J MED SCI SPOR, V23, pE270, DOI 10.1111/sms.12074; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gregson W, 2011, AM J SPORT MED, V39, P1316, DOI 10.1177/0363546510395497; Hausswirth C, 2011, PLOS ONE, V12, P1; Karki A, 2004, THERMOL INT, V14, P137; Lombardi G, 2013, PLOS ONE, V8, P1; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Reynolds JD, 2007, P NATL ACAD SCI USA, V104, P17058, DOI 10.1073/pnas.0707958104; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Savic M, 2013, J THERM BIOL, V38, P186, DOI 10.1016/j.jtherbio.2013.02.004; Selfe J, 2006, ARCH PHYS MED REHAB, V87, P1630, DOI 10.1016/j.apmr.2006.08.346; Selfe J, 2010, KNEE, V17, P319, DOI 10.1016/j.knee.2009.10.005; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Twist C, 2012, J SPORT SCI, V30, P359, DOI 10.1080/02640414.2011.640707; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0; Ziemann E, 2012, J ATHL TRAINING, V47, P664, DOI 10.4085/1062-6050-47.6.13	35	51	55	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86420	10.1371/journal.pone.0086420	http://dx.doi.org/10.1371/journal.pone.0086420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489726	Green Accepted, Green Published, gold			2022-12-27	WOS:000330570000039
J	Yang, X; Hu, JW; Qiu, MT; Li, M; Yin, R; Wang, J; Xu, L; Zhang, Q				Yang, Xin; Hu, Jing-Wen; Qiu, Man-Tang; Li, Ming; Yin, Rong; Wang, Jie; Xu, Lin; Zhang, Qin			Association of Matrix Metalloproteinase-3-1171(5A > 6A) Polymorphism with Cancer Risk: A Meta-Analysis of 41 Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL SUBMUCOUS FIBROSIS; COLORECTAL-CANCER; BREAST-CANCER; PROMOTER REGIONS; METALLOPROTEINASE (MMP)-1; FUNCTIONAL POLYMORPHISMS; HEPATOCELLULAR-CARCINOMA; GENE PROMOTER; LUNG-CANCER	Background and Objective: Evidence has shown that matrix metalloproteinases-3 (MMP3) is important for cancer progression. Recent studies about the association between the -1171(5A > 6A) polymorphism in MMP3 promoter region and cancer risk have yielded conflicting results. Methodology/Principal Findings: We performed a meta-analysis of 41 studies including 11112 cases and 11091 controls to determine whether the -1171(5A > 6A) polymorphism of MMP3 was associated with cancer risk. We assessed the strength of association and performed sub-group analyses by cancer types, ethnicity, smoking status, genotyping method, source of controls and sample size. The pooled results revealed that no significant association of the -1171(5A > 6A) polymorphism with overall cancer risk in any of four models. Further sub-group analysis revealed that individuals with the 6A allele had lower risk of gastrointestinal cancer in two models: heterozygote comparison (6A/5A vs. 5A/5A: OR = 0.74, 95% CI: 0.60-0.91; I-2 = 1.9%), and dominant model (6A/6A+6A/5A vs. 5A/5A: OR = 0.77, 95% CI: 0.64-0.94; I-2 = 29.0%). Additionally, the associations were significant in Asian populations for three models: homozygote comparison (6A/6A vs. 5A/5A, OR = 0.68, 95% CI: 0.52-0.90; I-2 = 26.7%), heterozygote comparison (6A/5A vs. 5A/5A: OR = 0.75, 95% CI: 0.58-0.98; I-2 = 0.0%), and dominant model (6A/6A+6A/5A vs. 5A/5A: OR = 0.69, 95% CI: 0.54-0.88; I-2 = 0.5%). It was noteworthy that we had a contrary finding in non-smokers: the variant 6A/6A homozygote might statistically increase cancer risk compared with 6A/5A+5A/5A genotype (OR = 1.92, 95% CI: 1.25-2.96; I-2 = 72.7%). Conclusion: This meta-analysis suggests that the -1171(5A > 6A) polymorphism in MMP3 promoter region is not associated with overall cancer risk, but it may contribute to decreased cancer risk in Asian population when compared with Caucasian population and significantly reduce the risk of gastrointestinal cancer.	[Yang, Xin] Nanjing Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China; [Yang, Xin; Hu, Jing-Wen; Qiu, Man-Tang; Li, Ming; Yin, Rong; Xu, Lin; Zhang, Qin] Nanjing Med Univ, Dept Thorac Surg, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Yang, Xin; Hu, Jing-Wen; Qiu, Man-Tang; Li, Ming; Yin, Rong; Wang, Jie; Xu, Lin; Zhang, Qin] Jiangsu Key Lab Mol & Translat Canc Res, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Nanjing Med Univ, Dept Sci Res, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Xu, L (corresponding author), Nanjing Med Univ, Dept Thorac Surg, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	xulin83cn@gmail.com; ctzs123@sina.com	Qiu, Mantang/L-8937-2019		National Natural Science Foundation of China [81201830, 81372321]; special fund of Jiangsu Key laboratory of Cancer Molecular Biology and Translational Medicine [BM2013007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund of Jiangsu Key laboratory of Cancer Molecular Biology and Translational Medicine	This work was supported by the National Natural Science Foundation of China (81201830, 81372321), and the special fund of Jiangsu Key laboratory of Cancer Molecular Biology and Translational Medicine(BM2013007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biondi ML, 2000, CLIN CHEM, V46, P2023; BOISSEL JP, 1988, EUR J CLIN PHARMACOL, V34, P535, DOI 10.1007/BF00615213; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chaudhary AK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-369; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Dey S, 2012, MOL CARCINOGEN, V51, pE42, DOI 10.1002/mc.21837; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elander N, 2006, ANTICANCER RES, V26, P791; Fakhoury HMA, 2012, GENET TEST MOL BIOMA, V16, P988, DOI 10.1089/gtmb.2012.0042; Fang SM, 2005, CARCINOGENESIS, V26, P481, DOI 10.1093/carcin/bgh327; Fathy M, 2013, MOL DIAGN THER; Ghilardi G, 2002, CLIN CANCER RES, V8, P3820; Gonzalez-Arriaga P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-121; Grudny Jacek, 2013, Pneumonol Alergol Pol, V81, P308; Han H, 2008, J SHANXI MED, V37, P1088; Hashimoto T, 2004, CANCER LETT, V211, P19, DOI 10.1016/j.canlet.2004.01.032; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Hirata H, 2004, CARCINOGENESIS, V25, P2379, DOI 10.1093/carcin/bgh254; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kader AK, 2006, CANCER RES, V66, P11644, DOI 10.1158/0008-5472.CAN-06-1212; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lei HX, 2007, BREAST CANCER RES TR, V103, P61, DOI 10.1007/s10549-006-9345-2; Lei HX, 2002, CLIN CHEM, V48, P798; Li DH, 2002, CANCER RES, V62, P4566; Li Y, 2006, GYNECOL ONCOL, V101, P92, DOI 10.1016/j.ygyno.2005.09.058; Li Yan, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P472; Lievre A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-270; Lu Zhong-Qiang, 2007, Ai Zheng, V26, P463; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; Motovali-Bashi M, 2012, J RES MED SCI, V17, P962; Nishizawa R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-187; Okamoto K, 2005, RES COMMUN MOL PATH, V117, P77; Okamoto K, 2010, INTERNAL MED, V49, P887, DOI 10.2169/internalmedicine.49.3268; Pan HF, 2011, LUPUS, V20, P945, DOI 10.1177/0961203311400114; Peng B, 2010, MUTAGENESIS, V25, P41, DOI 10.1093/mutage/gep041; Qiu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050887; Smolarz Beata, 2003, Pol J Pathol, V54, P233; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Sternlicht MD, 2000, ONCOGENE, V19, P1102, DOI 10.1038/sj.onc.1203347; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Tu HF, 2006, J ORAL PATHOL MED, V35, P99, DOI 10.1111/j.1600-0714.2006.00370.x; Vairaktaris E, 2009, ORAL ONCOL, V45, P247, DOI 10.1016/j.oraloncology.2008.05.003; Vairaktaris E, 2007, ANTICANCER RES, V27, P4095; Van Themsche C, 2004, BIOCHEM BIOPH RES CO, V315, P884, DOI 10.1016/j.bbrc.2004.01.144; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Wynder E L, 1992, J Natl Cancer Inst Monogr, P87; Xu EP, 2006, DIS COLON RECTUM, V49, P1439, DOI 10.1007/s10350-006-0652-9; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062181; YE S, 1995, BRIT HEART J, V73, P209; Yi YC, 2010, CLIN CHEM LAB MED, V48, P337, DOI 10.1515/CCLM.2010.082; Yin L, 2000, ARCH DERMATOL RES, V292, P188, DOI 10.1007/s004030050476; Zhai Y, 2007, GUT, V56, P445, DOI 10.1136/gut.2006.112706; Zhang JH, 2004, CARCINOGENESIS, V25, P2519, DOI 10.1093/carcin/bgh269; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570; Zinzindohoue F, 2004, ANTICANCER RES, V24, P2021	62	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87562	10.1371/journal.pone.0087562	http://dx.doi.org/10.1371/journal.pone.0087562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489939	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000160
J	Craig, SM; Reagon, M; Resnick, LE; Caicedo, AL				Craig, Stephanie M.; Reagon, Michael; Resnick, Lauren E.; Caicedo, Ana L.			Allele Distributions at Hybrid Incompatibility Loci Facilitate the Potential for Gene Flow between Cultivated and Weedy Rice in the US	PLOS ONE			English	Article							ORYZA-SATIVA L.; RED RICE; WIDE-COMPATIBILITY; NEUTRAL ALLELES; MALE-STERILITY; POLYMORPHISM; EVOLUTION; SYSTEM	The accumulation of independent mutations over time in two populations often leads to reproductive isolation. Reproductive isolation between diverging populations may be reinforced by barriers that occur either pre- or postzygotically. Hybrid sterility is the most common form of postzygotic isolation in plants. Four postzygotic sterility loci, comprising three hybrid sterility systems (Sa, s5, DPL), have been recently identified in Oryza sativa. These loci explain, in part, the limited hybridization that occurs between the domesticated cultivated rice varieties, O. sativa spp. japonica and O. sativa spp. indica. In the United States, cultivated fields of japonica rice are often invaded by conspecific weeds that have been shown to be of indica origin. Crop-weed hybrids have been identified in crop fields, but at low frequencies. Here we examined the possible role of these hybrid incompatibility loci in the interaction between cultivated and weedy rice. We identified a novel allele at Sa that seemingly prevents loss of fertility in hybrids. Additionally, we found wide-compatibility type alleles at strikingly high frequencies at the Sa and s5 loci in weed groups, and a general lack of incompatible alleles between crops and weeds at the DPL loci. Our results suggest that weedy individuals, particularly those of the SH and BRH groups, should be able to freely hybridize with the local japonica crop, and that prezygotic factors, such as differences in flowering time, have been more important in limiting weed-crop gene flow in the past. As the selective landscape for weedy rice changes due to increased use of herbicide resistant strains of cultivated rice, the genetic barriers that hinder indica-japonica hybridization cannot be counted on to limit the flow of favorable crop genes into weeds.	[Craig, Stephanie M.; Resnick, Lauren E.; Caicedo, Ana L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Reagon, Michael] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Lima, OH 45804 USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University	Caicedo, AL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	caicedo@bio.umass.edu			U.S. National Science Foundation Plant Genome Research Program [IOS-1032023]	U.S. National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was funded by a grant from the U.S. National Science Foundation Plant Genome Research Program (IOS-1032023) to A. L. C., Kenneth M. Olsen and Yulin Jia (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 1032023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bres-Patry C, 2001, THEOR APPL GENET, V102, P118, DOI 10.1007/s001220051626; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Delouche J. C, 2007, 188 FAO; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Gealy DR, 2005, CROP FERALITY AND VOLUNTEERISM, P323, DOI 10.1201/9781420037999.ch20; Harushima Y, 2002, GENETICS, V160, P313; Kubo T, 2008, GENES GENET SYST, V83, P443, DOI 10.1266/ggs.83.443; Li JQ, 2012, PLANT SYST EVOL, V298, P33, DOI 10.1007/s00606-011-0520-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OKA H. -I., 1957, Journal of Genetics, V55, P397, DOI 10.1007/BF02984059; OKA HI, 1974, GENETICS, V77, P521; Orr HA, 1996, GENETICS, V144, P1331; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Ouyang YD, 2009, CHINESE SCI BULL, V54, P2332, DOI 10.1007/s11434-009-0371-4; Rajguru SN, 2005, WEED SCI, V53, P946; Reagon M, 2011, MOL ECOL, V20, P3743, DOI 10.1111/j.1365-294X.2011.05216.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Reflinur, 2012, GENES GENOM, V34, P355, DOI 10.1007/s13258-011-0209-8; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rozen S, 2000, Methods Mol Biol, V132, P365; Salassi ME, 2012, POTENTIAL UNCONVENTI, P17; Sha XY, 2007, CROP SCI, V47, P1177, DOI 10.2135/cropsci2006.09.0592; Shi LG, 2009, CHINESE SCI BULL, V54, P3813, DOI 10.1007/s11434-009-0571-y; Shivrain VK, 2010, CROP PROT, V29, P336, DOI 10.1016/j.cropro.2009.10.002; Shivrain VK, 2009, PEST MANAG SCI, V65, P1124, DOI 10.1002/ps.1802; Song Z. P., 2001, International Rice Research Notes, V26, P31; Sun J, 2013, NEW PHYTOL, V197, P290, DOI 10.1111/nph.12012; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Wang GW, 2009, PLANT BREEDING, V128, P451, DOI 10.1111/j.1439-0523.2008.01514.x; Wang Y, 2010, PLANTA, V231, P559, DOI 10.1007/s00425-009-1063-7; Yang CY, 2004, CHINESE SCI BULL, V49, P1718, DOI 10.1360/04wc0197; Yang JY, 2012, SCIENCE, V337, P1336, DOI 10.1126/science.1223702	40	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86647	10.1371/journal.pone.0086647	http://dx.doi.org/10.1371/journal.pone.0086647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489758	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000068
J	Dreze, M; Calkins, AS; Galicza, J; Echelman, DJ; Schnorenberg, MR; Fell, GL; Iwai, S; Fisher, DE; Szuts, D; Iglehart, JD; Lazaro, JB				Dreze, Matija; Calkins, Anne S.; Galicza, Judit; Echelman, Daniel J.; Schnorenberg, Mathew R.; Fell, Gillian L.; Iwai, Shigenori; Fisher, David E.; Szuets, David; Iglehart, J. Dirk; Lazaro, Jean-Bernard			Monitoring Repair of UV-Induced 6-4-Photoproducts with a Purified DDB2 Protein Complex	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-BINDING PROTEIN; XERODERMA-PIGMENTOSUM; DAMAGED DNA; UBIQUITIN LIGASE; IN-VIVO; MOLECULAR-BASIS; RECOGNITION; PHOTOPRODUCTS; XPC	Because cells are constantly subjected to DNA damaging insults, DNA repair pathways are critical for genome integrity [1]. DNA damage recognition protein complexes (DRCs) recognize DNA damage and initiate DNA repair. The DNA-Damage Binding protein 2 (DDB2) complex is a DRC that initiates nucleotide excision repair (NER) of DNA damage caused by ultraviolet light (UV) [2-4]. Using a purified DDB2 DRC, we created a probe ("DDB2 proteo-probe") that hybridizes to nuclei of cells irradiated with UV and not to cells exposed to other genotoxins. The DDB2 proteo-probe recognized UV-irradiated DNA in classical laboratory assays, including cyto-and histo-chemistry, flow cytometry, and slot-blotting. When immobilized, the proteo-probe also bound soluble UV-irradiated DNA in ELISA-like and DNA pull-down assays. In vitro, the DDB2 proteo-probe preferentially bound 6-4-photoproducts [(6-4) PPs] rather than cyclobutane pyrimidine dimers (CPDs). We followed UV-damage repair by cyto-chemistry in cells fixed at different time after UV irradiation, using either the DDB2 proteo-probe or antibodies against CPDs, or (6-4) PPs. The signals obtained with the DDB2 proteo-probe and with the antibody against (6-4) PPs decreased in a nearly identical manner. Since (6-4) PPs are repaired only by nucleotide excision repair (NER), our results strongly suggest the DDB2 proteo-probe hybridizes to DNA containing (6-4) PPs and allows monitoring of their removal during NER. We discuss the general use of purified DRCs as probes, in lieu of antibodies, to recognize and monitor DNA damage and repair.	[Dreze, Matija; Calkins, Anne S.; Echelman, Daniel J.; Schnorenberg, Mathew R.; Iglehart, J. Dirk; Lazaro, Jean-Bernard] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Dreze, Matija; Fell, Gillian L.; Iglehart, J. Dirk] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Galicza, Judit; Szuets, David] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Iwai, Shigenori] Osaka Univ, Div Chem, Grad Sch Engn Sci, Osaka, Japan; [Fisher, David E.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Osaka University; Harvard University; Massachusetts General Hospital	Lazaro, JB (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean-bernard_lazaro@dfci.harvard.edu	Fisher, David/AAH-2878-2019; Dreze, Matija/AAZ-3293-2020; Szuts, David/N-1149-2016	Schnorenberg, Mathew/0000-0002-2876-573X; /0000-0001-7002-8488; Rajkumar, Anne/0000-0003-0614-0840; Szuts, David/0000-0001-7985-0136	Pallotta Investigator Fund; Susan F. Smith Center for Women's Cancers; Marjorie Powell Allen Memorial Fund; Barbara and Paul Ferry Fund for Cancer Research; Hungarian Academy of Sciences; Breast Cancer Research Foundation of New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Pallotta Investigator Fund; Susan F. Smith Center for Women's Cancers; Marjorie Powell Allen Memorial Fund; Barbara and Paul Ferry Fund for Cancer Research; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Breast Cancer Research Foundation of New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pallotta Investigator Fund (J.-B.L.), the Susan F. Smith Center for Women's Cancers (J.-B.L. and J.D.I.), the Marjorie Powell Allen Memorial Fund (J.-B.L.), The Barbara and Paul Ferry Fund for Cancer Research (J.D.I.), and a Momentum Grant of the Hungarian Academy of Sciences (D. S.). J.D.I. is supported by The Breast Cancer Research Foundation of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dejmek J, 2009, MOL CANCER RES, V7, P581, DOI 10.1158/1541-7786.MCR-08-0049; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Fei J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001183; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Fujiwara Y, 1999, J BIOL CHEM, V274, P20027, DOI 10.1074/jbc.274.28.20027; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REARDON JT, 1993, J BIOL CHEM, V268, P21301; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Szuts D, 2008, NUCLEIC ACIDS RES, V36, P6767, DOI 10.1093/nar/gkn651; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; TREIBER DK, 1992, NUCLEIC ACIDS RES, V20, P5805, DOI 10.1093/nar/20.21.5805; Varga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052472; Vermeulen W, 2011, DNA REPAIR, V10, P760, DOI 10.1016/j.dnarep.2011.04.015	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e85896	10.1371/journal.pone.0085896	http://dx.doi.org/10.1371/journal.pone.0085896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489677	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330510000022
J	Richter, LM; Lonnroth, K; Desmond, C; Jackson, R; Jaramillo, E; Weil, D				Richter, Linda M.; Loennroth, Knut; Desmond, Chris; Jackson, Robin; Jaramillo, Ernesto; Weil, Diana			Economic Support to Patients in HIV and TB Grants in Rounds 7 and 10 from the Global Fund to Fight AIDS, Tuberculosis and Malaria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK-FACTORS; RESISTANT TUBERCULOSIS; HEALTH-CARE; COSTS; ADHERENCE; BURDEN; ACCESS; HOUSEHOLDS; INFECTION	People with TB and/or HIV frequently experience severe economic barriers to health care, including out-of-pocket expenses related to diagnosis and treatment, as well as indirect costs due to loss of income. These barriers can both aggravate economic hardship and prevent or delay diagnosis, treatment and successful outcome, leading to increased transmission, morbidity and mortality. WHO, UNAIDS and the ILO argue that economic support of various kinds is essential to enable vulnerable people to protect themselves from infection, avoid delayed diagnosis and treatment, overcome barriers to adherence, and avert destitution. This paper analyses successful country proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria that include economic support in Rounds 7 and 10; 36 and 20 HIV and TB grants in Round 7 and 32 and 26, respectively, in Round 10. Of these, up to 84 percent included direct or indirect economic support for beneficiaries, although the amount constituted a very small proportion of the total grant. In TB grants, the objectives of economic support were generally clearly stated, and focused on mechanisms to improve treatment uptake and adherence, and the case was most clearly made for MDR-TB patients. In HIV grants, the objectives were much broader in scope, including mitigation of adverse economic and social effects of HIV and its treatment on both patients and families. The analysis shows that economic support is on the radar for countries developing Global Fund proposals, and a wide range of economic support activities are in place. In order to move forward in this area, the wealth of country experience that exists needs to be collated, assessed and disseminated. In addition to trials, operational research and programme evaluations, more precise guidance to countries is needed to inform evidence-based decision about activities that are cost-effective, affordable and feasible.	[Richter, Linda M.; Desmond, Chris] Human Sci Res Council, Durban, Kwazulu Natal, South Africa; [Richter, Linda M.; Desmond, Chris] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, Gauteng, South Africa; [Loennroth, Knut; Jaramillo, Ernesto; Weil, Diana] World Hlth Org, HIV AIDS TB Malaria & Neglected Trop Dis HTM, Geneva, Switzerland; [Jackson, Robin] World Food Programme, Rome, Italy	Human Sciences Research Council-South Africa; University of Witwatersrand; World Health Organization	Richter, LM (corresponding author), Human Sci Res Council, Durban, Kwazulu Natal, South Africa.	lrichter@hsrc.ac.za	Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256	Swedish International Development Cooperation Agency (SIDA), through HelpAge International; World Health Organization; Global Fund	Swedish International Development Cooperation Agency (SIDA), through HelpAge International; World Health Organization(World Health Organization); Global Fund	The Swedish International Development Cooperation Agency (SIDA), through HelpAge International, funded Linda Richter's secondment to the Global Fund from June 2010 to July 2012. The World Health Organization and the Global Fund provided support for the interns who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, UNAIDS EXP BUS CAS E; Beith A, 2009, PERFORMANCE INCENTIV, P237; Bobrova N, 2007, INT J DRUG POLICY, V18, P313, DOI 10.1016/j.drugpo.2007.01.015; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bridge J, 2012, INT J DRUG POLICY, V23, P279, DOI 10.1016/j.drugpo.2012.01.013; Brigido LFM, 2001, AIDS PATIENT CARE ST, V15, P587, DOI 10.1089/108729101753287685; Buchanan RJ, 1997, AM J PUBLIC HEALTH, V87, P2014, DOI 10.2105/AJPH.87.12.2014; Burstrom B, 2009, INT J HEALTH SERV, V39, P271, DOI 10.2190/HS.39.2.c; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; ILO, 2011, SOC PROT FLOOR FAIR; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Kielmann K, 2010, AIDS CARE, V22, P21, DOI 10.1080/09540121003721000; Kim MH, 2012, JAIDS-J ACQ IMM DEF, V59, P173, DOI 10.1097/QAI.0b013e3182405f8f; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Louis C, 2007, AIDS CARE, V19, P487, DOI 10.1080/09540120701203246; Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154; Lutge EE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007952.pub2; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Msellati P, 2003, AIDS, V17, pS63, DOI 10.1097/00002030-200317003-00009; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Muko K N, 2004, SAHARA J, V1, P107; Muniyandi M., 2005, Indian Journal of Tuberculosis, V52, P188; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; PETERS DH, 2007, INT J EQUITY HEALTH, V1136, P161; Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688; Qian DF, 2009, HEALTH POLICY PLANN, V24, P324, DOI 10.1093/heapol/czp016; Riyarto S, 2010, HEALTH POLICY PLANN, V25, P272, DOI 10.1093/heapol/czq004; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Rouzier VA, 2010, INT J TUBERC LUNG D, V14, P1316; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Subbaro K, 1997, SAFETY NET PROGRAMS; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ukwaja KN, 2012, INT J TUBERC LUNG D, V16, P733, DOI 10.5588/ijtld.11.0193; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Volmink J, 2000, COCHRANE DB SYST REV, V2; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHO, 2010, WOR HEALT REP, P1; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	50	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86225	10.1371/journal.pone.0086225	http://dx.doi.org/10.1371/journal.pone.0086225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489702	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000037
J	Botelho, AL; Shin, Y; Liu, JK; Lin, X				Botelho, Andre Leitao; Shin, Yongwoo; Liu, Jiakai; Lin, Xi			Structure and Optical Bandgap Relationship of pi-Conjugated Systems	PLOS ONE			English	Article							ABSORPTION-SPECTRA; ISOTHIANAPHTHENE OLIGOMERS; POLYMER; GAP; SOLITONS; DESIGN; ALTERNATION; CELLS; CHAIN	In bulk heterojunction photovoltaic systems both the open-circuit voltage as well as the short-circuit current, and hence the power conversion efficiency, are dependent on the optical bandgap of the electron-donor material. While first-principles methods are computationally intensive, simpler model Hamiltonian approaches typically suffer from one or more flaws: inability to optimize the geometries for their own input; absence of general, transferable parameters; and poor performance for non-planar systems. We introduce a set of new and revised parameters for the adapted Su-Schrieffer-Heeger (aSSH) Hamiltonian, which is capable of optimizing geometries, along with rules for applying them to any pi-conjugated system containing C, N, O, or S, including non-planar systems. The predicted optical bandgaps show excellent agreement to UV-vis spectroscopy data points from literature, with a coefficient of determination R-2 = 0.95, a mean error of -0.05 eV, and a mean absolute deviation of 0.16 eV. We use the model to gain insights from PEDOT, fused thiophene polymers, poly-isothianaphthene, copolymers, and pentacene as sources of design rules in the search for low bandgap materials. Using the model as an in-silico design tool, a copolymer of benzodithiophenes along with a small-molecule derivative of pentacene are proposed as optimal donor materials for organic photovoltaics.	[Lin, Xi] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA; Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA	Boston University; Boston University	Lin, X (corresponding author), Boston Univ, Dept Mech Engn, Boston, MA 02215 USA.	linx@bu.edu	lin, xi/GZL-4959-2022; Liu, Jiakai/AGO-2094-2022; Shin, Yongwoo/G-5838-2011; Lin, Xi/D-5321-2011; Botelho, Andre/M-5369-2013	Shin, Yongwoo/0000-0001-7760-9883; Botelho, Andre/0000-0002-5246-8161	Honda RD Co., Ltd; Idaho National Laboratory; Nenter Co., Inc; NSF XSEDE [DMR-090073]	Honda RD Co., Ltd; Idaho National Laboratory(United States Department of Energy (DOE)); Nenter Co., Inc; NSF XSEDE(National Science Foundation (NSF))	This work is partially supported by Honda R&D Co., Ltd, Idaho National Laboratory, Nenter & Co., Inc, and NSF XSEDE under Grant No. DMR-090073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS L, 1982, J PHYS CHEM-US, V86, P2916, DOI 10.1021/j100212a023; BECKER RS, 1963, J CHEM PHYS, V38, P2144, DOI 10.1063/1.1733946; Bendikov M, 2004, J AM CHEM SOC, V126, P7416, DOI 10.1021/ja048919w; Blouin N, 2008, J AM CHEM SOC, V130, P732, DOI 10.1021/ja0771989; Botelho AL, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/45/455501; BURROUGHES JH, 1988, NATURE, V335, P137, DOI 10.1038/335137a0; CHANDROSS EA, 1966, J CHEM PHYS, V45, P3546, DOI 10.1063/1.1727371; Cohen AJ, 2008, SCIENCE, V321, P792, DOI 10.1126/science.1158722; Davis WB, 1998, NATURE, V396, P60, DOI 10.1038/23912; DIAZ AF, 1981, J ELECTROANAL CHEM, V121, P355, DOI 10.1016/0368-1874(81)80028-7; ECKHARDT H, 1989, J CHEM PHYS, V91, P1303, DOI 10.1063/1.457153; Gidron O, 2010, J AM CHEM SOC, V132, P2148, DOI 10.1021/ja9093346; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Guo XG, 2011, J AM CHEM SOC, V133, P13685, DOI 10.1021/ja205398u; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; Hellstrom S, 2009, DALTON T, P10032, DOI 10.1039/b913769f; Hinderhofer A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2786992; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; HONG SY, 1992, J CHEM PHYS, V96, P5497, DOI 10.1063/1.462705; Kaur I, 2010, J AM CHEM SOC, V132, P1261, DOI 10.1021/ja9095472; Kertesz M, 2005, CHEM REV, V105, P3448, DOI 10.1021/cr990357p; KHAN ZH, 1973, J CHEM PHYS, V59, P3015, DOI 10.1063/1.1680437; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; KURTI J, 1991, PHYS REV B, V44, P597, DOI 10.1103/PhysRevB.44.597; Kuzmany H, 1989, SPRINGER SERIES SOLI, V91; LEE YS, 1988, J CHEM PHYS, V88, P2609, DOI 10.1063/1.454040; Li G, 2012, NAT PHOTONICS, V6, P153, DOI [10.1038/NPHOTON.2012.11, 10.1038/nphoton.2012.11]; Li MH, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155141; Li MH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.153102; Lin X, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198303; Lin X, 2005, INT J QUANTUM CHEM, V102, P980, DOI 10.1002/qua.20433; Lin X, 2006, P NATL ACAD SCI USA, V103, P8943, DOI 10.1073/pnas.0601314103; LONGUETHIGGINS HC, 1959, PROC R SOC LON SER-A, V251, P172, DOI 10.1098/rspa.1959.0100; Mattuck R.D., 1976, GUIDE FEYNMAN DIAGRA; Parr RG, 1989, INT SERIES MONOGRAPH, V16; Payne MM, 2005, J AM CHEM SOC, V127, P8028, DOI 10.1021/ja051798v; Peierls R. E., 1955, INT SERIES MONOGRAPH; POMERANTZ M, 1993, SYNTHETIC MET, V55, P960, DOI 10.1016/0379-6779(93)90182-V; POPLE JA, 1987, J CHEM PHYS, V87, P5968, DOI 10.1063/1.453520; Price SC, 2010, MACROMOLECULES, V43, P4609, DOI 10.1021/ma100051v; QUATTROCCHI C, 1993, MACROMOLECULES, V26, P1260, DOI 10.1021/ma00058a010; QUATTROCCHI C, 1995, J PHYS CHEM-US, V99, P3932, DOI 10.1021/j100012a011; Rang Z, 2001, APPL PHYS LETT, V79, P2731, DOI 10.1063/1.1410878; RICE MJ, 1982, PHYS REV LETT, V49, P1455, DOI 10.1103/PhysRevLett.49.1455; Risko C, 2011, CHEM SCI, V2, P1200, DOI 10.1039/c0sc00642d; Roncali J, 2007, MACROMOL RAPID COMM, V28, P1761, DOI 10.1002/marc.200700345; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Shimizu Y, 2002, TETRAHEDRON LETT, V43, P8485, DOI 10.1016/S0040-4039(02)02054-3; Shin YW, 2013, J PHYS CHEM C, V117, P12432, DOI 10.1021/jp402137b; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; SUBBASWAMY KR, 1981, PHYS REV B, V24, P2168, DOI 10.1103/PhysRevB.24.2168; Tonshoff C, 2010, ANGEW CHEM INT EDIT, V49, P4125, DOI 10.1002/anie.200906355; van Faassen M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186401; WALKER IC, 1990, CHEM PHYS, V141, P365, DOI 10.1016/0301-0104(90)87070-R; WUDL F, 1984, J ORG CHEM, V49, P3382, DOI 10.1021/jo00192a027; Yang F, 2005, NAT MATER, V4, P37, DOI 10.1038/nmat1285; Yang SJ, 2004, SYNTHETIC MET, V141, P171, DOI 10.1016/j.synthmet.2003.08.019; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhou HX, 2011, ANGEW CHEM INT EDIT, V50, P2995, DOI 10.1002/anie.201005451	62	29	29	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86370	10.1371/journal.pone.0086370	http://dx.doi.org/10.1371/journal.pone.0086370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497944	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900022
J	De Meulder, B; Berger, F; Bareke, E; Depiereux, S; Michiels, C; Depiereux, E				De Meulder, Bertrand; Berger, Fabrice; Bareke, Eric; Depiereux, Sophie; Michiels, Carine; Depiereux, Eric			Meta-Analysis and Gene Set Analysis of Archived Microarrays Suggest Implication of the Spliceosome in Metastatic and Hypoxic Phenotypes	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; INDUCIBLE FACTORS; BREAST-CANCER; GLOBAL TEST; T-TEST; IDENTIFICATION; LISTS; OLIGONUCLEOTIDE; MECHANISMS; REGULATORS	We propose to make use of the wealth of underused DNA chip data available in public repositories to study the molecular mechanisms behind the adaptation of cancer cells to hypoxic conditions leading to the metastatic phenotype. We have developed new bioinformatics tools and adapted others to identify with maximum sensitivity those genes which are expressed differentially across several experiments. The comparison of two analytical approaches, based on either Over Representation Analysis or Functional Class Scoring, by a meta-analysis-based approach, led to the retrieval of known information about the biological situation - thus validating the model - but also more importantly to the discovery of the previously unknown implication of the spliceosome, the cellular machinery responsible for mRNA splicing, in the development of metastasis.	[De Meulder, Bertrand; Berger, Fabrice; Depiereux, Eric] Univ Namur, Microorganism Biol Res Unit NARILIS, Namur, Belgium; [Bareke, Eric] Univ Montreal, St Justine Univ Hosp Ctr Res Ctr, Montreal, PQ, Canada; [Depiereux, Sophie] Univ Namur, Environm & Evolut Res Unit, Namur, Belgium; [Michiels, Carine] Univ Namur, Cellular Biol Res Unit NARILIS, Namur, Belgium	University of Namur; Universite de Montreal; University of Namur; University of Namur	Depiereux, E (corresponding author), Univ Namur, Microorganism Biol Res Unit NARILIS, Namur, Belgium.	eric.depiereux@fundp.ac.be		Bareke, Eric/0000-0003-3928-7160	FRS-FNRS Televie; FRS-FRNS; Division of Hematology-Oncology, Sainte-Justine UHC Research Center, University of Montreal	FRS-FNRS Televie(Fonds de la Recherche Scientifique - FNRS); FRS-FRNS(Fonds de la Recherche Scientifique - FNRS); Division of Hematology-Oncology, Sainte-Justine UHC Research Center, University of Montreal	This work was supported by the FRS-FNRS Televie (BDM) and FRS-FRNS(SD). FB is a volunteer for the University of Namur Biology Department. EB is funded by Prof. Daniel Sinnett (Division of Hematology-Oncology, Sainte-Justine UHC Research Center, University of Montreal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsarraj J, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/670632; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Bareke E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-528; Barrantes ID, 2012, BIOCHEM SOC T, V40, P79, DOI 10.1042/BST20110676; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Berger F, 2008, CENT EUR J BIOL, V3, P327, DOI 10.2478/s11535-008-0030-9; Berger F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-510; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buda A, 2011, CELL COMMUN ADHES, V18, P131, DOI 10.3109/15419061.2011.636465; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Cunha IW, 2010, TRANSL ONCOL, V3, P23, DOI 10.1593/tlo.09166; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dawany NB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-483; De Hertogh B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-17; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Ellison LF, 2009, HEALTH REP, V20; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fujita Andre, 2006, BMC Bioinformatics, V7, P469; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatakeyama S, 2009, P NATL ACAD SCI USA, V106, P3095, DOI 10.1073/pnas.0810110106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Irizarry R, 2005, AFFYCOMP GRAPHIC TOO; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Kim TJ, 2008, CANCER SCI, V99, P31, DOI 10.1111/j.1349-7006.2007.00652.x; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Lee JH, 2008, CANCER RES, V68, P639, DOI 10.1158/0008-5472.CAN-07-2632; Li LP, 2011, PROTEOMICS, V11, P429, DOI 10.1002/pmic.200900819; Lim K, 2011, INT J RADIAT ONCOL, V79, P348, DOI 10.1016/j.ijrobp.2009.10.075; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Majid S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-7; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Meseguer S, 2011, J BIOL CHEM, V286, P4150, DOI 10.1074/jbc.M110.167817; Mezi S, 2012, INT J ONCOL, V41, P2128, DOI 10.3892/ijo.2012.1642; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Nieder C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034300; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252; Palermo NY, 2012, J PEPT SCI, V18, P252, DOI 10.1002/psc.2393; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park YM, 2012, MOL CELL BIOL, V32, P4237, DOI 10.1128/MCB.00443-12; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Peinado H, 2008, NAT CELL BIOL, V10, P253, DOI 10.1038/ncb0308-253; Pierre M., 2011, J PROTEOMICS BIOINFO, V04; Pierre M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-176; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shu YJ, 2006, J THORAC ONCOL, V1, P160, DOI 10.1097/01243894-200602000-00010; Simpson RJS, 1904, BRIT MED J, V1904, P1243; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suganuma M, 2011, CANCER SCI, V102, P317, DOI 10.1111/j.1349-7006.2010.01805.x; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Thomas P, 2011, CLIN EXP METASTAS, V28, P923, DOI 10.1007/s10585-011-9419-3; Valles I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042086; van Alphen RJ, 2009, BRIT J CANCER, V100, P228, DOI 10.1038/sj.bjc.6604801; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Walton J, 2012, ARCH OTOLARYNGOL, V138, P243, DOI 10.1001/archoto.2012.16; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Wu Z, 2004, DEP BIOSTATISTICS WO; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zheng XY, 2012, WORLD J GASTROENTERO, V18, P821, DOI 10.3748/wjg.v18.i8.821	73	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86699	10.1371/journal.pone.0086699	http://dx.doi.org/10.1371/journal.pone.0086699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497970	gold, Green Submitted, Green Published			2022-12-27	WOS:000330621900036
J	Williamson, VJ; Liikkanen, LA; Jakubowski, K; Stewart, L				Williamson, Victoria J.; Liikkanen, Lassi A.; Jakubowski, Kelly; Stewart, Lauren			Sticky Tunes: How Do People React to Involuntary Musical Imagery?	PLOS ONE			English	Article							WORKING-MEMORY; MIND; ATTENTION; SPEECH; STUCK	The vast majority of people experience involuntary musical imagery (INMI) or 'earworms'; perceptions of spontaneous, repetitive musical sound in the absence of an external source. The majority of INMI episodes are not bothersome, while some cause disruption ranging from distraction to anxiety and distress. To date, little is known about how the majority of people react to INMI, in particular whether evaluation of the experience impacts on chosen response behaviours or if attempts at controlling INMI are successful or not. The present study classified 1046 reports of how people react to INMI episodes. Two laboratories in Finland and the UK conducted an identical qualitative analysis protocol on reports of INMI reactions and derived visual descriptive models of the outcomes using grounded theory techniques. Combined analysis carried out across the two studies confirmed that many INMI episodes were considered neutral or pleasant, with passive acceptance and enjoyment being among the most popular response behaviours. A significant number of people, however, reported on attempts to cope with unwanted INMI. The most popular and effective behaviours in response to INMI were seeking out the tune in question, and musical or verbal distraction. The outcomes of this study contribute to our understanding of the aetiology of INMI, in particular within the framework of memory theory, and present testable hypotheses for future research on successful INMI coping strategies.	[Williamson, Victoria J.] Lucerne Univ Appl Sci & Arts, Hsch Luzern Mus, Luzern, Switzerland; [Williamson, Victoria J.] Univ Sheffield, Dept Mus, Sheffield, S Yorkshire, England; [Liikkanen, Lassi A.] Aalto Univ, Helsinki Inst Informat Technol, Espoo, Finland; [Jakubowski, Kelly; Stewart, Lauren] Univ London, Dept Psychol, London, England	University of Sheffield; Aalto University; University of Helsinki; University of London	Williamson, VJ (corresponding author), Lucerne Univ Appl Sci & Arts, Hsch Luzern Mus, Luzern, Switzerland.	v.williamson@sheffield.ac.uk	Stewart, Lauren/HHC-2911-2022	Jakubowski, Kelly/0000-0002-4954-7117; stewart, lauren/0000-0002-6221-6064	Leverhulme Trust [RPG - 297]	Leverhulme Trust(Leverhulme Trust)	This research was funded by a Leverhulme Trust grant (http://www.leverhulme.ac.uk/) to LS (RPG - 297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Beaman CP, 2010, BRIT J PSYCHOL, V101, P637, DOI 10.1348/000712609X479636; Berntsen D, 2010, CURR DIR PSYCHOL SCI, V19, P138, DOI 10.1177/0963721410370301; Brown S, 2006, J CONSCIOUSNESS STUD, V13, P43; Charmaz K., 2008, HDB EMERGENT METHODS, P155, DOI DOI 10.1080/15332691.2013.779094; FLORIDOU G, 2012, P ICMPC ESCOM 12 THE, P302; Halpern AR, 2011, MUSIC PERCEPT, V28, P425, DOI 10.1525/mp.2011.28.4.425; Hemming J., 2009, MUSIKPSYCHOLOGIE, V20, P184; Hyman IE, 2013, APPL COGNITIVE PSYCH, V27, P204, DOI 10.1002/acp.2897; Jones D, 1999, J EXP PSYCHOL LEARN, V25, P464, DOI 10.1037/0278-7393.25.2.464; Jones DM., 1996, MODELS SHORT TERM ME, P209; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kvavilashvili L, 2004, COGNITIVE PSYCHOL, V48, P47, DOI 10.1016/S0010-0285(03)00115-4; Liikkanen LA, 2012, MUSIC SCI, V16, P217, DOI 10.1177/1029864912440770; Liikkanen LA, 2012, PSYCHOL MUSIC, V40, P236, DOI 10.1177/0305735611406578; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McVay JC, 2009, PSYCHON B REV, V16, P857, DOI 10.3758/PBR.16.5.857; Mullensiefen D, 2014, MUSIC PERCE IN PRESS; Neath I, 2000, PSYCHON B REV, V7, P403, DOI 10.3758/BF03214356; Payne S, 2007, ANAL QUALITATIVE DAT, P65, DOI [DOI 10.4135/9781446207536, 10.4135/9781446207536.d12, DOI 10.4135/9781446207536.D12]; Sacks O, 2007, MUSICOPHILIA TALES M; Schulze K, 2012, ANN NY ACAD SCI, V1252, P229, DOI 10.1111/j.1749-6632.2012.06447.x; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, PSYCHON B REV, V14, P527, DOI 10.3758/BF03194102; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smith JD, 1992, AUDITORY IMAGERY, P95; Strauss A., 1990, BASICS QUALITATIVE R; Urquhart, 2013, GROUNDED THEORY QUAL; Wammes M, 2009, J CONSCIOUSNESS STUD, V16, P37; Williamson V. J., 2012, P 12 INT C MUS PERC, P1124; Williamson VJ, 2014, PSYCHOL MUSIC, V42, P653, DOI 10.1177/0305735613483848; Williamson VJ, 2012, PSYCHOL MUSIC, V40, P259, DOI 10.1177/0305735611418553; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Zeigarnik B., 1967, SOURCEBOOK GESTALT P, P300	37	36	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86170	10.1371/journal.pone.0086170	http://dx.doi.org/10.1371/journal.pone.0086170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	302RF	24497938	Green Accepted, Green Published, gold			2022-12-27	WOS:000330621900018
J	Yao, YX; Lu, YH; Chen, WC; Jiang, YP; Cheng, T; Ma, YP; Lu, L; Dai, W				Yao, Yixin; Lu, Yinghua; Chen, Wen-chi; Jiang, Yongping; Cheng, Tao; Ma, Yupo; Lu, Lou; Dai, Wei			Cobalt and Nickel Stabilize Stem Cell Transcription Factor OCT4 through Modulating Its Sumoylation and Ubiquitination	PLOS ONE			English	Article							SELF-RENEWAL; INDUCED PLURIPOTENT; EXPRESSION; PROMOTES; GENE; DIFFERENTIATION; LIVER; MICE; AKT	Stem cell research can lead to the development of treatments for a wide range of ailments including diabetes, heart disease, aging, neurodegenerative diseases, spinal cord injury, and cancer. OCT4 is a master regulator of self-renewal of undifferentiated embryonic stem cells. OCT4 also plays a crucial role in reprogramming of somatic cells into induced pluripotent stem (iPS) cells. Given known vivo reproductive toxicity of cobalt and nickel metals, we examined the effect of these metals on expression of several stem cell factors in embryonic Tera-1 cells, as well as stem cells. Cobalt and nickel induced a concentration-dependent increase of OCT4 and HIF-1 alpha, but not NANOG or KLF4. OCT4 induced by cobalt and nickel was due primarily to protein stabilization because MG132 stabilized OCT4 in cells treated with either metals and because neither nickel nor cobalt significantly modulated its steady-state mRNA level. OCT4 stabilization by cobalt and nickel was mediated largely through reactive oxygen species (ROS) as co-treatment with ascorbic acid abolished OCT4 increase. Moreover, nickel and cobalt treatment increased sumoylation and mono-ubiquitination of OCT4 and K123 was crucial for mediating these modifications. Combined, our observations suggest that nickel and cobalt may exert their reproductive toxicity through perturbing OCT4 activity in the stem cell compartment.	[Yao, Yixin; Lu, Yinghua; Chen, Wen-chi; Dai, Wei] NYU, Dept Environm Med, Langone Med Ctr, Tuxedo Pk, NY USA; [Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou, Peoples R China; [Jiang, Yongping] Peking Union Med Coll, Suzhou, Peoples R China; [Cheng, Tao] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China; [Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Cheng, Tao] Peking Union Med Coll, Tianjin, Peoples R China; [Ma, Yupo] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Lu, Lou] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA USA; [Dai, Wei] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, Tuxedo Pk, NY USA	New York University; NYU Langone Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University; NYU Langone Medical Center	Dai, W (corresponding author), NYU, Dept Environm Med, Langone Med Ctr, Tuxedo Pk, NY USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; Jiang, Yongping/0000-0001-6024-4187; Cheng, Tao/0000-0002-5925-2769; Yao, Yixin/0000-0003-1891-7186	US Public Service [CA090658, ES019929]; NIEHS Center grant Nickel and cobalt stabilize [ES000260]; key State project of China on iPS and stem cell research [2011ZX09102-010-04]; NATIONAL CANCER INSTITUTE [R01CA090658, P30CA016087] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R03ES019929] Funding Source: NIH RePORTER	US Public Service; NIEHS Center grant Nickel and cobalt stabilize; key State project of China on iPS and stem cell research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported in part by US Public Service Awards to WD (CA090658 and ES019929), an NIEHS Center grant Nickel and cobalt stabilize (ES000260) and a key State project of China on iPS and stem cell research (2011ZX09102-010-04). The funders had no role in study design, data collection and analysis, and decision to publish, or preparation of the manuscript.	Bae D, 2012, STEM CELLS DEV, V21, P1344, DOI 10.1089/scd.2011.0225; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Campbell PA, 2013, STEM CELLS, V31, P1107, DOI 10.1002/stem.1365; Cangul H, 2002, TOXICOL LETT, V127, P69, DOI 10.1016/S0378-4274(01)00485-4; Clarson LH, 2003, J PHYSIOL-LONDON, V550, P515, DOI 10.1113/jphysiol.2003.044149; Dhodapkar KM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25205; Forgacs Z, 2012, J ENVIRON SCI HEAL A, V47, P1249, DOI 10.1080/10934529.2012.672114; Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507; HANNA PM, 1992, CHEM RES TOXICOL, V5, P109, DOI 10.1021/tx00025a019; Harvey AJ, 2004, BIOL REPROD, V71, P1108, DOI 10.1095/biolreprod.104.028639; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jungwirth U, 2011, ANTIOXID REDOX SIGN, V15, P1085, DOI 10.1089/ars.2010.3663; Li QY, 2013, FEBS LETT, V587, P2105, DOI 10.1016/j.febslet.2013.05.027; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065095; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu CM, 2013, J AGR FOOD CHEM, V61, P1146, DOI 10.1021/jf304562b; Liu LM, 1996, J BIOL CHEM, V271, P16683, DOI 10.1074/jbc.271.28.16683; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Mathieu J, 2013, STEM CELLS; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oda M, 2006, METHOD ENZYMOL, V419, P387, DOI 10.1016/S0076-6879(06)19015-1; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Paksy K, 1999, ENVIRON RES, V80, P340, DOI 10.1006/enrs.1998.3933; Pantazis P, 2012, CELL CYCLE, V11, P2055, DOI 10.4161/cc.20118; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; RODRIGUEZ RE, 1991, TOXICOL LETT, V57, P269, DOI 10.1016/0378-4274(91)90201-G; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Salnikow K, 2000, CANCER RES, V60, P3375; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; STORENG R, 1981, TOXICOLOGY, V20, P45, DOI 10.1016/0300-483X(81)90104-9; STORENG R, 1980, TOXICOLOGY, V17, P183, DOI 10.1016/0300-483X(80)90092-X; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; Vaktskjold Arild, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P327, DOI 10.2478/v10001-0070034-0; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang ZH, 2007, FASEB J, V21, P3042, DOI 10.1096/fj.06-6914com; Zhang ZN, 2013, STEM CELLS; Zhao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064503; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052	47	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86620	10.1371/journal.pone.0086620	http://dx.doi.org/10.1371/journal.pone.0086620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497960	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900029
J	Havelka, D; Kucera, O; Deriu, MA; Cifra, M				Havelka, Daniel; Kucera, Ondrej; Deriu, Marco A.; Cifra, Michal			Electro-Acoustic Behavior of the Mitotic Spindle: A Semi-Classical Coarse-Grained Model	PLOS ONE			English	Article							HIGH MAGNETIC-FIELDS; ELECTRIC-FIELDS; ELECTROMAGNETIC-FIELD; VIBRATION ANALYSIS; DIPOLE-MOMENT; MICROTUBULES; TUBULIN; FREQUENCY; DYNAMICS; CHROMOSOMES	The regulation of chromosome separation during mitosis is not fully understood yet. Microtubules forming mitotic spindles are targets of treatment strategies which are aimed at (i) the triggering of the apoptosis or (ii) the interruption of uncontrolled cell division. Despite these facts, only few physical models relating to the dynamics of mitotic spindles exist up to now. In this paper, we present the first electromechanical model which enables calculation of the electromagnetic field coupled to acoustic vibrations of the mitotic spindle. This electromagnetic field originates from the electrical polarity of microtubules which form the mitotic spindle. The model is based on the approximation of resonantly vibrating microtubules by a network of oscillating electric dipoles. Our computational results predict the existence of a rapidly changing electric field which is generated by either driven or endogenous vibrations of the mitotic spindle. For certain values of parameters, the intensity of the electric field and its gradient reach values which may exert a not-inconsiderable force on chromosomes which are aligned in the spindle midzone. Our model may describe possible mechanisms of the effects of ultra-short electrical and mechanical pulses on dividing cells-a strategy used in novel methods for cancer treatment.	[Havelka, Daniel; Kucera, Ondrej; Cifra, Michal] Acad Sci Czech Republ, Inst Photon & Elect, Prague, Czech Republic; [Havelka, Daniel] Czech Tech Univ, Fac Elect Engn, Dept Electromagnet Field, CR-16635 Prague, Czech Republic; [Deriu, Marco A.] Univ Appl Sci & Arts Southern Switzerland SUPSI, Inst Comp Integrated Mfg Sustainable Innovat, Dept Innovat Technol, Manno, Switzerland	Czech Academy of Sciences; Institute of Photonics & Electronics of the Czech Academy of Sciences; Czech Technical University Prague	Havelka, D (corresponding author), Acad Sci Czech Republ, Inst Photon & Elect, Prague, Czech Republic.	havelka@ufe.cz	Deriu, Marco Agostino Agostino/GPW-8179-2022; Kucera, Ondrej/F-6806-2014; Deriu, Marco Agostino/M-5161-2016; Havelka, Daniel/F-6807-2014; Cifra, Michal/D-4416-2013	Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Kucera, Ondrej/0000-0002-9559-1717; Deriu, Marco Agostino/0000-0003-1918-1772; Havelka, Daniel/0000-0001-5695-168X; Cifra, Michal/0000-0002-8853-9523	Czech Science Foundation; GA CR [P102/11/0649]; Grant Agency of the Czech Technical University in Prague [SGS13/077/OHK3/1T/13]	Czech Science Foundation(Grant Agency of the Czech Republic); GA CR(Grant Agency of the Czech Republic); Grant Agency of the Czech Technical University in Prague	Research presented in this paper was supported by the Czech Science Foundation, GA CR, grant no. P102/11/0649, and the Grant Agency of the Czech Technical University in Prague, grant no. SGS13/077/OHK3/1T/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm KJ, 2005, ELECTROMAGN BIOL MED, V24, P319, DOI 10.1080/15368370500380010; Bras W, 1998, BIOPHYS J, V74, P1509, DOI 10.1016/S0006-3495(98)77863-4; Breton M, 2012, BIOELECTROMAGNETICS, V33, P106, DOI 10.1002/bem.20692; Cifra M, 2010, BIOSYSTEMS, V100, P122, DOI 10.1016/j.biosystems.2010.02.007; Daneshmand F, 2012, J BIOL PHYS, V38, P429, DOI 10.1007/s10867-012-9263-y; Deriu MA, 2010, BIOPHYS J, V99, P2190, DOI 10.1016/j.bpj.2010.06.070; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Foster KR, 2000, J BIOL PHYS, V26, P255, DOI 10.1023/A:1010306216654; FRICKEL RH, 1988, CAN J CHEM, V66, P2161, DOI 10.1139/v88-343; Ghavanloo E, 2010, PHYSICA E, V43, P192, DOI 10.1016/j.physe.2010.07.016; Glade N, 2005, BIOPHYS CHEM, V115, P29, DOI 10.1016/j.bpc.2004.12.048; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; HAMEROFF SR, 1986, BIOPHYS J, V49, pA58; Havelka D, 2011, J PHYS CONF SER, V329, DOI 10.1088/1742-6596/329/1/012014; Havelka D, 2011, J THEOR BIOL, V286, P31, DOI 10.1016/j.jtbi.2011.07.007; Holzel R, 2009, IET NANOBIOTECHNOL, V3, P28, DOI 10.1049/iet-nbt.2008.0014; Ibrahim B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001555; Kaatze U, 2003, MEAS SCI TECHNOL, V14, pN55, DOI 10.1088/0957-0233/14/9/401; Kasas S, 2004, BIOL CELL, V96, P697, DOI 10.1016/j.biolcel.2004.09.002; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kucera O, 2012, BIOSYSTEMS, V109, P346, DOI 10.1016/j.biosystems.2012.04.009; Kucera O, 2010, EUR BIOPHYS J BIOPHY, V39, P1465, DOI 10.1007/s00249-010-0597-8; Li HB, 2013, EUR J MECH A-SOLID, V39, P11, DOI 10.1016/j.euromechsol.2012.10.007; Liu YF, 2006, P NATL ACAD SCI USA, V103, P10654, DOI 10.1073/pnas.0510381103; Mallakzadeh M, 2013, COMMUN NONLINEAR SCI, V18, P2240, DOI 10.1016/j.cnsns.2012.12.014; Mershin A, 2004, BIOSYSTEMS, V77, P73, DOI 10.1016/j.biosystems.2004.04.003; Minoura I, 2006, BIOPHYS J, V90, P3739, DOI 10.1529/biophysj.105.071324; Mohrbach H, 2012, EUR BIOPHYS J BIOPHY, V41, P217, DOI 10.1007/s00249-011-0778-0; Naruse Y, 2002, BIOSYSTEMS, V66, P55, DOI 10.1016/S0303-2647(02)00033-3; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pavicic I, 2008, TOXICOL IN VITRO, V22, P1344, DOI 10.1016/j.tiv.2008.04.014; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pokorny J, 2003, ELECTROMAGN BIOL MED, V22, P15, DOI 10.1081/JBC-120020349; Pokorny J, 2001, ELECTRO MAGNETOBIOL, V20, P59, DOI 10.1081/JBC-100103160; Portet S, 2005, EUR BIOPHYS J BIOPHY, V34, P912, DOI 10.1007/s00249-005-0461-4; Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183; Preto J, 2013, PHYS LETT A, V377, P587, DOI 10.1016/j.physleta.2012.12.034; Preto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041904; Priel A, 2005, ELECTROMAGN BIOL MED, V24, P221, DOI 10.1080/15368370500379590; Qian XS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717573; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ramalho RR, 2007, MAT SCI ENG C-BIO S, V27, P1207, DOI 10.1016/j.msec.2006.09.045; Samarbakhsh A, 2011, EUR BIOPHYS J BIOPHY, V40, P937, DOI 10.1007/s00249-011-0709-0; Samsonov A, 2013, BIOELECTROMAGNETICS, V34, P133, DOI 10.1002/bem.21760; Shen HS, 2011, CURR APPL PHYS, V11, P812, DOI 10.1016/j.cap.2010.11.116; Simonson T, 2003, REP PROG PHYS, V66, P737, DOI 10.1088/0034-4885/66/5/202; Stracke R, 2002, BIOCHEM BIOPH RES CO, V293, P602, DOI 10.1016/S0006-291X(02)00251-6; Taj M, 2012, BIOCHEM BIOPH RES CO, V424, P89, DOI 10.1016/j.bbrc.2012.06.072; Tuszynski JA, 2005, EUR PHYS J E, V17, P29, DOI 10.1140/epje/i2004-10102-5; Tuszynski JA, 2005, MATH COMPUT MODEL, V41, P1055, DOI 10.1016/j.mcm.2005.05.002; Tyner KM, 2007, BIOPHYS J, V93, P1163, DOI 10.1529/biophysj.106.092452; Uppalapati M, 2011, INTEGR BIOL-UK, V3, P57, DOI 10.1039/c0ib00065e; van den Heuvel MGL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118301; VASSILEV PM, 1982, BIOSCIENCE REP, V2, P1025, DOI 10.1007/BF01122171; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Wang CY, 2008, J BIOMECH, V41, P1892, DOI 10.1016/j.jbiomech.2008.03.029; Wang CY, 2006, PHYSICA E, V35, P48, DOI 10.1016/j.physe.2006.05.008; Xiang P, 2012, J SOUND VIB, V331, P213, DOI 10.1016/j.jsv.2011.08.024; Zhao Y, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-26	60	26	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86501	10.1371/journal.pone.0086501	http://dx.doi.org/10.1371/journal.pone.0086501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497952	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100018
J	Huang, EYK; Tsui, PF; Kuo, TT; Tsai, JJ; Chou, YC; Ma, HI; Chiang, YH; Chen, YH				Huang, Eagle Yi-Kung; Tsui, Pi-Fen; Kuo, Tung-Tai; Tsai, Jing-Jr; Chou, Yu-Ching; Ma, Hsin-I; Chiang, Yung-Hsiao; Chen, Yuan-Hao			Amantadine Ameliorates Dopamine-Releasing Deficits and Behavioral Deficits in Rats after Fluid Percussion Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; PLACEBO-CONTROLLED TRIAL; WATER MAZE PERFORMANCE; OXIDATIVE STRESS; BASAL GANGLIA; HEAD-INJURY; STRIATUM; METHYLPHENIDATE; TRANSPORTER	Aims: To investigate the role of dopamine in cognitive and motor learning skill deficits after a traumatic brain injury (TBI), we investigated dopamine release and behavioral changes at a series of time points after fluid percussion injury, and explored the potential of amantadine hydrochloride as a chronic treatment to provide behavioral recovery. Materials and Methods: In this study, we sequentially investigated dopamine release at the striatum and behavioral changes at 1, 2, 4, 6, and 8 weeks after fluid percussion injury. Rats subjected to 6-Pa cerebral cortical fluid percussion injury were treated by using subcutaneous infusion pumps filled with either saline (sham group) or amantadine hydrochloride, with a releasing rate of 3.6mg/kg/hour for 8 weeks. The dopamine-releasing conditions and metabolism were analyzed sequentially by fast scan cyclic voltammetry (FSCV) and high-pressure liquid chromatography (HPLC). Novel object recognition (NOR) and fixed-speed rotarod (FSRR) behavioral tests were used to determine treatment effects on cognitive and motor deficits after injury. Results: Sequential dopamine-release deficits were revealed in 6-Pa-fluid-percussion cerebral cortical injured animals. The reuptake rate (tau value) of dopamine in injured animals was prolonged, but the tau value became close to the value for the control group after amantadine therapy. Cognitive and motor learning impairments were shown evidenced by the NOR and FSRR behavioral tests after injury. Chronic amantadine therapy reversed dopamine-release deficits, and behavioral impairment after fluid percussion injuries were ameliorated in the rats treated by using amantadine-pumping infusion. Conclusion: Chronic treatment with amantadine hydrochloride can ameliorate dopamine-release deficits as well as cognitive and motor deficits caused by cerebral fluid-percussion injury.	[Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Tsai, Jing-Jr; Ma, Hsin-I; Chen, Yuan-Hao] Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, PhD Program Neural Regenerat Med, Dept Neurosurg,Grad Inst Neural Regenerat Med, Taipei, Taiwan	National Defense Medical Center; National Taipei University of Technology; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital	Chen, YH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Neurol Surg, Taipei, Taiwan.	nova.chenyuanhao@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of Taiwan [NSC 101-2314-B-016-008]; Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital of Taiwan	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Berman SB, 1996, J NEUROCHEM, V67, P593; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; CHAPMAN AG, 1989, NEUROSCI LETT, V107, P256, DOI 10.1016/0304-3940(89)90827-6; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; FILLOUX F, 1991, SYNAPSE, V8, P281, DOI 10.1002/syn.890080406; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEIKKILA RE, 1972, EUR J PHARMACOL, V20, P156, DOI 10.1016/0014-2999(72)90144-6; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; OLNEY JW, 1990, EXP NEUROL, V108, P269, DOI 10.1016/0014-4886(90)90134-E; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Takahashi T, 1996, BRAIN RES BULL, V41, P363, DOI 10.1016/S0361-9230(96)00211-0; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Von Voigtlander P F, 1971, Science, V174, P408, DOI 10.1126/science.174.4007.408; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang T, 2013, J NEUROTRAUMA; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	63	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86354	10.1371/journal.pone.0086354	http://dx.doi.org/10.1371/journal.pone.0086354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497943	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100013
J	Klawitter, J; Klawitter, J; Schmitz, V; Shokati, T; Epshtein, E; Thurman, JM; Christians, U				Klawitter, Jelena; Klawitter, Jost; Schmitz, Volker; Shokati, Touraj; Epshtein, Ekaterina; Thurman, Joshua M.; Christians, Uwe			Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism	PLOS ONE			English	Article							CARDIOVASCULAR RISK PROFILE; RENAL-ALLOGRAFT REJECTION; TRANSPLANT RECIPIENTS; NMR-SPECTROSCOPY; RANDOMIZED-TRIAL; IN-VIVO; MAINTENANCE IMMUNOSUPPRESSION; CYCLOSPORINE NEPHROTOXICITY; ACID PHARMACOKINETICS; ORGAN-TRANSPLANTATION	Background and Purpose: Mycophenolate mofetil (MMF) per se is not known to have negative effects on the kidney. MMF alone or in combination with sirolimus, can be the basis of calcineurin inhibitor (CNI)-free, kidney sparing drug protocols. However, long-term outcomes in patients on MMF/SRL seem to be inferior to those treated with regimens that include the CNI tacrolimus (TAC) due to an increased risk of allo-immune reactions. Interestingly, potential enhancement of the negative effects of SRL and TAC on the kidney by MMF has never been considered. Experimental Approach: It was our aim to study the effects of TAC, SRL and MMF alone and evaluate their interactions when combined on the rat kidney. For this purpose we used a comprehensive molecular marker approach including measurements of urinary 8-isoprostane concentrations (oxidative stress marker) and changes of urinary metabolite patterns (H-1-NMR spectroscopy) and comparing these markers to renal function (glomerular filtration rate (GFR)) and morphologic alterations (histology). Key Results: While MMF alone did not impact GFR, its interaction with SRL and TAC led to a significant decrease of rats' renal function. The decline went in parallel with a significant increase in urinary isoprostane concentrations and an enhancement of negative effects on urinary metabolite patterns. Conclusions: In broad summary, the present study showed that MMF may enhance the negative effects of TAC on kidney function and may even display nephrotoxic properties when combined with SRL.	[Klawitter, Jelena; Klawitter, Jost; Schmitz, Volker; Shokati, Touraj; Epshtein, Ekaterina; Christians, Uwe] Univ Colorado, Dept Anesthesiol, Aurora, CO 80045 USA; [Klawitter, Jelena; Thurman, Joshua M.] Univ Colorado, Div Renal Dis & Hypertens, Aurora, CO USA; [Schmitz, Volker] Charite, Dept Gen Visceral & Transplantat Surg, Berlin, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klawitter, J (corresponding author), Univ Colorado, Dept Anesthesiol, Aurora, CO 80045 USA.	jelena.klawitter@ucdenver.edu	Klawitter, Jost/F-3976-2015	Klawitter, Jost/0000-0002-6413-4820; Thurman, Joshua Michael/0000-0002-3476-9956	United States National Institutes of Health [R01 DK065094]; University of Colorado Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065094] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the United States National Institutes of Health grant R01 DK065094. The NMR experiments were performed at the University of Colorado NMR core facility, funded by the University of Colorado Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2004, TRANSPLANTATION, V77, P686, DOI 10.1097/01.TP.0000113850.34945.DC; Akira K, 2008, J PHARMACEUT BIOMED, V46, P550, DOI 10.1016/j.jpba.2007.11.017; Artz MA, 2004, AM J TRANSPLANT, V4, P937, DOI 10.1111/j.1600-6143.2004.00427.x; Augustine JJ, 2004, AM J TRANSPLANT, V4, P2001, DOI 10.1111/j.1600-6143.2004.00612.x; Augustine JJ, 2006, TRANSPLANTATION, V81, P1004, DOI 10.1097/01.tp.0000202880.78509.b4; Bairaktari E, 1998, CLIN CHEM, V44, P1256; CALNE RY, 1978, LANCET, V2, P1323; Campistol JM, 2001, TRANSPLANTATION, V71, pSS42; Cattaneo D, 2005, AM J TRANSPLANT, V5, P2937, DOI 10.1111/j.1600-6143.2005.01107.x; Christians U, 2004, BRIT J PHARMACOL, V143, P388, DOI 10.1038/sj.bjp.0705939; Christians U, 2008, THER DRUG MONIT, V30, P151, DOI 10.1097/FTD.0b013e31816b9063; Ciancio G, 2006, TRANSPLANTATION, V81, P845, DOI 10.1097/01.tp.0000203894.53714.27; Cravedi P, 2010, KIDNEY INT, V78, P1068, DOI 10.1038/ki.2010.268; Crescioli C, 2008, EXP CELL RES, V314, P1337, DOI 10.1016/j.yexcr.2007.12.016; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Filler G, 2000, PEDIATR NEPHROL, V14, P100, DOI 10.1007/s004670050021; Fleck C, 1999, PHYSIOL RES, V48, P267; FOXALL PJD, 1993, KIDNEY INT, V43, P234, DOI 10.1038/ki.1993.37; Fung J J, 1990, Clin Transpl, P115; Gallon L, 2006, AM J TRANSPLANT, V6, P1617, DOI 10.1111/j.1600-6143.2006.01340.x; GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242; Guerra G, 2011, J AM SOC NEPHROL, V22, P1758, DOI 10.1681/ASN.2011010006; Halloran PF, 2000, LANCET, V356, P179, DOI 10.1016/S0140-6736(00)02473-9; Haschke M, 2007, CLIN CHEM, V53, P489, DOI 10.1373/clinchem.2006.078972; Hauet T, 2000, CRYOBIOLOGY, V41, P280, DOI 10.1006/cryo.2000.2291; Holt DW, 2003, TRANSPL P, V35, p157S, DOI 10.1016/S0041-1345(03)00214-8; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Johnston A, 1999, BRIT J CLIN PHARMACO, V47, P339, DOI 10.1046/j.1365-2125.1999.00911.x; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Klawitter J, 2012, J PROTEOME RES, V11, P5135, DOI 10.1021/pr300260e; Klawitter J, 2011, RAPID COMMUN MASS SP, V25, P463, DOI 10.1002/rcm.4871; Klawitter J, 2010, BRIT J CLIN PHARMACO, V70, P241, DOI 10.1111/j.1365-2125.2010.03689.x; Klawitter J, 2010, J PROTEOME RES, V9, P865, DOI 10.1021/pr900761m; Klawitter J, 2009, CHEM RES TOXICOL, V22, P118, DOI 10.1021/tx800253x; Klein IHHT, 2002, TRANSPLANTATION, V73, P732, DOI 10.1097/00007890-200203150-00012; Kovarik JM, 2004, THER DRUG MONIT, V26, P499, DOI 10.1097/00007691-200410000-00007; Kuypers DRJ, 2010, CLIN J AM SOC NEPHRO, V5, P341, DOI 10.2215/CJN.07111009; Kuypers DRJ, 2005, TRANSPL INT, V18, P140, DOI 10.1111/j.1432-2277.2004.00041.x; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lee RA, 2012, AM J HEALTH-SYST PH, V69, P1961, DOI 10.2146/ajhp110624; Ligtenberg G, 2001, J AM SOC NEPHROL, V12, P368, DOI 10.1681/ASN.V122368; Lorenz JN, 1999, AM J PHYSIOL-RENAL, V276, pF172, DOI 10.1152/ajprenal.1999.276.1.F172; Lucey MR, 2005, AM J TRANSPLANT, V5, P1111, DOI 10.1111/j.1600-6143.2005.00808.x; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Meier-Kriesche HU, 2006, AM J TRANSPLANT, V6, P1111, DOI 10.1111/j.1600-6143.2006.01270.x; Meier-Kriesche HU, 2005, AM J TRANSPLANT, V5, P2273, DOI 10.1111/j.1600-6143.2005.01019.x; Mendez R, 2005, TRANSPLANTATION, V80, P303, DOI 10.1097/01.tp.0000167757.63922.42; MIHATSCH MJ, 1988, TRANSPLANT P, V20, P759; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Morales JM, 2005, J HYPERTENS, V23, P1609, DOI 10.1097/01.hjh.0000180159.81640.2f; Neild GH, 1997, NEPHROL DIAL TRANSPL, V12, P404, DOI 10.1093/ndt/12.3.404; Opelz G, 2008, TRANSPLANTATION, V86, P371, DOI 10.1097/TP.0b013e31817fdddb; Perry TW, 2007, CLIN TRANSPLANT, V21, P413, DOI 10.1111/j.1399-0012.2007.00662.x; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Podder H, 2001, J AM SOC NEPHROL, V12, P1059, DOI 10.1681/ASN.V1251059; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Robertson DG, 2000, TOXICOL SCI, V57, P326, DOI 10.1093/toxsci/57.2.326; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sagrinati C, 2010, TRANSPL INT, V23, P914, DOI 10.1111/j.1432-2277.2010.01078.x; Schmitz V, 2009, NEPHRON EXP NEPHROL, V111, pE80, DOI 10.1159/000209208; Shockcor John P., 2002, Current Topics in Medicinal Chemistry, V2, P35, DOI 10.2174/1568026023394498; Smith KD, 2003, J AM SOC NEPHROL, V14, P1037, DOI 10.1097/01.ASN.0000057542.86377.5A; Sottili M, 2009, EXP CELL RES, V315, P264, DOI 10.1016/j.yexcr.2008.10.025; Srinivas TR, 2007, AM J TRANSPLANT, V7, P586, DOI 10.1111/j.1600-6143.2006.01658.x; STEPKOWSKI SM, 1991, TRANSPLANT P, V23, P3262; Taylor DO, 2006, J HEART LUNG TRANSPL, V25, P869, DOI 10.1016/j.healun.2006.05.002; Tyagi R, 2013, J APPL TOXICOL, V33, P134, DOI 10.1002/jat.1730; van Leuven SI, 2012, ANN RHEUM DIS, V71, P408, DOI 10.1136/annrheumdis-2011-200071; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF; Zucker K, 1999, THER DRUG MONIT, V21, P35, DOI 10.1097/00007691-199902000-00006; Zucker K, 1997, TRANSPL IMMUNOL, V5, P225, DOI 10.1016/S0966-3274(97)80042-1	74	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86202	10.1371/journal.pone.0086202	http://dx.doi.org/10.1371/journal.pone.0086202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497939	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100012
J	Cibiel, A; Quang, NN; Gombert, K; Theze, B; Garofalakis, A; Duconge, F				Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic			From Ugly Duckling to Swan: Unexpected Identification from Cell-SELEX of an Anti-Annexin A2 Aptamer Targeting Tumors	PLOS ONE			English	Article							SYSTEMATIC EVOLUTION; EXPONENTIAL ENRICHMENT; LIVE CELLS; RNA; LIGANDS; BINDING; PROTEIN; TOMOGRAPHY; POLYMERASE; SELECTION	Background: Cell-SELEX is now widely used for the selection of aptamers against cell surface biomarkers. However, despite negative selection steps using mock cells, this method sometimes results in aptamers against undesirable targets that are expressed both on mock and targeted cells. Studying these junk aptamers might be useful for further applications than those originally envisaged. Methodology/Principal Findings: Cell-SELEX was performed to identify aptamers against CHO-K1 cells expressing human Endothelin type B receptor (ETBR). CHO-K1 cells were used for negative selection of aptamers. Several aptamers were identified but no one could discriminate between both cell lines. We decided to study one of these aptamers, named ACE4, and we identified that it binds to the Annexin A2, a protein overexpressed in many cancers. Radioactive binding assays and flow cytometry demonstrated that the aptamer was able to bind several cancer cell lines from different origins, particularly the MCF-7 cells. Fluorescence microscopy revealed it could be completely internalized in cells in 2 hours. Finally, the tumor targeting of the aptamer was evaluated in vivo in nude mice xenograft with MCF-7 cells using fluorescence diffuse optical tomography (fDOT) imaging. Three hours after intravenous injection, the aptamer demonstrated a significantly higher uptake in the tumor compared to a scramble sequence. Conclusions/Significance: Although aptamers could be selected during cell-SELEX against other targets than those initially intended, they represent a potential source of ligands for basic research, diagnoses and therapy. Here, studying such aptamers, we identify one with high affinity for Annexin A2 that could be a promising tool for biomedical application.	[Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] SHFJ, Intitut Imagerie Biomed I2BM, Commissariat Energie Atom & Energies Alternat CEA, DSV, Orsay, France; [Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] Univ Paris 11, INSERM, U1023, Lab Imagerie Mol Expt, F-91405 Orsay, France; [Cibiel, Agnes; Nam Nguyen Quang; Gombert, Karine; Theze, Benoit; Garofalakis, Anikitos; Duconge, Frederic] Univ Paris 11, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Duconge, F (corresponding author), SHFJ, Intitut Imagerie Biomed I2BM, Commissariat Energie Atom & Energies Alternat CEA, DSV, Orsay, France.	frederic.duconge@cea.fr	Duconge, Frederic/C-6729-2012; Quang, Nam Nguyen/E-8234-2013; Garofalakis, Anikitos/AAU-7459-2020	Duconge, Frederic/0000-0002-8595-0050; Quang, Nam Nguyen/0000-0001-9321-155X; 	Agence Nationale pour la Recherche; FMT-XCT European program [201792]; European Molecular Imaging Laboratory (EMIL) network [EU] [LSH-2004-503569]; CEA-irtelis	Agence Nationale pour la Recherche(French National Research Agency (ANR)); FMT-XCT European program; European Molecular Imaging Laboratory (EMIL) network [EU]; CEA-irtelis	This work was supported by grants from the "Agence Nationale pour la Recherche" [projects ANR-RNTS TomoFluo3D, ANR-PNANO nanorings and under the frame of Euro- NanoMed (project META)]; the FMT-XCT European program [Grant agreement no. 201792] and the European Molecular Imaging Laboratory (EMIL) network [EU contract LSH-2004-503569]. AC was supported by a PhD fellowship [CEA-irtelis]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard B, 2011, DNA CELL BIOL, V30, P727, DOI 10.1089/dna.2011.1239; Aquino-Jarquin G, 2011, INT J MOL SCI, V12, P9155, DOI 10.3390/ijms12129155; Aukrust I, 2007, J MOL BIOL, V368, P1367, DOI 10.1016/j.jmb.2007.02.094; Berezovski MV, 2008, J AM CHEM SOC; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Cibiel A, 2011, PHARMACEUTICALS-BASE, V4, P1216, DOI 10.3390/ph4091216; Cibiel A, 2012, BIOCHIMIE, V94, P1595, DOI 10.1016/j.biochi.2012.02.025; Da Pieve C, 2009, NUCL MED BIOL, V36, P703, DOI 10.1016/j.nucmedbio.2009.04.004; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dassah M, 2009, GEN PHYSIOL BIOPHYS, V28, pF20; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; Garofalakis A, 2010, OPT LETT, V35, P3024, DOI 10.1364/OL.35.003024; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Grimshaw MJ, 2004, CANCER RES, V64, P2461, DOI 10.1158/0008-5472.CAN-03-1069; Gu F, 2008, P NATL ACAD SCI US; Hansske F, 1979, Methods Enzymol, V59, P172; Herve L, 2007, APPL OPTICS, V46, P4896, DOI 10.1364/AO.46.004896; Hicke BJ, 2006, J NUCL MED, V47, P668; Hwang DW, 2010, J NUCL MED, V51, P98, DOI 10.2967/jnumed.109.069880; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kesavan K, 2010, J BIOL CHEM, V285, P4366, DOI 10.1074/jbc.M109.066092; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Li N., 2009, J PROTEOME RES; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Lokman NA, 2011, CANCER MICROENVIRON, V4, P199, DOI 10.1007/s12307-011-0064-9; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Meyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071798; Ohuchi S, 2012, BIORESEARCH OPEN ACC, V1, P265, DOI 10.1089/biores.2012.0253; Ohuchi Shoji P, 2005, Nucleic Acids Symp Ser (Oxf), P351; Ohuchi SP, 2006, BIOCHIMIE; Palchetti I, 2012, ANAL BIOANAL CHEM, V402, P3103, DOI 10.1007/s00216-012-5769-1; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Pastor F, 2010, NATURE, V465, P227, DOI 10.1038/nature08999; Pestourie C, 2005, BIOCHIMIE, V87, P921, DOI 10.1016/j.biochi.2005.04.013; Pestourie C, 2006, OLIGONUCLEOTIDES, V16, P323, DOI 10.1089/oli.2006.16.323; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Sousa R, 2000, METHOD ENZYMOL, V317, P65; Sun W, 2011, CURR PHARM DESIGN, V17, P80, DOI 10.2174/138161211795049769; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Tavitian B, 2009, EUR J NUCL MED MOL I, V36, P1475, DOI 10.1007/s00259-009-1192-z; Thiel WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043836; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 2009, DIS SPECIFIC BIOMARK; Wang CL, 2003, J BIOTECHNOL, V102, P15, DOI 10.1016/S0168-1656(02)00360-7; Wang RE, 2011, CURR MED CHEM, V18, P4175; Zhou J, 2008, MOL THER; Zueva E, 2011, INT J CANCER, V128, P797, DOI 10.1002/ijc.25401	53	29	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87002	10.1371/journal.pone.0087002	http://dx.doi.org/10.1371/journal.pone.0087002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489826	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000091
J	Range, F; Viranyi, Z				Range, Friederike; Viranyi, Zsofia			Wolves Are Better Imitators of Conspecifics than Dogs	PLOS ONE			English	Article							HUMAN POINTING GESTURES; FREE-RANGING DOGS; CANIS-FAMILIARIS; GENETIC-EVIDENCE; DOMESTIC DOGS; EVOLUTION; BEHAVIOR; LUPUS; WOLF; DISCRIMINATION	Domestication is thought to have influenced the cognitive abilities of dogs underlying their communication with humans, but little is known about its effect on their interactions with conspecifics. Since domestication hypotheses offer limited predictions in regard to wolf-wolf compared to dog-dog interactions, we extend the cooperative breeding hypothesis suggesting that the dependency of wolves on close cooperation with conspecifics, including breeding but also territory defense and hunting, has created selection pressures on motivational and cognitive processes enhancing their propensity to pay close attention to conspecifics' actions. During domestication, dogs' dependency on conspecifics has been relaxed, leading to reduced motivational and cognitive abilities to interact with conspecifics. Here we show that 6-month-old wolves outperform same aged dogs in a two-action-imitation task following a conspecific demonstration. While the wolves readily opened the apparatus after a demonstration, the dogs failed to solve the problem. This difference could not be explained by differential motivation, better physical insight of wolves, differential developmental pathways of wolves and dogs or a higher dependency of dogs from humans. Our results are best explained by the hypothesis that higher cooperativeness may come together with a higher propensity to pay close attention to detailed actions of others and offer an alternative perspective to domestication by emphasizing the cooperativeness of wolves as a potential source of dog-human cooperation.	[Range, Friederike; Viranyi, Zsofia] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Range, Friederike; Viranyi, Zsofia] Wolf Sci Ctr, Ernstbrunn, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Range, F (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	friederike.range@vetmeduni.ac.at		Range, Friederike/0000-0003-3127-5536	Austrian Science Fund (FWF) [P21244-B17]; ERC [311870]; WWTF [CS11-026]; Austrian Science Fund (FWF) [P 21244] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); WWTF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was financially supported by Austrian Science Fund (FWF) project P21244-B17. Writing was supported by ERC Starting Grant CanCoop (311870) to the first and by the WWTF project CS11-026 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardalan A, 2011, ECOL EVOL, V1, P373, DOI 10.1002/ece3.35; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bonanni R, 2010, ANIM BEHAV, V79, P957, DOI 10.1016/j.anbehav.2010.01.016; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Burkart JM, 2010, ANIM COGN, V13, P1, DOI 10.1007/s10071-009-0263-7; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Feddersen-Petersen D.U., 2004, HUNDEPSYCHOLOGIE; Fiset S., 2013, Open Journal of Animal Sciences, V3, P1; Fiset S, 2013, J COMP PSYCHOL, V127, P115, DOI 10.1037/a0030595; FRANK H, 1985, J COMP PSYCHOL, V99, P266, DOI 10.1037/0735-7036.99.3.266; FRANK H, 1982, APPL ANIM ETHOL, V8, P507, DOI 10.1016/0304-3762(82)90215-2; FRANK H, 1989, B PSYCHONOMIC SOC, V27, P455; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; FRANK H, 1980, Z TIERPSYCHOL, V53, P389; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Hare B, 2005, TRENDS COGN SCI, V9, P464, DOI 10.1016/j.tics.2005.08.010; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Heyes C, 2009, PHILOS T R SOC B, V364, P2293, DOI 10.1098/rstb.2009.0049; Heyes CM, 2013, SIGNALLING COMMITMEN; Hopkins WD, 2002, ANIM COGN, V5, P27, DOI 10.1007/s10071-001-0121-8; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; Huber L, 2013, LEARN MOTIV, V44, P258, DOI 10.1016/j.lmot.2013.04.005; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Mech L. David, 2003, P1; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Range F, 2012, ANIM COGN, V15, P597, DOI 10.1007/s10071-012-0488-8; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Scott JP., 1965, GENETICS SOCIAL BEHA; Slabbert JM, 1997, APPL ANIM BEHAV SCI, V53, P309, DOI 10.1016/S0168-1591(96)01163-X; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Topal J, 1997, ANTHROZOOS, V10, P214, DOI 10.2752/089279397787000987; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Valentini F, 2012, VISUAL PERCEPTION DO; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Viranyi Zs, 2008, LEARNING ANIMALS; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	55	57	57	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86559	10.1371/journal.pone.0086559	http://dx.doi.org/10.1371/journal.pone.0086559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489744	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000048
J	Geddes, RI; Sribnick, EA; Sayeed, I; Stein, DG				Geddes, Rastafa I.; Sribnick, Eric A.; Sayeed, Iqbal; Stein, Donald G.			Progesterone Treatment Shows Benefit in a Pediatric Model of Moderate to Severe Bilateral Brain Injury	PLOS ONE			English	Article							IMMATURE RATS; RECEPTOR KNOCKOUT; SEX-DIFFERENCES; FEMALE RATS; RECOVERY; BEHAVIOR; EDEMA; YOUNG; GABA; MICE	Purpose: Controlled cortical impact (CCI) models in adult and aged Sprague-Dawley (SD) rats have been used extensively to study medial prefrontal cortex (mPFC) injury and the effects of post-injury progesterone treatment, but the hormone's effects after traumatic brain injury (TBI) in juvenile animals have not been determined. In the present proof-of-concept study we investigated whether progesterone had neuroprotective effects in a pediatric model of moderate to severe bilateral brain injury. Methods: Twenty-eight-day old (PND 28) male Sprague Dawley rats received sham (n = 24) or CCI (n = 47) injury and were given progesterone (4, 8, or 16 mg/kg per 100 g body weight) or vehicle injections on post-injury days (PID) 1-7, subjected to behavioral testing from PID 9-27, and analyzed for lesion size at PID 28. Results: The 8 and 16 mg/kg doses of progesterone were observed to be most beneficial in reducing the effect of CCI on lesion size and behavior in PND 28 male SD rats. Conclusion: Our findings suggest that a midline CCI injury to the frontal cortex will reliably produce a moderate TBI comparable to what is seen in the adult male rat and that progesterone can ameliorate the injury-induced deficits.	[Geddes, Rastafa I.; Sribnick, Eric A.; Sayeed, Iqbal; Stein, Donald G.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	dstei04@emory.edu	Sribnick, Eric/AAH-6693-2020; Stein, Donald/AAJ-5139-2020	Geddes, Rastafa/0000-0002-7313-761X	Allen and Company; Centers for Injury Control [R49CE001494-04]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE001494] Funding Source: NIH RePORTER	Allen and Company; Centers for Injury Control; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by gifts in support of research from Allen and Company and by the Centers for Injury Control Grant No. R49CE001494-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; Blumberg MS, 1998, DEV PSYCHOBIOL, V33, P107, DOI 10.1002/(SICI)1098-2302(199809)33:2<107::AID-DEV2>3.0.CO;2-N; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Clancy B, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.020.2009; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Coomber B, 2010, BRAIN RES, V1361, P124, DOI 10.1016/j.brainres.2010.09.037; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frye CA, 2011, J PSYCHOPHARMACOL, V25, P421, DOI 10.1177/0269881109349836; Galanopoulou AS, 2008, EPILEPSY RES, V80, P99, DOI 10.1016/j.eplepsyres.2008.04.013; GAYTAN F, 1988, ANDROLOGIA, V20, P450; Gerrish CJ, 1998, PHYSIOL BEHAV, V64, P463, DOI 10.1016/S0031-9384(98)00077-8; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Golub MS, 2006, BIRTH DEFECTS RES B, V77, P455, DOI 10.1002/bdrb.20089; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0476, 10.3233/RNN-2009-0475]; Kolb B, 1996, BEHAV NEUROSCI, V110, P1271, DOI 10.1037/0735-7044.110.6.1271; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; McCarthy MM, 2002, TRENDS NEUROSCI, V25, P307, DOI 10.1016/S0166-2236(02)02182-3; Nold C, 2013, AM J OBSTET GYNECOL, V208, pS26, DOI 10.1016/j.ajog.2012.10.216; Norwitz Errol R, 2011, Rev Obstet Gynecol, V4, P60; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Reddy DS, 2005, BRAIN RES, V1033, P96, DOI 10.1016/j.brainres.2004.11.026; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Silva-Gomez AB, 2003, BRAIN RES, V973, P285, DOI 10.1016/S0006-8993(03)02537-X; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	50	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87252	10.1371/journal.pone.0087252	http://dx.doi.org/10.1371/journal.pone.0087252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489882	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000120
J	Mackenzie, CL; Ormondroyd, GA; Curling, SF; Ball, RJ; Whiteley, NM; Malham, SK				Mackenzie, Clara L.; Ormondroyd, Graham A.; Curling, Simon F.; Ball, Richard J.; Whiteley, Nia M.; Malham, Shelagh K.			Ocean Warming, More than Acidification, Reduces Shell Strength in a Commercial Shellfish Species during Food Limitation	PLOS ONE			English	Article							MYTILUS-EDULIS; SEAWATER ACIDIFICATION; CARBONIC-ACID; BLUE MUSSEL; HIGH CO2; TEMPERATURE; GROWTH; CALCIFICATION; DISSOCIATION; ADAPTATION	Ocean surface pH levels are predicted to fall by 0.3-0.4 pH units by the end of the century and are likely to coincide with an increase in sea surface temperature of 2-4 degrees C. The combined effect of ocean acidification and warming on the functional properties of bivalve shells is largely unknown and of growing concern as the shell provides protection from mechanical and environmental challenges. We examined the effects of near-future pH (ambient pH -0.4 pH units) and warming (ambient temperature +4 degrees C) on the shells of the commercially important bivalve, Mytilus edulis when fed for a limited period (4-6 h day(-1)). After six months exposure, warming, but not acidification, significantly reduced shell strength determined as reductions in the maximum load endured by the shells. However, acidification resulted in a reduction in shell flex before failure. Reductions in shell strength with warming could not be explained by alterations in morphology, or shell composition but were accompanied by reductions in shell surface area, and by a fall in whole-body condition index. It appears that warming has an indirect effect on shell strength by re-allocating energy from shell formation to support temperature-related increases in maintenance costs, especially as food supply was limited and the mussels were probably relying on internal energy reserves. The maintenance of shell strength despite seawater acidification suggests that biomineralisation processes are unaffected by the associated changes in CaCO3 saturation levels. We conclude that under near-future climate change conditions, ocean warming will pose a greater risk to shell integrity in M. edulis than ocean acidification when food availability is limited.	[Mackenzie, Clara L.; Malham, Shelagh K.] Bangor Univ, Coll Nat Sci, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Ormondroyd, Graham A.; Curling, Simon F.] Bangor Univ, Biocomposites Ctr, Bangor, Gwynedd, Wales; [Ball, Richard J.] Univ Bath, Dept Architecture & Civil Engn, Bath, Somerset, England; [Whiteley, Nia M.] Bangor Univ, Coll Nat Sci, Sch Biol Sci, Bangor, Gwynedd, Wales	Bangor University; Bangor University; University of Bath; Bangor University	Whiteley, NM (corresponding author), Bangor Univ, Coll Nat Sci, Sch Biol Sci, Bangor, Gwynedd, Wales.	n.m.whiteley@bangor.ac.uk	Malham, Shelagh K/O-9054-2014	Curling, Simon/0000-0002-3486-0311; Ball, Richard/0000-0002-7413-3944; Mackenzie, Clara/0000-0002-5797-6106	Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme; EPSRC [EP/K025597/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K025597/1] Funding Source: researchfish	Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funded by the project entitled: Shellfish Productivity in the Irish Sea, working towards a sustainable future (SUSFISH). SUSFISH is part-funded by the European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme 2007-2013. INTERREG 4A is managed in Ireland by the Southern and Eastern Regional Assembly on behalf of the Irish Government, the Welsh Government and the European Commission. http:// www.irelandwales.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMADAVILLELA PC, 1982, J EXP MAR BIOL ECOL, V59, P275, DOI 10.1016/0022-0981(82)90121-6; BAYNE BL, 1970, HELGOLAND WISS MEER, V20, P526, DOI 10.1007/BF01609927; Beesley A, 2008, CLIM RES, V37, P215, DOI 10.3354/cr00765; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Branch TA, 2013, TRENDS ECOL EVOL, V28, P178, DOI 10.1016/j.tree.2012.10.001; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Carter JG, 1980, SKELETAL GROWTH AQUA, P69; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dumousseaud C, 2011, PRACTICAL GUIDE UK O; Dunphy BJ, 2001, MAR FRESHWATER RES, V52, P781, DOI 10.1071/MF99189; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; *FAO, 2008, STAT WORLD FISH AQ S; Findlay HS, 2011, MAR BIOL RES, V7, P565, DOI 10.1080/17451000.2010.547200; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Hiebenthal C, 2012, AQUAT BIOL, V14, P289, DOI 10.3354/ab00405; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Holt T., 1998, BIOGENIC REEFS; Huning A, 2013, MAR BIOL, V160, P1845, DOI 10.1007/s00227-012-1930-9; Kontoyannis CG, 2000, ANALYST, V125, P251, DOI 10.1039/a908609i; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Leonard GH, 1999, ECOLOGY, V80, P1; Lewis E., 1998, PROGRAM DEV CO2 SYST; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; LUCAS A, 1985, AQUACULTURE, V44, P187, DOI 10.1016/0044-8486(85)90243-1; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Matoo OB, 2013, COMP BIOCHEM PHYS A, V164, P545, DOI 10.1016/j.cbpa.2012.12.025; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nagarajan R, 2006, J EXP MAR BIOL ECOL, V339, P241, DOI 10.1016/j.jembe.2006.08.001; Nicholls RJ, 2007, CLIMATIC CHANGE 2007, P315, DOI 10.2134/jeq2008.0015br; Olson IC, 2012, J AM CHEM SOC, V134, P7351, DOI 10.1021/ja210808s; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Roleda MY, 2012, J PHYCOL, V48, P840, DOI 10.1111/j.1529-8817.2012.01195.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SEED R, 1968, J MAR BIOL ASSOC UK, V48, P561, DOI 10.1017/S0025315400019159; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Vermeij G.J., 1993, NATURAL HIST SHELLS; Wang RZ, 2011, ANNU REV MATER RES, V41, P41, DOI 10.1146/annurev-matsci-062910-095806; Welladsen HM, 2010, MOLLUSCAN RES, V30, P125; Wheeler A.P., 1992, P179; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zuschin M, 2001, PALAIOS, V16, P161, DOI 10.2307/3515527	58	79	79	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86764	10.1371/journal.pone.0086764	http://dx.doi.org/10.1371/journal.pone.0086764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489785	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000079
J	Murakami, A; Takahashi, F; Nurwidya, F; Kobayashi, I; Minakata, K; Hashimoto, M; Nara, T; Kato, M; Tajima, K; Shimada, N; Iwakami, S; Moriyama, M; Moriyama, H; Koizumi, F; Takahashi, K				Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Hashimoto, Muneaki; Nara, Takeshi; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Iwakami, Shin-ichiro; Moriyama, Mariko; Moriyama, Hiroyuki; Koizumi, Fumiaki; Takahashi, Kazuhisa			Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor	PLOS ONE			English	Article							FACTOR-I RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; PHASE-II; MET AMPLIFICATION; MUTANT; SENSITIVITY; COMBINATION; MECHANISMS; MUTATIONS	Accumulating evidence indicates that a small population of cancer stem cells (CSCs) is involved in intrinsic resistance to cancer treatment. The hypoxic microenvironment is an important stem cell niche that promotes the persistence of CSCs in tumors. Our aim here was to elucidate the role of hypoxia and CSCs in the resistance to gefitinib in non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation. NSCLC cell lines, PC9 and HCC827, which express the EGFR exon 19 deletion mutations, were exposed to high concentration of gefitinib under normoxic or hypoxic conditions. Seven days after gefitinib exposure, a small fraction of viable cells were detected, and these were referred to as "gefitinib-resistant persisters'' (GRPs). CD133, Oct4, Sox2, Nanog, CXCR4, and ALDH1A1-all genes involved in stemness- were highly expressed in GRPs in PC9 and HCC827 cells, and PC9 GRPs exhibited a high potential for tumorigenicity in vivo. The expression of insulin-like growth factor 1 (IGF1) was also upregulated and IGF1 receptor (IGF1R) was activated on GRPs. Importantly, hypoxic exposure significantly increased sphere formation, reflecting the self-renewal capability, and the population of CD133- and Oct4-positive GRPs. Additionally, hypoxia upregulated IGF1 expression through hypoxia-inducible factor 1 alpha (HIF1 alpha), and markedly promoted the activation of IGF1R on GRPs. Knockdown of IGF1 expression significantly reduced phosphorylated IGF1R-expressing GRPs under hypoxic conditions. Finally, inhibition of HIF1 alpha or IGF1R by specific inhibitors significantly decreased the population of CD133- and Oct4-positive GRPs, which were increased by hypoxia in PC9 and HCC827 cells. Collectively, these findings suggest that hypoxia increased the population of lung CSCs resistant to gefitinib in EGFR mutation-positive NSCLC by activating IGF1R. Targeting the IGF1R pathway may be a promising strategy for overcoming gefitinib resistance in EGFR mutation-positive NSCLC induced by lung CSCs and microenvironment factors such as tumor hypoxia.	[Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Murakami, Akiko; Takahashi, Fumiyuki; Nurwidya, Fariz; Kobayashi, Isao; Minakata, Kunihiko; Kato, Motoyasu; Tajima, Ken; Shimada, Naoko; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Ages, Tokyo, Japan; [Hashimoto, Muneaki; Nara, Takeshi] Juntendo Univ, Grad Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Iwakami, Shin-ichiro] Juntendo Univ, Shizuoka Hosp, Shizuoka, Japan; [Moriyama, Mariko; Moriyama, Hiroyuki] Kinki Univ, Sch Med, Pharmaceut Res & Technol Inst, Osaka 589, Japan; [Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Kindai University (Kinki University); National Cancer Center - Japan	Takahashi, F (corresponding author), Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan.	fumiyuki@dol.hi-ho.ne.jp	Nurwidya, Fariz/E-4375-2015; Nurwidya, Fariz/AAS-1206-2020; Hashimoto, Muneaki/L-6386-2018	Nurwidya, Fariz/0000-0002-8379-9510; Nurwidya, Fariz/0000-0002-8379-9510; Hashimoto, Muneaki/0000-0001-7215-7558	Ministry of Education, Culture, Sports, Science and Technology of Japan [23591906]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aids for Scientific Research No. 23591906 (Fumiyuki Takahashi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2008, CLIN CANCER RES, V14, P4079, DOI 10.1158/1078-0432.CCR-07-5030; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Costa DB, 2007, LUNG CANCER, V58, P95, DOI 10.1016/j.lungcan.2007.05.017; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Habben K, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7584; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jameson MJ, 2011, MOL CANCER THER, V10, P2124, DOI 10.1158/1535-7163.MCT-11-0294; Jassem J, 2010, J CLIN ONCOL S, V28; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung MJ, 2013, ONCOGENE, V32, P209, DOI 10.1038/onc.2012.37; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lin Q, 2010, CANCER BIOL THER, V9, P949, DOI 10.4161/cbt.9.12.12347; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minakata K, 2012, CANCER SCI, V103, P1946, DOI 10.1111/j.1349-7006.2012.02408.x; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110	36	94	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86459	10.1371/journal.pone.0086459	http://dx.doi.org/10.1371/journal.pone.0086459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489728	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000051
J	Zimmer, A; Durand, C; Loira, N; Durrens, P; Sherman, DJ; Marullo, P				Zimmer, Adrien; Durand, Cecile; Loira, Nicolas; Durrens, Pascal; Sherman, David James; Marullo, Philippe			QTL Dissection of Lag Phase in Wine Fermentation Reveals a New Translocation Responsible for Saccharomyces cerevisiae Adaptation to Sulfite	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATION; NUCLEOTIDE RESOLUTION; ADAPTIVE EVOLUTION; RESISTANCE GENE; YEAST; REARRANGEMENTS; TRAIT; SSU1; DUPLICATION; POPULATIONS	Quantitative genetics and QTL mapping are efficient strategies for deciphering the genetic polymorphisms that explain the phenotypic differences of individuals within the same species. Since a decade, this approach has been applied to eukaryotic microbes such as Saccharomyces cerevisiae in order to find natural genetic variations conferring adaptation of individuals to their environment. In this work, a QTL responsible for lag phase duration in the alcoholic fermentation of grape juice was dissected by reciprocal hemizygosity analysis. After invalidating the effect of some candidate genes, a chromosomal translocation affecting the lag phase was brought to light using de novo assembly of parental genomes. This newly described translocation (XV-t-XVI) involves the promoter region of ADH1 and the gene SSU1 and confers an increased expression of the sulfite pump during the first hours of alcoholic fermentation. This translocation constitutes another adaptation route of wine yeast to sulfites in addition to the translocation VIII-t-XVI previously described. A population survey of both translocation forms in a panel of domesticated yeast strains suggests that the translocation XV-t-XVI has been empirically selected by human activity.	[Zimmer, Adrien; Durand, Cecile; Marullo, Philippe] LAFFORT, Bordeaux, France; [Zimmer, Adrien; Durand, Cecile; Marullo, Philippe] Univ Bordeaux, ISVV, EA OEnol 4577, Villenave Dornon, France; [Loira, Nicolas] Univ Chile, Ctr Genome Regulat FONDAP 15090007, Santiago, Chile; [Durrens, Pascal; Sherman, David James] Univ Bordeaux, CNRS, UMR 5800, INRIA Project Team Magnome, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Marullo, P (corresponding author), LAFFORT, Bordeaux, France.	philippe.marullo@u-bordeaux2.fr		Marullo, Philippe/0000-0002-3594-5173; Sherman, David James/0000-0002-2316-1005	Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]; Investissements d'avenir, Convention attributive d'aide [ANR-10-EQPX-16-01]; Conseil Regional d'Aquitaine (SAGESSE)	Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER(European Commission); Investissements d'avenir, Convention attributive d'aide(French National Research Agency (ANR)); Conseil Regional d'Aquitaine (SAGESSE)	Genome sequencing presented in the present publication were performed at the Genomic and Transcriptomic Facility of Bordeaux (grants from the Conseil Regional d'Aquitaine no20030304002FA and 20040305003FA and from the European Union, FEDER no2003227 and from Investissements d'avenir, Convention attributive d'aide NoANR-10-EQPX-16-01). NL received a grant from Conseil Regional d'Aquitaine (SAGESSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albertin W, PLOS ONE IN PRESS; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; [Anonymous], 2010, R LANG ENV STAT COMP; Araya CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-88; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; BIDENNE C, 1992, CURR GENET, V22, P1, DOI 10.1007/BF00351734; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CASALONE E, 1992, CURR GENET, V22, P435, DOI 10.1007/BF00326407; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Divol B, 2012, APPL MICROBIOL BIOT, V95, P601, DOI 10.1007/s00253-012-4186-x; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Egli CM, 1998, J APPL MICROBIOL, V85, P779, DOI 10.1046/j.1365-2672.1998.00521.x; Ehrenreich IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002570; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Engle EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002763; Favier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049082; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; Galeote V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017872; Galeote V, 2010, MICROBIOL-SGM, V156, P3754, DOI 10.1099/mic.0.041673-0; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goto-Yamamoto N, 1998, J FERMENT BIOENG, V86, P427, DOI 10.1016/S0922-338X(98)80146-3; Greig D, 2009, HEREDITY, V102, P39, DOI 10.1038/hdy.2008.73; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Henick-Kling T, 1998, J APPL MICROBIOL, V84, P865, DOI 10.1046/j.1365-2672.1998.00423.x; HINZE H, 1986, ARCH MICROBIOL, V145, P27, DOI 10.1007/BF00413023; Infante JJ, 2003, GENETICS, V165, P1745; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; King T, 2006, GENETICS, V172, P2071, DOI 10.1534/genetics.105.053892; Koszul R, 2006, GENETICS, V172, P2211, DOI 10.1534/genetics.105.048058; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liti G, 2005, ANNU REV MICROBIOL, V59, P135, DOI 10.1146/annurev.micro.59.030804.121400; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2007, FEMS YEAST RES, V7, P1295, DOI 10.1111/j.1567-1364.2007.00281.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Nardi T, 2010, MICROBIOL-SGM, V156, P1686, DOI 10.1099/mic.0.036723-0; NESS F, 1995, GENETICS, V140, P945; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; P Ribereau-Gayon, 2000, HDB ENOLOGY; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park H, 2008, J MICROBIOL, V46, P542, DOI 10.1007/s12275-008-0053-y; PATE JB, 1962, ANAL CHEM, V34, P1660, DOI 10.1021/ac60192a001; Pennaneach V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006389; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Romano GH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.1; Rossi B, 2010, GENETICS, V186, P775, DOI 10.1534/genetics.110.120683; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Shibata Y, 2009, NUCLEIC ACIDS RES, V37, P6454, DOI 10.1093/nar/gkp650; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; STRATFORD M, 1987, J GEN MICROBIOL, V133, P2173; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THORNTON RJ, 1982, EUR J APPL MICROBIOL, V14, P159, DOI 10.1007/BF00497893; Tosato V, 2009, CHROMOSOMA, V118, P179, DOI 10.1007/s00412-008-0187-z; Umezu K, 2002, GENETICS, V160, P97; WELCH JW, 1983, MOL CELL BIOL, V3, P1353, DOI 10.1128/MCB.3.8.1353; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; XU X, 1994, CURR GENET, V25, P488, DOI 10.1007/BF00351667; Yang YD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003693; Yu X, 2004, GENETICS, V166, P741, DOI 10.1534/genetics.166.2.741; Yuasa N, 2005, BIOSCI BIOTECH BIOCH, V69, P1584, DOI 10.1271/bbb.69.1584; Yuasa N, 2004, J BIOSCI BIOENG, V98, P394, DOI 10.1016/S1389-1723(04)00303-2; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	83	71	71	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86298	10.1371/journal.pone.0086298	http://dx.doi.org/10.1371/journal.pone.0086298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489712	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000045
J	Cheng, JW; Wang, WL; Zhang, YJ; Liu, X; Li, MX; Wu, Z; Liu, ZW; Lv, Y; Wang, B				Cheng, Jiwen; Wang, Wanli; Zhang, Yingjun; Liu, Xi; Li, Muxing; Wu, Zheng; Liu, Zhengwen; Lv, Yi; Wang, Bo			Prognostic Role of Pre-Treatment Serum AFP-L3% in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							REACTIVE ALPHA-FETOPROTEIN; GAMMA-CARBOXY PROTHROMBIN; TUMOR-MARKERS; RADIOFREQUENCY ABLATION; FUCOSYLATED FRACTION; CURATIVE TREATMENT; RECURRENCE; IMMUNOASSAY; STATISTICS; PREDICTION	Background: Serum lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) has been widely used for HCC diagnosis and follow-up surveillance as tumor serologic marker. However, the prognostic value of high pre-treatment serum AFP-L3% in patients with hepatocellular carcinoma (HCC) remains controversial. We therefore conduct a meta-analysis to assess the relationship between high pre-treatment serum AFP-L3% and clinical outcome of HCC. Methods: Eligible studies were identified through systematic literature searches. A meta-analysis of fifteen studies (4,465 patients) was carried out to evaluate the association between high pre-treatment serum AFP-L3% and overall survival (OS) and disease-free survival (DFS) in HCC patients. Sensitivity and subgroup analyses were also conducted in this meta-analysis. Results: Our analysis results showed that high pre-treatment serum AFP-L3% implied poor OS (HR: 1.65, 95% CI: 1.45-1.89 p<0.00001) and DFS (HR: 1.80, 95% CI: 1.49-2.17 p<0.00001) of HCC. Subgroup analysis revealed that there was association between pre-treatment serum AFP-L3% and endpoint (OS and DFS) in low AFP concentration HCC patients (HR: 1.96, 95% CI: 1.24-3.10, p = 0.004; HR: 2.53, 95% CI: 1.09-5.89, p = 0.03, respectively). Conclusion: The current evidence suggests that high pre-treatment serum AFP-L3% levels indicated a poor prognosis for patients with HCC and AFP-L3% may have significant prognostic value in HCC patients with low AFP concentration.	[Cheng, Jiwen; Wang, Wanli; Li, Muxing; Wu, Zheng; Lv, Yi; Wang, Bo] Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Sch Med, Xian, Shaanxi, Peoples R China; [Wang, Wanli; Zhang, Yingjun] Bazhong Cent Hosp, Dept Gen Surg, Bazhong, Sichuan, Peoples R China; [Cheng, Jiwen; Li, Muxing; Liu, Zhengwen; Lv, Yi] Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Xian, Shaanxi, Peoples R China; [Liu, Zhengwen] Xi An Jiao Tong Univ, Dept Infect Dis, Affiliated Hosp 1, Sch Med, Xian, Shaanxi, Peoples R China; [Liu, Xi] Xi An Jiao Tong Univ, Dept Pathol, Affiliated Hosp 1, Sch Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Sch Med, Xian, Shaanxi, Peoples R China.	1uyi169@126.com; bobwang75@126.com	cheng, jiwen/AFI-8299-2022	cheng, jiwen/0000-0001-5907-9436	National Natural Science Foundation of China [81270521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (Grant no. 81270521). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Y, 1998, CANCER, V83, P2076, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L; Beppu T, 2010, INT J MOL MED, V26, P425, DOI 10.3892/ijmm_00000482; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fujiyama S, 2002, ONCOLOGY-BASEL, V62, P57, DOI 10.1159/000048277; Fukuda Hitoshi, 1998, Kurume Medical Journal, V45, P187; Hayashi K, 1999, AM J GASTROENTEROL, V94, P3028, DOI 10.1016/S0002-9270(99)00434-7; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; Kawabata T, 2008, ELECTROPHORESIS, V29, P1399, DOI 10.1002/elps.200700898; Kobayashi M, 2007, HEPATOL RES, V37, P914, DOI 10.1111/j.1872-034X.2007.00147.x; Kobayashi M, 2011, HEPATOL RES, V41, P1036, DOI 10.1111/j.1872-034X.2011.00858.x; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Leerapun A, 2007, CLIN GASTROENTEROL H, V5, P394, DOI 10.1016/j.cgh.2006.12.005; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Miyaaki H, 2007, J GASTROENTEROL, V42, P962, DOI 10.1007/s00535-007-2117-x; Nouso K, 2011, J GASTROEN HEPATOL, V26, P1195, DOI 10.1111/j.1440-1746.2011.06720.x; Oka H, 2001, J GASTROEN HEPATOL, V16, P1378, DOI 10.1046/j.1440-1746.2001.02643.x; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Reeves BC, 2013, RES SYNTH METHODS, V4, P1, DOI 10.1002/jrsm.1068; Saito Y, 2012, HEPATOL RES, V42, P887, DOI 10.1111/j.1872-034X.2012.01004.x; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Shiozawa K, 2009, MOL MED REP, V2, P89, DOI 10.3892/mmr_00000067; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song BC, 2002, J CLIN GASTROENTEROL, V35, P398, DOI 10.1097/00004836-200211000-00008; Takeji S, 2013, J GASTROEN HEPATOL, V28, P671, DOI 10.1111/jgh.12076; Tamura Y, 2010, DIGEST DIS SCI, V55, P3576, DOI 10.1007/s10620-010-1222-5; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tateishi R, 2006, HEPATOLOGY, V44, P1518, DOI 10.1002/hep.21408; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P111, DOI 10.1016/S1542-3565(05)00855-4; Toyoda H, 2008, J HEPATOL, V49, P223, DOI 10.1016/j.jhep.2008.04.013; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Wells G., 1999, NEWCASTLE OTTAWA SCA; Yamashita F, 1996, GASTROENTEROLOGY, V111, P996, DOI 10.1016/S0016-5085(96)70067-7; Zhang XF, 2011, ANN SURG ONCOL, V18, P2218, DOI 10.1245/s10434-011-1613-7	37	42	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87011	10.1371/journal.pone.0087011	http://dx.doi.org/10.1371/journal.pone.0087011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498011	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100045
J	Lou, PH; Lucchinetti, E; Zhang, LY; Affolter, A; Schaub, MC; Gandhi, M; Hersberger, M; Warren, BE; Lemieux, H; Sobhi, HF; Clanachan, AS; Zaugg, M				Lou, Phing-How; Lucchinetti, Eliana; Zhang, Liyan; Affolter, Andreas; Schaub, Marcus C.; Gandhi, Manoj; Hersberger, Martin; Warren, Blair E.; Lemieux, Helene; Sobhi, Hany F.; Clanachan, Alexander S.; Zaugg, Michael			The Mechanism of Intralipid (R)-Mediated Cardioprotection Complex IV Inhibition by the Active Metabolite, Palmitoylcarnitine, Generates Reactive Oxygen Species and Activates Reperfusion Injury Salvage Kinases	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; FATTY-ACID OXIDATION; UNCOUPLING PROTEIN-3; LIPID EMULSION; IN-VIVO; ISCHEMIA; HEARTS; CARNITINE; RECOVERY; PROTECTS	Background: Intralipid (R) administration at reperfusion elicits protection against myocardial ischemia-reperfusion injury. However, the underlying mechanisms are not fully understood. Methods: Sprague-Dawley rat hearts were exposed to 15 min of ischemia and 30 min of reperfusion in the absence or presence of Intralipid (R) 1% administered at the onset of reperfusion. In separate experiments, the reactive oxygen species (ROS) scavenger N-(2-mercaptopropionyl)-glycine was added either alone or with Intralipid (R). Left ventricular work and activation of Akt, STAT3, and ERK1/2 were used to evaluate cardioprotection. ROS production was assessed by measuring the loss of aconitase activity and the release of hydrogen peroxide using Amplex Red. Electron transport chain complex activities and proton leak were measured by high-resolution respirometry in permeabilized cardiac fibers. Titration experiments using the fatty acid intermediates of Intralipid (R) palmitoyl-, oleoyl- and linoleoylcarnitine served to determine concentration-dependent inhibition of complex IV activity and mitochondrial ROS release. Results: Intralipid (R) enhanced postischemic recovery and activated Akt and Erk1/2, effects that were abolished by the ROS scavenger N-(2-mercaptopropionyl) glycine. Palmitoylcarnitine and linoleoylcarnitine, but not oleoylcarnitine concentration-dependently inhibited complex IV. Only palmitoylcarnitine reached high tissue concentrations during early reperfusion and generated significant ROS by complex IV inhibition. Palmitoylcarnitine (1 mu M), administered at reperfusion, also fully mimicked Intralipid (R)-mediated protection in an N-(2-mercaptopropionyl)-glycine -dependent manner. Conclusions: Our data describe a new mechanism of postconditioning cardioprotection by the clinically available fat emulsion, Intralipid (R). Protection is elicited by the fatty acid intermediate palmitoylcarnitine, and involves inhibition of complex IV, an increase in ROS production and activation of the RISK pathway.	[Lou, Phing-How] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Lucchinetti, Eliana; Zhang, Liyan; Zaugg, Michael] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Affolter, Andreas; Hersberger, Martin] Univ Childrens Hosp Zurich, Dept Clin Chem, Zurich, Switzerland; [Schaub, Marcus C.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Gandhi, Manoj; Clanachan, Alexander S.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Warren, Blair E.; Lemieux, Helene] Univ Alberta, Edmonton, AB, Canada; [Sobhi, Hany F.] Coppin State Univ, Coppin Ctr Organ Synth, Baltimore, MD USA	University of Alberta; University of Alberta; University Children's Hospital Zurich; University of Zurich; University of Alberta; University of Alberta; University System of Maryland; Coppin State University	Zaugg, M (corresponding author), Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada.	michael.zaugg@ualberta.ca	Zhang, Li/GWM-7501-2022; Zaugg, Michael/G-4287-2016	Lucchinetti, Eliana/0000-0003-3338-1279; lemieux, Helene/0000-0002-8864-6062; Zaugg, Michael/0000-0002-2016-8973; Hersberger, Martin/0000-0002-4472-329X	Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut (Canada); Canadian Institutes of Health Research [MOP115055]; Natural Sciences and Engineering Research Council of Canada; Mazankowski Alberta Heart Institute, Edmonton, Canada; Campus Saint-Jean of the University of Alberta, Edmonton, Canada	Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut (Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mazankowski Alberta Heart Institute, Edmonton, Canada; Campus Saint-Jean of the University of Alberta, Edmonton, Canada	This work was supported by the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut (Canada), and the Canadian Institutes of Health Research (MOP115055), a discovery grant from the Natural Sciences and Engineering Research Council of Canada, and a grant from the Mazankowski Alberta Heart Institute, Edmonton, Canada. BEW was supported by a "Bourse pour apprentis-chercheurs" from the Campus Saint-Jean of the University of Alberta, Edmonton, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Cave G, 2009, ACAD EMERG MED, V16, P815, DOI 10.1111/j.1553-2712.2009.00499.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; HEATHERS GP, 1993, J CARDIOVASC PHARM, V22, P857; Hiser C, 2013, BIOCHEMISTRY-US, V52, P1385, DOI 10.1021/bi3014505; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; HULSMANN WC, 1985, BIOCHIM BIOPHYS ACTA, V847, P62, DOI 10.1016/0167-4889(85)90153-3; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ito M, 2010, AM J PHYSIOL-HEART C, V298, pH1426, DOI 10.1152/ajpheart.00284.2009; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kudej RK, 2011, CARDIOVASC RES, V92, P394, DOI 10.1093/cvr/cvr215; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Li JY, 2012, ANESTHESIOLOGY, V117, P836, DOI 10.1097/ALN.0b013e3182655e73; Lou PH, 2013, CARDIOVASC RES, V97, P251, DOI 10.1093/cvr/cvs323; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lucchinetti E, 2011, BRIT J ANAESTH, V106, P792, DOI 10.1093/bja/aer065; Mirtallo JM, 2010, ANN PHARMACOTHER, V44, P688, DOI 10.1345/aph.1M626; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; MURTHY MSR, 1985, BIOCHEM J, V230, P657, DOI 10.1042/bj2300657; ORAM JF, 1973, J BIOL CHEM, V248, P5299; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Partownavid P, 2012, CRIT CARE MED, V40, P2431, DOI 10.1097/CCM.0b013e3182544f48; Penna C, 2006, BASIC RES CARDIOL, V101, P180, DOI 10.1007/s00395-006-0584-5; Penna C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0371-z; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Pillutla P, 2005, AM J PHYSIOL-ENDOC M, V288, pE1229, DOI 10.1152/ajpendo.00273.2004; Rahman S, 2011, ANESTHESIOLOGY, V115, P242, DOI 10.1097/ALN.0b013e318223b8b9; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stanley WC, 2012, CIRC RES, V110, P764, DOI [10.1161/CIRCRESAHA.111.253104, 10.1161/circresaha.111.253104]; TAKEUCHI Y, 1991, ARCH BIOCHEM BIOPHYS, V289, P33, DOI 10.1016/0003-9861(91)90438-O; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; Van de Velde M, 2000, CARDIOVASC RES, V48, P129, DOI 10.1016/S0008-6363(00)00151-6; VandeVelde M, 1996, CARDIOVASC RES, V32, P1008, DOI 10.1016/S0008-6363(96)00165-4; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Wang LG, 2010, ANESTHESIOLOGY, V113, P541, DOI 10.1097/ALN.0b013e3181e2c1a1; Xie NL, 2011, ARCH MED RES, V42, P171, DOI 10.1016/j.arcmed.2011.04.008; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zaugg M, 2012, ANESTHESIOLOGY, V116, P648, DOI 10.1097/ALN.0b013e318247225a; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	52	39	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87205	10.1371/journal.pone.0087205	http://dx.doi.org/10.1371/journal.pone.0087205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498043	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330617100058
J	Callari, M; Lembo, A; Bianchini, G; Musella, V; Cappelletti, V; Gianni, L; Daidone, MG; Provero, P				Callari, Maurizio; Lembo, Antonio; Bianchini, Giampaolo; Musella, Valeria; Cappelletti, Vera; Gianni, Luca; Daidone, Maria Grazia; Provero, Paolo			Accurate Data Processing Improves the Reliability of Affymetrix Gene Expression Profiles from FFPE Samples	PLOS ONE			English	Article							BREAST-CANCER; RNA; CLASSIFICATION; CHEMOTHERAPY; SET	Formalin fixed paraffin-embedded (FFPE) tumor specimens are the conventionally archived material in clinical practice, representing an invaluable tissue source for biomarkers development, validation and routine implementation. For many prospective clinical trials, this material has been collected allowing for a prospective-retrospective study design which represents a successful strategy to define clinical utility for candidate markers. Gene expression data can be obtained even from FFPE specimens with the broadly used Affymetrix HG-U133 Plus 2.0 microarray platform. Nevertheless, important major discrepancies remain in expression data obtained from FFPE compared to fresh-frozen samples, prompting the need for appropriate data processing which could help to obtain more consistent results in downstream analyses. In a publicly available dataset of matched frozen and FFPE expression data, the performances of different normalization methods and specifically designed Chip Description Files (CDFs) were compared. The use of an alternative CDFs together with fRMA normalization significantly improved frozen-FFPE sample correlations, frozen-FFPE probeset correlations and agreement of differential analysis between different tumor subtypes. The relevance of our optimized data processing was assessed and validated using two independent datasets. In this study we demonstrated that an appropriate data processing can significantly improve the reliability of gene expression data derived from FFPE tissues using the standard Affymetrix platform. Tools for the implementation of our data processing algorithm are made publicly available at http://www.biocut.unito.it/cdf-ffpe/.	[Callari, Maurizio; Musella, Valeria; Cappelletti, Vera; Daidone, Maria Grazia] Fondaz IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Lembo, Antonio; Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Life Sci, Turin, Italy; [Bianchini, Giampaolo; Gianni, Luca] Univ Milan, Osped San Raffaele, Dept Med Oncol, I-20127 Milan, Italy; [Provero, Paolo] Univ Milan, Osped San Raffaele, Ctr Translat Genom & Bioinformat, I-20127 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Turin; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Daidone, MG (corresponding author), Fondaz IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	MariaGrazia.Daidone@istitutotumori.mi.it; paolo.provero@unito.it	Callari, Maurizio/AAF-7089-2019; Daidone, Maria Grazia/E-9232-2017; Provero, Paolo/AAC-1930-2019; Musella, Valeria/H-4458-2016; Cappelletti, Vera/B-9310-2017	Callari, Maurizio/0000-0001-5239-0918; Daidone, Maria Grazia/0000-0002-4786-1321; Musella, Valeria/0000-0001-9517-2670; Cappelletti, Vera/0000-0002-9709-0676; Bianchini, Giampaolo/0000-0002-6790-6267; GIANNI, LUCA/0000-0002-2372-9625	Italian Association for Cancer Research (AIRC) [IG4915, IG 10611, IG 9408]; Ministero della Salute (Progetto Oncologico di Medicina Molecolare: \ Tumori Femminili)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Progetto Oncologico di Medicina Molecolare: \ Tumori Femminili)	This work was supported by: the Italian Association for Cancer Research (AIRC) [IG4915 to LG], [IG 10611 to MGD] and [IG 9408 to PP] and the Ministero della Salute (Progetto Oncologico di Medicina Molecolare: vertical bar Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bianchini G, 2011, J CLIN ONCOL; Bianchini G, 2013, J CLIN ONCOL, V31; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Frei E, 2013, J CLIN PATHOL, V66, P956, DOI 10.1136/jclinpath-2013-201619; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianni L, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-S6-7; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Pardo PG, 2011, J CLIN ONCOL, V29; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Waldron L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-124; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164	32	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86511	10.1371/journal.pone.0086511	http://dx.doi.org/10.1371/journal.pone.0086511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489733	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000043
J	Chung, SD; Liu, SP; Li, HC; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Li, Hsien-Chang; Lin, Herng-Ching			Health Care Service Utilization among Patients with Bladder Pain Syndrome/Interstitial Cystitis in a Single Payer Healthcare System	PLOS ONE			English	Article							INTERSTITIAL CYSTITIS; POPULATION; PREVALENCE; WOMEN; SYMPTOMS	Background: This study aims to investigate the differences in the utilization of healthcare services between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and patients without using a population-based database in Taiwan. Methods: This study comprised of 350 patients with BPS/IC and 1,750 age-matched controls. Healthcare resource utilization was evaluated in the one-year follow-up period as follows: number of outpatient visits and inpatient days, and the mean costs of outpatient and inpatient treatment. A multivariate regression analysis was used to evaluate the relationship between BPS/IC and total costs of health care services. Results: For urological services, patients with BPS/IC had a significantly higher number of outpatient visits (2.5 vs. 0.2, p < 0.001) as well as significantly higher outpatient costs ($US166 vs. $US6.8, p < 0.001) than the controls. For non-urologic services, patients with BPS/IC had a significantly high number of outpatient visits (35.0 vs. 21.3, p < 0.001) as well as significantly higher outpatient cots ($US912 vs. $US675, p < 0.001) as compared to the controls. Overall, patients with BPS/IC had 174% more outpatient visits and 150% higher total costs than the controls. Multiple-regression-analyses also showed that the patients with BPS/IC had significantly higher total costs for all healthcare services than the controls. Conclusions: This study found that patients with BPS/IC have a significantly higher number of healthcare related visits, and have significantly higher healthcare related costs than age-matched controls. The high level of healthcare services utilization accrued with BPS/IC was not necessarily exclusive for BPS/IC, but may have also been associated with medical co-morbidities.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Li, Hsien-Chang; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Clemens JQ, 2008, UROLOGY, V71, P776, DOI 10.1016/j.urology.2007.11.154; CLEMENS JQ, 2006, J UROLOGY S, V175, P94; Driscoll A, 2001, J UROLOGY, V166, P2118, DOI 10.1016/S0022-5347(05)65517-6; Forrest John B, 2002, Rev Urol, V4 Suppl 1, pS44; Keller JJ, NEUROUROL U IN PRESS; Leppilahti M, 2002, J UROLOGY, V168, P139, DOI 10.1016/S0022-5347(05)64847-1; Metts JF, 2001, AM FAM PHYSICIAN, V64, P1199; Michael YL, 2000, J UROLOGY, V164, P423, DOI 10.1016/S0022-5347(05)67376-4; Parsons CL, 2002, UROLOGY, V60, P573, DOI 10.1016/S0090-4295(02)01829-0; Payne CK, 2007, J UROLOGY, V177, P2042, DOI 10.1016/j.juro.2007.01.124; Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95; Wu EQ, 2006, PHARMACOECONOMICS, V24, P55, DOI 10.2165/00019053-200624010-00005	12	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87522	10.1371/journal.pone.0087522	http://dx.doi.org/10.1371/journal.pone.0087522			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489932	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000157
J	Friedlander, AM; Obura, D; Aumeeruddy, R; Ballesteros, E; Church, J; Cebrian, E; Sala, E				Friedlander, Alan M.; Obura, David; Aumeeruddy, Riaz; Ballesteros, Enric; Church, Julie; Cebrian, Emma; Sala, Enric			Coexistence of Low Coral Cover and High Fish Biomass at Farquhar Atoll, Seychelles	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF FISHES; RESILIENCE; IMPACTS; COMMUNITIES; ISLANDS; ECOLOGY; SIZE	We report a reef ecosystem where corals may have lost their role as major reef engineering species but fish biomass and assemblage structure is comparable to unfished reefs elsewhere around the world. This scenario is based on an extensive assessment of the coral reefs of Farquhar Atoll, the most southern of the Seychelles Islands. Coral cover and overall benthic community condition at Farquhar was poor, likely due to a combination of limited habitat, localized upwelling, past coral bleaching, and cyclones. Farquhar Atoll harbors a relatively intact reef fish assemblage with very large biomass (3.2 t ha(-1)) reflecting natural ecological processes that are not influenced by fishing or other local anthropogenic factors. The most striking feature of the reef fish assemblage is the dominance by large groupers, snappers, and jacks with large (>1 m) potato cod (Epinephelus tukula) and marbled grouper (E. polyphekadion), commonly observed at many locations. Napoleon wrasse (Cheilinus undulatus) and bumphead parrotfish (Bolbometopon muricatum) are listed as endangered and vulnerable, respectively, but were frequently encountered at Farquhar. The high abundance and large sizes of parrotfishes at Farquhar also appears to regulate macroalgal abundance and enhance the dominance of crustose corallines, which are a necessary condition for maintenance of healthy reef communities. Overall fish biomass and biomass of large predators at Farquhar are substantially higher than other areas within the Seychelles, and are some of the highest recorded in the Indian Ocean. Remote islands like Farquhar Atoll with low human populations and limited fishing pressure offer ideal opportunities for understanding whether reefs can be resilient from global threats if local threats are minimized.	[Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Obura, David] Coastal Res & Dev Indian Ocean CORDIO, Mombasa, Kenya; [Aumeeruddy, Riaz] Isl Conservat Soc, Mahe, Seychelles; [Ballesteros, Enric; Cebrian, Emma; Sala, Enric] Ctr Estudis Avancats Blanes, Blanes, Spain; [Church, Julie] UniquEco Designs Ltd, Nairobi, Kenya; [Sala, Enric] Natl Geog Soc, Washington, DC USA	University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society	Friedlander, AM (corresponding author), Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	Cebrian, Emma/J-9640-2012	Cebrian, Emma/0000-0001-7588-0135	National Geographic Society; National Research Council of Spain	National Geographic Society(National Geographic Society); National Research Council of Spain	Funding for this work was provided by the National Geographic Society and the National Research Council of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Braithwaite C.J.R., 1971, S ZOOL SOC LOND, V28, P39; Clarke K., 2001, PRIMER V5 USER MANUA; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Froese R., 2012, FISHBASE; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, SCIENCE, V334, P1494, DOI 10.1126/science.334.6062.1494-b; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Jennings S, 2002, CORAL REEFS INDIAN O, P383; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kobayashi D. R., 2011, NOAATMNMFSPIFSC26; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Ludwig J. A., 1988, STAT ECOLOGY; MAPSTONE BD, 1998, GREAT BARRIER REEF M, V47; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Mumby PJ, 2013, CORAL REEFS, V32, P213, DOI 10.1007/s00338-012-0966-0; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2011, FRONT ECOL ENVIRON, V9, P94, DOI 10.1890/11.WB.002; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nageon de Lestang J, 1999, CASE STUDIES MANAGEM, P285; Naim Odile, 2000, P353; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Novozhilov AV, 1992, ATOLL RES B, V366, P1; Obura D, 2009, RESILIENCE ASSESSMEN; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Payet R, 2006, AMBIO, V35, P182, DOI 10.1579/0044-7447(2006)35[182:CCITSI]2.0.CO;2; PLUMMER PS, 1995, J AFR EARTH SCI, V20, P91, DOI 10.1016/0899-5362(95)00035-R; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett Morgan S., 2011, Diversity, V3, P424, DOI 10.3390/d3030424; Randall J. E, 1967, STUD TROP OCEANOGR U, V5, P665; Robinson J, 2008, B MAR SCI, V83, P415; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; STODDART D R, 1970, Atoll Research Bulletin, V136, P7; Zar JH, 1999, BIOSTATISTICAL ANAL	55	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87359	10.1371/journal.pone.0087359	http://dx.doi.org/10.1371/journal.pone.0087359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489903	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000137
J	Kim, DW; Lee, SA; Kim, H; Won, YS; Kim, BJ				Kim, Dong-Won; Lee, Seoung-Ae; Kim, Hong; Won, You-Sub; Kim, Bum-Joon			Naturally Occurring Mutations in the Nonstructural Region 5B of Hepatitis C Virus (HCV) from Treatment-Naive Korean Patients Chronically Infected with HCV Genotype 1b	PLOS ONE			English	Article							ALPHA-2A PLUS RIBAVIRIN; T-CELL RESPONSE; NS5B POLYMERASE; HEPATOCELLULAR-CARCINOMA; GENETIC-VARIATION; INTERFERON-ALPHA; VIRAL LOAD; COMBINATION; ASSOCIATION; THERAPY	The nonstructural 5B (NS5B) protein of the hepatitis C virus (HCV) with RNA-dependent RNA polymerase (RdRp) activity plays a pivotal role in viral replication. Therefore, monitoring of its naturally occurring mutations is very important for the development of antiviral therapies and vaccines. In the present study, mutations in the partial NS5B gene (492 bp) from 166 quasispecies of 15 genotype-1b (GT) treatment-naive Korean chronic patients were determined and mutation patterns and frequencies mainly focusing on the T cell epitope regions were evaluated. The mutation frequency within the CD8+ T cell epitopes was significantly higher than those outside the CD8+ T cell epitopes. Of note, the mutation frequency within predicted CD4+ T cell epitopes, a particular mutational hotspot in Korean patients was significantly higher than it was in patients from other areas, suggesting distinctive CD4+ T cell-mediated immune pressure against HCV infection in the Korean population. The mutation frequency in the NS5B region was positively correlated with patients with carrier-stage rather than progressive liver disease (chronic hepatitis, liver cirrhosis and hepatocellular carcinoma). Furthermore, the mutation frequency in four codons (Q309, A333, V338 and Q355) known to be related to the sustained virological response (SVR) and end-of treatment response (ETR) was also significantly higher in Korean patients than in patients from other areas. In conclusion, a high degree of mutation frequency in the HCV GT-1b NS5B region, particularly in the predicted CD4+ T cell epitopes, was found in Korean patients, suggesting the presence of distinctive CD4+ T cell pressure in the Korean population. This provides a likely explanation of why relatively high levels of SVR after a combined therapy of pegylated interferon (PEG-IFN) and ribavirin (RBV) in Korean chronic patients with GT-1b infections are observed.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Seoul, South Korea; Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci Microbiol & Immunol, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022; Kim, Bum Joon/J-2739-2012	Kim, Bum Joon/0000-0003-0085-6709; Kim, Hong/0000-0003-1383-6803	National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2013-005810]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013-005810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Ali L, 2010, J GEN VIROL, V91, P1931, DOI 10.1099/vir.0.018119-0; Blackard JT, 2010, J CLIN MICROBIOL, V48, P4256, DOI 10.1128/JCM.01613-10; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; BRUGUERA M, 1974, GUT, V15, P799, DOI 10.1136/gut.15.10.799; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chang KM, 2001, HEPATOLOGY, V33, P267, DOI 10.1053/jhep.2001.21162; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cheney IW, 2002, VIROLOGY, V297, P298, DOI 10.1006/viro.2002.1461; Chung HY, 2010, KOREAN J LAB MED, V30, P1, DOI 10.3343/kjlm.2010.30.1.1; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; DILELIO A, 1989, RADIOLOGY, V172, P389, DOI 10.1148/radiology.172.2.2526349; Ferrari E, 2008, J BIOL CHEM, V283, P33893, DOI 10.1074/jbc.M803094200; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hamano K, 2005, J GASTROEN HEPATOL, V20, P1401, DOI 10.1111/j.1440-1746.2005.04024.x; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Heo NY, 2013, CLIN MOL HEPATOL, V19, P60, DOI 10.3350/cmh.2013.19.1.60; Jaspe RC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-214; Kim DW, 2012, PLOS ONE, V7; Kobayashi K, 2005, CLIN EXP IMMUNOL, V141, P81, DOI 10.1111/j.1365-2249.2005.02018.x; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Liu Z, 2009, HEPATOLOGY, V50, P25, DOI 10.1002/hep.22987; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Ludmerer SW, 2005, ANTIMICROB AGENTS CH, V49, P2059, DOI 10.1128/AAC.49.5.2059-2069.2005; Lyoo K, 2011, J CLIN VIROL, V52, P363, DOI 10.1016/j.jcv.2011.08.006; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; Minton EJ, 1998, J INFECT DIS, V178, P39, DOI 10.1086/514258; Missiha S, 2007, AM J GASTROENTEROL, V102, P2181, DOI 10.1111/j.1572-0241.2007.01431.x; Mo HM, 2005, ANTIMICROB AGENTS CH, V49, P4305, DOI 10.1128/AAC.49.10.4305-4314.2005; Nakatani SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010150; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Neumann-Haefelin C, 2011, HEPATOLOGY, V54, P1157, DOI 10.1002/hep.24541; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Oh DJ, 2012, ANN LAB MED, V32, P210, DOI 10.3343/alm.2012.32.3.210; Pawlotsky JM, 2002, HEPATOLOGY, V36, pS65, DOI 10.1053/jhep.2002.36815; Plaza Z, 2011, J ANTIMICROB CHEMOTH, V66, P2838, DOI 10.1093/jac/dkr385; Puoti Claudio, 2004, Rom J Gastroenterol, V13, P329; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sinn DH, 2013, WORLD J GASTROENTERO, V19, P2256, DOI 10.3748/wjg.v19.i14.2256; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thio CL, 2001, J INFECT DIS, V184, P16, DOI 10.1086/321005; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uzicanin S, 2012, J MED VIROL, V84, P1571, DOI 10.1002/jmv.23361; van Asten L, 2004, J INFECT DIS, V189, P292, DOI 10.1086/380821; Watanabe K, 2005, J MED VIROL, V75, P504, DOI 10.1002/jmv.20301; Yan KK, 2008, WORLD J GASTROENTERO, V14, P3416, DOI 10.3748/wjg.14.3416; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87773	10.1371/journal.pone.0087773	http://dx.doi.org/10.1371/journal.pone.0087773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489961	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000178
J	Li, W; Teng, GJ; Tong, HF; Jiao, YM; Zhang, T; Chen, H; Wu, H				Li, Wei; Teng, Guangju; Tong, Hongfei; Jiao, Yanmei; Zhang, Tong; Chen, Hui; Wu, Hao			Study on Risk Factors for Severe Hand, Foot and Mouth Disease in China	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; ENTEROVIRUS 71; CEREBROSPINAL-FLUID; INFECTIONS; CHILDREN; CYTOKINES; FEATURES; THERAPY; TAIWAN	Background: Epidemics of HFMD are elevated every year globally, especially in mainland China. The disease now presents as an increasing threat to public health worldwide. Methods: Five hundred and seventy-one EV71-infected HFMD patients in Beijing You'an Hospital were grouped by disease severity: Mild (no severe complication) (n = 221), and Severe group (complicated with brainstem encephalitis (BE), and/or pulmonary edema (PE) (n = 350)). Clinical and laboratory findings and levels of 7 serum cytokines were analyzed. Results: Univariate analysis showed that (RR)> 26/min (p < 0.001), age, 4 yo (p = 0.001), GLU > 8.3 mmol/L (p = 0.008), CL < 98 mmol/L (p = 0.026), and WBC > 1.2x10(9)/L (p = 0.040) were associated with severe cases. Results of multivariate analysis indicated five independent risk factors (RR > 26/min (p < 0.001), Age, 4 yo (p < 0.001), GLU > 8.3 mmol/L (p = 0.011), LYM > 40% (p = 0.010), and ALT > 40 U/L (p = 0.045)). In addition to single-factor analysis, we further analyzed the use of different combinations of risk factors. "GLU > 8.3 and CL < 98 and RR > 26'' (confidence ration (CR) = 100%) is the top indicator, followed by "ALT > 40 and LYM > 40% and RR > 26 and Age, 4 yo'' (CR = 92.9%). Serum levels of IL-2, IL-4, IL-10, IFN gamma, GM-CSF, and TNF alpha were higher in severe cases than in mild cases. A new evaluation scoring system by scoring each risk factor 1 and independent risk factor 2 was developed for early identification of severe HFMD cases. Conclusions: Five independent risk factors, along with indicative combinations of risk factors, for severe cases were identified, and a scoring system was created to facilitate the use of indicators for early medical intervention.	[Li, Wei; Jiao, Yanmei; Zhang, Tong; Wu, Hao] Capital Med Univ, Ctr Infect Dis, Beijing Youan Hosp, Beijing, Peoples R China; [Teng, Guangju] 302 Mil Hosp China, Dept Noninfect Liver Disorders, Beijing, Peoples R China; [Tong, Hongfei] Wenzhou Med Coll, Affiliated Hosp 2, Dept Gen Surg, Wenzhou, Zhejiang, Peoples R China; [Chen, Hui] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital; Wenzhou Medical University; Capital Medical University	Chen, H (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	exjhww8@163.com; wuhao90000@gmail.com	Li, Wei/I-8060-2014; Zhang, Tong/HGC-1090-2022	Li, Wei/0000-0002-9991-7892; Chen, Hui/0000-0002-0048-0193	National Natural Science Foundation of China [81371332, 81161120423/H19]; Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006/003]; Beijing Key Laboratory [BZ0089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelve-five Project for Control and Prevention of Major Infectious Diseases; Beijing Key Laboratory	This work was supported by National Natural Science Foundation of China [81371332], National Natural Science Foundation of China [81161120423/H19], Twelve-five Project for Control and Prevention of Major Infectious Diseases [2012ZX10001-006/003], Beijing Key Laboratory [BZ0089]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE Y, 1994, IMMUNOL REV, V139, P5, DOI 10.1111/j.1600-065X.1994.tb00854.x; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Griffiths MJ, 2012, J INFECT DIS, V206, P881, DOI 10.1093/infdis/jis446; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Mao G, 2008, CHIN J INFECT DIS, V26, P3; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yu L, 2011, CHIN PEDIAT EMERG ME, V18, P2; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067430; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	22	39	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87603	10.1371/journal.pone.0087603	http://dx.doi.org/10.1371/journal.pone.0087603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489943	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000163
J	Maxim, L; van der Sluijs, JP				Maxim, Laura; van der Sluijs, Jeroen P.			Qualichem In Vivo: A Tool for Assessing the Quality of In Vivo Studies and Its Application for Bisphenol A	PLOS ONE			English	Article							DEVELOPMENTAL NEUROTOXICITY; UNCERTAINTY; IMPACT	In regulatory toxicology, quality assessment of in vivo studies is a critical step for assessing chemical risks. It is crucial for preserving public health studies that are considered suitable for regulating chemicals are robust. Current procedures for conducting quality assessments in safety agencies are not structured, clear or consistent. This leaves room for criticism about lack of transparency, subjective influence and the potential for insufficient protection provided by resulting safety standards. We propose a tool called "Qualichem in vivo'' that is designed to systematically and transparently assess the quality of in vivo studies used in chemical health risk assessment. We demonstrate its use here with 12 experts, using two controversial studies on Bisphenol A (BPA) that played an important role in BPA regulation in Europe. The results obtained with Qualichem contradict the quality assessments conducted by expert committees in safety agencies for both of these studies. Furthermore, they show that reliance on standardized guidelines to ensure scientific quality is only partially justified. Qualichem allows experts with different disciplinary backgrounds and professional experiences to express their individual and sometimes divergent views-an improvement over the current way of dealing with minority opinions. It provides a transparent framework for expressing an aggregated, multi-expert level of confidence in a study, and allows a simple graphical representation of how well the study integrates the best available scientific knowledge. Qualichem can be used to compare assessments of the same study by different health agencies, increasing transparency and trust in the work of expert committees. In addition, it may be used in systematic evaluation of in vivo studies submitted by industry in the dossiers that are required for compliance with the REACH Regulation. Qualichem provides a balanced, common framework for assessing the quality of studies that may or may not be following standardized guidelines.	[Maxim, Laura] CNRS, UPS 3088, Inst Commun Sci, Paris, France; [van der Sluijs, Jeroen P.] Univ Utrecht, Copernicus Inst, Utrecht, Netherlands	Centre National de la Recherche Scientifique (CNRS); Utrecht University	Maxim, L (corresponding author), CNRS, UPS 3088, Inst Commun Sci, Paris, France.	laura.maxim@iscc.cnrs.fr	van der Sluijs, Jeroen P/B-6302-2008; Maxim, Laura/F-4605-2019	van der Sluijs, Jeroen P/0000-0002-1346-5953; Maxim, Laura/0000-0001-9641-6649	French Ministry of Ecology	French Ministry of Ecology	This work has been funded by the French Ministry of Ecology in the framework of the PNRPE 2010 programme (URL: http://www.pnrpe.fr/), as part of the project "Toolkit for uncertainty and knowledge quality analysis of endocrine disruptors' risk assessments: the case study of Bisphenol A'' (DICO-Risk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151; ANSES (Agence Nationale de Securite Sanitaire Alimentation Environnement Travail), 2013, PERT END EV RISQ BIS, V1; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Beronius A, 2010, REPROD TOXICOL, V29, P132, DOI 10.1016/j.reprotox.2009.11.007; Brozek JL, 2011, ALLERGY, V66, P588, DOI 10.1111/j.1398-9995.2010.02530.x; Chateauraynaud F, 2011, DOSE TOUJOURS POISON; Craye M., 2005, INT J RISK ASSESSMEN, V5, P216, DOI DOI 10.1504/IJRAM.2005.007169; de Jong A, 2012, ENVIRON SCI POLICY, V16, P114, DOI 10.1016/j.envsci.2011.11.012; ECB, 2003, EUR UN RISK ASS REP, p[179, 214]; ECHA, 2011, GUID INF REQ CHEM SA; EFSA, 2010, EFSA J, V8, P116; EFSA, 2010, EFSA J, V8, P67; European Food Safety Authority, 2006, EFSA J, V2006, P1, DOI [DOI 10.2903/J.EFSA.2006.69R, DOI 10.2903/J.EFSA.2006.365]; Funtowicz S. O., 1990, UNCERTAINTY QUALITY; Hartung T, 2009, ALTEX-ALTERN TIEREXP, V26, P75; Hillier S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-23; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076; Kloprogge P, 2011, ENVIRON MODELL SOFTW, V26, P289, DOI 10.1016/j.envsoft.2009.06.009; Knol AB, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-19; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Makris SL, 2009, ENVIRON HEALTH PERSP, V117, P17, DOI 10.1289/ehp.11447; Maxim L, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014006; Maxim L, 2013, SCI PRECAUTIONARY PR, P401; Maxim L, 2011, ENVIRON SCI POLICY, V14, P482, DOI 10.1016/j.envsci.2011.01.003; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Noelle-Neumann E, 1986, SPIRAL SILENCE; OECD, 2000, OECD SER PRINC GOOD, V5; OECD, 2007, OECD GUID TEST CHEM; OECD, 2001, OECD GUID TEST CHEM; Organisation for Economic Co-operation and Development, 1998, OECD SER PRINC GOOD, V1; Ruden C, 2001, REGUL TOXICOL PHARM, V34, P3, DOI 10.1006/rtph.2001.1482; SCF, 2002, OP SCI COMM FOOD BIS, P7; Schneider K, 2009, TOXICOL LETT, V189, P138, DOI 10.1016/j.toxlet.2009.05.013; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Stump DG, 2009, DIETARY DEV NEUROTOX, V1; Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; Tyl RW, 2006, 80057 CAS BPA RTI IN; [United States Environmental Protection Agency Pesticides and Toxic Substances Office of Prevention], 1998, HLTH EFF TEST GUID; *US EPA, 1998, HLTH EFF TEST GUID O; van der Sluijs JP, 2007, ENVIRON MODELL SOFTW, V22, P590, DOI 10.1016/j.envsoft.2005.12.020; van der Sluijs JP, 2005, RISK ANAL, V25, P481, DOI 10.1111/j.1539-6924.2005.00604.x; Van der Sluijs JP, 2005, ENVIRON MONIT ASSESS, V105, P229, DOI 10.1007/s10661-005-3697-7; van der Sluijs JP, 2002, FUTURES, V34, P133, DOI 10.1016/S0016-3287(01)00051-9; Van Gijlswijk R, 2004, UNCERTAINTY ASSESSME; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; vom Saal FS, 2010, TOXICOL SCI, V115, P612, DOI 10.1093/toxsci/kfq048; Wandall B, 2007, ARCH TOXICOL, V81, P605, DOI 10.1007/s00204-007-0194-5	50	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87738	10.1371/journal.pone.0087738	http://dx.doi.org/10.1371/journal.pone.0087738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489958	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000175
J	Szalowska, E; van der Burg, B; Man, HY; Hendriksen, PJM; Peijnenburg, AACM				Szalowska, Ewa; van der Burg, Bart; Man, Hai-Yen; Hendriksen, Peter J. M.; Peijnenburg, Ad A. C. M.			Model Steatogenic Compounds (Amiodarone, Valproic Acid, and Tetracycline) Alter Lipid Metabolism by Different Mechanisms in Mouse Liver Slices	PLOS ONE			English	Article							GENE-EXPRESSION; RAT-LIVER; HEPATIC STEATOSIS; INDUCED CHOLESTASIS; OXIDATIVE STRESS; FATTY-ACIDS; DRUG; HEPATOCYTES; INDUCTION; MICE	Although drug induced steatosis represents a mild type of hepatotoxicity it can progress into more severe non-alcoholic steatohepatitis. Current models used for safety assessment in drug development and chemical risk assessment do not accurately predict steatosis in humans. Therefore, new models need to be developed to screen compounds for steatogenic properties. We have studied the usefulness of mouse precision-cut liver slices (PCLS) as an alternative to animal testing to gain more insight into the mechanisms involved in the steatogenesis. To this end, PCLS were incubated 24 h with the model steatogenic compounds: amiodarone (AMI), valproic acid (VA), and tetracycline (TET). Transcriptome analysis using DNA microarrays was used to identify genes and processes affected by these compounds. AMI and VA upregulated lipid metabolism, whereas processes associated with extracellular matrix remodelling and inflammation were downregulated. TET downregulated mitochondrial functions, lipid metabolism, and fibrosis. Furthermore, on the basis of the transcriptomics data it was hypothesized that all three compounds affect peroxisome proliferator activated-receptor (PPAR) signaling. Application of PPAR reporter assays classified AMI and VA as PPAR gamma and triple PPAR alpha/(beta/delta)/gamma agonist, respectively, whereas TET had no effect on any of the PPARs. Some of the differentially expressed genes were considered as potential candidate biomarkers to identify PPAR agonists (i.e. AMI and VA) or compounds impairing mitochondrial functions (i.e. TET). Finally, comparison of our findings with publicly available transcriptomics data showed that a number of processes altered in the mouse PCLS was also affected in mouse livers and human primary hepatocytes exposed to known PPAR agonists. Thus mouse PCLS are a valuable model to identify early mechanisms of action of compounds altering lipid metabolism.	[Szalowska, Ewa; Hendriksen, Peter J. M.; Peijnenburg, Ad A. C. M.] Univ Wageningen & Res Ctr, Cluster Bioassays & Toxicol, RIKILT Inst Food Safety, Wageningen, Netherlands; [van der Burg, Bart; Man, Hai-Yen] BDS BioDetect Syst, Amsterdam, Netherlands	Wageningen University & Research	Szalowska, E (corresponding author), Univ Wageningen & Res Ctr, Cluster Bioassays & Toxicol, RIKILT Inst Food Safety, Wageningen, Netherlands.	ewa.szalowska@wur.nl		Hendriksen, Peter/0000-0002-0951-3270	Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research; Netherlands Toxicogenomics Centre [05060510]	Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Toxicogenomics Centre	This work was supported by the Netherlands Genomics Initiative, the Netherlands Organisation for Scientific Research, and the Netherlands Toxicogenomics Centre (grant number 05060510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNATHY CO, 1992, P SOC EXP BIOL MED, V199, P54; Amacher DE, 2011, EXPERT OPIN DRUG MET, V7, P949, DOI 10.1517/17425255.2011.577740; Amacher DE, 1997, FUND APPL TOXICOL, V40, P256, DOI 10.1006/faat.1997.2389; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Antherieu S, 2013, HEPATOLOGY, V57, P1518, DOI 10.1002/hep.26160; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754; Cherkaoui-Malki M, 2012, CURR DRUG METAB, V13, P1412, DOI 10.2174/138920012803762765; Dandel M, 2010, TRANSPL IMMUNOL, V23, P93, DOI 10.1016/j.trim.2010.04.007; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; de Longueville F, 2003, TOXICOL SCI, V75, P378, DOI 10.1093/toxsci/kfg196; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durand J L, 1979, Adv Intern Med, V24, P97; Ernst MC, 2010, PHARMACOL RES, V62, P408, DOI 10.1016/j.phrs.2010.07.004; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513; FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377; Fujimura H, 2009, J APPL TOXICOL, V29, P356, DOI 10.1002/jat.1420; Furuno T, 2001, BIOCHEM PHARMACOL, V62, P1037, DOI 10.1016/S0006-2952(01)00745-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gijsbers L, 2013, J AGR FOOD CHEM, V61, P3419, DOI 10.1021/jf304790a; Gijsbers L, 2011, ANAL BIOCHEM, V414, P77, DOI 10.1016/j.ab.2011.02.032; Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261; Hirode M, 2008, TOXICOL APPL PHARM, V229, P290, DOI 10.1016/j.taap.2008.01.036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illsinger S, 2011, CLIN TRANSPLANT, V25, P584, DOI 10.1111/j.1399-0012.2010.01301.x; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Larrain S, 2012, CLIN LIVER DIS, V16, P525, DOI 10.1016/j.cld.2012.05.009; Letteron P, 1996, J HEPATOL, V24, P200, DOI 10.1016/S0168-8278(96)80030-4; McCarthy TC, 2004, J PHARMACOL EXP THER, V311, P864, DOI 10.1124/jpet.104.072785; Nakajima Y, 2004, DRUG METAB DISPOS, V32, P1383, DOI 10.1124/dmd.104.000661; Pessayre D, 1999, CELL BIOL TOXICOL, V15, P367, DOI 10.1023/A:1007649815992; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Rogue A, 2012, DRUG METAB DISPOS, V40, P151, DOI 10.1124/dmd.111.042028; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Shen C, 2009, TOXICOL APPL PHARM, V238, P178, DOI 10.1016/j.taap.2009.05.014; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; Spaniol M, 2001, J HEPATOL, V35, P628, DOI 10.1016/S0168-8278(01)00189-1; Staels B, 2013, HEPATOLOGY; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; TIMBRELL JA, 1980, J PHARMACOL EXP THER, V213, P364; van der Toorn M, 2007, FEBS J, V274, P3003, DOI 10.1111/j.1742-4658.2007.05827.x; Vassallo P, 2007, JAMA-J AM MED ASSOC, V298, P1312, DOI 10.1001/jama.298.11.1312; Videla LA, 2012, PPAR RES, V2012, DOI 10.1155/2012/107434; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Yin HQ, 2006, TOXICOL SCI, V94, P206, DOI 10.1093/toxsci/kfl078; Yu HY, 2009, TOXICOLOGY, V261, P112, DOI 10.1016/j.tox.2009.04.058	55	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86795	10.1371/journal.pone.0086795	http://dx.doi.org/10.1371/journal.pone.0086795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489787	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000070
J	Zhu, HL; Xi, Q; Liu, LY; Wang, JN; Gu, MJ				Zhu, Hongling; Xi, Qian; Liu, Lianyong; Wang, Jingnan; Gu, Mingjun			Quantitative Assessment of Common Genetic Variants on FOXE1 and Differentiated Thyroid Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; LOCI; POLYMORPHISMS; CONFIRMATION; CARCINOMA; PALATE; 14Q13; 9Q22	Forkhead box E1 encodes the transcription factor FOXE1 (or TTF-2), which together with Homeobox protein NKX2-1, PAX8 and HHEX, are pivotal proteins required for thyroid gland formation, differentiation and function. Recently, genome-wide association studies have identified FOXE1 as a thyroid cancer (TC) susceptibility gene in populations of European descent. After that, a number of studies reported that the rs965513, rs1867277, and rs71369530 polymorphism in FOXE1 has been implicated in TC risk. However, the causal variants remain unknown. To derive a more precise estimation of the relationship, a meta-analysis of 9,828 TC cases and 109,995 controls from 14 case-control studies was performed. Overall, significant results were observed for rs965513 (OR = 1.71, 95% CI: 1.59-1.85, P<10(-5)), rs1867277 (OR = 1.64, 95% CI: 1.51-1.78, P<10(-5)) and rs71369530 (OR = 2.01, 95% CI: 1.66-2.44, P<10(-5)) polymorphism. In the subgroup analysis by ethnicity, we found that rs965513 polymorphism confer high risk for Caucasians with per-allele OR of 1.80 (95% CI: 1.69-1.92, P<10(-5)) compared to East Asians of 1.35 (95% CI: 1.09-1.67, P = 0.006). There was strong evidence of heterogeneity, which largely disappeared after stratification by ethnicity. In the subgroup analysis by sample size, and study design, significantly increased risks were found for the polymorphism. In conclusion, this meta-analysis demonstrated that common variations of FOXE1 are a risk factor associated with increased TC susceptibility.	[Zhu, Hongling; Xi, Qian; Liu, Lianyong; Wang, Jingnan; Gu, Mingjun] Shanghai Pudong New Area Gongli Hosp, Dept Endocrine, Shanghai, Peoples R China		Gu, MJ (corresponding author), Shanghai Pudong New Area Gongli Hosp, Dept Endocrine, Shanghai, Peoples R China.	mingjun_gu@163.com			National Natural Science Foundation of China [81272722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81272722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bullock M, 2012, J CLIN ENDOCR METAB, V97, pE1814, DOI 10.1210/jc.2012-1456; Carre A, 2007, HUM GENET, V122, P467, DOI 10.1007/s00439-007-0420-5; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Damiola F, 2014, INT J CANCER, V134, P1659, DOI 10.1002/ijc.28483; Dathan N, 2002, DEV DYNAM, V224, P450, DOI 10.1002/dvdy.10118; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; DeLellis RA, 2004, PATHOLOGY GENETICS T, P320; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hrafnkelsson J, 2001, J MED GENET, V38, P189, DOI 10.1136/jmg.38.3.189; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Kallel R, 2010, CANCER BIOMARK, V8, P43, DOI 10.3233/DMA-2011-0824; Kohler A, 2013, J CLIN ENDOCR METAB, V98, pE1674, DOI 10.1210/jc.2013-1941; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Liyanarachchi S, 2013, THYROID, V23, P1532, DOI 10.1089/thy.2013.0102; Matsuse M, 2011, J MED GENET, V48, P645, DOI 10.1136/jmedgenet-2011-100063; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Parlato R, 2004, DEV BIOL, V276, P464, DOI 10.1016/j.ydbio.2004.08.048; Ruiz-Llorente S, 2007, CANCER RES, V67, P9561, DOI 10.1158/0008-5472.CAN-07-1638; Schneider AB, 2005, NAT CLIN PRACT ENDOC, V1, P82, DOI 10.1038/ncpendmet0022; Sequeira MJ, 2001, THYROID, V11, P995, DOI 10.1089/105072501753271662; Takahashi M, 2010, HUM MOL GENET, V19, P2516, DOI 10.1093/hmg/ddq123; Tomaz RA, 2012, CLIN ENDOCRINOL, V77, P926, DOI 10.1111/j.1365-2265.2012.04505.x; Wang YL, 2013, J MED GENET, V50, P689, DOI 10.1136/jmedgenet-2013-101687; Williams D, 2002, NAT REV CANCER, V2, P543, DOI 10.1038/nrc845; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Wu S, 2013, PLOS ONE, V8; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066865	40	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87332	10.1371/journal.pone.0087332	http://dx.doi.org/10.1371/journal.pone.0087332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489898	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000133
J	Hu, JY; Wang, GH; Liu, XT; Zhou, LN; Jiang, ML; Yang, L				Hu, Jinyue; Wang, Guihua; Liu, Xueting; Zhou, Lina; Jiang, Manli; Yang, Li			A20 Is Critical for the Induction of Pam3CSK4-Tolerance in Monocytic THP-1 Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; ENDOTOXIN-TOLERANCE; CROSS-TOLERANCE; IRAK-M; NEGATIVE REGULATOR; ENZYME A20; EXPERIMENTAL COLITIS; COMPLEX-FORMATION; UP-REGULATION	A20 functions to terminate Toll-like receptor (TLR)-induced immune response, and play important roles in the induction of lipopolysacchride (LPS)-tolerance. However, the molecular mechanism for Pam3CSK4-tolerance is uncertain. Here we report that TLR1/2 ligand Pam3CSK4 induced tolerance in monocytic THP-1 cells. The pre-treatment of THP-1 cells with Pam3CSK4 down-regulated the induction of pro-inflammatory cytokines induced by Pam3CSK4 re-stimulation. Pam3CSK4 pre-treatment also down-regulated the signaling transduction of JNK, p38 and NF-kappa B induced by Pam3CSK4 re-stimulation. The activation of TLR1/2 induced a rapid and robust up-regulation of A20, suggesting that A20 may contribute to the induction of Pam3CSK4-tolerance. This hypothesis was proved by the observation that the over-expression of A20 by gene transfer down-regulated Pam3CSK4-induced inflammatory responses, and the down-regulation of A20 by RNA interference inhibited the induction of tolerance. Moreover, LPS induced a significant up-regulation of A20, which contributed to the induction of cross-tolerance between LPS and Pam3CSK4. A20 was also induced by the treatment of THP-1 cells with TNF-alpha and IL-1 beta. The pre-treatment with TNF-alpha and IL-1 beta partly down-regulated Pam3CSK4-induced activation of MAPKs. Furthermore, pharmacologic inhibition of GSK3 signaling down-regulated Pam3CSK4-induced A20 expression, up-regulated Pam3CSK4-induced inflammatory responses, and partly reversed Pam3CSK4 pre-treatment-induced tolerance, suggesting that GSK3 is involved in TLR1/2-induced tolerance by up-regulation of A20 expression. Taken together, these results indicated that A20 is a critical regulator for TLR1/2-induced pro-inflammatory responses.	[Hu, Jinyue; Liu, Xueting; Jiang, Manli] Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Wang, Guihua] Changsha Cent Hosp, Ctr Canc, Changsha, Hunan, Peoples R China; [Zhou, Lina] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan, Hubei, Peoples R China; [Yang, Li] Changsha Cent Hosp, TB Res Ctr, Changsha, Hunan, Peoples R China	Wuhan University	Hu, JY (corresponding author), Changsha Cent Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China.	jinyueh@yahoo.com; YL7618@126.com			National Science and Technology Major Project [2013ZX10005004]	National Science and Technology Major Project	This work was supported by National Science and Technology Major Project (2013ZX10005004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; de Vos AF, 2009, J IMMUNOL, V183, P533, DOI 10.4049/jimmunol.0802189; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; Fernandez ED, 2002, CRIT CARE MED, V30, P165; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hofmann SR, 2012, CLIN IMMUNOL, V145, P69, DOI 10.1016/j.clim.2012.07.012; Hu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078832; Huang X, 2006, J IMMUNOL, V177, P548, DOI 10.4049/jimmunol.177.1.548; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lemaire LCJM, 1998, J CLIN IMMUNOL, V18, P414, DOI 10.1023/A:1023282706945; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu ZJ, 2008, J SURG RES, V150, P34, DOI 10.1016/j.jss.2007.12.759; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Rehani K, 2009, J IMMUNOL, V182, P547, DOI 10.4049/jimmunol.182.1.547; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen E, 2008, J CELL BIOCHEM, V104, P329, DOI 10.1002/jcb.21629; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Xiong YB, 2011, J BIOL CHEM, V286, P7905, DOI 10.1074/jbc.M110.182873; Yokota SI, 2008, FASEB J, V22, P74, DOI 10.1096/fj.07-8976com; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87528	10.1371/journal.pone.0087528	http://dx.doi.org/10.1371/journal.pone.0087528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489933	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000140
J	Keshavarz-Motamed, Z; Garcia, J; Gaillard, E; Capoulade, R; Le Ven, F; Cloutier, G; Kadem, L; Pibarot, P				Keshavarz-Motamed, Zahra; Garcia, Julio; Gaillard, Emmanuel; Capoulade, Romain; Le Ven, Florent; Cloutier, Guy; Kadem, Lyes; Pibarot, Philippe			Non-Invasive Determination of Left Ventricular Workload in Patients with Aortic Stenosis Using Magnetic Resonance Imaging and Doppler Echocardiography	PLOS ONE			English	Article							PARADOXICAL LOW-FLOW; VALVULOARTERIAL IMPEDANCE; EJECTION FRACTION; VALVE STENOSIS; PRESSURE; GRADIENT; QUANTIFICATION; HEART; LOAD; AFTERLOAD	Early detection and accurate estimation of aortic stenosis (AS) severity are the most important predictors of successful long-term outcomes in patients. Current clinical parameters used for evaluation of the AS severity have several limitations including flow dependency. Estimation of AS severity is specifically challenging in patients with low-flow and low transvalvular pressure gradient conditions. A proper diagnosis in these patients needs a comprehensive evaluation of the left ventricle (LV) hemodynamic loads. This study has two objectives: (1) developing a lumped-parameter model to describe the ventricular-valvular-arterial interaction and to estimate the LV stroke work (SW); (2) introducing and validating a new index, the normalized stroke work (N-SW), to assess the global hemodynamic load imposed on the LV. N-SW represents the global hemodynamic load that the LV faces for each unit volume of blood ejected. The model uses a limited number of parameters which all can be measured non-invasively using current clinical imaging modalities. The model was first validated by comparing its calculated flow waveforms with the ones measured using Cardiovascular Magnetic Resonance (CMR) in 49 patients and 8 controls. A very good correlation and concordance were found throughout the cycle (median root mean square: 12.21 mL/s) and between the peak values (r = 0.98; SEE = 0.001, p < 0.001). The model was then used to determine SW using the parameters measured with transthoracic Doppler-echocardiography (TTE) and CMR. N-SW showed very good correlations with a previously-validated index of global hemodynamic load, the valvular arterial impedance (Z(VA)), using data from both imaging modalities (TTE: r = 0.82, SEE = 0.01, p < 0.001; CMR: r = 0.74, SEE = 0.01, p < 0.001). Furthermore, unlike, N-SW was almost independent from variations in the flow rate. This study suggests that considering N-SW may provide incremental diagnostic and prognostic information, beyond what standard indices of stenosis severity and provide, particularly in patients with low LV outflow.	[Keshavarz-Motamed, Zahra; Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra; Gaillard, Emmanuel; Kadem, Lyes] Concordia Univ, Lab Cardiovasc Fluid Dynam Mech & Ind Engn, Montreal, PQ, Canada; [Garcia, Julio] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Garcia, Julio; Capoulade, Romain; Le Ven, Florent; Pibarot, Philippe] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada; Northwestern University; Laval University; Quebec Heart & Lung Institute; Universite de Montreal; Universite de Montreal	Keshavarz-Motamed, Z (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	zahra.keshavarz@crchum.qc.ca	Garcia, Julio/F-6305-2014; Flores, Julio Garcia/AAI-3938-2020; Pibarot, Philippe/ABD-5300-2021; Capoulade, Romain/A-3966-2019; Garcia, Julio/AAF-7659-2020	Garcia, Julio/0000-0001-9528-8155; Flores, Julio Garcia/0000-0001-9528-8155; Capoulade, Romain/0000-0002-7233-7409; Le Ven, Florent/0000-0003-0555-1816	Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT)	Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT)	Dr. Pibarot is the director of the Canada Research Chair in Valvular Heart Diseases, Canadian Institutes of Health Research, Ottawa, Ontario, Canada. Dr. Keshavarz-Motamed was supported by a Fonds de la Recherche du Quebec postdoctoral Grant (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Bonow RO, 2008, CIRCULATION, V2008, p[118, e523], DOI DOI 10.1161/CIRCULATI0NAHA.108.190748; Braunwald E., 2001, VALVULAR HEART DIS, P1643; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1; Cawley PJ, 2009, CIRCULATION, V119, P468, DOI 10.1161/CIRCULATIONAHA.107.742486; Chan KL, 2003, J AM COLL CARDIOL, V42, P593, DOI 10.1016/S0735-1097(03)00786-1; Dumesnil JG, 2010, EUR HEART J, V31, P281, DOI 10.1093/eurheartj/ehp361; Garcia D, 2005, J BIOMECH, V38, P1303, DOI 10.1016/j.jbiomech.2004.06.018; Garcia D, 2006, WILEY ENCY BIOMEDICA, P1; Garcia J, 2013, EUR HEART J CARDIOVA, P1; Garcia J, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-23; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Hachicha Z, 2007, CIRCULATION, V115, P2856, DOI 10.1161/CIRCULATIONAHA.106.668681; Hachicha Z, 2009, J AM COLL CARDIOL, V54, P1003, DOI 10.1016/j.jacc.2009.04.079; Hung J, 2009, JASE, V22, P1; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Lancellotti P, 2011, EUR J ECHOCARDIOGR, V12, P354, DOI 10.1093/ejechocard/jer044; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Omran H, 2003, LANCET, V361, P1241, DOI 10.1016/S0140-6736(03)12978-9; Page A, 2010, J AM COLL CARDIOL, V55, P1867, DOI 10.1016/j.jacc.2009.11.083; Pibarot P, 2012, J AM COLL CARDIOL, V60, P1845, DOI 10.1016/j.jacc.2012.06.051; Pibarot P, 2012, J AM COLL CARDIOL, V60, P169, DOI 10.1016/j.jacc.2011.11.078; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rieck AE, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-43; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH424, DOI 10.1152/ajpheart.1999.276.2.H424; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; Yap SC, 2007, J CARDIOVASC MAGN R, V9, P899, DOI 10.1080/10976640701693717	31	23	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86793	10.1371/journal.pone.0086793	http://dx.doi.org/10.1371/journal.pone.0086793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489786	Green Published, gold			2022-12-27	WOS:000330510000080
J	Liu, GZ; Li, XL; Jin, SX; Liu, XY; Zhu, LF; Nie, YC; Zhang, XL				Liu, Guanze; Li, Xuelin; Jin, Shuangxia; Liu, Xuyan; Zhu, Longfu; Nie, Yichun; Zhang, Xianlong			Overexpression of Rice NAC Gene SNAC1 Improves Drought and Salt Tolerance by Enhancing Root Development and Reducing Transpiration Rate in Transgenic Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM-L; TRANSCRIPTION FACTOR; STRESS TOLERANCE; GRAIN-YIELD; FUNCTIONAL-ANALYSIS; ARABIDOPSIS; PLANTS; IDENTIFICATION; EXPRESSION; RESISTANCE	The SNAC1 gene belongs to the stress-related NAC superfamily of transcription factors. It was identified from rice and overexpressed in cotton cultivar YZ1 by Agrobacterium tumefaciens-mediated transformation. SNAC1-overexpressing cotton plants showed more vigorous growth, especially in terms of root development, than the wild-type plants in the presence of 250 mM NaCl under hydroponic growth conditions. The content of proline was enhanced but the MDA content was decreased in the transgenic cotton seedlings under drought and salt treatments compared to the wild-type. Furthermore, SNAC1-overexpressing cotton plants also displayed significantly improved tolerance to both drought and salt stresses in the greenhouse. The performances of the SNAC1-overexpressing lines under drought and salt stress were significantly better than those of the wild-type in terms of the boll number. During the drought and salt treatments, the transpiration rate of transgenic plants significantly decreased in comparison to the wild-type, but the photosynthesis rate maintained the same at the flowering stage in the transgenic plants. These results suggested that overexpression of SNAC1 improve more tolerance to drought and salt in cotton through enhanced root development and reduced transpiration rates.	[Liu, Guanze; Jin, Shuangxia; Liu, Xuyan; Zhu, Longfu; Nie, Yichun; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Liu, Guanze] Yunnan Agr Univ, Coll Tobacco Sci, Kunming, Yunnan, Peoples R China; [Li, Xuelin] Henan Univ Sci & Technol, Coll Agr, Luoyang, Henan, Peoples R China	Huazhong Agricultural University; Yunnan Agricultural University; Henan University of Science & Technology	Zhang, XL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	xlzhang@mail.hzau.edu.cn		Zhang, Xianlong/0000-0002-7703-524X; Jin, Shuangxia/0000-0002-1495-9154	National High-Tech Program of China [2013AA102601-4]; Ministry of Agriculture of China [2013ZX08005-004]	National High-Tech Program of China(National High Technology Research and Development Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the National High-Tech Program of China (2013AA102601-4) and the project from Ministry of Agriculture of China (2013ZX08005-004). The funders had no role in study design, data cellection and analysis, decision to publish or preparation of the manuscript.	Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Jin S, 2006, BIOL PLANTARUM, V50, P519, DOI 10.1007/s10535-006-0082-5; Jin SX, 2005, PLANT CELL TISS ORG, V81, P229, DOI 10.1007/s11240-004-5209-9; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Liu GZ, 2012, PLANT CELL TISS ORG, V110, P261, DOI 10.1007/s11240-012-0148-3; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Meng CM, 2009, PLANT SCI, V176, P352, DOI 10.1016/j.plantsci.2008.12.003; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Peng H, 2009, PLANT PHYSIOL BIOCH, V47, P1037, DOI 10.1016/j.plaphy.2009.09.002; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; STEWART JMD, 1977, PLANTA, V137, P113, DOI 10.1007/BF00387547; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xue GP, 2011, MOL PLANT, V4, P697, DOI 10.1093/mp/ssr013; Yan JQ, 2004, PLANT CELL PHYSIOL, V45, P1007, DOI 10.1093/pcp/pch115; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Yokotani N, 2009, PLANTA, V229, P1065, DOI 10.1007/s00425-009-0895-5; You J, 2013, J EXP BOT, V64, P569, DOI 10.1093/jxb/ers349; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	33	144	174	5	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86895	10.1371/journal.pone.0086895	http://dx.doi.org/10.1371/journal.pone.0086895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489802	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000087
J	Sansone, A; Hassenklover, T; Syed, AS; Korsching, SI; Manzini, I				Sansone, Alfredo; Hassenkloever, Thomas; Syed, Adnan S.; Korsching, Sigrun I.; Manzini, Ivan			Phospholipase C and Diacylglycerol Mediate Olfactory Responses to Amino Acids in the Main Olfactory Epithelium of an Amphibian	PLOS ONE			English	Article							XENOPUS-LAEVIS TADPOLES; RECEPTOR POTENTIAL CHANNEL; SIGNAL-TRANSDUCTION; ODORANT RECEPTOR; VOMERONASAL NEURONS; SENSORY NEURONS; SYSTEM; TRPC2; ORGAN; ORGANIZATION	The semi-aquatic lifestyle of amphibians represents a unique opportunity to study the molecular driving forces involved in the transition of aquatic to terrestrial olfaction in vertebrates. Most amphibians have anatomically segregated main and vomeronasal olfactory systems, but at the cellular and molecular level the segregation differs from that found in mammals. We have recently shown that amino acid responses in the main olfactory epithelium (MOE) of larval Xenopus laevis segregate into a lateral and a medial processing stream, and that the former is part of a vomeronasal type 2 receptor expression zone in the MOE. We hypothesized that the lateral amino acid responses might be mediated via a vomeronasal-like transduction machinery. Here we report that amino acid-responsive receptor neurons in the lateral MOE employ a phospholipase C (PLC) and diacylglycerol-mediated transduction cascade that is independent of Ca2+ store depletion. Furthermore, we found that putative transient receptor potential (TRP) channel blockers inhibit most amino acid-evoked responses in the lateral MOE, suggesting that ion channels belonging to the TRP family may be involved in the signaling pathway. Our data show, for the first time, a widespread PLC-and diacylglycerol-dependent transduction cascade in the MOE of a vertebrate already possessing a vomeronasal organ.	[Sansone, Alfredo; Hassenkloever, Thomas; Manzini, Ivan] Univ Gottingen, Inst Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany; [Syed, Adnan S.; Korsching, Sigrun I.] Univ Cologne, Inst Genet, Cologne, Germany; [Hassenkloever, Thomas; Manzini, Ivan] Univ Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany	University of Gottingen; University of Cologne; University of Gottingen	Manzini, I (corresponding author), Univ Gottingen, Inst Neurophysiol & Cellular Biophys, D-37073 Gottingen, Germany.	imanzin@gwdg.de	Manzini, Ivan/V-4545-2019; Manzini, Ivan/F-8927-2015	Manzini, Ivan/0000-0002-3575-9637; Manzini, Ivan/0000-0002-3575-9637; Sansone, Alfredo/0000-0002-1197-7322; Hassenklover, Thomas/0000-0002-9895-1263	DFG; Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain	DFG(German Research Foundation (DFG)); Cluster of Excellence; DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was supported by DFG Schwerpunktprogramm 1392 (I. M. and S. I. K.; URL: http://cms.uni-konstanz.de/spp/) and Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (I. M.; URL: http://www.cmpb.uni-goettingen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brann JH, 2002, J NEUROCHEM, V83, P1452, DOI 10.1046/j.1471-4159.2002.01266.x; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Delay RJ, 2002, CHEM SENSES, V27, P673, DOI 10.1093/chemse/27.8.673; DeMaria S, 2013, J NEUROSCI, V33, P15235, DOI 10.1523/JNEUROSCI.2339-13.2013; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gliem S, 2013, CELL MOL LIFE SCI, V70, P1965, DOI 10.1007/s00018-012-1226-8; Gonzalez A, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00130; Hagino-Yamagishi K, 2004, J COMP NEUROL, V472, P246, DOI 10.1002/cne.20073; Hamdani EH, 2007, PROG NEUROBIOL, V82, P80, DOI 10.1016/j.pneurobio.2007.02.007; Hansen A, 1998, J COMP NEUROL, V398, P273, DOI 10.1002/(SICI)1096-9861(19980824)398:2<273::AID-CNE8>3.0.CO;2-Y; Hansen A, 2003, J NEUROSCI, V23, P9328; Hassenklover T, 2008, GLIA, V56, P1614, DOI 10.1002/glia.20714; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Inamura K, 1997, NEUROSCI LETT, V233, P129, DOI 10.1016/S0304-3940(97)00655-1; Junek S, 2009, BIOPHYS J, V96, P3801, DOI 10.1016/j.bpj.2008.12.3962; Kuang DH, 2003, J BIOL CHEM, V278, P42551, DOI 10.1074/jbc.M307120200; LO YH, 1994, CHEM SENSES, V19, P371, DOI 10.1093/chemse/19.5.371; LO YH, 1993, BIOCHEMISTRY-US, V32, P12358, DOI 10.1021/bi00097a012; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Ma L, 1998, J NEUROPHYSIOL, V79, P1183, DOI 10.1152/jn.1998.79.3.1183; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V551, P115, DOI 10.1113/jphysiol.2003.043059; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiss JO, 1997, J NEUROBIOL, V32, P213, DOI 10.1002/(SICI)1097-4695(199702)32:2<213::AID-NEU6>3.0.CO;2-B; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; Spehr M, 2002, J NEUROSCI, V22, P8429; Syed AS, 2013, P NATL ACAD SCI USA, V110, P7714, DOI 10.1073/pnas.1302088110; Taniguchi K, 2011, J VET MED SCI, V73, P139, DOI 10.1292/jvms.10-0316; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Zhang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1253, DOI 10.1152/ajpcell.00271.2009; Zufall F, 2005, PFLUG ARCH EUR J PHY, V451, P61, DOI 10.1007/s00424-005-1432-4	36	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87721	10.1371/journal.pone.0087721	http://dx.doi.org/10.1371/journal.pone.0087721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489954	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000146
J	Tebben, J; Guest, JR; Sin, TM; Steinberg, PD; Harder, T				Tebben, Jan; Guest, James R.; Sin, Tsai M.; Steinberg, Peter D.; Harder, Tilmann			Corals Like It Waxed: Paraffin-Based Antifouling Technology Enhances Coral Spat Survival	PLOS ONE			English	Article							EARLY POSTSETTLEMENT MORTALITY; PHASE-SHIFTS; SCLERACTINIAN CORALS; MASS-CULTURE; RECRUITMENT; SETTLEMENT; ALGAE; REEFS; GROWTH; COMPETITION	The early post-settlement stage is the most sensitive during the life history of reef building corals. However, few studies have examined the factors that influence coral mortality during this period. Here, the impact of fouling on the survival of newly settled coral spat of Acropora millepora was investigated by manipulating the extent of fouling cover on settlement tiles using non-toxic, wax antifouling coatings. Survival of spat on coated tiles was double that on control tiles. Moreover, there was a significant negative correlation between percentage cover of fouling and spat survival across all tiles types, suggesting that fouling in direct proximity to settled corals has detrimental effects on early post-settlement survival. While previous studies have shown that increased fouling negatively affects coral larval settlement and health of juvenile and adult corals, to the best of our knowledge, this is the first study to show a direct relationship between fouling and early post-settlement survival for a broadcast spawning scleractinian coral. The negative effects of fouling on this sensitive life history stage may become more pronounced in the future as coastal eutrophication increases. Our results further suggest that targeted seeding of coral spat on artificial surfaces in combination with fouling control could prove useful to improve the efficiency of sexual reproduction-based coral propagation for reef rehabilitation.	[Tebben, Jan; Guest, James R.; Steinberg, Peter D.; Harder, Tilmann] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Guest, James R.; Steinberg, Peter D.] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Singapore 639798, Singapore; [Sin, Tsai M.] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tebben, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	jan.tebben@unsw.edu.au	Harder, Tilmann/B-6861-2008; Tebben, Jan/ABD-2247-2020; Guest, James/D-5179-2011	Harder, Tilmann/0000-0003-3173-6806; Tebben, Jan/0000-0002-2780-2236; Guest, James/0000-0002-9714-9009; Steinberg, Peter/0000-0002-1781-0726	Centre for Marine Bio-Innovation (Sydney); Advanced Environmental Biotechnology Centre (Singapore); Singapore National Parks Board	Centre for Marine Bio-Innovation (Sydney); Advanced Environmental Biotechnology Centre (Singapore); Singapore National Parks Board	The project work was partly funded by the Centre for Marine Bio-Innovation (Sydney), the Advanced Environmental Biotechnology Centre (Singapore) and a research grant from the Singapore National Parks Board awarded to JR Guest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida E, 2007, PROG ORG COAT, V59, P2, DOI 10.1016/j.porgcoat.2007.01.017; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BAK RPM, 1984, OECOLOGIA, V63, P194, DOI 10.1007/BF00379877; Baria MVB, 2010, J EXP MAR BIOL ECOL, V394, P149, DOI 10.1016/j.jembe.2010.08.003; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; CHORNESKY EA, 1983, BIOL BULL, V165, P569, DOI 10.2307/1541466; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; DALBY JE, 1992, MAR ECOL PROG SER, V80, P221, DOI 10.3354/meps080221; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Den Hartog JC, 1977, P 3 INT COR REEF S B, V1; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Edwards AJ, 2010, REEF REHABILITATION; Epstein N, 2001, RESTOR ECOL, V9, P432, DOI 10.1046/j.1526-100X.2001.94012.x; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guest J., 2010, REEF REHABILITATION; Guest JR, 2005, CORAL REEFS, V24, P112, DOI 10.1007/s00338-004-0433-7; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hatta M., 2004, MANUAL RESTORATION R, P14; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Heyward AJ, 2002, MAR ECOL PROG SER, V230, P113, DOI 10.3354/meps230113; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hoipkemeier-Wilson L, 2004, BIOFOULING, V20, P53, DOI 10.1080/08927010410001662689; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kavanagh CJ, 2003, BIOFOULING, V19, P381, DOI 10.1080/08927010310001623296; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Lee E, 2013, STAT METHODS SURVIVA; Linares C, 2012, MAR ECOL PROG SER, V452, P81, DOI 10.3354/meps09586; Maida M, 2001, MAR ECOL-P S Z N I, V22, P397, DOI 10.1046/j.1439-0485.2001.01709.x; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Nugues MM, 2006, CORAL REEFS, V25, P585, DOI 10.1007/s00338-006-0147-0; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Omori M, 2005, CORAL REEFS, V24, P563, DOI 10.1007/s00338-005-0030-4; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Shafir S, 2009, J EXP MAR BIOL ECOL, V368, P124, DOI 10.1016/j.jembe.2008.08.017; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SR, 1992, AM ZOOL, V32, P663; Steele MA, 2002, ECOLOGY, V83, P1076, DOI 10.1890/0012-9658(2002)083[1076:EPPOTR]2.0.CO;2; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Truby K, 2000, BIOFOULING, V15, P141, DOI 10.1080/08927010009386305; Vermeij MJA, 2009, OECOLOGIA, V159, P325, DOI 10.1007/s00442-008-1223-7; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Wilson J, 2005, CORAL REEFS, V24, P418, DOI 10.1007/s00338-005-0033-1; Zar J. H., 1996, BIOSTATISTICAL ANAL	63	13	13	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87545	10.1371/journal.pone.0087545	http://dx.doi.org/10.1371/journal.pone.0087545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489936	Green Published, gold			2022-12-27	WOS:000330510000143
J	Wolfe, JD; Johnson, MD; Ralph, CJ				Wolfe, Jared D.; Johnson, Matthew D.; Ralph, C. John			Do Birds Select Habitat or Food Resources? Nearctic-Neotropic Migrants in Northeastern Costa Rica	PLOS ONE			English	Article							FOREST; AVAILABILITY; EVOLUTION; MIGRATION; PATTERNS; WARBLERS; COLOR	Nearctic-neotropic migrant birds need to replenish energy reserves during stopover periods to successfully complete their semiannual movements. In this study we used linear models to examine the habitat use of 11 migrant species in northeastern Costa Rica to better understand the influence of food and structural resources on the presence of birds during stopover periods. Our models indicated that frugivorous migrants primarily used food abundance, while insectivorous migrants chiefly used vegetation structure as cues for habitat use during stopover. In addition to habitat use models, we documented fruiting plant phenology and found a general relationship between migrant arrival and the timing of ripe fruit availability. Our results suggest that insectivorous migrants probably rely on structural features when using habitat because it may be inherently difficult to assess cryptic-arthropod availability during a short period of time in a novel habitat, such as stopover periods.	[Wolfe, Jared D.] Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA; [Wolfe, Jared D.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Wolfe, Jared D.; Johnson, Matthew D.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Ralph, C. John] US Forest Serv, Redwood Sci Lab, USDA, Arcata, CA USA; [Ralph, C. John] Klamath Bird Observ, Ashland, OR USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; California State University System; California State Polytechnic University, Humboldt; United States Department of Agriculture (USDA); United States Forest Service	Wolfe, JD (corresponding author), Louisiana State Univ Agr Ctr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA.	jwolfe5@lsu.edu		Wolfe, Jared/0000-0001-5575-086X	United States Department of Agriculture Forest Service's Redwood Sciences Laboratory; Klamath Bird Observatory; United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship; Stanley Harris Scholarship	United States Department of Agriculture Forest Service's Redwood Sciences Laboratory; Klamath Bird Observatory; United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship; Stanley Harris Scholarship	This project was funded in part by United States Department of Agriculture Forest Service's Redwood Sciences Laboratory, Klamath Bird Observatory, United States Fish and Wildlife Service Richard J. Guadagno Memorial Scholarship and the Stanley Harris Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BLAKE JG, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P257; Bond AB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI 10.1146/annurev.ecolsys.38.091206.095728; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burnham K. P., 1998, MODEL SELECTION INFE; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; Chernetsov N, 2006, J ORNITHOL, V147, P185, DOI 10.1007/s10336-006-0064-6; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; Holdridge LR, 1987, ECOLOGIA BASADA ZONA; Janzen DH, 1983, COSTA RICAN NATURAL; Johnson MD, 2000, J FIELD ORNITHOL, V71, P88, DOI 10.1648/0273-8570-71.1.88; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Johnson MD, 2000, ENTOMOL NEWS, V111, P270; LEFEBVRE G, 1992, WILSON BULL, V104, P400; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; LOISELLE BA, 1994, CONDOR, V96, P368, DOI 10.2307/1369321; Martin T.E., 1985, Journal of Tropical Ecology, V1, P157; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; McGrath LJ, 2009, J ANIM ECOL, V78, P22, DOI 10.1111/j.1365-2656.2008.01464.x; Morton E.S., 1980, P437; Ogden LJE, 2013, AUK, V130, P98, DOI 10.1525/auk.2012.11229; Parrish JD, 2000, STUD AVIAN BIOL-SER, P53; Parrish JD, 1997, CONDOR, V99, P681, DOI 10.2307/1370480; Poulin B, 1996, AUK, V113, P277, DOI 10.2307/4088894; POWELL GVN, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P287; R Development Core Team, 2010, R LANG ENV STAT COMP; Sapir N, 2004, NATURWISSENSCHAFTEN, V91, P544, DOI 10.1007/s00114-004-0564-2; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Seewagen CL, 2010, ACTA OECOL, V36, P484, DOI 10.1016/j.actao.2010.06.005; Sherry Thomas W., 2005, P414; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; SLUD PAUL, 1964, BULL AMER MUS NATUR HIST, V128, P1; Tietz JR, 2007, CONDOR, V109, P795, DOI 10.1650/0010-5422(2007)109[795:SEAHSO]2.0.CO;2; Willis E.O., 1980, P205; WILLSON MF, 1990, AM NAT, V136, P790, DOI 10.1086/285132; Wolfe Jared D., 2009, Journal of Caribbean Ornithology, V22, P37; Wolfe JD, 2009, AUK, V126, P809, DOI 10.1525/auk.2009.08018	41	23	27	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86221	10.1371/journal.pone.0086221	http://dx.doi.org/10.1371/journal.pone.0086221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489701	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000036
J	Hermans, M; Schrauwen, B; Bienstman, P; Dambre, J				Hermans, Michiel; Schrauwen, Benjamin; Bienstman, Peter; Dambre, Joni			Automated Design of Complex Dynamic Systems	PLOS ONE			English	Article							ROBOTS	Several fields of study are concerned with uniting the concept of computation with that of the design of physical systems. For example, a recent trend in robotics is to design robots in such a way that they require a minimal control effort. Another example is found in the domain of photonics, where recent efforts try to benefit directly from the complex nonlinear dynamics to achieve more efficient signal processing. The underlying goal of these and similar research efforts is to internalize a large part of the necessary computations within the physical system itself by exploiting its inherent non-linear dynamics. This, however, often requires the optimization of large numbers of system parameters, related to both the system's structure as well as its material properties. In addition, many of these parameters are subject to fabrication variability or to variations through time. In this paper we apply a machine learning algorithm to optimize physical dynamic systems. We show that such algorithms, which are normally applied on abstract computational entities, can be extended to the field of differential equations and used to optimize an associated set of parameters which determine their behavior. We show that machine learning training methodologies are highly useful in designing robust systems, and we provide a set of both simple and complex examples using models of physical dynamical systems. Interestingly, the derived optimization method is intimately related to direct collocation a method known in the field of optimal control. Our work suggests that the application domains of both machine learning and optimal control have a largely unexplored overlapping area which envelopes a novel design methodology of smart and highly complex physical systems.	[Hermans, Michiel; Schrauwen, Benjamin; Dambre, Joni] Univ Ghent, ELIS Dept, B-9000 Ghent, Belgium; [Bienstman, Peter] Univ Ghent, INTEC Dept, B-9000 Ghent, Belgium	Ghent University; Ghent University	Hermans, M (corresponding author), Univ Ghent, ELIS Dept, B-9000 Ghent, Belgium.	michiel.hermans@ugent.be	Dambre, Joni/C-2926-2013	Dambre, Joni/0000-0002-9373-1210	interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office; ERC	interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office; ERC(European Research Council (ERC)European Commission)	This work is supported by the interuniversity attraction pole (IAP) Photonics@be of the Belgian Science Policy Office and the ERC NaResCo Starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A., 2005, REACTION DIFFUSION C; AGRAWAL GP, 1989, IEEE J QUANTUM ELECT, V25, P2297, DOI 10.1109/3.42059; [Anonymous], 2007, BODY SHAPES WAY WE T; Arena P, 2004, IEEE T SYST MAN CY B, V34, P1823, DOI 10.1109/TSMCB.2004.828593; Becker R, 2000, SIAM J CONTROL OPTIM, V39, P113, DOI 10.1137/S0363012999351097; Bertsekas DP, 1995, DYNAMIC PROGRAMMING; Boltyanskii VG, 1960, THEORY OPTIMAL PROCE; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Brunner D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2368; Dale K, 2010, ARTIF LIFE, V16, P1, DOI 10.1162/artl.2009.16.1.16100; DOYA K, 1992, 1992 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-6, P2777, DOI 10.1109/ISCAS.1992.230622; Fiers M, 2012, J OPT SOC AM B, V29, P896, DOI 10.1364/JOSAB.29.000896; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hawkes PW, 1966, QUADRUPOLE OPTICS; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Larger L, 2012, OPT EXPRESS, V20, P3241, DOI 10.1364/OE.20.003241; LeCun Y., 1988, P 1988 CONNECTIONIST, DOI DOI 10.3168/JDS.S0022-0302(88)79586-7; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; Liu L, 2010, NAT PHOTONICS, V4, P182, DOI 10.1038/NPHOTON.2009.268; Mozer M.C., 1995, BACKPROPAGATION THEO, P137; Oden T, 2014, COMPUTATIONAL SCI 3; OLSSON NA, 1989, J LIGHTWAVE TECHNOL, V7, P1071, DOI 10.1109/50.29634; Paquot Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00287; Paul C, 2006, IEEE T ROBOT, V22, P944, DOI 10.1109/TRO.2006.878980; Pearlmutter BA, 1989, NEURAL COMPUT, V1, P263, DOI 10.1162/neco.1989.1.2.263; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Robinson A.J, 1987, CUEDFINFENGTR1; Rumelhart D. E., 1986, LEARNING INTERNAL RE; Shinya A, 2006, OPT EXPRESS, V14, P1230, DOI 10.1364/OE.14.001230; Sutskever I., 2011, P 28 INT C MACH LEAR; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vandoorne K, 2008, OPT EXPRESS, V16, P11182, DOI 10.1364/OE.16.011182; Vandoorne K, 2011, IEEE T NEURAL NETWOR, V22, P1469, DOI 10.1109/TNN.2011.2161771; Vinh NX, 1981, OPTIMAL TRAJECTORIES; von Neumann J., 1951, GEN LOGICAL THEORY A; Werbos P.J., 1994, ROOTS BACKPROPAGATIO, V1; Werbos P.J., 2006, AUTOMATIC DIFFERENTI, P15; WERBOS PJ, 1988, NEURAL NETWORKS, V1, P339, DOI 10.1016/0893-6080(88)90007-X; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270	42	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86696	10.1371/journal.pone.0086696	http://dx.doi.org/10.1371/journal.pone.0086696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497969	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900035
J	Hosokawa, K; Ohnishi, T; Sameshima, H; Miura, N; Koide, T; Maruyama, I; Tanaka, KA				Hosokawa, Kazuya; Ohnishi, Tomoko; Sameshima, Hisayo; Miura, Naoki; Koide, Takehiko; Maruyama, Ikuro; Tanaka, Kenichi A.			Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; PHASE-II TRIAL; DOUBLE-BLIND; RIVAROXABAN; DABIGATRAN; ANTICOAGULANTS; ACTIVATION; GENERATION; PLATELETS; COMBINATION	Dabigatran and rivaroxaban are novel oral anticoagulants that specifically inhibit thrombin and factor Xa, respectively. The aim of this study is to elucidate antithrombotic properties of these anticoagulant agents under arterial and venous shear conditions. Whole blood samples treated with dabigatran or rivaroxaban at 250, 500, and 1000 nM, with/without aspirin and AR-C66096, a P2Y12 antagonist, were perfused over a microchip coated with collagen and tissue thromboplastin at shear rates of 240 and 600 s(-1). Fibrin-rich platelet thrombus formation was quantified by monitoring flow pressure changes. Dabigatran at higher concentrations (500 and 1000 nM) potently inhibited thrombus formation at both shear rates, whereas 1000 nM of rivaroxaban delayed, but did not completely inhibit, thrombus formation. Dual antiplatelet agents weakly suppressed thrombus formation at both shear rates, but intensified the anticoagulant effects of dabigatran and rivaroxaban. The anticoagulant effects of dabigatran and rivaroxaban were also evaluated under static conditions using thrombin generation (TG) assay. In platelet-poor plasma, dabigatran at 250 and 500 nM efficiently prolonged the lag time (LT) and moderately reduce peak height (PH) of TG, whereas rivaroxaban at 250 nM efficiently prolonged LT and reduced PH of TG. In platelet-rich plasma, however, both anticoagulants efficiently delayed LT and reduced PH of TG. Our results suggest that dabigatran and rivaroxaban may exert distinct antithrombotic effects under flow conditions, particularly in combination with dual antiplatelet therapy.	[Hosokawa, Kazuya; Ohnishi, Tomoko; Sameshima, Hisayo] Fujimori Kogyo Co, Res Inst, Yokohama, Kanagawa, Japan; [Hosokawa, Kazuya; Koide, Takehiko; Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima 890, Japan; [Miura, Naoki] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 890, Japan; [Tanaka, Kenichi A.] Univ Pittsburgh, Med Ctr, Vasc Med Inst, Dept Anesthesiol, Pittsburgh, PA 15260 USA	Kagoshima University; Kagoshima University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tanaka, KA (corresponding author), Univ Pittsburgh, Med Ctr, Vasc Med Inst, Dept Anesthesiol, Pittsburgh, PA 15260 USA.	tanakak@upmc.edu	Miura, Naoki/O-6997-2016; Miura, Naoki/A-5734-2010	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231	Grants-in-Aid for Scientific Research [25670764] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andre P, 2003, CIRCULATION, V108, P2697, DOI 10.1161/01.CIR.0000093279.36628.12; Becker EM, 2012, J THROMB HAEMOST, V10, P2470, DOI 10.1111/jth.12033; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fogelson AL, 2005, PATHOPHYSIOL HAEMO T, V34, P91, DOI 10.1159/000089930; Furugohri T, 2011, THROMB HAEMOSTASIS, V106, P1076, DOI 10.1160/TH11-06-0382; Garcia D, 2010, BLOOD, V115, P15, DOI 10.1182/blood-2009-09-241851; Gross PL, 2008, ARTERIOSCL THROM VAS, V28, P380, DOI 10.1161/ATVBAHA.108.162677; Gurbel PA, 2010, CIRCULATION, V121, P569, DOI 10.1161/CIRCULATIONAHA.109.853085; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hosokawa K, 2011, J THROMB HAEMOST, V9, P2029, DOI 10.1111/j.1538-7836.2011.04464.x; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Kroll MH, 1996, BLOOD, V88, P1525; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Lev EI, 2004, J AM COLL CARDIOL, V43, P966, DOI 10.1016/j.jacc.2003.09.060; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Marlu R, 2012, THROMB HAEMOSTASIS, V108, P217, DOI 10.1160/TH12-03-0179; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; Oldgren J, 2011, EUR HEART J, V32, P2781, DOI 10.1093/eurheartj/ehr113; Perzborn E, 2010, ARTERIOSCL THROM VAS, V30, P376, DOI 10.1161/ATVBAHA.110.202978; Rubboli A, 2007, INTERN EMERG MED, V2, P177, DOI 10.1007/s11739-007-0055-5; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; SWARTZ MJ, 1977, J BIOL CHEM, V252, P8105; Wallentin L, 2003, LANCET, V362, P789, DOI 10.1016/S0140-6736(03)14287-0	28	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86491	10.1371/journal.pone.0086491	http://dx.doi.org/10.1371/journal.pone.0086491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497951	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000330621900025
J	Li, X; Jiang, XY; Ge, J; Wang, J; Chen, GJ; Xu, L; Xie, DY; Yuan, TY; Zhang, DS; Zhang, H; Chen, YH				Li, Xiang; Jiang, Xiao-Yan; Ge, Jin; Wang, Jing; Chen, Guo-Jun; Xu, Liang; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han			Aberrantly Expressed lncRNAs in Primary Varicose Great Saphenous Veins	PLOS ONE			English	Article							LONG NONCODING RNAS; VENOUS REFLUX; RISK; IDENTIFICATION; PATHOGENESIS; TRANSCRIPTS; DYSFUNCTION; METABOLISM; MECHANISMS; PERIOSTIN	Long non-coding RNAs (lncRNAs) are key regulatory molecules involved in a variety of biological processes and human diseases. However, the pathological effects of lncRNAs on primary varicose great saphenous veins (GSVs) remain unclear. The purpose of the present study was to identify aberrantly expressed lncRNAs involved in the prevalence of GSV varicosities and predict their potential functions. Using microarray with 33,045 lncRNA and 30,215 mRNA probes, 557 lncRNAs and 980 mRNAs that differed significantly in expression between the varicose great saphenous veins and control veins were identified in six pairs of samples. These lncRNAs were sub-grouped and mRNAs expressed at different levels were clustered into several pathways with six focused on metabolic pathways. Quantitative real-time PCR replication of nine lncRNAs was performed in 32 subjects, validating six lncRNAs (AF119885, AK021444, NR_027830, G36810, NR_027927, uc.345). A coding-non-coding gene co-expression network revealed that four of these six lncRNAs may be correlated with 11 mRNAs and pathway analysis revealed that they may be correlated with another 8 mRNAs associated with metabolic pathways. In conclusion, aberrantly expressed lncRNAs for GSV varicosities were here systematically screened and validated and their functions were predicted. These findings provide novel insight into the physiology of lncRNAs and the pathogenesis of varicose veins for further investigation. These aberrantly expressed lncRNAs may serve as new therapeutic targets for varicose veins. The Human Ethnics Committee of Shanghai East Hospital, Tongji University School of Medicine approved the study (NO.: 2011-DF-53).	[Li, Xiang; Jiang, Xiao-Yan; Wang, Jing; Xu, Liang; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han] Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China; [Li, Xiang; Jiang, Xiao-Yan; Wang, Jing; Xie, Duan-Yang; Yuan, Tian-You; Zhang, Da-Sheng; Zhang, Hong; Chen, Yi-Han] Tongji Univ, Inst Med Genet, Shanghai 200092, Peoples R China; [Li, Xiang; Jiang, Xiao-Yan; Xie, Duan-Yang; Yuan, Tian-You; Chen, Yi-Han] Tongji Univ, Sch Med, Dept Pathol & Pathophysiol, Shanghai 200092, Peoples R China; [Ge, Jin; Chen, Guo-Jun] Tongji Univ, Sch Med, Dept Vasc Surg, East Hosp, Shanghai 200092, Peoples R China	Ministry of Education, China; Tongji University; Tongji University; Tongji University; Tongji University	Chen, YH (corresponding author), Tongji Univ, Sch Med, Key Lab Arrhythmia, Minist Educ China,East Hosp, Shanghai 200092, Peoples R China.	yihanchen@tongji.edu.cn	Chen, Yi/HIR-2608-2022		Major International Joint Research Program Fund of China [81120108004]; Foundation for Innovative Research Groups of China [81221001]; National Key Basic Research Program of China [2013CB531100]; National Natural Science Foundation of China [31271214, 81100551]; Shanghai Natural Science Fund [10JC1414700]; Shanghai Municipal Natural Science Foundation [11ZR1438600]; Fundamental Research Funds for the Central Universities [1500219042]	Major International Joint Research Program Fund of China; Foundation for Innovative Research Groups of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund; Shanghai Municipal Natural Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Major International Joint Research Program Fund of China (81120108004), the Foundation for Innovative Research Groups of China (81221001), the National Key Basic Research Program of China (2013CB531100), the National Natural Science Foundation of China (31271214, 81100551), the Shanghai Natural Science Fund (10JC1414700), the grant from Shanghai Municipal Natural Science Foundation (11ZR1438600), and the Fundamental Research Funds for the Central Universities (1500219042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher E, 2001, J VASC SURG, V33, P1080, DOI 10.1067/mva.2001.113976; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Fowkes FGR, 2001, INT J EPIDEMIOL, V30, P846, DOI 10.1093/ije/30.4.846; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Labropoulos N, 2003, J VASC SURG, V38, P793, DOI 10.1016/S0741-5214(03)00424-5; Lee JD, 2012, PHLEBOLOGY, V27, P409, DOI 10.1258/phleb.2011.011051; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Lorenzen JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0245-9; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan YF, 2011, CHINESE MED J-PEKING, V124, P2378, DOI 10.3760/cma.j.issn.0366-6999.2011.15.023; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schleithoff C, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-7; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Takase S, 2000, ANN VASC SURG, V14, P427, DOI 10.1007/s100169910092; van Groenendael L, 2009, J VASC SURG, V50, P1106, DOI 10.1016/j.jvs.2009.06.057; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563	43	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86156	10.1371/journal.pone.0086156	http://dx.doi.org/10.1371/journal.pone.0086156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497937	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900017
J	Robertson, T; Benzeval, M				Robertson, Tony; Benzeval, Michaela			Do Mismatches between Pre- and Post-Natal Environments Influence Adult Physiological Functioning?	PLOS ONE			English	Article							BRITISH WOMENS HEART; LOW-BIRTH-WEIGHT; DEPENDENT DIABETES-MELLITUS; FETAL ORIGINS; BLOOD-PRESSURE; CHILDHOOD GROWTH; LUNG-FUNCTION; CARDIOVASCULAR-DISEASE; RESPIRATORY-FUNCTION; INFANT GROWTH	Purpose: Mismatches between pre- and post-natal environments have implications for disease in adulthood. However, less is known about how this mismatch can affect physiological systems more generally, especially at younger ages. We hypothesised that mismatches between pre- and post-natal environments, as measured by the measures of birthweight and adult leg length, would be associated with poorer biomarker levels across five key physiological systems in young adults. Methods: Data were collected from 923, 36 year-old respondents from the West of Scotland Twenty-07 Study. The biomarkers were: systolic blood pressure (sBP); forced expiratory volume (FEV1); glycated haemoglobin (HbA(1c)); glomerular filtration rate (eGFR); and gamma-glutamyltransferase (GGT). These biomarkers were regressed against pre-natal conditions (birthweight), post-natal conditions (leg length) and the interaction between pre- and post-natal measures. Sex, childhood socioeconomic position and adult lifestyle characteristics were adjusted for as potential effect modifiers and confounders, respectively. Results: There were no associations between birthweight and leg length and sBP, FEV1, HbA(1c), or GGT. Higher birthweight and longer leg length were associated with better kidney function (eGFR). However, there was no evidence for mismatches between birthweight and leg length to be associated with worse sBP, FEV1, HbA(1c), eGFR or GGT levels (P>0.05). Conclusions: Our hypothesis that early signs of physiological damage would be present in young adults given mismatches in childhood environments, as measured by growth markers, was not proven. This lack of association could be because age 36 is too young to identify significant trends for future health, or the associations simply not being present.	[Robertson, Tony] Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland; [Benzeval, Michaela] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England	University of Edinburgh; University of Essex	Robertson, T (corresponding author), Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland.	tony.robertson@ed.ac.uk	Benzeval, Michaela/J-3163-2015; Robertson, Tony/L-5062-2015	Benzeval, Michaela/0000-0002-0372-2098; Robertson, Tony/0000-0002-1962-5874	Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC); Chief Scientist Office of Scotland; UK Economic and Social Research Council; University of Essex; MRC; MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme [MC_UU_12017/7]; Medical Research Council [MC_UU_12017/7, MC_UP_A540_1021, MR/K023209/1] Funding Source: researchfish; MRC [MC_UU_12017/7, MR/K023209/1, MC_UP_A540_1021] Funding Source: UKRI	Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of Scotland; UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); University of Essex; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Tony Robertson is funded by a grant awarded to the Scottish Collaboration for Public Health Research and Policy from the UK Medical Research Council (MRC) and the Chief Scientist Office of Scotland. Professor Michaela Benzeval is funded by the UK Economic and Social Research Council and the University of Essex. The Twenty-07 Study is funded by the MRC. At the time the work for this project was conducted, both authors were employed by the MRC and based at the MRC/CSO Social and Public Health Sciences Unit, Glasgow as part of the Social Patterning of Health over the Lifecourse programme (grant number: MC_UU_12017/7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1993, BRIT HEART J, V69, P195; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bateson P, 2012, INT J EPIDEMIOL, V41, P219, DOI 10.1093/ije/dyr240; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Bonellie S, 2005, NEW CENTILE CHARTS B; Boubred F, 2009, AM J PHYSIOL-RENAL, V297, pF943, DOI 10.1152/ajprenal.90704.2008; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Canoy D, 2007, THORAX, V62, P396, DOI 10.1136/thx.2006.066241; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COLE TJ, 1975, J R STAT SOC A STAT, V138, P297, DOI 10.2307/2344580; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; FALL C, 1992, EUR J CLIN NUTR, V46, pS57; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Gunnell DJ, 1998, PAEDIATR PERINAT EP, V12, P96, DOI 10.1046/j.1365-3016.1998.0120s1096.x; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hancox RJ, 2009, THORAX, V64, P228, DOI 10.1136/thx.2008.103978; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P644; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Kinshuck D, 2011, CONTROL TYPE 2 DIABE; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lawlor DA, 2005, THORAX, V60, P851, DOI 10.1136/thx.2005.042408; Lawlor DA, 2005, CURR OPIN NEPHROL HY, V14, P259, DOI 10.1097/01.mnh.0000165893.13620.2b; Lawlor DA, 2003, DIABETES CARE, V26, P97, DOI 10.2337/diacare.26.1.97; Lawlor DA, 2003, PAEDIATR PERINAT EP, V17, P148, DOI 10.1046/j.1365-3016.2003.00479.x; Lawlor DA, 2007, COMPREHENSIVE HYPERT, P41; Leon DA, 2004, INT J EPIDEMIOL, V33, P1167, DOI 10.1093/ije/dyh389; Lewit EM, 1997, FUTURE CHILD, V7, P149, DOI 10.2307/1602393; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; NHLBI, 2012, US NAT HEART LUNG BL; Orfei L, 2008, ARCH DIS CHILD, V93, P570, DOI 10.1136/adc.2006.112201; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Pike KC, 2008, BJOG-INT J OBSTET GY, V115, P149, DOI 10.1111/j.1471-0528.2007.01603.x; Puukka K, 2006, ALCOHOL ALCOHOLISM, V41, P522, DOI 10.1093/alcalc/agl052; Robinson R, 2001, BMJ, P322; SCHIELE F, 1977, CLIN CHEM, V23, P1023; Schmidt IM, 2005, KIDNEY INT, V68, P731, DOI 10.1111/j.1523-1755.2005.00451.x; ScottishGovernment, 2012, SCOTT HLTH SURV 2011, V1; Seaman S, 2011, 27 MRCCSO SOC PUBL H; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Silva LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037356; Singh GR, 2004, AM J KIDNEY DIS, V43, P254, DOI 10.1053/j.ajkd.2003.10.015; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Spencer J, 2001, AM J KIDNEY DIS, V37, P915, DOI 10.1016/S0272-6386(05)80006-X; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Tate AR, 2005, INT J EPIDEMIOL, V34, P688, DOI 10.1093/ije/dyi029; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440	66	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86953	10.1371/journal.pone.0086953	http://dx.doi.org/10.1371/journal.pone.0086953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498001	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000330621900051
J	Seror, J; Amand, G; Guibourdenche, J; Ceccaldi, PF; Luton, D				Seror, Jeremy; Amand, Gaelle; Guibourdenche, Jean; Ceccaldi, Pierre-Francois; Luton, Dominique			Anti-TPO Antibodies Diffusion through the Placental Barrier during Pregnancy	PLOS ONE			English	Article							THYROID-DISEASE; ANTIPHOSPHOLIPID SYNDROME; HYPOTHYROIDISM; AUTOANTIBODIES; ABNORMALITIES; DYSFUNCTION; MANAGEMENT	Background: Hashimoto's thyroiditis is the principal aetiology of hypothyroidism with presence of anti-thyroperoxidase antibodies (anti-TPO). The association between anti-TPO and foeto-placental complications has been observed in previous studies. To go further in the understanding, the current study compares the level of anti-TPO in maternal blood and in the cord blood of her fetus at the moment of childbirth to demonstrate the passage of anti-TPO through the placenta barrier. Methods and Findings: This study was realised in a maternity ward located in the Northern district of Paris, France from 2006 to 2007. Women with normal pregnancy were included in a first study and only women with no abnormal thyroid dosage at baseline and tested positive with anti-TPO were prospectively enrolled. Maternal blood samples were collected in the third trimester and at the arrival to the ward when patients came to deliver. After delivery, cord blood sample was collected. Pearson's correlation coefficient was computed. 5941 patients delivered in the ward during the study, 33 pregnant women were included. We found a correlation between the anti-TPO levels in maternal and in the cord blood of their fetus with a correlation coefficient of 0.98 and a p-value<0.001. Conclusions: This is the first demonstration of the free passage through the placental barrier of anti-TPO from the mother to the fetus at the moment of childbirth. These findings can be extrapolated all along pregnancy and open the door to a direct action of the anti-TPO on fetus and to a possible action on the fetal thyroid.	[Seror, Jeremy; Amand, Gaelle; Ceccaldi, Pierre-Francois; Luton, Dominique] Univ Paris 07, Paris, France; [Seror, Jeremy; Amand, Gaelle; Ceccaldi, Pierre-Francois; Luton, Dominique] Beaujon Bichat Hosp, AP HP, Dept Gynecol & Obstet, Clichy, France; [Guibourdenche, Jean] Cochin Hosp, AP HP, Dept Hormonal & Metab Biol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Seror, J (corresponding author), Univ Paris 07, Paris, France.	jeremy.seror@bjn.aphp.fr	Ceccaldi, Pierre-Francois/B-7966-2008	Ceccaldi, Pierre-Francois/0000-0003-4716-9199	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris [CRC 04-106]	Development and Clinical Research Department Ile de France of Assistance Publique - Hopitaux de Paris	The project was funded by Development and Clinical Research Department Ile de France (CRC 04-106) of Assistance Publique - Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarian M, 2004, MISES JOUR GYNECOLOG, VXXVIII; Azlin MIN, 2010, J OBSTET GYNAECOL, V30, P675, DOI 10.3109/01443615.2010.503908; BLANK M, 1991, P NATL ACAD SCI USA, V88, P3069, DOI 10.1073/pnas.88.8.3069; Brown R S, 1996, Endocr Pract, V2, P53; de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Elahi S., 2005, Pakistan Journal of Medical Sciences, V21, P325; Ghafoor Farkhanda, 2006, J Coll Physicians Surg Pak, V16, P468; Girling JC., 2006, CURRENT OBSTET GYNAE, V16, P47; GLINOER D, 1991, J CLIN ENDOCR METAB, V73, P421, DOI 10.1210/jcem-73-2-421; GOODWIN TM, 1992, AM J OBSTET GYNECOL, V167, P648, DOI 10.1016/S0002-9378(11)91565-8; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Harborne LR, 2005, AUST NZ J OBSTET GYN, V45, P239, DOI 10.1111/j.1479-828X.2005.00365.x; Kuppens SMI, 2011, CLIN ENDOCRINOL, V75, P382, DOI 10.1111/j.1365-2265.2011.04083.x; Lazarus JH, 2000, CLIN ENDOCRINOL, V53, P265, DOI 10.1046/j.1365-2265.2000.01087.x; Lee YL, 2009, FERTIL STERIL, V91, P2104, DOI 10.1016/j.fertnstert.2008.07.1704; LEJEUNE B, 1993, BRIT J OBSTET GYNAEC, V100, P669, DOI 10.1111/j.1471-0528.1993.tb14236.x; Luton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014707; Mannisto T, 2009, J CLIN ENDOCR METAB, V94, P772, DOI 10.1210/jc.2008-1520; Montoro MN, 1997, CLIN OBSTET GYNECOL, V40, P65, DOI 10.1097/00003081-199703000-00008; Nguyen PH, 2004, EMEDICINE WORLD MED; Oken E, 2009, J CLIN ENDOCR METAB, V94, P497, DOI 10.1210/jc.2008-0936; Poppe K, 2003, HUM REPROD UPDATE, V9, P149, DOI 10.1093/humupd/dmg012; Schlienger J, 2001, THYROIDE CONCEPTS PR, P503; Seror J, 2005, 6 JNGOF C PAR FRANC; Smyth PPA, 2005, THYROID, V15, P474, DOI 10.1089/thy.2005.15.474; THORPEBEESTON JG, 1991, NEW ENGL J MED, V324, P532, DOI 10.1056/NEJM199102213240805; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103; Williams GR, 2008, J NEUROENDOCRINOL, V20, P784, DOI 10.1111/j.1365-2826.2008.01733.x; Ziporen L, 1997, RHEUM DIS CLIN N AM, V23, P99, DOI 10.1016/S0889-857X(05)70317-3	32	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e84647	10.1371/journal.pone.0084647	http://dx.doi.org/10.1371/journal.pone.0084647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497920	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900007
J	Verma, SS; Rahman, MH; Deyholos, MK; Basu, U; Kav, NNV				Verma, Shiv S.; Rahman, Muhammad H.; Deyholos, Michael K.; Basu, Urmila; Kav, Nat N. V.			Differential Expression of miRNAs in Brassica napus Root following Infection with Plasmodiophora brassicae	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; MICROARRAY-BASED ANALYSIS; CLUBROOT RESISTANCE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; SMALL RNAS; ARABIDOPSIS; PLANT; AUXIN; IDENTIFICATION	Canola (oilseed rape, Brassica napus L.) is susceptible to infection by the biotrophic protist Plasmodiophora brassicae, the causal agent of clubroot. To understand the roles of microRNAs (miRNAs) during the post-transcriptional regulation of disease initiation and progression, we have characterized the changes in miRNA expression profiles in canola roots during clubroot disease development and have compared these to uninfected roots. Two different stages of clubroot development were targeted in this miRNA profiling study: an early time of 10-dpi for disease initiation and a later 20-dpi, by which time the pathogen had colonized the roots (as evident by visible gall formation and histological observations). P. brassicae responsive miRNAs were identified and validated by qRT-PCR of miRNAs and the subsequent validation of the target mRNAs through starBase degradome analysis, and through 5' RLM-RACE. This study identifies putative miRNA-regulated genes with roles during clubroot disease initiation and development. Putative target genes identified in this study included: transcription factors (TFs), hormone-related genes, as well as genes associated with plant stress response regulation such as cytokinin, auxin/ethylene response elements. The results of our study may assist in elucidating the role of miRNAs in post-transcriptional regulation of target genes during disease development and may contribute to the development of strategies to engineer durable resistance to this important phytopathogen.	[Verma, Shiv S.; Rahman, Muhammad H.; Basu, Urmila; Kav, Nat N. V.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Deyholos, Michael K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Kav, NNV (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	nat@ualberta.ca	Verma, Shiv Shankar/AAI-6913-2021; Verma, Shiv Shankar/N-3726-2016		Natural Sciences and Engineering Research Council (NSERC) of Canada; Agriculture Funding Consortium; Alberta Canola Producers Commission; Alberta Crop Industry Development Fund	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture Funding Consortium; Alberta Canola Producers Commission; Alberta Crop Industry Development Fund	Funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada, Agriculture Funding Consortium, Alberta Canola Producers Commission, and Alberta Crop Industry Development Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Agarwal A, 2011, FUNCT PLANT BIOL, V38, P462, DOI 10.1071/FP11026; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Bulman S, 2007, PROTIST, V158, P423, DOI 10.1016/j.protis.2007.04.005; Cao T, 2008, PLANT SCI, V174, P97, DOI 10.1016/j.plantsci.2007.10.002; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Czimmerer Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055168; Dastidar MG, 2012, WIRES DEV BIOL, V1, P329, DOI 10.1002/wdev.17; Devos S, 2006, MOL PLANT MICROBE IN, V19, P1431, DOI 10.1094/MPMI-19-1431; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Ding YF, 2011, J EXP BOT, V62, P3563, DOI 10.1093/jxb/err046; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; Dougherty WJ, 1981, STAINING PROCEDURES, P27; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gravot A, 2012, PLANT CELL PHYSIOL, V53, P901, DOI 10.1093/pcp/pcs037; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Hwang SF, 2012, CAN J PLANT SCI, V92, P1175, DOI [10.4141/CJPS2011-149, 10.4141/cjps2011-149]; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kato T, 2013, BREEDING SCI, V63, P116, DOI 10.1270/jsbbs.63.116; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2010, METHODS MOL BIOL, V592, P107, DOI 10.1007/978-1-60327-005-2_8; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Malinowski R, 2012, PLANT J, V71, P226, DOI 10.1111/j.1365-313X.2012.04983.x; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Moldovan D, 2010, J EXP BOT, V61, P165, DOI 10.1093/jxb/erp296; Naqvi AR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-281; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Pande S, 2005, AUST J AGR RES, V56, P317, DOI 10.1071/AR04143; Peng G, 2011, PLANT PATHOL, V60, P566, DOI 10.1111/j.1365-3059.2010.02400.x; SACRISTAN MD, 1979, THEOR APPL GENET, V54, P129, DOI 10.1007/BF01159467; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Siemens J, 2009, PLANT PATHOL, V58, P130, DOI 10.1111/j.1365-3059.2008.01943.x; Siemens J, 2006, MOL PLANT MICROBE IN, V19, P480, DOI 10.1094/MPMI-19-0480; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Strelkov SE, 2007, J PHYTOPATHOL, V155, P706, DOI 10.1111/j.1439-0434.2007.01303.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sundelin T, 2011, J EUKARYOT MICROBIOL, V58, P310, DOI 10.1111/j.1550-7408.2011.00551.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2008, BMC PLANT BIOL, V8, P1471; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Tewari JP, 2005, CAN J PLANT PATHOL, V27, P143; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xin M, 2010, BMC PLANT BIOL, V10, P1471; Yang JH, 2011, NUCLEIC ACIDS RES, V39, P30; Yeung Edward C., 2005, V77, P517; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	76	34	38	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86648	10.1371/journal.pone.0086648	http://dx.doi.org/10.1371/journal.pone.0086648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497962	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900031
J	Colli, L; Joost, S; Negrini, R; Nicoloso, L; Crepaldi, P; Ajmone-Marsan, P				Colli, Licia; Joost, Stephane; Negrini, Riccardo; Nicoloso, Letizia; Crepaldi, Paola; Ajmone-Marsan, Paolo		ECONOGENE Consortium	Assessing The Spatial Dependence of Adaptive Loci in 43 European and Western Asian Goat Breeds Using AFLP Markers	PLOS ONE			English	Article							DETECT CANDIDATE LOCI; LANDSCAPE GENOMICS; POPULATION GENOMICS; POSITIVE SELECTION; ADAPTATION; GENETICS; POLYMORPHISM; DIVERSITY; DOMINANT; PROMISE	Background: During the past decades, neutral DNA markers have been extensively employed to study demography, population genetics and structure in livestock, but less interest has been devoted to the evaluation of livestock adaptive potential through the identification of genomic regions likely to be under natural selection. Methodology/Principal findings: Landscape genomics can greatly benefit the entire livestock system through the identification of genotypes better adapted to specific or extreme environmental conditions. Therefore we analyzed 101 AFLP markers in 43 European and Western Asian goat breeds both with MATSAM software, based on a correlative approach (SAM), and with MCHEZA and BAYESCAN, two F-ST based software able to detect markers carrying signatures of natural selection. MATSAM identified four loci possibly under natural selection - also confirmed by F-ST-outlier methods - and significantly associated with environmental variables such as diurnal temperature range, frequency of precipitation, relative humidity and solar radiation. Conclusions/Significance: These results show that landscape genomics can provide useful information on the environmental factors affecting the adaptive potential of livestock living in specific climatic conditions. Besides adding conservation value to livestock genetic resources, this knowledge may lead to the development of novel molecular tools useful to preserve the adaptive potential of local breeds during genetic improvement programs, and to increase the adaptability of industrial breeds to changing environments.	[Colli, Licia; Negrini, Riccardo; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Ist Zootecn, Lab Genet Anim, Piacenza, Italy; [Colli, Licia; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, BioDNA Res Ctr, Piacenza, Italy; [Joost, Stephane] Ecole Polytech Fed Lausanne, Lab Geog Informat Syst LASIG, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland; [Negrini, Riccardo] Assoc Italiana Allevatori, Rome, Italy; [Nicoloso, Letizia; Crepaldi, Paola] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Milan	Colli, L (corresponding author), Univ Cattolica Sacro Cuore, Ist Zootecn, Lab Genet Anim, Piacenza, Italy.	licia.colli@unicatt.it	Bruford, Michael W/D-3750-2009; Bruford, Michael/Y-7463-2019; Colli, Licia/AAC-2985-2021; Crepaldi, Paola/L-4681-2017; Beja-Pereira, Albano/B-3681-2008; D'Andrea, Mariasilvia/E-5760-2012; D'ANDREA, Mariasilvia/AAQ-9396-2020; Pérez, Trinidad/AAC-6729-2019; Hoda, Anila/GRY-7191-2022; Joost, Stéphane/B-4152-2010; AJMONE MARSAN, Paolo/M-2466-2018; Canon Ferreras, Francisco Javier/M-5704-2018; Cortes Gardyn, Oscar/K-7545-2014; valentini, alessio/L-3970-2013	Bruford, Michael W/0000-0001-6357-6080; Bruford, Michael/0000-0001-6357-6080; Crepaldi, Paola/0000-0002-6526-2162; Beja-Pereira, Albano/0000-0002-1607-7382; D'Andrea, Mariasilvia/0000-0002-8932-4057; Pérez, Trinidad/0000-0003-1216-5593; Hoda, Anila/0000-0003-0906-2550; Joost, Stéphane/0000-0002-1184-7501; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Ibeagha-Awemu, Eveline/0000-0001-8810-9294; Marletta, Donata/0000-0002-8408-7443; CANALI, Gabriele/0000-0001-9244-8184; Canon Ferreras, Francisco Javier/0000-0003-1137-0958; PILLA, Fabio/0000-0002-1781-994X; Cortes Gardyn, Oscar/0000-0001-7685-3980; Dobi, Petrit/0000-0002-6101-0101; LIGDA, CHRISTINA/0000-0003-4980-3026; NEGRINI, Riccardo/0000-0002-8735-0286; Baret, Philippe/0000-0002-6189-666X; Carta, Antonello/0000-0003-0534-4876; valentini, alessio/0000-0003-4733-7519	EU ECONOGENE [QLK5-CT-2001-02461]	EU ECONOGENE	This work has been supported by the EU ECONOGENE contract QLK5-CT-2001-02461. The content of the publication does not represent necessarily the views of the European Commission or its services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Avise J, 2004, MOL MARKERS NATURAL; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Buitkamp J, 1996, PARASITOL RES, V82, P693, DOI 10.1007/s004360050187; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Goodchild MF., 1996, ANTHR SPACE GEOGRAPH, P214; Hahn MW, 2008, EVOLUTION, V62, P255, DOI 10.1111/j.1558-5646.2007.00308.x; Hanotte O, 2010, SCIENCE, V328, P1640, DOI 10.1126/science.1186254; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jones MR, 2013, EVOLUTION, V67, P3455, DOI 10.1111/evo.12237; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Joost S, 2008, MOL ECOL RESOUR, V8, P957, DOI 10.1111/j.1755-0998.2008.02162.x; Joost S, 2013, MOL ECOL, V22, P3659, DOI 10.1111/mec.12352; Joost S, 2011, CONSERV GENET RESOUR, V3, P785, DOI 10.1007/s12686-011-9457-9; Lampkin NH, 2001, ORGANIC FARM MANAGEM; LEWONTIN RC, 1973, GENETICS, V74, P175; Li HP, 2011, MOL BIOL EVOL, V28, P365, DOI 10.1093/molbev/msq211; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nielsen EE, 2005, CAN J FISH AQUAT SCI, V62, P2219, DOI 10.1139/F05-139; ORGANIZACION DE LAS NACIONES UNIDAS PARA LA AGRICULTURA Y LA ALIMENTACION (FAO), 2010, 6 SESS INT TECHN WOR; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7; Phillips PC, 2005, GENETICA, V123, P15, DOI 10.1007/s10709-004-2704-1; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; SanCristobal M, 2006, ANIM GENET, V37, P232, DOI 10.1111/j.1365-2052.2006.01440.x; Schlotterer C, 2005, MOL B INT U, P55, DOI 10.1007/0-387-27651-3_5; Scholtz MM, 2011, LIVEST SCI, V142, P195, DOI 10.1016/j.livsci.2011.07.014; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Storz JF, 2005, HEREDITY, V95, P3, DOI 10.1038/sj.hdy.6800683; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	52	13	14	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86668	10.1371/journal.pone.0086668	http://dx.doi.org/10.1371/journal.pone.0086668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497965	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330617100024
J	Schmidt, AH; Sauter, J; Pingel, J; Ehninger, G				Schmidt, Alexander H.; Sauter, Juergen; Pingel, Julia; Ehninger, Gerhard			Toward an Optimal Global Stem Cell Donor Recruitment Strategy	PLOS ONE			English	Article							HLA HAPLOTYPE FREQUENCIES; HIGH-RESOLUTION; NATIONAL REGISTRY; TRANSPLANTATION; POPULATION; ALLELES; ANTIGEN; IMPACT; PROBABILITY; PROGRAM	Population-specific matching probabilities (MP) are a key parameter to assess the benefits of unrelated stem cell donor registries and the need for further donor recruitment efforts. In this study, we describe a general framework for MP estimations of specific and mixed patient populations under consideration of international stem cell donor exchange. Calculations were based on population-specific 4-locus (HLA-A, -B, -C, -DRB1) high-resolution haplotype frequencies (HF) of up to 21 populations. In various scenarios, we calculated several quantities of high practical relevance, including the maximal MP that can be reached by recruiting a fixed number of donors, the corresponding optimal composition by population of new registrants, and the minimal number of donors who need to be recruited to reach a defined MP. Starting at current donor numbers, the largest MP increases due to n = 500,000 additional same-population donors were observed for patients from Bosnia-Herzegovina (+0.25), Greece (+0.21) and Romania (+0.20). Especially small MP increases occurred for European Americans (+0.004), Germans (+0.01) and Hispanic Americans (+0.01). Due to the large Chinese population, the optimal distribution of n = 5,000,000 new donors worldwide included 3.9 million Chinese donors. As a general result of our calculations, we observed a need for same-population donor recruitment in order to increase population-specific MP efficiently. This result was robust despite limitations of our input data, including the use of HF derived from relatively small samples ranging from n = 1028 (Bosnia-Herzegovina) to n = 33,083 (Turkey) individuals. National strategies that neglect domestic donor recruitment should therefore be critically re-assessed, especially if only few donors have been recruited so far.	[Schmidt, Alexander H.; Sauter, Juergen; Pingel, Julia] DKMS German Bone Marrow Donor Ctr, Tubingen, Germany; [Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dresden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmidt, AH (corresponding author), DKMS German Bone Marrow Donor Ctr, Tubingen, Germany.	schmidt@dkms.de; sauter@dkms.de			DKMS German Bone Marrow Donor Center	DKMS German Bone Marrow Donor Center	This work was funded by DKMS German Bone Marrow Donor Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; BEATTY PG, 1995, TRANSPLANTATION, V60, P778, DOI 10.1097/00007890-199510270-00003; Bergstrom TC, 2009, AM ECON REV, V99, P1309, DOI 10.1257/aer.99.4.1309; Bray RA, 2008, BIOL BLOOD MARROW TR, V14, P45, DOI 10.1016/j.bbmt.2008.06.014; Buhler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041400; Castelli EC, 2010, TISSUE ANTIGENS, V76, P459, DOI 10.1111/j.1399-0039.2010.01539.x; Confer DL, 2001, CANCER, V91, P274, DOI 10.1002/1097-0142(20010101)91:1+<274::AID-CNCR18>3.0.CO;2-E; Dehn J, 2011, BIOL BLOOD MARROW TR, V17, pS170, DOI 10.1016/j.bbmt.2010.12.059; Eberhard HP, 2010, TISSUE ANTIGENS, V76, P352, DOI 10.1111/j.1399-0039.2010.01518.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Gratwohl A, 2007, BONE MARROW TRANSPL, V39, P71, DOI 10.1038/sj.bmt.1705555; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Hwang WYK, 2009, ANN ACAD MED SINGAP, V38, P340; Kollman C, 2004, TRANSPLANTATION, V78, P89, DOI 10.1097/01.TP.0000132327.40702.97; Kollman C, 2007, HUM IMMUNOL, V68, P950, DOI 10.1016/j.humimm.2007.10.009; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Lazaro AM, 2011, TISSUE ANTIGENS, V77, P54, DOI 10.1111/j.1399-0039.2010.01558.x; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; LONJOU C, 1995, TRANSPLANTATION, V60, P375, DOI 10.1097/00007890-199508270-00013; Mack SJ, 2009, TISSUE ANTIGENS, V73, P17, DOI 10.1111/j.1399-0039.2008.01151.x; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Mueller CR, 2012, HUM IMMUNOL, V73, P121, DOI 10.1016/j.humimm.2012.07.240; Muller CR, 2003, HUM IMMUNOL, V64, P137, DOI 10.1016/S0198-8859(02)00706-1; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Qin PQ, 2011, INT J IMMUNOGENET, V38, P475, DOI 10.1111/j.1744-313X.2011.01029.x; Rendine S, 1998, TISSUE ANTIGENS, V52, P135, DOI 10.1111/j.1399-0039.1998.tb02277.x; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Schmidt AH, 2010, TISSUE ANTIGENS, V76, P362, DOI 10.1111/j.1399-0039.2010.01520.x; Schmidt AH, 2009, BONE MARROW TRANSPL, V44, P405, DOI 10.1038/bmt.2009.55; Schmidt AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073835; Schmidt AH, 2013, TISSUE ANTIGENS, V81, P270; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Schmidt AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020268; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Shaw BE, 2010, BRIT J HAEMATOL, V150, P251, DOI 10.1111/j.1365-2141.2010.08224.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; SONNENBERG FA, 1989, BLOOD, V74, P2569; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; Tu B, 2013, TISSUE ANTIGENS, V81, P150, DOI 10.1111/tan.12072; World Marrow Donor Association, WORLD MARR DON ASS A	44	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86605	10.1371/journal.pone.0086605	http://dx.doi.org/10.1371/journal.pone.0086605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497958	gold, Green Submitted, Green Published			2022-12-27	WOS:000330617100021
J	Wu, W; Liu, L; Yin, ZH; Guan, P; Li, XL; Zhou, BS				Wu, Wei; Liu, Lu; Yin, Zhihua; Guan, Peng; Li, Xuelian; Zhou, Baosen			Association of X-Ray Repair Cross-Complementing Group 1 Arg194Trp, Arg399Gln and Arg280His Polymorphisms with Head and Neck Cancer Susceptibility: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; SISTER-CHROMATID-EXCHANGE; GENETIC POLYMORPHISMS; XRCC1 POLYMORPHISMS; INCREASED RISK; ORAL-CANCER; DNA-DAMAGE; COLORECTAL-CANCER; POOLED ANALYSIS	Background: Previous studies on the association of X-ray repair cross-complementing group 1 (XRCC1) Arg194Trp, Arg399Gln, and Arg280His polymorphisms with head and neck cancer (HNC) have produced inconsistent results. The aim of the present study was to evaluate the effects of these three polymorphic variants on HNC risk. Methods: The PubMed and EMBASE databases were searched for genetic association studies on the XRCC1 Arg194Trp, Arg399Gln, and Arg280His polymorphisms and HNC risk. (The most recent search was conducted on 20 August, 2013.) Twenty-six studies were identified and meta-analysis was performed to evaluate the association between the polymorphism and HNC by calculating combined odds ratios and 95% confidence intervals. Results: No significant association was found under the allelic, homozygous, heterozygote, and dominant genetic models in the overall comparison. Further, no significant association between the XRCC1 Arg399Gln and Arg280His polymorphisms and HNC risk was detected under the four genetic models in subgroup analyses based on ethnicity, cancer site, and whether or not the studies had been adjusted for cigarette smoking and alcohol. However, in stratified analyses based on cancer site, a significant association was found between the XRCC1 Arg194Trp polymorphism and oral cancer under the allelic, heterozygote, and dominant models. The XRCC1 Arg194Trp polymorphism was significantly associated with HNC risk in studies that were adjusted for smoking and alcohol under the homozygous and heterozygote models. Conclusion: The meta-analysis results suggest that the XRCC1 Arg399Gln and Arg280His polymorphisms are probably not associated with the risk of HNC, but the XRCC1 Arg194Trp polymorphism was associated with increased risk of HNC in the subgroup analysis of studies adjusted for smoking and alcohol and with increased risk of oral cancer in the stratified analyses based on cancer site. Further studies with larger samples are needed to confirm these findings.	[Wu, Wei; Yin, Zhihua; Guan, Peng; Li, Xuelian; Zhou, Baosen] China Med Univ, Dept Epidemiol, Sch Publ Hlth, Shenyang, Peoples R China; [Wu, Wei; Yin, Zhihua; Guan, Peng; Li, Xuelian; Zhou, Baosen] Univ Liaoning Prov, Key Lab Canc Etiol & Intervent, Shenyang, Peoples R China; [Liu, Lu] China Med Univ, Dept Prevent Dent, Sch Stomatol, Shenyang, Peoples R China	China Medical University; China Medical University	Zhou, BS (corresponding author), China Med Univ, Dept Epidemiol, Sch Publ Hlth, Shenyang, Peoples R China.	bszhou@mail.cmu.edu.cn	Guan, Peng/GWM-9170-2022		National Natural Science Foundation of China [81272293, 81102194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant no. 81272293 from National Natural Science Foundation of China, grant no. 81102194 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 2000, CANCER LETT, V159, P63, DOI 10.1016/S0304-3835(00)00532-2; Applebaum KM, 2009, INT J CANCER, V124, P2690, DOI 10.1002/ijc.24256; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CARRANO AV, 1986, MUTAT RES, V162, P233, DOI 10.1016/0027-5107(86)90090-4; Chuang SC, 2011, FRONT ONCOL, V1, P1, DOI 10.3389/fonc.2011.00013; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; Csejtei A, 2009, ANTICANCER RES, V29, P4169; Demokan S, 2005, PATHOL ONCOL RES, V11, P22, DOI 10.1007/BF03032401; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; dos Reis MB, 2013, J ORAL PATHOL MED, V42, P180, DOI 10.1111/j.1600-0714.2012.01192.x; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064001; Flores-Obando RE, 2010, BIOMARKERS, V15, P379, DOI 10.3109/13547501003797664; Gajecka M, 2005, ADV OTO-RHINO-LARYNG, V62, P25; Gugatschka M, 2011, EXP MOL PATHOL, V91, P331, DOI 10.1016/j.yexmp.2011.03.004; Harth V, 2008, J TOXICOL ENV HEAL A, V71, P887, DOI 10.1080/15287390801988160; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hiyama T, 2008, INT J ONCOL, V32, P945; Ho T, 2007, CANCER, V110, P318, DOI 10.1002/cncr.22794; Hu ZB, 2005, CANCER EPIDEM BIOMAR, V14, P1810, DOI 10.1158/1055-9965.EPI-04-0793; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Kietthubthew S, 2006, INT J HYG ENVIR HEAL, V209, P21, DOI 10.1016/j.ijheh.2005.06.002; Kostrzewska-Poczekaj M, 2013, EUR ARCH OTO-RHINO-L, V270, P271, DOI 10.1007/s00405-012-1993-8; Kowalski M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-37; Krupa R., 2011, Experimental Oncology, V33, P55; Kumar A, 2012, MUTAT RES-FUND MOL M, V729, P24, DOI 10.1016/j.mrfmmm.2011.09.001; Lei YC, 2002, MUTAT RES-GEN TOX EN, V519, P93, DOI 10.1016/S1383-5718(02)00127-4; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Lunn RM, 1999, CANCER RES, V59, P2557; Majumder M, 2005, CANCER EPIDEM BIOMAR, V14, P2106, DOI 10.1158/1055-9965.EPI-05-0108; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848; Nissar S, 2013, ONCOL LETT, V5, P959, DOI 10.3892/ol.2013.1104; Olshan AF, 2002, CANCER LETT, V178, P181, DOI 10.1016/S0304-3835(01)00822-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Ramachandran S, 2006, ORAL ONCOL, V42, P350, DOI 10.1016/j.oraloncology.2005.08.010; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Rydzanicz M, 2005, CANCER LETT, V224, P263, DOI 10.1016/j.canlet.2005.01.015; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Sturgis EM, 1999, CARCINOGENESIS, V20, P2125, DOI 10.1093/carcin/20.11.2125; Szymanska K, 2010, CARCINOGENESIS, V31, P1054, DOI 10.1093/carcin/bgp212; Tae K, 2004, INT J CANCER, V111, P805, DOI 10.1002/ijc.20338; Takanami T, 2005, MUTAT RES-GEN TOX EN, V582, P135, DOI 10.1016/j.mrgentox.2005.01.007; THOMPSON LH, 1982, SOMAT CELL GENET, V8, P759, DOI 10.1007/BF01543017; Tian Z, 2013, MOL BIOL REP, V40, P4147, DOI 10.1007/s11033-012-2463-5; Vaezi A, 2011, PHARMACOGEN PERS MED, V4, P47, DOI 10.2147/PGPM.S20317; Varzim G, 2003, EUR J CANCER PREV, V12, P495, DOI 10.1097/00008469-200312000-00008; Veld CWOH, 1998, MUTAT RES-FUND MOL M, V398, P83, DOI 10.1016/S0027-5107(97)00243-1; Wang ML, 2013, J BIOMED RES, V27, P179, DOI 10.7555/JBR.27.20130034; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Yan L, 2009, DIS ESOPHAGUS, V22, P396, DOI 10.1111/j.1442-2050.2008.00912.x; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Yuan H, 2012, EXP THER MED, V3, P719, DOI 10.3892/etm.2012.476; Zhang K, 2012, GENE, V510, P93, DOI 10.1016/j.gene.2012.08.039; Zhang Y, 2013, TUMOR BIOL, V34, P2321, DOI 10.1007/s13277-013-0779-y	65	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86798	10.1371/journal.pone.0086798	http://dx.doi.org/10.1371/journal.pone.0086798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497981	gold, Green Submitted, Green Published			2022-12-27	WOS:000330617100033
J	Generous, N; Margevicius, KJ; Taylor-McCabe, KJ; Brown, M; Daniel, WB; Castro, L; Hengartner, A; Deshpande, A				Generous, Nicholas; Margevicius, Kristen J.; Taylor-McCabe, Kirsten J.; Brown, Mac; Daniel, W. Brent; Castro, Lauren; Hengartner, Andrea; Deshpande, Alina			Selecting Essential Information for Biosurveillance-A Multi-Criteria Decision Analysis	PLOS ONE			English	Article							PUBLIC-HEALTH	The National Strategy for Biosurveillancedefines biosurveillance as "the process of gathering, integrating, interpreting, and communicating essential information related to all-hazards threats or disease activity affecting human, animal, or plant health to achieve early detection and warning, contribute to overall situational awareness of the health aspects of an incident, and to enable better decision-making at all levels." However, the strategy does not specify how "essential information" is to be identified and integrated into the current biosurveillance enterprise, or what the metrics qualify information as being "essential". Thequestion of data stream identification and selection requires a structured methodology that can systematically evaluate the tradeoffs between the many criteria that need to be taken in account. Multi-Attribute Utility Theory, a type of multi-criteria decision analysis, can provide a well-defined, structured approach that can offer solutions to this problem. While the use of Multi-Attribute Utility Theoryas a practical method to apply formal scientific decision theoretical approaches to complex, multi-criteria problems has been demonstrated in a variety of fields, this method has never been applied to decision support in biosurveillance. We have developed a formalized decision support analytic framework that can facilitate identification of "essential information" for use in biosurveillance systems or processes and we offer this framework to the global BSV community as a tool for optimizing the BSV enterprise. To demonstrate utility, we applied the framework to the problem of evaluating data streams for use in an integrated global infectious disease surveillance system.	[Generous, Nicholas; Margevicius, Kristen J.; Brown, Mac; Daniel, W. Brent; Castro, Lauren; Hengartner, Andrea; Deshpande, Alina] Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA; [Taylor-McCabe, Kirsten J.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Generous, N (corresponding author), Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA.	generous@lanl.gov		Deshpande, Alina/0000-0003-4541-4410; Generous, Nicholas/0000-0003-2238-428X; Margevicius, Kristen/0000-0002-4116-8307	Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense; U.S. Department of Energy [B114525l]; Los Alamos National Laboratory	Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	The Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense is acknowledged as the sponsor of this work, under a "work for others" arrangement, issued under the prime contract for research, development, test, and evaluation services between the U.S. Department of Energy and Los Alamos National Laboratory (#B114525l). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, STAT METHODS COUNTER, DOI [10.1007/0-387-35209-0_9, DOI 10.1007/0-387-35209-0_, DOI 10.1007/0-387-35209-0]; Awasthi A, 2011, MATH COMPUT MODEL, V53, P98, DOI 10.1016/j.mcm.2010.07.023; Baltussen R, 2010, HEALTH POLICY, V96, P262, DOI 10.1016/j.healthpol.2010.01.009; Bots PWG, 2000, J MULTICRITERIA DECI, V9, P56, DOI DOI 10.1002/1099-1360(200001/05)9:1/3; Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124; Corley CD, 2012, BIOSECUR BIOTERROR, V10, P131, DOI 10.1089/bsp.2011.0096; Deshpande A, 2013, SYSTEMATIC EVALUATIO; Drewe JA, 2015, TRANSBOUND EMERG DIS, V62, P33, DOI 10.1111/tbed.12063; Drewe JA, 2012, EPIDEMIOL INFECT, V140, P575, DOI 10.1017/S0950268811002160; EDWARDS W, 1994, ORGAN BEHAV HUM DEC, V60, P306, DOI 10.1006/obhd.1994.1087; Gajewski K, 2012, ISDS 2012 C P OJPHI, V5, DOI 10.52102Fojphi.v5i1.4444; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Keeney RL, 1976, DECISIONS MULTIPLE O, P1; KORHONEN P, 1992, EUR J OPER RES, V63, P361, DOI 10.1016/0377-2217(92)90155-3; Logical Decisions, 2007, LOGICAL DECISIONS DE; Malecki KC, 2008, J PUBLIC HEALTH MAN, V14, P543, DOI 10.1097/01.PHH.0000338366.74327.c9; Margevicius M, 2013, PLOS UNPUB; Miller CC, 2005, ACAD MANAGE EXEC, V19, P19, DOI 10.5465/AME.2005.15841948; Pappaioanou M, 2003, SOC SCI MED, V57, P1925, DOI 10.1016/S0277-9536(03)00058-3; Regos G, 2013, CENT EUR J OPER RES, V21, P845, DOI 10.1007/s10100-012-0257-4; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Siegrist David, 2004, MMWR Suppl, V53, P152; SLOVIC P, 1977, ANNU REV PSYCHOL, V28, P1, DOI 10.1146/annurev.ps.28.020177.000245; Sosin DM, 2004, CDC MMWR S, V53, P125; White House (United States), 2012, NAT STRAT BIOS; Winterfeldt DV, 1973, MULTIATTRIBUTE UTILI	26	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86601	10.1371/journal.pone.0086601	http://dx.doi.org/10.1371/journal.pone.0086601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489748	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000049
J	Gueriau, P; Mocuta, C; Dutheil, DB; Cohen, SX; Thiaudiere, D; Charbonnier, S; Clement, G; Bertrand, L				Gueriau, Pierre; Mocuta, Cristian; Dutheil, Didier B.; Cohen, Serge X.; Thiaudiere, Dominique; Charbonnier, Sylvain; Clement, Gael; Bertrand, Loic		OT1 Consortium	Trace Elemental Imaging of Rare Earth Elements Discriminates Tissues at Microscale in Flat Fossils	PLOS ONE			English	Article							SYNCHROTRON; MOROCCO; PRESERVATION; BIOAPATITES; SYSTEMATICS; SEDIMENTS; TAPHONOMY; CALCIUM	The interpretation of flattened fossils remains a major challenge due to compression of their complex anatomies during fossilization, making critical anatomical features invisible or hardly discernible. Key features are often hidden under greatly preserved decay prone tissues, or an unpreparable sedimentary matrix. A method offering access to such anatomical features is of paramount interest to resolve taxonomic affinities and to study fossils after a least possible invasive preparation. Unfortunately, the widely-used X-ray micro-computed tomography, for visualizing hidden or internal structures of a broad range of fossils, is generally inapplicable to flattened specimens, due to the very high differential absorbance in distinct directions. Here we show that synchrotron X-ray fluorescence spectral raster-scanning coupled to spectral decomposition or a much faster Kullback-Leibler divergence based statistical analysis provides microscale visualization of tissues. We imaged exceptionally well-preserved fossils from the Late Cretaceous without needing any prior delicate preparation. The contrasting elemental distributions greatly improved the discrimination of skeletal elements material from both the sedimentary matrix and fossilized soft tissues. Aside content in alkaline earth elements and phosphorus, a critical parameter for tissue discrimination is the distinct amounts of rare earth elements. Local quantification of rare earths may open new avenues for fossil description but also in paleoenvironmental and taphonomical studies.	[Gueriau, Pierre; Charbonnier, Sylvain; Clement, Gael] UPMC, MNHN, UMR CNRS 7207, CR2P, Paris, France; [Gueriau, Pierre; Cohen, Serge X.; Bertrand, Loic] MCC, USR CNRS 3461, IPANEMA, Gif Sur Yvette, France; [Mocuta, Cristian; Thiaudiere, Dominique; Bertrand, Loic] Synchrotron SOLEIL, Gif Sur Yvette, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; SOLEIL Synchrotron	Gueriau, P (corresponding author), UPMC, MNHN, UMR CNRS 7207, CR2P, Paris, France.	gueriau@mnhn.fr; loic.bertrand@synchrotron-soleil.fr	BERTRAND, Loic E/D-3556-2013; /ABG-2074-2021; BERTRAND, Loïc/ABA-5354-2020; Gueriau, Pierre/X-6682-2019; MOCUTA, Cristian/AAZ-9342-2020; Charbonnier, Sylvain/AAU-9571-2020	BERTRAND, Loic E/0000-0001-6622-9113; Gueriau, Pierre/0000-0002-7529-3456; Dutheil, Didier/0000-0002-4856-0918; JALIL, Nour-Eddine/0000-0002-7617-7625	French ANR under the TERRES project [ANR-2010-BLAN-607-03]; CNRS/MNHN/UPMC [UMR 7207 CR2P]; ATM biodiversite actuelle et fossile (MNHN); Cadi Ayyad University, Marrakesh, Morocco	French ANR under the TERRES project(French National Research Agency (ANR)); CNRS/MNHN/UPMC; ATM biodiversite actuelle et fossile (MNHN); Cadi Ayyad University, Marrakesh, Morocco	This work was supported by the French ANR (http://www.agence-nationale-recherche.fr/) under the TERRES project (ANR-2010-BLAN-607-03 grant). The field campaign was supported by the UMR 7207 CR2P (CNRS/MNHN/UPMC), the ATM biodiversite actuelle et fossile (MNHN), and the Cadi Ayyad University, Marrakesh, Morocco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Z.S., 1980, SOC EC PALEONTOL MIN, V29, P19; Ardanova LI, 2010, INORG CHEM, V49, P10687, DOI 10.1021/ic1015127; ARRHENIUS G, 1957, NATURE, V180, P85, DOI 10.1038/180085a0; Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; Bernard S, 2009, REV PALAEOBOT PALYNO, V156, P248, DOI 10.1016/j.revpalbo.2008.09.002; Bernat M., 1975, CAH ORSTROM SR GEOL, V7, P65; Bertrand L, 2012, PHYS REP, V519, P51, DOI 10.1016/j.physrep.2012.03.003; BRIGGS DEG, 1981, LETHAIA, V14, P157, DOI 10.1111/j.1502-3931.1981.tb01918.x; Cai YP, 2012, PALAEOGEOGR PALAEOCL, V326, P109, DOI 10.1016/j.palaeo.2012.02.009; Dutheil DB, 1999, J VERTEBR PALEONTOL, V19, P243, DOI 10.1080/02724634.1999.10011138; DUTHEIL DB, 1999, MESOZOIC FISHES, V2, P553; Edwards N, 2012, APPL PHYS A, P1; Edwards NP, 2011, P ROY SOC B-BIOL SCI, V278, P3209, DOI 10.1098/rspb.2011.0135; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Filleul A, 2004, J VERTEBR PALEONTOL, V24, P290, DOI 10.1671/3004; Filleul A, 2001, J VERTEBR PALEONTOL, V21, P774, DOI 10.1671/0272-4634(2001)021[0774:SOAFAF]2.0.CO;2; Friel JJ, 2006, MICROSC MICROANAL, V12, P2, DOI 10.1017/S1431927606060211; Gaines RR, 2012, P NATL ACAD SCI USA, V109, P5180, DOI 10.1073/pnas.1111784109; Garassino Alessandro, 2006, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V147, P3; Get'man EI, 2008, RUSS J INORG CHEM+, V53, P1342, DOI 10.1134/S0036023608080329; Herwartz D, 2013, GEOCHIM COSMOCHIM AC, V103, P161, DOI 10.1016/j.gca.2012.10.038; Houssaye A, 2011, J VERTEBR PALEONTOL, V31, P2, DOI 10.1080/02724634.2011.539650; Kocsis L, 2010, GEOCHIM COSMOCHIM AC, V74, P6077, DOI 10.1016/j.gca.2010.08.007; Koenig AE, 2009, GEOLOGY, V37, P511, DOI 10.1130/G25551A.1; MARTILL DM, 1992, PALAEONTOLOGY, V35, P869; Matton O, 2012, PALAEOGEOGR PALAEOCL, V361, P73, DOI 10.1016/j.palaeo.2012.08.004; Orr PJ, 2009, PALAEOGEOGR PALAEOCL, V277, P1, DOI 10.1016/j.palaeo.2009.02.009; Orr PJ, 1998, SCIENCE, V281, P1173, DOI 10.1126/science.281.5380.1173; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Seilacher A., 1970, MONATSHEFTE, V1970, P34; Smith SY, 2009, P NATL ACAD SCI USA, V106, P12013, DOI 10.1073/pnas.0901468106; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Trueman CN, 2013, PALAEONTOLOGY, V56, P475, DOI 10.1111/pala.12041; Trueman CN, 2011, PALAEOGEOGR PALAEOCL, V310, P124, DOI 10.1016/j.palaeo.2011.01.002; Tutken T, 2011, GEOCHIM COSMOCHIM AC, V75, P5951, DOI 10.1016/j.gca.2011.07.024; Wogelius RA, 2011, SCIENCE, V333, P1622, DOI 10.1126/science.1205748	37	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86946	10.1371/journal.pone.0086946	http://dx.doi.org/10.1371/journal.pone.0086946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489809	gold, Green Published			2022-12-27	WOS:000330570000082
J	Lin, BB; Fuller, RA; Bush, R; Gaston, KJ; Shanahan, DF				Lin, Brenda B.; Fuller, Richard A.; Bush, Robert; Gaston, Kevin J.; Shanahan, Danielle F.			Opportunity or Orientation? Who Uses Urban Parks and Why	PLOS ONE			English	Article							BASE-LINE SYNDROME; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; GREEN SPACE; ASSOCIATIONS; BENEFITS; CONSERVATION; ACCESS; SCALE; HEART	There is growing recognition that interactions with nature provide many desirable human well-being outcomes, yet increasing urbanization is degrading the quality and quantity of nature experiences. Thus, it has become increasingly important to understand how and why urban dwellers interact with nature. Studies of urban green space use have largely focused on the availability and ease of access to green space, suggesting that greater opportunities to experience such space will lead to increased use. However, a growing literature emphasizes the potential for an individual's nature orientation to affect their interaction with green space. Here we measure the importance of both opportunity and orientation factors in explaining urban park use. An urban lifestyle survey was deployed across Brisbane, Australia in November 2012 to assess patterns of green space use. Participants (n = 1479) were asked to provide information on demographics, private yard use, park visitations in the past week, and their orientation toward nature. About 60% of those surveyed had visited a park in the past week, and while this park user population had significantly greater nearby park coverage (within a 250 m radius; p = 0.006), a much stronger determinant of visitation was their higher nature orientation (p<0.00001), suggesting that while both opportunity and orientation are important drivers for park visitation, nature orientation is the primary effect. Park users also spent significantly more time in their yards than non-park users (p<0.00001), suggesting that yard use does not necessarily compensate for lower park use. Park users with stronger nature orientation (i) spent more time in their yard, (ii) traveled further to green spaces, and (iii) made longer visits than park visitors with weaker nature orientation. Overall, our results suggest that measures to increase people's connection to nature could be more important than measures to increase urban green space availability if we want to encourage park visitation.	[Lin, Brenda B.] CSIRO, Climate Adaptat Flagship Marine & Atmospher Res, Melbourne, Vic, Australia; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Bush, Robert] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Shanahan, Danielle F.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Exeter; University of Queensland	Lin, BB (corresponding author), CSIRO, Climate Adaptat Flagship Marine & Atmospher Res, Melbourne, Vic, Australia.	bbclin@gmail.com	Lin, Brenda B/A-8834-2011; Fuller, Richard/B-7971-2008; Shanahan, Danielle/F-8437-2013; Lin, Brenda/O-3578-2019	Lin, Brenda B/0000-0002-6011-9172; Fuller, Richard/0000-0001-9468-9678; Lin, Brenda/0000-0002-6011-9172; Gaston, Kevin J./0000-0002-7235-7928	Australian Research Council [DP120102857]; Australian Research Council Future Fellowship	Australian Research Council(Australian Research Council); Australian Research Council Future Fellowship(Australian Research Council)	Funding was provided by the Australian Research Council Discovery grant DP120102857 (http://www.arc.gov.au/), and an Australian Research Council Future Fellowship to RAF. In kind contributions were made by the Commonwealth Scientific and Industrial Research Organisation Climate Adaptation Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WORLD URB PROSP 2009; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Barbosa O, 2007, LANDSCAPE URBAN PLAN, V83, P187, DOI 10.1016/j.landurbplan.2007.04.004; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Bixler RD, 2002, ENVIRON BEHAV, V34, P795, DOI 10.1177/001391602237248; Cochrane T, 2009, INT J ENV RES PUB HE, V6, P654, DOI 10.3390/ijerph6020654; Cohen DA, 2007, AM J PUBLIC HEALTH, V97, P509, DOI 10.2105/AJPH.2005.072447; Department of Health, 2005, CHOOS ACT PHYS ACT A; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Dutcher DD, 2007, ENVIRON BEHAV, V39, P474, DOI 10.1177/0013916506298794; Gobster PH, 2001, LANDSCAPE URBAN PLAN, V56, P35, DOI 10.1016/S0169-2046(01)00164-5; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hillsdon M, 2008, J EPIDEMIOL COMMUN H, V62, P344, DOI 10.1136/jech.2006.058610; Kaplan R, 1989, EXPERIENCE NATURE PS; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Kessel A, 2009, PUBLIC HEALTH, V123, P32, DOI 10.1016/j.puhe.2008.08.005; Kweon BS, 1998, ENVIRON BEHAV, V30, P832, DOI 10.1177/001391659803000605; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P212, DOI 10.1093/pubmed/fdq068; Lin BB, 2013, J APPL ECOL, V50, P1161, DOI 10.1111/1365-2664.12118; Marmot M., 2014, STRATEGIC REV HLTH I; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Morris N., 2003, HLTH WELL BEING OPEN; Nabhan G.P., 1993, BIOPHILIA HYPOTHESIS, P229; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pyle RM, 2002, CHILDREN AND NATURE, P305; PYLE RM, 1977, HORTICULTURE, V55, P65; Queensland Government, 2009, S E QUEENSL REG PLAN; R Core Team, 2012, R LANG ENV STAT COMP; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rung AL, 2011, J PHYS ACT HEALTH, V8, pS178, DOI 10.1123/jpah.8.s2.s178; Sacker A, 2006, EUR J PUBLIC HEALTH, V16, P331, DOI 10.1093/eurpub/cki189; Shaw KA, 2006, COCHRANE DATABASE SY, P4; Standish RJ, 2012, LANDSCAPE ECOLOGY, P1; Stigsdotter UK, 2010, SCAND J PUBLIC HEALT, V38, P411, DOI 10.1177/1403494810367468; Stokes DL, 2006, BIOSCIENCE, V56, P6; Sugiyama T, 2010, AM J PUBLIC HEALTH, V100, P1752, DOI 10.2105/AJPH.2009.182006; Thomas D, 2006, COCHRANE DATABASE SY, V3; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; World Health Organization (WHO), 2012, URB POP GROWTH SIT T	43	224	228	10	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87422	10.1371/journal.pone.0087422	http://dx.doi.org/10.1371/journal.pone.0087422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489913	Green Published, gold			2022-12-27	WOS:000330570000144
J	Martins-Green, M; Adhami, N; Frankos, M; Valdez, M; Goodwin, B; Lyubovitsky, J; Dhall, S; Garcia, M; Egiebor, I; Martinez, B; Green, HW; Havel, C; Yu, L; Liles, S; Matt, G; Destaillats, H; Sleiman, M; Gundel, LA; Benowitz, N; Jacob, P; Hovell, M; Winickoff, JP; Curras-Collazo, M				Martins-Green, Manuela; Adhami, Neema; Frankos, Michael; Valdez, Mathew; Goodwin, Benjamin; Lyubovitsky, Julia; Dhall, Sandeep; Garcia, Monika; Egiebor, Ivie; Martinez, Bethanne; Green, Harry W.; Havel, Christopher; Yu, Lisa; Liles, Sandy; Matt, Georg; Destaillats, Hugo; Sleiman, Mohammed; Gundel, Laura A.; Benowitz, Neal; Jacob, Peyton, III; Hovell, Melbourne; Winickoff, Jonathan P.; Curras-Collazo, Margarita			Cigarette Smoke Toxins Deposited on Surfaces: Implications for Human Health	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SECONDHAND SMOKE; THIRDHAND-SMOKE; METABOLIC SYNDROME; 2ND-HAND SMOKE; US POPULATION; NITROUS-ACID; EXPOSURE; AIR; NONSMOKERS	Cigarette smoking remains a significant health threat for smokers and nonsmokers alike. Secondhand smoke (SHS) is intrinsically more toxic than directly inhaled smoke. Recently, a new threat has been discovered - Thirdhand smoke (THS) the accumulation of SHS on surfaces that ages with time, becoming progressively more toxic. THS is a potential health threat to children, spouses of smokers and workers in environments where smoking is or has been allowed. The goal of this study is to investigate the effects of THS on liver, lung, skin healing, and behavior, using an animal model exposed to THS under conditions that mimic exposure of humans. THS-exposed mice show alterations in multiple organ systems and excrete levels of NNAL (a tobacco-specific carcinogen biomarker) similar to those found in children exposed to SHS (and consequently to THS). In liver, THS leads to increased lipid levels and non-alcoholic fatty liver disease, a precursor to cirrhosis and cancer and a potential contributor to cardiovascular disease. In lung, THS stimulates excess collagen production and high levels of inflammatory cytokines, suggesting propensity for fibrosis with implications for inflammation-induced diseases such as chronic obstructive pulmonary disease and asthma. In wounded skin, healing in THS-exposed mice has many characteristics of the poor healing of surgical incisions observed in human smokers. Lastly, behavioral tests show that THS-exposed mice become hyperactive. The latter data, combined with emerging associated behavioral problems in children exposed to SHS/THS, suggest that, with prolonged exposure, they may be at significant risk for developing more severe neurological disorders. These results provide a basis for studies on the toxic effects of THS in humans and inform potential regulatory policies to prevent involuntary exposure to THS.	[Martins-Green, Manuela; Adhami, Neema; Frankos, Michael; Valdez, Mathew; Goodwin, Benjamin; Dhall, Sandeep; Garcia, Monika; Egiebor, Ivie; Martinez, Bethanne; Curras-Collazo, Margarita] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Lyubovitsky, Julia] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Green, Harry W.] Univ Calif Riverside, Grad Div, Riverside, CA 92521 USA; [Havel, Christopher; Yu, Lisa; Benowitz, Neal; Jacob, Peyton, III] Univ Calif San Francisco, Div Clin Pharmacol, San Francisco, CA 94143 USA; [Liles, Sandy; Hovell, Melbourne] San Diego State Univ, Ctr Behav Epidemiol & Community Hlth, Sch Publ Hlth, San Diego, CA 92182 USA; [Matt, Georg] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Destaillats, Hugo; Sleiman, Mohammed; Gundel, Laura A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Indoor Environm Grp, Berkeley, CA 94720 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, MGH Ctr Child & Adolescent Hlth Res & Policy, Boston, MA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California San Francisco; California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University; Harvard Medical School	Martins-Green, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	manuela.martins@ucr.edu	Destaillats, Hugo/B-7936-2013	Matt, Georg/0000-0001-5604-4609; Sleiman, Mohamad/0000-0002-2273-1053	Tobacco Research Disease Related Program (TRDRP) [19XT-0166]; American Physiological Society; University of California Institute for Mexico; United States/Consejo Nacional de Ciencia y Tecnologia; California Consortium on Third Hand Smoke, TRDRP [20PT-0184]; National Institutes of Health [S10 RR026437, P30 DA012393]; Maternal & Child Health Bureau [R4O MC 00185]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026437, P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	Tobacco Research Disease Related Program (TRDRP); American Physiological Society; University of California Institute for Mexico; United States/Consejo Nacional de Ciencia y Tecnologia; California Consortium on Third Hand Smoke, TRDRP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal & Child Health Bureau(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by Tobacco Research Disease Related Program (TRDRP) grant #19XT-0166 to MM-G, a Porter Fellowship from the American Physiological Society to MV and a The University of California Institute for Mexico and the United States/Consejo Nacional de Ciencia y Tecnologia grant to MC-C. The Analytical Chemistry work done at the University of California, San Francisco, was supported by the California Consortium on Third Hand Smoke, TRDRP 20PT-0184, and the National Institutes of Health, grants #S10 RR026437 and #P30 DA012393. Child NNAL assays were supported by a grant from Maternal & Child Health Bureau #R4O MC 00185 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, HLTH CONS INV EXP TO; Anthony HM, 1985, REVS ENV HLTH, V8, P25; Asotra K, 2009, P INT S CANC CHEM TR, P3; Azambuja E, 2005, PULM PHARMACOL THER, V18, P363, DOI 10.1016/j.pupt.2005.01.007; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Burton A, 2011, ENVIRON HEALTH PERSP, V119, pA71; Chaouachi K, 2009, INT J ENV RES PUB HE, V6, P798, DOI 10.3390/ijerph6020798; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; de Zeeuw P, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.12; Demarin V, 2010, ACTA CLIN CROAT, V49, P429; Drehmer JE, 2012, AM J PREV MED, V43, P533, DOI 10.1016/j.amepre.2012.07.020; EPA, 2004, ICR19960 EPA ETS; Fmlayson-Pitts BJ, 2000, CHEM UPPER LOWER ATM, P847; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hang B, 2013, MUTAGENESIS IN PRESS, DOI [10.1093/mutage/get013, DOI 10.1093/MUTAGE/GET013)]; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Hovell MF, 2009, NICOTINE TOB RES, V11, P1383, DOI 10.1093/ntr/ntp148; Jacob P, 2008, ANAL CHEM, V80, P8115, DOI 10.1021/ac8009005; Kabir Z, 2011, PEDIATRICS, V128, P263, DOI 10.1542/peds.2011-0023; Kisfali P, 2010, CURR MED CHEM, V17, P3533, DOI 10.2174/092986710792927822; Kupiainen H, 2012, PULM MED, V2012, DOI 10.1155/2012/725024; Lee K, 2002, ENVIRON HEALTH PERSP, V110, P145, DOI 10.1289/ehp.02110145; Levy DE, 2011, PEDIATRICS, V128, P650, DOI 10.1542/peds.2011-1067; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Matsuki Hideaki, 2008, Journal of UOEH, V30, P235; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Matt GE, 2013, TOB CONTROL, V0, P1, DOI [10.1136/tobaccocontrol-2012-05082, DOI 10.1136/T0BACC0C0NTR0L-2012-050824]; Matt GE, 2008, NICOTINE TOB RES, V10, P1467, DOI 10.1080/14622200802279898; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; Matt GE, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037382; National Institutes of Heath, 1994, SMOK TOB CONTR MPOON, V7; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Ott W, 2008, J EXPO SCI ENV EPID, V18, P312, DOI 10.1038/sj.jes.7500601; Pirkle JL, 2006, ENVIRON HEALTH PERSP, V114, P853, DOI 10.1289/ehp.8850; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Prignot JJ, 2011, INT J ENV RES PUB HE, V8, P648, DOI 10.3390/ijerph8030648; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Schick SF, 2013, TOP CONTROL IN PRESS, DOI [10.1136/tobaccocontrol-2012-050915, DOI 10.1136/T0BACC0C0NTR0L-2012-050915)]; Singer BC, 2003, ATMOS ENVIRON, V37, P5551, DOI 10.1016/j.atmosenv.2003.07.015; Sleiman M, 2010, ATMOS ENVIRON, V44, P4191, DOI 10.1016/j.atmosenv.2010.07.023; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Sorensen LT, 2010, ADV WOUND CARE, V1, P83, DOI 10.1089/awc.2009.0134; Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199; U.S. Food and Drug Administration, 2012, GUID REG COMPL HARMF; Venn A, 2007, CIRCULATION, V115, P990, DOI 10.1161/CIRCULATIONAHA.106.648469; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184; Yolton K, 2003, ENVIRON HEALTH PERSP, V113, P98; Yolton K, 2009, NEUROTOXICOL TERATOL, V31, P356, DOI 10.1016/j.ntt.2009.07.004; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026	51	90	95	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86391	10.1371/journal.pone.0086391	http://dx.doi.org/10.1371/journal.pone.0086391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489722	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000037
J	Ni, YL; Kuan, AS; Chen, TY				Ni, Yu-Li; Kuan, Ai-Seon; Chen, Tsung-Yu			Activation and Inhibition of TMEM16A Calcium-Activated Chloride Channels	PLOS ONE			English	Article							CL-CHANNEL; CONDUCTANCE; COMPONENTS; MECHANISM; AFFINITY; CA2+	Calcium-activated chloride channels (CaCC) encoded by family members of transmembrane proteins of unknown function 16 (TMEM16) have recently been intensely studied for functional properties as well as their physiological roles as chloride channels in various tissues. One technical hurdle in studying these channels is the well-known channel rundown that frequently impairs the precision of electrophysiological measurements for the channels. Using experimental protocols that employ fast-solution exchange, we circumvented the problem of channel rundown by normalizing the Ca2+-induced current to the maximally-activated current obtained within a time period in which the channel rundown was negligible. We characterized the activation of the TMEM16A-encoded CaCC (also called ANO1) by Ca2+, Sr2+, and Ba2+, and discovered that Mg2+ competes with Ca2+ in binding to the divalent-cation binding site without activating the channel. We also studied the permeability of the ANO1 pore for various anions and found that the anion occupancy in the pore-as revealed by the permeability ratios of these anions-appeared to be inversely correlated with the apparent affinity of the ANO1 inhibition by niflumic acid (NFA). On the other hand, the NFA inhibition was neither affected by the degree of the channel activation nor influenced by the types of divalent cations used for the channel activation. These results suggest that the NFA inhibition of ANO1 is likely mediated by altering the pore function but not through changing the channel gating. Our study provides a precise characterization of ANO1 and documents factors that can affect divalent cation activation and NFA inhibition of ANO1.	[Ni, Yu-Li; Kuan, Ai-Seon; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, TY (corresponding author), Univ Calif Davis, Dept Neurol, Ctr Neurosci, Davis, CA 95616 USA.	tycchen@ucdavis.edu		Ni, Yu Li/0000-0003-1600-9854	National Institutes of Health, USA [R01GM065447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant from National Institutes of Health, USA (R01GM065447) to TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomaviciene A, 2013, J PHYSIOL-LONDON, V591, P3487, DOI 10.1113/jphysiol.2013.251660; Arreola J, 1996, J GEN PHYSIOL, V108, P35, DOI 10.1085/jgp.108.1.35; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen YF, 2011, J MEMBRANE BIOL, V240, P121, DOI 10.1007/s00232-011-9350-1; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2008, SCIENCE, V322, P534, DOI 10.1126/science.1165668; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kunzelmann K, 2013, PFLUGERS ARCH; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Lee TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055930; Machaca K, 2002, CURR TOP MEMBR, V53, P3; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Qu ZQ, 2001, J BIOL CHEM, V276, P18423, DOI 10.1074/jbc.M101264200; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Richman DP, 2012, NEUROMOL MED, V14, P328, DOI 10.1007/s12017-012-8190-1; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2012, EXP PHYSIOL, V97, P177, DOI 10.1113/expphysiol.2011.058198; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607; Zhang XD, 2009, J GEN PHYSIOL, V133, P43, DOI 10.1085/jgp.200810004; Zhou Y, 2012, P NATL ACAD SCI USA, V109, P11413, DOI 10.1073/pnas.1204444109	43	43	46	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86734	10.1371/journal.pone.0086734	http://dx.doi.org/10.1371/journal.pone.0086734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489780	Green Published, gold			2022-12-27	WOS:000330570000066
J	Sasabe, J; Suzuki, M; Miyoshi, Y; Tojo, Y; Okamura, C; Ito, S; Konno, R; Mita, M; Hamase, K; Aiso, S				Sasabe, Jumpei; Suzuki, Masataka; Miyoshi, Yurika; Tojo, Yosuke; Okamura, Chieko; Ito, Sonomi; Konno, Ryuichi; Mita, Masashi; Hamase, Kenji; Aiso, Sadakazu			Ischemic Acute Kidney Injury Perturbs Homeostasis of Serine Enantiomers in the Body Fluid in Mice: Early Detection of Renal Dysfunction Using the Ratio of Serine Enantiomers	PLOS ONE			English	Article							AMINO-ACID OXIDASE; D-ASPARTATE RECEPTOR; PERFORMANCE LIQUID-CHROMATOGRAPHY; FUNCTIONAL NMDA RECEPTORS; INDUCED NEPHROTOXICITY; ATYPICAL PROPERTIES; HUMAN-PLASMA; RACEMASE; SERUM; EXPRESSION	The imbalance of blood and urine amino acids in renal failure has been studied mostly without chiral separation. Although a few reports have shown the presence of D-serine, an enantiomer of L-serine, in the serum of patients with severe renal failure, it has remained uncertain how serine enantiomers are deranged in the development of renal failure. In the present study, we have monitored serine enantiomers using a two-dimensional HPLC system in the serum and urine of mice after renal ischemia-reperfusion injury (IRI), known as a mouse model of acute kidney injury. In the serum, the level of D-serine gradually increased after renal IRI in parallel with that of creatinine, whereas the L-serine level decreased sharply in the early phase after IRI. The increase of D-serine was suppressed in part by genetic inactivation of a D-serine-degrading enzyme, D-amino acid oxidase (DAO), but not by disruption of its synthetic enzyme, serine racemase, in mice. Renal DAO activity was detected exclusively in proximal tubules, and IRI reduced the number of DAO-positive tubules. On the other hand, in the urine, D-serine was excreted at a rate nearly triple that of L-serine in mice with sham operations, indicating that little D-serine was reabsorbed while most L-serine was reabsorbed in physiological conditions. IRI significantly reduced the ratio of urinary D-/L-serine from 2.82+/-0.18 to 1.10+/-0.26 in the early phase and kept the ratio lower than 0.5 thereafter. The urinary D-/L-serine ratio can detect renal ischemia earlier than kidney injury molecule-1 (KIM-1) or neutrophil gelatinase-associated lipocalin (NGAL) in the urine, and more sensitively than creatinine, cystatin C, or the ratio of D-/L-serine in the serum. Our findings provide a novel understanding of the imbalance of amino acids in renal failure and offer a potential new biomarker for an early detection of acute kidney injury.	[Sasabe, Jumpei; Suzuki, Masataka; Ito, Sonomi; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Miyoshi, Yurika; Hamase, Kenji] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 812, Japan; [Tojo, Yosuke; Okamura, Chieko; Mita, Masashi] Shiseido Co Ltd, Innovat Sci Res & Dev Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Konno, Ryuichi] Int Univ Hlth & Welf, Dept Pharmacol Sci, Ohtawara, Tochigi, Japan	Keio University; Kyushu University; Shiseido Company, Limited; International University of Health & Welfare	Sasabe, J (corresponding author), Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Shinanomachi, Tokyo, Japan.	sasabe@a8.keio.jp; aiso@a3.keio.jp	Suzuki, Masataka/HHC-1883-2022	Suzuki, Masataka/0000-0001-5352-8595	Grants-in-Aid for Scientific Research [25293007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anderson M, 2011, AM J PHYSIOL-CELL PH, V300, pC22, DOI 10.1152/ajpcell.00268.2010; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; BRUCKNER H, 1993, J CHROMATOGR-BIOMED, V614, P7, DOI 10.1016/0378-4347(93)80218-S; Deng AH, 2009, AM J PHYSIOL-RENAL, V296, pF976, DOI 10.1152/ajprenal.90391.2008; FUKUSHIMA T, 1995, BIOL PHARM BULL, V18, P1130; FURST P, 1989, J AM COLL NUTR, V8, P310; GANOTE CE, 1974, AM J PATHOL, V77, P269; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; KALTENBACH JP, 1982, EXP MOL PATHOL, V37, P225, DOI 10.1016/0014-4800(82)90038-7; Kawasaka K, 1998, CLIN NEPHROL, V49, P214; Kottgen M, 2011, AM J PHYSIOL-CELL PH, V300, pC9, DOI 10.1152/ajpcell.00453.2010; Krug AW, 2007, AM J PHYSIOL-RENAL, V293, pF382, DOI 10.1152/ajprenal.00441.2006; Leung JC, 2002, AM J PHYSIOL-REG I, V283, pR964, DOI 10.1152/ajpregu.00629.2001; Maekawa M, 2005, CHEM RES TOXICOL, V18, P1678, DOI 10.1021/tx0500326; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Miyoshi Y, 2012, AMINO ACIDS, V43, P1919, DOI 10.1007/s00726-012-1398-4; Miyoshi Y, 2011, J CHROMATOGR B, V879, P3184, DOI 10.1016/j.jchromb.2010.08.024; Miyoshi Y, 2009, J CHROMATOGR B, V877, P2506, DOI 10.1016/j.jchromb.2009.06.028; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NAGATA Y, 1987, CLIN SCI, V73, P105, DOI 10.1042/cs0730105; Obermuller N, 2013, INT UROL NE IN PRESS; Pundir M, 2013, J SURG RES, V183, P668, DOI 10.1016/j.jss.2013.01.040; Sasabe J, 2012, P NATL ACAD SCI USA, V109, P627, DOI 10.1073/pnas.1114639109; Silbernagl S, 1999, AM J PHYSIOL-RENAL, V276, pF857, DOI 10.1152/ajprenal.1999.276.6.F857; Sproul A, 2011, AM J PHYSIOL-RENAL, V301, pF44, DOI 10.1152/ajprenal.00666.2010; TIZIANELLO A, 1989, CONTRIB NEPHROL, V75, P185; WATANABE T, 1978, ANAL BIOCHEM, V86, P310, DOI 10.1016/0003-2697(78)90347-0; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Xia MH, 2004, MOL BRAIN RES, V125, P96, DOI 10.1016/j.molbrainres.2004.03.007; Yang CC, 2008, AM J PHYSIOL-RENAL, V294, pF1433, DOI 10.1152/ajprenal.00481.2007; Zhang HZ, 2012, AMINO ACIDS, V42, P337, DOI 10.1007/s00726-010-0811-0	35	43	49	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86504	10.1371/journal.pone.0086504	http://dx.doi.org/10.1371/journal.pone.0086504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489731	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000041
J	Wei, MT; He, YZ; Wang, JR; Chen, N; Zhou, ZG; Wang, ZQ				Wei, MingTian; He, YaZhou; Wang, JiaRong; Chen, Nan; Zhou, ZongGuang; Wang, ZiQiang			Laparoscopic versus Open Hepatectomy with or without Synchronous Colectomy for Colorectal Liver Metastasis: A Meta-Analysis	PLOS ONE			English	Article							SIMULTANEOUS RESECTION; HEPATIC RESECTION; CANCER; EXPERIENCE; OUTCOMES; TUMOR; SAFE	Background: To compare short-term and long-term results of colorectal patients undergoing laparoscopic and open hepatectomy. Moreover, outcomes of laparoscopic versus open procedures for simultaneous primary colorectal tumor and liver metastasis resection were compared. Methods: A systematic search was conducted in the PubMed and EmBase databases (until Oct. 22. 2013) with no limits. Bibliographic citation management software (EndNote X6) was used for extracted literature management. Quality assessment was performed according to a modification of the Newcastle-Ottawa Scale. The data were analyzed using Review Manager (Version 5.1), and sensitivity analysis was performed by sequentially omitting each study. Results: Finally, 14 studies, including a total of 975 CLM (colorectal liver metastasis) patients, compared laparoscopic with open hepatectomy. 3 studies of them, including a total of 107 CLM patients, compared laparoscopic with open procedures for synchronous hepatectomy and colectomy. Laparoscopic hepatectomy was associated with a significantly less blood loss, shorter hospitalization time, and less operative transfusion rate. In addition, lower hospital morbidity rate (OR = 0.57, 95% CI: 0.42-0.78, P = 0.0005) and better R0 resection (OR = 2.44, 95% CI: 1.21-4.94, P = 0.01) were observed in laparoscopic hepatectomy. For long-term outcomes, there were no significant differences between two surgical procedures on recurrence and overall survival. In comparison of synchronous hepatectomy and colectomy, laparoscopic procedure displayed shorter hospitalization (MD = 23.40, 95%CI: -4.37-2.44, P<0.00001) than open procedure. Other outcomes, including surgical time, estimated blood loss, hospital morbidity, and overall survival did not differ significantly in the comparison. Conclusions: Laparoscopic hepatectomy with or without synchronous colectomy are acceptable for selective CLM patients. We suggest standard inclusion criteria of CLM patients be formulated.	[Wei, MingTian; He, YaZhou; Zhou, ZongGuang; Wang, ZiQiang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [He, YaZhou; Wang, JiaRong; Chen, Nan] Sichuan Univ, West China Med Sch, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Wang, ZQ (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	wangzqzyh@163.com	He, Yazhou/K-8890-2019	, Zongguang/0000-0002-7616-1199	National Natural Science Foundation of China [81172373]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (grant 81172373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hilal M, 2010, BRIT J SURG, V97, P927, DOI 10.1002/bjs.7034; Abu Hilal M, 2012, ARCH SURG-CHICAGO, V147, P42, DOI 10.1001/archsurg.2011.856; Akiyoshi T, 2009, DIGEST SURG, V26, P471, DOI 10.1159/000237109; Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Bretagnol F, 2008, SURGERY, V144, P436, DOI 10.1016/j.surg.2008.04.014; Cannon RM, 2012, SURGERY, V152, P567, DOI 10.1016/j.surg.2012.07.013; Castaing D, 2009, ANN SURG, V250, P849, DOI 10.1097/SLA.0b013e3181bcaf63; Chen KY, 2011, CHINESE MED J-PEKING, V124, P2990, DOI 10.3760/cma.j.issn.0366-6999.2011.19.006; Cheung TT, 2013, ANZ J SURG, V83, P847, DOI 10.1111/j.1445-2197.2012.06270.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doughtie CA, 2013, AM SURGEON, V79, P566; Feroci F, 2013, SURG ENDOSC, V27, P1130, DOI 10.1007/s00464-012-2559-y; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/00000658-200207000-00014; Guerron AD, 2013, SURG ENDOSC, V27, P1138, DOI 10.1007/s00464-012-2563-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hu MG, 2012, SURG LAPARO ENDO PER, V22, P364, DOI 10.1097/SLE.0b013e31825af6b2; Huh JW, 2011, SURG ENDOSC, V25, P193, DOI 10.1007/s00464-010-1158-z; Inoue Y, 2013, AM SURGEON, V79, P495; Iwahashi S, 2013, SURG ENDOSC; Johnstone PAS, 1996, J CLIN ONCOL, V14, P1950, DOI 10.1200/JCO.1996.14.6.1950; Karakousis GC, 2011, ANN SURG ONCOL, V18, P1599, DOI 10.1245/s10434-010-1517-y; Kazaryan AM, 2010, ARCH SURG-CHICAGO, V145, P34, DOI 10.1001/archsurg.2009.229; Lesurtel M, 2003, J AM COLL SURGEONS, V196, P236, DOI 10.1016/S1072-7515(02)01622-8; Leung KL, 2006, J LAPAROENDOSC ADV S, V16, P486, DOI 10.1089/lap.2006.16.486; Mala T, 2002, SURG ENDOSC, V16, P1059, DOI 10.1007/s00464-001-9176-5; Martin R, 2003, J AM COLL SURGEONS, V197, P233, DOI 10.1016/S1072-7515(03)00390-9; Nguyen KT, 2009, ANN SURG, V250, P842, DOI 10.1097/SLA.0b013e3181bc789c; O'Rourke Nicholas, 2004, HPB (Oxford), V6, P230, DOI 10.1080/13651820410023978; Paolucci V, 1999, WORLD J SURG, V23, P989, DOI 10.1007/s002689900613; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pathak S, 2010, EJSO-EUR J SURG ONC, V36, P1044, DOI 10.1016/j.ejso.2010.08.137; Pham TH, 2010, AM J SURG, V199, P594, DOI 10.1016/j.amjsurg.2010.01.005; Qiu JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060153; Sasaki A, 2009, BRIT J SURG, V96, P274, DOI 10.1002/bjs.6472; Tanaka K, 2004, SURGERY, V136, P650, DOI 10.1016/j.surg.2004.02.012; Thelen A, 2007, INT J COLORECTAL DIS, V22, P1269, DOI 10.1007/s00384-007-0286-y; Topal H, 2012, SURG ENDOSC, V26, P2451, DOI 10.1007/s00464-012-2209-4; Uchiyama K, 2010, WORLD J SURG, V34, P2953, DOI 10.1007/s00268-010-0764-1; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Vibert E, 2006, BRIT J SURG, V93, P67, DOI 10.1002/bjs.5150; Weber JC, 2003, BRIT J SURG, V90, P956, DOI 10.1002/bjs.4132; Zhou YY, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-13	44	29	32	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87461	10.1371/journal.pone.0087461	http://dx.doi.org/10.1371/journal.pone.0087461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489916	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000147
J	Fu, RG; Zhang, T; Wang, L; Du, Y; Jia, LN; Hou, JJ; Yao, GL; Liu, XD; Zhang, L; Chen, L; Gui, BS; Xue, RL				Fu, Rong-Guo; Zhang, Tao; Wang, Li; Du, Yan; Jia, Li-Ning; Hou, Jing-Jing; Yao, Gang-Lian; Liu, Xiao-Dan; Zhang, Lei; Chen, Ling; Gui, Bao-Song; Xue, Rong-Liang			Inhibition of the K+ Channel K(Ca)3.1 Reduces TGF-beta 1-Induced Premature Senescence, Myofibroblast Phenotype Transition and Proliferation of Mesangial Cells	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; SMALL-CONDUCTANCE; RENAL FIBROSIS; EXPRESSION; MARKER; KCA3.1; MODULATION; BLOCKADE; KINASE; ACTIN	Objective: K(Ca)3.1 channel participates in many important cellular functions. This study planned to investigate the potential involvement of K(Ca)3.1 channel in premature senescence, myofibroblast phenotype transition and proliferation of mesangial cells. Methods & Materials: Rat mesangial cells were cultured together with TGF-beta 1 (2 ng/ml) and TGF-beta 1 (2 ng/ml) + TRAM-34 (16 nM) separately for specified times from 0 min to 60 min. The cells without treatment served as controls. The location of K(Ca)3.1 channels in mesangial cells was determined with Confocal laser microscope, the cell cycle of mesangial cells was assessed with flow cytometry, the protein and mRNA expression of K(Ca)3.1, alpha-smooth muscle actin (alpha-SMA) and fibroblast-specific protein-1 (FSP-1) were detected with Western blot and RT-PCR. One-way analysis of variance (ANOVA) and Student-Newman-Keuls-q test (SNK-q) were used to do statistical analysis. Statistical significance was considered at P<0.05. Results: K(ca)3.1 channels were located in the cell membranes and/or in the cytoplasm of mesangial cells. The percentage of cells in G(0)-G(1) phase and the expression of K(ca)3.1, alpha-SMA and FSP-1 were elevated under the induction of TGF-beta 1 when compared to the control and decreased under the induction of TGF-beta 1+TRAM-34 when compared to the TGF-beta 1 induced (P<0.05 or P<0.01). Conclusion: Targeted disruption of K(Ca)3.1 inhibits TGF-beta 1-induced premature aging, myofibroblast-like phenotype transdifferentiation and proliferation of mesangial cells.	[Fu, Rong-Guo; Wang, Li; Du, Yan; Jia, Li-Ning; Yao, Gang-Lian; Gui, Bao-Song] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Nephrol, Xian, Shaanxi Provinc, Peoples R China; [Zhang, Tao; Hou, Jing-Jing] Xi An Jiao Tong Univ, Sch Med, Xian, Shaanxi Provinc, Peoples R China; [Liu, Xiao-Dan] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Cadres Ward, Xian, Shaanxi Provinc, Peoples R China; [Zhang, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Med Lab, Xian, Shaanxi Provinc, Peoples R China; [Chen, Ling] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Xian, Shaanxi Provinc, Peoples R China; [Xue, Rong-Liang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesia, Xian, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Gui, BS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Nephrol, Xian, Shaanxi Provinc, Peoples R China.	guibsdoctor@sina.com; xuerl2h@126.com			National Natural Science Foundation of China [81100530, 81070590, 30901926]; Scientific and Technological Project of Shaanxi Province [2011K14-09-02, 2012K16-08-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Project of Shaanxi Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81100530, 81070590, 30901926) (http://www.nsfc.gov.cn), and Scientific and Technological Project of Shaanxi Province (Nos. 2011K14-09-02, 2012K16-08-04) (http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K. -I., 2010, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/175381; Bariety J, 2003, NEPHROL DIAL TRANSPL, V18, P1777, DOI 10.1093/ndt/gfg231; Bedi Surmeet, 2008, Transplant Rev (Orlando), V22, P1, DOI 10.1016/j.trre.2007.09.004; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Catacuzzeno Luigi, 2012, J Signal Transduct, V2012, P421564, DOI 10.1155/2012/421564; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Dorado F, 2008, NEPHROL DIAL TRANSPL, V23, P3403, DOI 10.1093/ndt/gfn333; Fu RG, 2013, RENAL FAILURE, V35, P1142, DOI 10.3109/0886022X.2013.817279; Garneau L, 2009, J BIOL CHEM, V284, P389, DOI 10.1074/jbc.M805700200; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Huang C, 2013, NEPHROL DIAL TRANSPL; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jiao SM, 2012, MOL CELL BIOCHEM, V365, P9, DOI 10.1007/s11010-011-1197-3; JOHNSON RJ, 1992, J AM SOC NEPHROL, V2, pS190; Kaneko Y, 2003, PATHOL INT, V53, P507, DOI 10.1046/j.1440-1827.2003.01507.x; Kimura Kuniko, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P160; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Lee DH, 2012, AM J PHYSIOL-RENAL, V302, pF183, DOI 10.1152/ajprenal.00407.2011; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Ma R, 2005, PHYSIOLOGY, V20, P102, DOI 10.1152/physiol.00050.2004; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Stephenson LA, 1998, KIDNEY INT, V54, P1175, DOI 10.1046/j.1523-1755.1998.00101.x; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Strutz F, 2000, KIDNEY INT, V57, P1521, DOI 10.1046/j.1523-1755.2000.00997.x; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Vandorpe DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008732; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yoshimura H, 2009, EXP MOL PATHOL, V87, P70, DOI 10.1016/j.yexmp.2009.02.002	46	10	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87410	10.1371/journal.pone.0087410	http://dx.doi.org/10.1371/journal.pone.0087410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489911	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000133
J	Hua, RX; Li, HP; Liang, YB; Zhu, JH; Zhang, B; Ye, S; Dai, QS; Xiong, SQ; Gu, Y; Sun, XZ				Hua, Rui-Xi; Li, He-Ping; Liang, Yan-Bing; Zhu, Jin-Hong; Zhang, Bing; Ye, Sheng; Dai, Qiang-Sheng; Xiong, Shi-Qiu; Gu, Yong; Sun, Xiang-Zhou			Association between the PARP1 Val762Ala Polymorphism and Cancer Risk: Evidence from 43 Studies	PLOS ONE			English	Article							EXCISION-REPAIR GENES; SINGLE-NUCLEOTIDE POLYMORPHISMS; NON-HODGKIN-LYMPHOMA; DNA-REPAIR; GASTRIC-CANCER; BREAST-CANCER; COLORECTAL-CANCER; CERVICAL-CANCER; PATHWAY GENES; POLY(ADP-RIBOSE) POLYMERASE-1	Background: Poly (ADP-ribose) polymerase-1 (PARP-1) plays critical roles in the detection and repair of damaged DNA, as well as cell proliferation and death. Numerous studies have examined the associations between PARP1 Val762Ala (rs1136410 T>C) polymorphism and cancer susceptibility; nevertheless, the findings from different research groups remain controversial. Methods: We searched literatures from MEDLINE, EMBASE and CBM pertaining to such associations, and then calculated pooled odds ratio (OR) and 95% confidence interval (CI) by using random-effects model. The false-positive report probability (FPRP) analysis was used to confirm the validity of significant findings. Moreover, potential effects of rs1136410 variants on PARP1 mRNA expression were analyzed for three ethnicities by combining data from HapMap (genotype) and SNPexp (mRNA expression). Results: The final meta-analysis incorporated 43 studies, consisting of 17,351 cases and 22,401 controls. Overall, our results did not suggest significant associations between Ala variant (Ala/Ala or Ala/Val genotype) and cancer risk. However, further stratification analysis showed significantly increased risk for gastric cancer (Ala/Ala vs. Val/Val: OR = 1.56, 95% CI = 1.01-2.42, Ala/Val vs. Val/Val: OR = 1.34, 95% CI = 1.14-1.58, dominant model: OR = 1.41, 95% CI = 1.21-1.65 and Ala vs. Val: OR = 1.29, 95% CI = 1.07-1.55). On the contrary, decreased risk for brain tumor (Ala/Val vs. Val/Val: OR = 0.77, 95% CI = 0.68-0.87, dominant model: OR = 0.77, 95% CI = 0.68-0.87 and Ala vs. Val: OR = 0.82, 95% CI = 0.74-0.91). Additionally, we found that the Ala carriers had a significantly increased risk in all models for Asians. Our mRNA expression data provided further biological evidence to consolidate this finding. Conclusions: Despite some limitations, this meta-analysis found evidence for an association between the PAPR1 Val762Ala and cancer susceptibility within gastric cancer, brain tumor and Asian subgroups.	[Hua, Rui-Xi; Li, He-Ping; Ye, Sheng; Dai, Qiang-Sheng] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Yan-Bing] Sun Yat Sen Univ, Gen Dept Internal Med, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Jin-Hong] Harbin Med Univ, Dept Mol Epidemiol & Lab Med, Affiliated Tumor Hosp, Harbin, Peoples R China; [Zhang, Bing] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Shi-Qiu] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Gu, Yong] Sun Yat Sen Univ, Dept Thorac Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Xiang-Zhou] Sun Yat Sen Univ, Dept Urinary Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Harbin Medical University; Sun Yat Sen University; University of Cambridge; Sun Yat Sen University; Sun Yat Sen University	Gu, Y (corresponding author), Sun Yat Sen Univ, Dept Thorac Surg, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	pea333@163.com; sxz973@126.com		Hua, Rui-Xi/0000-0001-5319-656X; Zhu, Jinhong/0000-0002-0408-3101	Science and Technology Projects Foundation of Guangdong Province [2012B031800501]; Natural Science Foundation of Guangdong Province [S2012010008827, S2011010005282]	Science and Technology Projects Foundation of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by grants from the Science and Technology Projects Foundation of Guangdong Province (No. 2012B031800501) and Natural Science Foundation of Guangdong Province (No. S2012010008827 and No. S2011010005282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt SI, 2007, CANCER RES, V67, P1395, DOI 10.1158/0008-5472.CAN-06-1390; Brevik A, 2010, CANCER EPIDEM BIOMAR, V19, P3167, DOI 10.1158/1055-9965.EPI-10-0606; Cao WH, 2007, MUTAT RES-GEN TOX EN, V632, P20, DOI 10.1016/j.mrgentox.2007.04.011; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Gao R, 2010, CANCER BIOL THER, V10, P13, DOI 10.4161/cbt.10.1.12172; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; He J, 2013, INT J CANCER, V133, P1765, DOI 10.1002/ijc.28089; He J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049308; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; Huang MS, 2007, CANCER EPIDEM BIOMAR, V16, P84, DOI 10.1158/1055-9965.EPI-06-0712; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin XM, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-38; Kang SL, 2010, WORLD J GASTROENTERO, V18, P1434; Kim J, 2011, DNA CELL BIOL, V30, P1011, DOI 10.1089/dna.2011.1250; Landi S, 2006, CANCER RES, V66, P11062, DOI 10.1158/0008-5472.CAN-06-1039; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0505-z; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Nakao M, 2012, J EPIDEMIOL, V22, P477, DOI 10.2188/jea.JE20120010; Pabalan N, 2012, MOL BIOL REP, V39, P11061, DOI 10.1007/s11033-012-2009-x; Pan XF, 2012, ASIAN PAC J CANCER P, V13, P5637, DOI 10.7314/APJCP.2012.13.11.5637; Parikh SS, 1997, STRUCTURE, V5, P1543, DOI 10.1016/S0969-2126(97)00303-1; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Roszak A, 2013, MOL DIAGN THER; Santonocito C, 2012, CLIN CHIM ACTA, V413, P1519, DOI 10.1016/j.cca.2012.06.013; Santos LS, 2012, ONCOL REP, V28, P1859, DOI 10.3892/or.2012.1975; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Shi TY, 2013, HUM GENET, V132, P301, DOI 10.1007/s00439-012-1245-4; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stern MC, 2007, CANCER EPIDEM BIOMAR, V16, P2363, DOI 10.1158/1055-9965.EPI-07-0268; Tang LY, 2013, GENE, V524, P84, DOI 10.1016/j.gene.2013.04.064; Tang X, 2012, J MED RES, V41, P151; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang KP, 2011, OCCUP HLTH, V72, P2165; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Wen YY, 2012, ASIAN PAC J CANCER P, V13, P2139, DOI 10.7314/APJCP.2012.13.5.2139; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Ye CC, 2010, SHIJIE HUAREN XIAO H, V18, P1275; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037446; Yosunkaya E, 2010, BRIT J NEUROSURG, V24, P561, DOI 10.3109/02688697.2010.489655; Yu HP, 2012, GENET EPIDEMIOL, V36, P56, DOI 10.1002/gepi.20663; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan H, 2012, EXP THER MED, V3, P719, DOI 10.3892/etm.2012.476; Zhai XJ, 2006, ONCOL REP, V15, P247; Zhang LH, 2012, ONCOL LETT, V3, P351, DOI 10.3892/ol.2011.463; Zhang MF, 2011, DNA REPAIR, V10, P111, DOI 10.1016/j.dnarep.2010.08.005; Zhang QB, 2009, MOL BIOL REP, V36, P1461, DOI 10.1007/s11033-008-9336-y; [张全保 ZHANG Quanbao], 2008, [中华普通外科杂志, Chinese Journal of General Surgery], V23, P706; Zhang XM, 2005, CANCER RES, V65, P722; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zhang Zhi, 2006, Ai Zheng, V25, P7; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036293	69	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87057	10.1371/journal.pone.0087057	http://dx.doi.org/10.1371/journal.pone.0087057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489833	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000101
J	Jankowski, K; Schindler, DE; Horner-Devine, MC				Jankowski, KathiJo; Schindler, Daniel E.; Horner-Devine, M. Claire			Resource Availability and Spatial Heterogeneity Control Bacterial Community Response to Nutrient Enrichment in Lakes	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; MICROBIAL DIVERSITY; FRESH-WATER; BACTERIOPLANKTON COMMUNITY; PRODUCTIVITY; EUTROPHICATION; ABUNDANCE; PATTERNS; BIODIVERSITY; VARIABILITY	The diversity and composition of ecological communities often co-vary with ecosystem productivity. However, the relative importance of productivity, or resource abundance, versus the spatial distribution of resources in shaping those ecological patterns is not well understood, particularly for the bacterial communities that underlie most important ecosystem functions. Increasing ecosystem productivity in lakes has been shown to influence the composition and ecology of bacterial communities, but existing work has only evaluated the effect of increasing resource supply and not heterogeneity in how those resources are distributed. We quantified how bacterial communities varied with the trophic status of lakes and whether community responses differed in surface and deep habitats in response to heterogeneity in nutrient resources. Using ARISA fingerprinting, we found that bacterial communities were more abundant, richer, and more distinct among habitats as lake trophic state and vertical heterogeneity in nutrients increased, and that spatial resource variation produced habitat specific responses of bacteria in response to increased productivity. Furthermore, changes in communities in high nutrient lakes were not produced by turnover in community composition but from additional taxa augmenting core bacterial communities found in lower productivity lakes. These data suggests that bacterial community responses to nutrient enrichment in lakes vary spatially and are likely influenced disproportionately by rare taxa.	[Jankowski, KathiJo; Schindler, Daniel E.; Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Jankowski, K (corresponding author), Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA.	kathijo@u.washington.edu		Jankowski, Kathi Jo/0000-0002-3292-4182; Horner-Devine, Claire/0000-0002-0783-3406	University of Washington Keeler Professorship; Seattle ARCS Foundation; EPA STAR Fellowship	University of Washington Keeler Professorship; Seattle ARCS Foundation; EPA STAR Fellowship(United States Environmental Protection Agency)	University of Washington Keeler Professorship to Daniel Schindler, Seattle ARCS Foundation and EPA STAR Fellowship to KathiJo Jankowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Barnett A, 2007, ECOLOGY, V88, P1675, DOI 10.1890/06-1056.1; Bell T, 2010, BIOL LETTERS, V6, P639, DOI 10.1098/rsbl.2010.0027; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; De Wever A, 2005, APPL ENVIRON MICROB, V71, P5029, DOI 10.1128/AEM.71.9.5029-5037.2005; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Dorigo U, 2006, FEMS MICROBIOL ECOL, V58, P109, DOI 10.1111/j.1574-6941.2006.00139.x; Eaton A. D., 2005, STANDARD METHODS EXA; Eilts JA, 2011, AM NAT, V177, P574, DOI 10.1086/659633; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Garcia SL, 2013, ENV MICROBIOL REP, V5, P549, DOI 10.1111/1758-2229.12044; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Horner-Devine MC, 2003, ECOL LETT, V6, P613; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jankowski K, 2012, LIMNOL OCEANOGR, V57, P671, DOI 10.4319/lo.2012.57.3.0671; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kolmonen E, 2011, AQUAT MICROB ECOL, V62, P241, DOI 10.3354/ame01461; Korhonen JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022041; Kovacs A, 2010, RES MICROBIOL, V161, P192, DOI 10.1016/j.resmic.2010.01.006; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184; Longmuir A, 2007, ECOLOGY, V88, P1663, DOI 10.1890/06-1448.1; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Madigan MT, 2010, BROCK BIOL MICROORGA; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PACE ML, 1994, MICROBIAL ECOL, V28, P181, DOI 10.1007/BF00166807; R Core Team, 2012, R LANG ENV STAT COMP; Reich PB, 2012, J ECOL, V100, P539, DOI 10.1111/j.1365-2745.2011.01922.x; Reid W.V., 2005, MILLENNIUM ECOSYSTEM, DOI [10.1196/annals.1439.003, DOI 10.1196/ANNALS.1439.003]; Ribalet F, 2010, P NATL ACAD SCI USA, V107, P16571, DOI 10.1073/pnas.1005638107; ROZENZWEIG ML, 1995, SPECIES DIVERSITY SP; Schindler DE, 2003, IMPORTANCE SPECIES P; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x; Shurin JB, 2010, ECOL LETT, V13, P453, DOI 10.1111/j.1461-0248.2009.01438.x; Smith VH, 2007, FEMS MICROBIOL ECOL, V62, P181, DOI 10.1111/j.1574-6941.2007.00381.x; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Tilman D., 1982, Monographs in Population Biology, pi; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Yannarell AC, 2005, APPL ENVIRON MICROB, V71, P227, DOI 10.1128/AEM.71.1.227-239.2005; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	60	27	31	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86991	10.1371/journal.pone.0086991	http://dx.doi.org/10.1371/journal.pone.0086991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489823	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000098
J	Liang, Z; Diepstra, A; Xu, CH; van Imhoff, G; Plattel, W; Van Den Berg, A; Visser, L				Liang, Zheng; Diepstra, Arjan; Xu, Chuanhui; van Imhoff, Gustaaf; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia			Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma	PLOS ONE			English	Article							FACTOR-I RECEPTOR; FACTOR TYPE-1 RECEPTOR; PROSTATE-CANCER CELLS; HUMAN BREAST-CANCER; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASES; IGF-I; EXPRESSION; SURVIVAL	The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment includes aberrant activity of receptor tyrosine kinases. In this study we evaluated the expression, functionality and prognostic significance of Insulin-like growth factor-1 receptor (IGF-1R) in cHL. IGF-1R was overexpressed in 55% (44/80) of cHL patients. Phosphorylated IGF-1R was detectable in a minority of the IGF-1R positive tumor cells. The overall survival (OS, 98%) and 5-year progression-free survival (PFS, 93%) was significantly higher in IGF-1R positive cHL patients compared to IGF-1R negative patients (OS 83%, p = .029 and PFS 77%, p = .047, respectively). Three cHL cell lines showed expression of IGF-1R, with strong staining especially in the mitotic cells and expression of IGF-1. IGF-1 treatment had a prominent effect on the cell growth of L428 and L1236 cells and resulted in an increased phosphorylation of IGF1R, Akt and ERK. Inhibition of IGF-1R with cyclolignan picropodophyllin (PPP) decreased cell growth and induced a G2/M cell cycle arrest in all three cell lines. Moreover, a decrease in pCcd2 and an increase in CyclinB1 levels were observed which is consistent with the G2/M cell cycle arrest. In conclusion, IGF-1R expression in HRS cells predicts a favorable outcome, despite the oncogenic effect of IGF-1R in cHL cell lines.	[Liang, Zheng; Diepstra, Arjan; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Liang, Zheng; Diepstra, Arjan; van Imhoff, Gustaaf; Plattel, Wouter; Van Den Berg, Anke; Visser, Lydia] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Liang, Zheng] Tianjin Med Univ, Canc Inst & Hosp, Canc Cell Biol Lab, Tianjin, Peoples R China; [Liang, Zheng] Tianjin Med Univ, Gen Hosp, Dept Otolaryngol, Tianjin, Peoples R China; [Xu, Chuanhui] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; Tianjin Medical University; Tianjin Medical University; Peking University; University of Groningen	Visser, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	l.visser@umcg.nl	van den Berg, Anke/H-1718-2011; Plattel, Wouter J/A-4135-2012	van den Berg, Anke/0000-0002-8894-2638; Liang, Zheng/0000-0003-4532-4888; Xu, Chuanhui/0000-0002-3222-7168; Diepstra, Arjan/0000-0001-9239-1050	Abel Tasman Talent fellowship (UMCG); Dutch Cancer Society (KWF) fellowship	Abel Tasman Talent fellowship (UMCG); Dutch Cancer Society (KWF) fellowship	Zheng Liang is supported by an Abel Tasman Talent fellowship (UMCG). Wouter Plattel and Arjan Diepstra are both supported by a Dutch Cancer Society (KWF) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen J, 2005, CLIN CANCER RES, V11, P206; Allison AS, 2007, HUM PATHOL, V38, P1590, DOI 10.1016/j.humpath.2007.03.013; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Baserga R, 2000, GROWTH HORM IGF RES, V10, pS43, DOI 10.1016/S1096-6374(00)90021-2; Buettner M, 2005, HEMATOL ONCOL, V23, P127, DOI 10.1002/hon.764; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dutton A, 2005, J PATHOL, V205, P498, DOI 10.1002/path.1725; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; FLORKE RR, 1990, EUR J BIOCHEM, V191, P473, DOI 10.1111/j.1432-1033.1990.tb19146.x; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garcia JF, 2003, BLOOD, V101, P681, DOI 10.1182/blood-2002-04-1128; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; JOHNSON EW, 1992, J IMMUNOL, V148, P63; Kikuchi R, 2012, ANN SURG ONCOL, V19, pS412, DOI 10.1245/s10434-011-1878-x; Kornprat P, 2006, J CLIN PATHOL, V59, P202, DOI 10.1136/jcp.2005.028480; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2002, ADV CANCER RES, V84, P277, DOI 10.1016/S0065-230X(02)84009-X; Kuppers R, 1998, ANNU REV IMMUNOL, V16, P471, DOI 10.1146/annurev.immunol.16.1.471; Lara PC, 2011, ORAL ONCOL, V47, P615, DOI 10.1016/j.oraloncology.2011.05.005; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; LeRoith D, 1995, ANN NY ACAD SCI, V766, P402, DOI 10.1111/j.1749-6632.1995.tb26689.x; Liu YC, 2002, J BIOMED SCI, V9, P665, DOI 10.1159/000067282; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; PAPA V, 1993, CANCER RES, V53, P3736; Pinheiro GS, 2007, SAO PAULO MED J, V125, P77, DOI 10.1590/S1516-31802007000200003; Reiss K, 2001, ONCOGENE, V20, P490, DOI 10.1038/sj.onc.1204112; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Renne C, 2007, INT J CANCER, V120, P2504, DOI 10.1002/ijc.22511; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Scott DW, 2013, J CLIN ONCOL, V31, P692, DOI 10.1200/JCO.2012.43.4589; SEELY BL, 1995, J BIOL CHEM, V270, P19151, DOI 10.1074/jbc.270.32.19151; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Vishwamitra D, 2011, HAEMATOL-HEMATOL J, V96, P871, DOI 10.3324/haematol.2010.031567; Xu CH, 2012, HAEMATOL-HEMATOL J, V97, P572, DOI 10.3324/haematol.2011.056101; Yakar S, 2005, CYTOKINE GROWTH F R, V16, P407, DOI 10.1016/j.cytogfr.2005.01.010; Zumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958	44	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87474	10.1371/journal.pone.0087474	http://dx.doi.org/10.1371/journal.pone.0087474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489919	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000136
J	McMinn, A; Muller, MN; Martin, A; Ryan, KG				McMinn, Andrew; Mueller, Marius N.; Martin, Andrew; Ryan, Ken G.			The Response of Antarctic Sea Ice Algae to Changes in pH and CO2	PLOS ONE			English	Article							INORGANIC CARBON ACQUISITION; GLOBAL CLIMATE-CHANGE; OCEAN ACIDIFICATION; PHYTOPLANKTON; GROWTH; DIATOM; PHOTOSYNTHESIS; SENSITIVITY; PERFORMANCE; ORGANISMS	Ocean acidification substantially alters ocean carbon chemistry and hence pH but the effects on sea ice formation and the CO2 concentration in the enclosed brine channels are unknown. Microbial communities inhabiting sea ice ecosystems currently contribute 10-50% of the annual primary production of polar seas, supporting overwintering zooplankton species, especially Antarctic krill, and seeding spring phytoplankton blooms. Ocean acidification is occurring in all surface waters but the strongest effects will be experienced in polar ecosystems with significant effects on all trophic levels. Brine algae collected from McMurdo Sound (Antarctica) sea ice was incubated in situ under various carbonate chemistry conditions. The carbon chemistry was manipulated with acid, bicarbonate and bases to produce a pCO(2) and pH range from 238 to 6066 mu atm and 7.19 to 8.66, respectively. Elevated pCO(2) positively affected the growth rate of the brine algal community, dominated by the unique ice dinoflagellate, Polarella glacialis. Growth rates were significantly reduced when pH dropped below 7.6. However, when the pH was held constant and the pCO(2) increased, growth rates of the brine algae increased by more than 20% and showed no decline at pCO(2) values more than five times current ambient levels. We suggest that projected increases in seawater pCO(2), associated with OA, will not adversely impact brine algal communities.	[McMinn, Andrew; Mueller, Marius N.; Martin, Andrew] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Martin, Andrew; Ryan, Ken G.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Tasmania; Victoria University Wellington	McMinn, A (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Andrew.mcminn@utas.edu.au	Müller, Marius Nils/N-9338-2014; McMinn, Andrew/A-9910-2008	Müller, Marius Nils/0000-0003-4765-3933; McMinn, Andrew/0000-0002-2133-3854; Martin, Andrew/0000-0001-8260-5529; Ryan, Ken/0000-0001-7075-0112	Australian Antarctic Division [AAS 4008]; Australian Research Council (ARC) [DP1093801]	Australian Antarctic Division; Australian Research Council (ARC)(Australian Research Council)	Financial support for this project came from the Australian Antarctic Division (AAS 4008) and the Australian Research Council (ARC) Discovery Project DP1093801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Bach LT, 2012, BIOGEOSCIENCES, V9, P3449, DOI 10.5194/bg-9-3449-2012; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Beardall J, 2009, PLANT ECOL DIVERS, V2, P191, DOI 10.1080/17550870903271363; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Boelen P, 2011, J EXP MAR BIOL ECOL, V406, P38, DOI 10.1016/j.jembe.2011.06.012; Boyd PW, 2013, NAT CLIM CHANGE, V3, P530, DOI 10.1038/nclimate1881; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Chen SW, 2011, HYDROBIOLOGIA, V675, P105, DOI 10.1007/s10750-011-0807-0; Crawfurd KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026695; de Kluijver A, 2013, BIOGEOSCIENCES, V10, P1425, DOI 10.5194/bg-10-1425-2013; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Dupont S, 2013, MAR BIOL, V160, P1835, DOI 10.1007/s00227-012-1921-x; Evans CA, 1987, HDB MEASUREMENT CHLO; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GYURE RA, 1987, APPL ENVIRON MICROB, V53, P2069, DOI 10.1128/AEM.53.9.2069-2076.1987; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; KOTTMEIER ST, 1987, MAR ECOL PROG SER, V36, P287, DOI 10.3354/meps036287; Krembs C, 2000, J EXP MAR BIOL ECOL, V243, P55, DOI 10.1016/S0022-0981(99)00111-2; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Li G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055562; Matson PG, 2011, ANTARCT SCI, V23, P607, DOI 10.1017/S0954102011000551; McMinn A, 2005, J PHYCOL, V41, P732, DOI 10.1111/j.1529-8817.2005.00095.x; McMinn A, 1999, POLAR BIOL, V21, P220, DOI 10.1007/s003000050356; Mitchell C, 1996, POLAR BIOL, V16, P95; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Ralph PJ, 2005, J PHYCOL, V41, P763, DOI 10.1111/j.1529-8817.2005.00106.x; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2004, J OCEANOGR, V60, P719, DOI 10.1007/s10872-004-5764-z; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rost B, 2006, PLANT CELL ENVIRON, V29, P810, DOI 10.1111/j.1365-3040.2005.01450.x; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Ryan KG, 2012, J PHYCOL, V48, P74, DOI 10.1111/j.1529-8817.2011.01104.x; Schnack-Schiel SB, 2001, POLAR BIOL, V24, P724, DOI 10.1007/s003000100273; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; The Royal Society, 2005, 1205 ROYAL SOC; Thomas DN, 2004, SEA ICE INTRO ITS PH; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P1485, DOI 10.4319/lo.2000.45.7.1485; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Trimborn S, 2013, LIMNOL OCEANOGR, V58, P997, DOI 10.4319/lo.2013.58.3.0997; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002	48	48	49	1	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86984	10.1371/journal.pone.0086984	http://dx.doi.org/10.1371/journal.pone.0086984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489821	gold, Green Accepted, Green Published			2022-12-27	WOS:000330510000097
J	Vagedes, J; Bialkowski, A; Wiechers, C; Poets, CF; Dietz, K				Vagedes, Jan; Bialkowski, Anja; Wiechers, Cornelia; Poets, Christian F.; Dietz, Klaus			A Conversion Formula for Comparing Pulse Oximeter Desaturation Rates Obtained with Different Averaging Times	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; TUCSON CHILDRENS ASSESSMENT; POSITIVE AIRWAY PRESSURE; OXYGEN-SATURATION; PRETERM INFANTS; BREATHING PATTERNS; HEART-RATE; CARE-UNIT; ACCURACY; ARTIFACT	Objective: The number of desaturations determined in recordings of pulse oximeter saturation (SpO(2)) primarily depends on the time over which values are averaged. As the averaging time in pulse oximeters is not standardized, it varies considerably between centers. To make SpO(2) data comparable, it is thus desirable to have a formula that allows conversion between desaturation rates obtained using different averaging times for various desaturation levels and minimal durations. Methods: Oxygen saturation was measured for 170 hours in 12 preterm infants with a mean number of 65 desaturations <90% per hour of arbitrary duration by using a pulse oximeter in a 2-4 s averaging mode. Using 7 different averaging times between 3 and 16 seconds, the raw red-to-infrared data were reprocessed to determine the number of desaturations (D). The whole procedure was carried out for 7 different minimal desaturation durations (>= 1, >= 5, >= 10, >= 15, >= 20, >= 25, >= 30 s) below SpO(2) threshold values of 80%, 85% or 90% to finally reach a conversion formula. The formula was validated by splitting the infants into two groups of six children each and using one group each as a training set and the other one as a test set. Results: Based on the linear relationship found between the logarithm of the desaturation rate and the logarithm of the averaging time, the conversion formula is: D-2 = D-1 (T-2/T-1)(c), where D-2 is the desaturation rate for the desired averaging time T-2, and D-1 is the desaturation rate for the original averaging time T-1, with the exponent c depending on the desaturation threshold and the minimal desaturation duration. The median error when applying this formula was 2.6%. Conclusion: This formula enables the conversion of desaturation rates between different averaging times for various desaturation thresholds and minimal desaturation durations.	[Vagedes, Jan; Bialkowski, Anja; Wiechers, Cornelia; Poets, Christian F.] Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Vagedes, Jan] Filderklin, ARCIM Inst, Res Dept, Filderstadt, Germany; [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Poets, CF (corresponding author), Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany.	Christian-F.Poets@med.uni-tuebingen.de	Wiechers, Cornelia/AAU-9008-2021; Dietz, Klaus/R-9268-2016	Wiechers, Cornelia/0000-0002-6850-6249; Dietz, Klaus/0000-0001-8503-9737				Accardo JA, 2010, SLEEP, V33, P1333, DOI 10.1093/sleep/33.10.1333; Adler JN, 1998, ACAD EMERG MED, V5, P965, DOI 10.1111/j.1553-2712.1998.tb02772.x; Ahmed SJM, 2010, PEDIATRICS, V125, pE115, DOI 10.1542/peds.2008-1749; AMAR D, 1989, J CLIN MONITOR, V5, P135, DOI 10.1007/BF01617888; Barker SJ, 2002, ANESTH ANALG, V95, P967, DOI 10.1213/01.ANE.0000029029.03601.08; Brockmann PE, 2011, ARCH DIS CHILD-FETAL, V96, pF335, DOI 10.1136/adc.2010.196758; Craig S, 2009, J SLEEP RES, V18, P329, DOI 10.1111/j.1365-2869.2008.00726.x; Davila DG, 2003, SLEEP, V26, P91; Davila DG, 2002, CHEST, V122, P1654, DOI 10.1378/chest.122.5.1654; Farre R, 1998, SLEEP, V21, P386, DOI 10.1093/sleep/21.4.386; Goodwin JL, 2010, J PEDIATR-US, V157, P57, DOI 10.1016/j.jpeds.2010.01.033; Goodwin JL, 2001, SLEEP, V24, P937, DOI 10.1093/sleep/24.8.937; HAY WW, 1989, PEDIATRICS, V83, P717; Heimann K, 2010, NEONATOLOGY, V97, P311, DOI 10.1159/000255163; Hensey CC, 2013, ARCH DIS CHILD FETAL; Korcarz CE, 2010, SLEEP, V33, P1081, DOI 10.1093/sleep/33.8.1081; LANGTON JA, 1990, BRIT J ANAESTH, V65, P564, DOI 10.1093/bja/65.4.564; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; McBride GB, 2005, HAM2005062 NIWA; Ortega Rafael, 2011, N Engl J Med, V364, pe33, DOI 10.1056/NEJMvcm0904262; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Petterson MT, 2007, ANESTH ANALG, V105, pS78, DOI 10.1213/01.ane.0000278134.47777.a5; POETS CF, 1993, PEDIATR RES, V34, P144, DOI 10.1203/00006450-199308000-00007; POETS CF, 1991, J DEV PHYSIOL, V15, P341; POETS CF, 1993, PEDIATRICS, V92, P686; POETS CF, 1994, PEDIATRICS, V93, P737; POETS CF, 1991, EARLY HUM DEV, V26, P1, DOI 10.1016/0378-3782(91)90038-5; POETS CF, 1991, ARCH DIS CHILD, V66, P574, DOI 10.1136/adc.66.5.574; Poets CF, 1997, EUR J PEDIATR, V156, P808, DOI 10.1007/s004310050719; Quan SF, 2011, SLEEP, V34, P303, DOI 10.1093/sleep/34.3.303; Rheineck-Leyssius AT, 1999, J CLIN ANESTH, V11, P196, DOI 10.1016/S0952-8180(98)00133-0; Rheineck-Leyssius AT, 1998, J CLIN MONITOR COMP, V14, P151, DOI 10.1023/A:1007431305610; Rheineck-Leyssius RT, 1999, J CLIN ANESTH, V11, P192, DOI 10.1016/S0952-8180(99)00034-3; Robertson FA, 2004, ANESTH ANALG, V98, P617, DOI 10.1213/01.ANE.0000101601.43781.15; Salyer John W, 2003, Respir Care, V48, P386; SEVERINGHAUS JW, 1990, ANESTHESIOLOGY, V73, P532, DOI 10.1097/00000542-199009000-00025; Singh JKSB, 2008, J PAEDIATR CHILD H, V44, P273, DOI 10.1111/j.1440-1754.2007.01250.x; Urschitz MS, 2003, CHEST, V123, P96, DOI 10.1378/chest.123.1.96; Vagedes J, 2012, ARCH DIS CHILD FETAL; Villanueva R, 1999, J CLIN ANESTH, V11, P317, DOI 10.1016/S0952-8180(99)00054-9	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87280	10.1371/journal.pone.0087280	http://dx.doi.org/10.1371/journal.pone.0087280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489887	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000123
J	Cortes, VA; Smalley, SV; Goldenberg, D; Lagos, CF; Hodgson, MI; Santos, JL				Cortes, Victor A.; Smalley, Susan V.; Goldenberg, Denisse; Lagos, Carlos F.; Hodgson, Maria I.; Santos, Jose L.			Divergent Metabolic Phenotype between Two Sisters with Congenital Generalized Lipodystrophy Due to Double AGPAT2 Homozygous Mutations. A Clinical, Genetic and In Silico Study	PLOS ONE			English	Article							HEPATIC STEATOSIS; CLUSTAL-W; 1-ACYLGLYCEROL-3-PHOSPHATE-O-ACYLTRANSFERASE-2; DISEASE; MICE	Congenital generalized lipodystrophy (CGL) is a rare autosomal recessive disorder characterized by extreme reduction of white adipose tissue (WAT) mass. CGL type 1 is the most frequent form and is caused by mutations in AGPAT2. Genetic and clinical studies were performed in two affected sisters of a Chilean family. These patients have notoriously dissimilar metabolic abnormalities that correlate with differential levels of circulating leptin and soluble leptin receptor fraction. Sequencing of AGPAT2 exons and exon-intron boundaries revealed two homozygous mutations in both sisters. Missense mutation c.299G>A changes a conserved serine in the acyltransferase NHX4D motif of AGPAT2 (p.Ser100Asn). Intronic c.493-1G>C mutation destroy a conserved splicing site that likely leads to exon 4 skipping and deletion of whole AGPAT2 substrate binding domain. In silico protein modeling provided insights of the mechanisms of lack of catalytic activity owing to both mutations.	[Cortes, Victor A.; Smalley, Susan V.; Goldenberg, Denisse; Hodgson, Maria I.; Santos, Jose L.] Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Sch Med, Santiago, Chile; [Lagos, Carlos F.] Pontificia Univ Catolica Chile, Dept Endocrinol, Sch Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Cortes, VA (corresponding author), Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Sch Med, Alameda 340, Santiago, Chile.	vcortes@med.puc.cl; jsantos@med.puc.cl	Lagos, Carlos F./N-1445-2019; Santos, Jose Luis/D-1818-2017	Lagos, Carlos F./0000-0002-5432-9747; Santos, Jose Luis/0000-0003-2895-0369; Cortes, Victor/0000-0002-1658-0965	Fondecyt-Chile grants [11100168, 1120586]; Conicyt-PAI [79100019]	Fondecyt-Chile grants(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt-PAI	This work was supported with Fondecyt-Chile grants # 11100168 to V.A.C and # 1120586 to J.L.S. and Conicyt-PAI 79100019 to V.A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Aiyar A, 2000, Methods Mol Biol, V132, P221; Cartwright BR, 2012, J LIPID RES, V53, P1042, DOI 10.1194/jlr.R023754; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fiorenza CG, 2011, NAT REV ENDOCRINOL, V7, P137, DOI 10.1038/nrendo.2010.199; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Haque W, 2005, BIOCHEM BIOPH RES CO, V327, P446, DOI 10.1016/j.bbrc.2004.12.024; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Magre J, 2003, DIABETES, V52, P1573, DOI 10.2337/diabetes.52.6.1573; Salud OMdl, 2013, DIABETES FACT SHEET; Subauste AR, 2012, DIABETES, V61, P2922, DOI 10.2337/db12-0004; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Vogel P, 2011, VET PATHOL, V48, P642, DOI 10.1177/0300985810383870; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105	28	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87173	10.1371/journal.pone.0087173	http://dx.doi.org/10.1371/journal.pone.0087173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498038	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900074
J	Fang, KY; Wilmking, M; Davi, N; Zhou, FF; Liu, CZ				Fang, Keyan; Wilmking, Martin; Davi, Nicole; Zhou, Feifei; Liu, Changzhi			An Ensemble Weighting Approach for Dendroclimatology: Drought Reconstructions for the Northeastern Tibetan Plateau	PLOS ONE			English	Article							TREE-RINGS; PRECIPITATION VARIATION; CHINA; CLIMATE; GROWTH; AD; MONSOON; SERIES; RIVER; PART	Traditional detrending methods assign equal mean value to all tree-ring series for chronology developments, despite that the mean annual growth changes in different time periods. We find that the strength of a tree-ring model can be improved by giving more weights to tree-ring series that have a stronger climate signal and less weight to series that have a weaker signal. We thus present an ensemble weighting method to mitigate these potential biases and to more accurately extract the climate signals in dendroclimatology studies. This new method has been used to develop the first annual precipitation reconstruction (previous August to current July) at the Songmingyan Mountain and to recalculate the tree-ring chronology from Shenge site in Dulan area in northeastern Tibetan Plateau (TP), a marginal area of Asian summer monsoon. The ensemble weighting method explains 31.7% of instrumental variance for the reconstructions at Songmingyan Mountain and 57.3% of the instrumental variance in the Dulan area, which are higher than those developed using traditional methods. We focus on the newly introduced reconstruction at Songmingyan Mountain, which showsextremely dry (wet) epochs from 1862-1874, 1914-1933 and 1991-1999 (1882-1905). These dry/wet epochs were also found in the marginal areas of summer monsoon and the Indian subcontinent, indicating the linkages between regional hydroclimate changes and the Indian summer monsoon.	[Fang, Keyan; Zhou, Feifei] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Coll Geog Sci, Fuzhou, Fujian Province, Peoples R China; [Fang, Keyan; Liu, Changzhi] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Res Sch Arid Environm & Climate Change, Minist Educ, Lanzhou 730000, Gansu, Peoples R China; [Fang, Keyan] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Wilmking, Martin] Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Mecklenburg Vor, Germany; [Davi, Nicole] Columbia Univ, Tree Ring Lab, Lamont Doherty Earth Observ, Palisades, NY USA; [Davi, Nicole] William Paterson Univ, Dept Environm Sci, Wayne, NJ USA	Fujian Normal University; Lanzhou University; University of Helsinki; Ernst Moritz Arndt Universitat Greifswald; Columbia University	Fang, KY (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Coll Geog Sci, Fuzhou, Fujian Province, Peoples R China.	kujanfang@gmail.com	Wilmking, Martin/AAV-9310-2020	Wilmking, Martin/0000-0003-4964-2402; Fang, Keyan/0000-0002-0207-0112; Davi, Nicole/0000-0002-4529-5418	National Basic Research Program of China [2012CB955301]; National Science Foundation of China [41001115, 41171039]; Minjiang Special-term Professor fellowship; NSF AGS [1137729]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minjiang Special-term Professor fellowship; NSF AGS	This research is financed by National Basic Research Program of China (2012CB955301), the National Science Foundation of China (41001115 and 41171039), and the Minjiang Special-term Professor fellowship. Support for Davi comes from NSF AGS # 1137729. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00388; Bollasina MA, 2011, SCIENCE, V334, P502, DOI 10.1126/science.1204994; Briffa KR, 2009, DENDROCLIMATOLOGY PR; Bunn AG, 2011, CLIMATIC CHANGE, V105, P627, DOI 10.1007/s10584-010-0005-5; Chen FH, 2010, QUATERNARY SCI REV, V29, P1055, DOI 10.1016/j.quascirev.2010.01.005; Cook E, 1990, METHODS DENDROCHOLOG; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; D'Arrigo RD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002249; Davi NK, 2009, INT J CLIMATOL, V29, P1508, DOI 10.1002/joc.1798; Davi NK, 2013, WATER RESOUR RES, V49, P151, DOI 10.1029/2012WR011834; Ding YH, 2008, INT J CLIMATOL, V28, P1139, DOI 10.1002/joc.1615; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Fan ZX, 2008, INT J CLIMATOL, V28, P1879, DOI 10.1002/joc.1689; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2010, INT J CLIMATOL, V30, P1137, DOI 10.1002/joc.1974; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Fritts H.C, 1976, TREE RINGS CLIMATE; Gong DY, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032409; Gou XH, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005705; Gou XH, 2010, CHINESE SCI BULL, V55, P4179, DOI 10.1007/s11434-010-4215-z; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liu Y, 2006, SCI CHINA SER D, V49, P408, DOI 10.1007/s11430-006-0408-3; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; MEKO D, 1995, WATER RESOUR BULL, V31, P605; Melvin TM, 2008, DENDROCHRONOLOGIA, V26, P71, DOI 10.1016/j.dendro.2007.12.001; Pederson N, 2001, J CLIMATE, V14, P872, DOI 10.1175/1520-0442(2001)014<0872:HRFNMD>2.0.CO;2; Ramage C.S., 1971, MONSOON METEOROLOGY; Ran YH, 2012, INT J GEOGR INF SCI, V26, P169, DOI 10.1080/13658816.2011.577745; Sachs J, 2009, NATURE GEOSCIENCE, DOI [10.1038/NGEO1554, DOI 10.1038/NGE01554]; Shao XM, 2005, SCI CHINA SER D, V48, P939, DOI 10.1360/03yd0146; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sontakke NA, 2008, HOLOCENE, V18, P1055, DOI 10.1177/0959683608095576; Tan LC, 2008, CLIM PAST, V4, P19; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; YANG B, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001GL014485; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; 张德二, 2003, [应用气象学报, Journal of Applied Meteorolgical Science], V14, P379	48	8	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86689	10.1371/journal.pone.0086689	http://dx.doi.org/10.1371/journal.pone.0086689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497967	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900034
J	Tapper, WJ; Foulds, N; Cross, NCP; Aranaz, P; Score, J; Hidalgo-Curtis, C; Robinson, DO; Gibson, J; Ennis, S; Temple, IK; Collins, A				Tapper, William J.; Foulds, Nicola; Cross, Nicholas C. P.; Aranaz, Paula; Score, Joannah; Hidalgo-Curtis, Claire; Robinson, David O.; Gibson, Jane; Ennis, Sarah; Temple, I. Karen; Collins, Andrew			Megalencephaly Syndromes: Exome Pipeline Strategies for Detecting Low-Level Mosaic Mutations	PLOS ONE			English	Article							OVERGROWTH; FORMAT; PIK3CA	Two megalencephaly (MEG) syndromes, megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyriapolydactyly-hydrocephalus (MPPH), have recently been defined on the basis of physical and neuroimaging features. Subsequently, exome sequencing of ten MEG cases identified de-novo postzygotic mutations in PIK3CA which cause MCAP and de-novo mutations in AKT and PIK3R2 which cause MPPH. Here we present findings from exome sequencing three unrelated megalencephaly patients which identified a causal PIK3CA mutation in two cases and a causal PIK3R2 mutation in the third case. However, our patient with the PIK3R2 mutation which is considered to cause MPPH has a marked bifrontal band heterotopia which is a feature of MCAP. Furthermore, one of our patients with a PIK3CA mutation lacks syndactyly/polydactyly which is a characteristic of MCAP. These findings suggest that the overlap between MCAP and MPPH may be greater than the available studies suggest. In addition, the PIK3CA mutation in one of our patients could not be detected using standard exome analysis because the mutation was observed at a low frequency consistent with somatic mosaicism. We have therefore investigated several alternative methods of exome analysis and demonstrate that alteration of the initial allele frequency spectrum (AFS), used as a prior for variant calling in samtools, had the greatest power to detect variants with low mutant allele frequencies in our 3 MEG exomes and in simulated data. We therefore recommend non-default settings of the AFS in combination with stringent quality control when searching for causal mutation(s) that could have low levels of mutant reads due to post-zygotic mutation.	[Tapper, William J.; Foulds, Nicola; Cross, Nicholas C. P.; Score, Joannah; Hidalgo-Curtis, Claire; Robinson, David O.; Gibson, Jane; Ennis, Sarah; Temple, I. Karen; Collins, Andrew] Univ Southampton, Fac Med, Dept Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Tapper, William J.; Cross, Nicholas C. P.; Aranaz, Paula; Score, Joannah; Hidalgo-Curtis, Claire; Robinson, David O.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Foulds, Nicola; Temple, I. Karen] Univ Southampton, Fac Med, UHS NHS Fdn Trust, Southampton SO9 5NH, Hants, England; [Aranaz, Paula] Univ Navarra, Sch Sci, Dept Genet, E-31080 Pamplona, Spain	University of Southampton; Salisbury District Hospital; University of Southampton; University of Navarra	Tapper, WJ (corresponding author), Univ Southampton, Fac Med, Dept Human Genet & Genom Med, Southampton SO9 5NH, Hants, England.	wjt@soton.ac.uk	temple, isabel K/K-2391-2015; Collins, Andrew/A-6595-2010; Cross, Nicholas/B-4817-2009; Gibson, Jane/I-1630-2012; Collins, Andrew/S-2196-2019	Collins, Andrew/0000-0001-7108-0771; Cross, Nicholas/0000-0001-5481-2555; Gibson, Jane/0000-0002-0973-8285; Collins, Andrew/0000-0001-7108-0771; Temple, Isabel Karen/0000-0002-6045-1781; Tapper, William/0000-0002-5896-1889	University of Southampton Medical School; Leukaemia & Lymphoma Research; Hampshire and Isle of Wight CLRN	University of Southampton Medical School; Leukaemia & Lymphoma Research; Hampshire and Isle of Wight CLRN	This work is supported by funding from University of Southampton Medical School, Leukaemia & Lymphoma Research, and the Hampshire and Isle of Wight CLRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baradaran-Heravi A, 2012, CLIN GENET, V82, P523, DOI 10.1111/cge.12001; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Martinez-Glez V, 2010, AM J MED GENET A, V152A, P3101, DOI 10.1002/ajmg.a.33514; Mirzaa GM, 2012, AM J MED GENET A, V158A, P269, DOI 10.1002/ajmg.a.34402; Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	14	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86940	10.1371/journal.pone.0086940	http://dx.doi.org/10.1371/journal.pone.0086940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497998	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330621900049
J	von Gillhaussen, P; Rascher, U; Jablonowski, ND; Pluckers, C; Beierkuhnlein, C; Temperton, VM				von Gillhaussen, Philipp; Rascher, Uwe; Jablonowski, Nicolai D.; Plueckers, Christine; Beierkuhnlein, Carl; Temperton, Vicky M.			Priority Effects of Time of Arrival of Plant Functional Groups Override Sowing Interval or Density Effects: A Grassland Experiment	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; BIODIVERSITY EXPERIMENT; DIVERSITY; COMMUNITIES; COMPETITION; PRODUCTIVITY; FACILITATION; RESTORATION; MIXTURES; RICHNESS	Priority effects occur when species that arrive first in a habitat significantly affect the establishment, growth, or reproduction of species arriving later and thus affect functioning of communities. However, we know little about how the timing of arrival of functionally different species may alter structure and function during assembly. Even less is known about how plant density might interact with initial assembly. In a greenhouse experiment legumes, grasses or forbs were sown a number of weeks before the other two plant functional types were sown (PFT) in combination with a sowing density treatment. Legumes, grasses or non-legume forbs were sown first at three different density levels followed by sowing of the remaining PFTs after three or six-weeks. We found that the order of arrival of different plant functional types had a much stronger influence on aboveground productivity than sowing density or interval between the sowing events. The sowing of legumes before the other PFTs produced the highest aboveground biomass. The larger sowing interval led to higher asymmetric competition, with highest dominance of the PFT sown first. It seems that legumes were better able to get a head-start and be productive before the later groups arrived, but that their traits allowed for better subsequent establishment of non-legume PFTs. Our study indicates that the manipulation of the order of arrival can create priority effects which favour functional groups of plants differently and thus induce different assembly routes and affect community composition and functioning.	[von Gillhaussen, Philipp; Rascher, Uwe; Jablonowski, Nicolai D.; Plueckers, Christine; Temperton, Vicky M.] Forschungszentrum Julich, Inst Bio & Geosci Plant Sci IBG 2, D-52425 Julich, Germany; [von Gillhaussen, Philipp; Plueckers, Christine; Beierkuhnlein, Carl; Temperton, Vicky M.] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany	Helmholtz Association; Research Center Julich; University of Bayreuth	von Gillhaussen, P (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci Plant Sci IBG 2, D-52425 Julich, Germany.	p.von.gillhaussen@fz-juelich.de	Beierkuhnlein, Carl/ABF-8797-2021; Beierkuhnlein, Carl/ABF-9693-2021; Rascher, Uwe/D-5457-2009; Jablonowski, Nicolai David/AAA-8672-2022	Beierkuhnlein, Carl/0000-0002-6456-4628; Rascher, Uwe/0000-0002-9993-4588; Jablonowski, Nicolai David/0000-0002-5298-5521; Temperton, Vicky/0000-0003-0543-4521	Plant Sciences (IBG-2); Forschungszentrum Julich; Tenure Track group of Vicky Temperton	Plant Sciences (IBG-2); Forschungszentrum Julich(Helmholtz Association); Tenure Track group of Vicky Temperton	This research was funded by Plant Sciences (IBG-2) and the Forschungszentrum Julich and Philipp von Gillhaussen was funded within the Tenure Track group of Vicky Temperton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Bezemer TM, 2007, NATURE, V446, pE6, DOI 10.1038/nature05749; Bullock JM, 2007, J APPL ECOL, V44, P6, DOI 10.1111/j.1365-2664.2006.01252.x; Carter DL, 2012, ECOL APPL, V22, P1308, DOI 10.1890/11-1970.1; Chalk PM, 1998, AUST J AGR RES, V49, P303, DOI 10.1071/A97013; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; DRAKE JA, 1993, J ANIM ECOL, V62, P117, DOI 10.2307/5487; DREW TJ, 1977, FOREST SCI, V23, P517; Eisenhauer N, 2012, PLANT SOIL, V351, P1, DOI 10.1007/s11104-011-1027-0; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; ELLENBERG H, 1979, Scripta Geobotanica, V9, P1; Ellenberg H., 1988, VEGETATION ECOLOGY C; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Finn JA, 2013, J APPL ECOL, V50, P365, DOI 10.1111/1365-2664.12041; Fukami T, 2004, ECOLOGY, V85, P3234, DOI 10.1890/04-0340; Grman E, 2010, RESTOR ECOL, V18, P664, DOI 10.1111/j.1526-100X.2008.00497.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kirwan L, 2009, ECOLOGY, V90, P2032, DOI 10.1890/08-1684.1; Korner C, 2008, NEW PHYTOL, V177, P698, DOI 10.1111/j.1469-8137.2007.02287.x; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Matthiessen B, 2006, ECOL LETT, V9, P652, DOI 10.1111/j.1461-0248.2006.00916.x; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Oelmann Y, 2011, GEODERMA, V167-68, P178, DOI 10.1016/j.geoderma.2011.09.012; Pluckers C, 2013, ACTA OECOL, V53, P110, DOI 10.1016/j.actao.2013.09.004; Roscher C, 2008, J ECOL, V96, P477, DOI 10.1111/j.1365-2745.2008.01353.x; Roscher C, 2011, PLANT SOIL, V341, P333, DOI 10.1007/s11104-010-0647-0; SHULMAN MJ, 1983, ECOLOGY, V64, P1508, DOI 10.2307/1937505; TEMPERTON V. M., 2004, ASSEMBLY RULES RESTO; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U	41	51	52	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86906	10.1371/journal.pone.0086906	http://dx.doi.org/10.1371/journal.pone.0086906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497995	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900047
J	Kamm, CP; El-Koussy, M; Humpert, S; Findling, O; Burren, Y; Schwegler, G; Donati, F; Muller, M; Muller, F; Slotboom, J; Kappos, L; Naegelin, Y; Mattle, HP				Kamm, Christian P.; El-Koussy, Marwan; Humpert, Sebastian; Findling, Oliver; Burren, Yuliya; Schwegler, Guido; Donati, Filippo; Mueller, Martin; Mueller, Felix; Slotboom, Johannes; Kappos, Ludwig; Naegelin, Yvonne; Mattle, Heinrich P.		SWABIMS Study Grp	Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial	PLOS ONE			English	Article							SIMVASTATIN TREATMENT; IMMUNE CELLS; LEWIS RATS; STATINS; DISABILITY; THERAPY; COMORBIDITY; COMBINATION; RESPONSES; EFFICACY	Background: Statins have anti-inflammatory and immunomodulatory properties in addition to lipid-lowering effects. Objectives: To report the 12-month extension of a phase II trial evaluating the efficacy, safety and tolerability of atorvastatin 40 mg/d added to interferon beta-1b (IFNB-1b) in relapsing-remitting multiple sclerosis (RRMS). Methods: In the randomized, multicenter, parallel-group, rater-blinded core study, 77 RRMS patients started IFNB-1b. At month three they were randomized 1: 1 to receive atorvastatin 40 mg/d or not in addition to IFNB-1b until month 15. In the subsequent extension study, patients continued with unchanged medication for another 12 months. Data at study end were compared to data at month three of the core study. Results: 27 of 72 patients that finished the core study entered the extension study. 45 patients were lost mainly due to a safety analysis during the core study including a recruitment stop for the extension study. The primary end point, the proportion of patients with new lesions on T2-weighted images was equal in both groups (odds ratio 1.926; 95% CI 0.265-14.0007; p = 0.51). All secondary endpoints including number of new lesions and total lesion volume on T2-weighted images, total number of Gd-enhancing lesions on T1-weighted images, volume of grey and white matter, EDSS, MSFC, relapse rate, number of relapse-free patients and neutralizing antibodies did not show significant differences either. The combination therapy was well tolerated. Conclusions: Atorvastatin 40 mg/day in addition to IFNB-1b did not have any beneficial effects on RRMS compared to IFNB-1b monotherapy over a period of 24 months.	[Kamm, Christian P.; Humpert, Sebastian; Findling, Oliver; Mattle, Heinrich P.] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Kamm, Christian P.; El-Koussy, Marwan; Humpert, Sebastian; Findling, Oliver; Burren, Yuliya; Slotboom, Johannes; Mattle, Heinrich P.] Univ Bern, Bern, Switzerland; [El-Koussy, Marwan; Burren, Yuliya; Slotboom, Johannes] Univ Hosp Bern, Inselspital, Dept Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Schwegler, Guido] Cantonal Hosp Aarau, Dept Neurol, Aarau, Switzerland; [Donati, Filippo] Spitalzentrum Biel, Dept Neurol, Biel, Switzerland; [Mueller, Martin] Cantonal Hosp Lucerne, Dept Neurol, Luzern, Switzerland; [Mueller, Felix] Cantonal Hosp, Dept Neurol, Muensterlingen, Muensterlingen, Switzerland; [Kappos, Ludwig; Naegelin, Yvonne] Univ Basel, Univ Hosp, Dept Neurol, Basel, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; University of Basel	Mattle, HP (corresponding author), Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland.	heinrich.mattle@insel.ch	Findling, Oliver/AAE-3815-2019		Bayer Schering Pharma (Switzerland); Pfizer (Switzerland); Department of Neurology of the University Hospital Bern, Switzerland	Bayer Schering Pharma (Switzerland)(Bayer AG); Pfizer (Switzerland)(Pfizer); Department of Neurology of the University Hospital Bern, Switzerland	This work was supported by grants of Bayer Schering Pharma (Switzerland) and Pfizer (Switzerland). The sponsor was the Department of Neurology of the University Hospital Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beller EM, 2002, MED J AUSTRALIA, V177, P565, DOI 10.5694/j.1326-5377.2002.tb04955.x; Bertolotto A, 2002, J NEUROL NEUROSUR PS, V73, P148, DOI 10.1136/jnnp.73.2.148; Bhardwaj S, 2012, AM J HEALTH-SYST PH, V69, P1494, DOI 10.2146/ajhp110675; Birnbaum G, 2008, NEUROLOGY, V71, P1390, DOI 10.1212/01.wnl.0000319698.40024.1c; Brescia Morra V, 2012, ECTRIMS LYON; Chataway J, 2012, ECTRIMS; Dhawan N, 2007, NEUROLOGY, V68, pA364; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Feng X, 2012, ARCH NEUROL-CHICAGO, V69, P1303, DOI 10.1001/archneurol.2012.465; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH, 1996, ICH HARM TRIP GUID G; Kamm CP, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-115; Kamm CP, 2012, J NEUROL, V259, P2401, DOI 10.1007/s00415-012-6513-7; Kieseier BC, 2004, ARCH NEUROL-CHICAGO, V61, P929, DOI 10.1001/archneur.61.6.929; Klopfleisch S, 2008, J NEUROSCI, V28, P13609, DOI 10.1523/JNEUROSCI.2765-08.2008; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2010, MULT SCLER J, V16, P450, DOI 10.1177/1352458509358909; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lee H, 2008, PSYCHIAT RES-NEUROIM, V164, P172, DOI 10.1016/j.pscychresns.2007.12.008; Markovic-Plese S, 2008, FUTUR NEUROL, V3, P153, DOI 10.2217/14796708.3.2.153; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Miron VE, 2009, AM J PATHOL, V174, P1880, DOI 10.2353/ajpath.2009.080947; Neuhaus O, 2002, NEUROLOGY, V59, P990, DOI 10.1212/WNL.59.7.990; Paul F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001928; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rudick RA, 2009, NEUROLOGY, V72, P1989, DOI 10.1212/WNL.0b013e3181a92b96; Slotboom J, 2008, INVEST RADIOL, V43, P843, DOI 10.1097/RLI.0b013e3181893605; Sorensen PS, 2011, LANCET NEUROL, V10, P691, DOI 10.1016/S1474-4422(11)70144-2; Stanislaus R, 1999, NEUROSCI LETT, V269, P71, DOI 10.1016/S0304-3940(99)00414-0; Stanislaus R, 2001, J NEUROSCI RES, V66, P155, DOI 10.1002/jnr.1207; Togha M, 2010, MULT SCLER J, V16, P848, DOI 10.1177/1352458510369147; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wang J, 2011, COCHRANE DB SYST REV, V7; WHO Expert Committee on Biological Standardization, 1985, WHO TECH REP SER, V725, P1; *WORLD MED ASS, 2006, DECL HELS ETH PRINC; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86663	10.1371/journal.pone.0086663	http://dx.doi.org/10.1371/journal.pone.0086663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497963	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100023
J	Liang, F; Tang, BX; Wang, YQ; Wang, JF; Yu, CX; Chen, X; Zhu, JW; Yan, JW; Zhao, WM; Li, RJ				Liang, Fang; Tang, Bixia; Wang, Yanqing; Wang, Jianfeng; Yu, Caixia; Chen, Xu; Zhu, Junwei; Yan, Jiangwei; Zhao, Wenming; Li, Rujiao			WBSA: Web Service for Bisulfite Sequencing Data Analysis	PLOS ONE			English	Article							DNA METHYLATION; GENOME; IDENTIFICATION; EPIGENOMICS; ALIGNMENT	Whole-Genome Bisulfite Sequencing (WGBS) and genome-wide Reduced Representation Bisulfite Sequencing (RRBS) are widely used to study DNA methylation. However, data analysis is complicated, lengthy, and hampered by a lack of seamless analytical pipelines. To address these issues, we developed a convenient, stable, and efficient web service called Web Service for Bisulfite Sequencing Data Analysis (WBSA) to analyze bisulfate sequencing data. WBSA focuses on not only CpG methylation, which is the most common biochemical modification in eukaryotic DNA, but also non-CG methylation, which have been observed in plants, iPS cells, oocytes, neurons and stem cells of human. WBSA comprises three main modules as follows: WGBS data analysis, RRBS data analysis, and differentially methylated region (DMR) identification. The WGBS and RRBS modules execute read mapping, methylation site identification, annotation, and advanced analysis, whereas the DMR module identifies actual DMRs and annotates their correlations to genes. WBSA can be accessed and used without charge either online or local version. WBSA also includes the executables of the Portable Batch System (PBS) and standalone versions that can be downloaded from the website together with the installation instructions. WBSA is available at no charge for academic users at http://wbsa.big.ac.cn.	[Liang, Fang; Tang, Bixia; Wang, Yanqing; Wang, Jianfeng; Yu, Caixia; Chen, Xu; Zhu, Junwei; Yan, Jiangwei; Zhao, Wenming; Li, Rujiao] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhao, WM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	zhaowm@big.ac.cn; lirj@big.ac.cn			Natural Science Foundation of China [31000584]; Apparatus Function Innovation Program of the Chinese Academy of Sciences [201212]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Apparatus Function Innovation Program of the Chinese Academy of Sciences	This work was supported by the Natural Science Foundation of China (31000584 to RL), (http://www.nsfc.gov.cn/Portal0/default152.htm); and the Apparatus Function Innovation Program of the Chinese Academy of Sciences (201212 to WZ), (http://www.cas.cn/); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Benoukraf T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1281; Biliya S, 2010, EXP BIOL MED, V235, P139, DOI 10.1258/ebm.2009.009251; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI YX, 2009, BMC BIOINFORMATICS, V10; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Sun ZF, 2012, BIOINFORMATICS, V28, P2180, DOI 10.1093/bioinformatics/bts337; Wang T, 2013, HUM MUTAT; Warden CD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt242; Xu YH, 2007, BIOTECHNIQUES, V43, P334, DOI 10.2144/000112537; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504	30	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86707	10.1371/journal.pone.0086707	http://dx.doi.org/10.1371/journal.pone.0086707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497972	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100026
J	Chandrasekaran, P; Moore, V; Buckley, M; Spurrier, J; Kehrl, JH; Venkatesan, S				Chandrasekaran, Prabha; Moore, Victoria; Buckley, Monica; Spurrier, Joshua; Kehrl, John H.; Venkatesan, Sundararajan			HIV-1 Nef Down-Modulates C-C and C-X-C Chemokine Receptors via Ubiquitin and Ubiquitin-Independent Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CELL-SURFACE EXPRESSION; REGULATES MHC-I; TYPE-1 NEF; ENDOCYTIC PATHWAY; WW DOMAINS; MEMBRANE TRAFFICKING; ARRESTIN-2 INTERACTS; PERIPHERAL-TISSUES	Human and Simian Immunodeficiency virus (HIV-1, HIV-2, and SIV) encode an accessory protein, Nef, which is a pathogenesis and virulence factor. Nef is a multivalent adapter that dysregulates the trafficking of many immune cell receptors, including chemokine receptors (CKRs). Physiological endocytic itinerary of agonist occupied CXCR4 involves ubiquitinylation of the phosphorylated receptor at three critical lysine residues and dynamin-dependent trafficking through the ESCRT pathway into lysosomes for degradation. Likewise, Nef induced CXCR4 degradation was critically dependent on the three lysines in the C-terminal -SSLKILSKGK-motif. Nef directly recruits the HECT domain E3 ligases AIP4 or NEDD4 to CXCR4 in the resting state. This mechanism was confirmed by ternary interactions of Nef, CXCR4 and AIP4 or NEDD4; by reversal of Nef effect by expression of catalytically inactive AIP4-C830A mutant; and siRNA knockdown of AIP4, NEDD4 or some ESCRT-0 adapters. However, ubiquitinylation dependent lysosomal degradation was not the only mechanism by which Nef downregulated CKRs. Agonist and Nef mediated CXCR2 (and CXCR1) degradation was ubiquitinylation independent. Nef also profoundly downregulated the naturally truncated CXCR4 associated with WHIM syndrome and engineered variants of CXCR4 that resist CXCL12 induced internalization via an ubiquitinylation independent mechanism.	[Chandrasekaran, Prabha; Moore, Victoria; Buckley, Monica; Spurrier, Joshua; Venkatesan, Sundararajan] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Kehrl, John H.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Venkatesan, S (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sv1s@nih.gov	Kehrl, John/AAE-6292-2019	Spurrier, Joshua/0000-0002-6267-7231; Kehrl, John/0000-0002-6526-159X	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Intramural Research Program of National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Arora VK, 2002, MICROBES INFECT, V4, P189, DOI 10.1016/S1286-4579(01)01527-1; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Baugher PJ, 2008, J BIOL CHEM, V283, P30868, DOI 10.1074/jbc.M804054200; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Casartelli N, 2003, J VIROL, V77, P11536, DOI 10.1128/JVI.77.21.11536-11545.2003; Chandrasekaran P, 2012, J BIOL CHEM, V287, P41481, DOI 10.1074/jbc.M112.361782; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen N, 2006, EUR J IMMUNOL, V36, P278, DOI 10.1002/eji.200535487; Chrobak P, 2010, J IMMUNOL, V185, P3948, DOI 10.4049/jimmunol.1001064; Collins KL, 1999, IMMUNOL REV, V168, P65, DOI 10.1111/j.1600-065X.1999.tb01283.x; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Drakesmith H, 2005, P NATL ACAD SCI USA, V102, P11017, DOI 10.1073/pnas.0504823102; El-Far M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054295; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kawai T, 2005, EXP HEMATOL, V33, P460, DOI 10.1016/j.exphem.2005.01.001; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kuo LS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-47; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lama J, 2000, J VIROL, V74, P9396, DOI 10.1128/JVI.74.20.9396-9402.2000; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2009, METHOD ENZYMOL, V460, P413, DOI 10.1016/S0076-6879(09)05221-5; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Michel N, 2006, MOL BIOL CELL, V17, P3578, DOI 10.1091/mbc.E06-02-0117; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shinya E, 2004, VIROLOGY, V326, P79, DOI 10.1016/j.virol.2004.06.004; Signoret N, 1998, J CELL SCI, V111, P2819; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2000, J VIROL, V74, P5691, DOI 10.1128/JVI.74.12.5691-5701.2000; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Vigerust DJ, 2005, J LEUKOCYTE BIOL, V77, P522, DOI 10.1189/jlb.0804454; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Yamada T, 2003, J VIROL, V77, P1589, DOI 10.1128/JVI.77.2.1589-1594.2003; Yi L, 2010, J BIOL CHEM, V285, P30884, DOI 10.1074/jbc.M110.135947	104	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86998	10.1371/journal.pone.0086998	http://dx.doi.org/10.1371/journal.pone.0086998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489825	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000090
J	Schirer, Y; Malishkevich, A; Ophir, Y; Lewis, J; Giladi, E; Gozes, I				Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Lewis, Jada; Giladi, Eliezer; Gozes, Illana			Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEUROFIBRILLARY TANGLES; SPLICING FACTORS; UP-REGULATION; GENE; BRAIN; EXPRESSION; INTERACTS; ISOFORMS; LOCALIZATION	Tauopathy, a major pathology in Alzheimer's disease, is also found in similar to 50% of frontotemporal dementias (FTDs). Tau transcript, a product of a single gene, undergoes alternative splicing to yield 6 protein species, each with either 3 or 4 microtubule binding repeat domains (tau 3R or 4R, associated with dynamic and stable microtubules, respectively). While the healthy human brain shows a 1/1 ratio of tau 3R/4R, this ratio may be dramatically changed in the FTD brain. We have previously discovered that activity-dependent neuroprotective protein (ADNP) is essential for brain formation in the mouse, with ADNP+/- mice exhibiting tauopathy, age-driven neurodegeneration and behavioral deficits. Here, in transgenic mice overexpressing a mutated tau 4R species, in the cerebral cortex but not in the cerebellum, we showed significantly increased ADNP expression (similar to 3-fold transcripts) in the cerebral cortex of young transgenic mice (similar to disease onset), but not in the cerebellum, as compared to control littermates. The transgene-age-related increased ADNP expression paralleled augmented dynamic tau 3R transcript level compared to control littermates. Blocking mutated tau 4R transgene expression resulted in normalization of ADNP and tau 3R expression. ADNP was previously shown to be a member of the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex. Here, Brahma (Brm), a component of the SWI/SNF complex regulating alternative splicing, showed a similar developmental expression pattern to ADNP. Immunoprecipitations further suggested Brm-ADNP interaction coupled to ADNP - polypyrimidine tract-binding protein (PTB)-associated splicing factor (PSF)-binding, with PSF being a direct regulator of tau transcript splicing. It should be noted that although we have shown a correlation between levels of ADNP and tau isoform expression three months of age, we are not presenting evidence of a direct link between the two. Future research into ADNP/tau relations is warranted.	[Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Lily & Avraham Gil, Adams Super Ctr Brain Studies,Elton Lab Neuroendo, IL-69978 Tel Aviv, Israel; [Schirer, Yulie; Malishkevich, Anna; Ophir, Yotam; Giladi, Eliezer; Gozes, Illana] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Lewis, Jada] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; State University System of Florida; University of Florida	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Lily & Avraham Gil, Adams Super Ctr Brain Studies,Elton Lab Neuroendo, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il			AMN Foundation; Montreal Circle of Friend; Joe and Grace Alter; Barbara and Don Seal; Oberfeld family; Adams family; Allon Therapeutics Inc.	AMN Foundation; Montreal Circle of Friend; Joe and Grace Alter; Barbara and Don Seal; Oberfeld family; Adams family; Allon Therapeutics Inc.	Support was provided by the AMN Foundation, Montreal Circle of Friend, Joe and Grace Alter, Barbara and Don Seal, the Oberfeld family and the Adams family and Allon Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboonq MS, 2012, J MOL NEUROSCI, V46, P33, DOI 10.1007/s12031-011-9562-y; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Antunes-Martins A, 2007, LEARN MEMORY, V14, P693, DOI 10.1101/lm.640307; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Borozdin Wiktor, 2007, Hum Mutat, V28, P830, DOI 10.1002/humu.9502; Braitch M, 2010, NEUROIMMUNOMODULAT, V17, P120, DOI 10.1159/000258695; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cohen-Armon M, 2006, CHEM BIODIVERS, V3, P535, DOI 10.1002/cbdv.200690057; Cosgrave AS, 2009, J MOL NEUROSCI, V39, P9, DOI 10.1007/s12031-008-9169-0; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Dresner E, 2011, EUR NEUROPSYCHOPHARM, V21, P355, DOI 10.1016/j.euroneuro.2010.06.004; Fernandez-Montesinos R, 2010, J MOL NEUROSCI, V41, P114, DOI 10.1007/s12031-009-9300-x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; de Barreda EG, 2010, FEBS LETT, V584, P2265, DOI 10.1016/j.febslet.2010.03.032; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gozes I, 2010, CURR ALZHEIMER RES, V7, P685, DOI 10.2174/156720510793611628; Gozes I, 2013, J ALZHEIMER IN PRESS; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Gozes Illana, 2005, Current Alzheimer Research, V2, P149, DOI 10.2174/1567205053585873; Gozes I, 2008, J MOL NEUROSCI, V36, P115, DOI 10.1007/s12031-008-9105-3; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Ito T, 2008, BIOCHEM J, V411, P201, DOI 10.1042/BJ20071075; Jouroukhin Y, 2013, NEUROBIOL DIS; Kalbfuss B, 2001, J BIOL CHEM, V276, P42986, DOI 10.1074/jbc.M105113200; Ke YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035678; Lee BC, 1996, BLOOD, V87, P2283, DOI 10.1182/blood.V87.6.2283.bloodjournal8762283; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Mandel S, 2008, J MOL NEUROSCI, V35, P127, DOI 10.1007/s12031-007-9013-y; Mandel S, 2007, J BIOL CHEM, V282, P34448, DOI 10.1074/jbc.M704756200; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Monroy-Ramirez HC, 2013, J ALZHEIMERS DIS, V36, P503, DOI 10.3233/JAD-122401; Mosch K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015894; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051458; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Quraishe S, 2013, MOL PSYCHIATR, V18, P834, DOI 10.1038/mp.2013.32; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Ray P, 2011, J MOL NEUROSCI, V45, P453, DOI 10.1007/s12031-011-9634-z; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shav-Tal Y, 2000, EXP HEMATOL, V28, P1029, DOI 10.1016/S0301-472X(00)00510-5; Shiryaev N, 2011, CURR PHARM DES; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Tsukahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058749; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Yang MH, 2012, J PROTEOMICS, V75, P3617, DOI 10.1016/j.jprot.2012.04.017; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200	55	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87383	10.1371/journal.pone.0087383	http://dx.doi.org/10.1371/journal.pone.0087383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489906	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000139
J	Bu, T; Liu, L; Sun, Y; Zhao, L; Peng, Y; Zhou, SD; Li, LX; Chen, SD; Gao, YH				Bu, Tao; Liu, Li; Sun, Yong; Zhao, Li; Peng, Yang; Zhou, Shudong; Li, Lixia; Chen, Sidong; Gao, Yanhui			XRCC1 Arg399Gln Polymorphism Confers Risk of Breast Cancer in American Population: A Meta-Analysis of 10846 Cases and 11723 Controls	PLOS ONE			English	Article							DNA-REPAIR GENES; XPD LYS751GLN; ASSOCIATION; PATHWAY; SUSCEPTIBILITY; ARG194TRP; SMOKING	Background: In the X-ray repair cross-complementing group 1 (XRCC1) gene, a polymorphism, Arg399Gln (rs25487), has been shown to change neoconservative amino acid and thus result in alternation of DNA repair capacity. Numerous studies have investigated the association between Arg399Gln and breast cancer risk in the American population, but yielding inconsistent results. This study aimed to clarify the role of this polymorphism in susceptibility to breast cancer. Methods: Literatures were searched in multiple databases including PubMed, Springer Link, Ovid, EBSCO and ScienceDirect databases up to April 2013. A comprehensive meta-analysis was conducted to estimate the overall odds ratio (OR), by integrating data from 18 case control studies of 10846 cases and 11723 controls in the American population. Results: Overall, significant association was observed between the Arg399Gln polymorphism and breast cancer risk under the random-effects model (OR for dominant model = 1.12, 95% CI: 1.02-1.24, P-heterogeneity = 0.003; OR for additive model = 1.07, 95% CI: 1.01-1.14, P-heterogeneity = 0.017). Further sensitivity analysis supported the robust stability of this current result by showing similar ORs before and after removal of a single study. Conclusions: This meta-analysis suggests that the XRCC1 Arg399Gln polymorphism may significantly contribute to susceptibility of breast cancer in the American population.	[Bu, Tao; Liu, Li; Zhao, Li; Peng, Yang; Zhou, Shudong; Li, Lixia; Chen, Sidong; Gao, Yanhui] Guangdong Pharmaceut Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Bu, Tao; Liu, Li; Zhao, Li; Peng, Yang; Zhou, Shudong; Li, Lixia; Chen, Sidong; Gao, Yanhui] Guangdong Pharmaceut Univ, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Bu, Tao; Sun, Yong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Prevent & Hlth Care, Urumqi, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Xinjiang Medical University	Chen, SD (corresponding author), Guangdong Pharmaceut Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	sdchen2@126.com; gao_yanhui@163.com	Peng, Yang/J-8980-2016	Peng, Yang/0000-0002-9119-5506	Medical Scientific Research Foundation of Guangdong Province [B2012176]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [2012LYM_0082]	Medical Scientific Research Foundation of Guangdong Province; Foundation for Distinguished Young Talents in Higher Education of Guangdong	This work was supported by Medical Scientific Research Foundation of Guangdong Province B2012176 and Foundation for Distinguished Young Talents in Higher Education of Guangdong 2012LYM_0082 to Li Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MF, 2008, ONCOL REP, V19, P1033; American Cancer Society, 2013, CANC FACTS FIG 2013; Brewster AM, 2006, BREAST CANCER RES TR, V95, P73, DOI 10.1007/s10549-005-9045-3; Bu DW, 2006, BREAST CANCER RES TR, V99, P257, DOI 10.1007/s10549-006-9210-3; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; Duell EJ, 2001, CANCER EPIDEM BIOMAR, V10, P217; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Espinosa E, 2012, CANCER METAST REV, V31, P41, DOI 10.1007/s10555-011-9327-7; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Guo SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056213; Han JL, 2003, CANCER RES, V63, P8536; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068457; Huang YS, 2009, MUTAGENESIS, V24, P331, DOI 10.1093/mutage/gep013; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Li HH, 2009, BREAST, V18, P183, DOI 10.1016/j.breast.2009.03.008; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pachkowski BF, 2006, CANCER RES, V66, P2860, DOI 10.1158/0008-5472.CAN-05-3388; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Patel AV, 2005, BREAST CANCER RES, V7, pR1168, DOI 10.1186/bcr1355; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Saadat M, 2009, BREAST CANCER RES TR, V115, P137, DOI 10.1007/s10549-008-0051-0; Shen J, 2005, CANCER EPIDEM BIOMAR, V14, P336, DOI 10.1158/1055-9965.EPI-04-0414; Shen MR, 1998, CANCER RES, V58, P604; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Smith TR, 2003, CANCER LETT, V190, P183, DOI 10.1016/S0304-3835(02)00595-5; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Thyagarajan B, 2006, CANCER DETECT PREV, V30, P313, DOI 10.1016/j.cdp.2006.07.002; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KS, 2011, ASIAN PAC J CANCER P, V12, P2237; Yuan P, 2010, CANCER BIOL THER, V10, P858, DOI 10.4161/cbt.10.9.13238; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zipprich Jennifer, 2010, J Carcinog, V9, P4, DOI 10.4103/1477-3163.62535	41	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86086	10.1371/journal.pone.0086086	http://dx.doi.org/10.1371/journal.pone.0086086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489692	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000032
J	Li, HY; Bu, Q; Chen, B; Shao, X; Hu, ZT; Deng, PC; Lv, L; Deng, Y; Zhu, RM; Li, Y; Zhang, BL; Hou, J; Du, CM; Zhao, Q; Fu, DQ; Zhao, YL; Cen, XB				Li, Hongyu; Bu, Qian; Chen, Bo; Shao, Xue; Hu, Zhengtao; Deng, Pengchi; Lv, Lei; Deng, Yi; Zhu, Ruiming; Li, Yan; Zhang, Baolai; Hou, Jing; Du, Changman; Zhao, Qian; Fu, Dengqi; Zhao, Yinglan; Cen, Xiaobo			Mechanisms of Metabonomic for a Gateway Drug: Nicotine Priming Enhances Behavioral Response to Cocaine with Modification in Energy Metabolism and Neurotransmitter Level	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; INDUCED DOPAMINE OVERFLOW; NUCLEUS-ACCUMBENS; PREFRONTAL CORTEX; EXCITATORY INPUTS; BLOOD-GLUCOSE; LONG-TERM; EXPOSURE; BRAIN; REWARD	Nicotine, one of the most commonly used drugs, has become a major concern because tobacco serves as a gateway drug and is linked to illicit drug abuse, such as cocaine and marijuana. However, previous studies mainly focused on certain genes or neurotransmitters which have already been known to participate in drug addiction, lacking endogenous metabolic profiling in a global view. To further explore the mechanism by which nicotine modifies the response to cocaine, we developed two conditioned place preference (CPP) models in mice. In threshold dose model, mice were pretreated with nicotine, followed by cocaine treatment at the dose of 2 mg/kg, a threshold dose of cocaine to induce CPP in mice. In high-dose model, mice were only treated with 20 mg/kg cocaine, which induced a significant CPP. H-1 nuclear magnetic resonance based on metabonomics was used to investigate metabolic profiles of the nucleus accumbens (NAc) and striatum. We found that nicotine pretreatment dramatically increased CPP induced by 2 mg/kg cocaine, which was similar to 20 mg/kg cocaine-induced CPP. Interestingly, metabolic profiles showed considerable overlap between these two models. These overlapped metabolites mainly included neurotransmitters as well as the molecules participating in energy homeostasis and cellular metabolism. Our results show that the reinforcing effect of nicotine on behavioral response to cocaine may attribute to the modification of some specific metabolites in NAc and striatum, thus creating a favorable metabolic environment for enhancing conditioned rewarding effect of cocaine. Our findings provide an insight into the effect of cigarette smoking on cocaine dependence and the underlying mechanism.	[Li, Hongyu; Bu, Qian; Chen, Bo; Shao, Xue; Hu, Zhengtao; Lv, Lei; Deng, Yi; Zhu, Ruiming; Li, Yan; Zhang, Baolai; Hou, Jing; Du, Changman; Zhao, Qian; Fu, Dengqi; Zhao, Yinglan; Cen, Xiaobo] Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Deng, Pengchi] Sichuan Univ, Analyt & Testing Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Cen, XB (corresponding author), Sichuan Univ, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	xbcenalan@vip.sina.com			National Natural Sciences Foundation of China 483 [81271467, 30970938]; National Innovative Drug Development [2012ZX09302-004]	National Natural Sciences Foundation of China 483; National Innovative Drug Development	This work was supported by the Project of the National Natural Sciences Foundation of China 483 (81271467 and 30970938), and National Innovative Drug Development (2012ZX09302-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnwell S, 1984, INHIBITION UPTAKE AM, P101; Bechtholt AJ, 2002, PSYCHOPHARMACOLOGY, V162, P178, DOI 10.1007/s00213-002-1079-1; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BUCCAFUSCO JJ, 1995, PSYCHOPHARMACOLOGY, V120, P256, DOI 10.1007/BF02311172; CAMPFIELD LA, 1986, BRAIN RES BULL, V17, P427, DOI 10.1016/0361-9230(86)90250-9; Canis M, 2009, NEUROSCI RES, V64, P429, DOI 10.1016/j.neures.2009.04.017; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Collins SL, 2004, NEUROPHARMACOLOGY, V46, P349, DOI 10.1016/j.neuropharm.2003.09.024; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Debora E, 2011, LIPIDS HLTH DIS, V16, P18; Duarte I, 2013, MOL PHARM; Gao M, 2010, J NEUROSCI, V30, P13814, DOI 10.1523/JNEUROSCI.1943-10.2010; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hu ZT, 2012, BEHAV BRAIN RES, V231, P11, DOI 10.1016/j.bbr.2012.02.026; Itzhak Y, 1998, NEUROREPORT, V9, P2485, DOI 10.1097/00001756-199808030-00011; Ivanov A, 2011, FRONTIERS NEUROENERG, V3; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Jutkiewicz EM, 2008, PSYCHOPHARMACOLOGY, V200, P93, DOI 10.1007/s00213-008-1159-y; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374; Kelley BM, 1999, J ADDICT DIS, V18, P27, DOI 10.1300/J069v18n03_04; Kelley BM, 2004, INT J DEV NEUROSCI, V22, P339, DOI 10.1016/j.ijdevneu.2004.04.002; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Lan MJ, 2009, MOL PSYCHIATR, V14, P269, DOI 10.1038/sj.mp.4002130; Levin ED, 2004, NEUROTOXICOL TERATOL, V26, P731, DOI 10.1016/j.ntt.2004.06.010; LEVIN L, 1983, EUR J CANCER CLIN ON, V19, P711, DOI 10.1016/0277-5379(83)90002-0; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Li Y, 2012, NEUROSCIENCE, V218, P196, DOI 10.1016/j.neuroscience.2012.05.019; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Macallan DC, 1998, CLIN SCI, V94, P321, DOI 10.1042/cs0940321; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mao DY, 2011, J NEUROSCI, V31, P6710, DOI 10.1523/JNEUROSCI.5671-10.2011; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McFarland K, 2003, J NEUROSCI, V23, P3531; McMillen BA, 2005, EUR J PHARMACOL, V509, P161, DOI 10.1016/j.ejphar.2005.01.002; O'DONNELL J A, 1979, National Institute on Drug Abuse Research Monograph, P30; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; RITTER RC, 1981, SCIENCE, V213, P451, DOI 10.1126/science.6264602; Rothman RB, 2006, TRENDS PHARMACOL SCI, V27, P612, DOI 10.1016/j.tips.2006.10.006; Salas R, 2008, NEUROSCI LETT, V440, P32, DOI 10.1016/j.neulet.2008.05.038; Salek RM, 2008, NEUROCHEM RES, V33, P292, DOI 10.1007/s11064-007-9542-3; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sun LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060598; Sziraki I, 1999, ANN NY ACAD SCI, V877, P800, DOI 10.1111/j.1749-6632.1999.tb09326.x; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; TORABI MR, 1993, J SCHOOL HEALTH, V63, P302, DOI 10.1111/j.1746-1561.1993.tb06150.x; Uys JD, 2008, CNS NEUROL DISORD-DR, V7, P482, DOI 10.2174/187152708786927868; Willuhn I, 2012, P NATL ACAD SCI USA, V109, P20703, DOI 10.1073/pnas.1213460109; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Yao JK, 2005, MOL NEUROBIOL, V31, P193, DOI 10.1385/MN:31:1-3:193; Zernig G, 1997, EUR J PHARMACOL, V337, P1, DOI 10.1016/S0014-2999(97)01184-9; Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004	59	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87040	10.1371/journal.pone.0087040	http://dx.doi.org/10.1371/journal.pone.0087040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489831	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000100
J	Ye, J; Vives-Pi, M; Gillespie, KM				Ye, Jody; Vives-Pi, Marta; Gillespie, Kathleen M.			Maternal Microchimerism: Increased in the Insulin Positive Compartment of Type 1 Diabetes Pancreas but Not in Infiltrating Immune Cells or Replicating Islet Cells	PLOS ONE			English	Article							BETA-CELLS; T-CELLS; ENDOCRINE; EXPANSION; ANTIGENS	Background: Maternal microchimeric cells (MMc) transfer across the placenta during pregnancy. Increased levels of MMc have been observed in several autoimmune diseases including type 1 diabetes but their role is unknown. It has been suggested that MMc are 1) effector cells of the immune response, 2) targets of the autoimmune response or 3) play a role in tissue repair. The aim of this study was to define the cellular phenotype of MMc in control (n = 14) and type 1 diabetes pancreas (n = 8). Methods: Using sex chromosome-based fluorescence in-situ hybridization, MMc were identified in male pancreas and their phenotype determined by concomitant immunofluorescence. Results: In normal pancreas, MMc positive for endocrine, exocrine, duct and acinar markers were identified suggesting that these cells are derived from maternal progenitors. Increased frequencies of MMc were observed in type 1 diabetes pancreas (p = 0.03) with particular enrichment in the insulin positive fraction (p = 0.01). MMc did not contribute to infiltrating immune cells or Ki67+ islet cell populations in type 1 diabetes. Conclusion: These studies provide support for the hypothesis that MMc in human pancreas are derived from pancreatic precursors. Increased frequencies of MMc beta cells may contribute to the initiation of autoimmunity or to tissue repair but do not infiltrate islets in type 1 diabetes.	[Ye, Jody; Gillespie, Kathleen M.] Univ Bristol, Sch Clin Sci, Diabet & Metab Unit, Bristol, Avon, England; [Vives-Pi, Marta] Inst Recerca Germans Trias & Pujol, Dept Immunol, Badalona, Spain	University of Bristol	Gillespie, KM (corresponding author), Univ Bristol, Sch Clin Sci, Diabet & Metab Unit, Bristol, Avon, England.	K.M.Gillespie@bristol.ac.uk	Vives-Pi, Marta/AAM-8158-2020	Vives-Pi, Marta/0000-0003-3735-0779; Ye, Jody/0000-0003-0926-6107	Diabetes United Kingdom PhD studentship; Diabetes UK [12/0004564] Funding Source: researchfish	Diabetes United Kingdom PhD studentship(Diabetes UK); Diabetes UK(Diabetes UK)	This study was funded by a Diabetes United Kingdom PhD studentship to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Dutta Partha, 2010, Chimerism, V1, P2, DOI 10.4161/chim.1.1.12667; EHRIE MG, 1974, DIABETES, V23, P583, DOI 10.2337/diab.23.7.583; Gallo R, 2007, CELL DEATH DIFFER, V14, P1860, DOI 10.1038/sj.cdd.4402199; Karafin MS, 2010, INT J CLIN EXP PATHO, V3, P47; Ketola I, 2004, MOL CELL ENDOCRINOL, V226, P51, DOI 10.1016/j.mce.2004.06.007; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Neelson JL, 2008, SCI AM, V298, P72; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Reed AM, 2004, J IMMUNOL, V172, P5041, DOI 10.4049/jimmunol.172.8.5041; Roy E, 2011, J AUTOIMMUN, V36, P253, DOI 10.1016/j.jaut.2011.02.003; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Stene LC, 2013, DIABETOLOGIA; Stevens AM, 2003, LANCET, V362, P1617, DOI 10.1016/S0140-6736(03)14795-2; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vanzyl Berendine, 2010, Chimerism, V1, P45, DOI 10.4161/chim.1.2.13891; Ziegler AG, 2012, DIABETOLOGIA, V55, P1937, DOI 10.1007/s00125-012-2472-x	24	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86985	10.1371/journal.pone.0086985	http://dx.doi.org/10.1371/journal.pone.0086985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498006	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900054
J	Wang, W; Wang, SY; Hou, CL; Xing, YP; Cao, JW; Wu, KF; Liu, CX; Zhang, D; Zhang, L; Zhang, YR; Zhou, HM				Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin			Genome-Wide Detection of Copy Number Variations among Diverse Horse Breeds by Array CGH	PLOS ONE			English	Article							SCALE VARIATION; GENE; VARIANTS; MAP; IDENTIFICATION; POLYMORPHISM; SEQUENCE	Recent studies have found that copy number variations (CNVs) are widespread in human and animal genomes. CNVs are a significant source of genetic variation, and have been shown to be associated with phenotypic diversity. However, the effect of CNVs on genetic variation in horses is not well understood. In the present study, CNVs in 6 different breeds of mare horses, Mongolia horse, Abaga horse, Hequ horse and Kazakh horse (all plateau breeds) and Debao pony and Thoroughbred, were determined using aCGH. In total, seven hundred CNVs were identified ranging in size from 6.1 Kb to 0.57 Mb across all autosomes, with an average size of 43.08 Kb and a median size of 15.11 Kb. By merging overlapping CNVs, we found a total of three hundred and fifty-three CNV regions (CNVRs). The length of the CNVRs ranged from 6.1 Kb to 1.45 Mb with average and median sizes of 38.49 Kb and 13.1 Kb. Collectively, 13.59 Mb of copy number variation was identified among the horses investigated and accounted for approximately 0.61% of the horse genome sequence. Five hundred and eighteen annotated genes were affected by CNVs, which corresponded to about 2.26% of all horse genes. Through the gene ontology (GO), genetic pathway analysis and comparison of CNV genes among different breeds, we found evidence that CNVs involving 7 genes may be related to the adaptation to severe environment of these plateau horses. This study is the first report of copy number variations in Chinese horses, which indicates that CNVs are ubiquitous in the horse genome and influence many biological processes of the horse. These results will be helpful not only in mapping the horse whole-genome CNVs, but also to further research for the adaption to the high altitude severe environment for plateau horses.	[Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China; [Wang, Wei; Wang, Shenyuan; Hou, Chenglin; Xing, Yanping; Cao, Junwei; Wu, Kaifeng; Liu, Chunxia; Zhang, Dong; Zhang, Li; Zhang, Yanru; Zhou, Huanmin] Key Lab Biol Mfg, Hohhot, Peoples R China	Inner Mongolia Agricultural University	Zhang, YR (corresponding author), Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Peoples R China.	yanru1964@hotmail.com; huanminzhou@263.net	zhou, huan/GYJ-4398-2022; Zhang, Dong/AAZ-1678-2020		Chinese Inner Mongol Agricultural University	Chinese Inner Mongol Agricultural University	Financial support was provided by the Chinese Inner Mongol Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Cicconardi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-124; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Dupuis MC, 2013, ANIM GENET, V44, P206, DOI 10.1111/j.1365-2052.2012.02373.x; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Fadista J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003916; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fontanesi L, 2009, CYTOGENET GENOME RES, V126, P333, DOI 10.1159/000268089; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-131; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li XB, 2010, GENETICA, V138, P1221, DOI 10.1007/s10709-010-9521-5; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Molla M, 2007, THESIS U WISCONSIN M; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sykulski Maciej, 2013, J Clin Bioinforma, V3, P12, DOI 10.1186/2043-9113-3-12; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; WORKMAN C, 2002, GENOME BIOL, V0003; Yang Hong, 2010, Yichuan, V32, P211, DOI 10.3724/SP.J.1005.2010.00211; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372	42	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86860	10.1371/journal.pone.0086860	http://dx.doi.org/10.1371/journal.pone.0086860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497987	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100035
J	Wang, W; Xu, LF; Cavazos, J; Huang, HH; Kay, M				Wang, Wei; Xu, Lifan; Cavazos, John; Huang, Howie H.; Kay, Matthew			Fast Acceleration of 2D Wave Propagation Simulations Using Modern Computational Accelerators	PLOS ONE			English	Article							DIFFERENCE METHOD	Recent developments in modern computational accelerators like Graphics Processing Units (GPUs) and coprocessors provide great opportunities for making scientific applications run faster than ever before. However, efficient parallelization of scientific code using new programming tools like CUDA requires a high level of expertise that is not available to many scientists. This, plus the fact that parallelized code is usually not portable to different architectures, creates major challenges for exploiting the full capabilities of modern computational accelerators. In this work, we sought to overcome these challenges by studying how to achieve both automated parallelization using OpenACC and enhanced portability using OpenCL. We applied our parallelization schemes using GPUs as well as Intel Many Integrated Core (MIC) coprocessor to reduce the run time of wave propagation simulations. We used a well-established 2D cardiac action potential model as a specific case-study. To the best of our knowledge, we are the first to study auto-parallelization of 2D cardiac wave propagation simulations using OpenACC. Our results identify several approaches that provide substantial speedups. The OpenACC-generated GPU code achieved more than 150x speedup above the sequential implementation and required the addition of only a few OpenACC pragmas to the code. An OpenCL implementation provided speedups on GPUs of at least 200x faster than the sequential implementation and 30x faster than a parallelized OpenMP implementation. An implementation of OpenMP on Intel MIC coprocessor provided speedups of 120x with only a few code changes to the sequential implementation. We highlight that OpenACC provides an automatic, efficient, and portable approach to achieve parallelization of 2D cardiac wave simulations on GPUs. Our approach of using OpenACC, OpenCL, and OpenMP to parallelize this particular model on modern computational accelerators should be applicable to other computational models of wave propagation in multi-dimensional media.	[Wang, Wei; Xu, Lifan; Cavazos, John] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Huang, Howie H.; Kay, Matthew] George Washington Univ, Dept Elect & Comp Engn, Washington, DC USA	University of Delaware; George Washington University	Wang, W (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	weiwang@udel.edu	Kay, Matthew Wyatt/AAH-7336-2019	Kay, Matthew Wyatt/0000-0003-2756-5055	GWU Institute of Biomedical Engineering; NVIDIA Academic Partnership Award; NSF [IOS-1124813, 0953667]; NIH [R01-HL095828]; DARPA Computer Science Study Group (CSSG); Direct For Biological Sciences [1124813, 1124804] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095828] Funding Source: NIH RePORTER	GWU Institute of Biomedical Engineering; NVIDIA Academic Partnership Award; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA Computer Science Study Group (CSSG); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant from the GWU Institute of Biomedical Engineering (http://www.ibe.gwu.edu), an NVIDIA Academic Partnership Award (https://research.nvidia.com), NSF grant IOS-1124813 (http://www.nsf.gov/), NIH grant R01-HL095828 (http://www.nih.gov/), NSF Career Award 0953667 (http://www.nsf.gov/), and the DARPA Computer Science Study Group (CSSG) (http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2007, AM J PHYSIOL-HEART C, V293, pH503, DOI 10.1152/ajpheart.01060.2006; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Campbell D, 2006, Proceedings of the HPCMP Users Group Conference 2006, P315; CAPS, CAPS COMP; CUDA, WHAT IS CUDA; Daga M., 2011, 2011 IEEE 1st International Conference on Computational Advances in Bio and Medical Sciences (ICCABS), P75, DOI 10.1109/ICCABS.2011.5729946; DROUHARD JP, 1987, COMPUT BIOMED RES, V20, P333, DOI 10.1016/0010-4809(87)90048-6; Grauer-Gray S., 2013, P 6 WORKSHOP GEN PUR, VGPGPU-6, P127, DOI [10.1145/2458523.2458536, DOI 10.1145/2458523.2458536]; Hart A, 2012, EUR PHYS J-SPEC TOP, V210, P5, DOI 10.1140/epjst/e2012-01634-y; Herdman JA, 2012, 2012 SC COMPANION: HIGH PERFORMANCE COMPUTING, NETWORKING, STORAGE AND ANALYSIS (SCC), P465, DOI 10.1109/SC.Companion.2012.66; Kay MW, 2005, IEEE T BIO-MED ENG, V52, P50, DOI 10.1109/TBME.2004.839798; MIC, INT MAN INT COR ARCH; Michalakes J, 2008, PARALLEL PROCESS LET, V18, P531, DOI 10.1142/S0129626408003557; Mirin AA, 2012, INT CONF HIGH PERFOR; Neic A, 2012, IEEE T BIO-MED ENG, V59, P2281, DOI 10.1109/TBME.2012.2202661; Niederer S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00014; Oliveira RS, 2012, LECT NOTES COMPUT SC, V7204, P111, DOI 10.1007/978-3-642-31500-8_12; OpenACC, OPENACC DIR ACC; OpenMP, OPENMP THE OPENMP AP; Pope BJ, 2011, IEEE ENG MED BIO, P433, DOI 10.1109/IEMBS.2011.6090058; Pope BJ, 2011, IEEE T BIO-MED ENG, V58, P2965, DOI 10.1109/TBME.2011.2161580; Reyes R, 2013, J SUPERCOMPUT, V65, P1063, DOI 10.1007/s11227-012-0853-z; Reyes R, 2012, IEEE I C EMBED SOFTW, P410, DOI 10.1109/HPCC.2012.62; Richards DF, 2013, COMPUT METHOD BIOMEC, V16, P802, DOI 10.1080/10255842.2013.795556; Scarle S, 2009, COMPUT BIOL CHEM, V33, P253, DOI 10.1016/j.compbiolchem.2009.05.001; Spurzem R., 2010, Proceedings of the 2010 IEEE 10th International Conference on Computer and Information Technology (CIT 2010), P1189, DOI 10.1109/CIT.2010.215; Su LJ, 2011, APPL NUMER MATH, V61, P946, DOI 10.1016/j.apnum.2011.02.007; ten Tusscher KHWJ, 2005, MULTISCALE MODEL SIM, V3, P265, DOI 10.1137/030602654; Tessmer E, 2000, GEOPHYSICS, V65, P1290, DOI 10.1190/1.1444820; Wang W, 2011, IEEE ENG MED BIO, P724, DOI 10.1109/IEMBS.2011.6090164; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; Wienke S, 2012, LECT NOTES COMPUT SC, V7484, P859, DOI 10.1007/978-3-642-32820-6_85; Xiaoquan Su, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P173, DOI 10.1109/ISB.2011.6033151; Zhang ZY, 2011, INT J COMPUT MATH, V88, P2178, DOI 10.1080/00207160.2010.534139	34	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86484	10.1371/journal.pone.0086484	http://dx.doi.org/10.1371/journal.pone.0086484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497950	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100017
J	Wong, JWY; Lucas, C; Kolliker, M				Wong, Janine W. Y.; Lucas, Christophe; Koelliker, Mathias			Cues of Maternal Condition Influence Offspring Selfishness	PLOS ONE			English	Article							EARWIGS FORFICULA-AURICULARIA; EUROPEAN EARWIG; PARENTAL BEHAVIOR; BURYING BEETLES; QUALITY AFFECTS; FAMILY-LIFE; CONFLICT; CARE; COADAPTATION; SIGNALS	The evolution of parent-offspring communication was mostly studied from the perspective of parents responding to begging signals conveying information about offspring condition. Parents should respond to begging because of the differential fitness returns obtained from their investment in offspring that differ in condition. For analogous reasons, offspring should adjust their behavior to cues/signals of parental condition: parents that differ in condition pay differential costs of care and, hence, should provide different amounts of food. In this study, we experimentally tested in the European earwig (Forficula auricularia) if cues of maternal condition affect offspring behavior in terms of sibling cannibalism. We experimentally manipulated female condition by providing them with different amounts of food, kept nymph condition constant, allowed for nymph exposure to chemical maternal cues over extended time, quantified nymph survival (deaths being due to cannibalism) and extracted and analyzed the females' cuticular hydrocarbons (CHC). Nymph survival was significantly affected by chemical cues of maternal condition, and this effect depended on the timing of breeding. Cues of poor maternal condition enhanced nymph survival in early broods, but reduced nymph survival in late broods, and vice versa for cues of good condition. Furthermore, female condition affected the quantitative composition of their CHC profile which in turn predicted nymph survival patterns. Thus, earwig offspring are sensitive to chemical cues of maternal condition and nymphs from early and late broods show opposite reactions to the same chemical cues. Together with former evidence on maternal sensitivities to condition-dependent nymph chemical cues, our study shows context-dependent reciprocal information exchange about condition between earwig mothers and their offspring, potentially mediated by cuticular hydrocarbons.	[Wong, Janine W. Y.; Koelliker, Mathias] Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland; [Lucas, Christophe] Univ Tours, CNRS, UMR 7261, Inst Rech Biol Insecte, Tours, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours	Kolliker, M (corresponding author), Univ Basel, Dept Environm Sci Zool & Evolut, Basel, Switzerland.	mathias.koelliker@unibas.ch	Lucas, Christophe/A-4186-2011	Lucas, Christophe/0000-0003-2839-7583	Swiss National Science Foundation [PP00P3-139188]; Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel); Nikolaus und Bertha Burckhardt-Burgin-Stiftung; PRES Centre Val de Loire Universite [APR-IA2012]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel); Nikolaus und Bertha Burckhardt-Burgin-Stiftung; PRES Centre Val de Loire Universite	The study was financially supported by the Swiss National Science Foundation (grant-no. PP00P3-139188 to MK), the Fonds zur Forderung von Lehre und Forschung (Freie Akademische Gesellschaft FAG Basel), the Nikolaus und Bertha Burckhardt-Burgin-Stiftung (PhD support to JWYW), and the PRES Centre Val de Loire Universite (APR-IA2012 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; Biedermann PHW, 2011, P NATL ACAD SCI USA, V108, P17064, DOI 10.1073/pnas.1107758108; Bize P, 2006, P R SOC B, V273, P2063, DOI 10.1098/rspb.2006.3546; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BLOMQVIST GJ, 2003, INSECT PHEROMONE BIO; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Clutton-Brock T. H., 1988, REPROD SUCCESS; Cocroft RB, 1999, BEHAVIOUR, V136, P1, DOI 10.1163/156853999500640; D'Ettorre P, 2008, SOCIOBIOLOGY COMMUNI; Dobler R, 2011, ANIM BEHAV, V82, P667, DOI 10.1016/j.anbehav.2011.06.017; Dobler R, 2010, BEHAV ECOL, V21, P257, DOI 10.1093/beheco/arp184; Falk J, AM NAT; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Gomez Y, 2013, J EVOLUTION BIOL, V26, P1903, DOI 10.1111/jeb.12184; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hamel JA, 2012, P ROY SOC B-BIOL SCI, V279, P3820, DOI 10.1098/rspb.2012.1181; Hinde CA, 2010, SCIENCE, V327, P1373, DOI 10.1126/science.1186056; Holman L, 2012, EVOLUTION, V66, P2094, DOI 10.1111/j.1558-5646.2012.01603.x; Johnstone RA, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P1, DOI 10.1007/0-306-47660-6_1; Johnstone RA, 1996, P ROY SOC B-BIOL SCI, V263, P1677, DOI 10.1098/rspb.1996.0245; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kolliker M, 2007, ECOL ENTOMOL, V32, P24, DOI 10.1111/j.1365-2311.2006.00831.x; Kolliker M, 2012, EVOLUTION OF PARENTAL CARE, P285; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703; Krause J, 2002, LIVING GROUPS; LAMB RJ, 1976, CAN ENTOMOL, V108, P609, DOI 10.4039/Ent108609-6; Lynch M., 1998, GENETICS ANAL QUANTI; Mas F, 2011, BIOL LETTERS, V7, P352, DOI 10.1098/rsbl.2010.1094; Mas F, 2009, P R SOC B, V276, P2847, DOI 10.1098/rspb.2009.0498; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MCCARTHY ED, 1968, ANAL CHEM, V40, P1475, DOI 10.1021/ac60266a021; Meunier J, 2012, P ROY SOC B-BIOL SCI, V279, P3981, DOI 10.1098/rspb.2012.1416; Meunier J, 2012, BIOL LETTERS, V8, P547, DOI 10.1098/rsbl.2012.0151; Meunier J, 2012, EVOL ECOL, V26, P669, DOI 10.1007/s10682-011-9510-x; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock DW, 2011, BEHAV ECOL, V22, P909, DOI 10.1093/beheco/arr091; MOCK DW, 1984, SCIENCE, V225, P731, DOI 10.1126/science.225.4663.731; Morales J, 2013, ANIM BEHAV, V86, P11, DOI 10.1016/j.anbehav.2013.04.001; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller JK, 2003, BEHAV ECOL, V14, P212, DOI 10.1093/beheco/14.2.212; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Nelson DR, 1978, ADV INSECT PHYSL, P1; OCONNOR RJ, 1978, ANIM BEHAV, V26, P79, DOI 10.1016/0003-3472(78)90008-8; PARKER GA, 1989, AM NAT, V133, P846, DOI 10.1086/284956; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Promonis JG, 1980, J CHEM ECOL, V6, P965; RADL RC, 1991, ETHOLOGY, V89, P287, DOI 10.1111/j.1439-0310.1991.tb00374.x; Roulin A, 2012, EVOLUTION OF PARENTAL CARE, P133; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P327; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Rutter M., 2006, GENES BEHAV; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; Smiseth PT, 2010, BEHAV ECOL, V21, P526, DOI 10.1093/beheco/arq019; Staerkle M, 2008, ETHOLOGY, V114, P844, DOI 10.1111/j.1439-0310.2008.01526.x; Steiger S, 2007, P R SOC B, V274, P2211, DOI 10.1098/rspb.2007.0656; TRIVERS RL, 1974, AM ZOOL, V14, P249; VANCASSEL M, 1984, ADV STUD BEHAV, V14, P51, DOI 10.1016/S0065-3454(08)60299-5; Weyrauch WK, 1927, BIOL ZENTRALBLATT, V49, P553; Wong JWY, 2013, ECOL ENTOMOL, V38, P123, DOI 10.1111/een.12000; Wong JWY, 2012, ETHOLOGY, V118, P450, DOI 10.1111/j.1439-0310.2012.02030.x; Yip EC, 2013, ANIM BEHAV, V85, P1161, DOI 10.1016/j.anbehav.2013.03.016	67	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e87214	10.1371/journal.pone.0087214	http://dx.doi.org/10.1371/journal.pone.0087214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498046	Green Published, gold, Green Accepted			2022-12-27	WOS:000330617100061
J	Chen, M; Ma, YL; Su, YZ; Yang, L; Zhang, RZ; Yang, CJ; Chen, HC; Yan, WY; Shi, YH; Dong, LJ; Chen, L; Jia, MH; Lu, L				Chen, Min; Ma, Yanling; Su, Yingzhen; Yang, Li; Zhang, Renzhong; Yang, Chaojun; Chen, Huichao; Yan, Wenyun; Shi, Yuhua; Dong, Lijuan; Chen, Ling; Jia, Manhong; Lu, Lin			HIV-1 Genetic Characteristics and Transmitted Drug Resistance among Men Who Have Sex with Men in Kunming, China	PLOS ONE			English	Article							CIRCULATING RECOMBINANT; TYPE-1; YUNNAN; PREVALENCE; EPIDEMIC; SUBTYPES; TRANSMISSION; POPULATION; CHALLENGES; DIVERSITY	Background: Yunnan has been severely affected by HIV/AIDS in China. Recently, the reported prevalence of HIV-1 among men who have sex with men (MSM) in Yunnan was high in China. To monitor dynamic HIV-1 epidemic among Yunnan MSM, HIV-1 genetic characteristics and transmitted drug resistance (TDR) were investigated. Methods: Blood samples from 131 newly HIV-1 diagnosed MSM were continuously collected at fixed sites from January 2010 to December 2012 in Kunming City, Yunnan Province. Partial gag, pol and env genes were sequenced. Phylogenetic, evolutionary and genotypic drug resistance analyses were performed. Results: Multiple genotypes were identified among MSM in Kunming, including CRF01_AE (64.9%), CRF07_BC (25.2%), unique recombinant forms (URFs, 5.3%), subtype B (3.1%) and CRF08_BC (1.5%). CRF01_AE and CRF07_BC were the predominant strains. The mean of genetic distance within CRF01_AE were larger than that within CRF07_BC. The estimated introducing time of CRF01_AE in Yunnan MSM (1996.9) is earlier than that of CRF07_BC (2002.8). In this study, subtype B was first identified in Yunnan MSM. CRF08_BC seems to be the distinctive strain in Yunnan MSM, which was seldom found among MSM outside Yunnan. The proportion of URFs increased, which further contributed to genetic diversity among MSM. Strikingly, genetic relatedness was found among these strains with MSM isolates from multiple provinces, which suggested that a nationwide transmission network may exist. TDR-associated mutations were identified in 4.6% individuals. The multivariate analysis revealed that non-native MSM and divorced/widowed MSM were independently associated with a higher TDR rate. Conclusion: This work revealed diverse HIV-1 genetics, national transmission networks and a baseline level of TDR in MSM. These findings enhance our understanding of the distribution and evolution of HIV-1 in MSM, and are valuable for developing HIV prevention strategies for MSM.	[Chen, Min; Ma, Yanling; Su, Yingzhen; Yang, Li; Zhang, Renzhong; Yang, Chaojun; Chen, Huichao; Yan, Wenyun; Shi, Yuhua; Dong, Lijuan; Chen, Ling; Jia, Manhong; Lu, Lin] Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China; [Lu, Lin] Kunming Med Univ, Coll Publ Hlth, Kunming, Yunnan, Peoples R China	Kunming Medical University	Jia, MH (corresponding author), Yunnan Ctr Dis Control & Prevent, Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China.	jiamanhong@hotmail.com; lulin@yncdc.cn	MA, YAN/HHN-2912-2022		Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development [2011ZX10004-903, 2012ZX10001006]	Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development	This work was supported by the Major Project of China's "Twelfth Five-Year Plan" for Science and Technology Development (2011ZX10004-903) and (2012ZX10001006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chen Min, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P75; CHENG HH, 1994, LANCET, V344, P953, DOI 10.1016/S0140-6736(94)92304-3; China Ministry of Health UNAIDS WHO, 2012, CHIN J AIDS STD, V18, P1; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Li L, 2012, AIDS RES HUM RETROVI; Li L, 2012, AIDS RES HUM RETROV, V28, P947, DOI [10.1089/aid.2011.0379, 10.1089/AID.2011.0379]; Li L, 2011, INFECT GENET EVOL, V11, P1487, DOI 10.1016/j.meegid.2011.05.017; Li Z, 2010, J KUNMING MED U, V10, P127; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Yan-ling, 2008, Zhonghua Yufang Yixue Zazhi, V42, P892; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052373; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Weber J, 2010, AIDS, V24, pS27, DOI 10.1097/01.aids.0000390705.73759.2c; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3; Yang ChaoJun, 2011, Modern Preventive Medicine, V38, P686; Yang J, 2013, ARCH VIROL, V158, P839, DOI 10.1007/s00705-012-1557-7; YAO J, 2002, CHIN J STD AIDS PREV, V8, P131; Yu XF, 2003, AIDS RES HUM RETROV, V19, P1051, DOI 10.1089/088922203322588422; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao B, 2011, AIDS RES HUM RETROV, V27, P1047, DOI [10.1089/aid.2010.0119, 10.1089/AID.2010.0119]; Zhao Guang-lu, 2012, Zhonghua Yi Xue Za Zhi, V92, P1165	42	23	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87033	10.1371/journal.pone.0087033	http://dx.doi.org/10.1371/journal.pone.0087033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489829	gold, Green Submitted, Green Published			2022-12-27	WOS:000330570000093
J	Li, J; Huang, Y; Zhang, BN; Fan, JH; Huang, R; Zhang, P; Wang, SL; Zheng, S; Zhang, B; Yang, HJ; Xie, XM; Tang, ZH; Li, H; He, JJ; Hsieh, E; Qiao, YL; Li, JY				Li, Jing; Huang, Yuan; Zhang, Bao-Ning; Fan, Jin-Hu; Huang, Rong; Zhang, Pin; Wang, Shu-Lian; Zheng, Shan; Zhang, Bin; Yang, Hong-Jian; Xie, Xiao-Ming; Tang, Zhong-Hua; Li, Hui; He, Jian-Jun; Hsieh, Evelyn; Qiao, You-Lin; Li, Jia-Yuan			Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; RISK-FACTORS; ESTROGEN-RECEPTOR; HORMONE-RECEPTOR; POOLED ANALYSIS; TUMOR SUBTYPES; FEMALE BREAST; ASSOCIATION; SURVIVAL; THERAPY	Background: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. Methods: Four thousand two hundred and eleven breast cancer patients were selected randomly from seven geographic regions of China from 1999 to 2008. Demographic data, risk factors, pathologic features, and biological receptor status of cases were collected from the medical charts. Chi-square test, fisher exact test, rank-correlation analysis, and multivariate logistic regression model were adopted to explore whether BMI differed according to biological receptor status in pre- and post-menopausal women. Results: Three thousand two hundred and eighty one eligible cases with BMI data were included. No statistically significant differences in demographic characteristics were found between the cases with BMI data and those without. In the rank-correlation analysis, the rates of PR+ and HER2+ were positively correlated with increasing BMI among post-menopausal women (r(s) (BMI,) (PR+) = 0.867, P = 0.001; r(s) (BMI,) (HER2+) = 0.636, P = 0.048), but the ER+ rates did not vary by increasing BMI. Controlling for confounding factors, multivariate logistic regression models with BMI<24 kg/m(2) as the reference group were performed and found that BMI >= 24 kg/m(2) was only positively correlated with PR+ status among post-menopausal breast cancer cases (adjusted OR = 1.420, 95% CI: 1.116-1.808, Wald = 8.116, P = 0.004). Conclusions: Post-menopausal women with high BMI (>= 24 kg/m(2)) have a higher proportion of PR+ breast cancer. In addition to effects mediated via the estrogen metabolism pathway, high BMI might increase the risk of breast cancer by other routes, which should be examined further in future etiological mechanism studies.	[Li, Jing] Sichuan Univ, Dept Environm Hlth & Occupat Med, West China Sch Publ Hlth, Chengdu 610064, Peoples R China; [Li, Jing; Huang, Yuan; Huang, Rong; Li, Jia-Yuan] Sichuan Univ, West China Teaching Hosp 4, Chengdu 610064, Peoples R China; [Huang, Yuan; Huang, Rong; Li, Jia-Yuan] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu 610064, Peoples R China; [Li, Jing; Fan, Jin-Hu; Huang, Rong; Qiao, You-Lin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Canc Epidemiol, Beijing 100730, Peoples R China; [Li, Jing; Zhang, Bao-Ning; Fan, Jin-Hu; Huang, Rong; Zhang, Pin; Wang, Shu-Lian; Zheng, Shan; Qiao, You-Lin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Bao-Ning] Chinese Acad Med Sci, Canc Inst & Hosp, Ctr Breast Dis, Beijing 100730, Peoples R China; [Zhang, Pin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Wang, Shu-Lian] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Radiat Oncol, Beijing 100730, Peoples R China; [Zheng, Shan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Zhang, Bin] Liaoning Canc Hosp, Dept Breast Surg, Shenyang, Peoples R China; [Yang, Hong-Jian] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Zhejiang, Peoples R China; [Xie, Xiao-Ming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Zhong-Hua] Cent S Univ, Xiangya Hosp 2, Dept Breast Thyroid Surg, Changsha, Hunan, Peoples R China; [Li, Hui] Second Peoples Hosp Sichuan Prov, Dept Breast Surg, Chengdu, Peoples R China; [He, Jian-Jun] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Oncosurg, Xian 710049, Peoples R China; [Hsieh, Evelyn] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Zhejiang Cancer Hospital; Sun Yat Sen University; Central South University; Xi'an Jiaotong University; Yale University	Qiao, YL (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Canc Epidemiol, Beijing 100730, Peoples R China.	qiaoy@cicams.ac.cn; lijiayuan73@163.com	li, jia/GVT-7587-2022; Qiao, You-Lin/B-4139-2012	Qiao, You-Lin/0000-0001-6380-0871; fan, jinhu/0000-0003-3159-7893; Hsieh, Evelyn/0000-0001-5018-8409	Cancer Foundation of China (CFC)	Cancer Foundation of China (CFC)	The authors also thank the Cancer Foundation of China (CFC) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Bao PP, 2011, AM J EPIDEMIOL, V174, P661, DOI 10.1093/aje/kwr145; Dowsett M, 2001, CANCER RES, V61, P8452; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fernandez AG, 2012, BREAST, V21, P366, DOI 10.1016/j.breast.2012.03.004; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Harvie M, 2005, CANCER EPIDEM BIOMAR, V14, P656, DOI 10.1158/1055-9965.EPI-04-0001; Huang JunHui, 2008, Journal of Practical Oncology, V23, P8; Huang ZheZhou, 2012, Tumor, V32, P435; Kawai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-149; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-364; Li Xiao-yan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P683; LIPPMAN ME, 1989, J STEROID BIOCHEM, V34, P107, DOI 10.1016/0022-4731(89)90071-X; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; Mauland KK, 2011, BRIT J CANCER, V104, P921, DOI 10.1038/bjc.2011.46; Osborne CK, 2005, BREAST, V14, P458, DOI 10.1016/j.breast.2005.08.024; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; RICKETTS D, 1991, CANCER RES, V51, P1817; Rusiecki JA, 2005, CANCER DETECT PREV, V29, P419, DOI 10.1016/j.cdp.2005.07.004; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Song QK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072175; Suzuki R, 2011, INT J CANCER, V129, P1214, DOI 10.1002/ijc.25744; Tao MH, 2006, AM J EPIDEMIOL, V163, P101, DOI 10.1093/aje/kwj017; Thomas HV, 1997, CANCER CAUSE CONTROL, V8, P922, DOI 10.1023/A:1018476631561; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Wang Q, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-122; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yoo KY, 2001, CANCER LETT, V167, P57, DOI 10.1016/S0304-3835(01)00463-3; Zarbo RJ, 2003, ARCH PATHOL LAB MED, V127, P549; Zheng S, 2012, INT J CANCER, V131, P2622, DOI 10.1002/ijc.27513; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5	35	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87224	10.1371/journal.pone.0087224	http://dx.doi.org/10.1371/journal.pone.0087224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489874	Green Published, Green Submitted, gold			2022-12-27	WOS:000330570000121
J	Zamorano, F; Billeke, P; Hurtado, JM; Lopez, V; Carrasco, X; Ossandon, T; Aboitiz, F				Zamorano, Francisco; Billeke, Pablo; Hurtado, Jose M.; Lopez, Vladimir; Carrasco, Ximena; Ossandon, Tomas; Aboitiz, Francisco			Temporal Constraints of Behavioral Inhibition: Relevance of Inter-stimulus Interval in a Go-Nogo Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STOP-SIGNAL TASK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; RESPONSE-INHIBITION; GO/NOGO TASK; INTEGRATIVE THEORY; FUNCTIONAL MRI; COGNITIVE CONTROL	The capacity to inhibit prepotent and automatic responses is crucial for proper cognitive and social development, and inhibitory impairments have been considered to be key for some neuropsychiatric conditions. One of the most used paradigms to analyze inhibitory processes is the Go-Nogo task (GNG). This task has been widely used in psychophysical and cognitive EEG studies, and more recently in paradigms using fMRI. However, a technical limitation is that the time resolution of fMRI is poorer than that of the EEG technique. In order to compensate for these temporal constraints, it has become common practice in the fMRI field to use longer inter-stimulus intervals (ISI) than those used in EEG protocols. Despite the noticeable temporal differences between these two techniques, it is currently assumed that both approaches assess similar inhibitory processes. We performed an EEG study using a GNG task with both short ISI (fast-condition, FC, as in EEG protocols) and long ISI (slow-condition, SC, as in fMRI protocols). We found that in the FC there was a stronger Nogo-N2 effect than in the SC. Moreover, in the FC, but not in the SC, the number of preceding Go trials correlated positively with the Nogo-P3 amplitude and with the Go trial reaction time; and negatively with commission errors. In addition, we found significant topographical differences for the Go-P3 elicited in FC and SC, which is interpreted in terms of different neurotransmitter dynamics. Taken together, our results provide evidence that frequency of stimulus presentation in the GNG task strongly modulates the behavioral response and the evoked EEG activity. Therefore, it is likely that short-ISI EEG protocols and long-ISI fMRI protocols do not assess equivalent inhibitory processes.	[Zamorano, Francisco; Billeke, Pablo; Hurtado, Jose M.; Lopez, Vladimir; Carrasco, Ximena; Ossandon, Tomas; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Santiago, Chile; [Zamorano, Francisco; Billeke, Pablo; Ossandon, Tomas; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Dept Psiquiatria, Escuela Med, Santiago, Chile; [Zamorano, Francisco; Billeke, Pablo] Univ Desarrollo, Fac Gobierno, Ctr Invest Complejidad Social, Santiago, Chile; [Zamorano, Francisco; Carrasco, Ximena] Univ Desarrollo, Clin Alemana, Santiago, Chile; [Lopez, Vladimir] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile; [Hurtado, Jose M.] Inst Sistemas Complejos Valparaiso, Valparaiso, Chile; [Carrasco, Ximena] Univ Chile, Fac Med, Hosp Luis Calvo Mackenna, Serv Neurol & Psiquiatria, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad del Desarrollo; Clinica Alemana; Universidad del Desarrollo; Pontificia Universidad Catolica de Chile; Universidad de Chile	Zamorano, F (corresponding author), Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Alameda 340, Santiago, Chile.	fzamorano@udd.cl	Lopez, Vladimir/N-7188-2017; Ossandon, Tomas/ABE-8069-2020; Billeke, Pablo/D-5311-2011; Zamorano, Francisco/J-4869-2015	Ossandon, Tomas/0000-0002-7306-7754; Billeke, Pablo/0000-0003-4261-0678; Zamorano, Francisco/0000-0002-3516-3630	Millenium Center for the Neuroscience of Memory, Chile [NC10-001-F]; Innovation for Competitivity from the Ministry for Economics, Fomentation and Tourism, Chile	Millenium Center for the Neuroscience of Memory, Chile; Innovation for Competitivity from the Ministry for Economics, Fomentation and Tourism, Chile	This work was supported by the Millenium Center for the Neuroscience of Memory, Chile (NC10-001-F), which is developed with funds from the Innovation for Competitivity from the Ministry for Economics, Fomentation and Tourism, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Billeke P, 2013, CEREB CORTEX, V23, P2872, DOI 10.1093/cercor/bhs269; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Bruin KJ, 2001, CLIN NEUROPHYSIOL, V112, P1660, DOI 10.1016/S1388-2457(01)00601-0; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; DAWSON MRW, 1988, BEHAV RES METH INSTR, V20, P54, DOI 10.3758/BF03202603; Detre JA, 2002, CLIN NEUROPHYSIOL, V113, P621, DOI 10.1016/S1388-2457(02)00038-X; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Donchin E, 1998, BEHAV BRAIN SCI, V21, P152, DOI 10.1017/S0140525X98230950; DONCHIN E, 1973, PERCEPT PSYCHOPHYS, V14, P319, DOI 10.3758/BF03212398; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Durston S, 2002, NEUROIMAGE, V16, P449, DOI 10.1006/nimg.2002.1074; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; FALKENSTEIN M, 1995, EVOKED POTENTIAL, V96, P36, DOI 10.1016/0013-4694(94)00182-K; Fallgatter AJ, 2004, CLIN NEUROPHYSIOL, V115, P973, DOI 10.1016/j.clinph.2003.11.036; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Ford JM, 2004, ARCH GEN PSYCHIAT, V61, P119, DOI 10.1001/archpsyc.61.2.119; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gaspar PA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-29; Henriquez M, 2012, J ATTEN DISORD; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; JERVIS BW, 1988, MED BIOL ENG COMPUT, V26, P2, DOI 10.1007/BF02441820; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Kopp B, 1996, ELECTROEN CLIN NEURO, V99, P19, DOI 10.1016/0921-884X(96)95617-9; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Nakata H, 2005, EXP BRAIN RES, V162, P293, DOI 10.1007/s00221-004-2195-4; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Pliszka SR, 2006, AM J PSYCHIAT, V163, P1052, DOI 10.1176/appi.ajp.163.6.1052; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Ramautar JR, 2006, BRAIN RES, V1105, P143, DOI 10.1016/j.brainres.2006.02.091; Recio G, 2009, BIOL PSYCHOL, V80, P246, DOI 10.1016/j.biopsycho.2008.10.007; Salisbury DF, 2004, CLIN NEUROPHYSIOL, V115, P1550, DOI 10.1016/j.clinph.2004.01.028; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; Schacht A, 2010, COGN AFFECT BEHAV NE, V10, P349, DOI 10.3758/CABN.10.3.349; Schulz KP, 2009, HUM BRAIN MAPP, V30, P2821, DOI 10.1002/hbm.20706; Senkowski D, 2002, CLIN NEUROPHYSIOL, V113, P1742, DOI 10.1016/S1388-2457(02)00266-3; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smallwood J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033706; Smith JF, 2011, J PHASE EQUILIB DIFF, V32, P177, DOI 10.1007/s11669-011-9881-2; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Smith JL, 2010, INT J PSYCHOPHYSIOL, V75, P217, DOI 10.1016/j.ijpsycho.2009.11.002; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; van der Meere JJ, 2009, CHILD NEUROPSYCHOL, V15, P554, DOI 10.1080/09297040902758803; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170	72	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87232	10.1371/journal.pone.0087232	http://dx.doi.org/10.1371/journal.pone.0087232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489875	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000122
J	Zografou, K; Kati, V; Grill, A; Wilson, RJ; Tzirkalli, E; Pamperis, LN; Halley, JM				Zografou, Konstantina; Kati, Vassiliki; Grill, Andrea; Wilson, Robert J.; Tzirkalli, Elli; Pamperis, Lazaros N.; Halley, John M.			Signals of Climate Change in Butterfly Communities in a Mediterranean Protected Area	PLOS ONE			English	Article							SPECIES RICHNESS; MULTIVARIATE ANALYSES; ECOLOGICAL STRUCTURE; DADIA RESERVE; CONSERVATION; HABITAT; DIVERSITY; BIODIVERSITY; LANDSCAPE; RANGE	The European protected-area network will cease to be efficient for biodiversity conservation, particularly in the Mediterranean region, if species are driven out of protected areas by climate warming. Yet, no empirical evidence of how climate change influences ecological communities in Mediterranean nature reserves really exists. Here, we examine long-term (1998-2011/2012) and short-term (2011-2012) changes in the butterfly fauna of Dadia National Park (Greece) by revisiting 21 and 18 transects in 2011 and 2012 respectively, that were initially surveyed in 1998. We evaluate the temperature trend for the study area for a 22-year-period (1990-2012) in which all three butterfly surveys are included. We also assess changes in community composition and species richness in butterfly communities using information on (a) species' elevational distributions in Greece and (b) Community Temperature Index (calculated from the average temperature of species' geographical ranges in Europe, weighted by species' abundance per transect and year). Despite the protected status of Dadia NP and the subsequent stability of land use regimes, we found a marked change in butterfly community composition over a 13 year period, concomitant with an increase of annual average temperature of 0.95 degrees C. Our analysis gave no evidence of significant year-to-year (2011-2012) variability in butterfly community composition, suggesting that the community composition change we recorded is likely the consequence of long-term environmental change, such as climate warming. We observe an increased abundance of low-elevation species whereas species mainly occurring at higher elevations in the region declined. The Community Temperature Index was found to increase in all habitats except agricultural areas. If equivalent changes occur in other protected areas and taxonomic groups across Mediterranean Europe, new conservation options and approaches for increasing species' resilience may have to be devised.	[Zografou, Konstantina; Tzirkalli, Elli; Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece; [Kati, Vassiliki] Univ Patras, Dept Environm & Nat Resources Management, Seferi, Agrinio, Greece; [Grill, Andrea] Univ Vienna, Dept Trop Ecol & Anim Biodivers, Vienna, Austria; [Grill, Andrea] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Wilson, Robert J.] Univ Exeter Cornwall Campus, Ctr Ecol & Conservat, Penryn, England	University of Ioannina; University of Patras; University of Vienna; Salzburg University; University of Exeter	Zografou, K (corresponding author), Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece.	ntinazografou@yahoo.co.uk	Kati, Vassiliki I/AAB-9418-2020; Zografou, Konstantina/J-4609-2015; Halley, John M/AAP-3004-2020; Wilson, Robert J/I-8726-2014	Kati, Vassiliki I/0000-0003-3357-4556; Zografou, Konstantina/0000-0003-4305-0238; Wilson, Robert J/0000-0003-4477-7068; Tzirkalli, Elli/0000-0002-7839-2150	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II Investing in knowledge society through the European Social Fund; Austrian Science Fund (FWF) [V 169] Funding Source: researchfish	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II Investing in knowledge society through the European Social Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakopoulos T, 1995, SPECIFIC ENV STUDY D; Anderson MJ, 2005, PERMANOVA FORTRAN CO; [Anonymous], 2010, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2010-1.RLTS; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Argyropoulou MD, 2005, BELG J ZOOL, V135, P127; Asher J, 2001, MILLENNIUM ATLAS BUT; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Dapporto L, 2013, BIOL CONSERV, V157, P229, DOI 10.1016/j.biocon.2012.09.016; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Filz KJ, 2013, EUR J ENTOMOL, V110, P633, DOI 10.14411/eje.2013.086; Gatzogiannis S, 1999, GUIDLINES PREPARATIO; Gerard F, 2010, PROG PHYS GEOG, V34, P183, DOI 10.1177/0309133309360141; Gonzalez-Estebanez FJ, 2011, AGR ECOSYST ENVIRON, V144, P262, DOI 10.1016/j.agee.2011.09.002; Grill A, 2003, BIOL CONSERV, V114, P427, DOI 10.1016/S0006-3207(03)00070-3; Halley JM, 2011, CLIMATIC CHANGE, V109, P549, DOI 10.1007/s10584-011-0053-5; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; IPCC, 2007, 3 ASS REP INT PAN CL; K?llander, 2010, DADIA LEFKIMI SOUFLI; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kati V, 2004, BIOL CONSERV, V115, P33, DOI 10.1016/S0006-3207(03)00091-0; Kati V, 2007, AMPHIBIA-REPTILIA, V28, P517, DOI 10.1163/156853807782152471; Kati Vassiliki, 2000, Naturalistes Belges, V81, P269; Kati V, 2010, BIODIVERS CONSERV, V19, P1585, DOI 10.1007/s10531-010-9788-y; Kati VI, 2006, DIVERS DISTRIB, V12, P620, DOI 10.1111/j.1366-9516.2006.00288.x; Korakis G, 2006, FLORA MEDITERRANEA, V16, P11; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maris F, 2010, DADIA LEFKIMI SOUFLI, P41; Matter SF, 2011, INSECT SCI, V18, P385, DOI 10.1111/j.1744-7917.2011.01407.x; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Merrill RM, 2008, J ANIM ECOL, V77, P145, DOI 10.1111/j.1365-2656.2007.01303.x; Morecroft MD, 2012, J APPL ECOL, V49, P546, DOI 10.1111/j.1365-2664.2012.02147.x; New TR, 1997, J INSECT CONSERV, V1, P5, DOI 10.1023/A:1018433406701; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Pamperis LN, 2009, BUTTERFLIES GREECE; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Pinheiro J, 2003, NLME LINEAR NONLINEA; Robinson N, 2012, ENTOMOL EXP APPL, V145, P50, DOI 10.1111/j.1570-7458.2012.01308.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schindler S, 2010, INTEGRATED STUDY LAN; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2014, ZOOKEYS, P65, DOI 10.3897/zookeys.367.6185; Settele J, 2008, CLIMATIC RISK ATLAS; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Stefanescu C, 2013, ECOGRAPHY, V36, P474, DOI 10.1111/j.1600-0587.2012.07738.x; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Stefanescu C, 2009, INSECT CONSERV DIVER, V2, P261, DOI 10.1111/j.1752-4598.2009.00063.x; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; Van Swaay CAM, 2012, VS2012019 VLIND; van Swaay C, 2011, BIOL CONSERV, V144, P470, DOI 10.1016/j.biocon.2010.09.034; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	67	39	40	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87245	10.1371/journal.pone.0087245	http://dx.doi.org/10.1371/journal.pone.0087245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489880	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000125
J	Fontes, MSC; Raaijmakers, AJA; van Doorn, T; Kok, B; Nieuwenhuis, S; van der Nagel, R; Vos, MA; de Boer, TP; van Rijen, HVM; Bierhuizen, MFA				Fontes, Magda S. C.; Raaijmakers, Antonia J. A.; van Doorn, Tessa; Kok, Bart; Nieuwenhuis, Sylvia; van der Nagel, Roel; Vos, Marc A.; de Boer, Teun P.; van Rijen, Harold V. M.; Bierhuizen, Marti F. A.			Changes in Cx43 and Na(V)1.5 Expression Precede the Occurrence of Substantial Fibrosis in Calcineurin-Induced Murine Cardiac Hypertrophy	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; HUMAN HEART-FAILURE; CONNECTIVE-TISSUE; MICRORNA THERAPEUTICS; GENE-EXPRESSION; SODIUM-CHANNEL; GAP-JUNCTIONS; CONNEXIN43; CARDIOMYOPATHY; MECHANISMS	In mice, the calcium-dependent phosphatase calcineurin A (CnA) induces a transcriptional pathway leading to pathological cardiac hypertrophy. Interestingly, induction of CnA has been frequently noticed in human hypertrophic and failing hearts. Independently, the arrhythmia vulnerability of such hearts has been regularly associated with remodeling of parameters determining electrical conduction (expression level of connexin43 (Cx43) and Na(V)1.5, connective tissue architecture), for which the precise molecular basis and sequence of events is still unknown. Recently, we observed reduced Cx43 and Na(V)1.5 expression in 4-week old mouse hearts, overexpressing a constitutively active form of CnA (MHC-CnA model), but the order of events is still unknown. Therefore, three key parameters of conduction (Cx43, Na(V)1.5 and connective tissue expression) were characterized in MHC-CnA ventricles versus wild-type (WT) during postnatal development on a weekly basis. At postnatal week 1, CnA overexpression induced cardiac hypertrophy in MHC-CnA. Moreover, protein and RNA levels of both Cx43 and Na(V)1.5 were reduced by at least 50% as compared to WT. Cx43 immunoreactive signal was reduced at week 2 in MHC-CnA. At postnatal week 3, Cx43 was less phosphorylated and RNA level of Cx43 normalized to WT values, although the protein level was still reduced. Additionally, MHC-CnA hearts displayed substantial fibrosis relative to WT, which was accompanied by increased RNA levels for genes previously associated with fibrosis such as Col1a1, Col1a2, Col3a1, Tgfb1, Ctgf, Timp1 and microRNA miR-21. In MHC-CnA, reduction in Cx43 and Na(V)1.5 expression thus coincided with overexpression of CnA and hypertrophy development and preceded significant presence of fibrosis. At postnatal week 4 the alterations in conductional parameters observed in the MHC-CnA model lead to abnormal conduction and arrhythmias, similar to those observed in cardiac remodeling in heart failure patients. The MHC-CnA model, therefore, provides for a unique model to resolve the molecular origin of conductional remodeling in detail.	[Fontes, Magda S. C.; Raaijmakers, Antonia J. A.; van Doorn, Tessa; Kok, Bart; Nieuwenhuis, Sylvia; van der Nagel, Roel; Vos, Marc A.; de Boer, Teun P.; van Rijen, Harold V. M.; Bierhuizen, Marti F. A.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bierhuizen, MFA (corresponding author), Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands.	m.f.a.bierhuizen@umcutrecht.nl		de Boer, Teun/0000-0002-0561-6491; van Rijen, Harold/0000-0001-6740-7428	Dutch Heart Foundation [2009B072, 2010T045]	Dutch Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Dutch Heart Foundation (grant numbers 2009B072 and 2010T045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; de Boer TP, 2007, DIFFERENTIATION, V75, P208, DOI 10.1111/j.1432-0436.2006.00133.x; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fabritz L, 2011, J AM COLL CARDIOL, V57, P740, DOI 10.1016/j.jacc.2010.09.046; Fieller E., 1940, J ROYAL STAT SOC S, V7, P1, DOI [10.2307/2983630, DOI 10.2307/2983630]; Fontes MSC, 2012, BBA-BIOMEMBRANES, V1818, P2020, DOI 10.1016/j.bbamem.2011.07.039; Guo J, 2006, AM J PHYSIOL-HEART C, V291, pH2669, DOI 10.1152/ajpheart.01247.2005; Haq S, 2001, CIRCULATION, V103, P670; Hatanka K, 2004, JPN HEART J, V45, P1007, DOI 10.1536/jhj.45.1007; Jansen JA, 2012, CIRC-ARRHYTHMIA ELEC, V5, P380, DOI 10.1161/CIRCEP.111.966580; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pauschinger M, 1998, CARDIOVASC RES, V37, P123, DOI 10.1016/S0008-6363(97)00217-4; R Core Team, 2012, R LANG ENV STAT COMP; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shang LJL, 2007, CIRC RES, V101, P1146, DOI 10.1161/CIRCRESAHA.107.152918; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; SWEAT F, 1964, ARCH PATHOL, V78, P69; Teunissen BEJ, 2007, DNA CELL BIOL, V26, P108, DOI 10.1089/dna.2006.0540; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; van Veen TAB, 2002, J MOL CELL CARDIOL, V34, P1411, DOI 10.1006/jmcc.2002.2102	46	29	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87226	10.1371/journal.pone.0087226	http://dx.doi.org/10.1371/journal.pone.0087226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498049	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900077
J	Saulnier-Talbot, E; Gregory-Eaves, I; Simpson, KG; Efitre, J; Nowlan, TE; Taranu, ZE; Chapman, LJ				Saulnier-Talbot, Emilie; Gregory-Eaves, Irene; Simpson, Kyle G.; Efitre, Jackson; Nowlan, Tobias E.; Taranu, Zofia E.; Chapman, Lauren J.			Small Changes in Climate Can Profoundly Alter the Dynamics and Ecosystem Services of Tropical Crater Lakes	PLOS ONE			English	Article							WATER-RESOURCES; TANGANYIKA; AFRICA; SEDIMENTS	African tropical lakes provide vital ecosystem services including food and water to some of the fastest growing human populations, yet they are among the most understudied ecosystems in the world. The consequences of climate change and other stressors on the tropical lakes of Africa have been informed by long-term analyses, but these studies have largely focused on the massive Great Rift Valley lakes. Our objective was to evaluate how recent climate change has altered the functioning and services of smaller tropical lakes, which are far more abundant on the landscape. Based on a paired analysis of 20 years of high-resolution water column data and a paleolimnological record from a small crater lake in western Uganda, we present evidence that even a modest warming of the air (similar to 0.9 degrees C increase over 20 years) and changes in the timing and intensity of rainfall can have significant consequences on the dynamics of this common tropical lake type. For example, we observed a significant nonlinear increase (R-adj(2) = 0.23, e.d.f. = 7, p < 0.0001) in thermal stability over the past 20 years. This resulted in the expansion of anoxic waters and consequent deterioration of fish habitat and appears to have abated primary production; processes that may impair ecosystem services for a vulnerable human population. This study on a system representative of small tropical crater lakes highlights the far-reaching effects of global climatic change on tropical waters. Increased research efforts into tropical aquatic ecosystem health and the development of sound management practices are necessary in order to strengthen adaptive capabilities in tropical regions.	[Saulnier-Talbot, Emilie; Gregory-Eaves, Irene; Simpson, Kyle G.; Nowlan, Tobias E.; Taranu, Zofia E.; Chapman, Lauren J.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Efitre, Jackson] Makerere Univ, Sch Biosci, Dept Biol Sci, Coll Nat Sci, Kampala, Uganda	McGill University; Makerere University	Saulnier-Talbot, E (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	emiliest@hotmail.com	Gregory-Eaves, Irene/U-9325-2019	Gregory-Eaves, Irene/0000-0002-0380-5061	National Science Foundation (NSF); Wildlife Conservation Society; National Science and Engineering Research Council of Canada (NSERC); Canada Research Chair in Respiratory Ecology; NSERC; Canadian Foundation for Innovation (CFI); Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT); Percy Sladen Memorial Fund	National Science Foundation (NSF)(National Science Foundation (NSF)); Wildlife Conservation Society; National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Respiratory Ecology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); Percy Sladen Memorial Fund	This research was supported by grants from the National Science Foundation (NSF; http://www.nsf.gov/), the Wildlife Conservation Society (http://www.wcs.org/), the National Science and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/) and the Canada Research Chair in Respiratory Ecology to LJC, and by NSERC and the Canadian Foundation for Innovation (CFI) grants to IGE. EST and ZET benefitted from postdoctoral and doctoral fellowships from Fonds quebecois pour la Recherche sur la Nature et les Technologies (FQRNT; http://www.fqrnt.gouv.qc.ca/) and EST from a grant from the Percy Sladen Memorial Fund (http://www.linnean.org/The-Society/awards_and_grants/Awards+and+Grants). No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, TRACKING ENV CHANGE, DOI DOI 10.1007/0-306-47668-1_15; Appleby PG, 2008, HOLOCENE, V18, P83, DOI 10.1177/0959683607085598; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, pS31, DOI 10.1016/S0959-3780(99)00017-5; Chapman LJ, 1998, HYDROBIOLOGIA, V385, P201, DOI 10.1023/A:1003527016384; Chapman LJ, 2003, CONSERV ECOL, P474; Efitre J, 2007, THESIS U FLORIDA; Efitre J, 2009, ENVIRON BIOL FISH, V85, P63, DOI 10.1007/s10641-009-9461-z; Guilizzoni P, 2002, ENCY ENV MICROBIOLOG, P2306, DOI DOI 10.1002/0471263397.ENV313; Hartter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032408; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Kizito Yusuf S., 1993, Limnologica, V23, P335; KLING GW, 1988, LIMNOL OCEANOGR, V33, P27, DOI 10.4319/lo.1988.33.1.0027; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Lewis William M. Jr., 2000, Lakes Reservoirs Research and Management, V5, P35, DOI 10.1046/j.1440-1770.2000.00091.x; Lewis WM, 1996, PERSPECTIVES IN TROPICAL LIMNOLOGY, P43; LEWIS WM, 1973, LIMNOL OCEANOGR, V18, P200, DOI 10.4319/lo.1973.18.2.0200; Margalef R, 1983, LIMNOLOGIA; MELACK JM, 1978, ARCH HYDROBIOL, V84, P430; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Sarmento H, 2013, FRESHWATER BIOL, V58, P2208, DOI 10.1111/fwb.12140; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Taranu ZE, 2012, GLOBAL CHANGE BIOL, V18, P3477, DOI 10.1111/gcb.12015; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Vollmer MK, 2005, LIMNOL OCEANOGR, V50, P727, DOI 10.4319/lo.2005.50.2.0727; Washington R, 2006, B AM METEOROL SOC, V87, P1355, DOI 10.1175/BAMS-87-10-1355; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	29	36	37	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86561	10.1371/journal.pone.0086561	http://dx.doi.org/10.1371/journal.pone.0086561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497954	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900026
J	Bowd, C; Weinreb, RN; Balasubramanian, M; Lee, I; Jang, GJ; Yousefi, S; Zangwill, LM; Medeiros, FA; Girkin, CA; Liebmann, JM; Goldbaum, MH				Bowd, Christopher; Weinreb, Robert N.; Balasubramanian, Madhusudhanan; Lee, Intae; Jang, Giljin; Yousefi, Siamak; Zangwill, Linda M.; Medeiros, Felipe A.; Girkin, Christopher A.; Liebmann, Jeffrey M.; Goldbaum, Michael H.			Glaucomatous Patterns in Frequency Doubling Technology (FDT) Perimetry Data Identified by Unsupervised Machine Learning Classifiers	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; RELEVANCE VECTOR MACHINE; VISUAL-FIELD DEFECTS; INDEPENDENT COMPONENT ANALYSIS; ARTIFICIAL NEURAL-NETWORK; FUNCTIONAL MEASUREMENTS; DIAGNOSTIC-ACCURACY; OPTIC DISC; MIXTURE; EYES	Purpose: The variational Bayesian independent component analysis-mixture model (VIM), an unsupervised machine-learning classifier, was used to automatically separate Matrix Frequency Doubling Technology (FDT) perimetry data into clusters of healthy and glaucomatous eyes, and to identify axes representing statistically independent patterns of defect in the glaucoma clusters. Methods: FDT measurements were obtained from 1,190 eyes with normal FDT results and 786 eyes with abnormal FDT results from the UCSD-based Diagnostic Innovations in Glaucoma Study (DIGS) and African Descent and Glaucoma Evaluation Study (ADAGES). For all eyes, VIM input was 52 threshold test points from the 24-2 test pattern, plus age. Results: FDT mean deviation was -1.00 dB (S.D. = 2.80 dB) and -5.57 dB (S.D. = 5.09 dB) in FDT-normal eyes and FDT-abnormal eyes, respectively (p<0.001). VIM identified meaningful clusters of FDT data and positioned a set of statistically independent axes through the mean of each cluster. The optimal VIM model separated the FDT fields into 3 clusters. Cluster N contained primarily normal fields (1109/1190, specificity 93.1%) and clusters G(1) and G(2) combined, contained primarily abnormal fields (651/786, sensitivity 82.8%). For clusters G(1) and G(2) the optimal number of axes were 2 and 5, respectively. Patterns automatically generated along axes within the glaucoma clusters were similar to those known to be indicative of glaucoma. Fields located farther from the normal mean on each glaucoma axis showed increasing field defect severity. Conclusions: VIM successfully separated FDT fields from healthy and glaucoma eyes without a priori information about class membership, and identified familiar glaucomatous patterns of loss.	[Bowd, Christopher; Weinreb, Robert N.; Balasubramanian, Madhusudhanan; Lee, Intae; Jang, Giljin; Yousefi, Siamak; Zangwill, Linda M.; Medeiros, Felipe A.; Goldbaum, Michael H.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA; [Jang, Giljin] Ulsan Natl Inst Sci & Technol, Sch Elect & Comp Engn, Ulsan, South Korea; [Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Liebmann, Jeffrey M.] NYU, Dept Ophthalmol, Sch Med, New York, NY 10016 USA; [Liebmann, Jeffrey M.] New York Eye & Ear Infirm, New York, NY 10003 USA	University of California System; University of California San Diego; Ulsan National Institute of Science & Technology (UNIST); University of Alabama System; University of Alabama Birmingham; New York University; New York Eye & Ear Infirmary of Mount Sinai	Bowd, C (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	cbowd@ucsd.edu	Goldbaum, Michael/AAG-4258-2020	Goldbaum, Michael/0000-0002-7721-2736; Bowd, Christopher/0000-0001-9330-9987; Girkin, Chris/0000-0002-9676-4499; Girkin, Christopher/0000-0002-5781-7682	NIH [EY022039, EY020518, EY011008, EY014267, EY019869, EY021818]; Research to Prevent Blindness; Eyesight Foundation of Alabama; Corinne Graber Research Fund of the New York Glaucoma Research Institute; Alcon Laboratories; Allergan; Pfizer; NATIONAL EYE INSTITUTE [R00EY020518, R01EY019869, P30EY022589, R01EY022039, U10EY014267, R01EY011008, R01EY021818, K99EY020518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Eyesight Foundation of Alabama; Corinne Graber Research Fund of the New York Glaucoma Research Institute; Alcon Laboratories(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH EY022039, EY020518, NIH EY011008, NIH EY014267, NIH EY019869, NIH EY021818, and an unrestricted grant from Research to Prevent Blindness, Eyesight Foundation of Alabama, Corinne Graber Research Fund of the New York Glaucoma Research Institute. The authors also would like to acknowledge funding from Alcon Laboratories, Allergan, and Pfizer in the form of glaucoma medications at no cost to study participants to which they are prescribed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armaly M F, 1971, Trans Am Ophthalmol Soc, V69, P147; Bengtsson B, 2005, INVEST OPHTH VIS SCI, V46, P3730, DOI 10.1167/iovs.05-0175; Bizios D, 2007, J GLAUCOMA, V16, P20, DOI 10.1097/IJG.0b013e31802b34e4; Bowd C, 2005, INVEST OPHTH VIS SCI, V46, P1322, DOI 10.1167/iovs.04-1122; Bowd C, 2002, INVEST OPHTH VIS SCI, V43, P3444; Bowd C, 2006, ACTA OPHTHALMOL SCAN, V84, P569; Bowd C, 2008, INVEST OPHTH VIS SCI, V49, P945, DOI 10.1167/iovs.07-1083; Bowd C, 2012, INVEST OPHTH VIS SCI, V53, P2382, DOI 10.1167/iovs.11-7951; Brigatti L, 1996, AM J OPHTHALMOL, V121, P511, DOI 10.1016/S0002-9394(14)75425-X; Burgansky-Eliash Z, 2005, INVEST OPHTH VIS SCI, V46, P4147, DOI 10.1167/iovs.05-0366; Chan K, 2003, J MACH LEARN RES, V3, P99, DOI 10.1162/153244303768966120; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Choudrey RA, 2003, NEURAL COMPUT, V15, P213, DOI 10.1162/089976603321043766; De Moraes CGV, 2012, ARCH OPHTHALMOL-CHIC, V130, P833, DOI 10.1001/archophthalmol.2012.786; DRANCE SM, 1972, BRIT J OPHTHALMOL, V56, P186, DOI 10.1136/bjo.56.3.186; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; Goldbaum MH, 2005, INVEST OPHTH VIS SCI, V46, P3676, DOI 10.1167/iovs.04-1167; GOLDBAUM MH, 1994, INVEST OPHTH VIS SCI, V35, P3362; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Goldbaum MH, 2012, INVEST OPHTH VIS SCI, V53, P6557, DOI 10.1167/iovs.11-8363; Goldbaum Michael H, 2009, Trans Am Ophthalmol Soc, V107, P136; Goldbaum Michael Henry, 2005, Trans Am Ophthalmol Soc, V103, P270; Grewal DS, 2008, EUR J OPHTHALMOL, V18, P915, DOI 10.1177/112067210801800610; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Hothorn T, 2003, ARTIF INTELL MED, V27, P65, DOI 10.1016/S0933-3657(02)00085-4; Keltner JL, 2003, ARCH OPHTHALMOL-CHIC, V121, P643, DOI 10.1001/archopht.121.5.643; Kiviluoto K, 1998, ICONIP'98: THE FIFTH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING JOINTLY WITH JNNS'98: THE 1998 ANNUAL CONFERENCE OF THE JAPANESE NEURAL NETWORK SOCIETY - PROCEEDINGS, VOLS 1-3, P895; Lee TW, 2000, IEEE T PATTERN ANAL, V22, P1078, DOI 10.1109/34.879789; Lietman T, 1999, J GLAUCOMA, V8, P77; Maddess T, 2011, INVEST OPHTH VIS SCI, V52, P3759, DOI 10.1167/iovs.11-7405; MAKEIG S, 1996, ADV NEUR IN, V88, P145; McKay D, 1995, NETWORK COMPUTATION, P469; Racette L, 2008, INVEST OPHTH VIS SCI, V49, P954, DOI 10.1167/iovs.07-0493; Racette L, 2010, J GLAUCOMA, V19, P167, DOI 10.1097/IJG.0b013e3181a98b85; Sample PA, 2004, INVEST OPHTH VIS SCI, V45, P2596, DOI 10.1167/iovs.03-0343; Sample PA, 2000, INVEST OPHTH VIS SCI, V41, P1783; Skillicorn D, 2006, EMERGENT INFORM TECH, P331; SPENCELEY SE, 1994, OPHTHAL PHYSL OPT, V14, P239, DOI 10.1111/j.1475-1313.1994.tb00004.x; Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158; Townsend KA, 2008, BRIT J OPHTHALMOL, V92, P814, DOI 10.1136/bjo.2007.133074; Turpin A, 2002, INVEST OPHTH VIS SCI, V43, P709; Turpin A, 2002, INVEST OPHTH VIS SCI, V43, P322; Uchida H, 1996, INVEST OPHTH VIS SCI, V37, P2393; Wall M, 2009, INVEST OPHTH VIS SCI, V50, P974, DOI 10.1167/iovs.08-1789; Wroblewski D, 2009, GRAEF ARCH CLIN EXP, V247, P1517, DOI 10.1007/s00417-009-1121-7; Zangwill LM, 2004, INVEST OPHTH VIS SCI, V45, P3144, DOI 10.1167/iovs.04-0202	46	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85941	10.1371/journal.pone.0085941	http://dx.doi.org/10.1371/journal.pone.0085941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497932	Green Published, gold			2022-12-27	WOS:000330617100011
J	Nunna, S; Reinhardt, R; Ragozin, S; Jeltsch, A				Nunna, Suneetha; Reinhardt, Richard; Ragozin, Sergey; Jeltsch, Albert			Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells	PLOS ONE			English	Article							DNA METHYLATION; EP-CAM; ZINC FINGERS; TRANSCRIPTION FACTORS; EPIGENETIC MARKS; BREAST-CANCER; OVEREXPRESSION; CATUMAXOMAB; SELECTION; ANTIGEN	The Epithelial Cell Adhesion Molecule (EpCAM) is overexpressed in many cancers including ovarian cancer and EpCAM overexpression correlates with decreased survival of patients. It was the aim of this study to achieve a targeted methylation of the EpCAM promoter and silence EpCAM gene expression using an engineered zinc finger protein that specifically binds the EpCAM promoter fused to the catalytic domain of the Dnmt3a DNA methyltransferase. We show that transient transfection of this construct increased the methylation of the EpCAM promoter in SKOV3 cells from 4-8% in untreated cells to 30%. Up to 48% methylation was observed in stable cell lines which express the chimeric methyltransferase. Control experiments confirmed that the methylation was dependent on the fusion of the Zinc finger and the methyltransferase domains and specific for the target region. The stable cell lines with methylated EpCAM promoter showed a 60-80% reduction of EpCAM expression as determined at mRNA and protein level and exhibited a significantly reduced cell proliferation. Our data indicate that targeted methylation of the EpCAM promoter could be an approach in the therapy of EpCAM overexpressing cancers.	[Nunna, Suneetha; Ragozin, Sergey; Jeltsch, Albert] Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany; [Reinhardt, Richard] Max Planck Genomzentrum Koln, Cologne, Germany	University of Stuttgart; Max Planck Society	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany.	albert.jeltsch@ibc.uni-stuttgart.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290; Reinhardt, Richard/0000-0001-9376-2132	Sander Foundation; DAAD (Deutscher Akademischer Austauschdienst)	Sander Foundation; DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	This work has been supported by the Sander Foundation and the DAAD (Deutscher Akademischer Austauschdienst). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Barnholtz-Sloan JS, 2003, AM J OBSTET GYNECOL, V189, P1120, DOI 10.1067/S0002-9378(03)00579-9; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bokemeyer C, 2010, EXPERT OPIN BIOL TH, V10, P1259, DOI 10.1517/14712598.2010.504706; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; de Groote ML, 2012, NUCLEIC ACIDS RES, V40, P10596, DOI 10.1093/nar/gks863; Frampton JE, 2012, DRUGS, V72, P1399, DOI 10.2165/11209040-000000000-00000; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gommans WM, 2007, MOL CARCINOGEN, V46, P391, DOI 10.1002/mc.20289; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; JAMIESON AC, 1994, BIOCHEMISTRY-US, V33, P5689, DOI 10.1021/bi00185a004; Jeltsch A, 2007, APPL MICROBIOL BIOT, V75, P1233, DOI 10.1007/s00253-007-0966-0; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jurkowska RZ, 2010, METHODS MOL BIOL, V649, P149, DOI 10.1007/978-1-60761-753-2_9; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Liu Q, 1997, P NATL ACAD SCI USA, V94, P5525, DOI 10.1073/pnas.94.11.5525; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mostert B, 2009, CANCER TREAT REV, V35, P463, DOI 10.1016/j.ctrv.2009.03.004; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Oberneder R, 2006, EUR J CANCER, V42, P2530, DOI 10.1016/j.ejca.2006.05.029; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Rescigno P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852839; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Schwartzberg LS, 2001, CRIT REV ONCOL HEMAT, V40, P17, DOI 10.1016/S1040-8428(01)00131-7; Seimetz D, 2010, CANCER TREAT REV, V36, P458, DOI 10.1016/j.ctrv.2010.03.001; Shigdar S, 2011, CANCER SCI, V102, P991, DOI 10.1111/j.1349-7006.2011.01897.x; Siddique A, 2013, J MOL BIOL, V425, P479, DOI 10.1016/j.jmb.2012.11.038; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Thiery JP, 1996, J CELL BIOCHEM, V61, P489; van der Gun BTF, 2013, BRIT J CANCER, V108, P881, DOI 10.1038/bjc.2013.45; van der Gun BTF, 2011, BRIT J CANCER, V105, P312, DOI 10.1038/bjc.2011.231; van der Gun BTF, 2008, INT J CANCER, V123, P484, DOI 10.1002/ijc.23476; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wimberger P, 2009, ANTICANCER RES, V29, P1787; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Xiang W, 2003, J CANCER RES CLIN, V129, P341, DOI 10.1007/s00432-003-0438-6; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Zhang Yingying, 2009, V507, P177, DOI 10.1007/978-1-59745-522-0_14	66	49	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87703	10.1371/journal.pone.0087703	http://dx.doi.org/10.1371/journal.pone.0087703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489952	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000172
J	Cremene, M; Dumitrescu, D; Cremene, L				Cremene, Marcel; Dumitrescu, D.; Cremene, Ligia			A Strategic Interaction Model of Punishment Favoring Contagion of Honest Behavior	PLOS ONE			English	Article							EVOLUTIONARY; CORRUPTION; EMERGENCE; TRAGEDY	The punishment effect on social behavior is analyzed within the strategic interaction framework of Cellular Automata and computational Evolutionary Game Theory. A new game, called Social Honesty (SH), is proposed. The SH game is analyzed in spatial configurations. Probabilistic punishment is used as a dishonesty deterrence mechanism. In order to capture the intrinsic uncertainty of social environments, payoffs are described as random variables. New dynamics, with a new relation between punishment probability and punishment severity, are revealed. Punishment probability proves to be more important than punishment severity in guiding convergence towards honesty as predominant behavior. This result is confirmed by empirical evidence and reported experiments. Critical values and transition intervals for punishment probability and severity are identified and analyzed. Clusters of honest or dishonest players emerge spontaneously from the very first rounds of interaction and are determinant for the future dynamics and outcomes.	[Cremene, Marcel; Cremene, Ligia] Tech Univ Cluj Napoca, Cluj Napoca, Romania; [Dumitrescu, D.] Univ Babes Bolyai, R-3400 Cluj Napoca, Romania	Technical University of Cluj Napoca; Babes Bolyai University from Cluj	Cremene, M (corresponding author), Tech Univ Cluj Napoca, Cluj Napoca, Romania.	cremene.marcel@gmail.com	Cremene, Marcel/AAO-9204-2021; Cremene, Ligia/AAG-3198-2021; Cremene, Marcel/AAG-3193-2021	Cremene, Ligia/0000-0003-1262-2221; Cremene, Marcel/0000-0003-2276-8662	 [TE 252];  [33/2010]	; 	This work was supported by the national grant TE 252, contract no. 33/2010, founded by CNCS-UEFISCDI of Romania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A, 2010, GAME OF LIFE CELLULAR AUTOMATA, P1, DOI 10.1007/978-1-84996-217-9; Aidt TS, 2009, OXFORD REV ECON POL, V25, P271, DOI 10.1093/oxrep/grp012; Akerlof George, 2009, ANIMAL SPIRITS HUMAN; [Anonymous], 1965, LOGIC COLLECTIVE ACT; Ariely D., 2012, HONEST TRUTH DISHONE; Axelrod R., 2006, EVOLUTION COOPERATIO; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Becker GS, 1974, ESSAYS EC CRIME PUNI; Binmore K., 2006, PAPERS EC EVOLUTION; Binmore K, 1998, GAME THEORY SOCIAL C; Bonabeau E, 2004, HARVARD BUS REV, V82, P135; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fukuyama F, 2000, GREAT DISRUPTION HUM; GARDNER M, 1970, SCI AM, V223, P120, DOI 10.1038/scientificamerican1070-120; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gladwell M., 2006, TIPPING POINT LITTLE; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Hofbauer J, 1998, EVOLUTIONARY GAMES P; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Nagin DS, 2001, CRIMINOLOGY, V39, P865, DOI 10.1111/j.1745-9125.2001.tb00943.x; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Rotberg RI, 2009, CORRUPTION, GLOBAL SECURITY, AND WORLD ORDER, P1; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Schuster HG, 2009, ANN REV NONLINEAR DY, V2; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; von Hirsch A, 1999, CRIMINAL DETERRENCE; vonNeumann J, 1951, CEREBRAL MECH BEHAV, P2070; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Watson JB, 1913, PSYCHOL REV, V20, P158, DOI 10.1037/h0074428	41	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87471	10.1371/journal.pone.0087471	http://dx.doi.org/10.1371/journal.pone.0087471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489917	gold, Green Published, Green Submitted			2022-12-27	WOS:000330510000134
J	Eves-van den Akker, S; Lilley, CJ; Ault, JR; Ashcroft, AE; Jones, JT; Urwin, PE				Eves-van den Akker, Sebastian; Lilley, Catherine J.; Ault, James R.; Ashcroft, Alison E.; Jones, John T.; Urwin, Peter E.			The Feeding Tube of Cyst Nematodes: Characterisation of Protein Exclusion	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; GREEN-FLUORESCENT PROTEIN; ION MOBILITY MEASUREMENTS; MASS-SPECTROMETRY; GLOMERULAR-FILTRATION; HETERODERA-SCHACHTII; ARABIDOPSIS-THALIANA; SIZE-SELECTIVITY; AGGREGATION; CELLS	Plant parasitic nematodes comprise several groups; the most economically damaging of these are the sedentary endoparasites. Sedentary endoparasitic nematodes are obligate biotrophs and modify host root tissue, using a suite of effector proteins, to create a feeding site that is their sole source of nutrition. They feed by withdrawing host cell assimilate from the feeding site though a structure known as the feeding tube. The function, composition and molecular characteristics of feeding tubes are poorly characterised. It is hypothesised that the feeding tube facilitates uptake of host cell assimilate by acting as a molecular sieve. Several studies, using molecular mass as the sole indicator of protein size, have given contradictory results about the exclusion limits of the cyst nematode feeding tube. In this study we propose a method to predict protein size, based on protein database coordinates in silico. We tested the validity of these predictions using travelling wave ion mobility spectrometry - mass spectrometry, where predictions and measured values were within approximately 6%. We used the predictions, coupled with mass spectrometry, analytical ultracentrifugation and protein electrophoresis, to resolve previous conflicts and define the exclusion characteristics of the cyst nematode feeding tube. Heterogeneity was tested in the liquid, solid and gas phase to provide a comprehensive evaluation of three proteins of particular interest to feeding tube size exclusion, GFP, mRFP and Dual PI. The data and procedures described here could be applied to the design of plant expressed defence compounds intended for uptake into cyst nematodes. We also highlight the need to assess protein heterogeneity when creating novel fusion proteins.	[Eves-van den Akker, Sebastian; Lilley, Catherine J.; Urwin, Peter E.] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Eves-van den Akker, Sebastian; Jones, John T.] James Hutton Inst, Dundee, Scotland; [Ault, James R.; Ashcroft, Alison E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; James Hutton Institute; University of Leeds	Urwin, PE (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	P.E.Urwin@leeds.ac.uk	Ault, James R/O-8904-2019	Ault, James R/0000-0002-5131-438X; Urwin, Peter Edward/0000-0003-0398-2372; Jones, John/0000-0003-2074-0551; Eves-van den Akker, Sebastian/0000-0002-8833-9679	UK Biotechnology and Biological Sciences Research Council (BBSRC); James Hutton Institute; University of Leeds [SRIF4]; Scottish Government; BBSRC [BB/D009944/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [959589, BB/D009944/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); James Hutton Institute; University of Leeds; Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SEvdA was supported by a Ph.D. studentship jointly funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and The James Hutton Institute. The Synapt HDMS mass spectrometer was purchased with funds from the University of Leeds (SRIF4). The James Hutton Institute receives funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCKENHOFF A, 1994, PARASITOLOGY, V109, P249, DOI 10.1017/S003118200007637X; Carpenter JF, 1999, METHOD ENZYMOL, V309, P236; Cellmer T, 2007, TRENDS BIOTECHNOL, V25, P254, DOI 10.1016/j.tibtech.2007.03.011; Clemmer DE, 1997, J MASS SPECTROM, V32, P577; Edwards A, 1999, AM J PHYSIOL-RENAL, V276, pF892, DOI 10.1152/ajprenal.1999.276.6.F892; FIELDS GB, 1992, J PHYS CHEM-US, V96, P3974, DOI 10.1021/j100189a013; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Goverse A, 1998, PHYSIOL MOL PLANT P, V52, P275, DOI 10.1006/pmpp.1998.0154; GUASCH A, 1993, J CLIN INVEST, V92, P2274, DOI 10.1172/JCI116831; Hogan CJ, 2011, J PHYS CHEM B, V115, P3614, DOI 10.1021/jp109172k; Hopper JTS, 2009, J AM SOC MASS SPECTR, V20, P1851, DOI 10.1016/j.jasms.2009.06.010; HUSSEY RS, 1991, PROTOPLASMA, V162, P99, DOI 10.1007/BF02562553; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kiese S, 2008, J PHARM SCI-US, V97, P4347, DOI 10.1002/jps.21328; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Mack E, 1925, J AM CHEM SOC, V47, P2468, DOI 10.1021/ja01687a007; McCarter J, 2010, J NEMATOL, V42, P256; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; Raso SW, 2005, PROTEIN SCI, V14, P2246, DOI 10.1110/ps.051489405; RAZAK AR, 1976, NEMATOLOGICA, V22, P182; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; RUMPENHORST HJ, 1984, NEMATOLOGICA, V30, P77, DOI 10.1163/187529284X00473; Rutschow HL, 2011, PLANT PHYSIOL, V155, P1817, DOI 10.1104/pp.110.168187; Shelimov KB, 1997, J AM CHEM SOC, V119, P2240, DOI 10.1021/ja9619059; Shvartsburg AA, 1998, J CHEM PHYS, V108, P2416, DOI 10.1063/1.475625; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Shvartsburg AA, 2007, J PHYS CHEM A, V111, P2002, DOI 10.1021/jp066953m; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Sobczak M, 1999, NEMATOLOGY, V1, P363, DOI 10.1163/156854199508351; Tencer J, 1998, KIDNEY INT, V53, P709, DOI 10.1046/j.1523-1755.1998.00797.x; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; Treuheit MJ, 2002, PHARM RES-DORDR, V19, P511, DOI 10.1023/A:1015108115452; Trudgill DL, 1997, PLANT PATHOL, V46, P26, DOI 10.1046/j.1365-3059.1997.d01-201.x; Urwin PE, 1997, MOL PLANT MICROBE IN, V10, P394, DOI 10.1094/MPMI.1997.10.3.394; Urwin PE, 1998, PLANTA, V204, P472, DOI 10.1007/s004250050281; Valentine SJ, 1997, J PHYS CHEM B, V101, P3891, DOI 10.1021/jp970217o; Valentine TA, 2007, PLANT BIOTECHNOL J, V5, P827, DOI 10.1111/j.1467-7652.2007.00289.x; van Duijn E, 2009, J AM CHEM SOC, V131, P1452, DOI 10.1021/ja8055134; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Woods LA, 2011, NAT CHEM BIOL, V7, P730, DOI [10.1038/nchembio.635, 10.1038/NCHEMBIO.635]; WYSS U, 1992, NETH J PLANT PATHOL, V98, P165, DOI 10.1007/BF01974483; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	43	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87289	10.1371/journal.pone.0087289	http://dx.doi.org/10.1371/journal.pone.0087289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489891	Green Published, gold			2022-12-27	WOS:000330510000125
J	Fan, FF; Xu, Q; Sun, Q; Zhao, SJ; Wang, P; Guo, XR				Fan, Fang-Fang; Xu, Qin; Sun, Qi; Zhao, Sheng-Jun; Wang, Ping; Guo, Xue-Rui			Assessment of the Reporting Quality of Randomized Controlled Trials on Treatment of Coronary Heart Disease with Traditional Chinese Medicine from the Chinese Journal of Integrated Traditional and Western Medicine: A Systematic Review	PLOS ONE			English	Review							CLINICAL-TRIALS; SAMPLE-SIZE; INTENTION; STATEMENT	Background: Due to language limitations, little is known about the reporting quality of randomized clinical trials (RCTs) on the treatment of coronary heart disease (CHD) with traditional Chinese medicine (TCM) in Chinese Journal of Integrated Traditional and Western Medicine (CJITWM). Objective: In this study, we utilized the CONSORT 2010 statement to understand the reporting quality of RCTs on CHD with TCM from the CJITWM. Methods: The China National Knowledge Infrastructure (CNKI) electronic database was searched for CJITWM RCTs on the treatment of CHD with TCM, published between Janurary 1, 2006 and December 31, 2011. We excluded articles reported as "animal studies," "topic review," "diagnostic test," "editorials," or "others." The CONSORT checklist was applied to evaluate the reporting quality of all eligible articles by two independent authors after extensive discussion. Each item was graded as either "yes" or "no" depending on whether the authors had reported it or not. Results: We identified 21 articles meeting our inclusion criteria. The percentage of 11 of the 37 items was 4.8 similar to 95.2%, 14 of the 37 items were reported in all included articles, while 12 items were not mentioned at all. The average reporting percentage for the "title and abstract" section was 52.4%, for the "introduction" section 100.0%, for the "methods" section 45.4%, for the "results" section 57.1%, for the "discussion" section 79.4%, and for the "other information" section 17.5%. Conclusion: In general, the reviewed RCTs were not consistent with the CONSORT 2010 statement. Authors should adhere to the CONSORT statement in reporting RCTs; editorial departments may consider the CONSORT statement as a guideline and should instruct authors to write manuscripts, and reviewers to judge them according to CONSORT statutes.	[Fan, Fang-Fang; Zhao, Sheng-Jun; Wang, Ping] Xinjiang Med Univ, Affiliated Tradit Med Hosp, Dept Pharm, Urumqi, Xinjiang Uygur, Peoples R China; [Xu, Qin; Sun, Qi] Xinjiang Med Univ, Affiliated Tradit Med Hosp, Med Res Design & Data Anal Ctr, Urumqi, Xinjiang Uygur, Peoples R China; [Guo, Xue-Rui] Xinjiang Med Univ, Affiliated Tradit Med Hosp, Dept Pediat, Urumqi, Xinjiang Uygur, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Sun, Q (corresponding author), Xinjiang Med Univ, Affiliated Tradit Med Hosp, Med Res Design & Data Anal Ctr, Urumqi, Xinjiang Uygur, Peoples R China.	cums6140@hotmail.com; zyyzsj0707@126.com	Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022					ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; ALTMAN DG, 2000, STAT CONFIDENCE CONF, P6; [Anonymous], 1997, JAMA, V277, P927; [Anonymous], 1986, LANCET, V2, P57; Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bian Zhaoxiang, 2011, Front Med, V5, P171, DOI 10.1007/s11684-011-0132-z; CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Cheng WL, 2009, ZHONGGUO ZHONG XI YI, V29, P1055; Cui Xiao-yun, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P30; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; [樊涛 FAN Tao], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P461; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Guo Zhi-bin, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P311; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Hawthorne V, 2002, HEART, V88, P222; Herman A, 2009, J BONE JOINT SURG AM, V91A, P2137, DOI 10.2106/JBJS.H.01481; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hu Yuan-Hui, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P309; Jing Lu, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P18; Lachin JL, 2000, CONTROL CLIN TRIALS, V21, P526, DOI 10.1016/S0197-2456(00)00092-1; LEE YJ, 1991, STAT MED, V10, P1595, DOI 10.1002/sim.4780101011; LEWIS JA, 1993, BRIT J CANCER, V68, P647, DOI 10.1038/bjc.1993.402; Li Ai-Min, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P830; Liu Ping, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P42; Lu Xiao-Yan, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P13; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; [毛兵 MAO Bing], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P880; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Peng Wei, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P191; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Sadler LC, 2000, BRIT J OBSTET GYNAEC, V107, P909, DOI 10.1111/j.1471-0528.2000.tb11091.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SHEINER LB, 1995, CLIN PHARMACOL THER, V57, P6, DOI 10.1016/0009-9236(95)90260-0; Wang Li-Jie, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P399; Wei Zi-Tai, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P418; Wu Tong-qi, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P357; Xin Li, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1191; [徐航 Xu Hang], 2012, [中国全科医学, Chinese General Practice], V15, P2304; Xu Hao, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P8; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; [徐秦 XU Qin], 2009, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V9, P113; Yan Ling-Yun, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P695; Yin Cheng-hua, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P380; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Zang Qian, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P402; Zhang Qiong, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P509; [张小利 ZHANG Xiaoli], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P586; Zhang Ying, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P1066; Zhao S, 2007, ZHONG XI YI JIE HE X, V5, P383; Zhou DZ, 2000, CHINESE TRADITIONAL, V22, P578; Zhu Hong-jun, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P361; Zhu Hui, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P474; [朱晓峰 Zhu Xiaofeng], 2012, [中成药, Chinese Traditional Patent Medicine], V34, P596	63	18	20	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86360	10.1371/journal.pone.0086360	http://dx.doi.org/10.1371/journal.pone.0086360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489719	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000048
J	Glebes, TY; Sandoval, NR; Reeder, PJ; Schilling, KD; Zhang, M; Gill, RT				Glebes, Tirzah Y.; Sandoval, Nicholas R.; Reeder, Philippa J.; Schilling, Katherine D.; Zhang, Min; Gill, Ryan T.			Genome-Wide Mapping of Furfural Tolerance Genes in Escherichia coli	PLOS ONE			English	Article							ETHANOL-PRODUCTION; LIPOPOLYSACCHARIDE BIOSYNTHESIS; SCALE IDENTIFICATION; OUTER-MEMBRANE; PLASMID DNA; OVEREXPRESSION; GROWTH; EXPRESSION; EVOLUTION; STRAINS	Advances in genomics have improved the ability to map complex genotype-to-phenotype relationships, like those required for engineering chemical tolerance. Here, we have applied the multiSCale Analysis of Library Enrichments (SCALEs; Lynch et al. (2007) Nat. Method.) approach to map, in parallel, the effect of increased dosage for >10(5) different fragments of the Escherichia coli genome onto furfural tolerance (furfural is a key toxin of lignocellulosic hydrolysate). Only 268 of >4,000 E. coli genes (similar to 6%) were enriched after growth selections in the presence of furfural. Several of the enriched genes were cloned and tested individually for their effect on furfural tolerance. Overexpression of thyA, lpcA, or groESL individually increased growth in the presence of furfural. Overexpression of lpcA, but not groESL or thyA, resulted in increased furfural reduction rate, a previously identified mechanism underlying furfural tolerance. We additionally show that plasmid-based expression of functional LpcA or GroESL is required to confer furfural tolerance. This study identifies new furfural tolerant genes, which can be applied in future strain design efforts focused on the production of fuels and chemicals from lignocellulosic hydrolysate.	[Glebes, Tirzah Y.; Sandoval, Nicholas R.; Reeder, Philippa J.; Schilling, Katherine D.; Gill, Ryan T.] Univ Colorado, Boulder, CO 80309 USA; [Zhang, Min] Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO USA	University of Colorado System; University of Colorado Boulder; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Gill, RT (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	rtg@colorado.edu	Sandoval, Nicholas R./Y-5605-2019	Sandoval, Nicholas R./0000-0002-1743-3975	Department of Energy [ZCO-7-77431-001]; National Science Foundation [CBET 1067730]; National Science Foundation	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Department of Energy through subcontract no. ZCO-7-77431-001 to the National Renewable Energy Laboratory. This work was also supported by the National Science Foundation award number CBET 1067730. With the exception of study conception and roles consistent with authorship by MZ, the funding agencies had no role in the study design, data collection and analysis, or decision to publish. TYG and NRS were supported as National Science Foundation Graduate Research Fellowship Program recipients.	Allen SA, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-2; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bonomo J, 2008, METAB ENG, V10, P109, DOI 10.1016/j.ymben.2007.10.002; Boyle NR, 2012, CURR OPIN BIOTECH, V23, P666, DOI 10.1016/j.copbio.2012.01.012; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Cho RJ, 1998, P NATL ACAD SCI USA, V95, P3752, DOI 10.1073/pnas.95.7.3752; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; Gall S, 2008, METAB ENG, V10, P382, DOI 10.1016/j.ymben.2008.08.003; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Gill RT, 2002, P NATL ACAD SCI USA, V99, P7033, DOI 10.1073/pnas.102154799; Gill RT, 1998, BIOTECHNOL BIOENG, V59, P248, DOI 10.1002/(SICI)1097-0290(19980720)59:2<248::AID-BIT12>3.0.CO;2-A; Gutierrez T, 2006, J BIOTECHNOL, V121, P154, DOI 10.1016/j.jbiotec.2005.07.003; Gutierrez T, 2002, APPL BIOCHEM BIOTECH, V98, P327, DOI 10.1385/ABAB:98-100:1-9:327; HADI SM, 1989, MUTAT RES, V225, P101, DOI 10.1016/0165-7992(89)90125-5; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; KHAN QA, 1995, CANCER LETT, V89, P95, DOI 10.1016/0304-3835(95)90163-9; KHAN QA, 1993, BIOCHEM MOL BIOL INT, V29, P1153; Lynch MD, 2007, NAT METHODS, V4, P87, DOI 10.1038/NMETH946; Martinez A, 2000, BIOTECHNOL PROGR, V16, P637, DOI 10.1021/bp0000508; Miller EN, 2010, BIOTECHNOL LETT, V32, P661, DOI 10.1007/s10529-010-0209-9; Miller EN, 2009, APPL ENVIRON MICROB, V75, P4315, DOI 10.1128/AEM.00567-09; Miller EN, 2009, APPL ENVIRON MICROB, V75, P6132, DOI 10.1128/AEM.01187-09; Mills TY, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-26; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nicolaou SA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr817; NIKAIDO H, 1976, BIOCHIM BIOPHYS ACTA, V433, P118, DOI 10.1016/0005-2736(76)90182-6; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sandoval NR, 2011, METAB ENG, V13, P214, DOI 10.1016/j.ymben.2010.12.001; Sandoval NR, 2012, P NATL ACAD SCI US; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Shahabuddin Rahman A, 1991, FOOD CHEM TOXICOL, V29, P719; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Singh A, 2010, APPL ENVIRON MICROB, V76, P5463, DOI 10.1128/AEM.00583-10; Singh A, 2009, METAB ENG, V11, P347, DOI 10.1016/j.ymben.2009.07.002; Skerker JM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.30; Spindler EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055052; Struble JM, 2009, PLOS ONE, V4, pA6, DOI 10.1371/journal.pone.0006576; Taylor PL, 2008, J BIOL CHEM, V283, P2835, DOI 10.1074/jbc.M706163200; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JQ, 2012, BIOTECHNOL BIOENG, V109, P3133, DOI 10.1002/bit.24574; Wang X, 2011, APPL ENVIRON MICROB, V77, P5132, DOI 10.1128/AEM.05008-11; Wang X, 2013, P NATL ACAD SCI USA, V110, P4021, DOI 10.1073/pnas.1217958110; Wang X, 2012, APPL ENVIRON MICROB, V78, P2452, DOI 10.1128/AEM.07783-11; Warnecke TE, 2010, METAB ENG, V12, P241, DOI 10.1016/j.ymben.2009.12.002; Warnecke TE, 2008, METAB ENG, V10, P154, DOI 10.1016/j.ymben.2008.04.004; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Woodruff LBA, 2013, METAB ENG, V15, P124, DOI 10.1016/j.ymben.2012.10.007; Woodruff LBA, 2011, CURR OPIN BIOTECH, V22, P576, DOI 10.1016/j.copbio.2011.04.019; Woodruff LB, 2013, METAB ENG; YAMAMORI T, 1980, J BACTERIOL, V142, P843, DOI 10.1128/JB.142.3.843-851.1980; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yomano LP, 1998, J IND MICROBIOL BIOT, V20, P132, DOI 10.1038/sj.jim.2900496; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zheng HB, 2013, APPL ENVIRON MICROB, V79, P3202, DOI 10.1128/AEM.00149-13; Zheng HB, 2012, APPL ENVIRON MICROB, V78, P4346, DOI 10.1128/AEM.00356-12; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18; Zingaro KA, 2013, METAB ENG, V15, P196, DOI 10.1016/j.ymben.2012.07.009; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	69	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87540	10.1371/journal.pone.0087540	http://dx.doi.org/10.1371/journal.pone.0087540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489935	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000142
J	Melo, RDC; Longhini, AL; Bigarella, CL; Baratti, MO; Traina, F; Favaro, P; Campos, PD; Saad, STO				Carvalho Melo, Rita de Cassia; Longhini, Ana Leda; Bigarella, Carolina Louzao; Baratti, Mariana Ozello; Traina, Fabiola; Favaro, Patricia; Campos, Paula de Melo; Olalla Saad, Sara Teresinha			CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CELL-MIGRATION; VASCULAR ENDOTHELIUM; BETA-ARRESTIN; CD34(+) CELLS; PROTEIN; SDF-1; CROSSTALK; SURVIVAL; BINDS	Recently, a novel CXCL12-binding receptor, has been identified. This CXCL12-binding receptor commonly known as CXCR7 (CXC chemokine receptor 7), has lately, based on a novel nomenclature, has received the name ACKR3 (atypical chemokine receptor 3). In this study, we aimed to investigate the expression of CXCR7 in leukemic cells, as well as its participation in CXCL12 response. Interesting, we clearly demonstrated that CXCR7 is highly expressed in acute lymphoid leukemic cells compared with myeloid or normal hematopoietic cells and that CXCR7 contributed to T-acute lymphoid leukemic cell migration induced by CXCL12. Moreover, we showed that the cellular location of CXCR7 varied among T-lymphoid cells and this finding may be related to their migration capacity. Finally, we hypothesized that CXCR7 potentiates CXCR4 response and may contribute to the maintenance of leukemia by initiating cell recruitment to bone marrow niches that were once occupied by normal hematopoietic stem cells.	[Carvalho Melo, Rita de Cassia; Longhini, Ana Leda; Bigarella, Carolina Louzao; Baratti, Mariana Ozello; Traina, Fabiola; Favaro, Patricia; Campos, Paula de Melo; Olalla Saad, Sara Teresinha] Univ Estadual Campinas, Ctr Hematol & Hemoterapia, Sao Paulo, Brazil; [Favaro, Patricia] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Melo, RDC (corresponding author), Univ Estadual Campinas, Ctr Hematol & Hemoterapia, Sao Paulo, Brazil.	ritacmelo@hotmail.com	Traina, Fabiola/L-3809-2014; Traina, Fabiola/U-1451-2019; De Melo Campos, Paula/HIK-1076-2022; CTC USP, CEPID 13 18/J-8951-2014	Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	Aperfeicoamento Pessoal de Nivel Superior (CAPES); CNPq; FAPESP; INCT-Sangue	Aperfeicoamento Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT-Sangue	This study was funded by grants from Aperfeicoamento Pessoal de Nivel Superior (CAPES). The authors also thank CNPq, FAPESP, and INCT-Sangue for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Bigarella CL, 2009, BBA-MOL CELL RES, V1793, P806, DOI 10.1016/j.bbamcr.2009.02.010; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Broustas CG, 2012, J BIOL CHEM, V287, P41324, DOI 10.1074/jbc.M112.402784; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Butler JT, 2009, J NEUROSCI RES, V87, P626, DOI 10.1002/jnr.21882; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Faaij CMJM, 2010, PEDIATR BLOOD CANCER, V55, P344, DOI 10.1002/pbc.22500; Favaro P, 2013, J LEUKOCYTE BIOL, V94, P503, DOI 10.1189/jlb.0113057; Grymula K, 2010, INT J CANCER, V127, P2554, DOI 10.1002/ijc.25245; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kucia M, 2004, J MOL HISTOL, V35, P233; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li T, 2011, J PATHOL, V223, P519, DOI 10.1002/path.2829; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Mahabaleshwar H, 2008, CELL ADHES MIGR, V2, P69, DOI 10.4161/cam.2.2.6027; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Traina F, 2003, FEBS LETT, V535, P17, DOI 10.1016/S0014-5793(02)03845-0; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Werner L, 2011, J LEUKOCYTE BIOL, V90, P583, DOI 10.1189/jlb.0111101; Yao X, 2011, J INT MED RES, V39, P1253, DOI 10.1177/147323001103900413; Yoshida D, 2009, J NEUROENDOCRINOL, V21, P481, DOI 10.1111/j.1365-2826.2009.01867.x; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73	52	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e85926	10.1371/journal.pone.0085926	http://dx.doi.org/10.1371/journal.pone.0085926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497931	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900012
J	Memmel, S; Sukhorukov, VL; Horing, M; Westerling, K; Fiedler, V; Katzer, A; Krohne, G; Flentje, M; Djuzenova, CS				Memmel, Simon; Sukhorukov, Vladimir L.; Hoering, Marcus; Westerling, Katherine; Fiedler, Vanessa; Katzer, Astrid; Krohne, Georg; Flentje, Michael; Djuzenova, Cholpon S.			Cell Surface Area and Membrane Folding in Glioblastoma Cell Lines Differing in PTEN and p53 Status	PLOS ONE			English	Article							SWELLING-ACTIVATED PATHWAYS; FATTY-ACID SYNTHASE; GAIN-OF-FUNCTION; DIELECTRIC-PROPERTIES; GLIOMA-CELLS; T-LYMPHOCYTES; TUMOR-CELLS; CHLORIDE CHANNELS; HSP90 INHIBITORS; EXPRESSION	Glioblastoma multiforme (GBM) is characterized by rapid growth, invasion and resistance to chemo-/radiotherapy. The complex cell surface morphology with abundant membrane folds, microvilli, filopodia and other membrane extensions is believed to contribute to the highly invasive behavior and therapy resistance of GBM cells. The present study addresses the mechanisms leading to the excessive cell membrane area in five GBM lines differing in mutational status for PTEN and p53. In addition to scanning electron microscopy (SEM), the membrane area and folding were quantified by dielectric measurements of membrane capacitance using the single-cell electrorotation (ROT) technique. The osmotic stability and volume regulation of GBM cells were analyzed by video microscopy. The expression of PTEN, p53, mTOR and several other marker proteins involved in cell growth and membrane synthesis were examined by Western blotting. The combined SEM, ROT and osmotic data provided independent lines of evidence for a large variability in membrane area and folding among tested GBM lines. Thus, DK-MG cells (wild type p53 and wild type PTEN) exhibited the lowest degree of membrane folding, probed by the area-specific capacitance C-m = 1.9 mu F/cm(2). In contrast, cell lines carrying mutations in both p53 and PTEN (U373-MG and SNB19) showed the highest C-m values of 3.7-4.0 mu F/cm(2), which corroborate well with their heavily villated cell surface revealed by SEM. Since PTEN and p53 are well-known inhibitors of mTOR, the increased membrane area/folding in mutant GBM lines may be related to the enhanced protein and lipid synthesis due to a deregulation of the mTOR-dependent downstream signaling pathway. Given that membrane folds and extensions are implicated in tumor cell motility and metastasis, the dielectric approach presented here provides a rapid and simple tool for screening the biophysical cell properties in studies on targeting chemo-or radiotherapeutically the migration and invasion of GBM and other tumor types.	[Memmel, Simon; Sukhorukov, Vladimir L.; Hoering, Marcus; Westerling, Katherine] Univ Wurzburg, Lehrstuhl Biotechnol & Biophys, D-97070 Wurzburg, Germany; [Fiedler, Vanessa; Katzer, Astrid; Flentje, Michael; Djuzenova, Cholpon S.] Univ Hosp Wurzburg, Dept Radiat Oncol, Wurzburg, Germany; [Krohne, Georg] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Sukhorukov, VL (corresponding author), Univ Wurzburg, Lehrstuhl Biotechnol & Biophys, Hubland, D-97070 Wurzburg, Germany.	sukhorukov@biozentrum.uni-wuerzburg.de; djuzenova@ukw.de	Sukhorukov, Vladimir L/ACO-0333-2022; Katzer, Astrid/GQZ-8457-2022	Horing, Marcus/0000-0002-3651-392X	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto Jiro, 2005, Brain Tumor Pathol, V22, P21, DOI 10.1007/s10014-005-0173-6; ARNOLD WM, 1988, J ELECTROSTAT, V21, P151, DOI 10.1016/0304-3886(88)90027-7; Asami K, 2013, BIOELECTROCHEMISTRY, V92, P14, DOI 10.1016/j.bioelechem.2013.02.003; Asami K, 2011, BIOELECTROCHEMISTRY, V81, P28, DOI 10.1016/j.bioelechem.2011.01.002; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; BLACK PM, 1982, J NEUROSURG, V56, P62, DOI 10.3171/jns.1982.56.1.0062; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; Bostrom J, 1998, CANCER RES, V58, P29; Catacuzzeno L, 2011, J CELL PHYSIOL, V226, P1926, DOI 10.1002/jcp.22523; Chan KL, 1997, BBA-LIPID LIPID MET, V1349, P182, DOI 10.1016/S0005-2760(97)00092-1; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Djuzenova CS, 2009, MOL MED REP, V2, P633, DOI 10.3892/mmr_00000149; Drappatz J, 2009, EXPERT REV NEUROTHER, V9, P519, DOI [10.1586/ern.09.10, 10.1586/ERN.09.10]; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gascoyne PRC, 2013, ELECTROPHORESIS, V34, P1042, DOI 10.1002/elps.201200496; Gascoyne PRC, 2009, ANAL CHEM, V81, P8878, DOI 10.1021/ac901470z; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Giannini C, 1997, BRAIN PATHOL, V7, P785, DOI 10.1111/j.1750-3639.1997.tb01064.x; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gimsa J, 1996, BIOPHYS J, V71, P495, DOI 10.1016/S0006-3495(96)79251-2; Han SI, 2013, ANALYST, V138, P1529, DOI 10.1039/c3an36261b; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Hoa N, 2010, J IMMUNOL, V185, P4793, DOI 10.4049/jimmunol.1001526; Hofer S, 2001, J CANCER RES CLIN, V127, P91, DOI 10.1007/s004320000171; Jones T. B., 2005, ELECTROMECHANICS PAR; KENNEDY PGE, 1987, NEUROPATH APPL NEURO, V13, P327, DOI 10.1111/j.1365-2990.1987.tb00190.x; Kiesel M, 2006, BIOPHYS J, V90, P4720, DOI 10.1529/biophysj.105.078725; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Kraus JA, 2000, J NEURO-ONCOL, V48, P89, DOI 10.1023/A:1006402614838; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lei U, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3659282; Li YQ, 2008, CANCER RES, V68, P1723, DOI 10.1158/0008-5472.CAN-07-1963; Machado CML, 2009, MICROSC RES TECHNIQ, V72, P310, DOI 10.1002/jemt.20653; Lucio AD, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041906; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Mise-Omata S, 2005, BIOCHEM BIOPH RES CO, V328, P1034, DOI 10.1016/j.bbrc.2005.01.066; Niewidok N, 2012, TRANSL ONCOL, V5, P356, DOI 10.1593/tlo.12211; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohira K, 2006, BIOCHEM BIOPH RES CO, V342, P867, DOI 10.1016/j.bbrc.2006.02.033; Pethig R, 2002, ELECTROPHORESIS, V23, P2057, DOI 10.1002/1522-2683(200207)23:13<2057::AID-ELPS2057>3.0.CO;2-X; Quick QA, 2006, J NEUROSURG, V105, P111, DOI 10.3171/jns.2006.105.1.111; Reardon DA, 2008, EXPERT OPIN INV DRUG, V17, P1225, DOI 10.1517/13543784.17.8.1225 ; ROSS PE, 1994, BIOPHYS J, V66, P169, DOI 10.1016/S0006-3495(94)80754-4; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; SCHROEDER TE, 1979, DEV BIOL, V70, P306, DOI 10.1016/0012-1606(79)90030-7; Scott KEN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029761; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUKHORUKOV VL, 1994, J MEMBRANE BIOL, V142, P77; Sukhorukov VL, 2009, BBA-BIOMEMBRANES, V1788, P1841, DOI 10.1016/j.bbamem.2009.06.016; Teodori L, 2006, CYTOM PART A, V69A, P75, DOI 10.1002/cyto.a.20208; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; WESTPHAL M, 1988, CANCER RES, V48, P731; Yamanaka R, 2009, ANN NEUROL, V66, P717, DOI 10.1002/ana.21793; Zaguia F, 2011, CANCER BIOL THER, V11, P1, DOI 10.4161/cbt.11.1.14498; Zhao W, 2006, BRIT J CANCER, V95, P869, DOI 10.1038/sj.bjc.6603350	68	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87052	10.1371/journal.pone.0087052	http://dx.doi.org/10.1371/journal.pone.0087052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498019	Green Published, Green Submitted, gold			2022-12-27	WOS:000330621900063
J	Hu, Y; Zhou, M; Zhang, K; Kong, XQ; Hu, XY; Li, K; Liu, L				Hu, Yue; Zhou, Min; Zhang, Kai; Kong, Xiangquan; Hu, Xiaoyan; Li, Kang; Liu, Li			Lack of Association between Insulin Receptor Substrate2 rs1805097 Polymorphism and the Risk of Colorectal and Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-2; G1057D POLYMORPHISM; GENE POLYMORPHISM; TUMOR MUTATIONS; IRS-2; COLON; IGF1; VARIANTS; PROTEINS; ASPIRIN	Background: Insulin receptor substrate-2 (IRS-2), a signaling adaptor protein, was involved in two cancer-related pathways (the phosphatidylinositol 3'-kinase (PI3K) and the extracellular signal-regulated kinase (ERK) pathways). Several studies have evaluated the association between IRS2 rs1805097 (G>A) polymorphisms and the risk of colorectal and breast cancer. However, the results were inconsistent. Methodology/Principal Findings: A meta-analysis of seven published case-control studies (4 studies with 4798 cases and 5478 controls for colorectal cancer and 3 studies with 2108 cases and 2507 controls for breast cancer) were conducted to assess the strength of association using crude odd ratios (ORs) with 95% confidence intervals (CIs). For colorectal cancer, no obvious associations were found for all genetic models (homozygote comparison OR = 0.96, 95% CI 0.85-1.08, P-heterogeneity = 0.97; heterozygote comparison: OR = 0.91, 95% CI 0.73-1.13, P-heterogeneity<0.01; dominant model: OR = 0.92, 95% CI 0.80-1.06, P-heterogeneity = 0.05; recessive model: OR = 1.02, 95% CI 0.91-1.14, P-heterogeneity = 0.60). In the subgroup analysis by ethnicity, control source and consistency of frequency with Hardy-Weinberg equilibrium (HWE), still no significant associations were observed. For breast cancer, also no obvious associations were found for all genetic models (homozygote comparison: OR = 0.95, 95% CI 0.71-1.26, P-heterogeneity = 0.10; heterozygote comparison: OR = 1.00, 95% CI 0.89-1.14, P-heterogeneity = 0.71; dominant model: OR = 0.98, 95% CI 0.87-1.10, P-heterogeneity = 0.55; recessive model: OR = 0.95, 95% CI 0.72-1.25, P-heterogeneity = 0.07). We performed subgroup analyses by sample size and did not find an association. Conclusions: This meta-analysis indicated that IRS2 rs1805097 polymorphism was not associated with colorectal and breast cancer risk.	[Hu, Yue; Zhang, Kai; Hu, Xiaoyan; Li, Kang; Liu, Li] Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Zhou, Min; Kong, Xiangquan] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, L (corresponding author), Huazhong Univ Sci & Technol, Ctr Canc, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	liulixiehe2004@163.com		Liu, Li/0000-0003-2314-8756	National Natural Science Foundation of China [81171979]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81171979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068822; Birmann BM, 2009, CANCER EPIDEM BIOMAR, V18, P282, DOI 10.1158/1055-9965.EPI-08-0778; Bodhini D, 2007, INT J OBESITY, V31, P97, DOI 10.1038/sj.ijo.0803356; Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Cayan F, 2011, BALK MED J, V28, P14, DOI 10.5174/tutfd.2009.03134.1; Cayan F, 2010, GYNECOL ENDOCRINOL, V26, P378, DOI 10.3109/09513591003632241; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; Chang C. Q., 2013, EUR J HUM GENET; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; D'Alfonso R, 2003, J CLIN ENDOCR METAB, V88, P317, DOI 10.1210/jc.2002-020807; Day E, 2013, INT J EXP PATHOL, V94, P203, DOI 10.1111/iep.12021; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding YC, 2012, CANCER EPIDEM BIOMAR, V21, P1362, DOI 10.1158/1055-9965.EPI-12-0229; Dong XQ, 2012, CANCER EPIDEMIOL, V36, P206, DOI 10.1016/j.canep.2011.05.013; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feigelson HS, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2114; Guo Shaodong, 2013, Drug Discov Today Dis Mech, V10, pe27; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Karimi K, 2013, ASIAN PAC J CANCER P, V14, P5011, DOI 10.7314/APJCP.2013.14.9.5011; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; Mammarella S, 2000, HUM MOL GENET, V9, P2517, DOI 10.1093/hmg/9.17.2517; Mantel N, 1959, CHALLENGE EPIDEMIOLO, V1, P533; Morini E, 2009, DIABETOLOGIA, V52, P1852, DOI 10.1007/s00125-009-1426-4; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Neuhausen SL, 2005, PROSTATE, V64, P168, DOI 10.1002/pros.20216; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Porter HA, 2013, CANC LETT; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Reuveni H, 2013, CANCER RES, V73, P4383, DOI 10.1158/0008-5472.CAN-12-3385; Samowitz WS, 2006, MUTAT RES-FUND MOL M, V595, P117, DOI 10.1016/j.mrfmmm.2005.10.014; Slattery ML, 2007, BREAST CANCER RES TR, V104, P197, DOI 10.1007/s10549-006-9403-9; Slattery ML, 2008, INT J CANCER, V122, P1611, DOI 10.1002/ijc.23135; Slattery ML, 2009, MUTAT RES-FUND MOL M, V660, P12, DOI 10.1016/j.mrfmmm.2008.10.001; Slattery ML, 2006, CANCER CAUSE CONTROL, V17, P239, DOI 10.1007/s10552-005-0411-6; Slattery ML, 2005, INT J CANCER, V115, P148, DOI 10.1002/ijc.20843; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P1206; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538; Stohr O, 2011, BBA-MOL BASIS DIS, V1812, P573, DOI 10.1016/j.bbadis.2011.02.006; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Wagner K, 2004, CARCINOGENESIS, V25, P2473, DOI 10.1093/carcin/bgh263; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050857; Zhao XM, 2012, WORLD J GASTRO ONCOL, V4, P9, DOI 10.4251/wjgo.v4.i1.9	48	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86911	10.1371/journal.pone.0086911	http://dx.doi.org/10.1371/journal.pone.0086911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497996	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100040
J	Zhang, LM; Liang, SL; Zhang, GJ; Liu, ZZ; Lv, H; Fang, F; Wang, YJ; Zhang, SH; Kang, XX				Zhang, Limin; Liang, Shuli; Zhang, Guojun; Liu, Zhizhong; Lv, Hong; Fang, Fang; Wang, Yajie; Zhang, Shaohui; Kang, Xixiong			Seizure Control of Current Shunt on Rats with Temporal Lobe Epilepsy and Neocortical Epilepsy	PLOS ONE			English	Article							INDUCED FOCAL EPILEPSY; ELECTRICAL-STIMULATION; LONG-TERM; BRAIN-STIMULATION; ANTERIOR NUCLEUS; THALAMUS; SUPPRESSION; EEG	Purpose: To examine the effects of current shunt on rats with temporal lobe epilepsy and neocortex epilepsy. Experimental Design: A kainic acid (KA)-induced model of temporal lobe seizure and a penicillin-induced model of neocortical partial seizure were used in this study. Rats of each model were randomly allocated into two groups: control and model groups. The model group was further divided into the KA or penicillin group, sham conduction group and conduction group. The current shunt was realized through the implantation of a customized conduction electrode. After surgery, electroencephalogram (EEG) was recorded for two hours for each rat under anesthesia. Subsequently, the rats were video monitored for 72 h to detect the occurrence of behavioral seizures upon awakening. The average number and duration of seizures on EEG and the number of behavioral seizures were measured. Results: In KA model, the number of total EEG seizures in conduction group (9.57 +/- 2.46) was significantly less than that in sham conduction group (15.13 +/- 3.45) (p<0.01). The duration of EEG seizures in conduction group (26.13 +/- 7.81 s) was significantly shorter than that in sham conduction group (34.17 +/- 7.25 s) (p=0.001). A significant reduction of behavioral seizures was observed in the conduction group compared with KA (p=0.000) and sham conduction groups (p=0.000). In penicillin model, there was a 61% reduction in total EEG seizures in conduction group compared with sham conduction group (p<0.01), and the duration of EEG seizures in conduction group (6.29 +/- 2.64 s) was significantly shorter than that in the sham conduction group (12.07 +/- 3.81 s) (p=0.002). A significant reduction of behavioral seizures was observed in conduction group compared with penicillin (p<0.01) and sham conduction groups (p<0.01). Conclusion: Current shunt effectively reduces the onset and severity of seizures. Current shunt therapy could be an effective alternative minimally invasive approach for temporal lobe epilepsy and neocortex epilepsy.	[Zhang, Limin; Zhang, Guojun; Liu, Zhizhong; Lv, Hong; Fang, Fang; Wang, Yajie; Kang, Xixiong] Capital Med Univ, Beijing Tiantan Hosp, Lab Diag Ctr, Beijing, Peoples R China; [Zhang, Limin; Liang, Shuli; Zhang, Shaohui] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Capital Epilepsy Therapy Ctr, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Chinese People's Liberation Army General Hospital	Liang, SL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Capital Epilepsy Therapy Ctr, Dept Neurosurg, Beijing, Peoples R China.	liangsl_304@sina.com; kangxx@vip.sina.com	Liang, Shuli/GWC-5028-2022		National Natural Science Foundation of China [81000555]; Beijing Science & Technology New-star Training Program [2010B084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science & Technology New-star Training Program	This work was supported by National Natural Science Foundation of China (Grant No. 81000555, http://www.nsfc.gov.cn/Portal0/default152.htm) and Beijing Science & Technology New-star Training Program (2010B084, http://www.bjast.ac.cn/Html/List/list173.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Barz H, 2013, MED HYPOTHESES, V81, P768, DOI 10.1016/j.mehy.2013.07.049; Bear M.F., 2007, NEUROSCIENCE, Vthird; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Boon P, 2007, EPILEPSIA, V48, P1551, DOI 10.1111/j.1528-1167.2007.01005.x; Canan S, 2008, EPILEPSY RES, V82, P7, DOI 10.1016/j.eplepsyres.2008.06.005; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; GEORGE R, 1995, NEUROLOGY, V45, P224, DOI 10.1212/wnl.45.2.224; Gross RE, 2000, NEUROL RES, V22, P247; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Jan MM, 2010, CAN J NEUROL SCI, V37, P439, DOI 10.1017/S0317167100010441; Javidan M, 2012, EPILEPSY RES TREAT, DOI [10.1155/2012/637430, DOI 10.1155/2012/637430.EPUB2012]; Kortelainen J, 2010, IEEE ENG MED BIO, P6674, DOI 10.1109/IEMBS.2010.5627154; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Leach JP, 2013, CLIN MED, V13, P84, DOI 10.7861/clinmedicine.13-1-84; Liang SL, 2010, STEREOT FUNCT NEUROS, V88, P246, DOI 10.1159/000315462; Liang SL, 2010, EPILEPSY RES, V90, P60, DOI 10.1016/j.eplepsyres.2010.03.008; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Longo DL, 2011, HARRISONS PRINCIP 17; Makiranta M, 2005, NEUROIMAGE, V27, P715, DOI 10.1016/j.neuroimage.2005.05.025; Paxinos G., 1998, RAT BRAIN STEROTAXIC; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghavendra S, 2012, EPILEPSY RES TREAT, DOI [10.1155/2012/204693, DOI 10.1155/2012/204693.EPUB]; Sakamoto Americo C, 2004, Suppl Clin Neurophysiol, V57, P383; SANDER JW, 2003, EPILEPSIA S1, V44, P17; Silfverhuth MJ, 2011, SEIZURE-EUR J EPILEP, V20, P513, DOI 10.1016/j.seizure.2011.03.006; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Wyckhuys T, 2010, EPILEPSIA, V51, P2297, DOI 10.1111/j.1528-1167.2010.02750.x	31	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86477	10.1371/journal.pone.0086477	http://dx.doi.org/10.1371/journal.pone.0086477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497949	gold, Green Submitted, Green Published			2022-12-27	WOS:000330617100016
J	Attri, P; Baik, KY; Venkatesu, P; Kim, IT; Choi, EH				Attri, Pankaj; Baik, Ku Youn; Venkatesu, Pannuru; Kim, In Tae; Choi, Eun Ha			Influence of Hydroxyl Group Position and Temperature on Thermophysical Properties of Tetraalkylammonium Hydroxide Ionic Liquids with Alcohols	PLOS ONE			English	Article							EXCESS MOLAR VOLUMES; BINARY-MIXTURES; PHYSICAL-PROPERTIES; THERMODYNAMIC PROPERTIES; STRUCTURAL-CHARACTERIZATION; MOLECULAR-INTERACTIONS; CHAIN-LENGTH; DENSITIES; SOLVENTS; WATER	In this work, we have explored the thermophysical properties of tetraalkylammonium hydroxide ionic liquids (ILs) such as tetrapropylammonium hydroxide (TPAH) and tetrabutylammonium hydroxide (TBAH) with isomers of butanol (1-butanol, 2-butanol and 2-methyl-2-propanol) within the temperature range 293.15-313.15 K, with interval of 5 K and over the varied concentration range of ILs. The molecular interactions between ILs and butanol isomers are essential for understanding the function of ILs in related measures and excess functions are sensitive probe for the molecular interactions. Therefore, we calculated the excess molar volume (V-E) and the deviation in isentropic compressibility (Delta kappa(s)) using the experimental values such as densities (rho) and ultrasonic sound velocities (u) that are measured over the whole compositions range at five different temperatures (293.15, 298.15, 303.15, 308.15 and 313.15 K) and atmospheric pressure. These excess functions were adequately correlated by using the Redlich-Kister polynomial equation. It was observed that for all studied systems, the V-E and Delta kappa(s) values are negative for the whole composition range at 293.15 K. And, the excess function follows the sequence: 2-butanol>1-butanol>2-methyl-2-propanol, which reveals that (primary or secondary or tertiary) position of hydroxyl group influence the magnitude of interactions with ILs. The negative values of excess functions are contributions from the ion-dipole interaction, hydrogen bonding and packing efficiency between the ILs and butanol isomers. Hence, the position of hydroxyl group plays an important role in the interactions with ILs. The hydrogen bonding features between ILs and alcohols were analysed using molecular modelling program by using HyperChem 7.	[Attri, Pankaj; Baik, Ku Youn; Choi, Eun Ha] Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea; [Venkatesu, Pannuru] Univ Delhi, Dept Chem, Delhi 110007, India; [Kim, In Tae] Kwangwoon Univ, Dept Chem, Seoul, South Korea	Kwangwoon University; University of Delhi; Kwangwoon University	Attri, P (corresponding author), Kwangwoon Univ, Dept Elect & Biol Phys, Plasma Biosci Res Ctr, Seoul, South Korea.	chem.pankaj@gmail.com; ehchoi@kw.ac.kr	Attri, Pankaj/ABE-7522-2020; Choi, Eun Ha/AFN-9488-2022	Attri, Pankaj/0000-0002-5036-7877; Choi, Eun Ha/0000-0001-5385-1878	SRC program of National Research Foundation of Korea (NRF); Korean Government (MEST) [20100029418]; Kwangwoon University	SRC program of National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Kwangwoon University	We gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (No. 20100029418) and in part by Kwangwoon University 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abareshi M, 2009, J MOL LIQ, V149, P66, DOI 10.1016/j.molliq.2009.08.004; Alvarez VH, 2011, J CHEM THERMODYN, V43, P997, DOI 10.1016/j.jct.2011.01.014; Annat G, 2012, J PHYS CHEM B, V116, P8251, DOI 10.1021/jp3012602; Anouti M, 2010, J CHEM ENG DATA, V55, P5719, DOI 10.1021/je100671v; Arce A, 2006, J SOLUTION CHEM, V35, P63, DOI 10.1007/s10953-006-8939-y; Attri P., 2013, PLOS ONE, V88, DOI [DOI 10.1371/J0URNAL.P0NE.0068970, 10.1371/journal.pone.0068970.]; Attri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075096; Attri P, 2012, ORG BIOMOL CHEM, V10, P7475, DOI 10.1039/c2ob26001h; Attri P, 2011, J PHYS CHEM B, V115, P10086, DOI 10.1021/jp2059084; Attri P, 2011, PHYS CHEM CHEM PHYS, V13, P2788, DOI 10.1039/c0cp01291b; Attri P, 2010, J PHYS CHEM B, V114, P13415, DOI 10.1021/jp108003x; Attri P, 2010, J PHYS CHEM B, V114, P6126, DOI 10.1021/jp101209j; Capelo SB, 2012, J PHYS CHEM B, V116, P11302, DOI 10.1021/jp3066822; Bravo-Sanchez MG, 2010, J CHEM ENG DATA, V55, P2310, DOI 10.1021/je900722m; Chen T, 2010, J PHYS CHEM B, V114, P5790, DOI 10.1021/jp911372j; Chiappe C, 2011, J PHYS CHEM B, V115, P9653, DOI 10.1021/jp2045788; Couadou E, 2013, J PHYS CHEM B, V117, P1389, DOI 10.1021/jp308139r; Davis JH, 2004, CHEM LETT, V33, P1072, DOI 10.1246/cl.2004.1072; de Cominges BE, 2002, J THERM ANAL CALORIM, V70, P217, DOI 10.1023/A:1020626205538; Deetlefs M, 2006, PHYS CHEM CHEM PHYS, V8, P642, DOI 10.1039/b513453f; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3898, DOI 10.1021/ja00299a023; Domanska U, 2012, J CHEM THERMODYN, V48, P101, DOI 10.1016/j.jct.2011.12.003; Dominguez M, 2000, J CHEM THERMODYN, V32, P1551; Fox ET, 2013, J PHYS CHEM C, V117, P78, DOI 10.1021/jp3089403; Gnanakumari P, 2007, FLUID PHASE EQUILIBR, V252, P137, DOI 10.1016/j.fluid.2006.12.012; Gomez E, 2012, J CHEM THERMODYN, V45, P9, DOI 10.1016/j.jct.2011.08.028; Gonzalez B, 2008, J CHEM ENG DATA, V53, P881, DOI 10.1021/je700700f; Gonzalez EJ, 2007, J CHEM ENG DATA, V52, P1641, DOI 10.1021/je700029q; Gonzalez EJ, 2013, J CHEM ENG DATA, V58, P1440, DOI 10.1021/je300384g; Greaves TL, 2008, CHEM REV, V108, P206, DOI 10.1021/cr068040u; Hou MY, 2013, J MOL LIQ, V178, P149, DOI 10.1016/j.molliq.2012.11.030; Huq F, 2002, J MOL MODEL, V8, P81, DOI 10.1007/s00894-002-0073-1; Janikowski J, 2013, CHEMPLUSCHEM, V78, P486, DOI 10.1002/cplu.201300068; Jiang HC, 2012, J CHEM THERMODYN, V47, P203, DOI 10.1016/j.jct.2011.10.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kavitha T, 2012, J PHYS CHEM B, V116, P4561, DOI 10.1021/jp3015386; Lachwa J, 2006, J CHEM ENG DATA, V51, P2215, DOI 10.1021/je060307z; Lehmann J, 2010, J CHEM ENG DATA, V55, P4068, DOI 10.1021/je1002237; Liu ZP, 2006, PHYS CHEM CHEM PHYS, V8, P1096, DOI 10.1039/b515905a; Marsh KN, 2004, FLUID PHASE EQUILIBR, V219, P93, DOI 10.1016/j.fluid.2004.02.003; Mokhtarani B, 2009, J CHEM THERMODYN, V41, P1432, DOI 10.1016/j.jct.2009.06.023; Nain AK, 2007, J SOLUTION CHEM, V36, P497, DOI 10.1007/s10953-007-9122-9; Noda A, 2003, J PHYS CHEM B, V107, P4024, DOI 10.1021/jp022347p; Pereiro AB, 2007, J CHEM THERMODYN, V39, P1168, DOI 10.1016/j.jct.2006.12.005; Pop E, 1997, INT J QUANTUM CHEM, V65, P1057, DOI 10.1002/(SICI)1097-461X(1997)65:6<1057::AID-QUA4>3.0.CO;2-U; Qian W, 2012, J CHEM THERMODYN, V49, P87, DOI 10.1016/j.jct.2012.01.013; Reddy PM, 2011, J PHYS CHEM B, V115, P4752, DOI 10.1021/jp201826v; Riddick J.A., 1986, TECHNIQUES CHEM, V4; Rilo E, 2010, FLUID PHASE EQUILIBR, V296, P53, DOI 10.1016/j.fluid.2010.03.039; Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313; Seddon KR, 1997, J CHEM TECHNOL BIOT, V68, P351, DOI 10.1002/(SICI)1097-4660(199704)68:4<351::AID-JCTB613>3.0.CO;2-4; Vercher E, 2007, J CHEM ENG DATA, V52, P1468, DOI 10.1021/je7001804; Weng WL, 1999, J CHEM ENG DATA, V44, P788, DOI 10.1021/je980283z; Wilkes JS, 2004, J MOL CATAL A-CHEM, V214, P11, DOI 10.1016/j.molcata.2003.11.029; Zhang SJ, 2006, J PHYS CHEM REF DATA, V35, P1475, DOI 10.1063/1.2204959; Zhu AL, 2011, J CHEM THERMODYN, V43, P796, DOI 10.1016/j.jct.2010.12.027	56	33	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86530	10.1371/journal.pone.0086530	http://dx.doi.org/10.1371/journal.pone.0086530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489741	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000046
J	Chen, DF; Zuo, D; Luan, C; Liu, M; Na, ML; Ran, L; Sun, YY; Persson, A; Englund, E; Salford, LG; Renstrom, E; Fan, XL; Zhang, EM				Chen, Dongfeng; Zuo, Duo; Luan, Cheng; Liu, Min; Na, Manli; Ran, Liang; Sun, Yingyu; Persson, Annette; Englund, Elisabet; Salford, Leif G.; Renstrom, Erik; Fan, Xiaolong; Zhang, Enming			Glioma Cell Proliferation Controlled by ERK Activity-Dependent Surface Expression of PDGFRA	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEURAL STEM-CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; INTEGRATED GENOMIC ANALYSIS; ALPHA-RECEPTOR EXPRESSION; GROWTH-FACTOR RECEPTOR; MALIGNANT GLIOMAS; GLIAL PROGENITORS; TUMOR-SUPPRESSOR; BRAIN-TUMORS	Increased PDGFRA signaling is an essential pathogenic factor in many subtypes of gliomas. In this context the cell surface expression of PDGFRA is an important determinant of ligand sensing in the glioma microenvironment. However, the regulation of spatial distribution of PDGFRA in glioma cells remains poorly characterized. Here, we report that cell surface PDGFRA expression in gliomas is negatively regulated by an ERK-dependent mechanism, resulting in reduced proliferation of glioma cells. Glioma tumor tissues and their corresponding cell lines were isolated from 14 patients and analyzed by single-cell imaging and flow cytometry. In both cell lines and their corresponding tumor samples, glioma cell proliferation correlated with the extent of surface expression of PDGFRA. High levels of surface PDGFRA also correlated to high tubulin expression in glioma tumor tissue in vivo. In glioma cell lines, surface PDGFRA declined following treatment with inhibitors of tubulin, actin and dynamin. Screening of a panel of small molecule compounds identified the MEK inhibitor U0126 as a potent inhibitor of surface PDGFRA expression. Importantly, U0126 inhibited surface expression in a reversible, dose-and time-dependent manner, without affecting general PDGFRA expression. Treatment with U0126 resulted in reduced co-localization between PDGFRA and intracellular trafficking molecules e. g. clathrin, RAB11 and early endosomal antigen-1, in parallel with enhanced co-localization between PDGFRA and the Golgi cisternae maker, Giantin, suggesting a deviation of PDGFRA from the endosomal trafficking and recycling compartment, to the Golgi network. Furthermore, U0126 treatment in glioma cells induced an initial inhibition of ERK1/2 phosphorylation, followed by up-regulated ERK1/2 phosphorylation concomitant with diminished surface expression of PDGFRA. Finally, down-regulation of surface PDGFRA expression by U0126 is concordant with reduced glioma cell proliferation. These findings suggest that manipulation of spatial expression of PDGFRA can potentially be used to combat gliomas.	[Chen, Dongfeng; Liu, Min; Na, Manli; Salford, Leif G.] Lund Univ, Dept Neurosurg, Rausing Lab, Lund, Sweden; [Zuo, Duo; Ran, Liang; Sun, Yingyu; Fan, Xiaolong] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Beijing 100875, Peoples R China; [Persson, Annette; Englund, Elisabet] Lund Univ, Dept Pathol, Lund, Sweden; [Luan, Cheng; Renstrom, Erik; Zhang, Enming] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University; Beijing Normal University; Lund University; Lund University	Fan, XL (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Lab Neurosci & Brain Dev, Beijing 100875, Peoples R China.	xfan@bnu.edu.cn; enming.zhang@med.lu.se	Na, Manli/AAM-9864-2020; Zhang, Enming/B-9438-2013	Zhang, Enming/0000-0002-0401-4608; Luan, Cheng/0000-0003-4466-0687; Na, Manli/0000-0002-7306-8941; Englund, Elisabet/0000-0002-2708-2443	National Natural Science Foundation of China [81072080]; Ministry of Science and Technology of China [2012DFA30470]; Hans and Marit Rausing Charitable Foundation; Swedish Research Council [12234]; EU; collaborative SRC grant; Swedish Strategic Research EXODIAB	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Hans and Marit Rausing Charitable Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); collaborative SRC grant; Swedish Strategic Research EXODIAB	This study was supported by National Natural Science Foundation of China (grant 81072080), international collaborative program of the Ministry of Science and Technology of China (grant 2012DFA30470), and the Hans and Marit Rausing Charitable Foundation. The study was also supported by grants to E.R. from the Swedish Research Council (project 12234), clinical research grants (ALF). EZ's position receives funding from the EU Integrated project BetaBat and a collaborative SRC grant, as well as the Swedish Strategic Research EXODIAB. This work was done using imaging equipment financed by the Knut and Alice Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chen DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061556; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chojnacki A, 2011, J NEUROSCI, V31, P9503, DOI 10.1523/JNEUROSCI.1531-11.2011; Clarke ID, 2003, ONCOGENE, V22, P722, DOI 10.1038/sj.onc.1206160; Colello D, 2012, J BIOL CHEM, V287, P2520, DOI 10.1074/jbc.M111.254128; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fukazawa H, 2000, CANCER RES, V60, P2104; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Houle FO, 2003, MOL BIOL CELL, V14, P1418, DOI 10.1091/mbc.E02-04-0235; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Idbaih A, 2008, INT J CANCER, V122, P1778, DOI 10.1002/ijc.23270; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Labussiere M, 2010, NEUROLOGY, V74, P1886, DOI 10.1212/WNL.0b013e3181e1cf3a; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Lokker NA, 2002, CANCER RES, V62, P3729; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mariani L, 2006, J CLIN ONCOL, V24, P4758, DOI 10.1200/JCO.2006.05.9238; Martinho O, 2009, BRIT J CANCER, V101, P973, DOI 10.1038/sj.bjc.6605225; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neel NF, 2012, MOL CELL BIOL, V32, P1374, DOI 10.1128/MCB.06291-11; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Uhrbom L, 1998, CANCER RES, V58, P5275; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 2010, CLIN CANCER RES, V16, P1170, DOI 10.1158/1078-0432.CCR-09-2482; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Yip-Schneider MT, 2009, J PHARMACOL EXP THER, V329, P1063, DOI 10.1124/jpet.108.147306; Zhang J, 2013, NAT GENET; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	66	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87281	10.1371/journal.pone.0087281	http://dx.doi.org/10.1371/journal.pone.0087281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489888	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000129
J	Leimgruber, KL; Ward, AF; Widness, J; Norton, MI; Olson, KR; Gray, K; Santos, LR				Leimgruber, Kristin L.; Ward, Adrian F.; Widness, Jane; Norton, Michael I.; Olson, Kristina R.; Gray, Kurt; Santos, Laurie R.			Give What You Get: Capuchin Monkeys (Cebus apella) and 4-Year-Old Children Pay Forward Positive and Negative Outcomes to Conspecifics	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; INDIRECT RECIPROCITY; UPSTREAM RECIPROCITY; PROSOCIAL BEHAVIOR; PUBLIC-GOODS; EVOLUTION; COOPERATION; REPUTATION; GRATITUDE; ALTRUISM	The breadth of human generosity is unparalleled in the natural world, and much research has explored the mechanisms underlying and motivating human prosocial behavior. Recent work has focused on the spread of prosocial behavior within groups through paying-it-forward, a case of human prosociality in which a recipient of generosity pays a good deed forward to a third individual, rather than back to the original source of generosity. While research shows that human adults do indeed pay forward generosity, little is known about the origins of this behavior. Here, we show that both capuchin monkeys (Cebus apella) and 4-year-old children pay forward positive and negative outcomes in an identical testing paradigm. These results suggest that a cognitively simple mechanism present early in phylogeny and ontogeny leads to paying forward positive, as well as negative, outcomes.	[Leimgruber, Kristin L.; Widness, Jane; Olson, Kristina R.; Santos, Laurie R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Ward, Adrian F.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Norton, Michael I.] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA; [Gray, Kurt] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Yale University; Harvard University; Harvard University; University System of Maryland; University of Maryland College Park	Leimgruber, KL (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	Kleimgruber@gmail.com	Ward, Adrian F/M-7961-2018	Ward, Adrian F/0000-0001-8318-7963; Gray, Kurt/0000-0001-5816-2676; Widness, Jane/0000-0002-9284-2066	Templeton Positive Neuroscience Award; National Science Foundation Research Experiences for Undergraduates Program [SMA-1004797]	Templeton Positive Neuroscience Award; National Science Foundation Research Experiences for Undergraduates Program(National Science Foundation (NSF))	This research was supported in part by funding from The Templeton Positive Neuroscience Award and the National Science Foundation Research Experiences for Undergraduates Program (SMA-1004797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred KG, 1997, ORGAN BEHAV HUM DEC, V70, P175, DOI 10.1006/obhd.1997.2705; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; ANDERSON JR, 1989, PRIMATES, V30, P581, DOI 10.1007/BF02380884; Andreoni J, 2004, J PUBLIC ECON, V88, P1605, DOI 10.1016/S0047-2727(03)00040-9; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Barnes JL, 2008, BIOL LETTERS, V4, P638, DOI 10.1098/rsbl.2008.0410; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barta Z, 2011, P ROY SOC B-BIOL SCI, V278, P843, DOI 10.1098/rspb.2010.1634; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Bekkers R, 2011, NONPROF VOLUNT SEC Q, V40, P924, DOI 10.1177/0899764010380927; BenZeev A, 1996, J THEOR SOC BEHAV, V26, P81, DOI 10.1111/j.1468-5914.1996.tb00287.x; Beran MJ, 2009, J EXP PSYCHOL-ANIM B, V35, P371, DOI 10.1037/a0014626; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Buhrmester D., 1992, J EARLY ADOLESCENCE, V12, P61, DOI [10.1177/0272431692012001004, DOI 10.1177/0272431692012001004]; CUNNINGHAM MR, 1980, J PERS SOC PSYCHOL, V38, P181, DOI 10.1037/0022-3514.38.2.181; Dana J, 2007, ECON THEOR, V33, P67, DOI 10.1007/s00199-006-0153-z; Dawkins MS, 2000, AM ZOOL, V40, P883, DOI 10.1668/0003-1569(2000)040[0883:AMAAE]2.0.CO;2; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; de Waal FBM, 2010, PHILOS T R SOC B, V365, P2711, DOI 10.1098/rstb.2010.0119; Dufwenberg M, 2000, EXPT TEST DIRECT IND; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Emerson RW, 1841, COMPENSATION ESSAYS; Emmons RA, 2000, J SOC CLIN PSYCHOL, V19, P56, DOI 10.1521/jscp.2000.19.1.56; Epley N, 2006, J PERS SOC PSYCHOL, V91, P872, DOI 10.1037/0022-3514.91.5.872; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FLAVELL JH, 1995, MONOGR SOC RES CHILD, V60, pR5; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Franklin B, 1784, COMMUNICATION; Gallup GG, 1998, BEHAV PROCESS, V42, P239, DOI 10.1016/S0376-6357(97)00079-X; Grant A, 2012, PSYCHOL SCI, V23, P1033, DOI 10.1177/0956797612439424; Gray K, 2012, J EXP PSYCHOL GEN, V142, P1; Greiner B, 2005, J ECON PSYCHOL, V26, P711, DOI 10.1016/j.joep.2004.04.003; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Gustison ML, 2012, STRESS, V15, P608, DOI 10.3109/10253890.2012.668589; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Hare B, 2003, ANIM BEHAV, V65, P131, DOI 10.1006/anbe.2002.2017; Hattori Y, 2010, ANIM COGN, V13, P87, DOI 10.1007/s10071-009-0248-6; Henrich J, 2003, DAHL WS ENV, P445; ISEN AM, 1972, J PERS SOC PSYCHOL, V21, P384, DOI 10.1037/h0032317; Itakura S, 1996, CAH PSYCHOL COGN, V15, P103; Iwagami A, 2010, J THEOR BIOL, V265, P297, DOI 10.1016/j.jtbi.2010.05.010; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; JOHNSONLAIRD PN, 1992, COGNITION EMOTION, V6, P201, DOI 10.1080/02699939208411069; Judge PG, 2012, AM J PRIMATOL, V74, P199, DOI 10.1002/ajp.21987; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lotze K, 2012, HUFFINGT POST; MacDonald K, 2010, PEPTIDE BINDS SYSTEM, DOI DOI 10.3109/10673220903523615.ACCESSED; Marcus-Newhall A, 2000, J PERS SOC PSYCHOL, V78, P670, DOI 10.1037/0022-3514.78.4.670; McAdams D.P., 2004, PSYCHOL GRATITUDE, P81, DOI DOI 10.1093/ACPROF:OSO/9780195150100.003.0005; Mohtashemi M, 2003, J THEOR BIOL, V223, P523, DOI 10.1016/S0022-5193(03)00143-7; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Ortony A., 2005, WHO NEEDS EMOTIONS B, P173, DOI DOI 10.1093/ACPROF:OSO/9780195166194.003.0007; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Perner J, 1991, UNDERSTANDING REPRES; Pfeiffer T, 2005, P ROY SOC B-BIOL SCI, V272, P1115, DOI 10.1098/rspb.2004.2988; Piazza J, 2008, EVOL HUM BEHAV, V29, P172, DOI 10.1016/j.evolhumbehav.2007.12.002; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rankin DJ, 2009, EVOLUTION, V63, P1913, DOI 10.1111/j.1558-5646.2009.00656.x; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Stanca L, 2009, J ECON PSYCHOL, V30, P190, DOI 10.1016/j.joep.2008.07.010; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Trivers R, 1971, Q REV BIOL, DOI DOI 10.2307/2822435.ACCESSED; Tsang JA, 2006, COGNITION EMOTION, V20, P138, DOI 10.1080/02699930500172341; Tsang Jo-Ann, 2007, J POSITIVE PSYCH, V2, P157, DOI DOI 10.1080/17439760701229019; van Doorn GS, 2012, EVOLUTION, V66, P651, DOI 10.1111/j.1558-5646.2011.01479.x; Virgin CE, 1997, AM J PRIMATOL, V42, P25, DOI 10.1002/(SICI)1098-2345(1997)42:1<25::AID-AJP2>3.3.CO;2-T; Weiner B., 1986, HDB MOTIVATION COGNI, P281; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Whiten A, 1997, MACHIAVELLIAN INTELL, P403; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	82	42	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87035	10.1371/journal.pone.0087035	http://dx.doi.org/10.1371/journal.pone.0087035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489830	gold, Green Published			2022-12-27	WOS:000330570000094
J	Verstraeten, R; Van Royen, K; Ochoa-Aviles, A; Penafiel, D; Holdsworth, M; Donoso, S; Maes, L; Kolsteren, P				Verstraeten, Roosmarijn; Van Royen, Kathleen; Ochoa-Aviles, Angelica; Penafiel, Daniela; Holdsworth, Michelle; Donoso, Silvana; Maes, Lea; Kolsteren, Patrick			A Conceptual Framework for Healthy Eating Behavior in Ecuadorian Adolescents: A Qualitative Study	PLOS ONE			English	Article							BALANCE-RELATED BEHAVIORS; ENVIRONMENTAL-INFLUENCES; RISK-FACTORS; FOCUS GROUPS; OBESITY; CHILDREN; DISEASE; DIETARY; INCOME; OVERWEIGHT	Objective: The objective of this study was to identify factors influencing eating behavior of Ecuadorian adolescents - from the perspective of parents, school staff and adolescents - to develop a conceptual framework for adolescents' eating behavior. Study design: Twenty focus groups (N = 144 participants) were conducted separately with adolescents aged 11-15 y (n (focus groups) = 12, N (participants) = 80), parents (n = 4, N = 32) and school staff (n = 4, N = 32) in rural and urban Ecuador. A semi-structured questioning route was developed based on the 'Attitude, Social influences and Self-efficacy' model and the socio-ecological model to assess the relevance of behavioral and environmental factors in low-and middle-income countries. Two researchers independently analyzed verbatim transcripts for emerging themes, using deductive thematic content analysis. Data were analyzed using NVivo 8. Results: All groups recognized the importance of eating healthily and key individual factors in Ecuadorian adolescents' food choices were: financial autonomy, food safety perceptions, lack of self-control, habit strength, taste preferences and perceived peer norms. Environmental factors included the poor nutritional quality of food and its easy access at school. In their home and family environment, time and convenience completed the picture as barriers to eating healthily. Participants acknowledged the impact of the changing socio-cultural environment on adolescents' eating patterns. Availability of healthy food at home and financial constraints differed between settings and socio-economic groups. Conclusion: Our findings endorse the importance of investigating behavioral and environmental factors that influence and mediate healthy dietary behavior prior to intervention development. Several culture-specific factors emerged that were incorporated into a conceptual framework for developing health promotion interventions in Ecuador.	[Verstraeten, Roosmarijn; Kolsteren, Patrick] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Verstraeten, Roosmarijn; Van Royen, Kathleen; Ochoa-Aviles, Angelica; Penafiel, Daniela; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Ochoa-Aviles, Angelica; Donoso, Silvana] Univ Cuenca, Food Nutr & Hlth Program, Cuenca, Ecuador; [Penafiel, Daniela] Escuela Super Politecn Litoral, Rural Res Ctr, Guayaquil, Ecuador; [Holdsworth, Michelle] Univ Sheffield, Publ Hlth Sect, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Maes, Lea] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Institute of Tropical Medicine (ITM); Ghent University; Universidad de Cuenca; Escuela Superior Politecnica del Litoral; University of Sheffield; Ghent University	Verstraeten, R (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	roosmarijn.verstraeten@ugent.be	Maes, Lea/D-6014-2013; holdsworth, michelle/AAH-5400-2020; Van Royen, Kathleen/E-9669-2018	holdsworth, michelle/0000-0001-6028-885X; Van Royen, Kathleen/0000-0001-8182-7971; Penafiel, Daniela/0000-0001-6593-8217; Ochoa-Aviles, Angelica/0000-0001-7926-3644	Flemish Inter-University Collaboration (VLIR-IUC)	Flemish Inter-University Collaboration (VLIR-IUC)	This qualitative research study was part of a programme funded by a Flemish Inter-University Collaboration (VLIR-IUC, http://www.vliruos.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abraham C, 2011, HEALTH EDUC RES, V26, P624, DOI 10.1093/her/cyr018; Baillie K, 2008, OBES REV, V9, P146, DOI 10.1111/j.1467-789X.2007.00457.x; Bisogni CA, 2012, J NUTR EDUC BEHAV, V44, P282, DOI 10.1016/j.jneb.2011.11.009; Brug J, 2008, P NUTR SOC, V67, P307, DOI 10.1017/S0029665108008616; Burg J, 2006, J NUTR EDUC BEHAV, V38, P73, DOI 10.1016/j.jneb.2005.11.027; Cerin E, 2009, J NUTR EDUC BEHAV, V41, P309, DOI 10.1016/j.jneb.2009.03.129; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Ebrahim Shahul, 2007, Prev Chronic Dis, V4, pA32; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Haerens L, 2009, HEALTH EDUC RES, V24, P381, DOI 10.1093/her/cyn033; Kennedy C, 2001, NURS RES, V50, P184, DOI 10.1097/00006199-200105000-00010; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Krolner R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-112; Krueger R.A., 2015, FOCUS GROUPS PRACTIC; Kubik MY, 2005, J ADOLESCENT HEALTH, V36, P494, DOI 10.1016/j.jadohealth.2004.05.010; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lachat C, 2009, AM J CLIN NUTR, V90, P1648, DOI 10.3945/ajcn.2009.28371; LAU RR, 1990, J HEALTH SOC BEHAV, V31, P240, DOI 10.2307/2136890; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Nago ES, 2012, J NUTR EDUC BEHAV, V44, P548, DOI 10.1016/j.jneb.2011.06.006; Neumark-Sztainer D, 1999, J AM DIET ASSOC, V99, P929, DOI 10.1016/S0002-8223(99)00222-9; Ochoa-Aviles A, 2012, PEDIATR OBES, V7, P274, DOI 10.1111/j.2047-6310.2012.00061.x; Pettinger C, 2006, PUBLIC HEALTH NUTR, V9, P1020, DOI 10.1017/PHN2006945; POPKIN BM, 1995, OBES RES, V3, pS145, DOI 10.1002/j.1550-8528.1995.tb00457.x; Power TG, 2010, J SCHOOL HEALTH, V80, P13, DOI 10.1111/j.1746-1561.2009.00461.x; Rasmussen M, 2006, DETERMINANTS FRUIT 1; Sandvik C, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-57; Smith LT, 2004, PREV CHRONIC DIS, V1, P1; Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Townsend N, 2013, PUBLIC HEALTH NUTR, V16, P1101, DOI 10.1017/S1368980011002655; Verloigne M, 2012, PUBLIC HEALTH NUTR, V15, P1380, DOI 10.1017/S1368980011003168; Verstraeten R, 2012, AM J CLIN NUTR, V96, P415, DOI 10.3945/ajcn.112.035378; Virdis A, 2009, CURR PHARM DESIGN, V15, P1063, DOI 10.2174/138161209787846900; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; World Health Organization, 2002, WHO TECH REP SER, P916	43	44	45	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87183	10.1371/journal.pone.0087183	http://dx.doi.org/10.1371/journal.pone.0087183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489865	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330570000115
J	Wan, YW; Mach, CM; Allen, GI; Anderson, ML; Liu, ZD				Wan, Ying-Wooi; Mach, Claire M.; Allen, Genevera I.; Anderson, Matthew L.; Liu, Zhandong			On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles	PLOS ONE			English	Article								Dysregulated microRNA (miRNA) expression is a well-established feature of human cancer. However, the role of specific miRNAs in determining cancer outcomes remains unclear. Using Level 3 expression data from the Cancer Genome Atlas (TCGA), we identified 61 miRNAs that are associated with overall survival in 469 ovarian cancers profiled by microarray (p<0.01). We also identified 12 miRNAs that are associated with survival when miRNAs were profiled in the same specimens using Next Generation Sequencing (miRNA-Seq) (p<0.01). Surprisingly, only 1 miRNA transcript is associated with ovarian cancer survival in both datasets. Our analyses indicate that this discrepancy is due to the fact that miRNA levels reported by the two platforms correlate poorly, even after correcting for potential issues inherent to signal detection algorithms. Corrections for false discovery and microRNA abundance had minimal impact on this discrepancy. Further investigation is warranted.	[Wan, Ying-Wooi; Allen, Genevera I.; Liu, Zhandong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wan, Ying-Wooi; Mach, Claire M.; Anderson, Matthew L.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Mach, Claire M.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Wan, Ying-Wooi; Anderson, Matthew L.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Anderson, Matthew L.; Liu, Zhandong] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Liu, Zhandong] Baylor Coll Med, Computat & Integrat Biomed Res CIBR Ctr, Houston, TX 77030 USA; [Allen, Genevera I.; Liu, Zhandong] Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA; [Allen, Genevera I.] Rice Univ, Dept Stat & Elect & Comp Engn, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Anderson, ML (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	matthew@bcm.edu; Zhandonl@bcm.edu	Anderson, Matthew/C-4755-2019	Anderson, Matthew/0000-0002-2081-4672; Liu, Zhandong/0000-0002-7608-0831	Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University; John and Ann Doerr Fund for Computational Biomedicine; Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine; NSF [DMS-1209017, DMS-1263932]; Houston Bioinformatics Endowment	Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University; John and Ann Doerr Fund for Computational Biomedicine; Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine; NSF(National Science Foundation (NSF)); Houston Bioinformatics Endowment	This work is supported in part through the Collaborative Advances in Biomedical Computing Seed Funding Program at the Ken Kennedy Institute for Information Technology at Rice University supported by the John and Ann Doerr Fund for Computational Biomedicine and through the Center for Computational and Integrative Biomedical Research Seed Funding Program at Baylor College of Medicine. GA is also partially supported by NSF DMS-1209017. ZD is supported by the Houston Bioinformatics Endowment and NSF DMS-1263932. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Eder M, 2005, NEW ENGL J MED, V352, P2446, DOI 10.1056/NEJMcibr051201; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Marchini S, 2011, LANCET ONCOL, V12, P273, DOI 10.1016/S1470-2045(11)70012-2; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yauk CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-330; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	18	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87782	10.1371/journal.pone.0087782	http://dx.doi.org/10.1371/journal.pone.0087782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489963	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000180
J	Chollet, MB; Aldridge, K; Pangborn, N; Weinberg, SM; DeLeon, VB				Chollet, Madeleine B.; Aldridge, Kristina; Pangborn, Nicole; Weinberg, Seth M.; DeLeon, Valerie B.			Landmarking the Brain for Geometric Morphometric Analysis: An Error Study	PLOS ONE			English	Article							SHAPE; PATTERNS; AUTISM; MRI	Neuroanatomic phenotypes are often assessed using volumetric analysis. Although powerful and versatile, this approach is limited in that it is unable to quantify changes in shape, to describe how regions are interrelated, or to determine whether changes in size are global or local. Statistical shape analysis using coordinate data from biologically relevant landmarks is the preferred method for testing these aspects of phenotype. To date, approximately fifty landmarks have been used to study brain shape. Of the studies that have used landmark-based statistical shape analysis of the brain, most have not published protocols for landmark identification or the results of reliability studies on these landmarks. The primary aims of this study were two-fold: (1) to collaboratively develop detailed data collection protocols for a set of brain landmarks, and (2) to complete an intra-and inter-observer validation study of the set of landmarks. Detailed protocols were developed for 29 cortical and subcortical landmarks using a sample of 10 boys aged 12 years old. Average intra-observer error for the final set of landmarks was 1.9 mm with a range of 0.72 mm-5.6 mm. Average inter-observer error was 1.1 mm with a range of 0.40 mm-3.4 mm. This study successfully establishes landmark protocols with a minimal level of error that can be used by other researchers in the assessment of neuroanatomic phenotypes.	[Chollet, Madeleine B.; Pangborn, Nicole; DeLeon, Valerie B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA; [Aldridge, Kristina] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Weinberg, Seth M.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA	Johns Hopkins University; University of Missouri System; University of Missouri Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chollet, MB (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21218 USA.	mchollet@wustl.edu		Aldridge, Kristina/0000-0003-3924-761X; Weinberg, Seth/0000-0001-9467-4556	National Institutes of Dental and Craniofacial Research [F31 DE021302-01, 5 R01 DE014399-05]; Johns Hopkins University Libraries; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE021302] Funding Source: NIH RePORTER	National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Johns Hopkins University Libraries(Johns Hopkins University); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants F31 DE021302-01 and 5 R01 DE014399-05 from the National Institutes of Dental and Craniofacial Research. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1996, BRAIN BEHAV EVOLUT, V47, P225, DOI 10.1159/000113243; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Aldridge K, 2005, ANAT REC PART A, V285A, P690, DOI 10.1002/ar.a.20201; Aldridge K, 2005, J ANAT, V206, P373, DOI 10.1111/j.1469-7580.2005.00397.x; Aldridge K, 2002, J ANAT, V201, P31, DOI 10.1046/j.1469-7580.2002.00074.x; Aldridge K, 2004, ORG HUMAN BRAIN DEV; Aldridge K, 2011, J HUM EVOL, V60, P94, DOI 10.1016/j.jhevol.2010.09.007; ANDREASEN NC, 1994, P NATL ACAD SCI USA, V91, P93, DOI 10.1073/pnas.91.1.93; ANDREASEN NC, 1992, J NEUROPSYCH CLIN N, V4, P125; ANDREASEN NC, 1993, J NEUROPSYCH CLIN N, V5, P121; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.0.CO;2-P; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Cachia A, 2003, IEEE T MED IMAGING, V22, P754, DOI 10.1109/TMI.2003.814781; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Caviness VS, 1999, BRAIN DEV-JPN, V21, P289; Ceyhan E, 2012, CURR ALZHEIMER RES, V9, P972, DOI 10.2174/156720512803251138; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; DEACON TW, 1990, AM ZOOL, V30, P629; DeQuardo JR, 1996, PSYCHIAT RES-NEUROIM, V67, P81; DeQuardo JR, 1999, BIOL PSYCHIAT, V45, P1321, DOI 10.1016/S0006-3223(98)00181-4; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Free SL, 2001, NEUROIMAGE, V13, P801, DOI 10.1006/nimg.2001.0748; GERHART J, 1997, CELL EMBRYOS EVOLUTI; Gharaibeh WS, 2000, BIOL PSYCHIAT, V48, P398, DOI 10.1016/S0006-3223(00)00916-1; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Joseph J, 2014, HUM BRAIN MAPP, V35, P659, DOI 10.1002/hbm.22209; Joshi SH, 2013, NEUROIMAGE, V64, P547, DOI 10.1016/j.neuroimage.2012.09.024; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Lohmann G, 2000, MED IMAGE ANAL, V4, P179, DOI 10.1016/S1361-8415(00)00024-4; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Magnotta VA, 2002, COMPUT MED IMAG GRAP, V26, P251, DOI 10.1016/S0895-6111(02)00011-3; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Maudgil DD, 1998, J ANAT, V193, P559, DOI 10.1046/j.1469-7580.1998.19340559.x; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mullick R, 1998, ANN M SOC COMP APPL; Mullick R, 1999, BIOM IM S VIS FUT BI; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Pantazis D, 2010, NEUROIMAGE, V49, P2479, DOI 10.1016/j.neuroimage.2009.09.027; Pierson R, 2011, NEUROIMAGE, V54, P328, DOI 10.1016/j.neuroimage.2010.06.047; Purves D, 1996, INDIVIDUAL DEV LIFES, P162; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Richtsmeier J. T., 2001, INTER DISC; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Shattuck DW, 2009, J NEUROSCI METH, V178, P385, DOI 10.1016/j.jneumeth.2008.12.025; Sherwood CC, 2009, ENCY NEUROSCIENCE, P1334; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Valeri CJ, 1998, AM J PHYS ANTHROPOL, V107, P113, DOI 10.1002/(SICI)1096-8644(199809)107:1<113::AID-AJPA9>3.3.CO;2-U; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Weinberg SM, 2009, J ANAT, V214, P926, DOI 10.1111/j.1469-7580.2009.01084.x; Zhong JD, 2010, NEUROIMAGE, V52, P131, DOI 10.1016/j.neuroimage.2010.03.085	57	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86005	10.1371/journal.pone.0086005	http://dx.doi.org/10.1371/journal.pone.0086005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489689	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000330510000030
J	Galukande, M; Duffy, K; Bitega, JP; Rackara, S; Bbaale, DS; Nakaggwa, F; Nagaddya, T; Wooding, N; Dea, M; Coutinho, A				Galukande, Moses; Duffy, Kevin; Bitega, Jean Paul; Rackara, Sam; Bbaale, Denis Sekavuga; Nakaggwa, Florence; Nagaddya, Teddy; Wooding, Nick; Dea, Monica; Coutinho, Alex			Adverse Events Profile of PrePex a Non-Surgical Device for Adult Male Circumcision in a Ugandan Urban Setting	PLOS ONE			English	Article							HIV PREVENTION; MEN	Background: Safe Male Circumcision is a proven approach for partial HIV prevention. Several sub Saharan African countries have plans to reach a prevalence of 80% of their adult males circumcised by 2015. These targets require out of ordinary organization, demand creation, timely execution and perhaps the use of SMC devices. Objective: To profile Adverse Events rate and acceptance of PrePex, a non surgical device for adult male circumcision. Methods: A prospective study, conducted at International Hospital Kampala, Uganda, between August and October 2012. Ethical approval was obtained from Uganda National Council of Science and Technology. Results: Of 1,040 men received to undergo SMC, 678 opted for PrePex, 36 were excluded at an initial physical examination screening. 642 were enrolled and consented, and another 17 were excluded before device placement. 625 underwent the procedure. Average age was 24 years (+/- 7). Twelve moderate AEs occurred among 10 participants 12/625, (1.9%). These were all reversible. Five had device displacement, one had an everted foreskin; five had bleeding after the device was removed and one had voiding difficulties. The majority (279 out of 300) of men interviewed complained of some pain within the week of placement. Mean pain score at device placement (using visual analogue scale) was 0.5, at device removal 4.5 and within 2 min of removal the pain score was 1.4. Over 70% of the devices were placed and removed by non-physician clinicians. Presented with a choice, 60% of men chose PrePex over surgical SMC. Close to 90% would recommend the device to their friends. Odour from the necrotic skin was a concern. Removals done 1-2 days earlier than day 7 were beneficial and conferred no extra risk. Conclusion: AEs of a moderate or severe nature associated with PrePex were low and reversible. PrePex is feasible for mass safe male circumcision scaling up.	[Galukande, Moses; Rackara, Sam] Int Hosp Kampala, Kampala, Uganda; [Duffy, Kevin] Int Med Grp, Kampala, Uganda; [Bitega, Jean Paul] Kanombe Hosp, Kigali, Rwanda; [Galukande, Moses] Mulago Hosp, Dept Surg, Kampala, Uganda; [Bbaale, Denis Sekavuga; Coutinho, Alex] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Nakaggwa, Florence; Nagaddya, Teddy; Wooding, Nick] Int Hlth Sci Univ, Kampala, Uganda; [Dea, Monica] Ctr Dis Control, Kampala, Uganda	Mulago National Referral Hospital; Makerere University	Galukande, M (corresponding author), Int Hosp Kampala, Kampala, Uganda.	mosesg@img.co.ug	Wooding, Nicholas/L-7934-2019	Nakaggwa, Florence/0000-0001-6768-6412; Nagaddya, Teddy/0000-0001-8812-139X	Ministry of Health; CDC	Ministry of Health; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	IDI staff and management, Ministry of Health and CDC for their support of the project and program.	[Anonymous], 2005, WHO REP GUID; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Davis P, 2001, ADVERSE EVENTS NZ PU; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Male Circumcision for HIV Preventionc, 2013, 1 MAL CIRC HIV PREV; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Study Group 5 of the Global Harmonisation Task Force (DHTF), 2012, REP EV PREM CLIN INV; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406	14	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86631	10.1371/journal.pone.0086631	http://dx.doi.org/10.1371/journal.pone.0086631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489754	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000065
J	Han, YC; Liu, ZQ; Wang, SJ; Li, LJ; Tan, J				Han, Ying-Chao; Liu, Zhu-Qing; Wang, Shan-Jin; Li, Li-Jun; Tan, Jun			Is Anterior Cervical Discectomy and Fusion Superior to Corpectomy and Fusion for Treatment of Multilevel Cervical Spondylotic Myelopathy? A Systemic Review and Meta-Analysis	PLOS ONE			English	Review							TERM-FOLLOW-UP; SPINE SURGERY; RECONSTRUCTIVE TECHNIQUES; SURGICAL-TREATMENT; TITANIUM CAGES; DECOMPRESSION; ARTHRODESIS; INTERBODY; COMPLICATIONS; MANAGEMENT	Objective: Both anterior cervical discectomy with fusion (ACDF) and anterior cervical corpectomy with fusion (ACCF) are used to treat cervical spondylotic myelopathy (CSM), however, there is considerable controversy as to whether ACDF or ACCF is the optimal treatment for this condition. To compare the clinical outcomes, complications, and surgical trauma between ACDF and ACCF for the treatment of CSM, we conducted a meta-analysis. Methods: We conducted a comprehensive search in MEDLINE, EMBASE, PubMed, Google Scholar and Cochrane databases, searching for relevant controlled trials up to July 2013 that compared ACDF and ACCF for the treatment of CSM. We performed title and abstract screening and full-text screening independently and in duplicate. A random effects model was used for heterogeneous data; otherwise, a fixed effect model was used to pool data, using mean difference (MD) for continuous outcomes and odds ratio (OR) for dichotomous outcomes. Results: Of 2157 citations examined, 15 articles representing 1372 participants were eligible. Overall, there were significant differences between the two treatment groups for hospital stay (M = -5.60, 95% CI = -7.09 to -4.11), blood loss (MD = -151.35, 95% CI = -253.22 to -49.48), complications (OR = 0.50, 95% CI = 0.35 to 0.73) and increased lordosis of C2-C7 (MD = 3.70, 95% CI = 0.96 to 6.45) and fusion segments angles (MD = 3.38, 95% CI = 2.54 to 4.22). However, there were no significant differences in the operation time (MD = -29.34, 95% CI = -42.99 to 24.31), JOA (MD = 0.24, 95% CI = -0.10 to 0.57), VAS (MD = -0.06, 95% CI = -0.81 to 0.70), NDI (MD = -1.37, 95% CI = -3.17 to 0.43), Odom criteria (OR = 0.88, 95% CI = 0.60 to 1.30) or fusion rate (OR = 1.17, 95% CI = 0.34 to 4.11). Conclusions: Based on this meta-analysis, although complications and increased lordosis are significantly better in the ACDF group, there is no strong evidence to support the routine use of ACDF over ACCF in CSM.	[Han, Ying-Chao; Wang, Shan-Jin; Li, Li-Jun; Tan, Jun] Tongji Univ, Sch Med, Dept Spinal Surg, East Hosp, Shanghai 200092, Peoples R China; [Liu, Zhu-Qing] Tongji Univ, Sch Med, Dept Med Oncol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, SJ (corresponding author), Tongji Univ, Sch Med, Dept Spinal Surg, East Hosp, Shanghai 200092, Peoples R China.	kingspine@163.com; drtan@139.com						Apfelbaum RI, 2000, SPINE, V25, P2906, DOI 10.1097/00007632-200011150-00012; Ba ZY, 2012, SPINE, V37, pE1260, DOI 10.1097/BRS.0b013e318265df75; Burkhardt JK, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.3.FOCUS1396; Carette S, 2005, NEW ENGL J MED, V353, P392, DOI 10.1056/NEJMcp043887; CLEMENTS DH, 1990, SPINE, V15, P1023, DOI 10.1097/00007632-199015100-00008; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Dean CL, 2009, SPINE J, V9, P439, DOI 10.1016/j.spinee.2008.11.010; DICKMAN CA, 1994, SPINE, V19, pS2266; Emery SE, 1998, J BONE JOINT SURG AM, V80A, P941, DOI 10.2106/00004623-199807000-00002; Fountas KN, 2007, SPINE, V32, P2310, DOI 10.1097/BRS.0b013e318154c57e; Ghogawala Z, 2007, SPINE, V32, P429, DOI 10.1097/01.brs.0000255068.94058.8a; Gore DR, 2001, SPINE, V26, P1259, DOI 10.1097/00007632-200106010-00016; Grob D, 2010, EUR SPINE J, V19, P1801, DOI 10.1007/s00586-010-1571-y; Guo QF, 2011, EUR SPINE J, V20, P1539, DOI 10.1007/s00586-011-1735-4; HAHER TR, 1995, SPINE, V20, P1575, DOI 10.1097/00007632-199507150-00005; Hee HT, 2003, J SPINAL DISORD TECH, V16, P1, DOI 10.1097/00024720-200302000-00001; HEENEMAN H, 1973, LARYNGOSCOPE, V83, P17, DOI 10.1288/00005537-197301000-00002; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilibrand AS, 2001, J BONE JOINT SURG AM, V83A, P668, DOI 10.2106/00004623-200105000-00004; Hilibrand AS, 2002, SPINE, V27, P146, DOI 10.1097/00007632-200201150-00005; Hwang SL, 2007, J SPINAL DISORD TECH, V20, P565, DOI 10.1097/BSD.0b013e318036b463; Lebl Darren R, 2011, HSS J, V7, P170, DOI 10.1007/s11420-011-9208-1; Lee MJ, 2007, SPINE J, V7, P141, DOI 10.1016/j.spinee.2006.02.024; Li JF, 2013, ARCH ORTHOP TRAUM SU, V133, P745, DOI 10.1007/s00402-013-1719-4; Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9; Liu Y, 2012, EUR SPINE J, V21, P2428, DOI 10.1007/s00586-012-2323-y; Liu Y, 2012, SPINE, V37, pE1450, DOI 10.1097/BRS.0b013e31826c72b4; Nirala AP, 2004, BRIT J NEUROSURG, V18, P227, DOI 10.1080/02688690410001732643; Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a; Park Y, 2010, SPINE J, V10, P193, DOI 10.1016/j.spinee.2009.09.006; Rao RD, 2006, J BONE JOINT SURG AM, V88A, P1619, DOI 10.2106/JBJS.F.00014; Sasso RC, 2003, SPINE, V28, P140, DOI 10.1097/00007632-200301150-00009; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Song KJ, 2012, EUR SPINE J, V21, P1551, DOI 10.1007/s00586-012-2296-x; Swank M L, 1997, Eur Spine J, V6, P138, DOI 10.1007/BF01358747; Sypert GW, 1999, SURG NEUROL, V51, P4; Toledano M, 2013, NEUROL CLIN, V31, P287, DOI 10.1016/j.ncl.2012.09.003; Uribe JS, 2009, EUR SPINE J, V18, P654, DOI 10.1007/s00586-009-0897-9; Vaccaro AR, 1998, J SPINAL DISORD, V11, P410; Wang JC, 2003, SPINE, V28, P1016, DOI 10.1097/00007632-200305150-00011; Wang JC, 2001, J SPINAL DISORD, V14, P222, DOI 10.1097/00002517-200106000-00006; WELSH LW, 1987, ANN OTO RHINOL LARYN, V96, P112, DOI 10.1177/000348948709600125; YONENOBU K, 1985, SPINE, V10, P710, DOI 10.1097/00007632-198510000-00004; Young WF, 2000, AM FAM PHYSICIAN, V62, P1064	44	32	38	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87191	10.1371/journal.pone.0087191	http://dx.doi.org/10.1371/journal.pone.0087191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489868	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000115
J	Jay, M; Bradley, S; McDearmid, JR				Jay, Michael; Bradley, Sophie; McDearmid, Jonathan Robert			Effects of Nitric Oxide on Neuromuscular Properties of Developing Zebrafish Embryos	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; SYNTHASE-IMMUNOREACTIVE NEURONS; GROWTH CONE FILOPODIA; WHITE MUSCLE-FIBERS; ACETYLCHOLINE-RECEPTOR; SPINAL-CORD; SKELETAL-MUSCLE; TIME-COURSE; RETINOTECTAL PROJECTION; LOCOMOTOR NETWORK	Nitric oxide is a bioactive signalling molecule that is known to affect a wide range of neurodevelopmental processes. However, its functional relevance to neuromuscular development is not fully understood. Here we have examined developmental roles of nitric oxide during formation and maturation of neuromuscular contacts in zebrafish. Using histochemical approaches we show that elevating nitric oxide levels reduces the number of neuromuscular synapses within the axial swimming muscles whilst inhibition of nitric oxide biosynthesis has the opposite effect. We further show that nitric oxide signalling does not change synapse density, suggesting that the observed effects are a consequence of previously reported changes in motor axon branch formation. Moreover, we have used in vivo patch clamp electrophysiology to examine the effects of nitric oxide on physiological maturation of zebrafish neuromuscular junctions. We show that developmental exposure to nitric oxide affects the kinetics of spontaneous miniature end plate currents and impacts the neuromuscular drive for locomotion. Taken together, our findings implicate nitrergic signalling in the regulation of zebrafish neuromuscular development and locomotor maturation.	[Jay, Michael; Bradley, Sophie; McDearmid, Jonathan Robert] Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	McDearmid, JR (corresponding author), Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	jrm33@le.ac.uk		Bradley, Sophie/0000-0001-5505-3765	BBSRC [BBE015352, BBF01516X]; BBSRC [BB/E015352/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015352/1, 1068275] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a BBSRC studentship to MJ, a BBSRC studentship to SB, and in part by BBSRC grants BBE015352 and BBF01516X to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausborn J, 2012, P NATL ACAD SCI USA, V109, pE3631, DOI 10.1073/pnas.1216256110; Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Bradley S, 2010, J NEUROSCI, V30, P16818, DOI 10.1523/JNEUROSCI.4456-10.2010; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Bruning G, 1996, NEUROSCI LETT, V202, P189, DOI 10.1016/0304-3940(95)12239-7; Buckingham SD, 2004, J EXP BIOL, V207, P841, DOI 10.1242/jeb.00839; Bukcharaeva EA, 1999, J PHYSIOL-LONDON, V517, P879, DOI 10.1111/j.1469-7793.1999.0879s.x; Buss RR, 2002, J NEUROPHYSIOL, V87, P1244, DOI 10.1152/jn.00659.2001; Buss RR, 2000, J NEUROPHYSIOL, V84, P1545, DOI 10.1152/jn.2000.84.3.1545; Campello-Costa P, 2000, J NEUROBIOL, V44, P371, DOI 10.1002/1097-4695(20000915)44:4<371::AID-NEU1>3.0.CO;2-X; Chung YH, 2004, NEUROSCI LETT, V360, P1, DOI 10.1016/j.neulet.2004.01.002; Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO;2-6; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; DELCASTILLO J, 1978, J CELL BIOL, V78, P782, DOI 10.1083/jcb.78.3.782; Drapeau P, 2001, J NEUROPHYSIOL, V86, P2951, DOI 10.1152/jn.2001.86.6.2951; Ernst AF, 2000, J NEUROSCI, V20, P1458; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; FORSTERMANN U, 1986, CIRC RES, V58, P531, DOI 10.1161/01.RES.58.4.531; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Gibbs SM, 2001, J NEUROSCI, V21, P7705, DOI 10.1523/JNEUROSCI.21-19-07705.2001; Godfrey EW, 2007, DEV BIOL, V307, P195, DOI 10.1016/j.ydbio.2007.04.021; Godfrey EW, 2003, J NEUROCYTOL, V32, P591, DOI 10.1023/B:NEUR.0000020612.87729.98; Gotti S, 2005, MICROSC RES TECHNIQ, V68, P13, DOI 10.1002/jemt.20219; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; Hindley S, 1997, J NEUROSCI RES, V47, P427; Holmqvist B, 2004, J EXP BIOL, V207, P923, DOI 10.1242/jeb.00845; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Iwase K, 1998, MOL BRAIN RES, V53, P1, DOI 10.1016/S0169-328X(97)00139-3; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Jones MG, 2000, NETW COMPUT, V11, P16; Judas M, 1999, MICROSC RES TECHNIQ, V45, P401, DOI 10.1002/(SICI)1097-0029(19990615)45:6<401::AID-JEMT7>3.0.CO;2-Q; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KULLBERG RW, 1980, DEV BIOL, V75, P255, DOI 10.1016/0012-1606(80)90161-X; Kyriakatos A, 2009, J NEUROSCI, V29, P13283, DOI 10.1523/JNEUROSCI.3069-09.2009; LIU DWC, 1992, J NEUROSCI, V12, P1859; Luna VM, 2006, J GEN PHYSIOL, V128, P89, DOI 10.1085/jgp.200609501; Luna VM, 2004, J NEUROPHYSIOL, V92, P2003, DOI 10.1152/jn.00454.2004; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; McLean DL, 2004, J NEUROSCI, V24, P9561, DOI 10.1523/JNEUROSCI.1817-04.2004; Menelaou E, 2012, J NEUROSCI, V32, P10925, DOI 10.1523/JNEUROSCI.1809-12.2012; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Mongeon R, 2011, J GEN PHYSIOL, V138, P353, DOI 10.1085/jgp.201110649; NARANJO D, 1993, SCIENCE, V260, P1811, DOI 10.1126/science.8511590; Nguyen PV, 1999, J NEUROPHYSIOL, V81, P2852, DOI 10.1152/jn.1999.81.6.2852; Oermann E, 1999, ANAT EMBRYOL, V200, P27, DOI 10.1007/s004290050256; Panzer JA, 2005, DEV BIOL, V285, P340, DOI 10.1016/j.ydbio.2005.06.027; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Ribera J, 1998, J NEUROSCI RES, V51, P90, DOI 10.1002/(SICI)1097-4547(19980101)51:1<90::AID-JNR10>3.0.CO;2-C; ROSKAMS AJ, 1994, NEURON, V13, P289; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Samigullin D, 2003, PHYSIOL RES, V52, P475; Schwarte RC, 2004, DEV BIOL, V273, P276, DOI 10.1016/j.ydbio.2004.06.003; Sylvain NJ, 2011, NEUROTOXICOL TERATOL, V33, P313, DOI 10.1016/j.ntt.2010.12.001; Terada H, 2001, DEV BRAIN RES, V128, P121, DOI 10.1016/S0165-3806(01)00162-6; Terada H, 1996, J CHEM NEUROANAT, V10, P273, DOI 10.1016/0891-0618(96)00141-X; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; Tornieri K, 2007, DEV NEUROBIOL, V67, P1932, DOI 10.1002/dneu.20572; Tricoire L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00082; Trimm KR, 2004, EUR J NEUROSCI, V19, P809, DOI 10.1111/j.0953-816X.2004.03182.x; Van Wagenen S, 1999, J NEUROBIOL, V39, P168, DOI 10.1002/(SICI)1097-4695(199905)39:2<168::AID-NEU2>3.0.CO;2-F; Van Wagenen S, 2001, J NEUROBIOL, V46, P206, DOI 10.1002/1097-4695(20010215)46:3<206::AID-NEU1003>3.3.CO;2-J; VANRAAMSDONK W, 1978, ANAT EMBRYOL, V153, P137; WANG T, 1995, NATURE, V374, P262, DOI 10.1038/374262a0; Welshhans K, 2005, EUR J NEUROSCI, V22, P3006, DOI 10.1111/j.1460-9568.2005.04490.x; Welshhans K, 2007, EUR J NEUROSCI, V26, P1537, DOI 10.1111/j.1460-9568.2007.05768.x; Wen H, 2005, J NEUROSCI, V25, P8104, DOI 10.1523/JNEUROSCI.2611-05.2005; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wu HH, 2000, DEV BRAIN RES, V120, P105, DOI 10.1016/S0165-3806(99)00145-5; Wu J, 2001, PAIN, V94, P47, DOI 10.1016/S0304-3959(01)00340-2; Yamada RX, 2006, NEUROREPORT, V17, P661, DOI 10.1097/00001756-200604240-00021; Yamazaki M, 2006, NEUROSCI LETT, V393, P222, DOI 10.1016/j.neulet.2005.09.068; Zhang YT, 2002, BRAIN RES BULL, V58, P385, DOI 10.1016/S0361-9230(02)00808-0	80	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86930	10.1371/journal.pone.0086930	http://dx.doi.org/10.1371/journal.pone.0086930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489806	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000089
J	Manzoor, U; Kim, DK; Islam, M; Bhatti, AS				Manzoor, Umair; Kim, Do K.; Islam, Mohammad; Bhatti, Arshad S.			Removal of Micrometer Size Morphological Defects and Enhancement of Ultraviolet Emission by Thermal Treatment of Ga-Doped ZnO Nanostructures	PLOS ONE			English	Article							ZINC-OXIDE; THIN-FILMS; TEMPERATURE; PHOTOLUMINESCENCE; SUBLIMATION; MECHANISMS; SUBSTRATE; GROWTH	Mixed morphologies of Ga-doped Zinc Oxide (ZnO) nanostructures are synthesized by vapor transport method. Systematic scanning electron microscope (SEM) studies of different morphologies, after periodic heat treatments, gives direct evidence of sublimation. SEM micrographs give direct evidence that morphological defects of nanostructures can be removed by annealing. Ultra Violet (UV) and visible emission depends strongly on the annealing temperatures and luminescent efficiency of UV emission is enhanced significantly with each subsequent heat treatment. X-Ray diffraction (XRD) results suggest that crystal quality improved by annealing and phase separation may occur at high temperatures.	[Manzoor, Umair] King Saud Univ, Alamoudi Water Chair, Riyadh, Saudi Arabia; [Manzoor, Umair; Bhatti, Arshad S.] COMSATS Inst Informat Technol, Ctr Micro & Nano Devices, Dept Phys, Islamabad, Pakistan; [Kim, Do K.] Korea Adv Inst Sci & Technol KAIST, Dept Mat Sci & Engn, Taejon, South Korea; [Islam, Mohammad] King Saud Univ, Coll Engn, Riyadh, Saudi Arabia	King Saud University; COMSATS University Islamabad (CUI); Korea Advanced Institute of Science & Technology (KAIST); King Saud University	Manzoor, U (corresponding author), King Saud Univ, Alamoudi Water Chair, Riyadh, Saudi Arabia.	umanzoor@comsats.edu.pk	Bhatti, Arshad S/D-5104-2011; Islam, Mohammad/K-8385-2013; Kim, Do Kyung/C-2039-2011; manzoor, Umair/K-1178-2014	Islam, Mohammad/0000-0003-0117-6422; Kim, Do Kyung/0000-0001-9092-9427; 	Higher Education Commission (HEC) Pakistan; King Saud University [RGP-VPP-283]	Higher Education Commission (HEC) Pakistan(Higher Education Commission of Pakistan); King Saud University(King Saud University)	Authors would like to thank Higher Education Commission (HEC) Pakistan for the financial support through "National Research Program for Universities". The authors would also like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project no. RGP-VPP-283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2012, SENSORS-BASEL, V12, P13842, DOI 10.3390/s121013842; Assuncao V, 2003, THIN SOLID FILMS, V442, P102, DOI 10.1016/S0040-6090(03)00955-6; Chen Z, 2005, SCRIPTA MATER, V52, P63, DOI 10.1016/j.scriptamat.2004.08.024; Cheong KY, 2002, THIN SOLID FILMS, V410, P142, DOI 10.1016/S0040-6090(02)00286-9; Fang ZB, 2005, APPL SURF SCI, V241, P303, DOI 10.1016/j.apsusc.2004.07.056; Fortunato E, 2003, THIN SOLID FILMS, V442, P121, DOI 10.1016/S0040-6090(03)00958-1; Goncalves AD, 2006, J SOLID STATE CHEM, V179, P1330, DOI 10.1016/j.jssc.2006.01.046; GOPEL W, 1979, J VAC SCI TECHNOL, V16, P1229, DOI 10.1116/1.570197; Greene LE, 2006, INORG CHEM, V45, P7535, DOI 10.1021/ic0601900; GRUNZE M, 1981, J CRYST GROWTH, V52, P241, DOI 10.1016/0022-0248(81)90199-8; Gu F, 2003, CHEM PHYS LETT, V372, P451, DOI 10.1016/S0009-2614(03)00440-8; IWANAGA H, 1979, J CRYST GROWTH, V47, P703, DOI 10.1016/0022-0248(79)90015-0; Janotti A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165202; Ko HJ, 2002, J APPL PHYS, V92, P4354, DOI 10.1063/1.1509103; KOHL D, 1974, SURF SCI, V41, P403, DOI 10.1016/0039-6028(74)90057-0; Kolmakov A, 2004, ANNU REV MATER RES, V34, P151, DOI 10.1146/annurev.matsci.34.040203.112141; Lannoo M., 1983, POINT DEFECTS SEMICO, V2; Law M, 2004, ANNU REV MATER RES, V34, P83, DOI 10.1146/annurev.matsci.34.040203.112300; Lim J, 2004, MAT SCI ENG B-SOLID, V107, P301, DOI 10.1016/j.mseb.2003.12.006; Lin BX, 2001, APPL PHYS LETT, V79, P943, DOI 10.1063/1.1394173; Manzoor U, 2006, SCRIPTA MATER, V54, P807, DOI 10.1016/j.scriptamat.2005.11.012; Mtangi W, 2012, J APPL PHYS, V111; Oh SJ, 2008, PHYSICA E, V41, P31, DOI 10.1016/j.physe.2008.05.019; Peterson RB, 2004, LANGMUIR, V20, P5114, DOI 10.1021/la049683c; Roberts N, 1998, PHYS REV B, V57, P5734, DOI 10.1103/PhysRevB.57.5734; Simon H, 2013, CRYST GROWTH DES, V13, P572, DOI 10.1021/cg301640v; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; Wang RP, 1996, CHEM MATER, V8, P433, DOI 10.1021/cm950372k; Zhang YT, 2004, SEMICOND SCI TECH, V19, P755, DOI 10.1088/0268-1242/19/6/017	29	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86418	10.1371/journal.pone.0086418	http://dx.doi.org/10.1371/journal.pone.0086418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489725	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000050
J	Jia, W; Zhang, R; Wu, B; Dai, ZX; Zhu, YS; Li, PP; Zhu, F				Jia, Wei; Zhang, Rui; Wu, Bin; Dai, Zun-xiao; Zhu, Yong-sheng; Li, Ping-ping; Zhu, Feng			Metabotropic Glutamate Receptor 3 Is Associated with Heroin Dependence but Not Depression or Schizophrenia in a Chinese Population	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; VENTRAL TEGMENTAL AREA; TYPE-3 GENE GRM3; GROUP-II; NUCLEUS-ACCUMBENS; MOOD DISORDERS; JAPANESE POPULATION; AGONIST LY379268; COCAINE; SEEKING	Metabotropic glutamate receptor subtype 3 (mGluR3, encoded by GRM3) plays important roles in the pathophysiology of schizophrenia, depression, and drug dependence. GRM3 polymorphisms were reported to be associated with prefrontal activity, cognitive shifting, and memory capability in healthy subjects, as well as susceptibility to schizophrenia and depression. The goal of this study was to replicate the association of GRM3 with schizophrenia and depression and to explore GRM3's potential association with heroin dependence (HD) in a Chinese population. Seventeen SNPs throughout the GRM3 gene were genotyped using MALDI-TOF within the MassARRAY system, and the allele and genotype distributions were compared between 619 healthy controls and 433 patients with schizophrenia, 409 patients with major depression, and 584 unrelated addicts. We found that GRM3 polymorphisms modulate the susceptibility to HD but do not significantly influence the risk for schizophrenia or depression. An increased risk of HD was significantly associated with the minor alleles of two GRM3 SNPs, including the T allele of rs274618 (Odds ratio (OR) = 1.631, 95% confidence interval (95% CI): 1.317-2.005), the T allele of rs274622 (OR = 1.652, 95% CI: 1.336-2.036), compared with the major alleles. The addicts carrying the minor allele of rs274618 or rs274622 had a shortened duration for transition from first use to dependence (DTFUD) in comparison to homozygote for major allele (P<0.0001 for each SNP using log rank test). Additionally, a 6-SNP haplotype within 5' region of the GRM3 including the minor alleles of the two aforementioned SNPs was significantly associated with an increased risk of HD (P = 0.00001, OR = 1.668, 95% CI: 1.335-2.084). Our data indicated that GRM3 polymorphisms do not contribute to genetic susceptibility to schizophrenia and depression, but they confer an increased risk of HD in a Chinese population.	[Jia, Wei; Zhang, Rui; Wu, Bin; Dai, Zun-xiao] Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Shannxi, Peoples R China; [Zhu, Yong-sheng] Xi An Jiao Tong Univ, Coll Med, Forens Dept, Xian 710049, Shaanxi, Peoples R China; [Li, Ping-ping; Zhu, Feng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Ctr Translat Med, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhu, YS (corresponding author), Xi An Jiao Tong Univ, Coll Med, Forens Dept, West Yanta Rd, Xian 710049, Shaanxi, Peoples R China.	zhuyongsheng3000@aliyun.com; zhufeng0714@gmail.com	Zhu, Feng/CAH-0203-2022; Li, Ping/GYV-4914-2022	Zhu, Feng/0000-0003-3986-8803; 	Research and Development foundation of Science and Technology of Shaanxi Province [2011k15-01-01]	Research and Development foundation of Science and Technology of Shaanxi Province	The project was supported by the Research and Development foundation of Science and Technology of Shaanxi Province (2011k15-01-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Adewale AS, 2006, J PHARMACOL EXP THER, V318, P922, DOI 10.1124/jpet.106.105387; Albalushi T, 2008, AM J MED GENET B, V147B, P392, DOI 10.1002/ajmg.b.30610; Backstrom P, 2005, EUR J PHARMACOL, V528, P110, DOI 10.1016/j.ejphar.2005.10.051; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baune BT, GENES BRAIN BEHAV, V9, P459; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bespalov AY, 2008, EUR J PHARMACOL, V592, P96, DOI 10.1016/j.ejphar.2008.06.089; Bishop JR, 2011, HUM PSYCHOPHARM CLIN, V26, P7; Bossert JM, 2005, NEUROREPORT, V16, P1013, DOI 10.1097/00001756-200506210-00026; Bossert JM, 2004, J NEUROSCI, V24, P10726, DOI 10.1523/JNEUROSCI.3207-04.2004; Chen Q, 2005, SCHIZOPHR RES, V73, P21, DOI 10.1016/j.schres.2004.07.002; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 2001, BIOCHEM BIOPH RES CO, V286, P381, DOI 10.1006/bbrc.2001.5391; Dalvie S, AFR J PSYCHIAT JOHAN, V13, P297; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fujii Y, 2003, PSYCHIAT GENET, V13, P71, DOI 10.1097/01.ypg.0000056682.82896.b0; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Herman E J, 2012, Handb Exp Pharmacol, P297, DOI 10.1007/978-3-642-25758-2_11; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kawakubo Y, PLOS ONE, V6; Kenny PJ, 2004, TRENDS PHARMACOL SCI, V25, P265, DOI 10.1016/j.tips.2004.03.009; Kenny PJ, 2003, J PHARMACOL EXP THER, V306, P1068, DOI 10.1124/jpet.103.052027; Kim JH, 2005, EUR J NEUROSCI, V21, P295, DOI 10.1111/j.1460-9568.2004.03822.x; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Marenco S, 2006, AM J PSYCHIAT, V163, P740, DOI 10.1176/appi.ajp.163.4.740; Marti SB, 2002, AM J MED GENET, V114, P46, DOI 10.1002/ajmg.1624; Martin G, 1999, J PHARMACOL EXP THER, V288, P30; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Morishima Y, 2005, P NATL ACAD SCI USA, V102, P4170, DOI 10.1073/pnas.0500914102; Moussawi K, 2010, EUR J PHARMACOL, V639, P115, DOI 10.1016/j.ejphar.2010.01.030; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Neugebauer V, 2000, J NEUROPHYSIOL, V84, P759, DOI 10.1152/jn.2000.84.2.759; Norton N, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-23; Parsons CG, 2005, HANDB EXP PHARM, V169, P249; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Peters J, 2006, PSYCHOPHARMACOLOGY, V186, P143, DOI 10.1007/s00213-006-0372-9; Robbe D, 2002, EUR J NEUROSCI, V16, P2231, DOI 10.1046/j.1460-9568.2002.02273.x; Scherer SW, 1996, GENOMICS, V31, P230, DOI 10.1006/geno.1996.0036; Stone JM, 2007, J PSYCHOPHARMACOL, V21, P440, DOI 10.1177/0269881106073126; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Tochigi M, 2006, SCHIZOPHR RES, V88, P260, DOI 10.1016/j.schres.2006.07.008; Tsunoka T, 2009, PROG NEURO-PSYCHOPH, V33, P875, DOI 10.1016/j.pnpbp.2009.04.007; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Witkin Jeffrey M., 2007, CNS & Neurological Disorders-Drug Targets, V6, P87, DOI 10.2174/187152707780363302; Wright RA, 2001, J PHARMACOL EXP THER, V298, P453; Xi ZX, 2006, J NEUROSCI, V26, P8531, DOI 10.1523/JNEUROSCI.0726-06.2006; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735; Xi ZX, NEUROPHARMACOLOGY, V58, P304; Zhu F-C, 2013, PLOS ONE IN PRESS	54	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87247	10.1371/journal.pone.0087247	http://dx.doi.org/10.1371/journal.pone.0087247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498053	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900078
J	Ezcurra, MD				Ezcurra, Martin D.			The Osteology of the Basal Archosauromorph Tasmaniosaurus triassicus from the Lower Triassic of Tasmania, Australia	PLOS ONE			English	Article							TEMNOSPONDYL AMPHIBIANS; AXIAL SKELETON; KAROO BASIN; REPTILE; SKULL; PHYLOGENY; EVOLUTION; REDESCRIPTION; REVISION; REAPPRAISAL	Proterosuchidae are the most taxonomically diverse archosauromorph reptiles sampled in the immediate aftermath of the Permo-Triassic mass extinction and represent the earliest radiation of Archosauriformes (archosaurs and closely related species). Proterosuchids are potentially represented by approximately 15 nominal species collected from South Africa, China, Russia, Australia and India, but the taxonomic content of the group is currently in a state of flux because of the poor anatomic and systematic information available for several of its putative members. Here, the putative proterosuchid Tasmaniosaurus triassicus from the Lower Triassic of Hobart, Tasmania (Australia), is redescribed. The holotype and currently only known specimen includes cranial and postcranial remains and the revision of this material sheds new light on the anatomy of the animal, including new data on the cranial endocast. Several bones are re-identified or reinterpreted, contrasting with the descriptions of previous authors. The new information provided here shows that Tasmaniosaurus closely resembles the South African proterosuchid Proterosuchus, but it differed in the presence of, for example, a slightly downturned premaxilla, a shorter anterior process of maxilla, and a diamond-shaped anterior end of interclavicle. Previous claims for the presence of gut contents in the holotype of Tasmaniosaurus are considered ambiguous. The description of the cranial endocast of Tasmaniosaurus provides for the first time information about the anatomy of this region in proterosuchids. The cranial endocast preserves possibly part of the vomero-nasal (= Jacobson's) system laterally to the olfactory bulbs. Previous claims of the absence of the vomero-nasal organs in archosaurs, which is suggested by the extant phylogenetic bracket, are questioned because its absence in both clades of extant archosaurs seems to be directly related with the independent acquisition of a non-ground living mode of life.	[Ezcurra, Martin D.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Ezcurra, Martin D.] Univ Munich, GeoBioctr, Munich, Germany	University of Birmingham; University of Munich	Ezcurra, MD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	martindezcurra@yahoo.com.ar			DFG Emmy Noether Programme [BU 2587/3-1]	DFG Emmy Noether Programme(German Research Foundation (DFG))	The research was funded by a grant of the DFG Emmy Noether Programme to Richard Butler (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcucci A, 1998, J VERTEBR PALEONTOL, V18, P228, DOI 10.1080/02724634.1998.10011046; Banks M.R., 1978, Australian Natural History, V19, P150; BANKS MR, 1967, PAPERS P ROYAL SOC T, V101, P17; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; BENTON MJ, 1985, ZOOL J LINN SOC-LOND, V84, P97, DOI 10.1111/j.1096-3642.1985.tb01796.x; BERTMAR G, 1981, EVOLUTION, V35, P359, DOI 10.1111/j.1558-5646.1981.tb04893.x; Bhatnagar KP, 1998, MICROSC RES TECHNIQ, V43, P465, DOI 10.1002/(SICI)1097-0029(19981215)43:6<465::AID-JEMT1>3.0.CO;2-1; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Broili F, 1934, SITZUNGSBERICHTE BAY, V3, P225; Broom R, 1906, P ZOOL SOC LOND, V1906, P591; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Camp CL, 1978, ALCHERINGA, V2, P143, DOI 10.1080/03115517808619085; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; CARROLL R L, 1976, Annals of the South African Museum, V72, P37; Charig A. J, 1970, Biol. J., V2, P125, DOI 10.1111/j.1095-8312.1970.tb01708.x; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; Cheng ZW, 1980, MESOZOIC STRATIGRAPH, P114; Chiappe L.M., 2007, GLORIFIED DINOSAURS; Cosgriff J.W., 1974, Special Pap geol Soc Am, VNo. 149, P1; Cruickshank A.R.I., 1972, P89; Damiani RJ, 2004, GONDWANA RES, V7, P165, DOI 10.1016/S1342-937X(05)70315-4; Damiani RJ, 2001, ZOOL J LINN SOC-LOND, V133, P379, DOI 10.1006/zjls.2001.0304; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Dias-da-Silva S, 2011, J SYST PALAEONTOL, V9, P305, DOI 10.1080/14772019.2010.492664; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; DZIEWA T J, 1980, Papers and Proceedings of the Royal Society of Tasmania, V114, P145; Edinger L, 1908, J COMP NEUROL PSYCHO, V18, P437, DOI 10.1002/cne.920180502; EVANS SE, 1981, ZOOL J LINN SOC-LOND, V73, P81, DOI 10.1111/j.1096-3642.1981.tb01580.x; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Ezcurra MD, 2013, GEOL SOC LOND SPEC P, DOI [10.1144/SP379.11, DOI 10.1144/SP379.11)]; Ezcurra MD, 2012, REUN AN EST PAL 2012, P18; Forsyth S., 1974, PAP P R SOC TASMANIA, V108, P107, DOI [10.26749/rstpp.108.107, DOI 10.26749/RSTPP.108.107]; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gauthier J, 1984, THESIS U CALIFORNIA; GITTLEMAN JL, 1991, J ZOOL, V225, P253, DOI 10.1111/j.1469-7998.1991.tb03815.x; Gorman M.L., 1989, P57; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; GOW C E, 1975, Palaeontologia Africana, V18, P89; Gower David J., 2000, P140; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1996, ZOOL J LINN SOC-LOND, V116, P347, DOI 10.1006/zjls.1996.0024; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Heckert AB, 2006, PALAEONTOLOGY, V49, P621, DOI 10.1111/j.1475-4983.2006.00556.x; Hewison RH, 1996, PALAEONTOLOGY, V39, P305; Hopson J.A., 1979, P39; Huene F. F. von, 1960, Palaeontographica A, V114, P105; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Juul Lars, 1994, Palaeontologia Africana, V31, P1; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Macdonald D.W., 1985, P619; Maier W., 1980, P219; Martinelli AG, 2008, CR PALEVOL, V7, P371, DOI 10.1016/j.crpv.2008.05.002; Meyer H.von., 1830, ISIS OKEN, V1830, P517; Modesto SR, 2004, ZOOL J LINN SOC-LOND, V140, P335, DOI 10.1111/j.1096-3642.2003.00102.x; Negus V., 1958, COMP ANATOMY PHYSL N; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Parrington F. R., 1935, Annals & Magazine of Natural History, V16, P197; Piechowski R, 2010, J VERTEBR PALEONTOL, V30, P1127, DOI 10.1080/02724634.2010.483547; PRITZ MB, 1975, J COMP NEUROL, V164, P323, DOI 10.1002/cne.901640305; REIG O, 1970, Bulletin of the Museum of Comparative Zoology, V139, P229; RIEPPEL O, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P123; Romer A. S., 1971, Breviora, VNo. 379, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sampson SD, 2010, MEM SOC VERT PALEONT, V8, P32; Sennikov A.G., 1997, PALEONTOL J, V31, P94; Sennikov AG, 1996, PALAEOGEOGR PALAEOCL, V120, P331, DOI 10.1016/0031-0182(95)00041-0; Senter P, 2002, PALEOBIOLOGY, V28, P544, DOI 10.1666/0094-8373(2002)028<0544:LOAPSI>2.0.CO;2; SHUBIN NH, 1991, PALEOBIOLOGY, V17, P214, DOI 10.1017/S0094837300010575; Spielmann J.A., 2008, NEW MEXICO MUSEUM NA, V43, P1; Spielmann Justin A., 2009, Palaeodiversity, P283; Steyer JS, 2003, J VERTEBR PALEONTOL, V23, P544, DOI 10.1671/1740; Stocker MR, 2013, GEOL SOC LOND SPEC P, P379, DOI [10.1144/SP379.5, DOI 10.1144/SP379.5)]; Sues H-D, 2013, GEOL SOC LOND SPEC P, V379, DOI [10.1144/SP379.13, DOI 10.1144/SP379.13)]; Sues HD, 2003, CAN J EARTH SCI, V40, P635, DOI 10.1139/E02-048; Sulej T, 2010, ZOOL J LINN SOC-LOND, V158, P860, DOI 10.1111/j.1096-3642.2009.00566.x; Tatarinov LP., 1961, PALEONTOL ZH, V1961, P117; Tatarinov LP., 1960, PALEONTOL J, V1960, P74; THULBORN R A, 1979, Memoirs of the Queensland Museum, V19, P331; Thulborn R.A., 1986, Journal of Vertebrate Paleontology, V6, P123; von Huene FRF, 1946, BIOL ZBL, V65, P268; Warren A, 2000, J VERTEBR PALEONTOL, V20, P462, DOI 10.1671/0272-4634(2000)020[0462:APOTBT]2.0.CO;2; Warren A., 1972, Australian nat Hist, V17, P279; Warren AA, 2006, GEOL MAG, V143, P877, DOI 10.1017/S0016756806002524; WARREN AA, 1990, ALCHERINGA, V14, P149, DOI 10.1080/03115519008527816; WEEMS RE, 1980, T AM PHILOS SOC, V70, P3; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Whitfield A, 2010, THESIS U TASMANIA HO; WIBLE JR, 1990, ZOOL J LINN SOC-LOND, V98, P203, DOI 10.1111/j.1096-3642.1990.tb01207.x; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 1999, J VERTEBR PALEONTOL, V19, P302, DOI 10.1080/02724634.1999.10011143; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Young C. C., 1936, Bulletin of the Geological Society of China, V15, P291; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1	111	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86864	10.1371/journal.pone.0086864	http://dx.doi.org/10.1371/journal.pone.0086864			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497988	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100036
J	Feuermann, Y; Kang, K; Shamay, A; Robinson, GW; Hennighausen, L				Feuermann, Yonatan; Kang, Keunsoo; Shamay, Avi; Robinson, Gertraud W.; Hennighausen, Lothar			MiR-21 Is under Control of STAT5 but Is Dispensable for Mammary Development and Lactation	PLOS ONE			English	Article							CELL-PROLIFERATION; GENE; MICRORNA-21; EXPRESSION; DIFFERENTIATION; TARGETS; EPITHELIUM; SURVIVAL; TOPHAT; PDCD4	Development of mammary alveolar epithelium during pregnancy is controlled by prolactin, through the transcription factors STAT5A/B that activate specific sets of target genes. Here we asked whether some of STAT5's functions are mediated by microRNAs. The miR-21 promoter sequence contains a bona-fide STAT5 binding site and miR-21 levels increased in HC11 mammary cells upon prolactin treatment. In vivo miR-21 was abundantly expressed in mammary epithelium at day 6 of pregnancy. Analysis of mice lacking miR-21 revealed that their mammary tissue developed normally during pregnancy and dams were able to nurse their pups. Our study demonstrated that although expression of miR-21 is under prolactin control through the transcription factors STAT5A/B its presence is dispensable for mammary development and lactation.	[Feuermann, Yonatan; Kang, Keunsoo; Robinson, Gertraud W.; Hennighausen, Lothar] NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA; [Shamay, Avi] Minist Agr, Volcani Ctr, Dept Anim Sci, Bet Dagan, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Feuermann, Y (corresponding author), NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA.	feuermanny@mail.nih.gov		Feuermann, Yonatan/0000-0002-6561-6397; Hennighausen, Lothar/0000-0001-8319-9841	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK061000, ZICDK071001] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the intramural programs of The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Feuermann Y, 2012, GENESIS; Friedland DR, 2009, OTOL NEUROTOL, V30, P998, DOI 10.1097/MAO.0b013e3181b4e91f; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Li G, 2009, BLOOD; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Ohno M, 2009, MOL CANCER RES, V7, P2022, DOI 10.1158/1541-7786.MCR-09-0319; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shen XH, 2009, MOL REPROD DEV, V76, P854, DOI 10.1002/mrd.21048; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109; Yoshinaga H, 1999, PATHOL INT, V49, P1067, DOI 10.1046/j.1440-1827.1999.00995.x; Zhu BM, 2008, BLOOD, V112, P2071, DOI 10.1182/blood-2007-12-127480	35	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e85123	10.1371/journal.pone.0085123	http://dx.doi.org/10.1371/journal.pone.0085123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497923	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100006
J	Megison, ML; Gillory, LA; Stewart, JE; Nabers, HC; Mroczek-Musulman, E; Waters, AM; Coleman, JM; Kelly, V; Markert, JM; Gillespie, GY; Friedman, GK; Beierle, EA				Megison, Michael L.; Gillory, Lauren A.; Stewart, Jerry E.; Nabers, Hugh C.; Mroczek-Musulman, Elizabeth; Waters, Alicia M.; Coleman, Jennifer M.; Kelly, Virginia; Markert, James M.; Gillespie, G. Yancey; Friedman, Gregory K.; Beierle, Elizabeth A.			Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; IONIZING-RADIATION; RENAL TUMORS; RHABDOID TUMORS; REPLICATION; THERAPY; CANCER; KIDNEY; HEPATOBLASTOMA; EXPERIENCE	Recently, investigators showed that mice with syngeneic murine gliomas that were treated with a neuroattenuated oncolytic herpes simplex virus-1 (oHSV), M002, had a significant increase in survival. M002 has deletions in both copies of the gamma(1)34.5 gene, enabling replication in tumor cells but precluding infection of normal cells. Previous studies have shown antitumor effects of other oHSV against a number of adult tumors including hepatocellular carcinoma and renal cell carcinoma. The purpose of the current study was to investigate the oncolytic potential of M002 against difficult to treat pediatric liver and kidney tumors. We showed that the oHSV, M002, infected, replicated, and decreased cell survival in hepatoblastoma, malignant rhabdoid kidney tumor, and renal sarcoma cell lines. In addition, we showed that in murine xenografts, treatment with M002 significantly increased survival and decreased tumor growth. Finally, these studies showed that the primary entry protein for oHSV, CD111 (nectin-1) was present in human hepatoblastoma and malignant rhabdoid kidney tumor specimens. We concluded that M002 effectively targeted these rare aggressive tumor types and that M002 may have potential for use in children with unresponsive or relapsed pediatric solid tumors.	[Megison, Michael L.; Gillory, Lauren A.; Stewart, Jerry E.; Nabers, Hugh C.; Waters, Alicia M.; Beierle, Elizabeth A.] Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA; [Mroczek-Musulman, Elizabeth] Childrens Alabama, Dept Pathol, Birmingham, AL USA; [Coleman, Jennifer M.; Markert, James M.; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Kelly, Virginia; Friedman, Gregory K.] Univ Alabama Birmingham, Div Hematol Oncol, Dept Pediat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Beierle, EA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Pediat Surg, Birmingham, AL 35294 USA.	elizabeth.beierle@childrensal.org		Gillespie, George/0000-0001-6436-9542; Beierle, Elizabeth/0000-0002-4613-0527; Friedman, Gregory/0000-0002-6653-7420	National Cancer Institute [T32CA091078, K08CA118178, P20CA151129]; St. Baldrick's Foundation; UAB [P30 AR048311, P30 AI027767]; NATIONAL CANCER INSTITUTE [P20CA151129, T32CA091078, K08CA118178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; UAB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Cancer Institute including T32CA091078 (M. L. M., L. A. G. and A. M. W.), K08CA118178 (E. A. B.) and P20CA151129 (G.Y.G., J.M.M.). The content of this manuscript was solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute. G. K. F. is supported by a grant from St. Baldrick's Foundation. The authors would also like to thank the support of the UAB Comprehensive Flow Cytometry Core (Grants P30 AR048311 and P30 AI027767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumilli PS, 2007, ANN SURG ONCOL, V14, P258, DOI 10.1245/s10434-006-9127-4; Adusumilli PS, 2005, ANN THORAC SURG, V80, P409, DOI 10.1016/j.athoracsur.2005.01.048; Advani SJ, 2011, GENE THER, V18, P1098, DOI 10.1038/gt.2011.61; Advani SJ, 1998, GENE THER, V5, P160, DOI 10.1038/sj.gt.3300546; Allan BJ, 2013, HPB OXFORD, DOI [10.1111/hpb.12112, DOI 10.1111/HPB.12112.[]; Amar AM, 2001, J PEDIAT HEMATOL ONC, V23, P105, DOI 10.1097/00043426-200102000-00007; Andreansky S, 1998, GENE THER, V5, P121, DOI 10.1038/sj.gt.3300550; Argnani R, 2011, LIVER INT, V31, P1542, DOI 10.1111/j.1478-3231.2011.02628.x; Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Bharatan NS, 2002, J PEDIAT HEMATOL ONC, V24, P447, DOI 10.1097/00043426-200208000-00008; Blank SV, 2002, HUM GENE THER, V13, P627, DOI 10.1089/10430340252837224; Chung SM, 2002, GENE THER, V9, P75, DOI 10.1038/sj.gt.3301620; Dome JS, 2013, PEDIATR BLOOD CANCER, V60, P994, DOI 10.1002/pbc.24419; Friedman GK, 2009, J NEURO-ONCOL, V95, P199, DOI 10.1007/s11060-009-9926-0; Friedman GK, 2009, MOL THER, V17, P1125, DOI 10.1038/mt.2009.73; Fu XP, 2007, INT J ONCOL, V30, P1561; GARVIN AJ, 1993, AM J PATHOL, V142, P375; GIACOMANTONIO M, 1984, J PEDIATR SURG, V19, P523, DOI 10.1016/S0022-3468(84)80095-0; Gillory LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077753; Gillory LA, 2013, TRANSL ONCOL, V6, P206, DOI 10.1593/tlo.12505; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Isaacs H, 2008, J PEDIATR SURG, V43, P1587, DOI 10.1016/j.jpedsurg.2008.03.052; Jana SS, 2002, FEBS LETT, V515, P184, DOI 10.1016/S0014-5793(02)02467-5; JURGENS H, 1988, CANCER, V61, P349, DOI 10.1002/1097-0142(19880115)61:2<349::AID-CNCR2820610226>3.0.CO;2-0; KELLEHER L, 1994, APPL IMMUNOHISTOCHEM, V2, P164; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Kuroda T, 2006, CANCER RES, V66, P10127, DOI 10.1158/0008-5472.CAN-06-2744; KUSHNER BH, 1991, CANCER, V67, P1825, DOI 10.1002/1097-0142(19910401)67:7<1825::AID-CNCR2820670702>3.0.CO;2-3; LAGUNOFF M, 1995, J VIROL, V69, P3615, DOI 10.1128/JVI.69.6.3615-3623.1995; MARINA NM, 1989, CANCER-AM CANCER SOC, V64, P1952, DOI 10.1002/1097-0142(19891101)64:9<1952::AID-CNCR2820640931>3.0.CO;2-W; Markert JM, 2012, J VIROL, V86, P5304, DOI 10.1128/JVI.06998-11; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Mezhir JJ, 2005, CANCER RES, V65, P9479, DOI 10.1158/0008-5472.CAN-05-1927; Morton CL, 2010, PEDIATR BLOOD CANCER, V55, P295, DOI 10.1002/pbc.22535; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117; RodriguezGalindo C, 1997, CANCER-AM CANCER SOC, V79, P2243, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2243::AID-CNCR24>3.0.CO;2-V; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; STOCKER JT, 1994, SEMIN DIAGN PATHOL, V11, P136; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922; Yamamoto M, 2011, CLIN EXP IMMUNOL, V165, P211, DOI 10.1111/j.1365-2249.2011.04421.x; Zhang SC, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-427; Zhuge Y, 2010, J SURG RES, V163, P257, DOI 10.1016/j.jss.2010.03.061	44	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86843	10.1371/journal.pone.0086843	http://dx.doi.org/10.1371/journal.pone.0086843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497984	gold, Green Submitted, Green Published			2022-12-27	WOS:000330617100034
J	Qiu, SL; Chen, J; Qin, T; Hu, YL; Wang, DY; Fan, Q; Zhang, CS; Chen, XY; Chen, XL; Liu, C; Gao, ZZ; Li, XP				Qiu, Shulei; Chen, Jin; Qin, Tao; Hu, Yuanliang; Wang, Deyun; Fan, Qiang; Zhang, Cunshuai; Chen, Xingying; Chen, Xiaolan; Liu, Cui; Gao, Zhenzhen; Li, Xiuping			Effects of Selenylation Modification on Immune-Enhancing Activity of Garlic Polysaccharide	PLOS ONE			English	Article							CHINESE; ADJUVANTICITY	The garlic polysaccharide was modified by HNO3-Na2SeO3 method according to orthogonal design L-9(3(4)) to obtain nine selenizing garlic polysaccharides, sGPS(1)-sGPS(9). Their effects on chicken peripheral lymphocytes proliferation in vitro were compared by MTT assay. The results showed that sGPSs could significantly promote lymphocytes proliferation, sGPS(3), sGPS(5) and sGPS(6) presented stronger efficacy. In vivo experiment, 14-day-old chickens were injected respectively with sGPS(3), sGPS(5) and sGPS(6) when they were vaccinated with ND vaccine taking unmodified GPS as control. The results showed that three sGPSs could significantly promote lymphocyte proliferation, enhance serum antibody titer, IFN-gamma and IL-2 contents. These results indicated that selenylation modification could significantly enhance the immune-enhancing activity of GPS, sGPS(6) possessed the best efficacy and could be as a candidate drug of immunoenhancer. Its optimal modification conditions were 400 mg of sodium selenite for 500 mg of GPS, reaction temperature of 70 degrees C and reaction time of 6 h.	[Qiu, Shulei; Qin, Tao; Hu, Yuanliang; Wang, Deyun; Chen, Xingying; Chen, Xiaolan; Liu, Cui; Gao, Zhenzhen; Li, Xiuping] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jin] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing, Jiangsu, Peoples R China; [Fan, Qiang; Zhang, Cunshuai] China Inst Vet Drug Control, Beijing, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; China Institute of Veterinary Drug Control	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Natural Science Foundation of China [31272596]; National Technological Supporting Program of China [2011BAD34B02]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technological Supporting Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	The project was supported by National Natural Science Foundation of China (31272596), National Technological Supporting Program of China (2011BAD34B02), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abula S, 2011, CARBOHYD POLYM, V85, P687, DOI 10.1016/j.carbpol.2011.03.032; ADETUMBI MA, 1983, MED HYPOTHESES, V12, P227, DOI 10.1016/0306-9877(83)90040-3; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Cao J., 2010, CHINESE FOLK MED, V19, P61; Cui Q, 2003, CHINESE J BIOCH PHAR, V24, P155; Decker T, 2005, NAT REV IMMUNOL, V19, P1; [高建忠 GAO Jianzhong], 2006, [分析科学学报, Journal of Analytical Science], V22, P157; Gong X, 1997, J SHENZHEN U, V14, P68; Guichard E, 2000, FOOD CHEM, V71, P301, DOI 10.1016/S0308-8146(00)00181-3; Guo LW, 2012, INT J BIOL MACROMOL, V50, P512, DOI 10.1016/j.ijbiomac.2012.01.002; Hu Q, 2001, J CHINESE MARINE DRU, V5, P20; Irie T, 2003, DEV COMP IMMUNOL, V27, P413, DOI 10.1016/S0145-305X(02)00137-4; Koch H. P., 1996, GARLIC SCI THERAPEUT, P1; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; LAU BHS, 1983, NUTR RES, V3, P119, DOI 10.1016/S0271-5317(83)80128-6; Li CR, 2007, CELL IMMUNOL, V250, P40, DOI 10.1016/j.cellimm.2008.01.003; [李公斌 Li Gongbin], 2008, [东北林业大学学报, Journal of North-East Forestry University], V36, P66; Li X., 2008, HUBEI J NATL I NATUR, V26, P456; Li X, 2006, CHINESE HERBAL MED, V37, P7; Liang L.J., 2008, THESIS NANCHANG U; Liu J, 2003, BEVE FAST FROZEN FOO, V9, P27; Liu J, 2013, J NUTR, V35, P36; Lu ZQ, 2013, CARBOHYD POLYM, V96, P131, DOI 10.1016/j.carbpol.2013.03.063; Piraprez G, 1998, FOOD CHEM, V61, P119, DOI 10.1016/S0308-8146(97)00120-9; Qin T, 2013, CARBOHYD POLYM, V95, P183, DOI 10.1016/j.carbpol.2013.02.072; Qin T, 2013, CARBOHYD POLYM, V92, P645, DOI 10.1016/j.carbpol.2012.08.097; [邱妍 QIU Yan], 2007, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V38, P723; Staaf M, 2000, CARBOHYD RES, V326, P113, DOI 10.1016/S0008-6215(00)00027-6; Tang J, 1988, BIOCH BIOPHYSICS, V20, P259; Thekisoe MMO, 2004, VET MICROBIOL, V101, P23, DOI 10.1016/j.vetmic.2004.03.011; Veterinary Pharmacopoeia Commission of the People's Republic of China, 2010, VET PHARM PEOPL RE 1, V72-73; Wang DY, 2005, VACCINE, V23, P3704, DOI 10.1016/j.vaccine.2005.02.011; [王红连 WANG Hong-lian], 2009, [食品科学, Food Science], V30, P316; Wang Y., 2009, ANIMAL HUSBANDRY VET, V41, P71; Yang H C, 1997, ANIMAL IMMUNOLOGY, P129; Yang J., 2009, CHINESE PATENT MED, V32, P1065; Yu W., 2009, FOOD SCI TECHNOLOGY, V10, P262; Yu W., 2009, J FOOD SCI TECH MYS, V10, P256; Zhang X., 2000, OCEANOLOGY LIMNOLOGY, V31, P643; Zheng M, 2003, J XIANNING COLL, V17, P85; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	41	33	41	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86377	10.1371/journal.pone.0086377	http://dx.doi.org/10.1371/journal.pone.0086377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497946	Green Published, gold, Green Submitted			2022-12-27	WOS:000330617100014
J	Weston-Bell, NJ; Forconi, F; Kluin-Nelemans, HC; Sahota, SS				Weston-Bell, Nicola J.; Forconi, Francesco; Kluin-Nelemans, Hanneke C.; Sahota, Surinder S.			Variant B Cell Receptor Isotype Functions Differ in Hairy Cell Leukemia with Mutated BRAF and IGHV Genes	PLOS ONE			English	Article							ANTIGEN RECEPTOR; TUMOR-CELLS; ACTIVATION; RAF; IMMUNOGLOBULIN; CD27; SURVIVAL; SIGNALS; PHOSPHORYLATION; INHIBITION	A functional B-cell receptor (BCR) is critical for survival of normal B-cells, but whether it plays a comparable role in B-cell malignancy is as yet not fully delineated. Typical Hairy Cell Leukemia (HCL) is a rare B-cell tumor, and unique in expressing multiple surface immunoglobulin (sIg) isotypes on individual tumor cells (mult-HCL), to raise questions as to their functional relevance. Typical mult-HCL also displays a mutated BRAF V(600) E lesion. Since wild type BRAF is a primary conduit for transducing normal BCR signals, as revealed by deletion modelling studies, it is as yet not apparent if mutated BRAF alters BCR signal transduction in mult-HCL. To address these questions, we examined BCR signalling in mult-HCL cases uniformly displaying mutated BRAF and IGHV genes. Two apparent functional sets were delineated by IgD co-expression. In sIgD(+ve) mult-HCL, IgD mediated persistent Ca2+ flux, also evident via >1 sIgH isotype, linked to increased ERK activation and BCR endocytosis. In sIgD(-ve) mult-HCL however, BCR-mediated signals and downstream effects were restricted to a single sIgH isotype, with sIgM notably dysfunctional and remaining immobilised on the cell surface. These observations reveal discordance between expression and function of individual isotypes in mult-HCL. In dual sIgL expressing cases, only a single sIgL was fully functional. We examined effects of anti-BCR stimuli on mult-HCL survival ex-vivo. Significantly, all functional non-IgD isotypes increased ERK1/2 phosphorylation but triggered apoptosis of tumor cells, in both subsets. IgD stimuli, in marked contrast retained tumor viability. Despite mutant BRAF, BCR signals augment ERK1/2 phosphorylation, but isotype dictates functional downstream outcomes. In mult-HCL, sIgD retains a potential to transduce BCR signals for tumor survival in-vivo. The BCR in mult-HCL emerges as subject to complex regulation, with apparent conflicting signalling by individual isotypes when co-expressed with sIgD. This suggests the possibility that mutant BRAF by-passes BCR constraints in mult-HCL.	[Weston-Bell, Nicola J.; Sahota, Surinder S.] Univ Southampton, Fac Med, Canc Sci Acad Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England; [Forconi, Francesco] Univ Southampton, Fac Med, Canc Sci Acad Unit, Haematol Oncol Grp, Southampton SO9 5NH, Hants, England; [Kluin-Nelemans, Hanneke C.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Haematol, Div Haematol, NL-9713 AV Groningen, Netherlands	University of Southampton; University of Southampton; University of Groningen	Sahota, SS (corresponding author), Univ Southampton, Fac Med, Canc Sci Acad Unit, Tumour Immunogenet Grp, Southampton SO9 5NH, Hants, England.	s.s.sahota@soton.ac.uk	Kluin-Nelemans, Johanna C/F-8658-2018; Forconi, Francesco/AAO-2694-2021	Kluin-Nelemans, Johanna C/0000-0003-2617-9427; Forconi, Francesco/0000-0002-2211-1831; Weston-Bell, Nicola/0000-0003-0075-7276	Leukaemia & Lymphoma Research (UK); Hairy Cell Leukemia Foundation (USA)	Leukaemia & Lymphoma Research (UK); Hairy Cell Leukemia Foundation (USA)	This work was funded by Leukaemia & Lymphoma Research (UK). Additional support funding was provided by the Hairy Cell Leukemia Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Clark MR, 2003, ANN NY ACAD SCI, V987, P26, DOI 10.1111/j.1749-6632.2003.tb06030.x; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; Dietrich S, 2012, NEW ENGL J MED, V366, P2038, DOI 10.1056/NEJMc1202124; Eeva J, 2003, EUR J IMMUNOL, V33, P2783, DOI 10.1002/eji.200324227; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Follows GA, 2013, BRIT J HAEMATOL, V161, P150, DOI 10.1111/bjh.12201; Forconi F, 2005, HAEMATOLOGICA, V90, P266; Forconi F, 2004, BLOOD, V104, P3312, DOI 10.1182/blood-2004-03-0950; Forconi F, 2001, BLOOD, V98, P1174, DOI 10.1182/blood.V98.4.1174; Forconi F, 2011, HEMATOL ONCOL, V29, P55, DOI 10.1002/hon.975; Hase H, 2002, J BIOL CHEM, V277, P46950, DOI 10.1074/jbc.M209050200; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; KIM KM, 1995, J EXP MED, V181, P1005, DOI 10.1084/jem.181.3.1005; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; KLUINNELEMANS HC, 1990, BLOOD, V75, P972; Koncz G, 2002, IMMUNOL LETT, V82, P41, DOI 10.1016/S0165-2478(02)00017-2; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MAYUMI M, 1994, J ALLERGY CLIN IMMUN, V94, P612, DOI 10.1016/0091-6749(94)90137-6; Morabito F, 2010, BRIT J HAEMATOL, V149, P160, DOI 10.1111/j.1365-2141.2009.08032.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petlickovski A, 2005, BLOOD, V105, P4820, DOI 10.1182/blood-2004-07-2669; Peyrade F, 2013, HAEMATOLOGICA, V98, pE20, DOI 10.3324/haematol.2012.082404; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Slupsky JR, 2007, AM J PATHOL, V170, P745, DOI 10.2353/ajpath.2007.060557; Smith SH, 2004, MOL CELL, V14, P696, DOI 10.1016/j.molcel.2004.06.015; Sozzi E, 2011, HEMATOL ONCOL, V29, P31, DOI 10.1002/hon.952; Tiacci E, 2001, NEW ENGL J MED, V364, P2305; Tiacci E, 2013, HAEMATOLOGICA, V98, P635, DOI 10.3324/haematol.2012.078071; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weston-Bell N, 2009, LEUKEMIA, V23, P2075, DOI 10.1038/leu.2009.178; Weston-Bell NJ, 2013, LEUKEMIA, V27, P241, DOI 10.1038/leu.2012.163; Weston-Bell NJ, 2011, BLOOD, V118, P681, DOI 10.1182/blood.V118.21.1567.1567; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	43	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86556	10.1371/journal.pone.0086556	http://dx.doi.org/10.1371/journal.pone.0086556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497953	Green Accepted, gold, Green Published			2022-12-27	WOS:000330617100019
J	de Boer, MJ; Steinhagen, HE; Versteegen, GJ; Struys, MMRF; Sanderman, R				de Boer, Maaike J.; Steinhagen, Hannemike E.; Versteegen, Gerbrig J.; Struys, Michel M. R. F.; Sanderman, Robbert			Mindfulness, Acceptance and Catastrophizing in Chronic Pain	PLOS ONE			English	Article							EXPERIENTIAL AVOIDANCE; MOVEMENT (RE)INJURY; COMMITMENT THERAPY; SCALE; DISABILITY; VALIDATION; MODEL; FEAR	Objectives: Catastrophizing is often the primary target of the cognitive-behavioral treatment of chronic pain. Recent literature on acceptance and commitment therapy (ACT) suggests an important role in the pain experience for the concepts mindfulness and acceptance. The aim of this study is to examine the influence of mindfulness and general psychological acceptance on pain-related catastrophizing in patients with chronic pain. Methods: A cross-sectional survey was conducted, including 87 chronic pain patients from an academic outpatient pain center. Results: The results show that general psychological acceptance (measured with the AAQ-II) is a strong predictor of pain-related catastrophizing, independent of gender, age and pain intensity. Mindfulness (measured with the MAAS) did not predict levels of pain-related catastrophizing. Discussion: Acceptance of psychological experiences outside of pain itself is related to catastrophizing. Thus, acceptance seems to play a role in the pain experience and should be part of the treatment of chronic pain. The focus of the ACT treatment of chronic pain does not necessarily have to be on acceptance of pain per se, but may be aimed at acceptance of unwanted experiences in general. Mindfulness in the sense of "acting with awareness" is however not related to catastrophizing. Based on our research findings in comparisons with those of other authors, we recommend a broader conceptualization of mindfulness and the use of a multifaceted questionnaire for mindfulness instead of the unidimensional MAAS.	[de Boer, Maaike J.; Steinhagen, Hannemike E.; Versteegen, Gerbrig J.; Struys, Michel M. R. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Pain Ctr, Groningen, Netherlands; [Sanderman, Robbert] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands	University of Groningen; University of Groningen	de Boer, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Pain Ctr, Groningen, Netherlands.	m.j.de.boer@umcg.nl	de Boer, M.J./H-8014-2014	Struys, Michel/0000-0003-0421-536X				Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bishop SR, 2002, PSYCHOSOM MED, V64, P71, DOI 10.1097/00006842-200201000-00010; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carlson LE, 2005, J PSYCHOSOM RES, V58, P29, DOI 10.1016/j.jpsychores.2004.04.366; Chiros C, 2011, J BEHAV MED, V34, P307, DOI 10.1007/s10865-011-9313-0; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes S.C., 2004, MINDFULNESS ACCEPTAN; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Jacobs N., 2008, GEDRAGSTHERAPIE, V41, P349; McCracken LM, 2007, PAIN, V131, P63, DOI 10.1016/j.pain.2006.12.013; McCracken LM, 2010, EUR J PAIN, V14, P170, DOI 10.1016/j.ejpain.2009.03.004; McCracken LM, 2009, J PSYCHOPATHOL BEHAV, V31, P75, DOI 10.1007/s10862-008-9099-8; McCracken LM, 1998, PAIN, V74, P21, DOI 10.1016/S0304-3959(97)00146-2; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Schroevers M., 2008, GEDRAGSTHERAPIE, V41, P225; Schutze R, 2010, PAIN, V148, P120, DOI 10.1016/j.pain.2009.10.030; Severeijns R, 2001, CLIN J PAIN, V17, P165, DOI 10.1097/00002508-200106000-00009; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; van Damme S, 2000, GEDRAGSTHERAPIE, V33, P209; Viane I, 2003, PAIN, V106, P65, DOI 10.1016/S0304-3959(03)00291-4; Vlaeyen JWS, 1995, J OCCUP REHABIL, V5, P235, DOI 10.1007/BF02109988; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Wetherell JL, 2011, PAIN, V152, P2098, DOI 10.1016/j.pain.2011.05.016	29	38	38	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87445	10.1371/journal.pone.0087445	http://dx.doi.org/10.1371/journal.pone.0087445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489915	Green Published, gold, Green Submitted			2022-12-27	WOS:000330570000146
J	Rocklin, D; Levrel, H; Drogou, M; Herfaut, J; Veron, G				Rocklin, Delphine; Levrel, Harold; Drogou, Mickael; Herfaut, Johanna; Veron, Gerard			Combining Telephone Surveys and Fishing Catches Self-Report: The French Sea Bass Recreational Fishery Assessment	PLOS ONE			English	Article							LONG-TERM CHANGES; NONRESPONSE BIAS; STOCK ASSESSMENT; RELEASE SCIENCE; HARVEST; MANAGEMENT; MORTALITY; IMPACT; CONSERVATION; KNOWLEDGE	Fisheries statistics are known to be underestimated, since they are mainly based on information about commercial fisheries. However, various types of fishing activities exist and evaluating them is necessary for implementing effective management plans. This paper assesses the characteristics and catches of the French European sea bass recreational fishery along the Atlantic coasts, through the combination of large-scale telephone surveys and fishing diaries study. Our results demonstrated that half of the total catches (mainly small fish) were released at sea and that the mean length of a kept sea bass was 46.6 cm. We highlighted different patterns of fishing methods and type of gear used. Catches from boats were greater than from the shore, both in abundance and biomass, considering mean values per fishing trip as well as CPUE. Spearfishers caught the highest biomass of sea bass per fishing trip, but the fishing rod with lure was the most effective type of gear in terms of CPUE. Longlines had the highest CPUE value in abundance but not in biomass: they caught numerous but small sea bass. Handlines were less effective, catching few sea bass in both abundance and biomass. We estimated that the annual total recreational sea bass catches was 3,173 tonnes of which 2,345 tonnes were kept. Since the annual commercial catches landings were evaluated at 5,160 tonnes, recreational landings represent 30% of the total fishing catches on the Atlantic coasts of France. Using fishers' self-reports was a valuable way to obtain new information on data-poor fisheries. Our results underline the importance of evaluating recreational fishing as a part of the total amount of fisheries catches. More studies are critically needed to assess overall fish resources caught in order to develop effective fishery management tools.	[Rocklin, Delphine] Univ Brest, Observ Sci Univers, Inst Univ Europeen Mer, UMR Amenagement Usages Ressources & Espaces Marin, Brest, France; [Levrel, Harold; Herfaut, Johanna] IFREMER, UMR Amenagement Usages Ressources & Espaces Marin, Unite Econ Maritime, Plouzane, France; [Drogou, Mickael; Veron, Gerard] IFREMER, Dept Ressources Biol & Environm, Unite Sci & Tech Halieut, Plouzane, France	Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Ifremer; Ifremer	Rocklin, D (corresponding author), Univ Brest, Observ Sci Univers, Inst Univ Europeen Mer, UMR Amenagement Usages Ressources & Espaces Marin, Brest, France.	delphine.rocklin@gmail.com	Rocklin, Delphine/G-6359-2012	Rocklin, Delphine/0000-0003-4442-0704; Veron, Gerard/0000-0003-0865-9371; Levrel, Harold/0000-0002-4611-3639	European Union; French "Direction des Peches Maritimes et de l'Aquaculture"; IFREMER	European Union(European Commission); French "Direction des Peches Maritimes et de l'Aquaculture"; IFREMER	This study was carried out thanks to Data Collection Framework fundings of the European Union, the French "Direction des Peches Maritimes et de l'Aquaculture" and IFREMER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts TWPM, 2008, GLOBAL CHALLENGE REC, P39; Aas Oystein, 2008, GLOBAL CHALLENGES RE; Alos J, 2008, ICES J MAR SCI, V65, P899, DOI 10.1093/icesjms/fsn067; Alos J, 2009, FISH RES, V97, P270, DOI 10.1016/j.fishres.2009.03.003; Andrews R, 2012, CHANGES SAMPLING EST; Arlinghaus R, 2008, GLOBAL CHALLENGES RE, P25; Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Bartholomew A, 2005, REV FISH BIOL FISHER, V15, P129, DOI 10.1007/s11160-005-2175-1; Bertignac M., 1987, EXPLOITATION BAR DIC; Bray K, 2000, AUSIUU20066 FAO; Cardona-Pons F, 2010, FISH RES, V106, P575, DOI 10.1016/j.fishres.2010.09.026; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Chuenpagdee R., 2006, FISHERIES CTR RES RE, V14, P112; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Colman Jonathan E., 2008, P111, DOI 10.1002/9780470697597.ch6; Cooke SJ, 2007, FISHERIES MANAG ECOL, V14, P73, DOI 10.1111/j.1365-2400.2007.00527.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Donaldson MR, 2008, FISH FISH, V9, P79, DOI 10.1111/j.1467-2979.2007.00265.x; Dorow M, 2011, AM FISH S S, V75, P319; Douglas J, 2010, FISH RES, V106, P18, DOI 10.1016/j.fishres.2010.06.006; Dowling CE, 2010, HYDROBIOLOGIA, V641, P145, DOI 10.1007/s10750-009-0073-6; Drogou M, 2011, SYNTHESE INFORM DISP; EU, 2004, FISH EUR MED GUAR SU; Euston ET, 2006, AM FISH S S, V51, P295; FAO, 2020, STAT WORLD FISH AQ, DOI 10.4060/ca9229-n; Ferter K, 2013, ICES J MAR SCI, V70, P1319, DOI 10.1093/icesjms/fst104; Fisher MR, 1996, T AM FISH SOC, V125, P118, DOI 10.1577/1548-8659(1996)125&lt;0118:ETEONB&gt;2.3.CO;2; Fraidenburg M.E., 1982, N AM J FISH MANAGE, V2, P351; Frijlink K, 2010, SOCIOECONOMIC ASSESS; Gale MK, 2011, FISH FISH, P1; Gerdeaux D, 2009, FISH RES, V96, P6, DOI 10.1016/j.fishres.2008.09.016; Gomez S, 2006, COAST MANAGE, V34, P217, DOI 10.1080/08920750500531389; Greiner R, 2010, FISHERIES MANAG ECOL, V17, P336, DOI 10.1111/j.1365-2400.2009.00727.x; Griffiths SP, 2013, REV FISH BIOL FISHER, V23, P395, DOI 10.1007/s11160-012-9299-x; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Gutowsky LFG, 2011, FISH RES, V109, P379, DOI 10.1016/j.fishres.2011.02.022; Hall KC, 2009, J FISH BIOL, V75, P2737, DOI 10.1111/j.1095-8649.2009.02474.x; Hartill BW, 2011, N AM J FISH MANAGE, V31, P1197, DOI 10.1080/02755947.2011.646454; Henry GW, 2003, NATL RECREATIONAL IN; Herfaut J, 2013, OCEAN COAST MANAGE, V78, P121, DOI 10.1016/j.ocecoaman.2013.02.026; ICES, 2011, CM2011ACOM23 ICES PG; ICES, 2010, 2010ACOM21 ICES CM; ICES, 2010, 2010ACOM34 ICES PGRF; Ihde TF, 2011, FISH RES, V108, P268, DOI 10.1016/j.fishres.2010.12.016; Johnston FD, 2011, FISH RES, V110, P189, DOI 10.1016/j.fishres.2011.04.006; Kearney R., 2002, RECREATIONAL FISHERI, P17, DOI [10.1002/9780470995402.ch2, DOI 10.1002/9780470995402.CH2]; Klefoth T, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011072; Landsman SJ, 2011, FISH RES, V110, P377, DOI 10.1016/j.fishres.2011.05.005; Le Floc'h P, 2008, AQUAT LIVING RESOUR, V21, P307, DOI 10.1051/alr:2008047; Le Guennec J, 2002, INS METH ACT JOURN M; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lyle J.M., 2002, RECREATIONAL FISHERI, P207; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; NMFS, 2012, MAR RECR FISH STAT S; NOAA, 2011, MAR RECR INF PROGR I; Normandeau Associates, 2007, ASS SPRING 2005 HUDS; NRC, 1999, SUST MAR FISH; NRC (National Research Council), 2006, REV RECR FISH SURV M, DOI 10.17226/11616; ONEIL MJ, 1979, PUBLIC OPIN QUART, V43, P218, DOI 10.1086/268513; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pawson MG, 2007, ICES J MAR SCI, V64, P332, DOI 10.1093/icesjms/fsl035; Pickett G., 1994, SEA BASS BIOL EXPLOI; Pitcher T.J., 2002, RECREATIONAL FISHERI, P53; Pitcher T.J., 2002, RECREATIONAL FISHERI, P1; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Pollock Kenneth H., 1997, North American Journal of Fisheries Management, V17, P11, DOI 10.1577/1548-8675(1997)017&lt;0011:CREFRA&gt;2.3.CO;2; R Development Core Team, 2011, R LANG ENV STAT COMP; Rangel MO, 2007, FISHERIES MANAG ECOL, V14, P343, DOI 10.1111/j.1365-2400.2007.00560.x; Reid DD, 2008, RECREATIONAL FISHERI, P13; Rocklin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023820; Rudd MA, 2002, RECREATIONAL FISHERI, P34, DOI DOI 10.1002/9780470995402.CH3; Salz RJ, 2011, NONRESPONSE BIAS STU; Sautory O, 1993, MACRO CALMAR REDRESS; Singh R, 2009, J ENVIRON ECON MANAG, V58, P72, DOI 10.1016/j.jeem.2008.08.005; Steinmetz F, 2008, AQUAT LIVING RESOUR, V21, P317, DOI 10.1051/alr:2008048; Strehlow HV, 2012, ICES J MAR SCI, V69, P1769, DOI 10.1093/icesjms/fss152; Thomson CJ, 1991, EFFECTS AVIDITY BIAS, V12, P356; Unal V, 2010, MEDITERR MAR SCI, V11, P315, DOI 10.12681/mms.79; Veiga P, 2010, J FISH BIOL, V76, P2216, DOI 10.1111/j.1095-8649.2010.02665.x; Wallmo K, 2008, N AM J FISH MANAGE, V28, P1459, DOI 10.1577/M07-062.1; Wilberg MJ, 2009, FISH RES, V99, P239, DOI 10.1016/j.fishres.2009.06.008; Zeller D, 2008, FISH RES, V91, P88, DOI 10.1016/j.fishres.2007.11.010; Zeller D, 2007, HIST CATCH RECONSTRU	85	35	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87271	10.1371/journal.pone.0087271	http://dx.doi.org/10.1371/journal.pone.0087271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489885	Green Published, gold			2022-12-27	WOS:000330570000127
J	Shive, HR; West, RR; Embree, LJ; Golden, CD; Hickstein, DD				Shive, Heather R.; West, Robert R.; Embree, Lisa J.; Golden, Champa D.; Hickstein, Dennis D.			brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish	PLOS ONE			English	Article							BREAST-CANCER; GENETIC-HETEROGENEITY; MUTATOR PHENOTYPE; OVARIAN-CANCER; TUMOR TYPES; MUTATIONS; P53	Germline mutations in the tumor suppressor genes BRCA2 and TP53 significantly influence human cancer risk, and cancers from humans who inherit one mutant allele for BRCA2 or TP53 often display loss of the wildtype allele. In addition, BRCA2-associated cancers often exhibit mutations in TP53. To determine the relationship between germline heterozygous mutation (haploinsufficiency) and somatic loss of heterozygosity (LOH) for BRCA2 and TP53 in carcinogenesis, we analyzed zebrafish with heritable mutations in these two genes. Tumor-bearing zebrafish were examined by histology, and normal and neoplastic tissues were collected by laser-capture microdissection for LOH analyses. Zebrafish on a heterozygous tp53(M214K) background had a high incidence of malignant tumors. The brca2(Q658X) mutation status determined both the incidence of LOH and the malignant tumor phenotype. LOH for tp53 occurred in the majority of malignant tumors from brca2 wildtype and heterozygous mutant zebrafish, and most of these were malignant peripheral nerve sheath tumors. Malignant tumors in zebrafish with heterozygous mutations in both brca2 and tp53 frequently displayed LOH for both genes. In contrast, LOH for tp53 was uncommon in malignant tumors from brca2 homozygotes, and these tumors were primarily undifferentiated sarcomas. Thus, carcinogenesis in zebrafish with combined mutations in tp53 and brca2 typically requires biallelic mutation or loss of at least one of these genes, and the specific combination of inherited mutations influences the development of LOH and the tumor phenotype. These results provide insight into cancer development associated with heritable BRCA2 and TP53 mutations.	[Shive, Heather R.; West, Robert R.; Embree, Lisa J.; Golden, Champa D.; Hickstein, Dennis D.] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shive, HR (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	shiveh@mail.nih.gov		West, Robert/0000-0002-2079-0922	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010549] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Birkbak NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080023; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; Dworkin AM, 2009, FAM CANCER, V8, P339, DOI 10.1007/s10689-009-9240-1; Feitsma H, 2008, CANCER RES, V68, P5059, DOI 10.1158/0008-5472.CAN-08-0019; Greenblatt MS, 2001, CANCER RES, V61, P4092; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Norquist BM, 2010, CANCER-AM CANCER SOC, V116, P5261, DOI 10.1002/cncr.25439; Ramus SJ, 1999, GENE CHROMOSOME CANC, V25, P91, DOI 10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Rowley M, 2011, GASTROENTEROLOGY, V140, P1303, DOI 10.1053/j.gastro.2010.12.039; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Schmitt MW, 2012, ANN NY ACAD SCI, V1267, P110, DOI 10.1111/j.1749-6632.2012.06590.x; Shive HR, 2010, P NATL ACAD SCI USA, V107, P19350, DOI 10.1073/pnas.1011630107; Tutt ANJ, 2002, EMBO REP, V3, P255, DOI 10.1093/embo-reports/kvf037; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	27	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87177	10.1371/journal.pone.0087177	http://dx.doi.org/10.1371/journal.pone.0087177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489863	Green Published, gold			2022-12-27	WOS:000330570000113
J	Tavano, A; Pesarin, A; Murino, V; Cristani, M				Tavano, Alessandro; Pesarin, Anna; Murino, Vittorio; Cristani, Marco			Automatic Conversational Scene Analysis in Children with Asperger Syndrome/High-Functioning Autism and Typically Developing Peers	PLOS ONE			English	Article							RESONANCE; SPEECH; INFANTS; MIND	Individuals with Asperger syndrome/High Functioning Autism fail to spontaneously attribute mental states to the self and others, a life-long phenotypic characteristic known as mindblindness. We hypothesized that mindblindness would affect the dynamics of conversational interaction. Using generative models, in particular Gaussian mixture models and observed influence models, conversations were coded as interacting Markov processes, operating on novel speech/silence patterns, termed Steady Conversational Periods (SCPs). SCPs assume that whenever an agent's process changes state (e. g., from silence to speech), it causes a general transition of the entire conversational process, forcing inter-actant synchronization. SCPs fed into observed influence models, which captured the conversational dynamics of children and adolescents with Asperger syndrome/High Functioning Autism, and age-matched typically developing participants. Analyzing the parameters of the models by means of discriminative classifiers, the dialogs of patients were successfully distinguished from those of control participants. We conclude that meaning-free speech/silence sequences, reflecting inter-actant synchronization, at least partially encode typical and atypical conversational dynamics. This suggests a direct influence of theory of mind abilities onto basic speech initiative behavior.	[Tavano, Alessandro] Univ Leipzig, Inst Psychol, D-04109 Leipzig, Germany; [Tavano, Alessandro] Sci Inst E Medea, San Vito Al Tagliamento, Pordenone, Italy; [Pesarin, Anna; Cristani, Marco] Univ Verona, Dept Comp Sci, I-37100 Verona, Italy; [Murino, Vittorio; Cristani, Marco] Italian Inst Technol, Genoa, Italy	Leipzig University; IRCCS Eugenio Medea; University of Verona; Istituto Italiano di Tecnologia - IIT	Cristani, M (corresponding author), Univ Verona, Dept Comp Sci, I-37100 Verona, Italy.	marco.cristani@univr.it		Murino, Vittorio/0000-0002-8645-2328; Tavano, Alessandro/0000-0002-2096-5542	Italian Ministry of Health, "E. Medea" Research Institute [3:06]; University of Leipzig by a DFG (German Research Foundation)	Italian Ministry of Health, "E. Medea" Research Institute; University of Leipzig by a DFG (German Research Foundation)	The study was funded by the Italian Ministry of Health (www.salute.gov.it) as part of a two-year project on "Neurorehabilitation of prosodic and pragmatic skills in individuals with High-functioning Autism, Specific Language Impairment and Williams syndrome", Principal Investigator Alessandro Tavano, RC-2007/8, 3:06, "E. Medea" Research Institute. Alessandro Tavano was also supported at the University of Leipzig by a DFG (German Research Foundation) Reinhart-Koselleck Project grant, awarded to Professor E. Schroger. Psychologist Elisa Cravello was employed within the project for data analysis purposes and participated to the present study acting as the adult conversational partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056; Aitchison J, 2008, ARTICULATE MAMMAL IN; [Anonymous], 19 INT C PATT REC IC; Asavathiratham C., 2000, THESIS MIT; Austin J. L., 1946, P ARISTOTELIAN SOC, V20, P148, DOI DOI 10.1093/019283021X.001.0001; Basu S., 2001, 539 MIT MEDIALAB; Bilmes JA, 1997, ICSITR97021; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Cristani M, 2011, PATTERN RECOGN, V44, P1785, DOI 10.1016/j.patcog.2011.01.013; Duda R.O., 2006, PATTERN CLASSIFICATI; Duin R, 2004, PRTOOLS VERS 4 1 MAT; Fisher JW, 2004, IEEE T MULTIMEDIA, V6, P406, DOI 10.1109/TMM.2004.827503; Frith CD, 2008, PHILOS T R SOC B, V363, P3875, DOI 10.1098/rstb.2008.0156; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Frith U., 2003, AUTISM EXPLAINING EN; Goldinger SD, 2004, BEHAV BRAIN SCI, V27, P199, DOI 10.1017/S0140525X04320054; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Grice Paul., 1989, STUDIES WAY WORDS; Heilmann J, 2013, AM J SPEECH-LANG PAT, V22, P463, DOI 10.1044/1058-0360(2012/11-0035); Hird K, 2002, BRAIN LANG, V80, P536, DOI 10.1006/brln.2001.2613; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jaakkola TS, 1999, ADV NEUR IN, V11, P487; Korkman M, 2011, NEPSY 2 DEV NEUROPSY; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lewis A., 2004, BRIT J LEARN DISABIL, V32, P191, DOI DOI 10.1111/J.1468-3156.2004.00313.X; Lord C., 2005, AUTISM DIAGNOSTIC OB; Manning C.D., 1999, FDN STAT NATURAL LAN; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Miller G, 2005, SCIENCE, V308, P945, DOI 10.1126/science.308.5724.945; Miller VH, 2008, BIOL CYBERN, V99, P459, DOI 10.1007/s00422-008-0253-x; NARENDRA P, 1977, IEEE T COMPUT, V26, P917, DOI 10.1109/TC.1977.1674939; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perina A., 2009, ADV NEURAL INFORM PR, P1428; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Schiller NO, 2004, BEHAV BRAIN SCI, V27, P208, DOI 10.1017/S0140525X0441005X; Schopler E, 1980, J AUTISM DEV DISORD, V10, P91103; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Smith N., 2001, NIPS, P1197; Solomon M, 2004, J AUTISM DEV DISORD, V34, P649, DOI 10.1007/s10803-004-5286-y; Stambak M, 1980, PROVE RITMO; Talwar V, 2007, DEV PSYCHOL, V43, P804, DOI 10.1037/0012-1649.43.3.804; Tavano A, 2013, MEC PROTOCOLLO MONTR; Tsuda K, 2002, NEURAL COMPUT, V14, P2397, DOI 10.1162/08997660260293274; Uchiyama HT, 2012, CORTEX, V48, P563, DOI 10.1016/j.cortex.2011.01.004; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WARNER RM, 1983, J APPL PHYSIOL, V54, P1324, DOI 10.1152/jappl.1983.54.5.1324; Wechsler D., 1986, WECHSLER INTELLIGENC; Williams DM, 2012, DEV PSYCHOPATHOL, V24, P225, DOI 10.1017/S0954579411000794; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Zion-Golumbic E, 2012, TRENDS COGN SCI, V16, P363, DOI 10.1016/j.tics.2012.05.004	60	1	1	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e85819	10.1371/journal.pone.0085819	http://dx.doi.org/10.1371/journal.pone.0085819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301ZC	24489674	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000018
J	Xiao, Y; Yin, J; Wei, J; Shang, Z				Xiao, Yi; Yin, Jin; Wei, Jia; Shang, Zhen			Incidence and Risk of Cardiotoxicity Associated with Bortezomib in the Treatment of Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							STEM-CELL TRANSPLANTATION; PEGYLATED LIPOSOMAL DOXORUBICIN; THALIDOMIDE PLUS DEXAMETHASONE; DIAGNOSED MULTIPLE-MYELOMA; RANDOMIZED PHASE-III; INDUCTION TREATMENT; DOSE DEXAMETHASONE; CARDIAC-FAILURE; COMBINATION; MELPHALAN	Background: We conducted a systematic review and meta-analysis to clarify the incidence and risk of cardiotoxicity associated with bortezomib in cancer patients. Methods: Databases from PubMed, Web of Science and abstracts presented at ASCO meeting up to July 31, 2013 were searched to identify relevant studies. Eligible studies included prospective phase II and III trials evaluating bortezomib in cancer patients with adequate data on cardiotoxicity. Statistical analyses were conducted to calculate the summary incidence, odds ratio (OR) and 95% confidence intervals (CIs) by using either random effects or fixed effect models according to the heterogeneity of included studies. Results: A total of 5718 patients with a variety of malignancies from 25 clinical trials were included in our analysis. The incidence of all-grade and high-grade cardiotoxicity associated with bortezomib was 3.8% (95% CI: 2.6-5.6%) and 2.3% (1.63.5%), with a mortality of 3.0% (1.4-6.5%). Patients treated with bortezomib did not significantly increase the risk of all-grade (OR 1.15, 95% CI: 0.82-1.62, p = 0.41) and high-grade (OR 1.13, 95% CI: 0.58-2.24, p = 0.72) cardiotoxicity compared with patients treated with control medication. Sub-group analysis showed that the incidence of cardiotoxicity varied with tumor types, treatment regimens and phases of trials. No evidence of publication bias was observed. Conclusions: The use of bortezomib does not significantly increase the risk of cardiotoxicity compared to control patients. Further studies are recommended to investigate this association and risk differences among different tumor types, treatment regimens and phases of trials.	[Xiao, Yi; Yin, Jin; Wei, Jia; Shang, Zhen] Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Xiao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Hematol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	xiaoyi130929@163.com			Natural Science Foundation of Hubei Province [2012FFB02435]; central university [2013QN191]	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); central university	The study was supported by grants from the Natural Science Foundation of Hubei Province (No. 2012FFB02435) and the central university special funding (No. 2013QN191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; [Anonymous], 2008, VELCADE LABEL ACCESS; Baiz D, 2009, BIOCHIMIE, V91, P373, DOI 10.1016/j.biochi.2008.10.015; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belch A, 2007, ANN ONCOL, V18, P116, DOI 10.1093/annonc/mdl316; Besse B, 2012, LUNG CANCER, V76, P78, DOI 10.1016/j.lungcan.2011.09.006; Bockorny M, 2012, ACTA HAEMATOL-BASEL, V128, P244, DOI 10.1159/000340050; Bringhen S, 2010, BLOOD, V116, P4745, DOI 10.1182/blood-2010-07-294983; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Chanan-Khan Asher, 2004, J Support Oncol, V2, P251; Charaf E, 2009, CURR CARDIOL REV, V5, P228, DOI 10.2174/157340309788970360; Chen CI, 2007, J CLIN ONCOL, V25, P1570, DOI 10.1200/JCO.2006.07.8659; Coiffier B, 2011, LANCET ONCOL, V12, P773, DOI 10.1016/S1470-2045(11)70150-4; Dispenzieri A, 2010, LEUKEMIA, V24, P1406, DOI 10.1038/leu.2010.129; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Galimberti S, 2008, LEUKEMIA RES, V32, P103, DOI 10.1016/j.leukres.2007.05.023; Garderet L, 2012, J CLIN ONCOL, V30, P2475, DOI 10.1200/JCO.2011.37.4918; Gupta A, 2012, CARDIOVASC TOXICOL, V12, P184, DOI 10.1007/s12012-011-9146-7; Hacihanefioglu A, 2008, INT J HEMATOL, V88, P219, DOI 10.1007/s12185-008-0139-7; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Hjorth M, 2012, EUR J HAEMATOL, V88, P485, DOI 10.1111/j.1600-0609.2012.01775.x; Houot R, 2012, ANN ONCOL, V23, P1555, DOI 10.1093/annonc/mdr450; Jakubowiak AJ, 2009, J CLIN ONCOL, V27, P5015, DOI 10.1200/JCO.2008.19.5370; Jancso G, 2005, J CARDIOVASC PHARM, V46, P295, DOI 10.1097/01.fjc.0000175240.64444.68; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Lu GR, 2008, CANCER BIOL THER, V7, P603, DOI 10.4161/cbt.7.4.5564; Mateos MV, 2006, BLOOD, V108, P2165, DOI 10.1182/blood-2006-04-019778; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreau P, 2011, BLOOD, V118, P5752, DOI 10.1182/blood-2011-05-355081; NCI, 2006, CANC THER EV PROGR C; Nowis D, 2010, AM J PATHOL, V176, P2658, DOI 10.2353/ajpath.2010.090690; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Palumbo A, 2008, ANN ONCOL, V19, P1160, DOI 10.1093/annonc/mdn018; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Paramore A, 2003, NAT REV DRUG DISCOV, V2, P611, DOI 10.1038/nrd1159; Parma G, 2012, INT J GYNECOL CANCER, V22, P792, DOI 10.1097/IGC.0b013e318251051a; Popat R, 2009, BRIT J HAEMATOL, V144, P887, DOI 10.1111/j.1365-2141.2008.07572.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Ruan J, 2011, J CLIN ONCOL, V29, P690, DOI 10.1200/JCO.2010.31.1142; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Suvannasankha A, 2006, CLIN LYMPHOMA MYELOM, V7, P131, DOI 10.3816/CLM.2006.n.050; Takamatsu H, 2010, INT J HEMATOL, V91, P903, DOI 10.1007/s12185-010-0586-9; Versari D, 2006, ARTERIOSCL THROM VAS, V26, P2132, DOI 10.1161/01.ATV.0000232501.08576.73; Voortman J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-129; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	51	71	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e87671	10.1371/journal.pone.0087671	http://dx.doi.org/10.1371/journal.pone.0087671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489948	Green Submitted, Green Published, gold			2022-12-27	WOS:000330570000168
J	Biere, L; Donal, E; Terrien, G; Kervio, G; Willoteaux, S; Furber, A; Prunier, F				Biere, Loic; Donal, Erwan; Terrien, Gwenola; Kervio, Gaelle; Willoteaux, Serge; Furber, Alain; Prunier, Fabrice			Longitudinal Strain Is a Marker of Microvascular Obstruction and Infarct Size in Patients with Acute ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR FUNCTION; WALL-MOTION SCORE; 2-DIMENSIONAL STRAIN; CLINICAL-IMPLICATIONS; EJECTION FRACTION; QUANTIFICATION; REPERFUSION; VALIDATION; ANGIOPLASTY	Objectives: We assessed the value of speckle tracking imaging performed early after a first ST-segment elevation myocardial infarction (STEMI) in order to predict infarct size and functional recovery at 3-month follow-up. Methods: 44 patients with STEMI who underwent revascularization within 12 h of symptom onset were prospectively enrolled. Echocardiography was performed 3.9 +/- 1.2 days after myocardial reperfusion, assessing circumferential (CGS), radial (RGS), and longitudinal global (GLS) strains. Late gadolinium-enhanced cardiac magnetic imaging (CMR), for assessing cardiac function, infarct size, and microvascular obstruction (MVO), was conducted 5.6 +/- 2.5 days and 99.4 +/- 4.6 days after myocardial reperfusion. Results: GLS was evaluable in 97% of the patients, while CGS and RGS could be assessed in 85%. Infarct size significantly correlated with GLS (R = 0.601, p < 0.001), RGS (R = -0.405, p = 0.010), CGS (R = 0.526, p = 0.001), ejection fraction (R = -0.699, p < 0.001), wall motion score index (WMSI) (R = 0.539, p = 0.001), and left atrial volume (R = 0.510, p < 0.001). Baseline ejection fraction and GLS were independent predictors of 3-month infarct size. MVO mass significantly correlated with GLS (R = 0.376, p = 0.010), WMSI (R = 0.387, p = 0.011), and ejection fraction (R = -0.389, p = 0.011). In multivariate analysis, GLS was the only independent predictor of MVO mass (p = 0.015). Longitudinal strain >-6.0% within the infarcted area exhibited 96% specificity and 61% sensitivity for predicting the persistence of akinesia (>= 3 segments) at 3-month follow-up. Conclusions: Speckle-tracking strain imaging performed early after a STEMI is easy-to-use as a marker for persistent akinetic territories at 3 months. In addition, GLS correlated significantly with MVO and final infarct size, both parameters being relevant post-MI prognostic factors, usually obtained via CMR.	[Biere, Loic; Terrien, Gwenola; Willoteaux, Serge; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France; [Biere, Loic; Terrien, Gwenola; Furber, Alain; Prunier, Fabrice] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Cardiol, Angers, France; [Donal, Erwan; Kervio, Gaelle] CHU Rennes, Serv Cardiol, Rennes, France; [Donal, Erwan; Kervio, Gaelle] CHU Rennes, CIC IT 804, Rennes, France; [Donal, Erwan; Kervio, Gaelle] INSERM, U1099, Lab Traitement Signal & Image, Rennes, France; [Willoteaux, Serge] Univ Angers, CHU Angers, Lab Cardioprotect Remodelage & Thrombose, UPRES,EA3860,Serv Radiol, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	FaPrunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; donal, erwan/ABC-9736-2020					Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Antoni ML, 2010, EUR HEART J, V31, P1640, DOI 10.1093/eurheartj/ehq105; Bergerot C, 2010, EUR HEART J, V31, P1060; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chan J, 2006, J AM COLL CARDIOL, V48, P2026, DOI 10.1016/j.jacc.2006.07.050; Cimino S, 2013, EUR HEART J-CARD IMG, V14, P805, DOI 10.1093/ehjci/jes295; Gerber B L, 2000, Top Magn Reson Imaging, V11, P372, DOI 10.1097/00002142-200012000-00006; Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734; Gerber BL, 2002, CIRCULATION, V106, P1083, DOI 10.1161/01.CIR.0000027818.15792.1E; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; Grabka M, 2013, CORONARY ARTERY DIS, V24, P127, DOI 10.1097/MCA.0b013e32835b6798; Hanekom L, 2005, CIRCULATION, V112, P3892, DOI 10.1161/CIRCULATIONAHA.104.489310; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Ingul CB, 2005, J AM SOC ECHOCARDIOG, V18, P411, DOI 10.1016/j.echo.2005.01.032; KAN G, 1986, BRIT HEART J, V56, P422; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Mollema SA, 2009, HEART, V95, P1732, DOI 10.1136/hrt.2008.161836; Mollema SA, 2010, CIRC-CARDIOVASC IMAG, V3, P15, DOI 10.1161/CIRCIMAGING.108.802785; Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042; Munk K, 2010, CIRC-CARDIOVASC IMAG, V3, P656, DOI 10.1161/CIRCIMAGING.110.957340; Ortiz-Perez JT, 2008, JACC-CARDIOVASC IMAG, V1, P282, DOI 10.1016/j.jcmg.2008.01.014; Park YH, 2008, J AM SOC ECHOCARDIOG, V21, P262, DOI 10.1016/j.echo.2007.08.026; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Reant P, 2008, J AM COLL CARDIOL, V51, P149, DOI 10.1016/j.jacc.2007.07.088; Reant P, 2012, J AM SOC ECHOCARDIOG, V25, P68, DOI 10.1016/j.echo.2011.10.009; Savoye C, 2006, AM J CARDIOL, V98, P1144, DOI 10.1016/j.amjcard.2006.06.011; Sjoli B, 2009, JACC-CARDIOVASC IMAG, V2, P24, DOI 10.1016/j.jcmg.2008.10.007; Solomon SD, 2005, CIRCULATION, V111, P3411, DOI 10.1161/CIRCULATIONAHA.104.508093; SUTTON JM, 1994, CIRCULATION, V89, P1126, DOI 10.1161/01.CIR.89.3.1126; Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejcts.2004.11.026; Vartdal T, 2007, J AM COLL CARDIOL, V49, P1715, DOI 10.1016/j.jacc.2006.12.047; Wu KC, 1998, J AM COLL CARDIOL, V32, P1756, DOI 10.1016/S0735-1097(98)00429-X; Wu KC, 1999, CURR OPIN CARDIOL, V14, P480, DOI 10.1097/00001573-199911000-00005; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Zhang Y, 2005, J AM COLL CARDIOL, V46, P864, DOI 10.1016/j.jacc.2005.05.054	41	26	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86959	10.1371/journal.pone.0086959	http://dx.doi.org/10.1371/journal.pone.0086959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489816	Green Published, gold			2022-12-27	WOS:000330510000094
J	Bokenkamp, R; van Brempt, R; van Munsteren, JC; van den Wijngaert, I; de Hoogt, R; Finos, L; Goeman, J; Gittenberger-de Groot, AC; Poelmann, RE; Blom, NA; DeRuiter, MC				Bokenkamp, Regina; van Brempt, Ronald; van Munsteren, Jacoba Cornelia; van den Wijngaert, Ilse; de Hoogt, Ronald; Finos, Livio; Goeman, Jelle; Gittenberger-de Groot, Adriana Cornelia; Poelmann, Robert Eugen; Blom, Nicolaas Andreas; DeRuiter, Marcus Cornelis			Dlx1 and Rgs5 in the Ductus Arteriosus: Vessel-Specific Genes Identified by Transcriptional Profiling of Laser-Capture Microdissected Endothelial and Smooth Muscle Cells	PLOS ONE			English	Article							HOMEOBOX GENES; EXPRESSION; PROTEIN; DIFFERENTIATION; MUTATIONS; PATHWAY; SYSTEM; TISSUE; ARTERY	Closure of the ductus arteriosus (DA) is a crucial step in the transition from fetal to postnatal life. Patent DA is one of the most common cardiovascular anomalies in children with significant clinical consequences especially in premature infants. We aimed to identify genes that specify the DA in the fetus and differentiate it from the aorta. Comparative microarray analysis of laser-captured microdissected endothelial (ECs) and vascular smooth muscle cells (SMCs) from the DA and aorta of fetal rats (embryonic day 18 and 21) identified vessel-specific transcriptional profiles. We found a strong age-dependency of gene expression. Among the genes that were upregulated in the DA the regulator of the G-protein coupled receptor 5 (Rgs5) and the transcription factor distal-less homeobox 1 (Dlx1) exhibited the highest and most significant level of differential expression. The aorta showed a significant preferential expression of the Purkinje cell protein 4 (Pcp4) gene. The results of the microarray analysis were validated by real-time quantitative PCR and immunohistochemistry. Our study confirms vessel-specific transcriptional profiles in ECs and SMCs of rat DA and aorta. Rgs5 and Dlx1 represent novel molecular targets for the regulation of DA maturation and closure.	[Bokenkamp, Regina; Blom, Nicolaas Andreas] Leiden Univ, Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands; [Bokenkamp, Regina; van Brempt, Ronald] Leiden Univ, Dept Intens Care, Med Ctr, Leiden, Netherlands; [van Brempt, Ronald; van den Wijngaert, Ilse; de Hoogt, Ronald] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium; [van Munsteren, Jacoba Cornelia; Gittenberger-de Groot, Adriana Cornelia; Poelmann, Robert Eugen; DeRuiter, Marcus Cornelis] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Finos, Livio] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Goeman, Jelle] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Gittenberger-de Groot, Adriana Cornelia] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johnson & Johnson; Janssen Pharmaceuticals; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bokenkamp, R (corresponding author), Leiden Univ, Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands.	r.bokenkamp@lumc.nl	Finos, Livio/AAQ-6411-2020; Goeman, Jelle/AAT-1300-2020	Finos, Livio/0000-0003-3181-8078; Goeman, Jelle/0000-0003-4283-0259	Madeleine Schickedanz-KinderKrebs-Stiftung	Madeleine Schickedanz-KinderKrebs-Stiftung	This work was supported by the Madeleine Schickedanz-KinderKrebs-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bergwerff M, 1996, ANAT EMBRYOL, V194, P545; Bergwerff M, 2000, VIRCHOWS ARCH, V436, P12, DOI 10.1007/PL00008193; Bergwerff M, 1998, CIRC RES, V82, P221; Bhandari V, 2009, PEDIATRICS, V123, P669, DOI 10.1542/peds.2008-1117; Bokenkamp R, 2009, NEONATOLOGY, V98; Bokenkamp R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023975; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Coceani F, 2011, J PHYSIOL SCI, V61, P443, DOI 10.1007/s12576-011-0161-z; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Dagle JM, 2009, PEDIATRICS, V123, P1116, DOI 10.1542/peds.2008-0313; DERUITER MC, 1989, ANAT EMBRYOL, V179, P319; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fowlie PW, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000174.pub2; Fox J., 2011, R COMPANION APPL REG, Vsecond, P1; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hong ZG, 2006, CIRCULATION, V114, P1372, DOI 10.1161/CIRCULATIONAHA.106.641126; Huber A, 2005, OBSTET GYNECOL, V105, P91, DOI 10.1097/01.AOG.0000146636.61611.e3; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Lee SY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-113; LEWIS AB, 1978, J PEDIATR-US, V93, P481, DOI 10.1016/S0022-3476(78)81171-8; Momma K, 2003, PEDIATR RES, V53, P479, DOI 10.1203/01.PDR.0000049516.70216.2E; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Moser M, 2003, LAB INVEST, V83, P571, DOI 10.1097/01.LAB.0000064703.92382.50; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Paulsen SJ, 2011, METHODS MOL BIOL, V789, P127, DOI 10.1007/978-1-61779-310-3_7; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Slomp J, 1997, DIFFERENTIATION, V61, P305, DOI 10.1046/j.1432-0436.1997.6150305.x; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Starkova J, 2011, HAEMATOL-HEMATOL J, V96, P820, DOI 10.3324/haematol.2010.031179; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Waleh N, 2010, PEDIATR RES, V68, P292, DOI 10.1203/00006450-201011001-00571; Wang X, 2008, J MOL CELL CARDIOL, V44, P539, DOI 10.1016/j.yjmcc.2007.11.019; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; ZHANG HL, 2011, CHINESE J HYDRODYNAM, V26, P1; Zhao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022908	45	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86892	10.1371/journal.pone.0086892	http://dx.doi.org/10.1371/journal.pone.0086892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489801	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000086
J	de Oliveira, IT; Dias, JG; Padmadas, SS				de Oliveira, Isabel Tiago; Dias, Jose G.; Padmadas, Sabu S.			Dominance of Sterilization and Alternative Choices of Contraception in India: An Appraisal of the Socioeconomic Impact	PLOS ONE			English	Article							SON PREFERENCE; MARRIED-WOMEN; FAMILY; EMERGENCY	Background: The recent decline in fertility in India has been unprecedented especially in southern India, where fertility is almost exclusively controlled by means of permanent contraceptive methods, mainly female sterilization, which constitutes about two-thirds of overall contraceptive use. Many Indian women undergo sterilization at relatively young ages as a consequence of early marriage and childbearing in short birth intervals. This research aims to investigate the socioeconomic factors determining the choices for alternative contraceptive choices against the dominant preference for sterilization among married women in India. Methods: Data for this study are drawn from the 2005-06 National Family Health Surveys focusing on a sample of married women who reported having used a method of contraception in the five years preceding the survey. A multilevel multinomial logit regression is used to estimate the impact of socioeconomic factors on contraceptive choices, differentiating temporary modern or traditional methods versus sterilization. Findings: Religious affiliation, women's education and occupation had overarching influence on method choices amongst recent users. Muslim women were at higher odds of choosing a traditional or modern temporary method than sterilization. Higher level of women's education increased the odds of modern temporary method choices but the education effect on traditional method choices was only marginally significant. Recent users belonging to wealthier households had higher odds of choosing modern methods over sterilization. Exposure to family planning messages through radio had a positive effect on modern and traditional method choices. Community variations in method choices were highly significant. Conclusion: The persistent dominance of sterilization in the Indian family planning programme is largely determined by socioeconomic conditions. Reproductive health programmes should address the socioeconomic barriers and consider multiple cost-effective strategies such as mass media to promote awareness of modern temporary methods.	[de Oliveira, Isabel Tiago; Dias, Jose G.] Inst Univ Lisboa ISCTE IUL, CIES IUL, Lisbon, Portugal; [Padmadas, Sabu S.] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; [Padmadas, Sabu S.] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	Instituto Universitario de Lisboa; University of Southampton; University of Southampton	de Oliveira, IT (corresponding author), Inst Univ Lisboa ISCTE IUL, CIES IUL, Lisbon, Portugal.	Isabel.Oliveira@iscte.pt	Dias, José G./N-6217-2015; Oliveira, Isabel/AAE-4688-2022	Oliveira, Isabel/0000-0002-9350-4130; Padmadas, Sabu/0000-0002-6538-9374; Dias, Jose G./0000-0003-4732-7230	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/CS-DEM/108033/2008]; Fundação para a Ciência e a Tecnologia [PTDC/CS-DEM/108033/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by the Fundacao para a Ciencia e Tecnologia (Portugal), Grant PTDC/CS-DEM/108033/2008. URL: http://www.fct.pt/index.phtml.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold F, 1998, POP STUD-J DEMOG, V52, P301, DOI 10.1080/0032472031000150486; BARU R, 2010, EC POLITIC WKLY, V65, P49; BASU AM, 1985, ECON POLIT WEEKLY, V20, P422; Berg E, 2010, INDIAS POOR RELY MAI; Bose A, 1993, INDIA ASIAN POPULATI; Chacko E, 2001, HEALTH PLACE, V7, P197, DOI 10.1016/S1353-8292(01)00009-0; Clark S, 2000, DEMOGRAPHY, V37, P95, DOI 10.2307/2648099; GWATKIN DR, 1979, POPUL DEV REV, V5, P29, DOI 10.2307/1972317; Harkavy O., 2007, GLOBAL FAMILY PLANNI, P301; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Iyer S, 2002, J SCI STUD RELIG, V41, P711, DOI 10.1111/1468-5906.00156; Jayaraman A, 2009, INT PERSPECT SEX R H, V35, P29, DOI 10.1363/ifpp.35.029.09; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Koenig MA, 2000, STUD FAMILY PLANN, V31, P1, DOI 10.1111/j.1728-4465.2000.00001.x; Kumar M, 2011, J SEX MED, V8, P376, DOI 10.1111/j.1743-6109.2010.02047.x; Leon Federico R., 2011, OPEN FAMILY STUDIES, V4, P1; McNay K, 2003, POP STUD-J DEMOG, V57, P21, DOI 10.1080/0032472032000061703; Mistry R, 2009, SOC SCI MED, V69, P926, DOI 10.1016/j.socscimed.2009.07.008; Moursund A, 2003, POP STUD-J DEMOG, V57, P285, DOI 10.1080/0032472032000137817; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Pande R., 2006, SON PREFERENCE DAUGH; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; RAY P, 1973, ECONOMETRICA, V41, P987, DOI 10.2307/1913820; Saavala M, 1999, STUD FAMILY PLANN, V30, P288, DOI 10.1111/j.1728-4465.1999.t01-1-.x; Santhya KG, 2003, CHANGING FAMILY PLAN; Singh A, 2012, INT PERSPECT SEX R H, V38, P187, DOI 10.1363/3818712; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Srinivasan K., 1995, REGULATING REPROD IN; SRINIVASAN K., 1998, DEMOGRAPHY INDIA, V27, P1; Srinivasan K, 2006, LECT 5 C CHANDRASEKH; Stephenson R, 2008, STUD FAMILY PLANN, V39, P177, DOI 10.1111/j.1728-4465.2008.165.x; Visaria L, 1999, INT FAM PLAN PERSPEC, V25, pS44, DOI 10.2307/2991871; Zavier F, 2000, INT FAM PLAN PERSPEC, V26, P29, DOI 10.2307/2648287	34	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86654	10.1371/journal.pone.0086654	http://dx.doi.org/10.1371/journal.pone.0086654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489759	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330510000069
J	Fernandez-Del-Olmo, M; Rio-Rodriguez, D; Iglesias-Soler, E; Acero, RM				Fernandez-Del-Olmo, Miguel; Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Acero, Rafael M.			Startle Auditory Stimuli Enhance the Performance of Fast Dynamic Contractions	PLOS ONE			English	Article							SIMPLE REACTION-TIME; RESPONSE FORCE; ELECTROMECHANICAL DELAY; VOLUNTARY MOVEMENT; INTENSITY; FATIGUE; HUMANS; REFLEX; MUSCLE; FACILITATION	Fast reaction times and the ability to develop a high rate of force development (RFD) are crucial for sports performance. However, little is known regarding the relationship between these parameters. The aim of this study was to investigate the effects of auditory stimuli of different intensities on the performance of a concentric bench-press exercise. Concentric bench-presses were performed by thirteen trained subjects in response to three different conditions: a visual stimulus (VS); a visual stimulus accompanied by a non-startle auditory stimulus (AS); and a visual stimulus accompanied by a startle auditory stimulus (SS). Peak RFD, peak velocity, onset movement, movement duration and electromyography from pectoralis and tricep muscles were recorded. The SS condition induced an increase in the RFD and peak velocity and a reduction in the movement onset and duration, in comparison with the VS and AS condition. The onset activation of the pectoralis and tricep muscles was shorter for the SS than for the VS and AS conditions. These findings point out to specific enhancement effects of loud auditory stimulation on the rate of force development. This is of relevance since startle stimuli could be used to explore neural adaptations to resistance training.	[Fernandez-Del-Olmo, Miguel; Rio-Rodriguez, Dan; Iglesias-Soler, Eliseo; Acero, Rafael M.] Univ A Coruna, INEF Galicia, Learning & Human Movement Control Grp, La Coruna, Spain	Universidade da Coruna	Fernandez-Del-Olmo, M (corresponding author), Univ A Coruna, INEF Galicia, Learning & Human Movement Control Grp, La Coruna, Spain.	mafo@udc.es	Iglesias-Soler, Eliseo/G-5144-2010; MARTÍN-ACERO, RAFAEL/AAB-9221-2021; Rio-Rodriguez, Dan/C-6775-2014	Iglesias-Soler, Eliseo/0000-0002-1212-4188; MARTÍN-ACERO, RAFAEL/0000-0002-7117-8055; Fernandez del Olmo, Miguel/0000-0001-5325-503X; Rio-Rodriguez, Dan/0000-0002-1790-9013	Xunta de Galicia [CN2012/1702]	Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Xunta de Galicia (CN2012/1702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; ANGEL A, 1973, Q J EXP PSYCHOL, V25, P193, DOI 10.1080/14640747308400338; Anzak A, 2011, EXP BRAIN RES, V208, P237, DOI 10.1007/s00221-010-2474-1; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2007, EXP BRAIN RES, V176, P199, DOI 10.1007/s00221-006-0610-8; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Davis M., 1984, P287; Frere J, 2011, INT J SPORTS MED, V32, P28, DOI 10.1055/s-0030-1267199; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; GRUNER JA, 1989, J NEUROSCI METH, V27, P13, DOI 10.1016/0165-0270(89)90049-6; Harwood B, 2012, J APPL PHYSIOL, V113, P1821, DOI 10.1152/japplphysiol.00879.2012; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; JASKOWSKI P, 1995, ACTA NEUROBIOL EXP, V55, P57; KOHFELD DL, 1969, J EXP PSYCHOL, V82, P88, DOI 10.1037/h0028033; LEE WA, 1990, EXP BRAIN RES, V82, P304; LIEGEOISCHAUVEL C, 1989, BRAIN, V112, P375, DOI 10.1093/brain/112.2.375; Miller J, 1999, J EXP PSYCHOL HUMAN, V25, P1454, DOI 10.1037/0096-1523.25.5.1454; Newton RU, 1997, EUR J APPL PHYSIOL O, V75, P333, DOI 10.1007/s004210050169; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; ROSSIGNOL S, 1976, ELECTROEN CLIN NEURO, V41, P83, DOI 10.1016/0013-4694(76)90217-0; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Stahl J, 2005, ACTA PSYCHOL, V120, P1, DOI 10.1016/j.actpsy.2005.02.003; Ulrich R, 1998, J EXP PSYCHOL HUMAN, V24, P915, DOI 10.1037/0096-1523.24.3.915; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; VANDIEEN JH, 1991, EUR J APPL PHYSIOL O, V63, P216, DOI 10.1007/BF00233851; VencesBrito AM, 2011, J ELECTROMYOGR KINES, V21, P1023, DOI 10.1016/j.jelekin.2011.09.007; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhou S, 1996, EUR J APPL PHYSIOL, V72, P410, DOI 10.1007/BF00242269	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87805	10.1371/journal.pone.0087805	http://dx.doi.org/10.1371/journal.pone.0087805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301CJ	24489967	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000150
J	Ruggles, DR; Freyman, RL; Oxenham, AJ				Ruggles, Dorea R.; Freyman, Richard L.; Oxenham, Andrew J.			Influence of Musical Training on Understanding Voiced and Whispered Speech in Noise	PLOS ONE			English	Article							TEMPORAL FINE-STRUCTURE; HEARING-IMPAIRED LISTENERS; HUMAN BRAIN-STEM; IN-NOISE; RECEPTION THRESHOLDS; PITCH DISCRIMINATION; FLUCTUATING MASKERS; INTERFERING SPEECH; BACKGROUND-NOISE; MUSICIANS	This study tested the hypothesis that the previously reported advantage of musicians over non-musicians in understanding speech in noise arises from more efficient or robust coding of periodic voiced speech, particularly in fluctuating backgrounds. Speech intelligibility was measured in listeners with extensive musical training, and in those with very little musical training or experience, using normal (voiced) or whispered (unvoiced) grammatically correct nonsense sentences in noise that was spectrally shaped to match the long-term spectrum of the speech, and was either continuous or gated with a 16-Hz square wave. Performance was also measured in clinical speech-in-noise tests and in pitch discrimination. Musicians exhibited enhanced pitch discrimination, as expected. However, no systematic or statistically significant advantage for musicians over non-musicians was found in understanding either voiced or whispered sentences in either continuous or gated noise. Musicians also showed no statistically significant advantage in the clinical speech-in-noise tests. Overall, the results provide no evidence for a significant difference between young adult musicians and non-musicians in their ability to understand speech in noise.	[Ruggles, Dorea R.; Oxenham, Andrew J.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Freyman, Richard L.] Univ Massachusetts, Dept Commun Disorders, Amherst, MA 01003 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Amherst	Ruggles, DR (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	druggles@umn.edu		Oxenham, Andrew/0000-0002-9365-1157	National Institutes of Health (NIH) [R01 DC005216, R01 DC001625]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001625, R01DC005216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) R01 DC005216 and NIH R01 DC001625 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JGW, 2011, J ACOUST SOC AM, V130, P473, DOI 10.1121/1.3589440; Bernstein JGW, 2009, J ACOUST SOC AM, V125, P3358, DOI 10.1121/1.3110132; Bidelman GM, 2011, EUR J NEUROSCI, V33, P530, DOI 10.1111/j.1460-9568.2010.07527.x; Binns C, 2007, J ACOUST SOC AM, V122, P1765, DOI 10.1121/1.2751394; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Corrigall KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00222; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Freyman RL, 2012, J ACOUST SOC AM, V132, P2514, DOI 10.1121/1.4747614; Helfer KS, 1997, J SPEECH LANG HEAR R, V40, P432, DOI 10.1044/jslhr.4002.432; Hopkins K, 2010, J ACOUST SOC AM, V127, P1595, DOI 10.1121/1.3293003; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Levitin DJ, 2012, NEURON, V73, P633, DOI 10.1016/j.neuron.2012.01.017; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Miller SE, 2010, J ACOUST SOC AM, V128, P435, DOI 10.1121/1.3397384; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Nelson PB, 2004, J ACOUST SOC AM, V115, P2286, DOI 10.1121/1.1703538; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P457, DOI 10.1121/1.3021299; Parbery-Clark A, 2011, NEUROPSYCHOLOGIA, V49, P3338, DOI 10.1016/j.neuropsychologia.2011.08.007; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Peters RW, 1998, J ACOUST SOC AM, V103, P577, DOI 10.1121/1.421128; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Skoe E, 2012, J NEUROSCI, V32, P11507, DOI 10.1523/JNEUROSCI.1949-12.2012; Soli SD, 2008, INT J AUDIOL, V47, P356, DOI 10.1080/14992020801895136; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Strait DL, 2012, BRAIN LANG, V123, P191, DOI 10.1016/j.bandl.2012.09.001; Strelcyk O, 2009, J ACOUST SOC AM, V125, P3328, DOI 10.1121/1.3097469; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Wechsler D, 2011, WECHSLER ABBREVIATED; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816	38	97	99	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86980	10.1371/journal.pone.0086980	http://dx.doi.org/10.1371/journal.pone.0086980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489819	gold, Green Submitted, Green Published			2022-12-27	WOS:000330510000095
J	Wright, EP; Prasad, KAG; Padula, MP; Coorssen, JR				Wright, Elise P.; Prasad, Kali A. G.; Padula, Matthew P.; Coorssen, Jens R.			Deep Imaging: How Much of the Proteome Does Current Top-Down Technology Already Resolve?	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; IMMOBILIZED PH GRADIENTS; RESOLUTION; PROTEINS; DATABASE; TOOLS	Effective proteome analyses are based on interplay between resolution and detection. It had been claimed that resolution was the main factor limiting the use of two-dimensional gel electrophoresis. Improved protein detection now indicates that this is unlikely to be the case. Using a highly refined protocol, the rat brain proteome was extracted, resolved, and detected. In order to overcome the stain saturation threshold, high abundance protein species were excised from the gel following standard imaging. Gels were then imaged again using longer exposure times, enabling detection of lower abundance, less intensely stained protein species. This resulted in a significant enhancement in the detection of resolved proteins, and a slightly modified digestion protocol enabled effective identification by standard mass spectrometric methods. The data indicate that the resolution required for comprehensive proteome analyses is already available, can assess multiple samples in parallel, and preserve critical information concerning post-translational modifications. Further optimization of staining and detection methods promises additional improvements to this economical, widely accessible and effective top-down approach to proteome analysis.	[Wright, Elise P.; Prasad, Kali A. G.; Coorssen, Jens R.] Univ Western Sydney, Campbelltown, NSW, Australia; [Wright, Elise P.; Prasad, Kali A. G.; Coorssen, Jens R.] Univ Western Sydney, Sch Med, UWS Mol Med Res Grp, Campbelltown, NSW, Australia; [Padula, Matthew P.] Univ Technol Sydney, Fac Sci, Prote Core Facil, Sydney, NSW, Australia	Western Sydney University; Western Sydney University; University of Technology Sydney	Coorssen, JR (corresponding author), Univ Western Sydney, Campbelltown, NSW, Australia.	j.coorssen@uws.edu.au	Padula, Matthew P/R-6150-2016	Padula, Matthew P/0000-0002-8283-0643	UWS School of Medicine; Bellberry Ltd.	UWS School of Medicine; Bellberry Ltd.	This study was funded by the UWS School of Medicine and Bellberry Ltd. An anonymous private foundation provided a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Berggren KN, 2002, PROTEOMICS, V2, P486, DOI 10.1002/1615-9861(200205)2:5<486::AID-PROT486>3.0.CO;2-X; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Butt RH, 2007, MOL CELL PROTEOMICS, V6, P1574, DOI 10.1074/mcp.M700083-MCP200; Butt RH, 2006, J PROTEOME RES, V5, P3161, DOI 10.1021/pr060282n; Butt RH, 2006, J PROTEOME RES, V5, P437, DOI 10.1021/pr0503634; Butt RH, 2005, J PROTEOME RES, V4, P982, DOI 10.1021/pr050054d; Fountoulakis M, 2003, ANAL BIOCHEM, V313, P267, DOI 10.1016/S0003-2697(02)00617-6; Gauci V. J., 2010, J CHEM BIOL, V4, P3; Gauci VJ, 2013, J PROTEOMICS, V90, P96, DOI 10.1016/j.jprot.2013.01.027; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Gorg A, 1999, ELECTROPHORESIS, V20, P712; Harris LR, 2007, J PROTEOME RES, V6, P1418, DOI 10.1021/pr0700246; Herbert B.R., 1997, PROTEOME RES NEW FRO, P13; Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540; Hoving S, 2000, ELECTROPHORESIS, V21, P2617, DOI 10.1002/1522-2683(20000701)21:13<2617::AID-ELPS2617>3.0.CO;2-C; Jungblut P, 1996, ELECTROPHORESIS, V17, P839, DOI 10.1002/elps.1150170505; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; Levanen B, 2009, 2 DIMENSIONAL ELECTR, P112; Ly L, 2011, PROTEOMICS, V11, P513, DOI 10.1002/pmic.201000394; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RAYMOND S, 1964, ANN NY ACAD SCI, V121, P350, DOI 10.1111/j.1749-6632.1964.tb14208.x; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Schluter H, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-11; Shaw J, 2003, PROTEOMICS, V3, P1181, DOI 10.1002/pmic.200300439; Smejkal GB, 2004, ELECTROPHORESIS, V25, P2511, DOI 10.1002/elps.200406005; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wu CC, 2002, CURR OPIN MOL THER, V4, P242	33	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86058	10.1371/journal.pone.0086058	http://dx.doi.org/10.1371/journal.pone.0086058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489691	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000031
J	Yuan, T; Zheng, XQ; Hu, X; Zhou, W; Wang, W				Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei; Wang, Wei			A Method for the Evaluation of Image Quality According to the Recognition Effectiveness of Objects in the Optical Remote Sensing Image Using Machine Learning Algorithm	PLOS ONE			English	Article							VEHICLE DETECTION; RESOLUTION SATELLITE; CLASSIFICATION; FRAMEWORK	Objective and effective image quality assessment (IQA) is directly related to the application of optical remote sensing images (ORSI). In this study, a new IQA method of standardizing the target object recognition rate (ORR) is presented to reflect quality. First, several quality degradation treatments with high-resolution ORSIs are implemented to model the ORSIs obtained in different imaging conditions; then, a machine learning algorithm is adopted for recognition experiments on a chosen target object to obtain ORRs; finally, a comparison with commonly used IQA indicators was performed to reveal their applicability and limitations. The results showed that the ORR of the original ORSI was calculated to be up to 81.95%, whereas the ORR ratios of the quality-degraded images to the original images were 65.52%, 64.58%, 71.21%, and 73.11%. The results show that these data can more accurately reflect the advantages and disadvantages of different images in object identification and information extraction when compared with conventional digital image assessment indexes. By recognizing the difference in image quality from the application effect perspective, using a machine learning algorithm to extract regional gray scale features of typical objects in the image for analysis, and quantitatively assessing quality of ORSI according to the difference, this method provides a new approach for objective ORSI assessment.	[Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei; Wang, Wei] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Yuan, Tao; Zheng, Xinqi; Hu, Xuan; Zhou, Wei] Minist Land & Resources, Key Lab Land Regulat, Beijing, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China	Yuan, T (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	yuantaobj@qq.com			Fundamental Research Funds for the Central Universities [2652011299]; National Natural Science Foundation of China [41240008, 41301118]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (2652011299) and the National Natural Science Foundation of China (41240008, 41301118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnec M, 2008, SIGNAL PROCESS-IMAGE, V23, P239, DOI 10.1016/j.image.2008.02.003; Chen Y, 2009, IMAGE VISION COMPUT, V27, P1421, DOI 10.1016/j.imavis.2007.12.002; Eikvil L, 2009, ISPRS J PHOTOGRAMM, V64, P65, DOI 10.1016/j.isprsjprs.2008.09.005; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Guo QH, 2012, PHOTOGRAMM ENG REM S, V78, P595, DOI 10.14358/PERS.78.6.595; Holt AC, 2009, PHOTOGRAMM ENG REM S, V75, P871, DOI 10.14358/PERS.75.7.871; Jin XY, 2007, IMAGE VISION COMPUT, V25, P1422, DOI 10.1016/j.imavis.2006.12.011; Leitloff J, 2010, IEEE T GEOSCI REMOTE, V48, P2795, DOI 10.1109/TGRS.2010.2043109; Niu XT, 2006, ISPRS J PHOTOGRAMM, V61, P170, DOI 10.1016/j.isprsjprs.2006.08.004; Seghir ZA, 2011, SIGNAL PROCESS-IMAGE, V26, P534, DOI 10.1016/j.image.2011.06.003; Sharma G, 2006, INT J REMOTE SENS, V27, P779, DOI 10.1080/01431160500238901; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Wang Z, 2002, INT CONF ACOUST SPEE, P3313; Zhang J, 2011, SIGNAL PROCESS-IMAGE, V26, P13, DOI 10.1016/j.image.2010.11.003	14	13	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86528	10.1371/journal.pone.0086528	http://dx.doi.org/10.1371/journal.pone.0086528			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489739	Green Published, Green Submitted, gold			2022-12-27	WOS:000330510000057
J	Zhu, C; Wang, JX; Cheng, T; Li, QT; Shen, H; Qin, H; Cheng, MQ; Zhang, XL				Zhu, Chen; Wang, Jiaxing; Cheng, Tao; Li, Qingtian; Shen, Hao; Qin, Hui; Cheng, Mengqi; Zhang, Xianlong			The Potential Role of Increasing the Release of Mouse beta-Defensin-14 in the Treatment of Osteomyelitis in Mice: A Primary Study	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANT STAPHYLOCOCCUS; GENE-EXPRESSION; BACTERICIDAL ACTIVITY; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; BIOFILM FORMATION; JOINT INFECTIONS; INNATE IMMUNITY; SYNOVIAL-FLUID; IN-VITRO	Mammalian beta-defensins are small cationic peptides that have been implicated in mediating innate immune defenses against microbial infection. Mouse beta-defensin-14 (MBD-14), based on structural and functional similarities, appears to be an ortholog of human beta-defensin-3 (HBD-3). Previous studies identified signaling pathway p38 mitogen-activated protein kinase (MAPK) that contributed to the expression of MBD-14 in mouse osteoblasts upon contacted with methicillin-resistance Staphylococcus aureus (MRSA) supernatant, which provided a theoretical basis as a promising therapeutic target in the treatment of intramedullary infection with MRSA in vivo. In this study, the medullary cavities of tibiae were contaminated with MRSA 10(3) colony forming units and different doses of p38 MAPK agonists anisomycin were followed as group III or IV in 30 mice. Fifteen animals that received phosphate-buffered saline served as group II and 15 mice were not contaminated with MRSA and received phosphate-buffered saline served as controls (group I). Follow-up was 7 days. In day 1, day 4 and day 7 postoperatively, infection was evaluated by blood routine, microbiological and histological analyses after sacrifice. All animals of group II developed microbiological and histological signs of infection. Histological signs of infection, white blood counts and cultures of group III and IV showed significantly reduced bacterial growth compared to cultures of group II. Simultaneously, different doses of anisomycin significantly induced the expression of osteoblast-associated genes, including alkaline phosphatase, osteocalcin and collagen type I. In addition, the expression of HBD-3 in human interfacial membranes around infected periprosthetic joint by staphylococcus contaminated was evaluated, and the expression pattern changed with significant induction of HBD-3 in infected periprosthetic joint compared with aseptic loosening under inflammatory conditions. Our primary study indicated that the potential antibacterial role of increased MBD-14 in the osteomyelitis mouse model.	[Zhu, Chen; Wang, Jiaxing; Cheng, Tao; Shen, Hao; Qin, Hui; Cheng, Mengqi; Zhang, Xianlong] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Chen] Anhui Med Univ, Anhui Prov Hosp, Dept Orthopaed Surg, Hefei, Peoples R China; [Li, Qingtian] Shanghai Jiao Tong Univ, Dept Med Microbiol & Parasitol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Anhui Medical University; Shanghai Jiao Tong University	Zhang, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China.	zxl40@vip.sina.com	zhang, xian/GYA-0290-2022		Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University [YG2011MS30]; Shanghai Municipal health Bureau Science Fund for Young Scholars [2010QJ036A]; Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure [SKL201206SIC]; National Natural Science Foundation of China [81171688, 81271962]	Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University; Shanghai Municipal health Bureau Science Fund for Young Scholars; Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University (Grant no. YG2011MS30), the Shanghai Municipal health Bureau Science Fund for Young Scholars (Grant no. 2010QJ036A), the Opening Project of State Key Laboratory of High Performance Ceramics and Superfine Microstructure (Grant no. SKL201206SIC), the National Natural Science Foundation of China (Grant no. 81171688) and the National Natural Science Foundation of China (Grant no. 81271962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Baumbauer KM, 2006, BEHAV BRAIN RES, V173, P299, DOI 10.1016/j.bbr.2006.06.041; Bernardi RE, 2007, BEHAV NEUROSCI, V121, P156, DOI 10.1037/0735-7044.121.1.156; Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; Cunningham R, 1996, J MED MICROBIOL, V44, P157, DOI 10.1099/00222615-44-3-157; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Hancock REW, 2005, LANCET INFECT DIS, V5, P209, DOI 10.1016/S1473-3099(05)70051-7; Hein-Kristensen L, 2010, SCAND J IMMUNOL, V72, P302, DOI 10.1111/j.1365-3083.2010.02431.x; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Kim JM, 2005, J IMMUNOL, V174, P1239, DOI 10.4049/jimmunol.174.3.1239; Klees RF, 2005, MOL BIOL CELL, V16, P881, DOI 10.1091/mbc.e04-08-0695; KOCHI SK, 1993, EXP CELL RES, V208, P296, DOI 10.1006/excr.1993.1249; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lambrecht FY, 2008, J RADIOANAL NUCL CH, V277, P555, DOI 10.1007/s10967-007-7135-x; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Li JY, 2012, ACTA PHARMACOL SIN, V33, P935, DOI 10.1038/aps.2012.46; Liberatore M, 2009, J NUCL MED, V50, P823, DOI 10.2967/jnumed.108.055533; Lippross S, 2012, INJURY, V43, P137, DOI 10.1016/j.injury.2011.03.044; LittlewoodEvans AJ, 1997, INFECT IMMUN, V65, P3438, DOI 10.1128/IAI.65.8.3438-3443.1997; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4; Ma GF, 2006, ARTHRITIS RHEUM, V54, P2928, DOI 10.1002/art.22064; Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806-809.2006; Menzies BE, 2006, INFECT IMMUN, V74, P6847, DOI 10.1128/IAI.00389-06; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]; Nihonyanagi S, 2012, INFLAMMATION, V35, P927, DOI 10.1007/s10753-011-9395-4; Pan XY, 2012, J SURG RES, V176, P484, DOI 10.1016/j.jss.2011.09.047; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Ren W, 2004, SCAND J RHEUMATOL, V33, P349, DOI 10.1080/03009740410005944; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415; Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084; Varoga D, 2009, HISTOCHEM CELL BIOL, V131, P207, DOI 10.1007/s00418-008-0522-8; WALAKOVITS LA, 1992, ARTHRITIS RHEUM, V35, P35, DOI 10.1002/art.1780350106; Warnke PH, 2006, BONE, V38, P400, DOI 10.1016/j.bone.2005.09.003; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586; Xing FY, 2008, J IMMUNOTHER, V31, P858, DOI 10.1097/CJI.0b013e3181869873; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; YOSHIDA K, 1992, INT ARCH ALLERGY IMM, V98, P286, DOI 10.1159/000236200; Yu TC, 2004, ACTA BIOCH BIOPH SIN, V36, P741, DOI 10.1093/abbs/36.11.741; Zhu C, 2013, INFLAMMATION, V36, P983, DOI 10.1007/s10753-013-9630-2; Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048; Zhu C, 2013, INT J MOL MED, V31, P1484, DOI 10.3892/ijmm.2013.1346	56	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e86874	10.1371/journal.pone.0086874	http://dx.doi.org/10.1371/journal.pone.0086874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489798	Green Submitted, Green Published, gold			2022-12-27	WOS:000330510000085
J	Liu, X; Zhang, JL; Gu, TY; Zhang, WM; Shen, QR; Yin, SX; Qiu, HZ				Liu, Xing; Zhang, Junlian; Gu, Tianyu; Zhang, Wenming; Shen, Qirong; Yin, Shixue; Qiu, Huizhen			Microbial Community Diversities and Taxa Abundances in Soils along a Seven-Year Gradient of Potato Monoculture Using High Throughput Pyrosequencing Approach	PLOS ONE			English	Article							CROPPING SYSTEMS; BACTERIAL COMMUNITIES; SOILBORNE DISEASES; TILLAGE; POPULATIONS; MANAGEMENT; CULTIVARS; DYNAMICS; ROTATION; PLANT	Background: Previous studies have focused on linking soil community structure, diversity, or specific taxa to disturbances. Relatively little attention has been directed to crop monoculture soils, particularly potato monoculture. Information about microbial community changes over time between monoculture and non-monoculture treatments is lacking. Furthermore, few studies have examined microbial communities in potato monoculture soils using a high throughput pyrosequencing approach. Methodology/Principal Findings: Soils along a seven-year gradient of potato monoculture were collected and microbial communities were characterized using high throughput pyrosequencing approach. Principal findings are as follows. First, diversity (H-Shannon) and richness (S-Chao1) indices of bacterial community, but not of fungal community, were linearly decreased over time and corresponded to a decline of soil sustainability represented by yield decline and disease incidence increase. Second, Fusarium, the only soilborne pathogen-associated fungal genus substantially detected, was linearly increased over time in abundance and was closely associated with yield decline. Third, Fusarium abundance was negatively correlated with soil organic matter (OM) and total nitrogen (TN) but positively with electrical conductivity (EC). Fourth, Fusarium was correlated in abundances with 6 bacterial taxa over time. Conclusions: Soil bacterial and fungal communities exhibited differential responses to the potato monoculture. The overall soil bacterial communities were shaped by potato monoculture. Fusarium was the only soilborne pathogen-associated genus associated with disease incidence increase and yield decline. The changes of soil OM, TN and EC were responsible for Fusarium enrichment, in addition to selections by the monoculture crop. Acidobacteria and Nitrospirae were linearly decreased over time in abundance, corresponding to the decrease of OM, suggesting their similar ecophysiologial trait. Correlations between abundance of Fusarium with several other bacterial taxa suggested their similar behaviors in responses to potato monoculture and/or soil variables, providing insights into the ecological behaviors of these taxa in the environment.	[Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Coll Resources & Environm Sci, Lanzhou, Gansu, Peoples R China; [Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Coll Agron, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Gansu, Peoples R China; [Gu, Tianyu; Yin, Shixue] Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China; [Shen, Qirong] Nanjing Agr Univ, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing, Jiangsu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Yangzhou University; Nanjing Agricultural University	Yin, SX (corresponding author), Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China.	sxyin@yzu.edu.cn; hzqiu@gsau.edu.cn	Shen, Qirong/AAB-6531-2020; Liu, Xing/GPG-3245-2022	Liu, Xing/0000-0001-8578-3769; Liu, Xinting/0000-0002-2798-448X; zhang, wenming/0000-0001-6567-8099	Agricultural Ministry of China [201103004]; Natural Science Foundation of China [31360500]; National Nature Science Foundation of China [41071177]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agricultural Ministry of China (201103004), the Natural Science Foundation of China (31360500) and the National Nature Science Foundation of China (41071177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V., 2010, Diversity, V2, P910; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arroita M, 2013, J HAZARD MATER, V263, P139, DOI 10.1016/j.jhazmat.2013.06.049; Bernard E, 2012, APPL SOIL ECOL, V52, P29, DOI 10.1016/j.apsoil.2011.10.002; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cardenas E, 2010, APPL ENVIRON MICROB, V76, P6778, DOI 10.1128/AEM.01097-10; Ceja-Navarro JA, 2010, PLANT SOIL, V329, P127, DOI 10.1007/s11104-009-0140-9; Cook RJ, 2006, P NATL ACAD SCI USA, V103, P18389, DOI 10.1073/pnas.0605946103; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Xuan DT, 2012, BIOL FERT SOILS, V48, P217, DOI 10.1007/s00374-011-0618-5; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fiers M, 2012, AGRON SUSTAIN DEV, V32, P93, DOI 10.1007/s13593-011-0035-z; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; HOPKINS DL, 1992, PHYTOPATHOLOGY, V82, P290, DOI 10.1094/Phyto-82-290; HOPKINS DL, 1984, PLANT DIS, V68, P129, DOI 10.1094/PD-69-129; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Jeger MJ, 1996, POTATO RES, V39, P437, DOI 10.1007/BF02357949; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Larkin RP, 2010, PLANT DIS, V94, P1491, DOI 10.1094/PDIS-03-10-0172; Larkin RP, 2006, PHYTOPATHOLOGY, V96, P68, DOI 10.1094/PHYTO-96-0068; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEACH SS, 1981, PHYTOPATHOLOGY, V71, P623, DOI 10.1094/Phyto-71-623; Lee J, 2011, BIODEGRADATION, V22, P687, DOI 10.1007/s10532-010-9429-x; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Norris TB, 2002, APPL ENVIRON MICROB, V68, P6300, DOI 10.1128/AEM.68.12.6300-6309.2002; Silva MCPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051554; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; SHIPTON PJ, 1977, ANNU REV PHYTOPATHOL, V15, P387, DOI 10.1146/annurev.py.15.090177.002131; Silva MCPE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00077; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; van Bruggen AHC, 2006, EUR J PLANT PATHOL, V115, P105, DOI 10.1007/s10658-005-1250-8; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	52	95	113	7	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86610	10.1371/journal.pone.0086610	http://dx.doi.org/10.1371/journal.pone.0086610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497959	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100022
J	Liu, YR; Fang, JX; Joo, KI; Wong, MK; Wang, P				Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wong, Michael K.; Wang, Pin			Codelivery of Chemotherapeutics via Crosslinked Multilamellar Liposomal Vesicles to Overcome Multidrug Resistance in Tumor	PLOS ONE			English	Article							SMALL INTERFERING RNA; BREAST-CANCER; PACLITAXEL; DOXORUBICIN; DELIVERY; NANOPARTICLES; COMBINATIONS; AGENTS	Multidrug resistance (MDR) is a significant challenge to effective cancer chemotherapy treatment. However, the development of a drug delivery system that allows for the sustained release of combined drugs with improved vesicle stability could overcome MDR in cancer cells. To achieve this, we have demonstrated codelivery of doxorubicin (Dox) and paclitaxel (PTX) via a crosslinked multilamellar vesicle (cMLV). This combinatorial delivery system achieves enhanced drug accumulation and retention, in turn resulting in improved cytotoxicity against tumor cells, including drug-resistant cells. Moreover, this delivery approach significantly overcomes MDR by reducing the expression of P-glycoprotein (P-gp) in cancer cells, thus improving antitumor activity in vivo. Thus, by enhancing drug delivery to tumors and lowering the apoptotic threshold of individual drugs, this combinatorial delivery system represents a potentially promising multimodal therapeutic strategy to overcome MDR in cancer therapy.	[Liu, Yarong; Fang, Jinxu; Joo, Kye-Il; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wong, Michael K.] Univ So Calif, Keck Sch Med, Div Med Oncol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, P (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Institutes of Health [R01AI068978, R01CA170820, P01CA132681]; Joint Center for Translational Medicine; National Cancer Institute [P30CA014089]; Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Translational Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ming Hsieh Institute for Research on Engineering Medicine for Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants (R01AI068978, R01CA170820 and P01CA132681), a translational acceleration grant from the Joint Center for Translational Medicine, the National Cancer Institute (P30CA014089), and a grant from the Ming Hsieh Institute for Research on Engineering Medicine for Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Bird BRJH, 2008, CLIN CANCER RES, V14, P14, DOI 10.1158/1078-0432.CCR-07-1033; Calabro F, 2009, CANCER-AM CANCER SOC, V115, P2652, DOI 10.1002/cncr.24313; Chen YC, 2010, J BIOL CHEM, V285, P22639, DOI 10.1074/jbc.M110.125906; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; De Laurentiis M, 2008, J CLIN ONCOL, V26, P44, DOI 10.1200/JCO.2007.11.3787; Dean-Colomb W, 2008, SEMIN ONCOL, V35, pS31, DOI 10.1053/j.seminoncol.2008.02.008; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gao HL, 2014, CURR PHARM BIOTECHNO, V15, P210, DOI 10.2174/1389201015666140617092552; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Grasselli G, 2001, J CLIN ONCOL, V19, P2222, DOI 10.1200/JCO.2001.19.8.2222; Gustafson DL, 2005, CANCER LETT, V220, P161, DOI 10.1016/j.canlet.2004.09.007; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Joo KI, 2013, BIOMATERIALS, V34, P3098, DOI 10.1016/j.biomaterials.2013.01.039; Kataja V, 2008, ANN ONCOL, V19, P11, DOI 10.1093/annonc/mdn072; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lespine A, 2012, INT J PARASITOL-DRUG, V2, P230; Liu YR, 2014, NANO LIFE, V4, DOI 10.1142/S1793984414410074; Liu YR, 2014, MOL PHARMACEUT, V11, P1651, DOI 10.1021/mp5000373; Liu Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/378380; Mamounas EP, 2001, SEMIN ONCOL, V28, P24, DOI 10.1053/sonc.2001.26432; Rahman AM, 2007, INT J NANOMED, V2, P567; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teicher BA, 2009, BIOCHEM PHARMACOL, V77, P1665, DOI 10.1016/j.bcp.2009.01.006; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang H, 2011, BIOMATERIALS, V32, P8281, DOI 10.1016/j.biomaterials.2011.07.032; Xu D, 2005, MOL THER, V11, P523, DOI 10.1016/j.ymthe.2004.12.019; Yu ZQ, 2013, J AM CHEM SOC, V135, P2883, DOI 10.1021/ja311090e	37	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2014	9	10							e110611	10.1371/journal.pone.0110611	http://dx.doi.org/10.1371/journal.pone.0110611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT8TF	24489844	gold, Green Submitted, Green Published			2022-12-27	WOS:000345204100095
J	Wei, XW; Ma, XW; Lu, R; Bai, G; Zhang, JW; Deng, RF; Gu, N; Feng, N; Guo, XH				Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui			Genetic Variants in PCSK1 Gene Are Associated with the Risk of Coronary Artery Disease in Type 2 Diabetes in a Chinese Han Population: A Case Control Study	PLOS ONE			English	Article							INSULIN SENSITIVITY; HEART-DISEASE; OBESITY; PROINSULIN; MELLITUS	Background: Insulin and glucagon-like peptide 1 (GLP-1), converted by proprotein convertase 1 (PC1/3) from proinsulin and proglucagon, are associated with type 2 diabetes (T2DM) and coronary artery disease (CAD). The aim of this study is to investigate the association of PCSK1 gene, which encodes PC1/3, with the risk of CAD in Chinese patients with T2DM. Methods: We selected and genotyped 5 haplotype-tagging single nucleotide polymorphisms (SNPs) at PCSK1 gene (across 39873bp locus) in a case-control study of Chinese Han population involving 425 diabetic patients (62.1% male, mean age 63.2 years) with CAD as positive cases and 258 diabetic patients (44.2% male, mean age 62.0 years) without CAD as controls. Results: The allele frequencies at rs3811951 were significantly different between cases and controls (30.7% vs. 37.2%), with the allele G associated with decreased risk for CAD (OR = 0.75, 95% CI = 0.59-0.94, p = 0.013). In recessive inheritance mode, the carriers of GG had a lower risk (OR = 0.50, 95% CI = 0.31-0.82, p = 0.005), even after adjusted for gender, age, BMI and smoking (OR = 0.43, 95% CI = 0.24-0.77, p = 0.004). The carriers of the minor allele A at rs156019 had a higher risk (OR = 1.66, 95% CI = 1.10-2.50, p = 0.016 after adjustment) in dominant inheritance mode. The SNP rs6234 was also significantly associated with CAD risk in women, with the carriers of the minor allele G at rs6234 associated with a reduced CAD risk in recessive inheritance mode (OR = 0.42, 95% CI = 0.18-0.95, p = 0.036 after adjustment). Conclusions: Our results found that common genetic variants in PCSK1 were associated with CAD in Chinese patients with T2DM.	[Wei, Xiaowei; Ma, Xiaowei; Lu, Ran; Bai, Ge; Zhang, Jianwei; Deng, Ruifen; Gu, Nan; Feng, Nan; Guo, Xiaohui] Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China	Peking University	Ma, XW (corresponding author), Peking Univ, Dept Endocrinol, Hosp 1, Beijing 100871, Peoples R China.	mxiaowei@yahoo.com	FENG, NAN/HGD-3255-2022; lu, ran/HHC-8613-2022; Blanco, Juan A./A-4554-2009	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	National 973 project in China [2006CB503903, 2006CB503908]	National 973 project in China(National Basic Research Program of China)	The study was granted by National 973 project (2006CB503903, 2006CB503908) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2011, DIABETES OBES METAB, V13, P302, DOI 10.1111/j.1463-1326.2010.01345.x; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; Chang YC, 2010, OBESITY, V18, P1404, DOI 10.1038/oby.2009.390; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Gjesing AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023907; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kaplan M, 2012, PHARMACOL THERAPEUT, V136, P175, DOI 10.1016/j.pharmthera.2012.08.002; Mbikay M, 2011, MOL GENET METAB, V104, P682, DOI 10.1016/j.ymgme.2011.09.027; Qi Q, 2010, PLOS ONE, V5; Schneider Hans, 2003, Clin Biochem Rev, V24, P77; Sirois F, 2012, J COMMUN GENET, V3, P319, DOI 10.1007/s12687-012-0081-5; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Zethelius B, 2005, DIABETOLOGIA, V48, P862, DOI 10.1007/s00125-005-1711-9; Zethelius B, 2002, CIRCULATION, V105, P2153, DOI 10.1161/01.CIR.0000015855.04844.E7	19	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87168	10.1371/journal.pone.0087168	http://dx.doi.org/10.1371/journal.pone.0087168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24586964	Green Submitted, gold, Green Published			2022-12-27	WOS:000330510000113
J	Mick, E; McGough, J; Deutsch, CK; Frazier, JA; Kennedy, D; Goldberg, RJ				Mick, Eric; McGough, James; Deutsch, Curtis K.; Frazier, Jean A.; Kennedy, David; Goldberg, Robert J.			Genome-Wide Association Study of Proneness to Anger	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PEDIATRIC BIPOLAR DISORDER; LONG-TERM POTENTIATION; DEFICIT HYPERACTIVITY DISORDER; ATHEROSCLEROSIS RISK; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; COMMON VARIANTS; SELF-REGULATION; CELLULAR PRION	Background: Community samples suggest that approximately 1 in 20 children and adults exhibit clinically significant anger, hostility, and aggression. Individuals with dysregulated emotional control have a greater lifetime burden of psychiatric morbidity, severe impairment in role functioning, and premature mortality due to cardiovascular disease. Methods: With publically available data secured from dbGaP, we conducted a genome-wide association study of proneness to anger using the Spielberger State-Trait Anger Scale in the Atherosclerosis Risk in Communities (ARIC) study (n = 8,747). Results: Subjects were, on average, 54 (range 45-64) years old at baseline enrollment, 47% (n = 4,117) were male, and all were of European descent by self-report. The mean Angry Temperament and Angry Reaction scores were 5.861.8 and 7.662.2. We observed a nominally significant finding (p = 2.9E-08, lambda = 1.027 - corrected p(gc) = 2.2E-07, lambda = 1.0015) on chromosome 6q21 in the gene coding for the non-receptor protein-tyrosine kinase, Fyn. Conclusions: Fyn interacts with NDMA receptors and inositol-1,4,5-trisphosphate (IP3)-gated channels to regulate calcium influx and intracellular release in the post-synaptic density. These results suggest that signaling pathways regulating intracellular calcium homeostasis, which are relevant to memory, learning, and neuronal survival, may in part underlie the expression of Angry Temperament.	[Mick, Eric; Goldberg, Robert J.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [McGough, James] Univ Calif Los Angeles, David Geffen Sch Med, Div Child & Adolescent Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Deutsch, Curtis K.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr, Worcester, MA USA; [Frazier, Jean A.] Univ Massachusetts, Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat, Worcester, MA 01655 USA; [Kennedy, David] Univ Massachusetts, Sch Med, Dept Psychiat, Div Neuroinformat, Worcester, MA 01655 USA; [Kennedy, David] Univ Massachusetts, Sch Med, Child & Adolescent NeuroDev Initiat, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mick, E (corresponding author), Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA 01605 USA.	eric.mick@umassmed.edu		Mick, Eric/0000-0001-8505-8145; Garin-Bastuji, Bruno/0000-0002-4486-1182; Jay, Maryne/0000-0003-0443-5565	department of Psychiatry at the University of Massachusetts Medical School; department of Quantitative Health Sciences at the University of Massachusetts Medical School; UMass Center for Clinical and Translational Science [P30HD004147]; NIH; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC- -55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694]; National Human Genome Research Institute [U01-HG-004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055022, N01HC055019, N01HC055021, N01HC055015, N01HC055016, N01HC055018] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL059367, R01HL087641] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083320] Funding Source: NIH RePORTER	department of Psychiatry at the University of Massachusetts Medical School; department of Quantitative Health Sciences at the University of Massachusetts Medical School; UMass Center for Clinical and Translational Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by institutional funds provided by the departments of Psychiatry and Quantitative Health Sciences at the University of Massachusetts Medical School and by the UMass Center for Clinical and Translational Science (P30HD004147) supported by the NIH. Phenotypes and genotypes were downloaded from the National Center for Biotechnology Information (NCBI) database of genotypes and phenotypes (dbGaP) for the NHLBI funded Atherosclerosis Risk in Communities (ARIC) Study (Accessions: phs000280.v1.p1 and phs000090.v1.p1). ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC- -55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01-HL-087641, R01-HL-59367 and R01-HL-086694; National Human Genome Research Institute contract U01-HG-004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The individual institutions represented had no further role in study design; in the collection, analysis or interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ahern CA, 2005, CIRC RES, V96, P991, DOI 10.1161/01.RES.0000166324.00524.dd; Althoff RR, 2006, BIOL PSYCHIAT, V60, P903, DOI 10.1016/j.biopsych.2006.02.025; Althoff RR, 2010, J AM ACAD CHILD PSY, V49, P1105, DOI 10.1016/j.jaac.2010.08.006; Arantes C, 2009, GLIA, V57, P1439, DOI 10.1002/glia.20861; Ayer L, 2009, J CHILD PSYCHOL PSYC, V50, P1291, DOI 10.1111/j.1469-7610.2009.02089.x; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Biederman J, 2009, J CLIN PSYCHIAT, V70, P732, DOI 10.4088/JCP.08m04821; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Coccaro EF, 2011, J AFFECTIVE DISORDER; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Diler RS, 2009, J CHILD ADOL PSYCHOP, V19, P23, DOI 10.1089/cap.2008.067; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Gold AE, 1996, CURRENT DEV HLTH PSY, P105; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Greene R W, 1999, Clin Child Fam Psychol Rev, V2, P129, DOI 10.1023/A:1021850921476; Greene RW, 2003, J PSYCHOSOM RES, V55, P67, DOI 10.1016/S0022-3999(02)00585-8; Hudziak JJ, 2005, BIOL PSYCHIAT, V58, P562, DOI 10.1016/j.biopsych.2005.03.024; Hudziak JJ, 2005, AM J PSYCHIAT, V162, P1614, DOI 10.1176/appi.ajp.162.9.1614; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; Iribarren C, 2005, SOC SCI MED, V60, P471, DOI 10.1016/j.socscimed.2004.06.007; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Krebs B, 2007, J NEUROCHEM, V100, P358, DOI 10.1111/j.1471-4159.2006.04256.x; Kubzansky LD, 2011, ARCH GEN PSYCHIAT, V68, P400, DOI 10.1001/archgenpsychiatry.2011.23; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meyer SE, 2009, J AFFECT DISORDERS, V113, P227, DOI 10.1016/j.jad.2008.05.024; Mick E, 2010, GENETIC ASS STUDY EM; Mick E, 2011, J AM ACAD CHILD PSY, V50, P807, DOI 10.1016/j.jaac.2011.05.001; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mizuno M, 2003, LEARN MEMORY, V10, P108, DOI 10.1101/lm.56003; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Player MS, 2007, ANN FAM MED, V5, P403, DOI 10.1370/afm.738; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Spielberger C.D., 1983, ADV PERSONAL ASSESS, V2, P161; Surman CBH, 2011, AM J PSYCHIAT, V168, P617, DOI 10.1176/appi.ajp.2010.10081172; Thalhammer A, 2009, J NEUROCHEM, V109, P297, DOI 10.1111/j.1471-4159.2009.05951.x; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Vansteelandt S, 2009, GENET EPIDEMIOL, V33, P394, DOI 10.1002/gepi.20393; Volk HE, 2007, BIOL PSYCHIAT, V62, P115, DOI 10.1016/j.biopsych.2006.05.036; Williams Janice E, 2006, Prev Cardiol, V9, P14, DOI 10.1111/j.1520-037X.2006.1610.x; Williams JE, 2007, AM J EPIDEMIOL, V165, P1296, DOI 10.1093/aje/kwm001; Williams JE, 2000, CIRCULATION, V101, P2034, DOI 10.1161/01.CIR.101.17.2034; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625; Williams JE, 2001, AM J EPIDEMIOL, V154, P230, DOI 10.1093/aje/154.3.230; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Youngstrom E, 2005, BIOL PSYCHIAT, V58, P569, DOI 10.1016/j.biopsych.2005.04.004	57	81	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87257	10.1371/journal.pone.0087257	http://dx.doi.org/10.1371/journal.pone.0087257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489884	gold, Green Published			2022-12-27	WOS:000330510000122
J	Xu, YH; Shen, ST; Sun, LZ; Yang, HW; Jin, B; Cao, XH				Xu, Yuhong; Shen, Shutong; Sun, Lizhou; Yang, Haiwei; Jin, Bai; Cao, Xiaohui			Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CARDIOMETABOLIC RISK; GLUCOSE REGULATION; CHINESE WOMEN; FOLLOW-UP; MELLITUS; HYPERGLYCEMIA; HISTORY; ASSOCIATION; INTOLERANCE; PREGNANCY	Background: A number of studies have been conducted to investigate the risk of metabolic syndrome (MS) after gestational diabetes mellitus (GDM), but the results are contradictory. Accordingly, we performed a systematic review and meta-analysis to assess the association between these two conditions. The aim was to better understand the risks of MS with prior gestational diabetes. Methods: Pubmed, ISI Web of Science, and Cochrane databases from September 1, 1979 to July 11, 2013 were searched to identify relevant studies. 17 studies containing 5832 women and 1149 MS events were included. We calculated the odds ratio (OR) with 95% confidence interval (CI) in analysis for each study using a random-effect or fixed-effect model. We also determined heterogeneity among these 17 articles and their publication bias. Results: Women with a history of gestational diabetes had a significantly higher risk of MS than those who had a normal pregnancy (OR, 3.96; 95% CI, 2.99 to 5.26), but had significant heterogeneity (I-2 = 52.6%). The effect remained robust (OR, 4.54; 95% CI, 3.78-5.46) in the subgroup of Caucasians, but no association (OR, 1.28; 95% CI, 0.64-2.56) was found in Asians. Heterogeneity was reduced (body mass index (BMI) matched group I-2 = 14.2%, BMI higher in the GDM group I-2 = 13.2%) in the subgroup of BMI. In addition, mothers with higher BMI in the GDM group had higher risk of MS than those in the BMI matched group (BMI higher in GDM group OR, 5.39; 95% CI, 4.47-6.50, BMI matched group OR, 2.53; 95% CI, 1.88-3.41). Conclusions: This meta-analysis demonstrated increased risk of MS after gestational diabetes. Therefore, attention should be given to preventing or delaying the onset of MS in GDM mothers, particularly in Caucasian and obese mothers.	[Xu, Yuhong; Sun, Lizhou; Jin, Bai; Cao, Xiaohui] Nanjing Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shen, Shutong] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China; [Yang, Haiwei] Nanjing Med Univ, Affiliated Hosp 1, Clin Res Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Sun, LZ (corresponding author), Nanjing Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	Lizhou_sun121@hotmail.com	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310	Natural Science Foundation of China [81270710]; Jiangsu provincial Science and Technology Projects [XK201112]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022601, R01DE021726] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial Science and Technology Projects; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Natural Science Foundation of China (grant number 81270710), Jiangsu provincial Science and Technology Projects (XK201112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci B, 2011, GYNECOL ENDOCRINOL, V27, P361, DOI 10.3109/09513590.2010.492885; Akinci B, 2011, DIABETES RES CLIN PR, V91, P26, DOI 10.1016/j.diabres.2010.09.028; Akinci B, 2010, FERTIL STERIL, V93, P1248, DOI 10.1016/j.fertnstert.2008.12.007; Albareda M, 2005, METABOLISM, V54, P1115, DOI 10.1016/j.metabol.2005.03.017; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Balkau B, 2007, DIABETES METAB, V33, P405, DOI 10.1016/j.diabet.2007.08.001; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bo S, 2004, J ENDOCRINOL INVEST, V27, P629, DOI 10.1007/BF03347494; Bo Simona, 2006, Metabolic Syndrome and Related Disorders, V4, P113, DOI 10.1089/met.2006.4.113; Chatzi L, 2009, DIABETES METAB, V35, P490, DOI 10.1016/j.diabet.2009.07.003; Costacou Tina, 2008, Prev Cardiol, V11, P106; Di Cianni G, 2007, DIABETES-METAB RES, V23, P135, DOI 10.1002/dmrr.661; Edalat B, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-8; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Huopio H, 2013, EUR J ENDOCRINOL, V169, P291, DOI 10.1530/EJE-13-0286; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim C, 2006, AM J PUBLIC HEALTH, V96, P1643, DOI 10.2105/AJPH.2005.065722; Kousta E, 2006, DIABETOLOGIA, V49, P36, DOI 10.1007/s00125-005-0058-6; Krishnaveni GV, 2007, DIABETES RES CLIN PR, V78, P398, DOI 10.1016/j.diabres.2007.06.002; Kriska A, 2013, PEDIATRICS, V131, pE850, DOI 10.1542/peds.2012-0620; Lauenborg J, 2005, J CLIN ENDOCR METAB, V90, P4004, DOI 10.1210/jc.2004-1713; Madarasz E, 2009, DIABETES RES CLIN PR, V85, P197, DOI 10.1016/j.diabres.2009.05.001; Malcolm J, 2012, DIABETES-METAB RES, V28, P307, DOI 10.1002/dmrr.2275; Mao HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045882; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Niu Jian-min, 2013, Zhonghua Fu Chan Ke Za Zhi, V48, P92; Pereira MA, 2009, INT J ENV RES PUB HE, V6, P2568, DOI 10.3390/ijerph6102568; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; Schneider S, 2012, J PERINAT MED, V40, P511, DOI 10.1515/jpm-2012-0015; Shek NW, 2013, ARCH GYNECOL OBSTET; Takata Hiroshi, 2013, Nihon Rinsho, V71, P266; Tam WH, 2007, DIABETES-METAB RES, V23, P485, DOI 10.1002/dmrr.741; Tam WH, 2012, GYNECOL OBSTET INVES, V73, P168, DOI 10.1159/000329339; Verma A, 2002, J CLIN ENDOCR METAB, V87, P3227, DOI 10.1210/jc.87.7.3227; Vrachnis N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/458610; Wender-Ozegowska Ewa, 2007, Pol Arch Med Wewn, V117, P457; Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598	43	115	120	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87863	10.1371/journal.pone.0087863	http://dx.doi.org/10.1371/journal.pone.0087863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24489768	Green Published, gold, Green Submitted			2022-12-27	WOS:000330621900188
J	Liu, Y; Wang, J; Liu, DB; Li, ZG; Zhang, GS; Tao, Y; Xie, J; Pan, JF; Chen, F				Liu, Yi; Wang, Jing; Liu, Dongbi; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang			Straw Mulching Reduces the Harmful Effects of Extreme Hydrological and Temperature Conditions in Citrus Orchards	PLOS ONE			English	Article							WATER-USE EFFICIENCY; ZEA-MAYS L.; SOIL-TEMPERATURE; LOESS PLATEAU; MANAGEMENT-PRACTICES; GRASS COVER; YIELD; RUNOFF; MOISTURE; MAIZE	Extreme weather conditions with negative impacts can strongly affect agricultural production. In the Danjiangkou reservoir area, citrus yields were greatly influenced by cold weather conditions and drought stress in 2011. Soil straw mulching (SM) practices have a major effect on soil water and thermal regimes. A two-year field experiment was conducted to evaluate whether the SM practices can help achieve favorable citrus fruit yields. Results showed that the annual total runoff was significantly (P<0.05) reduced with SM as compared to the control (CK). Correspondingly, mean soil water storage in the top 100 cm of the soil profile was increased in the SM as compared to the CK treatment. However, this result was significant only in the dry season (Jan to Mar), and not in the wet season (Jul to Sep) for both years. Interestingly, the SM treatment did not significantly increase citrus fruit yield in 2010 but did so in 2011, when the citrus crop was completely destroyed (zero fruit yield) in the CK treatment plot due to extremely low temperatures during the citrus overwintering stage. The mulch probably acted as an insulator, resulting in smaller fluctuations in soil temperature in the SM than in the CK treatment. The results suggested that the small effects on soil water and temperature changes created by surface mulch had limited impact on citrus fruit yield in a normal year (e. g., in 2010). However, SM practices can positively impact citrus fruit yield in extreme weather conditions.	[Liu, Yi; Wang, Jing; Li, Zhiguo; Zhang, Guoshi; Tao, Yong; Xie, Juan; Pan, Junfeng; Chen, Fang] Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Liu, Dongbi] Hubei Acad Agr Sci, Inst Plant Protect & Soil Fertilizer, Wuhan, Peoples R China; [Zhang, Guoshi; Chen, Fang] IPNI, China Program, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Hubei Academy of Agricultural Sciences	Chen, F (corresponding author), Chinese Acad Sci China, Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	fchenipni@126.com	Liu, Yarong/B-4952-2015; zhang, guoshi/GSD-3017-2022	Joo, Kye Il/0000-0001-8834-5561	National Key Technology RD Program [2012BAD15B01]; NSFC [31100386]; Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences [Y152741s04]; International Plant Nutrition Institute [IPNI-HB-33]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA170820, P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	National Key Technology RD Program(National Key Technology R&D Program); NSFC(National Natural Science Foundation of China (NSFC)); Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences; International Plant Nutrition Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by the National Key Technology R&D Program (2012BAD15B01), the NSFC (31100386), the Open Funding Project (Y152741s04) of the Key Laboratory of Aquatic Botany and Watershed Ecology, Chinese Academy of Sciences and the Cooperated Program with the International Plant Nutrition Institute (IPNI-HB-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Balwinder-Singh, 2011, FIELD CROP RES, V121, P209, DOI 10.1016/j.fcr.2010.12.005; Bao S., 2000, SOIL AGROCHEMICAL AN; Carrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050755; Chen SY, 2007, ANN APPL BIOL, V150, P261, DOI 10.1111/j.1744-7348.2007.00144.x; Doring TF, 2005, FIELD CROP RES, V94, P238, DOI 10.1016/j.fcr.2005.01.006; Edwards L, 2000, AGR ECOSYST ENVIRON, V81, P217, DOI 10.1016/S0167-8809(00)00162-6; Fang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047369; Farkas C, 2009, BIOLOGIA, V64, P624, DOI 10.2478/s11756-009-0079-6; Ghosh PK, 2006, FIELD CROP RES, V99, P76, DOI 10.1016/j.fcr.2006.03.004; Gutierrez J, 1996, J ARID ENVIRON, V34, P287, DOI 10.1006/jare.1996.0110; Huang YL, 2005, AGR WATER MANAGE, V72, P209, DOI 10.1016/j.agwat.2004.09.012; Kar G, 2007, AGR WATER MANAGE, V94, P109, DOI 10.1016/j.agwat.2007.08.004; LAL R, 1976, GEODERMA, V16, P377, DOI 10.1016/0016-7061(76)90002-1; Li R, 2012, SOIL RES, V50, P105, DOI 10.1071/SR11331; Li XH, 2011, PEDOSPHERE, V21, P238, DOI 10.1016/S1002-0160(11)60123-9; Liu WZ, 2011, CLEAN-SOIL AIR WATER, V39, P109, DOI 10.1002/clen.200900212; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Liu Y, 2010, AGR FOREST METEOROL, V150, P606, DOI 10.1016/j.agrformet.2010.02.003; Liu Y, 2010, AGR WATER MANAGE, V97, P769, DOI 10.1016/j.agwat.2010.01.010; Lou YL, 2011, CATENA, V86, P117, DOI 10.1016/j.catena.2011.03.006; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN; Novak MD, 2000, AGR FOREST METEOROL, V102, P155, DOI 10.1016/S0168-1923(00)00097-6; Olasantan FO, 1999, SOIL TILL RES, V50, P215, DOI 10.1016/S0167-1987(98)00192-5; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Ramakrishna A, 2006, FIELD CROP RES, V95, P115, DOI 10.1016/j.fcr.2005.01.030; Sarkar S, 2007, SOIL TILL RES, V93, P94, DOI 10.1016/j.still.2006.03.015; She DL, 2009, PESQUI AGROPECU BRAS, V44, P189, DOI 10.1590/S0100-204X2009000200011; Silvente S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038554; van der Velde M, 2012, CLIMATIC CHANGE, V113, P751, DOI 10.1007/s10584-011-0368-2; Wakindiki IIC, 2011, AFR J AGR RES, V6, P725; Wang YJ, 2011, AGR WATER MANAGE, V101, P88, DOI 10.1016/j.agwat.2011.09.006; Zhang QF, 2009, J AM WATER RESOUR AS, V45, P1238, DOI 10.1111/j.1752-1688.2009.00357.x; Zhang SL, 2009, SOIL TILL RES, V102, P78, DOI 10.1016/j.still.2008.07.019; Zhao H, 2012, PLASTIC FILM MULCH H	35	32	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2014	9	1							e87094	10.1371/journal.pone.0087094	http://dx.doi.org/10.1371/journal.pone.0087094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301CJ	24489844	Green Published, gold, Green Submitted			2022-12-27	WOS:000330510000107
J	Liu, DG; Wang, LJ; Zhai, H; Song, XJ; He, SZ; Liu, QC				Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang			A Novel alpha/beta-Hydrolase Gene IbMas Enhances Salt Tolerance in Transgenic Sweetpotato	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; PROLINE ACCUMULATION; PLANT-REGENERATION; PHOSPHOLIPASE-D; SOYBEAN PLANTS; DROUGHT; MECHANISMS; CLONING; OVEREXPRESSION; PROTEINS	Salt stress is one of the major environmental stresses in agriculture worldwide and affects crop productivity and quality. The development of crops with elevated levels of salt tolerance is therefore highly desirable. In the present study, a novel maspardin gene, named IbMas, was isolated from salt-tolerant sweetpotato (Ipomoea batatas (L.) Lam.) line ND98. IbMas contains maspardin domain and belongs to alpha/beta-hydrolase superfamily. Expression of IbMas was up-regulated in sweetpotato under salt stress and ABA treatment. The IbMas-overexpressing sweetpotato (cv. Shangshu 19) plants exhibited significantly higher salt tolerance compared with the wild-type. Proline content was significantly increased, whereas malonaldehyde content was significantly decreased in the transgenic plants. The activities of superoxide dismutase (SOD) and photosynthesis were significantly enhanced in the transgenic plants. H2O2 was also found to be significantly less accumulated in the transgenic plants than in the wild-type. Overexpression of IbMas up-regulated the salt stress responsive genes, including pyrroline-5-carboxylate synthase, pyrroline-5-carboxylate reductase, SOD, psbA and phosphoribulokinase genes, under salt stress. These findings suggest that overexpression of IbMas enhances salt tolerance of the transgenic sweetpotato plants by regulating osmotic balance, protecting membrane integrity and photosynthesis and increasing reactive oxygen species scavenging capacity.	[Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China	China Agricultural University	Liu, QC (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31371680, 31271777]; China Agriculture Research System [CARS-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31371680, 31271777) and China Agriculture Research System (CARS-11, Sweetpotato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Alia, 2001, AMINO ACIDS, V21, P195; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; de Ronde JA, 2000, PLANT GROWTH REGUL, V32, P13, DOI 10.1023/A:1006338911617; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deng XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069881; Dhir SK, 1998, PLANT CELL REP, V17, P665, DOI 10.1007/s002990050462; Fernandez-Falcon M, 2006, SCI HORTIC-AMSTERDAM, V107, P373, DOI 10.1016/j.scienta.2005.08.009; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hanna MC, 2009, NEUROGENETICS, V10, P217, DOI 10.1007/s10048-009-0172-6; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Huang P, 2013, PLANT SCI, V203, P98, DOI 10.1016/j.plantsci.2012.12.019; Jiang T, 2013, SCI HORTIC-AMSTERDAM, V158, P22, DOI 10.1016/j.scienta.2013.04.027; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Liu DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093935; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QC, 2001, IN VITRO CELL DEV-PL, V37, P564; Liu QC, 2011, PLANT OMICS, V4, P295; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Peng XJ, 2013, PLANT CELL TISS ORG, V113, P245, DOI 10.1007/s11240-012-0264-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Sun YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059924; Swapna T. S., 2002, Indian Journal of Experimental Biology, V40, P1056; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tan CM, 2013, INT J MOL SCI, V14, P20204, DOI 10.3390/ijms141020204; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang L, 2013, PLANT CELL TISS ORG, V113, P407, DOI 10.1007/s11240-012-0280-0; Zang N, 2009, SCI HORTIC-AMSTERDAM, V122, P649, DOI 10.1016/j.scienta.2009.06.023; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	58	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115128	10.1371/journal.pone.0115128	http://dx.doi.org/10.1371/journal.pone.0115128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	24489818	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400074
J	Filho, MAM; Dutra, JDL; Rocha, GB; Simas, AM; Freire, RO				Filho, Manoel A. M.; Dutra, Jose Diogo L.; Rocha, Gerd B.; Simas, Alfredo M.; Freire, Ricardo O.			Semiempirical Quantum Chemistry Model for the Lanthanides: RM1 (Recife Model 1) Parameters for Dysprosium, Holmium and Erbium	PLOS ONE			English	Article							CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL AM1 CALCULATION; SINGLE-MOLECULE MAGNET; SPARKLE MODEL; COORDINATION POLYHEDRON; COMPLEXES; EUROPIUM(III); PHOTOLUMINESCENCE; PSEUDOPOTENTIALS; PREDICTION	Complexes of dysprosium, holmium, and erbium find many applications as single-molecule magnets, as contrast agents for magnetic resonance imaging, as anti-cancer agents, in optical telecommunications, etc. Therefore, the development of tools that can be proven helpful to complex design is presently an active area of research. In this article, we advance a major improvement to the semiempirical description of lanthanide complexes: the Recife Model 1, RM1, model for the lanthanides, parameterized for the trications of Dy, Ho, and Er. By representing such lanthanide in the RM1 calculation as a three-electron atom with a set of 5 d, 6 s, and 6 p semiempirical orbitals, the accuracy of the previous sparkle models, mainly concentrated on lanthanide-oxygen and lanthanide-nitrogen distances, is extended to other types of bonds in the trication complexes' coordination polyhedra, such as lanthanide-carbon, lanthanide-chlorine, etc. This is even more important as, for example, lanthanide-carbon atom distances in the coordination polyhedra of the complexes comprise about 30% of all distances for all complexes of Dy, Ho, and Er considered. Our results indicate that the average unsigned mean error for the lanthanide-carbon distances dropped from an average of 0.30 angstrom, for the sparkle models, to 0.04 angstrom for the RM1 model for the lanthanides; for a total of 509 such distances for the set of all Dy, Ho, and Er complexes considered. A similar behavior took place for the other distances as well, such as lanthanide-chlorine, lanthanide-bromine, lanthanide, phosphorus and lanthanide-sulfur. Thus, the RM1 model for the lanthanides, being advanced in this article, broadens the range of application of semiempirical models to lanthanide complexes by including comprehensively many other types of bonds not adequately described by the previous models.	[Filho, Manoel A. M.; Dutra, Jose Diogo L.; Freire, Ricardo O.] Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil; [Rocha, Gerd B.] Univ Fed Paraiba, CCEN, Dept Quim, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Sergipe; Universidade Federal da Paraiba; Universidade Federal de Pernambuco	Freire, RO (corresponding author), Univ Fed Sergipe, Dept Quim, Pople Computat Chem Lab, Sao Cristovao, SE, Brazil.	rfreire@ufs.br	Lisboa Dutra, José Diogo/I-7088-2013; Freire, Ricardo O/B-7685-2008; Rocha, Gerd B/G-5115-2010; Freire, Ricardo/AGR-4537-2022; Filho, Manoel Alves Machado/R-2505-2019; DUTRA, JOSE DIOGO LISBOA/AAJ-9870-2021; Simas, Alfredo M/B-1096-2008; Cominetti, Marcia Regina/B-8080-2012; Vieira, Paulo Cezar/B-9504-2012; Franceschini Sarria, Andre Lucio/C-8189-2012	Freire, Ricardo O/0000-0002-3603-3184; Rocha, Gerd B/0000-0001-9805-9497; Freire, Ricardo/0000-0002-3603-3184; DUTRA, JOSE DIOGO LISBOA/0000-0003-2123-2209; Simas, Alfredo M/0000-0003-3653-6328; Cominetti, Marcia Regina/0000-0001-6385-7392; Vieira, Paulo Cezar/0000-0003-4207-6217; Paranhos, Caio M./0000-0002-2261-0585; Franceschini Sarria, Andre Lucio/0000-0003-0616-624X; Blanque Becceneri, Amanda/0000-0001-5223-961X	CNPq; FAPITEC-SE; FACEPE (Pronex); INAMI	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPITEC-SE; FACEPE (Pronex)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); INAMI	This work received financial support from the Brazilian agencies, institutes and networks: CNPq, FAPITEC-SE, FACEPE (Pronex), and INAMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlDamen MA, 2009, INORG CHEM, V48, P3467, DOI 10.1021/ic801630z; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P407, DOI 10.1107/S0108768102004895; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; BAYOUTH JE, 1995, J NUCL MED, V36, P730; Conover WJ, 1999, PRACTICAL NONPARAMET; da Costa NB, 2005, POLYHEDRON, V24, P3046, DOI 10.1016/j.poly.2005.06.027; da Costa NB, 2005, INORG CHEM COMMUN, V8, P831, DOI 10.1016/j.inoche.2005.06.014; DEANDRADE AVM, 1994, CHEM PHYS LETT, V227, P349, DOI 10.1016/0009-2614(94)00829-9; deAndrade AVM, 1996, J CHEM SOC FARADAY T, V92, P1835, DOI 10.1039/ft9969201835; DEANDRADE AVM, 1995, J ALLOY COMPD, V225, P55, DOI 10.1016/0925-8388(94)07009-1; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DOLG M, 1989, THEOR CHIM ACTA, V75, P173, DOI 10.1007/BF00528565; DOLG M, 1989, J CHEM PHYS, V90, P1730, DOI 10.1063/1.456066; Dolg M, 2012, CHEM REV, V112, P403, DOI 10.1021/cr2001383; Dutra JDL, 2013, J CHEM THEORY COMPUT, V9, P3333, DOI 10.1021/ct301012h; Ertl P, 2003, J CHEM INF COMP SCI, V43, P374, DOI 10.1021/ci0255782; Faustino WM, 2006, J PHYS CHEM A, V110, P2510, DOI 10.1021/jp056180m; Faustino WM, 2000, J MOL STRUC-THEOCHEM, V527, P245, DOI 10.1016/S0166-1280(00)00497-8; Filho MAM, 2013, RSC ADV, V3, P16747, DOI 10.1039/c3ra41406j; Freire RO, 2006, J ORGANOMET CHEM, V691, P2584, DOI 10.1016/j.jorganchem.2006.01.044; Freire RO, 2006, CHEM PHYS LETT, V425, P138, DOI 10.1016/j.cplett.2006.04.103; Freire RO, 2010, J CHEM THEORY COMPUT, V6, P2019, DOI 10.1021/ct100192c; Freire RO, 2009, J BRAZIL CHEM SOC, V20, P1638, DOI 10.1590/S0103-50532009000900011; Freire RO, 2006, J MOL MODEL, V12, P373, DOI 10.1007/s00894-005-0027-5; Freire RO, 2005, J COMPUT CHEM, V26, P1524, DOI 10.1002/jcc.20288; Freire RO, 2005, INORG CHEM, V44, P3299, DOI 10.1021/ic048530+; Freire RO, 2005, J LUMIN, V111, P81, DOI 10.1016/j.jlumin.2004.07.001; Ishikawa N, 2003, J AM CHEM SOC, V125, P8694, DOI 10.1021/ja029629n; Ishikawa N, 2008, INORG CHEM, V47, P10217, DOI 10.1021/ic8014892; Kaufman L., 2009, FINDING GROUPS DATA; Lin PH, 2009, ANGEW CHEM INT EDIT, V48, P9489, DOI 10.1002/anie.200903199; Nilsson S, 1996, ACTA RADIOL, V37, P27; Norek M, 2011, PROG NUCL MAG RES SP, V59, P64, DOI 10.1016/j.pnmrs.2010.08.002; Orpen AG, 2002, ACTA CRYSTALLOGR B, V58, P398, DOI 10.1107/S0108768102002446; Park OH, 2003, J MATER RES, V18, P1039, DOI 10.1557/JMR.2003.0143; Rinehart JD, 2011, NAT CHEM, V3, P538, DOI 10.1038/nchem.1063; Rocha GB, 2004, INORG CHEM, V43, P2346, DOI 10.1021/ic034882p; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Simas AM, 2008, J ORGANOMET CHEM, V693, P1952, DOI 10.1016/j.jorganchem.2008.01.029; Stewart J. J. P., 2012, MOPAC2012; STEWART JPP, 2007, MOPAC2007; Sun LN, 2005, ADV FUNCT MATER, V15, P1041, DOI 10.1002/adfm.200400386; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; WIKSTROM M, 1992, ACTA RADIOL, V33, P1; Zhang P, 2013, COORDIN CHEM REV, V257, P1728, DOI 10.1016/j.ccr.2013.01.012	45	28	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e86376	10.1371/journal.pone.0086376	http://dx.doi.org/10.1371/journal.pone.0086376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24497945	gold, Green Published, Green Submitted			2022-12-27	WOS:000330621900023
J	Liu, DF; Sui, SZ; Ma, J; Li, ZN; Guo, YL; Luo, DP; Yang, JF; Li, MY				Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang			Transcriptomic Analysis of Flower Development in Wintersweet (Chimonanthus praecox)	PLOS ONE			English	Article							FLORAL SCENT PRODUCTION; LINALOOL SYNTHASE GENE; RNA-SEQ DATA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL EXPRESSION; CLARKIA-BREWERI; SALICYLIC-ACID; SENESCENCE; IDENTIFICATION; HORMONE	Wintersweet (Chimonanthus praecox) is familiar as a garden plant and woody ornamental flower. On account of its unique flowering time and strong fragrance, it has a high ornamental and economic value. Despite a long history of human cultivation, our understanding of wintersweet genetics and molecular biology remains scant, reflecting a lack of basic genomic and transcriptomic data. In this study, we assembled three cDNA libraries, from three successive stages in flower development, designated as the flower bud with displayed petal, open flower and senescing flower stages. Using the Illumina RNA-Seq method, we obtained 21,412,928, 26,950,404, 24,912,954 qualified Illumina reads, respectively, for the three successive stages. The pooled reads from all three libraries were then assembled into 106,995 transcripts, 51,793 of which were annotated in the NCBI non-redundant protein database. Of these annotated sequences, 32,649 and 21,893 transcripts were assigned to gene ontology categories and clusters of orthologous groups, respectively. We could map 15,587 transcripts onto 312 pathways using the Kyoto Encyclopedia of Genes and Genomes pathway database. Based on these transcriptomic data, we obtained a large number of candidate genes that were differentially expressed at the open flower and senescing flower stages. An analysis of differentially expressed genes involved in plant hormone signal transduction pathways indicated that although flower opening and senescence may be independent of the ethylene signaling pathway in wintersweet, salicylic acid may be involved in the regulation of flower senescence. We also succeeded in isolating key genes of floral scent biosynthesis and proposed a biosynthetic pathway for monoterpenes and sesquiterpenes in wintersweet flowers, based on the annotated sequences. This comprehensive transcriptomic analysis presents fundamental information on the genes and pathways which are involved in flower development in wintersweet. And our data provided a useful database for further research of wintersweet and other Calycanthaceae family plants.	[Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang] Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China	Southwest University - China	Li, MY (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China.	limy@swu.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31070622]; Fundamental Research Funds for the Central Universities [XDJK2013A004]; postdoctoral research foundation of Chongqing [Xm201345]; "111" Project [B12006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); postdoctoral research foundation of Chongqing; "111" Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (Grant nos. 31070622), the Fundamental Research Funds for the Central Universities (XDJK2013A004), the postdoctoral research foundation of Chongqing (Xm201345) and the "111" Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Arora A, 2004, J PLANT BIOCHEM BIOT, V13, P123, DOI 10.1007/BF03263206; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma Hiroshi, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P197; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Benjamini Y, 2001, ANN STAT, V29, P1165; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Breeze E, 2004, PLANT BIOTECHNOL J, V2, P155, DOI 10.1111/j.1467-7652.2004.00059.x; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Deng CH, 2004, Z NATURFORSCH C, V59, P636; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 1996, PLANT PHYSIOL, V111, P815; Eason JR, 2002, FUNCT PLANT BIOL, V29, P1055, DOI 10.1071/PP01174; Fahnrich A, 2011, MOL PLANT, V4, P965, DOI 10.1093/mp/ssr021; Feng JQ, 2007, J BEIJING FORESTR S1, P4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Harada T, 2010, J EXP BOT, V61, P2345, DOI 10.1093/jxb/erq064; Hunter DA, 2002, PLANT SCI, V163, P13, DOI 10.1016/S0168-9452(02)00068-7; Iordachescu M, 2005, J EXP BOT, V56, P2011, DOI 10.1093/jxb/eri199; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; JONES ML, 1995, PLANT MOL BIOL, V28, P505, DOI 10.1007/BF00020397; Kitajima M, 2006, TETRAHEDRON LETT, V47, P3199, DOI 10.1016/j.tetlet.2006.03.047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, PLANT PHYSIOL, V147, P1017, DOI 10.1104/pp.108.115824; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y., 2000, GUIHAIA, V20, P295; Lin CF, 2008, PLANT PHYSIOL, V146, P940, DOI 10.1104/pp.107.109553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2012, HORTSCIENCE, V47, P1472, DOI 10.21273/HORTSCI.47.10.1472; Ma L, 2012, AGR SCI TECHN, V13, P88; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2007, TRENDS BIOTECHNOL, V25, P105, DOI 10.1016/j.tibtech.2007.01.002; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Shahri W, 2011, BOT REV, V77, P152, DOI 10.1007/s12229-011-9063-2; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Sheng AiWu, 1999, Journal of Beijing Forestry University, V21, P48; Spiller M, 2010, THEOR APPL GENET, V120, P1461, DOI 10.1007/s00122-010-1268-y; Sui SZ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/134596; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; VALPUESTA V, 1995, PLANT MOL BIOL, V28, P575, DOI 10.1007/BF00020403; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagstaff C, 2002, J EXP BOT, V53, P233, DOI 10.1093/jexbot/53.367.233; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xiang L, 2010, PLANT PHYSIOL BIOCH, V48, P845, DOI 10.1016/j.plaphy.2010.08.015; ZHANG RH, 1998, WAX SHRUBS WORLD CAL; Zhao KG, 2007, HORTSCIENCE, V42, P1144, DOI 10.21273/HORTSCI.42.5.1144; [赵莹 ZHAO Ying], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P622	69	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86976	10.1371/journal.pone.0086976	http://dx.doi.org/10.1371/journal.pone.0086976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489818	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000087
J	Zhu, L; Xu, YF; Ferretti, JJ; Kreth, J				Zhu, Lin; Xu, Yifan; Ferretti, Joseph J.; Kreth, Jens			Probing Oral Microbial Functionality - Expression of spxB in Plaque Samples	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; GENE-EXPRESSION; VIRULENCE; BACTERIA; GORDONII; SANGUINIS; SURFACES; GENOME	The Human Oral Microbiome Database (HOMD) provides an extensive collection of genome sequences from oral bacteria. The sequence information is a static snapshot of the microbial potential of the so far sequenced species. A major challenge is to connect the microbial potential encoded in the metagenome to an actual function in the in vivo oral biofilm. In the present study we took a reductionist approach and identified a considerably conserved metabolic gene, spxB to be encoded by a majority of oral streptococci using the HOMD metagenome information. spxB encodes the pyruvate oxidase responsible for the production of growth inhibiting amounts of hydrogen peroxide (H2O2) and has previously been shown as important in the interspecies competition in the oral biofilm. Here we demonstrate a strong correlation of H2O2 production and the presence of the spxB gene in dental plaque. Using Real-Time RT PCR we show that spxB is expressed in freshly isolated human plaque samples from several donors and that the expression is relative constant when followed over time in one individual. This is the first demonstration of an oral community encoded gene expressed in vivo suggesting a functional role of spxB in oral biofilm physiology. This also demonstrates a possible strategy to connect the microbial potential of the metagenome to its functionality in future studies by identifying similar highly conserved genes in the oral microbial community.	[Zhu, Lin] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Dept Periodont, Oklahoma City, OK 73190 USA; [Xu, Yifan; Ferretti, Joseph J.; Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Xu, Yifan] China Med Univ, Hosp 1, Dept Surg Oncol, Shenyang, Peoples R China; [Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Coll Dent, Dept Oral Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; China Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kreth, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	JKreth@ouhsc.edu	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310	National Institutes of Health - National Institute of Dental and Craniofacial Research [DE022601]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022601, R01DE021726] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health - National Institute of Dental and Craniofacial Research grant (DE022601) to J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Carlsson J, 1987, Oral Microbiol Immunol, V2, P15, DOI 10.1111/j.1399-302X.1987.tb00264.x; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; HERZBERG MC, 1990, INFECT IMMUN, V58, P515, DOI 10.1128/IAI.58.2.515-522.1990; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Kilic AO, 1999, PLASMID, V42, P67, DOI 10.1006/plas.1999.1408; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Qi FX, 2001, APPL ENVIRON MICROB, V67, P15, DOI 10.1128/AEM.67.1.15-21.2001; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; RYAN CS, 1995, ARCH ORAL BIOL, V40, P753, DOI 10.1016/0003-9969(95)00029-O; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shelburne CE, 2002, J MICROBIOL METH, V49, P147, DOI 10.1016/S0167-7012(01)00362-1; Shelburne SA, 2004, CURR OPIN MICROBIOL, V7, P283, DOI 10.1016/j.mib.2004.04.013; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003; Walters S, 2009, J DENT RES, V88, P34, DOI 10.1177/0022034508328381; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x; Zaura E, 2012, Adv Dent Res, V24, P81, DOI 10.1177/0022034512449466; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	38	115	120	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86685	10.1371/journal.pone.0086685	http://dx.doi.org/10.1371/journal.pone.0086685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489768	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000060
J	Wei, XH; Blanco, JA				Wei, Xiaohua; Blanco, Juan A.			Significant Increase in Ecosystem C Can Be Achieved with Sustainable Forest Management in Subtropical Plantation Forests	PLOS ONE			English	Article							CHINESE-FIR PLANTATIONS; CARBON SEQUESTRATION; CUNNINGHAMIA-LANCEOLATA; NITROGEN DEPOSITION; BIOMASS PRODUCTION; SIMULATION-MODEL; PHOEBE-BOURNEI; DOUGLAS-FIR; PRODUCTIVITY; IMPACTS	Subtropical planted forests are rapidly expanding. They are traditionally managed for intensive, short-term goals that often lead to long-term yield decline and reduced carbon sequestration capacity. Here we show how it is possible to increase and sustain carbon stored in subtropical forest plantations if management is switched towards more sustainable forestry. We first conducted a literature review to explore possible management factors that contribute to the potentials in ecosystem C in tropical and subtropical plantations. We found that broadleaves plantations have significantly higher ecosystem C than conifer plantations. In addition, ecosystem C increases with plantation age, and reaches a peak with intermediate stand densities of 1500-2500 trees ha(-1). We then used the FORECAST model to simulate the regional implications of switching from traditional to sustainable management regimes, using Chinese fir (Cunninghamia lanceolata) plantations in subtropical China as a study case. We randomly simulated 200 traditional short-rotation pure stands and 200 sustainably-managed mixed Chinese fir - Phoebe bournei plantations, for 120 years. Our results showed that mixed, sustainably-managed plantations have on average 67.5% more ecosystem C than traditional pure conifer plantations. If all pure plantations were gradually transformed into mixed plantations during the next 10 years, carbon stocks could rise in 2050 by 260.22 TgC in east-central China. Assuming similar differences for temperate and boreal plantations, if sustainable forestry practices were applied to all new forest plantation types in China, stored carbon could increase by 1,482.80 TgC in 2050. Such an increase would be equivalent to a yearly sequestration rate of 40.08 TgC yr(-1), offsetting 1.9% of China's annual emissions in 2010. More importantly, this C increase can be sustained in the long term through the maintenance of higher amounts of soil organic carbon and the production of timber products with longer life spans.	[Wei, Xiaohua] Univ British Columbia, Dept Earth & Environm Sci, Kelowna, BC, Canada; [Blanco, Juan A.] Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain	University of British Columbia; Universidad Publica de Navarra	Blanco, JA (corresponding author), Univ Publ Navarra, Dept Ciencias Medio Nat, Navarra, Spain.	juan.blanco@unavarra.es	FENG, NAN/HGD-3255-2022; lu, ran/HHC-8613-2022; Blanco, Juan A./A-4554-2009	Blanco, Juan A./0000-0002-6524-4335; Wei, Xiaohua (Adam)/0000-0003-2711-5636; Gu, Nan/0000-0001-9852-0060	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon [XDA05060101]; BC-China Innovation and Commercialization Strategic Development Program [ICSD-2007-Wei-Kimmins]	Forest Carbon Counting Method Project of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; BC-China Innovation and Commercialization Strategic Development Program	Funding for this research was provided by: 1) Forest Carbon Counting Method Project (XDA05060101) of the Chinese Academy of Science Strategic and Flagship Program on the Chinese Ecological and Engineering Projects and their Contributions to Carbon; and 2) BC-China Innovation and Commercialization Strategic Development Program (ICSD-2007-Wei-Kimmins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoroso MM, 2006, CAN J FOREST RES, V36, P1484, DOI 10.1139/X06-042; Bauhus J, 2000, CAN J FOREST RES, V30, P1886, DOI 10.1139/cjfr-30-12-1886; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Blanco JA, 2010, J TROP FOR SCI, V22, P139; Blanco JA, 2005, FOREST ECOL MANAG, V213, P209, DOI 10.1016/j.foreco.2005.03.042; Blanco JA, 2007, CAN J FOREST RES, V37, P1808, DOI 10.1139/X07-041; Blanco JA, 2012, SCI TOTAL ENVIRON, V437, P91, DOI 10.1016/j.scitotenv.2012.07.082; Blanco JA, 2012, CAN J FOREST RES, V42, P437, DOI [10.1139/X2012-004, 10.1139/x2012-004]; Cannell MGR, 2003, BIOMASS BIOENERG, V24, P97, DOI 10.1016/S0961-9534(02)00103-4; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; [陈淑容 CHEN Shu-rong], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P157; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; CHEN XY, 2009, JIANGXI FOREST SCI T, V1, P14, DOI DOI 10.3724/SP.J.1227.00001; Cheng Y, 2003, THESIS FUJIAN AGR FO; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Ding Y. X., 1995, Pedosphere, V5, P57; Ding YX, 1999, FOREST STUD CHINA, V1, P34; Du Juan, 2010, Journal of Zhejiang Forestry Science and Technology, V30, P37; Du Juan, 2009, Journal of Zhejiang Forestry Science and Technology, V29, P9; Duan W, 2008, SICHUAN ENV, V27, P57; Eriksson E, 2007, CAN J FOREST RES, V37, P671, DOI 10.1139/X06-257; Erskine PD, 2006, FOREST ECOL MANAG, V233, P205, DOI 10.1016/j.foreco.2006.05.013; Evans J., 2001, 2 FAO FOR RES DEV SE; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fan X, 2001, FOR RES, V14, P11; FAO, 2012, STAT WORLDS FOR 2012; FAO, 2006, 38 FAO; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Guan BT, 2012, FOREST ECOL MANAG, V267, P50, DOI 10.1016/j.foreco.2011.11.028; Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; [郭玉硕 GUO Yushuo], 2007, [福建林学院学报, Journal of Fujian College of Forestry], V27, P199; Hu JingNan, 2010, Journal of Anhui Agricultural University, V37, P541; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jie C, 2011, P 2011 19 INT C GEOI, DOI [10.1109/GeoInformatics.2011.5981581, DOI 10.1109/GE0INF0RMATICS.2011.5981581]; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Kimmins J.P., 2010, FORECASTING FOREST F; Kimmins JP, 2008, FOREST ECOL MANAG, V256, P1646, DOI [10.1016/j.foreco.2008.03.011, 10.1016/j.foreco.2008.02.057]; Kimmins JP, 1999, ECOL MODEL, V122, P195, DOI 10.1016/S0304-3800(99)00138-6; Kirilenko AP, 2007, P NATL ACAD SCI USA, V104, P19697, DOI 10.1073/pnas.0701424104; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Li MH, 1999, NEW FOREST, V18, P131, DOI 10.1023/A:1006558900234; Liao CZ, 2012, GLOBAL ECOL BIOGEOGR, V21, P318, DOI 10.1111/j.1466-8238.2011.00690.x; Liao H, 1989, J FUJIAN COLL FOREST, V9, P80; Liao L., 2000, ACTA PHYTOECCOL SIN, V24, P27; Lin Kai-min, 2010, Journal of Plant Resources and Environment, V19, P34; [林开敏 LIN KaiMin], 2006, [生态学报, Acta Ecologica Sinica], V26, P2732; Lin KM, 2001, SCI SILVAE SINICAE, V37, P94, DOI DOI 10.11707/J.1001-7488.2001S117; Lin T, 2011, JIANGXI FORESTRY SCI, V3, P16; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Liu F, 1991, J NANJING FOR U, P7; Liu P, 2012, FORESTS, V3, P417, DOI 10.3390/f3020417; Liu Q, 2009, J JIANXI FORESTRY SC, V1, P31; Lo YH, 2012, FOREST ECOSYSTEMS MO, P339; Lu M, 2006, THESIS FUJIAN AGR FO; Lu Zhao-hua, 2002, Journal of Forestry Research (Harbin), V13, P319, DOI 10.1007/BF02860099; Ma MingDong, 2008, Scientia Silvae Sinicae, V44, P34; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Masera OR, 2003, ECOL MODEL, V164, P177, DOI 10.1016/S0304-3800(02)00419-2; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nabuurs GJ, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P541; Niu XZ, 2006, FOREST ECOL MANAG, V223, P415, DOI 10.1016/j.foreco.2005.12.044; Pan WC, 1983, J CENTRAL S FORESTRY, V3, P1; Paquette A, 2010, FRONT ECOL ENVIRON, V8, P27, DOI 10.1890/080116; Peng L, 2008, J FUJIAN FORESTRY SC, V35, P10; Peng L, 2008, J FUJIAN FOR SIC TEC, V35, P15; Peng LongFu, 2003, Journal of Fujian College of Forestry, V23, P128; Perez-Garcia J, 2005, WOOD FIBER SCI, V37, P140; Pretzsch H, 2013, EUR J FOREST RES, V132, P263, DOI 10.1007/s10342-012-0673-y; Primicia I, 2013, EUR J FOREST RES, V132, P121, DOI 10.1007/s10342-012-0662-1; Qi G, 2011, THESIS CHINESE ACAD; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ren CH, 1990, J FUJIAN COLL FOREST, V10, P67; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Seely B, 2002, FOREST ECOL MANAG, V169, P123, DOI 10.1016/S0378-1127(02)00303-1; Seely B, 2010, ECOL INDIC, V10, P999, DOI 10.1016/j.ecolind.2010.02.008; Shao L, 1992, RES SITE DEGRADATION, P87; State Forestry Administration People's Republic of China, 2009, APFSOS2WP200911 FAO; Tian DL, 2011, FORESTRY, V84, P411, DOI 10.1093/forestry/cpr029; Tian DL, 1994, STUDIES FOREST ECOSY, P136; Tian DL, 1989, J CENT S FOR U, V9, P38; Tian DL, 1989, J CENTRAL S FOR COLL, V9, P45; Tummer B, 2006, DATATHEIF 3 V1 6; [吴载璋 Tun Zaizhang], 2004, [福建林学院学报, Journal of Fujian College of Forestry], V24, P371; van Minnen Jelle G, 2008, Carbon Balance Manag, V3, P3, DOI 10.1186/1750-0680-3-3; Wang WF, 2013, FOREST ECOL MANAG, V300, P21, DOI 10.1016/j.foreco.2012.06.044; Wei XH, 2012, SCI TOTAL ENVIRON, V416, P351, DOI 10.1016/j.scitotenv.2011.11.087; Wu W. M., 2009, CHINA FOR SCI TECHNO, V23, P75; Wu ZaiZhang, 2005, Journal of Fujian College of Forestry, V25, P142; Wu ZL, 1984, CHINESE FIR CHINA FO; [项文化 Xiang Wenhua], 2003, [生态学报, Acta Ecologica Sinica], V23, P695; Xiao W, 1999, FOR RES, V3, P253; Yan W, 2003, FOR RES, V16, P82; Yang YuSheng, 2000, Journal of Nanjing Forestry University, V24, P25; Yang YuSheng, 1999, Scientia Silvae Sinicae, V35, P32; Yu X., 1997, SILVICULTURE CHINESE; Yu XT, 1999, CHINESE FORESTS, P1; Zhang G, 2009, ANHUI AGR SCI B, V15, P131; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; ZHONG AL, 1993, FOREST ECOL MANAG, V62, P245, DOI 10.1016/0378-1127(93)90053-P; Zhou H, 1999, J FUJIAN COLL FOR, V2, P165; Zhou X, 1991, J NANJING FOR U, V3, P47; Zhou X. F, 1994, LONG TERM RES CHINAS	110	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89688	10.1371/journal.pone.0089688	http://dx.doi.org/10.1371/journal.pone.0089688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586964	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700073
J	Kawaza, K; Machen, HE; Brown, J; Mwanza, Z; Iniguez, S; Gest, A; Smith, EO; Oden, M; Richards-Kortum, RR; Molyneux, E				Kawaza, Kondwani; Machen, Heather E.; Brown, Jocelyn; Mwanza, Zondiwe; Iniguez, Suzanne; Gest, Al; Smith, E. O'Brian; Oden, Maria; Richards-Kortum, Rebecca R.; Molyneux, Elizabeth			Efficacy of a Low-Cost Bubble CPAP System in Treatment of Respiratory Distress in a Neonatal Ward in Malawi	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; PRETERM INFANTS; BIRTH; SUPPORT; CARE; INTUBATION	Background: Respiratory failure is a leading cause of neonatal mortality in the developing world. Bubble continuous positive airway pressure (bCPAP) is a safe, effective intervention for infants with respiratory distress and is widely used in developed countries. Because of its high cost, bCPAP is not widely utilized in low-resource settings. We evaluated the performance of a new bCPAP system to treat severe respiratory distress in a low resource setting, comparing it to nasal oxygen therapy, the current standard of care. Methods: We conducted a non-randomized convenience sample study to test the efficacy of a low-cost bCPAP system treating newborns with severe respiratory distress in the neonatal ward of Queen Elizabeth Central Hospital, in Blantyre, Malawi. Neonates weighing >1,000 g and presenting with severe respiratory distress who fulfilled inclusion criteria received nasal bCPAP if a device was available; if not, they received standard care. Clinical assessments were made during treatment and outcomes compared for the two groups. Findings: 87 neonates (62 bCPAP, 25 controls) were recruited. Survival rate for neonates receiving bCPAP was 71.0% (44/62) compared with 44.0% (11/25) for controls. 65.5% (19/29) of very low birth weight neonates receiving bCPAP survived to discharge compared to 15.4% (1/13) of controls. 64.6% (31/48) of neonates with respiratory distress syndrome (RDS) receiving bCPAP survived to discharge, compared to 23.5% (4/17) of controls. 61.5% (16/26) of neonates with sepsis receiving bCPAP survived to discharge, while none of the seven neonates with sepsis in the control group survived. Interpretation: Use of a low-cost bCPAP system to treat neonatal respiratory distress resulted in 27% absolute improvement in survival. The beneficial effect was greater for neonates with very low birth weight, RDS, or sepsis. Implementing appropriate bCPAP devices could reduce neonatal mortality in developing countries.	[Kawaza, Kondwani; Mwanza, Zondiwe; Molyneux, Elizabeth] Queen Elizabeth Cent Hosp, Dept Pediat, Coll Med, Blantyre, Malawi; [Machen, Heather E.; Smith, E. O'Brian] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brown, Jocelyn; Oden, Maria; Richards-Kortum, Rebecca R.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Iniguez, Suzanne] Texas Childrens Hosp, Dept Resp Care, Houston, TX 77030 USA	University of Malawi; Baylor College of Medicine; Rice University; Baylor College of Medicine	Richards-Kortum, RR (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467	United States Agency for International Development (USAID); Government of Norway; Bill & Melinda Gates Foundation; Grand Challenges Canada; World Bank; African Network for Drugs and Diagnostics Innovation (ANDI); USAID [AID-OAA-A-13-00014]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of Norway; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Grand Challenges Canada(CGIAR); World Bank(The World Bank India); African Network for Drugs and Diagnostics Innovation (ANDI); USAID(United States Agency for International Development (USAID))	This work was made possible through the generous support of the Saving Lives at Birth partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the World Bank. It was prepared by William Marsh Rice University and does not necessarily reflect the views of the Saving Lives at Birth Partners. Funding was also provided by the African Network for Drugs and Diagnostics Innovation (ANDI). 1. USAID Cooperative Agreement Award No. AID-OAA-A-13-00014, www.usaid.gov 2. African Network for Drugs and Diagnostics Innovation (ANDI), www.andi-africa.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Buckmaster AG, 2007, PEDIATRICS, V120, P509, DOI 10.1542/peds.2007-0775; Clair CS, 2008, AM J PERINAT, V25, P473, DOI 10.1055/s-0028-1085066; Courtney SE, 2001, PEDIATRICS, V107, P304, DOI 10.1542/peds.107.2.304; De Klerk AM, 2001, J PAEDIATR CHILD H, V37, P161, DOI 10.1046/j.1440-1754.2001.00624.x; DiBlasi RM, 2009, RESP CARE, V54, P1209; Duke T, 2005, ARCH DIS CHILD-FETAL, V90, P211, DOI 10.1136/adc.2003.048108; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620; Gnanaratnem J, 2000, CURR OPIN PEDIATR, V12, P227, DOI 10.1097/00008480-200006000-00009; Kamath BD, 2011, PEDIATRICS, V127, P1139, DOI 10.1542/peds.2010-3212; Koti J, 2010, INDIAN PEDIATR, V47, P139, DOI 10.1007/s13312-010-0021-6; Koyamaibole L, 2006, J TROP PEDIATRICS, V52, P249, DOI 10.1093/tropej/fmi109; Lawn JE, 2009, BJOG-INT J OBSTET GY, V116, P49, DOI 10.1111/j.1471-0528.2009.02328.x; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Malik K., 2013, HUMAN DEV REPORT 201; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Nowadzky T, 2009, PEDIATRICS, V123, P1534, DOI 10.1542/peds.2008-1279; Pieper CH, 2003, J TROP PEDIATRICS, V49, P148, DOI 10.1093/tropej/49.3.148; Rehan V K, 2001, J Perinatol, V21, P521, DOI 10.1038/sj.jp.7210587; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Sweet D, 2007, J PERINAT MED, V35, P175, DOI 10.1515/JPM.2007.048; Tagare A, 2010, J TROP PEDIATRICS, V56, P191, DOI 10.1093/tropej/fmp092; Urs PS, 2009, INDIAN PEDIATR, V46, P409; Van den Heuvel M, 2011, ANN TROP PAEDIATR, V31, P59, DOI 10.1179/1465328110Y.0000000001; Wilson PT, 2012, J PEDIAT; Zupan J, 2006, NEONATAL PERINATAL M, Viv	29	93	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86327	10.1371/journal.pone.0086327	http://dx.doi.org/10.1371/journal.pone.0086327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	27895847	Green Published, gold			2022-12-27	WOS:000330570000033
J	Wu, FQ; Price, BW; Haider, W; Seufferheld, G; Nelson, R; Hanzawa, Y				Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Nelson, Randall; Hanzawa, Yoshie			Functional and Evolutionary Characterization of the CONSTANS Gene Family in Short-Day Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; TIME GENE; LOCUS-T; ARABIDOPSIS; EXPRESSION; MATURITY; ORTHOLOG; SEQUENCE; NEOFUNCTIONALIZATION; DUPLICATION	CONSTANS (CO) plays a central role in photoperiodic flowering control of plants. However, much remains unknown about the function of the CO gene family in soybean and the molecular mechanisms underlying short-day photoperiodic flowering of soybean. We identified 26 CO homologs (GmCOLs) in the soybean genome, many of them previously unreported. Phylogenic analysis classified GmCOLs into three clades conserved among flowering plants. Two homeologous pairs in Clade I, GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b, showed the highest sequence similarity to Arabidopsis CO. The mRNA abundance of GmCOL1a and GmCOL1b exhibited a strong diurnal rhythm under flowering-inductive short days and peaked at dawn, which coincided with the rise of GmFT5a expression. In contrast, the mRNA abundance of GmCOL2a and GmCOL2b was extremely low. Our transgenic study demonstrated that GmCOL1a, GmCOL1b, GmCOL2a and GmCOL2b fully complemented the late flowering effect of the co-1 mutant in Arabidopsis. Together, these results indicate that GmCOL1a and GmCOL1b are potential inducers of flowering in soybean. Our data also indicate rapid regulatory divergence between GmCOL1a/GmCOL1b and GmCOL2a/GmCOL2b but conservation of their protein function. Dynamic evolution of GmCOL regulatory mechanisms may underlie the evolution of photoperiodic signaling in soybean.	[Wu, Faqiang; Price, Brian William; Haider, Waseem; Seufferheld, Gabriela; Hanzawa, Yoshie] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Nelson, Randall] Univ Illinois, Dept Crop Sci, USDA Agr Res Serv, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Hanzawa, Y (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	yhanzawa@illinois.edu	Haider, Waseem/AAD-6214-2019	Haider, Waseem/0000-0001-9200-6714; Hanzawa, Yoshie/0000-0003-4704-8872	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [USDA-NIFA2011-00078]; ARS [ARS-0424505] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is supported by the Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture (USDA-NIFA2011-00078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, THEOR APPL GENET, V106, P445, DOI 10.1007/s00122-002-1073-3; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borthwick HA, 1939, BOT GAZ, V101, P341, DOI 10.1086/334874; Campoli C, 2012, PLANT J, V69, P868, DOI 10.1111/j.1365-313X.2011.04839.x; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gonzalez-Schain ND, 2008, BIOL PLANTARUM, V52, P251, DOI 10.1007/s10535-008-0054-z; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Gu XF, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001649; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; He YH, 2012, TRENDS PLANT SCI, V17, P556, DOI 10.1016/j.tplants.2012.05.001; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Herrmann D, 2010, THEOR APPL GENET, V121, P865, DOI 10.1007/s00122-010-1356-z; Hsu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045448; Imamura S, 1967, PHYSL FLOWERING PHAR; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Liu L, 2011, RUSS J PLANT PHYSL+, V58, P330, DOI 10.1134/S1021443711020105; Ma JinHua, 2009, Plant Physiology Communications, V46, P17; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Molnar SJ, 2003, GENOME, V46, P1024, DOI [10.1139/g03-079, 10.1139/G03-079]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Song YH, 2012, SCIENCE, V336, P1045, DOI 10.1126/science.1219644; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu F, 2014, HDB PLANT CROP PHYSL, P129; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang QingZhe, 2010, Acta Agronomica Sinica, V36, P539; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2	59	97	105	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e85754	10.1371/journal.pone.0085754	http://dx.doi.org/10.1371/journal.pone.0085754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24489881	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500105
J	He, XL; Huang, X; Shen, YZ; Huang, ZJ				He, Xiaoliang; Huang, Xi; Shen, Yinzhu; Huang, Zhanjing			Wheat V-H+-ATPase Subunit Genes Significantly Affect Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							PROTON TRANSPORT; NACL REGULATION; OSMOTIC-STRESS; EXPRESSION; PLANT; CLONING; MECHANISM; GROWTH; LEAVES	Genes for V-H+-ATPase subunits were identified and cloned from the salt-tolerant wheat mutant RH8706-49. Sequences of these genes are highly conserved in plants. Overexpression of these genes in Arabidopsis thaliana improved its salt tolerance, and increased the activities of V-H+-ATPase and Na+/H+ exchange, with the largest increase in plants carrying the c subunit of V-H+-ATPase. Results from quantitative RT-PCR analysis indicated that the mRNA level of each V-H+-ATPase subunit in the Arabidopsis increased under salt stress. Overall, our results suggest that each V-H+-ATPase subunit plays a key role in enhancing salt tolerance in plants.	[Huang, Xi; Shen, Yinzhu; Huang, Zhanjing] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [He, Xiaoliang] Hebei Univ Sci & Technol, Sch Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Huang, ZJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China.	huangzhanjing@sohu.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Natural Science Fund [30971766]; Hebei Provincial Natural Science Fund [C2009000278]; Doctor Fund of Hebei University of Science and Technology [QD201046]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Hebei Provincial Natural Science Fund; Doctor Fund of Hebei University of Science and Technology	This work was supported by National Natural Science Fund (30971766), Hebei Provincial Natural Science Fund (No. C2009000278), and Doctor Fund of Hebei University of Science and Technology (QD201046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Forgac M, 2000, J EXP BIOL, V203, P71; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Ge RC, 2007, PLANT SCI, V173, P55, DOI 10.1016/j.plantsci.2007.04.005; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He XL, 2012, PLANT MOL BIOL REP, V30, P807, DOI 10.1007/s11105-011-0390-6; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lehr A, 1999, PLANT MOL BIOL, V39, P463, DOI 10.1023/A:1006158310891; Li PH, 2004, ACTA BOT SIN, V46, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller ML, 1996, J BIOL CHEM, V271, P1916; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NARASIMHAN ML, 1991, PLANT PHYSIOL, V97, P562, DOI 10.1104/pp.97.2.562; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang L, 2011, PLANTA, V234, P1, DOI 10.1007/s00425-011-1383-2; WARD JM, 1992, PLANT PHYSIOL, V99, P925, DOI 10.1104/pp.99.3.925; Xu CX, 2011, PLANT MOL BIOL REP, V29, P424, DOI 10.1007/s11105-010-0247-4; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhao Q, 2009, PLANT MOL BIOL, V69, P33, DOI 10.1007/s11103-008-9403-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86982	10.1371/journal.pone.0086982	http://dx.doi.org/10.1371/journal.pone.0086982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498005	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100043
J	Zhou, JH; Wang, YF; Wang, Y; Yin, X; He, YF; Chen, LL; Wang, WW; Liu, T; Di, W				Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen			FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; BREAST-CANCER; REPAIR; RESISTANCE; CELLS; CONTRIBUTES; EXPRESSION	Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in ovarian cancers with chemoresistance to cisplatin. Our results indicate that FOXM1 is upregulated in chemoresistant ovarian cancer samples, and defends ovarian cancer cells against cytotoxicity of cisplatin. FOXM1 facilitates DNA repair through regulating direct transcriptional target EXO1 to protect ovarian cancer cells from cisplatin-mediated apoptosis. Attenuating FOXM1 and EXO1 expression by small interfering RNA, augments the chemotherapy efficacy against ovarian cancer. Our findings indicate that targeting FOXM1 and its target gene EXO1 could improve cisplatin effect in ovarian cancer, confirming their role in modulating cisplatin sensitivity.	[Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Wang, You; Yin, Xia; He, Yifeng; Chen, Lilan; Wang, Wenwen; Liu, Ting; Di, Wen] Shanghai Key Lab Gynecol Oncol, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Focus Construct Subject Shanghai Educ Dept, Shanghai, Peoples R China; [Zhou, Jinhua; Wang, Yunfei; Di, Wen] Shanghai Hlth Bur Key Disciplines & Specialties F, Shanghai, Peoples R China; [Zhou, Jinhua] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Di, W (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	diwen163@163.com	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	National Natural Science Foundation of China [81272882, 81302275, 81072137]; Shanghai Committee of Science and Technology [12411950200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	In accomplish of this manuscript, the authors have received the support of the National Natural Science Foundation of China (Grant No. 81272882, 81302275, 81072137) and Shanghai Committee of Science and Technology (Grant No. 12411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carozzi VA, 2010, CURR CANCER DRUG TAR, V10, P670; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Furuta T, 2002, CANCER RES, V62, P4899; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031761; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Miller DS, 2009, J CLIN ONCOL, V27, P2686, DOI 10.1200/JCO.2008.19.2963; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Ruggiero A, 2013, ANTI-CANCER DRUG, V24, P1007, DOI 10.1097/CAD.0b013e3283650bda; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039; Zhao R, 2014, MOL CANCER RES, V12, P370, DOI 10.1158/1541-7786.MCR-13-0281; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045	40	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e96989	10.1371/journal.pone.0096989	http://dx.doi.org/10.1371/journal.pone.0096989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	24824601	Green Submitted, Green Published, gold			2022-12-27	WOS:000336369200045
J	Zhou, J; Xiao, KF; Wei, BY; Wang, Z; Tian, Y; Tian, YX; Song, QS				Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng			Bioaccumulation of Cry1Ab Protein from an Herbivore Reduces Anti-Oxidant Enzyme Activities in Two Spider Species	PLOS ONE			English	Article							BT RICE; SUPEROXIDE-DISMUTASE; BROWN PLANTHOPPER; FIELD-EVALUATION; TRANSGENIC RICE; GENES; RESISTANCE; DIVERSITY; LINES	Cry proteins are expressed in rice lines for lepidopteran pest control. These proteins can be transferred from transgenic rice plants to non-target arthropods, including planthoppers and then to a predatory spider. Movement of Cry proteins through food webs may reduce fitness of non-target arthropods, although recent publications indicated no serious changes in nontarget populations. Nonetheless, Cry protein intoxication influences gene expression in Cry-sensitive insects. We posed the hypothesis that Cry protein intoxication influences enzyme activities in spiders acting in tri-trophic food webs. Here we report on the outcomes of experiments designed to test our hypothesis with two spider species. We demonstrated that the movement of CryAb protein from Drosophila culture medium into fruit flies maintained on the CryAb containing medium and from the flies to the spiders Ummeliata insecticeps and Pardosa pseudoannulata. We also show that the activities of three key metabolic enzymes, acetylcholine esterase (AchE), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) were significantly influenced in the spiders after feeding on Cry1Ab-containing fruit flies. We infer from these data that Cry proteins originating in transgenic crops impacts non-target arthropods at the physiological and biochemical levels, which may be one mechanism of Cry protein-related reductions in fitness of non-target beneficial predators.	[Zhou, Ji; Xiao, Kaifu; Wei, Baoyang; Wang, Zhi; Tian, Yun; Tian, Yixing; Song, Qisheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Hunan Agricultural University; University of Missouri System; University of Missouri Columbia	Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	wangzhispider@hotmail.com; SongQ@missouri.edu	Xia, Kai/GYU-7618-2022; Singh, Brijesh Kumar/C-1093-2009	Yen, Paul/0000-0002-3790-8114; Singh, Brijesh Kumar/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433	Natural Science Foundation of P. R. China [31071943, 31272339]; Scientific Research Fund of Hunan Provincial Education Department [10A054]	Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was in part supported by the Natural Science Foundation of P. R. China (No. 31071943). The additional part of the funding of the study has come from Natural Science Foundation of P. R. China (No. 31272339) and Scientific Research Fund of Hunan Provincial Education Department(No. 10A054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K, 2004, MOL BREEDING, V13, P301, DOI 10.1023/B:MOLB.0000034078.54872.25; Bernal CC, 2002, ENTOMOL EXP APPL, V102, P21, DOI 10.1023/A:1015278618586; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Chen H, 2008, J ECON ENTOMOL, V101, P182, DOI 10.1603/0022-0493(2008)101[182:EOTBTR]2.0.CO;2; Chen Mao, 2003, Acta Phytophylacica Sinica, V30, P365; Chen Mao, 2003, Journal of Zhejiang University (Agriculture and Life Sciences), V29, P29; Chen Mao, 2005, Acta Entomologica Sinica, V48, P208; Chen M, 2007, BIOL CONTROL, V42, P242, DOI 10.1016/j.biocontrol.2007.05.005; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; GORUN V, 1978, ANAL BIOCHEM, V86, P324, DOI 10.1016/0003-2697(78)90350-0; Hoefler CD, 2006, J ECON ENTOMOL, V99, P432, DOI 10.1603/0022-0493-99.2.432; Jones AK, 2010, ADV EXP MED BIOL, V683, P25; Li FF, 2007, ENVIRON ENTOMOL, V36, P646, DOI 10.1603/0046-225X(2007)36[646:AAADIB]2.0.CO;2; Liu Li-Jun, 2010, Acta Arachnologica Sinica, V19, P47; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Missirlis F, 2003, PROCEEDINGS OF THE MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH, EUROPEAN SECTION, P147; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oppert B, 2012, PLOS ONE, V4; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Riaz N, 2006, S AFR J BOT, V72, P217, DOI 10.1016/j.sajb.2005.07.005; Rogina B, 2000, BIOGERONTOLOGY, V1, P163, DOI 10.1023/A:1010039813107; Sigsgaard L, 2007, B ENTOMOL RES, V97, P533, DOI 10.1017/S0007485307005196; Sogawa K, 2003, CHINESE J RICE SCI, V17, P47; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Ye RJ, 2009, PEST MANAG SCI, V65, P1015, DOI 10.1002/ps.1788; Zaidi MA, 2009, MOL BIOTECHNOL, V43, P232, DOI 10.1007/s12033-009-9201-9	28	158	163	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2014	9	1							e84724	10.1371/journal.pone.0084724	http://dx.doi.org/10.1371/journal.pone.0084724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292SL	24824601	Green Published, gold, Green Submitted			2022-12-27	WOS:000329922500016
J	He, X; Pu, GB; Tang, R; Zhang, DM; Pan, WQ				He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing			Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							MICRORNAS; LIVER; EXPRESSION; FIBROSIS; DISEASE; FIBROGENESIS	Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-kappa B), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-kappa B was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-kappa B signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-kappa B activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-kappa B signaling) in HSCs opposed those of NF-kappa B signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-kappa B signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-kappa B signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.	[He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Naval Medical University	Zhang, DM (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	dmzhangcn@gmail.com; wqpan0912@aliyun.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Basic Research Program (973 Program) [2007CB513100]; National Science and Technology Program of China [2012ZX10004220]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Program of China	This study was supported by grants from the National Basic Research Program (973 Program) (2007CB513100) and the National Science and Technology Program of China (2012ZX10004220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067037; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuah C, 2014, TRENDS PARA IN PRESS; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Liang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042490; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006	35	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104323	10.1371/journal.pone.0104323	http://dx.doi.org/10.1371/journal.pone.0104323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	24498005	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400042
